# RGD-PIPELINE: ftp-file-extracts # MODULE: cell lines build 2020-05-19 # GENERATED-ON: 2026/01/31 00:46:28 # CONTACT: rgd.data@mcw.edu # FORMAT: tab delimited text # NOTES: # This file provides cell line data in RGD. # The cell line data is either curated in RGD, or imported from Cellosaurus resource. # The file is in the tab-delimited format. # Multiple values in a single column are separated by ';' # COUNT: 167167 cell lines RGD ID Symbol Name Type Species Cellosaurus ID Description Source SO_ACC_ID Genomic Alteration Notes Origin Research Use Availability Gender Characteristics Phenotype Germline Competent Groups Caution 10053737 Crlj:WI-ES1/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced by mating Crlj:WI female with WI-Tg(L2-Venus)Nips male. has germ-line transmission Cryopreserved Female media used: 3i+LIF This ES cell line has ubiquitous venus gene expression. Yes 10053738 Crlj:WI-ES5/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced by mating Crlj:WI female with WI-Tg(L2-Venus)Nips male. has germ-line transmission Cryopreserved Female media used: 3i+LIF This ES cell line has ubiquitous Venus gene expression. Yes 10053739 Crlj:WI-ES10/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced by mating Crlj:WI female with WI-Tg(L2-Venus)Nips male. Cryopreserved Male media used: 3i+LIF This ES cell line has ubiquitous Venus gene expression. No 10053740 WI-Tg(CAG/Venus)Nips-ES4/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WI-Tg(CAG/Venus)Nips Cryopreserved Male media used: 3i+LIF This ES cell line has ubiquitous Venus gene expression. No 10053741 BN/CrlCrlj-ES4/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from BN/CrlCrlj has germ-line transmission Cryopreserved Male media used: 2i+LIF Yes 10053742 BN/CrlCrlj-ES6/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from BN/CrlCrlj Cryopreserved Female media used: 2i+LIF No 10053744 BN/CrlCrlj-ES3/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from BN/CrlCrlj Cryopreserved Male media used: 3i+LIF No 10053745 BN/CrlCrlj-ES5/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from BN/CrlCrlj has germ-line transmission Cryopreserved Male media used: 3i+LIF Yes 10054005 DA/Slc-ES1/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from DA/Slc has germ-line transmission Cryopreserved Male media used: 3i+LIF Yes 10054006 Crlj:WI-ES11/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from Crlj:WI has germ-line transmission Cryopreserved Male media used: 2i+LIF+Forskolin Yes 10054007 Crlj:WI-ES13/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from Crlj:WI has germ-line transmission Cryopreserved Male media used: 2i+LIF+Forskolin Yes 10054008 BN/CrlCrlj-ES7/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was electroporated with humanized Kusabira-Orange (huKO) gene (CAG/huKO-neo plasmid; 7.5 kb) into BN/CrlCrlj-ES4/Nips. has germ-line transmission Cryopreserved Male media used: 2i+rLIF This ES cell line has ubiquitous huKO gene expression. Yes 10054009 DA/Slc-ES2/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was electroporated with humanized Kusabira-Orange (huKO) gene (CAG/huKO-neo plasmid; 7.5 kb) into DA/Slc-ES1/Nips. has germ-line transmission Cryopreserved Male media used: 3i+LIF This ES cell line has ubiquitous huKO gene expression. Yes 10054010 WDB/Nips-ES1/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB/Nips has germ-line transmission Cryopreserved Male media used: 2i+LIF This ES cell lines can participate in chimerae and transmit the characteristics through germline at high efficiency. Yes 10054011 WDB/Nips-ES41/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB/Nips has germ-line transmission Cryopreserved Male media used: 2i+LIF Yes 10054012 WDB/Nips-ES47/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB/Nips Cryopreserved Male media used: 2i+LIF No 10054013 WDB/Nips-ES48/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB/Nips has germ-line transmission Cryopreserved Male media used: 2i+LIF+Forskolin Yes 10054014 WDB/Nips-ES3/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB/Nips has germ-line transmission Cryopreserved Male media used: 2i+LIF+Forskolin Yes 10054015 WDB/Nips-ES4/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB/Nips has germ-line transmission Cryopreserved Male media used: 2i+LIF+Forskolin Yes 10054016 WDB/Nips-ES6/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB/Nips has germ-line transmission Cryopreserved Male media used: 2i+Forskolin Yes 10054017 WDB/Nips-ES7/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPANi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB/Nips Cryopreserved Male media used: 2i+Forskolin No 10054019 WDB/Nips-ES8/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPANi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB/Nips has germ-line transmission Cryopreserved Male media used: 2i+Forskolin Yes 10054021 WDB/Nips-ES14/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB/Nips has germ-line transmission Cryopreserved Male media used: 2i Yes 10054022 WDB/Nips-ES32/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB/Nips has germ-line transmission Cryopreserved Male media used: 2i Yes 10054023 WDB/Nips-ES37/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB/Nips has germ-line transmission Cryopreserved Male media used: 2i Yes 10054025 WI-Tg(CAG/Venus)Nips-ES13/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WI-Tg(CAG/Venus)Nips Cryopreserved Male media used: 2i+LIF This ES cell line has ubiquitous Venus gene expression. No 10054026 WI-Tg(CAG/Venus)Nips-ES17/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WI-Tg(CAG/Venus)Nips Cryopreserved Male media used: 2i+LIF This ES cell line has ubiquitous Venus gene expression. No 10054027 F344/NSlc-ES37/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from F344/NSlc has germ-line transmission Cryopreserved Male media used: 2i+LIF+Forskolin Yes 10054029 WI-Tg(CAG/Venus)Nips-ES12/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WI-Tg(CAG/Venus)Nips has germ-line transmission Cryopreserved Male media used: 2i+LIF+Forskolin This ES cell line has ubiquitous Venus gene expression. Yes 10054030 WI-Tg(CAG/Venus)Nips-ES20/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WI-Tg(CAG/Venus)Nips has germ-line transmission Cryopreserved Male media used: 2i+LIF+Forskolin This ES cell line has ubiquitous Venus gene expression. Yes 10054032 WDB-Rosa26em1(RT2)Nips-ES2/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst produced from WDB-Rosa26em1(RT2)Nips has germ-line transmission Cryopreserved Male media used: 2i+LIF+Forskolin This ES cell line has ubiquitous tdTomato gene expression. Yes 10054033 WI-Tg(CAG/Venus)Nips-ES2/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst prepared by treatment of ovulated homozygote of WI-Tg(CAG/Venus)Nips female rat oocytes with ionomycin and cycloheximide. Cryopreserved Female Parthenogenetic ES cell line; media used: 2i+LIF+Forskolin This ES cell line has ubiquitous Venus gene expression. No 10054034 WI-Tg(CAG/Venus)Nips-ES5/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst prepared by treatment of ovulated homozygote of WI-Tg(CAG/Venus)Nips female rat oocytes with ionomycin and cycloheximide. has germ-line transmission Cryopreserved Female Parthenogenetic ES cell line; media used: 2i+LIF+Forskolin This ES cell line has ubiquitous Venus gene expression. Yes 10054035 WI-Tg(CAG/Venus)Nips-ES10/Nips embryonic stem cell Norway rat National Institute for Physiological Sciences, Okazaki Aichi, JAPAN CL:0000010 This ES cell line was made from blastocyst prepared by treatment of ovulated homozygote of WI-Tg(CAG/Venus)Nips female rat oocytes with ionomycin and cycloheximide. Cryopreserved Female Parthenogenetic ES cell line; media used: 2i+LIF+Forskolin This ES cell line has ubiquitous Venus gene expression. No 127227593 CVCL_A2JC MDCK-C09 transformed cell line dog CVCL_A2JC CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Omics: Transcriptomics; RNAseq Female Characteristics: Has a low tumorigenic potential (PubMed=32928630) 127227594 CVCL_A2JD MDCK-C35 transformed cell line dog CVCL_A2JD CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Omics: Transcriptomics; RNAseq Female Characteristics: Has a low tumorigenic potential (PubMed=32928630) 127227595 CVCL_A2JE MDCK-W73 transformed cell line dog CVCL_A2JE CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female Characteristics: Has a high tumorigenic potential (PubMed=32928630) 127227596 CVCL_A8BA THP1-Dual KO-MAVS cancer cell line human CVCL_A8BA CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:29233; MAVS; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-komavs). 127227597 CVCL_A8BC THP1-Dual KO-RIG-I cancer cell line human CVCL_A8BC CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:19102; RIGI; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-korigi). 127227598 CVCL_A8BB THP1-Dual KO-MDA5 cancer cell line human CVCL_A8BB CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:18873; IFIH1; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-komda5). 127227599 CVCL_A8BE THP1-HMGB1-Lucia cancer cell line human CVCL_A8BE CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4983; HMGB1; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Designed to monitor ferroptosis, a form of non-apoptotic cell death Stably express an HMGB1::Lucia luciferase fusion protein in the cytoplasm, following ferroptosis activation, the cell membrane ruptures and HMGB1::Lucia is released in the extracellular milieu (InvivoGen=thp1-gb1lc). 127227600 CVCL_A8BD THP1-Dual KI-mSTING cancer cell line human CVCL_A8BD CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:27962; STING1; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=MGI; MGI:1919762; Sting1; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-mstg). 127227601 CVCL_A8BG THP1-Dual KI-hSTING-H232 cancer cell line human CVCL_A8BG CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:27962; STING1; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27962; STING1 (Note=With p.Arg232His); Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-h232). 127227602 CVCL_A8BF THP1-Dual KI-hSTING-A162 cancer cell line human CVCL_A8BF CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:27962; STING1; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27962; STING1 (Note=With p.Ser162Ala); Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-a162). 127227603 CVCL_A8AX THP1-Dual KO-TLR4 cancer cell line human CVCL_A8AX CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:11850; TLR4; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-kotlr4). 127227604 CVCL_A8AW THP1-Dual KO-TLR2 cancer cell line human CVCL_A8AW CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:11848; TLR2; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-kotlr2). 127227605 CVCL_A8AZ THP1-Dual KO-IKKepsilon cancer cell line human CVCL_A8AZ CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:14552; IKBKE; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-koikke). 127227606 CVCL_A8AY THP1-Dual KO-TBK1 cancer cell line human CVCL_A8AY CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:11584; TBK1; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-kotbk). 127227607 CVCL_A8AP THP1-KO-CASP4 cancer cell line human CVCL_A8AP CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:1505; CASP4; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227608 CVCL_A8AR THP1-KO-NLRC4 cancer cell line human CVCL_A8AR CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:16412; NLRC4; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227609 CVCL_A8AQ THP1-KO-GSDMD cancer cell line human CVCL_A8AQ CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:25697; GSDMD; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227610 CVCL_A8AT THP1-ASC-GFP cancer cell line human CVCL_A8AT CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16608; PYCARD; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses a PYCARD-GFP construct under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thp-ascgfp). 127227611 CVCL_A8AS THP1-KO-NLRP3 cancer cell line human CVCL_A8AS CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:16400; NLRP3; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227612 CVCL_A8AV THP1-Dual KO-IRF3 cancer cell line human CVCL_A8AV CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:6118; IRF3; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-koirf3). 127227613 CVCL_A8AU THP1-Dual KO-IFI16 cancer cell line human CVCL_A8AU CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:5395; IFI16; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-koifi16). 127227614 CVCL_A8AH THP1-Dual KO-STING cancer cell line human CVCL_A8AH CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:27962; STING1; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-kostg). 127227615 CVCL_A8AG Raji-hVISTA cancer cell line human CVCL_A8AG CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:30085; VSIR; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 127227616 CVCL_A8AJ THP1-Dual KO-TREX1 cancer cell line human CVCL_A8AJ CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:12269; TREX1; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-kotrex). 127227617 CVCL_A8AI THP1-Dual KO-cGAS cancer cell line human CVCL_A8AI CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:21367; CGAS; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-kocgas). 127227618 CVCL_A8AL THP1-Dual KO-IFNAR2 cancer cell line human CVCL_A8AL CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:5433; IFNAR2; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-koifnar2). 127227619 CVCL_A8AK THP1-Null2 cancer cell line human CVCL_A8AK CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227620 CVCL_A8AN THP1-KO-ASC cancer cell line human CVCL_A8AN CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:16608; PYCARD; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227621 CVCL_A8AM THP1-Dual KO-TRIF cancer cell line human CVCL_A8AM CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:18348; TICAM1; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-kotrif). 127227622 CVCL_A8CB RAW-Difluo mLC3 cancer cell line house mouse CVCL_A8CB CL:0000010 Genetic integration: Method=Transfection; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.); Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection; Gene=MGI; MGI:1914693; Map1lc3b; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male Characteristics: Allows monitoring of autophagic flux in real time by detecting the appearance of dual red and green RFP:GFP:LC3 puncta or single red RFP:LC3 puncta by fluorescence microscopy Early in autophagy, both RFP and GFP signals are detected. As the fusion of the autophagosomes with the lysosomes progresses, the GFP fluorescence diminishes, leaving only the RFP fluorescence visible. The percentages of RFP-GFP positive and of RFP positive cells can be determined and these values can be used to assess autophagic flux (InvivoGen=rawdf-mlc3).; Characteristics: Stably expresses a RFP-GFP-Map1lc3b construct (InvivoGen=rawdf-mlc3) 127227623 CVCL_A8CA HeLa-Difluo hLC3 cancer cell line human CVCL_A8CA CL:0000010 Genetic integration: Method=Transfection; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.); Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13352; MAP1LC3B; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Characteristics: Allows monitoring of autophagic flux in real time by detecting the appearance of dual red and green RFP:GFP:LC3 puncta or single red RFP:LC3 puncta by fluorescence microscopy Early in autophagy, both RFP and GFP signals are detected. As the fusion of the autophagosomes with the lysosomes progresses, the GFP fluorescence diminishes, leaving only the RFP fluorescence visible. The percentages of RFP-GFP positive and of RFP positive cells can be determined and these values can be used to assess autophagic flux (InvivoGen=heldf-hlc3).; Characteristics: Stably expresses a RFP-GFP-MAP1LC3B construct (InvivoGen=heldf-hlc3) 127227624 CVCL_A8CD 293-hMyD88 transformed cell line human CVCL_A8CD CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7562; MYD88 (Note=With p.Leu252Pro (c.755T>C)); Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Designed to study SARS-CoV-2-host cell fusion Upon transient transfection, with a spike expression plasmid, these cells become a SARS-CoV-2 mimic, which can then fuse with permissive reporter cells (InvivoGen=293-hmyd). Group: SARS-CoV-2 research cell line 127227625 CVCL_A8CC THP1-Blue KI-IP10 cancer cell line human CVCL_A8CC CL:0000010 Knockout cell: Method=Homologous recombination; HGNC; HGNC:10637; CXCL10; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: The coding sequence of CXCL10 has been replaced with the Lucia luciferase reporter gene under the control of the endogenous promoter and thus allows the direct study of CXCL10 induction (InvivoGen=thpb-ip10kilc); Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 copies of the NF-kappaB consensus TRE and 3 copies of the c-Rel binding site (InvivoGen=thpb-ip10kilc) 127227626 CVCL_A8CF HEK-Blue IL-10 transformed cell line human CVCL_A8CF CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5964; IL10RA; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5965; IL10RB; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11364; STAT3; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Designed to detect bioactive human IL10 (and to a lesser extent mouse IL10) by monitoring the activation of the STAT3 pathway (InvivoGen=hkb-il10); Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the STAT3 promoter (InvivoGen=hkb-il10) 127227627 CVCL_A8CE HEK-Blue CD40L transformed cell line human CVCL_A8CE CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11919; CD40; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Designed to detect bioactive CD40L by monitoring the activation of the NF-kappaB pathway (InvivoGen=hkb-cd40); Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-cd40) 127227628 CVCL_A8CH HEK-Blue IL-23 transformed cell line human CVCL_A8CH CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5971; IL12RB1; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19100; IL23R; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Designed to detect bioactive human and mouse IL23 by monitoring the activation of the STAT3 pathway (InvivoGen=hkb-il23); Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the STAT3 promoter (InvivoGen=hkb-il23) 127227629 CVCL_A8CG HEK-Blue IL-22 transformed cell line human CVCL_A8CG CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5965; IL10RB; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13700; IL22RA1; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11364; STAT3; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Designed to detect bioactive human and mouse IL22 by monitoring the activation of the STAT3 pathway (InvivoGen=hkb-il22); Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the STAT3 promoter (InvivoGen=hkb-il22) 127227630 CVCL_A8BY HEK-Blue STAT6-hSTING-R232 transformed cell line human CVCL_A8BY CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11368; STAT6; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27962; STING1; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a STAT6-responsive promoter (InvivoGen=hkb-st6r232) 127227631 CVCL_A8BX HT29-Lucia AhR cancer cell line human CVCL_A8BX CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Female Characteristics: Used for the study of aryl hydrocarbon receptor (AhR) genomic signaling induction (InvivoGen=ht2l-ahr); Characteristics: The Lucia luciferase reporter gene is under the control of a minimal promoter coupled with the human CYP1A1 gene entire regulatory sequence which contains 6 dioxin responsive elements (DRE) (InvivoGen=ht2l-ahr) 127227632 CVCL_A8BZ THP1-Difluo hLC3 cancer cell line human CVCL_A8BZ CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.); Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13352; MAP1LC3B; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Allows monitoring of autophagic flux in real time by detecting the appearance of dual red and green RFP:GFP:LC3 puncta or single red RFP:LC3 puncta by fluorescence microscopy Early in autophagy, both RFP and GFP signals are detected. As the fusion of the autophagosomes with the lysosomes progresses, the GFP fluorescence diminishes, leaving only the RFP fluorescence visible. The percentages of RFP-GFP positive and of RFP positive cells can be determined and these values can be used to assess autophagic flux (InvivoGen=thpdf-hlc3).; Characteristics: Stably expresses a RFP-GFP-MAP1LC3B construct (InvivoGen=thpdf-hlc3) 127227633 CVCL_A8BQ HEK-Blue ISG transformed cell line human CVCL_A8BQ CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=hkb-isg-1) 127227634 CVCL_A8BP 293-Dual mSTING transformed cell line human CVCL_A8BP CL:0000010 Knockout cell: Method=Homologous recombination; HGNC; HGNC:5434; IFNB1; Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=MGI; MGI:1919762; Sting1; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase ALPP expression is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). The Lucia luciferase reporter gene expression depends on the activation of the endogenous IFNB1 promoter as the IFNB1 gene has been replaced by Lucia (InvivoGen=293d-mstg). 127227635 CVCL_A8BS HepG2-Dual cancer cell line human CVCL_A8BS CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 c-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=hepg2d-nfis). 127227636 CVCL_A8BR HEK-Blue ISG-KO-STING transformed cell line human CVCL_A8BR CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:27962; STING1; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Specifically designed to study the STING/TBK1/IRF3 signaling pathway Can detect bioactive type I IFNs through the activation of the JAK-STAT-IRF9 (InvivoGen=hkb-isgkostg).; Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=hkb-isgkostg) 127227637 CVCL_A8BU HEK-Blue KO-ALPK1 transformed cell line human CVCL_A8BU CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:20917; ALPK1; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-koalpk) 127227638 CVCL_A8BT HepG2-Lucia AhR cancer cell line human CVCL_A8BT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Characteristics: Used for the study of aryl hydrocarbon receptor (AhR) genomic signaling induction (InvivoGen=hpgl-ahr); Characteristics: The Lucia luciferase reporter gene is under the control of a minimal promoter coupled with the human CYP1A1 gene entire regulatory sequence which contains 6 dioxin responsive elements (DRE) (InvivoGen=hpgl-ahr) 127227639 CVCL_A8BW THP1-Dual KO-TLR8 cancer cell line human CVCL_A8BW CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:15632; TLR8; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-kotlr8). 127227640 CVCL_A8BV HEK-Blue KO-TIFA transformed cell line human CVCL_A8BV CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:19075; TIFA; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-kotifa) 127227641 CVCL_A8BI THP1-Dual KI-hSTING-R232 cancer cell line human CVCL_A8BI CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:27962; STING1; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27962; STING1; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-r232). 127227642 CVCL_A8BH THP1-Dual KI-hSTING-M155 cancer cell line human CVCL_A8BH CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:27962; STING1; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27962; STING1 (Note=With p.Val155Met); Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-m155). 127227643 CVCL_A8BK 293-Dual Null transformed cell line human CVCL_A8BK CL:0000010 Knockout cell: Method=Homologous recombination; HGNC; HGNC:5434; IFNB1; Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase ALPP expression is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). The Lucia luciferase reporter gene expression depends on the activation of the endogenous IFNB1 promoter as the IFNB1 gene has been replaced by Lucia (InvivoGen=293d-null). 127227644 CVCL_A8BJ THP1-Dual KI-hSTING-S154 cancer cell line human CVCL_A8BJ CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:27962; STING1; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27962; STING1 (Note=With p.Asn154Ser); Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-s154). 127227645 CVCL_A8BM 293-Dual hSTING-H232 transformed cell line human CVCL_A8BM CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:5434; IFNB1; Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27962; STING1 (Note=With p.Arg232His); Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase ALPP expression is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). The Lucia luciferase reporter gene expression depends on the activation of the endogenous IFNB1 promoter as the IFNB1 gene has been replaced by Lucia (InvivoGen=293d-h232). 127227646 CVCL_A8BL 293-Dual hSTING-A162 transformed cell line human CVCL_A8BL CL:0000010 Knockout cell: Method=Homologous recombination; HGNC; HGNC:5434; IFNB1; Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27962; STING1 (Note=With p.Ser162Ala); Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase ALPP expression is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). The Lucia luciferase reporter gene expression depends on the activation of the endogenous IFNB1 promoter as the IFNB1 gene has been replaced by Lucia (InvivoGen=293d-a162). 127227647 CVCL_A8BN 293-Dual hSTING-R232 transformed cell line human CVCL_A8BN CL:0000010 Knockout cell: Method=Homologous recombination; HGNC; HGNC:5434; IFNB1; Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27962; STING1; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase ALPP expression is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE). The Lucia luciferase reporter gene expression depends on the activation of the endogenous IFNB1 promoter as the IFNB1 gene has been replaced by Lucia (InvivoGen=293d-r232). 127227648 CVCL_A8AB Raji-Null cancer cell line human CVCL_A8AB CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 127227649 CVCL_A8AA Raji-hLAG3 cancer cell line human CVCL_A8AA CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6476; LAG3; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 127227650 CVCL_A8AD Raji-hPD-1 cancer cell line human CVCL_A8AD CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8760; PDCD1; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 127227651 CVCL_A8AC Raji-hOX40 cancer cell line human CVCL_A8AC CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11918; TNFRSF4; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 127227652 CVCL_A8AF Raji-hTIGIT cancer cell line human CVCL_A8AF CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:26838; TIGIT; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 127227653 CVCL_A8AE Raji-hPD-L1 cancer cell line human CVCL_A8AE CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17635; CD274; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 127227654 CVCL_A7ZZ Raji-hICOS cancer cell line human CVCL_A7ZZ CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5351; ICOS; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 127227655 CVCL_A7ZY Raji-HER2 cancer cell line human CVCL_A7ZY CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 127227656 CVCL_A7ZR A549-Dual KO-MDA5 hACE2-TMPRSS2 cancer cell line human CVCL_A7ZR CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:18873; IFIH1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13557; ACE2; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11876; TMPRSS2; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Ideal for studying SARS-CoV-2 viral entry into host cells, the viral RNA sensing pathway, as well as screening small molecule inhibitors and neutralizing antibodies These cells are permissive to infection by SARS-CoV-2 Spike-pseudotyped viral particles (InvivoGen=a549d-komda5-cov2r).; Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=a549d-komda5-cov2r). Group: SARS-CoV-2 research cell line 127227657 CVCL_A7ZQ A549-Dual hACE2-TMPRSS2 cancer cell line human CVCL_A7ZQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13557; ACE2; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11876; TMPRSS2; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Ideal for studying SARS-CoV-2 viral entry into host cells, the viral RNA sensing pathway, as well as screening small molecule inhibitors and neutralizing antibodies These cells are permissive to infection by SARS-CoV-2 Spike-pseudotyped viral particles (InvivoGen=a549d-cov2r).; Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=a549d-cov2r). Group: SARS-CoV-2 research cell line 127227658 CVCL_A7ZT Jurkat-Lucia NFAT-CD16 cancer cell line human CVCL_A7ZT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3619; FCGR3A (Note=With p.Phe176Val); Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter fused to 6 NFAT consensus transcriptional response elements (InvivoGen=jktl-nfat-cd16) 127227659 CVCL_A7ZS A549-Dual KO-RIG-I hACE2-TMPRSS2 cancer cell line human CVCL_A7ZS CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:19102; RIGI; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13557; ACE2; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11876; TMPRSS2; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Ideal for studying SARS-CoV-2 viral entry into host cells, the viral RNA sensing pathway, as well as screening small molecule inhibitors and neutralizing antibodies These cells are permissive to infection by SARS-CoV-2 Spike-pseudotyped viral particles (InvivoGen=a549d-korigi-cov2r).; Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=a549d-korigi-cov2r). Group: SARS-CoV-2 research cell line 127227660 CVCL_A7ZV Raji-h4-1BB cancer cell line human CVCL_A7ZV CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11924; TNFRSF9; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 127227661 CVCL_A7ZU Jurkat-Lucia NFAT-CD32 cancer cell line human CVCL_A7ZU CL:0000010 Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3616; FCGR2A; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter fused to 6 NFAT consensus transcriptional response elements (InvivoGen=jktl-nfat-cd32) 127227662 CVCL_A7ZX Raji-hEGFR cancer cell line human CVCL_A7ZX CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 127227663 CVCL_A7ZW Raji-hCTLA4 cancer cell line human CVCL_A7ZW CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2505; CTLA4; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 127227664 CVCL_A7ZJ RAW-ASC KO-NLRC4 cancer cell line house mouse CVCL_A7ZJ CL:0000010 Knockout cell: Method=Not specified; MGI; MGI:3036243; Nlrc4; Genetic integration: Method=Transfection; Gene=MGI; MGI:1931465; Pycard; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male 127227665 CVCL_A7ZI RAW-ASC KO-CASP11 cancer cell line house mouse CVCL_A7ZI CL:0000010 Knockout cell: Method=Not specified; MGI; MGI:107700; Casp4; Genetic integration: Method=Transfection; Gene=MGI; MGI:1931465; Pycard; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male 127227666 CVCL_A7ZL RAW-Dual KO-TLR4 cancer cell line house mouse CVCL_A7ZL CL:0000010 Knockout cell: Method=Homologous recombination; MGI; MGI:1340094; Cxcl2; Knockout cell: Method=Homologous recombination; MGI; MGI:96824; Tlr4; Genetic integration: Method=Homologous recombination; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase ALPP expression depends on the activation of the endogenous MIP-2/CXCL2 promoter as the Cxcl2 gene has been replaced by ALPP. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=rawd-kotlr4). 127227667 CVCL_A7ZK RAW-Dual cancer cell line house mouse CVCL_A7ZK CL:0000010 Knockout cell: Method=Homologous recombination; MGI; MGI:1340094; Cxcl2; Genetic integration: Method=Homologous recombination; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase ALPP expression depends on the activation of the endogenous MIP-2/CXCL2 promoter as the Cxcl2 gene has been replaced by ALPP. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=rawd-ismip). 127227668 CVCL_A7ZN A549-Dual KO-RIG-I cancer cell line human CVCL_A7ZN CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:19102; RIGI; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=a549d-korigi). 127227669 CVCL_A7ZM A549-Dual KO-MAVS cancer cell line human CVCL_A7ZM CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:29233; MAVS; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=a549d-komavs). 127227670 CVCL_A7ZP A549-Dual KO-MDA5 cancer cell line human CVCL_A7ZP CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:18873; IFIH1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=a549d-komda5). 127227671 CVCL_A7ZB RAW-Lucia ISG-KO-TRIF cancer cell line house mouse CVCL_A7ZB CL:0000010 Knockout cell: Method=Homologous recombination; MGI; MGI:2147032; Ticam1; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=rawl-kotrif) 127227672 CVCL_A7ZA RAW-Lucia ISG-KO-IRF1 cancer cell line house mouse CVCL_A7ZA CL:0000010 Knockout cell: Method=Homologous recombination; MGI; MGI:96590; Irf1; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=rawl-koirf1) 127227673 CVCL_A7ZD RAW-Lucia ISG-KO-IRF7 cancer cell line house mouse CVCL_A7ZD CL:0000010 Knockout cell: Method=Homologous recombination; MGI; MGI:1859212; Irf7; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=rawl-koirf7) 127227674 CVCL_A7ZC RAW-Lucia ISG-KO-IRF5 cancer cell line house mouse CVCL_A7ZC CL:0000010 Knockout cell: Method=Homologous recombination; MGI; MGI:1350924; Irf5; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=rawl-koirf5) 127227675 CVCL_A7ZF RAW-Lucia ISG-KO-MDA5 cancer cell line house mouse CVCL_A7ZF CL:0000010 Knockout cell: Method=Homologous recombination; MGI; MGI:1918836; Ifih1; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=rawl-komda5) 127227676 CVCL_A7ZE RAW-Lucia ISG-KO-MAVS cancer cell line house mouse CVCL_A7ZE CL:0000010 Knockout cell: Method=Homologous recombination; MGI; MGI:2444773; Mavs; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=rawl-komavs) 127227677 CVCL_A7ZH RAW-ASC KO-GSDMD cancer cell line house mouse CVCL_A7ZH CL:0000010 Knockout cell: Method=Not specified; MGI; MGI:1916396; Gsdmd; Genetic integration: Method=Transfection; Gene=MGI; MGI:1931465; Pycard; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male 127227678 CVCL_A7ZG RAW-ASC cancer cell line house mouse CVCL_A7ZG CL:0000010 Genetic integration: Method=Transfection; Gene=MGI; MGI:1931465; Pycard; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male 127227679 CVCL_A8JI 3G7 hybridoma house mouse CVCL_A8JI CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227680 CVCL_A8JH 3G6 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8JH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227681 CVCL_A8JK 3H4 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8JK CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227682 CVCL_A8JJ 3H2 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8JJ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227683 CVCL_A8JM 5A1 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8JM CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227684 CVCL_A8JL 3H6 hybridoma house mouse CVCL_A8JL CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227685 CVCL_A8JN 9F2 hybridoma house mouse CVCL_A8JN CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227686 CVCL_A8JA 3F1 hybridoma house mouse CVCL_A8JA CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227687 CVCL_A8JC 3F4 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8JC CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227688 CVCL_A8JB 3F2 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8JB CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227689 CVCL_A8JE 3F6 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8JE CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227690 CVCL_A8JD 3F5 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8JD CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227691 CVCL_A8JG 3G2 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8JG CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227692 CVCL_A8JF 3G1 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8JF CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227693 CVCL_A8IX 3E1 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IX CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227694 CVCL_A8IW 3D7 hybridoma house mouse CVCL_A8IW CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227695 CVCL_A8IZ 3E5 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IZ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227696 CVCL_A8IY 3E4 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IY CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227697 CVCL_A8IP 3C2 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IP CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227698 CVCL_A8IR 3C6 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IR CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227699 CVCL_A8IQ 3C4 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IQ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227700 CVCL_A8IT 3D2 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IT CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227701 CVCL_A8IS 3D1 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IS CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227702 CVCL_A8IV 3D5 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IV CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227703 CVCL_A8IU 3D3 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IU CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227704 CVCL_A8HG DHMi002-A induced pluripotent stem cell human CVCL_A8HG From: German Heart Center Munich; Munich; Germany CL:0000010 Population: African; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227705 CVCL_A8HF DHMi001-A induced pluripotent stem cell human CVCL_A8HF From: German Heart Center Munich; Munich; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227706 CVCL_A8HI MLi004-A induced pluripotent stem cell human CVCL_A8HI From: Faculty of Medicine, University of Ljubljana; Ljubljana; Slovenia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2214; COL7A1; Simple; p.Arg682Ter (c.2044C>T); ClinVar=VCV001047976; Zygosity=Heterozygous (PubMed=34284275); Sequence variation: Mutation; HGNC; HGNC:2214; COL7A1; Simple; c.6900+4A>G (IVS87+4A>G) (p.Gly2278_Gln2300del); ClinVar=VCV000374314; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=34284275) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH Female 127227707 CVCL_A8HH DHMi003-A induced pluripotent stem cell human CVCL_A8HH From: German Heart Center Munich; Munich; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127227708 CVCL_A8HK JHUi003-A induced pluripotent stem cell human CVCL_A8HK From: Johns Hopkins University; Baltimore; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9305; PPP2R2B; Repeat_expansion; CAG[69]; ClinVar=VCV000005614; Zygosity=Heterozygous (PubMed=34087983); Sequence variation: Mutation; HGNC; HGNC:9305; PPP2R2B; Repeat_expansion_edited; CAG[72]; ClinVar=VCV000005614; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34087983) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127227709 CVCL_A8HJ MUi023-A induced pluripotent stem cell human CVCL_A8HJ From: Mahidol University; Bangkok; Thailand CL:0000010 Discontinued: hPSCreg; MUi023-A; true. 127227710 CVCL_A8HM RCPFi005-A induced pluripotent stem cell human CVCL_A8HM From: Principe Felipe Centro de Investigacion; Valencia; Spain CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9039; PLA2G6; Simple; p.Leu337Gln (c.1010T>A); Zygosity=Heterozygous (PubMed=34087982); Sequence variation: Mutation; HGNC; HGNC:9039; PLA2G6; Simple; p.Ala343Thr (c.1027G>A); ClinVar=VCV000159725; Zygosity=Heterozygous (PubMed=34087982) Population: Caucasian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227711 CVCL_A8HL RCPFi004-A induced pluripotent stem cell human CVCL_A8HL From: Principe Felipe Centro de Investigacion; Valencia; Spain CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9039; PLA2G6; Simple; p.Glu786Lys (c.2356G>A); ClinVar=VCV001012262; Zygosity=Homozygous (PubMed=34087982) Population: Arab; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227712 CVCL_A8HA RC01001-A induced pluripotent stem cell human CVCL_A8HA From: Nuwacell Biotechnologies Co.; Hefei; China CL:0000010 Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227713 CVCL_A8HC BJTTHi001-A-2 induced pluripotent stem cell human CVCL_A8HC From: Beijing Tiantan Hospital; Beijing; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10586; SCN1B Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227714 CVCL_A8HB BJTTHi001-A-1 induced pluripotent stem cell human CVCL_A8HB From: Beijing Tiantan Hospital; Beijing; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10585; SCN1A Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227715 CVCL_A8HE SCMCi001-A-1 induced pluripotent stem cell human CVCL_A8HE From: Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine; Shanghai; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9585; PTCH1 Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127227716 CVCL_A8HD SCMCi001-A induced pluripotent stem cell human CVCL_A8HD From: Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine; Shanghai; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127227717 CVCL_A8GV ZIPi015-F induced pluripotent stem cell human CVCL_A8GV From: Zentrum fur Integrative Psychiatrie; Kiel; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227718 CVCL_A8GU ZIPi015-E induced pluripotent stem cell human CVCL_A8GU From: Zentrum fur Integrative Psychiatrie; Kiel; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227719 CVCL_A8GX ZIPi015-H induced pluripotent stem cell human CVCL_A8GX From: Zentrum fur Integrative Psychiatrie; Kiel; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227720 CVCL_A8GW ZIPi015-G induced pluripotent stem cell human CVCL_A8GW From: Zentrum fur Integrative Psychiatrie; Kiel; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227721 CVCL_A8GZ ZIPi015-J induced pluripotent stem cell human CVCL_A8GZ From: Zentrum fur Integrative Psychiatrie; Kiel; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227722 CVCL_A8GY ZIPi015-I induced pluripotent stem cell human CVCL_A8GY From: Zentrum fur Integrative Psychiatrie; Kiel; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227723 CVCL_A8GN CHO.DogSLAMtag spontaneously immortalized cell line CVCL_A8GN CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=VGNC; VGNC:46206; Dog SLAMF1 (Note=With a N-terminal HA tag) Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female 127227724 CVCL_A8GM CHO.CowSLAMtag spontaneously immortalized cell line CVCL_A8GM CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=VGNC; VGNC:34653; Bovine SLAMF1 (Note=With a N-terminal HA tag) Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female 127227725 CVCL_A8GP SAS-R cancer cell line human CVCL_A8GP CL:0000010 Population: Japanese; Transformant: NCIt; C17262; X-Ray; Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Female Characteristics: Radioresistant Can proliferate with daily exposure to 2 Gy X-rays for more than 30 days (PubMed=21716292). 127227726 CVCL_A8GR ZIPi015-B induced pluripotent stem cell human CVCL_A8GR From: Zentrum fur Integrative Psychiatrie; Kiel; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227727 CVCL_A8GQ ZIPi015-A induced pluripotent stem cell human CVCL_A8GQ From: Zentrum fur Integrative Psychiatrie; Kiel; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227728 CVCL_A8GT ZIPi015-D induced pluripotent stem cell human CVCL_A8GT From: Zentrum fur Integrative Psychiatrie; Kiel; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227729 CVCL_A8GS ZIPi015-C induced pluripotent stem cell human CVCL_A8GS From: Zentrum fur Integrative Psychiatrie; Kiel; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227730 CVCL_A8IH 3A2 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227731 CVCL_A8IG 3A1 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IG CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227732 CVCL_A8IJ 3A7 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IJ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227733 CVCL_A8II 3A6 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8II CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227734 CVCL_A8IL 3B3 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IL CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227735 CVCL_A8IK 3B1 hybridoma house mouse CVCL_A8IK CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227736 CVCL_A8IN 3B6 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IN CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227737 CVCL_A8IM 3B4 [Mouse hybridoma against SARS-CoV-2 spike] hybridoma house mouse CVCL_A8IM CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127227738 CVCL_A8IB ESi101-A induced pluripotent stem cell human CVCL_A8IB From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11782; TH; Simple; p.Arg233His (c.698G>A); ClinVar=VCV000016236; Zygosity=Homozygous (BNLC) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227739 CVCL_A8IA ESi084-A induced pluripotent stem cell human CVCL_A8IA From: El Instituto de Investigacion Biomedica de A Coruna, University of Coruna; Barcelona; Spain CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227740 CVCL_A8ID ESi103-A induced pluripotent stem cell human CVCL_A8ID CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227741 CVCL_A8IC ESi102-A induced pluripotent stem cell human CVCL_A8IC From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11782; TH; Simple; p.Arg328Trp (c.982C>T); Zygosity=Heterozygous (BNLC); Sequence variation: Mutation; HGNC; HGNC:11782; TH; Simple; p.Thr399Met (c.1196C>T) (p.Thr368Met, c.1103C>T); ClinVar=VCV000378729; Zygosity=Heterozygous (BNLC) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227742 CVCL_A8IF HepG2-N10 cancer cell line human CVCL_A8IF From: Xia, Ning-Shao; Xiamen University; Xiamen; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Virology: Transfected with a hepatitis B virus (HBV) subtype adw2 genome 127227743 CVCL_A8IE M9-ENL1 transformed cell line human CVCL_A8IE CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7132; KMT2A (Note=KMT2A-MLLT1 fusion); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7134; MLLT1 (Note=KMT2A-MLLT1 fusion); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: KMT2A-MLLT1; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Characteristics: Expresses a transfected KMT2A-MLLT1 (MLL-ENL) fusion protein Mimics the features of primary human pro-B cell acute lymphoblastic leukemia (PubMed=22160482). 127227744 CVCL_A8HW IMT-KO9 conditionally immortalized cell line house mouse CVCL_A8HW CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1349215; Abcd1; Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Astrocyte; CL=CL_0000127; Breed/subspecies: C57BL/6J Abcd1-/- x H2kb-tsA58 transgenic. Male 127227745 CVCL_A8HV IMT-KO4 conditionally immortalized cell line house mouse CVCL_A8HV CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1349215; Abcd1; Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Astrocyte; CL=CL_0000127; Breed/subspecies: C57BL/6J Abcd1-/- x H2kb-tsA58 transgenic. Male 127227746 CVCL_A8HY ESi085-A induced pluripotent stem cell human CVCL_A8HY From: Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Sevilla; Spain CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227747 CVCL_A8HX SBKMS-KS1 cancer cell line human CVCL_A8HX CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=19289832) Derived from site: Metastatic; Groin; UBERON=UBERON_0008337. Female 127227748 CVCL_A8HZ ESi083-A induced pluripotent stem cell human CVCL_A8HZ From: El Instituto de Investigacion Biomedica de A Coruna, University of Coruna; Barcelona; Spain CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227749 CVCL_A8HN RCPFi006-A induced pluripotent stem cell human CVCL_A8HN From: Principe Felipe Centro de Investigacion; Valencia; Spain CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9039; PLA2G6; Simple; p.Tyr790Ter (c.2370T>G); ClinVar=VCV000006195; Zygosity=Homozygous (PubMed=34087982) Population: Caucasian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227750 CVCL_A8HQ AND-1 EGFP-2A-SCL embryonic stem cell human CVCL_A8HQ From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11556; TAL1; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Karyotypic information: 47,XY,-1,+der(1)dup(1q11->1qter::1q11->1qter)-7,+i(7)p,+13 (BNLC); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Transduced with a pRRL-EF1a-EGFP-2A-SCL-PGKp-Neo construct Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227751 CVCL_A8HP CQ4ed-iPSC induced pluripotent stem cell human CVCL_A8HP From: Josep Carreras Leukemia Research Institute; Barcelona; Spain CL:0000010 Sequence variation: Mutation; HGNC; HGNC:19693; COQ4; Simple_corrected; p.Glu161Asp (c.483G>C); ClinVar=VCV000380493; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=28465093) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227752 CVCL_A8HS HS181 EGFP-2A-RUNX1c embryonic stem cell human CVCL_A8HS From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10471; RUNX1 (Note=Isoform AML-1C); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Transduced with a pRRL-EF1a-EGFP-2A-RUNX1c-PGKp-Neo construct Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227753 CVCL_A8HR HS181 EGFP-2A-SCL embryonic stem cell human CVCL_A8HR From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11556; TAL1; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Karyotypic information: 46,XX [15]; 46,XX,der(5)t(q35;?)+der(12)t(q11;?) [7] (BNLC); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Transduced with a pRRL-EF1a-EGFP-2A-SCL-PGKp-Neo construct Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127227754 CVCL_A8HU IMT-KO2 conditionally immortalized cell line house mouse CVCL_A8HU CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1349215; Abcd1; Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Astrocyte; CL=CL_0000127; Breed/subspecies: C57BL/6J Abcd1-/- x H2kb-tsA58 transgenic. Male 127227755 CVCL_A8HT K562/GM-CSF cancer cell line human CVCL_A8HT CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2434; CSF2; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: Caucasian; Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. Biotechnology: Used for the production of the Sorento Therapeutics STI-6991 SARS-CoV-2 (COVID-19) vaccine candidate The cell line which is lethally irradiated is used to produce the recombinant SARS-CoV-2 spike protein rSARS-CoV-2 which is the active part of the vaccine formulation (PubMed=32289117). Female Characteristics: Does not express HLA class I or II antigens, potentially decreasing the magnitude of the alloresponses generated on repeated immunizations (PubMed=10466632) 127227756 CVCL_A8FE HT43 hybridoma house mouse CVCL_A8FE CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227757 CVCL_A8FD HT41 hybridoma house mouse CVCL_A8FD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227758 CVCL_A8FG HT45 hybridoma house mouse CVCL_A8FG CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227759 CVCL_A8FF HT44 hybridoma house mouse CVCL_A8FF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227760 CVCL_A8FI HT53 hybridoma house mouse CVCL_A8FI CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227761 CVCL_A8FH HT52 hybridoma house mouse CVCL_A8FH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227762 CVCL_A8FK HT58 [Mouse hybridoma against human TLR4] hybridoma house mouse CVCL_A8FK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227763 CVCL_A8FJ HT55 hybridoma house mouse CVCL_A8FJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227764 CVCL_A8FA HT3 hybridoma house mouse CVCL_A8FA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227765 CVCL_A8FC HT40 hybridoma house mouse CVCL_A8FC CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227766 CVCL_A8FB HT4 [Mouse hybridoma against human TLR4] hybridoma house mouse CVCL_A8FB CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227767 CVCL_A8ET mTX11 hybridoma CVCL_A8ET CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227768 CVCL_A8ES 5A5 [Mouse/rat hybridoma against human CD14] hybridoma CVCL_A8ES CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P08571; Human CD14. 127227769 CVCL_A8EV HT16 hybridoma house mouse CVCL_A8EV CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227770 CVCL_A8EU HT11 hybridoma house mouse CVCL_A8EU CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227771 CVCL_A8EX HT2 [Mouse hybridoma against human TLR4] hybridoma house mouse CVCL_A8EX CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227772 CVCL_A8EW HT17 hybridoma house mouse CVCL_A8EW CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q9Y6Y9; Human LY96; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227773 CVCL_A8EZ HT29 hybridoma house mouse CVCL_A8EZ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227774 CVCL_A8EY HT26 hybridoma house mouse CVCL_A8EY CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q9Y6Y9; Human LY96; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227775 CVCL_A8EL mTX12 hybridoma CVCL_A8EL CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227776 CVCL_A8EK mTX10 hybridoma CVCL_A8EK CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227777 CVCL_A8EN 1B12 [Mouse hybridoma against human CD14] hybridoma CVCL_A8EN CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08571; Human CD14. 127227778 CVCL_A8EM GFP5 hybridoma CVCL_A8EM CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: FPbase; R9NL8; eGFP (Note=Enhanced GFP). 127227779 CVCL_A8EP 1E1 [Mouse hybridoma against human CD14] hybridoma CVCL_A8EP CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08571; Human CD14. 127227780 CVCL_A8ER 1F1 [Mouse hybridoma against human CD14] hybridoma CVCL_A8ER CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08571; Human CD14. 127227781 CVCL_A8EQ 1E12 hybridoma CVCL_A8EQ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P08571; Human CD14. 127227782 CVCL_A8GF hLp4 hybridoma CVCL_A8GF CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P18428; Human LBP. 127227783 CVCL_A8GE hLp1 hybridoma CVCL_A8GE CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P18428; Human LBP. 127227784 CVCL_A8GH CLC12N2 cancer cell line human CVCL_A8GH CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr103fs*37 (c.308_321delTGTGTAACAGTTCC); Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16412; NLRC4 (Note=With p.Leu152_Ala1024del, CARD domain, C12N2 construct); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5331; NOD2 (Note=With p.Met1_Ala216del, NACHT+LRR domains, C12N2 construct); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Male 127227785 CVCL_A8GG HeLa-R cancer cell line human CVCL_A8GG CL:0000010 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C17262; X-Ray; Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Characteristics: Radioresistant Can proliferate with daily exposure to 2 Gy X-rays for more than 30 days (PubMed=27681752). 127227786 CVCL_A8GJ MAIL8-19 transformed cell line human CVCL_A8GJ CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16412; NLRC4 (Note=With p.Leu152_Ala1024del, CARD domain, C12N2 construct); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5331; NOD2 (Note=With p.Met1_Ala216del, NACHT+LRR domains, C12N2 construct); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16608; PYCARD; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 127227787 CVCL_A8GI NUC12N2 cancer cell line human CVCL_A8GI CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16412; NLRC4 (Note=With p.Leu152_Ala1024del, CARD domain, C12N2 construct); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5331; NOD2 (Note=With p.Met1_Ala216del, NACHT+LRR domains, C12N2 construct) Population: Japanese; Derived from site: Metastatic; Paragastric lymph node; UBERON=UBERON_8480059. Female 127227788 CVCL_A8GL CHO.B95aSLAMtag spontaneously immortalized cell line CVCL_A8GL CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; Q9GJT3; Saguinus oedipus SLAMF1 (Note=With a N-terminal HA tag) Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female 127227789 CVCL_A8GK Vero.DogSLAMtag spontaneously immortalized cell line green monkey CVCL_A8GK CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=VGNC; VGNC:46206; Dog SLAMF1 (Note=With a N-terminal HA tag) Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819; Cell type: Epithelial cell of kidney; CL=CL_0002518. Female Virology: Highly susceptible to infection by canine distemper virus (CDV) (PubMed=12941904) Group: Non-human primate cell line 127227790 CVCL_A8GB M14-23 hybridoma CVCL_A8GB CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14. 127227791 CVCL_A8GA M14-21 hybridoma CVCL_A8GA CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14. 127227792 CVCL_A8GD M14-29 hybridoma CVCL_A8GD CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14. 127227793 CVCL_A8GC M14-26 hybridoma CVCL_A8GC CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14. 127227794 CVCL_A8FU M14-9 hybridoma CVCL_A8FU CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14. 127227795 CVCL_A8FT HepG2-R cancer cell line human CVCL_A8FT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Transformant: NCIt; C17262; X-Ray; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Characteristics: Radioresistant Can proliferate with daily exposure to 2 Gy X-rays for more than 30 days (PubMed=21716292). 127227796 CVCL_A8FW M14-11 hybridoma CVCL_A8FW CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14. 127227797 CVCL_A8FV M14-10 hybridoma CVCL_A8FV CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14. 127227798 CVCL_A8FY M14-16 hybridoma CVCL_A8FY CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14. 127227799 CVCL_A8FX M14-14 hybridoma CVCL_A8FX CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14. 127227800 CVCL_A8FZ M14-17 hybridoma CVCL_A8FZ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P10810; Mouse Cd14. 127227801 CVCL_A8FM HT60 hybridoma house mouse CVCL_A8FM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227802 CVCL_A8FL HT59 hybridoma house mouse CVCL_A8FL CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q9Y6Y9; Human LY96; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227803 CVCL_A8FN HT66 hybridoma house mouse CVCL_A8FN CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227804 CVCL_A8FQ HTB1 hybridoma house mouse CVCL_A8FQ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227805 CVCL_A8FP HT68 hybridoma house mouse CVCL_A8FP CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227806 CVCL_A8FS HepG2-8960-R cancer cell line human CVCL_A8FS CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Selected for resistance to: NCIt; C17262; X-Ray; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Characteristics: Radioresistant Can proliferate with daily exposure to 2 Gy X-rays for more than 30 days (PubMed=19215227). 127227807 CVCL_A8FR HTB2 hybridoma house mouse CVCL_A8FR CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; O00206; Human TLR4. 127227808 CVCL_A8DC Sf9 SARS-CoV-2 Spike S1 spontaneously immortalized cell line CVCL_A8DC CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S) (Note=AA 1-685; S1) Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female Group: Insect cell line; Group: SARS-CoV-2 research cell line 127227809 CVCL_A8DB HEK293T SARS-CoV-2 Spike transformed cell line human CVCL_A8DB CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Discontinued: ABM; T6793; true Female Group: SARS-CoV-2 research cell line 127227810 CVCL_A8DE MUi028-A induced pluripotent stem cell human CVCL_A8DE From: Mahidol University; Bangkok; Thailand CL:0000010 Population: Southeast Asian; Thai; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227811 CVCL_A8DD Sf9 SARS-CoV-2 Spike S2 spontaneously immortalized cell line CVCL_A8DD CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S) (Note=AA 816-1273; S2) Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female Group: Insect cell line; Group: SARS-CoV-2 research cell line 127227812 CVCL_A8DG PCIi030-A induced pluripotent stem cell human CVCL_A8DG From: Phenocell SAS; Grasse; France CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127227813 CVCL_A8DF PCIi029-A induced pluripotent stem cell human CVCL_A8DF From: Phenocell SAS; Grasse; France CL:0000010 Sequence variation: Mutation; HGNC; HGNC:8617; PAX3; Simple; c.-70_85+366del; Zygosity=Heterozygous (PubMed=36989619) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227814 CVCL_A8DI WAe009-A-60 embryonic stem cell human CVCL_A8DI From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9886; KDM5A (Note=NUP98-KDM5 fusion); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8068; NUP98 (Note=NUP98-KDM5 fusion); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127227815 CVCL_A8DH PCIi031-A induced pluripotent stem cell human CVCL_A8DH From: Phenocell SAS; Grasse; France CL:0000010 Sequence variation: Mutation; HGNC; HGNC:8617; PAX3; Simple; c.-70_85+366del; Zygosity=Heterozygous (PubMed=36989619) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127227816 CVCL_A8CZ HEK-Blue TGF-beta transformed cell line human CVCL_A8CZ CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6769; SMAD3; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6770; SMAD4; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11772; TGFBR1; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Discontinued: InvivoGen; hkb-tgfb; true Female Characteristics: Designed to detect bioactive TGF-beta by monitoring the activation of the TGF-beta/SMAD pathway (InvivoGen=hkb-tgfb); Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a beta-globin minimal promoter fused to 3 SMAD3/4-binding elements (SBE) (InvivoGen=hkb-tgfb) 127227817 CVCL_A8CY HEK-Dual IFN-gamma transformed cell line human CVCL_A8CY CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11362; STAT1; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Allows the detection of bioactive human IFN-gamma by monitoring the activation of the JAK/STAT1 pathway (InvivoGen=hkd-ifng); Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line both genes are under the control of an ISG54 minimal promoter in conjunction with four IFN-gamma activated sites (GAS) (InvivoGen=hkd-ifng). 127227818 CVCL_A8DA HEK-Blue IL-4/IL-13 transformed cell line human CVCL_A8DA CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11368; STAT6; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Designed to detect bioactive human IL4 and IL13 by monitoring the activation of the STAT-6 pathway (InvivoGen=hkb-il413); Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a STAT6-responsive promoter (InvivoGen=hkb-il413) 127227819 CVCL_A8CR HEK-Blue-Lucia hTLR2 (NF/IL8) transformed cell line human CVCL_A8CR CL:0000010 Knockout cell: Method=Homologous recombination; HGNC; HGNC:6025; CXCL8; Knockout cell: Method=Not specified; HGNC; HGNC:11849; TLR3; Knockout cell: Method=Not specified; HGNC; HGNC:11851; TLR5; Knockout cell: Method=Not specified; HGNC; HGNC:11916; TNFRSF1A; Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1628; CD14; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11848; TLR2; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites. The Lucia luciferase reporter gene expression depends on the activation of the endogenous CXCL8/IL8 promoter as the CXCL8 gene has been replaced by Lucia (InvivoGen=hkd-htlr2ni). 127227820 CVCL_A8CQ HEK-Blue-Lucia Null (NF/IL8) transformed cell line human CVCL_A8CQ CL:0000010 Knockout cell: Method=Homologous recombination; HGNC; HGNC:6025; CXCL8; Knockout cell: Method=Not specified; HGNC; HGNC:11849; TLR3; Knockout cell: Method=Not specified; HGNC; HGNC:11851; TLR5; Knockout cell: Method=Not specified; HGNC; HGNC:11916; TNFRSF1A; Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites. The Lucia luciferase reporter gene expression depends on the activation of the endogenous CXCL8/IL8 promoter as the CXCL8 gene has been replaced by Lucia (InvivoGen=hkd-nullni). 127227821 CVCL_A8CT HEK-Blue-Lucia hTLR5 (NF/IL8) transformed cell line human CVCL_A8CT CL:0000010 Knockout cell: Method=Homologous recombination; HGNC; HGNC:6025; CXCL8; Knockout cell: Method=Not specified; HGNC; HGNC:11849; TLR3; Knockout cell: Method=Not specified; HGNC; HGNC:11851; TLR5; Knockout cell: Method=Not specified; HGNC; HGNC:11916; TNFRSF1A; Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11851; TLR5; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites. The Lucia luciferase reporter gene expression depends on the activation of the endogenous CXCL8/IL8 promoter as the CXCL8 gene has been replaced by Lucia (InvivoGen=hkd-htlr5ni). 127227822 CVCL_A8CS HEK-Blue-Lucia hTLR3 (NF/IL8) transformed cell line human CVCL_A8CS CL:0000010 Knockout cell: Method=Homologous recombination; HGNC; HGNC:6025; CXCL8; Knockout cell: Method=Not specified; HGNC; HGNC:11849; TLR3; Knockout cell: Method=Not specified; HGNC; HGNC:11851; TLR5; Knockout cell: Method=Not specified; HGNC; HGNC:11916; TNFRSF1A; Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11849; TLR3; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites. The Lucia luciferase reporter gene expression depends on the activation of the endogenous CXCL8/IL8 promoter as the CXCL8 gene has been replaced by Lucia (InvivoGen=hkd-htlr3ni). 127227823 CVCL_A8CV HEK-Blue-Lucia mTLR4 (NF/IL8) transformed cell line human CVCL_A8CV CL:0000010 Knockout cell: Method=Homologous recombination; HGNC; HGNC:6025; CXCL8; Knockout cell: Method=Not specified; HGNC; HGNC:11849; TLR3; Knockout cell: Method=Not specified; HGNC; HGNC:11851; TLR5; Knockout cell: Method=Not specified; HGNC; HGNC:11916; TNFRSF1A; Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=MGI; MGI:88318; Cd14; Genetic integration: Method=Transfection; Gene=MGI; MGI:1341909; Ly96; Genetic integration: Method=Transfection; Gene=MGI; MGI:96824; Tlr4; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites. The Lucia luciferase reporter gene expression depends on the activation of the endogenous CXCL8/IL8 promoter as the CXCL8 gene has been replaced by Lucia (InvivoGen=hkd-mtlr4ni). 127227824 CVCL_A8CU HEK-Blue-Lucia hTLR9 (NF/IL8) transformed cell line human CVCL_A8CU CL:0000010 Knockout cell: Method=Homologous recombination; HGNC; HGNC:6025; CXCL8; Knockout cell: Method=Not specified; HGNC; HGNC:11849; TLR3; Knockout cell: Method=Not specified; HGNC; HGNC:11851; TLR5; Knockout cell: Method=Not specified; HGNC; HGNC:11916; TNFRSF1A; Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15633; TLR9; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites. The Lucia luciferase reporter gene expression depends on the activation of the endogenous CXCL8/IL8 promoter as the CXCL8 gene has been replaced by Lucia (InvivoGen=hkd-htlr9ni). 127227825 CVCL_A8CX HEK-Blue-Lucia TNF-alpha transformed cell line human CVCL_A8CX CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:7562; MYD88; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line both genes are under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 c-Rel binding sites (InvivoGen=hkd-tnfa). 127227826 CVCL_A8CW HEK-Blue-Lucia mTLR7 (NF/IL8) transformed cell line human CVCL_A8CW CL:0000010 Knockout cell: Method=Homologous recombination; HGNC; HGNC:6025; CXCL8; Knockout cell: Method=Not specified; HGNC; HGNC:11849; TLR3; Knockout cell: Method=Not specified; HGNC; HGNC:11851; TLR5; Knockout cell: Method=Not specified; HGNC; HGNC:11916; TNFRSF1A; Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=MGI; MGI:2176882; Tlr7; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites. The Lucia luciferase reporter gene expression depends on the activation of the endogenous CXCL8/IL8 promoter as the CXCL8 gene has been replaced by Lucia (InvivoGen=hkd-mtlr7ni). 127227827 CVCL_A8CJ HEK-Blue RANKL transformed cell line human CVCL_A8CJ CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11908; TNFRSF11A; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Designed to detect bioactive human and mouse TNFSF11/RANKL by monitoring the activation of the NF-kappaB and AP-1 pathway (InvivoGen=hkb-rankl); Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a promoter with NF-kappaB and AP-1-binding sites (InvivoGen=hkb-rankl) 127227828 CVCL_A8CI HEK-Blue TPO transformed cell line human CVCL_A8CI CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7217; MPL; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11367; STAT5B; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Designed to detect bioactive human and mouse TPO by monitoring the activation of the STAT5 pathway (InvivoGen=hkb-tpo); Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a STAT5 promoter (InvivoGen=hkb-tpo) 127227829 CVCL_A8CL HEK-Blue IL-1beta transformed cell line human CVCL_A8CL CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:11849; TLR3; Knockout cell: Method=Not specified; HGNC; HGNC:11851; TLR5; Knockout cell: Method=Not specified; HGNC; HGNC:11916; TNFRSF1A; Knockout cell: Method=Not specified; HGNC; HGNC:11917; TNFRSF1B; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Discontinued: InvivoGen; hkb-il1b; true Female Characteristics: Designed to detect bioactive human and mouse IL1B monitoring the activation of the NF-kappaB and AP-1 pathways In addition, the TNF-alpha, TLR3 and TLR5 responses have been blocked (InvivoGen=hkb-il1b).; Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-il1b) 127227830 CVCL_A8CK HEK-Blue IL-17C transformed cell line human CVCL_A8CK CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5985; IL17RA; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:18439; IL17RE; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1343; TRAF3IP2; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Designed to detect bioactive human and murine IL17C and IL17F by monitoring the activation of the NF-kappaB and AP-1 pathways (InvivoGen=hkb-il17c); Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of the IFN-beta minimal promoter fused to five NF-kappaB and five AP-1 binding sites (InvivoGen=hkb-il17c) 127227831 CVCL_A8CN HEK-Lucia Null transformed cell line human CVCL_A8CN CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=hkl-null) 127227832 CVCL_A8CM HEK-Blue IL-1R transformed cell line human CVCL_A8CM CL:0000010 Knockout cell: Method=Not specified; HGNC; HGNC:11849; TLR3; Knockout cell: Method=Not specified; HGNC; HGNC:11851; TLR5; Knockout cell: Method=Not specified; HGNC; HGNC:11916; TNFRSF1A; Knockout cell: Method=Not specified; HGNC; HGNC:11917; TNFRSF1B; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=MGI; MGI:96545; Il1r1; Genetic integration: Method=Transfection; Gene=MGI; MGI:104975; Il1rap; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Designed to detect bioactive human and mouse IL1A and IL1B by monitoring the activation of the NF-kappaB and AP-1 pathways In addition, the TNF-alpha, TLR3 and TLR5 responses have been blocked (InvivoGen=hkb-il1r).; Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-il1r) 127227833 CVCL_A8CP HEK-Lucia RIG-I transformed cell line human CVCL_A8CP CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:19102; RIGI; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=hkl-hrigi) 127227834 CVCL_A8ED TES101 hybridoma house mouse CVCL_A8ED CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227835 CVCL_A8EC mTX6 hybridoma CVCL_A8EC CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227836 CVCL_A8EF mTES101-RP(N6035) hybridoma house mouse CVCL_A8EF CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227837 CVCL_A8EE mTES101-RP(N6002) hybridoma house mouse CVCL_A8EE CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227838 CVCL_A8EH mTX7 hybridoma CVCL_A8EH CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227839 CVCL_A8EG Ts4 hybridoma house mouse CVCL_A8EG CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227840 CVCL_A8EJ mTX9 hybridoma CVCL_A8EJ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227841 CVCL_A8EI mTX8 hybridoma CVCL_A8EI CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227842 CVCL_A8DZ mTX3 hybridoma CVCL_A8DZ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227843 CVCL_A8EB mTX5.2 hybridoma CVCL_A8EB CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227844 CVCL_A8EA mTX4 hybridoma CVCL_A8EA CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227845 CVCL_A8DS NCC-CC4-3 cancer cell line human CVCL_A8DS CL:0000010 Population: Japanese; Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704. Male 127227846 CVCL_A8DR NCC-CC4-2 cancer cell line human CVCL_A8DR CL:0000010 Population: Japanese; Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704. Male 127227847 CVCL_A8DU NCC-CC6-2 cancer cell line human CVCL_A8DU CL:0000010 Population: Japanese; Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704. Male 127227848 CVCL_A8DT NCC-CC6-1 cancer cell line human CVCL_A8DT CL:0000010 Population: Japanese; Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704. Male 127227849 CVCL_A8DW GFP2 hybridoma CVCL_A8DW CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: FPbase; R9NL8; eGFP (Note=Enhanced GFP). 127227850 CVCL_A8DV HeLa NEK1 KO cancer cell line human CVCL_A8DV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7744; NEK1 Miscellaneous: Cell line information from personal communication of Laflamme, Carl Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 127227851 CVCL_A8DY mTX1 hybridoma CVCL_A8DY CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101. 127227852 CVCL_A8DX mk34 hybridoma CVCL_A8DX CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9CWP4; Mouse Ly6k. 127227853 CVCL_A8DK RCPCMi007-A-1 induced pluripotent stem cell human CVCL_A8DK From: Federal Research and Clinical Center of Physical-Chemical Medicine; Moscow; Russia CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227854 CVCL_A8DJ RCPCMi007-A induced pluripotent stem cell human CVCL_A8DJ From: Federal Research and Clinical Center of Physical-Chemical Medicine; Moscow; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227855 CVCL_A8DM UM281-1 PGD embryonic stem cell human CVCL_A8DM From: University of Michigan; Ann Arbor; USA CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Unspecified Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-21-0486 127227856 CVCL_A8DL PS1 finite cell line human CVCL_A8DL CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Discontinued: JCRB; KURB2002; probable Female 127227857 CVCL_A8DN NCC-BD3 cancer cell line human CVCL_A8DN CL:0000010 Population: Japanese; Derived from site: In situ; Bile duct; UBERON=UBERON_0002394. Male 127227858 CVCL_A8DQ NCC-BD4-2 cancer cell line human CVCL_A8DQ CL:0000010 Population: Japanese; Derived from site: In situ; Bile duct; UBERON=UBERON_0002394. Male 127227859 CVCL_A8DP NCC-BD4-1 cancer cell line human CVCL_A8DP CL:0000010 Population: Japanese; Derived from site: In situ; Bile duct; UBERON=UBERON_0002394. Male 127227860 CVCL_A4SV UMGi079-A induced pluripotent stem cell human CVCL_A4SV From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127227861 CVCL_A4SU UMGi078-A induced pluripotent stem cell human CVCL_A4SU From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127227862 CVCL_A4SX UMGi081-A induced pluripotent stem cell human CVCL_A4SX From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127227863 CVCL_A4SW UMGi080-A induced pluripotent stem cell human CVCL_A4SW From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127227864 CVCL_A4SZ UMGi083-A induced pluripotent stem cell human CVCL_A4SZ From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127227865 CVCL_A4SY UMGi082-A induced pluripotent stem cell human CVCL_A4SY From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127227866 CVCL_A4SN UMGi072-A induced pluripotent stem cell human CVCL_A4SN From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127227867 CVCL_A4SM UMGi071-A induced pluripotent stem cell human CVCL_A4SM From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127227868 CVCL_A4SP UMGi073-A induced pluripotent stem cell human CVCL_A4SP From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127227869 CVCL_A4SR UMGi075-A induced pluripotent stem cell human CVCL_A4SR From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127227870 CVCL_A4SQ UMGi074-A induced pluripotent stem cell human CVCL_A4SQ From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127227871 CVCL_A4ST UMGi077-A induced pluripotent stem cell human CVCL_A4ST From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127227872 CVCL_A4SS UMGi076-A induced pluripotent stem cell human CVCL_A4SS From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127227873 CVCL_A4SF WT1-iPSC induced pluripotent stem cell human CVCL_A4SF CL:0000010 Derived from site: In situ; Foreskin, skin, dermis; UBERON=UBERON_0001471+UBERON_0002067; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 127227874 CVCL_A4SE ActiCre-B1 embryonic stem cell CVCL_A4SE CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg Fused to Cre = CreERT2).; Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Ubiquitously expresses the tamoxifen-inducible Cre-driver ERT2iCreERT2 Using CRISPR/Cas9 a IRES-ERT2iCreERT2-IRES-Hyg construct was introduced into the 3'UTR of ACTB (PubMed=33453576). Group: Non-human primate cell line 127227875 CVCL_A4SH WT3-iPSC induced pluripotent stem cell human CVCL_A4SH CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227876 CVCL_A4SG WT2-iPSC induced pluripotent stem cell human CVCL_A4SG CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127227877 CVCL_A4SJ SAA2-iPSC induced pluripotent stem cell human CVCL_A4SJ CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127227878 CVCL_A4SI SAA1-iPSC induced pluripotent stem cell human CVCL_A4SI CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127227879 CVCL_A4SL UMGi070-A induced pluripotent stem cell human CVCL_A4SL From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127227880 CVCL_A4SK SAA3-iPSC induced pluripotent stem cell human CVCL_A4SK CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227881 CVCL_A5LN TMMR-1 hybridoma house mouse CVCL_A5LN CL:0000010 Monoclonal antibody isotype: IgG1. 127227882 CVCL_A5LM H14-YAP1 embryonic stem cell human CVCL_A5LM CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16262; YAP1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127227883 CVCL_A5LP TMMR-2 hybridoma house mouse CVCL_A5LP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human 26 kDa protein on osteosarcoma cell lines. 127227884 CVCL_A5LR OSEV cancer cell line human CVCL_A5LR CL:0000010 Unspecified 127227885 CVCL_A5LQ TMMR-3 hybridoma house mouse CVCL_A5LQ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: Human 97 kDa protein on osteosarcoma cell lines. 127227886 CVCL_A5LT OSFN cancer cell line human CVCL_A5LT CL:0000010 Unspecified 127227887 CVCL_A5LS OSFL cancer cell line human CVCL_A5LS CL:0000010 Unspecified 127227888 CVCL_A5LF FM3A AC2 cancer cell line house mouse CVCL_A5LF CL:0000010 Selected for resistance to: ChEBI; CHEBI_2766; Aphidicolin; Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: C3H/He. Female 127227889 CVCL_A5LE FM3A AC1 cancer cell line house mouse CVCL_A5LE CL:0000010 Selected for resistance to: ChEBI; CHEBI_2766; Aphidicolin; Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: C3H/He. Female 127227890 CVCL_A5LH BC3H1#1 cancer cell line house mouse CVCL_A5LH CL:0000010 Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU); Derived from site: Metastatic; Brain; UBERON=UBERON_0000955; Breed/subspecies: C3H. Unspecified Characteristics: Spontaneously fusing clone of BC3H1 Can form multinucleated myocytes (PubMed=10852349). 127227891 CVCL_A5LG FM3A AC3 cancer cell line house mouse CVCL_A5LG CL:0000010 Selected for resistance to: ChEBI; CHEBI_2766; Aphidicolin; Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: C3H/He. Female 127227892 CVCL_A5LJ MF2S cancer cell line house mouse CVCL_A5LJ CL:0000010 127227893 CVCL_A5LI EUE6 cancer cell line human CVCL_A5LI CL:0000010 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Problematic cell line: Contaminated Parent cell line (EUE) has been shown to be a HeLa derivative. 127227894 CVCL_A5LL H7-YAP1 embryonic stem cell human CVCL_A5LL CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16262; YAP1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127227895 CVCL_A5LK H7v1,17q,i20 embryonic stem cell human CVCL_A5LK CL:0000010 Karyotypic information: 47,XX,+del(1)(p22p22),der(6)t(6;17)(q27;q1),t(12;20)(q13;q11.2),i(2)(q10)ish dup(20)(q11.21;q11.21) (PubMed=34407428); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Aneuploid WA07 subline with gain of chromosome 1 that has an interstitial deletion at 1p22, gain of chromosome 17q and isochromosome of the long (q) arm of chromosome 20 (PubMed=34407428) 127227896 CVCL_A5LB FM3A SR-01 cancer cell line house mouse CVCL_A5LB CL:0000010 Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG); Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: C3H/He. Female Characteristics: Revertant of parent cell line for cell growth at 39 Celsius (PubMed=1995072) 127227897 CVCL_A5LA FM3A G258 cancer cell line house mouse CVCL_A5LA CL:0000010 Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG); Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: C3H/He. Female Characteristics: Temperature-sensitive Deficient in cell growth, asparagine glycosylation and synthesis of oligosaccharide-lipid. Selection is effected by tritium suicide selection. Mutagenized cells are bathed in tritiated mannose and stored so as to allow time for cells that had taken up the mannose to be killed by radiation damage (PubMed=1995072; PubMed=6725415). 127227898 CVCL_A5LD FM3A SR-12 cancer cell line house mouse CVCL_A5LD CL:0000010 Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG); Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: C3H/He. Female Characteristics: Revertant of parent cell line for cell growth at 39 Celsius (PubMed=1995072) 127227899 CVCL_A5LC FM3A SR-11 cancer cell line house mouse CVCL_A5LC CL:0000010 Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG); Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: C3H/He. Female Characteristics: Revertant of parent cell line for cell growth at 39 Celsius (PubMed=1995072) 127227900 CVCL_A5KU H14.BJ1 embryonic stem cell human CVCL_A5KU CL:0000010 Karyotypic information: 48,XY,+12,+der(17)hsr(17)(p11.2) del(17) (p13.3); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Aneuploid WA14 subline with gain of chromosome 12 and chromosome 17 that incorporates an hsr comprising amplification of chromosomal region 17p13.3 127227901 CVCL_A5KT H7v20q embryonic stem cell human CVCL_A5KT CL:0000010 Karyotypic information: 46,XX,ish dup(20)(q11.21;q11.21) (PubMed=34407428); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Aneuploid WA07 subline with gain of a copy number variant 20q11.21 (PubMed=34407428) 127227902 CVCL_A5KW H7.s6-GFP embryonic stem cell human CVCL_A5KW CL:0000010 Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Karyotypic information: 48,XX,+del(1)(p22;p22),der(6)t(6;17)(q27;q1),+12,ish dup(q11.21;q11.21) (PubMed=27829140); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Aneuploid WA07 subline with gain of chromosome 1 that has an interstitial deletion at 1p22, gain of chromosome 17q, trisomy chromosome 12 and gain of copy number variant 20q11.21 (PubMed=27829140) 127227903 CVCL_A5KV H14.s9 embryonic stem cell human CVCL_A5KV CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127227904 CVCL_A5KY H7.s14-Tomato embryonic stem cell human CVCL_A5KY CL:0000010 Genetic integration: Method=Transfection; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127227905 CVCL_A5KX H14.BJ1-GFP embryonic stem cell human CVCL_A5KX CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Karyotypic information: 48,XY,+12,+der(17)hsr(17)(p11.2) del(17) (p13.3); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Aneuploid WA14 subline with gain of chromosome 12 and chromosome 17 that incorporates an hsr comprising amplification of chromosomal region 17p13.3 127227906 CVCL_A5KZ ND15079 transformed cell line human CVCL_A5KZ CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15079; probable Male 127227907 CVCL_A5MN GM27925 induced pluripotent stem cell human CVCL_A5MN CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2198; COL1A2; Simple; p.Gly700Cys (c.2098G>T) (G610C); ClinVar=VCV000641929; Zygosity=Heterozygous (Coriell=GM27925) Population: Caucasian; Amish; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127227908 CVCL_A5MQ GM27938 induced pluripotent stem cell human CVCL_A5MQ CL:0000010 Population: Caucasian; Donor information: The donor is mosaic for the disease causing KIF1A mutation, this cell line originate from a wild-type cell (Coriell=GM27938); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127227909 CVCL_A5MP GM27937 induced pluripotent stem cell human CVCL_A5MP CL:0000010 Sequence variation: Mutation; HGNC; HGNC:888; KIF1A; Simple; p.Arg203Ser (c.609G>T); Zygosity=Mosaic (Coriell=GM27937) Population: Caucasian; Donor information: The donor is mosaic for the disease causing KIF1A mutation, this cell line originate from a diseased cell (Coriell=GM27937); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127227910 CVCL_A5MS 77-1 cancer cell line human CVCL_A5MS CL:0000010 Population: Japanese; Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429. Male Doubling time: 1.4 days (PubMed=7817386; PubMed=10328163) 127227911 CVCL_A5MR GM27978 induced pluripotent stem cell human CVCL_A5MR CL:0000010 Sequence variation: Mutation; HGNC; HGNC:20311; CHAMP1; Simple; p.Ser181Cysfs*5 (c.542_543delCT); ClinVar=VCV000217909; Zygosity=Heterozygous (Coriell=GM27978) Population: Caucasian and Native North American; Alaskan; Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127227912 CVCL_A5MU SNUe004-A-2 embryonic stem cell human CVCL_A5MU From: Seoul National University; Seoul; South Korea CL:0000010 Population: Korean; Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127227913 CVCL_A5MT SNUe004-A-1 embryonic stem cell human CVCL_A5MT From: Seoul National University; Seoul; South Korea CL:0000010 Population: Korean; Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127227914 CVCL_A5MG GM28029 finite cell line human CVCL_A5MG CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28029); Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Arg230Ter (c.688C>T); ClinVar=VCV000280010; Zygosity=Heterozygous (Coriell=GM28029) Population: Native North American; Cherokee, Caucasian and Mexican; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227915 CVCL_A5MF GM28026 transformed cell line human CVCL_A5MF CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6408; MAFB; Simple; p.Pro71Arg (c.212C>G); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28026) Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127227916 CVCL_A5MI GM28031 finite cell line human CVCL_A5MI CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28031); Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Ser282Cysfs*9 (c.841_842CT[2]) (c.845_846delCT); ClinVar=VCV000012770; Zygosity=Heterozygous (Coriell=GM28031) Population: Caucasian; Polish; Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127227917 CVCL_A5MH GM28030 finite cell line human CVCL_A5MH CL:0000010 Population: Caucasian; Polish; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127227918 CVCL_A5MK GM27901 transformed cell line human CVCL_A5MK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11497; SYNGAP1; Simple; p.Arg1240Ter (c.3718C>T); ClinVar=VCV000225077; Zygosity=Heterozygous (Coriell=GM27901) Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127227919 CVCL_A5MJ GM28032 finite cell line human CVCL_A5MJ CL:0000010 Population: Caucasian; Polish; Derived from site: In situ; Back, skin; UBERON=UBERON_0001068; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227920 CVCL_A5MM GM27918 induced pluripotent stem cell human CVCL_A5MM CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227921 CVCL_A5ML GM27957 induced pluripotent stem cell human CVCL_A5ML CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11497; SYNGAP1; Simple; p.Arg1240Ter (c.3718C>T); ClinVar=VCV000225077; Zygosity=Heterozygous (Coriell=GM27957) Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127227922 CVCL_A5MA GM28019 finite cell line human CVCL_A5MA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Glu1366Lys (c.4096G>A); ClinVar=VCV000200036; Zygosity=Heterozygous (Coriell=GM28019); Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu90Pro (c.269T>C); ClinVar=VCV000381516; Zygosity=Heterozygous (Coriell=GM28019); Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28019) Population: Caucasian; Dutch; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227923 CVCL_A5MC GM28021 finite cell line human CVCL_A5MC CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu90Pro (c.269T>C); ClinVar=VCV000381516; Zygosity=Heterozygous (Coriell=GM28021); Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28021) Population: Caucasian; Dutch; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127227924 CVCL_A5MB GM28020 finite cell line human CVCL_A5MB CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Glu1366Lys (c.4096G>A); ClinVar=VCV000200036; Zygosity=Heterozygous (Coriell=GM28020); Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu90Pro (c.269T>C); ClinVar=VCV000381516; Zygosity=Heterozygous (Coriell=GM28020); Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28020) Population: Caucasian; Dutch; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127227925 CVCL_A5ME GM28023 finite cell line human CVCL_A5ME CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Glu1366Lys (c.4096G>A); ClinVar=VCV000200036; Zygosity=Heterozygous (Coriell=GM28023); Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu90Pro (c.269T>C); ClinVar=VCV000381516; Zygosity=Heterozygous (Coriell=GM28023) Population: Caucasian; Dutch; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127227926 CVCL_A5MD GM28022 finite cell line human CVCL_A5MD CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28022) Population: Caucasian; Dutch; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227927 CVCL_A5LV OSPR cancer cell line human CVCL_A5LV CL:0000010 Unspecified 127227928 CVCL_A5LU OSON cancer cell line human CVCL_A5LU CL:0000010 Unspecified 127227929 CVCL_A5LX OSSM cancer cell line human CVCL_A5LX CL:0000010 Unspecified 127227930 CVCL_A5LW OSSK cancer cell line human CVCL_A5LW CL:0000010 Unspecified 127227931 CVCL_A5LZ U2OS-ATRkd cancer cell line human CVCL_A5LZ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:882; ATR (Note=With p.Asp2494Glu = ATRkd); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 127227932 CVCL_A5LY OSWO cancer cell line human CVCL_A5LY CL:0000010 Unspecified 127227933 CVCL_A5JL ND15114 transformed cell line human CVCL_A5JL CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15114; probable Male 127227934 CVCL_A5JK ND15099 transformed cell line human CVCL_A5JK CL:0000010 Population: Caucasian; British; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15099; probable Male 127227935 CVCL_A5JN ND15139 transformed cell line human CVCL_A5JN CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15139; probable Female 127227936 CVCL_A5JM ND15118 transformed cell line human CVCL_A5JM CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15118; probable Female 127227937 CVCL_A5JP ND15147 transformed cell line human CVCL_A5JP CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15147; probable Male 127227938 CVCL_A5JR ND15149 transformed cell line human CVCL_A5JR CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15149; probable Female 127227939 CVCL_A5JQ ND15148 transformed cell line human CVCL_A5JQ CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15148; probable Female 127227940 CVCL_A5JD ND14972 transformed cell line human CVCL_A5JD CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND14972; probable Male 127227941 CVCL_A5JC ND14970 transformed cell line human CVCL_A5JC CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND14970; probable Female 127227942 CVCL_A5JF ND14974 transformed cell line human CVCL_A5JF CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND14974; probable Female 127227943 CVCL_A5JE ND14973 transformed cell line human CVCL_A5JE CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND14973; probable Male 127227944 CVCL_A5JH ND15056 transformed cell line human CVCL_A5JH CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15056; probable Male 127227945 CVCL_A5JG ND15001 transformed cell line human CVCL_A5JG CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15001; probable Male 127227946 CVCL_A5JJ ND15096 transformed cell line human CVCL_A5JJ CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15096; probable Male 127227947 CVCL_A5JI ND15058 transformed cell line human CVCL_A5JI CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15058; probable Male 127227948 CVCL_A5IZ ND14720 transformed cell line human CVCL_A5IZ CL:0000010 Population: Jewish; Ashkenazi; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND14720; probable Male 127227949 CVCL_A5JB ND14883 transformed cell line human CVCL_A5JB CL:0000010 Population: Jewish; Ashkenazi; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND14883; probable Female 127227950 CVCL_A5JA ND14761 transformed cell line human CVCL_A5JA CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND14761; probable Female 127227951 CVCL_A5IS MP 4112 hybrid cell line human CVCL_A5IS CL:0000010 Selected for resistance to: ChEBI; CHEBI_472805; Ouabain; Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG). Group: Hybridoma fusion partner cell line; Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2128 127227952 CVCL_A5IR MP 4109 hybrid cell line human CVCL_A5IR CL:0000010 Selected for resistance to: ChEBI; CHEBI_472805; Ouabain; Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG). Group: Hybridoma fusion partner cell line; Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2129 127227953 CVCL_A5IU UKAi004-A induced pluripotent stem cell human CVCL_A5IU From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Ser972Leu (c.2915C>T); ClinVar=VCV000133443; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:7780; NFE2; Simple; p.Glu261Alafs*3 (c.782_785delAGAG); Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Cys973Alafs*34 (c.2917delT); Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Ile1762Val (c.5284A.G); ClinVar=VCV000135287; Zygosity=Homozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Heterozygous (PubMed=33512435) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Established from a patient that has a KIT p.Asp816Val mutation, but this cell line does not contain this mutation 127227954 CVCL_A5IT MP 4126 hybrid cell line human CVCL_A5IT CL:0000010 Selected for resistance to: ChEBI; CHEBI_472805; Ouabain; Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG). Group: Hybridoma fusion partner cell line; Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2615 127227955 CVCL_A5IW UKAi004-C induced pluripotent stem cell human CVCL_A5IW From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Ser972Leu (c.2915C>T); ClinVar=VCV000133443; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp816Val (c.2447A>T); ClinVar=VCV000013852; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:7780; NFE2; Simple; p.Glu261Alafs*3 (c.782_785delAGAG); Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Ile1762Val (c.5284A.G); ClinVar=VCV000135287; Zygosity=Homozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Heterozygous (PubMed=33512435) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227956 CVCL_A5IV UKAi004-B induced pluripotent stem cell human CVCL_A5IV From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Ser972Leu (c.2915C>T); ClinVar=VCV000133443; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:7780; NFE2; Simple; p.Glu261Alafs*3 (c.782_785delAGAG); Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Cys973Alafs*34 (c.2917delT); Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Ile1762Val (c.5284A.G); ClinVar=VCV000135287; Zygosity=Homozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Heterozygous (PubMed=33512435) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Established from a patient that has a KIT p.Asp816Val mutation, but this cell line does not contain this mutation 127227957 CVCL_A5IY UKAi004-E induced pluripotent stem cell human CVCL_A5IY From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Ser972Leu (c.2915C>T); ClinVar=VCV000133443; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp816Val (c.2447A>T); ClinVar=VCV000013852; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:7780; NFE2; Simple; p.Glu261Alafs*3 (c.782_785delAGAG); Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Ile1762Val (c.5284A.G); ClinVar=VCV000135287; Zygosity=Homozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Heterozygous (PubMed=33512435) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227958 CVCL_A5IX UKAi004-D induced pluripotent stem cell human CVCL_A5IX From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Ser972Leu (c.2915C>T); ClinVar=VCV000133443; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp816Val (c.2447A>T); ClinVar=VCV000013852; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:7780; NFE2; Simple; p.Glu261Alafs*3 (c.782_785delAGAG); Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Ile1762Val (c.5284A.G); ClinVar=VCV000135287; Zygosity=Homozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Heterozygous (PubMed=33512435) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127227959 CVCL_A5KM CHO-K1 mutant 29 transformed cell line CVCL_A5KM CL:0000010 Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Defective in the incorporation of ethanolamine into phosphatidylethanolamine (PubMed=2684962) 127227960 CVCL_A5KL CHO-tsH1-C9D9 spontaneously immortalized cell line CVCL_A5KL CL:0000010 Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Compared to the parent cell line, it has reduced system L transport activity Selection is effected by tritium suicide selection. Mutagenized cells are bathed in tritiated D-leucine and stored so as to allow time for cells that had taken up the D-leucine to be killed by radiation damage. 127227961 CVCL_A5KN CHO-K1 PSA-1 transformed cell line CVCL_A5KN CL:0000010 Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Require exogenous phosphatidylserine for growth (PubMed=3084470) 127227962 CVCL_A5KQ CHO-K1 PSA-3 transformed cell line CVCL_A5KQ CL:0000010 Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Require exogenous phosphatidylserine for growth (PubMed=3084470) Defective for phosphatidylserine synthase 1 (Ptdss1) (PubMed=1748687). 127227963 CVCL_A5KP CHO-K1 PSA-2 transformed cell line CVCL_A5KP CL:0000010 Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Require exogenous phosphatidylserine for growth (PubMed=3084470) 127227964 CVCL_A5KS H7v17q embryonic stem cell human CVCL_A5KS CL:0000010 Miscellaneous: Cell line information from personal communication of Price, Christopher John Karyotypic information: 46,XX,der(6)t(6;17)(q27;q1) (Direct_author_submission); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Aneuploid WA07 subline with gain of chromosome 17q 127227965 CVCL_A5KR H7v1q embryonic stem cell human CVCL_A5KR CL:0000010 Karyotypic information: 46,XX,dup(1)(q21;q42) (PubMed=34407428); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Aneuploid WA07 subline with gain of chromosome 1q (PubMed=34407428) 127227966 CVCL_A5KE CHO-K1 Mev-SM transformed cell line CVCL_A5KE CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=RGD; 2804; Hmgcs2 Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Repairs the deficiency in mevalonate biosynthesis of the parent cell line (PubMed=7961793) 127227967 CVCL_A5KD CHO-K1 Mev-1 transformed cell line CVCL_A5KD CL:0000010 Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Deficient for mevalonate biosynthesis Lacks hydroxymethylglutaryl-CoA synthase activity (PubMed=4019518). 127227968 CVCL_A5KG CHO-tsH1-D10 spontaneously immortalized cell line CVCL_A5KG CL:0000010 Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Temperature-resistant revertant of CHO-tsH1 with constitutively elevated system L transport activity (PubMed=6863284) 127227969 CVCL_A5KF CHO-tsH1-C11 spontaneously immortalized cell line CVCL_A5KF CL:0000010 Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Temperature-resistant revertant of CHO-tsH1 with constitutively elevated system L transport activity (PubMed=6863284) 127227970 CVCL_A5KI CHO-tsH1-C11B6 spontaneously immortalized cell line CVCL_A5KI CL:0000010 Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Temperature-resistant revertant of CHO-tsH1 with constitutively elevated system L transport activity (PubMed=2777768) 127227971 CVCL_A5KH CHO-tsH1-F10 spontaneously immortalized cell line CVCL_A5KH CL:0000010 Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Temperature-resistant revertant of CHO-tsH1 with constitutively elevated system L transport activity (PubMed=6863284) 127227972 CVCL_A5KK CHO-tsH1-C5D9 spontaneously immortalized cell line CVCL_A5KK CL:0000010 Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Compared to the parent cell line, it has reduced system L transport activity Selection is effected by tritium suicide selection. Mutagenized cells are bathed in tritiated D-leucine and stored so as to allow time for cells that had taken up the D-leucine to be killed by radiation damage. 127227973 CVCL_A5KJ CHO-tsH1-C4B4 spontaneously immortalized cell line CVCL_A5KJ CL:0000010 Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Compared to the parent cell line, it has reduced system L transport activity Selection is effected by tritium suicide selection. Mutagenized cells are bathed in tritiated D-leucine and stored so as to allow time for cells that had taken up the D-leucine to be killed by radiation damage. 127227974 CVCL_A5KA A549-hACE2 [Invivogen] cancer cell line human CVCL_A5KA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13557; ACE2; Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Permissive to infection by SARS-CoV-2 and/or spike-pseudotyped lentiviral particles (InvivoGen=a549-hace2) Group: SARS-CoV-2 research cell line 127227975 CVCL_A5KC HUES 17v12,17 embryonic stem cell human CVCL_A5KC CL:0000010 Miscellaneous: Cell line information from personal communication of Price, Christopher John Karyotypic information: 48,XY,+12,+17 (Direct_author_submission); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Aneuploid HUES 17 subline with gain of chromosomes 12 and 17 127227976 CVCL_A5KB A549-hACE2-TMPRSS2 cancer cell line human CVCL_A5KB CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13557; ACE2; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11876; TMPRSS2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Virology: Highly susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) and/or spike-pseudotyped lentiviral particles (InvivoGen=a549-hace2tpsa) Group: SARS-CoV-2 research cell line 127227977 CVCL_A5JT ND15167 transformed cell line human CVCL_A5JT CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15167; probable Male 127227978 CVCL_A5JS ND15150 transformed cell line human CVCL_A5JS CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15150; probable Male 127227979 CVCL_A5JV K9STS cancer cell line dog CVCL_A5JV CL:0000010 Unspecified Doubling time: 35.04 +- 8.1 hours (PubMed=18562222). 127227980 CVCL_A5JU ND15171 transformed cell line human CVCL_A5JU CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Coriell; ND15171; probable Male 127227981 CVCL_A5JX FM3A tsFT5 cancer cell line house mouse CVCL_A5JX CL:0000010 Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG); Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: C3H/He. Female Characteristics: Temperature sensitive phenotype Stop growing at 39 Celsius. Defective in DNA replication. Contains a thermolabile Uba1 (PubMed=8344958). Doubling time: ~18 hours (PubMed=8344958) 127227982 CVCL_A5JW FM3A ts85R-MN3 cancer cell line house mouse CVCL_A5JW CL:0000010 Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG); Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: C3H/He. Female Characteristics: Revertant of parent cell line (ts85) 127227983 CVCL_A5JZ BW5147.PHAR2.1 cancer cell line house mouse CVCL_A5JZ CL:0000010 Selected for resistance to: UniProtKB; P05087; Phaseolus vulgaris leucoagglutinating phytohemagglutinin (PHA-L); Derived from site: In situ; Thymus; UBERON=UBERON_0002370; Breed/subspecies: AKR/J. Characteristics: Deficient in alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase (Mgat5) (PubMed=6216250) 127227984 CVCL_A5JY FM3A tsFT50 cancer cell line house mouse CVCL_A5JY CL:0000010 Sequence variation: Mutation; MGI; MGI:1927222; Diaph3; Simple; p.Gln668Ter (c.2002C>T); Zygosity=Homozygous (PubMed=33187357) Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG); Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: C3H/He. Female Characteristics: Temperature sensitive phenotype Cytokinesis is blocked at 39 Celsius. 127227985 CVCL_A5HJ UCLAi004-A induced pluripotent stem cell human CVCL_A5HJ From: University of California, Los Angeles; Los Angeles; USA CL:0000010 Population: Caucasian; Donor information: Established from monozygotic twin of UCLAi001-A (Cellosaurus=CVCL_WT92), UCLAi001-B (Cellosaurus=CVCL_WT93) and UCLAi001-C (Cellosaurus=CVCL_WT94); Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227986 CVCL_A5HI UCLAi003-C induced pluripotent stem cell human CVCL_A5HI From: University of California, Los Angeles; Los Angeles; USA CL:0000010 Donor information: Established from monozygotic twin of UCLAi002-A (Cellosaurus=CVCL_A5HD), UCLAi002-B (Cellosaurus=CVCL_A5HE) and UCLAi002-C (Cellosaurus=CVCL_A5HF); Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227987 CVCL_A5HL UCLAi004-C induced pluripotent stem cell human CVCL_A5HL From: University of California, Los Angeles; Los Angeles; USA CL:0000010 Population: Caucasian; Donor information: Established from monozygotic twin of UCLAi001-A (Cellosaurus=CVCL_WT92), UCLAi001-B (Cellosaurus=CVCL_WT93) and UCLAi001-C (Cellosaurus=CVCL_WT94); Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227988 CVCL_A5HK UCLAi004-B induced pluripotent stem cell human CVCL_A5HK From: University of California, Los Angeles; Los Angeles; USA CL:0000010 Population: Caucasian; Donor information: Established from monozygotic twin of UCLAi001-A (Cellosaurus=CVCL_WT92), UCLAi001-B (Cellosaurus=CVCL_WT93) and UCLAi001-C (Cellosaurus=CVCL_WT94); Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227989 CVCL_A5HN aMoS7 transformed cell line house mouse CVCL_A5HN CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Small intestine, ileum, intestinal crypt; UBERON=UBERON_0013481; Cell type: Epithelial cell of intestine; CL=CL_0002563; Breed/subspecies: BALB/c. Female 127227990 CVCL_A5HM aMoC1 transformed cell line house mouse CVCL_A5HM CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Colon, intestinal crypt; UBERON=UBERON_0013485; Cell type: Epithelial cell of colon; CL=CL_0011108; Breed/subspecies: BALB/c. Female 127227991 CVCL_A5HP U-251MG IDH1 R132C cancer cell line human CVCL_A5HP CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5382; IDH1 (Note=With p.Arg132Cys); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872. Male 127227992 CVCL_A5HB HES-3 NKX2.1GFP/w embryonic stem cell human CVCL_A5HB CL:0000010 Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Using homologous recombination an EGFP reporter gene was introduced in one allele of the NKX2.1 locus Registration: Swiss research registry; BAG-hES-IMP-0067 127227993 CVCL_A5HA ESIBIe003-A-6 embryonic stem cell human CVCL_A5HA From: Universite Libre de Bruxelles; Brussels; Belgium CL:0000010 Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11825; NKX2-1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8622; PAX8 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Transduced with a lentiviral cassette containing an NKX2.1-IRES-PAX8 construct under the control of a promoter inducible by doxycycline via a tetracycline response element; Characteristics: Using homologous recombination an EGFP reporter gene was introduced in one allele of the INS locus 127227994 CVCL_A5HD UCLAi002-A induced pluripotent stem cell human CVCL_A5HD From: University of California, Los Angeles; Los Angeles; USA CL:0000010 Donor information: Established from monozygotic twin of UCLAi003-A (Cellosaurus=CVCL_A5HG), UCLAi003-B (Cellosaurus=CVCL_A5HH) and UCLAi003-C (Cellosaurus=CVCL_A5HI); Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227995 CVCL_A5HC HOC-I cancer cell line human CVCL_A5HC CL:0000010 Population: Japanese; Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female Doubling time: ~75 hours (PubMed=2723484) 127227996 CVCL_A5HF UCLAi002-C induced pluripotent stem cell human CVCL_A5HF From: University of California, Los Angeles; Los Angeles; USA CL:0000010 Donor information: Established from monozygotic twin of UCLAi003-A (Cellosaurus=CVCL_A5HG), UCLAi003-B (Cellosaurus=CVCL_A5HH) and UCLAi003-C (Cellosaurus=CVCL_A5HI); Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227997 CVCL_A5HE UCLAi002-B induced pluripotent stem cell human CVCL_A5HE From: University of California, Los Angeles; Los Angeles; USA CL:0000010 Donor information: Established from monozygotic twin of UCLAi003-A (Cellosaurus=CVCL_A5HG), UCLAi003-B (Cellosaurus=CVCL_A5HH) and UCLAi003-C (Cellosaurus=CVCL_A5HI); Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227998 CVCL_A5HH UCLAi003-B induced pluripotent stem cell human CVCL_A5HH From: University of California, Los Angeles; Los Angeles; USA CL:0000010 Donor information: Established from monozygotic twin of UCLAi002-A (Cellosaurus=CVCL_A5HD), UCLAi002-B (Cellosaurus=CVCL_A5HE) and UCLAi002-C (Cellosaurus=CVCL_A5HF); Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127227999 CVCL_A5HG UCLAi003-A induced pluripotent stem cell human CVCL_A5HG From: University of California, Los Angeles; Los Angeles; USA CL:0000010 Donor information: Established from monozygotic twin of UCLAi002-A (Cellosaurus=CVCL_A5HD), UCLAi002-B (Cellosaurus=CVCL_A5HE) and UCLAi002-C (Cellosaurus=CVCL_A5HF); Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228000 CVCL_A5GY IBMS-iPSC-068-02 induced pluripotent stem cell human CVCL_A5GY From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan CL:0000010 Population: Asian. Male 127228001 CVCL_A5GX TBN spontaneously immortalized cell line CVCL_A5GX CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Neural cell; CL=CL_0002319. Omics: Transcriptomics; RNAseq Unspecified Characteristics: Optimal growth temperature is 32 Celsius Does not grow at 16 Celsius. Doubling time: 4.84 days (Note=In 2.5% FBS), 2.66 days (Note=In 7.5% FBS), 2.44 days (Note=In 10% FBS), 2.59 days (Note=In 15% FBS), 4.84 days (Note=In 20% FBS) (PubMed=33258111) Group: Fish cell line 127228002 CVCL_A5GZ UNIBSi014-A induced pluripotent stem cell human CVCL_A5GZ From: University of Brescia; Brescia; Italy CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228003 CVCL_A5GQ UKAi001-A-1 induced pluripotent stem cell human CVCL_A5GQ From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5358; IRF8; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous (hPSCreg=UKAi001-A-1) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 127228004 CVCL_A5GP UKAi001-C induced pluripotent stem cell human CVCL_A5GP From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous (hPSCreg=UKAi001-C) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 127228005 CVCL_A5GS UKAi001-C-1 induced pluripotent stem cell human CVCL_A5GS From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5358; IRF8; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous (hPSCreg=UKAi001-C-1) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 127228006 CVCL_A5GR UKAi001-B-1 induced pluripotent stem cell human CVCL_A5GR From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5358; IRF8; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous (hPSCreg=UKAi001-B-1) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 127228007 CVCL_A5GU ZZUi029-A induced pluripotent stem cell human CVCL_A5GU From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China. CL:0000010 127228008 CVCL_A5GT ZZUi027-A induced pluripotent stem cell human CVCL_A5GT From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:16499; RAB39B; Simple; p.Glu179fs*48 (c.536dupA); Zygosity=Hemizygous (PubMed=34247111) Population: Chinese; Han; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228009 CVCL_A5GW NOSCC1 cancer cell line human CVCL_A5GW CL:0000010 Population: Japanese; Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female Characteristics: Established from tumors in super-immunodeficient NSG (NOD.Cg-Prkdc(scid)Il2rg(tm1Wjl)/SzJ) mice subcutanously injected with the patient tumor pieces (PubMed=33300248) 127228010 CVCL_A5GV EZB-ICR cancer cell line human CVCL_A5GV CL:0000010 Population: Iranian; Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Female Doubling time: ~31 hours (Note=At 25th passage) (PubMed=33507685) 127228011 CVCL_A5IK ips#202 induced pluripotent stem cell house mouse CVCL_A5IK CL:0000010 Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620; Breed/subspecies: Isl1:Cre/Rosa26-YFP transgenic. Unspecified 127228012 CVCL_A5IJ NCC-DDLPS2-C1 cancer cell line human CVCL_A5IJ CL:0000010 Population: Japanese; Derived from site: In situ; Right thigh; UBERON=UBERON_0000376. Omics: Phenotyping; Drug screening; Omics: Variations; SNP array analysis Female Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi); Doubling time: ~54 hours (PubMed=33555519) Part of: NCC sarcoma cell line panel 127228013 CVCL_A5IM ips#137 induced pluripotent stem cell house mouse CVCL_A5IM CL:0000010 Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620; Breed/subspecies: Isl1:Cre/Rosa26-LacZ transgenic. Unspecified 127228014 CVCL_A5IL ips#231 induced pluripotent stem cell house mouse CVCL_A5IL CL:0000010 Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620; Breed/subspecies: Isl1:Cre/Rosa26-YFP transgenic. Unspecified 127228015 CVCL_A5IN NS-(f)iPS Isl1C somatic stem cell house mouse CVCL_A5IN CL:0000010 Genetic integration: Method=Transgenic mouse; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620; Breed/subspecies: Isl1:Cre/Rosa26-YFP transgenic. Unspecified Characteristics: Neural stem cell 127228016 CVCL_A5IQ hTERT-1604-PMS134 telomerase immortalized cell line human CVCL_A5IQ CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9122; PMS2 (Note=With p.Arg134Ter = PMS134); Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: African American; Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597; Cell type: Fibroblast of lung; CL=CL_0002553. Male 127228017 CVCL_A5IP HEK293 HADH-/- transformed cell line human CVCL_A5IP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4799; HADH Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 127228018 CVCL_A5IC UM-Chor5C cancer cell line human CVCL_A5IC CL:0000010 Population: Caucasian; Derived from site: Metastatic; Salivary gland, parotid gland; UBERON=UBERON_0001831. Male Doubling time: 3.794 days (Chordoma Foundation) 127228019 CVCL_A5IB Vero-SCARB2 spontaneously immortalized cell line green monkey CVCL_A5IB CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1665; SCARB2; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819; Cell type: Epithelial cell of kidney; CL=CL_0002518. Female Virology: Highly susceptible to infection by enterovirus type 71 (EV71) and coxsackievirus A group type 16 (CA16) (PubMed=23919614) Group: Non-human primate cell line 127228020 CVCL_A5IE U-CH18 cancer cell line human CVCL_A5IE CL:0000010 Derived from site: In situ; Bone, chest; UBERON=UBERON_0003459. Male Doubling time: ~7-8 days (Chordoma Foundation) 127228021 CVCL_A5ID UM-Chor5D cancer cell line human CVCL_A5ID CL:0000010 Population: Caucasian; Derived from site: In situ; Bone, cranium, clivus; UBERON=UBERON_0004108. Male Doubling time: 4.632 days (Chordoma Foundation) 127228022 CVCL_A5IG UM-Chor6 cancer cell line human CVCL_A5IG CL:0000010 Derived from site: In situ; Bone, cranium, clivus; UBERON=UBERON_0004108. Male Doubling time: ~21 days (Chordoma Foundation) 127228023 CVCL_A5IF U-CH19 cancer cell line human CVCL_A5IF CL:0000010 Population: Caucasian; Derived from site: In situ; Bone, sacrum; UBERON=UBERON_0003690. Male Doubling time: ~7 days (Chordoma Foundation) 127228024 CVCL_A5II U-CHCF365 cancer cell line human CVCL_A5II CL:0000010 Derived from site: Metastatic; Scalp; UBERON=UBERON_0000403. Male Characteristics: Established from the CF365 patient-derived xenograft Doubling time: ~4 days (Chordoma Foundation); ~4-5 days (ATCC=CRL-3518) 127228025 CVCL_A5IH U-CHCF359B cancer cell line human CVCL_A5IH CL:0000010 Derived from site: Metastatic; Brain, pineal gland; UBERON=UBERON_0001905. Female Characteristics: Established from the CF359B patient-derived xenograft Doubling time: 5-6 days (Chordoma Foundation) 127228026 CVCL_A5HZ 293-SCARB2 transformed cell line human CVCL_A5HZ CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1665; SCARB2; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Virology: Highly susceptible to infection by enterovirus type 71 (EV71) and coxsackievirus A group type 16 (CA16) (PubMed=23919614) 127228027 CVCL_A5HY TS516 cancer cell line human CVCL_A5HY CL:0000010 Miscellaneous: Cell line has been lost (personal communication of Weis-Garcia, Frances M.B.); Miscellaneous: Doubling time from MSKCC antibody and bioresource core facility Derived from site: In situ; Brain; UBERON=UBERON_0000955. Doubling time: ~2 days (Direct_author_submission) 127228028 CVCL_A5IA RD-SCARB2 cancer cell line human CVCL_A5IA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1665; SCARB2; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Pelvis, muscle; UBERON=UBERON_0001325. Female Virology: Highly susceptible to infection by enterovirus type 71 (EV71) and coxsackievirus A group type 16 (CA16) (PubMed=23919614) 127228029 CVCL_A5HR U-251MG IDH1 WT cancer cell line human CVCL_A5HR CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5382; IDH1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872. Male 127228030 CVCL_A5HQ U-251MG IDH1 R132H cancer cell line human CVCL_A5HQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5382; IDH1 (Note=With p.Arg132His); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872. Male 127228031 CVCL_A5HT NCH645 cancer cell line human CVCL_A5HT CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Group: Cancer stem cell line 127228032 CVCL_A5HS NCH620 cancer cell line human CVCL_A5HS CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Group: Cancer stem cell line 127228033 CVCL_A5HV NCH1681 cancer cell line human CVCL_A5HV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Unspecified (PubMed=33504762) Derived from site: In situ; Brain; UBERON=UBERON_0000955. Group: Cancer stem cell line 127228034 CVCL_A5HU NCH551b cancer cell line human CVCL_A5HU CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Group: Cancer stem cell line 127228035 CVCL_A5HX TS676 cancer cell line human CVCL_A5HX CL:0000010 Miscellaneous: STR profile and doubling time from MSKCC antibody and bioresource core facility Derived from site: In situ; Brain; UBERON=UBERON_0000955. Male Doubling time: ~7 days (Direct_author_submission) 127228036 CVCL_A5HW TS603 cancer cell line human CVCL_A5HW CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Heterozygous (PubMed=23558169; PubMed=33504762) Miscellaneous: STR profile and doubling time from MSKCC antibody and bioresource core facility Derived from site: In situ; Brain; UBERON=UBERON_0000955. Doubling time: ~7 days (Direct_author_submission) 127228037 CVCL_A5FH IBBISTi001-D induced pluripotent stem cell human CVCL_A5FH From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Ala1206Profs*4 (c.3612delA); ClinVar=VCV000037533; Zygosity=Heterozygous (PubMed=33631522) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228038 CVCL_A5FG IBBISTi001-C induced pluripotent stem cell human CVCL_A5FG From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Ala1206Profs*4 (c.3612delA); ClinVar=VCV000037533; Zygosity=Heterozygous (PubMed=33631522) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228039 CVCL_A5FJ IBBISTi002-B induced pluripotent stem cell human CVCL_A5FJ From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228040 CVCL_A5FI IBBISTi002-A induced pluripotent stem cell human CVCL_A5FI From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228041 CVCL_A5FL IBBISTi003-B induced pluripotent stem cell human CVCL_A5FL From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Unexplicit; c.156_157insAlu; ClinVar=VCV000126018; Zygosity=Heterozygous (PubMed=34087993) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228042 CVCL_A5FK IBBISTi003-A induced pluripotent stem cell human CVCL_A5FK From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Unexplicit; c.156_157insAlu; ClinVar=VCV000126018; Zygosity=Heterozygous (PubMed=34087993) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228043 CVCL_A5FN IBBISTi003-D induced pluripotent stem cell human CVCL_A5FN From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Unexplicit; c.156_157insAlu; ClinVar=VCV000126018; Zygosity=Heterozygous (from autologous cell lines IBBISTi003-A; IBBISTi003-B; IBBISTi003-C) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228044 CVCL_A5FM IBBISTi003-C induced pluripotent stem cell human CVCL_A5FM From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Unexplicit; c.156_157insAlu; ClinVar=VCV000126018; Zygosity=Heterozygous (PubMed=34087993) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228045 CVCL_A5FB HPIi001-B induced pluripotent stem cell human CVCL_A5FB From: Harry Perkins Institute of Medical Research, University of Western Australia; Nedlands; Australia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Arg185Ser (c.553C>A); ClinVar=VCV000420099; Zygosity=Heterozygous (PubMed=33740643) Population: Turkish; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228046 CVCL_A5FA HPIi001-A induced pluripotent stem cell human CVCL_A5FA From: Harry Perkins Institute of Medical Research, University of Western Australia; Nedlands; Australia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Arg185Ser (c.553C>A); ClinVar=VCV000420099; Zygosity=Heterozygous (PubMed=33740643) Population: Turkish; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228047 CVCL_A5FD HPIi002-B induced pluripotent stem cell human CVCL_A5FD From: Harry Perkins Institute of Medical Research, University of Western Australia; Nedlands; Australia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Asp179Asn (c.541G>A); Zygosity=Heterozygous (PubMed=34388489) Population: Caucasian; French; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228048 CVCL_A5FC HPIi002-A induced pluripotent stem cell human CVCL_A5FC From: Harry Perkins Institute of Medical Research, University of Western Australia; Nedlands; Australia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Asp179Asn (c.541G>A); Zygosity=Heterozygous (PubMed=34388489) Population: Caucasian; French; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228049 CVCL_A5FF IBBISTi001-B induced pluripotent stem cell human CVCL_A5FF From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Ala1206Profs*4 (c.3612delA); ClinVar=VCV000037533; Zygosity=Heterozygous (PubMed=33631522) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228050 CVCL_A5FE IBBISTi001-A induced pluripotent stem cell human CVCL_A5FE From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Ala1206Profs*4 (c.3612delA); ClinVar=VCV000037533; Zygosity=Heterozygous (PubMed=33631522) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228051 CVCL_A5EW EHTJUi003-A induced pluripotent stem cell human CVCL_A5EW From: East Hospital Affiliated to Tongji University; Shanghai; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Leu460Trpfs*6 (c.1377delC); ClinVar=VCV000188548; Zygosity=Heterozygous (PubMed=34087980) Population: Chinese; Han; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; Whole exome sequencing Female 127228052 CVCL_A5EV CRICKi002-A induced pluripotent stem cell human CVCL_A5EV From: The Francis Crick Institute Limited; London; United Kingdom CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Unspecified 127228053 CVCL_A5EY FDCHi005-B induced pluripotent stem cell human CVCL_A5EY From: Children's Hospital of Fudan University; Shanghai; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3091; DYRK1A; Simple_corrected; p.Val577Asp (c.1730T>A); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=33813175) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228054 CVCL_A5EX FDCHi005-A induced pluripotent stem cell human CVCL_A5EX From: Children's Hospital of Fudan University; Shanghai; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3091; DYRK1A; Simple; p.Val577Asp (c.1730T>A); Zygosity=Heterozygous (PubMed=33813175) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228055 CVCL_A5EZ GZHMCi005-A induced pluripotent stem cell human CVCL_A5EZ From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China CL:0000010 Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173. Male 127228056 CVCL_A5EN 2T9 transformed cell line house mouse CVCL_A5EN CL:0000010 Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339; Cell type: Osteoblast; CL=CL_0000062; Breed/subspecies: Bmp2 promoter T-Ag-3 transgenic. Unspecified 127228057 CVCL_A5EQ WAe009-A-56 embryonic stem cell human CVCL_A5EQ From: Eye & ENT Hospital, Shanghai Medical School, Fudan University; Shanghai; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6694; LRP2 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127228058 CVCL_A5EP WAe009-A-50 embryonic stem cell human CVCL_A5EP From: Anzhen Hospital, Capital Medical University; Beijing; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11167; SNTA1 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Caution: There is another H9SNTA1KO cell line established in China (Cellosaurus=CVCL_C5TU) 127228059 CVCL_A5ES WTC-DMD-mEGFP-cl96 induced pluripotent stem cell human CVCL_A5ES CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP) Population: Japanese; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Using CRISPR/Cas9 DMD has been endogenously tagged in one allele at the C-terminus with mEGFP (Coriell=AICS-0063-096) Part of: Allen Cell Collection 127228060 CVCL_A5ER MDA-MB-231 met2 cancer cell line human CVCL_A5ER CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase; Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female Characteristics: Metastatic to lung Established from a lung tumor after injection of the parent cell line into the tail vein of athymic nude mice (PubMed=30337562). Group: Triple negative breast cancer (TNBC) cell line 127228061 CVCL_A5EU CRICKi001-A induced pluripotent stem cell human CVCL_A5EU From: The Francis Crick Institute Limited; London; United Kingdom CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Arg1203Cys (c.3607C>T); Zygosity=Heterozygous; Note=De novo mutation (PubMed=33799280) Population: Caucasian; Derived from site: In situ; Hair root; UBERON=UBERON_0000329; Cell type: Keratinocyte; CL=CL_0000312. Male 127228062 CVCL_A5ET WTC-CLYBL-dCas9-TagBFP-KRAB-cl391 induced pluripotent stem cell human CVCL_A5ET CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; BFJKS; TagBFP (Note=Blue fluorescent protein derived from eqFP578); Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB) Population: Japanese; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Using CRISPR/Cas9 a dCas9-TagBFP-KRAB construct is expressed from a CAGGS promoter edited into the 2nd intron of the CLYBL safe harbor Part of: Allen Cell Collection 127228063 CVCL_A5GI UNCi002-A induced pluripotent stem cell human CVCL_A5GI From: University of North Carolina at Chapel Hill; Chapel Hill; USA CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228064 CVCL_A5GK UMi030-A induced pluripotent stem cell human CVCL_A5GK From: Miller School of Medicine, University of Miami; Miami; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Val37Ile (c.109G>A); ClinVar=VCV000017023; Zygosity=Homozygous (PubMed=34883447) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228065 CVCL_A5GJ UMGi156-A induced pluripotent stem cell human CVCL_A5GJ From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228066 CVCL_A5GM UKAi001-A induced pluripotent stem cell human CVCL_A5GM From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous (hPSCreg=UKAi001-A) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 127228067 CVCL_A5GL WMUi021-A induced pluripotent stem cell human CVCL_A5GL From: Wenzhou Medical University; Wenzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10912; SLC12A3; Simple; p.Thr60Met (c.179C>T); ClinVar=VCV000101514; Zygosity=Homozygous (PubMed=33735743) Population: Chinese; Han; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male 127228068 CVCL_A5GN UKAi001-B induced pluripotent stem cell human CVCL_A5GN From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous (hPSCreg=UKAi001-B) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 127228069 CVCL_A5GA SCVI-19 induced pluripotent stem cell human CVCL_A5GA From: Stanford Cardiovascular Institute; Palo Alto; USA. CL:0000010 127228070 CVCL_A5GC SCVI-273 induced pluripotent stem cell human CVCL_A5GC From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228071 CVCL_A5GB SCVI-15 induced pluripotent stem cell human CVCL_A5GB From: Stanford Cardiovascular Institute; Palo Alto; USA. CL:0000010 127228072 CVCL_A5GE TIGETi003-A induced pluripotent stem cell human CVCL_A5GE From: San Raffaele Telethon Institute for Gene Therapy, Ospedale San Raffaele; Milan; Italy CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228073 CVCL_A5GD TIGETi001-A induced pluripotent stem cell human CVCL_A5GD From: San Raffaele Telethon Institute for Gene Therapy, Ospedale San Raffaele; Milan; Italy CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228074 CVCL_A5FX SCVIi004-A induced pluripotent stem cell human CVCL_A5FX From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple; p.Arg79Ter (c.235C>T); ClinVar=VCV000006754; Zygosity=Heterozygous (PubMed=33743362) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228075 CVCL_A5FW SCVIi003-A induced pluripotent stem cell human CVCL_A5FW From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple; p.His733Alafs*8 (c.2197_2202delinsG) (p.His689fs, c.2065_2070delinsG); ClinVar=VCV000045063; Zygosity=Heterozygous (PubMed=33743362) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228076 CVCL_A5FZ SCVI-114 induced pluripotent stem cell human CVCL_A5FZ From: Stanford Cardiovascular Institute; Palo Alto; USA. CL:0000010 127228077 CVCL_A5FY SCVIi005-A induced pluripotent stem cell human CVCL_A5FY From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple; p.Arg577Aspfs*5 (c.1725_1728dupGATG); ClinVar=VCV000406551; Zygosity=Heterozygous (PubMed=33743362) Population: East Asian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228078 CVCL_A5FP MRIi025-A induced pluripotent stem cell human CVCL_A5FP From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Asn308Ser (c.923A>G); ClinVar=VCV000013327; Zygosity=Heterozygous (PubMed=34988410) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228079 CVCL_A5FR MUNIe009-A embryonic stem cell human CVCL_A5FR From: Masaryk University; Brno; Czech Republic CL:0000010 Donor information: Embryo is sibling to that giving rise to MUNIe008-A (Cellosaurus=CVCL_A5FQ); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127228080 CVCL_A5FQ MUNIe008-A embryonic stem cell human CVCL_A5FQ From: Masaryk University; Brno; Czech Republic CL:0000010 Donor information: Embryo is sibling to that giving rise to MUNIe009-A (Cellosaurus=CVCL_A5FR); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127228081 CVCL_A5FT RCMGi005-A induced pluripotent stem cell human CVCL_A5FT From: Research Centre for Medical Genetics; Moscow; Russia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=36067639) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228082 CVCL_A5FS NCKDi002-A induced pluripotent stem cell human CVCL_A5FS From: National Center of Kidney Diseases; Nanjing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg363Gly (c.1087A>G) (p.Arg219Gly, c.655A>G); Zygosity=Heterozygous (PubMed=33780729) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228083 CVCL_A5FV SCVIi002-A induced pluripotent stem cell human CVCL_A5FV From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; c.3330+2T>G; ClinVar=VCV000008621; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=33743363) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228084 CVCL_A5FU SCVIi001-A induced pluripotent stem cell human CVCL_A5FU From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; c.3330+2T>G; ClinVar=VCV000008621; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=33743363) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228085 CVCL_A5TV U-251MG PAX6-/- 2A.28 cancer cell line human CVCL_A5TV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8620; PAX6; Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872. Male 127228086 CVCL_A5TU U-251MG PAX6-/- 2.10 cancer cell line human CVCL_A5TU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8620; PAX6; Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872. Male 127228087 CVCL_A5TX CEM/ara-G cancer cell line human CVCL_A5TX CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_73141; 9-beta-D-arabinofuranosylguanine (ara-G); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female Doubling time: 21.4 hours (PubMed=25070259) 127228088 CVCL_A5TW U-251MG PAX6-/- 2A.3 cancer cell line human CVCL_A5TW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8620; PAX6; Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872. Male 127228089 CVCL_A5TZ CCRF/CEM/ara-C/D cancer cell line human CVCL_A5TZ CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female 127228090 CVCL_A5TY CCRF/CEM/ara-C/B cancer cell line human CVCL_A5TY CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female 127228091 CVCL_A5TN UM-SCC-5PT cancer cell line human CVCL_A5TN CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16020667) Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP); Derived from site: In situ; Larynx, supraglottis; UBERON=UBERON_0036263. Male 127228092 CVCL_A5TM irPSCc3 transformed cell line Norway rat CVCL_A5TM CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Cell type: Pancreatic stellate cell; CL=CL_0002410; Breed/subspecies: Sprague Dawley; RS=RS_0000681. Unspecified 127228093 CVCL_A5TP UM-SCC-10BPT cancer cell line human CVCL_A5TP CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16020667) Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP); Derived from site: Metastatic; Submental lymph node; UBERON=UBERON_0016397. Male 127228094 CVCL_A5TR CalH2 cancer cell line human CVCL_A5TR CL:0000010 127228095 CVCL_A5TQ Ca1 cancer cell line human CVCL_A5TQ CL:0000010 127228096 CVCL_A5TT UK1 cancer cell line human CVCL_A5TT CL:0000010 127228097 CVCL_A5TS CalH3 cancer cell line human CVCL_A5TS CL:0000010 127228098 CVCL_A5TF sciCHO:hACE2:hTMPRSS2 spontaneously immortalized cell line CVCL_A5TF CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2; Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11876; TMPRSS2; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Discontinued: CLS; 603483; true Female Characteristics: Adapted to growth in suspension (CLS=603483) Doubling time: 18-22 hours (CLS=603483) Group: SARS-CoV-2 research cell line; Group: Serum/protein free medium cell line 127228099 CVCL_A5TE sciCHO:hACE2 spontaneously immortalized cell line CVCL_A5TE CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Discontinued: CLS; 603482; true Female Characteristics: Can be used for ACE2 binding assays, flow cytometry, screening of ACE2 antibodies (CLS=603482); Characteristics: Adapted to growth in suspension (CLS=603482) Doubling time: 18-22 hours (CLS=603482) Group: SARS-CoV-2 research cell line; Group: Serum/protein free medium cell line 127228100 CVCL_A5TH imPSCc1 transformed cell line house mouse CVCL_A5TH CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Cell type: Pancreatic stellate cell; CL=CL_0002410; Breed/subspecies: C57BL/6. Unspecified Doubling time: 45 hours (PubMed=20847583) 127228101 CVCL_A5TG RLT-PSC transformed cell line human CVCL_A5TG CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Cell type: Pancreatic stellate cell; CL=CL_0002410. Unspecified Doubling time: 28.6 +- 2.5 hours (PubMed=30621293) 127228102 CVCL_A5TJ imPSCc3 transformed cell line house mouse CVCL_A5TJ CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Cell type: Pancreatic stellate cell; CL=CL_0002410; Breed/subspecies: C57BL/6. Unspecified Doubling time: 51 hours (PubMed=20847583) 127228103 CVCL_A5TI imPSCc2 transformed cell line house mouse CVCL_A5TI CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Cell type: Pancreatic stellate cell; CL=CL_0002410; Breed/subspecies: C57BL/6. Unspecified Doubling time: 45 hours (PubMed=20847583) 127228104 CVCL_A5TL irPSCc2 transformed cell line Norway rat CVCL_A5TL CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Cell type: Pancreatic stellate cell; CL=CL_0002410; Breed/subspecies: Sprague Dawley; RS=RS_0000681. Unspecified 127228105 CVCL_A5TK irPSCc1 transformed cell line Norway rat CVCL_A5TK CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Cell type: Pancreatic stellate cell; CL=CL_0002410; Breed/subspecies: Sprague Dawley; RS=RS_0000681. Unspecified 127228106 CVCL_A5TB HSC-Li transformed cell line human CVCL_A5TB CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Population: Chinese; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatic stellate cell; CL=CL_0000632. Unspecified Characteristics: Produces both HGF and TGFB1 in a time-dependent manner (PubMed=25678842) Doubling time: 8 hours (PubMed=25678842) 127228107 CVCL_A5TA ASHe spontaneously immortalized cell line CVCL_A5TA CL:0000010 Derived from site: In situ; Heart; UBERON=UBERON_0000948; Cell type: Cardiac endothelial cell; CL=CL_0010008. Unspecified Group: Fish cell line 127228108 CVCL_A5TD sciCHO spontaneously immortalized cell line CVCL_A5TD CL:0000010 Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Discontinued: CLS; 603481; true; Discontinued: CLS; 613481; true Female Characteristics: Adapted to growth in suspension Optimized for the generation of stable populations and clones for high-yield recombinant protein production (CLS=603481). Doubling time: 18-22 hours (CLS=603481) Group: Serum/protein free medium cell line 127228109 CVCL_A5TC CAISMOV24 cancer cell line human CVCL_A5TC CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=29132324) Population: Brazilian; Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Omics: Variations; Array-based CGH Female Doubling time: 71.2 hours (PubMed=29132324) 127228110 CVCL_A5UW JW18 spontaneously immortalized cell line fruit fly CVCL_A5UW CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein) Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Omics: Transcriptomics; RNAseq Unspecified Characteristics: Expresses a Jupiter-GFP fusion protein; Characteristics: Constitutively infected with Wolbachia Group: Insect cell line 127228111 CVCL_A5UV S2-DGRC-attP-25C6 spontaneously immortalized cell line fruit fly CVCL_A5UV CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)) Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276. Male Characteristics: Using CRISPR/Cas9 a Actin5C promoter-dsRed cassette flanked by attP sites was introduced in the 25C6 locus (PubMed=33963853) Group: Insect cell line 127228112 CVCL_A5UY CCRF/CEM/ara-C/C cancer cell line human CVCL_A5UY CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female 127228113 CVCL_A5UX JW18DOX spontaneously immortalized cell line fruit fly CVCL_A5UX CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Unspecified Characteristics: Expresses a Jupiter-GFP fusion protein; Characteristics: Cured of Wolbachia infection through doxycycline treatment Group: Insect cell line 127228114 CVCL_A5UZ S2:DER2f spontaneously immortalized cell line fruit fly CVCL_A5UZ CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0000434; Der; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276. Male Group: Insect cell line 127228115 CVCL_A5UN S2R+-(FEx-10%) spontaneously immortalized cell line fruit fly CVCL_A5UN CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276. Male Characteristics: Adapted to growth in M3 + 10% Fly Extract (FEx) medium Group: Insect cell line; Group: Serum/protein free medium cell line 127228116 CVCL_A5UQ Kc167-(M3-FEx-2.5%) spontaneously immortalized cell line fruit fly CVCL_A5UQ CL:0000010 Female Characteristics: Adapted to growth in M3 + 2.5% Fly Extract (FEx) medium. Group: Insect cell line; Group: Serum/protein free medium cell line 127228117 CVCL_A5UP Kc167-(M3) spontaneously immortalized cell line fruit fly CVCL_A5UP CL:0000010 Female Characteristics: Adapted to growth in M3 medium. Group: Insect cell line; Group: Serum/protein free medium cell line 127228118 CVCL_A5US Kc167-attP-25C6 spontaneously immortalized cell line fruit fly CVCL_A5US CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)). Female Characteristics: Using CRISPR/Cas9 a Actin5C promoter-dsRed cassette flanked by attP sites was introduced in the 25C6 locus (PubMed=33963853) Group: Insect cell line 127228119 CVCL_A5UR Kc167-(M3BPYE-FEx2.5%) spontaneously immortalized cell line fruit fly CVCL_A5UR CL:0000010 Female Characteristics: Adapted to growth in M3 + BPYE + 2.5% Fly Extract (FEx) medium. Group: Insect cell line; Group: Serum/protein free medium cell line 127228120 CVCL_A5UU S2R+-attP-99F8 spontaneously immortalized cell line fruit fly CVCL_A5UU CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276. Male Group: Insect cell line 127228121 CVCL_A5UT Kc167-attP-99F8 spontaneously immortalized cell line fruit fly CVCL_A5UT CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)). Female Characteristics: Using CRISPR/Cas9 a Actin5C promoter-dsRed cassette flanked by attP sites was introduced in the 99F8 locus (PubMed=33963853) Group: Insect cell line 127228122 CVCL_A5UG S2R+-Apc-KO-E5 spontaneously immortalized cell line fruit fly CVCL_A5UG CL:0000010 Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0015589; Apc; Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)); Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag) Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276. Male Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line S2R+-MT::Cas9) Group: Insect cell line 127228123 CVCL_A5UF S2R+-Moe-KO-21B4 spontaneously immortalized cell line fruit fly CVCL_A5UF CL:0000010 Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0011661; Moe; Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)); Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag) Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276. Male Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line S2R+-MT::Cas9) Group: Insect cell line 127228124 CVCL_A5UI S2R+-Pex19-KO-A1 spontaneously immortalized cell line fruit fly CVCL_A5UI CL:0000010 Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0032407; Pex19; Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)); Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag) Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276. Male Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line S2R+-MT::Cas9) Group: Insect cell line 127228125 CVCL_A5UH S2R+-TSC1-KO-C5 spontaneously immortalized cell line fruit fly CVCL_A5UH CL:0000010 Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0026317; Tsc1; Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)); Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag) Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276. Male Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line S2R+-MT::Cas9) Group: Insect cell line 127228126 CVCL_A5UK S2R+-Slik-KO-22C2 spontaneously immortalized cell line fruit fly CVCL_A5UK CL:0000010 Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0035001; Slik; Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)); Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag) Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276. Male Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line S2R+-MT::Cas9) Group: Insect cell line 127228127 CVCL_A5UJ S2R+-Pten-KO-1A4 spontaneously immortalized cell line fruit fly CVCL_A5UJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0026379; Pten; Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)); Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag) Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276. Male Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line S2R+-MT::Cas9) Group: Insect cell line 127228128 CVCL_A5UM S2R+-(FEx-2.5%) spontaneously immortalized cell line fruit fly CVCL_A5UM CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276. Male Characteristics: Adapted to growth in M3 + 2.5% Fly Extract (FEx) medium Group: Insect cell line; Group: Serum/protein free medium cell line 127228129 CVCL_A5UL S2R+-Yki-KO-G7 spontaneously immortalized cell line fruit fly CVCL_A5UL CL:0000010 Knockout cell: Method=CRISPR/Cas9; FlyBase_Gene; FBgn0034970; yki; Genetic integration: Method=Protein trap; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)); Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a N-termial FLAG tag) Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276. Male Characteristics: Transfected with a pMT-FLAG-Cas9 construct where the expression of N-terminally FLAG-tagged Cas9 is driven by a copper-inducible metallothionein promoter (from parent cell line S2R+-MT::Cas9) Group: Insect cell line 127228130 CVCL_A5UA CCRF/CEM/ara-C/G cancer cell line human CVCL_A5UA CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female 127228131 CVCL_A5UC CCRF/CEM/ara-C/J cancer cell line human CVCL_A5UC CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female 127228132 CVCL_A5UB CCRF/CEM/ara-C/I cancer cell line human CVCL_A5UB CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female 127228133 CVCL_A5UE HFF-2 IRR finite cell line human CVCL_A5UE CL:0000010 Transformant: NCIt; C17262; X-Ray; Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Discontinued: ATCC; SCRC-1042.1; true Male Characteristics: Used as feeder cells to support the growth of stem cells in the undifferentiated state; Characteristics: Growth-arrested by irradiation with 6000 rads 127228134 CVCL_A5UD SACC-LM-KRT19-KD cancer cell line human CVCL_A5UD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6436; KRT19 Miscellaneous: Cell line information from personal communication of Kong, Lu Population: Chinese; Derived from site: In situ; Salivary gland, sublingual gland; UBERON=UBERON_0001832. Female 127228135 CVCL_A5RT CD#01 iPSC induced pluripotent stem cell human CVCL_A5RT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Glu129Argfs*8 (c.382delC); ClinVar=VCV000551932; Zygosity=Heterozygous (PubMed=33304759); Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Arg168Cys (c.502C>T); ClinVar=VCV000813438; Zygosity=Heterozygous (PubMed=33304759); Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Tyr231Tyr (c.693C>T); ClinVar=VCV000197621; Zygosity=Heterozygous (PubMed=33304759) Cell type: Fibroblast; CL=CL_0000057. Male 127228136 CVCL_A5RS FFF0082001 induced pluripotent stem cell human CVCL_A5RS CL:0000010 Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Glu129Argfs*8 (c.382delC); ClinVar=VCV000551932; Zygosity=Heterozygous (PubMed=33304759); Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Arg168Cys (c.502C>T); ClinVar=VCV000813438; Zygosity=Heterozygous (PubMed=33304759); Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Tyr231Tyr (c.693C>T); ClinVar=VCV000197621; Zygosity=Heterozygous (PubMed=33304759) Cell type: Fibroblast; CL=CL_0000057. Male 127228137 CVCL_A5RV HBLT-11 transformed cell line human CVCL_A5RV CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40). Male Characteristics: Established from a tumor induced in nude mice by inoculation of late passage HBL-100 (PubMed=2840847) Problematic cell line: Misidentified Parent cell line (HBL-100) has been shown to have a Y chromosome while originally thought to be of female origin. 127228138 CVCL_A5RU CD#68T-13 iPSC induced pluripotent stem cell human CVCL_A5RU CL:0000010 Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Glu285Ala (c.854A>C); ClinVar=VCV000002605; Zygosity=Homozygous (PubMed=33304759); Genetic integration: Method=TALEN; Gene=HGNC; HGNC:756; ASPA; Genetic integration: Method=TALEN; Gene=HGNC; HGNC:1633; CD19 (Note=With p.Lys324_Arg556del = CD19t) Population: Jewish; Cell type: Fibroblast; CL=CL_0000057. Male Characteristics: Using TALEN a EF1a promoter-ASPA-T2A-CD19t construct was introduced in the AAVS1 safe harbor locus (PubMed=33304759) 127228139 CVCL_A5RX HBLT-13 transformed cell line human CVCL_A5RX CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40). Male Characteristics: Established from a tumor induced in nude mice by inoculation of late passage HBL-100 (PubMed=2840847) Problematic cell line: Misidentified Parent cell line (HBL-100) has been shown to have a Y chromosome while originally thought to be of female origin. 127228140 CVCL_A5RW HBLT-12 transformed cell line human CVCL_A5RW CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40). Male Characteristics: Established from a tumor induced in nude mice by inoculation of late passage HBL-100 (PubMed=2840847) Problematic cell line: Misidentified Parent cell line (HBL-100) has been shown to have a Y chromosome while originally thought to be of female origin. 127228141 CVCL_A5RZ ARD-pUTX cancer cell line human CVCL_A5RZ CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:12637; KDM6A; Zygosity=Homozygous (PubMed=29045832); Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5732; IGKV1-16; Name(s)=IGKV1-16-IGKJ4 (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:5723; IGKJ5 + HGNC; HGNC:5732; IGKV1-16; Name(s)=IGKV1-16-IGKJ5 (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12637; KDM6A Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Plasma cell; CL=CL_0000786. Omics: Transcriptomics; RNAseq Female Characteristics: KDM6A/UTX expression is inducible by doxycycline (PubMed=29045832) 127228142 CVCL_A5RY ARD-EZH2i-R cancer cell line human CVCL_A5RY CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:12637; KDM6A; Zygosity=Homozygous (PubMed=29045832); Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5732; IGKV1-16; Name(s)=IGKV1-16-IGKJ4 (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:5723; IGKJ5 + HGNC; HGNC:5732; IGKV1-16; Name(s)=IGKV1-16-IGKJ5 (from parent cell line) Selected for resistance to: ChEBI; CHEBI_167693; 1-isopropyl-N-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-6-(2-(4-methylpiperazin-1-yl)pyridin-4-yl)-1H-indazole-4-carboxamide (GSK343); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Plasma cell; CL=CL_0000786. Omics: Transcriptomics; RNAseq Female 127228143 CVCL_A5RL CD#60 ipsC induced pluripotent stem cell human CVCL_A5RL CL:0000010 Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Gly176Asp (c.527C>A); Zygosity=Heterozygous (PubMed=33304759); Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Ala305Glu (c.914C>A); ClinVar=VCV000002607; Zygosity=Heterozygous (PubMed=33304759) Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Fibroblast; CL=CL_0000057. Male 127228144 CVCL_A5RK CD#59 ipsC induced pluripotent stem cell human CVCL_A5RK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Gly176Asp (c.527C>A); Zygosity=Heterozygous (PubMed=33304759); Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Ala305Glu (c.914C>A); ClinVar=VCV000002607; Zygosity=Heterozygous (PubMed=33304759); Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Arg249Trp (c.745C>T); ClinVar=VCV000126510; Zygosity=Homozygous (from parent cell line) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228145 CVCL_A5RN FF08711992 finite cell line human CVCL_A5RN CL:0000010 Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Met82Asnfs*7 (c.244dupA); Zygosity=Homozygous (PubMed=33304759) Cell type: Fibroblast; CL=CL_0000057. Female 127228146 CVCL_A5RM CD#68 iPSC induced pluripotent stem cell human CVCL_A5RM CL:0000010 Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Glu285Ala (c.854A>C); ClinVar=VCV000002605; Zygosity=Homozygous (PubMed=33304759) Population: Jewish; Cell type: Fibroblast; CL=CL_0000057. Male 127228147 CVCL_A5RP CD#92 iPSC induced pluripotent stem cell human CVCL_A5RP CL:0000010 Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Met82Asnfs*7 (c.244dupA); Zygosity=Homozygous (PubMed=33304759) Cell type: Fibroblast; CL=CL_0000057. Female 127228148 CVCL_A5RR CD#00 iPSC induced pluripotent stem cell human CVCL_A5RR CL:0000010 Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.His244Arg (c.731A>G); ClinVar=VCV000371086; Zygosity=Homozygous (PubMed=33304759) Cell type: Fibroblast; CL=CL_0000057. Male 127228149 CVCL_A5RQ FFF0282000 finite cell line human CVCL_A5RQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.His244Arg (c.731A>G); ClinVar=VCV000371086; Zygosity=Homozygous (PubMed=33304759) Cell type: Fibroblast; CL=CL_0000057. Male 127228150 CVCL_A5RD KCLi013-A induced pluripotent stem cell human CVCL_A5RD From: King's College London; London; United Kingdom CL:0000010 Sequence variation: Mutation; HGNC; HGNC:535; ANXA11; Simple; p.Arg235Gln (c.704G>A); dbSNP=rs765489119; Zygosity=Heterozygous (PubMed=33610019) Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228151 CVCL_A5RC KCLi012-A induced pluripotent stem cell human CVCL_A5RC From: King's College London; London; United Kingdom CL:0000010 Sequence variation: Mutation; HGNC; HGNC:535; ANXA11; Simple; p.Asp40Gly (c.119A>G); ClinVar=VCV000488353; Zygosity=Heterozygous (PubMed=33610019) Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228152 CVCL_A5RF ICANi001-A-1 induced pluripotent stem cell human CVCL_A5RF From: INSERM U1166-Institute of Cardiometabolism and Nutrition; Paris; France CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple_corrected; p.Arg403Leu (c.1208G>T); ClinVar=VCV000014101; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=33610018) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228153 CVCL_A5RE ICANi001-A induced pluripotent stem cell human CVCL_A5RE From: INSERM U1166-Institute of Cardiometabolism and Nutrition; Paris; France CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple_edited; p.Arg403Leu (c.1208G>T); ClinVar=VCV000014101; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=33610018) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228154 CVCL_A5RH IEC6-Cdx2L1 finite cell line Norway rat CVCL_A5RH CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88361; Cdx2; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Small intestine; UBERON=UBERON_0002108; Cell type: Epithelial cell of intestine; CL=CL_0002563; Breed/subspecies: Charles River Sprague Dawley (CD(SD)); RS=RS_0000695. Male Characteristics: Cdx2 can conditionally be expressed by addition of IPTG in the culture media This cell line was engineered with the LacSwitch system in this case composed of two plasmids, pOPRSVI-Cdx2 that contains a RSV LTR promoter, 2 lacO sites (lactose repressor), cdX2 and a neo gene and p3'SS that contains the LacI and hph genes. Thus when IPTG is added to the culture media, repression mediated by lacI is removed and Cdx2 is expressed (PubMed=8552090). 127228156 CVCL_A5RJ IEC6-Cdx2MT15 finite cell line Norway rat CVCL_A5RJ CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88361; Cdx2; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Small intestine; UBERON=UBERON_0002108; Cell type: Epithelial cell of intestine; CL=CL_0002563; Breed/subspecies: Charles River Sprague Dawley (CD(SD)); RS=RS_0000695. Male Characteristics: The transfected Cdx2 gene is under the csheep MT1 gene (PubMed=8552090) 127228157 CVCL_A5RI IEC6-Cdx2L2 finite cell line Norway rat CVCL_A5RI CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88361; Cdx2; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03023; Escherichia coli lacI; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Small intestine; UBERON=UBERON_0002108; Cell type: Epithelial cell of intestine; CL=CL_0002563; Breed/subspecies: Charles River Sprague Dawley (CD(SD)); RS=RS_0000695. Male Characteristics: Cdx2 can conditionally be expressed by addition of IPTG in the culture media This cell line was engineered with the LacSwitch system in this case composed of two plasmids, pOPRSVI-Cdx2 that contains a RSV LTR promoter, 2 lacO sites (lactose repressor), cdX2 and a neo gene and p3'SS that contains the LacI and hph genes. Thus when IPTG is added to the culture media, repression mediated by lacI is removed and Cdx2 is expressed (PubMed=8552090). 127228158 CVCL_A5QZ KCLi009-A induced pluripotent stem cell human CVCL_A5QZ From: King's College London; London; United Kingdom CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.Arg521His (c.1562G>A); ClinVar=VCV000016225; Zygosity=Heterozygous (PubMed=33610019) Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228159 CVCL_A5RB KCLi011-A induced pluripotent stem cell human CVCL_A5RB From: King's College London; London; United Kingdom CL:0000010 Sequence variation: Mutation; HGNC; HGNC:535; ANXA11; Simple; p.Gly38Arg (c.112G>A); ClinVar=VCV000488354; Zygosity=Heterozygous (PubMed=33610019) Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228160 CVCL_A5RA KCLi010-A induced pluripotent stem cell human CVCL_A5RA From: King's College London; London; United Kingdom CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.Arg522Gly (c.1564A>G); ClinVar=VCV000540279; Zygosity=Heterozygous (PubMed=33610019) Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228161 CVCL_A5SU KDM/JuB2 cancer cell line dog CVCL_A5SU CL:0000010 Derived from site: In situ; Liver; UBERON=UBERON_0002107; Breed/subspecies: Labrador Retriever; VBO=VBO_0200800. Female Characteristics: Established from the xenograft Ju Doubling time: 31.6 hours (PubMed=22839755) 127228162 CVCL_A5ST KDM/JuA1 cancer cell line dog CVCL_A5ST CL:0000010 Derived from site: In situ; Liver; UBERON=UBERON_0002107; Breed/subspecies: Labrador Retriever; VBO=VBO_0200800. Female Characteristics: Established from the xenograft Ju 127228163 CVCL_A5SW KDM/Re12 cancer cell line dog CVCL_A5SW CL:0000010 Derived from site: In situ; Heart, right atrium; UBERON=UBERON_0002078; Breed/subspecies: Golden Retriever; VBO=VBO_0200610. Male Characteristics: Established from the xenograft Re 127228164 CVCL_A5SV KDM/JuB4 cancer cell line dog CVCL_A5SV CL:0000010 Derived from site: In situ; Liver; UBERON=UBERON_0002107; Breed/subspecies: Labrador Retriever; VBO=VBO_0200800. Female Characteristics: Established from the xenograft Ju 127228165 CVCL_A5SY KDM/Ud2 cancer cell line dog CVCL_A5SY CL:0000010 Derived from site: In situ; Spleen; UBERON=UBERON_0002106; Breed/subspecies: Papillion; VBO=VBO_0200985. Female Characteristics: Established from the xenograft Ud Doubling time: 23.5 hours (PubMed=22839755) 127228166 CVCL_A5SX KDM/Re21 cancer cell line dog CVCL_A5SX CL:0000010 Derived from site: In situ; Heart, right atrium; UBERON=UBERON_0002078; Breed/subspecies: Golden Retriever; VBO=VBO_0200610. Male Characteristics: Established from the xenograft Re 127228167 CVCL_A5SZ KDM/Ud6 cancer cell line dog CVCL_A5SZ CL:0000010 Derived from site: In situ; Spleen; UBERON=UBERON_0002106; Breed/subspecies: Papillion; VBO=VBO_0200985. Female Characteristics: Established from the xenograft Ud 127228168 CVCL_A5SM Wilms11 finite cell line human CVCL_A5SM CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; None_reported; -; Zygosity=- (PubMed=33379206); Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Homozygous; Note=Somatic (PubMed=33379206) Population: Caucasian; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male 127228169 CVCL_A5SL Wilms10T finite cell line human CVCL_A5SL CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:12796; WT1; Zygosity=Homozygous; Note=Nested within a heterozygous 11p13 deletion (PubMed=27213811; PubMed=33379206); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Homozygous (PubMed=27213811; PubMed=33379206) Population: Caucasian; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Omics: Transcriptomics; Microarray Female 127228170 CVCL_A5SN imWilms1 conditionally immortalized cell line human CVCL_A5SN CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Heterozygous (PubMed=33379206); Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Ser50Ter (c.149C>A); Zygosity=Homozygous (PubMed=33379206); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Population: Caucasian; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Female 127228171 CVCL_A5SQ imWilms6 conditionally immortalized cell line human CVCL_A5SQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Homozygous (PubMed=33379206); Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg390Ter (c.1168C>T) (p.Arg463Ter, c.1387C>T); ClinVar=VCV000003494; Zygosity=Homozygous (PubMed=33379206); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Population: Caucasian; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male 127228172 CVCL_A5SP imWilms3 conditionally immortalized cell line human CVCL_A5SP CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; None_reported; -; Zygosity=- (PubMed=33379206); Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Val432Serfs*87 (c.1293_1294insA); Zygosity=Homozygous; Note=Somatic (PubMed=33379206); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Population: Caucasian; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male 127228173 CVCL_A5SS PEC transformed cell line pig CVCL_A5SS CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Endometrium; UBERON=UBERON_0001295. Female Virology: Susceptible to infection by porcine reproductive and respiratory syndrome virus (PRRSV) (PubMed=31426793) 127228174 CVCL_A5SR Y79/EDR cancer cell line human CVCL_A5SR CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; Ex2-6del; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; IVS20+1G>A; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16); Derived from site: In situ; Eye, globe; UBERON=UBERON_0010230. Omics: Transcriptomics; RNAseq Female Doubling time: 14.5 hours (DOI=10.3969/j.issn.1673-713X.2017.04.002) 127228175 CVCL_A5SE Wilms2 finite cell line human CVCL_A5SE CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Tyr (c.134C>A); ClinVar=VCV000375895; Zygosity=Heterozygous (PubMed=20106868; PubMed=33379206); Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg362Ter (c.1084C>T) (p.Arg435Ter, c.1303C>T); ClinVar=VCV000003497; Zygosity=Homozygous (PubMed=20106868; PubMed=24619359; PubMed=33379206) Population: Caucasian; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male 127228176 CVCL_A5SD Wilms1-2r finite cell line human CVCL_A5SD CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Cys (c.134C>G); ClinVar=VCV000376242; Zygosity=Heterozygous (PubMed=33379206); Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Ser50Ter (c.149C>A); Zygosity=Homozygous (PubMed=33379206) Population: Caucasian; Donor information: Established from the right kidney of the recurrence (2nd tumor) of the patient; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Female 127228177 CVCL_A5SG Wilms4 finite cell line human CVCL_A5SG CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:12796; WT1; Zygosity=Heterozygous (PubMed=20106868; PubMed=33379206); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (PubMed=20106868; PubMed=33379206); Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.His438Profs*7 (c.1311_1312insC); Zygosity=Heterozygous (PubMed=20106868; PubMed=33379206) Population: Caucasian; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male 127228178 CVCL_A5SF Wilms3 finite cell line human CVCL_A5SF CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; None_reported; -; Zygosity=- (PubMed=20106868; PubMed=33379206); Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Val432Serfs*87 (c.1293_1294insA); Zygosity=Homozygous; Note=Somatic (PubMed=20106868; PubMed=24619359; PubMed=33379206) Population: Caucasian; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male 127228179 CVCL_A5SI Wilms6 finite cell line human CVCL_A5SI CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Homozygous (PubMed=33379206); Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg390Ter (c.1168C>T) (p.Arg463Ter, c.1387C>T); ClinVar=VCV000003494; Zygosity=Homozygous (PubMed=33379206) Population: Caucasian; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male 127228180 CVCL_A5SH Wilms5 finite cell line human CVCL_A5SH CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; None_reported; -; Zygosity=- (PubMed=20106868; PubMed=33379206); Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg433Profs*84 (c.1296_1299delGC); Zygosity=Homozygous; Note=Somatic (PubMed=20106868; PubMed=33379206) Population: Caucasian; Donor information: The patient has a germline WT1 p.Arg390Ter (c.1168C>T) mutation that was lost in the tumor; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male 127228181 CVCL_A5SK Wilms10M finite cell line human CVCL_A5SK CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:12796; WT1; Zygosity=Homozygous; Note=Nested within a heterozygous 11p13 deletion (PubMed=33379206); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Homozygous (PubMed=33379206) Population: Caucasian; Derived from site: Metastatic; Lung; UBERON=UBERON_0002048. Female 127228182 CVCL_A5SJ Wilms8 finite cell line human CVCL_A5SJ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Ala (c.133T>G); ClinVar=VCV000376241; Zygosity=Heterozygous (PubMed=33379206); Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg390Ter (c.1168C>T) (p.Arg463Ter, c.1387C>T); ClinVar=VCV000003494; Zygosity=Homozygous (PubMed=33379206) Population: Caucasian; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Omics: Genomics; Whole exome sequencing Male 127228183 CVCL_A5SA KMS-34-SCC1 cancer cell line human CVCL_A5SA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp146Ter (c.438G>A); ClinVar=VCV000428890; Zygosity=Homozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175; Cell type: Plasma cell; CL=CL_0000786. Female 127228184 CVCL_A5SC Wilms1-2l finite cell line human CVCL_A5SC CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Heterozygous (PubMed=20106868; PubMed=33379206); Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Ser50Ter (c.149C>A); Zygosity=Homozygous (PubMed=20106868; PubMed=33379206) Population: Caucasian; Donor information: Established from the left kidney of the recurrence (2nd tumor) of the patient; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Female 127228185 CVCL_A5SB KMS-34-SCC2 cancer cell line human CVCL_A5SB CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp146Ter (c.438G>A); ClinVar=VCV000428890; Zygosity=Homozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175; Cell type: Plasma cell; CL=CL_0000786. Female 127228186 CVCL_A5PR NB90-6 cancer cell line human CVCL_A5PR CL:0000010 127228187 CVCL_A5PQ NB90-4 cancer cell line human CVCL_A5PQ CL:0000010 127228188 CVCL_A5PT A2780/CP8 cancer cell line human CVCL_A5PT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line) Population: African American; Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP); Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female Doubling time: 22.1 +- 0.7 hours (PubMed=3539322) 127228189 CVCL_A5PS A2780/CP20 cancer cell line human CVCL_A5PS CL:0000010 Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val173Phe (c.517G>T); Zygosity=Unspecified (PubMed=8557231) Population: African American; Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP); Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female 127228190 CVCL_A5PV EG [Human ovarian carcinoma] cancer cell line human CVCL_A5PV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val143fs (c.427_458del32); Zygosity=Unspecified (PubMed=8557231) Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female 127228191 CVCL_A5PU EC [Human ovarian carcinoma] cancer cell line human CVCL_A5PU CL:0000010 Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female 127228192 CVCL_A5PX NMH spontaneously immortalized cell line house mouse CVCL_A5PX CL:0000010 Karyotypic information: Near diploid karyotype; Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182; Breed/subspecies: CD-1. Male Doubling time: 19 hours (PubMed=7525051) 127228193 CVCL_A5PW ML3B transformed cell line human CVCL_A5PW CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female 127228194 CVCL_A5PJ AAKIPSi001-A induced pluripotent stem cell human CVCL_A5PJ From: INSERM; Paris; France CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228195 CVCL_A5PI LRVA-4 cancer cell line human CVCL_A5PI CL:0000010 Miscellaneous: Cell line has been lost (PubMed=14518029) Derived from site: In situ; Prostate; UBERON=UBERON_0002367. Male 127228196 CVCL_A5PL AAKIPSi003-A induced pluripotent stem cell human CVCL_A5PL From: INSERM; Paris; France CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228197 CVCL_A5PK AAKIPSi002-A induced pluripotent stem cell human CVCL_A5PK From: INSERM; Paris; France CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228198 CVCL_A5PN BALB/3T3 clone A31T spontaneously immortalized cell line house mouse CVCL_A5PN CL:0000010 Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: BALB/c. Unspecified 127228199 CVCL_A5PM N11 [Mouse microglial] transformed cell line house mouse CVCL_A5PM CL:0000010 Transformant: Recombinant retrovirus 3RV/VN-11; Derived from site: In situ; Embryonic brain; UBERON=UBERON_0006238; Cell type: Microglial cell; CL=CL_0000129; Breed/subspecies: CD-1. Unspecified 127228200 CVCL_A5PP PNET-1 cancer cell line human CVCL_A5PP CL:0000010 127228201 CVCL_A5PB GM25134 transformed cell line human CVCL_A5PB CL:0000010 Sequence variation: Mutation; HGNC; HGNC:758; ASS1; Simple; p.Gly156Asp (c.467G>A); Zygosity=Homozygous (Coriell=GM25134) Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228202 CVCL_A5PA GM25995 transformed cell line human CVCL_A5PA CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228203 CVCL_A5PD GM25154 transformed cell line human CVCL_A5PD CL:0000010 Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Ter355Aspext*48 (c.1063delT) (X355D); Zygosity=Unspecified (Coriell=GM25154) Population: Asian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228204 CVCL_A5PC GM25153 transformed cell line human CVCL_A5PC CL:0000010 Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Simple; p.Ter355Aspext*48 (c.1063delT) (X355D); Zygosity=Unspecified (Coriell=GM25153) Population: Asian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228205 CVCL_A5PF GM25166 transformed cell line human CVCL_A5PF CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228206 CVCL_A5PE GM25155 transformed cell line human CVCL_A5PE CL:0000010 Population: African American; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228207 CVCL_A5PH GM25170 transformed cell line human CVCL_A5PH CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:2928; DMD; Zygosity=Hemizygous (Coriell=GM25170) Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228208 CVCL_A5PG GM25168 transformed cell line human CVCL_A5PG CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4289; GK; Simple; p.Trp114Glnfs*7 (c.338-1G>A) (IVS4-1G>A) (Ex5del); Zygosity=Hemizygous; Note=Splice acceptor mutation (Coriell=GM25168) Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228209 CVCL_A5QS UMi028-A-2 induced pluripotent stem cell human CVCL_A5QS From: Miller School of Medicine, University of Miami; Miami; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12393; TTC3; Simple_edited; p.Ser1038Cys (c.3113C>G); dbSNP=rs377155188; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33626494) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228210 CVCL_A5QR CEIi001-A induced pluripotent stem cell human CVCL_A5QR From: Cole Eye Institute, Cleveland Clinic; Cleveland; USA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29021; CEP290 Population: Caucasian; Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597; Cell type: Fibroblast of lung; CL=CL_0002553. Female 127228211 CVCL_A5QU WAe001-A-55 embryonic stem cell human CVCL_A5QU From: University of Manchester; Manchester; United Kingdom CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6847; MAP2K7 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127228212 CVCL_A5QT WAe001-A-54 embryonic stem cell human CVCL_A5QT From: University of Manchester; Manchester; United Kingdom CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6847; MAP2K7 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127228213 CVCL_A5QW WAe001-A-30 embryonic stem cell human CVCL_A5QW From: University of Houston; Houston; USA CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127228214 CVCL_A5QV WAe001-A-56 embryonic stem cell human CVCL_A5QV From: University of Houston; Houston; USA CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:7059; MGMT (Note=With p.Gly180_Asn207del and 19 mutations = SNAP-tag) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Using CRISPR/Cas9 a SNAP-tag was in-frame inserted at the C-terminus of the SOD1 coding region following a 3 amino-acid linker (PubMed=34118566) 127228215 CVCL_A5QY KCLi008-A induced pluripotent stem cell human CVCL_A5QY From: King's College London; London; United Kingdom CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.Gln519Glu (c.1555C>G); ClinVar=VCV000650787; Zygosity=Heterozygous (PubMed=33610019) Population: Chinese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228216 CVCL_A5QX WAe014-A-1 embryonic stem cell human CVCL_A5QX From: Korea University Cell Function Regulation Lab; Seoul; South Korea CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:61; ABCD1 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127228217 CVCL_A5QK WMUi022-A induced pluripotent stem cell human CVCL_A5QK From: Wenzhou Medical University; Wenzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9829; RAF1; Simple; p.Ser257Leu (c.770C>T); ClinVar=VCV000013957; Zygosity=Heterozygous (PubMed=33901818) Population: Chinese; Han; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male 127228218 CVCL_A5QJ WMUi020-A induced pluripotent stem cell human CVCL_A5QJ From: Wenzhou Medical University; Wenzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:17985; ROBO4; Simple; p.Gln54Arg (c.161A>G); ClinVar=VCV001277602; Zygosity=Heterozygous (PubMed=33631418) Population: Chinese; Han; Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002. Female 127228219 CVCL_A5QM WMUi006-A induced pluripotent stem cell human CVCL_A5QM From: Wenzhou Medical University; Wenzhou; China. CL:0000010 127228220 CVCL_A5QL WMUi023-A induced pluripotent stem cell human CVCL_A5QL From: Wenzhou Medical University; Wenzhou; China. CL:0000010 Female 127228221 CVCL_A5QN NUIGi040-B induced pluripotent stem cell human CVCL_A5QN From: National University of Ireland Galway; Galway; Ireland CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228222 CVCL_A5QQ Ep-1 induced pluripotent stem cell human CVCL_A5QQ CL:0000010 Population: Caucasian; Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597; Cell type: Fibroblast of lung; CL=CL_0002553. Female 127228223 CVCL_A5QP UMGi157-A induced pluripotent stem cell human CVCL_A5QP From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228224 CVCL_A5QC ciPSC line 3 induced pluripotent stem cell dog CVCL_A5QC CL:0000010 Derived from site: In situ; Fetus; UBERON=UBERON_0000323; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: Beagle; VBO=VBO_0200131. Male 127228225 CVCL_A5QB JLUEYEi001-A induced pluripotent stem cell human CVCL_A5QB From: Eye Center of Second Hospital, Jilin University; Changchun; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2200; COL2A1; Unexplicit; IVS22-1C>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=33647874) Population: Mongolian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228226 CVCL_A5QE ciPSC P9 induced pluripotent stem cell dog CVCL_A5QE CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Breed/subspecies: Beagle; VBO=VBO_0200131. Female 127228227 CVCL_A5QD ciPSC line 6 induced pluripotent stem cell dog CVCL_A5QD CL:0000010 Derived from site: In situ; Fetus; UBERON=UBERON_0000323; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: Beagle; VBO=VBO_0200131. Male 127228228 CVCL_A5QG UMGi041-B.3 induced pluripotent stem cell human CVCL_A5QG From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Ala2254Val (c.6761C>T); Zygosity=Heterozygous (PubMed=33640691) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228229 CVCL_A5QF JLUEYEi002-A induced pluripotent stem cell human CVCL_A5QF From: Eye Center of Second Hospital, Jilin University; Changchun; China CL:0000010 Population: Mongolian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228230 CVCL_A5QI JMUi001-A-3 induced pluripotent stem cell human CVCL_A5QI From: Comprehensive Heart Failure Center, University Clinic Wurzburg; Wurzburg; Germany CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3049; DSG2 Population: Caucasian; Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 127228231 CVCL_A5QH JMUi001-A-2 induced pluripotent stem cell human CVCL_A5QH From: Comprehensive Heart Failure Center, University Clinic Wurzburg; Wurzburg; Germany CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9024; PKP2 Population: Caucasian; Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 127228232 CVCL_A5PZ COS-7 1C7 transformed cell line CVCL_A5PZ CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3180; EDNRB; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1); Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male Characteristics: Useful to study endothelin analogues for agonist or antagonist activity (PubMed=7509982) Group: Non-human primate cell line 127228233 CVCL_A5PY UOK85 cancer cell line human CVCL_A5PY CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Unspecified 127228234 CVCL_A5QA COS-F2-130 transformed cell line CVCL_A5QA CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2590; CYP11A1; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3638; FDX1; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3642; FDXR; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1); Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male Characteristics: Useful system for studying steroidogenesis Converts cholesterol to pregnenolone but lack downstream enzymes that catalyze other steroidogenic reactions (PubMed=11356706).; Characteristics: Transfected with the F2 construct that consist of the fusion of P450scc-adrenodoxin reductase-adrenodoxin (PubMed=11356706) Group: Non-human primate cell line 127228235 CVCL_A5NP GM25858 transformed cell line human CVCL_A5NP CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228236 CVCL_A5NR GM25861 transformed cell line human CVCL_A5NR CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228237 CVCL_A5NQ GM25860 transformed cell line human CVCL_A5NQ CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228238 CVCL_A5NT GM25873 transformed cell line human CVCL_A5NT CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228239 CVCL_A5NS GM25872 transformed cell line human CVCL_A5NS CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228240 CVCL_A5NV GM25929 transformed cell line human CVCL_A5NV CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228241 CVCL_A5NU GM25886 transformed cell line human CVCL_A5NU CL:0000010 Population: Caucasian; English/German; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228242 CVCL_A5NH STF-4 finite cell line human CVCL_A5NH CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127228243 CVCL_A5NG STF-6 finite cell line human CVCL_A5NG CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127228244 CVCL_A5NJ H7-H2B-RFP embryonic stem cell human CVCL_A5NJ CL:0000010 Genetic integration: Method=Transfection; Gene=FPbase; 5YCFA; mRFP1 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4761; H2BC11 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: The H2B-mRFP1 fusion construct is under the control of the CAG promoter 127228245 CVCL_A5NI STF-5 finite cell line human CVCL_A5NI CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127228246 CVCL_A5NL HUES 17-H2B-RFP embryonic stem cell human CVCL_A5NL CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; 5YCFA; mRFP1 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4761; H2BC11 Miscellaneous: Cell line information from personal communication of Price, Christopher John Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: The H2B-mRFP1 fusion construct is under the control of the CAG promoter 127228247 CVCL_A5NK H14-H2B-RFP embryonic stem cell human CVCL_A5NK CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; 5YCFA; mRFP1 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4761; H2BC11 Miscellaneous: Cell line information from personal communication of Price, Christopher John Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: The H2B-mRFP1 fusion construct is under the control of the CAG promoter 127228248 CVCL_A5NN GM25857 transformed cell line human CVCL_A5NN CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228249 CVCL_A5NM GM25856 transformed cell line human CVCL_A5NM CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228250 CVCL_A5NB UKAi008-A induced pluripotent stem cell human CVCL_A5NB From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:8803; PDGFRA; Simple; p.Ser478Pro (c.1432T>C); ClinVar=VCV000041794; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Leu34Phe (c.100C>T); ClinVar=VCV000135308; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Val218Met (c.652G>A); ClinVar=VCV000135321; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Ile1762Val (c.5284A>G); ClinVar=VCV000135287; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.His1778Arg (c.5333A>G); ClinVar=VCV000135289; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Homozygous (PubMed=33512435) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Established from a patient that has a KIT p.Asp816Val mutation, but this cell line does not contain this mutation 127228251 CVCL_A5NA UKAi007-B induced pluripotent stem cell human CVCL_A5NA From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Gly725Ser (c.2173G>A) (p.Gly706Ser, c.2116G>A); ClinVar=VCV000133445; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Val178Ile (c.532G>A); ClinVar=VCV000134520; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp816Val (c.2447A>T); ClinVar=VCV000013852; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:8803; PDGFRA; Simple; p.Ser478Pro (c.1432T>C); ClinVar=VCV000041794; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:10471; RUNX1; Simple; p.Met133Ile (c.399G>A); Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:10783; SRSF2; Simple; p.Pro95_Arg102del (c.284_307del); dbSNP=rs766200080; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Arg1261Cys (c.3781C>T); Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Ser1292Arg (c.3876C>G); Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Homozygous (PubMed=33512435) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 127228252 CVCL_A5ND UKAi008-C induced pluripotent stem cell human CVCL_A5ND From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp816Val (c.2447A>T); ClinVar=VCV000013852; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:8803; PDGFRA; Simple; p.Ser478Pro (c.1432T>C); ClinVar=VCV000041794; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Leu34Phe (c.100C>T); ClinVar=VCV000135308; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Val218Met (c.652G>A); ClinVar=VCV000135321; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Ile1762Val (c.5284A>G); ClinVar=VCV000135287; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.His1778Arg (c.5333A>G); ClinVar=VCV000135289; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Homozygous (PubMed=33512435) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228253 CVCL_A5NC UKAi008-B induced pluripotent stem cell human CVCL_A5NC From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:8803; PDGFRA; Simple; p.Ser478Pro (c.1432T>C); ClinVar=VCV000041794; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Leu34Phe (c.100C>T); ClinVar=VCV000135308; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Val218Met (c.652G>A); ClinVar=VCV000135321; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Ile1762Val (c.5284A>G); ClinVar=VCV000135287; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.His1778Arg (c.5333A>G); ClinVar=VCV000135289; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Homozygous (PubMed=33512435) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Established from a patient that has a KIT p.Asp816Val mutation, but this cell line does not contain this mutation 127228254 CVCL_A5NF BRE finite cell line human CVCL_A5NF CL:0000010 Sequence variation: Mutation; HGNC; HGNC:43; TAP1; Simple; p.Asp273fs (c.819delC); Zygosity=Homozygous (PubMed=10074495) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228255 CVCL_A5NE STF-1 finite cell line human CVCL_A5NE CL:0000010 Sequence variation: Mutation; HGNC; HGNC:44; TAP2; Simple; p.Arg273Ter (c.817C>T) (R253*); ClinVar=VCV000013727; Zygosity=Homozygous (from autologous cell line ST-EMO) Population: Moroccan; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228256 CVCL_A5MW SNUe003-A-2 embryonic stem cell human CVCL_A5MW From: Seoul National University; Seoul; South Korea CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)); Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Korean; Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Using CRISPR/Cas9 a T2A-mCherry-polyA-PGKp-Neo-polyA construct was introduced at the C-terminus of one allele of Brachyury (PubMed=33878708) 127228257 CVCL_A5MV SNUe003-A-1 embryonic stem cell human CVCL_A5MV From: Seoul National University; Seoul; South Korea CL:0000010 Population: Korean; Karyotypic information: 47,XY,+12 (hPSCreg=SNUe003-A-1); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127228258 CVCL_A5MY UKAi006-A induced pluripotent stem cell human CVCL_A5MY From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple; p.Ile859Thr (c.2576T>C) (p.Ile848Thr, c.2543T>C); ClinVar=VCV000006350; Zygosity=Heterozygous (PubMed=30720580) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228259 CVCL_A5MX UKAi005-A induced pluripotent stem cell human CVCL_A5MX From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple; p.Ile859Thr (c.2576T>C) (p.Ile848Thr, c.2543T>C); ClinVar=VCV000006350; Zygosity=Heterozygous (PubMed=30720580) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228260 CVCL_A5MZ UKAi007-A induced pluripotent stem cell human CVCL_A5MZ From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Gly725Ser (c.2173G>A) (p.Gly706Ser, c.2116G>A); ClinVar=VCV000133445; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Val178Ile (c.532G>A); ClinVar=VCV000134520; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:8803; PDGFRA; Simple; p.Ser478Pro (c.1432T>C); ClinVar=VCV000041794; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:10471; RUNX1; Simple; p.Val101Alafs*31 (c.302_318del); Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:10783; SRSF2; Simple; p.Pro95_Arg102del (c.284_307del); dbSNP=rs766200080; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Ser1292Arg (c.3876C>G); Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Arg1465Ter (c.4393C>T); ClinVar=VCV001899776; Zygosity=Heterozygous (PubMed=33512435); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Homozygous (PubMed=33512435) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Characteristics: Established from a patient that has a KIT p.Asp816Val mutation, but this cell line does not contain this mutation 127228261 CVCL_A5NX GM25933 transformed cell line human CVCL_A5NX CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228262 CVCL_A5NW GM25932 finite cell line human CVCL_A5NW CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228263 CVCL_A5NZ GM25991 transformed cell line human CVCL_A5NZ CL:0000010 Population: Asian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: No OTC mutation found 127228264 CVCL_A5NY GM25944 finite cell line human CVCL_A5NY CL:0000010 Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266; Cell type: Fibroblast of periodontal ligament; CL=CL_2000017. Female 127228265 CVCL_A4ZU ZZUNEUi019-A induced pluripotent stem cell human CVCL_A4ZU From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10259; RORB; Simple; c.94-1G>A; ClinVar=VCV001683646; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=33540281) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228266 CVCL_A4ZT ZZUNEUi018-A induced pluripotent stem cell human CVCL_A4ZT From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China. CL:0000010 127228267 CVCL_A4ZW Muntjak-T4 undefined cell line type CVCL_A4ZW CL:0000010 Discontinued: ATCC; CRL-6573; true. Male Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982) 127228268 CVCL_A4ZV PoEKC spontaneously immortalized cell line CVCL_A4ZV CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Unspecified Group: Fish cell line 127228269 CVCL_A4ZY 250 MK finite cell line human CVCL_A4ZY CL:0000010 Derived from site: In situ; Milk; UBERON=UBERON_0001913; Cell type: Lactiferous duct luminal epithelial cell; CL=CL_0002662. Female 127228270 CVCL_A4ZX Muntjak(Fe) undefined cell line type CVCL_A4ZX CL:0000010 Discontinued: ATCC; CRL-6572; true. Female Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982) 127228271 CVCL_A4ZZ KIJ308T cancer cell line human CVCL_A4ZZ CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113. 127228272 CVCL_A4ZM BGUi009-A induced pluripotent stem cell human CVCL_A4ZM From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Sequence variation: Mutation; HGNC; HGNC:29131; PLEKHM2; Simple; p.Lys645Alafs*12 (c.1932_1933delAG) (c.2156_2157delAG); ClinVar=VCV000253148; Zygosity=Homozygous (PubMed=34088011) Population: Bedouin; Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384. Male 127228273 CVCL_A4ZL BGUi008-A induced pluripotent stem cell human CVCL_A4ZL From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Sequence variation: Mutation; HGNC; HGNC:29131; PLEKHM2; Simple; p.Lys645Alafs*12 (c.1932_1933delAG) (c.2156_2157delAG); ClinVar=VCV000253148; Zygosity=Heterozygous (PubMed=34088011) Population: Bedouin; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228274 CVCL_A4ZN BGUi010-A induced pluripotent stem cell human CVCL_A4ZN From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Sequence variation: Mutation; HGNC; HGNC:29131; PLEKHM2; Simple; p.Lys645Alafs*12 (c.1932_1933delAG) (c.2156_2157delAG); ClinVar=VCV000253148; Zygosity=Homozygous (PubMed=34088011) Population: Bedouin; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228275 CVCL_A4ZQ ZZUNEUi015-A induced pluripotent stem cell human CVCL_A4ZQ From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:17574; ALPK3; Simple; p.Thr136Ile (c.407C>T) (p.Thr338Ile, c.1013C>T); ClinVar=VCV000389853; Zygosity=Heterozygous (PubMed=33607470) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228276 CVCL_A4ZP BGUi014-A induced pluripotent stem cell human CVCL_A4ZP From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 127228277 CVCL_A4ZS ZZUNEUi017-A induced pluripotent stem cell human CVCL_A4ZS From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple; p.Glu12513fs (c.37537delG); Zygosity=Heterozygous (PubMed=33610015) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228278 CVCL_A4ZR ZZUNEUi016-A induced pluripotent stem cell human CVCL_A4ZR From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Ala355Thr (c.1063G>A); ClinVar=VCV000042820; Zygosity=Heterozygous (PubMed=33636496) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228279 CVCL_A4ZE UMGi014-C induced pluripotent stem cell human CVCL_A4ZE From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228280 CVCL_A4ZD UMGi141-A induced pluripotent stem cell human CVCL_A4ZD From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228281 CVCL_A4ZG UMGi092-A induced pluripotent stem cell human CVCL_A4ZG From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228282 CVCL_A4ZF UMGi014-D induced pluripotent stem cell human CVCL_A4ZF From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228283 CVCL_A4ZI UMGi099-B induced pluripotent stem cell human CVCL_A4ZI From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228284 CVCL_A4ZH UMGi099-A induced pluripotent stem cell human CVCL_A4ZH From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228285 CVCL_A4ZK BGUi007-A induced pluripotent stem cell human CVCL_A4ZK From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Homozygous (PubMed=34419746) Population: Jewish; Ashkenazi; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228286 CVCL_A4ZJ BGUi006-A induced pluripotent stem cell human CVCL_A4ZJ From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5959; ELP1; Simple; c.2204+6T>C (2507+6T>C) (IVS20+6T>C) (Ex20del); ClinVar=VCV000006085; Zygosity=Heterozygous (PubMed=34419746) Population: Jewish; Ashkenazi; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228287 CVCL_A4XZ WMUi018-A induced pluripotent stem cell human CVCL_A4XZ From: Wenzhou Medical University; Wenzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9208; POR; Simple; p.Arg454His (c.1361G>A) (p.Arg457His, c.1370G>A); ClinVar=VCV000016907; Zygosity=Homozygous (PubMed=33631521) Population: Chinese; Han; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Female 127228288 CVCL_A4YB WMUi016-A induced pluripotent stem cell human CVCL_A4YB From: Wenzhou Medical University; Wenzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2023; CLCN5; Simple; p.Arg718Ter (c.2152C>T); ClinVar=VCV000011797; Zygosity=Hemizygous (PubMed=33545640) Population: Chinese; Han; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male 127228289 CVCL_A4YA WMUi019-A induced pluripotent stem cell human CVCL_A4YA From: Wenzhou Medical University; Wenzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10910; SLC12A1; Simple; p.Ala244Asp (c.731C>A); Zygosity=Homozygous (PubMed=33607471) Population: Chinese; Han; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Female 127228290 CVCL_A4XS SDQLCHi036-A induced pluripotent stem cell human CVCL_A4XS From: Qilu Children's Hospital of Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:8512; OTC; Unexplicit; Ex3-9del; Zygosity=Heterozygous (PubMed=33550136) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228291 CVCL_A4XR SDQLCHi035-A induced pluripotent stem cell human CVCL_A4XR From: Qilu Children's Hospital of Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Leu79Cysfs*3 (c.235delC); ClinVar=VCV000017014; Zygosity=Heterozygous (PubMed=33517119); Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.His100Argfs*14 (c.299_300delAT); ClinVar=VCV000044736; Zygosity=Heterozygous (PubMed=33517119) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228292 CVCL_A4XU SDQLCHi040-A induced pluripotent stem cell human CVCL_A4XU From: Qilu Children's Hospital of Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5964; IL10RA; Simple; p.Arg101Trp (c.301C>T); ClinVar=VCV000039432; Zygosity=Homozygous (PubMed=34530396) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228293 CVCL_A4XT SDQLCHi038-A induced pluripotent stem cell human CVCL_A4XT From: Qilu Children's Hospital of Shandong University; Jinan; China. CL:0000010 127228294 CVCL_A4XW SDUBMSi009-A induced pluripotent stem cell human CVCL_A4XW From: School of Basic Medical Sciences, Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:8108; OCRL; Simple; c.940-11G>A; ClinVar=VCV000279859; Zygosity=Hemizygous (PubMed=33540283) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228295 CVCL_A4XV SDQLCHi041-A induced pluripotent stem cell human CVCL_A4XV From: Qilu Children's Hospital of Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple; p.Arg203Gln (c.608G>A); ClinVar=VCV001029750; Zygosity=Heterozygous (PubMed=33550137); Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple; p.Glu446Lys (c.1336G>A); ClinVar=VCV000553423; Zygosity=Heterozygous (PubMed=33550137) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228296 CVCL_A4XY WMUi014-A induced pluripotent stem cell human CVCL_A4XY From: Wenzhou Medical University; Wenzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Simple; c.2013insA; Zygosity=Hemizygous (PubMed=33472124) Population: Chinese; Han; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male 127228297 CVCL_A4XX WMUi017-A induced pluripotent stem cell human CVCL_A4XX From: Wenzhou Medical University; Wenzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9330; PQBP1; Simple; p.Pro609Ala (c.1825C>G); Zygosity=Hemizygous (PubMed=33477035) Population: Chinese; Han; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male 127228298 CVCL_A4XK SDQLCHi028-A induced pluripotent stem cell human CVCL_A4XK From: Qilu Children's Hospital of Shandong University; Jinan; China. CL:0000010 127228299 CVCL_A4XJ SDQLCHi027-A induced pluripotent stem cell human CVCL_A4XJ From: Qilu Children's Hospital of Shandong University; Jinan; China. CL:0000010 127228300 CVCL_A4XM SDQLCHi030-A induced pluripotent stem cell human CVCL_A4XM From: Qilu Children's Hospital of Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5157; HPRT1; Simple; p.Arg170Ter (c.508C>T); ClinVar=VCV000010063; Zygosity=Hemizygous (PubMed=38154384) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228301 CVCL_A4XL SDQLCHi029-A induced pluripotent stem cell human CVCL_A4XL From: Qilu Children's Hospital of Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6930; MC2R; Simple; p.Arg137Trp (c.409C>T); ClinVar=VCV000003265; Zygosity=Heterozygous (PubMed=38430736); Sequence variation: Mutation; HGNC; HGNC:6930; MC2R; Simple; p.Thr143Ile (c.428C>T); Zygosity=Heterozygous (PubMed=38430736) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228302 CVCL_A4XN SDQLCHi031-A induced pluripotent stem cell human CVCL_A4XN From: Qilu Children's Hospital of Shandong University; Jinan; China. CL:0000010 127228303 CVCL_A4XQ SDQLCHi034-A induced pluripotent stem cell human CVCL_A4XQ From: Qilu Children's Hospital of Shandong University; Jinan; China. CL:0000010 127228304 CVCL_A4XP SDQLCHi032-A induced pluripotent stem cell human CVCL_A4XP From: Qilu Children's Hospital of Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5154; HPGD; Simple; p.Leu104Alafs*3 (c.308_309CT[1]) (c.310_311delCT); ClinVar=VCV000156027; Zygosity=Homozygous (PubMed=33550138) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228305 CVCL_A4XC UUMCBi002-A induced pluripotent stem cell human CVCL_A4XC From: Department of Medical Cell Biology, Biomedical Centre; Uppsala; Sweden CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228306 CVCL_A4XB UUMCBi001-A induced pluripotent stem cell human CVCL_A4XB From: Department of Medical Cell Biology, Biomedical Centre; Uppsala; Sweden CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228307 CVCL_A4XE FINCBi003-A induced pluripotent stem cell human CVCL_A4XE From: Fondazione IRCCS Istituto Neurologico C Besta; Milan; Italy. CL:0000010 Sequence variation: Mutation; HGNC; HGNC:Group_1972; MT-@; Unexplicit; m.8469_13460del; Zygosity=Heteroplasmic; Note=In 30% (PubMed=33434818) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH Male 127228308 CVCL_A4XD FINCBi002-A induced pluripotent stem cell human CVCL_A4XD From: Fondazione IRCCS Istituto Neurologico C Besta; Milan; Italy. CL:0000010 Sequence variation: Mutation; HGNC; HGNC:Group_1972; MT-@; Unexplicit; m.9449_14550del; Zygosity=Heteroplasmic; Note=In 80% (PubMed=33434818) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH Male 127228309 CVCL_A4XG SDQLCHi039-A induced pluripotent stem cell human CVCL_A4XG From: Qilu Children's Hospital of Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1133; BTK; Simple; p.Tyr510_Glu513delGluTyrLeuGluinsGlu (c.1530_1538delATACCTGGA); Zygosity=Hemizygous (PubMed=33453577) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228310 CVCL_A4XF GWCMCi003-A induced pluripotent stem cell human CVCL_A4XF From: Guangzhou Women and Children's Medical Center; Guangzhou; China. CL:0000010 127228311 CVCL_A4XI PLAFMCi003-A induced pluripotent stem cell human CVCL_A4XI From: Chinese PLA General Hospital; Beijing; China CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:9008; PKD1; Zygosity=Heterozygous (PubMed=33485185); Sequence variation: Gene deletion; HGNC; HGNC:12363; TSC2; Zygosity=Heterozygous (PubMed=33485185) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228312 CVCL_A4XH SDQLCHi037-A induced pluripotent stem cell human CVCL_A4XH From: Qilu Children's Hospital of Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6188; JAG1; Simple; p.Gln539Ter (c.1615C>T); ClinVar=VCV000488807; Zygosity=Heterozygous (PubMed=33465531) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228313 CVCL_A4ZA UMGi101-A induced pluripotent stem cell human CVCL_A4ZA From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228314 CVCL_A4ZC UMGi140-A induced pluripotent stem cell human CVCL_A4ZC From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228315 CVCL_A4ZB UMGi132-A induced pluripotent stem cell human CVCL_A4ZB From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228316 CVCL_A4YT SUi002-B induced pluripotent stem cell human CVCL_A4YT From: Semmelweis University; Budapest; Hungary CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228317 CVCL_A4YS SUi002-A induced pluripotent stem cell human CVCL_A4YS From: Semmelweis University; Budapest; Hungary CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228318 CVCL_A4YV SUi003-B induced pluripotent stem cell human CVCL_A4YV From: Semmelweis University; Budapest; Hungary CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6316; KHSRP; Simple; p.Gly403Cys (c.1207G>T) (chr19:g.6416869C>A); Zygosity=Heterozygous; Note=De novo mutation (from autologous cell line SUi003-A); Sequence variation: Mutation; HGNC; HGNC:6329; KIR2DL1; Simple; c.412A>T (chr19:g.55286658A>T); Zygosity=Heterozygous; Note=De novo mutation (from autologous cell line SUi003-A); Sequence variation: Mutation; HGNC; HGNC:18531; LRRC7; Simple; p.Val1158Ile (c.3472G>A) (chr1:g.70505093G>A); Zygosity=Heterozygous; Note=De novo mutation (from autologous cell line SUi003-A) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228319 CVCL_A4YU SUi003-A induced pluripotent stem cell human CVCL_A4YU From: Semmelweis University; Budapest; Hungary CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6316; KHSRP; Simple; p.Gly403Cys (c.1207G>T) (chr19:g.6416869C>A); Zygosity=Heterozygous; Note=De novo mutation (PubMed=33503521); Sequence variation: Mutation; HGNC; HGNC:6329; KIR2DL1; Simple; c.412A>T (chr19:g.55286658A>T); Zygosity=Heterozygous; Note=De novo mutation (PubMed=33503521); Sequence variation: Mutation; HGNC; HGNC:18531; LRRC7; Simple; p.Val1158Ile (c.3472G>A) (chr1:g.70505093G>A); Zygosity=Heterozygous; Note=De novo mutation (PubMed=33503521) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228320 CVCL_A4YX KRIBBi001-A induced pluripotent stem cell human CVCL_A4YX From: Korea Research Institute of Bioscience and Biotechnology; Daejeon; South Korea CL:0000010 Population: Brazilian; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Female 127228321 CVCL_A4YW IBMS-iPSC-070-02 induced pluripotent stem cell human CVCL_A4YW From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan CL:0000010 Sequence variation: Mutation; HGNC; HGNC:15894; PANK2; Simple; p.Leu111Gln (c.332T>A); ClinVar=VCV000193506; Zygosity=Heterozygous (PubMed=33517123); Sequence variation: Mutation; HGNC; HGNC:15894; PANK2; Simple; c.1413-9_-14dupTTCCCC; Zygosity=Heterozygous (PubMed=33517123); Sequence variation: Mutation; HGNC; HGNC:15894; PANK2; Simple; p.Asn500Ile (c.1499A>T); dbSNP=rs759332123; Zygosity=Heterozygous (PubMed=33517123) Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228322 CVCL_A4YZ UMGi150-A induced pluripotent stem cell human CVCL_A4YZ From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228323 CVCL_A4YY UMGi153-A induced pluripotent stem cell human CVCL_A4YY From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228324 CVCL_A4YL BGUi012-A induced pluripotent stem cell human CVCL_A4YL From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Population: Jewish; Ashkenazi; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228325 CVCL_A4YK BGUi011-A induced pluripotent stem cell human CVCL_A4YK From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4588; GRIN2D; Simple; p.Val667Ile (c.1999G>A); ClinVar=VCV000267211; Zygosity=Heterozygous (PubMed=33482465) Population: Jewish; Ashkenazi; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228326 CVCL_A4YN BGUi015-A induced pluripotent stem cell human CVCL_A4YN From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Population: Caucasian; Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 127228327 CVCL_A4YM BGUi013-A induced pluripotent stem cell human CVCL_A4YM From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358. Female 127228328 CVCL_A4YP STBCi026-A-4 induced pluripotent stem cell human CVCL_A4YP From: StemBANCC; Oxford; United Kingdom CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Discontinued: ECACC; 66541208; true Female Characteristics: Using CRISPR/Cas9 a GFP tag was introduced at the C-terminus of PITX3 127228329 CVCL_A4YR SUi001-B induced pluripotent stem cell human CVCL_A4YR From: Semmelweis University; Budapest; Hungary CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228330 CVCL_A4YQ SUi001-A induced pluripotent stem cell human CVCL_A4YQ From: Semmelweis University; Budapest; Hungary CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228331 CVCL_A4YD UKWMPi002-A-1 induced pluripotent stem cell human CVCL_A4YD From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1753; CDH13 (Note=1 of 2 alleles) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228332 CVCL_A4YC UKWMPi002-A induced pluripotent stem cell human CVCL_A4YC From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228333 CVCL_A4YF UKWMPi002-B induced pluripotent stem cell human CVCL_A4YF From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228334 CVCL_A4YE UKWMPi002-A-2 induced pluripotent stem cell human CVCL_A4YE From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1753; CDH13 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228335 CVCL_A4YH UKWMPi001-A induced pluripotent stem cell human CVCL_A4YH From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228336 CVCL_A4YG UKWMPi002-C induced pluripotent stem cell human CVCL_A4YG From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228337 CVCL_A4YJ ZZUi028-A induced pluripotent stem cell human CVCL_A4YJ From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Leg, skin, dermis; UBERON=UBERON_0001511+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228338 CVCL_A4YI UKWMPi001-B induced pluripotent stem cell human CVCL_A4YI From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228339 CVCL_A4VY 4.3-01 induced pluripotent stem cell house mouse CVCL_A4VY CL:0000010 Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified Characteristics: Zfp57-/- z (M+Z-) genotype 127228340 CVCL_A4VX 4.2-05 induced pluripotent stem cell house mouse CVCL_A4VX CL:0000010 Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified Characteristics: Zfp57+/- (M+Z+) genotype 127228341 CVCL_A4VZ 4.3-04 induced pluripotent stem cell house mouse CVCL_A4VZ CL:0000010 Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified Characteristics: Zfp57-/- z (M+Z-) genotype 127228342 CVCL_A4VQ PN1-iPSC induced pluripotent stem cell human CVCL_A4VQ From: Children's Hospital of Philadelphia; Philadelphia; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:25792; USB1; Simple; c.693+1G>T; ClinVar=VCV000496749; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=26987923) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228343 CVCL_A4VP M3O-lenti-iPSC-LIF(-) induced pluripotent stem cell house mouse CVCL_A4VP CL:0000010 Male 127228344 CVCL_A4VS D1902 embryonic stem cell house mouse CVCL_A4VS CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: 129 x DBA/2. 127228345 CVCL_A4VR PN2-iPSC induced pluripotent stem cell human CVCL_A4VR From: Children's Hospital of Philadelphia; Philadelphia; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:25792; USB1; Simple; c.693+1G>T; ClinVar=VCV000496749; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=26987923) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228346 CVCL_A4VU D1904 embryonic stem cell house mouse CVCL_A4VU CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: 129 x DBA/2. 127228347 CVCL_A4VT D1903 embryonic stem cell house mouse CVCL_A4VT CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: 129 x DBA/2. 127228348 CVCL_A4VW D1911 embryonic stem cell house mouse CVCL_A4VW CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: 129 x DBA/2. 127228349 CVCL_A4VV D1906 embryonic stem cell house mouse CVCL_A4VV CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: 129 x DBA/2. 127228350 CVCL_A4VI FORTHi001A induced pluripotent stem cell human CVCL_A4VI From: Department of Biomedical Research, Foundation of Research and Technology-Hellas; Ioannina; Greece CL:0000010 Population: Caucasian; Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Omics: Transcriptomics; Microarray Male 127228351 CVCL_A4VH TLE3-447-D08-A01 embryonic stem cell human CVCL_A4VH From: Broad Institute of MIT and Harvard; Cambridge; USA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11839; TLE3 (Note=1 of 2 alleles) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127228352 CVCL_A4VK FORTHi001C induced pluripotent stem cell human CVCL_A4VK From: Department of Biomedical Research, Foundation of Research and Technology-Hellas; Ioannina; Greece CL:0000010 Population: Caucasian; Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Omics: Transcriptomics; Microarray Male 127228353 CVCL_A4VJ FORTHi001B induced pluripotent stem cell human CVCL_A4VJ From: Department of Biomedical Research, Foundation of Research and Technology-Hellas; Ioannina; Greece CL:0000010 Population: Caucasian; Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Omics: Transcriptomics; Microarray Male 127228354 CVCL_A4VM iPSC(OCT4) 2 induced pluripotent stem cell human CVCL_A4VM From: McMaster Stem Cell and Cancer Research Institute, Michael G DeGroote School of Medicine, McMaster University; Hamilton; Canada. CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH Male 127228355 CVCL_A4VL iPSC(OCT4) 1 induced pluripotent stem cell human CVCL_A4VL From: McMaster Stem Cell and Cancer Research Institute, Michael G DeGroote School of Medicine, McMaster University; Hamilton; Canada. CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH Female 127228356 CVCL_A4VN iPSC(OCT4) 3 induced pluripotent stem cell human CVCL_A4VN From: McMaster Stem Cell and Cancer Research Institute, Michael G DeGroote School of Medicine, McMaster University; Hamilton; Canada. CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH Female 127228357 CVCL_A4VA UMGi093-A induced pluripotent stem cell human CVCL_A4VA From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228358 CVCL_A4VC GWCMCi002-A induced pluripotent stem cell human CVCL_A4VC From: Guangzhou Women and Children's Medical Center; Guangzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2207; COL4A5; Simple; c.1517-1G>T; ClinVar=VCV000024421; Zygosity=Hemizygous; Note=Splice acceptor mutation (PubMed=34088015) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228359 CVCL_A4VB UMGi094-A induced pluripotent stem cell human CVCL_A4VB From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228360 CVCL_A4VE CREM040i-SA82-2 induced pluripotent stem cell human CVCL_A4VE From: Center for Regenerative Medicine; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (PubMed=28111279) Population: Arab; Saudi Arabian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Part of: Next Generation Genetic Association studies (Next Gen) program cell lines 127228361 CVCL_A4VD CREM039i-SA108 induced pluripotent stem cell human CVCL_A4VD From: Center for Regenerative Medicine; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (PubMed=28111279) Population: Arab; Saudi Arabian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Part of: Next Generation Genetic Association studies (Next Gen) program cell lines 127228362 CVCL_A4VG iPS-CTX-R395S induced pluripotent stem cell human CVCL_A4VG From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2605; CYP27A1; Simple; p.Arg395Ser (c.1183C>A); ClinVar=VCV000004261; Zygosity=Homozygous (PubMed=27879219) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228363 CVCL_A4VF CREM043i-SA210-1 induced pluripotent stem cell human CVCL_A4VF From: Center for Regenerative Medicine; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (PubMed=28111279) Population: Arab; Saudi Arabian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Part of: Next Generation Genetic Association studies (Next Gen) program cell lines 127228364 CVCL_A4WZ IGIBi002-A [2021] induced pluripotent stem cell human CVCL_A4WZ From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.92+5G>C (IVS1,G>C,+5) (IVS1-5G>C); ClinVar=VCV000015447; Zygosity=Homozygous (PubMed=33338925) Population: Indian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Caution: Two different cell lines were established by CSIR-IGIB with the same IGIBi002-A designation 127228365 CVCL_A4WY MCRIi019-A-1 induced pluripotent stem cell human CVCL_A4WY From: Murdoch Children's Research Institute; Melbourne; Australia CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31612; MIR26B Population: African American; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228366 CVCL_A4XA HUi002-A induced pluripotent stem cell human CVCL_A4XA From: Hanyang Biomedical Research Institute, Hanyang University; Seoul; South Korea CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228367 CVCL_A4WR LIBDi015-A induced pluripotent stem cell human CVCL_A4WR From: Lieber Institute for Brain Development; Baltimore; USA CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228368 CVCL_A4WQ LIBDi014-A induced pluripotent stem cell human CVCL_A4WQ From: Lieber Institute for Brain Development; Baltimore; USA CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:11634; TCF4; Zygosity=Heterozygous (PubMed=32971458) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228369 CVCL_A4WT LIBDi017-A induced pluripotent stem cell human CVCL_A4WT From: Lieber Institute for Brain Development; Baltimore; USA CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228370 CVCL_A4WS LIBDi016-A induced pluripotent stem cell human CVCL_A4WS From: Lieber Institute for Brain Development; Baltimore; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11634; TCF4; Simple; c.922+3G>T; ClinVar=VCV001204043; Zygosity=Heterozygous (PubMed=32971458) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228371 CVCL_A4WV LIBDi019-A induced pluripotent stem cell human CVCL_A4WV From: Lieber Institute for Brain Development; Baltimore; USA CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:11634; TCF4; Zygosity=Heterozygous (PubMed=32971458) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228372 CVCL_A4WU LIBDi018-A induced pluripotent stem cell human CVCL_A4WU From: Lieber Institute for Brain Development; Baltimore; USA CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228373 CVCL_A4WX SCSe001-A-3 embryonic stem cell human CVCL_A4WX From: Children's Hospital of Philadelphia; Philadelphia; USA CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.); Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Using homologous recombination an EGFP reporter gene was introduced in the INS locus and using CRISPR/Cas9 a tandem-dimer RFP was introduced in the SST gene (PubMed=33316598) 127228374 CVCL_A4WW LIBDi010-A induced pluripotent stem cell human CVCL_A4WW From: Lieber Institute for Brain Development; Baltimore; USA CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228375 CVCL_A4WJ MHHi019-A induced pluripotent stem cell human CVCL_A4WJ From: Hannover Medical School, LEBAO (MHH); Hannover; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7853; NME5; Simple; p.Ile139Tyrfs*8 (c.415delA); ClinVar=VCV001705858; Zygosity=Homozygous (PubMed=32950024) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228376 CVCL_A4WI MPIi007-A induced pluripotent stem cell human CVCL_A4WI From: Max Planck Institute for Molecular Biomedicine; Munster; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:713; ARSA; Simple; p.Thr393Ser (c.1178C>G) (p.Thr391Ser, c.1172C>G); ClinVar=VCV000021184; Zygosity=Heterozygous (PubMed=32950023) Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228377 CVCL_A4WL MHHi020-A induced pluripotent stem cell human CVCL_A4WL From: Hannover Medical School, LEBAO (MHH); Hannover; Germany. CL:0000010 127228378 CVCL_A4WK MHHi019-B induced pluripotent stem cell human CVCL_A4WK From: Hannover Medical School, LEBAO (MHH); Hannover; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7853; NME5; Simple; p.Ile139Tyrfs*8 (c.415delA); ClinVar=VCV001705858; Zygosity=Homozygous (PubMed=32950024) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228379 CVCL_A4WN LIBDi012-A induced pluripotent stem cell human CVCL_A4WN From: Lieber Institute for Brain Development; Baltimore; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11634; TCF4; Simple; p.Arg385Ter (c.1153C>T); ClinVar=VCV000007372; Zygosity=Heterozygous (PubMed=32971458) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228380 CVCL_A4WM LIBDi011-A induced pluripotent stem cell human CVCL_A4WM From: Lieber Institute for Brain Development; Baltimore; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11634; TCF4; Simple; p.Arg76Ter; Zygosity=Heterozygous (PubMed=32971458) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228381 CVCL_A4WP LIBDi013-A induced pluripotent stem cell human CVCL_A4WP From: Lieber Institute for Brain Development; Baltimore; USA CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228382 CVCL_A4WB WAe001-A-80 embryonic stem cell human CVCL_A4WB From: University of Wisconsin; Madison; USA CL:0000010 Genetic integration: Method=PiggyBac transposition; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=ZFN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=ZFN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Using ZFN a 2A-PuroR-CD43_promoter-eGFP was introduced in the AAVS1 safe harbor locus and CDH5(CD144) promoter-tdTomato-Zeo construct was transposed using a piggyBac transposon vector (PubMed=27879215) Registration: Swiss research registry; BAG-hES-IMP-0081 127228383 CVCL_A4WA 7.2-02 induced pluripotent stem cell house mouse CVCL_A4WA CL:0000010 Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified Characteristics: Zfp57-/- mz (M-Z-) genotype 127228384 CVCL_A4WD PH1-iPSC#2 induced pluripotent stem cell human CVCL_A4WD From: University of Bordeaux; Bordeaux; France CL:0000010 Sequence variation: Mutation; HGNC; HGNC:341; AGXT; Simple; p.Ile244Thr (c.731T>C); ClinVar=VCV000005646; Zygosity=Homozygous (PubMed=31151050) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228385 CVCL_A4WC PH1-iPSC#1 induced pluripotent stem cell human CVCL_A4WC From: University of Bordeaux; Bordeaux; France CL:0000010 Sequence variation: Mutation; HGNC; HGNC:341; AGXT; Simple; p.Ile244Thr (c.731T>C); ClinVar=VCV000005646; Zygosity=Homozygous (PubMed=31151050) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228386 CVCL_A4WF WT-iPSC#2 induced pluripotent stem cell human CVCL_A4WF From: University of Bordeaux; Bordeaux; France CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228387 CVCL_A4WE WT-iPSC#1 induced pluripotent stem cell human CVCL_A4WE From: University of Bordeaux; Bordeaux; France CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228388 CVCL_A4WH PH1-iPSC#2-TTRp-eGFP induced pluripotent stem cell human CVCL_A4WH From: University of Bordeaux; Bordeaux; France CL:0000010 Sequence variation: Mutation; HGNC; HGNC:341; AGXT; Simple; p.Ile244Thr (c.731T>C); ClinVar=VCV000005646; Zygosity=Homozygous (PubMed=31151050); Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: The transduced eGFP gene expression is under the control of transthyretin promoter (TTRp) (PubMed=31151050) 127228389 CVCL_A4WG PH1-iPSC#2-TTRp-AGXT induced pluripotent stem cell human CVCL_A4WG From: University of Bordeaux; Bordeaux; France CL:0000010 Sequence variation: Mutation; HGNC; HGNC:341; AGXT; Simple; p.Ile244Thr (c.731T>C); ClinVar=VCV000005646; Zygosity=Heterozygous; Note=No longer homozygous because of transduced wild-type gene (PubMed=31151050); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:341; AGXT Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: The transduced AGXT gene expression is under the control of transthyretin promoter (TTRp) (PubMed=31151050) 127228390 CVCL_A4TW CALM1-F142L iPSC c2 induced pluripotent stem cell human CVCL_A4TW CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1442; CALM1; Simple; p.Phe142Leu (c.426C>G) (c.9406C>G); ClinVar=VCV000183231; Zygosity=Heterozygous (PubMed=28158429) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228391 CVCL_A4TV CALM1-F142L iPSC c1 induced pluripotent stem cell human CVCL_A4TV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1442; CALM1; Simple; p.Phe142Leu (c.426C>G) (c.9406C>G); ClinVar=VCV000183231; Zygosity=Heterozygous (PubMed=28158429) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228392 CVCL_A4TY WAe001-A-57 embryonic stem cell human CVCL_A4TY From: Institute for Cardiovascular Science of Soochow University; Suzhou; China CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Using CRISPR/Cas9 a 2A-mCherry cassette was integrated in front of the stop codon of EFNB2 in one allele (PubMed=33611045) 127228393 CVCL_A4TX WAe001-A-47 embryonic stem cell human CVCL_A4TX From: Wenzhou Medical University; Wenzhou; China CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:28966; VGLL4; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Dox-inducible expression of VGLL4 The cell has been transfected with a PB-TRE6P-VGLL4-P2A-EGFP-3xFLAG-PA-EF1a-5'LTR-rtTA-T2A-puroR construct (PubMed=33385792). 127228394 CVCL_A4TZ WAe009-A-48 embryonic stem cell human CVCL_A4TZ From: Shenzhen People's Hospital; Shenzhen; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Glu1784Lys (c.5350G>A) (p.Glu1783Lys, c.5347G>A); ClinVar=VCV000009377; Zygosity=Heterozygous; Note=By method not specified (PubMed=33517120) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127228395 CVCL_A4TN CCD2-iPS 9 induced pluripotent stem cell human CVCL_A4TN From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10472; RUNX2; Simple; p.Gln67Ter (c.199C>T); Zygosity=Heterozygous (PubMed=29357927) Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729. Female 127228396 CVCL_A4TQ UMGi090-A induced pluripotent stem cell human CVCL_A4TQ From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228397 CVCL_A4TP CCD2-iPS 12 induced pluripotent stem cell human CVCL_A4TP From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10472; RUNX2; Simple; p.Gln67Ter (c.199C>T); Zygosity=Heterozygous (PubMed=29357927) Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729. Female 127228398 CVCL_A4TS Rev1-iPSC induced pluripotent stem cell human CVCL_A4TS From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10472; RUNX2; Simple_corrected; p.Arg391Ter (c.1171C>T); ClinVar=VCV000065625; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=29357927) Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729. Female 127228399 CVCL_A4TR UMGi091-A induced pluripotent stem cell human CVCL_A4TR From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228400 CVCL_A4TU UMGi130-A induced pluripotent stem cell human CVCL_A4TU From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228401 CVCL_A4TT UMGi014-E induced pluripotent stem cell human CVCL_A4TT From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male 127228402 CVCL_A4TG IHLPC transformed cell line human CVCL_A4TG CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Pericyte; CL=CL_0000669. Characteristics: Retains pericyte-specific characteristics, including normal pericyte morphology and expression of the commonly used pericyte markers, PDGFRB and NG2 (PubMed=33446892) 127228403 CVCL_A4TF UMGi148-A induced pluripotent stem cell human CVCL_A4TF From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male 127228404 CVCL_A4TI CCD1-iPS 4 induced pluripotent stem cell human CVCL_A4TI From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10472; RUNX2; Simple; p.Arg391Ter (c.1171C>T); ClinVar=VCV000065625; Zygosity=Heterozygous (PubMed=29357927) Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729. Female 127228405 CVCL_A4TH CCD1-iPS 2 induced pluripotent stem cell human CVCL_A4TH From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10472; RUNX2; Simple; p.Arg391Ter (c.1171C>T); ClinVar=VCV000065625; Zygosity=Heterozygous (PubMed=29357927) Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729. Female 127228406 CVCL_A4TK CCD2-iPS 4 induced pluripotent stem cell human CVCL_A4TK From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10472; RUNX2; Simple; p.Gln67Ter (c.199C>T); Zygosity=Heterozygous (PubMed=29357927) Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729. Female 127228407 CVCL_A4TJ CCD1-iPS 6 induced pluripotent stem cell human CVCL_A4TJ From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10472; RUNX2; Simple; p.Arg391Ter (c.1171C>T); ClinVar=VCV000065625; Zygosity=Heterozygous (PubMed=29357927) Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729. Female 127228408 CVCL_A4TM CCD2-iPS 8 induced pluripotent stem cell human CVCL_A4TM From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10472; RUNX2; Simple; p.Gln67Ter (c.199C>T); Zygosity=Heterozygous (PubMed=29357927) Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729. Female 127228409 CVCL_A4TL CCD2-iPS 7 induced pluripotent stem cell human CVCL_A4TL From: Department of Biochemistry, Tokyo Dental College; Tokyo; Japan CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10472; RUNX2; Simple; p.Gln67Ter (c.199C>T); Zygosity=Heterozygous (PubMed=29357927) Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729. Female 127228410 CVCL_A4TA UMGi084-A induced pluripotent stem cell human CVCL_A4TA From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127228411 CVCL_A4TC UMGi086-A induced pluripotent stem cell human CVCL_A4TC From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127228412 CVCL_A4TB UMGi085-A induced pluripotent stem cell human CVCL_A4TB From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127228413 CVCL_A4TE UMGi154-A induced pluripotent stem cell human CVCL_A4TE From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Urine; UBERON=UBERON_0001088. Female 127228414 CVCL_A4TD UMGi155-A induced pluripotent stem cell human CVCL_A4TD From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male 127228415 CVCL_A4UX UMGi102-A induced pluripotent stem cell human CVCL_A4UX From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228416 CVCL_A4UW UMGi109-A induced pluripotent stem cell human CVCL_A4UW From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 127228417 CVCL_A4UZ UMGi104-A induced pluripotent stem cell human CVCL_A4UZ From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228418 CVCL_A4UY UMGi103-A induced pluripotent stem cell human CVCL_A4UY From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228419 CVCL_A4UP UMGi105-A induced pluripotent stem cell human CVCL_A4UP From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 127228420 CVCL_A4UR UMGi106-B induced pluripotent stem cell human CVCL_A4UR From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 127228421 CVCL_A4UQ UMGi106-A induced pluripotent stem cell human CVCL_A4UQ From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 127228422 CVCL_A4UT UMGi107-B induced pluripotent stem cell human CVCL_A4UT From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 127228423 CVCL_A4US UMGi107-A induced pluripotent stem cell human CVCL_A4US From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 127228424 CVCL_A4UV UMGi108-B induced pluripotent stem cell human CVCL_A4UV From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 127228425 CVCL_A4UU UMGi108-A induced pluripotent stem cell human CVCL_A4UU From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 127228426 CVCL_A4UH UMGi128-A induced pluripotent stem cell human CVCL_A4UH From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228427 CVCL_A4UG UMGi127-A induced pluripotent stem cell human CVCL_A4UG From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228428 CVCL_A4UJ iMSMD-cohet.7 induced pluripotent stem cell human CVCL_A4UJ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5439; IFNGR1; Simple; c.373+1G>T (p.Val68Lysfs*6); Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29249666); Sequence variation: Mutation; HGNC; HGNC:5439; IFNGR1; Simple; p.Ile187fs (c.561_564delACTC) (c.561del4); Zygosity=Heterozygous (PubMed=29249666) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228429 CVCL_A4UI iMSMD-cohet.5 induced pluripotent stem cell human CVCL_A4UI CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5439; IFNGR1; Simple; c.373+1G>T (p.Val68Lysfs*6); Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29249666); Sequence variation: Mutation; HGNC; HGNC:5439; IFNGR1; Simple; p.Ile187fs (c.561_564delACTC) (c.561del4); Zygosity=Heterozygous (PubMed=29249666) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228430 CVCL_A4UL iMSMD-het.4 induced pluripotent stem cell human CVCL_A4UL CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5439; IFNGR1; Simple; c.373+1G>T (p.Val68Lysfs*6); Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29249666) Donor information: While obtained from a patient suffering from Mendelian susceptibility to mycobacterial diseases, this iPSC originates from the sister of this patient who was the donor for a hematopoietic stem cell transplantation; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228431 CVCL_A4UK iMSMD-cohet.17 induced pluripotent stem cell human CVCL_A4UK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5439; IFNGR1; Simple; c.373+1G>T (p.Val68Lysfs*6); Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29249666); Sequence variation: Mutation; HGNC; HGNC:5439; IFNGR1; Simple; p.Ile187fs (c.561_564delACTC) (c.561del4); Zygosity=Heterozygous (PubMed=29249666) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228432 CVCL_A4UN ZZUNEUi020-A induced pluripotent stem cell human CVCL_A4UN From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Arg719Gln (c.2156G>A); ClinVar=VCV000014107; Zygosity=Heterozygous (PubMed=33453578) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228433 CVCL_A4UM iMSMD-het.9 induced pluripotent stem cell human CVCL_A4UM CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5439; IFNGR1; Simple; c.373+1G>T (p.Val68Lysfs*6); Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29249666) Donor information: While obtained from a patient suffering from Mendelian susceptibility to mycobacterial diseases, this iPSC originates from the sister of this patient who was the donor for a hematopoietic stem cell transplantation; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228434 CVCL_A4UB WAe009-A-47 embryonic stem cell human CVCL_A4UB From: Peking University Third Hospital; Beijing; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2279; COX6A2 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127228435 CVCL_A4UA SPHi001-A induced pluripotent stem cell human CVCL_A4UA From: Shenzhen People's Hospital; Shenzhen; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228436 CVCL_A4UD UMGi126-A.9 induced pluripotent stem cell human CVCL_A4UD From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10582; SCN10A; Simple; p.Arg1250Gln (c.3749G>A); ClinVar=VCV000221068; Zygosity=Heterozygous (PubMed=31106349); Sequence variation: Mutation; HGNC; HGNC:10582; SCN10A; Simple; p.Arg1268Gln (c.3803G>A); ClinVar=VCV000240673; Zygosity=Heterozygous (PubMed=31106349) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi126-A) for a series of distinct clones 127228437 CVCL_A4UC WAe009-A-46 embryonic stem cell human CVCL_A4UC From: The Second People's Hospital of Liaocheng; Liaocheng; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7576; MYH6 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127228438 CVCL_A4UF UMGi126-A.13 induced pluripotent stem cell human CVCL_A4UF From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10582; SCN10A; Simple; p.Arg1250Gln (c.3749G>A); ClinVar=VCV000221068; Zygosity=Heterozygous (PubMed=31106349); Sequence variation: Mutation; HGNC; HGNC:10582; SCN10A; Simple; p.Arg1268Gln (c.3803G>A); ClinVar=VCV000240673; Zygosity=Heterozygous (PubMed=31106349) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi126-A) for a series of distinct clones 127228439 CVCL_A4UE UMGi126-A.12 induced pluripotent stem cell human CVCL_A4UE From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10582; SCN10A; Simple; p.Arg1250Gln (c.3749G>A); ClinVar=VCV000221068; Zygosity=Heterozygous (PubMed=31106349); Sequence variation: Mutation; HGNC; HGNC:10582; SCN10A; Simple; p.Arg1268Gln (c.3803G>A); ClinVar=VCV000240673; Zygosity=Heterozygous (PubMed=31106349) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi126-A) for a series of distinct clones 127228440 CVCL_A5DF CTR4#5 induced pluripotent stem cell human CVCL_A5DF CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228441 CVCL_A5DE 11H4-1C7 hybridoma CVCL_A5DE CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Mouse osteocyte antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12397 127228442 CVCL_A5DH CTR8#14 induced pluripotent stem cell human CVCL_A5DH CL:0000010 127228443 CVCL_A5DG CTR2#6 induced pluripotent stem cell human CVCL_A5DG CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228444 CVCL_A5DJ MS-HIPS RR16#5 induced pluripotent stem cell human CVCL_A5DJ CL:0000010 Miscellaneous: Sampling site from personal communication of BioKryo (ISENET Biobanking) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228445 CVCL_A5DI MS-HIPS PP9#1 induced pluripotent stem cell human CVCL_A5DI CL:0000010 Miscellaneous: Sampling site from personal communication of BioKryo (ISENET Biobanking) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH Female 127228446 CVCL_A5DL WFS2_3 finite cell line human CVCL_A5DL CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24212; CISD2; Simple; c.103+1G>A; ClinVar=VCV000638297; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29239282) Population: Caucasian; Italian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228447 CVCL_A5DK WFS2_4 finite cell line human CVCL_A5DK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24212; CISD2; Simple; c.103+1G>A; ClinVar=VCV000638297; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29239282) Population: Caucasian; Italian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228448 CVCL_A5DB 9A3-2G8 hybridoma CVCL_A5DB CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Mouse osteocyte antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12395 127228449 CVCL_A5DA 2T3 transformed cell line house mouse CVCL_A5DA CL:0000010 Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339; Cell type: Osteoblast; CL=CL_0000062; Breed/subspecies: Bmp2 promoter T-Ag-3 transgenic. Unspecified 127228450 CVCL_A5DD 9D9-2F5 hybridoma CVCL_A5DD CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Mouse osteocyte antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12396 127228451 CVCL_A5DC 9C11 [Rat hybridoma against mouse Pdpn] hybridoma CVCL_A5DC CL:0000010 Miscellaneous: This hybridoma was lost (Patent=US6358737). Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q62011; Mouse Pdpn 127228452 CVCL_A5CU HCCLM9 cancer cell line human CVCL_A5CU CL:0000010 Sequence variation: Mutation; HGNC; HGNC:14310; BRD7; Simple; p.Glu277Glyfs*18 (c.830_831delAG); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:23177; KEAP1; Simple; p.Pro445Glnfs*13 (c.1334delC); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu51Ter (c.151G>T); ClinVar=VCV000568781; Zygosity=Unspecified (from parent cell line) Population: Chinese; Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV). Male Characteristics: Established from pulmonary metastatic lesions produced in nude mice by 9 rounds of subcutaneous inoculation of parent cell line 127228453 CVCL_A5CT Hep-G2 VL-17A cancer cell line human CVCL_A5CT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2631; CYP2E1; Genetic integration: Method=Transfection; Gene=MGI; MGI:87921; Adh1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 127228454 CVCL_A5CW AF22 somatic stem cell human CVCL_A5CW CL:0000010 Miscellaneous: Sex of donor from personal communication of BioKryo (ISENET Biobanking) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Proteomics; Expression; Large antibody panel staining analysis; Omics: Transcriptomics; RNAseq Female Characteristics: Long term self-renewing neuroepithelial-like stem cells with stable neurogenic properties (PubMed=22272239) Part of: Human Protein Atlas, Cell Atlas panel 127228455 CVCL_A5CV CTR4#9 induced pluripotent stem cell human CVCL_A5CV CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228456 CVCL_A5CY AF24 somatic stem cell human CVCL_A5CY CL:0000010 Cell type: Neuroepithelial stem cell; CL=CL_0002259. Unspecified Characteristics: Long term self-renewing neuroepithelial-like stem cells with stable neurogenic properties (PubMed=22272239) 127228457 CVCL_A5CX AF23 somatic stem cell human CVCL_A5CX CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Neuroepithelial stem cell; CL=CL_0002259. Female Characteristics: Long term self-renewing neuroepithelial-like stem cells with stable neurogenic properties (PubMed=22272239) 127228458 CVCL_A5CZ HEK293 APPswe transformed cell line human CVCL_A5CZ CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:620; APP (Note=With p.Lys670_Met671delinsAsnLeu (c.2010_2011inv)); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 127228459 CVCL_A5CM CH12F3-2 cancer cell line house mouse CVCL_A5CM CL:0000010 Derived from site: In situ; Lymph node; UBERON=UBERON_0000029; Breed/subspecies: B10.H-2aH-4bp/Wts. 127228460 CVCL_A5CL U87DND cancer cell line human CVCL_A5CL CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line). Population: Caucasian Male Characteristics: Exhibits a remarkably low competence at producing ceramide de novo (PubMed=27894925) Problematic cell line: Misidentified Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala. 127228461 CVCL_A5CN F180 finite cell line human CVCL_A5CN CL:0000010 Cell type: Fibroblast; CL=CL_0000057. 127228462 CVCL_A5CQ Hep-G2 VA-13 cancer cell line human CVCL_A5CQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Genetic integration: Method=Transfection; Gene=MGI; MGI:87921; Adh1; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 127228463 CVCL_A5CP F184 finite cell line human CVCL_A5CP CL:0000010 Cell type: Fibroblast; CL=CL_0000057. 127228464 CVCL_A5CS Hep-G2 VI-7 cancer cell line human CVCL_A5CS CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Characteristics: Control cell line for Hep-G2 VA-13 (Cellosaurus=CVCL_A5CQ) and Hep-G2 VA-28 (Cellosaurus=CVCL_A5CR) (PubMed=11981770) 127228465 CVCL_A5CR Hep-G2 VA-28 cancer cell line human CVCL_A5CR CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Genetic integration: Method=Transfection; Gene=MGI; MGI:87921; Adh1; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 127228466 CVCL_A5EG HEK293T-GIGYF1/2-null transformed cell line human CVCL_A5EG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9126; GIGYF1; Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11960; GIGYF2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Doubling time: ~30-40 hours (DSMZ=ACC-874) 127228467 CVCL_A5EF HEK293T-DDX6-null transformed cell line human CVCL_A5EF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2747; DDX6; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Doubling time: ~30-40 hours (DSMZ=ACC-873) 127228468 CVCL_A5EI HEK293T-XRN1-null transformed cell line human CVCL_A5EI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30654; XRN1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Doubling time: ~24-30 hours (DSMZ=ACC-876) 127228469 CVCL_A5EH HEK293T-HELZ-null transformed cell line human CVCL_A5EH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16878; HELZ; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Omics: Transcriptomics; RNAseq Female Doubling time: ~24-30 hours (DSMZ=ACC-875) 127228470 CVCL_A5EK NS46C somatic stem cell house mouse CVCL_A5EK CL:0000010 Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Neural stem cell; CL=CL_0000047; Breed/subspecies: 129P2/Ola. Male Characteristics: Using homologous recombination the Sox1 reading frame was replaced by a GFP-IRES-PuroR construct Expresses eGFP under the control of the Sox-1 promoter (from parent cell line 46C). Doubling time: ~24 hours (PubMed=16086633) 127228471 CVCL_A5EJ Quad-GL261 cancer cell line house mouse CVCL_A5EJ CL:0000010 Genetic integration: Method=Transfection; Gene=CGNC; 49631; OVAL/SERPINB14 (Note=With p.Met1_Ser251del, p.Asn272_Ser317del and p.Glu347_Pro386del); Genetic integration: Method=Transfection; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10880; PMEL (Note=With p.Met1_Leu18del and p.Arg40_Val661del); Genetic integration: Method=Transfection; Gene=MGI; MGI:95900; H2-Ea (Note=With p.Met1_Leu70del and p.Glu100_Leu255del); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA); Derived from site: In situ; Brain; UBERON=UBERON_0000955; Breed/subspecies: C57BL/6. Characteristics: Transfected with the Quad Ag cassette encoding four peptides presented by H-2b class I or II molecules as a single coding sequence The peptides are human PMEL/gp100 AA 25-33 (presented by H-2Db), chicken OVA epitope OT-I (AA 258-265; presented by H-2Kb), chicken OVA epitope OT-II (AA 324-340; presented by I-Ab) and mouse H2-Ea/I-Ea AA 77-93(52-68) (presented by I-Ab). To facilitate processing, each peptide is flanked on both sides by the 6 amino acid residues that surrounded the peptide in the corresponding native protein. 127228472 CVCL_A5EM Cor1 somatic stem cell house mouse CVCL_A5EM CL:0000010 Miscellaneous: Sex of donor from personal communication of BioKryo (ISENET Biobanking) Derived from site: In situ; Embryonic brain, neocortex; UBERON=UBERON_0006238+UBERON_0001950; Cell type: Neural stem cell; CL=CL_0000047. Male 127228473 CVCL_A5EL CGR8-NS somatic stem cell house mouse CVCL_A5EL CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Neural stem cell; CL=CL_0000047; Breed/subspecies: 129P2/Ola. Male 127228474 CVCL_A5EA FAIK1-10 transformed cell line house mouse CVCL_A5EA CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: B6D2;C57BL/6N-Tg(EPO::Cre)1Rhw x B6.Cg-Gt(ROSA)26Sor/J). Omics: Transcriptomics; RNAseq 127228475 CVCL_A5EC FAIK3-5 transformed cell line house mouse CVCL_A5EC CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: B6D2;C57BL/6N-Tg(EPO::Cre)1hw x B6.Cg-Gt(ROSA)26Sor/J). Omics: Transcriptomics; RNAseq Female Characteristics: Produces Epo under hypoxia Doubling time: ~20-30 hours (DSMZ=ACC-861) 127228476 CVCL_A5EB FAIK2-5 transformed cell line house mouse CVCL_A5EB CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: B6D2;C57BL/6N-Tg(EPO::Cre)1Rhw x B6.Cg-Gt(ROSA)26Sor/J). Omics: Transcriptomics; RNAseq 127228477 CVCL_A5EE HEK293T-CAF40-null transformed cell line human CVCL_A5EE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10445; CNOT9; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Doubling time: ~30-40 hours (DSMZ=ACC-872) 127228478 CVCL_A5ED SB-28-Ohlfest cancer cell line house mouse CVCL_A5ED CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase Derived from site: In situ; Brain; UBERON=UBERON_0000955; Breed/subspecies: C57BL/6. Omics: Genomics; Whole exome sequencing Characteristics: Glioma was induced by intraventricular transfection of pT2/C-Luc/PGKp-SB100 and Sleeping Beauty (SB)-flanked pT2/CAG-NRasV12 and pT2/shp53/mPDGF Doubling time: ~30 hours (DSMZ=ACC-880) 127228479 CVCL_A5DV CB660SP somatic stem cell human CVCL_A5DV CL:0000010 Derived from site: In situ; Fetal spinal cord; UBERON=UBERON_0006241; Cell type: Neural stem cell; CL=CL_0000047. Female 127228480 CVCL_A5DU Sai3 somatic stem cell human CVCL_A5DU CL:0000010 Derived from site: In situ; Fetal brain, hindbrain; UBERON=UBERON_0007277. Characteristics: Neuroepithelial stem cell 127228481 CVCL_A5DX O4ANS somatic stem cell house mouse CVCL_A5DX CL:0000010 Derived from site: In situ; Brain, subventricular zone; UBERON=UBERON_0014940; Cell type: Neural stem cell; CL=CL_0000047; Breed/subspecies: 129 x MF1. Female Doubling time: ~30 hours (PubMed=16766697) 127228482 CVCL_A5DW aNS-1 somatic stem cell house mouse CVCL_A5DW CL:0000010 Derived from site: In situ; Brain, subventricular zone; UBERON=UBERON_0014940; Cell type: Neural stem cell; CL=CL_0000047; Breed/subspecies: CD-1. Male Doubling time: ~30 hours (PubMed=16766697) 127228483 CVCL_A5DZ JK-6L.39L cancer cell line human CVCL_A5DZ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000045116; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7795; NFKB2; Simple; p.Arg725Glufs*18 (c.2171delC); Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Tyr64Asp (c.190T>G); dbSNP=rs752508313; Zygosity=Unspecified (from parent cell line) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Plasma cell; CL=CL_0000786. Male Characteristics: Produces low quantity of IgG kappa; Characteristics: IL6 independent 127228484 CVCL_A5DY JK-6L.31H cancer cell line human CVCL_A5DY CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000045116; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7795; NFKB2; Simple; p.Arg725Glufs*18 (c.2171delC); Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Tyr64Asp (c.190T>G); dbSNP=rs752508313; Zygosity=Unspecified (from parent cell line) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Plasma cell; CL=CL_0000786. Male Characteristics: Produces high quantity of IgG kappa; Characteristics: IL6 independent 127228485 CVCL_A5DN WFS2_1 finite cell line human CVCL_A5DN CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24212; CISD2; Simple; c.103+1G>A; ClinVar=VCV000638297; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=29239282) Population: Caucasian; Italian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228486 CVCL_A5DM WFS2_2 finite cell line human CVCL_A5DM CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24212; CISD2; Simple; c.103+1G>A; ClinVar=VCV000638297; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=29239282) Population: Caucasian; Italian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228487 CVCL_A5DP MGM18004E finite cell line human CVCL_A5DP CL:0000010 Derived from site: In situ; Abdomen, skin, dermis; UBERON=UBERON_0001416+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228488 CVCL_A5DR F0075E finite cell line human CVCL_A5DR CL:0000010 Derived from site: In situ; Abdomen, skin, dermis; UBERON=UBERON_0001416+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228489 CVCL_A5DQ F0022E finite cell line human CVCL_A5DQ CL:0000010 Derived from site: In situ; Abdomen, skin, dermis; UBERON=UBERON_0001416+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228490 CVCL_A5DT Sai2 somatic stem cell human CVCL_A5DT CL:0000010 Miscellaneous: Sex of donor from personal communication of BioKryo (ISENET Biobanking) Derived from site: In situ; Fetal brain, hindbrain; UBERON=UBERON_0007277. Male Characteristics: Neuroepithelial stem cell 127228491 CVCL_A5DS Sai1 somatic stem cell human CVCL_A5DS CL:0000010 Derived from site: In situ; Fetal brain, hindbrain; UBERON=UBERON_0007277. Male Characteristics: Neuroepithelial stem cell 127228492 CVCL_A5BD SW1573/S1neo cancer cell line human CVCL_A5BD CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Female 127228493 CVCL_A5BC SW1573/S1(MRP) cancer cell line human CVCL_A5BC CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:51; ABCC1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Female 127228494 CVCL_A5BF MCTs conditionally immortalized cell line house mouse CVCL_A5BF CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pZIPSVtsA58); Derived from site: In situ; Rib, cartilage; UBERON=UBERON_0006288; Cell type: Chondrocyte; CL=CL_0000138. Unspecified Characteristics: Proliferates at the permissive temperature (32 Celsius) Dies at the restrictive temperature (37-39 Celsius) (PubMed=7822418). Doubling time: ~2 days (Note=At 32 Celsius) (PubMed=7822418) 127228495 CVCL_A5BE SW1573/S1ou cancer cell line human CVCL_A5BE CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88105; Atp1a1 Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_472805; Ouabain; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Female 127228496 CVCL_A5BH Hepa 1-6/10R cancer cell line house mouse CVCL_A5BH CL:0000010 Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Breed/subspecies: C57L/J. Female 127228497 CVCL_A5BG Vero 2.2 spontaneously immortalized cell line green monkey CVCL_A5BG CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; Q9J0X9; Human herpesvirus 1 (strain KOS) ICP27 (UL54); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819; Cell type: Epithelial cell of kidney; CL=CL_0002518. Female Group: Non-human primate cell line 127228498 CVCL_A5BJ WIF-B9 hybrid cell line CVCL_A5BJ CL:0000010 Doubling time: 2.6 +- 0.1 days (PubMed=17276572). 127228499 CVCL_A5BI LS174T/R cancer cell line human CVCL_A5BI CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP); Derived from site: In situ; Colon; UBERON=UBERON_0001155; Cell type: Epithelial cell of colon; CL=CL_0011108. Female 127228500 CVCL_A5AZ GLC-4/ADRpr cancer cell line human CVCL_A5AZ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Glu (c.394A>G); ClinVar=VCV000376626; Zygosity=Unspecified (from parent cell line) Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin); Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Male Characteristics: Partial revertant of GLC-4/ADR obtained after culturing in drug-free medium for a number of months (3 according to PubMed=3040227 and 6 according to PubMed=7809167) 127228501 CVCL_A5BB SW1573/S1(MDR1) cancer cell line human CVCL_A5BB CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:40; ABCB1 Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR); Derived from site: In situ; Lung; UBERON=UBERON_0002048. Female 127228502 CVCL_A5BA SW1573/S1 cancer cell line human CVCL_A5BA CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Female 127228503 CVCL_A5AS B203L-CD80 cancer cell line human CVCL_A5AS CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1700; CD80; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Japanese; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Unspecified 127228504 CVCL_A5AR B1203L-CD80 cancer cell line human CVCL_A5AR CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1700; CD80; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Chinese; Han and Lao; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 127228505 CVCL_A5AU Rosi EBV-B transformed cell line human CVCL_A5AU HLA typing: A*24:02,32:01; B*35:03,44:031; C*04:01,04:01 (PubMed=17131342) CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228506 CVCL_A5AT B901L-CD80 cancer cell line human CVCL_A5AT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1700; CD80; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Chinese/Asian ethnic group; Hakka and Japanese; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Female 127228507 CVCL_A5AW HepG2.105 cancer cell line human CVCL_A5AW CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Virology: Expresses a hepatitis B virus (HBV) subtype AYW genome under the control of a tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16 Transcription of HBV pre-genomic RNA is induced upon doxycycline removal from the culture medium, leading to capsid assembly and DNA synthesis (PubMed=16935386). 127228508 CVCL_A5AV Huh7.93 cancer cell line human CVCL_A5AV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Japanese; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Virology: Expresses a hepatitis B virus (HBV) subtype AYW genome under the control of a tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16 Transcription of HBV pre-genomic RNA is induced upon doxycycline removal from the culture medium, leading to capsid assembly and DNA synthesis (PubMed=16935386). 127228509 CVCL_A5AY HMR10-3 conditionally immortalized cell line Norway rat CVCL_A5AY CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=U19tsa); Derived from site: In situ; Embryonic brain, hippocampus; UBERON=UBERON_0006238+UBERON_0002421; Cell type: Hippocampal neuron; CL=CL_0002608; Breed/subspecies: Holtzman Sprague Dawley (HotHsd:SD); RS=RS_0002942. Unspecified Characteristics: Grows at the permissive temperature (33 Celsius) Differentiates to a neuronal phenotype at the nonpermissive temperature (39 Celsius) (PubMed=7820600). 127228510 CVCL_A5AX HepG2.117 cancer cell line human CVCL_A5AX CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Virology: Expresses a hepatitis B virus (HBV) subtype AYW genome under the control of a tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16 Transcription of HBV pre-genomic RNA is induced upon doxycycline removal from the culture medium, leading to capsid assembly and DNA synthesis (PubMed=16935386). 127228511 CVCL_A5AK G613M cancer cell line human CVCL_A5AK HLA typing: A*24:02,11:01; B*52:01,55:02; C*12:02,12:03 (PubMed=17131342). CL:0000010 Unspecified 127228512 CVCL_A5AJ Rosi cancer cell line human CVCL_A5AJ CL:0000010 Miscellaneous: Age/sex of donor and cancer type from personal communication of van Baren, Nicolas Derived from site: Metastatic; Not specified. Male 127228513 CVCL_A5AM A904L-CD80 cancer cell line human CVCL_A5AM CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1700; CD80; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Chinese; Han and Korean; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 127228514 CVCL_A5AL A904-EBV-B transformed cell line human CVCL_A5AL HLA typing: A*24:02,26:03; B*07:02,39:01; C*07:02 (PubMed=15994973) CL:0000010 Population: Chinese; Han and Korean; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228515 CVCL_A5AN A904L-A26 cancer cell line human CVCL_A5AN CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1700; CD80; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*26:03); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Chinese; Han and Korean; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 127228516 CVCL_A5AQ A529L-CD80 cancer cell line human CVCL_A5AQ CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1700; CD80; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Japanese; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 127228517 CVCL_A5AP A904L-B39 cancer cell line human CVCL_A5AP CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1700; CD80; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*39:01); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Chinese; Han and Korean; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 127228518 CVCL_A5CE UNIPDi007-A induced pluripotent stem cell human CVCL_A5CE From: University of Padova; Padova; Italy CL:0000010 Population: Caucasian; Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 127228519 CVCL_A5CD UNIPDi006-A induced pluripotent stem cell human CVCL_A5CD From: University of Padova; Padova; Italy CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3049; DSG2; Simple; p.Gln558Ter (c.1672C>T); ClinVar=VCV001075931; Zygosity=Heterozygous (PubMed=40106965) Population: Caucasian; Derived from site: In situ; Urine; UBERON=UBERON_0001088; Cell type: Epithelial cell of kidney; CL=CL_0002518. Male 127228520 CVCL_A5CG CV-1 D 5.2 finite cell line CVCL_A5CG CL:0000010 Genetic integration: Method=Transfection; Gene=MGI; MGI:88105; Atp1a1 Selected for resistance to: ChEBI; CHEBI_472805; Ouabain; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male Group: Non-human primate cell line 127228521 CVCL_A5CF TEX transformed cell line human CVCL_A5CF CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3446; ERG (Note=FUS-ERG fusion); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4010; FUS (Note=FUS-ERG fusion); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Unspecified Characteristics: Expresses a transfected FUS-ERG (TLS-ERG) fusion protein Mimics the features of primary human acute myeloid leukemia and of leukemia-initiating cells (LIC) and are more than 90% CD34+. Underwent step-wise transformation and immortalization through acquisition of additional genetic changes, such as expression of TERT, expression of LIC markers CD34, CD44 and CD123 and the stem cell gene BMI1 (PubMed=16094415; PubMed=22160482). 127228522 CVCL_A5CI CV-1 D 7.3 finite cell line CVCL_A5CI CL:0000010 Genetic integration: Method=Transfection; Gene=MGI; MGI:88105; Atp1a1 Selected for resistance to: ChEBI; CHEBI_472805; Ouabain; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male Group: Non-human primate cell line 127228523 CVCL_A5CH CV-1 D 6.1 finite cell line CVCL_A5CH CL:0000010 Genetic integration: Method=Transfection; Gene=MGI; MGI:88105; Atp1a1 Selected for resistance to: ChEBI; CHEBI_472805; Ouabain; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male Group: Non-human primate cell line 127228524 CVCL_A5CK CV-1 E 5.5 finite cell line CVCL_A5CK CL:0000010 Genetic integration: Method=Transfection; Gene=MGI; MGI:88105; Atp1a1 Selected for resistance to: ChEBI; CHEBI_472805; Ouabain; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male Group: Non-human primate cell line 127228525 CVCL_A5CJ CV-1 E 4.1 finite cell line CVCL_A5CJ CL:0000010 Genetic integration: Method=Transfection; Gene=MGI; MGI:88105; Atp1a1 Selected for resistance to: ChEBI; CHEBI_472805; Ouabain; Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male Group: Non-human primate cell line 127228526 CVCL_A5CA PCIi026-A induced pluripotent stem cell human CVCL_A5CA From: Phenocell SAS; Grasse; France CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228527 CVCL_A5CC PCIi028-A induced pluripotent stem cell human CVCL_A5CC From: Phenocell SAS; Grasse; France. CL:0000010 127228528 CVCL_A5CB PCIi027-A induced pluripotent stem cell human CVCL_A5CB From: Phenocell SAS; Grasse; France CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228529 CVCL_A5BT Bm7brm cancer cell line human CVCL_A5BT CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase Population: Chinese; Taiwan; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Metastatic to brain Established from intracardiac injection of parent cell in SCID mice and cultured from brain tissue. 127228530 CVCL_A5BS Bm7 cancer cell line human CVCL_A5BS CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase Population: Chinese; Taiwan; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Metastatic to brain Established from intracardiac injection of parent cell in SCID mice and cultured from brain tissue. 127228531 CVCL_A5BV Hki-8 transformed cell line human CVCL_A5BV CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8022; NT5C2; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 127228532 CVCL_A5BU HKiG2 transformed cell line human CVCL_A5BU CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8022; NT5C2; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Transfected with a NT5C2 fused to EGFP 127228533 CVCL_A5BX UMCGi008-B induced pluripotent stem cell human CVCL_A5BX From: University Medical Center Groningen; Groningen; Netherlands CL:0000010 Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228534 CVCL_A5BW U937-ASPI3K cancer cell line human CVCL_A5BW CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:795; ATM (Note=In antisense orientation); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Caucasian; Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. Male 127228535 CVCL_A5BZ UMCGi008-D induced pluripotent stem cell human CVCL_A5BZ From: University Medical Center Groningen; Groningen; Netherlands CL:0000010 Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228536 CVCL_A5BY UMCGi008-C induced pluripotent stem cell human CVCL_A5BY From: University Medical Center Groningen; Groningen; Netherlands CL:0000010 Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127228537 CVCL_A5BL WIF-B9/Rev hybrid cell line CVCL_A5BL CL:0000010 Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP). Characteristics: Established by culturing the parent cell line without cisplatin in the medium for 2 months Doubling time: 2.7 +- 0.1 days (PubMed=17276572) 127228538 CVCL_A5BK WIF-B9/R hybrid cell line CVCL_A5BK CL:0000010 Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP). Doubling time: 2.9 +- 0.3 days (PubMed=17276572) 127228539 CVCL_A5BN WIF12 hybrid cell line CVCL_A5BN CL:0000010 127228540 CVCL_A5BM WIF12-1 TGdelta hybrid cell line CVCL_A5BM CL:0000010 Karyotypic information: Has lost the human chromosome X; Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG). 127228541 CVCL_A5BP WIF12-6 hybrid cell line CVCL_A5BP CL:0000010 127228542 CVCL_A5BR CL1-5-F4-Luc cancer cell line human CVCL_A5BR CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase Population: Chinese; Taiwan; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 127228543 CVCL_A5BQ SCC-25/CP cancer cell line human CVCL_A5BQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg209Lysfs*6 (c.626_627delGA); ClinVar=VCV000372539; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP); Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Male 127228544 CVCL_A5AC A2780/m175 cancer cell line human CVCL_A5AC CL:0000010 Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Arg175His); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: African American; Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female 127228545 CVCL_A5AB A2780/cmv cancer cell line human CVCL_A5AB CL:0000010 Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: African American; Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female Characteristics: Control cell line for A2780/m175 (Cellosaurus=CVCL_A5AC), A2780/m248 (Cellosaurus=CVCL_A5AD) and A2780/m273 (Cellosaurus=CVCL_A5AE) (PubMed=9924699) 127228546 CVCL_A5AE A2780/m273 cancer cell line human CVCL_A5AE CL:0000010 Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Arg273His); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: African American; Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female 127228547 CVCL_A5AD A2780/m248 cancer cell line human CVCL_A5AD CL:0000010 Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Arg248Trp); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: African American; Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female 127228548 CVCL_A5AG 76N finite cell line human CVCL_A5AG CL:0000010 Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367; Cell type: Epithelial cell of mammary gland; CL=CL_0002327. Omics: Transcriptomics; Microarray Female 127228549 CVCL_A5AF Tera-CP cancer cell line human CVCL_A5AF CL:0000010 Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP); Derived from site: Metastatic; Lung; UBERON=UBERON_0002048. Male 127228550 CVCL_A5AI Mull cancer cell line human CVCL_A5AI CL:0000010 Miscellaneous: Age/sex of donor, exact cancer type and sampling site from personal communication of van Baren, Nicolas Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072. Female 127228551 CVCL_A5AH 76N-F2V transformed cell line human CVCL_A5AH CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6 (Note=With p.Phe9Val); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367; Cell type: Epithelial cell of mammary gland; CL=CL_0002327. Omics: Genomics; ChIP-seq; H2BK120ub; Omics: Genomics; ChIP-seq; H3K23ac; Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K27me3; Omics: Genomics; ChIP-seq; H3K36me3; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Genomics; ChIP-seq; H3K79me2; Omics: Genomics; ChIP-seq; H3K9ac; Omics: Genomics; ChIP-seq; H3K9me3; Omics: Genomics; ChIP-seq; H4K8ac Female 127228552 CVCL_A5AA PK-15(CD163) spontaneously immortalized cell line pig CVCL_A5AA CL:0000010 Genetic integration: Method=PiggyBac transposition; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=PiggyBac transposition; Gene=VGNC; VGNC:112737; Pig CD163 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: Hampshire; VBO=VBO_0001146. Male Characteristics: A construct containing a CMV promoter-pig CD163 and EF1a promoter-GFP-T2-Pac was transferred using a piggyBac transposon vector; Virology: Highly susceptible to infection by porcine reproductive and respiratory syndrome virus type 1 and type 2 (PRRSV-1/2) 127228553 CVCL_A6NN MANCHO18-3C1 hybridoma house mouse CVCL_A6NN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228554 CVCL_A6NQ MANCHO3-8A4 hybridoma house mouse CVCL_A6NQ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228555 CVCL_A6NP MANCHO2-9G3 hybridoma house mouse CVCL_A6NP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228556 CVCL_A6NS MANCHO5-4F11 hybridoma house mouse CVCL_A6NS CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228557 CVCL_A6NR MANCHO4-2G5 hybridoma house mouse CVCL_A6NR CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228558 CVCL_A6NU MANCHO7-7F3 hybridoma house mouse CVCL_A6NU CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228559 CVCL_A6NT MANCHO6-5A6 hybridoma house mouse CVCL_A6NT CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228560 CVCL_A6NG MSH3MAB10-9B11 hybridoma house mouse CVCL_A6NG CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3. 127228561 CVCL_A6NF MSH3MAB9-7A10 hybridoma house mouse CVCL_A6NF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3. 127228562 CVCL_A6NI MANCHO11-9F2 hybridoma house mouse CVCL_A6NI CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228563 CVCL_A6NH MANCHO10-9E10 hybridoma house mouse CVCL_A6NH CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228564 CVCL_A6NK MANCHO14-4E1 hybridoma house mouse CVCL_A6NK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228565 CVCL_A6NJ MANCHO13-2G12 hybridoma house mouse CVCL_A6NJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228566 CVCL_A6NM MANCHO17-4C8 hybridoma house mouse CVCL_A6NM CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228567 CVCL_A6NL MANCHO15-5C3 hybridoma house mouse CVCL_A6NL CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228568 CVCL_A6NA MSH3MAB4-8E6 hybridoma house mouse CVCL_A6NA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3 (Note=Also reacts with human). 127228569 CVCL_A6NC MSH3MAB6-5D6 hybridoma house mouse CVCL_A6NC CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3. 127228570 CVCL_A6NB MSH3MAB5-7H12 hybridoma house mouse CVCL_A6NB CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3. 127228571 CVCL_A6NE MSH3MAB8-2A9 hybridoma house mouse CVCL_A6NE CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3. 127228572 CVCL_A6ND MSH3MAB7-9E11 hybridoma house mouse CVCL_A6ND CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3. 127228573 CVCL_A6MV MANFU11-3E4 hybridoma house mouse CVCL_A6MV CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O75072; Human FKTN. 127228574 CVCL_A6MU MANFU10-5H10 hybridoma house mouse CVCL_A6MU CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; O75072; Human FKTN. 127228575 CVCL_A6MX MSH3MAB1-1F6 hybridoma house mouse CVCL_A6MX CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3. 127228576 CVCL_A6MW MANFU12-6B5 hybridoma house mouse CVCL_A6MW CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O75072; Human FKTN. 127228577 CVCL_A6MZ MSH3MAB3-5A5 hybridoma house mouse CVCL_A6MZ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3 (Note=Also reacts with human). 127228578 CVCL_A6MY MSH3MAB2-2F11 hybridoma house mouse CVCL_A6MY CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P13705; Mouse Msh3. 127228579 CVCL_A6NW 45E10 hybridoma house mouse CVCL_A6NW CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P35992; Drosophila melanogaster Ptp10D. 127228580 CVCL_A6NV 3B7B5 hybridoma house mouse CVCL_A6NV CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q9W266; Drosophila melanogaster wdp. 127228581 CVCL_A6NY 9D82B3 hybridoma house mouse CVCL_A6NY CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P16621; Drosophila melanogaster Lar. 127228582 CVCL_A6NX 4C71B7 hybridoma house mouse CVCL_A6NX CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P35832; Drosophila melanogaster Ptp99A. 127228583 CVCL_A6NZ MANEX1A-4C7 hybridoma house mouse CVCL_A6NZ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228584 CVCL_A6LM 6F9 hybridoma house mouse CVCL_A6LM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-1006 127228585 CVCL_A6LL 15G7 hybridoma house mouse CVCL_A6LL CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324. 127228586 CVCL_A6LN U2OS OPTN KO cancer cell line human CVCL_A6LN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17142; OPTN; Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Miscellaneous: Cell line information from personal communication of Laflamme, Carl Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 127228587 CVCL_A6LQ U2OS TBK1 KO cancer cell line human CVCL_A6LQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11584; TBK1; Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 127228588 CVCL_A6LP U2OS SQSTM1 KO cancer cell line human CVCL_A6LP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1; Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 127228589 CVCL_A6LS MANSIX5A2-3B4 hybridoma house mouse CVCL_A6LS CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228590 CVCL_A6LR MANSIX5A1-2A6 hybridoma house mouse CVCL_A6LR CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228591 CVCL_A6LE 11/9 hybridoma house mouse CVCL_A6LE CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127228592 CVCL_A6LD 182-D1106-362 hybridoma house mouse CVCL_A6LD CL:0000010 Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized IMAB362 (claudiximab; zolbetuximab) therapeutic antibody Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2810 127228593 CVCL_A6LG 1D4 [Mouse hybridoma against Drosophila fas2] hybridoma house mouse CVCL_A6LG CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P34082; Drosophila melanogaster fas2. 127228594 CVCL_A6LF 10C9 [Mouse hybridoma against Drosophila lmb] hybridoma house mouse CVCL_A6LF CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; Q24188; Drosophila melanogaster lbm. 127228595 CVCL_A6LI BP102 hybridoma house mouse CVCL_A6LI CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: Drosophila melanogaster antigen on CNS axons. 127228596 CVCL_A6LH 23C7 hybridoma house mouse CVCL_A6LH CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; M9PE88; Drosophila melanogaster wit. 127228597 CVCL_A6LK 15C12 hybridoma house mouse CVCL_A6LK CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324. 127228598 CVCL_A6LJ MDA-MB-435S/1 cancer cell line human CVCL_A6LJ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.150+2T>C (IVS1+2T>C); ClinVar=VCV000406712; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.455insCdel26; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Right buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072. Male Problematic cell line: Contaminated Grand-parent cell line (MDA-MB-435) has been shown to be a M14 derivative. 127228599 CVCL_A6LA 182-D1106-061 hybridoma house mouse CVCL_A6LA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2748 127228600 CVCL_A6LC 182-D1106-294 hybridoma house mouse CVCL_A6LC CL:0000010 Monoclonal antibody isotype: IgG3, kappa; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2809 127228601 CVCL_A6LB 182-D1106-279 hybridoma house mouse CVCL_A6LB CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2808 127228602 CVCL_A6KT 182-D1106-058 hybridoma house mouse CVCL_A6KT CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2740 127228603 CVCL_A6KS 182-D1106-057 hybridoma house mouse CVCL_A6KS CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2739 127228604 CVCL_A6KV 182-D1106-062 hybridoma house mouse CVCL_A6KV CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2742 127228605 CVCL_A6KU 182-D1106-059 hybridoma house mouse CVCL_A6KU CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2741 127228606 CVCL_A6KX 182-D758-035 hybridoma house mouse CVCL_A6KX CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2745 127228607 CVCL_A6KW 182-D1106-067 hybridoma house mouse CVCL_A6KW CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2743 127228608 CVCL_A6KZ 182-D758-040 hybridoma house mouse CVCL_A6KZ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2747 127228609 CVCL_A6KY 182-D758-036 hybridoma house mouse CVCL_A6KY CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2746 127228610 CVCL_A6MN MANFU4-3C7 hybridoma house mouse CVCL_A6MN CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O75072; Human FKTN. 127228611 CVCL_A6MM MANFU3-4E6 hybridoma house mouse CVCL_A6MM CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O75072; Human FKTN. 127228612 CVCL_A6MP MANFU5-7H2 hybridoma house mouse CVCL_A6MP CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O75072; Human FKTN. 127228613 CVCL_A6MR MANFU7-1B5 hybridoma house mouse CVCL_A6MR CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; O75072; Human FKTN. 127228614 CVCL_A6MQ MANFU6-4H8 hybridoma house mouse CVCL_A6MQ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O75072; Human FKTN. 127228615 CVCL_A6MT MANFU9-4E12 hybridoma house mouse CVCL_A6MT CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O75072; Human FKTN. 127228616 CVCL_A6MS MANFU8-2F5 hybridoma house mouse CVCL_A6MS CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; O75072; Human FKTN. 127228617 CVCL_A6MF MANSIX5B3-10D2 hybridoma house mouse CVCL_A6MF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228618 CVCL_A6ME MANSIX5B2-10B3 hybridoma house mouse CVCL_A6ME CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228619 CVCL_A6MH MANSIX5C2a-6C1 hybridoma house mouse CVCL_A6MH CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228620 CVCL_A6MG MANSIX5B4-9G10 hybridoma house mouse CVCL_A6MG CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228621 CVCL_A6MJ DAG-6F4 hybridoma house mouse CVCL_A6MJ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q14118; Human DAG1 (Note=AA 30-653 = Alpha-dystroglycan Also reacts with mouse).. 127228622 CVCL_A6MI MANSIX5C2b-3A1 hybridoma house mouse CVCL_A6MI CL:0000010 Monoclonal antibody isotype: IgG3; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228623 CVCL_A6ML MANFU2-10F9 hybridoma house mouse CVCL_A6ML CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O75072; Human FKTN. 127228624 CVCL_A6MK MANFU1-7A2 hybridoma house mouse CVCL_A6MK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O75072; Human FKTN. 127228625 CVCL_A6MB MANSIX5A11-2H1 hybridoma house mouse CVCL_A6MB CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228626 CVCL_A6MA MANSIX5A10-4H7 hybridoma house mouse CVCL_A6MA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228627 CVCL_A6MD MANSIX5B1-6E10 hybridoma house mouse CVCL_A6MD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228628 CVCL_A6MC MANSIX5A12-4E7 hybridoma house mouse CVCL_A6MC CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228629 CVCL_A6LU MANSIX5A4-3E11 hybridoma house mouse CVCL_A6LU CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228630 CVCL_A6LT MANSIX5A3-3D9 hybridoma house mouse CVCL_A6LT CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5 127228631 CVCL_A6LW MANSIX5A6-1C11 hybridoma house mouse CVCL_A6LW CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228632 CVCL_A6LV MANSIX5A5-10B12 hybridoma house mouse CVCL_A6LV CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228633 CVCL_A6LY MANSIX5A8-7G4 hybridoma house mouse CVCL_A6LY CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228634 CVCL_A6LX MANSIX5A7-3G10 hybridoma house mouse CVCL_A6LX CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228635 CVCL_A6LZ MANSIX5A9-2G8 hybridoma house mouse CVCL_A6LZ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8N196; Human SIX5. 127228636 CVCL_A6JK NU-RMESO-9 cancer cell line Norway rat CVCL_A6JK CL:0000010 Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos. 127228637 CVCL_A6JJ NU-RMESO-2 cancer cell line Norway rat CVCL_A6JJ CL:0000010 Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos. 127228638 CVCL_A6JM NU-RMESO-20 cancer cell line Norway rat CVCL_A6JM CL:0000010 Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos. 127228639 CVCL_A6JL NU-RMESO-14 cancer cell line Norway rat CVCL_A6JL CL:0000010 Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos. 127228640 CVCL_A6JN NU-RMESO-26 cancer cell line Norway rat CVCL_A6JN CL:0000010 Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos. 127228641 CVCL_A6JQ NU-RMESO-79 cancer cell line Norway rat CVCL_A6JQ CL:0000010 Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos. 127228642 CVCL_A6JP NU-RMESO-40 cancer cell line Norway rat CVCL_A6JP CL:0000010 Transformant: ChEBI; CHEBI_46666; Crocidolite asbestos. 127228643 CVCL_A6JC MUi022-A induced pluripotent stem cell human CVCL_A6JC From: Mahidol University; Bangkok; Thailand. CL:0000010 127228644 CVCL_A6JB MUi024-A induced pluripotent stem cell human CVCL_A6JB From: Mahidol University; Bangkok; Thailand. CL:0000010 127228645 CVCL_A6JE SDR-P-1D5 finite cell line Norway rat CVCL_A6JE CL:0000010 Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007; Breed/subspecies: Spontaneous dwarf rat (SDR); RS=RS_0002342. 127228646 CVCL_A6JD SDRL-2 finite cell line Norway rat CVCL_A6JD CL:0000010 Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182; Breed/subspecies: Spontaneous dwarf rat (SDR); RS=RS_0002342. 127228647 CVCL_A6JG IWT-1 cancer cell line human CVCL_A6JG CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Alafs*5 (c.723delC) (p.S241fs); ClinVar=VCV001074338; ClinVar=VCV001074338; Zygosity=Unspecified (PubMed=24587255) Population: Japanese; Derived from site: In situ; Ascites; UBERON=UBERON_0007795. Male 127228648 CVCL_A6JF MSH-P3 finite cell line pig CVCL_A6JF CL:0000010 Derived from site: In situ; Fetal pituitary gland; UBERON=UBERON_0034875; Breed/subspecies: Miniature pig. Unspecified Characteristics: Secretes prolactin (PubMed=29949606) 127228649 CVCL_A6JI bTS11 somatic stem cell human CVCL_A6JI CL:0000010 Male Characteristics: Trophoblast stem cell line Senescence: Senesces at 150 PDL (RCB=RCB4941); Doubling time: 21.7 +- 3.0 hours (PubMed=29249463). 127228650 CVCL_A6JH bTS5 somatic stem cell human CVCL_A6JH CL:0000010 Female Characteristics: Trophoblast stem cell line Senescence: Senesces at 150 PDL (RCB=RCB4940); Doubling time: 22.6 +- 2.5 hours (PubMed=29249463). 127228651 CVCL_A6IZ MUi026-A induced pluripotent stem cell human CVCL_A6IZ From: Mahidol University; Bangkok; Thailand CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; p.Gln1960Ter (c.5878C>T); ClinVar=VCV000562298; Zygosity=Heterozygous (PubMed=33799277) Population: Southeast Asian; Thai; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228652 CVCL_A6IY ZZUNEUi021-A induced pluripotent stem cell human CVCL_A6IY From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11949; TNNT2; Simple; p.Arg140Cys (c.418C>T); ClinVar=VCV000043636; Zygosity=Heterozygous (PubMed=34929444) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228653 CVCL_A6JA MUi027-A induced pluripotent stem cell human CVCL_A6JA From: Mahidol University; Bangkok; Thailand CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; c.7946_7947delCT; Zygosity=Heterozygous (PubMed=35629189) Population: Southeast Asian; Thai; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127228654 CVCL_A6IR FA-AML1C cancer cell line human CVCL_A6IR CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys2729Asn (c.8187G>T) (8415G>T); ClinVar=VCV000038142; Zygosity=Heterozygous (PubMed=12750298); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser2835Glu (c.8503_8504TC>GA) (8731TC>GA); Zygosity=Heterozygous; Note=Reverted (PubMed=12750298) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: IL3 dependent 127228655 CVCL_A6IQ FA-AML1 cancer cell line human CVCL_A6IQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys2729Asn (c.8187G>T) (8415G>T); ClinVar=VCV000038142; Zygosity=Heterozygous (PubMed=12750298); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser2835Glu (c.8503_8504TC>GA) (8731TC>GA); Zygosity=Heterozygous; Note=Reverted (PubMed=12750298) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: CSF2 and IL3 dependent 127228656 CVCL_A6IT IBL-SLO-7B spontaneously immortalized cell line CVCL_A6IT CL:0000010 Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female Doubling time: 20.8 hours (Note=At 28 Celsius) (DOI=10.1303/aez.32.179); 28.45 hours (DOI=10.6660/TESFE.1999004) Group: Insect cell line 127228657 CVCL_A6IS COL [Human plasma cell myeloma] cancer cell line human CVCL_A6IS CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Plasma cell; CL=CL_0000786. Unspecified 127228658 CVCL_A6IV SNU-899 R1 cancer cell line human CVCL_A6IV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly13Arg (c.37G>C); ClinVar=VCV000035554; Zygosity=Heterozygous (from parent cell line) Population: Korean; Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP); Derived from site: In situ; Larynx; UBERON=UBERON_0001737. Male 127228659 CVCL_A6IU PNUH-12 R1 cancer cell line human CVCL_A6IU CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Cys (c.722C>G); ClinVar=VCV000177791; Zygosity=Unspecified (from parent cell line) Population: Korean; Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP); Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051. Female 127228660 CVCL_A6IX ZZUNEUi022-A induced pluripotent stem cell human CVCL_A6IX From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male 127228661 CVCL_A6IW MDCK-UT-A1 spontaneously immortalized cell line dog CVCL_A6IW CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10919; SLC14A2 (Note=Isoform UT-A1); Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ); Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female Characteristics: Transfected with the pFRT/lacZeo and pcDNA5/FRT/UT-A1 plasmids (PubMed=14749217) 127228662 CVCL_A6KL 2E12 [Human/mouse hybridoma] hybridoma CVCL_A6KL CL:0000010 Monoclonal antibody isotype: IgM. 127228663 CVCL_A6KK TM-1 [Human leukemia] cancer cell line human CVCL_A6KK CL:0000010 Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. 127228664 CVCL_A6KN 3E9 [Human/mouse hybridoma against leukemia cell surface antigen] hybridoma CVCL_A6KN CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human leukemia cell surface antigen. 127228665 CVCL_A6KM 3E10 [Human/mouse hybridoma] hybridoma CVCL_A6KM CL:0000010 Monoclonal antibody isotype: IgM. 127228666 CVCL_A6KP BD9-D12 hybridoma house mouse CVCL_A6KP CL:0000010 Monoclonal antibody isotype: IgG, kappa; Monoclonal antibody target: Human antigen on lung cancer cell line A-549. 127228667 CVCL_A6KR 182-D1106-056 hybridoma house mouse CVCL_A6KR CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2738 127228668 CVCL_A6KQ 182-D1106-055 hybridoma house mouse CVCL_A6KQ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56856; Human CLDN18 (Note=Isoform A2 = CLDN18.2). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2737 127228669 CVCL_A6KD RF-S1 hybrid cell line CVCL_A6KD CL:0000010 Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine. Group: Hybridoma fusion partner cell line 127228670 CVCL_A6KC APM-3 hybridoma house mouse CVCL_A6KC CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: ChEBI; CHEBI_34905; Paraquat. 127228671 CVCL_A6KF MAb-G2 hybridoma CVCL_A6KF CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX). 127228672 CVCL_A6KE MAb-G1 hybridoma CVCL_A6KE CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX). 127228673 CVCL_A6KH MAb-G4 hybridoma CVCL_A6KH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX). 127228674 CVCL_A6KG MAb-G3 hybridoma CVCL_A6KG CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX). 127228675 CVCL_A6KJ A4H12 cancer cell line human CVCL_A6KJ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2514Argfs*4 (c.7541_7542delCT); ClinVar=VCV000581973; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln214Ter (c.640C>T); ClinVar=VCV000428759; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Group: Hybridoma fusion partner cell line 127228676 CVCL_A6KI MAb-G6 hybridoma CVCL_A6KI CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX). 127228677 CVCL_A6JZ PQXB2/2 hybridoma house mouse CVCL_A6JZ CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: ChEBI; CHEBI_34905; Paraquat. 127228678 CVCL_A6KB APM-2 hybridoma house mouse CVCL_A6KB CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: ChEBI; CHEBI_34905; Paraquat. 127228679 CVCL_A6KA APM-1 hybridoma house mouse CVCL_A6KA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: ChEBI; CHEBI_34905; Paraquat. 127228680 CVCL_A6JS rasSFME transformed cell line house mouse CVCL_A6JS CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: BALB/c. Unspecified Group: Serum/protein free medium cell line 127228681 CVCL_A6JR ChR2-C2C12 spontaneously immortalized cell line house mouse CVCL_A6JR CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; Q8RUT8; Chlamydomonas reinhardtii channelrhodopsin-2 (cop4) Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134; Cell type: Myoblast; CL=CL_0000056; Breed/subspecies: C3H. Female 127228682 CVCL_A6JU r/mHM-SFME-1 transformed cell line house mouse CVCL_A6JU CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val); Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:97250; Myc Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: BALB/c. Unspecified Characteristics: Established after 7 passages of the original cell line into BALB/c mice; Characteristics: Spontaneously metastasize into the lungs of syngeneic mice when injected subcutaneously Group: Serum/protein free medium cell line 127228683 CVCL_A6JT ras/mycSFME transformed cell line house mouse CVCL_A6JT CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val); Genetic integration: Method=Transfection; Gene=MGI; MGI:97250; Myc; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: BALB/c. Unspecified Group: Serum/protein free medium cell line 127228684 CVCL_A6JW KDS 101-2 hybridoma house mouse CVCL_A6JW CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P02788; Human LTF. 127228685 CVCL_A6JV KDS 101-1 hybridoma house mouse CVCL_A6JV CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P02788; Human LTF. 127228686 CVCL_A6JY PQXB1/2 hybridoma house mouse CVCL_A6JY CL:0000010 Discontinued: ECACC; 89050503; true. Monoclonal antibody isotype: IgG; Monoclonal antibody target: ChEBI; CHEBI_34905; Paraquat 127228687 CVCL_A6JX KDS 301-1 hybridoma house mouse CVCL_A6JX CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: UniProtKB; P24627; Bovine LTF. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8852 127228688 CVCL_A6HI LO-DNP-68 hybridoma Norway rat CVCL_A6HI CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228689 CVCL_A6HH LO-DNP-66 hybridoma Norway rat CVCL_A6HH CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228690 CVCL_A6HK LO-DNP-9 hybridoma Norway rat CVCL_A6HK CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228691 CVCL_A6HJ LO-DNP-7 hybridoma Norway rat CVCL_A6HJ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228692 CVCL_A6HM LO-DNP-58 hybridoma Norway rat CVCL_A6HM CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228693 CVCL_A6HL LO-DNP-41 hybridoma Norway rat CVCL_A6HL CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228694 CVCL_A6HN LO-DNP-67 hybridoma Norway rat CVCL_A6HN CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228695 CVCL_A6HA LO-DNP-47 hybridoma Norway rat CVCL_A6HA CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228696 CVCL_A6HC LO-DNP-49 hybridoma Norway rat CVCL_A6HC CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228697 CVCL_A6HB LO-DNP-48 hybridoma Norway rat CVCL_A6HB CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228698 CVCL_A6HE LO-DNP-55 hybridoma Norway rat CVCL_A6HE CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228699 CVCL_A6HD LO-DNP-51 hybridoma Norway rat CVCL_A6HD CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228700 CVCL_A6HG LO-DNP-62 hybridoma Norway rat CVCL_A6HG CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228701 CVCL_A6HF LO-DNP-56 hybridoma Norway rat CVCL_A6HF CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228702 CVCL_A6GX LO-DNP-39 hybridoma Norway rat CVCL_A6GX CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228703 CVCL_A6GW LO-DNP-3 hybridoma Norway rat CVCL_A6GW CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228704 CVCL_A6GZ LO-DNP-44 hybridoma Norway rat CVCL_A6GZ CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228705 CVCL_A6GY LO-DNP-4 hybridoma Norway rat CVCL_A6GY CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228706 CVCL_A6GP LO-DNP-10 hybridoma Norway rat CVCL_A6GP CL:0000010 Monoclonal antibody isotype: IgE, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228707 CVCL_A6GR LO-DNP-34 hybridoma Norway rat CVCL_A6GR CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228708 CVCL_A6GQ LO-DNP-30 hybridoma Norway rat CVCL_A6GQ CL:0000010 Monoclonal antibody isotype: IgE, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228709 CVCL_A6GT LO-DNP-15 hybridoma Norway rat CVCL_A6GT CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228710 CVCL_A6GS LO-DNP-40 hybridoma Norway rat CVCL_A6GS CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228711 CVCL_A6GV LO-DNP-22 hybridoma Norway rat CVCL_A6GV CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228712 CVCL_A6GU LO-DNP-20 hybridoma Norway rat CVCL_A6GU CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228713 CVCL_A6IJ FRTL-5/T transformed cell line Norway rat CVCL_A6IJ CL:0000010 Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046; Breed/subspecies: Fischer 344; RS=RS_0000215. Unspecified Characteristics: Established from tumor tissue of a xenograft obtained by subcutaneous injection of FRTL-5 in C3H nu/nu nude mice (PubMed=1694496) 127228714 CVCL_A6II FRT-L KiKi transformed cell line Norway rat CVCL_A6II CL:0000010 Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV); Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046; Breed/subspecies: Fischer 344; RS=RS_0000215. Unspecified 127228715 CVCL_A6IL FRTL-5/TP transformed cell line Norway rat CVCL_A6IL CL:0000010 Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046; Breed/subspecies: Fischer 344; RS=RS_0000215. Unspecified Characteristics: Established from tumor tissue of a xenograft obtained by subcutaneous injection of FRTL-5/T in C3H nu/nu nude mice (PubMed=1694496) 127228716 CVCL_A6IK FRTL-5/TA transformed cell line Norway rat CVCL_A6IK CL:0000010 Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046; Breed/subspecies: Fischer 344; RS=RS_0000215. Unspecified Characteristics: Established from tumor tissue of a xenograft obtained by subcutaneous injection of FRTL-5/T in C3H nu/nu nude mice (PubMed=1694496) 127228717 CVCL_A6IN 5UD5 transformed cell line Norway rat CVCL_A6IN CL:0000010 Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046; Breed/subspecies: Fischer 344; RS=RS_0000215. Unspecified Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10849 127228718 CVCL_A6IM FRA cancer cell line Norway rat CVCL_A6IM CL:0000010 Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046; Cell type: Epithelial cell; CL=CL_0000066; Breed/subspecies: Fischer 344; RS=RS_0000215. 127228719 CVCL_A6IP HNTB-2K finite cell line human CVCL_A6IP CL:0000010 Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046; Cell type: Follicular cell; CL=CL_0002258. Unspecified Doubling time: 69 hours (Note=At 45th passage) (PubMed=8090760) 127228720 CVCL_A6IB OM-B hybridoma house mouse CVCL_A6IB CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human mucinous cystadenocarcinoma antigen. 127228721 CVCL_A6IA OM-A hybridoma house mouse CVCL_A6IA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human mucinous cystadenocarcinoma antigen. 127228722 CVCL_A6ID FRT-U10 spontaneously immortalized cell line Norway rat CVCL_A6ID CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1706; CD8A; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046; Breed/subspecies: Fischer 344; RS=RS_0000215. Unspecified 127228723 CVCL_A6IC OM-C hybridoma house mouse CVCL_A6IC CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human mucinous cystadenocarcinoma antigen. 127228724 CVCL_A6IF CW39-1B10 hybridoma house mouse CVCL_A6IF CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P56202; Human CTSW. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2511 127228725 CVCL_A6IE FRT spontaneously immortalized cell line Norway rat CVCL_A6IE CL:0000010 Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046; Breed/subspecies: Fischer 344; RS=RS_0000215. Unspecified 127228726 CVCL_A6IH CW40-1B1 hybridoma house mouse CVCL_A6IH CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P56202; Human CTSW. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2513 127228727 CVCL_A6IG CW39-2B6 hybridoma house mouse CVCL_A6IG CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P56202; Human CTSW. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2512 127228728 CVCL_A6HY HH09A3 hybridoma human CVCL_A6HY CL:0000010 Monoclonal antibody isotype: IgG, kappa; Monoclonal antibody target: Sheep red blood cells (SRBC). 127228729 CVCL_A6HX HH09A2 hybridoma human CVCL_A6HX CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: Sheep red blood cells (SRBC). 127228730 CVCL_A6HZ 71-5.2F9 hybridoma CVCL_A6HZ CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human gastric carcinoma cell surface carbohydrate epitope. 127228731 CVCL_A6HQ WIL2 AGr9 clone 35-1 transformed cell line human CVCL_A6HQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Spleen; UBERON=UBERON_0002106; Cell type: B-cell; CL=CL_0000236. Male 127228732 CVCL_A6HP LO-DNP-65 hybridoma Norway rat CVCL_A6HP CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127228733 CVCL_A6HS WIL2 MTI-TG transformed cell line human CVCL_A6HS CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_44081; 6-methylthioinosine (6-methylmercaptopurine riboside); Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG); Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Spleen; UBERON=UBERON_0002106; Cell type: B-cell; CL=CL_0000236. Male 127228734 CVCL_A6HR WIL2 MTIr-107 transformed cell line human CVCL_A6HR CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_44081; 6-methylthioinosine (6-methylmercaptopurine riboside); Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Spleen; UBERON=UBERON_0002106; Cell type: B-cell; CL=CL_0000236. Male 127228735 CVCL_A6HU WIL2 H35.1.1 transformed cell line human CVCL_A6HU CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Spleen; UBERON=UBERON_0002106; Cell type: B-cell; CL=CL_0000236. Male Group: Hybridoma fusion partner cell line 127228736 CVCL_A6HT WIL2 AGr9 clone 3-1 transformed cell line human CVCL_A6HT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Spleen; UBERON=UBERON_0002106; Cell type: B-cell; CL=CL_0000236. Male 127228737 CVCL_A6HW MAC 40/43 hybridoma human CVCL_A6HW CL:0000010 Monoclonal antibody isotype: IgM, lambda; Monoclonal antibody target: Human breast cancer cells 47 kDa glycoprotein. Group: Patented cell line; Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 86111001 127228738 CVCL_A6HV 0467.3 transformed cell line human CVCL_A6HV CL:0000010 Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Group: Hybridoma fusion partner cell line 127228739 CVCL_A6VW MDCK-II Rab29-KO spontaneously immortalized cell line dog CVCL_A6VW CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45270; RAB29 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228740 CVCL_A6VV MDCK-II Rab28-KO spontaneously immortalized cell line dog CVCL_A6VV CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45269; RAB28 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228741 CVCL_A6VY MDCK-II Rab30-KO spontaneously immortalized cell line dog CVCL_A6VY CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45273; RAB30 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228742 CVCL_A6VX MDCK-II Rab3-KO spontaneously immortalized cell line dog CVCL_A6VX CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45282; RAB3A; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45283; RAB3B; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45284; RAB3C; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45285; RAB3D Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228743 CVCL_A6VZ MDCK-II Rab32/38-KO spontaneously immortalized cell line dog CVCL_A6VZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:53757; RAB32; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45280; RAB38 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228744 CVCL_A6VN MDCK-II Rab22-KO spontaneously immortalized cell line dog CVCL_A6VN CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45262; RAB22A; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45274; RAB31 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228745 CVCL_A6VQ MDCK-II Rab24-KO spontaneously immortalized cell line dog CVCL_A6VQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45264; RAB24 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228746 CVCL_A6VP MDCK-II Rab23-KO spontaneously immortalized cell line dog CVCL_A6VP CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45263; RAB23 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228747 CVCL_A6VS MDCK-II Rab26-KO spontaneously immortalized cell line dog CVCL_A6VS CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45266; RAB26 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228748 CVCL_A6VR MDCK-II Rab25-KO spontaneously immortalized cell line dog CVCL_A6VR CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45265; RAB25 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228749 CVCL_A6VU MDCK-II Rab27-KO spontaneously immortalized cell line dog CVCL_A6VU CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45267; RAB27A; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45268; RAB27B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228750 CVCL_A6VT MDCK-II Rab26/37-KO spontaneously immortalized cell line dog CVCL_A6VT CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45266; RAB26; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45279; RAB37 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228751 CVCL_A6VG MDCK-II Rab19-KO spontaneously immortalized cell line dog CVCL_A6VG CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45258; RAB19 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228752 CVCL_A6VF MDCK-II Rab18-KO spontaneously immortalized cell line dog CVCL_A6VF CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45257; RAB18 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228753 CVCL_A6VI MDCK-II Rab1A-KO spontaneously immortalized cell line dog CVCL_A6VI CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45259; RAB1A Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228754 CVCL_A6VH MDCK-II Rab19/43-KO spontaneously immortalized cell line dog CVCL_A6VH CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45258; RAB19; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45289; RAB43 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228755 CVCL_A6VK MDCK-II Rab2-KO spontaneously immortalized cell line dog CVCL_A6VK CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45271; RAB2A; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45272; RAB2B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228756 CVCL_A6VJ MDCK-II Rab1B-KO spontaneously immortalized cell line dog CVCL_A6VJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:52037; RAB1B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228757 CVCL_A6VM MDCK-II Rab21-KO spontaneously immortalized cell line dog CVCL_A6VM CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45261; RAB21 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228758 CVCL_A6VL MDCK-II Rab20-KO spontaneously immortalized cell line dog CVCL_A6VL CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45260; RAB20 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228759 CVCL_A6VA MDCK-II Rab12-KO spontaneously immortalized cell line dog CVCL_A6VA CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:103700; RAB12 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228760 CVCL_A6VC MDCK-II Rab14-KO spontaneously immortalized cell line dog CVCL_A6VC CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45254; RAB14 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228761 CVCL_A6VB MDCK-II Rab13-KO spontaneously immortalized cell line dog CVCL_A6VB CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45253; RAB13 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228762 CVCL_A6VE MDCK-II Rab17-KO spontaneously immortalized cell line dog CVCL_A6VE CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45256; RAB17 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228763 CVCL_A6VD MDCK-II Rab15-KO spontaneously immortalized cell line dog CVCL_A6VD CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45255; RAB15 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228764 CVCL_A6WX ECCD-2 hybridoma CVCL_A6WX CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P09803; Mouse Cdh1/Cd324. 127228765 CVCL_A6WW ECCD-1 hybridoma CVCL_A6WW CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P09803; Mouse Cdh1/Cd324. 127228766 CVCL_A6WZ NCC-CAD-299 hybridoma house mouse CVCL_A6WZ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P22223; Human CDH3. 127228767 CVCL_A6WY HECD-1 hybridoma house mouse CVCL_A6WY CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P12830; Human CDH1/CD324. 127228768 CVCL_A6WP MDCK-II Rab6-KO spontaneously immortalized cell line dog CVCL_A6WP CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:59055; RAB6A; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:59057; RAB6B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228769 CVCL_A6WR MDCK-II Rab7B-KO spontaneously immortalized cell line dog CVCL_A6WR CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45294; RAB7B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228770 CVCL_A6WQ MDCK-II Rab7A-KO spontaneously immortalized cell line dog CVCL_A6WQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45293; RAB7A Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228771 CVCL_A6WT MDCK-II Rab9-KO spontaneously immortalized cell line dog CVCL_A6WT CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45297; RAB9A; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45298; RAB9B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228772 CVCL_A6WS MDCK-II Rab8-KO spontaneously immortalized cell line dog CVCL_A6WS CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45295; RAB8A; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45296; RAB8B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228773 CVCL_A6WV MDCK-II Rab7AB-KO spontaneously immortalized cell line dog CVCL_A6WV CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45293; RAB7A; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45294; RAB7B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228774 CVCL_A6WU MDCK-II Rab7A/9-KO spontaneously immortalized cell line dog CVCL_A6WU CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45293; RAB7A; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45297; RAB9A; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45298; RAB9B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228775 CVCL_A6WH MDCK-II Rab39/42-KO spontaneously immortalized cell line dog CVCL_A6WH CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111679; RAB39A; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45281; RAB39B; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111685; RAB42 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228776 CVCL_A6WG MDCK-II Rab39-KO spontaneously immortalized cell line dog CVCL_A6WG CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111679; RAB39A; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45281; RAB39B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228777 CVCL_A6WJ MDCK-II Rab40-KO spontaneously immortalized cell line dog CVCL_A6WJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111680; RAB40B; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:112753; RAB40C Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228778 CVCL_A6WI MDCK-II Rab4-KO spontaneously immortalized cell line dog CVCL_A6WI CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45290; RAB4A; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:53756; RAB4B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228779 CVCL_A6WL MDCK-II Rab43-KO spontaneously immortalized cell line dog CVCL_A6WL CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45289; RAB43 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228780 CVCL_A6WK MDCK-II Rab42-KO spontaneously immortalized cell line dog CVCL_A6WK CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111685; RAB42 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228781 CVCL_A6WN MDCK-II Rab5C-KO spontaneously immortalized cell line dog CVCL_A6WN CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:55798; RAB5C Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228782 CVCL_A6WM MDCK-II Rab5AB-KO spontaneously immortalized cell line dog CVCL_A6WM CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45291; RAB5A; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45292; RAB5B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228783 CVCL_A6WB MDCK-II Rab34-KO spontaneously immortalized cell line dog CVCL_A6WB CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45277; RAB34 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228784 CVCL_A6WA MDCK-II Rab33-KO spontaneously immortalized cell line dog CVCL_A6WA CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45275; RAB33A; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45276; RAB33B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228785 CVCL_A6WD MDCK-II Rab35-KO spontaneously immortalized cell line dog CVCL_A6WD CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45278; RAB35 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228786 CVCL_A6WC MDCK-II Rab34/36-KO spontaneously immortalized cell line dog CVCL_A6WC CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45277; RAB34; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:49953; RAB36 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228787 CVCL_A6WF MDCK-II Rab37-KO spontaneously immortalized cell line dog CVCL_A6WF CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45279; RAB37 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228788 CVCL_A6WE MDCK-II Rab36-KO spontaneously immortalized cell line dog CVCL_A6WE CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:49953; RAB36 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228789 CVCL_A6TT ED-40810(-) cancer cell line human CVCL_A6TT CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: Lost its original IL2 dependency 127228790 CVCL_A6TW ED-70423C(-) cancer cell line human CVCL_A6TW CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: Lost its original IL2 dependency 127228791 CVCL_A6TV ED-41214(-) cancer cell line human CVCL_A6TV CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: IL2 dependent 127228792 CVCL_A6TY T3 [Human LCL] transformed cell line human CVCL_A6TY CL:0000010 Population: Japanese; Karyotypic information: 46,XX,add(19)(p13) (PubMed=15262425); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228793 CVCL_A6TX N6803-2 transformed cell line human CVCL_A6TX CL:0000010 Population: Japanese; Karyotypic information: 47,XY,dup(1)(25q32),add(4)(q35),+12,add(18)(p11),add(20)(q13.3) (PubMed=11520562); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 127228794 CVCL_A6TZ T3-2 [Human type 2 diabetes] transformed cell line human CVCL_A6TZ CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228795 CVCL_A6TM Sez507 cancer cell line human CVCL_A6TM CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Characteristics: IL2 dependent 127228796 CVCL_A6TL SezM3(-) transformed cell line human CVCL_A6TL CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Characteristics: Lost its original IL2 dependency 127228797 CVCL_A6TN ATL-72b(-) transformed cell line human CVCL_A6TN CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: Lost its original IL2 dependency 127228798 CVCL_A6TQ ATL-21C(-)/3.8 transformed cell line human CVCL_A6TQ CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: Lost its original IL2 dependency Cultured for 3.8 years without IL2. 127228799 CVCL_A6TP ATL-21C(-)/8.9 transformed cell line human CVCL_A6TP CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: Lost its original IL2 dependency Cultured for 8.9 years without IL2. 127228800 CVCL_A6TS CATL-3 transformed cell line human CVCL_A6TS CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Characteristics: IL2 dependent 127228801 CVCL_A6TR CATL-2 transformed cell line human CVCL_A6TR CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Characteristics: IL2 dependent 127228802 CVCL_A6TE ATL-72/2(-) transformed cell line human CVCL_A6TE CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228803 CVCL_A6TD ATL-45T transformed cell line human CVCL_A6TD CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228804 CVCL_A6TG Sez627(-) cancer cell line human CVCL_A6TG CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female Characteristics: Lost its original IL2 dependency 127228805 CVCL_A6TF ATL-2(-) transformed cell line human CVCL_A6TF CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: Lost its original IL2 dependency 127228806 CVCL_A6TI ATL-21C(-)/2 transformed cell line human CVCL_A6TI CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: Lost its original IL2 dependency Cultured for 2 years without IL2. 127228807 CVCL_A6TH ED-50823(-) transformed cell line human CVCL_A6TH CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Lost its original IL2 dependency 127228808 CVCL_A6TK SezM3 transformed cell line human CVCL_A6TK CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Characteristics: IL2 dependent 127228809 CVCL_A6TJ SezM transformed cell line human CVCL_A6TJ CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Characteristics: IL2 dependent 127228810 CVCL_A6TA ATL-72/2 transformed cell line human CVCL_A6TA CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228811 CVCL_A6TC ATL-72T transformed cell line human CVCL_A6TC CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228812 CVCL_A6TB ATL-72b transformed cell line human CVCL_A6TB CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228813 CVCL_A6UV RMM-A1 cancer cell line Norway rat CVCL_A6UV CL:0000010 Derived from site: In situ; Ear, pinna; UBERON=UBERON_0001757; Breed/subspecies: Fischer 344; RS=RS_0000215. Male Characteristics: Tumorigenic 127228814 CVCL_A6UU RMM-C cancer cell line Norway rat CVCL_A6UU CL:0000010 Derived from site: In situ; Ear, pinna; UBERON=UBERON_0001757; Breed/subspecies: Fischer 344; RS=RS_0000215. Male Characteristics: Established from the transplantable tumor RMM Doubling time: 17.2 hours (Note=At 10th passage), 14.8 hours (Note=At 30th passage) (PubMed=26949998) 127228815 CVCL_A6UX MDCK-II Rab10-KO spontaneously immortalized cell line dog CVCL_A6UX CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45247; RAB10 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228816 CVCL_A6UW RMM-CAF cancer cell line Norway rat CVCL_A6UW CL:0000010 Derived from site: In situ; Ear, pinna; UBERON=UBERON_0001757; Breed/subspecies: Fischer 344; RS=RS_0000215. Male Characteristics: Non-tumorigenic 127228817 CVCL_A6UZ MDCK-II Rab11/25-KO spontaneously immortalized cell line dog CVCL_A6UZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45248; RAB11A; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45249; RAB11B; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45265; RAB25 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228818 CVCL_A6UY MDCK-II Rab11-KO spontaneously immortalized cell line dog CVCL_A6UY CL:0000010 Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45248; RAB11A; Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:45249; RAB11B Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 127228819 CVCL_A6UN COLO 320DM#3 SIRT1 KO cl.4 cancer cell line human CVCL_A6UN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159. Female 127228820 CVCL_A6UM COLO 320DM#3 SIRT1 KO cl.3 cancer cell line human CVCL_A6UM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159. Female 127228821 CVCL_A6UP COLO 320DM#3 SIRT1 KO cl.5 cancer cell line human CVCL_A6UP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159. Female 127228822 CVCL_A6UR NP-2/CD4/CCR6 cancer cell line human CVCL_A6UR CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1607; CCR6; Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Japanese; Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811. Male 127228823 CVCL_A6UQ COLO 320DM#3 SIRT1 KO cl.6 cancer cell line human CVCL_A6UQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159. Female 127228824 CVCL_A6UT C8166/CCR5 transformed cell line human CVCL_A6UT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5 Population: Caucasian; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127228825 CVCL_A6US NP-2/CD4/FPRL1 cancer cell line human CVCL_A6US CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4; Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3827; FPR2; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Japanese; Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811. Male 127228826 CVCL_A6UF TD-2 fLuc-CXCR4 cancer cell line house mouse CVCL_A6UF CL:0000010 Genetic integration: Method=Transfection; Gene=MGI; MGI:109563; Cxcr4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Breed/subspecies: C57BL/6J x BALB/cJ TGFalpha/Trp53(+/-) transgenic. Male 127228827 CVCL_A6UE TD-2 fLuc-CCR7 cancer cell line house mouse CVCL_A6UE CL:0000010 Genetic integration: Method=Transfection; Gene=MGI; MGI:103011; Ccr7; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Breed/subspecies: C57BL/6J x BALB/cJ TGFalpha/Trp53(+/-) transgenic. Male 127228828 CVCL_A6UH EL16 embryonic stem cell CVCL_A6UH CL:0000010 Karyotypic information: 40,XX [30%]; 39,X0 [70%] (PubMed=10192391); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: Cast/EiJ x 129SvJae. Female 127228829 CVCL_A6UG 7C8 [Mouse hybridoma against rat Cav1] hybridoma house mouse CVCL_A6UG CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P41350; Rat Cav1 (Note=Also reacts with human and mouse). 127228830 CVCL_A6UJ COLO 320DM#3 cancer cell line human CVCL_A6UJ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159. Female Characteristics: Contains multiple DMs with amplified MYC (PubMed=3164477) 127228831 CVCL_A6UI EL16.7 embryonic stem cell CVCL_A6UI CL:0000010 Karyotypic information: 40,XX, one chromosome X from M.m.musculus and the other from M.m.castaneus (PubMed=10520993); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: Cast/EiJ x 129SvJae. Female 127228832 CVCL_A6UL COLO 320DM#3 SIRT1 KO cl.2 cancer cell line human CVCL_A6UL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159. Female 127228833 CVCL_A6UK COLO 320DM#3 SIRT1 KO cl.1 cancer cell line human CVCL_A6UK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser811Ter (c.2432C>G); ClinVar=VCV002203685; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159. Female 127228834 CVCL_A6UB T6 [Human LCL] transformed cell line human CVCL_A6UB CL:0000010 Population: Japanese; Karyotypic information: 47,XX,+2 (PubMed=15262425); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228835 CVCL_A6UA T5 [Human LCL] transformed cell line human CVCL_A6UA CL:0000010 Population: Japanese; Karyotypic information: 46,Y,add(X)(p22) (PubMed=15262425); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228836 CVCL_A6UD TD-2 fLuc cancer cell line house mouse CVCL_A6UD CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Breed/subspecies: C57BL/6J x BALB/cJ TGFalpha/Trp53(+/-) transgenic. Male 127228837 CVCL_A6UC TD-2 cancer cell line house mouse CVCL_A6UC CL:0000010 Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Breed/subspecies: C57BL/6J x BALB/cJ TGFalpha/Trp53(+/-) transgenic. Male 127228838 CVCL_A6RS GEM-322 cancer cell line CVCL_A6RS CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Erythrophore; CL=CL_0000574; Breed/subspecies: Ryukin; VBO=VBO_0017500. Unspecified Group: Fish cell line 127228839 CVCL_A6RR GEM-49 cancer cell line CVCL_A6RR CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Erythrophore; CL=CL_0000574; Breed/subspecies: Comet; VBO=VBO_0017498. Unspecified Group: Fish cell line 127228840 CVCL_A6RU IP-B12 cancer cell line Norway rat CVCL_A6RU CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305. Male Characteristics: Secretes PTHrP Doubling time: 17.9 hours (PubMed=12853701) 127228841 CVCL_A6RT IP-P cancer cell line Norway rat CVCL_A6RT CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305. Male Characteristics: Established from the transplantable tumor IP Doubling time: 17.5 hours (PubMed=12853701) 127228842 CVCL_A6RW N0003 post-immortalized transformed cell line human CVCL_A6RW CL:0000010 Population: Japanese; Karyotypic information: 46,XX,add(7)(q22),+12,der(13;14)(q10;q10) (PubMed=11520562); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female 127228843 CVCL_A6RV N0003 pre-immortalized transformed cell line human CVCL_A6RV CL:0000010 Population: Japanese; Karyotypic information: 45,XX,der(13;14)(q10;q10) (PubMed=11520562); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female 127228844 CVCL_A6RY N0005 post-immortalized transformed cell line human CVCL_A6RY CL:0000010 Population: Japanese; Karyotypic information: 46,XY,add(3)(p25),add(8)(q24.3),del(17)(p11.2) (PubMed=11520562); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 127228845 CVCL_A6RX N0005 pre-immortalized transformed cell line human CVCL_A6RX CL:0000010 Population: Japanese; Karyotypic information: 46,XY (PubMed=11520562); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 127228846 CVCL_A6RK MFVD A5 transformed cell line house mouse CVCL_A6RK CL:0000010 Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Embryonic vas deferens; UBERON=UBERON_0001000; Breed/subspecies: B10/CBA x Tag5 transgenic. Male 127228847 CVCL_A6RJ MFVD parental transformed cell line house mouse CVCL_A6RJ CL:0000010 Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Embryonic vas deferens; UBERON=UBERON_0001000; Breed/subspecies: B10/CBA x Tag5 transgenic. Male 127228848 CVCL_A6RM MFVD E2 transformed cell line house mouse CVCL_A6RM CL:0000010 Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Embryonic vas deferens; UBERON=UBERON_0001000; Breed/subspecies: B10/CBA x Tag5 transgenic. Male 127228849 CVCL_A6RL MFVD A6 transformed cell line house mouse CVCL_A6RL CL:0000010 Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Embryonic vas deferens; UBERON=UBERON_0001000; Breed/subspecies: B10/CBA x Tag5 transgenic. Omics: Proteomics; 2DE-MS Male 127228850 CVCL_A6RN MSP.1 undefined cell line type human CVCL_A6RN CL:0000010 Discontinued: ATCC; CRL-2774; true. Unspecified 127228851 CVCL_A6RQ HuOS cancer cell line human CVCL_A6RQ CL:0000010 Population: Japanese; Derived from site: Metastatic; Lung; UBERON=UBERON_0002048. Male Doubling time: 30 hours (PubMed=433590) 127228852 CVCL_A6RP 1A7 hybridoma house mouse CVCL_A6RP CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Anti-idiotypic against monoclonal antibody 14.G2a. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11786 127228853 CVCL_A6RC TROMA-2 hybridoma CVCL_A6RC CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P05784; Mouse Krt18. 127228854 CVCL_A6RB MAO A-7E10 hybridoma house mouse CVCL_A6RB CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P21397; Human MAOB. 127228855 CVCL_A6RE 3C7.14 hybridoma house mouse CVCL_A6RE CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P21214; Bovine TGFB2. 127228856 CVCL_A6RD 2G1.1.12 hybridoma house mouse CVCL_A6RD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P21214; Bovine TGFB2. 127228857 CVCL_A6RG 12H5 hybridoma house mouse CVCL_A6RG CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P01137; Human TGFB1. 127228858 CVCL_A6RF 2D7.20 hybridoma house mouse CVCL_A6RF CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P21214; Bovine TGFB2. 127228859 CVCL_A6RI 4A11 hybridoma house mouse CVCL_A6RI CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01137; Human TGFB1. 127228860 CVCL_A6RH 2G7 [Mouse hybridoma against human TFGB1/2/3] hybridoma house mouse CVCL_A6RH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01137; Human TGFB1; Monoclonal antibody target: UniProtKB; P61812; Human TGFB2; Monoclonal antibody target: UniProtKB; P10600; Human TGFB3. 127228861 CVCL_A6QZ MAO A-4F10 hybridoma house mouse CVCL_A6QZ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P21397; Human MAOB. 127228862 CVCL_A6QY MAO A-3C9 hybridoma house mouse CVCL_A6QY CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P21397; Human MAOB. 127228863 CVCL_A6RA MAO A-7B10 hybridoma house mouse CVCL_A6RA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P21397; Human MAOB. 127228864 CVCL_A6ST ATL-23 transformed cell line human CVCL_A6ST CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228865 CVCL_A6SS ATL-20 transformed cell line human CVCL_A6SS CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228866 CVCL_A6SV ATL-6 transformed cell line human CVCL_A6SV CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228867 CVCL_A6SU ATL-26C transformed cell line human CVCL_A6SU CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228868 CVCL_A6SX ATL-41T transformed cell line human CVCL_A6SX CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228869 CVCL_A6SW ATL-40T transformed cell line human CVCL_A6SW CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228870 CVCL_A6SZ ATL-46T transformed cell line human CVCL_A6SZ CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228871 CVCL_A6SY ATL-67T transformed cell line human CVCL_A6SY CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228872 CVCL_A6SL ATL-42T cancer cell line human CVCL_A6SL CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228873 CVCL_A6SK ED-50823 transformed cell line human CVCL_A6SK CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: IL2 dependent 127228874 CVCL_A6SN ATL-13 transformed cell line human CVCL_A6SN CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified 127228875 CVCL_A6SM ATL-11-6 transformed cell line human CVCL_A6SM CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228876 CVCL_A6SP ATL-14T transformed cell line human CVCL_A6SP CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228877 CVCL_A6SR ATL-18C transformed cell line human CVCL_A6SR CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: IL2 dependent 127228878 CVCL_A6SQ ATL-17C transformed cell line human CVCL_A6SQ CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: IL2 dependent 127228879 CVCL_A6SD N6803 post-immortalized transformed cell line human CVCL_A6SD CL:0000010 Population: Japanese; Karyotypic information: 47,XY,dup(3)(q27;q13),+8 (PubMed=11520562); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 127228880 CVCL_A6SC N6803 pre-immortalized transformed cell line human CVCL_A6SC CL:0000010 Population: Japanese; Karyotypic information: 46,XY (PubMed=11520562); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 127228881 CVCL_A6SF LLKF undefined cell line type CVCL_A6SF CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Fibroblast; CL=CL_0000057. Male 127228882 CVCL_A6SE ASMF undefined cell line type CVCL_A6SE CL:0000010 Derived from site: In situ; Muscle; UBERON=UBERON_0001630; Cell type: Fibroblast of muscle; CL=CL_1001609. Unspecified 127228883 CVCL_A6SH ATL-48Tb(-) cancer cell line human CVCL_A6SH CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: Lost its original IL2 dependency 127228884 CVCL_A6SG ATL-55T(-) cancer cell line human CVCL_A6SG CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: Lost its original IL2 dependency 127228885 CVCL_A6SJ ED-70423C cancer cell line human CVCL_A6SJ CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: IL2 dependent 127228886 CVCL_A6SI ED-41214 cancer cell line human CVCL_A6SI CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: IL2 dependent 127228887 CVCL_A6RZ N0005-A1 transformed cell line human CVCL_A6RZ CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 127228888 CVCL_A6SB N0013 post-immortalized transformed cell line human CVCL_A6SB CL:0000010 Population: Japanese; Karyotypic information: 46,XX,add(2)(q37),der(11)t(11;12)(p15;q13) (PubMed=11520562); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female 127228889 CVCL_A6SA N0013 pre-immortalized transformed cell line human CVCL_A6SA CL:0000010 Population: Japanese; Karyotypic information: 46,XX (PubMed=11520562); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female 127228890 CVCL_A6PQ MANDAG4-4G1 hybridoma house mouse CVCL_A6PQ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q14118; Human DAG1 (Note=AA 654-895 = Beta-dystroglycan). 127228891 CVCL_A6PP MANDAG3-4F7 hybridoma house mouse CVCL_A6PP CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; Q14118; Human DAG1 (Note=AA 654-895 = Beta-dystroglycan). 127228892 CVCL_A6PS MANHINGE1A-6F11 hybridoma house mouse CVCL_A6PS CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog). 127228893 CVCL_A6PR MANHINGE4A-5C11 hybridoma house mouse CVCL_A6PR CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228894 CVCL_A6PU MANHINGE1C-5D12 hybridoma house mouse CVCL_A6PU CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228895 CVCL_A6PT MANHINGE1B-10F9 hybridoma house mouse CVCL_A6PT CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228896 CVCL_A6PW MANHINGE2B-9C11 hybridoma house mouse CVCL_A6PW CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228897 CVCL_A6PV MANHINGE2A-8B11 hybridoma house mouse CVCL_A6PV CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228898 CVCL_A6PI MANDYS3-6A9 hybridoma house mouse CVCL_A6PI CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with mouse and Xenopus). 127228899 CVCL_A6PH 22Rv1-CabR2 cancer cell line human CVCL_A6PH CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_63584; Cabazitaxel; Derived from site: In situ; Prostate; UBERON=UBERON_0002367. Male Characteristics: Established from xenografts that were obtain by subcutaneously injecting 22Rv1 cells into the flanks of 8 weeks old, athymic male BALB/c nude mice and treating them with cabazitaxel (PubMed=31799745) 127228900 CVCL_A6PK MANEX7B-8E11 hybridoma house mouse CVCL_A6PK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog). 127228901 CVCL_A6PJ MANEX6-4H4 hybridoma house mouse CVCL_A6PJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228902 CVCL_A6PM MANDAG1-7A11 hybridoma house mouse CVCL_A6PM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q14118; Human DAG1 (Note=AA 654-895 = Beta-dystroglycan). 127228903 CVCL_A6PL MANEX7C-6F7 hybridoma house mouse CVCL_A6PL CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228904 CVCL_A6PN MANDAG2-7D11 hybridoma house mouse CVCL_A6PN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q14118; Human DAG1 (Note=AA 654-895 = Beta-dystroglycan). 127228905 CVCL_A6PA MANEX1B-1D6 hybridoma house mouse CVCL_A6PA CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228906 CVCL_A6PC MANDYS10-2E10 hybridoma house mouse CVCL_A6PC CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog and mouse). 127228907 CVCL_A6PB MANDYS1-3B7 hybridoma house mouse CVCL_A6PB CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P11532; Human DMD (Note=Also reacts with dog, mouse, pig and rabbit). 127228908 CVCL_A6PE Sp1/7-2 hybridoma house mouse CVCL_A6PE CL:0000010 Anecdotal: Together with Sp2/3-3 (Cellosaurus=CVCL_A6PD) these are the first hybridomas to have been created. Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Sheep red blood cells (SRBC) 127228909 CVCL_A6PD Sp2/3-3 hybridoma house mouse CVCL_A6PD CL:0000010 Anecdotal: Together with Sp1/7-2 (Cellosaurus=CVCL_A6PE) these are the first hybridomas to have been created. Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: Sheep red blood cells (SRBC) 127228910 CVCL_A6PG 22Rv1-CabR1 cancer cell line human CVCL_A6PG CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_63584; Cabazitaxel; Derived from site: In situ; Prostate; UBERON=UBERON_0002367. Male Characteristics: Established from xenografts that were obtain by subcutaneously injecting 22Rv1 cells into the flanks of 8 weeks old, athymic male BALB/c nude mice and treating them with cabazitaxel (PubMed=31799745) 127228911 CVCL_A6PF Sp1/HL hybridoma house mouse CVCL_A6PF CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Sheep red blood cells (SRBC). 127228912 CVCL_A6QR CK-5H5 hybridoma house mouse CVCL_A6QR CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P05122; Chicken CKB. 127228913 CVCL_A6QQ CK-2A7 hybridoma house mouse CVCL_A6QQ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P05122; Chicken CKB. 127228914 CVCL_A6QT TROMA-3 hybridoma CVCL_A6QT CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P19001; Mouse Krt19. 127228915 CVCL_A6QS TROMA-1 hybridoma CVCL_A6QS CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P11679; Mouse Krt8. 127228916 CVCL_A6QV ESC-BLC 1 T1 embryonic stem cell house mouse CVCL_A6QV CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: 129/Sv-ter/+. Male 127228917 CVCL_A6QU ESC-BLC 1 embryonic stem cell house mouse CVCL_A6QU CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: 129/Sv-ter/+. Male 127228918 CVCL_A6QX MAO B-1C2 hybridoma house mouse CVCL_A6QX CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P27338; Human MAOB. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8176 127228919 CVCL_A6QW ESC-BLC 1 T2/K26 embryonic stem cell house mouse CVCL_A6QW CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: 129/Sv-ter/+. Male 127228920 CVCL_A6QJ CK-JAC hybridoma house mouse CVCL_A6QJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P05122; Chicken CKB. 127228921 CVCL_A6QI CK-ART hybridoma house mouse CVCL_A6QI CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P00565; Chicken CKM. 127228922 CVCL_A6QL CK-JOE hybridoma house mouse CVCL_A6QL CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P05122; Chicken CKB. 127228923 CVCL_A6QK CK-JIL hybridoma house mouse CVCL_A6QK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P05122; Chicken CKB. 127228924 CVCL_A6QN CK-1F7 hybridoma house mouse CVCL_A6QN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P12277; Human CKB. 127228925 CVCL_A6QM CK-1B7 hybridoma house mouse CVCL_A6QM CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P06732; Human CKM. 127228926 CVCL_A6QP CK-5D11 hybridoma house mouse CVCL_A6QP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P06732; Human CKM. 127228927 CVCL_A6QB MANHINGE4B-9B1 hybridoma house mouse CVCL_A6QB CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228928 CVCL_A6QA MANHINGE3C-10E12 hybridoma house mouse CVCL_A6QA CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228929 CVCL_A6QD MANCHO1-2C7 hybridoma house mouse CVCL_A6QD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228930 CVCL_A6QC MANHINGE4C-10F2 hybridoma house mouse CVCL_A6QC CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228931 CVCL_A6QF MANCHO9-8C10 hybridoma house mouse CVCL_A6QF CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228932 CVCL_A6QE MANCHO8-5C5 hybridoma house mouse CVCL_A6QE CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228933 CVCL_A6QH MANCHO19-5D12 hybridoma house mouse CVCL_A6QH CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228934 CVCL_A6QG MANCHO16-9C2 hybridoma house mouse CVCL_A6QG CL:0000010 Monoclonal antibody isotype: IgG3; Monoclonal antibody target: UniProtKB; P46939; Human UTRN. 127228935 CVCL_A6PY MANHINGE3A-6D6 hybridoma house mouse CVCL_A6PY CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228936 CVCL_A6PX MANHINGE2C-8D11 hybridoma house mouse CVCL_A6PX CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228937 CVCL_A6PZ MANHINGE3B-12D2 hybridoma house mouse CVCL_A6PZ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P11532; Human DMD. 127228938 CVCL_A5ZT LERS-1 transformed cell line Norway rat CVCL_A5ZT CL:0000010 Miscellaneous: Cell line has been lost (PubMed=2788356) Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Spleen; UBERON=UBERON_0002106; Breed/subspecies: Lewis; RS=RS_0000121. Female 127228939 CVCL_A5ZS FIRT-1 transformed cell line Norway rat CVCL_A5ZS CL:0000010 Miscellaneous: Cell line has been lost (PubMed=2788356) Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Thymus; UBERON=UBERON_0002370; Breed/subspecies: Fischer 344; RS=RS_0000215. Female 127228940 CVCL_A5ZV HOZOT finite cell line human CVCL_A5ZV CL:0000010 Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Unspecified 127228941 CVCL_A5ZU LERT-1 transformed cell line Norway rat CVCL_A5ZU CL:0000010 Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Thymus; UBERON=UBERON_0002370; Breed/subspecies: Lewis; RS=RS_0000121. Female 127228942 CVCL_A5ZX UHOMi003-A induced pluripotent stem cell human CVCL_A5ZX From: University Hospital of Montpellier; Montpellier; France CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127228943 CVCL_A5ZW JSNK-1 transformed cell line pig CVCL_A5ZW CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatic stellate cell; CL=CL_0000632. Unspecified 127228944 CVCL_A5ZZ UHOMi005-A induced pluripotent stem cell human CVCL_A5ZZ From: University Hospital of Montpellier; Montpellier; France CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228945 CVCL_A5ZY UHOMi004-A induced pluripotent stem cell human CVCL_A5ZY From: University Hospital of Montpellier; Montpellier; France CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228946 CVCL_A5ZL HEL-N1 cancer cell line human CVCL_A5ZL CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Lys (c.398T>A); ClinVar=VCV002430159; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Male Characteristics: Subline that does not expresses KIT (PubMed=7538619) Doubling time: 19.0 +- 0.8 hours (Note=In serum-containing medium), 24.0 +- 1.1 hours (Note=In serum-free medium) (PubMed=7538619) 127228947 CVCL_A5ZK U937/EVI1 cancer cell line human CVCL_A5ZK CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3498; MECOM Population: Caucasian; Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. Male Characteristics: Transduced with a MECOM/EVI1-IRES-EGFP construct 127228948 CVCL_A5ZN BCBL-2 cancer cell line human CVCL_A5ZN CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV). Male 127228949 CVCL_A5ZM HEL-P1 cancer cell line human CVCL_A5ZM CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Lys (c.398T>A); ClinVar=VCV002430159; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Male Characteristics: Subline that highly expresses KIT and GYPA (PubMed=7538619) Doubling time: 18.9 +- 1.4 hours (Note=In serum-containing medium), 23.6 +- 0.9 hours (Note=In serum-free medium) (PubMed=7538619) 127228950 CVCL_A5ZP SWI3a-26 spontaneously immortalized cell line CVCL_A5ZP CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Biotechnology: Cell line for recombinase mediated cassette exchange (RMCE) that was generated by random integration of a FRT-flanked GFP reporter It contains a single copy of the GFP reporter transgene at a genetic locus that is protected from silencing. The integrated GFP cassette contains a selection trap that allows for selection of recombinant cells upon RMCE (PubMed=25804355). Female Characteristics: Transduced with the pEFFS-EGFP-dneo vector that contains eGFP under the control of the EF1a promoter The eGFP gene is flanked by a wild type FRT site and a synthetic variant (F3). A selection trap, an ATG-deleted, promoterless neo (Dneo) gene is located downstream of eGFP. When eGFP is exchanged by Flp-mediated recombination against a cassette including a promoter and start codon, Dneo becomes complemented and the cell becomes resistant against the antibiotic G418, thus allowing for selection of recombinant cells (PubMed=22174749). 127228951 CVCL_A5ZR FIRS-1 transformed cell line Norway rat CVCL_A5ZR CL:0000010 Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Spleen; UBERON=UBERON_0002106; Breed/subspecies: Fischer 344; RS=RS_0000215. Female 127228952 CVCL_A5ZQ LO-HM-7 hybridoma Norway rat CVCL_A5ZQ CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; P01871; Human immunoglobulin heavy chain mu. 127228953 CVCL_A5ZD HBCHU.15 transformed cell line human CVCL_A5ZD CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228954 CVCL_A5ZC HBCHU.09 transformed cell line human CVCL_A5ZC CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228955 CVCL_A5ZF HBCHU.18 transformed cell line human CVCL_A5ZF CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228956 CVCL_A5ZE HBCHU.16 transformed cell line human CVCL_A5ZE CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228957 CVCL_A5ZH Org MHH.1 hybrid cell line CVCL_A5ZH CL:0000010 Selected for resistance to: ChEBI; CHEBI_472805; Ouabain; Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG). Group: Hybridoma fusion partner cell line 127228958 CVCL_A5ZG HBCHU.20 transformed cell line human CVCL_A5ZG CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228959 CVCL_A5ZJ NH cancer cell line human CVCL_A5ZJ From: Suzukawa, Kazumi; University of Tsukuba; Tsukuba; Japan CL:0000010 Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526). 127228960 CVCL_A5ZI JOK-1/5.3 cancer cell line human CVCL_A5ZI CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1685; CD5; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127228961 CVCL_A5XZ HE-30 transformed cell line CVCL_A5XZ CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA30). 127228962 CVCL_A5XY HE-239 transformed cell line CVCL_A5XY CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA239). 127228963 CVCL_A5YA PNK-86 finite cell line CVCL_A5YA CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Virology: Susceptible to infection by herpes simplex virus, adenovirus type 7 (Ad7) and parainfluenza viruses types 1 to 3 Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 27 127228964 CVCL_A5XR NCI-H460/TPT10 ABCG2 KO cancer cell line human CVCL_A5XR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:74; ABCG2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Male Characteristics: Compared to the parent cell line, no longer resistant to topotecan (PubMed=33425914) 127228965 CVCL_A5XQ NCI-H460/TPT10 cancer cell line human CVCL_A5XQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_63632; Topotecan; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Male Doubling time: 22.46 +- 0.85 hours (PubMed=33425914) 127228966 CVCL_A5XT A4xS hybrid cell line pig CVCL_A5XT CL:0000010 Characteristics: Hybrid of pig embryonic kidney cells with pig splenocytes (Patent=RU2545720); Virology: Susceptible to infection by African swine fever virus (AFSV) (PubMed=26182658). Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 87 127228967 CVCL_A5XS AM-3 telomerase immortalized cell line human CVCL_A5XS CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Met1_Ala159del) Population: Japanese; Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684; Cell type: Ameloblast; CL=CL_0000059. Female 127228968 CVCL_A5XV M3-1 clone 650A spontaneously immortalized cell line CVCL_A5XV CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 127228969 CVCL_A5XU PPK-66B finite cell line pig CVCL_A5XU CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Unspecified 127228970 CVCL_A5XX T91M cancer cell line human CVCL_A5XX CL:0000010 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C17262; X-Ray; Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Characteristics: Derived from parent cell line after 800 rads of X-radiation (PubMed=5660764) Doubling time: 27-28 hours (DOI=10.2172/4683311) Problematic cell line: Contaminated Parent cell line (T-1) has been shown to be a HeLa derivative. 127228971 CVCL_A5XW M3-1 clone 650AB spontaneously immortalized cell line CVCL_A5XW CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Characteristics: Obtained after irradiation of parent cell line (650A) 127228972 CVCL_A5XJ ONS-99 cancer cell line human CVCL_A5XJ CL:0000010 Population: Japanese. Male 127228973 CVCL_A5XI ZK cancer cell line human CVCL_A5XI CL:0000010 Population: Japanese; Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. 127228974 CVCL_A5XL MINT2 cancer cell line human CVCL_A5XL CL:0000010 Population: Japanese; Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684. Male Doubling time: ~45 hours (PubMed=15943790) 127228975 CVCL_A5XK MINT1 cancer cell line human CVCL_A5XK CL:0000010 Population: Japanese; Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684. Male Doubling time: ~45 hours (PubMed=15943790) 127228976 CVCL_A5XN ONS-20 cancer cell line human CVCL_A5XN CL:0000010 Population: Japanese; Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified 127228977 CVCL_A5XM MINT3 cancer cell line human CVCL_A5XM CL:0000010 Population: Japanese; Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684. Male Doubling time: ~45 hours (PubMed=15943790) 127228978 CVCL_A5XP ZK-2 cancer cell line human CVCL_A5XP CL:0000010 Population: Japanese. Unspecified 127228979 CVCL_A5XB NULC-1 cancer cell line human CVCL_A5XB CL:0000010 Population: Japanese. Unspecified 127228980 CVCL_A5XA GC302 hybridoma house mouse CVCL_A5XA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human 40 kDa stomach oncofetal antigen. 127228981 CVCL_A5XD CSTO-1 hybridoma house mouse CVCL_A5XD CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human stomach adenocarcinoma-associated antigen. 127228982 CVCL_A5XC NULC-2 cancer cell line human CVCL_A5XC CL:0000010 Population: Japanese; Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072. 127228983 CVCL_A5XF LCT-6 cancer cell line human CVCL_A5XF CL:0000010 Population: Japanese; Derived from site: In situ; Larynx; UBERON=UBERON_0001737. 127228984 CVCL_A5XE FU-GC-16 cancer cell line human CVCL_A5XE CL:0000010 Population: Japanese; Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Male 127228985 CVCL_A5XH ZK-1 cancer cell line human CVCL_A5XH CL:0000010 Population: Japanese; Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429. Male Doubling time: 26 hours (PubMed=22575259) 127228986 CVCL_A5XG OKK-1 cancer cell line human CVCL_A5XG CL:0000010 Population: Japanese; Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764. Male 127228987 CVCL_A5YZ RUBHU.09 transformed cell line human CVCL_A5YZ CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228988 CVCL_A5ZB RABHU.02 transformed cell line human CVCL_A5ZB CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228989 CVCL_A5ZA RABHU.01 transformed cell line human CVCL_A5ZA CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228990 CVCL_A5YS HAVCH.03 transformed cell line CVCL_A5YS CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Group: Non-human primate cell line 127228991 CVCL_A5YR HAVCH.02 transformed cell line CVCL_A5YR CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Group: Non-human primate cell line 127228992 CVCL_A5YU HBCHU.02 transformed cell line human CVCL_A5YU CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228993 CVCL_A5YT HAVHU.01 transformed cell line human CVCL_A5YT CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228994 CVCL_A5YW RUBHU.02 transformed cell line human CVCL_A5YW CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228995 CVCL_A5YV HBCHU.01 transformed cell line human CVCL_A5YV CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228996 CVCL_A5YY RUBHU.08 transformed cell line human CVCL_A5YY CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228997 CVCL_A5YX RUBHU.03 transformed cell line human CVCL_A5YX CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 127228998 CVCL_A5YK ARH-77 clone A5P3 transformed cell line human CVCL_A5YK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=MGI; MGI:1349162; Sdc1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female Problematic cell line: Misclassified Parent cell line (ARH-77) was originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line. 127228999 CVCL_A5YJ BMEV transformed cell line CVCL_A5YJ CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Muscle; UBERON=UBERON_0001630; Cell type: Epithelial cell; CL=CL_0000066. Unspecified 127229000 CVCL_A5YM ACB-985 cancer cell line human CVCL_A5YM CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Plasma cell; CL=CL_0000786. Unspecified Characteristics: Produces IgG kappa 127229001 CVCL_A5YL MER cancer cell line human CVCL_A5YL CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Plasma cell; CL=CL_0000786. Unspecified 127229002 CVCL_A5YN C23/11 transformed cell line human CVCL_A5YN CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Doubling time: 16-18 hours (Note=At passage <10), 20-23 hours (Note=At 42th passage) (CelloPub=CLPUB00607) Problematic cell line: Misclassified Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (CelloPub=CLPUB00607). 127229003 CVCL_A5YQ HAVCH.01 transformed cell line CVCL_A5YQ CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Group: Non-human primate cell line 127229004 CVCL_A5YP HET-37 hybrid cell line CVCL_A5YP CL:0000010 Group: Hybridoma fusion partner cell line. 127229005 CVCL_A5YC KR-92 finite cell line CVCL_A5YC CL:0000010 Derived from site: In situ; Intestine; UBERON=UBERON_0000160. 127229006 CVCL_A5YB KEK-92 finite cell line CVCL_A5YB CL:0000010 Derived from site: In situ; Fetal intestine; UBERON=UBERON_0000160. Unspecified 127229007 CVCL_A5YE CGFR-Ca-1 spontaneously immortalized cell line dog CVCL_A5YE CL:0000010 Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630. Unspecified 127229008 CVCL_A5YD CC0066 transformed cell line human CVCL_A5YD CL:0000010 Karyotypic information: 47,XY,r(14) (PubMed=16152642); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: ECACC; 92063005; true Male Part of: ECACC chromosomal abnormality collection 127229009 CVCL_A5YG CGFR-Ca-3 telomerase immortalized cell line dog CVCL_A5YG CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630. Unspecified 127229010 CVCL_A5YF CGFR-Ca-2 spontaneously immortalized cell line dog CVCL_A5YF CL:0000010 Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Unexplicit; Not described; Zygosity=Unspecified (PubMed=15365251) Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630. Unspecified 127229011 CVCL_A5YI BMET telomerase immortalized cell line CVCL_A5YI CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Muscle; UBERON=UBERON_0001630; Cell type: Epithelial cell; CL=CL_0000066. Unspecified 127229012 CVCL_A5YH BMES spontaneously immortalized cell line CVCL_A5YH CL:0000010 Derived from site: In situ; Muscle; UBERON=UBERON_0001630; Cell type: Epithelial cell; CL=CL_0000066. Unspecified 127229013 CVCL_A5VX NCL2 [Human lung carcinoma] cancer cell line human CVCL_A5VX CL:0000010 Population: Chinese; Taiwan; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Established from a nude mouse xenograft of CL2 Doubling time: 30 hours (PubMed=1497905) 127229014 CVCL_A5VW F-49-1 cancer cell line human CVCL_A5VW CL:0000010 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Problematic cell line: Contaminated Parent cell line (AV3) has been shown to be a HeLa derivative. 127229015 CVCL_A5VZ TruHD-Q43Q17M telomerase immortalized cell line human CVCL_A5VZ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[43] (c.52CAG(43)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=30256717); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229016 CVCL_A5VY TruHD-Q21Q18F telomerase immortalized cell line human CVCL_A5VY CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229017 CVCL_A5VP F9-11 spontaneously immortalized cell line house mouse CVCL_A5VP CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine; Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C3H/An. Male Characteristics: The parent cell line was fused with yeast strain F9 (AB1380 with a neo gene integrated in ura3) spheroblasts (PubMed=8710496); Characteristics: Mixture of cells containing small integrations of yeast DNA (27% of cells), cells containing large numbers of small extrachromosomal elements (32% of cells, Fig 2C) and cells containing no yeast DNA (40% of cells) (PubMed=8710496). 127229018 CVCL_A5VR F9-13 spontaneously immortalized cell line house mouse CVCL_A5VR CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine; Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C3H/An. Male Characteristics: The parent cell line was fused with yeast strain F9 (AB1380 with a neo gene integrated in ura3) spheroblasts (PubMed=8710496); Characteristics: Contains a single small integration of yeast DNA into a mouse chromosome (PubMed=8710496) 127229019 CVCL_A5VQ F9-12 spontaneously immortalized cell line house mouse CVCL_A5VQ CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine; Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C3H/An. Male Characteristics: The parent cell line was fused with yeast strain F9 (AB1380 with a neo gene integrated in ura3) spheroblasts (PubMed=8710496); Characteristics: Mixture of cells with small integrations of yeast DNA (23%), cells with large numbers of small extrachromosomal elements (17%), cells with very large integrations of yeast DNA (18%), cells with a large novel chromosome (14%) and cells with no signal (28%) (PubMed=8710496) 127229020 CVCL_A5VT F9-5 spontaneously immortalized cell line house mouse CVCL_A5VT CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine; Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C3H/An. Male Characteristics: The parent cell line was fused with yeast strain F9 (AB1380 with a neo gene integrated in ura3) spheroblasts (PubMed=8710496); Characteristics: Contains a single small integration of yeast DNA into a mouse chromosome (PubMed=8710496) 127229021 CVCL_A5VS F9-15 spontaneously immortalized cell line house mouse CVCL_A5VS CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine; Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C3H/An. Male Characteristics: The parent cell line was fused with yeast strain F9 (AB1380 with a neo gene integrated in ura3) spheroblasts (PubMed=8710496); Characteristics: Contains a single small integration of yeast DNA into a mouse chromosome (PubMed=8710496) 127229022 CVCL_A5VV ICGi029-A induced pluripotent stem cell human CVCL_A5VV From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Asn515del (c.1543_1545delAAC); ClinVar=VCV000181070; Zygosity=Heterozygous (PubMed=33892289) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229023 CVCL_A5VU ICGi028-A induced pluripotent stem cell human CVCL_A5VU From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4801; HADHA; Simple; p.Glu510Gln (c.1528G>C); ClinVar=VCV000100085; Zygosity=Heterozygous (PubMed=33887580) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229024 CVCL_A5VH UT-SCC-91 cancer cell line human CVCL_A5VH CL:0000010 Derived from site: In situ; Nose, skin; UBERON=UBERON_0015476. 127229025 CVCL_A5VG UT-SCC-115 cancer cell line human CVCL_A5VG CL:0000010 Derived from site: Metastatic; Not specified. 127229026 CVCL_A5VJ Tu-107 cancer cell line human CVCL_A5VJ CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Characteristics: Primary glioma cell culture 127229027 CVCL_A5VI UT-SCC-59A cancer cell line human CVCL_A5VI CL:0000010 Derived from site: Metastatic; Temple, skin; UBERON=UBERON_8480028. Male 127229028 CVCL_A5VL Tu-323 cancer cell line human CVCL_A5VL CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Characteristics: Primary glioma cell culture 127229029 CVCL_A5VK Tu-159 cancer cell line human CVCL_A5VK CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Characteristics: Primary glioma cell culture 127229030 CVCL_A5VN QZG undefined cell line type human CVCL_A5VN CL:0000010 Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107. 127229031 CVCL_A5VM Tu-325 cancer cell line human CVCL_A5VM CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Characteristics: Primary glioma cell culture 127229032 CVCL_A5VB U-2OSMR cancer cell line human CVCL_A5VB CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin); Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 127229033 CVCL_A5VA S2:spi4 spontaneously immortalized cell line fruit fly CVCL_A5VA CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FlyBase_Gene; FBgn0005672; Spi; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276. Male Group: Insect cell line 127229034 CVCL_A5VD UCLA-PL3 transformed cell line human CVCL_A5VD CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229035 CVCL_A5VC U-2OSTR cancer cell line human CVCL_A5VC CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol); Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 127229036 CVCL_A5VF UT-SCC-105 cancer cell line human CVCL_A5VF CL:0000010 Derived from site: In situ; Face, skin; UBERON=UBERON_1000021. 127229037 CVCL_A5VE UT-SCC-111 cancer cell line human CVCL_A5VE CL:0000010 Derived from site: In situ; Face, skin; UBERON=UBERON_1000021. 127229038 CVCL_A5WY OUMS-16 transformed cell line human CVCL_A5WY CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Donor information: Established from a patient suffering from a chronic lymphatic leukemia; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. 127229039 CVCL_A5WX PC-5Ly transformed cell line human CVCL_A5WX CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Donor information: Established from a patient suffering from a lung carcinoma; Derived from site: In situ; Lymph node; UBERON=UBERON_0000029. Male 127229040 CVCL_A5WZ FU-MK-1 hybridoma house mouse CVCL_A5WZ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326. 127229041 CVCL_A5WQ GM16131 transformed cell line human CVCL_A5WQ CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093) Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Discontinued: Coriell; GM16131; probable Male 127229042 CVCL_A5WP GM16126 transformed cell line human CVCL_A5WP CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 9 repeats) (PubMed=28161093) Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Discontinued: Coriell; GM16126; probable Female 127229043 CVCL_A5WS UM-UC-3 LLWO1 cancer cell line human CVCL_A5WS CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln2800fs*6 (c.8400delG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:14446; PARD3B; Unexplicit; Ex9-18del; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe113Cys (c.338T>G); ClinVar=VCV000634690; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255. Male Characteristics: Transfected with the plasmid pUHD172-1neo which contains a rtTA under the control of the CMV promoter The reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 (PubMed=12914669). 127229044 CVCL_A5WR GM16330 transformed cell line human CVCL_A5WR CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Discontinued: Coriell; GM16330; probable Unspecified 127229045 CVCL_A5WU GM16345 transformed cell line human CVCL_A5WU CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093) Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Discontinued: Coriell; GM16345; probable Female 127229046 CVCL_A5WT UM-UC-3 LLWO2F cancer cell line human CVCL_A5WT CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln2800fs*6 (c.8400delG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:14446; PARD3B; Unexplicit; Ex9-18del; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe113Cys (c.338T>G); ClinVar=VCV000634690; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9281; PPP1CA (Note=With a N-terminal His6-HA tag); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255. Male Characteristics: Expresses PPP1CA induced by doxycycline Transfected with the plasmid 6-HA-PP1alpha-pTEP4m plasmid that express a 6His-HA tagged PP1C1 undert the control of a Teto/CMV promoter.; Characteristics: Transfected with the plasmid pUHD172-1neo which contains a rtTA under the control of the CMV promoter The reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 (PubMed=12914669). 127229047 CVCL_A5WW NPC-TY861 cancer cell line human CVCL_A5WW CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728. Male Doubling time: 18 hours (DOI=10.11334/jibi1954.34.1Supplement1_329) 127229048 CVCL_A5WV NPC-204 cancer cell line human CVCL_A5WV CL:0000010 Population: Chinese; Taiwan; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Doubling time: 24-30 hours (DOI=10.2183/pjab1945.46.453) 127229049 CVCL_A5WI GM16292 transformed cell line human CVCL_A5WI CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Discontinued: Coriell; GM16292; probable Female 127229050 CVCL_A5WH GM16291 transformed cell line human CVCL_A5WH CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093) Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Discontinued: Coriell; GM16291; probable Female 127229051 CVCL_A5WK GM16294 transformed cell line human CVCL_A5WK CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093) Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Discontinued: Coriell; GM16294; probable Female 127229052 CVCL_A5WJ GM16293 transformed cell line human CVCL_A5WJ CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Discontinued: Coriell; GM16293; probable Female 127229053 CVCL_A5WM GM16333 transformed cell line human CVCL_A5WM CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093) Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Discontinued: Coriell; GM16333; probable Female 127229054 CVCL_A5WL GM16295 transformed cell line human CVCL_A5WL CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Discontinued: Coriell; GM16295; probable Male 127229055 CVCL_A5WN GM16101 transformed cell line human CVCL_A5WN CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Discontinued: Coriell; GM16101; probable Female 127229056 CVCL_A5WA TruHD-Q50Q40F telomerase immortalized cell line human CVCL_A5WA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[40] (c.52CAG(40)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=30256717); Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[50] (c.52CAG(50)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=30256717); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229057 CVCL_A5WC GM16286 transformed cell line human CVCL_A5WC CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093) Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Discontinued: Coriell; GM16286; probable Female 127229058 CVCL_A5WB GM16285 transformed cell line human CVCL_A5WB CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093) Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Discontinued: Coriell; GM16285; probable Female 127229059 CVCL_A5WE GM16288 transformed cell line human CVCL_A5WE CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093) Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Discontinued: Coriell; GM16288; probable Male 127229060 CVCL_A5WD GM16287 transformed cell line human CVCL_A5WD CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:50800; DUX4; Zygosity=Unspecified; Note=D4Z4 repeat contraction (to 6 repeats) (PubMed=28161093) Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Discontinued: Coriell; GM16287; probable Male 127229061 CVCL_A5WG GM16290 transformed cell line human CVCL_A5WG CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Discontinued: Coriell; GM16290; probable Female 127229062 CVCL_A5WF GM16289 transformed cell line human CVCL_A5WF CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Discontinued: Coriell; GM16289; probable Female 127229063 CVCL_A6FG RG11/15 hybridoma house mouse CVCL_A6FG CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: Rat Ig kappa light chains (IgK-1b allotype). 127229064 CVCL_A6FF ONS-82 cancer cell line human CVCL_A6FF CL:0000010 Population: Japanese. Unspecified 127229065 CVCL_A6FI LO-MG1-15 hybridoma Norway rat CVCL_A6FI CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01868; Mouse immunoglobulin heavy chain gamma-1. 127229066 CVCL_A6FH LO-MG1-13 hybridoma Norway rat CVCL_A6FH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01868; Mouse immunoglobulin heavy chain gamma-1. 127229067 CVCL_A6FK LO-MG2a-7 hybridoma Norway rat CVCL_A6FK CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Mouse Ig heavy chain gamma-2a. 127229068 CVCL_A6FJ LO-MG2a-3 hybridoma Norway rat CVCL_A6FJ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Mouse Ig heavy chain gamma-2a. 127229069 CVCL_A6FM MAR 80.2 hybridoma house mouse CVCL_A6FM CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Rat Ig kappa light chains (allotype IgK-1a). 127229070 CVCL_A6FL LO-MG2b-1 hybridoma Norway rat CVCL_A6FL CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01867; Mouse immunoglobulin heavy chain gamma-2b. 127229071 CVCL_A6FA UNESP-MM4 cancer cell line dog CVCL_A6FA CL:0000010 Derived from site: In situ; Lymph node; UBERON=UBERON_0000029; Breed/subspecies: Dachshund; VBO=VBO_0200406. Female Doubling time: 10.28 hours (PubMed=33195606) 127229072 CVCL_A6FC NCC-SS4-C1 cancer cell line human CVCL_A6FC CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11335; SSX1; Name(s)=SS18-SSX1 (PubMed=33611700) Population: Japanese Omics: Phenotyping; Drug screening; Omics: Variations; SNP array analysis. Male Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi); Doubling time: ~245 hours (PubMed=33611700) Part of: NCC sarcoma cell line panel 127229073 CVCL_A6FB NCC-DDLPS3-C1 cancer cell line human CVCL_A6FB CL:0000010 Population: Japanese; Derived from site: In situ; Right thigh; UBERON=UBERON_0000376. Omics: Phenotyping; Drug screening; Omics: Variations; SNP array analysis Female Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi); Doubling time: ~47 hours (PubMed=33677797) Part of: NCC sarcoma cell line panel 127229074 CVCL_A6FE ONS-86 cancer cell line human CVCL_A6FE CL:0000010 Population: Japanese; Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified 127229075 CVCL_A6FD ONS-84 cancer cell line human CVCL_A6FD CL:0000010 Population: Japanese; Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified 127229076 CVCL_A6EV UNESP-CM11 cancer cell line dog CVCL_A6EV CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: Mixed breed; VBO=VBO_0200902. Female Doubling time: 7.45 hours (PubMed=33195606) 127229077 CVCL_A6EU UNESP-CM9 cancer cell line dog CVCL_A6EU CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: Mixed breed; VBO=VBO_0200902. Female Doubling time: 8.95 hours (PubMed=33195606) 127229078 CVCL_A6EX UNESP-CM61 cancer cell line dog CVCL_A6EX CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: Dachshund; VBO=VBO_0200406. Female Doubling time: 13.06 hours (PubMed=33195606) 127229079 CVCL_A6EW UNESP-CM60 cancer cell line dog CVCL_A6EW CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: Dachshund; VBO=VBO_0200406. Female Doubling time: 11.79 hours (PubMed=33195606) 127229080 CVCL_A6EZ UNESP-MM3 cancer cell line dog CVCL_A6EZ CL:0000010 Derived from site: In situ; Lymph node; UBERON=UBERON_0000029; Breed/subspecies: Dachshund; VBO=VBO_0200406. Female Doubling time: 34.17 hours (PubMed=33195606) 127229081 CVCL_A6EY UNESP-MM1 cancer cell line dog CVCL_A6EY CL:0000010 Derived from site: In situ; Bone; UBERON=UBERON_0002481; Breed/subspecies: Poodle; VBO=VBO_0201048. Female Doubling time: 25.41 hours (PubMed=33195606) 127229082 CVCL_A6EN MARM-4 hybridoma house mouse CVCL_A6EN CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Rat IgM heavy chain. 127229083 CVCL_A6EM MARL-5 hybridoma house mouse CVCL_A6EM CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Rat Ig lambda light chains. 127229084 CVCL_A6EP MARM-7 hybridoma house mouse CVCL_A6EP CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Rat IgM heavy chain. 127229085 CVCL_A6ER UNESP-CM1 cancer cell line dog CVCL_A6ER CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: Poodle; VBO=VBO_0201048. Female Doubling time: 6.31 hours (PubMed=33195606) 127229086 CVCL_A6EQ MARG2a-7 hybridoma house mouse CVCL_A6EQ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P20760; Rat immunoglobulin heavy chain gamma-2A. 127229087 CVCL_A6ET UNESP-CM5 cancer cell line dog CVCL_A6ET CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: Dachshund; VBO=VBO_0200406. Female Doubling time: 7.5 hours (PubMed=33195606) 127229088 CVCL_A6ES UNESP-CM4 cancer cell line dog CVCL_A6ES CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: Dachshund; VBO=VBO_0200406. Female Doubling time: 5.1 hours (PubMed=33195606) 127229089 CVCL_A6GH LO-DNP-1 hybridoma Norway rat CVCL_A6GH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127229090 CVCL_A6GG LO-DNP-45 hybridoma Norway rat CVCL_A6GG CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127229091 CVCL_A6GJ LO-DNP-16 hybridoma Norway rat CVCL_A6GJ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127229092 CVCL_A6GI LO-DNP-2 hybridoma Norway rat CVCL_A6GI CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127229093 CVCL_A6GL LO-DNP-11 hybridoma Norway rat CVCL_A6GL CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127229094 CVCL_A6GK LO-DNP-61 hybridoma Norway rat CVCL_A6GK CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127229095 CVCL_A6GN LO-DNP-64 hybridoma Norway rat CVCL_A6GN CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127229096 CVCL_A6GM LO-DNP-57 hybridoma Norway rat CVCL_A6GM CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP). 127229097 CVCL_A6GB LO-MA-10 hybridoma Norway rat CVCL_A6GB CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; P01878; Mouse immunoglobulin heavy chain alpha. 127229098 CVCL_A6GA LO-MA-7 hybridoma Norway rat CVCL_A6GA CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; P01878; Mouse immunoglobulin heavy chain alpha. 127229099 CVCL_A6GD LO-MG-7 hybridoma Norway rat CVCL_A6GD CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Mouse Ig heavy chain gamma. 127229100 CVCL_A6GC MAR 103.6 hybridoma house mouse CVCL_A6GC CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Rat Ig kappa light chains (allotype IgK-1b). 127229101 CVCL_A6GF LO-HA-9 hybridoma Norway rat CVCL_A6GF CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01876; Human immunoglobulin heavy chain alpha 1; Monoclonal antibody target: UniProtKB; P01877; Human immunoglobulin heavy chain alpha 2. 127229102 CVCL_A6GE MARG2c-5 hybridoma house mouse CVCL_A6GE CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P20762; Rat immunoglobulin heavy chain gamma-2C. 127229103 CVCL_A6FW LO-MD-6 hybridoma Norway rat CVCL_A6FW CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01881; Mouse immunoglobulin heavy chain delta. 127229104 CVCL_A6FV LO-MO-1 hybridoma Norway rat CVCL_A6FV CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P08571; Human CD14. 127229105 CVCL_A6FY LO-MG2a-9 hybridoma Norway rat CVCL_A6FY CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Mouse Ig heavy chain gamma-2a. 127229106 CVCL_A6FX LO-MD-8 hybridoma Norway rat CVCL_A6FX CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01881; Mouse immunoglobulin heavy chain delta. 127229107 CVCL_A6FZ LO-MG3-13 hybridoma Norway rat CVCL_A6FZ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P03987; Mouse immunoglobulin heavy chain gamma-3. 127229108 CVCL_A6FN LO-MK-2 hybridoma Norway rat CVCL_A6FN CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Mouse Ig kappa light chains. 127229109 CVCL_A6FQ LO-BG-1 hybridoma Norway rat CVCL_A6FQ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Porphyromonas gingivalis (strain ATCC 33277 / DSM 20709 / CIP 103683 / JCM 12257 / NCTC 11834 / 2561). 127229110 CVCL_A6FP LO-MK-3 hybridoma Norway rat CVCL_A6FP CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Mouse Ig kappa light chains. 127229111 CVCL_A6FS LO-SM-11 hybridoma Norway rat CVCL_A6FS CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Streptococcus mutans cell wall antigens. 127229112 CVCL_A6FR LO-SM-2 hybridoma Norway rat CVCL_A6FR CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Streptococcus mutans cell wall antigens. 127229113 CVCL_A6FU LO-CD2b hybridoma Norway rat CVCL_A6FU CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P06729; Human CD2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-802 127229114 CVCL_A6FT LO-panB-a hybridoma Norway rat CVCL_A6FT CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: Human antigen on leucocytes. 127229115 CVCL_A6DE EB-Y8 hybridoma Norway rat CVCL_A6DE CL:0000010 Monoclonal antibody isotype: IgG2c, kappa; Monoclonal antibody target: Yersinia enterocolitica serogroup O:8 lipopolysaccharide. 127229116 CVCL_A6DD EB-A7 hybridoma Norway rat CVCL_A6DD CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI_27680; Galactomannan. 127229117 CVCL_A6DG LO-MG2a-2 hybridoma Norway rat CVCL_A6DG CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Mouse Ig heavy chain gamma-2a. 127229118 CVCL_A6DF LO-MG1-2 hybridoma Norway rat CVCL_A6DF CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01868; Mouse immunoglobulin heavy chain gamma-1. 127229119 CVCL_A6DI LO-MG3-7 hybridoma Norway rat CVCL_A6DI CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; P03987; Mouse immunoglobulin heavy chain gamma-3. 127229120 CVCL_A6DH LO-MG2b-2 hybridoma Norway rat CVCL_A6DH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01867; Mouse immunoglobulin heavy chain gamma-2b. 127229121 CVCL_A6DK LO-MM-9 hybridoma Norway rat CVCL_A6DK CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01872; Mouse immunoglobulin heavy chain mu. 127229122 CVCL_A6DJ LO-MK-1 hybridoma Norway rat CVCL_A6DJ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Mouse Ig kappa light chains. 127229123 CVCL_A6DA EB-A4 hybridoma Norway rat CVCL_A6DA CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI_27680; Galactomannan. 127229124 CVCL_A6DC EB-A6 hybridoma Norway rat CVCL_A6DC CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI_27680; Galactomannan. 127229125 CVCL_A6DB EB-A5 hybridoma Norway rat CVCL_A6DB CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI_27680; Galactomannan. 127229126 CVCL_A6CT LO-CD4-a hybridoma Norway rat CVCL_A6CT CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P01730; Human CD4. Group: Patented cell line; Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 89012101 127229127 CVCL_A6CS LO-CD2a hybridoma Norway rat CVCL_A6CS CL:0000010 Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized siplizumab (MEDI-507) therapeutic antibody Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P06729; Human CD2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11423 127229128 CVCL_A6CV LO-CD6-a hybridoma Norway rat CVCL_A6CV CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P30203; Human CD6. 127229129 CVCL_A6CU LO-CD4-b hybridoma Norway rat CVCL_A6CU CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01730; Human CD4. Group: Patented cell line; Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 89012102 127229130 CVCL_A6CX EB-A1 hybridoma Norway rat CVCL_A6CX CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI_27680; Galactomannan. 127229131 CVCL_A6CW LO-Tmat hybridoma Norway rat CVCL_A6CW CL:0000010 Monoclonal antibody isotype: IgG2a. 127229132 CVCL_A6CZ EB-A3 hybridoma Norway rat CVCL_A6CZ CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI_27680; Galactomannan. 127229133 CVCL_A6CY EB-A2 hybridoma Norway rat CVCL_A6CY CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI_27680; Galactomannan. 127229134 CVCL_A6CL LO-PL3-a hybridoma Norway rat CVCL_A6CL CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08514; Human ITGA2B/CD41. 127229135 CVCL_A6CK LO-CD5-a hybridoma Norway rat CVCL_A6CK CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P06127; Human CD5. 127229136 CVCL_A6CN LO-PL4 hybridoma Norway rat CVCL_A6CN CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P21926; Human CD9. 127229137 CVCL_A6CM LO-PL3-b hybridoma Norway rat CVCL_A6CM CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08514; Human ITGA2B/CD41. 127229138 CVCL_A6CP LO-Tact-1 hybridoma Norway rat CVCL_A6CP CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P01589; Human IL2RA/CD25. 127229139 CVCL_A6CR LO-DR-a hybridoma Norway rat CVCL_A6CR CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: Human HLA-DR. 127229140 CVCL_A6CQ LO-Tact-2 hybridoma Norway rat CVCL_A6CQ CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P01589; Human IL2RA/CD25. 127229141 CVCL_A6EF MARG2b-8 hybridoma house mouse CVCL_A6EF CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P20761; Rat immunoglobulin heavy chain gamma-2B. 127229142 CVCL_A6EE MARG2b-3 hybridoma house mouse CVCL_A6EE CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P20761; Rat immunoglobulin heavy chain gamma-2B. 127229143 CVCL_A6EH MARG2c-3 hybridoma house mouse CVCL_A6EH CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P20762; Rat immunoglobulin heavy chain gamma-2C. 127229144 CVCL_A6EG MARG2c-2 hybridoma house mouse CVCL_A6EG CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P20762; Rat immunoglobulin heavy chain gamma-2C. 127229145 CVCL_A6EJ MARK-2 hybridoma house mouse CVCL_A6EJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Rat Ig kappa light chains (allotype IgK-1a). 127229146 CVCL_A6EI MARK-1 hybridoma house mouse CVCL_A6EI CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Rat Ig kappa light chains. 127229147 CVCL_A6EL MARL-4 hybridoma house mouse CVCL_A6EL CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: Rat Ig lambda light chains. 127229148 CVCL_A6EK MARL-15 hybridoma house mouse CVCL_A6EK CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Rat Ig lambda light chains. 127229149 CVCL_A6EB MARG1-1 hybridoma house mouse CVCL_A6EB CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P20759; Rat immunoglobulin heavy chain gamma-1. 127229150 CVCL_A6EA MARE-1 hybridoma house mouse CVCL_A6EA CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01855; Rat immunoglobulin heavy chain epsilon. 127229151 CVCL_A6ED MARG2a-8 hybridoma house mouse CVCL_A6ED CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P20760; Rat immunoglobulin heavy chain gamma-2A. 127229152 CVCL_A6EC MARG1-2 hybridoma house mouse CVCL_A6EC CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P20759; Rat immunoglobulin heavy chain gamma-1. 127229153 CVCL_A6DU LO-VX-4 hybridoma Norway rat CVCL_A6DU CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Potato virus X. 127229154 CVCL_A6DT LO-VX-10 hybridoma Norway rat CVCL_A6DT CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Potato virus X. 127229155 CVCL_A6DW LO-VX-9 hybridoma Norway rat CVCL_A6DW CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Potato virus X. 127229156 CVCL_A6DV LO-VX-6 hybridoma Norway rat CVCL_A6DV CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Potato virus X. 127229157 CVCL_A6DY MARA-2 hybridoma house mouse CVCL_A6DY CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Rat IgA heavy chain. 127229158 CVCL_A6DX MARA-1 hybridoma house mouse CVCL_A6DX CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Rat IgA heavy chain. 127229159 CVCL_A6DZ MARD-3 hybridoma house mouse CVCL_A6DZ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01883; Rat immunoglobulin heavy chain delta. 127229160 CVCL_A6DM LO-MM-8 hybridoma Norway rat CVCL_A6DM CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01872; Mouse immunoglobulin heavy chain mu. 127229161 CVCL_A6DL LO-MM-3 hybridoma Norway rat CVCL_A6DL CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; P01872; Mouse immunoglobulin heavy chain mu. 127229162 CVCL_A6DN LO-ME-2 hybridoma Norway rat CVCL_A6DN CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P06336; Mouse immunoglobulin heavy chain epsilon. 127229163 CVCL_A6DQ LO-Ea-10 hybridoma Norway rat CVCL_A6DQ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Erwinia amylovora. 127229164 CVCL_A6DP LO-ME-3 hybridoma Norway rat CVCL_A6DP CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P06336; Mouse immunoglobulin heavy chain epsilon. 127229165 CVCL_A6DS LO-Ea-18 hybridoma Norway rat CVCL_A6DS CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Erwinia amylovora. 127229166 CVCL_A6DR LO-Ea-15 hybridoma Norway rat CVCL_A6DR CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Erwinia amylovora. 127229167 CVCL_A6BC LO-HL-4 hybridoma Norway rat CVCL_A6BC CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human Ig lambda light chains. 127229168 CVCL_A6BB LO-HL-3 hybridoma Norway rat CVCL_A6BB CL:0000010 Monoclonal antibody isotype: IgG2a, lambda; Monoclonal antibody target: Human Ig lambda light chains. 127229169 CVCL_A6BE LO-HApoB-2 hybridoma Norway rat CVCL_A6BE CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04114; Human APOB. 127229170 CVCL_A6BD LO-HApoB-1 hybridoma Norway rat CVCL_A6BD CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04114; Human APOB. 127229171 CVCL_A6BG LO-HApoB-4 hybridoma Norway rat CVCL_A6BG CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04114; Human APOB. 127229172 CVCL_A6BF LO-HApoB-3 hybridoma Norway rat CVCL_A6BF CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04114; Human APOB. 127229173 CVCL_A6BI LO-HApoB-6 hybridoma Norway rat CVCL_A6BI CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P04114; Human APOB. 127229174 CVCL_A6BH LO-HApoB-5 hybridoma Norway rat CVCL_A6BH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04114; Human APOB. 127229175 CVCL_A6AZ LO-HG-23 hybridoma Norway rat CVCL_A6AZ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human IgG (all 4 classes). 127229176 CVCL_A6AY LO-HG-22 hybridoma Norway rat CVCL_A6AY CL:0000010 Monoclonal antibody isotype: IgG2c, kappa; Monoclonal antibody target: Human IgG (all 4 classes). 127229177 CVCL_A6BA LO-HL-2 hybridoma Norway rat CVCL_A6BA CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Human Ig lambda light chains. 127229178 CVCL_A6AR LO-HG-1 hybridoma Norway rat CVCL_A6AR CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human IgG (all 4 classes). 127229179 CVCL_A6AQ LO-HD-3 hybridoma Norway rat CVCL_A6AQ CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; P01880; Human immunoglobulin heavy chain delta. 127229180 CVCL_A6AT LO-HG-6 hybridoma Norway rat CVCL_A6AT CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Human IgG (all 4 classes). 127229181 CVCL_A6AS LO-HG-3 hybridoma Norway rat CVCL_A6AS CL:0000010 Monoclonal antibody isotype: IgG2c, kappa; Monoclonal antibody target: Human IgG (all 4 classes). 127229182 CVCL_A6AV LO-HG-19 hybridoma Norway rat CVCL_A6AV CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Human IgG (all 4 classes). 127229183 CVCL_A6AU LO-HG-7 hybridoma Norway rat CVCL_A6AU CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Human IgG (all 4 classes). 127229184 CVCL_A6AX LO-HG-21 hybridoma Norway rat CVCL_A6AX CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human IgG (all 4 classes). 127229185 CVCL_A6AW LO-HG-20 hybridoma Norway rat CVCL_A6AW CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Human IgG (all 4 classes). 127229186 CVCL_A6AJ LO-RK-1b-1 hybridoma Norway rat CVCL_A6AJ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Rat Ig kappa light chains (IgK-1b allotype). 127229187 CVCL_A6AI LO-RK-1a-1 hybridoma Norway rat CVCL_A6AI CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Rat Ig kappa light chains (IgK-1a allotype). 127229188 CVCL_A6AL LO-RG-1 hybridoma Norway rat CVCL_A6AL CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Rabbit IgG heavy chain. 127229189 CVCL_A6AK LO-RK-1b-2 hybridoma Norway rat CVCL_A6AK CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Rat Ig kappa light chains (IgK-1b allotype). 127229190 CVCL_A6AN LO-HM-8 hybridoma Norway rat CVCL_A6AN CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; P01871; Human immunoglobulin heavy chain mu. 127229191 CVCL_A6AM LO-HM-2 hybridoma Norway rat CVCL_A6AM CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01871; Human immunoglobulin heavy chain mu. 127229192 CVCL_A6AP LO-HD-1 hybridoma Norway rat CVCL_A6AP CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01880; Human immunoglobulin heavy chain delta. 127229193 CVCL_A6CD LO-HRP-17 hybridoma Norway rat CVCL_A6CD CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A. 127229194 CVCL_A6CC LO-HRP-16 hybridoma Norway rat CVCL_A6CC CL:0000010 Monoclonal antibody isotype: IgG, kappa; Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A. 127229195 CVCL_A6CF LO-HRP-19 hybridoma Norway rat CVCL_A6CF CL:0000010 Monoclonal antibody isotype: IgG, kappa; Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A. 127229196 CVCL_A6CE LO-HRP-18 hybridoma Norway rat CVCL_A6CE CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A. 127229197 CVCL_A6CH LO-VG2 hybridoma Norway rat CVCL_A6CH CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Xenopus laevis vitellogenin. 127229198 CVCL_A6CG LO-VG1 hybridoma Norway rat CVCL_A6CG CL:0000010 Monoclonal antibody isotype: IgG2; Monoclonal antibody target: Xenopus laevis vitellogenin. 127229199 CVCL_A6CJ LO-CD1-a hybridoma Norway rat CVCL_A6CJ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P06126; Human CD1A. 127229200 CVCL_A6CI LO-VG3 hybridoma Norway rat CVCL_A6CI CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Xenopus laevis vitellogenin. 127229201 CVCL_A6BZ LO-HRP-13 hybridoma Norway rat CVCL_A6BZ CL:0000010 Monoclonal antibody isotype: IgG, kappa; Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A. 127229202 CVCL_A6CB LO-HRP-15 hybridoma Norway rat CVCL_A6CB CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A. 127229203 CVCL_A6CA LO-HRP-14 hybridoma Norway rat CVCL_A6CA CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A. 127229204 CVCL_A6BS LO-HK-1 hybridoma Norway rat CVCL_A6BS CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Human Ig kappa light chains. 127229205 CVCL_A6BR LO-HE-7 hybridoma Norway rat CVCL_A6BR CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01854; Human immunoglobulin heavy chain epsilon. 127229206 CVCL_A6BU LO-HL-1 hybridoma Norway rat CVCL_A6BU CL:0000010 Monoclonal antibody isotype: IgG, kappa; Monoclonal antibody target: Human Ig lambda light chains. 127229207 CVCL_A6BT LO-HK-3 hybridoma Norway rat CVCL_A6BT CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Human Ig kappa light chains. 127229208 CVCL_A6BW LO-HRP-9 hybridoma CVCL_A6BW CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A. 127229209 CVCL_A6BV LO-HRP-8 hybridoma CVCL_A6BV CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A. 127229210 CVCL_A6BY LO-HRP-12 hybridoma Norway rat CVCL_A6BY CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A. 127229211 CVCL_A6BX LO-HRP-10 hybridoma CVCL_A6BX CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A. 127229212 CVCL_A6BK LO-HA-1 hybridoma Norway rat CVCL_A6BK CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01876; Human immunoglobulin heavy chain alpha 1. 127229213 CVCL_A6BM LO-HA-3 hybridoma Norway rat CVCL_A6BM CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01876; Human immunoglobulin heavy chain alpha 1; Monoclonal antibody target: UniProtKB; P01877; Human immunoglobulin heavy chain alpha 2. 127229214 CVCL_A6BL LO-HA-2 hybridoma Norway rat CVCL_A6BL CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01876; Human immunoglobulin heavy chain alpha 1. 127229215 CVCL_A6BN LO-HA-4 hybridoma Norway rat CVCL_A6BN CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01876; Human immunoglobulin heavy chain alpha 1; Monoclonal antibody target: UniProtKB; P01877; Human immunoglobulin heavy chain alpha 2. 127229216 CVCL_A6BQ LO-HA-6 hybridoma Norway rat CVCL_A6BQ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01876; Human immunoglobulin heavy chain alpha 1; Monoclonal antibody target: UniProtKB; P01877; Human immunoglobulin heavy chain alpha 2. 127229217 CVCL_A6BP LO-HA-5 hybridoma Norway rat CVCL_A6BP CL:0000010 Monoclonal antibody isotype: IgG, kappa; Monoclonal antibody target: UniProtKB; P01876; Human immunoglobulin heavy chain alpha 1; Monoclonal antibody target: UniProtKB; P01877; Human immunoglobulin heavy chain alpha 2. 127229218 CVCL_A6AB UHOMi006-A induced pluripotent stem cell human CVCL_A6AB From: University Hospital of Montpellier; Montpellier; France CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229219 CVCL_A6AA UHOMi007-A induced pluripotent stem cell human CVCL_A6AA From: University Hospital of Montpellier; Montpellier; France CL:0000010 Population: Caucasian; Donor information: Established from a healthy heavy smoker (>50 pack years) (PubMed=38723411); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229220 CVCL_A6AD 1E4-1D9 hybridoma house mouse CVCL_A6AD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P51654; Human GPC3. 127229221 CVCL_A6AC Tet-293/Ins6 transformed cell line human CVCL_A6AC CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6081; INS; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Secretes insulin induced by doxycyclin; Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 127229222 CVCL_A6AF 1E2-1D11 hybridoma house mouse CVCL_A6AF CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: Human heparan sulfate proteoglycans (HSPG). 127229223 CVCL_A6AE 1E4-1C2 hybridoma house mouse CVCL_A6AE CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Human heparan sulfate proteoglycans (HSPG). 127229224 CVCL_A6AH 1E2-2C9 hybridoma house mouse CVCL_A6AH CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: Human heparan sulfate proteoglycans (HSPG). 127229225 CVCL_A6AG 1E2-2B8 hybridoma house mouse CVCL_A6AG CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: Human heparan sulfate proteoglycans (HSPG). 127229226 CVCL_A7PP WS6KO finite cell line human CVCL_A7PP CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Senescence: Senesces at 19 PDL (PubMed=4083160) 127229227 CVCL_A7PR WS8KO finite cell line human CVCL_A7PR CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Senescence: Senesces at 19 PDL (PubMed=4083160) 127229228 CVCL_A7PQ WS7KO finite cell line human CVCL_A7PQ CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229229 CVCL_A7PT WS10KO finite cell line human CVCL_A7PT CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Senescence: Senesces at 17 PDL (PubMed=4083160) 127229230 CVCL_A7PS WS9KO finite cell line human CVCL_A7PS CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Senescence: Senesces at 12 PDL (PubMed=4083160) 127229231 CVCL_A7PV NHSF41 finite cell line human CVCL_A7PV CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Senescence: Senesces at 50 PDL (PubMed=4083160) 127229232 CVCL_A7PU WS12KO finite cell line human CVCL_A7PU CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Senescence: Senesces at 28 PDL (PubMed=4083160) 127229233 CVCL_A7PH WS10S finite cell line human CVCL_A7PH CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229234 CVCL_A7PG MBC-1 cancer cell line human CVCL_A7PG CL:0000010 Population: Japanese; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: B-cell; CL=CL_0000236. Unspecified 127229235 CVCL_A7PJ WS1KO finite cell line human CVCL_A7PJ CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Senescence: Senesces at 10 PDL (PubMed=4083160) 127229236 CVCL_A7PI WS11KO finite cell line human CVCL_A7PI CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Senescence: Senesces at 26 PDL (PubMed=4083160) 127229237 CVCL_A7PL WS3KO finite cell line human CVCL_A7PL CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Senescence: Senesces at 11 PDL (PubMed=4083160) 127229238 CVCL_A7PK WS2KO finite cell line human CVCL_A7PK CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229239 CVCL_A7PN WS5KO finite cell line human CVCL_A7PN CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Senescence: Senesces at 28 PDL (PubMed=4083160) 127229240 CVCL_A7PM WS4KO finite cell line human CVCL_A7PM CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Senescence: Senesces at 13 PDL (PubMed=4083160) 127229241 CVCL_A7PB K-TL-1 cancer cell line human CVCL_A7PB CL:0000010 Population: Japanese; Derived from site: In situ; Hair follicle, outer root sheath; UBERON=UBERON_0005942. Female Doubling time: 10 days (PubMed=6165463) 127229242 CVCL_A7PA T3-2 [Rat tooth germ] telomerase immortalized cell line Norway rat CVCL_A7PA CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Tooth bud, dental papilla, molar; UBERON=UBERON_0015844; Cell type: Odontoblast; CL=CL_0000060; Breed/subspecies: Sprague Dawley; RS=RS_0000681. 127229243 CVCL_A7PD AWT KoTa finite cell line human CVCL_A7PD CL:0000010 Population: Japanese; Karyotypic information: 46,XY,del(11)(p13) (JCRB=KURB2102); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229244 CVCL_A7PC MGH9009-1 cancer cell line human CVCL_A7PC CL:0000010 Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. Unspecified 127229245 CVCL_A7PF CFS414_1G10 transformed cell line CVCL_A7PF CL:0000010 Genetic integration: Method=PiggyBac transposition; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)); Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; J7RUA5; Staphylococcus aureus Cas9; Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: Continental Chestnut Flanked White; VBO=VBO_0017485. Male Characteristics: Constitutively expresses nuclear GFP (nGFP) and pac and conditionally expresses S.aureus Cas9 and mCherry in the presence of Cre recombinase; Characteristics: A FLEx-SaCas9-P2A-mCherry construct was transferred using a PiggyBac transposon vector Group: Bird cell line 127229246 CVCL_A7PE CFS414_F6 transformed cell line CVCL_A7PE CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: Continental Chestnut Flanked White; VBO=VBO_0017485. Male Group: Bird cell line 127229247 CVCL_A7QQ U2OS EGFP-H2B cancer cell line human CVCL_A7QQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4761; H2BC11 Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 127229248 CVCL_A7QP YTH 3.2.6 hybridoma Norway rat CVCL_A7QP CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P09564; Human CD7. 127229249 CVCL_A7QS LUMCi046-A induced pluripotent stem cell human CVCL_A7QS From: Leiden University Medical Center; Leiden; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; HGNC:25947; KLHL24; Simple; p.Met1Arg (c.2T>G); Zygosity=Heterozygous (PubMed=34688992) Population: Chilean; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229250 CVCL_A7QR LUMCi045-A induced pluripotent stem cell human CVCL_A7QR From: Leiden University Medical Center; Leiden; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; HGNC:25947; KLHL24; Simple; p.Met1Arg (c.2T>G); Zygosity=Heterozygous (PubMed=34688992) Population: Chilean; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229251 CVCL_A7QU LGLL-CL1 transformed cell line human CVCL_A7QU CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Population: Caucasian; Italian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229252 CVCL_A7QT LUMCi039-A induced pluripotent stem cell human CVCL_A7QT From: Leiden University Medical Center; Leiden; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg594Gln (c.1781G>A); ClinVar=VCV000053018; Zygosity=Heterozygous (PubMed=27470144) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229253 CVCL_A7QW M-2478 finite cell line human CVCL_A7QW CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 127229254 CVCL_A7QV LGLL-2 transformed cell line human CVCL_A7QV CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Population: African; Ethiopian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229255 CVCL_A7QI B82CAPR spontaneously immortalized cell line house mouse CVCL_A7QI CL:0000010 Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR); Selected for resistance to: ChEBI; CHEBI_17698; Chloramphenicol; Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C3H/An. Male 127229256 CVCL_A7QH MIN6 rho0 transformed cell line house mouse CVCL_A7QH CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Cell type: Pancreatic beta cell; CL=CL_0000169; Breed/subspecies: C57BL/6 IT6 transgenic. Unspecified Characteristics: Cell line devoid of mitochondrial DNA (rho0) Obtained by growth of parental cell line with bis-4-piperidyle-dichloride (PubMed=8824267). 127229257 CVCL_A7QK A3D8 hybridoma house mouse CVCL_A7QK CL:0000010 Monoclonal antibody isotype: IgG1 (PubMed=2646376); IgM (PubMed=6466869; PubMed=6863545); Monoclonal antibody target: UniProtKB; P16070; Human CD44. 127229258 CVCL_A7QJ SHSY-5Y Tet-On SNCA cancer cell line human CVCL_A7QJ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11138; SNCA; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del) Population: Caucasian; Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Female Characteristics: Inducible expression of SNCA upon treatment with doxycycline Serves as a model for both dopaminergic neuronal biology and a-synuclein pathology (Millipore=SCC291).; Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 127229259 CVCL_A7QM ED-S/ADM cancer cell line human CVCL_A7QM CL:0000010 Population: Japanese; Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin); Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male 127229260 CVCL_A7QL Hermes-2 hybridoma CVCL_A7QL CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P16070; Human CD44. 127229261 CVCL_A7QN YTH 66.9 hybridoma Norway rat CVCL_A7QN CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P31358; Human CD52. 127229262 CVCL_A7QA ATL-2/ADM cl-1 transformed cell line human CVCL_A7QA CL:0000010 Population: Japanese; Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin); Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified 127229263 CVCL_A7QC RIN-AhGh cancer cell line Norway rat CVCL_A7QC CL:0000010 Transformant: NCIt; C17262; X-Ray; Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Breed/subspecies: NEDH; RS=RS_0000603. Male 127229264 CVCL_A7QB ATL-2/ADM cl-2 transformed cell line human CVCL_A7QB CL:0000010 Population: Japanese; Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin); Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified 127229265 CVCL_A7QE RIN 1046-44 cancer cell line Norway rat CVCL_A7QE CL:0000010 Transformant: NCIt; C17262; X-Ray; Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Cell type: Pancreatic beta cell; CL=CL_0000169; Breed/subspecies: NEDH; RS=RS_0000603. Male Characteristics: Does not secrete glucagon, nor insulin, nor somatostatin (PubMed=2879852) 127229266 CVCL_A7QD RIN-AhLh cancer cell line Norway rat CVCL_A7QD CL:0000010 Transformant: NCIt; C17262; X-Ray; Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Breed/subspecies: NEDH; RS=RS_0000603. Male 127229267 CVCL_A7QG RIN-5AH-T2 cancer cell line Norway rat CVCL_A7QG CL:0000010 Transformant: NCIt; C17262; X-Ray; Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Breed/subspecies: NEDH; RS=RS_0000603. Male 127229268 CVCL_A7QF RIN 1046-43 cancer cell line Norway rat CVCL_A7QF CL:0000010 Transformant: NCIt; C17262; X-Ray; Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Cell type: Pancreatic beta cell; CL=CL_0000169; Breed/subspecies: NEDH; RS=RS_0000603. Male Characteristics: Secretes insulin and somatostatin (PubMed=2879852) 127229269 CVCL_A7PX NHSF63 finite cell line human CVCL_A7PX CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Senescence: Senesces at 42 PDL (PubMed=4083160) 127229270 CVCL_A7PW NHSF5 finite cell line human CVCL_A7PW CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Senescence: Senesces at 53 PDL (PubMed=4083160) 127229271 CVCL_A7PZ SALT-3/ADM cl-2 cancer cell line human CVCL_A7PZ CL:0000010 Population: Japanese; Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin); Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175; Cell type: T-cell; CL=CL_0000084. Male 127229272 CVCL_A7PY NHSF64 finite cell line human CVCL_A7PY CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Senescence: Senesces at 37 PDL (PubMed=4083160) 127229273 CVCL_A7NN UTP-L12 cancer cell line human CVCL_A7NN CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:4010; FUS; Name(s)=FUS-ERG, TLS-ERG; Note=In frame (PubMed=8187069) Population: Japanese; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Female 127229274 CVCL_A7NM IRTA21 cancer cell line human CVCL_A7NM CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:4010; FUS; Name(s)=FUS-ERG, TLS-ERG; Note=In frame (PubMed=7794765) Population: Japanese; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Female Doubling time: ~99 hours (PubMed=7794765) 127229275 CVCL_A7NP CS-R cancer cell line human CVCL_A7NP CL:0000010 Unspecified 127229276 CVCL_A7NR NU-T1 hybridoma house mouse CVCL_A7NR CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P06729; Human CD2. 127229277 CVCL_A7NQ SALT-3 cancer cell line human CVCL_A7NQ CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175; Cell type: T-cell; CL=CL_0000084. Male 127229278 CVCL_A7NT KOS-1 cancer cell line human CVCL_A7NT CL:0000010 Population: Japanese; Derived from site: In situ; Bone, distal femur; UBERON=UBERON_0004406. Female Doubling time: 27.4 hours (PubMed=10948649) 127229279 CVCL_A7NS NU-T2 hybridoma house mouse CVCL_A7NS CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P29016; Human CD1B. 127229280 CVCL_A7NF IMS-BC2 cancer cell line human CVCL_A7NF CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=9650450; PubMed=10071072) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Doubling time: 36 hours (PubMed=9650450) 127229281 CVCL_A7NE IMS-BC1 cancer cell line human CVCL_A7NE CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=9650450; PubMed=10071072) Population: Japanese; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Female Doubling time: 48 hours (PubMed=9650450) 127229282 CVCL_A7NH SZ-117 hybridoma house mouse CVCL_A7NH CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P08253; Human MMP2 (Note=Also recognizes filamin A). 127229283 CVCL_A7NG UACC-SARC1 cancer cell line human CVCL_A7NG CL:0000010 Omics: Variations; Array-based CGH. Female Characteristics: Obtained from a radiation-induced sarcoma Doubling time: 28.3 hours (PubMed=25644184) 127229284 CVCL_A7NJ 82.3 cancer cell line human CVCL_A7NJ CL:0000010 Population: Caucasian; Italian; Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704. Male Characteristics: Shows cross-resistance to gemcitabine, 5-fluorouracil, carboplatin and oxaliplatin (PubMed=33922695); Characteristics: Established from a 4th generation xenograft maintained in NOD/SCID mice (PubMed=33922695) Doubling time: 48-53 hours (PubMed=33922695) 127229285 CVCL_A7NI 2XSB cancer cell line human CVCL_A7NI CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=33707600); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=33707600); Sequence variation: Mutation; HGNC; HGNC:19291; CSMD3; Simple; p.Trp3337Ter (c.10010G>A); Zygosity=Heterozygous (PubMed=33707600); Sequence variation: Mutation; HGNC; HGNC:2976; DNMT1; Simple; c.2586+1G>A; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=33707600); Sequence variation: Mutation; HGNC; HGNC:6697; LRP5; Simple; p.Arg428Ter (c.1282C>T); ClinVar=VCV000006269; Zygosity=Heterozygous (PubMed=33707600); Sequence variation: Mutation; HGNC; HGNC:7765; NF1; None_reported; -; Zygosity=- (PubMed=33707600); Sequence variation: Mutation; HGNC; HGNC:8059; NUMA1; Simple; p.Leu1167Alafs*39 (c.3499_3500delCT); Zygosity=Heterozygous (PubMed=33707600); Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Pro38Ser (c.112C>T); ClinVar=VCV000127688; Zygosity=Homozygous (PubMed=33707600); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His178Asp (c.532C>G); ClinVar=VCV000482223; Zygosity=Homozygous (PubMed=33707600) Population: Caucasian; Derived from site: In situ; Right brachial nerve; UBERON=UBERON_0001814. Omics: Genomics; Whole exome sequencing; Omics: Variations; SNP array analysis Female Doubling time: 28.0 +- 3.09 hours (Note=At 6th passage), 27.3 +- 4.06 hours (Note=At 54th passage) (PubMed=33707600) 127229286 CVCL_A7NL IRTA17 cancer cell line human CVCL_A7NL CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:4010; FUS; Name(s)=FUS-ERG, TLS-ERG; Note=In frame (PubMed=7794765) Population: Japanese; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Female Doubling time: ~79 hours (PubMed=7794765) 127229287 CVCL_A7NK RRBL1 cancer cell line human CVCL_A7NK CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=17675267) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229288 CVCL_A7NB Sf-21-CB spontaneously immortalized cell line CVCL_A7NB CL:0000010 Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Biotechnology: Used for the production of the MSD Animal Health porcine circovirus type 2 (PCV2) vaccine Porcilis PCV Used to produce the PCV2 ORF2 capsid protein.; Biotechnology: Used for the production of the MSD Animal Health classical swine fever virus (CSFV) vaccine Porcilis Pesti Used to produce the CSFV envelope glycoprotein E2. Female Group: Insect cell line; Group: Recombinant protein production insect cell line; Group: Vaccine production cell line 127229289 CVCL_A7NA LSA-D6 cancer cell line CVCL_A7NA CL:0000010 Transformant: NCBI_TaxID; 11780; Feline sarcoma virus (strain Snyder-Theilen); Derived from site: In situ; Thymus; UBERON=UBERON_0002370. Unspecified Characteristics: Compared to the parent cell line, has increased interferon-alpha secretion activity 127229290 CVCL_A7ND GM28037 finite cell line human CVCL_A7ND CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28037); Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Tyr117Ter (c.351T>G); Zygosity=Heterozygous (Coriell=GM28037) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229291 CVCL_A7NC WAe009-A-58 embryonic stem cell human CVCL_A7NC From: Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine; Beijing; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2207; COL4A5 (Note=1 of 2 alleles) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127229292 CVCL_A7MU SAEC-H7 embryonic stem cell CVCL_A7MU CL:0000010 Derived from site: In situ; Morula; UBERON=UBERON_0000085; Cell type: Embryonic stem cell; CL=CL_0002322. Unspecified Doubling time: 1.7 days (PubMed=34044158) Group: Fish cell line 127229293 CVCL_A7MT BHK21-MERS-Rep spontaneously immortalized cell line CVCL_A7MT CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; K9N4V7; Middle East respiratory syndrome-related coronavirus (MERS-CoV) nucleoprotein (N); Genetic integration: Method=Transfection; Gene=UniProtKB; K9N7C7; Middle East respiratory syndrome-related coronavirus (MERS-CoV) replicase polyprotein 1ab; Genetic integration: Method=Transfection; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male Characteristics: Transfected with a pBAC-CMV-MERS-CoV replicon construct The MERS-CoV replicon contains the genes encoding the MERS-CoV polyproteins 1a and 1b and the N protein, neo, and the Renilla reniformis renilla-type luciferase (Rluc) gene (PubMed=33616893). 127229294 CVCL_A7MW SAEC-C1 embryonic stem cell CVCL_A7MW CL:0000010 Derived from site: In situ; Gastrula; UBERON=UBERON_0004734; Cell type: Embryonic stem cell; CL=CL_0002322. Unspecified Group: Fish cell line 127229295 CVCL_A7MV SAEC-A3 embryonic stem cell CVCL_A7MV CL:0000010 Derived from site: In situ; Morula; UBERON=UBERON_0000085; Cell type: Embryonic stem cell; CL=CL_0002322. Unspecified Doubling time: 1.7 days (PubMed=34044158) Group: Fish cell line 127229296 CVCL_A7MY LSA-D4-C cancer cell line CVCL_A7MY CL:0000010 Transformant: NCBI_TaxID; 11780; Feline sarcoma virus (strain Snyder-Theilen); Derived from site: In situ; Thymus; UBERON=UBERON_0002370. Unspecified Characteristics: Compared to the parent cell line, has increased interferon-alpha secretion activity 127229297 CVCL_A7MX SAEC-F1 embryonic stem cell CVCL_A7MX CL:0000010 Derived from site: In situ; Gastrula; UBERON=UBERON_0004734; Cell type: Embryonic stem cell; CL=CL_0002322. Unspecified Group: Fish cell line 127229298 CVCL_A7MZ LSA-D4-K17 cancer cell line CVCL_A7MZ CL:0000010 Transformant: NCBI_TaxID; 11780; Feline sarcoma virus (strain Snyder-Theilen); Derived from site: In situ; Thymus; UBERON=UBERON_0002370. Unspecified Characteristics: Compared to the parent cell line, has increased interferon-alpha secretion activity 127229299 CVCL_A7NV MCS-2 [Mouse hybridoma against human ANPEP] hybridoma house mouse CVCL_A7NV CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P15144; Human ANPEP/CD13. 127229300 CVCL_A7NU MCS-1 [Mouse hybridoma against sialyl Lewis X] hybridoma house mouse CVCL_A7NU CL:0000010 Monoclonal antibody isotype: IgG3; Monoclonal antibody target: ChEBI; CHEBI_61711; Alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc (Sialyl Lewis X; CD15; SSEA-1). 127229301 CVCL_A7NX WAe001-A-72 embryonic stem cell human CVCL_A7NX From: The First Affiliated Hospital of Zhejiang University School of Medicine; Hangzhou; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24678; FTO Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127229302 CVCL_A7NW PRHC-1 cancer cell line human CVCL_A7NW CL:0000010 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Virology: Resistant of the cytopathogenic effect of poliovirus infection (PubMed=3037186) 127229303 CVCL_A7NZ RTG spontaneously immortalized cell line Norway rat CVCL_A7NZ CL:0000010 Derived from site: In situ; Embryonic tooth bud, dental papilla, incisor; UBERON=UBERON_0003317; Breed/subspecies: Wistar; RS=RS_0000955. Unspecified Doubling time: ~19 hours (PubMed=293368) 127229304 CVCL_A7NY VMCs transformed cell line house mouse CVCL_A7NY CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339; Cell type: Osteoblast; CL=CL_0000062; Breed/subspecies: BALB/c. Doubling time: ~15 hours (PubMed=8228520) 127229305 CVCL_A7LL RUCDRi002-A-10 induced pluripotent stem cell human CVCL_A7LL From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229306 CVCL_A7LK RUCDRi002-A-9 induced pluripotent stem cell human CVCL_A7LK From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229307 CVCL_A7LN RUCDRi002-A-12 induced pluripotent stem cell human CVCL_A7LN From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229308 CVCL_A7LM RUCDRi002-A-11 induced pluripotent stem cell human CVCL_A7LM From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229309 CVCL_A7LP RUCDRi002-A-13 induced pluripotent stem cell human CVCL_A7LP From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229310 CVCL_A7LR RUCDRi002-A-15 induced pluripotent stem cell human CVCL_A7LR From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9) Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male Characteristics: Using CRISPR/Cas9 a dCas9-VPR-2A-tdTomato-WPRE construct containing dCas9 fused to heterotrimeric VPR transactivator consisting of VP64, p65, and RTA domains along with a tdTomato and a woodchuck hepatitis post-transcriptional regulatory element (WPRE) was introduced in the AAVS1 safe harbor locus (PubMed=34481190) 127229311 CVCL_A7LQ RUCDRi002-A-14 induced pluripotent stem cell human CVCL_A7LQ From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229312 CVCL_A7LD RUCDRi002-A-1 induced pluripotent stem cell human CVCL_A7LD From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229313 CVCL_A7LC DMBi001-A-1 induced pluripotent stem cell human CVCL_A7LC From: Department of Medical Biotechnology, Jagiellonian University; Krakow; Poland CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6482; LAMA2 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229314 CVCL_A7LF RUCDRi002-A-3 induced pluripotent stem cell human CVCL_A7LF From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229315 CVCL_A7LE RUCDRi002-A-2 induced pluripotent stem cell human CVCL_A7LE From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229316 CVCL_A7LH RUCDRi002-A-6 induced pluripotent stem cell human CVCL_A7LH From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229317 CVCL_A7LG RUCDRi002-A-4 induced pluripotent stem cell human CVCL_A7LG From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229318 CVCL_A7LJ RUCDRi002-A-8 induced pluripotent stem cell human CVCL_A7LJ From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229319 CVCL_A7LI RUCDRi002-A-7 induced pluripotent stem cell human CVCL_A7LI From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229320 CVCL_A7KZ UNIMGi003-A induced pluripotent stem cell human CVCL_A7KZ From: Universita degli Studi Magna Graecia di Catanzaro; Catanzaro; Italy CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2482; CSTB; Repeat_expansion; c.-210CCCCGCCCCGCG[(2_3)]; ClinVar=VCV000008398; Zygosity=Unspecified (PubMed=33865103) Population: Caucasian; Italian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229321 CVCL_A7LB CMC-hiPSC-022 induced pluripotent stem cell human CVCL_A7LB From: Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea; Seoul; South Korea CL:0000010 Population: Korean; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq; Omics: Variations; SNP array analysis 127229322 CVCL_A7LA UNIMGi004-A induced pluripotent stem cell human CVCL_A7LA From: Universita degli Studi Magna Graecia di Catanzaro; Catanzaro; Italy CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2482; CSTB; Repeat_expansion; c.-210CCCCGCCCCGCG[(2_3)]; ClinVar=VCV000008398; Zygosity=Unspecified (PubMed=33865103) Population: Caucasian; Italian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229323 CVCL_A7KS WMUi031-A induced pluripotent stem cell human CVCL_A7KS From: Wenzhou Medical University; Wenzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:8108; OCRL; Simple; p.Met876Asnfs (c.2626dupA); Zygosity=Hemizygous (PubMed=33765594) Population: Chinese; Han; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male 127229324 CVCL_A7KR SCVIi011-A induced pluripotent stem cell human CVCL_A7KR From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Leu987Argfs*70 (c.2960delT); ClinVar=VCV000943648; Zygosity=Heterozygous (PubMed=34051449) Population: Latino or Hispanic; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229325 CVCL_A7KU ZNHi001-B induced pluripotent stem cell human CVCL_A7KU From: Zhongnan Hospital of Wuhan University; Wuhan; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:16627; CHEK2; Simple; p.Arg180Cys (c.538C>T) (p.Arg223Cys, c.667C>T); ClinVar=VCV000128081; Zygosity=Heterozygous (PubMed=33780728) Population: Asian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229326 CVCL_A7KT ZNHi001-A induced pluripotent stem cell human CVCL_A7KT From: Zhongnan Hospital of Wuhan University; Wuhan; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:16627; CHEK2; Simple; p.Arg180Cys (c.538C>T) (p.Arg223Cys, c.667C>T); ClinVar=VCV000128081; Zygosity=Heterozygous (PubMed=33780728) Population: Asian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229327 CVCL_A7KW REGUi013-A induced pluripotent stem cell human CVCL_A7KW From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France CL:0000010 Population: Caucasian; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540. Omics: Variations; Array-based CGH Male 127229328 CVCL_A7KV REGUi012-A induced pluripotent stem cell human CVCL_A7KV From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France CL:0000010 Population: Caucasian; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540. Omics: Variations; Array-based CGH Male 127229329 CVCL_A7KY REGUi011-A induced pluripotent stem cell human CVCL_A7KY From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France. CL:0000010 127229330 CVCL_A7KX REGUi014-A induced pluripotent stem cell human CVCL_A7KX From: Institute for Regenerative Medecine and Biotherapy; Montpellier; France CL:0000010 Population: Caucasian; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540. Omics: Variations; Array-based CGH Male 127229331 CVCL_A7MM IMGTi003-B induced pluripotent stem cell human CVCL_A7MM From: Research Institute of Medical Genetics; Tomsk; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Caution: We assigned the IMGTi003-B name for consistency with the IMGTi003-A cell line 127229332 CVCL_A7ML TAF11 finite cell line human CVCL_A7ML CL:0000010 Population: Caucasian; Karyotypic information: 46,XY,r(8)(p23;q24.3); 45,XY,-8 (PubMed=33070101); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH Male 127229333 CVCL_A7MN IMGTi003-C induced pluripotent stem cell human CVCL_A7MN From: Research Institute of Medical Genetics; Tomsk; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Caution: We assigned the IMGTi003-C name for consistency with the IMGTi003-A cell line 127229334 CVCL_A7MQ ICGi024-B induced pluripotent stem cell human CVCL_A7MQ From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH; Omics: Variations; SNP array analysis Male Caution: We assigned the ICGi024-B name for consistency with the ICGi024-A cell line 127229335 CVCL_A7MP IMGTi003-D induced pluripotent stem cell human CVCL_A7MP From: Research Institute of Medical Genetics; Tomsk; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Caution: We assigned the IMGTi003-D name for consistency with the IMGTi003-A cell line 127229336 CVCL_A7MS TAF12 finite cell line human CVCL_A7MS CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH Male 127229337 CVCL_A7MR ICGi024-C induced pluripotent stem cell human CVCL_A7MR From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH; Omics: Variations; SNP array analysis Male Caution: We assigned the ICGi024-C name for consistency with the ICGi024-A cell line 127229338 CVCL_A7ME PER.C6 TetR transformed cell line human CVCL_A7ME From: Johnson & Johnson Janssen; Beerse; Belgium CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1); Derived from site: In situ; Fetal eye, retina; UBERON=UBERON_0003072; Cell type: Retinoblast; CL=CL_4023129. Biotechnology: Used for the production of the Janssen SARS-CoV-2 (COVID-19) vaccine (Trade name: Ad26.COV2.S) (DrugBank=DB15857) In the context of the vaccine production, the tetR repressor blocks the expression of the SARS-CoV-2 spike protein gene during production of the recombinant adenoviral vector, thereby optimising vector production. Unspecified Group: Vaccine production cell line 127229339 CVCL_A7MD WTC-mEGFP-TERF2-cl25 induced pluripotent stem cell human CVCL_A7MD CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP) Population: Japanese; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Using CRISPR/Cas9 TERF2 has been endogenously tagged in one allele at the N-terminus with mEGFP Part of: Allen Cell Collection 127229340 CVCL_A7MG ICGi025-B induced pluripotent stem cell human CVCL_A7MG From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH; Omics: Variations; SNP array analysis Male Caution: We assigned the ICGi025-B name for consistency with the ICGi025-A cell line 127229341 CVCL_A7MF CCA-OF cancer cell line CVCL_A7MF CL:0000010 Transformant: ChEBI; CHEBI_35807; N-nitrosodimethylamine (NDMA; Dimethylnitrosamine; DMN); Transformant: NCBI_TaxID; 147828; Opisthorchis felineus. Male Characteristics: Obtained by both Opisthorchis felineus infection and N-nitrosodimethylamine treatment (PubMed=33862109) Doubling time: 23.2 +- 2.7 hours (PubMed=33862109) 127229342 CVCL_A7MI ICGi025-D induced pluripotent stem cell human CVCL_A7MI From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH; Omics: Variations; SNP array analysis Male Caution: We assigned the ICGi025-D name for consistency with the ICGi025-A cell line 127229343 CVCL_A7MH ICGi025-C induced pluripotent stem cell human CVCL_A7MH From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH; Omics: Variations; SNP array analysis Male Caution: We assigned the ICGi025-C name for consistency with the ICGi025-A cell line 127229344 CVCL_A7MK ICGi025-F induced pluripotent stem cell human CVCL_A7MK From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH; Omics: Variations; SNP array analysis Male Caution: We assigned the ICGi025-F name for consistency with the ICGi025-A cell line 127229345 CVCL_A7MJ ICGi025-E induced pluripotent stem cell human CVCL_A7MJ From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH; Omics: Variations; SNP array analysis Male Caution: We assigned the ICGi025-E name for consistency with the ICGi025-A cell line 127229346 CVCL_A7MA RUCDRi002-A-24 induced pluripotent stem cell human CVCL_A7MA From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229347 CVCL_A7MC FAHZUi001-A induced pluripotent stem cell human CVCL_A7MC From: The First Affiliated Hospital of Zhejiang University School of Medicine; Hangzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:22947; NLRP7; Simple; p.Gln421Ter (c.1261C>T); Zygosity=Homozygous (PubMed=34087990) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229348 CVCL_A7MB RUCDRi002-A-25 induced pluripotent stem cell human CVCL_A7MB From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229349 CVCL_A7LT RUCDRi002-A-17 induced pluripotent stem cell human CVCL_A7LT From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9) Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male Characteristics: Using CRISPR/Cas9 a CAG-dCas9-KRAB-T2A-tdTomato-WPRE construct was introduced in the AAVS1 safe harbor locus 127229350 CVCL_A7LS RUCDRi002-A-16 induced pluripotent stem cell human CVCL_A7LS From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9) Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male Characteristics: Using CRISPR/Cas9 a CAG-dCas9-KRAB-T2A-tdTomato-EF1a-puroR construct was introduced in the AAVS1 safe harbor locus 127229351 CVCL_A7LV RUCDRi002-A-19 induced pluripotent stem cell human CVCL_A7LV From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP) Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male Characteristics: Using CRISPR/Cas9 TTN was tagged at the C-terminus with mEGFP 127229352 CVCL_A7LU RUCDRi002-A-18 induced pluripotent stem cell human CVCL_A7LU From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229353 CVCL_A7LX RUCDRi002-A-21 induced pluripotent stem cell human CVCL_A7LX From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229354 CVCL_A7LW RUCDRi002-A-20 induced pluripotent stem cell human CVCL_A7LW From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229355 CVCL_A7LZ RUCDRi002-A-23 induced pluripotent stem cell human CVCL_A7LZ From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229356 CVCL_A7LY RUCDRi002-A-22 induced pluripotent stem cell human CVCL_A7LY From: University Medical Center Goettingen; Goettingen; Germany CL:0000010 Population: Hispanic; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229357 CVCL_A7JJ TMPi002-A induced pluripotent stem cell human CVCL_A7JJ From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Female 127229358 CVCL_A7JI TMPi001-B induced pluripotent stem cell human CVCL_A7JI From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Male 127229359 CVCL_A7JL TMPi003-A induced pluripotent stem cell human CVCL_A7JL From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Male 127229360 CVCL_A7JK TMPi002-B induced pluripotent stem cell human CVCL_A7JK From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Female 127229361 CVCL_A7JN TMPi004-A induced pluripotent stem cell human CVCL_A7JN From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Female 127229362 CVCL_A7JM TMPi003-B induced pluripotent stem cell human CVCL_A7JM From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Male 127229363 CVCL_A7JP TMPi004-B induced pluripotent stem cell human CVCL_A7JP From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Female 127229364 CVCL_A7JB IGIBi007-A induced pluripotent stem cell human CVCL_A7JB From: Institute of Genomics and Integrative Biology (CSIR-IGIB); New Delhi; India CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9416; PRKG2; Simple; p.Asn164Lysfs*2 (c.491dup); ClinVar=VCV001326258; Zygosity=Homozygous (PubMed=33887582) Population: Indian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229365 CVCL_A7JA VRISGi001-A induced pluripotent stem cell human CVCL_A7JA From: Vinmec Research Insitute of Stem Cell and Gene Technology; Hanoi; Vietnam CL:0000010 Population: Southeast Asian; Vietnamese; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female 127229366 CVCL_A7JD JSPHi001-A induced pluripotent stem cell human CVCL_A7JD From: Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University; Nanjing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg335Trp (c.1003C>T); ClinVar=VCV000036473; Zygosity=Heterozygous (PubMed=33887581) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229367 CVCL_A7JC PLAFMCi004-A induced pluripotent stem cell human CVCL_A7JC From: Chinese PLA General Hospital; Beijing; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229368 CVCL_A7JF SDUBMSi011-A induced pluripotent stem cell human CVCL_A7JF From: School of Basic Medical Sciences, Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:20323; SMOC2; Simple; p.Leu359Arg (c.1076T>G); Zygosity=Heterozygous (PubMed=33892290) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229369 CVCL_A7JE HEBHMUi007-A induced pluripotent stem cell human CVCL_A7JE From: Hebei Medical University; Shijiazhuang; China CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229370 CVCL_A7JH TMPi001-A induced pluripotent stem cell human CVCL_A7JH From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Male 127229371 CVCL_A7JG CIBi009-A induced pluripotent stem cell human CVCL_A7JG From: Cell Inspire Biotechnology; Shenzhen; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:603; APOB; Simple; p.Asp540Tyr (c.1618G>T); ClinVar=VCV000925431; Zygosity=Heterozygous (PubMed=33892292); Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Leu414Arg (c.1241T>G); ClinVar=VCV000251747; Zygosity=Heterozygous (PubMed=33892292) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229372 CVCL_A7IY FLENIi001-A induced pluripotent stem cell human CVCL_A7IY From: Fundacion para la Lucha contra las Enfermedades Neurologicas de la Infancia; Buenos Aires; Argentina CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Thr119Ile (c.356C>T); ClinVar=VCV000625849; Zygosity=Heterozygous (PubMed=33839546) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229373 CVCL_A7IX HEBHMUi006-A induced pluripotent stem cell human CVCL_A7IX From: Hebei Medical University; Shijiazhuang; China CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: hPSCreg; HEBHMUi006-A; true Male 127229374 CVCL_A7IZ PUMCHi014-A induced pluripotent stem cell human CVCL_A7IZ From: Peking Union Medical College Hospital; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:23198; CYP4V2; Simple; c.802-8_810del17insGC (IVS6-8 del/insGC); ClinVar=VCV000039271; Zygosity=Heterozygous (PubMed=33857831); Sequence variation: Mutation; HGNC; HGNC:23198; CYP4V2; Simple; p.Trp340Ter (c.1020G>A); ClinVar=VCV000039248; Zygosity=Heterozygous (PubMed=33857831) Population: Chinese; Han; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229375 CVCL_A7IQ SHCDNi005-A induced pluripotent stem cell human CVCL_A7IQ From: Shanghai Children's Hospital, Shanghai Jiao Tong University; Shanghai; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:18060; ARX; Simple; p.Gln503Alafs*28 (c.1507_1508del); Zygosity=Hemizygous (PubMed=34968892) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229376 CVCL_A7IP CSUASOi007-A induced pluripotent stem cell human CVCL_A7IP From: Central South University, Aier School of Ophthalmology; Changsha; China. CL:0000010 127229377 CVCL_A7IS CMES40-OC embryonic stem cell CVCL_A7IS CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; TWJXO; mCerulean3 (Note=Bright cyan fluorescent protein derived from GFP); Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Using CRISPR/Cas9 a P2A-mCerulean3-T2A-PuroR construct was knocked in at the c-terminus of one allele of POU5F1/OCT4 (PubMed=33799281) Group: Non-human primate cell line 127229378 CVCL_A7IR 46C-Dip2c KO embryonic stem cell house mouse CVCL_A7IR CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1920179; Dip2c; Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)); Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: 129P2/Ola. Male Characteristics: Using CRISPR/Cas9 exon 8 of Dip2c was replaced by a PGKp-PuroR-P2A-mCherry construct (PubMed=33813174); Characteristics: Using homologous recombination the Sox1 reading frame was replaced by a GFP-IRES-PuroR construct Expresses eGFP under the control of the Sox-1 promoter (from parent cell line 46C). 127229379 CVCL_A7IU UALGi002-A induced pluripotent stem cell human CVCL_A7IU From: Universidade do Algarve; Faro; Portugal CL:0000010 Population: Caucasian; Portuguese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229380 CVCL_A7IT SYSUe008-A embryonic stem cell human CVCL_A7IT From: Sun Yat-sen University; Guangzhou; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24865; GPAM Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127229381 CVCL_A7IW PUMCSMi001-A induced pluripotent stem cell human CVCL_A7IW From: School of Basic Medicine, Peking Union Medical College; Beijing; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229382 CVCL_A7IV UALGi001-A induced pluripotent stem cell human CVCL_A7IV From: Universidade do Algarve; Faro; Portugal CL:0000010 Population: Caucasian; Portuguese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229383 CVCL_A7KK BCHi006-B induced pluripotent stem cell human CVCL_A7KK From: Children's Hospital Boston; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11411; CDKL5; Simple; p.Asp471Glufs*37 (c.1412delA); Zygosity=Heterozygous (PubMed=33714067) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229384 CVCL_A7KJ BCHi006-A induced pluripotent stem cell human CVCL_A7KJ From: Children's Hospital Boston; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11411; CDKL5; Simple; p.Asp471Glufs*37 (c.1412delA); Zygosity=Heterozygous (PubMed=33714067) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229385 CVCL_A7KM SCVIi007-A induced pluripotent stem cell human CVCL_A7KM From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Arg1712Gln (c.5135G>A); ClinVar=VCV000036642; Zygosity=Heterozygous (PubMed=34352619) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229386 CVCL_A7KL SCVIi006-A induced pluripotent stem cell human CVCL_A7KL From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Glu1356Lys (c.4066G>A); ClinVar=VCV000164294; Zygosity=Heterozygous (PubMed=34352619) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229387 CVCL_A7KN SCVIi008-A induced pluripotent stem cell human CVCL_A7KN From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Arg723Cys (c.2167C>T); ClinVar=VCV000014095; Zygosity=Heterozygous (PubMed=34352619) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229388 CVCL_A7KQ SCVIi010-A induced pluripotent stem cell human CVCL_A7KQ From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Ser624Cys (c.1870A>T); ClinVar=VCV000644725; Zygosity=Heterozygous (PubMed=34051449) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229389 CVCL_A7KP SCVIi009-A induced pluripotent stem cell human CVCL_A7KP From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Gly572Ser (c.1714G>A); ClinVar=VCV000067248; Zygosity=Heterozygous (PubMed=34051449) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229390 CVCL_A7KC BCHi002-B induced pluripotent stem cell human CVCL_A7KC From: Children's Hospital Boston; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11411; CDKL5; Simple; p.Arg558Thrfs*9 (c.1671dupA) (c.1671_1672insA); ClinVar=VCV000156643; Zygosity=Heterozygous (PubMed=33714067) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229391 CVCL_A7KB BCHi002-A induced pluripotent stem cell human CVCL_A7KB From: Children's Hospital Boston; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11411; CDKL5; Simple; p.Arg558Thrfs*9 (c.1671dupA) (c.1671_1672insA); ClinVar=VCV000156643; Zygosity=Heterozygous (PubMed=33714067) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229392 CVCL_A7KE BCHi003-B induced pluripotent stem cell human CVCL_A7KE From: Children's Hospital Boston; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11411; CDKL5; Simple; p.Leu629Ter (c.1886T>A); Zygosity=Mosaic (PubMed=33714067) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229393 CVCL_A7KD BCHi003-A induced pluripotent stem cell human CVCL_A7KD From: Children's Hospital Boston; Boston; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Established from a patient that is mosaic for a CDKL5 p.Leu629Ter mutation, but this cell line does not contain this mutation 127229394 CVCL_A7KG BCHi004-B induced pluripotent stem cell human CVCL_A7KG From: Children's Hospital Boston; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11411; CDKL5; Simple; p.Asp135Gly (c.404A>G); Zygosity=Mosaic (PubMed=33714067) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229395 CVCL_A7KF BCHi004-A induced pluripotent stem cell human CVCL_A7KF From: Children's Hospital Boston; Boston; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Established from a patient that is mosaic for a CDKL5 p.Asp135Gly mutation, but this cell line does not contain this mutation 127229396 CVCL_A7KI BCHi005-B induced pluripotent stem cell human CVCL_A7KI From: Children's Hospital Boston; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11411; CDKL5; Simple; p.Arg550Ter (c.1648C>T); ClinVar=VCV000143780; Zygosity=Heterozygous (PubMed=33714067) Population: Latino or Hispanic; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229397 CVCL_A7KH BCHi005-A induced pluripotent stem cell human CVCL_A7KH From: Children's Hospital Boston; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11411; CDKL5; Simple; p.Arg550Ter (c.1648C>T); ClinVar=VCV000143780; Zygosity=Heterozygous (PubMed=33714067) Population: Latino or Hispanic; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229398 CVCL_A7JZ BCHi001-A induced pluripotent stem cell human CVCL_A7JZ From: Children's Hospital Boston; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11411; CDKL5; Simple; p.Val718Met (c.2152G>A); ClinVar=VCV000143796; Zygosity=Mosaic (PubMed=33714067) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229399 CVCL_A7JY TMPi009-B induced pluripotent stem cell human CVCL_A7JY From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229400 CVCL_A7KA BCHi001-B induced pluripotent stem cell human CVCL_A7KA From: Children's Hospital Boston; Boston; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Established from a patient that is mosaic for a CDKL5 p.Val718Met mutation, but this cell line does not contain this mutation 127229401 CVCL_A7JR TMPi005-B induced pluripotent stem cell human CVCL_A7JR From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Male 127229402 CVCL_A7JQ TMPi005-A induced pluripotent stem cell human CVCL_A7JQ From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Male 127229403 CVCL_A7JT TMPi006-B induced pluripotent stem cell human CVCL_A7JT From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Male 127229404 CVCL_A7JS TMPi006-A induced pluripotent stem cell human CVCL_A7JS From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Male 127229405 CVCL_A7JV TMPi007-B induced pluripotent stem cell human CVCL_A7JV From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Male 127229406 CVCL_A7JU TMPi007-A induced pluripotent stem cell human CVCL_A7JU From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Hair; UBERON=UBERON_0001037; Cell type: Keratinocyte; CL=CL_0000312. Male 127229407 CVCL_A7JX TMPi009-A induced pluripotent stem cell human CVCL_A7JX From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229408 CVCL_A7JW TMPi008-A induced pluripotent stem cell human CVCL_A7JW From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229409 CVCL_A7XX 58F8dc1 hybridoma Norway rat CVCL_A7XX CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P50489; Plasmodium falciparum (isolate Camp / Malaysia) apical membrane antigen 1 (AMA-1). Group: Malaria research cell line 127229410 CVCL_A7XW 28G2dc1 hybridoma Norway rat CVCL_A7XW CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P50489; Plasmodium falciparum (isolate Camp / Malaysia) apical membrane antigen 1 (AMA-1). Group: Malaria research cell line 127229411 CVCL_A7XZ N1-2A8 hybridoma house mouse CVCL_A7XZ From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O96555; Plasmodium vivax ookinete surface protein (Pvs25). Group: Malaria research cell line 127229412 CVCL_A7XY N1-1H10 hybridoma house mouse CVCL_A7XY From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O96555; Plasmodium vivax ookinete surface protein (Pvs25). Group: Malaria research cell line 127229413 CVCL_A7XP BoMaMa-J2imm Tlr4-/- transformed cell line house mouse CVCL_A7XP From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:96824; Tlr4 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229414 CVCL_A7XR BoMaMa-J2imm Tlr7-/- transformed cell line house mouse CVCL_A7XR From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:2176882; Tlr7 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229415 CVCL_A7XQ BoMaMa-J2imm Tlr6-/- transformed cell line house mouse CVCL_A7XQ From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1341296; Tlr6 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229416 CVCL_A7XT BoMaMa-J2imm Tlr9-/- GFP transformed cell line house mouse CVCL_A7XT From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1932389; Tlr9; Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229417 CVCL_A7XS BoMaMa-J2imm Tlr9-/- transformed cell line house mouse CVCL_A7XS From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1932389; Tlr9 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229418 CVCL_A7XV 23A3dc1 hybridoma Norway rat CVCL_A7XV CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P50489; Plasmodium falciparum (isolate Camp / Malaysia) apical membrane antigen 1 (AMA-1). Group: Malaria research cell line 127229419 CVCL_A7XU 19H8dc1 hybridoma Norway rat CVCL_A7XU CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P04934; Plasmodium falciparum (isolate Camp / Malaysia) merozoite surface protein 1 (MSP1). Group: Malaria research cell line 127229420 CVCL_A7XH BoMaMa-J2imm Ticam2-/- transformed cell line house mouse CVCL_A7XH From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:3040056; Ticam2 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229421 CVCL_A7XG BoMaMa-J2imm Ticam1-/- Ticam2-/- transformed cell line house mouse CVCL_A7XG From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:2147032; Ticam1; Knockout cell: Method=KO mouse; MGI; MGI:3040056; Ticam2 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229422 CVCL_A7XJ BoMaMa-J2imm Tlr1-/- transformed cell line house mouse CVCL_A7XJ From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1341295; Tlr1 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229423 CVCL_A7XI BoMaMa-J2imm Tirap-/- transformed cell line house mouse CVCL_A7XI From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:2152213; Tirap Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229424 CVCL_A7XL BoMaMa-J2imm Tlr2-/- Tlr4-/- transformed cell line house mouse CVCL_A7XL From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1346060; Tlr2; Knockout cell: Method=KO mouse; MGI; MGI:96824; Tlr4 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229425 CVCL_A7XK BoMaMa-J2imm Tlr2-/- transformed cell line house mouse CVCL_A7XK From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1346060; Tlr2 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229426 CVCL_A7XN BoMaMa-J2imm Tlr3-/- transformed cell line house mouse CVCL_A7XN From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:2156367; Tlr3 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229427 CVCL_A7XM BoMaMa-J2imm Tlr2-/- Tlr9-/- transformed cell line house mouse CVCL_A7XM From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1346060; Tlr2; Knockout cell: Method=KO mouse; MGI; MGI:1932389; Tlr9 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229428 CVCL_A7XB BoMaMa-J2imm Irf3-/- Irf7-/- transformed cell line house mouse CVCL_A7XB From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1859179; Irf3; Knockout cell: Method=KO mouse; MGI; MGI:1859212; Irf7 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229429 CVCL_A7XA BoMaMa-J2imm Irf3-/- transformed cell line house mouse CVCL_A7XA From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1859179; Irf3 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229430 CVCL_A7XD BoMaMa-J2imm Myd88-/- transformed cell line house mouse CVCL_A7XD From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:108005; Myd88 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229431 CVCL_A7XC BoMaMa-J2imm Irf7-/- transformed cell line house mouse CVCL_A7XC From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1859212; Irf7 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229432 CVCL_A7XF BoMaMa-J2imm Ticam1-/- transformed cell line house mouse CVCL_A7XF From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:2147032; Ticam1 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229433 CVCL_A7XE BoMaMa-J2imm Myd88-/- Ticam1-/- transformed cell line house mouse CVCL_A7XE From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:108005; Myd88; Knockout cell: Method=KO mouse; MGI; MGI:2147032; Ticam1 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229434 CVCL_A7YY 293/mNOD2 transformed cell line human CVCL_A7YY CL:0000010 Genetic integration: Method=Transfection; Gene=MGI; MGI:2429397; Nod2; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 127229435 CVCL_A7YX 293/hNOD2 transformed cell line human CVCL_A7YX CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5331; NOD2; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 127229436 CVCL_A7YZ HEK-Blue Null2-k transformed cell line human CVCL_A7YZ CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-null2k) 127229437 CVCL_A7YQ HEK-Blue hNOD1 transformed cell line human CVCL_A7YQ CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16390; NOD1; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-hnod1) 127229438 CVCL_A7YP HEK-Blue Null1 transformed cell line human CVCL_A7YP CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-null1) 127229439 CVCL_A7YS HEK-Blue mNOD1 transformed cell line human CVCL_A7YS CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=MGI; MGI:1341839; Nod1; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-mnod1) 127229440 CVCL_A7YR HEK-Blue hNOD2 transformed cell line human CVCL_A7YR CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5331; NOD2; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Discontinued: InvivoGen; hkb-hnod2; true Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (Invivogen=hkb-hnod2) 127229441 CVCL_A7YU 293/Null transformed cell line human CVCL_A7YU CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 127229442 CVCL_A7YT HEK-Blue mNOD2 transformed cell line human CVCL_A7YT CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=MGI; MGI:2429397; Nod2; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-mnod2) 127229443 CVCL_A7YW 293/mNOD1 transformed cell line human CVCL_A7YW CL:0000010 Genetic integration: Method=Transfection; Gene=MGI; MGI:1341839; Nod1; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 127229444 CVCL_A7YV 293/hNOD1 transformed cell line human CVCL_A7YV CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16390; NOD1; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 127229445 CVCL_A7YI 293-SARS2-S transformed cell line human CVCL_A7YI CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stable expression of the SARS-CoV-2 spike protein For optimal expression, the C-terminal ER-retention signal has been removed. Has a functional furin cleavage site. Recommended for cell-cell fusion assays with ACE2-expressing cells (InvivoGen=293-cov2-s). Group: SARS-CoV-2 research cell line 127229446 CVCL_A7YH 297-17 hybridoma house mouse CVCL_A7YH CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Plasmodium sp thrombospondin-related anonymous protein (TRAP) (Note=Immunized with a synthetic peptide).. Group: Malaria research cell line 127229447 CVCL_A7YK HEK-Blue hACE2 transformed cell line human CVCL_A7YK CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13557; ACE2; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (Invivogen=hkb-hace2) Group: SARS-CoV-2 research cell line 127229448 CVCL_A7YJ 293-SARS2-S-dfur transformed cell line human CVCL_A7YJ CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stable expression of the SARS-CoV-2 spike protein with an inactive furin (dfur) cleavage site facilitating improved surface expression and detection for flow cytometry For optimal expression, the C-terminal ER-retention signal has been removed (InvivoGen=293-cov2-sdf). Group: SARS-CoV-2 research cell line 127229449 CVCL_A7YM HEK-Blue Null2 transformed cell line human CVCL_A7YM CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IL12 p40 minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-null2) 127229450 CVCL_A7YL HEK-Blue Null1-v transformed cell line human CVCL_A7YL CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-null1v) 127229451 CVCL_A7YN HEK-Blue Null1-k transformed cell line human CVCL_A7YN CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB and AP-1-binding sites (InvivoGen=hkb-null1k) 127229452 CVCL_A7YA N1-1A5 hybridoma house mouse CVCL_A7YA From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: IgG2; Monoclonal antibody target: UniProtKB; A0A024V850; Plasmodium falciparum (isolate FVO) merozoite surface protein 1 (MSP1) (Note=19 kDa fragment Also reacts with isolate 3D7).. Group: Malaria research cell line 127229453 CVCL_A7YC S1-1G3 hybridoma house mouse CVCL_A7YC From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; A0A024V850; Plasmodium falciparum (isolate FVO) merozoite surface protein 1 (MSP1) (Note=42 kDa fragment). Group: Malaria research cell line 127229454 CVCL_A7YB S1-1D7 hybridoma house mouse CVCL_A7YB From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; A0A024V850; Plasmodium falciparum (isolate FVO) merozoite surface protein 1 (MSP1) (Note=42 kDa fragment). Group: Malaria research cell line 127229455 CVCL_A7YE S1-4A4 hybridoma house mouse CVCL_A7YE From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; A0A024V850; Plasmodium falciparum (isolate FVO) merozoite surface protein 1 (MSP1) (Note=42 kDa fragment). Group: Malaria research cell line 127229456 CVCL_A7YD S1-3D6 hybridoma house mouse CVCL_A7YD From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; A0A024V850; Plasmodium falciparum (isolate FVO) merozoite surface protein 1 (MSP1) (Note=19 kDa fragment Also reacts with isolate 3D7).. Group: Malaria research cell line 127229457 CVCL_A7YG 141-32 hybridoma house mouse CVCL_A7YG CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Plasmodium sp thrombospondin-related anonymous protein (TRAP) (Note=Immunized with a synthetic peptide).. Group: Malaria research cell line 127229458 CVCL_A7YF 250-30 hybridoma house mouse CVCL_A7YF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Plasmodium sp thrombospondin-related anonymous protein (TRAP) (Note=Immunized with a synthetic peptide).. Group: Malaria research cell line 127229459 CVCL_A7VV N3-1D7 hybridoma house mouse CVCL_A7VV From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q7KQK5; Plasmodium falciparum apical membrane antigen 1 (AMA-1). Group: Malaria research cell line 127229460 CVCL_A7VU N3-1C8 hybridoma house mouse CVCL_A7VU From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q7KQK5; Plasmodium falciparum apical membrane antigen 1 (AMA-1). Group: Malaria research cell line 127229461 CVCL_A7VX N4-1F6 hybridoma house mouse CVCL_A7VX From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q7KQK5; Plasmodium falciparum apical membrane antigen 1 (AMA-1). Group: Malaria research cell line 127229462 CVCL_A7VW N3-2D9 hybridoma house mouse CVCL_A7VW From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q7KQK5; Plasmodium falciparum apical membrane antigen 1 (AMA-1). Group: Malaria research cell line 127229463 CVCL_A7VZ N4-2E3 hybridoma house mouse CVCL_A7VZ From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q7KQK5; Plasmodium falciparum apical membrane antigen 1 (AMA-1). Group: Malaria research cell line 127229464 CVCL_A7VY N4-1G6 hybridoma house mouse CVCL_A7VY From: Long, Carole A.; National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rockville; USA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q7KQK5; Plasmodium falciparum apical membrane antigen 1 (AMA-1). Group: Malaria research cell line 127229465 CVCL_A7VN 4C1 [Mouse hybridoma against P.falciparum csp] hybridoma house mouse CVCL_A7VN CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P02893; Plasmodium falciparum circumsporozoite protein. Group: Malaria research cell line 127229466 CVCL_A7VM 3D3 [Mouse hybridoma against P.falciparum csp] hybridoma house mouse CVCL_A7VM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P02893; Plasmodium falciparum circumsporozoite protein. Group: Malaria research cell line 127229467 CVCL_A7VP 4C6 [Mouse hybridoma against P.falciparum csp] hybridoma house mouse CVCL_A7VP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P02893; Plasmodium falciparum circumsporozoite protein. Group: Malaria research cell line 127229468 CVCL_A7VR 2F2 [Mouse hybridoma against P.vivax csp] hybridoma house mouse CVCL_A7VR CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P08677; Plasmodium vivax (strain Belem) circumsporozoite protein (CS) (Note=Also reacts with other strains). Group: Malaria research cell line 127229469 CVCL_A7VQ 2D4 [Mouse hybridoma against P.falciparum csp] hybridoma house mouse CVCL_A7VQ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P02893; Plasmodium falciparum circumsporozoite protein. Group: Malaria research cell line 127229470 CVCL_A7VT 2E10.2 hybridoma house mouse CVCL_A7VT CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: UniProtKB; P08677; Plasmodium vivax (strain Belem) circumsporozoite protein (CS) (Note=Also reacts with other strains). Group: Malaria research cell line 127229471 CVCL_A7VS LET1 transformed cell line house mouse CVCL_A7VS CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Epithelial cell; CL=CL_0000066; Breed/subspecies: C57BL/6. Virology: Supports spreading influenza virus infection in the absence of exogenous protease (PubMed=24243730) Doubling time: <24 hours (PubMed=24243730) 127229472 CVCL_A7VF SeGB spontaneously immortalized cell line CVCL_A7VF CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified Characteristics: Can grow at temperatures ranging from 15 to 32 Celsius (DOI=10.3147/jsfp.56.22) Group: Fish cell line 127229473 CVCL_A7VE 3D11 [Mouse hybridoma against P.berghei csp] hybridoma house mouse CVCL_A7VE CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P06915; Plasmodium berghei circumsporozoite protein. Group: Malaria research cell line 127229474 CVCL_A7VH SeGE-22 spontaneously immortalized cell line CVCL_A7VH CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Unspecified Characteristics: Can grow at temperatures ranging from 25 to 32 Celsius (DOI=10.3147/jsfp.56.22) Group: Fish cell line 127229475 CVCL_A7VG SeGE-12 spontaneously immortalized cell line CVCL_A7VG CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Unspecified Characteristics: Can grow at temperatures ranging from 25 to 32 Celsius (DOI=10.3147/jsfp.56.22) Group: Fish cell line 127229476 CVCL_A7VJ 2A10 [Mouse hybridoma against P.falciparum csp] hybridoma house mouse CVCL_A7VJ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P02893; Plasmodium falciparum circumsporozoite protein. Group: Malaria research cell line 127229477 CVCL_A7VI SeGF spontaneously immortalized cell line CVCL_A7VI CL:0000010 Derived from site: In situ; Fin; UBERON=UBERON_0008897. Unspecified Characteristics: Can grow at temperatures ranging from 15 to 32 Celsius (DOI=10.3147/jsfp.56.22) Group: Fish cell line 127229478 CVCL_A7VL 3C2 [Mouse hybridoma against P.falciparum csp] hybridoma house mouse CVCL_A7VL CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P02893; Plasmodium falciparum circumsporozoite protein. Group: Malaria research cell line 127229479 CVCL_A7VK 3C1 [Mouse hybridoma against P.falciparum csp] hybridoma house mouse CVCL_A7VK CL:0000010 Monoclonal antibody isotype: IgG3; Monoclonal antibody target: UniProtKB; P02893; Plasmodium falciparum circumsporozoite protein. Group: Malaria research cell line 127229480 CVCL_A7VB OUMS-15 transformed cell line human CVCL_A7VB CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Donor information: Established from a patient suffering from Hodgkin lymphoma; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. 127229481 CVCL_A7VA OUMS-14 transformed cell line human CVCL_A7VA CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. 127229482 CVCL_A7VD 3D1 [Mouse hybridoma against monkeypox vCCI] hybridoma house mouse CVCL_A7VD CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q6YLY9; Monkeypox virus (strain MPXV_ZAI1979_005) CC-type chemokine-binding protein (vCCI). 127229483 CVCL_A7VC OUMS-17 transformed cell line human CVCL_A7VC CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Donor information: Established from a patient suffering from a chronic lymphatic leukemia; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. 127229484 CVCL_A7WW BrMi-J2imm Tlr9-/- transformed cell line house mouse CVCL_A7WW From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1932389; Tlr9 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Microglial cell; CL=CL_0000129. 127229485 CVCL_A7WV BrMi-J2imm Tlr7-/- transformed cell line house mouse CVCL_A7WV From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:2176882; Tlr7 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Microglial cell; CL=CL_0000129. 127229486 CVCL_A7WY BoMaMa-J2imm Casp1-/- transformed cell line house mouse CVCL_A7WY From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:96544; Casp1 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229487 CVCL_A7WX BoMaMa-J2imm transformed cell line house mouse CVCL_A7WX From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229488 CVCL_A7WZ BoMaMa-J2imm Cd14-/- transformed cell line house mouse CVCL_A7WZ From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:88318; Cd14 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235. 127229489 CVCL_A7WN BrMi-J2imm Ticam1-/- transformed cell line house mouse CVCL_A7WN From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:2147032; Ticam1 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Microglial cell; CL=CL_0000129. 127229490 CVCL_A7WQ BrMi-J2imm Tlr1-/- transformed cell line house mouse CVCL_A7WQ From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1341295; Tlr1 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Microglial cell; CL=CL_0000129. 127229491 CVCL_A7WP BrMi-J2imm Ticam2-/- transformed cell line house mouse CVCL_A7WP From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:3040056; Ticam2 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Microglial cell; CL=CL_0000129. 127229492 CVCL_A7WS BrMi-J2imm Tlr3-/- transformed cell line house mouse CVCL_A7WS From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:2156367; Tlr3 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Microglial cell; CL=CL_0000129. 127229493 CVCL_A7WR BrMi-J2imm Tlr2-/- transformed cell line house mouse CVCL_A7WR From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1346060; Tlr2 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Microglial cell; CL=CL_0000129. 127229494 CVCL_A7WU BrMi-J2imm Tlr6-/- transformed cell line house mouse CVCL_A7WU From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1341296; Tlr6 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Microglial cell; CL=CL_0000129. 127229495 CVCL_A7WT BrMi-J2imm Tlr4-/- transformed cell line house mouse CVCL_A7WT From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:96824; Tlr4 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Microglial cell; CL=CL_0000129. 127229496 CVCL_A7WG g12 hybridoma house mouse CVCL_A7WG CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q08505; Plasmodium berghei p23-like protein. Group: Malaria research cell line 127229497 CVCL_A7WF c7 hybridoma house mouse CVCL_A7WF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Plasmodium berghei 52 kDa phosphoprotein. Group: Malaria research cell line 127229498 CVCL_A7WI L1.6 hybridoma house mouse CVCL_A7WI CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q25645; Plasmodium berghei merozoite surface protein 1. Group: Malaria research cell line 127229499 CVCL_A7WH F4.4 hybridoma house mouse CVCL_A7WH CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q25645; Plasmodium berghei merozoite surface protein 1. Group: Malaria research cell line 127229500 CVCL_A7WK BrMi-J2imm transformed cell line house mouse CVCL_A7WK From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Microglial cell; CL=CL_0000129. 127229501 CVCL_A7WJ W3.5 hybridoma house mouse CVCL_A7WJ CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: Plasmodium berghei erythrocytic-stage exoantigen. Group: Malaria research cell line 127229502 CVCL_A7WM BrMi-J2imm Myd88-/- Tirap-/- transformed cell line house mouse CVCL_A7WM From: Golenbock, Douglas T.; The University of Massachusetts Medical School; Worcester; USA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:108005; Myd88; Knockout cell: Method=KO mouse; MGI; MGI:2152213; Tirap Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Microglial cell; CL=CL_0000129. 127229503 CVCL_A7WL BrMi-J2imm Myd88-/- Ticam1-/- transformed cell line house mouse CVCL_A7WL CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:108005; Myd88; Knockout cell: Method=KO mouse; MGI; MGI:2147032; Ticam1 Miscellaneous: As no real cell line name was provided, we assigned the name based on the abbreviation of its description Transformant: Recombinant retrovirus J2; Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Microglial cell; CL=CL_0000129. 127229504 CVCL_A7WA em13.5 hybridoma house mouse CVCL_A7WA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P90574; Plasmodium chabaudi 93 kDa erythrocyte membrane protein (Pc(em)-93). Group: Malaria research cell line 127229505 CVCL_A7WC em16.8 hybridoma house mouse CVCL_A7WC CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Plasmodium chabaudi 65 kDa erythrocyte membrane protein (Pc(em)-65). Group: Malaria research cell line 127229506 CVCL_A7WB em16.3 hybridoma house mouse CVCL_A7WB CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Plasmodium chabaudi 65 kDa erythrocyte membrane protein (Pc(em)-65). Group: Malaria research cell line 127229507 CVCL_A7WE b5 hybridoma house mouse CVCL_A7WE CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q08168; Plasmodium berghei 58 kDa phosphoprotein. Group: Malaria research cell line 127229508 CVCL_A7WD em17.4 hybridoma house mouse CVCL_A7WD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Plasmodium chabaudi 46 kDa erythrocyte membrane protein (Pc(em)-46). Group: Malaria research cell line 127229509 CVCL_A7TT WIL2-A3 transformed cell line human CVCL_A7TT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Spleen; UBERON=UBERON_0002106; Cell type: B-cell; CL=CL_0000236. Male 127229510 CVCL_A7TS RPMI-7882 transformed cell line human CVCL_A7TS CL:0000010 Karyotypic information: 47,XY,+21 (PubMed=4266330); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229511 CVCL_A7TV BA886 finite cell line CVCL_A7TV CL:0000010 Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851; Cell type: Endothelial cell of aorta; CL=CL_0002544. Unspecified Characteristics: Susceptible to infection by Ehrlichia ruminantium (CelloPub=CLPUB00632); Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257) 127229512 CVCL_A7TU 1H8 [Mouse hybridoma against human BMSC] hybridoma house mouse CVCL_A7TU CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human 80 kDa protein on bone marrow stromal cells. 127229513 CVCL_A7TX BPA987 finite cell line CVCL_A7TX CL:0000010 Derived from site: In situ; Lung, artery, endothelium; UBERON=UBERON_0005317. Unspecified Characteristics: Susceptible to infection by Ehrlichia ruminantium (CelloPub=CLPUB00632) 127229514 CVCL_A7TW BA987 finite cell line CVCL_A7TW CL:0000010 Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851; Cell type: Endothelial cell of aorta; CL=CL_0002544. Unspecified Characteristics: Susceptible to infection by Ehrlichia ruminantium (CelloPub=CLPUB00632; PubMed=8300237) 127229515 CVCL_A7TZ Bushpig 1194 finite cell line CVCL_A7TZ CL:0000010 Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851; Cell type: Endothelial cell of aorta; CL=CL_0002544. Male Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=9577776) 127229516 CVCL_A7TY Buffalo 595 finite cell line CVCL_A7TY CL:0000010 Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851; Cell type: Endothelial cell of aorta; CL=CL_0002544. Female Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=9577776) 127229517 CVCL_A7TL RPMI-7712 transformed cell line human CVCL_A7TL CL:0000010 Karyotypic information: 47,XY,+21 (PubMed=4266330); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229518 CVCL_A7TK RPMI-7662 transformed cell line human CVCL_A7TK CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229519 CVCL_A7TN RPMI-7722 transformed cell line human CVCL_A7TN CL:0000010 Karyotypic information: 47,XX,+21 (PubMed=4266330); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229520 CVCL_A7TM RPMI-7762 transformed cell line human CVCL_A7TM CL:0000010 Karyotypic information: 47,XX,+21 (PubMed=4266330); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229521 CVCL_A7TP RPMI-7672 transformed cell line human CVCL_A7TP CL:0000010 Karyotypic information: 47,XY,+21 (PubMed=4266330); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229522 CVCL_A7TR RPMI-7912 transformed cell line human CVCL_A7TR CL:0000010 Karyotypic information: 47,XX,+21 (PubMed=4266330); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229523 CVCL_A7TQ RPMI-7822 transformed cell line human CVCL_A7TQ CL:0000010 Karyotypic information: 47,XY,+21 (PubMed=4266330); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229524 CVCL_A7TD RPMI-7572 transformed cell line human CVCL_A7TD CL:0000010 Karyotypic information: 47,XY,+21; 48,XY,+21+C (PubMed=4266330); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229525 CVCL_A7TC RPMI-7492 transformed cell line human CVCL_A7TC CL:0000010 Karyotypic information: 47,XX,+21 (PubMed=4266330); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229526 CVCL_A7TF RPMI-7532 transformed cell line human CVCL_A7TF CL:0000010 Karyotypic information: 47,XX,+21 (PubMed=4266330); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229527 CVCL_A7TE RPMI-7852 transformed cell line human CVCL_A7TE CL:0000010 Karyotypic information: 47,XY,+21 (PubMed=4266330); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229528 CVCL_A7TH RPMI-7542 transformed cell line human CVCL_A7TH CL:0000010 Karyotypic information: 47,XY,+21 (PubMed=4266330); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229529 CVCL_A7TG RPMI-7732 transformed cell line human CVCL_A7TG CL:0000010 Karyotypic information: 47,XX,+21 (PubMed=4266330); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229530 CVCL_A7TJ RPMI-7592 transformed cell line human CVCL_A7TJ CL:0000010 Karyotypic information: 47,XX,+21 (PubMed=4266330); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229531 CVCL_A7TI RPMI-7582 transformed cell line human CVCL_A7TI CL:0000010 Karyotypic information: 47,XY,+21 (PubMed=4266330); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229532 CVCL_A7SZ RPMI-7462 transformed cell line human CVCL_A7SZ CL:0000010 Karyotypic information: 47,XY,+21 (PubMed=4266330); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229533 CVCL_A7TB RPMI-8092 transformed cell line human CVCL_A7TB CL:0000010 Karyotypic information: 47,XY,+21 (PubMed=4266330); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229534 CVCL_A7TA RPMI-7552 transformed cell line human CVCL_A7TA CL:0000010 Karyotypic information: 47,XY,+21 (PubMed=4266330); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229535 CVCL_A7UU B-LCL-HROC68 transformed cell line human CVCL_A7UU HLA typing: A*02:01:01,29:02:01; B*13:02:01,47:03:01; C*06:02:01,16:01:01; DPB1*01:01:01,04:01:01; DQA1*02:01:01; DQB1*02:02:01; DRB1*07:01:01 (CLS=302078) From: Linnebacher, Michael; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 127229536 CVCL_A7UT B-LCL-HROC60 transformed cell line human CVCL_A7UT HLA typing: A*02:01:01,11:01:01; B*20:02:01,55:01:01; C*03:03:01,05:01:01; DPB1*04:01:01; DQA1*01:01:01,01:03:01; DQB1*05:01:01,06:03:01; DRB1*01:01:01,13:01:01 (CLS=302004) From: Linnebacher, Michael; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 127229537 CVCL_A7UW A549-hACE2 (HA-FLAG) cancer cell line human CVCL_A7UW From: Garcia-Sastre, Adolfo; Icahn School of Medicine at Mount Sinai Medical School; New York; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Expresses ACE2 with C-terminal HA and FLAG tags under the control the CMV promoter (BEI_Resources=NR-53522) Group: SARS-CoV-2 research cell line 127229538 CVCL_A7UV A549-hACE2 [BEI resources] cancer cell line human CVCL_A7UV From: Baric, Ralph Steven; Department of Epidemiology, University of North Carolina at Chapel Hill; Chapel Hill; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Expresses ACE2 under the control of the EF1a promoter (BEI_Resources=NR-53821) Group: SARS-CoV-2 research cell line 127229539 CVCL_A7UY DBT piD-2 transformed cell line house mouse CVCL_A7UY CL:0000010 Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin); Derived from site: In situ; Brain; UBERON=UBERON_0000955; Breed/subspecies: BALB/c x DBA/2. Female Virology: Persistently infected by mouse hepatitis virus (MHV) strain JHM (PubMed=8593285) 127229540 CVCL_A7UX DBT piD-10 transformed cell line house mouse CVCL_A7UX CL:0000010 Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin); Derived from site: In situ; Brain; UBERON=UBERON_0000955; Breed/subspecies: BALB/c x DBA/2. Female Virology: Persistently infected by mouse hepatitis virus (MHV) strain JHM (PubMed=8593285) 127229541 CVCL_A7UZ DBT piD-3 transformed cell line house mouse CVCL_A7UZ CL:0000010 Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin); Derived from site: In situ; Brain; UBERON=UBERON_0000955; Breed/subspecies: BALB/c x DBA/2. Female Virology: Persistently infected by mouse hepatitis virus (MHV) strain JHM (PubMed=8593285) 127229542 CVCL_A7UM B-LCL-HROC102 transformed cell line human CVCL_A7UM From: Linnebacher, Michael; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female 127229543 CVCL_A7UL B-LCL-HROC278 transformed cell line human CVCL_A7UL HLA typing: A*01:03:01,25:01:01; B*07:02:01,18:01:01; C*07:02:01,12:03:01; DPB1*02:01:02,04:01:02; DQA1*01:02:01,03:01:01; DQB1*03:02:01,06:02:01; DRB1*04:01:01,15:01:01 (CLS=302051) From: Linnebacher, Michael; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female 127229544 CVCL_A7UN B-LCL-HROC43 transformed cell line human CVCL_A7UN HLA typing: A*01:01:01,02:01:01; B*15:01:01,37:01:01; C*03:03:01,06:02:01; DPB1*01:01:01,05:01:01; DQA1*01:05:01,05:05:01; DQB1*03:01:01,05:01:01; DRB1*10:01:01,12:01:01 (CLS=302067) From: Linnebacher, Michael; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 127229545 CVCL_A7UQ B-LCL-HROC50 transformed cell line human CVCL_A7UQ HLA typing: A*02:01:01,03:01:01; B*07:02:01,27:01:01; C*06:02:01,07:02:01; DPB1*04:01:01; DQA1*01:02:01,02:01:01; DQB1*03:03:02,06:02:01; DRB1*07:01:01,15:01:01 (CLS=302069) From: Linnebacher, Michael; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female 127229546 CVCL_A7UP B-LCL-HROC46 transformed cell line human CVCL_A7UP HLA typing: A*01:01:01,02:01:01; B*07:02:01,08:01:01; C*07:01:01,07:02:01; DPB1*01:01:01,19:01:01; DQA1*01:02:01,05:01:01; DQB1*02:01:01,06:02:01; DRB1*03:01:01,15:01:01 (CLS=302068) From: Linnebacher, Michael; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 127229547 CVCL_A7US B-LCL-HROC59 transformed cell line human CVCL_A7US HLA typing: A*03:01:01,24:02:01; B*01:02:01,27:05:02; C*02:02:02,07:02:01; DPB1*04:01:01,14:01:01; DQA1*01:02:01,03:03:01; DQB1*03:02:01,06:02:01; DRB1*04:01:01,15:01:01 (CLS=302073) From: Linnebacher, Michael; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 127229548 CVCL_A7UR B-LCL-HROC57 transformed cell line human CVCL_A7UR HLA typing: A*01:01:01,02:01:01; B*08:01:01,27:01:01; C*06:02:01,07:01:01; DPB1*02:01:02,04:01:01; DQA1*02:01:01,05:01:01; DQB1*02:01:01,03:03:02; DRB1*03:01:01,07:01:01 (CLS=302072) From: Linnebacher, Michael; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 127229549 CVCL_A7UE BPA593/1 finite cell line CVCL_A7UE CL:0000010 Derived from site: In situ; Lung, artery, endothelium; UBERON=UBERON_0005317. Unspecified Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=8300237) 127229550 CVCL_A7UD BPA291 finite cell line CVCL_A7UD CL:0000010 Derived from site: In situ; Lung, artery, endothelium; UBERON=UBERON_0005317. Unspecified Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=8300237) 127229551 CVCL_A7UG BSV-793 finite cell line CVCL_A7UG CL:0000010 Derived from site: In situ; Limb, saphenous vein; UBERON=UBERON_0007318; Cell type: Endothelial cell of vein; CL=CL_0002543. Unspecified 127229552 CVCL_A7UF SBE-189 finite cell line CVCL_A7UF CL:0000010 Derived from site: In situ; Brain, microvascular endothelium; UBERON=UBERON_0000955+UBERON_0008339; Cell type: Endothelial cell; CL=CL_0000115. Unspecified Characteristics: Susceptible to infection by Ehrlichia ruminantium (CelloPub=CLPUB00633) 127229553 CVCL_A7UI Vero-Luc2p spontaneously immortalized cell line green monkey CVCL_A7UI CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2) Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819; Cell type: Epithelial cell of kidney; CL=CL_0002518. Biotechnology: Used in a quantitative and sensitive luciferase-based assay for bacterial toxins that inhibit protein synthesis (PubMed=20585113) Female Characteristics: Stably expresses luciferase Luc2p which is tagged with a PEST sequence which promotes rapid turnover Therefore, luciferase activity reflects the current level of protein synthesis (PubMed=20585113).; Characteristics: Transduced with a Luc2P-IRES-eGFP construct Group: Non-human primate cell line 127229554 CVCL_A7UH E5 finite cell line CVCL_A7UH CL:0000010 Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066; Cell type: Endothelial cell of umbilical vein; CL=CL_0002618. Unspecified Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=3329310; PubMed=3900854) 127229555 CVCL_A7UK HEK-293T-hACE2 transformed cell line human CVCL_A7UK CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Expresses ACE2 under the control of the EF1a promoter (BEI_Resources=NR-52511) Group: SARS-CoV-2 research cell line 127229556 CVCL_A7UJ Vero E6-high ACE2 spontaneously immortalized cell line green monkey CVCL_A7UJ CL:0000010 Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819; Cell type: Epithelial cell of kidney; CL=CL_0002518. Female Characteristics: Obtained by sorting Vero E6 cells for cells expressing high levels of endogenous ACE2; Characteristics: Application in SARS-CoV-2 research Group: Non-human primate cell line 127229557 CVCL_A7UA Sable 1194 finite cell line CVCL_A7UA CL:0000010 Derived from site: In situ; Lung, artery, endothelium; UBERON=UBERON_0005317. Female Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=9577776) 127229558 CVCL_A7UC BPA191 finite cell line CVCL_A7UC CL:0000010 Derived from site: In situ; Lung, artery, endothelium; UBERON=UBERON_0005317. Unspecified Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=8300237) 127229559 CVCL_A7UB Eland 895 finite cell line CVCL_A7UB CL:0000010 Derived from site: In situ; Aorta, endothelium; UBERON=UBERON_0004851; Cell type: Endothelial cell of aorta; CL=CL_0002544. Female Characteristics: Susceptible to infection by Ehrlichia ruminantium (PubMed=9577776) 127229560 CVCL_A7RR FHNG-00 transformed cell line human CVCL_A7RR HLA typing: A*23:01:01,24:39; B*44:03:01:01,40:02:01; C*04:01:01:01,02:02:02:01; DPA1*01:03:01:01,02:01:01:02; DPB1*16:01:01,10:01:01; DQA1*03:01:01,05:05:01; DQB1*03:05:01,03:01:01:03; DRB1*04:03:01,11:01:01:01; DRB3*02:02:01:02; DRB4*01:03:01 (PubMed=30844424) CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229561 CVCL_A7RQ FHSL-00 transformed cell line human CVCL_A7RQ HLA typing: A*30:02:01:01; B*07:02:01,35:01:01:02; C*07:02:01:03,04:01:01:01; DPA1*01:03:01:01,01:03:01:04; DPB1*04:01:01:01,02:01:02; DQA1*01:02:01; DQB1*06:02:01; DRB1*15:01:01; DRB5*01:01:01 (PubMed=30844424) CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229562 CVCL_A7RT FHNG-01 transformed cell line human CVCL_A7RT HLA typing: A*24:39,29:02:01:01; B*15:17:01:01,40:02:01; C*07:01:02,02:02:02:01; DPA1*01:03:01:01; DPB1*02:01:02,16:01:01; DQA1*01:02:01,05:05:01; DQB1*06:04:01,03:01:01:03; DRB1*13:02:01,11:01:01:01; DRB3*03:01:01,02:02:01:02 (PubMed=30844424) CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229563 CVCL_A7RS FHES-00 transformed cell line human CVCL_A7RS HLA typing: A*02:01:01:01,24:02:01:01; B*35:01:01:02,35:12:01; C*04:01:01:01; DPA1*01:03:01:05; DPB1*04:02:01:02; DQA1*03:01:01; DQB1*03:02:01; DRB1*04:07:01; DRB4*01:03:01 (PubMed=30844424) CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229564 CVCL_A7RV WAe009-A-62 embryonic stem cell human CVCL_A7RV From: Anzhen Hospital, Capital Medical University; Beijing; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6294; KCNQ1 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127229565 CVCL_A7RU FHES-01 transformed cell line human CVCL_A7RU HLA typing: A*68:03:01,02:01:01:01; B*40:02:01; C*03:05,02:02:02:01; DPA1*01:03:01:04,02:02:02; DPB1*02:01:02,05:01:01; DQA1*03:01:01,05:05:01; DQB1*03:02:01,03:01:01:03; DRB1*04:07:01,11:01:01:01; DRB3*02:02:01:02; DRB4*01:03:01 (PubMed=30844424) CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229566 CVCL_A7RX WAe009-A-59 embryonic stem cell human CVCL_A7RX From: Anzhen Hospital, Capital Medical University; Beijing; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4808; HAND2 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127229567 CVCL_A7RW WAe009-A-61 embryonic stem cell human CVCL_A7RW From: Anzhen Hospital, Capital Medical University; Beijing; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12010; TPM1 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127229568 CVCL_A7RJ LEO-10 transformed cell line human CVCL_A7RJ HLA typing: A*03:01:01:01; B*07:02:01; C*07:02:01:03; DPA1*01:03:01:02; DPB1*04:01:01:01; DQA1*01:02:01; DQB1*06:02:01; DRB1*15:01:01; DRB5*01:01:01 (PubMed=30844424) CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Unspecified Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229569 CVCL_A7RI AL-10 transformed cell line human CVCL_A7RI HLA typing: A*26:01:01:01; B*38:01:01; C*12:03:01:01; DPA1*01:03:01:04; DPB1*04:01:01:01; DQA1*03:01:01; DQB1*03:02:01; DRB1*04:02:01; DRB4*01:03:01 (PubMed=30844424) CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Unspecified Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229570 CVCL_A7RL FHBN transformed cell line human CVCL_A7RL HLA typing: A*02:01:01:01; B*15:01:01:01,44:03:01:01; C*03:03:01:01,04:09N; DPA1*01:03:01:01,01:03:01:02; DPB1*04:01:01:01(350:01),13:01:01; DQA1*02:01:01,01:02:01; DQB1*02:02:01:01,06:02:01; DRB1*07:01:01,15:01:01; DRB4*01:01:01:01; DRB5*01:01:01 (PubMed=30844424) CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229571 CVCL_A7RK FH90 transformed cell line human CVCL_A7RK HLA typing: A*11:01:01:01,26:01:01:01; B*35:01:01:02; C*08:01:01; C*03:03:01:01; DPA1*02:02:02,01:03:01:01; DPB1*05:01:01,02:01:02; DQA1*05:03,01:04:01; DQB1*03:01:01:01,05:03:01; DRB1*14:03:01,14:07:01; DRB3*01:01:02,02:02:01:01 (PubMed=30844424) CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Unspecified Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229572 CVCL_A7RN FHJQ-01 transformed cell line human CVCL_A7RN HLA typing: A*24:02:01:02L,01:01:01:01; B*37:01:01,08:01:01:01; C*01:02:01,07:01:01:01; DPA1*01:03:01:02,02:01:02; DPB1*04:01:01:01,01:01:01; DQA1*03:03:01:01,05:01:01:02; DQB1*03:01:01:01,02:01:01; DRB1*04:07:01,03:01:01; DRB3*01:01:02; DRB4*01:03:01 (PubMed=30844424) CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229573 CVCL_A7RM FHJQ-00 transformed cell line human CVCL_A7RM HLA typing: A*24:02:01:02L,02:01:01:01; B*37:01:01,07:02:01; C*01:02:01,07:02:01:03; DPA1*01:03:01:01,01:03:01:02; DPB1*04:01:01:01,02:01:02; DQA1*03:03:01:01,05:05:01; DQB1*03:01:01:01,03:01:01:03; DRB1*04:07:01,11:01:01:01; DRB3*02:02:01:02; DRB4*01:03:01 (PubMed=30844424) CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229574 CVCL_A7RP FHSL-01 transformed cell line human CVCL_A7RP HLA typing: A*11:01:01:01; B*07:02:01; C*07:02:01:03; DPA1*01:03:01:04; DPB1*04:01:01:01; DQA1*01:02:01,03:03:01:01; DQB1*06:02:01,03:01:01:01; DRB1*15:01:01,04:01:01; DRB4*01:03:01; DRB5*01:01:01 (PubMed=30844424) CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229575 CVCL_A7RB FH81 transformed cell line human CVCL_A7RB HLA typing: A*01:01:01:01,02:01:01:01; B*40:02:01,07:05:01:01; C*02:02:02:01,15:23; DPA1*01:03:01:04,01:03:01:05; DPB1*04:02:01:01(105:01),04:01:01:01(126:01); DQA1*01:02:02,05:05:01; DQB1*05:02:01,03:01:01:03; DRB1*16:02:01:02,01:03; DRB5*02:02 (PubMed=30844424) CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Unspecified Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229576 CVCL_A7RA FH80 transformed cell line human CVCL_A7RA HLA typing: A*02:01:01:01,02:03:01; B*40:01:02; C*03:17,07:02:01:01; DPA1*02:02:02; DPB1*135:01,05:01:01; DQA1*01:04:01,03:02; DQB1*05:03:01,03:03:02; DRB1*14:54:01,09:01:02; DRB3*02:02:01:01; DRB4*01:03:02 (PubMed=30844424) CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Unspecified Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229577 CVCL_A7RD FH83 transformed cell line human CVCL_A7RD HLA typing: A*02:01:01:01; B*07:02:01,40:02:01; C*07:02:01:03,02:06:01; DPA1*01:03:01:04; DPB1*04:01:01:01; DQA1*01:02:01; DQB1*06:02:01; DRB1*15:01:01; DRB5*01:01:01 (PubMed=30844424) CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Unspecified Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229578 CVCL_A7RC FH82 transformed cell line human CVCL_A7RC CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229579 CVCL_A7RF FH86 transformed cell line human CVCL_A7RF CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Unspecified Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229580 CVCL_A7RE FH85 transformed cell line human CVCL_A7RE HLA typing: A*03:01:01:01,32:01:01; B*18:01:01:02,40:02:01; C*07:01:01:01,15:02:01:02; DPA1*01:03:01:02,02:02:02; DPB1*04:02:01:02(105:01),04:01:01:01(126:01); DQA1*05:05:01,03:01:01; DQB1*03:01:01:03,03:02:01; DRB1*11:01:01:01,04:03:01; DRB3*02:02:01:02; DRB4*01:03:01 (PubMed=30844424) CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Unspecified Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229581 CVCL_A7RH FH89 transformed cell line human CVCL_A7RH HLA typing: A*02:01:01:01; B*15:01:01:01; C*03:04:01:01; DPA1*01:03:01:02,01:03:01:03; DPB1*03:01:01(124:01),04:01:01:01(350:01); DQA1*03:01:01; DQB1*03:02:01; DRB1*04:01:01; DRB4*01:03:01 (PubMed=30844424) CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229582 CVCL_A7RG FH87 transformed cell line human CVCL_A7RG HLA typing: A*02:01:01:01,01:01:01:01; B*40:02:01,08:01:01:01; C*15:02:01:02,07:01:01:01; DPA1*01:03:01:01; DPB1*02:01:02; DQA1*02:01:01,05:01:01:02; DQB1*02:02:01:01,02:01:01; DRB1*07:01:01,03:01:01; DRB3*01:01:02; DRB4*01:01:01:01 (PubMed=30844424) CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Unspecified Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229583 CVCL_A7QY M-4581 finite cell line human CVCL_A7QY CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127229584 CVCL_A7QX M-3773 finite cell line human CVCL_A7QX CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 127229585 CVCL_A7QZ FH79 transformed cell line human CVCL_A7QZ HLA typing: A*11:01:01:01,02:01:01:01; B*18:01:01:02,50:01:01; C*07:36,06:02:01:02; DPA1*01:03:01:04; DPB1*04:01:01:01; DQA1*05:05:01,02:01:01; DQB1*03:01:01:03,02:02:01:01; DRB1*11:01:01:01,07:01:01; DRB3*02:02:01:02; DRB4*01:03:01 (PubMed=30844424) CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel 127229586 CVCL_A7SS UM-55 transformed cell line human CVCL_A7SS CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229587 CVCL_A7SR UM-3 [Human LCL] transformed cell line human CVCL_A7SR CL:0000010 Miscellaneous: Source of immortalizing EBV is cell line UM-1 (Cellosaurus=CVCL_VJ00) Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female 127229588 CVCL_A7SU UM-39 transformed cell line human CVCL_A7SU CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229589 CVCL_A7ST UM-56 transformed cell line human CVCL_A7ST CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229590 CVCL_A7SW UM-11 transformed cell line human CVCL_A7SW CL:0000010 Miscellaneous: Source of immortalizing EBV is cell line UM-3 (Cellosaurus=CVCL_A7SR) Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 127229591 CVCL_A7SV UM-10 transformed cell line human CVCL_A7SV CL:0000010 Miscellaneous: Source of immortalizing EBV is cell line UM-3 (Cellosaurus=CVCL_A7SR) Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 127229592 CVCL_A7SY RPMI-7402 transformed cell line human CVCL_A7SY CL:0000010 Karyotypic information: 47,XY,+21; 46,XY (PubMed=4266330); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229593 CVCL_A7SX RPMI-7422 transformed cell line human CVCL_A7SX CL:0000010 Karyotypic information: 47,XY,+21 (PubMed=4266330); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229594 CVCL_A7SK OUMS-9 transformed cell line human CVCL_A7SK CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Donor information: Established from a patient suffering from Hodgkin lymphoma; Derived from site: In situ; Lymph node; UBERON=UBERON_0000029. Male 127229595 CVCL_A7SJ OUMS-8 transformed cell line human CVCL_A7SJ CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Donor information: Established from a patient suffering from Hodgkin lymphoma; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229596 CVCL_A7SM OUMS-11A transformed cell line human CVCL_A7SM CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Donor information: Established from a patient suffering from subacute myelo-optico-neuropathy; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229597 CVCL_A7SL OUMS-10 transformed cell line human CVCL_A7SL CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Donor information: Established from a patient suffering from Hodgkin lymphoma; Derived from site: In situ; Lymph node; UBERON=UBERON_0000029. Male 127229598 CVCL_A7SN OUMS-11B transformed cell line human CVCL_A7SN CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Donor information: Established from a patient suffering from subacute myelo-optico-neuropathy; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229599 CVCL_A7SQ OUMS-13 transformed cell line human CVCL_A7SQ CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Donor information: Established from a patient suffering from subacute myelo-optico-neuropathy; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229600 CVCL_A7SP OUMS-12 transformed cell line human CVCL_A7SP CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Donor information: Established from a patient suffering from acute myelogenous leukemia; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229601 CVCL_A7SC OUMS-21 [1972] transformed cell line human CVCL_A7SC CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Caution: Two cell lines named OUMS-21 have been created at Okayama University Medical School, one in 1972 from the peripheral blood of a normal adult donor (Cellosaurus=CVCL_A7SC) and one in 1993 from the SV40-transformed liver of a fetus (Cellosaurus=CVCL_9131) 127229602 CVCL_A7SB OUMS-20 transformed cell line human CVCL_A7SB CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229603 CVCL_A7SE OUMS-3 transformed cell line human CVCL_A7SE CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229604 CVCL_A7SD OUMS-22 [1972] transformed cell line human CVCL_A7SD CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Caution: Two cell lines named OUMS-22 have been created at Okayama University Medical School, one in 1972 from the peripheral blood of a normal adult donor (Cellosaurus=CVCL_A7SD) and one in 1993 from the SV40-transformed liver of a fetus (Cellosaurus=CVCL_9132) 127229605 CVCL_A7SG OUMS-5 transformed cell line human CVCL_A7SG CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229606 CVCL_A7SF OUMS-4 transformed cell line human CVCL_A7SF CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229607 CVCL_A7SI OUMS-7 transformed cell line human CVCL_A7SI CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Donor information: Established from a patient suffering from subacute myelo-optico-neuropathy; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229608 CVCL_A7SH OUMS-6 transformed cell line human CVCL_A7SH CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Donor information: Established from a patient suffering from Hodgkin lymphoma; Derived from site: In situ; Lymph node; UBERON=UBERON_0000029. Male 127229609 CVCL_A7RZ LUMCi046-A-1 induced pluripotent stem cell human CVCL_A7RZ From: Leiden University Medical Center; Leiden; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; HGNC:25947; KLHL24; Simple_edited; c.-3A>G; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34688992); Sequence variation: Mutation; HGNC; HGNC:25947; KLHL24; Simple_corrected; p.Met1Arg (c.2T>G); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34688992) Population: Chilean; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229610 CVCL_A7RY LUMCi045-A-1 induced pluripotent stem cell human CVCL_A7RY From: Leiden University Medical Center; Leiden; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; HGNC:25947; KLHL24; Simple_corrected; p.Met1Arg (c.2T>G); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34688992); Sequence variation: Mutation; HGNC; HGNC:25947; KLHL24; Simple_edited; p.Val2Val (c.6A>C); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34688992) Population: Chilean; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229611 CVCL_A7SA OUMS-18 transformed cell line human CVCL_A7SA CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229612 CVCL_A7AA HeLa M KIF13B-KO cancer cell line human CVCL_A7AA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14405; KIF13B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 127229613 CVCL_A7AC R15_Spike hybridoma house mouse CVCL_A7AC CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127229614 CVCL_A7AB HeLa M KIF13A/B-DKO cancer cell line human CVCL_A7AB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14566; KIF13A; Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14405; KIF13B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 127229615 CVCL_A7AE R31_Spike hybridoma house mouse CVCL_A7AE CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127229616 CVCL_A7AD R22_Spike hybridoma house mouse CVCL_A7AD CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127229617 CVCL_A7AG S1D7_Spike hybridoma house mouse CVCL_A7AG CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127229618 CVCL_A7AF R52_Spike hybridoma house mouse CVCL_A7AF CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127229619 CVCL_A6ZZ HeLa M KIF13A-KO cancer cell line human CVCL_A6ZZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14566; KIF13A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 127229620 CVCL_A6ZS 40LB spontaneously immortalized cell line house mouse CVCL_A6ZS CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88337; Cd40lg; Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1344376; Tnfsf13b; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: BALB/c. Unspecified Characteristics: Can be used as feeder cells for B cell culture Support efficient proliferation and survival of B cells (PubMed=21897376). 127229621 CVCL_A6ZR 3T3/40L spontaneously immortalized cell line house mouse CVCL_A6ZR CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88337; Cd40lg; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: BALB/c. Unspecified 127229622 CVCL_A6ZU T49-25 hybridoma house mouse CVCL_A6ZU CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O15197; Human EPHB6. 127229623 CVCL_A6ZT ABC-31 cancer cell line human CVCL_A6ZT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (PubMed=33829270) Population: Japanese; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female Characteristics: Resistant to the tyrosine kinase inhibitor osimertinib Has activated IGF1R (PubMed=33829270). 127229624 CVCL_A6ZW KM2048 hybridoma CVCL_A6ZW CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O15197; Human EPHB6. 127229625 CVCL_A6ZV KM1978 hybridoma CVCL_A6ZV CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; O15197; Human EPHB6. 127229626 CVCL_A6ZY HeLa M Rab8-DKO cancer cell line human CVCL_A6ZY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7007; RAB8A; Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30273; RAB8B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 127229627 CVCL_A6ZX KM2051 hybridoma CVCL_A6ZX CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O15197; Human EPHB6. 127229628 CVCL_A6ZK id5P cancer cell line Norway rat CVCL_A6ZK CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2) Transformant: ChEBI; CHEBI_141568; N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA); Derived from site: In situ; Kidney, renal tubule; UBERON=UBERON_0009773; Breed/subspecies: Wistar Crlj:WI; RS=RS_0001840. Male 127229629 CVCL_A6ZJ d5krm3 cancer cell line Norway rat CVCL_A6ZJ CL:0000010 Transformant: ChEBI; CHEBI_141568; N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA); Derived from site: In situ; Kidney, renal tubule; UBERON=UBERON_0009773; Breed/subspecies: Wistar Crlj:WI; RS=RS_0001840. Male Characteristics: Highly metastatic activity to lung by intracapsular transplantation (RCB=RCB4666) 127229630 CVCL_A6ZM id5krm7 cancer cell line Norway rat CVCL_A6ZM CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2) Transformant: ChEBI; CHEBI_141568; N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA); Derived from site: In situ; Kidney, renal tubule; UBERON=UBERON_0009773; Breed/subspecies: Wistar Crlj:WI; RS=RS_0001840. Male Characteristics: Highly metastatic activity to lung by intracapsular transplantation (RCB=RCB4668) 127229631 CVCL_A6ZL id5krm3 cancer cell line Norway rat CVCL_A6ZL CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2) Transformant: ChEBI; CHEBI_141568; N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA); Derived from site: In situ; Kidney, renal tubule; UBERON=UBERON_0009773; Breed/subspecies: Wistar Crlj:WI; RS=RS_0001840. Male Characteristics: Highly metastatic activity to lung by intracapsular transplantation (RCB=RCB4669) 127229632 CVCL_A6ZN BD1B hybridoma CVCL_A6ZN CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9R100; Mouse Cdh17. 127229633 CVCL_A6ZQ MOMA-2 [Mouse/rat hybridoma against mouse macrophages and monocytes] hybridoma CVCL_A6ZQ CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: Mouse macrophages and monocytes intracellular antigen. 127229634 CVCL_A6ZP MOMA-1 [Mouse/rat hybridoma against mouse Siglec1] hybridoma CVCL_A6ZP CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q62230; Mouse Siglec1/Cd169. 127229635 CVCL_A6ZC AQP4(E5505-3D12-129) hybridoma house mouse CVCL_A6ZC CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P55088; Mouse Aqp4 (Note=Isoform M23). 127229636 CVCL_A6ZB AQP4(E5504-2G2-105) hybridoma house mouse CVCL_A6ZB CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P55088; Mouse Aqp4 (Note=Isoform M23). 127229637 CVCL_A6ZE DP2(D5203-1D8-31) hybridoma house mouse CVCL_A6ZE CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q9Z2J6; Mouse Ptgdr2. 127229638 CVCL_A6ZD AQP4(E5507-3A1-113) hybridoma house mouse CVCL_A6ZD CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P55088; Mouse Aqp4 (Note=Isoform M23). 127229639 CVCL_A6ZF BLG-139-3 factor-dependent cell line house mouse CVCL_A6ZF CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Pro-B cell; CL=CL_0000826; Breed/subspecies: C3H. Characteristics: Transfected with a LexA-d1EGFP reporter that consists of 8 tandem copies of a LexA binding element, a minimal promoter from mouse Ifnb and d1EGFP (destabilized EGFP) (PubMed=15225556) Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse 127229640 CVCL_A6ZI d5krm7 cancer cell line Norway rat CVCL_A6ZI CL:0000010 Transformant: ChEBI; CHEBI_141568; N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA); Derived from site: In situ; Kidney, renal tubule; UBERON=UBERON_0009773; Breed/subspecies: Wistar Crlj:WI; RS=RS_0001840. Male Characteristics: Highly metastatic activity to lung by intracapsular transplantation (RCB=RCB4665) 127229641 CVCL_A6ZH rRCCd5 cancer cell line Norway rat CVCL_A6ZH CL:0000010 Transformant: ChEBI; CHEBI_141568; N-ethyl-N-(2-hydroxyethyl)nitrosamine (EENA); Derived from site: In situ; Kidney, renal tubule; UBERON=UBERON_0009773; Breed/subspecies: Wistar Crlj:WI; RS=RS_0001840. Male 127229642 CVCL_A6XY Cys-SN2(N3323) hybridoma house mouse CVCL_A6XY CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q9ULM6; Human CNOT6. 127229643 CVCL_A6XX Cys-SN2(N3316) hybridoma house mouse CVCL_A6XX CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01037; Human CST1 (Note=Isoform SN2). 127229644 CVCL_A6XZ Cys-SN2(N3331) hybridoma house mouse CVCL_A6XZ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01037; Human CST1 (Note=Isoform SN2). 127229645 CVCL_A6XQ LCHi002-B induced pluripotent stem cell human CVCL_A6XQ From: Lurie Children's Hospital of Chicago; Chicago; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2962; DYNC2H1; Simple; p.Thr3836Ile (c.11507C>T); Zygosity=Heterozygous (PubMed=37413951); Sequence variation: Mutation; HGNC; HGNC:7983; NR5A1; Unexplicit; Ex3del and part of Ex4; Zygosity=Heterozygous (PubMed=37413951); Sequence variation: Mutation; HGNC; HGNC:8783; PDE4D; Simple; p.Gly93Ser (c.277G>A); Zygosity=Heterozygous (PubMed=37413951); Sequence variation: Mutation; HGNC; HGNC:16700; ZFPM2; Simple; p.Asn1087Ser (c.3260A>G); Zygosity=Heterozygous (PubMed=37413951) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229646 CVCL_A6XP LCHi002-A induced pluripotent stem cell human CVCL_A6XP From: Lurie Children's Hospital of Chicago; Chicago; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2962; DYNC2H1; Simple; p.Thr3836Ile (c.11507C>T); Zygosity=Heterozygous (from autologous cell line LCHi002-A); Sequence variation: Mutation; HGNC; HGNC:7983; NR5A1; Unexplicit; Ex3del and part of Ex4; Zygosity=Heterozygous (from autologous cell line LCHi002-A); Sequence variation: Mutation; HGNC; HGNC:8783; PDE4D; Simple; p.Gly93Ser (c.277G>A); Zygosity=Heterozygous (from autologous cell line LCHi002-A); Sequence variation: Mutation; HGNC; HGNC:16700; ZFPM2; Simple; p.Asn1087Ser (c.3260A>G); Zygosity=Heterozygous (from autologous cell line LCHi002-A) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: hPSCreg; LCHi002-A; true Male 127229647 CVCL_A6XS UNINAi001-B induced pluripotent stem cell human CVCL_A6XS From: University of Naples Federico II; Napoli; Italy CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6297; KCNQ3; Simple; p.Phe534Ilefs*15 (c.1599dupT); ClinVar=VCV000205978; Zygosity=Homozygous (from autologous cell line UNINAi001-A) Population: Moroccan; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229648 CVCL_A6XR UNINAi001-A induced pluripotent stem cell human CVCL_A6XR From: University of Naples Federico II; Napoli; Italy CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6297; KCNQ3; Simple; p.Phe534Ilefs*15 (c.1599dupT); ClinVar=VCV000205978; Zygosity=Homozygous (PubMed=33799276) Population: Moroccan; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229649 CVCL_A6XU CCR4aN(Y6206) hybridoma house mouse CVCL_A6XU CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; Q9ULM6; Human CNOT6. 127229650 CVCL_A6XT UNINAi002-A induced pluripotent stem cell human CVCL_A6XT From: University of Naples Federico II; Napoli; Italy CL:0000010 Population: Moroccan; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229651 CVCL_A6XW Cys-SN2(N3312) hybridoma house mouse CVCL_A6XW CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01037; Human CST1 (Note=Isoform SN2). 127229652 CVCL_A6XV Cys-SN2(N3306) hybridoma house mouse CVCL_A6XV CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01037; Human CST1 (Note=Isoform SN2). 127229653 CVCL_A6XI WTC-mEGFP-EZH2-cl18 induced pluripotent stem cell human CVCL_A6XI CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP) Population: Japanese; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Using CRISPR/Cas9 EZH2 has been endogenously tagged in one allele at the N-terminus with mEGFP Part of: Allen Cell Collection 127229654 CVCL_A6XH WTC-mEGFP-POLR2A-cl74 induced pluripotent stem cell human CVCL_A6XH CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP) Population: Japanese; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Using CRISPR/Cas9 POLR2A has been endogenously tagged in one allele at the N-terminus with mEGFP Part of: Allen Cell Collection 127229655 CVCL_A6XK CSUi003-A induced pluripotent stem cell human CVCL_A6XK From: Central South University; Changsha; China CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229656 CVCL_A6XJ CSUi002-A induced pluripotent stem cell human CVCL_A6XJ From: Central South University; Changsha; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous (PubMed=33706202) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229657 CVCL_A6XM LCHi001-A induced pluripotent stem cell human CVCL_A6XM From: Lurie Children's Hospital of Chicago; Chicago; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Ile900Phe (c.2698A>T); ClinVar=VCV000464801; Zygosity=Hemizygous (PubMed=34233262) Population: Latino or Hispanic; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229658 CVCL_A6XL CSUi004-A induced pluripotent stem cell human CVCL_A6XL From: Central South University; Changsha; China CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229659 CVCL_A6XN LCHi001-B induced pluripotent stem cell human CVCL_A6XN From: Lurie Children's Hospital of Chicago; Chicago; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Ile900Phe (c.2698A>T); ClinVar=VCV000464801; Zygosity=Hemizygous (PubMed=34233262) Population: Latino or Hispanic; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229660 CVCL_A6XA NCD-2 hybridoma Norway rat CVCL_A6XA CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P10288; Chicken CDH2 (Note=Also reacts with Xenopus). 127229661 CVCL_A6XC HAM1C transformed cell line human CVCL_A6XC CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Characteristics: IL2 dependent 127229662 CVCL_A6XB PCD-1 hybridoma CVCL_A6XB CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P10287; Mouse Cdh3. 127229663 CVCL_A6XE USFi002-A induced pluripotent stem cell human CVCL_A6XE From: University of South Florida; Tampa; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3756; FLNC; Simple; p.Asp2116Argfs*37 (c.6345_6352delTGACAAGC); ClinVar=VCV000959711; Zygosity=Heterozygous (PubMed=34088019) Population: African American; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229664 CVCL_A6XD USFi001-A induced pluripotent stem cell human CVCL_A6XD From: University of South Florida; Tampa; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[781]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=34034220); Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[1092]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=34034220) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229665 CVCL_A6XG USFi004-A induced pluripotent stem cell human CVCL_A6XG From: University of South Florida; Tampa; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple; p.Asp600Valfs*56 (c.1799delA); ClinVar=VCV000202020; Zygosity=Heterozygous (PubMed=34034221) Population: Caribbean; Haitian and Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229666 CVCL_A6XF USFi003-A induced pluripotent stem cell human CVCL_A6XF From: University of South Florida; Tampa; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg541Cys (c.1621C>T); ClinVar=VCV000048046; Zygosity=Heterozygous (PubMed=34029931) Population: Hispanic; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229667 CVCL_A6YZ AQP4(E5415A-1H6-68) hybridoma house mouse CVCL_A6YZ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P55088; Mouse Aqp4 (Note=Isoform M23). 127229668 CVCL_A6YY AQP4(E5413-1G11-49) hybridoma house mouse CVCL_A6YY CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P55088; Mouse Aqp4 (Note=Isoform M23). 127229669 CVCL_A6ZA AQP4(E5415B-1H7-79) hybridoma house mouse CVCL_A6ZA CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P55088; Mouse Aqp4 (Note=Isoform M23). 127229670 CVCL_A6YR CHO hAQP4-M1 spontaneously immortalized cell line CVCL_A6YR CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:637; AQP4 (Note=Isoform M1); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female 127229671 CVCL_A6YQ AQP4(D15107-3D7-33) hybridoma house mouse CVCL_A6YQ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P55087; Human AQP4 (Note=Isoform M23 Also reacts with mouse).. 127229672 CVCL_A6YT CHO hAQP4-M23 spontaneously immortalized cell line CVCL_A6YT CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:637; AQP4 (Note=Isoform M23); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female 127229673 CVCL_A6YS CHO hAQP4-M1/M23 spontaneously immortalized cell line CVCL_A6YS CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:637; AQP4 (Note=Isoform M1); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:637; AQP4 (Note=Isoform M23); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female 127229674 CVCL_A6YV AQP4(D12092-1C3-02) hybridoma house mouse CVCL_A6YV CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P55087; Human AQP4 (Note=Isoform M23). 127229675 CVCL_A6YU AQP4(C9401-A3-29) hybridoma house mouse CVCL_A6YU CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P55087; Human AQP4 (Note=Isoform M23). 127229676 CVCL_A6YX AQP4(E5209-1C8-22) hybridoma house mouse CVCL_A6YX CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P55088; Mouse Aqp4 (Note=Isoform M23). 127229677 CVCL_A6YW AQP4(E5206-1B10-8) hybridoma house mouse CVCL_A6YW CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P55088; Mouse Aqp4 (Note=Isoform M23 Also reacts with human).. 127229678 CVCL_A6YJ Glut1(D4418-30) hybridoma house mouse CVCL_A6YJ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P11166; Human SLC2A1. 127229679 CVCL_A6YI Glut1(D4402-6) hybridoma house mouse CVCL_A6YI CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P11166; Human SLC2A1. 127229680 CVCL_A6YL hTobC(Y5432) hybridoma house mouse CVCL_A6YL CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P50616; Human TOB1. 127229681 CVCL_A6YK Glut1(D4404-9) hybridoma house mouse CVCL_A6YK CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P11166; Human SLC2A1. 127229682 CVCL_A6YN hTobC(Y5444) hybridoma house mouse CVCL_A6YN CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P50616; Human TOB1. 127229683 CVCL_A6YM hTobC(Y5443) hybridoma house mouse CVCL_A6YM CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P50616; Human TOB1. 127229684 CVCL_A6YP hTobC(Y5452) hybridoma house mouse CVCL_A6YP CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P50616; Human TOB1. 127229685 CVCL_A6YB Cys-SN2(N3349) hybridoma house mouse CVCL_A6YB CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01037; Human CST1 (Note=Isoform SN2). 127229686 CVCL_A6YA Cys-SN2(N3338) hybridoma house mouse CVCL_A6YA CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01037; Human CST1 (Note=Isoform SN2). 127229687 CVCL_A6YD Glut1(D3638-22) hybridoma house mouse CVCL_A6YD CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P11166; Human SLC2A1. 127229688 CVCL_A6YC Cys-SN2(N3372) hybridoma house mouse CVCL_A6YC CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01037; Human CST1 (Note=Isoform SN2). 127229689 CVCL_A6YF Glut1(D4425-2) hybridoma house mouse CVCL_A6YF CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P11166; Human SLC2A1. 127229690 CVCL_A6YE Glut1(D3643-9) hybridoma house mouse CVCL_A6YE CL:0000010 Monoclonal antibody isotype: IgG3, kappa; Monoclonal antibody target: UniProtKB; P11166; Human SLC2A1. 127229691 CVCL_A6YH Glut1(D4417-14) hybridoma house mouse CVCL_A6YH CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P11166; Human SLC2A1. 127229692 CVCL_A6YG Glut1(D4416-3) hybridoma house mouse CVCL_A6YG CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P11166; Human SLC2A1. 127229693 CVCL_A7HH Ctrl. BS PBiPS37-Sv4F-1 induced pluripotent stem cell human CVCL_A7HH From: Institut d'Investigacio Biomedica de Girona Dr Josep Trueta; Salt; Spain. CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127229694 CVCL_A7HG WAe009-A-55 embryonic stem cell human CVCL_A7HG From: Brown University; Providence; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple_edited; p.Arg208Ter (c.622C>T); ClinVar=VCV000002643; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33845243); Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple_edited; p.Asn210Asn (c.630C>T); ClinVar=VCV003678568; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33845243) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127229695 CVCL_A7HJ iPSC 09-25 induced pluripotent stem cell human CVCL_A7HJ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1480; CAPN3; Simple; p.Lys254Glu (c.760A>G); Zygosity=Heterozygous (PubMed=33862537); Sequence variation: Mutation; HGNC; HGNC:1480; CAPN3; Simple; p.Pro637Hisfs*25 (c.1910delC); Zygosity=Heterozygous (PubMed=33862537) Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229696 CVCL_A7HI iPSC 08-46 induced pluripotent stem cell human CVCL_A7HI CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1480; CAPN3; Simple; p.Arg490Trp (c.1468C>T); ClinVar=VCV000166790; Zygosity=Heterozygous (PubMed=33862537); Sequence variation: Mutation; HGNC; HGNC:1480; CAPN3; Simple; p.Arg788Serfs*14 (c.2362_2363delAGinsTCATCT); ClinVar=VCV000017618; Zygosity=Heterozygous (PubMed=33862537) Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014; Cell type: Fibroblast of skin; CL=CL_0002620. Male 127229697 CVCL_A7HL iPSC 09-88 induced pluripotent stem cell human CVCL_A7HL CL:0000010 Derived from site: In situ; Breast, skin; UBERON=UBERON_8480030; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229698 CVCL_A7HK ESi100-A induced pluripotent stem cell human CVCL_A7HK From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 127229699 CVCL_A7HN CalJa ESC 1 embryonic stem cell CVCL_A7HN CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Karyotypic information: 46,XX,-20,+mar (PubMed=33711687); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 127229700 CVCL_A7HM iPSC 11-03 induced pluripotent stem cell human CVCL_A7HM CL:0000010 Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 127229701 CVCL_A7HB WAe009-A-49 embryonic stem cell human CVCL_A7HB From: Brown University; Providence; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple_edited; c.509-1G>C (IVS5-1G>C); ClinVar=VCV000002644; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33845243) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127229702 CVCL_A7HA UKAi003-A-2 induced pluripotent stem cell human CVCL_A7HA From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple_corrected; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous; Note=By CRISPR/Cas9 (hPSCreg=UKAi003-A-2) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229703 CVCL_A7HD WAe009-A-52 embryonic stem cell human CVCL_A7HD From: Brown University; Providence; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple_edited; c.509-1G>C (IVS5-1G>C); ClinVar=VCV000002644; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=WAe009-A-52) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127229704 CVCL_A7HC WAe009-A-51 embryonic stem cell human CVCL_A7HC From: Brown University; Providence; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple_edited; c.509-1G>C (IVS5-1G>C); ClinVar=VCV000002644; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33845243) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127229705 CVCL_A7HF WAe009-A-54 embryonic stem cell human CVCL_A7HF From: Brown University; Providence; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple_edited; p.Arg208Ter (c.622C>T); ClinVar=VCV000002643; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33845243); Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple_edited; p.Asn210Asn (c.630C>T); ClinVar=VCV003678568; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33845243) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127229706 CVCL_A7HE WAe009-A-53 embryonic stem cell human CVCL_A7HE From: Brown University; Providence; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple_edited; c.509-1G>C (IVS5-1G>C); ClinVar=VCV000002644; Zygosity=Homozygous; Note=By CRISPR/Cas9 (hPSCreg=WAe009-A-53) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127229707 CVCL_A7GW UKAi002-A-1 induced pluripotent stem cell human CVCL_A7GW From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8861; PF4 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Characteristics: Established from a patient that has a JAK2 p.Val617Phe mutation, but this cell line does not contain this mutation 127229708 CVCL_A7GV UKAi002-B induced pluripotent stem cell human CVCL_A7GV From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous (hPSCreg=UKAi002-B) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229709 CVCL_A7GY UKAi003-A induced pluripotent stem cell human CVCL_A7GY CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (hPSCreg=UKAi003-A) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229710 CVCL_A7GX UKAi002-B-1 induced pluripotent stem cell human CVCL_A7GX From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8861; PF4; Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous (PubMed=34391098) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229711 CVCL_A7GZ UKAi003-A-1 induced pluripotent stem cell human CVCL_A7GZ From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous (hPSCreg=UKAi003-A-1); Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple_corrected; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=UKAi003-A-1) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229712 CVCL_A7GN MHHi009-A-4 induced pluripotent stem cell human CVCL_A7GN From: Hannover Medical School, LEBAO (MHH); Hannover; Germany CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=RedStar(nuc) (Note=Red fluorescent protein) Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229713 CVCL_A7GQ IIMCBi001-A induced pluripotent stem cell human CVCL_A7GQ From: International Institute of Molecular and Cell Biology; Warsaw; Poland CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229714 CVCL_A7GP MHHi009-A-eGFP induced pluripotent stem cell human CVCL_A7GP From: Hannover Medical School, LEBAO (MHH); Hannover; Germany CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; RNAseq Male 127229715 CVCL_A7GS SIGi001-A-14 induced pluripotent stem cell human CVCL_A7GS CL:0000010 Population: Caucasian; Cell type: Epithelial cell; CL=CL_0000066. Discontinued: ECACC; 66541213; true Female Characteristics: Contains a HA tag at the C-terminal of both alleles of MAPT (hPSCreg=SIGi001-A-14) 127229716 CVCL_A7GR IIMCBi002-A induced pluripotent stem cell human CVCL_A7GR From: International Institute of Molecular and Cell Biology; Warsaw; Poland CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 127229717 CVCL_A7GU UKAi002-A induced pluripotent stem cell human CVCL_A7GU From: Universitatsklinikum Aachen; Aachen; Germany CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Characteristics: Established from a patient that has a JAK2 p.Val617Phe mutation, but this cell line does not contain this mutation 127229718 CVCL_A7GT SIGi001-A-16 induced pluripotent stem cell human CVCL_A7GT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; p.Pro301Leu (c.902C>T) (P618L, c.1853C>T or P636L, c.1907C>T); ClinVar=VCV000014245; Zygosity=Homozygous; Note=By method not specified (hPSCreg=SIGi001-A-16); Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; c.1920+16C>T (c.2091+16C>T) (c.1866+16C>T) (c.915+16C>T) (c.828+16C>T) (IVS10+16C>T); ClinVar=VCV000098222; Zygosity=Homozygous; Note=By method not specified (EBiSC=SIGi001-A-16) Population: Caucasian; Cell type: Epithelial cell; CL=CL_0000066. Discontinued: ECACC; 66541215; true Female Characteristics: Contains a HA tag at the C-terminal of both alleles of MAPT (hPSCreg=SIGi001-A-16) 127229719 CVCL_A7II WAe001-A-60 embryonic stem cell human CVCL_A7II From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1494; ALX1 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127229720 CVCL_A7IH WAe001-A-63 embryonic stem cell human CVCL_A7IH From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:270; PARP1 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127229721 CVCL_A7IK WAe001-A-65 embryonic stem cell human CVCL_A7IK From: Nanfang Hospital, Southern Medical University; Guangzhou; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:160; ACTL6B Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 127229722 CVCL_A7IJ WAe001-A-58 embryonic stem cell human CVCL_A7IJ CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR; Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del); Genetic integration: Method=Transduction; Gene=UniProtKB; P0DTC9; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleoprotein (N); Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Transduced with a pB-TRE-[SARS-CoV-2-N]-EF1a-rtTA-2A-puroR-2A-EGFP construct In the presence of doxycycline rtTA undergo conformational change, binds to the TRE and activates SARS-CoV-2 N protein expression (PubMed=33771478). Group: SARS-CoV-2 research cell line 127229723 CVCL_A7IM UOMi005-A induced pluripotent stem cell human CVCL_A7IM From: University of Manitoba; Winnipeg; Canada CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Characteristics: While the patient has a 7.3 kb deletion in her mitochondrial DNA, this cell line does not show this deletion (PubMed=33756177; PubMed=33807701) 127229724 CVCL_A7IL WAe009-A-39 embryonic stem cell human CVCL_A7IL From: Zhongshan Ophthalmic Center, Sun Yat-sen University; Guangzhou; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7027; MERTK Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 127229725 CVCL_A7IN UOMi006-A induced pluripotent stem cell human CVCL_A7IN From: University of Manitoba; Winnipeg; Canada CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Characteristics: While the patient has a 5 kb deletion in her mitochondrial DNA, this cell line does not show this deletion (PubMed=33807701; PubMed=33901817) 127229726 CVCL_A7IA CalJa ESC 13 embryonic stem cell CVCL_A7IA CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 127229727 CVCL_A7IC CalJa ESC 15 embryonic stem cell CVCL_A7IC CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 127229728 CVCL_A7IB CalJa ESC 14 embryonic stem cell CVCL_A7IB CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 127229729 CVCL_A7IE CalJa ESC 17 embryonic stem cell CVCL_A7IE CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Donor information: Embryo is sibling to that giving rise to CalJa ESC 16 (Cellosaurus=CVCL_A7ID); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Group: Non-human primate cell line 127229730 CVCL_A7ID CalJa ESC 16 embryonic stem cell CVCL_A7ID CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Karyotypic information: 46,XY [4/9]; 46,X,+19 [2/9]; 47,XY,+19 [3/9] (PubMed=33711687); Donor information: Embryo is sibling to that giving rise to CalJa ESC 17 (Cellosaurus=CVCL_A7IE); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Group: Non-human primate cell line 127229731 CVCL_A7IG CPGHi003-A induced pluripotent stem cell human CVCL_A7IG From: Chinese PLA Institute of Otolaryngology, Chinese PLA General Hospital; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:8768; AIFM1; Simple; p.Arg422Gln (c.1265G>A); ClinVar=VCV000162480; Zygosity=Hemizygous (PubMed=34088005) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229732 CVCL_A7IF CPGHi002-A-1 induced pluripotent stem cell human CVCL_A7IF From: Chinese PLA Institute of Otolaryngology, Chinese PLA General Hospital; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:854; ATP6V1B2; Simple_corrected; p.Arg506Ter (c.1516C>T); ClinVar=VCV000203442; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=33714068) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229733 CVCL_A7HX CalJa ESC 10 embryonic stem cell CVCL_A7HX CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 127229734 CVCL_A7HW CalJa ESC 9 embryonic stem cell CVCL_A7HW CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Group: Non-human primate cell line 127229735 CVCL_A7HZ CalJa ESC 12 embryonic stem cell CVCL_A7HZ CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Karyotypic information: 46,XY [2/7]; 46,XY,del(13p) [4/7]; 46,XY,del(3q),del(13p) [1/7] (PubMed=33711687); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Group: Non-human primate cell line 127229736 CVCL_A7HY CalJa ESC 11 embryonic stem cell CVCL_A7HY CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Group: Non-human primate cell line 127229737 CVCL_A7HP CalJa ESC 2 embryonic stem cell CVCL_A7HP CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 127229738 CVCL_A7HR CalJa ESC 4 embryonic stem cell CVCL_A7HR CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Karyotypic information: 46,XX [2/6]; 46,XX,-20,+mar [1/6]; 47,XX,+5 [2/6]; 47,XX,+5,del(5p),del(13p) [1/6] (PubMed=33711687); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 127229739 CVCL_A7HQ CalJa ESC 3 embryonic stem cell CVCL_A7HQ CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Karyotypic information: 46,XX,del(13p) (PubMed=33711687); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 127229740 CVCL_A7HT CalJa ESC 6 embryonic stem cell CVCL_A7HT CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 127229741 CVCL_A7HS CalJa ESC 5 embryonic stem cell CVCL_A7HS CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 127229742 CVCL_A7HV CalJa ESC 8 embryonic stem cell CVCL_A7HV CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Karyotypic information: 46,XX,del(13p) [5/8]; 46,XX,-1,+4,del(4q),del(13p) [1/8]; 46,XX,+4,-5,del(4q) [1/8]; 47,XX,+15,del(13p) [1/8] (PubMed=33711687); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 127229743 CVCL_A7HU CalJa ESC 7 embryonic stem cell CVCL_A7HU CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Karyotypic information: 46,XY [2/5]; 46,XY,del(1p) [2/5]; 45,X,del(1p) [1/5] (PubMed=33711687); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Group: Non-human primate cell line 127229744 CVCL_A7FF WS9001 transformed cell line human CVCL_A7FF CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229745 CVCL_A7FE WS8901 transformed cell line human CVCL_A7FE CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229746 CVCL_A7FH WS12101 transformed cell line human CVCL_A7FH CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229747 CVCL_A7FG WS9401 transformed cell line human CVCL_A7FG CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229748 CVCL_A7FJ WS14101 transformed cell line human CVCL_A7FJ CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229749 CVCL_A7FI WS12701 transformed cell line human CVCL_A7FI CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229750 CVCL_A7FL WS6401 transformed cell line human CVCL_A7FL CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=10543396) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229751 CVCL_A7FK WS5802 transformed cell line human CVCL_A7FK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=10543396) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229752 CVCL_A7FB 7B5 hybridoma house mouse CVCL_A7FB CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; O14965; Human AURKA. 127229753 CVCL_A7FA 2E1 [Mouse hybridoma against human AURKA] hybridoma house mouse CVCL_A7FA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; O14965; Human AURKA. 127229754 CVCL_A7FD WS6104 transformed cell line human CVCL_A7FD CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=10543396) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229755 CVCL_A7FC WS10001 transformed cell line human CVCL_A7FC CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Homozygous (PubMed=10543396) Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229756 CVCL_A7EU UT-SCC-122 cancer cell line human CVCL_A7EU CL:0000010 Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956. Omics: Transcriptomics; Microarray; Omics: Variations; Array-based CGH Male 127229757 CVCL_A7ET UT-SCC-114 cancer cell line human CVCL_A7ET CL:0000010 Derived from site: In situ; Oral cavity, lower lip; UBERON=UBERON_0001835. Omics: Transcriptomics; Microarray; Omics: Variations; Array-based CGH Male 127229758 CVCL_A7EW HCC4006-OsiR cancer cell line human CVCL_A7EW CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu747_Glu749del (c.2239_2247delTAAGAGAA); ClinVar=VCV000177765; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205His (c.613T>C); ClinVar=VCV000376685; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_90943; Osimertinib (AZD9291); Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175; Cell type: Epithelial cell; CL=CL_0000066. Male 127229759 CVCL_A7EV PF130 cancer cell line human CVCL_A7EV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6840; MAP2K1; Simple; p.Glu102_Lys104delinsGln (c.303_310del8ins); Zygosity=Unspecified (PubMed=33669371) Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Male 127229760 CVCL_A7EY 35C1 hybridoma house mouse CVCL_A7EY CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; O14965; Human AURKA (Note=Also reacts with mouse). 127229761 CVCL_A7EX NCI-H1975 CS cancer cell line human CVCL_A7EX CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_edited; p.Cys797Ser (c.2389T>A); ClinVar=VCV000376342; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=32928921); Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Female 127229762 CVCL_A7EZ 1A3 [Mouse hybridoma against human AURKA] hybridoma house mouse CVCL_A7EZ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; O14965; Human AURKA. 127229763 CVCL_A7EM UT-SCC-73 cancer cell line human CVCL_A7EM CL:0000010 Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Omics: Transcriptomics; Microarray; Omics: Variations; Array-based CGH Female 127229764 CVCL_A7EL UT-SCC-72 cancer cell line human CVCL_A7EL CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828. Omics: Transcriptomics; Microarray; Omics: Variations; Array-based CGH Male 127229765 CVCL_A7EN UT-SCC-81 cancer cell line human CVCL_A7EN CL:0000010 Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Omics: Transcriptomics; Microarray; Omics: Variations; Array-based CGH Male 127229766 CVCL_A7EQ UT-SCC-95 cancer cell line human CVCL_A7EQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val143Gly (c.428T>G); ClinVar=VCV000486556; Zygosity=Heterozygous (PubMed=29970484) Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Omics: Transcriptomics; Microarray; Omics: Variations; Array-based CGH Female 127229767 CVCL_A7EP UT-SCC-87 cancer cell line human CVCL_A7EP CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile255Phe (c.763A>T); ClinVar=VCV000376621; Zygosity=Homozygous (PubMed=29970484) Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Omics: Transcriptomics; Microarray; Omics: Variations; Array-based CGH Female 127229768 CVCL_A7ES UT-SCC-112 cancer cell line human CVCL_A7ES CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828. Omics: Transcriptomics; Microarray; Omics: Variations; Array-based CGH Female 127229769 CVCL_A7ER UT-SCC-99 cancer cell line human CVCL_A7ER CL:0000010 Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Omics: Transcriptomics; Microarray; Omics: Variations; Array-based CGH Male 127229770 CVCL_A7GG SDUBMSi005-A induced pluripotent stem cell human CVCL_A7GG From: School of Basic Medical Sciences, Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1748; CDH1; Simple; p.Thr560Arg (c.1679C>G); ClinVar=VCV000234554; Zygosity=Heterozygous (PubMed=33770698) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229771 CVCL_A7GF SDUBMSi008-A induced pluripotent stem cell human CVCL_A7GF From: School of Basic Medical Sciences, Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2207; COL4A5; Simple; p.Arg266Ter (c.796C>T); ClinVar=VCV000024325; Zygosity=Hemizygous (PubMed=33878711) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229772 CVCL_A7GI SDUBMSi004-A induced pluripotent stem cell human CVCL_A7GI From: School of Basic Medical Sciences, Shandong University; Jinan; China. CL:0000010 Female 127229773 CVCL_A7GH SDUBMSi003-A induced pluripotent stem cell human CVCL_A7GH From: School of Basic Medical Sciences, Shandong University; Jinan; China. CL:0000010 Male 127229774 CVCL_A7GK MHHi021-A induced pluripotent stem cell human CVCL_A7GK From: Hannover Medical School, LEBAO (MHH); Hannover; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Arg723Gly (c.2167C>G); ClinVar=VCV000042885; Zygosity=Heterozygous (PubMed=33578365) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Caution: MYH7 mutation indicated incorrectly as being at c.2169C>G in PubMed=33578365 127229775 CVCL_A7GJ SIAISi013-A induced pluripotent stem cell human CVCL_A7GJ From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China. CL:0000010 127229776 CVCL_A7GM MHHi009-A induced pluripotent stem cell human CVCL_A7GM From: Hannover Medical School, LEBAO (MHH); Hannover; Germany CL:0000010 Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male 127229777 CVCL_A7GL MHHi021-B induced pluripotent stem cell human CVCL_A7GL From: Hannover Medical School, LEBAO (MHH); Hannover; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Arg723Gly (c.2167C>G); ClinVar=VCV000042885; Zygosity=Heterozygous (PubMed=33578365) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Caution: MYH7 mutation indicated incorrectly as being at c.2169C>G in PubMed=33578365 127229778 CVCL_A7GA MHHi001-A-5 induced pluripotent stem cell human CVCL_A7GA From: Hannover Medical School, LEBAO (MHH); Hannover; Germany CL:0000010 Genetic integration: Method=TALEN; Gene=FPbase; F5GKU; GCaMP6f (Note=Green fluorescent calcium sensor); Genetic integration: Method=TALEN; Gene=FPbase; -; RedStar(nuc) (Note=Red fluorescent protein) Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female Characteristics: Using TALEN two constructs, a CAG-promoter driven GCamP6f and a CAG-prpmoter driven RedStar(nuc) were introduced in both alleles of the AAVS1 safe harbor locus (PubMed=33571874) 127229779 CVCL_A7GC GZHMCi007-A induced pluripotent stem cell human CVCL_A7GC From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18078; ZBTB7A; Sequence variation: Mutation; HGNC; HGNC:4824; HBA2; Simple; p.Ter143Glnext*32 (c.427T>C); ClinVar=VCV000015624; Zygosity=Homozygous; Note=Hb Constant Spring (from parent cell line) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229780 CVCL_A7GB GZHMCi006-A induced pluripotent stem cell human CVCL_A7GB From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China CL:0000010 Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173. Male 127229781 CVCL_A7GE SDUBMSi007-A induced pluripotent stem cell human CVCL_A7GE From: School of Basic Medical Sciences, Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2207; COL4A5; Simple; p.Arg266Ter (c.796C>T); ClinVar=VCV000024325; Zygosity=Hemizygous (PubMed=33878711) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229782 CVCL_A7GD SDUBMSi006-A induced pluripotent stem cell human CVCL_A7GD From: School of Basic Medical Sciences, Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2204; COL4A3; Simple; p.Gly1406Arg (c.4216G>A); Zygosity=Heterozygous (PubMed=33601099); Sequence variation: Mutation; HGNC; HGNC:2204; COL4A3; Simple; p.Gly1415Arg (c.4243G>A); Zygosity=Heterozygous (PubMed=33601099) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229783 CVCL_A7FV 8H3 [Mouse hybridoma against human WRN] hybridoma house mouse CVCL_A7FV CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q14191; Human WRN. 127229784 CVCL_A7FU 4H12 [Mouse hybridoma against human WRN] hybridoma house mouse CVCL_A7FU CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q14191; Human WRN. 127229785 CVCL_A7FX JAWSII/EGFP spontaneously immortalized cell line house mouse CVCL_A7FX CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53; Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Dendritic cell; CL=CL_0000451; Breed/subspecies: C57BL/6 Trp53-/-. 127229786 CVCL_A7FW HEC-LTT conditionally immortalized cell line human CVCL_A7FW CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR; Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066; Cell type: Endothelial cell of umbilical vein; CL=CL_0002618. Unspecified Characteristics: Transduced with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16; Characteristics: In the presence of doxycycline, hTERT and SV40-TAg expression are activated, resulting in high cell proliferation and unlimited expansion In the absence of the doxycycline, cells stop proliferating and can be maintained in a growth-arrested state that reflects the status of endothelial cells in vivo (PubMed=26345505). 127229787 CVCL_A7FZ C3-luc transformed cell line house mouse CVCL_A7FZ CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val); Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Breed/subspecies: C57BL/6. Unspecified 127229788 CVCL_A7FY JAWSII/IL-12 spontaneously immortalized cell line house mouse CVCL_A7FY CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53; Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96539; Il12a; Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96540; Il12b Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Dendritic cell; CL=CL_0000451; Breed/subspecies: C57BL/6 Trp53-/-. 127229789 CVCL_A7FN WS12001 transformed cell line human CVCL_A7FN CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Tyr463Ter (c.1389T>A) (c.1620T>A); Zygosity=Homozygous (PubMed=10543396) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229790 CVCL_A7FM WS11701 transformed cell line human CVCL_A7FM CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; c.3460-7T>A (IVS29-7T>A); ClinVar=VCV000647377; Zygosity=Homozygous (PubMed=10543396) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229791 CVCL_A7FP WS25401 transformed cell line human CVCL_A7FP CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Ala1306Serfs*13 (c.3915dupA) (c.4146insA); ClinVar=VCV000005448; Zygosity=Homozygous (PubMed=10543396) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229792 CVCL_A7FR 3D12 [Mouse hybridoma against human WRN] hybridoma house mouse CVCL_A7FR CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q14191; Human WRN. 127229793 CVCL_A7FQ NSYM transformed cell line human CVCL_A7FQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=10543396) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Senescence: Not immortalized 127229794 CVCL_A7FT 4F8 [Mouse hybridoma against human WRN] hybridoma house mouse CVCL_A7FT CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q14191; Human WRN. 127229795 CVCL_A7FS 4D9 hybridoma house mouse CVCL_A7FS CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q14191; Human WRN. 127229796 CVCL_A7DD N0014 transformed cell line human CVCL_A7DD CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male Senescence: Not immortalized; senesces at 125 PDL (PubMed=9365237) 127229797 CVCL_A7DC N0012 transformed cell line human CVCL_A7DC CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female Senescence: Not immortalized; senesces at 103 PDL (PubMed=9365237) 127229798 CVCL_A7DF N0103 transformed cell line human CVCL_A7DF CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=9365237) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male Senescence: Not immortalized; senesces at 30 PDL (PubMed=9365237) 127229799 CVCL_A7DE N0102 transformed cell line human CVCL_A7DE CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=9365237; PubMed=10543396) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female Senescence: Not immortalized; senesces at 80 PDL (PubMed=9365237) 127229800 CVCL_A7DH N4702 transformed cell line human CVCL_A7DH CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Senescence: Not immortalized; senesces at 80 PDL (PubMed=9365237) 127229801 CVCL_A7DG N0104 transformed cell line human CVCL_A7DG CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous (PubMed=9365237) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female Senescence: Not immortalized; senesces at 136 PDL (PubMed=9365237) 127229802 CVCL_A7DJ 1E7 [Mouse hybridoma against mouse Celf3] hybridoma house mouse CVCL_A7DJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8CIN6; Mouse Celf3. 127229803 CVCL_A7DI N7401 transformed cell line human CVCL_A7DI CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Senescence: Not immortalized; senesces at 75 PDL (PubMed=9365237) 127229804 CVCL_A7CZ N0009 transformed cell line human CVCL_A7CZ CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male Senescence: Not immortalized; senesces at 58 PDL (PubMed=9365237) 127229805 CVCL_A7DB N0011 transformed cell line human CVCL_A7DB CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male Senescence: Not immortalized; senesces at 65 PDL (PubMed=9365237) 127229806 CVCL_A7DA N0010 transformed cell line human CVCL_A7DA CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male Senescence: Not immortalized; senesces at 75 PDL (PubMed=9365237) 127229807 CVCL_A7CS WS12301 transformed cell line human CVCL_A7CS CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous (PubMed=10543396) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229808 CVCL_A7CR WS11901 transformed cell line human CVCL_A7CR CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous (PubMed=9365237; PubMed=10543396) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229809 CVCL_A7CU N0002 transformed cell line human CVCL_A7CU CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Senescence: Not immortalized; senesces at 56 PDL (PubMed=9365237) 127229810 CVCL_A7CT N0001 transformed cell line human CVCL_A7CT CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Senescence: Not immortalized; senesces at 80 PDL (PubMed=9365237) 127229811 CVCL_A7CW N0006 transformed cell line human CVCL_A7CW CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male Senescence: Not immortalized; senesces at 150 PDL (PubMed=9365237) 127229812 CVCL_A7CV N0004 transformed cell line human CVCL_A7CV CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female Senescence: Not immortalized; senesces at 66 PDL (PubMed=9365237) 127229813 CVCL_A7CY N0008 transformed cell line human CVCL_A7CY CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male Senescence: Not immortalized; senesces at 149 PDL (PubMed=9365237) 127229814 CVCL_A7CX N0007 transformed cell line human CVCL_A7CX CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male Senescence: Not immortalized; senesces at 111 PDL (PubMed=9365237) 127229815 CVCL_A7CK WS11601 transformed cell line human CVCL_A7CK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237; PubMed=10543396) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229816 CVCL_A7CJ WS11301 transformed cell line human CVCL_A7CJ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous (PubMed=9365237); Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=9365237) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229817 CVCL_A7CM WS0702 transformed cell line human CVCL_A7CM CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229818 CVCL_A7CL WS0701 transformed cell line human CVCL_A7CL CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229819 CVCL_A7CN WS0801 transformed cell line human CVCL_A7CN CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237; PubMed=10543396) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229820 CVCL_A7CQ WS11801 transformed cell line human CVCL_A7CQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229821 CVCL_A7CP WS6201 transformed cell line human CVCL_A7CP CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Glu1149Glyfs (c.3446delA) (c.3677delA); ClinVar=VCV003595545; Zygosity=Homozygous (PubMed=9365237; PubMed=10543396) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229822 CVCL_A7EE UT-SCC-79A cancer cell line human CVCL_A7EE CL:0000010 Derived from site: Metastatic; Parotid lymph node; UBERON=UBERON_0015857. Omics: Genomics; Whole exome sequencing Female 127229823 CVCL_A7ED UT-SCC-63A cancer cell line human CVCL_A7ED CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828. Omics: Genomics; Whole exome sequencing Male 127229824 CVCL_A7EG UT-SCC-59B cancer cell line human CVCL_A7EG CL:0000010 Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429. Male 127229825 CVCL_A7EF UT-SCC-59C cancer cell line human CVCL_A7EF CL:0000010 Derived from site: Metastatic; Parotid lymph node; UBERON=UBERON_0015857. Omics: Genomics; Whole exome sequencing Male 127229826 CVCL_A7EI UT-SCC-79B cancer cell line human CVCL_A7EI CL:0000010 Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429. Female 127229827 CVCL_A7EH UT-SCC-63B cancer cell line human CVCL_A7EH CL:0000010 Derived from site: Metastatic; Not specified. Male 127229828 CVCL_A7EK UT-SCC-65 cancer cell line human CVCL_A7EK CL:0000010 Derived from site: In situ; Oral cavity, soft palate; UBERON=UBERON_0001733; Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372. Omics: Transcriptomics; Microarray; Omics: Variations; Array-based CGH Male 127229829 CVCL_A7EJ UT-SCC-67 cancer cell line human CVCL_A7EJ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=29970484) Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Omics: Transcriptomics; Microarray; Omics: Variations; Array-based CGH Female 127229830 CVCL_A7EA UT-SCC-76B cancer cell line human CVCL_A7EA CL:0000010 Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Omics: Genomics; Whole exome sequencing Male Caution: UT-SCC-76A and UT-SCC-76B are supposed to originate from the same patient but have totally different STR profiles 127229831 CVCL_A7EC UT-SCC-126A cancer cell line human CVCL_A7EC CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu130Phe (c.388C>T); ClinVar=VCV000216466; Zygosity=Heterozygous (PubMed=29970484); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Lys (c.511G>A); ClinVar=VCV000141566; Zygosity=Heterozygous (PubMed=29970484) Derived from site: In situ; Oral cavity, lower lip; UBERON=UBERON_0001835. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; Microarray; Omics: Variations; Array-based CGH Female 127229832 CVCL_A7EB UT-SCC-110A cancer cell line human CVCL_A7EB CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Homozygous (PubMed=29970484) Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; Microarray; Omics: Variations; Array-based CGH Male 127229833 CVCL_A7DT SCCNij172 cancer cell line human CVCL_A7DT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Unspecified (PubMed=33802339) Derived from site: In situ; Larynx, supraglottis; UBERON=UBERON_0036263. Unspecified Characteristics: Established from a xenograft maintained in mouse 127229834 CVCL_A7DS SCCNij167 cancer cell line human CVCL_A7DS CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Unspecified (PubMed=33802339) Derived from site: In situ; Larynx, supraglottis; UBERON=UBERON_0036263. Unspecified Characteristics: Established from a xenograft maintained in mouse 127229835 CVCL_A7DV SCCNij202 cancer cell line human CVCL_A7DV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.783-1G>T; ClinVar=VCV000634661; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=33802339) Derived from site: In situ; Larynx, supraglottis; UBERON=UBERON_0036263. Unspecified Characteristics: Established from a xenograft maintained in mouse 127229836 CVCL_A7DU SCCNij185 cancer cell line human CVCL_A7DU CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.His708Asn (c.2122C>A); Zygosity=Unspecified (PubMed=33802339); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Unspecified (PubMed=33802339); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Serfs*13 (c.457_469del); Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=33802339) Derived from site: In situ; Larynx, supraglottis; UBERON=UBERON_0036263. Unspecified Characteristics: Established from a xenograft maintained in mouse 127229837 CVCL_A7DX UT-SCC-74A cancer cell line human CVCL_A7DX CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Homozygous (PubMed=29970484) Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; Microarray; Omics: Variations; Array-based CGH Male 127229838 CVCL_A7DW UT-SCC-54C cancer cell line human CVCL_A7DW CL:0000010 Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. Omics: Genomics; Whole exome sequencing Female Caution: UT-SCC-54A, UT-SCC-54B and UT-SCC-54C are supposed to originate from the same patient but the STR profile of UT-SCC-54C is totally different from that of the two other cell lines 127229839 CVCL_A7DZ UT-SCC-76A cancer cell line human CVCL_A7DZ CL:0000010 Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; Microarray; Omics: Variations; Array-based CGH Male Caution: UT-SCC-76A and UT-SCC-76B are supposed to originate from the same patient but have totally different STR profiles 127229840 CVCL_A7DY UT-SCC-74B cancer cell line human CVCL_A7DY CL:0000010 Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429. Omics: Genomics; Whole exome sequencing Male 127229841 CVCL_A7DL Anti-Dgcr14 hybridoma house mouse CVCL_A7DL CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O70279; Mouse Ess2/Dgcr14. 127229842 CVCL_A7DK Anti-6330403k07Rik hybridoma house mouse CVCL_A7DK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8VBZ2; Mouse 6330403k07Rik. 127229843 CVCL_A7DN A5201A hybridoma house mouse CVCL_A7DN CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q92542; Human NCSTN. 127229844 CVCL_A7DM KN7 hybridoma CVCL_A7DM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Anti-idiotypic against monoclonal antibody TG40-BP1. 127229845 CVCL_A7DP A5226A hybridoma house mouse CVCL_A7DP CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: UniProtKB; Q92542; Human NCSTN. 127229846 CVCL_A7DR SCCNij153 cancer cell line human CVCL_A7DR CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Unspecified (PubMed=33802339) Derived from site: In situ; Larynx, supraglottis; UBERON=UBERON_0036263. Unspecified Characteristics: Established from a xenograft maintained in mouse 127229847 CVCL_A7DQ HepG2-NIAS cancer cell line human CVCL_A7DQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Characteristics: Can not only rapidly activate hepatic functions such as albumin secretion, urea synthesis and CYP3A4 activity but also induce the formation of bile canaliculus-like structures by utilizing a collagen vitrigel membrane as a culture substratum (RCB=RCB4679) 127229848 CVCL_A7BB CT30 somatic stem cell human CVCL_A7BB CL:0000010 Derived from site: In situ; Trophoblast, cytotrophoblast; UBERON=UBERON_0000319. Female Characteristics: Trophoblast stem cell line Senescence: Senesces at 150 PDL (RCB=RCB4938); Doubling time: 19.4 +- 1.6 hours (PubMed=29249463) 127229849 CVCL_A7BA CT29 somatic stem cell human CVCL_A7BA CL:0000010 Derived from site: In situ; Trophoblast, cytotrophoblast; UBERON=UBERON_0000319. Male Characteristics: Trophoblast stem cell line Senescence: Senesces at 150 PDL (RCB=RCB4937); Doubling time: 22.6 +- 2.5 hours (PubMed=29249463) 127229850 CVCL_A7BD MEF_Hsp47 KO-11 spontaneously immortalized cell line house mouse CVCL_A7BD CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:88283; Serpinh1 Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified 127229851 CVCL_A7BC MEF_Hsp47 WT-1 spontaneously immortalized cell line house mouse CVCL_A7BC CL:0000010 Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified Characteristics: Control cell line for MEF_Hsp47 KO-11 (Cellosaurus=CVCL_A7BD) and MEF_Hsp47 KO-13 (Cellosaurus=CVCL_A7BE) 127229852 CVCL_A7BF PSA4 cancer cell line house mouse CVCL_A7BF CL:0000010 Breed/subspecies: 129/Sv. 127229853 CVCL_A7BE MEF_Hsp47 KO-13 spontaneously immortalized cell line house mouse CVCL_A7BE CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:88283; Serpinh1 Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified 127229854 CVCL_A7BH eIF2ak(4KO) transformed cell line house mouse CVCL_A7BH CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353448; Eif2ak1; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353449; Eif2ak2; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1341830; Eif2ak3; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353427; Eif2ak4 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C57BL/6J. Unspecified 127229855 CVCL_A7BG PSA5-E cancer cell line house mouse CVCL_A7BG CL:0000010 Derived from site: In situ; Visceral endoderm; UBERON=UBERON_0004877; Breed/subspecies: 129/Sv. 127229856 CVCL_A7AY HEK-DsupdeltaC transformed cell line human CVCL_A7AY CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P0DOW4; Ramazzottius varieornatus Dsup (Note=With p.Lys360_Lys445del) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 127229857 CVCL_A7AX HEK-DsupKD transformed cell line human CVCL_A7AX CL:0000010 Knockout cell: Method=shRNA knockdown; UniProtKB; P0DOW4; Ramazzottius varieornatus Dsup; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P0DOW4; Ramazzottius varieornatus Dsup; Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Expresses Dsup under the control of a constitutive CAG promoter (PubMed=27649274) 127229858 CVCL_A7AZ CT27 somatic stem cell human CVCL_A7AZ CL:0000010 Derived from site: In situ; Trophoblast, cytotrophoblast; UBERON=UBERON_0000319. Female Characteristics: Trophoblast stem cell line Senescence: Senesces at 150 PDL (RCB=RCB4936); Doubling time: 24.0 +- 1.7 hours (PubMed=29249463) 127229859 CVCL_A7AQ MCC138c cancer cell line human CVCL_A7AQ CL:0000010 Population: Japanese; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Established from a xenograft induced in NOD/SCID/gammacnull (NOG) mice (PubMed=31019292) Doubling time: 48 hours (RCB=RCB5007) 127229860 CVCL_A7AP MCC121c cancer cell line human CVCL_A7AP CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048. Characteristics: Established from a xenograft induced in NOD/SCID/gammacnull (NOG) mice 127229861 CVCL_A7AS HeLa PRDX6 KO cancer cell line human CVCL_A7AS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16753; PRDX6 Miscellaneous: Cell line information from personal communication of Laflamme, Carl Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 127229862 CVCL_A7AR MCC148c cancer cell line human CVCL_A7AR CL:0000010 Population: Korean; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Established from a xenograft induced in NOD/SCID/gammacnull (NOG) mice (PubMed=31019292) Doubling time: 48 hours (RCB=RCB5008) 127229863 CVCL_A7AU HeLa/Fucci(CA)5 cancer cell line human CVCL_A7AU CL:0000010 Genetic integration: Method=Transfection; Gene=FPbase; 886AH; AzaleaB5 (Note=Red fluorescent protein from Montipora monasteriata); Genetic integration: Method=Transfection; Gene=FPbase; YQ25V; h2-3 (Note=Bright green/yellow fluorescent protein from Ricordea sp FP2-3).; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24576; CDT1 (Note=With p.Ser101_Leu546del and p.Arg68Ala, p.Arg69Ala and p.Leu70Ala); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17493; GMNN (Note=With p.Tyr111_Ile209del) Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Characteristics: Used for study of cell cycle progression thanks to the inclusion of a Fucci(CA5) (Fluorescent Ubiquitination-based Cell Cycle Indicator) construct (PubMed=37394513); Characteristics: Transfected with the Fucci(CA)5 probe which consist of the fusion of AzaleaB5 to the ubiquitination domain of human CDT1 (AA 1-100) but with the Cy motif 68-RRL-70 replaced by AAA and of h2-3 to the ubiquitination domain of human geminin (AA 1-110) (PubMed=37394513) 127229864 CVCL_A7AT CFS414 transformed cell line CVCL_A7AT CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: Continental Chestnut Flanked White; VBO=VBO_0017485. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male Doubling time: ~23.9 hours (PubMed=35288582) Group: Bird cell line 127229865 CVCL_A7AW HEK-Dsup transformed cell line human CVCL_A7AW CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P0DOW4; Ramazzottius varieornatus Dsup Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Expresses Dsup under the control of a constitutive CAG promoter (PubMed=27649274) 127229866 CVCL_A7AV HeLa/Fucci(SA)5 cancer cell line human CVCL_A7AV CL:0000010 Genetic integration: Method=Transfection; Gene=FPbase; 886AH; AzaleaB5 (Note=Red fluorescent protein from Montipora monasteriata); Genetic integration: Method=Transfection; Gene=FPbase; YQ25V; h2-3 (Note=Bright green/yellow fluorescent protein from Ricordea sp FP2-3).; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24576; CDT1 (Note=With p.Met1_Thr29del and p.Ser121_Leu546del); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17493; GMNN (Note=With p.Tyr111_Ile209del) Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Characteristics: Used for study of cell cycle progression thanks to the inclusion of a Fucci(SA5) (Fluorescent Ubiquitination-based Cell Cycle Indicator) construct (PubMed=37394513); Characteristics: Transfected with the Fucci(SA)5 probe which consist of the fusion of AzaleaB5 to the ubiquitination domain of human CDT1 (AA 30-120) and of h2-3 to the ubiquitination domain of human geminin (AA 1-110) (PubMed=37394513) 127229867 CVCL_A7AI HeLa M Rab10-KO cancer cell line human CVCL_A7AI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9759; RAB10 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 127229868 CVCL_A7AH S3D8_Spike hybridoma house mouse CVCL_A7AH CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). 127229869 CVCL_A7AK TSD-B4S cancer cell line Norway rat CVCL_A7AK CL:0000010 Derived from site: In situ; Testis; UBERON=UBERON_0000473; Breed/subspecies: Sprague Dawley; RS=RS_0000681. Male Doubling time: 13.4 hours (Note=At 5th passage) (PubMed=24723111) 127229870 CVCL_A7AJ HeLa M Rab22-DKO cancer cell line human CVCL_A7AJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9764; RAB22A; Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9771; RAB31 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 127229871 CVCL_A7AM TSD-P cancer cell line Norway rat CVCL_A7AM CL:0000010 Derived from site: In situ; Testis; UBERON=UBERON_0000473; Breed/subspecies: Sprague Dawley; RS=RS_0000681. Male Doubling time: 12.1 hours (Note=At 25th passage) (PubMed=24723111) 127229872 CVCL_A7AL TSD-F9R cancer cell line Norway rat CVCL_A7AL CL:0000010 Derived from site: In situ; Testis; UBERON=UBERON_0000473; Breed/subspecies: Sprague Dawley; RS=RS_0000681. Male Doubling time: 15.7 hours (Note=At 5th passage) (PubMed=24723111) 127229873 CVCL_A7AN MS-K cancer cell line house mouse CVCL_A7AN CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Breed/subspecies: C3H/HeNSlc. Male Doubling time: 9.4 hours (PubMed=2043753) 127229874 CVCL_A7CC WS10201 transformed cell line human CVCL_A7CC CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Homozygous (PubMed=9365237) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229875 CVCL_A7CB WS9801 transformed cell line human CVCL_A7CB CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229876 CVCL_A7CE WS10901 transformed cell line human CVCL_A7CE CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous (PubMed=9365237; PubMed=10543396) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Caution: Indicated as originating from a 60 year old female in PubMed=9365237 and from a 43 year old female in PubMed=10543396 127229877 CVCL_A7CD WS10501 transformed cell line human CVCL_A7CD CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Homozygous (PubMed=9365237) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229878 CVCL_A7CG WS9601 transformed cell line human CVCL_A7CG CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229879 CVCL_A7CF WS11201 transformed cell line human CVCL_A7CF CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys168Alafs*10 (c.502_503delAA) (c.733_734delAA); ClinVar=VCV000403979; Zygosity=Homozygous (PubMed=9365237) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Caution: Indicated as originating from a 49 year old female in PubMed=9365237 and from a 48 year old male in PubMed=10543396 127229880 CVCL_A7CI WS10801 transformed cell line human CVCL_A7CI CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237; PubMed=10543396) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229881 CVCL_A7CH WS10101 transformed cell line human CVCL_A7CH CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229882 CVCL_A7BZ WS24002 transformed cell line human CVCL_A7BZ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229883 CVCL_A7BY WS10402 transformed cell line human CVCL_A7BY CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229884 CVCL_A7CA WS9101 transformed cell line human CVCL_A7CA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229885 CVCL_A7BR WS5801 transformed cell line human CVCL_A7BR CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=9365237; PubMed=10543396) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229886 CVCL_A7BQ WS6801 transformed cell line human CVCL_A7BQ CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229887 CVCL_A7BT WS0101 transformed cell line human CVCL_A7BT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous (PubMed=9365237); Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=9365237) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229888 CVCL_A7BS WS6501 transformed cell line human CVCL_A7BS CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Heterozygous (PubMed=9365237; PubMed=10543396) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229889 CVCL_A7BV WS11001 transformed cell line human CVCL_A7BV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Homozygous (PubMed=9365237; PubMed=10543396) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229890 CVCL_A7BU WS2101 transformed cell line human CVCL_A7BU CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237; PubMed=10543396) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 127229891 CVCL_A7BX WS23703 transformed cell line human CVCL_A7BX CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Heterozygous (PubMed=9365237; PubMed=10543396); Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous (PubMed=9365237; PubMed=10543396) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Caution: Indicated as originating from a 51 year old male in PubMed=9365237 and from a 39 year old male in PubMed=10543396 127229892 CVCL_A7BW WS23702 transformed cell line human CVCL_A7BW CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Heterozygous (PubMed=9365237); Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous (PubMed=9365237) Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 127229893 CVCL_A7BJ eIF2ak(4KO+PERK) transformed cell line house mouse CVCL_A7BJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353448; Eif2ak1; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353449; Eif2ak2; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1341830; Eif2ak3; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353427; Eif2ak4; Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1353449; Eif2ak2 (Note=With a FLAG tag) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C57BL/6J. Unspecified 127229894 CVCL_A7BI eIF2ak(4KO+HRI) transformed cell line house mouse CVCL_A7BI CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353448; Eif2ak1; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353449; Eif2ak2; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1341830; Eif2ak3; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353427; Eif2ak4; Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1353448; Eif2ak1 (Note=With a FLAG tag) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C57BL/6J. Unspecified 127229895 CVCL_A7BL eIF2ak(4KO+GCN2) transformed cell line house mouse CVCL_A7BL CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353448; Eif2ak1; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353449; Eif2ak2; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1341830; Eif2ak3; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353427; Eif2ak4; Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1353427; Eif2ak4 (Note=With a FLAG tag) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C57BL/6J. Unspecified 127229896 CVCL_A7BK eIF2ak(4KO+PKR) transformed cell line house mouse CVCL_A7BK CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353448; Eif2ak1; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353449; Eif2ak2; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1341830; Eif2ak3; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1353427; Eif2ak4; Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1341830; Eif2ak3 (Note=With a FLAG tag) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C57BL/6J. Unspecified 127229897 CVCL_A7BN TFL-21-7G hybridoma house mouse CVCL_A7BN CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; A2A288; Human ZC3H12D. 127229898 CVCL_A7BM WT(MEF) SV40-immortalized transformed cell line house mouse CVCL_A7BM CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C57BL/6J. Unspecified 127229899 CVCL_A7BP NP-2/CD4/RDC1 cancer cell line human CVCL_A7BP CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:23692; ACKR3; Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Japanese; Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811. Male 150517732 CVCL_A0BH PS2C501 hybridoma house mouse CVCL_A0BH CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4226 150517733 CVCL_A0BI PS1Z134 hybridoma house mouse CVCL_A0BI CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4228 150517734 CVCL_A0BJ PS1Z125 hybridoma house mouse CVCL_A0BJ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4229 150517735 CVCL_A0BK HK1A523 hybridoma house mouse CVCL_A0BK CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P20151; Human KLK2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11876 150517736 CVCL_A0BL HK1D106.4 hybridoma house mouse CVCL_A0BL CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P20151; Human KLK2 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11937 150517737 CVCL_A0BM HK1G464.3 hybridoma house mouse CVCL_A0BM CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P20151; Human KLK2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11983 150517738 CVCL_A0BN HK1G586.1 hybridoma house mouse CVCL_A0BN CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P20151; Human KLK2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12026 150517739 CVCL_A0BA PSM773 hybridoma house mouse CVCL_A0BA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 150517740 CVCL_A0BB PS1P351 hybridoma house mouse CVCL_A0BB CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 150517741 CVCL_A0BC PS1R163 hybridoma house mouse CVCL_A0BC CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 150517742 CVCL_A0BD PS2C109 hybridoma house mouse CVCL_A0BD CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4227 150517743 CVCL_A0BE PS2C807 hybridoma house mouse CVCL_A0BE CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4223 150517744 CVCL_A0BF PS2C837 hybridoma house mouse CVCL_A0BF CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4224 150517745 CVCL_A0BG PS2C634 hybridoma house mouse CVCL_A0BG CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4225 150517746 CVCL_A0AW PR18 hybridoma house mouse CVCL_A0AW CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P28906; Human CD34. 150517747 CVCL_A0AX PSA399 hybridoma house mouse CVCL_A0AX CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 150517748 CVCL_A0AY PSB999 hybridoma house mouse CVCL_A0AY CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 150517749 CVCL_A0AZ PSJ206 hybridoma house mouse CVCL_A0AZ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 150517750 CVCL_A0AP NK92.39 hybridoma house mouse CVCL_A0AP CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P40200; Human CD96. 150517751 CVCL_A0AQ SKII.4 hybridoma house mouse CVCL_A0AQ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P15151; Human PVR/CD155. 150517752 CVCL_A0AR 12.2 hybridoma house mouse CVCL_A0AR CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q95460; Human MR1. 150517753 CVCL_A0AS 26.5 hybridoma house mouse CVCL_A0AS CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q95460; Human MR1 (Note=Also reacts with bovine, mouse and rat). 150517754 CVCL_A0AT CHO-S r34.1 (clone D8) spontaneously immortalized cell line CVCL_A0AT CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Expresses the murine 34.1 monoclonal antibody against the N-terminus of HSV-1 glycoprotein D (gD) (BEI_Resources=ARP-13578) Doubling time: ~24 hours (PubMed=30502324) 150517755 CVCL_A0AU UCSC.PG128.CHO.S.F4 spontaneously immortalized cell line CVCL_A0AU CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Expresses the PGT128 neutralizing monoclonal antibody against the HIV-1 gp120, specifically to the V3 glycan (BEI_Resources=ARP-13590) 150517756 CVCL_A0AV K6.1 hybridoma house mouse CVCL_A0AV CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P28906; Human CD34. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11085 150517757 CVCL_A0CI Pro104.C55.1 hybridoma house mouse CVCL_A0CI CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q9Y6M0; Human PRSS21. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5277 150517758 CVCL_A0CJ Pro104.D9.1 hybridoma house mouse CVCL_A0CJ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9Y6M0; Human PRSS21. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6077 150517759 CVCL_A0CK Pro104.K81.15 hybridoma house mouse CVCL_A0CK CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9Y6M0; Human PRSS21. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6078 150517760 CVCL_A0CL CEMx174/SIVmac316 clone 3D8 hybrid cell line human CVCL_A0CL CL:0000010 Virology: Infected with simian immunodeficiency virus isolate SIVmac316 (BEI_Resources=ARP-13239). 150517761 CVCL_A0CM 902 hybridoma house mouse CVCL_A0CM CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04578; HIV-1 isolate HXB2 env (Note=AA 33-511 = gp120). 150517762 CVCL_A0CN SCL1-CD4 clone 6 cancer cell line human CVCL_A0CN CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val197Ter; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Face, skin; UBERON=UBERON_1000021. Female 150517763 CVCL_A0CP RCMGi006-A induced pluripotent stem cell human CVCL_A0CP From: Research Centre for Medical Genetics; Moscow; Russia CL:0000010 Population: Caucasian; Russian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150517764 CVCL_A0CA 1G10 [Mouse hybridoma against HIV-1 rev] hybridoma house mouse CVCL_A0CA CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P04618; HIV-1 isolate HXB2 rev. 150517765 CVCL_A0CB 1G7 [Mouse hybridoma against HIV-1 rev] hybridoma house mouse CVCL_A0CB CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P04618; HIV-1 isolate HXB2 rev. 150517766 CVCL_A0CC 8E7 [Mouse hybridoma against HIV-1 rev] hybridoma house mouse CVCL_A0CC CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P04618; HIV-1 isolate HXB2 rev. 150517767 CVCL_A0CD 9G2 [Mouse hybridoma against HIV-1 rev] hybridoma house mouse CVCL_A0CD CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P04618; HIV-1 isolate HXB2 rev. 150517768 CVCL_A0CE 1D9 [Mouse hybridoma against HIV-1 isolate HXB2 tat] hybridoma house mouse CVCL_A0CE CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P04608; HIV-1 isolate HXB2 tat. 150517769 CVCL_A0CF 1C6.5 hybridoma house mouse CVCL_A0CF CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P20881; HIV-2 isolate ST vpx. 150517770 CVCL_A0CG 6D2.6 hybridoma house mouse CVCL_A0CG CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P20881; HIV-2 isolate ST vpx. 150517771 CVCL_A0CH Pro104.C25.1 hybridoma house mouse CVCL_A0CH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q9Y6M0; Human PRSS21. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6076 150517772 CVCL_A0BX VCaP-CR cancer cell line human CVCL_A0BX CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:11876; TMPRSS2; Name(s)=TMPRSS2-ERG (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7127; MLH1; Simple; p.Ile219Val (c.655A>G); ClinVar=VCV000036557; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Bone, vertebra; UBERON=UBERON_0002412. Omics: Proteomics; Omics: Transcriptomics; RNAseq Male Characteristics: Derived after a passage of the parent cell line in castrated nude mice; Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (from parent cell line VCaP) Doubling time: ~60 hours (PubMed=34402095) 150517773 CVCL_A0BY CHO MGAT1- A244_N332-rgp120 5F spontaneously immortalized cell line CVCL_A0BY CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Produces a gp120 from a modified A244 isolate (A244_N332-rgp120) where a glycosylation was moved from Asn-334 to Asn-332 It is enriched for mannose-5 glycans. The gp120 construct contains an N-terminal purification tag from HSV-1 glycoprotein D (gD) (PubMed=30071025). 150517774 CVCL_A0BP HK1H247 hybridoma house mouse CVCL_A0BP CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P20151; Human KLK2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12162 150517775 CVCL_A0BQ S14-1 transformed cell line house mouse CVCL_A0BQ CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA255); Derived from site: In situ; Testis; UBERON=UBERON_0000473; Cell type: Sertoli cell; CL=CL_0000216; Breed/subspecies: BALB/c. Male Characteristics: Expresses transferrin and SGP-2, lacks a FSH response, and is capable of forming epithelial tumors in nude mice (PubMed=8214009) 150517776 CVCL_A0BR NCC-ssRMS2-C1 cancer cell line human CVCL_A0BR CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7611; MYOD1; None_reported; -; Zygosity=- (PubMed=34164773) Population: Japanese; Derived from site: In situ; Back; UBERON=UBERON_0001137. Omics: Phenotyping; Drug screening; Omics: Variations; SNP array analysis Male Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi); Doubling time: ~41 hours (PubMed=34164773) Part of: NCC sarcoma cell line panel 150517777 CVCL_A0BT CHO MGAT1- TZ97008-rgp120 2D7 spontaneously immortalized cell line CVCL_A0BT CL:0000010 Knockout cell: Method=CRISPR/Cas9; UniProtKB; Q924C0; Mgat1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=HIV-1 isolate TZ97008 env (gp120) Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Produces a gp120 from a clade C isolate (TZ97008-rgp120) and enriched for mannose-5 glycans The gp120 construct contains an N-terminal purification tag from HSV-1 glycoprotein D (gD). Group: Serum/protein free medium cell line 150517778 CVCL_A0BU CHO MGAT1- TZ97008-rgp120 3E5 spontaneously immortalized cell line CVCL_A0BU CL:0000010 Knockout cell: Method=CRISPR/Cas9; UniProtKB; Q924C0; Mgat1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=HIV-1 isolate TZ97008 env (gp120) Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Produces a gp120 from a clade C isolate (TZ97008-rgp120) and enriched for mannose-5 glycans The gp120 construct contains an N-terminal purification tag from HSV-1 glycoprotein D (gD). Group: Serum/protein free medium cell line 150517779 CVCL_A0BV 34.1 hybridoma house mouse CVCL_A0BV CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q05059; Human herpesvirus 1 (strain F) glycoprotein D (gD) (Note=Recognizes the p.Lys26_Gln52 N-terminal region used as a purification tag). 150517780 CVCL_A0BW LAPC4-CR cancer cell line human CVCL_A0BW CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (from parent cell line) Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. Omics: Proteomics; Omics: Transcriptomics; RNAseq Male Characteristics: Derived after 4 passages of the parent cell line in castrated nude mice; Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (from parent cell line LAPC-4) Doubling time: ~50 hours (PubMed=34402095) 150517781 CVCL_A0AG 183-H12-5C hybridoma house mouse CVCL_A0AG CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P03347; HIV-1 isolate BH10 gag (Note=AA 133-363 = p24). 150517782 CVCL_A0AH 4B2 [Macaca B-cell transformed] transformed cell line CVCL_A0AH CL:0000010 Transformant: NCBI_TaxID; 45455; Rhesus lymphocryptovirus (Macacine herpesvirus 4); Derived from site: In situ; Lymph node; UBERON=UBERON_0000029; Cell type: B-cell; CL=CL_0000236. Unspecified Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: UniProtKB; E7CWP5; Simian immunodeficiency virus (isolate SIVmac239) (SIV-mac) env (gp41) Group: Non-human primate cell line 150517783 CVCL_A0AI 6E6 [Macaca B-cell transformed] transformed cell line CVCL_A0AI CL:0000010 Transformant: NCBI_TaxID; 45455; Rhesus lymphocryptovirus (Macacine herpesvirus 4); Derived from site: In situ; Lymph node; UBERON=UBERON_0000029; Cell type: B-cell; CL=CL_0000236. Unspecified Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: UniProtKB; E7CWP5; Simian immunodeficiency virus (isolate SIVmac239) (SIV-mac) env (gp41) Group: Non-human primate cell line 150517784 CVCL_A0AJ Cr24.1 hybridoma house mouse CVCL_A0AJ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; O95727; Human CRTAM/CD355. 150517785 CVCL_A0AK CR24.2.8 hybridoma house mouse CVCL_A0AK CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; O95727; Human CRTAM/CD355. 150517786 CVCL_A0AL 2.29 hybridoma house mouse CVCL_A0AL CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O95944; Human NCR2/CD336. 150517787 CVCL_A0AM 3.43 hybridoma house mouse CVCL_A0AM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O95944; Human NCR2/CD336. 150517788 CVCL_A0AN 11A8 hybridoma house mouse CVCL_A0AN CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q15762; Human CD226. 150517789 CVCL_A0AA 168B17-46-34 hybridoma house mouse CVCL_A0AA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P03409; Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) tax. 150517790 CVCL_A0AB 168B17-46-50 hybridoma house mouse CVCL_A0AB CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P03409; Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) tax. 150517791 CVCL_A0AC 168B17-46-70 hybridoma house mouse CVCL_A0AC CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P03409; Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) tax. 150517792 CVCL_A0AD 168B17-46-92 hybridoma house mouse CVCL_A0AD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P03409; Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) tax. 150517793 CVCL_A0AE 168A51-2 hybridoma house mouse CVCL_A0AE CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P03409; Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) tax. 150517794 CVCL_A0AF 168A51-42 hybridoma house mouse CVCL_A0AF CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P03409; Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) tax. 150517795 CVCL_A0JP JTUi005-A induced pluripotent stem cell human CVCL_A0JP From: Sixth People's Hospital, Shanghai Jiao Tong University; Shanghai; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:53924; NOTCH2NLC; Simple; c.-164GGC[(66_517)]; ClinVar=VCV000691867; Zygosity=Heterozygous; Note=62 GGC repeats (PubMed=36244083); Sequence variation: Mutation; HGNC; HGNC:53924; NOTCH2NLC; Simple; c.-164GGC[(66_517)]; ClinVar=VCV000691867; Zygosity=Heterozygous; Note=100 GGC repeats (PubMed=36244083) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517796 CVCL_A0JQ OFi001-A induced pluripotent stem cell human CVCL_A0JQ From: OrganFactory; Kiheung; South Korea CL:0000010 Population: East Asian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Female 150517797 CVCL_A0JR OFi002-A induced pluripotent stem cell human CVCL_A0JR From: OrganFactory; Kiheung; South Korea CL:0000010 Population: East Asian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Male 150517798 CVCL_A0JS YCMi004-A induced pluripotent stem cell human CVCL_A0JS From: Yonsei University College of Medicine; Seoul; South Korea CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple; p.Arg23351Ter (c.70051C>T); ClinVar=VCV000405145; Zygosity=Heterozygous (PubMed=34952434) Population: Korean; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517799 CVCL_A0JT YCMi005-A induced pluripotent stem cell human CVCL_A0JT From: Yonsei University College of Medicine; Seoul; South Korea CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12010; TPM1; Simple; p.Glu192Lys (c.574G>A); ClinVar=VCV000031882; Zygosity=Heterozygous (PubMed=35176663) Population: Korean; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150517800 CVCL_A0JU IUFi001-A induced pluripotent stem cell human CVCL_A0JU From: Leibniz Research Institute for Environmental Medicine; Dusseldorf; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Lys337Ter (c.1009A>T) (A1088T); ClinVar=VCV000550722; Zygosity=Heterozygous (PubMed=34271225); Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg857Ter (c.2569C>T); ClinVar=VCV000553383; Zygosity=Heterozygous (PubMed=34271225) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150517801 CVCL_A0JV SANi006-A induced pluripotent stem cell human CVCL_A0JV From: Sanquin; Amsterdam; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; HGNC:31928; NBEAL2; Simple; p.Cys2190Alafs*23 (c.6568delT); ClinVar=VCV000982280; Zygosity=Heterozygous (PubMed=34237592); Sequence variation: Mutation; HGNC; HGNC:31928; NBEAL2; Simple; p.Leu2646Pro (c.7937T>C); ClinVar=VCV000982281; Zygosity=Heterozygous (PubMed=34237592) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Female 150517802 CVCL_A0JW SANi007-A induced pluripotent stem cell human CVCL_A0JW From: Sanquin; Amsterdam; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3309; ELANE; Simple; c.614delG; Zygosity=Heterozygous (PubMed=34229202) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Female 150517803 CVCL_A0JH 31H12 hybridoma house mouse CVCL_A0JH CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: Salmonella enteritidis subserogroup E lipopolysaccharide (LPS) O:3 antigen. 150517804 CVCL_A0JI 45F6 hybridoma house mouse CVCL_A0JI CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Salmonella enteritidis subserogroup E lipopolysaccharide (LPS) O:3 antigen. 150517805 CVCL_A0JJ SDW18.1.1 hybridoma house mouse CVCL_A0JJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P01375; Human TNF. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9228 150517806 CVCL_A0JK 4C3 [Mouse hybridoma against human MSMB] hybridoma house mouse CVCL_A0JK CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08118; Human MSMB. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9121; Registration: Upjohn Culture Collection; UC HB-17 150517807 CVCL_A0JL 7A5F9 hybridoma house mouse CVCL_A0JL CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08118; Human MSMB. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9224; Registration: Upjohn Culture Collection; UC HB-18 150517808 CVCL_A0JM 8H4C7 hybridoma house mouse CVCL_A0JM CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08118; Human MSMB. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9225; Registration: Upjohn Culture Collection; UC HB-19 150517809 CVCL_A0JN 11C11B11 hybridoma house mouse CVCL_A0JN CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08118; Human MSMB. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9226; Registration: Upjohn Culture Collection; UC HB-20 150517810 CVCL_A0JA M32-8 hybridoma house mouse CVCL_A0JA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P00533; Human EGFR (Note=With p.Gly719Cys). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2012127 150517811 CVCL_A0JB M80-14 hybridoma house mouse CVCL_A0JB CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P00533; Human EGFR (Note=With p.Leu861Gln (c.2582T>A)). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201315 150517812 CVCL_A0JC M85-13 hybridoma house mouse CVCL_A0JC CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P00533; Human EGFR (Note=With p.Leu858Arg (c.2573T>G)). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2012125 150517813 CVCL_A0JD 177E6 hybridoma house mouse CVCL_A0JD CL:0000010 Monoclonal antibody isotype: IgA; Monoclonal antibody target: Salmonella enteritidis subserogroup OD1 lipopolysaccharide (LPS) O:9 antigen (Note=Also reacts with subserogroup OD3). 150517814 CVCL_A0JE 178H11 hybridoma house mouse CVCL_A0JE CL:0000010 Monoclonal antibody isotype: IgA; Monoclonal antibody target: Salmonella enteritidis subserogroup OD1 lipopolysaccharide (LPS) O:9 antigen. 150517815 CVCL_A0JF 24E6 hybridoma house mouse CVCL_A0JF CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Salmonella enteritidis subserogroup E lipopolysaccharide (LPS) O:3 antigen. 150517816 CVCL_A0JG 29E1 hybridoma house mouse CVCL_A0JG CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Salmonella enteritidis subserogroup E lipopolysaccharide (LPS) O:3 antigen. 150517817 CVCL_A0IW M120 hybridoma house mouse CVCL_A0IW CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P00533; Human EGFR (Note=With p.Gly863Asp). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201304 150517818 CVCL_A0IX M121#1 hybridoma house mouse CVCL_A0IX CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P00533; Human EGFR (Note=With p.Asp761Tyr). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201303 150517819 CVCL_A0IY M122#1 hybridoma house mouse CVCL_A0IY CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P00533; Human EGFR (Note=With p.Val769Leu (c.2305G>T)). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201316 150517820 CVCL_A0IZ M20-18 hybridoma house mouse CVCL_A0IZ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P00533; Human EGFR (Note=With p.Gly719Ser (c.2155G>A)). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2012118 150517821 CVCL_A0KQ UNIBSi016-A induced pluripotent stem cell human CVCL_A0KQ From: University of Brescia; Brescia; Italy CL:0000010 Sequence variation: Mutation; HGNC; HGNC:29253; CC2D2A; Simple; p.Glu1000Val (c.2999A>T); ClinVar=VCV000217604; Zygosity=Heterozygous (PubMed=34182252); Sequence variation: Mutation; HGNC; HGNC:29253; CC2D2A; Simple; p.Gly1213Alafs*7 (c.3638delG); ClinVar=VCV002040349; Zygosity=Heterozygous (PubMed=34182252) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150517822 CVCL_A0KR UNIBSi016-B induced pluripotent stem cell human CVCL_A0KR From: University of Brescia; Brescia; Italy CL:0000010 Sequence variation: Mutation; HGNC; HGNC:29253; CC2D2A; Simple; p.Glu1000Val (c.2999A>T); ClinVar=VCV000217604; Zygosity=Heterozygous (PubMed=34182252); Sequence variation: Mutation; HGNC; HGNC:29253; CC2D2A; Simple; p.Gly1213Alafs*7 (c.3638delG); ClinVar=VCV002040349; Zygosity=Heterozygous (PubMed=34182252) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150517823 CVCL_A0KS UNIBSi016-C induced pluripotent stem cell human CVCL_A0KS From: University of Brescia; Brescia; Italy CL:0000010 Sequence variation: Mutation; HGNC; HGNC:29253; CC2D2A; Simple; p.Glu1000Val (c.2999A>T); ClinVar=VCV000217604; Zygosity=Heterozygous (PubMed=34182252); Sequence variation: Mutation; HGNC; HGNC:29253; CC2D2A; Simple; p.Gly1213Alafs*7 (c.3638delG); ClinVar=VCV002040349; Zygosity=Heterozygous (PubMed=34182252) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150517824 CVCL_A0KT LANCEi020-A-1 induced pluripotent stem cell human CVCL_A0KT From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517825 CVCL_A0KU LANCEi020-A-10 induced pluripotent stem cell human CVCL_A0KU From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; c.3713-28_3833del (Ex31del); Zygosity=Heterozygous (PubMed=34174776); Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; c.3713-30_3833del (Ex31del); Zygosity=Heterozygous (PubMed=34174776) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517826 CVCL_A0KV LANCEi020-A-2 induced pluripotent stem cell human CVCL_A0KV From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517827 CVCL_A0KW LANCEi020-A-3 induced pluripotent stem cell human CVCL_A0KW From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517828 CVCL_A0KX LANCEi020-A-4 induced pluripotent stem cell human CVCL_A0KX From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3603; FBN1 (Note=1 of 2 alleles) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517829 CVCL_A0KI KUTTAMi002-A induced pluripotent stem cell human CVCL_A0KI From: Research Center for Translational Medicine, Koc Universitesi; Istanbul; Turkey CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150517830 CVCL_A0KJ KUTTAMi003-A induced pluripotent stem cell human CVCL_A0KJ From: Research Center for Translational Medicine, Koc Universitesi; Istanbul; Turkey CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150517831 CVCL_A0KK EMe-NH6W523S1 induced pluripotent stem cell human CVCL_A0KK From: Cincinnati Children's Hospital Medical Center Pluripotent Stem Cell Facility; Cincinnati; USA CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517832 CVCL_A0KL EMe-NH6W523XS7 induced pluripotent stem cell human CVCL_A0KL From: Cincinnati Children's Hospital Medical Center Pluripotent Stem Cell Facility; Cincinnati; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11079; SLC9A6; Simple; p.Trp523Ter (c.1569G>A); Zygosity=Hemizygous (PubMed=34182254) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517833 CVCL_A0KM EMe-NH6W523K5 induced pluripotent stem cell human CVCL_A0KM From: Cincinnati Children's Hospital Medical Center Pluripotent Stem Cell Facility; Cincinnati; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11079; SLC9A6; Simple_corrected; p.Trp523Ter (c.1569G>A); Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=34182254) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517834 CVCL_A0KN EMe-NH6W523K17 induced pluripotent stem cell human CVCL_A0KN From: Cincinnati Children's Hospital Medical Center Pluripotent Stem Cell Facility; Cincinnati; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11079; SLC9A6; Simple_corrected; p.Trp523Ter (c.1569G>A); Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=34182254) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517835 CVCL_A0KP UNIBSi015-A induced pluripotent stem cell human CVCL_A0KP From: University of Brescia; Brescia; Italy. CL:0000010 150517836 CVCL_A0KA HEBHMUi009-A induced pluripotent stem cell human CVCL_A0KA From: Hebei Medical University; Shijiazhuang; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=34218115) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517837 CVCL_A0KB UCLi014-A induced pluripotent stem cell human CVCL_A0KB From: University College London; London; United Kingdom CL:0000010 Sequence variation: Mutation; HGNC; HGNC:19977; RDH12; Simple; p.Phe254Leufs*24 (c.759delC); ClinVar=VCV000812389; Zygosity=Heterozygous (PubMed=34216980) Population: Kurdistani and Tunisian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150517838 CVCL_A0KC UCLi015-A induced pluripotent stem cell human CVCL_A0KC From: University College London; London; United Kingdom CL:0000010 Sequence variation: Mutation; HGNC; HGNC:19977; RDH12; Simple; p.Asn207Asp (c.619A>G); ClinVar=VCV000805924; Zygosity=Homozygous (PubMed=34216980) Population: Pakistani; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150517839 CVCL_A0KD UCLAi005-A induced pluripotent stem cell human CVCL_A0KD From: University of California, Los Angeles; Los Angeles; USA CL:0000010 Population: Asian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150517840 CVCL_A0KE UCLAi005-B induced pluripotent stem cell human CVCL_A0KE From: University of California, Los Angeles; Los Angeles; USA CL:0000010 Population: Asian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150517841 CVCL_A0KF UCLAi005-C induced pluripotent stem cell human CVCL_A0KF From: University of California, Los Angeles; Los Angeles; USA CL:0000010 Population: Asian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150517842 CVCL_A0KG CUIMCi003-A induced pluripotent stem cell human CVCL_A0KG From: Columbia University Irving Medical Center; New York; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:16876; ARNT2; Simple; p.Pro130Ala (c.388C>G); Zygosity=Heterozygous; Note=De novo mutation (PubMed=34214899; PubMed=35390757) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150517843 CVCL_A0KH KUTTAMi001-A induced pluripotent stem cell human CVCL_A0KH From: Research Center for Translational Medicine, Koc Universitesi; Istanbul; Turkey CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150517844 CVCL_A0JX SANi008-A induced pluripotent stem cell human CVCL_A0JX From: Sanquin; Amsterdam; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1968; LYST; Simple; p.Glu1441Valfs*11 (c.4322_4325delAGAG); ClinVar=VCV001173104; Zygosity=Heterozygous (PubMed=34224985); Sequence variation: Mutation; HGNC; HGNC:1968; LYST; Simple; p.Asn3376Ser (c.10127A>G); ClinVar=VCV000065529; Zygosity=Heterozygous (PubMed=34224985) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Male 150517845 CVCL_A0JY SANi009-A induced pluripotent stem cell human CVCL_A0JY From: Sanquin; Amsterdam; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; HGNC:566; AP3B1; Simple; p.Lys59Asnfs*5 (c.177delA); ClinVar=VCV000224763; Zygosity=Heterozygous (PubMed=34182253); Sequence variation: Mutation; HGNC; HGNC:566; AP3B1; Simple; c.1839_1842delTAGA; ClinVar=VCV000224764; Zygosity=Heterozygous (PubMed=34182253) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150517846 CVCL_A0JZ SANi010-A induced pluripotent stem cell human CVCL_A0JZ From: Sanquin; Amsterdam; Netherlands CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150517847 CVCL_A0HN 3G5 [Mouse hybridoma against human RPSA] hybridoma house mouse CVCL_A0HN CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517848 CVCL_A0HP 4C11 [Mouse hybridoma against human RPSA] hybridoma house mouse CVCL_A0HP CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517849 CVCL_A0HQ 4F6 [Mouse hybridoma against human RPSA] hybridoma house mouse CVCL_A0HQ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517850 CVCL_A0HR 7A5 hybridoma house mouse CVCL_A0HR CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517851 CVCL_A0HS 8E4 [Mouse hybridoma against human RPSA] hybridoma house mouse CVCL_A0HS CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517852 CVCL_A0HU 9D8 [Mouse hybridoma against human RPSA] hybridoma house mouse CVCL_A0HU CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517853 CVCL_A0HF 1A1/B2 hybridoma house mouse CVCL_A0HF CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: Opisthorchis felineus 105 Kda excretory-secretory antigen. Group: Patented cell line 150517854 CVCL_A0HG 10E4 hybridoma house mouse CVCL_A0HG CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517855 CVCL_A0HH 16A3 hybridoma house mouse CVCL_A0HH CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517856 CVCL_A0HI 1B5 [Mouse hybridoma against human RPSA] hybridoma house mouse CVCL_A0HI CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517857 CVCL_A0HJ 1D2 [Mouse hybridoma against human RPSA] hybridoma house mouse CVCL_A0HJ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517858 CVCL_A0HK 21H1 hybridoma house mouse CVCL_A0HK CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517859 CVCL_A0HL 2H9 [Mouse hybridoma against human RPSA] hybridoma house mouse CVCL_A0HL CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517860 CVCL_A0HM 3E6 [Mouse hybridoma against human RPSA] hybridoma house mouse CVCL_A0HM CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08865; Human RPSA. 150517861 CVCL_A0HA THP18 cancer cell line human CVCL_A0HA CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517862 CVCL_A0HB THP18-deltaA3A cancer cell line human CVCL_A0HB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17343; APOBEC3A; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517863 CVCL_A0HC THP18-deltaA3A/B cancer cell line human CVCL_A0HC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17343; APOBEC3A; Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17352; APOBEC3B; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150517864 CVCL_A0HD 1D6 [Mouse hybridoma against O.viverrini Ov-TSP-2] hybridoma house mouse CVCL_A0HD CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; M1G6I5; Opisthorchis viverrini tetraspanin 2A (Ov-TSP-2). 150517865 CVCL_A0HE 3F5 [Mouse hybridoma against O.viverrini Ov-TSP-2] hybridoma house mouse CVCL_A0HE CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; M1G6I5; Opisthorchis viverrini tetraspanin 2A (Ov-TSP-2). 150517866 CVCL_A0GU Mel-XY2 cancer cell line human CVCL_A0GU HLA typing: A*30,33; B*18,65 (PubMed=17448240) CL:0000010 Population: Caucasian; Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097. Male Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2831 150517867 CVCL_A0GV Mel-XY3 cancer cell line human CVCL_A0GV HLA typing: A*02:01,23; B*18,18 (PubMed=17448240) CL:0000010 Population: Caucasian; Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097. Male Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2832 150517868 CVCL_A0GW MGPK alphaVbeta6-C5 spontaneously immortalized cell line pig CVCL_A0GW CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=VGNC; VGNC:30323; Bovine ITGAV; Genetic integration: Method=Transduction; Gene=VGNC; VGNC:30331; Bovine ITGB6. Unspecified Virology: Combined treatment of the parent cell line with BVDV NS5A siRNA, interferon alpha and ribavirin has cured the cell line from bovine viral diarrhea virus (BVDV) infection (PubMed=34092457); Virology: Susceptible to infection by foot-and-mouth disease virus (PubMed=34092457) Problematic cell line: Misidentified Grand-parent cell line (LF-BK) was originally thought to be of bovine origin but originates from pig. 150517869 CVCL_A0GX MB5 transformed cell line human CVCL_A0GX CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S) 150517870 CVCL_A0GY MC8 transformed cell line human CVCL_A0GY CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S) 150517871 CVCL_A0GZ 5210-87-13 hybridoma CVCL_A0GZ CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: UniProtKB; Q9UH17; Human APOBEC3B (Note=Also partially reacts with APOBEC3A and APOBEC3G). 150517872 CVCL_A0IP K5-116-2-1 hybridoma house mouse CVCL_A0IP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11253 150517873 CVCL_A0IQ K5-70 hybridoma house mouse CVCL_A0IQ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11251 150517874 CVCL_A0IR T5-86 hybridoma house mouse CVCL_A0IR CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11254 150517875 CVCL_A0IS T6-16 hybridoma house mouse CVCL_A0IS CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11346 150517876 CVCL_A0IT M116 hybridoma house mouse CVCL_A0IT CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P00533; Human EGFR (Note=With p.Gly719Ala). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201301 150517877 CVCL_A0IU M117-10 hybridoma house mouse CVCL_A0IU CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P00533; Human EGFR (Note=With p.Asn826Ser). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201320 150517878 CVCL_A0IV M118#7 hybridoma house mouse CVCL_A0IV CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P00533; Human EGFR (Note=With p.Ala839Thr). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201302 150517879 CVCL_A0IG 31-6-1 hybridoma house mouse CVCL_A0IG CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P02778; Human CXCL10. Group: Patented cell line; Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00143 150517880 CVCL_A0IH JEV_1 hybridoma house mouse CVCL_A0IH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P27395; Japanese encephalitis virus (JEV) polyprotein (Note=AA 1-105 = Capsid protein C). Group: Patented cell line; Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00258 150517881 CVCL_A0II JEV_2 hybridoma house mouse CVCL_A0II CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P27395; Japanese encephalitis virus (JEV) polyprotein (Note=AA 1-105 = Capsid protein C). Group: Patented cell line; Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00259 150517882 CVCL_A0IJ 4G12 [Mouse hybridoma against ASFV CD2v] hybridoma house mouse CVCL_A0IJ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; A0A0A7W5A6; African swine fever virus (isolate DB/LN/2018) CD2 homolog (CD2v). Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.19947 150517883 CVCL_A0IK UN1 hybridoma house mouse CVCL_A0IK CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P16150; Human SPN/CD43. 150517884 CVCL_A0IL UMG1 hybridoma house mouse CVCL_A0IL CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P16150; Human SPN/CD43. Group: Patented cell line; Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 16001 150517885 CVCL_A0IM CDina26 hybridoma house mouse CVCL_A0IM CL:0000010 Biotechnology: Was used to produce the monoclonal antibody begelomab (Begedina) which was evaluated as a therapeutic agent against steroid-resistant acute graft-versus-host disease Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P27487; Human DPP4/CD26. Group: Patented cell line; Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 12002 150517886 CVCL_A0IN K5-107 hybridoma house mouse CVCL_A0IN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11252 150517887 CVCL_A0IA 1B-4971 hybridoma house mouse CVCL_A0IA CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1. Group: Patented cell line 150517888 CVCL_A0IB anti-MERS CoV P1 hybridoma house mouse CVCL_A0IB CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; K9N4V7; Middle East respiratory syndrome-related coronavirus (MERS-CoV) nucleoprotein (N). Group: Patented cell line; Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00331 150517889 CVCL_A0IC anti-MERS CoV P3 hybridoma house mouse CVCL_A0IC CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; K9N4V7; Middle East respiratory syndrome-related coronavirus (MERS-CoV) nucleoprotein (N). Group: Patented cell line; Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00332 150517890 CVCL_A0ID 124-11-2 hybridoma house mouse CVCL_A0ID CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P02778; Human CXCL10. Group: Patented cell line; Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00142 150517891 CVCL_A0IE 137-2-1 hybridoma house mouse CVCL_A0IE CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P02778; Human CXCL10. Group: Patented cell line; Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00145 150517892 CVCL_A0IF 28-2-3 hybridoma house mouse CVCL_A0IF CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P02778; Human CXCL10. Group: Patented cell line; Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00144 150517893 CVCL_A0HV 1A-3187 hybridoma house mouse CVCL_A0HV CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1. Group: Patented cell line 150517894 CVCL_A0HW 1A-4246 hybridoma house mouse CVCL_A0HW CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1. Group: Patented cell line 150517895 CVCL_A0HX 1B-3246 hybridoma house mouse CVCL_A0HX CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1. Group: Patented cell line 150517896 CVCL_A0HY 1B-3440 hybridoma house mouse CVCL_A0HY CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1. Group: Patented cell line 150517897 CVCL_A0HZ 1B-4863 hybridoma house mouse CVCL_A0HZ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q8NBJ4; Human GOLM1. Group: Patented cell line 150517898 CVCL_A0FL HCA-770H hybridoma house mouse CVCL_A0FL CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517899 CVCL_A0FM HCA-784H hybridoma house mouse CVCL_A0FM CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517900 CVCL_A0FN HCA-803H hybridoma house mouse CVCL_A0FN CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517901 CVCL_A0FP HCA-805 hybridoma house mouse CVCL_A0FP CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517902 CVCL_A0FQ HCA-805HDR hybridoma house mouse CVCL_A0FQ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517903 CVCL_A0FR HCA-838H hybridoma house mouse CVCL_A0FR CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517904 CVCL_A0FS HDA-202 hybridoma house mouse CVCL_A0FS CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; A0A0F7RNT6; Dog ANXA5; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517905 CVCL_A0FD HCA-57HDR hybridoma house mouse CVCL_A0FD CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517906 CVCL_A0FE HCA-627 hybridoma house mouse CVCL_A0FE CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5284 150517907 CVCL_A0FF HCA-646HD hybridoma house mouse CVCL_A0FF CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517908 CVCL_A0FG HCA-656 hybridoma house mouse CVCL_A0FG CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517909 CVCL_A0FH HCA-660HD hybridoma house mouse CVCL_A0FH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517910 CVCL_A0FI HCA-671H hybridoma house mouse CVCL_A0FI CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517911 CVCL_A0FJ HCA-69H hybridoma house mouse CVCL_A0FJ CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517912 CVCL_A0FK HCA-713 hybridoma house mouse CVCL_A0FK CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517913 CVCL_A0FA HCA-293HDR hybridoma house mouse CVCL_A0FA CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517914 CVCL_A0FB HCA-350DHR hybridoma house mouse CVCL_A0FB CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517915 CVCL_A0FC HCA-507HD hybridoma house mouse CVCL_A0FC CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517916 CVCL_A0ES W112 6G-2 hybridoma house mouse CVCL_A0ES CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human T-cell receptor variable beta-5.3. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9927 150517917 CVCL_A0ET 2D1 [Mouse hybridoma against human TcRv beta-8.1] hybridoma house mouse CVCL_A0ET CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human T-cell receptor variable beta-8.1. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9928 150517918 CVCL_A0EU 79RD27 finite cell line human CVCL_A0EU CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150517919 CVCL_A0EV AT3NG finite cell line human CVCL_A0EV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ser2860del (c.8575TCT[1]) (c.8578_8580delTCT) (Ser1512del); ClinVar=VCV000003018; Zygosity=Homozygous (PubMed=7792600) Population: Caucasian; Dutch; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 150517920 CVCL_A0EW HCA-155H hybridoma house mouse CVCL_A0EW CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517921 CVCL_A0EX HCA-212 hybridoma house mouse CVCL_A0EX CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517922 CVCL_A0EY HCA-231H hybridoma house mouse CVCL_A0EY CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517923 CVCL_A0EZ HCA-290 hybridoma house mouse CVCL_A0EZ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517924 CVCL_A0GM 2A5 [Mouse hybridoma against human IL1RL1] hybridoma house mouse CVCL_A0GM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM ABP-10189 150517925 CVCL_A0GN FB9 hybridoma house mouse CVCL_A0GN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM ABP-10190 150517926 CVCL_A0GP HB12 hybridoma house mouse CVCL_A0GP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM ABP-10191 150517927 CVCL_A0GQ ST2-BA-1.1-07E04-02B07-02G06 hybridoma house mouse CVCL_A0GQ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10431 150517928 CVCL_A0GR ST2-BA-1.1-09F08-02D04-01F05 hybridoma house mouse CVCL_A0GR CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10432 150517929 CVCL_A0GS Mel-XX4 cancer cell line human CVCL_A0GS HLA typing: A*24,33; B*18,65 (PubMed=17448240) CL:0000010 Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542. Female Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2829 150517930 CVCL_A0GT Mel-XY1 cancer cell line human CVCL_A0GT HLA typing: A*02:01,23; B*18,37 (PubMed=17448240) CL:0000010 Population: Caucasian; Derived from site: Metastatic; Lung; UBERON=UBERON_0002048. Male Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2830 150517931 CVCL_A0GE NCC-cOV1-C1 cancer cell line human CVCL_A0GE CL:0000010 Population: Japanese; Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Omics: Phenotyping; Drug screening; Omics: Variations; SNP array analysis Female Doubling time: 40 hours (DOI=10.2198/jelectroph.65.23) 150517932 CVCL_A0GF LK1 [Mouse ESC] embryonic stem cell house mouse CVCL_A0GF CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: C57BL/6. Male 150517933 CVCL_A0GG GSI-1 embryonic stem cell house mouse CVCL_A0GG CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: 129X1/SvJ. Unspecified 150517934 CVCL_A0GH HEK293-mST2L transformed cell line human CVCL_A0GH CL:0000010 Genetic integration: Method=Transfection; Gene=MGI; MGI:98427; Il1rl1; Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: The expression of the luciferase reporter gene is under the control of a NF-kappaB-inducible promoter 150517935 CVCL_A0GI CNTO2549 hybridoma CVCL_A0GI CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P14719; Mouse Il1rl1. 150517936 CVCL_A0GJ CNTO8195 hybridoma CVCL_A0GJ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P14719; Mouse Il1rl1. 150517937 CVCL_A0GK CNTO9195 hybridoma CVCL_A0GK CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P14719; Mouse Il1rl1. 150517938 CVCL_A0GL CNTO9383 hybridoma CVCL_A0GL CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P14719; Mouse Il1rl1. 150517939 CVCL_A0GA 4B2 [Mouse/rat hybridoma against mouse Clec7a] hybridoma CVCL_A0GA CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q6QLQ4; Mouse Clec7a/Cd369. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10151 150517940 CVCL_A0GB RH1 [Mouse/rat hybridoma against mouse Clec7a] hybridoma CVCL_A0GB CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q6QLQ4; Mouse Clec7a/Cd369. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10152 150517941 CVCL_A0GC SC30 hybridoma CVCL_A0GC CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q6QLQ4; Mouse Clec7a/Cd369. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10153 150517942 CVCL_A0GD CHO dhfr- Clone 20/1 transformed cell line CVCL_A0GD CL:0000010 Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line) Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Transformant: NCIt; C44386; Gamma radiation; Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female 150517943 CVCL_A0FT HDA-676 hybridoma house mouse CVCL_A0FT CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; A0A0F7RNT6; Dog ANXA5; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517944 CVCL_A0FU HDA-907 hybridoma house mouse CVCL_A0FU CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; A0A0F7RNT6; Dog ANXA5; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5286 150517945 CVCL_A0FV HDA-1018 hybridoma house mouse CVCL_A0FV CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; A0A0F7RNT6; Dog ANXA5; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517946 CVCL_A0FW HDA-1606 hybridoma house mouse CVCL_A0FW CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; A0A0F7RNT6; Dog ANXA5; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517947 CVCL_A0FX HDA-1884 hybridoma house mouse CVCL_A0FX CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; A0A0F7RNT6; Dog ANXA5; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517948 CVCL_A0FY HDA-1937 hybridoma house mouse CVCL_A0FY CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; A0A0F7RNT6; Dog ANXA5; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517949 CVCL_A0FZ HDA-2003 hybridoma house mouse CVCL_A0FZ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; A0A0F7RNT6; Dog ANXA5; Monoclonal antibody target: UniProtKB; P08758; Human ANXA5. 150517950 CVCL_A0DJ PF1-6.1.1.3 hybridoma house mouse CVCL_A0DJ CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5168 150517951 CVCL_A0DK PF1-11-2-1 hybridoma house mouse CVCL_A0DK CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6863 150517952 CVCL_A0DL PF1-11.2.1.4 hybridoma house mouse CVCL_A0DL CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5169 150517953 CVCL_A0DM EL-4 6.1 cancer cell line house mouse CVCL_A0DM CL:0000010 Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR); Selected for resistance to: ChEBI; CHEBI_472805; Ouabain; Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: T-cell; CL=CL_0000084; Breed/subspecies: C57BL/6N. Unspecified 150517954 CVCL_A0DN RL119 hybridoma CVCL_A0DN CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P18572; Mouse Bsg/Cd147. 150517955 CVCL_A0DP RL388 hybridoma CVCL_A0DP CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P10852; Mouse Slc3a2/Cd98. 150517956 CVCL_A0DQ RL73 hybridoma CVCL_A0DQ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P18572; Mouse Bsg/Cd147. 150517957 CVCL_A0DB PF8-2-43-1 hybridoma house mouse CVCL_A0DB CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG4, kappa; Monoclonal antibody target: UniProtKB; O14793; Human MSTN Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6575 150517958 CVCL_A0DC NC17 hybridoma CVCL_A0DC CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P04401; Mouse Il5. Group: Patented cell line 150517959 CVCL_A0DD TB13 hybridoma CVCL_A0DD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P04401; Mouse Il5. Group: Patented cell line 150517960 CVCL_A0DE MCIR1 cancer cell line human CVCL_A0DE CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=34214199); Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=34214199) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Transcriptomics; RNAseq Male Characteristics: Obtained from a ibrutinib-resistant tumor clone (PubMed=34214199) Doubling time: 32 hours (PubMed=34214199) 150517961 CVCL_A0DF 293C18P transformed cell line human CVCL_A0DF CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Group: Patented cell line; Group: Serum/protein free medium cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201913 150517962 CVCL_A0DG PF1-4-1-1 hybridoma house mouse CVCL_A0DG CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6862 150517963 CVCL_A0DH PF1-4.1.1.1 hybridoma house mouse CVCL_A0DH CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5166 150517964 CVCL_A0DI PF1-4.13.1.1 hybridoma house mouse CVCL_A0DI CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin Discontinued: ATCC; PTA-5167; true. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; P16410; Human CTLA4/CD152 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5167 150517965 CVCL_A0CY PF8-1-66-1 hybridoma house mouse CVCL_A0CY CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; O14793; Human MSTN Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6573 150517966 CVCL_A0CZ PF8-2-112-1 hybridoma house mouse CVCL_A0CZ CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG4, kappa; Monoclonal antibody target: UniProtKB; O14793; Human MSTN Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6574 150517967 CVCL_A0DA PF8-2-177-1 hybridoma house mouse CVCL_A0DA CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG4, kappa; Monoclonal antibody target: UniProtKB; O14793; Human MSTN Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6576 150517968 CVCL_A0CQ RBME-6 spontaneously immortalized cell line CVCL_A0CQ CL:0000010 Unspecified Doubling time: ~63 hours (PubMed=34230000). Group: Tick cell line 150517969 CVCL_A0CR PF8-1-116-1 hybridoma house mouse CVCL_A0CR CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; O14793; Human MSTN Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6566 150517970 CVCL_A0CS PF8-1-132-1 hybridoma house mouse CVCL_A0CS CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; O14793; Human MSTN Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6567 150517971 CVCL_A0CT PF8-1-136-3 hybridoma house mouse CVCL_A0CT CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; O14793; Human MSTN Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6568 150517972 CVCL_A0CU PF8-1-257-1 hybridoma house mouse CVCL_A0CU CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; O14793; Human MSTN Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6569 150517973 CVCL_A0CV PF8-1-268-1 hybridoma house mouse CVCL_A0CV CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; O14793; Human MSTN Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6570 150517974 CVCL_A0CW PF8-1-314-1 hybridoma house mouse CVCL_A0CW CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; O14793; Human MSTN Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6571 150517975 CVCL_A0CX PF8-1-46-1 hybridoma house mouse CVCL_A0CX CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; O14793; Human MSTN Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6572 150517976 CVCL_A0EK XMMPS-OP1 hybridoma house mouse CVCL_A0EK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Pseudomonas aeruginosa Fisher type 1 core lipopolysaccharide (LPS). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9384 150517977 CVCL_A0EL XMMPS-OP2 hybridoma house mouse CVCL_A0EL CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Pseudomonas aeruginosa Fisher type 2 core lipopolysaccharide (LPS). 150517978 CVCL_A0EM 5A6.E9 hybridoma house mouse CVCL_A0EM CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04234; Human CD3D. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9772 150517979 CVCL_A0EN deltaTCAR-3 hybridoma house mouse CVCL_A0EN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; B7Z8K6; Human TRDC. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9578 150517980 CVCL_A0EP RS2A-2-H-7 hybridoma house mouse CVCL_A0EP CL:0000010 Characteristics: Isotype switched derivative of deltaTCAR-3; Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; B7Z8K6; Human TRDC. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10110 150517981 CVCL_A0EQ 3A8 [Mouse hybridoma against human TRAC] hybridoma house mouse CVCL_A0EQ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P01848; Human TRAC. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9900 150517982 CVCL_A0ER 3D6 [Mouse hybridoma against human TRAC] hybridoma house mouse CVCL_A0ER CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P01848; Human TRAC. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9901 150517983 CVCL_A0EC Prost 185 hybridoma house mouse CVCL_A0EC CL:0000010 Monoclonal antibody isotype: IgG1. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11425 150517984 CVCL_A0ED Prost 30 hybridoma house mouse CVCL_A0ED CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human prostate epithelial-specific antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11424 150517985 CVCL_A0EE Prost C219 hybridoma house mouse CVCL_A0EE CL:0000010 Monoclonal antibody isotype: IgM. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11893 150517986 CVCL_A0EF Prost C37 hybridoma house mouse CVCL_A0EF CL:0000010 Monoclonal antibody isotype: IgM. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11892 150517987 CVCL_A0EG XMMEN-J5D hybridoma house mouse CVCL_A0EG CL:0000010 Monoclonal antibody isotype: IgG2a. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9083 150517988 CVCL_A0EH XMMEN-LY1 hybridoma house mouse CVCL_A0EH CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Salmonella minnesota R595 core lipopolysaccharide (LPS). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9082 150517989 CVCL_A0EI XMMEN-LY2 hybridoma house mouse CVCL_A0EI CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Salmonella minnesota R595 core lipopolysaccharide (LPS). 150517990 CVCL_A0EJ XMMPS-605 hybridoma house mouse CVCL_A0EJ CL:0000010 Monoclonal antibody isotype: IgG2; Monoclonal antibody target: Pseudomonas aeruginosa (strain PAC 605) core lipopolysaccharide (LPS). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8909 150517991 CVCL_A0DZ IgM-8 hybridoma house mouse CVCL_A0DZ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human IgM. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201850 150517992 CVCL_A0EA Prost 130 hybridoma house mouse CVCL_A0EA CL:0000010 Monoclonal antibody isotype: IgG1. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11427 150517993 CVCL_A0EB Prost 16 hybridoma house mouse CVCL_A0EB CL:0000010 Monoclonal antibody isotype: IgG1. 150517994 CVCL_A0DR HSB.2-A7-D2 cancer cell line human CVCL_A0DR CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:10879; STIL + HGNC; HGNC:11556; TAL1; Name(s)=STIL-TAL1, SIL-TAL1, SIL-SCL (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Pro1175Arg (c.3524C>G); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Tyr226His (c.676T>C); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg621His (c.1862G>A); ClinVar=VCV000016355; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Thr454Ile (c.1361C>T); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Gln455Lys (c.1363C>A); Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: Produces high level of IL2 in response to IL1 150517995 CVCL_A0DS HSB.2-A7-D9 cancer cell line human CVCL_A0DS CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:10879; STIL + HGNC; HGNC:11556; TAL1; Name(s)=STIL-TAL1, SIL-TAL1, SIL-SCL (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Pro1175Arg (c.3524C>G); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Tyr226His (c.676T>C); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg621His (c.1862G>A); ClinVar=VCV000016355; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Thr454Ile (c.1361C>T); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Gln455Lys (c.1363C>A); Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: Produces high level of IL2 in response to IL1 150517996 CVCL_A0DT HSB.2-C5-B2 cancer cell line human CVCL_A0DT CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:10879; STIL + HGNC; HGNC:11556; TAL1; Name(s)=STIL-TAL1, SIL-TAL1, SIL-SCL (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Pro1175Arg (c.3524C>G); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Tyr226His (c.676T>C); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg621His (c.1862G>A); ClinVar=VCV000016355; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1600Pro (c.4799T>C); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Thr454Ile (c.1361C>T); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Gln455Lys (c.1363C>A); Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: Produces high level of IL2 in response to IL1 150517997 CVCL_A0DU hIL1Rm10 hybridoma house mouse CVCL_A0DU CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P14778; Human IL1R1. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10556 150517998 CVCL_A0DV ASE [Anopheles] spontaneously immortalized cell line CVCL_A0DV CL:0000010 Unspecified Group: Insect cell line; Group: Malaria research cell line. 150517999 CVCL_A0DW HeLa S3 AGO2KO cancer cell line human CVCL_A0DW CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:3263; AGO2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Omics: Transcriptomics; RNAseq; Single cell Female 150518000 CVCL_A0DX RM3/1 hybridoma house mouse CVCL_A0DX CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q86VB7; Human CD163. 150518001 CVCL_A0DY MAC 2-158 hybridoma house mouse CVCL_A0DY CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q86VB7; Human CD163. 150518002 CVCL_A0RX 1E5 [Mouse hybridoma against human RB1] hybridoma house mouse CVCL_A0RX CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P06400; Human RB1 Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5710255 and to be FO (Cellosaurus=CVCL_6972) in PubMed=7510760. 150518003 CVCL_A0RY 1G5 [Mouse hybridoma against human RB1] hybridoma house mouse CVCL_A0RY CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P06400; Human RB1 Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5710255 and to be FO (Cellosaurus=CVCL_6972) in PubMed=7510760. 150518004 CVCL_A0RZ 4G2 [Mouse hybridoma against human RB1] hybridoma house mouse CVCL_A0RZ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P06400; Human RB1 Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5710255 and to be FO (Cellosaurus=CVCL_6972) in PubMed=7510760. 150518005 CVCL_A0RP MS-3 hybridoma house mouse CVCL_A0RP CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Metamycoplasma salivarium. 150518006 CVCL_A0RQ MS-4 hybridoma house mouse CVCL_A0RQ CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: Metamycoplasma salivarium. 150518007 CVCL_A0RR MS-5 [Mouse hybridoma against M.salivarium] hybridoma house mouse CVCL_A0RR CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Metamycoplasma salivarium. 150518008 CVCL_A0RS RB1-MAbP2 hybridoma house mouse CVCL_A0RS CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P06400; Human RB1 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10093 150518009 CVCL_A0RT TEC-11 hybridoma house mouse CVCL_A0RT CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P17813; Human ENG/CD105 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12311 Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5660827 and Patent=US5877289 and to be P3X63Ag8.653 (Cellosaurus=CVCL_4032) in PubMed=9815965. 150518010 CVCL_A0RU TEC-4 hybridoma house mouse CVCL_A0RU CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P17813; Human ENG/CD105 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12312 Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5660827 and Patent=US5877289 and to be P3X63Ag8.653 (Cellosaurus=CVCL_4032) in PubMed=9815965. 150518011 CVCL_A0RV 3C8 [Mouse hybridoma against human RB1] hybridoma house mouse CVCL_A0RV CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P06400; Human RB1 (Note=Binds to the C-terminal end) Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12313 Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5710255 and to be FO (Cellosaurus=CVCL_6972) in PubMed=7510760. 150518012 CVCL_A0RW 1D1 hybridoma house mouse CVCL_A0RW CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P06400; Human RB1 Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5710255 and to be FO (Cellosaurus=CVCL_6972) in PubMed=7510760. 150518013 CVCL_A0RH MH-3 hybridoma house mouse CVCL_A0RH CL:0000010 Monoclonal antibody isotype: IgG3, kappa; Monoclonal antibody target: Mesomycoplasma hyorhinis. 150518014 CVCL_A0RI MO-1 hybridoma house mouse CVCL_A0RI CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Metamycoplasma orale. 150518015 CVCL_A0RJ MO-2 hybridoma house mouse CVCL_A0RJ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Metamycoplasma orale. 150518016 CVCL_A0RK MO-3 hybridoma house mouse CVCL_A0RK CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Metamycoplasma orale. 150518017 CVCL_A0RL MP-1 hybridoma house mouse CVCL_A0RL CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Mycoplasmoides pneumoniae. 150518018 CVCL_A0RM MS-1 [Mouse hybridoma against M.salivarium] hybridoma house mouse CVCL_A0RM CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Metamycoplasma salivarium. 150518019 CVCL_A0RN MS-2 [Mouse hybridoma against M.salivarium] hybridoma house mouse CVCL_A0RN CL:0000010 Monoclonal antibody isotype: IgG3, kappa; Monoclonal antibody target: Metamycoplasma salivarium. 150518020 CVCL_A0RA AL-3 hybridoma house mouse CVCL_A0RA CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Acholeplasma laidlawii. 150518021 CVCL_A0RB MA-1 [Mouse hybridoma against M.arginini] hybridoma house mouse CVCL_A0RB CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Mycoplasmopsis arginini. 150518022 CVCL_A0RC MA-2 hybridoma house mouse CVCL_A0RC CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: Mycoplasmopsis arginini. 150518023 CVCL_A0RD MA-3 hybridoma house mouse CVCL_A0RD CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Mycoplasmopsis arginini. 150518024 CVCL_A0RE MA-4 hybridoma house mouse CVCL_A0RE CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Mycoplasmopsis arginini. 150518025 CVCL_A0RF MH-1 [Mouse hybridoma against M.hyorhinis] hybridoma house mouse CVCL_A0RF CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Mesomycoplasma hyorhinis. 150518026 CVCL_A0RG MH-2 [Mouse hybridoma against M.hyorhinis] hybridoma house mouse CVCL_A0RG CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Mesomycoplasma hyorhinis. 150518027 CVCL_A0SY MRIi027-A induced pluripotent stem cell human CVCL_A0SY From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518028 CVCL_A0SZ MRIi024-A induced pluripotent stem cell human CVCL_A0SZ From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10854; SHOX2; Simple; p.His259Gln (c.777C>A) (p.His283Gln, c.849C>A); Zygosity=Heterozygous (PubMed=32976766) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518029 CVCL_A0TA MRIi016-A induced pluripotent stem cell human CVCL_A0TA From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10854; SHOX2; Simple; c.*28T>C; dbSNP=rs138912749; Zygosity=Heterozygous (PubMed=32976766) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518030 CVCL_A0SQ U2OS ATXN3 KO cancer cell line human CVCL_A0SQ From: Durcan, Thomas M.; Montreal Neurological Institute, McGill University; Montreal; Canada CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7106; ATXN3; Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Miscellaneous: Cell line information from personal communication of Laflamme, Carl Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 150518031 CVCL_A0SR NCC-GCTB2-C1 cancer cell line human CVCL_A0SR CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=34304386) Population: Japanese; Derived from site: In situ; Bone, proximal tibia; UBERON=UBERON_0008772. Omics: Phenotyping; Drug screening; Omics: Variations; SNP array analysis Male Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi); Doubling time: 64 hours (PubMed=34304386) Part of: NCC sarcoma cell line panel 150518032 CVCL_A0SS NCC-GCTB3-C1 cancer cell line human CVCL_A0SS CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=34304386) Population: Japanese; Derived from site: In situ; Bone, proximal tibia; UBERON=UBERON_0008772. Omics: Phenotyping; Drug screening; Omics: Variations; SNP array analysis Female Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi); Doubling time: 26 hours (PubMed=34304386) Part of: NCC sarcoma cell line panel 150518033 CVCL_A0ST HL60/MRI cancer cell line human CVCL_A0ST CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Characteristics: Cell line established from the transplantable tumor of the same name 150518034 CVCL_A0SU LCPHi001-A induced pluripotent stem cell human CVCL_A0SU From: The Institute for Tissue Engineering and Regenerative Medicine, Liaocheng People's Hospital; Liaocheng; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (PubMed=34464855); Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Ala495Pro (c.1483G>C) (A456P); ClinVar=VCV000093450; Zygosity=Heterozygous (PubMed=34464855); Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Val499Val (c.1497G>C) (V460V); ClinVar=VCV000093451; Zygosity=Heterozygous (PubMed=34464855) Population: Chinese; Han; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518035 CVCL_A0SV BIUi001-A induced pluripotent stem cell human CVCL_A0SV From: Bar Ilan University; Ramat Gan; Israel CL:0000010 Sequence variation: Mutation; HGNC; HGNC:29456; TOR1AIP1; Simple; p.Arg321Ter (c.961C>T); ClinVar=VCV000804380; Zygosity=Homozygous (PubMed=34560421) Population: Arab; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518036 CVCL_A0SW BIUi002-A induced pluripotent stem cell human CVCL_A0SW From: Bar Ilan University; Ramat Gan; Israel CL:0000010 Sequence variation: Mutation; HGNC; HGNC:29456; TOR1AIP1; Simple; p.Arg321Ter (c.961C>T); ClinVar=VCV000804380; Zygosity=Homozygous (PubMed=34560421) Population: Arab; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518037 CVCL_A0SX MRIi026-A induced pluripotent stem cell human CVCL_A0SX From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518038 CVCL_A0SI mHypoE-36 transformed cell line house mouse CVCL_A0SI CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898. Female 150518039 CVCL_A0SJ mHypoE-43 transformed cell line house mouse CVCL_A0SJ CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Miscellaneous: Sex of donor from personal communication of Belsham, Denise D Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898. Female 150518040 CVCL_A0SK mHypoA-Kiss/GFP-1 transformed cell line house mouse CVCL_A0SK CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898; Breed/subspecies: 129S6/SvEvTac x C57BL/6NCr Kiss-1tm1.1(cre/EGFP)Stei/J. Male 150518041 CVCL_A0SL mHypoA-Kiss/GFP-2 transformed cell line house mouse CVCL_A0SL CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898; Breed/subspecies: 129S6/SvEvTac x C57BL/6NCr Kiss-1tm1.1(cre/EGFP)Stei/J. Male 150518042 CVCL_A0SM mHypoA-Kiss/GFP-3 transformed cell line house mouse CVCL_A0SM CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Brain, hypothalamus, arcuate nucleus; UBERON=UBERON_0001932; Breed/subspecies: 129S6/SvEvTac x C57BL/6NCr Kiss-1tm1.1(cre/EGFP)Stei/J. Female 150518043 CVCL_A0SN mHypoA-Kiss/GFP-4 transformed cell line house mouse CVCL_A0SN CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Brain, hypothalamus, anteroventral periventricular nucleus; UBERON=UBERON_0002690; Breed/subspecies: 129S6/SvEvTac x C57BL/6NCr Kiss-1tm1.1(cre/EGFP)Stei/J. Female 150518044 CVCL_A0SP HEK293T ATXN3 KO transformed cell line human CVCL_A0SP From: Durcan, Thomas M.; Montreal Neurological Institute, McGill University; Montreal; Canada CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7106; ATXN3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Miscellaneous: Cell line information from personal communication of Laflamme, Carl Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 150518045 CVCL_A0SA 4H6 [Mouse hybridoma against human RB1] hybridoma house mouse CVCL_A0SA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P06400; Human RB1 Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5710255 and to be FO (Cellosaurus=CVCL_6972) in PubMed=7510760 While this hybridoma is not described by the patent, 6 other hybridomas are described in both sources thus this one was probably produced in an identical manner.. 150518046 CVCL_A0SB 7F12 hybridoma house mouse CVCL_A0SB CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P06400; Human RB1 Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5710255 and to be FO (Cellosaurus=CVCL_6972) in PubMed=7510760. 150518047 CVCL_A0SC mHypoE-2 transformed cell line house mouse CVCL_A0SC CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Miscellaneous: Cell line no longer available (personal communication of Belsham, Denise D.) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898. Unspecified 150518048 CVCL_A0SD mHypoE-19 transformed cell line house mouse CVCL_A0SD CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Miscellaneous: Cell line no longer available (personal communication of Belsham, Denise D.) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898. Unspecified 150518049 CVCL_A0SE mHypoE-22 transformed cell line house mouse CVCL_A0SE CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Miscellaneous: Cell line no longer available (personal communication of Belsham, Denise D.) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898. Unspecified 150518050 CVCL_A0SF mHypoE-20 transformed cell line house mouse CVCL_A0SF CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898. Unspecified 150518051 CVCL_A0SG mHypoE-25 transformed cell line house mouse CVCL_A0SG CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898. Unspecified 150518052 CVCL_A0SH mHypoE-29 transformed cell line house mouse CVCL_A0SH CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898. Male 150518053 CVCL_A0PV IIID5 spontaneously immortalized cell line CVCL_A0PV CL:0000010 Derived from site: In situ; Blastula; UBERON=UBERON_0000307. Omics: Transcriptomics; RNAseq Characteristics: Bright, vacuoles; immovable, forms blastula-like sphere Group: Cnidaria cell line 150518054 CVCL_A0PW IIIB6 spontaneously immortalized cell line CVCL_A0PW CL:0000010 Miscellaneous: Cell line has been lost. Omics: Transcriptomics; RNAseq Characteristics: Bright, vacuoles; immovable, forms gastrula-like sphere Group: Cnidaria cell line 150518055 CVCL_A0PX EL4-Zbtb1 KO cancer cell line house mouse CVCL_A0PX CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2442326; Zbtb1 Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: T-cell; CL=CL_0000084; Breed/subspecies: C57BL/6N. Omics: Transcriptomics; miRNA profiling; Microarray Unspecified 150518056 CVCL_A0PY 18/1 hybridoma house mouse CVCL_A0PY CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P00746; Human CFD. 150518057 CVCL_A0PZ C18/3 hybridoma house mouse CVCL_A0PZ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P08603; Human CFH. 150518058 CVCL_A0PN GPC3-7C8 hybridoma house mouse CVCL_A0PN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P51654; Human GPC3. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201009 150518059 CVCL_A0PP IVB6 spontaneously immortalized cell line CVCL_A0PP CL:0000010 Omics: Transcriptomics; RNAseq. Characteristics: Brilliant brown; forms cell aggregates; immovable Group: Cnidaria cell line 150518060 CVCL_A0PQ IIC5 spontaneously immortalized cell line CVCL_A0PQ CL:0000010 Omics: Transcriptomics; RNAseq. Characteristics: Brilliant brown; forms filopodia; movable Group: Cnidaria cell line 150518061 CVCL_A0PR IVB4 spontaneously immortalized cell line CVCL_A0PR CL:0000010 Omics: Transcriptomics; RNAseq. Characteristics: Dark, fattened; amorphous; forms lamellipodia; movable Doubling time: 4-5 days (PubMed=33899125) Group: Cnidaria cell line 150518062 CVCL_A0PS IVC4 spontaneously immortalized cell line CVCL_A0PS CL:0000010 Omics: Transcriptomics; RNAseq. Characteristics: Dark, fattened; amorphous; forms lamellipodia; movable Doubling time: 4-5 days (PubMed=33899125) Group: Cnidaria cell line 150518063 CVCL_A0PT IVD1 spontaneously immortalized cell line CVCL_A0PT CL:0000010 Omics: Transcriptomics; RNAseq. Characteristics: Dark, fattened; amorphous; forms lamellipodia; movable Doubling time: 4-5 days (PubMed=33899125) Group: Cnidaria cell line 150518064 CVCL_A0PU IVC6 spontaneously immortalized cell line CVCL_A0PU CL:0000010 Omics: Transcriptomics; RNAseq. Characteristics: Bright, vacuoles; immovable, forms cell sheet Group: Cnidaria cell line 150518065 CVCL_A0PF 2C9 [Mouse hybridoma against aflatoxin M1] hybridoma house mouse CVCL_A0PF CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: ChEBI; CHEBI_78576; Aflatoxin M1 (AFM1). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201018 150518066 CVCL_A0PG 4F12 [Mouse hybridoma against aflatoxin] hybridoma house mouse CVCL_A0PG CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1); Monoclonal antibody target: ChEBI; CHEBI_48209; Aflatoxin B2 (AFB2); Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1); Monoclonal antibody target: ChEBI; CHEBI_80705; Aflatoxin G2 (AFG2). 150518067 CVCL_A0PH 4F3 [Mouse hybridoma against aflatoxins] hybridoma house mouse CVCL_A0PH CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1); Monoclonal antibody target: ChEBI; CHEBI_48209; Aflatoxin B2 (AFB2); Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1); Monoclonal antibody target: ChEBI; CHEBI_80705; Aflatoxin G2 (AFG2). 150518068 CVCL_A0PI 8E11 hybridoma house mouse CVCL_A0PI CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1); Monoclonal antibody target: ChEBI; CHEBI_48209; Aflatoxin B2 (AFB2); Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1); Monoclonal antibody target: ChEBI; CHEBI_80705; Aflatoxin G2 (AFG2). 150518069 CVCL_A0PJ 8F6 hybridoma house mouse CVCL_A0PJ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1); Monoclonal antibody target: ChEBI; CHEBI_48209; Aflatoxin B2 (AFB2); Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1); Monoclonal antibody target: ChEBI; CHEBI_80705; Aflatoxin G2 (AFG2). 150518070 CVCL_A0PK DE7 hybridoma house mouse CVCL_A0PK CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1) (Note=Also recognizes AFB1, AFG2 and AFM1). 150518071 CVCL_A0PL 2G6 [Mouse hybridoma against aflatoxins G] hybridoma house mouse CVCL_A0PL CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1); Monoclonal antibody target: ChEBI; CHEBI_80705; Aflatoxin G2 (AFG2). 150518072 CVCL_A0PM S-95-7 hybridoma house mouse CVCL_A0PM CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; A0A5P8NB39; Influenza A virus (strain A/California/7/2009 H1N1) hemagglutinin (HA). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201024 150518073 CVCL_A0PA 1C10 [Mouse hybridoma against aflatoxin G1] hybridoma house mouse CVCL_A0PA CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1) (Note=Also recognizes AFG2). 150518074 CVCL_A0PB 1C11 [Mouse hybridoma against aflatoxins] hybridoma house mouse CVCL_A0PB CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1); Monoclonal antibody target: ChEBI; CHEBI_48209; Aflatoxin B2 (AFB2); Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1); Monoclonal antibody target: ChEBI; CHEBI_80705; Aflatoxin G2 (AFG2). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201013 150518075 CVCL_A0PC 1C8 [Mouse hybridoma against aflatoxin G1] hybridoma house mouse CVCL_A0PC CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1) (Note=Also recognizes AFG2). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201017 150518076 CVCL_A0PD 1D3 [Mouse hybridoma against aflatoxins] hybridoma house mouse CVCL_A0PD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1); Monoclonal antibody target: ChEBI; CHEBI_48209; Aflatoxin B2 (AFB2); Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1); Monoclonal antibody target: ChEBI; CHEBI_80705; Aflatoxin G2 (AFG2). 150518077 CVCL_A0PE 1E10 [Mouse hybridoma against aflatoxins] hybridoma house mouse CVCL_A0PE CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1); Monoclonal antibody target: ChEBI; CHEBI_48209; Aflatoxin B2 (AFB2); Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1); Monoclonal antibody target: ChEBI; CHEBI_80705; Aflatoxin G2 (AFG2). 150518078 CVCL_A0QW ZN-5 hybridoma house mouse CVCL_A0QW From: Trevarrow, Bill; Institute of Neuroscience, University of Oregon; Eugene; USA CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q90460; Danio rerio alcama/cd166a. 150518079 CVCL_A0QX ZN-8 hybridoma house mouse CVCL_A0QX From: Trevarrow, Bill; Institute of Neuroscience, University of Oregon; Eugene; USA CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q90460; Danio rerio alcama/cd166a. 150518080 CVCL_A0QY AL-1 hybridoma house mouse CVCL_A0QY CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Acholeplasma laidlawii. 150518081 CVCL_A0QZ AL-2 hybridoma house mouse CVCL_A0QZ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Acholeplasma laidlawii. 150518082 CVCL_A0QP CGMCC-18525 hybridoma house mouse CVCL_A0QP CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_189548; 3,5-dinitrosalicylic acid hydrazide (DNSH). Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.18525 150518083 CVCL_A0QQ 30G8 hybridoma house mouse CVCL_A0QQ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Mycoplasmoides gallisepticum (strain R). Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-15207 150518084 CVCL_A0QR 34H1 hybridoma house mouse CVCL_A0QR CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Mycoplasmoides gallisepticum (strain R). 150518085 CVCL_A0QS 35A6 hybridoma house mouse CVCL_A0QS CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; F8WJY4; Mycoplasmoides gallisepticum (strain R) MGC3 (crMA) (Note=Also reacts with other strains, but not avirulent strain F). Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5244 150518086 CVCL_A0QT 35H5 hybridoma house mouse CVCL_A0QT CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Mycoplasmoides gallisepticum (strain R). Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-15206 150518087 CVCL_A0QU 38B7 hybridoma house mouse CVCL_A0QU CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Mycoplasmoides gallisepticum (strain R). Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-15205 150518088 CVCL_A0QV 39E8 hybridoma house mouse CVCL_A0QV CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Mycoplasmoides gallisepticum (strain R). Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-15208 150518089 CVCL_A0QG BRCA84D hybridoma house mouse CVCL_A0QG CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. Group: Patented cell line 150518090 CVCL_A0QH GB8 hybridoma house mouse CVCL_A0QH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. 150518091 CVCL_A0QI OVCA22 hybridoma house mouse CVCL_A0QI CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. 150518092 CVCL_A0QJ PRCA157 hybridoma house mouse CVCL_A0QJ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. Group: Patented cell line 150518093 CVCL_A0QK SG27 hybridoma house mouse CVCL_A0QK CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. 150518094 CVCL_A0QL TDH6 hybridoma house mouse CVCL_A0QL CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. 150518095 CVCL_A0QM TES7 hybridoma house mouse CVCL_A0QM CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. 150518096 CVCL_A0QN L20 [Mouse hybridoma against human CD276] hybridoma house mouse CVCL_A0QN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8913 150518097 CVCL_A0QA D10/4 hybridoma house mouse CVCL_A0QA CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P00746; Human CFD. 150518098 CVCL_A0QB L20/3 hybridoma house mouse CVCL_A0QB CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P08603; Human CFH. 150518099 CVCL_A0QC M13/12 hybridoma house mouse CVCL_A0QC CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P00751; Human CFB. 150518100 CVCL_A0QD P21/15 hybridoma house mouse CVCL_A0QD CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P00751; Human CFB. 150518101 CVCL_A0QE BRCA68D hybridoma house mouse CVCL_A0QE CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. 150518102 CVCL_A0QF BRCA69D hybridoma house mouse CVCL_A0QF CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. Group: Patented cell line 150518103 CVCL_A0NT 203E3 hybridoma house mouse CVCL_A0NT CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q9UKX5; Human ITGA11. 150518104 CVCL_A0NU 2H4 [Mouse hybridoma against human CALCA] hybridoma house mouse CVCL_A0NU CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01258; Human CALCA (Note=Recognizes propeptide). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014232 150518105 CVCL_A0NV CGMCC-10417 hybridoma house mouse CVCL_A0NV CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P01258; Human CALCA (Note=Recognizes propeptide). Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.10417 150518106 CVCL_A0NW 277 34B3 20170123 hybridoma house mouse CVCL_A0NW CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q5H943; Human CT83. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Technology and Evaluation; NITE BP-02527 150518107 CVCL_A0NX LT006 hybridoma house mouse CVCL_A0NX CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q16552; Human IL17A Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017102 150518108 CVCL_A0NY LT007 hybridoma house mouse CVCL_A0NY CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q16552; Human IL17A. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017165 150518109 CVCL_A0NZ 10C9 [Mouse hybridoma against aflatoxins] hybridoma house mouse CVCL_A0NZ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: ChEBI; CHEBI_2504; Aflatoxin B1 (AFB1); Monoclonal antibody target: ChEBI; CHEBI_48209; Aflatoxin B2 (AFB2); Monoclonal antibody target: ChEBI; CHEBI_80706; Aflatoxin G1 (AFG1); Monoclonal antibody target: ChEBI; CHEBI_80705; Aflatoxin G2 (AFG2). 150518110 CVCL_A0NL 7.10D7 hybridoma house mouse CVCL_A0NL CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. 150518111 CVCL_A0NM 7.10H2 hybridoma house mouse CVCL_A0NM CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. 150518112 CVCL_A0NN ZH68-2A4 hybridoma house mouse CVCL_A0NN CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; B0F9T9; Trichinella spiralis serine protease Ts-ZH68. Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.18317 150518113 CVCL_A0NP WN10-1H9 hybridoma house mouse CVCL_A0NP CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; B0F9T2; Trichinella spiralis Ts-WN10. Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.18316 150518114 CVCL_A0NQ C2C12-hITGA11 spontaneously immortalized cell line house mouse CVCL_A0NQ CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6136; ITGA11; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134; Cell type: Myoblast; CL=CL_0000056; Breed/subspecies: C3H. Female 150518115 CVCL_A0NR 203E1H5 hybridoma house mouse CVCL_A0NR CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q9UKX5; Human ITGA11. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3318 150518116 CVCL_A0NS 234H11E8 hybridoma house mouse CVCL_A0NS CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9UKX5; Human ITGA11. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3319 150518117 CVCL_A0ND 7.4A3 hybridoma house mouse CVCL_A0ND CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. 150518118 CVCL_A0NE 7.7G5 hybridoma house mouse CVCL_A0NE CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3899 150518119 CVCL_A0NF 7.8B3 hybridoma house mouse CVCL_A0NF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. 150518120 CVCL_A0NG 7.8C9 hybridoma house mouse CVCL_A0NG CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. 150518121 CVCL_A0NH 7.8H12 hybridoma house mouse CVCL_A0NH CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. 150518122 CVCL_A0NI 7.9D4 hybridoma house mouse CVCL_A0NI CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. 150518123 CVCL_A0NJ 7.9G8 hybridoma house mouse CVCL_A0NJ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. 150518124 CVCL_A0NK 7.9H5 hybridoma house mouse CVCL_A0NK CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. 150518125 CVCL_A0NA 7.2A1 hybridoma house mouse CVCL_A0NA CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. 150518126 CVCL_A0NB 7.2F5 hybridoma house mouse CVCL_A0NB CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. 150518127 CVCL_A0NC 7.2H2 hybridoma house mouse CVCL_A0NC CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. 150518128 CVCL_A0LR TRNDi012-H induced pluripotent stem cell human CVCL_A0LR From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518129 CVCL_A0LS TRNDi012-I induced pluripotent stem cell human CVCL_A0LS From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518130 CVCL_A0LT EURACi006-A induced pluripotent stem cell human CVCL_A0LT From: EURAC Research Institute for Biomedicine; Bolzano; Italy CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple; p.Gly548Valfs*15 (c.1643delG); ClinVar=VCV000202035; Zygosity=Heterozygous (PubMed=34134068) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518131 CVCL_A0LU EURACi006-A-1 induced pluripotent stem cell human CVCL_A0LU From: EURAC Research Institute for Biomedicine; Bolzano; Italy CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple_corrected; p.Gly548Valfs*15 (c.1643delG); ClinVar=VCV000202035; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34134068) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518132 CVCL_A0LV EURACi007-A induced pluripotent stem cell human CVCL_A0LV From: EURAC Research Institute for Biomedicine; Bolzano; Italy CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple; p.Asn346Leufs*12 (c.1035-5203_1171-13298del); Zygosity=Heterozygous (PubMed=34298432) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518133 CVCL_A0LW EURACi008-A induced pluripotent stem cell human CVCL_A0LW From: EURAC Research Institute for Biomedicine; Bolzano; Italy CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple; p.Asn346Leufs*12 (c.1035-5203_1171-13298del); Zygosity=Heterozygous (PubMed=34298432) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Characteristics: While harboring the same PKP2 mutation as a family member from which EURACi007-A (Cellosaurus=CVCL_A0LV) was derived, the donor of this cell line did not show any symptom of arrhythmogenic right ventricular dysplasia 150518134 CVCL_A0LX EURACi009-A induced pluripotent stem cell human CVCL_A0LX From: EURAC Research Institute for Biomedicine; Bolzano; Italy CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518135 CVCL_A0LY AIBNi001-A induced pluripotent stem cell human CVCL_A0LY From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518136 CVCL_A0LJ TRNDi012-A induced pluripotent stem cell human CVCL_A0LJ From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518137 CVCL_A0LK TRNDi012-B induced pluripotent stem cell human CVCL_A0LK From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (PubMed=34139597) Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518138 CVCL_A0LL TRNDi012-C induced pluripotent stem cell human CVCL_A0LL From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518139 CVCL_A0LM TRNDi012-D induced pluripotent stem cell human CVCL_A0LM From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518140 CVCL_A0LN TRNDi012-E induced pluripotent stem cell human CVCL_A0LN From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518141 CVCL_A0LP TRNDi012-F induced pluripotent stem cell human CVCL_A0LP From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518142 CVCL_A0LQ TRNDi012-G induced pluripotent stem cell human CVCL_A0LQ From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518143 CVCL_A0LB LANCEi020-A-8 induced pluripotent stem cell human CVCL_A0LB From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; c.3713-28_3833del (Ex31del); Zygosity=Heterozygous (PubMed=34174776) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518144 CVCL_A0LC LANCEi020-A-9 induced pluripotent stem cell human CVCL_A0LC From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3603; FBN1 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518145 CVCL_A0LG MCRIi024-A induced pluripotent stem cell human CVCL_A0LG From: Murdoch Children's Research Institute; Melbourne; Australia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Gly148Asp (c.443G>A); Zygosity=Heterozygous (PubMed=34157503) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518146 CVCL_A0LH MCRIi024-A-1 induced pluripotent stem cell human CVCL_A0LH From: Murdoch Children's Research Institute; Melbourne; Australia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple_corrected; p.Gly148Asp (c.443G>A); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34157503) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518147 CVCL_A0LI BCHNi001-A induced pluripotent stem cell human CVCL_A0LI From: Department of Nephrology, Beijing Children's Hospital Affiliated to Capital Medical University; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:18758; BBS7; Simple; p.Asp252Asn (c.754G>A); Zygosity=Heterozygous (PubMed=34146953); Sequence variation: Mutation; HGNC; HGNC:18758; BBS7; Simple; c.849+1G>C; ClinVar=VCV001507819; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=34146953) Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518148 CVCL_A0KY LANCEi020-A-5 induced pluripotent stem cell human CVCL_A0KY From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3603; FBN1 (Note=1 of 2 alleles) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518149 CVCL_A0KZ LANCEi020-A-6 induced pluripotent stem cell human CVCL_A0KZ From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3603; FBN1 (Note=1 of 2 alleles) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518150 CVCL_A0LA LANCEi020-A-7 induced pluripotent stem cell human CVCL_A0LA From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; c.3713-28_3833del (Ex31del); Zygosity=Heterozygous (PubMed=34174776) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518151 CVCL_A0MS 6.2E5 hybridoma house mouse CVCL_A0MS CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P18564; Human ITGB6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3897 150518152 CVCL_A0MT 6.3G9 hybridoma house mouse CVCL_A0MT CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P18564; Human ITGB6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3649 150518153 CVCL_A0MU 6.4B4 hybridoma house mouse CVCL_A0MU CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P18564; Human ITGB6. 150518154 CVCL_A0MV 6.6B5 hybridoma house mouse CVCL_A0MV CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P18564; Human ITGB6. 150518155 CVCL_A0MW 6.8B4 hybridoma house mouse CVCL_A0MW CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P18564; Human ITGB6. 150518156 CVCL_A0MX 6.8G6 hybridoma house mouse CVCL_A0MX CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P18564; Human ITGB6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3645 150518157 CVCL_A0MY 7.1C5 hybridoma house mouse CVCL_A0MY CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3900 150518158 CVCL_A0MZ 7.1G10 hybridoma house mouse CVCL_A0MZ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9Z0T9; Mouse Itgb6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3898 150518159 CVCL_A0MK SNUe003-A-3 embryonic stem cell human CVCL_A0MK From: Seoul National University; Seoul; South Korea CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Korean; Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Using CRISPR/Cas9 a T2A-EGFP-polyA-PGKp-PuroR-polyA construct was introduced at the C-terminus of MYH6 (PubMed=35427904) 150518160 CVCL_A0ML FDC-P1 Beta6 factor-dependent cell line house mouse CVCL_A0ML CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96615; Itgb6; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Breed/subspecies: DBA/2. 150518161 CVCL_A0MM NIH 3T3 Beta6 spontaneously immortalized cell line house mouse CVCL_A0MM CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96615; Itgb6; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: NIH Swiss. Male 150518162 CVCL_A0MN 6.1A8 hybridoma house mouse CVCL_A0MN CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P18564; Human ITGB6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3647 150518163 CVCL_A0MP 6.2A1 hybridoma house mouse CVCL_A0MP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P18564; Human ITGB6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3896 150518164 CVCL_A0MQ 6.2B1 hybridoma house mouse CVCL_A0MQ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P18564; Human ITGB6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3646 150518165 CVCL_A0MR 6.2B10 hybridoma house mouse CVCL_A0MR CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P18564; Human ITGB6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3648 150518166 CVCL_A0MC AUi001-A induced pluripotent stem cell human CVCL_A0MC From: Aarhus University; Aarhus; Denmark CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6118; IRF3; Simple; p.Arg285Gln (c.854G>A); ClinVar=VCV000208454; Zygosity=Heterozygous (hPSCreg=AUi001-A) Population: Caucasian; Danish; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518167 CVCL_A0MD AUi002-A induced pluripotent stem cell human CVCL_A0MD From: Aarhus University; Aarhus; Denmark. CL:0000010 150518168 CVCL_A0ME HRMSDUi001-A induced pluripotent stem cell human CVCL_A0ME From: Hospital for Reproductive Medicine Affiliated to Shandong University; Jinan; China CL:0000010 Population: Chinese; Han; Karyotypic information: 45,XY,der(13;14)(q10;q10) (PubMed=34284274); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518169 CVCL_A0MF KUMi002-A induced pluripotent stem cell human CVCL_A0MF From: Korea University Medical School Hospital; Seoul; South Korea CL:0000010 Population: Korean; Donor information: Established from a patient suffering from chronic myeloid leukemia with BCR-ABL but has a normal karyotype; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 150518170 CVCL_A0MG KUMi001-A induced pluripotent stem cell human CVCL_A0MG From: Korea University Medical School Hospital; Seoul; South Korea CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=34280890) Population: Korean; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 150518171 CVCL_A0MH XMMPS-OP3 hybridoma house mouse CVCL_A0MH CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Pseudomonas aeruginosa Fisher type 3 core lipopolysaccharide (LPS). 150518172 CVCL_A0MI XMMPS-OP4 hybridoma house mouse CVCL_A0MI CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Pseudomonas aeruginosa Fisher type 4 core lipopolysaccharide (LPS). 150518173 CVCL_A0MJ XMMPS-OP7 hybridoma house mouse CVCL_A0MJ CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: Pseudomonas aeruginosa Fisher type 7 core lipopolysaccharide (LPS). 150518174 CVCL_A0LZ AIBNi002-A induced pluripotent stem cell human CVCL_A0LZ From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518175 CVCL_A0MA NCUFi001-A induced pluripotent stem cell human CVCL_A0MA From: Niccolo Cusano University Foundation; Rome; Italy CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Gly314Ser (c.940G>A) (p.Gly187Ser, c.559G>A); ClinVar=VCV000003123; Zygosity=Heterozygous (PubMed=34130155) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518176 CVCL_A0MB UGOTSAi001-A induced pluripotent stem cell human CVCL_A0MB From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden. CL:0000010 Female 150518177 CVCL_A0ZX MUSIi015-A induced pluripotent stem cell human CVCL_A0ZX From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4174; GATA6; Simple; p.Glu51Lys (c.151G>T); Zygosity=Heterozygous (PubMed=35853413); Sequence variation: Mutation; HGNC; HGNC:32058; ZYG11A; Simple; p.Leu475Pro (c.1424T>C); Zygosity=Heterozygous (PubMed=35853413) Population: Southeast Asian; Thai; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518178 CVCL_A0ZY MUSIi001-A-1 induced pluripotent stem cell human CVCL_A0ZY From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M Population: Southeast Asian; Thai; Derived from site: In situ; Abdomen, skin, dermis; Note=From a cesarean section scar; UBERON=UBERON_0001416+UBERON_0002067. Female 150518179 CVCL_A0ZZ ZJUi005-A [Wrong name] induced pluripotent stem cell human CVCL_A0ZZ From: Women's Hospital, Zhejiang University School of Medicine; Hangzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys2245Tyr (c.6734G>A); ClinVar=VCV000968455; Zygosity=Heterozygous (PubMed=34298435) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male Caution: There are 2 cell lines generated by the same group with the same name This cell line should be renamed. 150518180 CVCL_A0ZP NCTC 2168 spontaneously immortalized cell line house mouse CVCL_A0ZP CL:0000010 Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C3H/An. Male Group: Serum/protein free medium cell line 150518181 CVCL_A0ZQ NCTC 1742 cancer cell line house mouse CVCL_A0ZQ CL:0000010 Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190; Breed/subspecies: C3H/HeN. Male 150518182 CVCL_A0ZR NCTC 2049 spontaneously immortalized cell line house mouse CVCL_A0ZR CL:0000010 Derived from site: In situ; Adipose tissue, hypodermis; UBERON=UBERON_0002190; Breed/subspecies: C3H/HeN. Male 150518183 CVCL_A0ZS PLAFMCi005-A induced pluripotent stem cell human CVCL_A0ZS From: Chinese PLA General Hospital; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11630; HNF1B; Simple; c.544+3_544+6delAAGT; ClinVar=VCV000635668; Zygosity=Heterozygous (PubMed=34359001) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518185 CVCL_A0ZU UMi031-A-2 induced pluripotent stem cell human CVCL_A0ZU From: Miller School of Medicine, University of Miami; Miami; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple_edited; p.Leu64Pro (c.191T>C); ClinVar=VCV001006297; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34352618) Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518186 CVCL_A0ZV MUSIi013-A induced pluripotent stem cell human CVCL_A0ZV From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand CL:0000010 Population: Southeast Asian; Thai; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: Natural killer cell; CL=CL_0000623. Female 150518187 CVCL_A0ZW MUSIi014-A induced pluripotent stem cell human CVCL_A0ZW From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand CL:0000010 Sequence variation: Mutation; HGNC; HGNC:32058; ZYG11A; Simple; p.Leu475Pro (c.1424T>C); Zygosity=Heterozygous (PubMed=35193007) Population: Southeast Asian; Thai; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518188 CVCL_A0ZH UWRBTi003-C induced pluripotent stem cell human CVCL_A0ZH From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3331; EMD; Simple; p.Ser52Alafs*13 (c.153delC); ClinVar=VCV001074960; Zygosity=Hemizygous (PubMed=34419748) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518189 CVCL_A0ZI UWRBTi004-A induced pluripotent stem cell human CVCL_A0ZI From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3331; EMD; Simple; p.Ser52Alafs*13 (c.153delC); ClinVar=VCV001074960; Zygosity=Hemizygous (PubMed=34419748) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518190 CVCL_A0ZJ UWRBTi004-B induced pluripotent stem cell human CVCL_A0ZJ From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3331; EMD; Simple; p.Ser52Alafs*13 (c.153delC); ClinVar=VCV001074960; Zygosity=Hemizygous (PubMed=34419748) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518191 CVCL_A0ZK UWRBTi004-C induced pluripotent stem cell human CVCL_A0ZK From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3331; EMD; Simple; p.Ser52Alafs*13 (c.153delC); ClinVar=VCV001074960; Zygosity=Hemizygous (from autologous cell lines UWRBTi004-A; UWRBTi004-B) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518192 CVCL_A0ZL HIHTFi001-A induced pluripotent stem cell human CVCL_A0ZL From: Hertie-Institut fur Klinische Hirnforschung; Tubingen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:21168; RHOT1; Simple_edited; p.Ser156Ala (c.466T>G); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34359002) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518193 CVCL_A0ZM HIHTFi001-B induced pluripotent stem cell human CVCL_A0ZM From: Hertie-Institut fur Klinische Hirnforschung; Tubingen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:21168; RHOT1; Simple_edited; p.Arg272Gln (c.815G>A); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34359002) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518194 CVCL_A0ZN HIHTFi001-C induced pluripotent stem cell human CVCL_A0ZN From: Hertie-Institut fur Klinische Hirnforschung; Tubingen; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:21168; RHOT1; Simple_edited; p.Lys572Arg (c.1714_1716AAA>CGG); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34359002) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518195 CVCL_A0YA OSRi010-A induced pluripotent stem cell human CVCL_A0YA From: Ospedale San Raffaele; Milan; Italy CL:0000010 Sequence variation: Mutation; HGNC; HGNC:15573; SETBP1; Simple; p.Ile871Thr (c.2612T>C); ClinVar=VCV000001031; Zygosity=Heterozygous (hPSCreg=OSRi010-A) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518196 CVCL_A0YB OSRi010-A-1 induced pluripotent stem cell human CVCL_A0YB From: Ospedale San Raffaele; Milan; Italy CL:0000010 Sequence variation: Mutation; HGNC; HGNC:15573; SETBP1; Simple_corrected; p.Ile871Thr (c.2612T>C); ClinVar=VCV000001031; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=OSRi010-A-1) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518197 CVCL_A0YC AIBNi003-A induced pluripotent stem cell human CVCL_A0YC From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518198 CVCL_A0YD AIBNi004-A induced pluripotent stem cell human CVCL_A0YD From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518199 CVCL_A0YE AIBNi005-A induced pluripotent stem cell human CVCL_A0YE From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518200 CVCL_A0YF AIBNi006-A induced pluripotent stem cell human CVCL_A0YF From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518201 CVCL_A0XV ZMAC-4 factor-dependent cell line pig CVCL_A0XV CL:0000010 Derived from site: In situ; Fetal lung, alveolus; UBERON=UBERON_0005597+UBERON_0002299; Cell type: Alveolar macrophage; CL=CL_0000583; Breed/subspecies: Landrace x Yorkshire x Duroc; VBO=VBO_0001161+VBO_0001212+VBO_0001127. Unspecified Characteristics: CSF1 dependent; Virology: Susceptible to infection by porcine reproductive and respiratory syndrome virus (PRRSV) (PubMed=21191013); Virology: Supports high level of replication of African swine fever virus attenuated strain OURT88/3 (PubMed=32515659) Doubling time: 3.9 +- 0.3 days (PubMed=32515659) 150518202 CVCL_A0XW PCIi032-A induced pluripotent stem cell human CVCL_A0XW From: Phenocell SAS; Grasse; France CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518203 CVCL_A0XX PCIi033-A induced pluripotent stem cell human CVCL_A0XX From: Phenocell SAS; Grasse; France CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518204 CVCL_A0XY OSRi009-A induced pluripotent stem cell human CVCL_A0XY From: Ospedale San Raffaele; Milan; Italy CL:0000010 Sequence variation: Mutation; HGNC; HGNC:15573; SETBP1; Simple; p.Asp868Asn (c.2602G>A); ClinVar=VCV000001032; Zygosity=Heterozygous (hPSCreg=OSRi009-A) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518205 CVCL_A0XZ OSRi009-A-1 induced pluripotent stem cell human CVCL_A0XZ From: Ospedale San Raffaele; Milan; Italy CL:0000010 Sequence variation: Mutation; HGNC; HGNC:15573; SETBP1; Simple_corrected; p.Asp868Asn (c.2602G>A); ClinVar=VCV000001032; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=OSRi009-A-1) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518206 CVCL_A0XN 12 060 cancer cell line human CVCL_A0XN CL:0000010 Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811. Male Doubling time: 6.6 days (PubMed=33251771) 150518207 CVCL_A0XP 12 073 cancer cell line human CVCL_A0XP CL:0000010 Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810. Male Doubling time: 4.2 days (PubMed=33251771) 150518208 CVCL_A0XQ 12 075 cancer cell line human CVCL_A0XQ CL:0000010 Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810. Female Doubling time: 13.6 days (PubMed=33251771) 150518209 CVCL_A0XR 12 079 cancer cell line human CVCL_A0XR CL:0000010 Derived from site: In situ; Brain, left parieto-occipital lobe. Female Doubling time: 2.3 days (PubMed=33251771) 150518210 CVCL_A0XS 13 019 cancer cell line human CVCL_A0XS CL:0000010 Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811. Male Doubling time: 1.6 days (PubMed=33251771) 150518211 CVCL_A0XT 13 025 cancer cell line human CVCL_A0XT CL:0000010 Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808. Male Doubling time: 4.7 days (PubMed=33251771) 150518212 CVCL_A0XU CL2621 spontaneously immortalized cell line CVCL_A0XU From: Boehringer Ingelheim Animal Health, Inc.; St Joseph; USA. CL:0000010 Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518. Unspecified Virology: Susceptible to infection by porcine reproductive and respiratory syndrome virus (PRRSV) Group: Non-human primate cell line Problematic cell line: Misidentified Parent cell line (MA-104) has been shown to be from Chlorocebus pygerythrus instead of Rhesus macaque. 150518213 CVCL_A0XF 11 045 cancer cell line human CVCL_A0XF CL:0000010 Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808. Male Doubling time: 2.3 days (PubMed=33251771) 150518214 CVCL_A0XG 11 068 cancer cell line human CVCL_A0XG CL:0000010 Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809. Male Doubling time: 3.5 days (PubMed=33251771) 150518215 CVCL_A0XH 11 091 cancer cell line human CVCL_A0XH CL:0000010 Derived from site: In situ; Brain, left fronto-parietal lobe. Female Doubling time: 13.4 days (PubMed=33251771) 150518216 CVCL_A0XI 12 040 cancer cell line human CVCL_A0XI CL:0000010 Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809. Male Doubling time: 6.7 days (PubMed=33251771) 150518217 CVCL_A0XJ 12 041 cancer cell line human CVCL_A0XJ CL:0000010 Derived from site: In situ; Brain, left parieto-occipital lobe. Female Doubling time: 2.2 days (PubMed=33251771) 150518218 CVCL_A0XK 12 046 cancer cell line human CVCL_A0XK CL:0000010 Derived from site: In situ; Brain, right temporo-occipital lobe. Female Doubling time: 10.3 days (PubMed=33251771) 150518219 CVCL_A0XL 12 058 cancer cell line human CVCL_A0XL CL:0000010 Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811. Male Doubling time: 8.5 days (PubMed=33251771) 150518220 CVCL_A0XM 12 059 cancer cell line human CVCL_A0XM CL:0000010 Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808. Female Doubling time: 5.8 days (PubMed=33251771) 150518221 CVCL_A0ZA UWRBTi001-B induced pluripotent stem cell human CVCL_A0ZA From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518222 CVCL_A0ZB UWRBTi001-C induced pluripotent stem cell human CVCL_A0ZB From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518223 CVCL_A0ZC UWRBTi002-A induced pluripotent stem cell human CVCL_A0ZC From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518224 CVCL_A0ZD UWRBTi002-B induced pluripotent stem cell human CVCL_A0ZD From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518225 CVCL_A0ZE UWRBTi002-C induced pluripotent stem cell human CVCL_A0ZE From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518226 CVCL_A0ZF UWRBTi003-A induced pluripotent stem cell human CVCL_A0ZF From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3331; EMD; Simple; p.Ser52Alafs*13 (c.153delC); ClinVar=VCV001074960; Zygosity=Hemizygous (from autologous cell lines UWRBTi003-B; UWRBTi003-C) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518227 CVCL_A0ZG UWRBTi003-B induced pluripotent stem cell human CVCL_A0ZG From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3331; EMD; Simple; p.Ser52Alafs*13 (c.153delC); ClinVar=VCV001074960; Zygosity=Hemizygous (PubMed=34419748) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518228 CVCL_A0YW 4TCYA1 hybridoma house mouse CVCL_A0YW CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P24522; Human GADD45A. 150518229 CVCL_A0YX MDA-MB-231bo cancer cell line human CVCL_A0YX CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Omics: Transcriptomics; RNAseq Female Characteristics: Metastatic to bone Established after injection of the parent cell line in the left ventricle of the heart of female nude mice and retrieving the bone metastatic cells and repeating this procedure 11 times. Group: Triple negative breast cancer (TNBC) cell line 150518230 CVCL_A0YY MDA-MB-231br cancer cell line human CVCL_A0YY CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female Characteristics: Metastatic to brain Established after injection of the parent cell line in the left ventricle of the heart of female nude mice and retrieving the brain metastatic cells and repeating this procedure 6 times. Group: Triple negative breast cancer (TNBC) cell line 150518231 CVCL_A0YZ UWRBTi001-A induced pluripotent stem cell human CVCL_A0YZ From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518232 CVCL_A0YP MHHi022-A induced pluripotent stem cell human CVCL_A0YP From: Hannover Medical School, LEBAO (MHH); Hannover; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1078; BMPR2; Simple; p.His533Arg (c.1598A>G); ClinVar=VCV000425962; Zygosity=Heterozygous (PubMed=34388490) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518233 CVCL_A0YQ MHHi023-A induced pluripotent stem cell human CVCL_A0YQ From: Hannover Medical School, LEBAO (MHH); Hannover; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1078; BMPR2; Simple; p.Cys84_Ser140del (c.248-1_418+1del171) (Ex3del); Zygosity=Heterozygous (PubMed=34388490) Population: Asian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518234 CVCL_A0YR MHHi024-A induced pluripotent stem cell human CVCL_A0YR From: Hannover Medical School, LEBAO (MHH); Hannover; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1078; BMPR2; Simple; p.Arg491Trp (c.1471C>T); ClinVar=VCV000008802; Zygosity=Heterozygous (PubMed=34388490) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518235 CVCL_A0YS UKEi070-A induced pluripotent stem cell human CVCL_A0YS From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Asp770Asn (c.2308G>A) (p.Asp770Serfs*98); ClinVar=VCV000036604; Zygosity=Heterozygous; Note=Causes aberrant splicing (PubMed=34375846) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518236 CVCL_A0YT UKEi070-A-1 induced pluripotent stem cell human CVCL_A0YT From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple_corrected; p.Asp770Asn (c.2308G>A) (p.Asp770Serfs*98); ClinVar=VCV000036604; Zygosity=Heterozygous; Note=By CRISPR/Cas9 Causes aberrant splicing (PubMed=34375846). Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518237 CVCL_A0YU UKEi070-A-2 induced pluripotent stem cell human CVCL_A0YU From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Asp770Asn (c.2308G>A) (p.Asp770Serfs*98); ClinVar=VCV000036604; Zygosity=Heterozygous; Note=Causes aberrant splicing (PubMed=34375846); Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple_edited; p.Arg943Ter (c.2827C>T); ClinVar=VCV000037039; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34375846) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518238 CVCL_A0YV 30T.14 hybridoma house mouse CVCL_A0YV CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P24522; Human GADD45A. 150518239 CVCL_A0YG AIBNi007-A induced pluripotent stem cell human CVCL_A0YG From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518240 CVCL_A0YH AIBNi008-A induced pluripotent stem cell human CVCL_A0YH From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518241 CVCL_A0YI AIBNi009-A induced pluripotent stem cell human CVCL_A0YI From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518242 CVCL_A0YJ AIBNi010-A induced pluripotent stem cell human CVCL_A0YJ From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518243 CVCL_A0YK AIBNi011-A induced pluripotent stem cell human CVCL_A0YK From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518244 CVCL_A0YL AIBNi012-A induced pluripotent stem cell human CVCL_A0YL From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518245 CVCL_A0YM NERCi001-A induced pluripotent stem cell human CVCL_A0YM From: National Engineering and Research Center of Human Stem Cell; Changsha; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; p.Arg599Gln (c.1796G>A); ClinVar=VCV000635412; Zygosity=Heterozygous (hPSCreg=NERCi001-A); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; p.Ser947Pro (c.2839T>C); ClinVar=VCV000635413; Zygosity=Heterozygous (hPSCreg=NERCi001-A); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; p.Glu1116Gln (c.3346G>C); ClinVar=VCV000635414; Zygosity=Heterozygous (hPSCreg=NERCi001-A) Derived from site: In situ; Placenta; UBERON=UBERON_0001987; Cell type: Mesenchymal stem cell; CL=CL_0000134. Male 150518246 CVCL_A0YN TJCi001-A induced pluripotent stem cell human CVCL_A0YN From: TJC Life; Seoul; South Korea CL:0000010 Population: Southeast Asian; Vietnamese; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540. Male 150518247 CVCL_A0WA A549-A2-ESO cancer cell line human CVCL_A0WA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:24198; CTAG1A; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*02); Genetic integration: Method=Transduction; Gene=Click beetle green luciferase (CBG) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Transduced with both a CBG-T2A-GFP construct and a NY-ESO-1-T2A-HLA-A2 construct 150518248 CVCL_A0WB BT-IMF spontaneously immortalized cell line CVCL_A0WB CL:0000010 Derived from site: In situ; Fetal intestine; UBERON=UBERON_0000160; Cell type: Myofibroblast; CL=CL_0000186. Unspecified 150518249 CVCL_A0WC GreenTad-HF1 spontaneously immortalized cell line CVCL_A0WC CL:0000010 Derived from site: In situ; Cephalic region; UBERON=UBERON_0007811; Cell type: Fibroblast; CL=CL_0000057. Unspecified Group: Amphibian cell line 150518250 CVCL_A0WD GreenTad-HF2 spontaneously immortalized cell line CVCL_A0WD CL:0000010 Derived from site: In situ; Cephalic region; UBERON=UBERON_0007811; Cell type: Fibroblast; CL=CL_0000057. Unspecified Group: Amphibian cell line 150518251 CVCL_A0VT ICGi030-A induced pluripotent stem cell human CVCL_A0VT From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.Lys1013Glnfs*15 (c.3036dupC); ClinVar=VCV000495410; Zygosity=Heterozygous (PubMed=34736038); Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.His1069Gln (c.3207C>A); ClinVar=VCV000003848; Zygosity=Heterozygous (PubMed=34736038) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518252 CVCL_A0VU WAe001-A-73 embryonic stem cell human CVCL_A0VU From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30778; GATAD2B Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 150518253 CVCL_A0VV WAe001-A-74 embryonic stem cell human CVCL_A0VV From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30778; GATAD2B Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 150518254 CVCL_A0VW DT4994 cancer cell line house mouse CVCL_A0VW From: Tuveson, David Arthur; Cold Spring Harbor Laboratory; Cold Spring Harbor; USA CL:0000010 Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp) Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Breed/subspecies: Tg(Pdx1-cre),LSL-Kras(G12D/+). 150518255 CVCL_A0VX DT6606 cancer cell line house mouse CVCL_A0VX From: Tuveson, David Arthur; Cold Spring Harbor Laboratory; Cold Spring Harbor; USA CL:0000010 Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp) Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Breed/subspecies: Tg(Pdx1-cre),LSL-Kras(G12D/+). 150518256 CVCL_A0VY DT6606-OVA cancer cell line house mouse CVCL_A0VY CL:0000010 Genetic integration: Method=Transfection; Gene=CGNC; 49631; OVAL/SERPINB14; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp) Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Breed/subspecies: Tg(Pdx1-cre),LSL-Kras(G12D/+). 150518257 CVCL_A0VZ A549-CBG cancer cell line human CVCL_A0VZ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=Click beetle green luciferase (CBG) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Transduced with a CBG-T2A-GFP construct 150518258 CVCL_A0VL MS-EwS-3 cancer cell line human CVCL_A0VL CL:0000010 Miscellaneous: STR profile from personal communication of Rossig, Claudia Derived from site: Metastatic; Lung; UBERON=UBERON_0002048. Male 150518259 CVCL_A0VM MS-EwS-4 cancer cell line human CVCL_A0VM CL:0000010 Derived from site: Metastatic; Liver; UBERON=UBERON_0002107. Male 150518260 CVCL_A0VN MS-EwS-6 cancer cell line human CVCL_A0VN CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (Direct_author_submission) Miscellaneous: Gene fusion, site of sampling and age of donor from personal communication of Rossig, Claudia Derived from site: Metastatic; Thoracic cavity; UBERON=UBERON_0002224. Male 150518261 CVCL_A0VP MS-EwS-15 cancer cell line human CVCL_A0VP CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (Direct_author_submission) Miscellaneous: Gene fusion from personal communication of Rossig, Claudia Derived from site: Metastatic; Not specified. Male 150518262 CVCL_A0VQ MS-EwS-16 cancer cell line human CVCL_A0VQ CL:0000010 Derived from site: Metastatic; Bone, vertebra; UBERON=UBERON_0002412. Male 150518263 CVCL_A0VR MS-EwS-34 cancer cell line human CVCL_A0VR CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ERG, EWS-ERG (Direct_author_submission) Miscellaneous: Gene fusion, site of sampling, sex and age of donor from personal communication of Rossig, Claudia Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Male 150518264 CVCL_A0VS MS-EwS-5 cancer cell line human CVCL_A0VS CL:0000010 Miscellaneous: STR profile and sex of donor from personal communication of Rossig, Claudia Derived from site: Metastatic; Lung; UBERON=UBERON_0002048. Male 150518265 CVCL_A0VD 10B1A2 hybridoma house mouse CVCL_A0VD CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q7Z7D3; Human VTCN1. 150518266 CVCL_A0VE 12B2E1 hybridoma house mouse CVCL_A0VE CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q7Z7D3; Human VTCN1. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201761 150518267 CVCL_A0VF 12H6G1 hybridoma house mouse CVCL_A0VF CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q7Z7D3; Human VTCN1. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201762 150518268 CVCL_A0VG 14A12G11 hybridoma house mouse CVCL_A0VG CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q7Z7D3; Human VTCN1. 150518269 CVCL_A0VH 3T3-mB7-H4 spontaneously immortalized cell line house mouse CVCL_A0VH CL:0000010 Genetic integration: Method=Transfection; Gene=MGI; MGI:3039619; Vtcn1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: NIH Swiss. Male 150518270 CVCL_A0VI 3E8 [Mouse hybridoma against mouse Vtcn1] hybridoma house mouse CVCL_A0VI CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; Q7TSP5; Mouse Vtcn1 (Note=Also reacts with human). 150518271 CVCL_A0VJ 4H8 hybridoma house mouse CVCL_A0VJ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q7TSP5; Mouse Vtcn1 (Note=Also reacts with human). 150518272 CVCL_A0VK MS-EwS-1 cancer cell line human CVCL_A0VK CL:0000010 Derived from site: Metastatic; Soft tissue; UBERON=UBERON_0034929. Male 150518273 CVCL_A0XA Wall cancer cell line dog CVCL_A0XA CL:0000010 Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Simple; p.Glu273Lys (c.818C>T); Zygosity=Unspecified (PubMed=34079834) Miscellaneous: Sampling site and breed from personal communication of Gola, Cecilia Derived from site: In situ; Bone, rib; UBERON=UBERON_0002228; Breed/subspecies: Giant Schnauzer; VBO=VBO_0200604. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518274 CVCL_A0XB SRH cancer cell line human CVCL_A0XB CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7611; MYOD1; Simple; p.Leu122Arg (c.365T>G); Zygosity=Homozygous (PubMed=33322555); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=33322555); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Unspecified (PubMed=33322555) Derived from site: In situ; Left leg, skeletal muscle; UBERON=UBERON_0001383. Omics: Variations; Array-based CGH Female Doubling time: 34.3 +- 2.5 hours (PubMed=33322555) 150518275 CVCL_A0XC SHG-140 cancer cell line human CVCL_A0XC CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Val178Ile (c.532G>A); ClinVar=VCV000134520; Zygosity=Homozygous (PubMed=33391433); Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Arg1968Ter (c.5902C>T) (p.Arg1947Ter, c.5839C>T); ClinVar=VCV000000343; Zygosity=Homozygous (PubMed=33391433); Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Homozygous (PubMed=33391433); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=33391433) Population: Chinese; Derived from site: In situ; Brain; UBERON=UBERON_0000955. Male 150518276 CVCL_A0XD 11 029 cancer cell line human CVCL_A0XD CL:0000010 Derived from site: In situ; Brain, right occipital lobe; UBERON=UBERON_0002807. Male Doubling time: 6.6 days (PubMed=33251771) 150518277 CVCL_A0XE 11 030 cancer cell line human CVCL_A0XE CL:0000010 Derived from site: In situ; Brain, right temporo-parietal junction; UBERON=UBERON_0023852. Female Doubling time: 1.8 days (PubMed=33251771) 150518278 CVCL_A0WU Dark cancer cell line dog CVCL_A0WU CL:0000010 Miscellaneous: Breed from personal communication of Gola, Cecilia Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029; Breed/subspecies: Beauceron; VBO=VBO_0200135. Male 150518279 CVCL_A0WV Desmond cancer cell line dog CVCL_A0WV CL:0000010 Miscellaneous: Sampling site and breed from personal communication of Gola, Cecilia Derived from site: In situ; Bone, distal radius; UBERON=UBERON_0004407; Breed/subspecies: Greyhound; VBO=VBO_0200638. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518280 CVCL_A0WW Lord cancer cell line dog CVCL_A0WW CL:0000010 Miscellaneous: Sampling site and breed from personal communication of Gola, Cecilia Derived from site: In situ; Bone, distal tibia; UBERON=UBERON_0004405; Breed/subspecies: Cane corso; VBO=VBO_0200712. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518281 CVCL_A0WX Pedro cancer cell line dog CVCL_A0WX CL:0000010 Miscellaneous: Sampling site and breed from personal communication of Gola, Cecilia Derived from site: In situ; Bone, distal radius; UBERON=UBERON_0004407; Breed/subspecies: Labrador Retriever; VBO=VBO_0200800. Omics: Genomics; Whole exome sequencing Male 150518282 CVCL_A0WY Penny cancer cell line dog CVCL_A0WY CL:0000010 Miscellaneous: Sampling site and breed from personal communication of Gola, Cecilia Derived from site: In situ; Bone, tail; UBERON=UBERON_0006068; Breed/subspecies: Boxer; VBO=VBO_0200210. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Female 150518283 CVCL_A0WZ Sky cancer cell line dog CVCL_A0WZ CL:0000010 Miscellaneous: Sampling site and breed from personal communication of Gola, Cecilia Derived from site: In situ; Bone, proximal femur; UBERON=UBERON_0004412; Breed/subspecies: Boxer; VBO=VBO_0200210. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518284 CVCL_A0WM mes-c-myc A1 transformed cell line house mouse CVCL_A0WM CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: Myc; Derived from site: In situ; Embryonic brain, mesencephalon; UBERON=UBERON_0009616; Breed/subspecies: CD-1. Omics: Proteomics; Subcellular; Secretome Unspecified Characteristics: Cease to divide and undergo morphological differentiation after serum withdrawal or addition of cAMP (PubMed=10527628); Characteristics: Established by infection with a replication-defective retrovirus bearing the MYC and neo genes under the control of MLV LTR promoter 150518285 CVCL_A0WN CLC-1 spontaneously immortalized cell line dog CVCL_A0WN CL:0000010 Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803; Cell type: Epithelial cell of ocular lens; CL=CL_0002224. Unspecified Doubling time: 48.8 +- 3.3 hours (PubMed=34248270) 150518286 CVCL_A0WP BHSK finite cell line CVCL_A0WP CL:0000010 Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Unspecified 150518287 CVCL_A0WQ BHST finite cell line CVCL_A0WQ CL:0000010 Derived from site: In situ; Fetal nose, nasal cavity, nasal turbinate; UBERON=UBERON_0035612. Unspecified 150518288 CVCL_A0WR BHSFL finite cell line CVCL_A0WR CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597. Unspecified Virology: Susceptible to infection by bovine parainfluenza virus 3 (BPIV-3), bovine respiratory syncytial virus (BRSV), bovine viral diarrhea virus (BVDV) and bovine herpesvirus 1 (BoHV-1) (PubMed=20357964) 150518289 CVCL_A0WS DOUG cancer cell line dog CVCL_A0WS CL:0000010 Derived from site: Metastatic; Bone, right proximal humerus; UBERON=UBERON_0004411; Breed/subspecies: Rottweiler; VBO=VBO_0201143. Omics: Transcriptomics; RNAseq; Single cell Male 150518290 CVCL_A0WT FSCSC cancer cell line CVCL_A0WT CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Derived from site: In situ; Right hindlimb, synovium; UBERON=UBERON_0002103+UBERON_0007616. Male 150518291 CVCL_A0WE GreenTad-HF3 spontaneously immortalized cell line CVCL_A0WE CL:0000010 Derived from site: In situ; Cephalic region; UBERON=UBERON_0007811; Cell type: Fibroblast; CL=CL_0000057. Unspecified Group: Amphibian cell line 150518292 CVCL_A0WF GreenTad-HE4 spontaneously immortalized cell line CVCL_A0WF CL:0000010 Derived from site: In situ; Cephalic region; UBERON=UBERON_0007811; Cell type: Epithelial cell; CL=CL_0000066. Unspecified Group: Amphibian cell line 150518293 CVCL_A0WG GreenTad-gill spontaneously immortalized cell line CVCL_A0WG CL:0000010 Derived from site: In situ; Gill; UBERON=UBERON_0002535. Unspecified Group: Amphibian cell line 150518294 CVCL_A0WH WoodTad-HE1 spontaneously immortalized cell line CVCL_A0WH CL:0000010 Derived from site: In situ; Cephalic region; UBERON=UBERON_0007811; Cell type: Epithelial cell; CL=CL_0000066. Unspecified Group: Amphibian cell line 150518295 CVCL_A0WI WoodTad-Bone spontaneously immortalized cell line CVCL_A0WI CL:0000010 Derived from site: In situ; Bone, hindlimb; UBERON=UBERON_0003464. Unspecified Group: Amphibian cell line 150518296 CVCL_A0WJ WoodTad-rpe spontaneously immortalized cell line CVCL_A0WJ CL:0000010 Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782; Cell type: Retinal pigment epithelial cell; CL=CL_0002586. Unspecified Group: Amphibian cell line 150518297 CVCL_A0WK TOS1 finite cell line human CVCL_A0WK CL:0000010 Miscellaneous: Age/sex of donor, sampling site and doubling time from personal communication of Brandi, Maria Luisa Derived from site: In situ; Bone, femur; UBERON=UBERON_0000981. Male Doubling time: 125 hours (Direct_author_submission) 150518298 CVCL_A0WL TOS1-CSCs cancer cell line human CVCL_A0WL CL:0000010 Miscellaneous: Age/sex of donor and sampling site from personal communication of Brandi, Maria Luisa Derived from site: In situ; Bone, femur; UBERON=UBERON_0000981. Male Group: Cancer stem cell line 150518299 CVCL_A0TZ 32D.C10 factor-dependent cell line house mouse CVCL_A0TZ CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Breed/subspecies: C3H/HeJ. Male Characteristics: IL3 dependent; Characteristics: Does not express endogenous Csf3r 150518300 CVCL_A0UA 32D/G-CSF-R factor-dependent cell line house mouse CVCL_A0UA CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2439; CSF3R; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Breed/subspecies: C3H/HeJ. Male 150518301 CVCL_A0UB 32D/G-CSF-R p.Gln741Ter factor-dependent cell line house mouse CVCL_A0UB CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2439; CSF3R (Note=With p.Gln741Ter); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Breed/subspecies: C3H/HeJ. Male 150518302 CVCL_A0TR G8B11 hybridoma house mouse CVCL_A0TR CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P03971; Human AMH. 150518303 CVCL_A0TS CHO-S/H9C2 spontaneously immortalized cell line CVCL_A0TS CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3546; F8; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014191 150518304 CVCL_A0TT WTH-1 hybridoma house mouse CVCL_A0TT CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q63493; Rat Cd1d (Note=Also reacts with mouse). 150518305 CVCL_A0TU WTH-2 hybridoma house mouse CVCL_A0TU CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q63493; Rat Cd1d (Note=Also reacts with mouse). 150518306 CVCL_A0TV GCLP hybridoma house mouse CVCL_A0TV CL:0000010 Monoclonal antibody isotype: Not specified. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014195 150518307 CVCL_A0TW 12H11 hybridoma house mouse CVCL_A0TW CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P05413; Human FABP3. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014196 150518308 CVCL_A0TX HGrC1-YAP transformed cell line human CVCL_A0TX CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16262; YAP1; Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170; Cell type: Granulosa cell; CL=CL_0000501. Female 150518309 CVCL_A0TY HGrC1-YAP(S127A) transformed cell line human CVCL_A0TY CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16262; YAP1 (Note=With p.Ser127Ala); Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170; Cell type: Granulosa cell; CL=CL_0000501. Female 150518310 CVCL_A0TJ HEK293 FUS KO transformed cell line human CVCL_A0TJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4010; FUS Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 150518311 CVCL_A0TK N2A Psen1/Psen2 dKO cancer cell line house mouse CVCL_A0TK CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1202717; Psen1; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:109284; Psen2 Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010; Cell type: Neural crest derived neuroblast; CL=CL_0002676; Breed/subspecies: A/J. Male 150518312 CVCL_A0TL RK-13/CD40L spontaneously immortalized cell line CVCL_A0TL CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; G1SKP7; Rabbit CD40LG Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518. Unspecified Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018180 150518313 CVCL_A0TM C9F2-2 hybridoma house mouse CVCL_A0TM CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P03971; Human AMH. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018183 150518314 CVCL_A0TN 7D11-1 hybridoma house mouse CVCL_A0TN CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P03971; Human AMH. 150518315 CVCL_A0TP C17B10 hybridoma house mouse CVCL_A0TP CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P03971; Human AMH. 150518316 CVCL_A0TQ C8H3-2 hybridoma house mouse CVCL_A0TQ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P03971; Human AMH. 150518317 CVCL_A0TB MRIi017-A induced pluripotent stem cell human CVCL_A0TB From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 150518318 CVCL_A0TC MRIi020-A induced pluripotent stem cell human CVCL_A0TC From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany. CL:0000010 150518319 CVCL_A0TD MRIi021-A induced pluripotent stem cell human CVCL_A0TD From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany. CL:0000010 150518320 CVCL_A0TE MRIi022-A induced pluripotent stem cell human CVCL_A0TE From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany. CL:0000010 150518321 CVCL_A0TF MRIi023-A induced pluripotent stem cell human CVCL_A0TF From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany. CL:0000010 150518322 CVCL_A0TG MRIi019-A induced pluripotent stem cell human CVCL_A0TG From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany. CL:0000010 150518323 CVCL_A0TH MRIi028-A induced pluripotent stem cell human CVCL_A0TH From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:25686; PPCS; Simple; p.Glu233Val (c.698A>T); ClinVar=VCV000590782; Zygosity=Homozygous (PubMed=35397396) Population: Arab; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Discontinued: ECACC; 66770027; true Male 150518324 CVCL_A0TI Huh-7.5 Tet-On cancer cell line human CVCL_A0TI CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:19102; RIGI; Simple; p.Thr55Ile (c.164C>T); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Japanese; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 150518325 CVCL_A0VA 4D1C2 hybridoma house mouse CVCL_A0VA CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q7Z7D3; Human VTCN1. 150518326 CVCL_A0VB 6F9D5 hybridoma house mouse CVCL_A0VB CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q7Z7D3; Human VTCN1. 150518327 CVCL_A0VC 8H3C4 hybridoma house mouse CVCL_A0VC CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q7Z7D3; Human VTCN1. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201760 150518328 CVCL_A0US SP2/0-01-SPINK1-SUN hybridoma house mouse CVCL_A0US CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P00995; Human SPINK1. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018213 150518329 CVCL_A0UT PGGG spontaneously immortalized cell line CVCL_A0UT CL:0000010 Derived from site: In situ; Gill; UBERON=UBERON_0002535. Unspecified Characteristics: Can be used to investigate the effect of the heavy metal cadmium on cytotoxicity and oxidative stress (PubMed=33396134) Doubling time: 41.8 hours (Note=At 20th passage), 41.4 hours (Note=At 40th passage), 37.7 hours (Note=At 60th passage) (PubMed=33396134) Group: Fish cell line 150518330 CVCL_A0UU 1C1H11 hybridoma house mouse CVCL_A0UU CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q7Z7D3; Human VTCN1. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201758 150518331 CVCL_A0UV MLA-144 clone E7T cancer cell line CVCL_A0UV CL:0000010 Transformant: NCBI_TaxID; 11840; Gibbon ape leukemia virus (GALV); Derived from site: In situ; Lymph node; UBERON=UBERON_0000029. Characteristics: Glucocorticoid sensitive clone Group: Non-human primate cell line 150518332 CVCL_A0UW MLA-144 clone 15T cancer cell line CVCL_A0UW CL:0000010 Transformant: NCBI_TaxID; 11840; Gibbon ape leukemia virus (GALV); Derived from site: In situ; Lymph node; UBERON=UBERON_0000029. Characteristics: Glucocorticoid sensitive clone Group: Non-human primate cell line 150518333 CVCL_A0UX MLA-144 clone 8T cancer cell line CVCL_A0UX CL:0000010 Transformant: NCBI_TaxID; 11840; Gibbon ape leukemia virus (GALV); Derived from site: In situ; Lymph node; UBERON=UBERON_0000029. Characteristics: Glucocorticoid resistant clone Group: Non-human primate cell line 150518334 CVCL_A0UY 2B12B6 hybridoma house mouse CVCL_A0UY CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q7Z7D3; Human VTCN1. 150518335 CVCL_A0UZ 3E5G7 hybridoma house mouse CVCL_A0UZ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q7Z7D3; Human VTCN1. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201759 150518336 CVCL_A0UK 4D1 [Mouse hybridoma against influenza A HA] hybridoma house mouse CVCL_A0UK CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q6DQ18; Influenza A virus (strain A/Chicken/Hong Kong/YU22/2002 H5N1 genotype Z) hemagglutinin (HA) (Note=Also reacts with other H5 isolates). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200606 150518337 CVCL_A0UL 3G4 [Mouse hybridoma against influenza HA] hybridoma house mouse CVCL_A0UL CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q6DQ18; Influenza A virus (strain A/Chicken/Hong Kong/YU22/2002 H5N1 genotype Z) hemagglutinin (HA) (Note=Also reacts with other H5 isolates). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200604 150518338 CVCL_A0UM 2F2 [Mouse hybridoma against influenza A HA] hybridoma house mouse CVCL_A0UM CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q6DQ18; Influenza A virus (strain A/Chicken/Hong Kong/YU22/2002 H5N1 genotype Z) hemagglutinin (HA) (Note=Also reacts with other H5 isolates). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200424 150518339 CVCL_A0UN 29A9 hybridoma house mouse CVCL_A0UN CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01258; Human CALCA (Note=Recognizes propeptide). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018181 150518340 CVCL_A0UP A4-1B1 hybridoma house mouse CVCL_A0UP CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P01258; Human CALCA (Note=Recognizes propeptide). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017144 150518341 CVCL_A0UQ A4-6A2 hybridoma house mouse CVCL_A0UQ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P01258; Human CALCA (Note=Recognizes propeptide). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017143 150518342 CVCL_A0UR AT 36-38 hybridoma house mouse CVCL_A0UR CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; A6NLP5; Human TTC36. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018196 150518343 CVCL_A0UC 32D/G-CSF-R p.Gln754Ter factor-dependent cell line house mouse CVCL_A0UC CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2439; CSF3R (Note=With p.Gln754Ter); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Breed/subspecies: C3H/HeJ. Male 150518344 CVCL_A0UD 32D/G-CSF-R p.Gln739Ter factor-dependent cell line house mouse CVCL_A0UD CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2439; CSF3R (Note=With p.Gln739Ter); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Breed/subspecies: C3H/HeJ. Male 150518345 CVCL_A0UE 32D/G-CSF-R p.Tyr727Phe factor-dependent cell line house mouse CVCL_A0UE CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2439; CSF3R (Note=With p.Tyr727Phe); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Breed/subspecies: C3H/HeJ. Male 150518346 CVCL_A0UF 32D/G-CSF-R p.Tyr752Phe factor-dependent cell line house mouse CVCL_A0UF CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2439; CSF3R (Note=With p.Tyr752Phe); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Breed/subspecies: C3H/HeJ. Male 150518347 CVCL_A0UG 32D/G-CSF-R p.Tyr767Phe factor-dependent cell line house mouse CVCL_A0UG CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2439; CSF3R (Note=With p.Tyr767Phe); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Breed/subspecies: C3H/HeJ. Male 150518348 CVCL_A0UH 32D/G-CSF-R p.Tyr787Phe factor-dependent cell line house mouse CVCL_A0UH CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2439; CSF3R (Note=With p.Tyr787Phe); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Breed/subspecies: C3H/HeJ. Male 150518349 CVCL_A0UI 8H5 [Mouse hybridoma against influenza A HA] hybridoma house mouse CVCL_A0UI CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q6DQ18; Influenza A virus (strain A/Chicken/Hong Kong/YU22/2002 H5N1 genotype Z) hemagglutinin (HA) (Note=Also reacts with other H5 isolates). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200607 150518350 CVCL_A0UJ 10F7 [Mouse hybridoma against influenza A HA] hybridoma house mouse CVCL_A0UJ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q6DQ18; Influenza A virus (strain A/Chicken/Hong Kong/YU22/2002 H5N1 genotype Z) hemagglutinin (HA) (Note=Also reacts with other H5 isolates). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200608 150518351 CVCL_A8RQ V-MG-6/STT cancer cell line human CVCL_A8RQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218Ala (c.653T>C); Zygosity=Unspecified (PubMed=8934553). 150518352 CVCL_A8RP V-MG-33 cancer cell line human CVCL_A8RP CL:0000010 150518353 CVCL_A8RS WTC dual tagged TOMM20-mEGFP/mTagRFPT-TUBA1B-cl79 induced pluripotent stem cell human CVCL_A8RS CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP); Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; LF3LJ; TagRFP-T (Note=Red fluorescent protein derived from eqFP578) Population: Japanese; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Using CRISPR/Cas9 TOMM20 has been endogenously tagged in one allele at the C-terminus with mEGFP and TUBA1AB has been endogenously tagged in one allele at the N-terminus with mTagRFP-T Part of: Allen Cell Collection 150518354 CVCL_A8RR WISH-Mx2/EGFP cancer cell line human CVCL_A8RR CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Biotechnology: Used for a reporter gene assay (RGA) of the human type 1 interferon potency (PubMed=22549076) Female Characteristics: Expression of eGFP is under the control of the control of the mouse Mx2 promoter (PubMed=22549076) Problematic cell line: Contaminated Parent cell line (WISH) has been shown to be a HeLa derivative. 150518355 CVCL_A8RU N1380 cancer cell line human CVCL_A8RU CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg112Gly (c.334C>G) (p.Pro126Arg, c.377C>G); ClinVar=VCV000233484; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Asn1651Ser (c.4952A>G); ClinVar=VCV000049335; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 Population: African; Shangaan; Karyotypic information: Has lost chromosome Y (from parent cell line PLC/PRF/5); Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV); Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Virology: Not susceptible to infection by porcine sapelovirus Transduced with Cas9 and then with the GeCKO v2 whole genome CRISPR/Cas9 library of guide RNAs. The resulting cells were then infected with porcine sapelovirus (PSV) (PubMed=32496007). 150518356 CVCL_A8RT WTC-mEGFP-PCNA-cl83 induced pluripotent stem cell human CVCL_A8RT CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP) Population: Japanese; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Using CRISPR/Cas9 PCNA has been endogenously tagged in one allele at the N-terminus with mEGFP Part of: Allen Cell Collection 150518357 CVCL_A8RW SK-N-BE(1)s cancer cell line human CVCL_A8RW From: Memorial Sloan Kettering Cancer Center; New York; USA CL:0000010 Population: Caucasian; Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Male 150518358 CVCL_A8RV SK-N-BE(1)n cancer cell line human CVCL_A8RV From: Memorial Sloan Kettering Cancer Center; New York; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=11196202) Population: Caucasian; Karyotypic information: 46,XY,del(1)(p32),der(3)t(3;17)(p21;q21),der(4)t(1;4)(q21;q3?5),dmin (PubMed=11196202); Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Male Characteristics: Neuroblastic type (N-type) (PubMed=15720811) 150518359 CVCL_A8RI MEL-11 cancer cell line human CVCL_A8RI CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Asp (c.1799_1800delTGinsAT); ClinVar=VCV000375939; Zygosity=Unspecified (PubMed=15009714). Unspecified 150518360 CVCL_A8RH TRNDi018-D induced pluripotent stem cell human CVCL_A8RH From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Leu318Pro (c.953T>C); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg390Pro (c.1169G>C); ClinVar=VCV000221580; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; German; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518361 CVCL_A8RK B-LCL-HROC117 transformed cell line human CVCL_A8RK From: Linnebacher, Michael; University of Rostock; Rostock; Germany CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female 150518362 CVCL_A8RJ MEL-31 cancer cell line human CVCL_A8RJ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Asp (c.1799_1800delTGinsAT); ClinVar=VCV000375939; Zygosity=Unspecified (PubMed=15009714). Unspecified 150518363 CVCL_A8RM V-MG-35/CE cancer cell line human CVCL_A8RM CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=8934553). 150518364 CVCL_A8RL B-LCL-HROC313 transformed cell line human CVCL_A8RL HLA typing: A*01:01:01,02:01:01; B*08:01:01,40:01:02; C*03:04:01,07:01:01; DPA1*04:01:01G,05:01:01G; DQA1*04:01:01,05:01:01; DQB1*02:01:01,04:02:01; DRB1*03:01:01,08:01:01 (CLS=302058) From: Linnebacher, Michael; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 150518365 CVCL_A8RN V-MG-35/FTC cancer cell line human CVCL_A8RN CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=8934553). 150518366 CVCL_A8RA OX-133 hybridoma house mouse CVCL_A8RA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: ChEBI; CHEBI_189421; N-ethylmaleimide-cysteine. 150518367 CVCL_A8RC WAe001-A-67 embryonic stem cell human CVCL_A8RC From: Wenzhou Medical University; Wenzhou; China CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11714; TEAD1 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Transduced with a TRE6P-TEAD1-P2A-EGFP construct Overexpression of TEAD1 is induced by doxycyclin. 150518368 CVCL_A8RB WAe001-A-64 embryonic stem cell human CVCL_A8RB From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11848; TLR2 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 150518369 CVCL_A8RE TRNDi018-A induced pluripotent stem cell human CVCL_A8RE From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Leu318Pro (c.953T>C); ClinVar=VCV003769564; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg390Pro (c.1169G>C); ClinVar=VCV000221580; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; German; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518370 CVCL_A8RD WAe001-A-68 embryonic stem cell human CVCL_A8RD From: Wenzhou Medical University; Wenzhou; China CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11717; TEAD4 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Transduced with a TRE6P-TEAD4-P2A-EGFP construct Overexpression of TEAD4 is induced by doxycyclin. 150518371 CVCL_A8RG TRNDi018-C induced pluripotent stem cell human CVCL_A8RG From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Leu318Pro (c.953T>C); ClinVar=VCV003769564; Zygosity=Heterozygous (PubMed=34051448); Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg390Pro (c.1169G>C); ClinVar=VCV000221580; Zygosity=Heterozygous (PubMed=34051448) Population: Caucasian; German; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518372 CVCL_A8RF TRNDi018-B induced pluripotent stem cell human CVCL_A8RF From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Leu318Pro (c.953T>C); ClinVar=VCV003769564; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg390Pro (c.1169G>C); ClinVar=VCV000221580; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; German; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518373 CVCL_A8QX MDS-L/GR-GFP-N cancer cell line human CVCL_A8QX CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1833; CEBPA; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000851673; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000219097; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.672+1G>A; ClinVar=VCV000216078; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; JYYJ1; rsEGFP (Note=rsGFP, red-shifted GFP); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2439; CSF3R; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Japanese; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Characteristics: Transduced with a 5'LTR-CSF3R-CMV-rsGFP-Neo-3'LTR construct 150518374 CVCL_A8QW MDS-L/GFP-N cancer cell line human CVCL_A8QW CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1833; CEBPA; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000851673; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000219097; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.672+1G>A; ClinVar=VCV000216078; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; JYYJ1; rsEGFP (Note=rsGFP, red-shifted GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Japanese; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Characteristics: Transduced with a 5'LTR-CMV-rsGFP-Neo-3'LTR construct 150518375 CVCL_A8QZ MDS-LGF cancer cell line human CVCL_A8QZ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1833; CEBPA; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000851673; Zygosity=Heterozygous (PubMed=29955132); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000219097; Zygosity=Heterozygous (PubMed=29955132); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.672+1G>A; ClinVar=VCV000216078; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=29955132) Population: Japanese; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Omics: Genomics; Whole exome sequencing Male Characteristics: IL3 independent Has lost the H3C3 p.Lys28Met mutation of the parent cell line. 150518376 CVCL_A8QY MDS-L-2007 cancer cell line human CVCL_A8QY CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1833; CEBPA; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000851673; Zygosity=Heterozygous (PubMed=29955132); Sequence variation: Mutation; HGNC; HGNC:4768; H3C3; Simple; p.Lys28Met (c.83A>T); Zygosity=Heterozygous (PubMed=29955132); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000219097; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.672+1G>A; ClinVar=VCV000216078; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=29955132) Population: Japanese; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Omics: Genomics; Whole exome sequencing Male Characteristics: IL3 dependent 150518377 CVCL_A8SR WTC-mEGFP-CTCF-cl20 induced pluripotent stem cell human CVCL_A8SR CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP) Population: Japanese; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Using CRISPR/Cas9 CTCF has been endogenously tagged in one allele at the N-terminus with mEGFP Part of: Allen Cell Collection 150518378 CVCL_A8SQ CHO-gmt4D-EPO-GnT I spontaneously immortalized cell line CVCL_A8SQ CL:0000010 Knockout cell: Method=ZFN; UniProtKB; Q2MH30; Dhfr; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3415; EPO; Genetic integration: Method=Transfection; Gene=UniProtKB; Q2MH30; Cricetulus griseus Dhfr; Genetic integration: Method=Transfection; Gene=UniProtKB; Q924C0; Cricetulus griseus Mgat1 Selected for resistance to: UniProtKB; P02879; Ricinus communis ricin; Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Transfected with the pEGD vector containing CMV-EPO-IRES-GnTI-IRES-DHFR 150518379 CVCL_A8ST VUi031-A induced pluripotent stem cell human CVCL_A8ST From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands CL:0000010 Cell type: Fibroblast; CL=CL_0000057. Male 150518380 CVCL_A8SS ISFi002-A induced pluripotent stem cell human CVCL_A8SS From: Institute for Stem Cell Research, Helmholtz Zentrum Munchen; Neuherberg; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 150518381 CVCL_A8SV VUi033-A induced pluripotent stem cell human CVCL_A8SV From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518382 CVCL_A8SU VUi032-A induced pluripotent stem cell human CVCL_A8SU From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518383 CVCL_A8SX PmLyO-Sf9 hybrid cell line CVCL_A8SX CL:0000010 Characteristics: Fusion of Sf9 cells with shrimp lymphoid organ cells (PubMed=33826940); Virology: Susceptible to infection by white spot syndrome virus (WSSV) (PubMed=33264652). Group: Crustacean cell line; Group: Insect cell line; Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC082 150518384 CVCL_A8SW TMOi001-A-4 induced pluripotent stem cell human CVCL_A8SW From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany CL:0000010 Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female Characteristics: Using CRISPR/Cas9 a HA tag was integrated at the C-terminus of SPG11 (PubMed=34479069) 150518385 CVCL_A8SJ JR1Nmyc6 cancer cell line human CVCL_A8SJ CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7559; MYCN; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: Metastatic; Lung; UBERON=UBERON_0002048. Female Characteristics: Expresses MYCN under the control of the CMV promoter (PubMed=10933967) 150518386 CVCL_A8SI JR1neo20 cancer cell line human CVCL_A8SI CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: Metastatic; Lung; UBERON=UBERON_0002048. Female Characteristics: Control cell line for JR1Nmyc6 (Cellosaurus=CVCL_A8SJ) and JR1Nmyc9 (Cellosaurus=CVCL_A8SK) (PubMed=10933967) 150518387 CVCL_A8SL JR1cmyc5 cancer cell line human CVCL_A8SL CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7553; MYC; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: Metastatic; Lung; UBERON=UBERON_0002048. Female Characteristics: Expresses MYC under the control of the CMV promoter 150518388 CVCL_A8SK JR1Nmyc9 cancer cell line human CVCL_A8SK CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7559; MYCN; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: Metastatic; Lung; UBERON=UBERON_0002048. Female Characteristics: Expresses MYCN under the control of the CMV promoter (PubMed=10933967) 150518389 CVCL_A8SM HCE-1(NM) cancer cell line human CVCL_A8SM CL:0000010 Derived from site: In situ; Esophagus; UBERON=UBERON_0001043. Female Characteristics: Established from a tumor transplanted in nude mice 150518390 CVCL_A8SP CHO-gmt4D spontaneously immortalized cell line CVCL_A8SP CL:0000010 Knockout cell: Method=ZFN; UniProtKB; Q2MH30; Dhfr; Sequence variation: Mutation; UniProtKB; Q924C0; Mgat1; Simple; p.Gln339Ter (c.1015C>T); Zygosity=Unspecified (from parent cell line) Selected for resistance to: UniProtKB; P02879; Ricinus communis ricin; Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Lacks N-acetylglucosaminyltransferase I activity 150518391 CVCL_A8SB CAP-pStbl-empty-Null transformed cell line human CVCL_A8SB CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transfection; Gene=UniProtKB; P03281; Human adenovirus C serotype 5 pIX Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B); Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173; Cell type: Amniocyte; CL=CL_0002323. Characteristics: Transduced with a pStbl-CMV-bsd-Null vector and a pEGP-CMV-Null vector 150518392 CVCL_A8SA CAP-CD63-tGFP-Null transformed cell line human CVCL_A8SA CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1692; CD63; Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transfection; Gene=UniProtKB; P03281; Human adenovirus C serotype 5 pIX Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B); Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173; Cell type: Amniocyte; CL=CL_0002323. Characteristics: Overexpresses CD63-turboGFP Transduced with a pStbl-CMV-bsd-CD63-tGFP vector and a pEGP-CMV-Null vector. 150518393 CVCL_A8SD CAP-CD63-tGFP-miRNA-744 transformed cell line human CVCL_A8SD CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1692; CD63; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:33658; MIR744; Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transfection; Gene=UniProtKB; P03281; Human adenovirus C serotype 5 pIX Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B); Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173; Cell type: Amniocyte; CL=CL_0002323. Characteristics: Overexpresses CD63-turboGFP and MIR744 Transduced with a pStbl-CMV-bsd-CD63-tGFP vector and a pEGP-CMV-hsa-miRNA-744 vector. 150518394 CVCL_A8SC CAP-CD63-tGFP-miRNA-493 transformed cell line human CVCL_A8SC CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1692; CD63; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:32082; MIR493; Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transfection; Gene=UniProtKB; P03281; Human adenovirus C serotype 5 pIX Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B); Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173; Cell type: Amniocyte; CL=CL_0002323. Characteristics: Overexpresses CD63-turboGFP and MIR493 Transduced with a pStbl-CMV-bsd-CD63-tGFP vector and a pEGP-CMV-hsa-miRNA-493 vector. 150518395 CVCL_A8SF SJ-GBM3 cancer cell line human CVCL_A8SF CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Unspecified (PubMed=9802058) Derived from site: In situ; Brain; UBERON=UBERON_0000955. Female 150518396 CVCL_A8SE SJ-GBM5 finite cell line human CVCL_A8SE CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (CelloPub=CLPUB00738; PubMed=9802058) Derived from site: In situ; Brain; UBERON=UBERON_0000955. Female Senescence: Undergoes crisis at approximately passage 35 (CelloPub=CLPUB00738) 150518397 CVCL_A8SH IMR32.ODC.CE cancer cell line human CVCL_A8SH CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P12337; Rabbit liver carboxylesterase 1 Population: Caucasian; Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916. Male Characteristics: Expresses the carboxylesterase (CE) gene under the control of an ornithine decarboxylase (ODC) promoter (PubMed=10933967) 150518398 CVCL_A8SG IMR32.CMV.neo cancer cell line human CVCL_A8SG CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916. Male Characteristics: Control cell line for IMR32.ODC.CE (Cellosaurus=CVCL_A8SH) (PubMed=10933967) 150518399 CVCL_A8RY CAP-CD63-tGFP transformed cell line human CVCL_A8RY CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1692; CD63; Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P03281; Human adenovirus C serotype 5 pIX Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B); Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173; Cell type: Amniocyte; CL=CL_0002323. Characteristics: Overexpresses CD63-turboGFP Transduced with a pStbl-CMV-bsd-CD63-tGFP vector. 150518400 CVCL_A8RX GPASE transformed cell line CVCL_A8RX CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7 Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Amnion; UBERON=UBERON_0000305; Cell type: Epithelial cell; CL=CL_0000066; Breed/subspecies: Hartley; VBO=VBO_0017521. Unspecified Virology: Susceptible to infection by guinea pig cytomegalovirus (GPCMV) (PubMed=32068527) 150518401 CVCL_A8RZ CAP-pStbl-empty transformed cell line human CVCL_A8RZ CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection; Gene=UniProtKB; P03281; Human adenovirus C serotype 5 pIX Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B); Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173; Cell type: Amniocyte; CL=CL_0002323. Characteristics: Transduced with a pStbl-CMV-bsd-Null vector 150518402 CVCL_A8PN UCSFi001-A-51 induced pluripotent stem cell human CVCL_A8PN From: University of Louisiana at Lafayette; Lafayette; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple_edited; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34536661) Population: Japanese; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518403 CVCL_A8PQ UCSFi001-A-53 induced pluripotent stem cell human CVCL_A8PQ From: University of Louisiana at Lafayette; Lafayette; USA CL:0000010 Population: Japanese; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518404 CVCL_A8PP UCSFi001-A-52 induced pluripotent stem cell human CVCL_A8PP From: University of Louisiana at Lafayette; Lafayette; USA CL:0000010 Population: Japanese; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518405 CVCL_A8PS UKEi001-B induced pluripotent stem cell human CVCL_A8PS From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518406 CVCL_A8PR UKEi001-A induced pluripotent stem cell human CVCL_A8PR From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518407 CVCL_A8PU UKEi003-B induced pluripotent stem cell human CVCL_A8PU From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518408 CVCL_A8PT UKEi003-A induced pluripotent stem cell human CVCL_A8PT From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518409 CVCL_A8PG UTA.00102.LQT1 induced pluripotent stem cell human CVCL_A8PG From: Institute of Biomedical Technology, University of Tampere; Tampere; Finland CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; c.1129-2A>G (IVS7-2A>G); dbSNP=rs768022350; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=28785673) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518410 CVCL_A8PF UMILi009-A induced pluripotent stem cell human CVCL_A8PF From: University of Milan; Milan; Italy CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12856; YY1; Simple; p.Asp129Ilefs*127 (c.385delG); ClinVar=VCV000817604; Zygosity=Unspecified (hPSCreg=UMILi009-A) Cell type: Fibroblast; CL=CL_0000057. Female 150518411 CVCL_A8PI UTA.04607.WT induced pluripotent stem cell human CVCL_A8PI From: Institute of Biomedical Technology, University of Tampere; Tampere; Finland CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518412 CVCL_A8PH UTA.00118.LQT1 induced pluripotent stem cell human CVCL_A8PH From: Institute of Biomedical Technology, University of Tampere; Tampere; Finland CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; c.1129-2A>G (IVS7-2A>G); dbSNP=rs768022350; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=28785673) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518413 CVCL_A8PK SHCMDLi002-A induced pluripotent stem cell human CVCL_A8PK From: Shanghai Children's Hospital; Shanghai; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518414 CVCL_A8PJ SHCMDLi001-A induced pluripotent stem cell human CVCL_A8PJ From: Shanghai Children's Hospital; Shanghai; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:20456; TRAF7; Simple; p.Arg655Gln (c.1964G>A); ClinVar=VCV000587685; Zygosity=Heterozygous; Note=De novo mutation (PubMed=34088006) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518415 CVCL_A8PM UCSFi001-A-50 induced pluripotent stem cell human CVCL_A8PM From: University of Louisiana at Lafayette; Lafayette; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple_edited; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=UCSFi001-A-50) Population: Japanese; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518416 CVCL_A8PL UCSFi001-A-49 induced pluripotent stem cell human CVCL_A8PL From: University of Louisiana at Lafayette; Lafayette; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple_edited; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34536661) Population: Japanese; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518417 CVCL_A8PA UBi002-A induced pluripotent stem cell human CVCL_A8PA From: Universidad Autonoma de Barcelona; Barcelona; Spain. CL:0000010 Female Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 150518418 CVCL_A8PC UBi004-A induced pluripotent stem cell human CVCL_A8PC From: Universidad Autonoma de Barcelona; Barcelona; Spain. CL:0000010 150518419 CVCL_A8PB UBi003-A induced pluripotent stem cell human CVCL_A8PB From: Universidad Autonoma de Barcelona; Barcelona; Spain. CL:0000010 150518420 CVCL_A8PE TRNDi031-A induced pluripotent stem cell human CVCL_A8PE From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6188; JAG1; Simple; p.Cys312Ter (c.936T>A); ClinVar=VCV001358138; Zygosity=Heterozygous (PubMed=34198154) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518421 CVCL_A8PD TRNDi030-A induced pluripotent stem cell human CVCL_A8PD From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:735; ASAH1; Simple; p.Tyr36Cys (c.107A>G) (p.Tyr52Cys, c.155A>G); ClinVar=VCV000000093; Zygosity=Homozygous (PubMed=34088014) Population: Tunisian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518422 CVCL_A8QP LB919-SCCHN cancer cell line human CVCL_A8QP From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Ile655Val (c.1963A>G); ClinVar=VCV000013873; Zygosity=Unspecified (PubMed=28765120). Unspecified 150518423 CVCL_A8QR UAMS-32P spontaneously immortalized cell line house mouse CVCL_A8QR CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9608; PTH1R Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Breed/subspecies: SAMR1. Unspecified 150518424 CVCL_A8QQ GM27463 induced pluripotent stem cell human CVCL_A8QQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11120; SMPD1; Simple; p.Leu304Pro (c.911T>C) (L302P); ClinVar=VCV000002989; Zygosity=Homozygous (Coriell=GM27463) Population: Jewish; Ashkenazi; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518425 CVCL_A8QT LF1 [Human lung myofibroblast] finite cell line human CVCL_A8QT CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Myofibroblast; CL=CL_0000186. Omics: Transcriptomics; Microarray Male Doubling time: ~2 days (PubMed=17986007) 150518426 CVCL_A8QS Me32A-DmATP7 finite cell line human CVCL_A8QS CL:0000010 Sequence variation: Mutation; HGNC; HGNC:869; ATP7A; Unexplicit; 4bp deletion within exon 6; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0030343; ATP7 (Note=With a N-terminal Myc tag); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 150518427 CVCL_A8QV MDS-L cancer cell line human CVCL_A8QV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1833; CEBPA; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000851673; Zygosity=Heterozygous (PubMed=29955132); Sequence variation: Mutation; HGNC; HGNC:4768; H3C3; Simple; p.Lys28Met (c.83A>T); Zygosity=Heterozygous (PubMed=29955132); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000219097; Zygosity=Heterozygous (PubMed=29955132); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.672+1G>A; ClinVar=VCV000216078; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=29955132) Population: Japanese; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Omics: Genomics; Whole exome sequencing Male Characteristics: IL3 dependent 150518428 CVCL_A8QU LF2 [Human lung myofibroblast] finite cell line human CVCL_A8QU CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Myofibroblast; CL=CL_0000186. Omics: Transcriptomics; Microarray Male Doubling time: ~3 days (PubMed=17986007) 150518429 CVCL_A8QH MIN6-cl4 transformed cell line house mouse CVCL_A8QH CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Cell type: Pancreatic beta cell; CL=CL_0000169; Breed/subspecies: C57BL/6 IT6 transgenic. Omics: Transcriptomics; RNAseq Unspecified Characteristics: Retains glucose-stimulated insulin secretion even after long-term culture (PubMed=23560115) 150518430 CVCL_A8QG MIN6-K8 transformed cell line house mouse CVCL_A8QG CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Cell type: Pancreatic beta cell; CL=CL_0000169; Breed/subspecies: C57BL/6 IT6 transgenic. Male Characteristics: Responsive to insulin, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) (PubMed=24843422) 150518431 CVCL_A8QJ ZYM-SVEC01 telomerase immortalized cell line pig CVCL_A8QJ CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Vein; UBERON=UBERON_0001638; Cell type: Endothelial cell of vein; CL=CL_0002543. Unspecified Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200841 150518432 CVCL_A8QI MIN6-CB4 transformed cell line house mouse CVCL_A8QI CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Cell type: Pancreatic beta cell; CL=CL_0000169; Breed/subspecies: C3/Hej x C57BL/6 IT6 transgenic. Omics: Transcriptomics; RNAseq Male Characteristics: Retains glucose-stimulated insulin secretion even after long-term culture (PubMed=33436850) 150518433 CVCL_A8QL Panc02-luc cancer cell line house mouse CVCL_A8QL CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA); Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Breed/subspecies: C57BL/6. Male 150518434 CVCL_A8QK CD126 spontaneously immortalized cell line house mouse CVCL_A8QK CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Thr1085_Ala1210del); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: NIH Swiss. Male 150518435 CVCL_A8QN KUL98-MELB cancer cell line human CVCL_A8QN CL:0000010 Unspecified 150518436 CVCL_A8QM KUL98-MELA cancer cell line human CVCL_A8QM CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=28765120). Unspecified 150518437 CVCL_A8QB HVRDe009-A-2 embryonic stem cell human CVCL_A8QB From: Arizona State University; Tempe; USA CL:0000010 Karyotypic information: 46,XX,inv(9)(p12;q13) (hPSCreg=HVRDe009-A-2); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Using CRISPR/Cas9 a 3xFLAG tag was introduced at the C-terminal region of CTNNB1 (PubMed=34736039) 150518438 CVCL_A8QA MRIi004-A induced pluripotent stem cell human CVCL_A8QA From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 150518439 CVCL_A8QD SCVI-112 induced pluripotent stem cell human CVCL_A8QD From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Population: Asian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518440 CVCL_A8QC SCVI-113 induced pluripotent stem cell human CVCL_A8QC From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518441 CVCL_A8QF MIN6-K20 transformed cell line house mouse CVCL_A8QF CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Cell type: Pancreatic beta cell; CL=CL_0000169; Breed/subspecies: C57BL/6 IT6 transgenic. Male Characteristics: Responsive to insulin, but not to glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) (PubMed=24843422) 150518442 CVCL_A8QE HXWMF-1 cancer cell line house mouse CVCL_A8QE CL:0000010 Derived from site: In situ; Hypodermis; UBERON=UBERON_0002072; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: BALB/c. Female Characteristics: Produced by subcutaneous injection of HXEX-ALL1 cells of BALB/c (nu/nu) nude mice (PubMed=33740980) Doubling time: 12-17 hours (PubMed=33740980) 150518443 CVCL_A8PW UMCGi010-A induced pluripotent stem cell human CVCL_A8PW From: University Medical Center Groningen; Groningen; Netherlands. CL:0000010 Male 150518444 CVCL_A8PV UKEi003-C induced pluripotent stem cell human CVCL_A8PV From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518445 CVCL_A8PY HighMan-S2 spontaneously immortalized cell line fruit fly CVCL_A8PY CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276. Male Characteristics: Using CRISPR/Cas9 the parent cell line was engineered to produce proteins with high-mannose N-glycan structures Doubling time: 18-24 hours (ExpreS2ion) Group: Insect cell line; Group: Recombinant protein production insect cell line 150518446 CVCL_A8PX SMBCi008-A induced pluripotent stem cell human CVCL_A8PX From: Shandong Medical Biotechnological Center; Jinan; China. CL:0000010 Male 150518447 CVCL_A8PZ HeLa SOD1 KO cancer cell line human CVCL_A8PZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11179; SOD1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 150518448 CVCL_A8NM VUi026-A induced pluripotent stem cell human CVCL_A8NM From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; HGNC:30348; POLR3B; Simple; p.Val523Glu (c.1568T>A); ClinVar=VCV000031166; Zygosity=Heterozygous (hPSCreg=VUi026-A); Sequence variation: Mutation; HGNC; HGNC:30348; POLR3B; Simple; c.2084-6A>G; ClinVar=VCV000419962; Zygosity=Heterozygous (hPSCreg=VUi026-A) Population: Caucasian; Cell type: Fibroblast; CL=CL_0000057. Male 150518449 CVCL_A8NL VUi025-A induced pluripotent stem cell human CVCL_A8NL From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; HGNC:30348; POLR3B; Simple; p.Tyr596Ter (c.1788C>A); ClinVar=VCV001184064; Zygosity=Heterozygous (hPSCreg=VUi025-A); Sequence variation: Mutation; HGNC; HGNC:30348; POLR3B; Simple; p.Leu727Ser (c.2180T>C); ClinVar=VCV001184068; Zygosity=Heterozygous (hPSCreg=VUi025-A) Population: Caucasian; Cell type: Fibroblast; CL=CL_0000057. Female 150518450 CVCL_A8NN VUi027-A induced pluripotent stem cell human CVCL_A8NN From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; HGNC:30074; POLR3A; Simple; p.Asp57Asn (c.169G>A); ClinVar=VCV001184032; Zygosity=Heterozygous (hPSCreg=VUi027-A); Sequence variation: Mutation; HGNC; HGNC:30074; POLR3A; Simple; p.Ile700Phe (c.2098A>T); ClinVar=VCV001184041; Zygosity=Heterozygous (hPSCreg=VUi027-A) Population: Caucasian; Cell type: Fibroblast; CL=CL_0000057. Female 150518451 CVCL_A8NQ VUi029-A induced pluripotent stem cell human CVCL_A8NQ From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; HGNC:30074; POLR3A; Simple; c.1771-6C>G; ClinVar=VCV000976718; Zygosity=Heterozygous (hPSCreg=VUi029-A); Sequence variation: Mutation; HGNC; HGNC:30074; POLR3A; Simple; p.Arg1069Trp (c.3205C>T); ClinVar=VCV001184053; Zygosity=Heterozygous (hPSCreg=VUi029-A) Population: Caucasian; Cell type: Fibroblast; CL=CL_0000057. Male 150518452 CVCL_A8NP VUi028-A induced pluripotent stem cell human CVCL_A8NP From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; HGNC:30348; POLR3B; Simple; c.303+1G>A; ClinVar=VCV001184092; Zygosity=Heterozygous; Note=Splice donor mutation (hPSCreg=VUi028-A); Sequence variation: Mutation; HGNC; HGNC:30348; POLR3B; Simple; p.Val523Glu (c.1568T>A); ClinVar=VCV000031166; Zygosity=Heterozygous (hPSCreg=VUi028-A) Population: Caucasian; Cell type: Fibroblast; CL=CL_0000057. Female 150518453 CVCL_A8NS TRNDi029-A induced pluripotent stem cell human CVCL_A8NS From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6188; JAG1; Simple; p.Arg465Arg (c.1395G>T) (chr20:g.10629709C>A); Zygosity=Heterozygous; Note=Splice site mutation (PubMed=34087995) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518454 CVCL_A8NR VUi030-A induced pluripotent stem cell human CVCL_A8NR From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; HGNC:30074; POLR3A; Simple; c.1048+5G>T; ClinVar=VCV000549560; Zygosity=Heterozygous (hPSCreg=VUi030-A); Sequence variation: Mutation; HGNC; HGNC:30074; POLR3A; Simple; c.1771-7C>G; ClinVar=VCV000449556; Zygosity=Heterozygous (hPSCreg=VUi030-A) Population: Caucasian; Cell type: Fibroblast; CL=CL_0000057. Female 150518455 CVCL_A8NE SBRIi004-A induced pluripotent stem cell human CVCL_A8NE From: Stem Cell and Brain Research, U1208 INSERM; Bron; France. CL:0000010 150518456 CVCL_A8ND SBRIi003-A induced pluripotent stem cell human CVCL_A8ND From: Stem Cell and Brain Research, U1208 INSERM; Bron; France. CL:0000010 150518457 CVCL_A8NG SCVIi013-A induced pluripotent stem cell human CVCL_A8NG From: Stanford Cardiovascular Institute; Palo Alto; USA. CL:0000010 150518458 CVCL_A8NF SCVIi012-A induced pluripotent stem cell human CVCL_A8NF From: Stanford Cardiovascular Institute; Palo Alto; USA. CL:0000010 150518459 CVCL_A8NI SDQLCHi043-A induced pluripotent stem cell human CVCL_A8NI From: Qilu Children's Hospital of Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:8654; PCCB; Simple; p.Arg111Ter (c.331C>T); ClinVar=VCV000553380; Zygosity=Heterozygous (PubMed=38394970); Sequence variation: Mutation; HGNC; HGNC:8654; PCCB; Simple; c.1498+2T>C; ClinVar=VCV000217895; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=38394970) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518460 CVCL_A8NH SDQLCHi042-A induced pluripotent stem cell human CVCL_A8NH From: Qilu Children's Hospital of Shandong University; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6677; LPL; Simple; c.88+1G>C; ClinVar=VCV000001542; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=34087978); Sequence variation: Mutation; HGNC; HGNC:6677; LPL; Simple; p.Leu279Arg (c.836T>G); ClinVar=VCV000851236; Zygosity=Heterozygous (PubMed=34087978) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518461 CVCL_A8NK iPSC-CB1RB9-WAS-GFP induced pluripotent stem cell human CVCL_A8NK CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Characteristics: Transduced with a lentiviral vector expressing GFP under the control of the WAS gene promoter (PubMed=28380349) 150518462 CVCL_A8NJ iPSC-CB1RB9 induced pluripotent stem cell human CVCL_A8NJ CL:0000010 Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. 150518463 CVCL_A8NA RCPCMi008-A induced pluripotent stem cell human CVCL_A8NA From: Federal Research and Clinical Center of Physical-Chemical Medicine; Moscow; Russia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11588; TBP; Repeat_expansion; CAG[47]; Zygosity=Heterozygous (PubMed=34171784) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518464 CVCL_A8NC SBRIi002-A induced pluripotent stem cell human CVCL_A8NC From: Stem Cell and Brain Research, U1208 INSERM; Bron; France. CL:0000010 Female 150518465 CVCL_A8NB SBRIi001-A induced pluripotent stem cell human CVCL_A8NB From: Stem Cell and Brain Research, U1208 INSERM; Bron; France. CL:0000010 Male 150518466 CVCL_A8MT NUIGi038-C induced pluripotent stem cell human CVCL_A8MT From: National University of Ireland Galway; Galway; Ireland CL:0000010 Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518467 CVCL_A8MS NNIi002-A induced pluripotent stem cell human CVCL_A8MS From: National Neuroscience Institute; Singapore; Singapore. CL:0000010 150518468 CVCL_A8MV PENNi001-A-1 induced pluripotent stem cell human CVCL_A8MV From: University of Pennsylvania; Philadelphia; USA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13557; ACE2 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518469 CVCL_A8MU OGHFUi001-A induced pluripotent stem cell human CVCL_A8MU From: Obstetrics and Gynecology Hospital of Fudan University; Shanghai; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:18060; ARX; Simple; p.Arg330Leu (c.989G>T); Zygosity=Hemizygous (PubMed=34087996) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518470 CVCL_A8MX PUFHi003-A induced pluripotent stem cell human CVCL_A8MX From: Peking University First Hospital; Beijing; China. CL:0000010 150518471 CVCL_A8MW PUFHi002-A induced pluripotent stem cell human CVCL_A8MW From: Peking University First Hospital; Beijing; China. CL:0000010 150518472 CVCL_A8MZ QDMHi001-A induced pluripotent stem cell human CVCL_A8MZ From: Qingdao Municipal Hospital; Qingdao; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys2258Arg (c.6772T>C); ClinVar=VCV000379489; Zygosity=Heterozygous (PubMed=34087733) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518473 CVCL_A8MY QBRIi012-A induced pluripotent stem cell human CVCL_A8MY From: Qatar Biomedical Research Institute; Doha; Quatar CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11006; SLC2A2; Simple; p.Arg301Ter (c.901C>T); ClinVar=VCV000016093; Zygosity=Homozygous (PubMed=34171785) Population: Palestinian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518474 CVCL_A8NU TUSMi010-A induced pluripotent stem cell human CVCL_A8NU From: Tongji University School of Medicine; Wuhan; China. CL:0000010 150518475 CVCL_A8NT TUSMi009-A induced pluripotent stem cell human CVCL_A8NT From: Tongji University School of Medicine; Wuhan; China CL:0000010 Population: Chinese; Han; Donor information: Established from a patient suffering from glioblastoma; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518476 CVCL_A8NW ZJUi007-A induced pluripotent stem cell human CVCL_A8NW From: The First Affiliated Hospital of Zhejiang University School of Medicine; Hangzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Trp47Ter (c.140G>A); Zygosity=Hemizygous (PubMed=34365103) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518477 CVCL_A8NV SMUSHi001-A induced pluripotent stem cell human CVCL_A8NV From: Southern Medical University, Shenzhen Hospital; Shenzhen; China CL:0000010 Population: Chinese; Han; Karyotypic information: 46,XX; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Ambiguous 150518478 CVCL_A8NY UABi001-A induced pluripotent stem cell human CVCL_A8NY From: University of Alabama at Birmingham; Birmingham; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=34392011) Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518479 CVCL_A8NX YCMi003-A induced pluripotent stem cell human CVCL_A8NX From: Yonsei University College of Medicine; Seoul; South Korea CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Asp364His (c.1090G>C); Zygosity=Heterozygous (PubMed=34438160) Population: Korean; Karyotypic information: 47,XYY (PubMed=34438160); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518480 CVCL_A8NZ UABi002-A induced pluripotent stem cell human CVCL_A8NZ From: University of Alabama at Birmingham; Birmingham; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=34392011) Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518481 CVCL_A8LK BGUi023-A induced pluripotent stem cell human CVCL_A8LK From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518482 CVCL_A8LJ BGUi022-A induced pluripotent stem cell human CVCL_A8LJ From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518483 CVCL_A8LM BGUi025-A induced pluripotent stem cell human CVCL_A8LM From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518484 CVCL_A8LL BGUi024-A induced pluripotent stem cell human CVCL_A8LL From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518485 CVCL_A8LN IBTCMi001-A induced pluripotent stem cell human CVCL_A8LN From: Institute of Basic Theory for Chinese Medicine; Beijing; China CL:0000010 Derived from site: In situ; Urine; UBERON=UBERON_0001088; Cell type: Epithelial cell of kidney; CL=CL_0002518. Male 150518486 CVCL_A8LQ JTUi004-A induced pluripotent stem cell human CVCL_A8LQ From: Sixth People's Hospital, Shanghai Jiao Tong University; Shanghai; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518487 CVCL_A8LP JTUi003-A induced pluripotent stem cell human CVCL_A8LP From: Sixth People's Hospital, Shanghai Jiao Tong University; Shanghai; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518488 CVCL_A8LC BCHNEUi012-A induced pluripotent stem cell human CVCL_A8LC From: Department of Neurology, Children's Hospital Boston; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:574; AP4M1; Simple; p.Asn73Lysfs*43 (c.218dupA); ClinVar=VCV000450739; Zygosity=Heterozygous (PubMed=34087981) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518489 CVCL_A8LB BCHNEUi011-A induced pluripotent stem cell human CVCL_A8LB From: Department of Neurology, Children's Hospital Boston; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:574; AP4M1; Simple; p.Asn73Lysfs*43 (c.218dupA); ClinVar=VCV000450739; Zygosity=Heterozygous (PubMed=34087981); Sequence variation: Mutation; HGNC; HGNC:574; AP4M1; Simple; p.Tyr284Ser (c.851A>C); ClinVar=VCV000471069; Zygosity=Heterozygous (PubMed=34087981) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518490 CVCL_A8LE BGUi017-A induced pluripotent stem cell human CVCL_A8LE From: Ben Gurion University of the Negev; Beer Sheva; Israel. CL:0000010 150518491 CVCL_A8LD BGUi016-A induced pluripotent stem cell human CVCL_A8LD From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518492 CVCL_A8LG BGUi019-A induced pluripotent stem cell human CVCL_A8LG From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518493 CVCL_A8LF BGUi018-A induced pluripotent stem cell human CVCL_A8LF From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518494 CVCL_A8LI BGUi021-A induced pluripotent stem cell human CVCL_A8LI From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518495 CVCL_A8LH BGUi020-A induced pluripotent stem cell human CVCL_A8LH From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518496 CVCL_A8KZ BCHNEUi009-A induced pluripotent stem cell human CVCL_A8KZ From: Department of Neurology, Children's Hospital Boston; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:574; AP4M1; Simple; p.Thr69Pro (c.205A>C); ClinVar=VCV001306889; Zygosity=Heterozygous (PubMed=34087981); Sequence variation: Mutation; HGNC; HGNC:574; AP4M1; Simple; c.1025+2dupT; ClinVar=rs750223135; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=34087981) Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518497 CVCL_A8KY BCHNEUi008-A induced pluripotent stem cell human CVCL_A8KY From: Department of Neurology, Children's Hospital Boston; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:574; AP4M1; Simple; p.Glu232Glyfs*21 (c.694dupG); ClinVar=VCV000818030; Zygosity=Heterozygous (PubMed=34087981) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518498 CVCL_A8LA BCHNEUi010-A induced pluripotent stem cell human CVCL_A8LA From: Department of Neurology, Children's Hospital Boston; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:574; AP4M1; Simple; c.1025+2dupT; ClinVar=rs750223135; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=34087981) Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518499 CVCL_A8KR EHTJUi004-A induced pluripotent stem cell human CVCL_A8KR From: East Hospital Affiliated to Tongji University; Shanghai; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3052; DSP; Simple; p.Leu1563Glufs*63 (c.4687_4688delCT) (c.4683_4684delCT); ClinVar=VCV001072470; Zygosity=Heterozygous (PubMed=34087998) Population: Chinese; Han; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female 150518500 CVCL_A8KQ CSSi012-A induced pluripotent stem cell human CVCL_A8KQ From: Fondazione Casa Sollievo della Sofferenza IRCCS; San Giovanni Rotondo; Italy CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Gly376Asp (c.1127G>A); Zygosity=Heterozygous (PubMed=34087986) Population: Caucasian; Italian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518501 CVCL_A8KT ESi086-A induced pluripotent stem cell human CVCL_A8KT From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain CL:0000010 Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 150518502 CVCL_A8KS EHTJUi005-A induced pluripotent stem cell human CVCL_A8KS From: East Hospital Affiliated to Tongji University; Shanghai; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female 150518503 CVCL_A8KV ESi086-A-2 induced pluripotent stem cell human CVCL_A8KV From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4171; GATA2; Simple_edited; p.Arg398Trp (c.1192C>T); ClinVar=VCV000029709; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34284273) Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 150518504 CVCL_A8KU ESi086-A-1 induced pluripotent stem cell human CVCL_A8KU From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4171; GATA2; Simple_edited; p.Arg396Gln (c.1187G>A); ClinVar=VCV000472437; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34284273) Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 150518505 CVCL_A8KX BCHNEUi007-A induced pluripotent stem cell human CVCL_A8KX From: Department of Neurology, Children's Hospital Boston; Boston; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:574; AP4M1; Simple; p.Glu232Glyfs*21 (c.694dupG); ClinVar=VCV000818030; Zygosity=Heterozygous (PubMed=34087981); Sequence variation: Mutation; HGNC; HGNC:574; AP4M1; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000561150; Zygosity=Heterozygous (PubMed=34087981) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518506 CVCL_A8KW AMUFAHi001-A induced pluripotent stem cell human CVCL_A8KW From: The First Affiliated Hospital of Anhui Medical University; Anhui; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:18576; CCNO; Simple; p.Gln88Argfs*8 (c.253_257GGCCC[3]) (c.258_262dupGGCCC) (c.262_263insGGCCC); ClinVar=VCV000139600; Zygosity=Homozygous (PubMed=34088001) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518507 CVCL_A8ML METUi001-A induced pluripotent stem cell human CVCL_A8ML From: Middle East Technical University; Ankara; Turkey CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518508 CVCL_A8MK LEIi018-A induced pluripotent stem cell human CVCL_A8MK From: Lions Eye Institute, University of Western Australia; Nedlands; Australia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; c.5461-10T>C; ClinVar=VCV000092870; Zygosity=Heterozygous (PubMed=34214897); Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Asn1868Ile (c.5603A>T); ClinVar=VCV000099390; Zygosity=Heterozygous (PubMed=34214897); Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Leu2026Pro (c.6077T>C); ClinVar=VCV000236144; Zygosity=Heterozygous (PubMed=34214897) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518509 CVCL_A8MN MRIi003-A induced pluripotent stem cell human CVCL_A8MN From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518510 CVCL_A8MM MILi001-A induced pluripotent stem cell human CVCL_A8MM From: Miltenyi Biotec B.V.; Gladbach; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 150518511 CVCL_A8MP MRIi018-A induced pluripotent stem cell human CVCL_A8MP From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:944; ADGRB2; Simple; p.Gly267Asp (c.800G>A); Zygosity=Unspecified; Note=De novo mutation (hPSCreg=MRIi018-A); Sequence variation: Mutation; HGNC; HGNC:28338; DENND5B; Simple; p.Lys799Arg (c.2396A>G); Zygosity=Unspecified; Note=De novo mutation (hPSCreg=MRIi018-A); Sequence variation: Mutation; HGNC; HGNC:26011; SYBU; Simple; p.Pro93Leu (c.278C>A); Zygosity=Unspecified; Note=De novo mutation (hPSCreg=MRIi018-A) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole exome sequencing Male 150518512 CVCL_A8MR NNIi001-A induced pluripotent stem cell human CVCL_A8MR From: National Neuroscience Institute; Singapore; Singapore. CL:0000010 150518513 CVCL_A8MQ NMIi010-A induced pluripotent stem cell human CVCL_A8MQ From: Natural and Medical Sciences Institute, University of Tubingen; Tubingen; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Variations; Array-based CGH Male 150518514 CVCL_A8MD LCSBi006-A induced pluripotent stem cell human CVCL_A8MD From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg CL:0000010 Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=34736041) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518515 CVCL_A8MC LCSBi005-B transformed cell line human CVCL_A8MC From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg CL:0000010 Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=34736041) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH Male 150518516 CVCL_A8MF LCSBi007-B induced pluripotent stem cell human CVCL_A8MF From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg CL:0000010 Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (PubMed=34826737) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH Female 150518517 CVCL_A8ME LCSBi007-A induced pluripotent stem cell human CVCL_A8ME From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg CL:0000010 Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Heterozygous (PubMed=34826737) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH Female 150518518 CVCL_A8MH LEIi016-B induced pluripotent stem cell human CVCL_A8MH From: Lions Eye Institute, University of Western Australia; Nedlands; Australia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Ile852Thr (c.2555T>C); ClinVar=VCV000099883; Zygosity=Heterozygous (PubMed=34034222); Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Asp1005Val (c.3014A>T); ClinVar=VCV000846589; Zygosity=Heterozygous (PubMed=34034222) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518519 CVCL_A8MG LEIi016-A induced pluripotent stem cell human CVCL_A8MG From: Lions Eye Institute, University of Western Australia; Nedlands; Australia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Ile852Thr (c.2555T>C); ClinVar=VCV000099883; Zygosity=Heterozygous (PubMed=34034222); Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Asp1005Val (c.3014A>T); ClinVar=VCV000846589; Zygosity=Heterozygous (PubMed=34034222) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518520 CVCL_A8MJ LEIi017-B induced pluripotent stem cell human CVCL_A8MJ From: Lions Eye Institute, University of Western Australia; Nedlands; Australia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Arg152Gln (c.455G>A); ClinVar=VCV000099301; Zygosity=Heterozygous (PubMed=34198153); Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Leu1388Pro (c.4163T>C); ClinVar=VCV000099254; Zygosity=Heterozygous (PubMed=34198153); Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; c.5461-10T>C; ClinVar=VCV000092870; Zygosity=Heterozygous (PubMed=34198153); Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Asn1868Ile (c.5603A>T); ClinVar=VCV000099390; Zygosity=Heterozygous (PubMed=34198153) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518521 CVCL_A8MI LEIi017-A induced pluripotent stem cell human CVCL_A8MI From: Lions Eye Institute, University of Western Australia; Nedlands; Australia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Arg152Gln (c.455G>A); ClinVar=VCV000099301; Zygosity=Heterozygous (PubMed=34198153); Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Leu1388Pro (c.4163T>C); ClinVar=VCV000099254; Zygosity=Heterozygous (PubMed=34198153); Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; c.5461-10T>C; ClinVar=VCV000092870; Zygosity=Heterozygous (PubMed=34198153); Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Asn1868Ile (c.5603A>T); ClinVar=VCV000099390; Zygosity=Heterozygous (PubMed=34198153) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518522 CVCL_A8LZ LCSBi004-A induced pluripotent stem cell human CVCL_A8LZ From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg CL:0000010 Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg275Trp (c.823C>T); ClinVar=VCV000007050; Zygosity=Heterozygous (PubMed=35378365) Population: Latino or Hispanic; Dominican; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH Female 150518523 CVCL_A8MB LCSBi005-A transformed cell line human CVCL_A8MB From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg CL:0000010 Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=34736041) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518524 CVCL_A8MA LCSBi004-B induced pluripotent stem cell human CVCL_A8MA From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg CL:0000010 Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg275Trp (c.823C>T); ClinVar=VCV000007050; Zygosity=Heterozygous (PubMed=35378365) Population: Latino or Hispanic; Dominican; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH Female 150518525 CVCL_A8LS INSRMi011-A induced pluripotent stem cell human CVCL_A8LS From: INSERM; Paris; France CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Arg169Pro (c.506G>C); Zygosity=Heterozygous (PubMed=35245853) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518526 CVCL_A8LR KEIOi002-A induced pluripotent stem cell human CVCL_A8LR From: Keio University; Tokyo; Japan CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518527 CVCL_A8LU LCSBi002-B induced pluripotent stem cell human CVCL_A8LU From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg CL:0000010 Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Ile368Asn (c.1103T>A); dbSNP=rs774647122; Zygosity=Homozygous (PubMed=35378365) Population: Caucasian; Polish; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH Male 150518528 CVCL_A8LT LCSBi002-A induced pluripotent stem cell human CVCL_A8LT From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg CL:0000010 Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Ile368Asn (c.1103T>A); dbSNP=rs774647122; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Polish; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518529 CVCL_A8LW LCSBi003-A induced pluripotent stem cell human CVCL_A8LW From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PubMed=34826737) Population: Caucasian; Greek; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH Female 150518530 CVCL_A8LV LCSBi002-C induced pluripotent stem cell human CVCL_A8LV From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg CL:0000010 Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Ile368Asn (c.1103T>A); dbSNP=rs774647122; Zygosity=Homozygous (PubMed=35378365) Population: Caucasian; Polish; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH Male 150518531 CVCL_A8LY LCSBi003-C induced pluripotent stem cell human CVCL_A8LY From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PubMed=34826737) Population: Caucasian; Greek; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH Female 150518532 CVCL_A8LX LCSBi003-B induced pluripotent stem cell human CVCL_A8LX From: Luxembourg Centre for Systems Biomedicine; Belvaux; Luxembourg CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Greek; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518533 CVCL_A8ZY SDZFYi001-A induced pluripotent stem cell human CVCL_A8ZY From: Shandong Academy of Occupational Health and Occupational Medicine; Jinan; China CL:0000010 Cell type: Fibroblast; CL=CL_0000057. Male 150518534 CVCL_A8ZX QBRIi013-A induced pluripotent stem cell human CVCL_A8ZX From: Qatar Biomedical Research Institute; Doha; Quatar CL:0000010 Population: Egyptian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518535 CVCL_A8ZZ UCSCi001-A induced pluripotent stem cell human CVCL_A8ZZ From: Universita Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A Gemelli; Rome; Italy. CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.Arg518Ile (c.1553G>T); Zygosity=Heterozygous (PubMed=34303285) Population: Caucasian; Italian; Derived from site: In situ; Leg, skin, dermis; UBERON=UBERON_0001511+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH Male 150518536 CVCL_A8ZQ NIAi001-I induced pluripotent stem cell human CVCL_A8ZQ From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Asn1437His (c.4309A>C); ClinVar=VCV000039183; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34087985) Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female 150518537 CVCL_A8ZP NIAi001-H induced pluripotent stem cell human CVCL_A8ZP From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Arg1441Cys (c.4321C>T); ClinVar=VCV000001938; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34087985) Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female 150518538 CVCL_A8ZS NIAi001-K induced pluripotent stem cell human CVCL_A8ZS From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Lys1906Met (c.5717A>T); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34087985) Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female 150518539 CVCL_A8ZR NIAi001-J induced pluripotent stem cell human CVCL_A8ZR From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Asn1437His (c.4309A>C); ClinVar=VCV000039183; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34087985) Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female 150518540 CVCL_A8ZU NIAi001-M induced pluripotent stem cell human CVCL_A8ZU From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18618; LRRK2 Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female 150518541 CVCL_A8ZT NIAi001-L induced pluripotent stem cell human CVCL_A8ZT From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Thr1348Asn (c.4043A>C); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34087985) Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female 150518542 CVCL_A8ZW FAHZUe001-A embryonic stem cell human CVCL_A8ZW From: The First Affiliated Hospital of Zhejiang University School of Medicine; Hangzhou; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20822; ADGRL4 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 150518543 CVCL_A8ZV NIAi001-N induced pluripotent stem cell human CVCL_A8ZV From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18618; LRRK2 Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female 150518544 CVCL_A8ZI NIAi001-B induced pluripotent stem cell human CVCL_A8ZI From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Ile2020Thr (c.6059C>T); ClinVar=VCV000001941; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34087985) Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female 150518545 CVCL_A8ZH NIAi001-A induced pluripotent stem cell human CVCL_A8ZH From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Ile2020Thr (c.6059C>T); ClinVar=VCV000001941; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34087985) Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female 150518546 CVCL_A8ZK NIAi001-D induced pluripotent stem cell human CVCL_A8ZK From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34087985) Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female 150518547 CVCL_A8ZJ NIAi001-C induced pluripotent stem cell human CVCL_A8ZJ From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34087985) Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female 150518548 CVCL_A8ZM NIAi001-F induced pluripotent stem cell human CVCL_A8ZM From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Tyr1699Cys (c.5096A>G); ClinVar=VCV000001937; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34087985) Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female 150518549 CVCL_A8ZL NIAi001-E induced pluripotent stem cell human CVCL_A8ZL From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Tyr1699Cys (c.5096A>G); ClinVar=VCV000001937; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34087985) Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female 150518550 CVCL_A8ZN NIAi001-G induced pluripotent stem cell human CVCL_A8ZN From: Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health; Bethesda; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Arg1441Cys (c.4321C>T); ClinVar=VCV000001938; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34087985) Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female 150518551 CVCL_A8ZA HVRDe008-A-1 embryonic stem cell human CVCL_A8ZA CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2); Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Using CRISPR/Cas9 a P2A-Luc2-IRES-PuroR-pA construct was integrated at the 3'end of one allele of GAPDH (PubMed=34088000) 150518552 CVCL_A8ZC CUi001-A-1 induced pluripotent stem cell human CVCL_A8ZC From: Chiba University; Chiba; Japan CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=34087989); Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple_corrected; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous; Note=By CRISPR/Cas9 Splice acceptor mutation (PubMed=34087989). Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518553 CVCL_A8ZB CUi001-A induced pluripotent stem cell human CVCL_A8ZB From: Chiba University; Chiba; Japan CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=34087989) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518554 CVCL_A8ZE PSHi001-A induced pluripotent stem cell human CVCL_A8ZE From: Plastic Surgery Hospital of Chinese Academy of Medical Sciences; Beijing; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518555 CVCL_A8ZD BCH001 induced pluripotent stem cell human CVCL_A8ZD From: Beijing Children's Hospital; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; c.2608-125C>T; Zygosity=Heterozygous (PubMed=34087988) Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518556 CVCL_A8ZG PSHi002-A induced pluripotent stem cell human CVCL_A8ZG From: Plastic Surgery Hospital of Chinese Academy of Medical Sciences; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11654; TCOF1; Simple; p.Ser657Trpfs*25 (c.1966_1969dup); Zygosity=Heterozygous (PubMed=34247110) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518557 CVCL_A8ZF CiSB spontaneously immortalized cell line CVCL_A8ZF CL:0000010 Derived from site: In situ; Swim bladder; UBERON=UBERON_0006860. Unspecified Virology: Susceptible to infection by grass carp reovirus (GCRV) genotype 2 (PubMed=33460745) Group: Fish cell line 150518558 CVCL_A8XW E01F finite cell line CVCL_A8XW CL:0000010 Derived from site: In situ; Back, skin; UBERON=UBERON_0001068; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; RNAseq Female Group: Non-human primate cell line 150518559 CVCL_A8XV NM-iPS induced pluripotent stem cell CVCL_A8XV CL:0000010 Derived from site: In situ; Back, skin; UBERON=UBERON_0001068; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; RNAseq Female Group: Non-human primate cell line 150518560 CVCL_A8XY OF35Y-iPS induced pluripotent stem cell dog CVCL_A8XY CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620; Breed/subspecies: Beagle; VBO=VBO_0200131. Omics: Transcriptomics; RNAseq Male 150518561 CVCL_A8XX RNA-iPSC #1 induced pluripotent stem cell CVCL_A8XX CL:0000010 Derived from site: In situ; Back, skin; UBERON=UBERON_0001068; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; RNAseq Female Group: Non-human primate cell line 150518562 CVCL_A8XZ K9 finite cell line dog CVCL_A8XZ CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; RNAseq Female 150518563 CVCL_A8XN FAFU&CU-Px-1 spontaneously immortalized cell line CVCL_A8XN CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Geneva 88. Unspecified Doubling time: 19 hours (DOI=10.1111/1744-7917.12533) Group: Insect cell line 150518564 CVCL_A8XQ FAFU&CU-Px-3 spontaneously immortalized cell line CVCL_A8XQ CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Geneva 88. Unspecified Doubling time: 23 hours (DOI=10.1111/1744-7917.12533) Group: Insect cell line 150518565 CVCL_A8XP FAFU&CU-Px-2 spontaneously immortalized cell line CVCL_A8XP CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Geneva 88. Unspecified Doubling time: 20 hours (DOI=10.1111/1744-7917.12533) Group: Insect cell line 150518566 CVCL_A8XS FAFU&CU-Px-5 spontaneously immortalized cell line CVCL_A8XS CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Geneva 88. Unspecified Doubling time: 19 hours (DOI=10.1111/1744-7917.12533) Group: Insect cell line 150518567 CVCL_A8XR FAFU&CU-Px-4 spontaneously immortalized cell line CVCL_A8XR CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Geneva 88. Unspecified Doubling time: 18 hours (DOI=10.1111/1744-7917.12533) Group: Insect cell line 150518568 CVCL_A8XU Tn5B-40 spontaneously immortalized cell line CVCL_A8XU CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Unspecified Doubling time: 22 hours (DOI=10.1111/j.1744-7917.2004.tb00236.x) Group: Insect cell line; Group: Recombinant protein production insect cell line 150518569 CVCL_A8XT FAFU&CU-Px-6 spontaneously immortalized cell line CVCL_A8XT CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Breed/subspecies: Geneva 88. Unspecified Doubling time: 18 hours (DOI=10.1111/1744-7917.12533) Group: Insect cell line 150518570 CVCL_A8XG LaNCE hiPSC-57 induced pluripotent stem cell human CVCL_A8XG From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518571 CVCL_A8XF BGUi009-B induced pluripotent stem cell human CVCL_A8XF From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Sequence variation: Mutation; HGNC; HGNC:29131; PLEKHM2; Simple; p.Lys645Alafs*12 (c.1932_1933delAG) (c.2156_2157delAG); ClinVar=VCV000253148; Zygosity=Homozygous (PubMed=34088011) Population: Bedouin; Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384. Male 150518572 CVCL_A8XI BGUi008-B induced pluripotent stem cell human CVCL_A8XI From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Sequence variation: Mutation; HGNC; HGNC:29131; PLEKHM2; Simple; p.Lys645Alafs*12 (c.1932_1933delAG) (c.2156_2157delAG); ClinVar=VCV000253148; Zygosity=Heterozygous (PubMed=34088011) Population: Bedouin; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518573 CVCL_A8XH LaNCE hiPSC-60 induced pluripotent stem cell human CVCL_A8XH From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518574 CVCL_A8XK NEAU-Ds-950821 spontaneously immortalized cell line CVCL_A8XK CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Unspecified Doubling time: 52.6 hours (DOI=10.1007/BF02855536) Group: Insect cell line 150518575 CVCL_A8XJ BGUi010-B induced pluripotent stem cell human CVCL_A8XJ From: Ben Gurion University of the Negev; Beer Sheva; Israel CL:0000010 Sequence variation: Mutation; HGNC; HGNC:29131; PLEKHM2; Simple; p.Lys645Alafs*12 (c.1932_1933delAG) (c.2156_2157delAG); ClinVar=VCV000253148; Zygosity=Homozygous (PubMed=34088011) Population: Bedouin; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518576 CVCL_A8XM TMs7311 spontaneously immortalized cell line CVCL_A8XM CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08160; Autographa californica nuclear polyhedrosis virus (AcMNPV) p35; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Unspecified Group: Insect cell line 150518577 CVCL_A8XL NEAU-Xc-920730 spontaneously immortalized cell line CVCL_A8XL CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Unspecified Group: Insect cell line 150518578 CVCL_A8XA LaNCE hiPSC-61 induced pluripotent stem cell human CVCL_A8XA From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518579 CVCL_A8XC LaNCE hiPSC-55 induced pluripotent stem cell human CVCL_A8XC From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518580 CVCL_A8XB LaNCE hiPSC-62 induced pluripotent stem cell human CVCL_A8XB From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518581 CVCL_A8XE LaNCE hiPSC-59 induced pluripotent stem cell human CVCL_A8XE From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518582 CVCL_A8XD LaNCE hiPSC-56 induced pluripotent stem cell human CVCL_A8XD From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518583 CVCL_A8YX F15553 induced pluripotent stem cell human CVCL_A8YX CL:0000010 Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Val717Leu (c.2149G>C); ClinVar=VCV000018105; Zygosity=Heterozygous (PubMed=30045758) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 150518584 CVCL_A8YW F12448 induced pluripotent stem cell human CVCL_A8YW CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9509; PSEN2; Simple; p.Asn141Ile (c.422A>T); ClinVar=VCV000008845; Zygosity=Heterozygous (PubMed=30045758) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518585 CVCL_A8YZ UOMELBi002-A induced pluripotent stem cell human CVCL_A8YZ From: University of Melbourne; Melbourne; Australia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_corrected; p.Val717Ile (c.2149G>A); ClinVar=VCV000018088; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34088002) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 150518586 CVCL_A8YY F16574 induced pluripotent stem cell human CVCL_A8YY CL:0000010 Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Val717Ile (c.2149G>A); ClinVar=VCV000018088; Zygosity=Heterozygous (PubMed=30045758) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 150518587 CVCL_A8YP I5061F B-3-15 iPSC induced pluripotent stem cell CVCL_A8YP CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; RNAseq Female Group: Non-human primate cell line 150518588 CVCL_A8YR CTXNS1 B-1 iPSC induced pluripotent stem cell CVCL_A8YR CL:0000010 Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956. Omics: Transcriptomics; RNAseq Female Group: Non-human primate cell line 150518589 CVCL_A8YQ I5061F B-3-3 iPSC induced pluripotent stem cell CVCL_A8YQ CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; RNAseq Female Group: Non-human primate cell line 150518590 CVCL_A8YT F11430 induced pluripotent stem cell human CVCL_A8YT From: University of Melbourne; Melbourne; Australia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.His163Arg (c.488A>G); ClinVar=VCV000018124; Zygosity=Heterozygous (PubMed=30045758) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518591 CVCL_A8YS CTXNS2 B-1 iPSC induced pluripotent stem cell CVCL_A8YS CL:0000010 Derived from site: In situ; Fetal brain, cerebral cortex; UBERON=UBERON_0006238+UBERON_0000956. Omics: Transcriptomics; RNAseq Female Group: Non-human primate cell line 150518592 CVCL_A8YV F12434 induced pluripotent stem cell human CVCL_A8YV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Gly217Arg (c.649G>C); ClinVar=VCV000018159; Zygosity=Heterozygous (PubMed=30045758) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518593 CVCL_A8YU F12424 induced pluripotent stem cell human CVCL_A8YU CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala79Val (c.236C>T); ClinVar=VCV000018157; Zygosity=Heterozygous (PubMed=30045758) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518594 CVCL_A8YH E01F A-2-6 iPSC induced pluripotent stem cell CVCL_A8YH CL:0000010 Derived from site: In situ; Back, skin; UBERON=UBERON_0001068; Cell type: Fibroblast of skin; CL=CL_0002620. Female Group: Non-human primate cell line 150518595 CVCL_A8YG E01F A-2-2 iPSC induced pluripotent stem cell CVCL_A8YG CL:0000010 Derived from site: In situ; Back, skin; UBERON=UBERON_0001068; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; RNAseq Female Group: Non-human primate cell line 150518596 CVCL_A8YJ E02M finite cell line CVCL_A8YJ CL:0000010 Derived from site: In situ; Back, skin; UBERON=UBERON_0001068; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; RNAseq Male Group: Non-human primate cell line 150518597 CVCL_A8YI E01F A-2-7 iPSC induced pluripotent stem cell CVCL_A8YI CL:0000010 Derived from site: In situ; Back, skin; UBERON=UBERON_0001068; Cell type: Fibroblast of skin; CL=CL_0002620. Female Group: Non-human primate cell line 150518598 CVCL_A8YL CM421F finite cell line CVCL_A8YL CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; RNAseq Female Group: Non-human primate cell line 150518599 CVCL_A8YK E02M B-0-7 iPSC induced pluripotent stem cell CVCL_A8YK CL:0000010 Derived from site: In situ; Back, skin; UBERON=UBERON_0001068; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; RNAseq Male Group: Non-human primate cell line 150518600 CVCL_A8YN I5061F finite cell line CVCL_A8YN CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; RNAseq Female Group: Non-human primate cell line 150518601 CVCL_A8YM CM421F B-0-12 iPSC induced pluripotent stem cell CVCL_A8YM CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; RNAseq Female Group: Non-human primate cell line 150518602 CVCL_A8YB K9 iPSC #2 induced pluripotent stem cell dog CVCL_A8YB CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; RNAseq Female 150518603 CVCL_A8YA K9 iPSC #1 induced pluripotent stem cell dog CVCL_A8YA CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; RNAseq Female 150518604 CVCL_A8YD N01F finite cell line pig CVCL_A8YD CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; RNAseq Female 150518605 CVCL_A8YC K9 iPSC #3 induced pluripotent stem cell dog CVCL_A8YC CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; RNAseq Female 150518606 CVCL_A8YF N01F iPSC #2 induced pluripotent stem cell pig CVCL_A8YF CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; RNAseq Female 150518607 CVCL_A8YE N01F iPSC #1 induced pluripotent stem cell pig CVCL_A8YE CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; RNAseq Female 150518608 CVCL_A8VU SRTF spontaneously immortalized cell line CVCL_A8VU CL:0000010 Derived from site: In situ; Fin; UBERON=UBERON_0008897; Breed/subspecies: Standard Ryukin Takafumi. Unspecified Virology: Susceptible to infection by cyprinid herpesvirus 2 (CyHV-2) (PubMed=23999703) Group: Fish cell line 150518609 CVCL_A8VT RKF spontaneously immortalized cell line CVCL_A8VT CL:0000010 Derived from site: In situ; Fin; UBERON=UBERON_0008897; Breed/subspecies: Ryukin; VBO=VBO_0017500. Unspecified Virology: Not susceptible to infection by cyprinid herpesvirus 2 (CyHV-2) (PubMed=23999703) Group: Fish cell line 150518610 CVCL_A8VW PKW-LWHT transformed cell line CVCL_A8VW CL:0000010 Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Tail, skin, dermis; UBERON=UBERON_0003534+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male Doubling time: 14.41 hours (PubMed=29596530) Group: Cetacean cell line 150518611 CVCL_A8VV GFF spontaneously immortalized cell line CVCL_A8VV CL:0000010 Derived from site: In situ; Fin; UBERON=UBERON_0008897. Unspecified Group: Fish cell line 150518612 CVCL_A8VY ZBE3 embryonic stem cell zebrafish CVCL_A8VY CL:0000010 Derived from site: In situ; Blastula; UBERON=UBERON_0000307; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: AB; VBO=VBO_0017495. Unspecified Characteristics: Grows at temperatures ranging from 20 to 32 Celsius The highest growth rate is obtained at 28 Celsius (PubMed=28833122). Group: Fish cell line 150518613 CVCL_A8VX SSK spontaneously immortalized cell line CVCL_A8VX CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Unspecified Characteristics: Optimal growth temperature is 28 Celsius (DOI=10.21077/ijf.2017.64.special-issue.76212-14) Group: Fish cell line 150518614 CVCL_A8VZ JFSK_alb spontaneously immortalized cell line CVCL_A8VZ CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Breed/subspecies: Albinos. Unspecified Characteristics: Capable of growing from 18 to 30 Celsius, the optimal temperature is 24 Celsius (PubMed=28698966) Group: Fish cell line 150518615 CVCL_A8VM B45 spontaneously immortalized cell line CVCL_A8VM CL:0000010 Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Breed/subspecies: INRA Sy derived homozygous clone B45. Female Virology: Highly susceptible to infection by viral hemorrhagic septicemia virus (VHSV) (PubMed=22514610) Group: Fish cell line 150518616 CVCL_A8VL A36 spontaneously immortalized cell line CVCL_A8VL CL:0000010 Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Breed/subspecies: INRA Sy derived homozygous clone A36. Female Virology: Susceptible to infection by viral hemorrhagic septicemia virus (VHSV) (PubMed=22514610) Group: Fish cell line 150518617 CVCL_A8VN B57 spontaneously immortalized cell line CVCL_A8VN CL:0000010 Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Breed/subspecies: INRA Sy derived homozygous clone B57. Omics: Transcriptomics; RNAseq Female Virology: Not susceptible to infection by viral hemorrhagic septicemia virus (VHSV) (PubMed=22514610) Group: Fish cell line 150518618 CVCL_A8VQ HFB-ES embryonic stem cell CVCL_A8VQ CL:0000010 Derived from site: In situ; Blastula; UBERON=UBERON_0000307; Cell type: Embryonic stem cell; CL=CL_0002322. Unspecified Group: Fish cell line 150518619 CVCL_A8VP BAASf spontaneously immortalized cell line CVCL_A8VP CL:0000010 Derived from site: In situ; Heart, bulbus arteriosus; UBERON=UBERON_0004152; Cell type: Fibroblast; CL=CL_0000057. Female Group: Fish cell line 150518620 CVCL_A8VS CSCVE spontaneously immortalized cell line CVCL_A8VS CL:0000010 Derived from site: In situ; Heart, blood vessel; UBERON=UBERON_0003498; Cell type: Endothelial cell of blood vessel; CL=CL_0000071. Unspecified Characteristics: Capable of growing from 22 to 32 Celsius, the optimal temperature is 28 Celsius (PubMed=25194832) Doubling time: 68 hours (Note=At 7th passage), 57 hours (Note=At 15th passage), 47 hours (Note=At 23th passage), 41 hours (Note=At 37th passage), 39 hours (Note=At 45th passage), 33 hours (Note=At 64th passage) (PubMed=25194832) Group: Fish cell line 150518621 CVCL_A8VR HKM spontaneously immortalized cell line CVCL_A8VR CL:0000010 Derived from site: In situ; Head kidney; UBERON=UBERON_0007132. Unspecified Characteristics: Can grow between 25 to 37 Celsius, with an optimal growth temperature of 28 Celsius (PubMed=25204072) Group: Fish cell line 150518622 CVCL_A8VE 9F8BO hybridoma house mouse CVCL_A8VE CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; Q9NRN5; Human OLFML3. Group: Patented cell line 150518623 CVCL_A8VD 46A9BO hybridoma house mouse CVCL_A8VD CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; Q9NRN5; Human OLFML3. Group: Patented cell line 150518624 CVCL_A8VG immKHC8 telomerase immortalized cell line human CVCL_A8VG CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Male 150518625 CVCL_A8VF Z14A7 hybridoma house mouse CVCL_A8VF CL:0000010 Monoclonal antibody isotype: IgG2c; Monoclonal antibody target: UniProtKB; Q9NRN5; Human OLFML3. Group: Patented cell line 150518626 CVCL_A8VI A2 [Carp] spontaneously immortalized cell line CVCL_A8VI CL:0000010 Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Breed/subspecies: INRA Sy derived homozygous clone A2. Female Virology: Not susceptible to infection by viral hemorrhagic septicemia virus (VHSV) (PubMed=22514610) Group: Fish cell line 150518627 CVCL_A8VH HeLa FUS KO cancer cell line human CVCL_A8VH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4010; FUS Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 150518628 CVCL_A8VK A3 [Oncorhynchus] spontaneously immortalized cell line CVCL_A8VK CL:0000010 Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Breed/subspecies: INRA Sy derived homozygous clone A3. Female Virology: Highly susceptible to infection by viral hemorrhagic septicemia virus (VHSV) (PubMed=22514610) Group: Fish cell line 150518629 CVCL_A8VJ A22 spontaneously immortalized cell line CVCL_A8VJ CL:0000010 Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Breed/subspecies: INRA Sy derived homozygous clone A22. Omics: Transcriptomics; RNAseq Female Virology: Susceptible to infection by viral hemorrhagic septicemia virus (VHSV) (PubMed=22514610) Group: Fish cell line 150518630 CVCL_A8VA immFHC1 telomerase immortalized cell line human CVCL_A8VA CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518631 CVCL_A8VC MW1C 6.3 cancer cell line human CVCL_A8VC CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234Ter (c.702C>A); Zygosity=Unspecified (PubMed=1961733) Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 150518632 CVCL_A8VB immFHC2 telomerase immortalized cell line human CVCL_A8VB CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518633 CVCL_A8WV ftiPSm-2 induced pluripotent stem cell CVCL_A8WV CL:0000010 Derived from site: In situ; Fetus; UBERON=UBERON_0000323; Cell type: Fibroblast; CL=CL_0000057. Male 150518634 CVCL_A8WU ftiPSm-1 induced pluripotent stem cell CVCL_A8WU CL:0000010 Derived from site: In situ; Fetus; UBERON=UBERON_0000323; Cell type: Fibroblast; CL=CL_0000057. Male 150518635 CVCL_A8WX ftiPSm-4 induced pluripotent stem cell CVCL_A8WX CL:0000010 Derived from site: In situ; Fetus; UBERON=UBERON_0000323; Cell type: Fibroblast; CL=CL_0000057. Male 150518636 CVCL_A8WW ftiPSm-3 induced pluripotent stem cell CVCL_A8WW CL:0000010 Derived from site: In situ; Fetus; UBERON=UBERON_0000323; Cell type: Fibroblast; CL=CL_0000057. Male 150518637 CVCL_A8WZ LaNCE hiPSC-58 induced pluripotent stem cell human CVCL_A8WZ From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518638 CVCL_A8WY ftiPSm-5 induced pluripotent stem cell CVCL_A8WY CL:0000010 Derived from site: In situ; Fetus; UBERON=UBERON_0000323; Cell type: Fibroblast; CL=CL_0000057. Male 150518639 CVCL_A8WN XACHi014-A induced pluripotent stem cell human CVCL_A8WN From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Ile145Serfs*92 (c.431delC); Zygosity=Heterozygous (PubMed=34088017) Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518640 CVCL_A8WM XACHi013-A induced pluripotent stem cell human CVCL_A8WM From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Trp392Ter (c.1175G>A) (p.Trp265Ter, c.794G>A); ClinVar=VCV000405268; Zygosity=Heterozygous (PubMed=34088017) Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518641 CVCL_A8WP fiPS-1 induced pluripotent stem cell CVCL_A8WP CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; RNAseq Female 150518642 CVCL_A8WR ftiPSf-19 induced pluripotent stem cell CVCL_A8WR CL:0000010 Derived from site: In situ; Fetus; UBERON=UBERON_0000323; Cell type: Fibroblast; CL=CL_0000057. Female 150518643 CVCL_A8WQ ftiPSf-1 induced pluripotent stem cell CVCL_A8WQ CL:0000010 Derived from site: In situ; Fetus; UBERON=UBERON_0000323; Cell type: Fibroblast; CL=CL_0000057. Female 150518644 CVCL_A8WT ftiPSf-4 induced pluripotent stem cell CVCL_A8WT CL:0000010 Derived from site: In situ; Fetus; UBERON=UBERON_0000323; Cell type: Fibroblast; CL=CL_0000057. Female 150518645 CVCL_A8WS ftiPSf-2 induced pluripotent stem cell CVCL_A8WS CL:0000010 Derived from site: In situ; Fetus; UBERON=UBERON_0000323; Cell type: Fibroblast; CL=CL_0000057. Female 150518646 CVCL_A8WF CP-94251 finite cell line human CVCL_A8WF CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=9453489) Derived from site: In situ; Esophagus; UBERON=UBERON_0001043; Cell type: Epithelial cell of esophagus; CL=CL_0002252. Male 150518647 CVCL_A8WE CP-52731 finite cell line human CVCL_A8WE CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Leu97Gln (c.290T>A); Zygosity=Unspecified (PubMed=9453489); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=9453489) Derived from site: In situ; Esophagus; UBERON=UBERON_0001043; Cell type: Epithelial cell of esophagus; CL=CL_0002252. Male 150518648 CVCL_A8WH HPCASRi002-A induced pluripotent stem cell human CVCL_A8WH CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1514; CASR; Simple; p.Ile554Serfs*73 (c.1656delA); Zygosity=Heterozygous (PubMed=34111698); Sequence variation: Mutation; HGNC; HGNC:1514; CASR; Simple; p.Cys739Ter (c.2217T>A); Zygosity=Heterozygous (PubMed=34111698) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518649 CVCL_A8WG KR-42421 finite cell line human CVCL_A8WG CL:0000010 Derived from site: In situ; Esophagus; UBERON=UBERON_0001043; Cell type: Epithelial cell of esophagus; CL=CL_0002252. Male 150518650 CVCL_A8WJ HEBHMUi008-A induced pluripotent stem cell human CVCL_A8WJ From: Hebei Medical University; Shijiazhuang; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=34088020) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518651 CVCL_A8WI KUCFRi003-A induced pluripotent stem cell human CVCL_A8WI From: Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University; Seoul; South Korea CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7427; MT-CYB; Simple; p.Asp171Asn (m.15257G>A); ClinVar=VCV000009674; Zygosity=Heteroplasmic (PubMed=34091428) Population: Caucasian; Cell type: Fibroblast; CL=CL_0000057. Female 150518652 CVCL_A8WL XACHi012-A induced pluripotent stem cell human CVCL_A8WL From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Ile145Serfs*92 (c.431delC); Zygosity=Heterozygous (PubMed=34088017); Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Trp392Ter (c.1175G>A) (p.Trp265Ter, c.794G>A); ClinVar=VCV000405268; Zygosity=Heterozygous (PubMed=34088017) Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518653 CVCL_A8WK WAe007-A-1 embryonic stem cell human CVCL_A8WK From: Institute for Cardiovascular Science of Soochow University; Suzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4173; GATA4; Simple_edited; p.Thr280Met (c.839C>T); ClinVar=VCV000030108; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34088018) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 150518654 CVCL_A8WB EMB spontaneously immortalized cell line CVCL_A8WB CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified Characteristics: Capable of growing from 18 to 30 Celsius, the optimal temperature is between 24 and 30 Celsius (PubMed=29333652) Group: Fish cell line 150518655 CVCL_A8WA JFSK_wt spontaneously immortalized cell line CVCL_A8WA CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097. Unspecified Characteristics: Capable of growing from 18 to 30 Celsius, the optimal temperature is 24 Celsius (PubMed=28698966) Group: Fish cell line 150518656 CVCL_A8WD CP-18821 finite cell line human CVCL_A8WD CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9453489); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser303Alafs*42 (c.906del); Zygosity=Unspecified (PubMed=9453489) Derived from site: In situ; Esophagus; UBERON=UBERON_0001043; Cell type: Epithelial cell of esophagus; CL=CL_0002252. Male 150518657 CVCL_A8WC ESCC-CL-Iran cancer cell line human CVCL_A8WC CL:0000010 Miscellaneous: As no cell line name was provided in the papers, we assigned the name based on the abbreviation of the cell line description Population: Iranian; Persian; Derived from site: In situ; Esophagus; UBERON=UBERON_0001043. Omics: Proteomics; 2DE-MS Female 150518658 CVCL_A8TS JXQ-3D-1436R3 cancer cell line human CVCL_A8TS CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518659 CVCL_A8TR JXQ-3D-1436R2 cancer cell line human CVCL_A8TR CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518660 CVCL_A8TU JXQ-3D-1436R5 cancer cell line human CVCL_A8TU CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518661 CVCL_A8TT JXQ-3D-1436R4 cancer cell line human CVCL_A8TT CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518662 CVCL_A8TW JXQ-3D-902R1 cancer cell line human CVCL_A8TW CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Female 150518663 CVCL_A8TV JXQ-3D-1436R6 cancer cell line human CVCL_A8TV CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518664 CVCL_A8TY JXQ-3D-902R3 cancer cell line human CVCL_A8TY CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Female 150518665 CVCL_A8TX JXQ-3D-902R2 cancer cell line human CVCL_A8TX CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Female 150518666 CVCL_A8TK JXQ-3D-1279R9 cancer cell line human CVCL_A8TK CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518667 CVCL_A8TJ JXQ-3D-1279R8 cancer cell line human CVCL_A8TJ CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518668 CVCL_A8TM JXQ-3D-1405R2 cancer cell line human CVCL_A8TM CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518669 CVCL_A8TL JXQ-3D-1405R1 cancer cell line human CVCL_A8TL CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518670 CVCL_A8TN JXQ-3D-1405R3 cancer cell line human CVCL_A8TN CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518671 CVCL_A8TQ JXQ-3D-1436R1 cancer cell line human CVCL_A8TQ CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518672 CVCL_A8TP JXQ-3D-1405R4 cancer cell line human CVCL_A8TP CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518673 CVCL_A8TC JXQ-3D-1279R1 cancer cell line human CVCL_A8TC CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518674 CVCL_A8TB JXQ-3D-668R4 cancer cell line human CVCL_A8TB CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518675 CVCL_A8TE JXQ-3D-1279R3 cancer cell line human CVCL_A8TE CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518676 CVCL_A8TD JXQ-3D-1279R2 cancer cell line human CVCL_A8TD CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518677 CVCL_A8TG JXQ-3D-1279R5 cancer cell line human CVCL_A8TG CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518678 CVCL_A8TF JXQ-3D-1279R4 cancer cell line human CVCL_A8TF CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518679 CVCL_A8TI JXQ-3D-1279R7 cancer cell line human CVCL_A8TI CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518680 CVCL_A8TH JXQ-3D-1279R6 cancer cell line human CVCL_A8TH CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518681 CVCL_A8SZ JXQ-3D-668R2 cancer cell line human CVCL_A8SZ CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518682 CVCL_A8SY JXQ-3D-668R1 cancer cell line human CVCL_A8SY CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518683 CVCL_A8TA JXQ-3D-668R3 cancer cell line human CVCL_A8TA CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Male 150518684 CVCL_A8UT IMR/KAT100 cancer cell line human CVCL_A8UT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Homozygous (PubMed=17974978) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_2761; Dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate (Antimony potassium tartrate; KAT); Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916. Male 150518685 CVCL_A8US RIT-1b cancer cell line human CVCL_A8US CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.748_755del8; Zygosity=Unspecified (PubMed=1933904) Donor information: Established from a patient originally treated by radiation therapy for a pituitary adenoma (PubMed=1933904). Unspecified 150518686 CVCL_A8UV immKEB1 telomerase immortalized cell line human CVCL_A8UV CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Male 150518687 CVCL_A8UU immFEB1 telomerase immortalized cell line human CVCL_A8UU CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518688 CVCL_A8UX immKEB2 telomerase immortalized cell line human CVCL_A8UX CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Male 150518689 CVCL_A8UW immFEB2 telomerase immortalized cell line human CVCL_A8UW CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518690 CVCL_A8UZ immFEB4 telomerase immortalized cell line human CVCL_A8UZ CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518691 CVCL_A8UY immFEB3 telomerase immortalized cell line human CVCL_A8UY CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518692 CVCL_A8UL HEK293-Survivin transformed cell line human CVCL_A8UL CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:593; BIRC5; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 150518693 CVCL_A8UK JXQ-3D-4256R3 cancer cell line human CVCL_A8UK CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Female 150518694 CVCL_A8UN HOT cancer cell line human CVCL_A8UN HLA typing: A*26; B*35,60; C*07 (PubMed=7671230). From: Sato, Noriyuki; Sapporo Medical College; Sapporo; Japan CL:0000010 Population: Japanese Female 150518695 CVCL_A8UM MaS-3 cancer cell line human CVCL_A8UM CL:0000010 Population: Caucasian; Karyotypic information: Hypotriploid to hypertriploid karyotype (PubMed=33727576); Derived from site: In situ; Kidney, renal pelvis; UBERON=UBERON_0001224; Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255. Omics: Proteomics Male Doubling time: 26 hours (PubMed=33727576); ~60-80 hours (DSMZ=ACC-901) 150518696 CVCL_A8UP OMYleb spontaneously immortalized cell line CVCL_A8UP CL:0000010 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Unspecified Group: Fish cell line 150518697 CVCL_A8UR hKC hTERT telomerase immortalized cell line human CVCL_A8UR CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Miscellaneous: Age/sex of donor from personal communication of Gurskaya, Nadya G Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Male 150518698 CVCL_A8UQ OMYsd spontaneously immortalized cell line CVCL_A8UQ CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097. Unspecified Group: Fish cell line 150518699 CVCL_A8UD JXQ-3D-902R8 cancer cell line human CVCL_A8UD CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Female 150518700 CVCL_A8UC JXQ-3D-902R7 cancer cell line human CVCL_A8UC CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Female 150518701 CVCL_A8UF JXQ-3D-4160R1 cancer cell line human CVCL_A8UF CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Female 150518702 CVCL_A8UE JXQ-3D-902R9 cancer cell line human CVCL_A8UE CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Female 150518703 CVCL_A8UH JXQ-3D-4160R3 cancer cell line human CVCL_A8UH CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Female 150518704 CVCL_A8UG JXQ-3D-4160R2 cancer cell line human CVCL_A8UG CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Female 150518705 CVCL_A8UJ JXQ-3D-4256R2 cancer cell line human CVCL_A8UJ CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Female 150518706 CVCL_A8UI JXQ-3D-4256R1 cancer cell line human CVCL_A8UI CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Female 150518707 CVCL_A8TZ JXQ-3D-902R4 cancer cell line human CVCL_A8TZ CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Female 150518708 CVCL_A8UB JXQ-3D-902R6 cancer cell line human CVCL_A8UB CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Female 150518709 CVCL_A8UA JXQ-3D-902R5 cancer cell line human CVCL_A8UA CL:0000010 Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Omics: Genomics; Whole exome sequencing; Omics: Transcriptomics; RNAseq Female 150518710 CVCL_A8KJ A69 cancer cell line human CVCL_A8KJ CL:0000010 Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Female Doubling time: 62 hours (PubMed=2910777) 150518711 CVCL_A8KI A175 cancer cell line human CVCL_A8KI CL:0000010 Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Female Doubling time: 59 hours (PubMed=2910777) 150518712 CVCL_A8KL A121(A) cancer cell line human CVCL_A8KL CL:0000010 Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Female Doubling time: 25 hours (PubMed=2910777) 150518713 CVCL_A8KK A90 cancer cell line human CVCL_A8KK CL:0000010 Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. Female Doubling time: 71 hours (PubMed=2910777) 150518714 CVCL_A8KN BRCi014-A-2 induced pluripotent stem cell human CVCL_A8KN CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Asian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Using CRISPR/Cas9 a 2A-tdTomato-EF1a-BleoR construct was knocked-in at the 3'end of one allele of the ISL1 gene (PubMed=34087992) 150518715 CVCL_A8KM BRCi014-A-1 induced pluripotent stem cell human CVCL_A8KM CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Asian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Using CRISPR/Cas9 a 2A-tdTomato-EF1a-BleoR construct was knocked-in at the 3'end of one allele of the ISL1 gene (PubMed=34087992) 150518716 CVCL_A8KP CHUVi001-A induced pluripotent stem cell human CVCL_A8KP From: Centre Hospitalier Universitaire Vaudois; Lausanne; Switzerland CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518717 CVCL_A8KB HML-1 hybridoma house mouse CVCL_A8KB CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P38570; Human ITGAE/CD103; Monoclonal antibody target: UniProtKB; P26010; Human ITGB7. 150518718 CVCL_A8KA RGL-1 hybridoma house mouse CVCL_A8KA CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: Rat antigen on intestinal intraepithelial lymphocytes. 150518719 CVCL_A8KD HML-3 hybridoma house mouse CVCL_A8KD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P38570; Human ITGAE/CD103; Monoclonal antibody target: UniProtKB; P26010; Human ITGB7. 150518720 CVCL_A8KC HML-2 [Mouse hybridoma against human ITGAE/ITGB7] hybridoma house mouse CVCL_A8KC CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P38570; Human ITGAE/CD103; Monoclonal antibody target: UniProtKB; P26010; Human ITGB7. 150518721 CVCL_A8KF HML-5 hybridoma house mouse CVCL_A8KF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P38570; Human ITGAE/CD103; Monoclonal antibody target: UniProtKB; P26010; Human ITGB7. 150518722 CVCL_A8KE HML-4 hybridoma house mouse CVCL_A8KE CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P38570; Human ITGAE/CD103; Monoclonal antibody target: UniProtKB; P26010; Human ITGB7. 150518723 CVCL_A8KH A1 [Human ovarian carcinoma] cancer cell line human CVCL_A8KH CL:0000010 Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Female Doubling time: 67 hours (PubMed=2910777) 150518724 CVCL_A8KG SPC-Gm-17 spontaneously immortalized cell line CVCL_A8KG CL:0000010 Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female Doubling time: 2.4 days (PubMed=12762839) Group: Insect cell line 150518725 CVCL_A8JY UACC-1273-4-3 cancer cell line human CVCL_A8JY CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12784; WNT5A; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097. Male 150518726 CVCL_A8JX HeLa-LTRHIV-1-Luc cancer cell line human CVCL_A8JX CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Characteristics: The expression of the luciferase reporter gene is under the control of the HIV-1 isolate BRU promoter (LTR from -454 to +338) (PubMed=17245432) 150518727 CVCL_A8JZ UACC-1273-4-7 cancer cell line human CVCL_A8JZ CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12784; WNT5A; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097. Male 150518728 CVCL_A8JQ HEK293T SYT1 KO transformed cell line human CVCL_A8JQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11509; SYT1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Miscellaneous: Cell line information from personal communication of Laflamme, Carl Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 150518729 CVCL_A8JP HEp-2-NS1 cancer cell line human CVCL_A8JP CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P0DOE9; Human respiratory syncytial virus A protein NS1; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Problematic cell line: Contaminated Parent cell line (HEp-2) has been shown to be a HeLa derivative. 150518730 CVCL_A8JS HES-3 NKX2.5eGFP/w embryonic stem cell human CVCL_A8JS CL:0000010 Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Using homologous recombination an EGFP reporter gene was introduced at the first exon of one allele of the NKX2.5 locus (PubMed=22020065) 150518731 CVCL_A8JR CMT-7364 cancer cell line dog CVCL_A8JR CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911. Female Characteristics: Tumorigenic in nude mice (PubMed=30309498) Doubling time: 21.12 hours (PubMed=30309498) Group: Triple negative breast cancer (TNBC) cell line 150518732 CVCL_A8JU PER-494 cancer cell line human CVCL_A8JU CL:0000010 Miscellaneous: Sampling site from personal communication of Kotecha, Rishi S Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Female 150518733 CVCL_A8JT HES-3 MESP1mCherry/w NKX2-5eGFP/w embryonic stem cell human CVCL_A8JT CL:0000010 Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Homologous recombination; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Useful for dissecting the molecular and cellular mechanisms related to the earliest steps in cardiac development in live cells (PubMed=25187301); Characteristics: Using homologous recombination an EGFP reporter gene was introduced at the first exon of one allele of the NKX2.5 locus; Characteristics: Using homologous recombination a mCherry reporter gene was introduced at the first exon of one allele of the MESP1 locus Registration: Swiss research registry; BAG-hES-IMP-0075 150518734 CVCL_A8JW ASTC-a-1 SCAT3 cancer cell line human CVCL_A8JW CL:0000010 Genetic integration: Method=Transfection; Gene=FPbase; 27HOS; ECFP (Note=Cyan fluorescent protein derived from GFP); Genetic integration: Method=Transfection; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo. Population: Chinese Unspecified Characteristics: Transfected with the SCAT3 reporter for caspase activation SCAT3 comprises the ECFP (enhanced cyan fluorescent protein) and Venus proteins linked by an 18 amino acid peptide that includes DEVD, a CASP3 cleavage sequence. 150518735 CVCL_A8JV PER-910 cancer cell line human CVCL_A8JV CL:0000010 Miscellaneous: Sampling site from personal communication of Kotecha, Rishi S Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518736 CVCL_A9NL 273 hybridoma house mouse CVCL_A9NL CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: Murine leukemia virus (MuLV) protein gp70. 150518737 CVCL_A9NK 715 hybridoma house mouse CVCL_A9NK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Murine leukemia virus (MuLV) protein gp70. 150518738 CVCL_A9NN Chessie 8 hybridoma house mouse CVCL_A9NN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P03377; HIV-1 isolate BRU/LAI env (Note=AA 517-861 = gp41). 150518739 CVCL_A9NM Chessie 6 hybridoma house mouse CVCL_A9NM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P03377; HIV-1 isolate BRU/LAI env (Note=AA 33-516 = gp120). 150518740 CVCL_A9NP Chessie 13-39.1 hybridoma house mouse CVCL_A9NP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P03377; HIV-1 isolate BRU/LAI env (Note=AA 33-516 = gp120). 150518741 CVCL_A9NR Rev-CEM-E7 cancer cell line human CVCL_A9NR CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female Characteristics: Transfected with a pNL-GFP-RRE(SA) construct that results in the expression of the GFP gene under the control of the HIV-1 LTR promoter in HIV-1 infected cells when Tat and Rev are present 150518742 CVCL_A9NQ Rev-CEM-D4 cancer cell line human CVCL_A9NQ CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female Characteristics: Transfected with a pNL-GFP-RRE(SA) construct that results in the expression of the GFP gene under the control of the HIV-1 LTR promoter in HIV-1 infected cells when Tat and Rev are present 150518743 CVCL_A9ND Een69 finite cell line human CVCL_A9ND CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified 150518744 CVCL_A9NC AGH-OG3 embryonic stem cell house mouse CVCL_A9NC CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: C57BL/6. Omics: Transcriptomics; RNAseq Male 150518745 CVCL_A9NF FX1G5 hybridoma house mouse CVCL_A9NF CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P01258; Human CALCA (Note=Recognizes propeptide). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2993 150518746 CVCL_A9NE FW5H6 hybridoma house mouse CVCL_A9NE CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P01258; Human CALCA (Note=Recognizes propeptide). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2996 150518747 CVCL_A9NH 2-189-H-1 hybridoma house mouse CVCL_A9NH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q9NZQ7; Human CD274. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015160 150518748 CVCL_A9NG FX7A7 hybridoma house mouse CVCL_A9NG CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P01258; Human CALCA (Note=Recognizes propeptide). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2997 150518749 CVCL_A9NJ 500 hybridoma house mouse CVCL_A9NJ CL:0000010 Monoclonal antibody isotype: IgG3; Monoclonal antibody target: Murine leukemia virus (MuLV) protein gp80. 150518750 CVCL_A9NI 55-2F12 hybridoma house mouse CVCL_A9NI CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P05894; Simian immunodeficiency virus (isolate Mm142-83) (SIV-mac) gag (Note=AA 136-364 = p24). 150518751 CVCL_A9MZ CL015 transformed cell line human CVCL_A9MZ CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Characteristics: Reference control cell line for pharmacogenomics testing Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9097; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200716 150518752 CVCL_A9NB L6565 cancer cell line house mouse CVCL_A9NB CL:0000010 150518753 CVCL_A9NA CL016 transformed cell line human CVCL_A9NA CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Characteristics: Reference control cell line for pharmacogenomics testing Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9098; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200717 150518754 CVCL_A9MS CL005 transformed cell line human CVCL_A9MS CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Characteristics: Reference control cell line for pharmacogenomics testing Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9087; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200706 150518755 CVCL_A9MR CL004 transformed cell line human CVCL_A9MR CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Characteristics: Reference control cell line for pharmacogenomics testing Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9086; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200705 150518756 CVCL_A9MU CL007 transformed cell line human CVCL_A9MU CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Characteristics: Reference control cell line for pharmacogenomics testing Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9089; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200708 150518757 CVCL_A9MT CL006 transformed cell line human CVCL_A9MT CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Characteristics: Reference control cell line for pharmacogenomics testing Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9088; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200707 150518758 CVCL_A9MW CL009 transformed cell line human CVCL_A9MW CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Characteristics: Reference control cell line for pharmacogenomics testing Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9091; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200710 150518759 CVCL_A9MV CL008 transformed cell line human CVCL_A9MV CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Characteristics: Reference control cell line for pharmacogenomics testing Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9090; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200709 150518760 CVCL_A9MY CL011 transformed cell line human CVCL_A9MY CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Characteristics: Reference control cell line for pharmacogenomics testing Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9093; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200712 150518761 CVCL_A9MX CL010 transformed cell line human CVCL_A9MX CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Characteristics: Reference control cell line for pharmacogenomics testing Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9092; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200711 150518762 CVCL_A9NT CHO-K1-UCSC spontaneously immortalized cell line CVCL_A9NT CL:0000010 Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Group: Serum/protein free medium cell line 150518763 CVCL_A9NS Rev-CEM-G2 cancer cell line human CVCL_A9NS CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female Characteristics: Transfected with a pNL-GFP-RRE(SA) construct that results in the expression of the GFP gene under the control of the HIV-1 LTR promoter in HIV-1 infected cells when Tat and Rev are present; Characteristics: Expresses the mCherry gene under the control of a EF-1a promoter 150518764 CVCL_A9NV Sup-T1 CCR5+ L23 cancer cell line human CVCL_A9NV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Cys251Tyr (c.752G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Arg177His (c.530G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Arg191Trp (c.571C>T); ClinVar=VCV000568557; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Asp (c.1635G>T); ClinVar=VCV000217293; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu970Lys (c.2908G>A); ClinVar=VCV001057635; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg682Cys (c.2044C>T); ClinVar=VCV000237466; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:15533; SPRY4; Simple; p.Arg25Trp (c.73C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Leu (c.800G>T); ClinVar=VCV000852206; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr Population: Caucasian; Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175; Cell type: T-cell; CL=CL_0000084. Male Characteristics: Expresses low level of CCR5 (BEI_Resources=ARP-13784) Caution: There seem to be at least 6 different cell lines derived from Sup-T1 by transfection of human CCR5: Sup-T1-CCR5 (Cellosaurus=CVCL_X633), SupT1.CCR5 (Cellosaurus=CVCL_WU88), SupT1-R5 (Cellosaurus=CVCL_WU89), Sup-T1 CCR5+ H6 (Cellosaurus=CVCL_A9NU), Sup-T1 CCR5+ L23 (Cellosaurus=CVCL_A9NV) and Sup-T1 CCR5+ M10 (Cellosaurus=CVCL_A9NW) 150518765 CVCL_A9NU Sup-T1 CCR5+ H6 cancer cell line human CVCL_A9NU CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Cys251Tyr (c.752G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Arg177His (c.530G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Arg191Trp (c.571C>T); ClinVar=VCV000568557; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Asp (c.1635G>T); ClinVar=VCV000217293; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu970Lys (c.2908G>A); ClinVar=VCV001057635; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg682Cys (c.2044C>T); ClinVar=VCV000237466; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:15533; SPRY4; Simple; p.Arg25Trp (c.73C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Leu (c.800G>T); ClinVar=VCV000852206; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr Population: Caucasian; Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175; Cell type: T-cell; CL=CL_0000084. Male Characteristics: Expresses high level of CCR5 (BEI_Resources=ARP-13783) Caution: There seem to be at least 6 different cell lines derived from Sup-T1 by transfection of human CCR5: Sup-T1-CCR5 (Cellosaurus=CVCL_X633), SupT1.CCR5 (Cellosaurus=CVCL_WU88), SupT1-R5 (Cellosaurus=CVCL_WU89), Sup-T1 CCR5+ H6 (Cellosaurus=CVCL_A9NU), Sup-T1 CCR5+ L23 (Cellosaurus=CVCL_A9NV) and Sup-T1 CCR5+ M10 (Cellosaurus=CVCL_A9NW) 150518766 CVCL_A9NX CHO C1s-/- MGAT1- spontaneously immortalized cell line CVCL_A9NX CL:0000010 Knockout cell: Method=CRISPR/Cas9; UniProtKB; Q924C0; Mgat1; Knockout cell: Method=CRISPR/Cas9; UniProtKB; G3GUR0; C1s Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: This cell line minimizes proteolysis of clade B HIV-1 envelope proteins commonly observed in the production of monomeric gp120 and gp140 as well as gp140 trimers; Characteristics: This cell line can only produce N-linked carbohydrates with early oligomannose glycans (Man5-9) Group: Serum/protein free medium cell line 150518767 CVCL_A9NW Sup-T1 CCR5+ M10 cancer cell line human CVCL_A9NW CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Cys251Tyr (c.752G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Arg177His (c.530G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Arg191Trp (c.571C>T); ClinVar=VCV000568557; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Asp (c.1635G>T); ClinVar=VCV000217293; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu970Lys (c.2908G>A); ClinVar=VCV001057635; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg682Cys (c.2044C>T); ClinVar=VCV000237466; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:15533; SPRY4; Simple; p.Arg25Trp (c.73C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Leu (c.800G>T); ClinVar=VCV000852206; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr Population: Caucasian; Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175; Cell type: T-cell; CL=CL_0000084. Male Characteristics: Expresses medium level of CCR5 (BEI_Resources=ARP-13782) Caution: There seem to be at least 6 different cell lines derived from Sup-T1 by transfection of human CCR5: Sup-T1-CCR5 (Cellosaurus=CVCL_X633), SupT1.CCR5 (Cellosaurus=CVCL_WU88), SupT1-R5 (Cellosaurus=CVCL_WU89), Sup-T1 CCR5+ H6 (Cellosaurus=CVCL_A9NU), Sup-T1 CCR5+ L23 (Cellosaurus=CVCL_A9NV) and Sup-T1 CCR5+ M10 (Cellosaurus=CVCL_A9NW) 150518768 CVCL_A9NZ CHO C1s-/- MGAT1- BaL-rgp120 spontaneously immortalized cell line CVCL_A9NZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; UniProtKB; Q924C0; Mgat1; Knockout cell: Method=CRISPR/Cas9; UniProtKB; G3GUR0; C1s; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q78225; HIV-1 isolate Ba-1 env; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Produces an unclipped gp120 from a clade B isolate (BaL-rgp120) and enriched for mannose-5 glycans The gp120 construct contains an N-terminal purification tag from HSV-1 glycoprotein D (gD) (PubMed=31087560). Group: Serum/protein free medium cell line 150518769 CVCL_A9NY CHO C1s-/- spontaneously immortalized cell line CVCL_A9NY CL:0000010 Knockout cell: Method=CRISPR/Cas9; UniProtKB; G3GUR0; C1s Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Group: Serum/protein free medium cell line 150518770 CVCL_A9DB RPMI-8226-mCherry cancer cell line human CVCL_A9DB CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)) Population: African American; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Plasma cell; CL=CL_0000786. Male Characteristics: Produces IgG lambda (from parent cell line RPMI-8226) 150518771 CVCL_A9DA RPMI-8226-Luc2-tdT cancer cell line human CVCL_A9DA CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2) Population: African American; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Plasma cell; CL=CL_0000786. Male Characteristics: Produces IgG lambda (from parent cell line RPMI-8226) 150518772 CVCL_A9DD PUMC-CRC1 cancer cell line human CVCL_A9DD CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1493fs (c.4476_4479delCACGinsACA); Zygosity=Heterozygous (PubMed=34162944); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=34162944); Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Val506Glu (c.1517T>C); Zygosity=Homozygous (PubMed=34162944) Population: Chinese; Derived from site: In situ; Cecum; UBERON=UBERON_0001153. Female Doubling time: 44 hours (PubMed=34162944); Microsatellite instability: Stable (MSS) (PubMed=34162944) 150518773 CVCL_A9DC RPMI-8226-tdT cancer cell line human CVCL_A9DC CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)) Population: African American; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Plasma cell; CL=CL_0000786. Male Characteristics: Produces IgG lambda (from parent cell line RPMI-8226) 150518774 CVCL_A9DF Daoy-luc2-tdT cancer cell line human CVCL_A9DF CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Phe (c.725G>T); ClinVar=VCV000376578; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2) Population: Caucasian; Derived from site: In situ; Brain, posterior fossa; UBERON=UBERON_0008788. Male 150518775 CVCL_A9DE S1-IR20 cancer cell line human CVCL_A9DE CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_80630; Irinotecan (Camptothecin-11; CPT-11); Derived from site: In situ; Colon; UBERON=UBERON_0001155. Female 150518776 CVCL_A9DH COLO 205-Luc2-tdT cancer cell line human CVCL_A9DH CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr103fs*37 (c.308_321delTGTGTAACAGTTCC); Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2) Population: Caucasian; Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Male 150518777 CVCL_A9DG COLO 205-EGFP cancer cell line human CVCL_A9DG CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr103fs*37 (c.308_321delTGTGTAACAGTTCC); Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Population: Caucasian; Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Male 150518778 CVCL_A9CY COLO 201-tdT cancer cell line human CVCL_A9CY CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)) Population: Caucasian; Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Male 150518779 CVCL_A9CX COLO 201-mCherry cancer cell line human CVCL_A9CX CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)) Population: Caucasian; Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Male 150518780 CVCL_A9CZ RPMI-8226-EGFP cancer cell line human CVCL_A9CZ CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:5722; IGKJ4 + HGNC; HGNC:5783; IGKV2-28; Name(s)=IGKV2-28-IGKJ4 (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:5865; IGLJ3 + HGNC; HGNC:5888; IGLV2-14; Name(s)=IGLV2-14-IGLJ3 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr751Ile (c.2252C>T); ClinVar=VCV000177773; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys191Leufs*60; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Population: African American; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Plasma cell; CL=CL_0000786. Male Characteristics: Produces IgG lambda (from parent cell line RPMI-8226) 150518781 CVCL_A9CQ HCT-8-Luc2-tdT cancer cell line human CVCL_A9CQ CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155; Cell type: Epithelial cell of colon; CL=CL_0011108. Male 150518782 CVCL_A9CP 293T-Luc2-tdT transformed cell line human CVCL_A9CP CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 150518783 CVCL_A9CS HCT-8-tdT cancer cell line human CVCL_A9CS CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155; Cell type: Epithelial cell of colon; CL=CL_0011108. Male 150518784 CVCL_A9CR HCT-8-mCherry cancer cell line human CVCL_A9CR CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155; Cell type: Epithelial cell of colon; CL=CL_0011108. Male 150518785 CVCL_A9CU RBE-Luc2-tdT cancer cell line human CVCL_A9CU CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Ser (c.394C>A); ClinVar=VCV000375893; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2) Population: Japanese; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Female 150518786 CVCL_A9CT CCC-REPF-1 finite cell line Norway rat CVCL_A9CT CL:0000010 Derived from site: In situ; Embryonic lung; UBERON=UBERON_0005597; Cell type: Fibroblast of lung; CL=CL_0002553. Unspecified 150518787 CVCL_A9CW COLO 201-Luc2-tdT cancer cell line human CVCL_A9CW CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2) Population: Caucasian; Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Male 150518788 CVCL_A9CV COLO 201-EGFP cancer cell line human CVCL_A9CV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Population: Caucasian; Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Male 150518789 CVCL_A9CI DU145-Cas9-539 cancer cell line human CVCL_A9CI CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Tyr (c.250G>T) (p.Arg98Leu, c.293G>T); ClinVar=VCV000376306; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys715Ter (c.2143A>T); ClinVar=VCV001786615; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys178fs*86 (c.532_536delAAGCC); Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag) Population: Caucasian; Derived from site: Metastatic; Brain; UBERON=UBERON_0000955. Male Characteristics: Transduced with a Cas9-FLAG-Neo construct 150518790 CVCL_A9CH H460/CIS cancer cell line human CVCL_A9CH CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP); Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Male Doubling time: 1.9 days (PubMed=11551417) 150518791 CVCL_A9CK DU145-Cas9-541 cancer cell line human CVCL_A9CK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Tyr (c.250G>T) (p.Arg98Leu, c.293G>T); ClinVar=VCV000376306; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys715Ter (c.2143A>T); ClinVar=VCV001786615; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys178fs*86 (c.532_536delAAGCC); Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag) Population: Caucasian; Derived from site: Metastatic; Brain; UBERON=UBERON_0000955. Male Characteristics: Transduced with a Cas9-FLAG-Neo construct 150518792 CVCL_A9CJ DU145-Cas9-540 cancer cell line human CVCL_A9CJ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Tyr (c.250G>T) (p.Arg98Leu, c.293G>T); ClinVar=VCV000376306; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys715Ter (c.2143A>T); ClinVar=VCV001786615; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys178fs*86 (c.532_536delAAGCC); Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag) Population: Caucasian; Derived from site: Metastatic; Brain; UBERON=UBERON_0000955. Male Characteristics: Transduced with a Cas9-FLAG-Neo construct 150518793 CVCL_A9CM 293T-mCherry transformed cell line human CVCL_A9CM CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 150518794 CVCL_A9CL 293T-tdT transformed cell line human CVCL_A9CL CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 150518795 CVCL_A9CN 293T-EGFP transformed cell line human CVCL_A9CN CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 150518796 CVCL_A9EC 110BH3 hybridoma house mouse CVCL_A9EC CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; P14174; Human MIF. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11345 150518797 CVCL_A9EB 9.6 hybridoma house mouse CVCL_A9EB CL:0000010 Monoclonal antibody isotype: IgG2a (Patent=US6010902); IgG2b (PubMed=6969782); Monoclonal antibody target: UniProtKB; P06729; Human CD2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10267 150518798 CVCL_A9EE PK15-B1 spontaneously immortalized cell line pig CVCL_A9EE CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: Hampshire; VBO=VBO_0001146. Male Virology: Can produce high titers of porcine circovirus 2 (PCV2) Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200936 150518799 CVCL_A9ED 205AD2 hybridoma house mouse CVCL_A9ED CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P14174; Human MIF. 150518800 CVCL_A9EG PK15-IFNgSB spontaneously immortalized cell line pig CVCL_A9EG CL:0000010 Genetic integration: Method=Sleeping Beauty transposition; Gene=VGNC; VGNC:89040; Pig IFNG Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: Hampshire; VBO=VBO_0001146. Male Characteristics: Contains a sleeping beauty (SB) integrated pTEG-IFNg-Fc vector containing a fusion of pig IFNG with pig IgG Fc domain; Virology: Highly susceptible to infection by porcine circovirus 2 (PCV2) 150518801 CVCL_A9EF PK15-IFNgRan spontaneously immortalized cell line pig CVCL_A9EF CL:0000010 Genetic integration: Method=Sleeping Beauty transposition; Gene=VGNC; VGNC:89040; Pig IFNG Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: Hampshire; VBO=VBO_0001146. Male Characteristics: Contains a randomly integrated pTEG-IFNg-Fc vector containing a fusion of pig IFNG with pig IgG Fc domain; Virology: Highly susceptible to infection by porcine circovirus 2 (PCV2) 150518802 CVCL_A9EI PK15-1E5 spontaneously immortalized cell line pig CVCL_A9EI CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: Hampshire; VBO=VBO_0001146. Male Characteristics: Grows adherently; Virology: Can produce high titers of porcine circovirus 2 (PCV2) 150518803 CVCL_A9EH PK15-1C8 spontaneously immortalized cell line pig CVCL_A9EH CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: Hampshire; VBO=VBO_0001146. Male Characteristics: Grows adherently; Virology: Can produce high titers of porcine circovirus 2 (PCV2) 150518804 CVCL_A9DZ LA9-IS11 EGF-2 spontaneously immortalized cell line house mouse CVCL_A9DZ CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3229; EGF Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine; Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C3H/An. Male Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50057 150518805 CVCL_A9DY A31-IS11 EGF-2 spontaneously immortalized cell line house mouse CVCL_A9DY CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3229; EGF Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: BALB/c. Unspecified Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50093 150518806 CVCL_A9EA L-IS11 IgE-9 spontaneously immortalized cell line house mouse CVCL_A9EA CL:0000010 Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C3H/An. Male Characteristics: Transfected with an IgE expression vector having the IL-2 leader sequence (Patent=US4935352) Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50056 150518807 CVCL_A9DR GBC-SD-Cas9-771 cancer cell line human CVCL_A9DR CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag) Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Male Characteristics: Transduced with a Cas9-FLAG-PuroR construct 150518808 CVCL_A9DQ GBC-SD-Cas9-770 cancer cell line human CVCL_A9DQ CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag) Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Male Characteristics: Transduced with a Cas9-FLAG-Neo construct 150518809 CVCL_A9DT GBC-SD-Cas9-773 cancer cell line human CVCL_A9DT CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag) Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Male Characteristics: Transduced with a Cas9-FLAG-PuroR construct 150518810 CVCL_A9DS GBC-SD-Cas9-772 cancer cell line human CVCL_A9DS CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag) Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Male Characteristics: Transduced with a Cas9-FLAG-PuroR construct 150518811 CVCL_A9DV GBC-SD-Cas9-775 cancer cell line human CVCL_A9DV CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag) Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Male Characteristics: Transduced with a Cas9-FLAG-PuroR construct 150518812 CVCL_A9DU GBC-SD-Cas9-774 cancer cell line human CVCL_A9DU CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag) Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Male Characteristics: Transduced with a Cas9-FLAG-PuroR construct 150518813 CVCL_A9DX L-bFGF-6 spontaneously immortalized cell line house mouse CVCL_A9DX CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3676; FGF2 Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR); Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C3H/An. Male 150518814 CVCL_A9DW L-bFGF-5 spontaneously immortalized cell line house mouse CVCL_A9DW CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3676; FGF2 Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR); Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C3H/An. Male Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50092 150518815 CVCL_A9DJ COLO 205-tdT cancer cell line human CVCL_A9DJ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr103fs*37 (c.308_321delTGTGTAACAGTTCC); Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)) Population: Caucasian; Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Male 150518816 CVCL_A9DI COLO 205-mCherry cancer cell line human CVCL_A9DI CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asn287Ser (c.860A>G); ClinVar=VCV000133954; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr103fs*37 (c.308_321delTGTGTAACAGTTCC); Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)) Population: Caucasian; Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Male 150518817 CVCL_A9DL GBC-SD-Cas9-766 cancer cell line human CVCL_A9DL CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag) Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Male Characteristics: Transduced with a Cas9-FLAG-Neo construct 150518818 CVCL_A9DK GBC-SD-Luc2-tdT cancer cell line human CVCL_A9DK CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2) Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Male 150518819 CVCL_A9DN GBC-SD-Cas9-768 cancer cell line human CVCL_A9DN CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag) Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Male Characteristics: Transduced with a Cas9-FLAG-Neo construct 150518820 CVCL_A9DM GBC-SD-Cas9-767 cancer cell line human CVCL_A9DM CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag) Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Male Characteristics: Transduced with a Cas9-FLAG-Neo construct 150518821 CVCL_A9DP GBC-SD-Cas9-769 cancer cell line human CVCL_A9DP CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag) Population: Chinese; Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110. Male Characteristics: Transduced with a Cas9-FLAG-Neo construct 150518822 CVCL_A9BB MDA-MB-231 NAT1 down cancer cell line human CVCL_A9BB CL:0000010 Knockout cell: Method=shRNA knockdown; HGNC; HGNC:7645; NAT1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7645; NAT1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female Characteristics: Transfected with a pcDNA5/FRT derived construct with a NATb promoter driving the expression of NAT1 (NATb/NAT1*4) Doubling time: 27.2 hours (PubMed=29315819) Group: Triple negative breast cancer (TNBC) cell line 150518823 CVCL_A9BA MDA-MB-231 NAT1 scrambled cancer cell line human CVCL_A9BA CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7645; NAT1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female Characteristics: Transfected with a scrambled NAT1 shRNA, control cell line for other NAT1 cell lines Doubling time: 27.4 hours (PubMed=29315819) Group: Triple negative breast cancer (TNBC) cell line 150518824 CVCL_A9BD MDA-MB-231 NAT1+/- 2-12 cancer cell line human CVCL_A9BD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7645; NAT1 (Note=1 of 2 alleles); Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female Characteristics: Transfected with a scrambled NAT1 shRNA Group: Triple negative breast cancer (TNBC) cell line 150518825 CVCL_A9BC MDA-MB-231 NAT1 up cancer cell line human CVCL_A9BC CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7645; NAT1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female Characteristics: Transfected with a pcDNA5/FRT derived construct with a NATb promoter driving the expression of NAT1 (NATb/NAT1*4) Doubling time: 23.4 hours (PubMed=29315819) Group: Triple negative breast cancer (TNBC) cell line 150518826 CVCL_A9BF MDA-MB-231 NAT1-/- 5-50 cancer cell line human CVCL_A9BF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7645; NAT1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female Characteristics: Transfected with a scrambled NAT1 shRNA Doubling time: 29.8 +- 0.7 hours (PubMed=29964355) Group: Triple negative breast cancer (TNBC) cell line 150518827 CVCL_A9BE MDA-MB-231 NAT1-/- 2-19 cancer cell line human CVCL_A9BE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7645; NAT1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female Characteristics: Transfected with a scrambled NAT1 shRNA Doubling time: 29.3 +- 1.1 hours (PubMed=29964355) Group: Triple negative breast cancer (TNBC) cell line 150518828 CVCL_A9AW LLC-M1 undefined cell line type house mouse CVCL_A9AW CL:0000010 Derived from site: In situ; Lymph node; UBERON=UBERON_0000029. Unspecified 150518829 CVCL_A9AV LLC-AS180 undefined cell line type house mouse CVCL_A9AV CL:0000010 Unspecified 150518830 CVCL_A9AY LLC-MS180 cancer cell line house mouse CVCL_A9AY CL:0000010 Breed/subspecies: Swiss Webster (CFW). Unspecified 150518831 CVCL_A9AX LLC-M3 undefined cell line type house mouse CVCL_A9AX CL:0000010 Unspecified 150518832 CVCL_A9AZ MDA-MB-231 CAPN2 KO cancer cell line human CVCL_A9AZ From: Greer, Peter A.; Queen's University; Kingston; Canada CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1479; CAPN2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line) Miscellaneous: Cell line information from personal communication of Laflamme, Carl Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female Group: Triple negative breast cancer (TNBC) cell line 150518833 CVCL_A9AN HOS-SL cancer cell line human CVCL_A9AN CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (PubMed=2531855) Population: Caucasian; Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV); Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981. Female Characteristics: Non-tumorigenic 150518834 CVCL_A9AQ Detroit 98/AGR cancer cell line human CVCL_A9AQ CL:0000010 Population: African American; Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Problematic cell line: Contaminated Ancestral cell line (Detroit 98) has been shown to be a HeLa derivative. 150518835 CVCL_A9AP IGR/Cut40 cancer cell line human CVCL_A9AP CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=21556589) Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Doubling time: ~28 hours (PubMed=21556589) 150518836 CVCL_A9AS GL PK/1 undefined cell line type human CVCL_A9AS CL:0000010 Unspecified Problematic cell line: Misidentified/contaminated Originally thought to be of pig kidney origin but found to be a human cell line (PubMed=13881104; PubMed=13881105).. 150518837 CVCL_A9AR Detroit 98/Apt cancer cell line human CVCL_A9AR CL:0000010 Population: African American; Selected for resistance to: ChEBI; CHEBI_22526; 4-aminofolic acid (Aminopterin); Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Problematic cell line: Contaminated Grand-parent cell line (Detroit 98) has been shown to be a HeLa derivative. 150518838 CVCL_A9AU LLC-HE1 undefined cell line type human CVCL_A9AU CL:0000010 Derived from site: In situ; Fetal trunk; UBERON=UBERON_0002100. Unspecified 150518839 CVCL_A9AT GLRK 7 spontaneously immortalized cell line CVCL_A9AT CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518. Unspecified Virology: Susceptible to infection by rubella virus (PubMed=4297026) Doubling time: ~120 hours (PubMed=4297026) 150518840 CVCL_A9AG SDUBMSi013-A induced pluripotent stem cell human CVCL_A9AG From: School of Basic Medical Sciences, Shandong University; Jinan; China. CL:0000010 150518841 CVCL_A9AF SDUBMSi012-A induced pluripotent stem cell human CVCL_A9AF From: School of Basic Medical Sciences, Shandong University; Jinan; China. CL:0000010 150518842 CVCL_A9AI SCVIi014-A induced pluripotent stem cell human CVCL_A9AI From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg190Gln (c.569G>A) (p.Arg63Gln, c.188G>A); ClinVar=VCV000003117; Zygosity=Heterozygous (PubMed=34411974) Population: Latino or Hispanic; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150518843 CVCL_A9AH SDUBMSi010-A induced pluripotent stem cell human CVCL_A9AH From: School of Basic Medical Sciences, Shandong University; Jinan; China. CL:0000010 150518844 CVCL_A9AK SCVIi016-A induced pluripotent stem cell human CVCL_A9AK From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg192Cysfs*91 (c.573_577delGCGCT) (p.Arg65Cysfs*91, c.192_196delGCGCT); ClinVar=VCV000053072; Zygosity=Heterozygous (PubMed=34411974) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518845 CVCL_A9AJ SCVIi015-A induced pluripotent stem cell human CVCL_A9AJ From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Lys196Serfs*41 (c.585delG) (p.Lys69Serfs*41, c.204delG); ClinVar=VCV000053076; Zygosity=Heterozygous (PubMed=34411974) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518846 CVCL_A9AM CG3 [Human leukemia] cancer cell line human CVCL_A9AM CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu289His (c.866T>A); Zygosity=Unspecified (PubMed=1336431) Population: Chinese; Taiwan; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 150518847 CVCL_A9AL CG2 cancer cell line human CVCL_A9AL CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr236His (c.706T>C); ClinVar=VCV000216469; Zygosity=Unspecified (PubMed=1336431); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Val (c.709A>G); ClinVar=VCV000182934; Zygosity=Unspecified (PubMed=1336431); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=1336431) Population: Chinese; Taiwan; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Unspecified 150518848 CVCL_A9CA PUMC-mips-C2 induced pluripotent stem cell house mouse CVCL_A9CA CL:0000010 150518849 CVCL_A9CC PUMC-mips-D2 induced pluripotent stem cell house mouse CVCL_A9CC CL:0000010 150518850 CVCL_A9CB PUMC-mips-C4 induced pluripotent stem cell house mouse CVCL_A9CB CL:0000010 150518851 CVCL_A9CE EAG3 cancer cell line human CVCL_A9CE CL:0000010 Population: Chinese; Derived from site: In situ; Endometrium; UBERON=UBERON_0001295. Female 150518852 CVCL_A9CD PUMC-mips-D3 induced pluripotent stem cell house mouse CVCL_A9CD CL:0000010 150518853 CVCL_A9CG TR-LNN-1 cancer cell line human CVCL_A9CG CL:0000010 Population: Chinese; Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. Male 150518854 CVCL_A9CF HCT-8/VCR cancer cell line human CVCL_A9CF CL:0000010 Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR); Derived from site: In situ; Colon; UBERON=UBERON_0001155; Cell type: Epithelial cell of colon; CL=CL_0011108. Male 150518855 CVCL_A9BX PUMC-mips-B4 induced pluripotent stem cell house mouse CVCL_A9BX CL:0000010 150518856 CVCL_A9BW PUMC-mips-B2 induced pluripotent stem cell house mouse CVCL_A9BW CL:0000010 150518857 CVCL_A9BZ PUMC-mips-B6 induced pluripotent stem cell house mouse CVCL_A9BZ CL:0000010 150518858 CVCL_A9BY PUMC-mips-B5 induced pluripotent stem cell house mouse CVCL_A9BY CL:0000010 150518859 CVCL_A9BP Ecad-231-7 cancer cell line human CVCL_A9BP CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1748; CDH1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female Group: Triple negative breast cancer (TNBC) cell line 150518860 CVCL_A9BR K562/HHT cancer cell line human CVCL_A9BR CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_71019; Omacetaxine mepesuccinate (Homoharringtonine; HHT); Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. Female 150518861 CVCL_A9BQ Ecad-231-9 cancer cell line human CVCL_A9BQ CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1748; CDH1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female Group: Triple negative breast cancer (TNBC) cell line 150518862 CVCL_A9BT PUMC-mips-A4 induced pluripotent stem cell house mouse CVCL_A9BT CL:0000010 150518863 CVCL_A9BS PUMC-mips-A2 induced pluripotent stem cell house mouse CVCL_A9BS CL:0000010 150518864 CVCL_A9BV PUMC-mips-B1 induced pluripotent stem cell house mouse CVCL_A9BV CL:0000010 150518865 CVCL_A9BU PUMC-mips-A5 induced pluripotent stem cell house mouse CVCL_A9BU CL:0000010 150518866 CVCL_A9BH VCAF2B telomerase immortalized cell line human CVCL_A9BH CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT Derived from site: In situ; Vulva; UBERON=UBERON_0000997; Cell type: Fibroblast; CL=CL_0000057. Female 150518867 CVCL_A9BG CerCAF telomerase immortalized cell line human CVCL_A9BG CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 150518868 CVCL_A9BJ LT97 cancer cell line human CVCL_A9BJ CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:583; APC; Zygosity=Homozygous (PubMed=12204677); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (PubMed=12204677; PubMed=17708598); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu257Arg (c.770T>G); ClinVar=VCV000142134; Zygosity=Heterozygous (PubMed=17708598); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.1100+30A>T; ClinVar=VCV000810938; Zygosity=Heterozygous (PubMed=17708598) Miscellaneous: STR profile mentioned in PubMed=27996158 but obtained from personal communication of Schlormann, Wiebke Derived from site: In situ; Colon; UBERON=UBERON_0001155. Female Characteristics: Contains 2 subpopulations of cells, one CD44+, the other CD44- (PubMed=17708598) Doubling time: ~96 hours (DOI=10.25365/thesis.6275) 150518869 CVCL_A9BI VCAF8 telomerase immortalized cell line human CVCL_A9BI CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT Derived from site: In situ; Vulva; UBERON=UBERON_0000997; Cell type: Fibroblast; CL=CL_0000057. Female 150518870 CVCL_A9BL DG6 cancer cell line house mouse CVCL_A9BL CL:0000010 Omics: Transcriptomics; Microarray. Characteristics: Poorly metastatic to lung (PubMed=15845378) 150518871 CVCL_A9BK DD1 cancer cell line house mouse CVCL_A9BK CL:0000010 Omics: Transcriptomics; Microarray. Characteristics: Highly metastatic to lung (PubMed=15845378) 150518872 CVCL_A9BN DG6-VAP33-GFP cancer cell line house mouse CVCL_A9BN CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12648; VAPA. Characteristics: Transfected with a VAPA-GFP construct 150518873 CVCL_A9BM DG6-GFP cancer cell line house mouse CVCL_A9BM CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP). 150518874 CVCL_A9AA JUCTCi017-A induced pluripotent stem cell human CVCL_A9AA From: Cell Therapy Center, University of Jordan; Amman; Jordan CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10806; SGCB; Simple; p.Leu287Serfs*14 (c.859delC); ClinVar=VCV000534946; Zygosity=Homozygous (PubMed=34087734) Population: Jordanian; Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518875 CVCL_A9AC JUCTCi017-C induced pluripotent stem cell human CVCL_A9AC From: Cell Therapy Center, University of Jordan; Amman; Jordan CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10806; SGCB; Simple; p.Leu287Serfs*14 (c.859delC); ClinVar=VCV000534946; Zygosity=Homozygous (from autologous cell line JUCTCi017-A) Population: Jordanian; Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518876 CVCL_A9AB JUCTCi017-B induced pluripotent stem cell human CVCL_A9AB From: Cell Therapy Center, University of Jordan; Amman; Jordan CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10806; SGCB; Simple; p.Leu287Serfs*14 (c.859delC); ClinVar=VCV000534946; Zygosity=Homozygous (from autologous cell line JUCTCi017-A) Population: Jordanian; Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518877 CVCL_A9AE LANCEi022-A induced pluripotent stem cell human CVCL_A9AE From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys617Terfs (c.1851_1852delTG); Zygosity=Heterozygous (PubMed=34062330) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Omics: Variations; SNP array analysis Male 150518878 CVCL_A9AD LANCEi021-A induced pluripotent stem cell human CVCL_A9AD From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Tyr2272Asp (c.6814T>G); Zygosity=Heterozygous (PubMed=34062330) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Omics: Variations; SNP array analysis Female 150518879 CVCL_A9LJ R456 embryonic stem cell CVCL_A9LJ CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 150518880 CVCL_A9LI R420 embryonic stem cell CVCL_A9LI CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 150518881 CVCL_A9LL R475 embryonic stem cell CVCL_A9LL CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 150518882 CVCL_A9LK R460 embryonic stem cell CVCL_A9LK CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Group: Non-human primate cell line 150518883 CVCL_A9LN YTH 24.5 hybridoma Norway rat CVCL_A9LN CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45. 150518884 CVCL_A9LM YAML 568.4 hybridoma Norway rat CVCL_A9LM CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45. 150518885 CVCL_A9LP YTH 5.3 hybridoma Norway rat CVCL_A9LP CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45. 150518886 CVCL_A9LB BHK-BTV-VP6 spontaneously immortalized cell line CVCL_A9LB CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; G9JKG2; Bluetongue virus serotype 1 (Chinese isolate) protein VP6; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male 150518887 CVCL_A9LA OPL spontaneously immortalized cell line CVCL_A9LA CL:0000010 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Unspecified Group: Fish cell line 150518888 CVCL_A9LD MDBK-Nectin-4 spontaneously immortalized cell line CVCL_A9LD CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transduction; Gene=VGNC; VGNC:43719; Dog NECTIN4 Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male Virology: Susceptible to infection by peste des petits ruminants virus (PPRV) 150518889 CVCL_A9LC DF-1-AvBD2 spontaneously immortalized cell line CVCL_A9LC CL:0000010 Genetic integration: Method=Transduction; Gene=CGNC; 49507; DEFB4A/Gallinacin-2; Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: East Lansing Line 0 (ELL-0). Unspecified Group: Bird cell line 150518890 CVCL_A9LF R366.4 embryonic stem cell CVCL_A9LF CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Group: Non-human primate cell line 150518891 CVCL_A9LE SMB [Scophthalmus] spontaneously immortalized cell line CVCL_A9LE CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified Group: Fish cell line 150518892 CVCL_A9LH R394.2 embryonic stem cell CVCL_A9LH CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Group: Non-human primate cell line 150518893 CVCL_A9LG R367B embryonic stem cell CVCL_A9LG CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Group: Non-human primate cell line 150518894 CVCL_A9KY FULA4 cancer cell line house mouse CVCL_A9KY CL:0000010 Miscellaneous: Age/sex of donor from personal communication of Giotopoulou, Georgia Transformant: ChEBI; CHEBI_17967; Urethane; Derived from site: In situ; Lung; UBERON=UBERON_0002048; Breed/subspecies: FVB. Omics: Transcriptomics; RNAseq Female 150518895 CVCL_A9KX FULA3 cancer cell line house mouse CVCL_A9KX CL:0000010 Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gln61Arg (c.182A>G); Zygosity=Heterozygous (PubMed=30828726) Miscellaneous: Age/sex of donor from personal communication of Giotopoulou, Georgia Transformant: ChEBI; CHEBI_17967; Urethane; Derived from site: In situ; Lung; UBERON=UBERON_0002048; Breed/subspecies: FVB. Omics: Transcriptomics; RNAseq Female 150518896 CVCL_A9KZ CHO Hu 164 SCF 17 spontaneously immortalized cell line CVCL_A9KZ CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6343; KITLG (Note=With p.Ser191_Val273del) Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10557 150518897 CVCL_A9KQ BELA1 cancer cell line house mouse CVCL_A9KQ CL:0000010 Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gln61His (c.183A>C); Zygosity=Heterozygous (PubMed=30828726) Miscellaneous: Age/sex of donor from personal communication of Giotopoulou, Georgia Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN); Derived from site: In situ; Lung; UBERON=UBERON_0002048; Breed/subspecies: BALB/c. Female 150518899 CVCL_A9KS BULA1 cancer cell line house mouse CVCL_A9KS CL:0000010 Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gln61Arg (c.182A>G); Zygosity=Heterozygous (PubMed=30828726) Miscellaneous: Age/sex of donor from personal communication of Giotopoulou, Georgia Transformant: ChEBI; CHEBI_17967; Urethane; Derived from site: In situ; Lung; UBERON=UBERON_0002048; Breed/subspecies: BALB/c. Female 150518900 CVCL_A9KR BELA2 cancer cell line house mouse CVCL_A9KR CL:0000010 Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gln61His (c.183A>C); Zygosity=Heterozygous (PubMed=30828726) Miscellaneous: Age/sex of donor from personal communication of Giotopoulou, Georgia Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN); Derived from site: In situ; Lung; UBERON=UBERON_0002048; Breed/subspecies: BALB/c. Female 150518901 CVCL_A9KU CULA cancer cell line house mouse CVCL_A9KU CL:0000010 Sequence variation: Mutation; MGI; MGI:96680; Kras; None_reported; -; Zygosity=- (Direct_author_submission) Miscellaneous: Age/sex of donor and Kras mutation status from personal communication of Giotopoulou, Georgia Transformant: ChEBI; CHEBI_17967; Urethane; Derived from site: In situ; Lung; UBERON=UBERON_0002048; Breed/subspecies: C57BL/6. Omics: Transcriptomics; RNAseq Female 150518902 CVCL_A9KT BULA2 cancer cell line house mouse CVCL_A9KT CL:0000010 Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gln61Arg (c.182A>G); Zygosity=Heterozygous (PubMed=30828726) Miscellaneous: Age/sex of donor from personal communication of Giotopoulou, Georgia Transformant: ChEBI; CHEBI_17967; Urethane; Derived from site: In situ; Lung; UBERON=UBERON_0002048; Breed/subspecies: BALB/c. Female 150518903 CVCL_A9KW FULA2 cancer cell line house mouse CVCL_A9KW CL:0000010 Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gln61Arg (c.182A>G); Zygosity=Heterozygous (PubMed=30828726) Miscellaneous: Age/sex of donor from personal communication of Giotopoulou, Georgia Transformant: ChEBI; CHEBI_17967; Urethane; Derived from site: In situ; Lung; UBERON=UBERON_0002048; Breed/subspecies: FVB. Female 150518904 CVCL_A9KV FULA1 cancer cell line house mouse CVCL_A9KV CL:0000010 Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gln61Arg (c.182A>G); Zygosity=Heterozygous (PubMed=30828726) Miscellaneous: Age/sex of donor from personal communication of Giotopoulou, Georgia Transformant: ChEBI; CHEBI_17967; Urethane; Derived from site: In situ; Lung; UBERON=UBERON_0002048; Breed/subspecies: FVB. Omics: Transcriptomics; RNAseq Female 150518905 CVCL_A9MK SW620-Luc2-tdT cancer cell line human CVCL_A9MK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2) Population: Caucasian; Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. Male 150518906 CVCL_A9MJ SW620-EGFP cancer cell line human CVCL_A9MJ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Population: Caucasian; Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. Male 150518907 CVCL_A9MM SW620-tdT cancer cell line human CVCL_A9MM CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)) Population: Caucasian; Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. Male 150518908 CVCL_A9ML SW620-mCherry cancer cell line human CVCL_A9ML CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)) Population: Caucasian; Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. Male 150518909 CVCL_A9MN CL001 transformed cell line human CVCL_A9MN CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Characteristics: Reference control cell line for pharmacogenomics testing Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9083; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200702 150518910 CVCL_A9MQ CL003 transformed cell line human CVCL_A9MQ CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Characteristics: Reference control cell line for pharmacogenomics testing Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9085; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200704 150518911 CVCL_A9MP CL002 transformed cell line human CVCL_A9MP CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Characteristics: Reference control cell line for pharmacogenomics testing Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9084; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200703 150518912 CVCL_A9MC A549-Cas9-861 cancer cell line human CVCL_A9MC CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Transduced with a Cas9-FLAG-Neo construct 150518913 CVCL_A9MB A549-Cas9-860 cancer cell line human CVCL_A9MB CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Transduced with a Cas9-FLAG-Neo construct 150518914 CVCL_A9ME A549-Cas9-863 cancer cell line human CVCL_A9ME CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Transduced with a Cas9-FLAG-Neo construct 150518915 CVCL_A9MD A549-Cas9-862 cancer cell line human CVCL_A9MD CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Transduced with a Cas9-FLAG-Neo construct 150518916 CVCL_A9MG SW480-Luc2-tdT cancer cell line human CVCL_A9MG CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 150518917 CVCL_A9MF SW480-EGFP cancer cell line human CVCL_A9MF CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 150518918 CVCL_A9MI SW480-tdT cancer cell line human CVCL_A9MI CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 150518919 CVCL_A9MH SW480-mCherry cancer cell line human CVCL_A9MH CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 150518920 CVCL_A9LZ WWX-GEEC03 finite cell line CVCL_A9LZ CL:0000010 Cell type: Epithelial cell; CL=CL_0000066. Group: Bird cell line; Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014137 150518921 CVCL_A9LY MHCC97H-GFP-LC3 cancer cell line human CVCL_A9LY CL:0000010 Sequence variation: Mutation; HGNC; HGNC:14310; BRD7; Simple; p.Glu277Glyfs*18 (c.830_831delAG); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:23177; KEAP1; Simple; p.Pro445Glnfs*13 (c.1334delC); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu51Ter (c.151G>T); ClinVar=VCV000568781; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6838; MAP1LC3A Population: Chinese; Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV). Male Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201097 150518922 CVCL_A9MA 12D7-MDR1 cancer cell line human CVCL_A9MA CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:40; ABCB1 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150518923 CVCL_A9LR YTH 65.3 hybridoma Norway rat CVCL_A9LR CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45. 150518924 CVCL_A9LQ YTH 54.12 hybridoma Norway rat CVCL_A9LQ CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45. 150518925 CVCL_A9LT YTH 72.1 hybridoma Norway rat CVCL_A9LT CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45. 150518926 CVCL_A9LS YTH 68.2 hybridoma Norway rat CVCL_A9LS CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45. 150518927 CVCL_A9LV YTH 79.6 hybridoma Norway rat CVCL_A9LV CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45. 150518928 CVCL_A9LU YTH 75.6 hybridoma Norway rat CVCL_A9LU CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45. 150518929 CVCL_A9LX YTH 891.1 hybridoma Norway rat CVCL_A9LX CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45. 150518930 CVCL_A9LW YTH 86.10 hybridoma Norway rat CVCL_A9LW CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45. 150518931 CVCL_A9JH CWBR-L2 finite cell line CVCL_A9JH CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Male 150518932 CVCL_A9JG HOS/GFP cancer cell line human CVCL_A9JG CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Population: Caucasian; Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981. Female 150518933 CVCL_A9JJ CWBR-S2 finite cell line CVCL_A9JJ CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518934 CVCL_A9JI CWBR-S1 finite cell line Norway rat CVCL_A9JI CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 150518935 CVCL_A9JL CWBR-T11 finite cell line CVCL_A9JL CL:0000010 Derived from site: In situ; Tail, skeletal muscle; UBERON=UBERON_0003665; Cell type: Fibroblast of muscle; CL=CL_1001609. Male 150518936 CVCL_A9JK CWBR-T10 finite cell line CVCL_A9JK CL:0000010 Derived from site: In situ; Tail, skeletal muscle; UBERON=UBERON_0003665; Cell type: Fibroblast of muscle; CL=CL_1001609. Male 150518937 CVCL_A9JN WB-S2 finite cell line CVCL_A9JN CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518938 CVCL_A9JM WB-S1 finite cell line CVCL_A9JM CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 150518939 CVCL_A9JB MDCK-XF04 spontaneously immortalized cell line dog CVCL_A9JB CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female Group: Patented cell line; Group: Serum/protein free medium cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018192 150518940 CVCL_A9JA MDCK-XF03 spontaneously immortalized cell line dog CVCL_A9JA CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female Group: Patented cell line; Group: Serum/protein free medium cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018191 150518941 CVCL_A9JD HepG2-CYP3A29 cancer cell line human CVCL_A9JD CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=VGNC; VGNC:103556; Pig CYP3A29 Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 150518942 CVCL_A9JC P815 Hsp65-IL-2 cancer cell line house mouse CVCL_A9JC CL:0000010 Sequence variation: Mutation; MGI; MGI:96677; Kit; Simple; p.Asp818Tyr (c.2452G>T) (D814Y); Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6001; IL2; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P9WPE7; Mycobacterium tuberculosis groL2 Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA); Breed/subspecies: DBA/2. Male Characteristics: Transfected with a groL2/Hsp65-IL2 construct 150518943 CVCL_A9JF DC-L1 finite cell line CVCL_A9JF CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553; Breed/subspecies: Holstein; VBO=VBO_0000237. Male 150518944 CVCL_A9JE GSQ-S1 finite cell line CVCL_A9JE CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518945 CVCL_A9IW BFR-K1 finite cell line CVCL_A9IW CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518. Male 150518946 CVCL_A9IV BMU-S1 finite cell line CVCL_A9IV CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518947 CVCL_A9IY BFR-S3 finite cell line CVCL_A9IY CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518948 CVCL_A9IX BFR-L1 finite cell line CVCL_A9IX CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Male 150518949 CVCL_A9IZ MDCK-XF02 spontaneously immortalized cell line dog CVCL_A9IZ CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female Doubling time: <21 hours (DOI=10.3969/j.issn.1002-2694.2019.00.172) Group: Patented cell line; Group: Serum/protein free medium cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018190 150518950 CVCL_A9IN HBR-S2 finite cell line CVCL_A9IN CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518951 CVCL_A9IQ BOS-3 finite cell line CVCL_A9IQ CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620; Breed/subspecies: Brahman; VBO=VBO_0000159. Female 150518952 CVCL_A9IP RK1 finite cell line Norway rat CVCL_A9IP CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Fibroblast; CL=CL_0000057. Unspecified 150518953 CVCL_A9IS BOS-2 finite cell line CVCL_A9IS CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518954 CVCL_A9IR BOS-4 finite cell line CVCL_A9IR CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620; Breed/subspecies: Brahman; VBO=VBO_0000159. Female 150518955 CVCL_A9IU BOS-6 finite cell line CVCL_A9IU CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 150518956 CVCL_A9IT BOS-5 finite cell line CVCL_A9IT CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 150518957 CVCL_A9KI 3C3E2 hybridoma house mouse CVCL_A9KI CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P60880; Human SNAP25 (Note=With p.Arg198_Gly206del = SNAP25(197)). 150518958 CVCL_A9KH 2C9B10 hybridoma house mouse CVCL_A9KH CL:0000010 Monoclonal antibody isotype: IgG3, kappa; Monoclonal antibody target: UniProtKB; P60880; Human SNAP25 (Note=With p.Arg198_Gly206del; SNAP25(197)). 150518959 CVCL_A9KK 5C8H5 hybridoma house mouse CVCL_A9KK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 first 15 residues). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014173 150518960 CVCL_A9KJ BTL2013 spontaneously immortalized cell line CVCL_A9KJ CL:0000010 Knockout cell: Method=siRNA knockdown; VGNC; VGNC:-; TRIM5 (Note=Isoform alpha) Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014116 150518961 CVCL_A9KM 10.2 hybridoma house mouse CVCL_A9KM CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P06127; Human CD5. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10269 150518962 CVCL_A9KL 9.3 hybridoma house mouse CVCL_A9KL CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P10747; Human CD28. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10271 150518963 CVCL_A9KN SRA01/01 transformed cell line human CVCL_A9KN CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-B-T Ag); Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803; Cell type: Epithelial cell of ocular lens; CL=CL_0002224. Male Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5858 150518964 CVCL_A9KA MCA 67 hybridoma house mouse CVCL_A9KA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Avian infectious bursal disease virus (isolate Delaware) (IBDV). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11122 150518965 CVCL_A9KC MCA BK9 hybridoma house mouse CVCL_A9KC CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Avian infectious bursal disease virus (isolate Delaware) (IBDV). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10157 150518966 CVCL_A9KB MCA 57 hybridoma house mouse CVCL_A9KB CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Avian infectious bursal disease virus (isolate GLS) (IBDV). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10156 150518967 CVCL_A9KE MCA 8 hybridoma house mouse CVCL_A9KE CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Avian infectious bursal disease virus (IBDV). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10174 150518968 CVCL_A9KD MCA 197 hybridoma house mouse CVCL_A9KD CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Avian infectious bursal disease virus (IBDV). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10158 150518969 CVCL_A9KG 1D3B8 hybridoma house mouse CVCL_A9KG CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; P60880; Human SNAP25 (Note=With p.Arg198_Gly206del; SNAP25(197)). 150518970 CVCL_A9KF DerP2 hybridoma house mouse CVCL_A9KF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P49278; Dermatophagoides pteronyssinus allergen Der p 2 (DERP2). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014112 150518971 CVCL_A9JX RM-1 [Macaca kidney] finite cell line CVCL_A9JX CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518. Unspecified Group: Non-human primate cell line 150518972 CVCL_A9JW RM-3 finite cell line CVCL_A9JW CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Group: Non-human primate cell line 150518973 CVCL_A9JZ MCA BK70 hybridoma house mouse CVCL_A9JZ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Avian infectious bursal disease virus (IBDV). 150518974 CVCL_A9JY RM-2 [Macaca kidney] finite cell line CVCL_A9JY CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518. Female Group: Non-human primate cell line 150518975 CVCL_A9JP WB-S3 finite cell line CVCL_A9JP CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518976 CVCL_A9JR WB-S5 finite cell line CVCL_A9JR CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518977 CVCL_A9JQ WB-S4 finite cell line CVCL_A9JQ CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518978 CVCL_A9JT HBMSC finite cell line human CVCL_A9JT CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540. Male 150518979 CVCL_A9JS HSF2 finite cell line human CVCL_A9JS CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518980 CVCL_A9JV MM-S4 finite cell line CVCL_A9JV CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Group: Non-human primate cell line 150518981 CVCL_A9JU RBMSC finite cell line Norway rat CVCL_A9JU CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540; Breed/subspecies: Sprague Dawley; RS=RS_0000681. Unspecified 150518982 CVCL_A9HF TS-L3 finite cell line CVCL_A9HF CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Male 150518983 CVCL_A9HE TS-K3 finite cell line CVCL_A9HE CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518. Male 150518984 CVCL_A9HH C57/B6-L finite cell line house mouse CVCL_A9HH CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Breed/subspecies: C57BL/6. Male 150518985 CVCL_A9HG TS-R1 finite cell line CVCL_A9HG CL:0000010 Derived from site: In situ; Muscle; UBERON=UBERON_0001630; Cell type: Fibroblast of muscle; CL=CL_1001609. Male 150518986 CVCL_A9HJ C57/B6-SPL finite cell line house mouse CVCL_A9HJ CL:0000010 Derived from site: In situ; Spleen; UBERON=UBERON_0002106; Breed/subspecies: C57BL/6. Male 150518987 CVCL_A9HI C57/B6-S finite cell line house mouse CVCL_A9HI CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Breed/subspecies: C57BL/6. Male 150518988 CVCL_A9HL PNA-T1 finite cell line CVCL_A9HL CL:0000010 Derived from site: In situ; Testis; UBERON=UBERON_0000473; Cell type: Epithelial cell; CL=CL_0000066. Male 150518989 CVCL_A9HK PNA-M1 finite cell line CVCL_A9HK CL:0000010 Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134; Cell type: Fibroblast of skeletal muscle; CL=CL_0011027. Male 150518990 CVCL_A9HB TS-EH-1 finite cell line CVCL_A9HB CL:0000010 Derived from site: In situ; Fetal heart; UBERON=UBERON_0003084; Cell type: Fibroblast of heart; CL=CL_0002548. Male 150518991 CVCL_A9HA HEH2 finite cell line human CVCL_A9HA CL:0000010 Derived from site: In situ; Fetal heart; UBERON=UBERON_0003084; Cell type: Fibroblast of heart; CL=CL_0002548. Male 150518992 CVCL_A9HD TS-S4 finite cell line CVCL_A9HD CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150518993 CVCL_A9HC TS-ES-1 finite cell line CVCL_A9HC CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150518994 CVCL_A9GU LPA-L1 finite cell line CVCL_A9GU CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Male 150518995 CVCL_A9GT LPA-K1 finite cell line CVCL_A9GT CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518. Male 150518996 CVCL_A9GW KMM-L2 finite cell line house mouse CVCL_A9GW CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553; Breed/subspecies: Kunming. Male 150518997 CVCL_A9GV LPA-M1 finite cell line CVCL_A9GV CL:0000010 Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134; Cell type: Fibroblast of skeletal muscle; CL=CL_0011027. Male 150518998 CVCL_A9GY GGA-E finite cell line CVCL_A9GY CL:0000010 Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified Group: Bird cell line 150518999 CVCL_A9GX BIN-S1 finite cell line CVCL_A9GX CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150519000 CVCL_A9GZ GGA-EH finite cell line CVCL_A9GZ CL:0000010 Derived from site: In situ; Embryonic heart; UBERON=UBERON_0003084; Cell type: Fibroblast of heart; CL=CL_0002548. Unspecified Group: Bird cell line 150519001 CVCL_A9GM LC-L4 finite cell line CVCL_A9GM CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Male 150519002 CVCL_A9GL LC-L3 finite cell line CVCL_A9GL CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Male 150519003 CVCL_A9GN LC-M4 finite cell line CVCL_A9GN CL:0000010 Derived from site: In situ; Muscle; UBERON=UBERON_0001630; Cell type: Fibroblast of muscle; CL=CL_1001609. Male 150519004 CVCL_A9GQ OCU-MSC1 finite cell line CVCL_A9GQ CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540. Male 150519005 CVCL_A9GP LC-S5 finite cell line CVCL_A9GP CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150519006 CVCL_A9GS LPA-H1 finite cell line CVCL_A9GS CL:0000010 Derived from site: In situ; Heart; UBERON=UBERON_0000948; Cell type: Fibroblast of heart; CL=CL_0002548. Male 150519007 CVCL_A9GR OCU-MSC2 finite cell line CVCL_A9GR CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540. Unspecified 150519008 CVCL_A9IG SM-S1 finite cell line CVCL_A9IG CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Group: Bat cell line 150519009 CVCL_A9IF GRB-S1 finite cell line CVCL_A9IF CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Group: Bat cell line 150519010 CVCL_A9II RM-S1 finite cell line CVCL_A9II CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Group: Non-human primate cell line 150519011 CVCL_A9IH STB-S2 finite cell line CVCL_A9IH CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Group: Bat cell line 150519012 CVCL_A9IK GSnFB-L2 finite cell line CVCL_A9IK CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Male Group: Bat cell line 150519013 CVCL_A9IJ OAR-L1 finite cell line CVCL_A9IJ CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Female 150519014 CVCL_A9IM HBR-M1 finite cell line CVCL_A9IM CL:0000010 Derived from site: In situ; Muscle; UBERON=UBERON_0001630; Cell type: Fibroblast of muscle; CL=CL_1001609. Male 150519015 CVCL_A9IL GSnFB-S1 finite cell line CVCL_A9IL CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Group: Bat cell line 150519016 CVCL_A9IA LHB-M4 finite cell line CVCL_A9IA CL:0000010 Derived from site: In situ; Muscle; UBERON=UBERON_0001630; Cell type: Fibroblast of muscle; CL=CL_1001609. Unspecified Group: Bat cell line 150519017 CVCL_A9IC MPC-L3 finite cell line CVCL_A9IC CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Male 150519018 CVCL_A9IB LHB-S3 finite cell line CVCL_A9IB CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Group: Bat cell line 150519019 CVCL_A9IE MPC-S3 finite cell line CVCL_A9IE CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150519020 CVCL_A9ID MPC-L4 finite cell line CVCL_A9ID CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Female 150519021 CVCL_A9HV DB-L1 finite cell line CVCL_A9HV CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Male Group: Bat cell line 150519022 CVCL_A9HU GH-M1 finite cell line CVCL_A9HU CL:0000010 Derived from site: In situ; Muscle; UBERON=UBERON_0001630; Cell type: Fibroblast of muscle; CL=CL_1001609. Female 150519023 CVCL_A9HX GHB-L3 finite cell line CVCL_A9HX CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Male Group: Bat cell line 150519024 CVCL_A9HW DB-M1 finite cell line CVCL_A9HW CL:0000010 Derived from site: In situ; Muscle; UBERON=UBERON_0001630; Cell type: Fibroblast of muscle; CL=CL_1001609. Male Group: Bat cell line 150519025 CVCL_A9HZ LHB-L2 finite cell line CVCL_A9HZ CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Male Group: Bat cell line 150519026 CVCL_A9HY GHB-S3 finite cell line CVCL_A9HY CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Male Group: Bat cell line 150519027 CVCL_A9HN CHB-S2 finite cell line CVCL_A9HN CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Female Group: Bat cell line 150519028 CVCL_A9HM MMY-S2 finite cell line CVCL_A9HM CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Group: Bat cell line 150519029 CVCL_A9HP CHP-M1 finite cell line CVCL_A9HP CL:0000010 Derived from site: In situ; Muscle; UBERON=UBERON_0001630; Cell type: Fibroblast of muscle; CL=CL_1001609. Male 150519030 CVCL_A9HR CHP-K3 finite cell line CVCL_A9HR CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Fibroblast; CL=CL_0000057. Female 150519031 CVCL_A9HQ CHP-S1 finite cell line CVCL_A9HQ CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150519032 CVCL_A9HT FFB-S3 finite cell line CVCL_A9HT CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Male Group: Bat cell line 150519033 CVCL_A9HS FFB-L3 finite cell line CVCL_A9HS CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Female Group: Bat cell line 150519034 CVCL_A9FD FCA-K1 finite cell line CVCL_A9FD CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518. Male 150519035 CVCL_A9FC HSA-S4 finite cell line human CVCL_A9FC CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150519036 CVCL_A9FF HARA-B-GFP cancer cell line human CVCL_A9FF CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val143Ala (c.428T>C); ClinVar=VCV000804214; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Population: Japanese; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Male 150519037 CVCL_A9FE LDG-2 finite cell line CVCL_A9FE CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Jianzhou big-eared; VBO=VBO_0017513. Male 150519038 CVCL_A9FH MM-S7 finite cell line CVCL_A9FH CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Group: Non-human primate cell line 150519039 CVCL_A9FG MM-S10 finite cell line CVCL_A9FG CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified Group: Non-human primate cell line 150519040 CVCL_A9FJ MM-E1 finite cell line CVCL_A9FJ CL:0000010 Derived from site: In situ; Fetus; UBERON=UBERON_0000323; Cell type: Fibroblast; CL=CL_0000057. Female Group: Non-human primate cell line 150519041 CVCL_A9FI MM-M7 finite cell line CVCL_A9FI CL:0000010 Derived from site: In situ; Muscle; UBERON=UBERON_0001630; Cell type: Fibroblast of muscle; CL=CL_1001609. Male Group: Non-human primate cell line 150519042 CVCL_A9EZ OCU-L1 finite cell line CVCL_A9EZ CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Female 150519043 CVCL_A9FB SEP-L2 finite cell line pig CVCL_A9FB CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553; Breed/subspecies: Miniature pig. Male 150519044 CVCL_A9FA SEP-L1 finite cell line pig CVCL_A9FA CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553; Breed/subspecies: Miniature pig. Female 150519045 CVCL_A9ES 6/11 hybridoma house mouse CVCL_A9ES CL:0000010 Monoclonal antibody isotype: IgM, kappa. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9072 150519046 CVCL_A9ER MAKM-4.3.16 hybridoma house mouse CVCL_A9ER CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P16070; Human CD44. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2158 150519047 CVCL_A9EU DG-S2 finite cell line CVCL_A9EU CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150519048 CVCL_A9ET BC18 hybridoma house mouse CVCL_A9ET CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P06729; Human CD2. 150519049 CVCL_A9EW OCU-S1 finite cell line CVCL_A9EW CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620; Breed/subspecies: Black. Female 150519050 CVCL_A9EV OCU-S2 finite cell line CVCL_A9EV CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150519051 CVCL_A9EY OCU-K4 finite cell line CVCL_A9EY CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518. Female 150519052 CVCL_A9EX OCU-M1 finite cell line CVCL_A9EX CL:0000010 Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134; Cell type: Fibroblast of skeletal muscle; CL=CL_0011027. Female 150519053 CVCL_A9EK PK15-1A6 spontaneously immortalized cell line pig CVCL_A9EK CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: Hampshire; VBO=VBO_0001146. Male Virology: Highly susceptible to infection by classical swine fever virus (CSFV) 150519054 CVCL_A9EJ PK15-2F11 spontaneously immortalized cell line pig CVCL_A9EJ CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: Hampshire; VBO=VBO_0001146. Male Characteristics: Grows adherently; Virology: Can produce high titers of porcine circovirus 2 (PCV2) 150519055 CVCL_A9EM Ea1C-35 transformed cell line human CVCL_A9EM From: MultiCell Technologies, Inc.; Woonsocket; USA CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Unspecified Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5565 150519056 CVCL_A9EL PK15-3B1 spontaneously immortalized cell line pig CVCL_A9EL CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: Hampshire; VBO=VBO_0001146. Male Virology: Low susceptibility to infection by classical swine fever virus (CSFV) 150519057 CVCL_A9EN HRP 16-1 hybridoma house mouse CVCL_A9EN CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P00433; Armoracia rusticana PRXC1A. Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Institute of Virology of the Slovak Academy of Sciences; Number_not_reported 150519058 CVCL_A9EQ MAKM-2.42.3 hybridoma house mouse CVCL_A9EQ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P16070; Human CD44. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2157 150519059 CVCL_A9EP MAKM-1.1.12 hybridoma house mouse CVCL_A9EP CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P16070; Human CD44. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2156 150519060 CVCL_A9GE GP-L2 finite cell line CVCL_A9GE CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Male 150519061 CVCL_A9GD GP-L1 finite cell line CVCL_A9GD CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Male 150519062 CVCL_A9GG GP-S2 finite cell line CVCL_A9GG CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150519063 CVCL_A9GF GP-M2 finite cell line CVCL_A9GF CL:0000010 Derived from site: In situ; Muscle; UBERON=UBERON_0001630; Cell type: Fibroblast of muscle; CL=CL_1001609. Male 150519064 CVCL_A9GI GP-S4 finite cell line CVCL_A9GI CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150519065 CVCL_A9GH GP-S3 finite cell line CVCL_A9GH CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150519066 CVCL_A9GK LC-L2 finite cell line CVCL_A9GK CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Female 150519067 CVCL_A9GJ LC-L1 finite cell line CVCL_A9GJ CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Female 150519068 CVCL_A9GA BTA-S2 finite cell line CVCL_A9GA CL:0000010 Derived from site: In situ; Scalp, skin; UBERON=UBERON_8300000; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150519069 CVCL_A9GC GP-K1 finite cell line CVCL_A9GC CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Fibroblast; CL=CL_0000057. Male 150519070 CVCL_A9GB GP-H2 finite cell line CVCL_A9GB CL:0000010 Derived from site: In situ; Heart; UBERON=UBERON_0000948; Cell type: Fibroblast of heart; CL=CL_0002548. Male 150519071 CVCL_A9FT MM-L2 finite cell line CVCL_A9FT CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Female Group: Non-human primate cell line 150519072 CVCL_A9FS MM-L1 finite cell line CVCL_A9FS CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Male Group: Non-human primate cell line 150519073 CVCL_A9FV SVU-K1 finite cell line CVCL_A9FV CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Fibroblast; CL=CL_0000057. Male 150519074 CVCL_A9FU SVU-H1 finite cell line CVCL_A9FU CL:0000010 Derived from site: In situ; Heart; UBERON=UBERON_0000948; Cell type: Fibroblast of heart; CL=CL_0002548. Male 150519075 CVCL_A9FX HAF finite cell line human CVCL_A9FX CL:0000010 Derived from site: In situ; Aorta; UBERON=UBERON_0000947; Cell type: Fibroblast; CL=CL_0000057. Female 150519076 CVCL_A9FW SVU-L1 finite cell line CVCL_A9FW CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Male 150519077 CVCL_A9FZ CAM-S finite cell line CVCL_A9FZ CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Group: Bird cell line 150519078 CVCL_A9FY CAM-M finite cell line CVCL_A9FY CL:0000010 Derived from site: In situ; Muscle; UBERON=UBERON_0001630; Cell type: Fibroblast of muscle; CL=CL_1001609. Female Group: Bird cell line 150519079 CVCL_A9FL DPLC1 somatic stem cell dog CVCL_A9FL CL:0000010 Derived from site: In situ; Placenta; UBERON=UBERON_0001987; Cell type: Mesenchymal stem cell; CL=CL_0000134; Breed/subspecies: Corgi; VBO=VBO_0200995. Female 150519080 CVCL_A9FK MM-E2 finite cell line CVCL_A9FK CL:0000010 Derived from site: In situ; Fetus; UBERON=UBERON_0000323; Cell type: Fibroblast; CL=CL_0000057. Female Group: Non-human primate cell line 150519081 CVCL_A9FN SSC-S4 finite cell line pig CVCL_A9FN CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 150519082 CVCL_A9FM SSC-S3 finite cell line pig CVCL_A9FM CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620; Breed/subspecies: Changbai Mountains wild boar. Female Group: Endangered species/breed cell line 150519083 CVCL_A9FP SSC-S5 finite cell line pig CVCL_A9FP CL:0000010 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150519084 CVCL_A9FR MM-K3 finite cell line CVCL_A9FR CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518. Female Group: Non-human primate cell line 150519085 CVCL_A9FQ MM-K2 finite cell line CVCL_A9FQ CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518. Female Group: Non-human primate cell line 150519086 CVCL_RS80 SH-SY5YrDOX10 cancer cell line human CVCL_RS80 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin); Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Female Part of: Resistant Cancer Cell Line (RCCL) collection 150519087 CVCL_B0H0 LB86 transformed cell line human CVCL_B0H0 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12591; UROD; Simple; p.Phe46Leu (c.138T>A); ClinVar=VCV001325337; Zygosity=Homozygous (PubMed=10397714) Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Doubling time: 38.25 hours (PubMed=10397714) 150519088 CVCL_B0GN SK-N-SH D cancer cell line human CVCL_B0GN CL:0000010 Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Female Characteristics: Can naturally differentiate as neuron-like cells (Patent=US10591466) Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-5010 150519089 CVCL_B0GQ HPS3918 induced pluripotent stem cell human CVCL_B0GQ CL:0000010 Population: Japanese; Donor information: Established from dizygotic twin of HPS3920 (Cellosaurus=CVCL_UP53); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519090 CVCL_B0H2 Sp2/0-Ag14 hEPO cancer cell line house mouse CVCL_B0H2 CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3415; EPO; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine; Cell type: Plasma cell; CL=CL_0000786; Breed/subspecies: BALB/c. Female Characteristics: Produces human EPO with full in vitro biological activity, but low in vivo biological activity 150519091 CVCL_B0GP CSUi002-A-1 induced pluripotent stem cell human CVCL_B0GP From: Central South University; Changsha; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Using CRISPR/Cas9 LMNB1 has been endogenously tagged in one allele at the N-terminus with EGFP (PubMed=34438319) 150519092 CVCL_B0H1 LB86-LUDSN11 transformed cell line human CVCL_B0H1 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12591; UROD; Simple; p.Phe46Leu (c.138T>A); ClinVar=VCV001325337; Zygosity=Homozygous (PubMed=10397714); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12591; UROD; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Doubling time: 21.1 hours (PubMed=10397714) 150519093 CVCL_B0GS PUMCHi016-A induced pluripotent stem cell human CVCL_B0GS From: Peking Union Medical College Hospital; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; c.8559-2A>G (p.Tyr2854_Arg2894del); ClinVar=VCV000048604; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=34419747) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519094 CVCL_B0H4 XMMLY-H65 hybridoma house mouse CVCL_B0H4 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P06127; Human CD5. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9286 150519095 CVCL_B0H3 4A2 [Mouse hybridoma against human CD7] hybridoma house mouse CVCL_B0H3 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P09564; Human CD7. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8350 150519096 CVCL_B0GR PUMCHi015-A induced pluripotent stem cell human CVCL_B0GR From: Peking Union Medical College Hospital; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Cys934Trp (c.2802T>G); ClinVar=VCV000143179; Zygosity=Heterozygous (PubMed=34419747); Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Arg4187His (c.12560G>A); ClinVar=VCV000865757; Zygosity=Heterozygous (PubMed=34419747) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519097 CVCL_B0H6 4H7H7 hybridoma house mouse CVCL_B0H6 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P42858; Human HTT (Note=Recognizes expanded poly-Gln region). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2847 150519098 CVCL_B0GU CHO-K1 hMCHR1 spontaneously immortalized cell line CVCL_B0GU CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4479; MCHR1 Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Discontinued: Euroscreen; Catalog number ES-370-C Female 150519099 CVCL_B0H5 1F11E5 hybridoma house mouse CVCL_B0H5 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P42858; Human HTT (Note=Recognizes expanded poly-Gln region). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2846 150519100 CVCL_B0GT XACHi015-A induced pluripotent stem cell human CVCL_B0GT From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Pro605Leu (c.1814C>T); ClinVar=VCV000067284; Zygosity=Heterozygous (PubMed=34438161) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519101 CVCL_B0GG 24/04-10B4-24-8-FACS 9-5 hybridoma CVCL_B0GG CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q8BRU4; Mouse Clec9a/Cd370 (Note=Also reacts with human). Group: Patented cell line; Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 08042901 150519102 CVCL_B0GF 24/04-10B4-24-8 hybridoma CVCL_B0GF CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q8BRU4; Mouse Clec9a/Cd370 (Note=Also reacts with human). Group: Patented cell line; Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 07121101 150519103 CVCL_B0GI 42/04-42D2-66-4-1-Clone 4 hybridoma CVCL_B0GI CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q8BRU4; Mouse Clec9a/Cd370. Group: Patented cell line; Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 08041902 150519104 CVCL_B0GH 42/04-42D2-66-4-1 hybridoma CVCL_B0GH CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q8BRU4; Mouse Clec9a/Cd370. Group: Patented cell line; Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 07121102 150519105 CVCL_B0GK 20/05-3A4-26-16-Clone 5 hybridoma CVCL_B0GK CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q6UXN8; Human CLEC9A/CD370. Group: Patented cell line; Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 08041903 150519106 CVCL_B0GJ 20/05-3A4-26-16 hybridoma CVCL_B0GJ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q6UXN8; Human CLEC9A/CD370. Group: Patented cell line; Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 07121103 150519107 CVCL_B0GM 23/05-4C6-29-3-Clone 5 hybridoma CVCL_B0GM CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q6UXN8; Human CLEC9A/CD370. Group: Patented cell line; Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 08041904 150519108 CVCL_B0GL 23/05-4C6-29-3 hybridoma CVCL_B0GL CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q6UXN8; Human CLEC9A/CD370. Group: Patented cell line; Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 07121104 150519109 CVCL_B0GA NimoAb101 hybridoma CVCL_B0GA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; O00187; Human MASP2. Group: Patented cell line; Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 03050904 150519110 CVCL_B0GC M0545YM035S2 hybridoma house mouse CVCL_B0GC CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; O00187; Human MASP2. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2660 150519111 CVCL_B0GB M0545YM029S2 hybridoma house mouse CVCL_B0GB CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; O00187; Human MASP2. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2657 150519112 CVCL_B0GE M0545YM048S2 hybridoma house mouse CVCL_B0GE CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; O00187; Human MASP2. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2659 150519113 CVCL_B0GD M0545YM046S2 hybridoma house mouse CVCL_B0GD CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; O00187; Human MASP2. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2658 150519114 CVCL_B0FV 1A4 [Mouse hybridoma against human AXL] hybridoma house mouse CVCL_B0FV CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P30530; Human AXL. Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-3947 150519115 CVCL_B0G7 ADx215 hybridoma house mouse CVCL_B0G7 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P10636; Human MAPT. Group: Patented cell line; Registration: International Depositary Authority, Belgian Coordinated Collections of Micro-organisms (BCCM); LMBP 9679CB 150519116 CVCL_B0FU 11D12 hybridoma house mouse CVCL_B0FU CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P30530; Human AXL. Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4116 150519117 CVCL_B0G6 ADx211 hybridoma house mouse CVCL_B0G6 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P10636; Human MAPT. Group: Patented cell line; Registration: International Depositary Authority, Belgian Coordinated Collections of Micro-organisms (BCCM); LMBP 8348CB 150519118 CVCL_B0FX 427B7 hybridoma house mouse CVCL_B0FX CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P30530; Human AXL. Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4518 150519119 CVCL_B0G9 MHG-8 hybridoma house mouse CVCL_B0G9 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q14392; Human LRRC32. Group: Patented cell line; Registration: International Depositary Authority, Belgian Coordinated Collections of Micro-organisms (BCCM); LMBP 10246CB 150519120 CVCL_B0FW 320G10 hybridoma house mouse CVCL_B0FW CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P30530; Human AXL. Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4514 150519121 CVCL_B0G8 Sp2/neo cancer cell line house mouse CVCL_B0G8 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine; Cell type: Plasma cell; CL=CL_0000786; Breed/subspecies: BALB/c. Female Group: Hybridoma fusion partner cell line 150519122 CVCL_B0FZ 530C8 hybridoma house mouse CVCL_B0FZ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P30530; Human AXL. Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4728 150519123 CVCL_B0FY 517F1 hybridoma house mouse CVCL_B0FY CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P30530; Human AXL. Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4502 150519124 CVCL_B0I1 GM28025 finite cell line human CVCL_B0I1 CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150519125 CVCL_B0HP H6-2.5F7 hybridoma house mouse CVCL_B0HP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P30203; Human CD6. 150519126 CVCL_B0I0 GM28024 finite cell line human CVCL_B0I0 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:21308; ELOVL5; Simple; c.246+3891C>T (p.Gln102Ter, c.304C>T); ClinVar=VCV000691282; Zygosity=Heterozygous (Coriell=GM28024); Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Met1_Ala5del (c-11_13delGGCCGGGTGCGATGGCGGCGGTGG) (c.-13_11del24); ClinVar=VCV000215241; Zygosity=Heterozygous (Coriell=GM28024); Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Leu105Ter (c.312_321del10insAT) (p.Pro104_Leu105insTer); ClinVar=VCV000215237; Zygosity=Heterozygous (Coriell=GM28024) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150519127 CVCL_B0I3 GM28034 finite cell line human CVCL_B0I3 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Trp278Ter (c.834G>A); ClinVar=VCV000928763; Zygosity=Heterozygous (Coriell=GM28034); Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Ser282Cysfs*9 (c.841_842CT[2]) (c.845_846delCT); ClinVar=VCV000012770; Zygosity=Heterozygous (Coriell=GM28034) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150519128 CVCL_B0HR H6-2.8A7 hybridoma house mouse CVCL_B0HR CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P30203; Human CD6. 150519129 CVCL_B0I2 GM28033 finite cell line human CVCL_B0I2 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Trp278Ter (c.834G>A); ClinVar=VCV000928763; Zygosity=Heterozygous (Coriell=GM28033); Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Ser282Cysfs*9 (c.841_842CT[2]) (c.845_846delCT); ClinVar=VCV000012770; Zygosity=Heterozygous (Coriell=GM28033) Population: Caucasian; Derived from site: In situ; Back, skin; UBERON=UBERON_0001068; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150519130 CVCL_B0HQ H6-2.7C7 hybridoma house mouse CVCL_B0HQ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P30203; Human CD6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12288 150519131 CVCL_B0I5 GM28036 finite cell line human CVCL_B0I5 CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150519132 CVCL_B0HT Prost J415 hybridoma house mouse CVCL_B0HT CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12109 150519133 CVCL_B0I4 GM28035 finite cell line human CVCL_B0I4 CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150519134 CVCL_B0HS Prost E99 hybridoma house mouse CVCL_B0HS CL:0000010 Monoclonal antibody isotype: IgG3; Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12101 150519135 CVCL_B0I7 GM28212 finite cell line human CVCL_B0I7 CL:0000010 Population: Bangladeshi; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150519136 CVCL_B0HV Prost J591 hybridoma house mouse CVCL_B0HV CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12126 150519137 CVCL_B0I6 GM28209 transformed cell line human CVCL_B0I6 CL:0000010 Population: Bangladeshi; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519138 CVCL_B0HU Prost J533 hybridoma house mouse CVCL_B0HU CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12127 150519139 CVCL_B0HH H6-2.12A5 hybridoma house mouse CVCL_B0HH CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P30203; Human CD6. 150519140 CVCL_B0HG H6-2.10D1 hybridoma house mouse CVCL_B0HG CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P30203; Human CD6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12290 150519141 CVCL_B0HJ H6-2.14H2 hybridoma house mouse CVCL_B0HJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P30203; Human CD6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12294 150519142 CVCL_B0HI H6-2.13C3 hybridoma house mouse CVCL_B0HI CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P30203; Human CD6. 150519143 CVCL_B0HL H6-2.16A3 hybridoma house mouse CVCL_B0HL CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P30203; Human CD6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12296 150519144 CVCL_B0HK H6-2.15B12 hybridoma house mouse CVCL_B0HK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P30203; Human CD6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12293 150519145 CVCL_B0HN H6-2.5E8 hybridoma house mouse CVCL_B0HN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P30203; Human CD6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12295 150519146 CVCL_B0HM H6-2.5D4 hybridoma house mouse CVCL_B0HM CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P30203; Human CD6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12291 150519147 CVCL_B0HB H6-1.12F10 hybridoma house mouse CVCL_B0HB CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P30203; Human CD6. 150519148 CVCL_B0HA 3B5H10 hybridoma house mouse CVCL_B0HA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P42858; Human HTT (Note=Recognizes expanded poly-Gln region). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2848 150519149 CVCL_B0HD H6-1.5E1 hybridoma house mouse CVCL_B0HD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P30203; Human CD6. 150519150 CVCL_B0HC H6-1.15D7 hybridoma house mouse CVCL_B0HC CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P30203; Human CD6. 150519151 CVCL_B0HF H6-2.10A5 hybridoma house mouse CVCL_B0HF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P30203; Human CD6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12289 150519152 CVCL_B0HE H6-1.7H6 hybridoma house mouse CVCL_B0HE CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P30203; Human CD6. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12292 150519153 CVCL_B0H8 4F1B5 hybridoma house mouse CVCL_B0H8 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P42858; Human HTT (Note=Recognizes expanded poly-Gln region). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2851 150519154 CVCL_B0GW LB44 transformed cell line human CVCL_B0GW CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12591; UROD; Simple; p.Gly281Glu (c.842G>A); ClinVar=VCV000000066; Zygosity=Homozygous (PubMed=10397714); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12591; UROD; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Doubling time: 34.5 hours (PubMed=10397714) 150519155 CVCL_B0H7 3A2D3 hybridoma house mouse CVCL_B0H7 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P42858; Human HTT (Note=Recognizes expanded poly-Gln region). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2849 150519156 CVCL_B0GV I3.4.2 cancer cell line human CVCL_B0GV CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4383; GNA15; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Caucasian; Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916. Male Characteristics: High expression of MCHR1 Responds to melanin-concentrating hormone (MCH) in Calcium-mobilization assays (PubMed=16524757). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5201 150519157 CVCL_B0GY LB45 transformed cell line human CVCL_B0GY CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12591; UROD; Simple; p.Gly281Glu (c.842G>A); ClinVar=VCV000000066; Zygosity=Homozygous (PubMed=10397714) Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Doubling time: 32.5 hours (PubMed=10397714) 150519158 CVCL_B0H9 3C4A6 hybridoma house mouse CVCL_B0H9 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P42858; Human HTT (Note=Recognizes expanded poly-Gln region). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2850 150519159 CVCL_B0GX LB44-LUDSN11 transformed cell line human CVCL_B0GX CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12591; UROD; Simple; p.Gly281Glu (c.842G>A); ClinVar=VCV000000066; Zygosity=Homozygous (from parent cell line) Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Doubling time: 19.4 hours (PubMed=10397714) 150519160 CVCL_B0GZ LB45-LUDSN11 transformed cell line human CVCL_B0GZ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12591; UROD; Simple; p.Gly281Glu (c.842G>A); ClinVar=VCV000000066; Zygosity=Homozygous (PubMed=10397714); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12591; UROD; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Doubling time: 21 hours (PubMed=10397714) 150519161 CVCL_B0EM 3D5.1.10 hybridoma house mouse CVCL_B0EM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O14763; Human TNFRSF10B/CD262 (Note=Also recognizes TNFRSF10A/CD261). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12536 150519162 CVCL_B0EL 3H3.14.5 hybridoma house mouse CVCL_B0EL CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O14763; Human TNFRSF10B/CD262. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12534 150519163 CVCL_B0F0 SZ-168 hybridoma house mouse CVCL_B0F0 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q86YL7; Human PDPN. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015185 150519164 CVCL_B0EN 38SB13 hybridoma house mouse CVCL_B0EN CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P28907; Human CD38. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7667 150519165 CVCL_B0EQ 38SB19 hybridoma house mouse CVCL_B0EQ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P28907; Human CD38. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7670 150519166 CVCL_B0F2 ZOSL-1 cancer cell line human CVCL_B0F2 CL:0000010 Population: Caucasian; Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981. Female Doubling time: 39.28 +- 3.04 hours (Patent=CN112080473B; PubMed=34221892) Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202088 Problematic cell line: Probably contaminated The STR profile is identical to that of the HOS cell line. Originally thought to originate from the lung metastasis of a 12 year old female Chinese osteosarcoma patient. 150519167 CVCL_B0F1 2F6 [Mouse hybridoma against human CKB/CKM] hybridoma house mouse CVCL_B0F1 CL:0000010 Monoclonal antibody isotype: IgG3; Monoclonal antibody target: UniProtKB; P12277; Human CKB; Monoclonal antibody target: UniProtKB; P06732; Human CKM. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202086 150519168 CVCL_B0EP 38SB18 hybridoma house mouse CVCL_B0EP CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P28907; Human CD38. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7669 150519169 CVCL_B0ES 38SB31 hybridoma house mouse CVCL_B0ES CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P28907; Human CD38. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7668 150519170 CVCL_B0F4 CGMCC-13827 hybridoma house mouse CVCL_B0F4 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Aspergillus fumigatus (strain ATCC-1022) galactomannan antigen (GM). Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.13827 150519171 CVCL_B0ER 38SB30 hybridoma house mouse CVCL_B0ER CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P28907; Human CD38. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7666 150519172 CVCL_B0F3 BLAC-20 spontaneously immortalized cell line CVCL_B0F3 CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Leukocyte; CL=CL_0000738. Unspecified 150519173 CVCL_B0EE 4H6.17.8 hybridoma house mouse CVCL_B0EE CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00220; Human TNFRSF10A/CD261. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12455 150519174 CVCL_B0ED 4G7.18.8 hybridoma house mouse CVCL_B0ED CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O00220; Human TNFRSF10A/CD261. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-99 150519175 CVCL_B0EG 7C2 [Mouse hybridoma against human ERBB2] hybridoma house mouse CVCL_B0EG CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12215 150519176 CVCL_B0EF 5G11.17.1 hybridoma house mouse CVCL_B0EF CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; O00220; Human TNFRSF10A/CD261. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12694 150519177 CVCL_B0EI 2C4 [Mouse hybridoma against human ERBB2] hybridoma house mouse CVCL_B0EI CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12697 150519178 CVCL_B0EH 7F3 hybridoma house mouse CVCL_B0EH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12216 150519179 CVCL_B0EK 3H1.18.10 hybridoma house mouse CVCL_B0EK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O14763; Human TNFRSF10B/CD262. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12535 150519180 CVCL_B0EJ 3F11.39.7 hybridoma house mouse CVCL_B0EJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O14763; Human TNFRSF10B/CD262. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12456 150519181 CVCL_B0EA 2A2.16.7 hybridoma house mouse CVCL_B0EA CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2; Monoclonal antibody target: UniProtKB; O00220; Human TNFRSF10A/CD261 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3360 150519182 CVCL_B0EC 4E7.24.3 hybridoma house mouse CVCL_B0EC CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O00220; Human TNFRSF10A/CD261. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11454 150519183 CVCL_B0EB 1H5.25.9 hybridoma house mouse CVCL_B0EB CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O00220; Human TNFRSF10A/CD261. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12695 150519184 CVCL_B0DT 759E3 hybridoma house mouse CVCL_B0DT CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10808; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10079 150519185 CVCL_B0E5 CA1 hybridoma house mouse CVCL_B0E5 CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Anti-idiotypic against monoclonal antibody 2C7. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11311 150519186 CVCL_B0DS 758G5 hybridoma house mouse CVCL_B0DS CL:0000010 Miscellaneous: This hybridoma was lost in a liquid nitrogen tank thaw (PubMed=2470501). Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340 150519187 CVCL_B0E4 PC3-EMT12 cancer cell line human CVCL_B0E4 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase Population: Caucasian; Derived from site: Metastatic; Bone; UBERON=UBERON_0002481. Omics: Transcriptomics; Microarray Male Characteristics: Transfected with a pLentilox-EV-Luc luciferase expression vector 150519188 CVCL_B0E7 3G9 hybridoma house mouse CVCL_B0E7 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: Neisseria gonorrhoeae lipo-oligosaccharide (LOS). 150519189 CVCL_B0DV 760C5 hybridoma house mouse CVCL_B0DV CL:0000010 Miscellaneous: This hybridoma was lost in a liquid nitrogen tank thaw (PubMed=2470501). Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340 150519190 CVCL_B0E6 2C7 [Mouse hybridoma against N.gonorrhoease LOS] hybridoma house mouse CVCL_B0E6 CL:0000010 Monoclonal antibody isotype: IgG3, lambda; Monoclonal antibody target: Neisseria gonorrhoeae lipo-oligosaccharide (LOS) (Note=Binds to the inner 15253 LOS structure found within WG LOS). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11859 150519191 CVCL_B0DU 759G12 hybridoma house mouse CVCL_B0DU CL:0000010 Miscellaneous: This hybridoma was lost in a liquid nitrogen tank thaw (PubMed=2470501). Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340 150519192 CVCL_B0E9 1G11.14.7 hybridoma house mouse CVCL_B0E9 CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2; Monoclonal antibody target: UniProtKB; O00220; Human TNFRSF10A/CD261 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3361 150519193 CVCL_B0DX 769E11 hybridoma house mouse CVCL_B0DX CL:0000010 Miscellaneous: This hybridoma was lost in a liquid nitrogen tank thaw (PubMed=2470501). Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340 150519194 CVCL_B0E8 1E10.16.4 hybridoma house mouse CVCL_B0E8 CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2; Monoclonal antibody target: UniProtKB; O00220; Human TNFRSF10A/CD261 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3359 150519195 CVCL_B0DW 761B10 hybridoma house mouse CVCL_B0DW CL:0000010 Miscellaneous: This hybridoma was lost in a liquid nitrogen tank thaw (PubMed=2470501). Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340 150519196 CVCL_B0DZ 788G6 hybridoma house mouse CVCL_B0DZ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human high molecular weight mucin. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8692; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10080 150519197 CVCL_B0DY 770G4 hybridoma house mouse CVCL_B0DY CL:0000010 Miscellaneous: This hybridoma was lost in a liquid nitrogen tank thaw (PubMed=2470501). Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340 150519198 CVCL_B0FN ZZUi030-A induced pluripotent stem cell human CVCL_B0FN From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11237; SPG7; Simple; p.Arg398Ter (c.1192C>T); ClinVar=VCV000545964; Zygosity=Heterozygous (PubMed=34509920) Population: Chinese; Han; Derived from site: In situ; Leg, skin, dermis; UBERON=UBERON_0001511+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150519199 CVCL_B0FM NUIGi056-A induced pluripotent stem cell human CVCL_B0FM From: National University of Ireland Galway; Galway; Ireland. CL:0000010 Female 150519200 CVCL_B0G1 535F7 hybridoma house mouse CVCL_B0G1 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P30530; Human AXL. Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4510 150519201 CVCL_B0FP ZZUi031-A induced pluripotent stem cell human CVCL_B0FP From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Leg, skin, dermis; UBERON=UBERON_0001511+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150519202 CVCL_B0G0 534G9 hybridoma house mouse CVCL_B0G0 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P30530; Human AXL. Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4729 150519203 CVCL_B0G3 1023F10 hybridoma house mouse CVCL_B0G3 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P30530; Human AXL. Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4507 150519204 CVCL_B0FR WAe009-A-69 embryonic stem cell human CVCL_B0FR From: Anzhen Hospital, Capital Medical University; Beijing; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7577; MYH7 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 150519205 CVCL_B0G2 547A1 hybridoma house mouse CVCL_B0G2 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P30530; Human AXL. Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4506 150519206 CVCL_B0FQ ZZUi032-A induced pluripotent stem cell human CVCL_B0FQ From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China. CL:0000010 Female 150519207 CVCL_B0FT 1613F12 hybridoma house mouse CVCL_B0FT CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P30530; Human AXL. Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4505 150519208 CVCL_B0G5 ADx210 hybridoma house mouse CVCL_B0G5 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P10636; Human MAPT. Group: Patented cell line; Registration: International Depositary Authority, Belgian Coordinated Collections of Micro-organisms (BCCM); LMBP 8347CB 150519209 CVCL_B0G4 1614G5 hybridoma house mouse CVCL_B0G4 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P30530; Human AXL. Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4519 150519210 CVCL_B0FS H9c2 Trpm4 KO spontaneously immortalized cell line Norway rat CVCL_B0FS CL:0000010 Knockout cell: Method=CRISPR/Cas9; RGD; 620244; Trpm4 Derived from site: In situ; Embryonic heart, cardiac muscle; UBERON=UBERON_0003084+UBERON_0001133; Breed/subspecies: BDIX; RS=RS_0000091. Unspecified 150519211 CVCL_B0FF HYB-241 hybridoma house mouse CVCL_B0FF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243. 150519212 CVCL_B0FE HYB-195 hybridoma house mouse CVCL_B0FE CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243. 150519213 CVCL_B0FH K562-R cancer cell line human CVCL_B0FH CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_41977; Daunorubicin (Daunomycin); Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. Female 150519214 CVCL_B0FG HYB-612 hybridoma house mouse CVCL_B0FG CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243. 150519215 CVCL_B0FJ C219 hybridoma house mouse CVCL_B0FJ CL:0000010 Miscellaneous: The patent US4837306 claims a mAB against ABCB1 but does not seem to specifically claim hybridoma C219. Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243 150519216 CVCL_B0FI G8-2 hybridoma house mouse CVCL_B0FI CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243. 150519217 CVCL_B0FL F4 hybridoma house mouse CVCL_B0FL CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11325 150519218 CVCL_B0FK JSB-1 hybridoma house mouse CVCL_B0FK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243. 150519219 CVCL_B0FB UIC2 hybridoma house mouse CVCL_B0FB CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11027 150519220 CVCL_B0FA MRK17 hybridoma house mouse CVCL_B0FA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243. 150519221 CVCL_B0FD SK-N-MC-IXC/VCR cancer cell line human CVCL_B0FD CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.170_572del; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR); Derived from site: Metastatic; Orbital region; UBERON=UBERON_0004088. Female Problematic cell line: Misclassified Grand-parent cell line (SK-N-MC) was originally thought to be a neuroblastoma cell line but shown to be from an Askin tumor. 150519222 CVCL_B0FC UIC2/A hybridoma house mouse CVCL_B0FC CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11287 150519223 CVCL_B0F6 2C5D6 hybridoma house mouse CVCL_B0F6 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; O76093; Human FGF18. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202091 150519224 CVCL_B0EU COVID19-SRBD-8 hybridoma house mouse CVCL_B0EU CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202167 150519225 CVCL_B0ET 38SB39 hybridoma house mouse CVCL_B0ET CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P28907; Human CD38. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7671 150519226 CVCL_B0F5 LCZ8A3 hybridoma house mouse CVCL_B0F5 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Human prostatic exosomal protein (PSEP). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2019144 150519227 CVCL_B0F8 4D8G7 hybridoma house mouse CVCL_B0F8 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; O76093; Human FGF18 (Note=Also recognizes FGF8 and FGF17). 150519228 CVCL_B0EW SZ-179 hybridoma house mouse CVCL_B0EW CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P04275; Human VWF. 150519229 CVCL_B0F7 3E4F7 hybridoma house mouse CVCL_B0F7 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; O76093; Human FGF18 (Note=Also recognizes FGF8 and FGF17). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202092 150519230 CVCL_B0EV SZ-176 hybridoma house mouse CVCL_B0EV CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P04275; Human VWF. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2019273 150519231 CVCL_B0EY SZ-125 hybridoma house mouse CVCL_B0EY CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P04275; Human VWF. 150519232 CVCL_B0F9 MRK16 hybridoma house mouse CVCL_B0F9 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243. 150519233 CVCL_B0EX SZ-123 hybridoma house mouse CVCL_B0EX CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P04275; Human VWF. 150519234 CVCL_B0EZ SZ-163 hybridoma house mouse CVCL_B0EZ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q86YL7; Human PDPN. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201613 150519235 CVCL_B0CK RAO-2 telomerase immortalized cell line human CVCL_B0CK CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gln61Leu); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367; Cell type: Epithelial cell of mammary gland; CL=CL_0002327. Female Characteristics: Does not show anchorage-independent growth in soft agar and is not tumorigenic in nude mice (PubMed=16395697) 150519236 CVCL_B0CJ RAO-1 telomerase immortalized cell line human CVCL_B0CJ CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367; Cell type: Epithelial cell of mammary gland; CL=CL_0002327. Female Doubling time: 36 hours (PubMed=29022488) 150519237 CVCL_B0CM RAO-4 telomerase immortalized cell line human CVCL_B0CM CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gln61Leu); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367; Cell type: Epithelial cell of mammary gland; CL=CL_0002327. Female Characteristics: Tumorigenic Generates human mammary epithelial carcinoma when injected into nude mice (PubMed=16395697). 150519238 CVCL_B0CL RAO-3 telomerase immortalized cell line human CVCL_B0CL CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gln61Leu); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367; Cell type: Epithelial cell of mammary gland; CL=CL_0002327. Female Characteristics: Tumorigenic Generates human mammary spindle cell carcinomas when injected into nude mice (PubMed=16395697). 150519239 CVCL_B0D0 HUPEC 002 FSGS G0/G0 conditionally immortalized cell line human CVCL_B0D0 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Population: Caucasian; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Urine; UBERON=UBERON_0001088; Cell type: Podocyte-like epithelial cell; CL=CL_0000653. Male 150519240 CVCL_B0CN PC3-EMT1 cancer cell line human CVCL_B0CN CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase Population: Caucasian; Derived from site: Metastatic; Bone; UBERON=UBERON_0002481. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Male Characteristics: Selected from a mesenchymal sub-population of the parent cell line; Characteristics: Transfected with a pLentilox-EV-Luc luciferase expression vector 150519241 CVCL_B0CQ 5E12.5 hybridoma house mouse CVCL_B0CQ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human 125 kDa antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-994 150519242 CVCL_B0D2 BB11 hybridoma house mouse CVCL_B0D2 CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P16581; Human SELE/CD62E. Group: Patented cell line; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10220 150519243 CVCL_B0CP 8G1.7 hybridoma house mouse CVCL_B0CP CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P25063; Human CD24. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-993 150519244 CVCL_B0D1 VIIIC3.78 hybridoma house mouse CVCL_B0D1 CL:0000010 Monoclonal antibody isotype: IgG3; Monoclonal antibody target: UniProtKB; C6C2D6; Borreliella burgdorferi (strain N40) outer surface protein A (ospA). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10878; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10256 150519245 CVCL_B0CC ART [Human OVCAR-8 contaminated cell line] cancer cell line human CVCL_B0CC CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gln26Arg (c.77A>G); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Gly776Val (c.2327G>T); ClinVar=VCV000163410; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Pro121His (c.362C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line); Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Population: Caucasian; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40). Female Characteristics: Engineered to overexpress the SV40 large T antigen; Virology: Can be used to evaluate the infectious entry of polyomaviruses (BKPyV, JCPyV, SV40, MCPyV) and human papillomaviruses Pathogenic variants of the JCPyV virus previously believed to be non-infectious can infect this cell line (ATCC=CRL-3468). Doubling time: ~34 hours (ATCC=CRL-3468) Problematic cell line: Contaminated Parent cell line (NCI-ADR-RES) has been shown to be a OVCAR-8 derivative. 150519246 CVCL_B0CB PC3-epi cancer cell line human CVCL_B0CB CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase Population: Caucasian; Derived from site: Metastatic; Bone; UBERON=UBERON_0002481. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Male Characteristics: Selected based on an epithelial cell morphology, bioluminescent intensity and expression of E-cadherin Selection was repeated twice and a stable epithelial population was obtained (PubMed=24124593).; Characteristics: Transfected with a pLentilox-EV-Luc luciferase expression vector 150519247 CVCL_B0CE MEL114433 cancer cell line house mouse CVCL_B0CE CL:0000010 Transformant: NCIt; C17231; Ultraviolet radiation; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Breed/subspecies: C57BL/6 BrafCA/+, Ptenflox/+, Cdkn2aflox/+, Tyr-CreERT2-tg. Omics: Genomics; Whole exome sequencing Female Doubling time: ~24 hours (ATCC=CRL-3473) 150519248 CVCL_B0CD SFT cancer cell line human CVCL_B0CD CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Thr116Leufs*8 (c.346_349delACTT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Glufs*3 (c.1024delC); ClinVar=VCV000428885; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Population: Caucasian; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Brain, right temporo-parietal junction; UBERON=UBERON_0023852. Female Virology: Can be used to evaluate the infectious entry of polyomaviruses (BKPyV, JCPyV, SV40) and human papillomaviruses Pathogenic variants of the JCPyV virus previously believed to be non-infectious can infect this cell line, especially in the presence of the chemical 3Fax-Peracetyl Neu5Ac (3Fax) (ATCC=CRL-3469). Doubling time: ~30 hours (ATCC=CRL-3469) 150519249 CVCL_B0CG B2905 cancer cell line house mouse CVCL_B0CG CL:0000010 Transformant: NCIt; C17231; Ultraviolet radiation; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Breed/subspecies: C57BL/6 Hgftg. Omics: Genomics; Whole exome sequencing Male Doubling time: ~16 hours (ATCC=CRL-3476) 150519250 CVCL_B0CF HCmel1274 cancer cell line house mouse CVCL_B0CF CL:0000010 Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Breed/subspecies: C57BL/6 Cdk4R24C/R24C, Hgftg. Omics: Genomics; Whole exome sequencing Female Doubling time: ~16-20 hours (ATCC=CRL-3475) 150519251 CVCL_B0CI HMEC 2.6 telomerase immortalized cell line human CVCL_B0CI CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Donor information: Established from a patient undergoing reduction mammoplasty with no known breast pathology (PubMed=29022488); Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367. Female Doubling time: ~3 days (PubMed=29022488) 150519252 CVCL_B0CH B9013HCB cancer cell line house mouse CVCL_B0CH CL:0000010 Transformant: NCIt; C17231; Ultraviolet radiation; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Breed/subspecies: C57BL/6 BrafCA/+, Cdkn2aflox/+, Tyr-CreERT2-tg, Hgftg. Omics: Genomics; Whole exome sequencing Female Doubling time: ~24-36 hours (ATCC=CRL-3474) 150519253 CVCL_B0BZ RCJ 3.1C5.25 spontaneously immortalized cell line Norway rat CVCL_B0BZ CL:0000010 Derived from site: In situ; Embryonic bone, calvaria; UBERON=UBERON_0004339; Cell type: Chondrocyte; CL=CL_0000138. 150519254 CVCL_B0BY RCJ 3.1C5.18 spontaneously immortalized cell line Norway rat CVCL_B0BY CL:0000010 Derived from site: In situ; Embryonic bone, calvaria; UBERON=UBERON_0004339; Cell type: Chondrocyte; CL=CL_0000138. 150519255 CVCL_B0CA HUPEC 005 FSGS G1/G2 conditionally immortalized cell line human CVCL_B0CA CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Population: African American; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Urine; UBERON=UBERON_0001088; Cell type: Podocyte-like epithelial cell; CL=CL_0000653. Male 150519256 CVCL_B0C3 BBG-30 hybridoma house mouse CVCL_B0C3 CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: Porphyromonas gingivalis fimbriae. Group: Patented cell line; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10103 150519257 CVCL_B0BR N17A3 transformed cell line human CVCL_B0BR CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428; Cell type: Epithelial cell of prostate; CL=CL_0002231. Omics: Transcriptomics; Microarray Male 150519258 CVCL_B0C2 BBG-25 hybridoma house mouse CVCL_B0C2 CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: Porphyromonas gingivalis lipopolysaccharide (LPS). 150519259 CVCL_B0BQ D5-NP118 transformed cell line human CVCL_B0BQ CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Intervertebral disc, nucleus pulposus; UBERON=UBERON_0002242. Male 150519260 CVCL_B0C5 BBG-42 hybridoma house mouse CVCL_B0C5 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Porphyromonas gingivalis. Group: Patented cell line; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10105 150519261 CVCL_B0BT NE6-E6E7 transformed cell line human CVCL_B0BT CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Esophagus; UBERON=UBERON_0001043. Male 150519262 CVCL_B0C4 BBG-31 hybridoma house mouse CVCL_B0C4 CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: Porphyromonas gingivalis fimbriae. Group: Patented cell line; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10104 150519263 CVCL_B0BS N33B2 transformed cell line human CVCL_B0BS CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428; Cell type: Epithelial cell of prostate; CL=CL_0002231. Omics: Transcriptomics; Microarray; Omics: Variations; SNP array analysis Male 150519264 CVCL_B0BV HAC-HPV16-E6/E7 transformed cell line human CVCL_B0BV CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transfection; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) (Note=p16HHMo); Derived from site: In situ; Articular cartilage; UBERON=UBERON_0010996; Cell type: Chondrocyte; CL=CL_0000138. Male 150519265 CVCL_B0C7 TDIII,IIIBB2 hybridoma house mouse CVCL_B0C7 CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Treponema denticola (strain ATCC 33520). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9967 150519266 CVCL_B0BU NE6-E6E7/hTERT transformed cell line human CVCL_B0BU CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Esophagus; UBERON=UBERON_0001043. Male 150519267 CVCL_B0C6 TDII,IAA11 hybridoma house mouse CVCL_B0C6 CL:0000010 Monoclonal antibody isotype: IgG3, kappa; Monoclonal antibody target: Treponema denticola (strain ATCC 33520). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9966 150519268 CVCL_B0C9 HUPEC 003 FSGS G0/G0 conditionally immortalized cell line human CVCL_B0C9 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Population: African American; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Urine; UBERON=UBERON_0001088; Cell type: Podocyte-like epithelial cell; CL=CL_0000653. Male 150519269 CVCL_B0BX RCJ 3.1C5 spontaneously immortalized cell line Norway rat CVCL_B0BX CL:0000010 Derived from site: In situ; Embryonic bone, calvaria; UBERON=UBERON_0004339; Cell type: Chondrocyte; CL=CL_0000138. Characteristics: Differentiates to form discrete cartilage nodules Nodule formation is regulated by Dex and vitamin D3 metabolites in a dose- and time-dependent manner (PubMed=2551636). 150519270 CVCL_B0C8 HUPEC 001 G0/G0 conditionally immortalized cell line human CVCL_B0C8 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Population: Asian; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Urine; UBERON=UBERON_0001088; Cell type: Podocyte-like epithelial cell; CL=CL_0000653. Male 150519271 CVCL_B0BW RCJ 3.1 spontaneously immortalized cell line Norway rat CVCL_B0BW CL:0000010 Derived from site: In situ; Embryonic bone, calvaria; UBERON=UBERON_0004339. Characteristics: Differentiates into myotubes, adipocytes, chondrocytes and osteoblasts in the presence of the glucocorticosteroid dexamethasone (Dex) (PubMed=3384856) 150519272 CVCL_B0DL 451C3 hybridoma house mouse CVCL_B0DL CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10810; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10081 150519273 CVCL_B0DK 451B7 hybridoma house mouse CVCL_B0DK CL:0000010 Miscellaneous: This hybridoma was lost in a liquid nitrogen tank thaw (PubMed=2470501). Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340 150519274 CVCL_B0DN 454A12 hybridoma house mouse CVCL_B0DN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10804; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10075 150519275 CVCL_B0DM 452E12 hybridoma house mouse CVCL_B0DM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human breast cancer 240 kDa antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10803; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10074 150519276 CVCL_B0DP 457D7 hybridoma house mouse CVCL_B0DP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human breast cancer 240 kDa antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10805; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10076 150519277 CVCL_B0E1 87H7 hybridoma house mouse CVCL_B0E1 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human breast cancer 230 kDa antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10788; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10059 150519278 CVCL_B0E0 871E3 hybridoma house mouse CVCL_B0E0 CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human high molecular weight mucin. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10813; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10084 150519279 CVCL_B0DR 736G9 hybridoma house mouse CVCL_B0DR CL:0000010 Miscellaneous: This hybridoma was lost in a liquid nitrogen tank thaw (PubMed=2470501). Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340 150519280 CVCL_B0E3 PC3-EMT14 cancer cell line human CVCL_B0E3 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase Population: Caucasian; Derived from site: Metastatic; Bone; UBERON=UBERON_0002481. Omics: Transcriptomics; Microarray Male Characteristics: Transfected with a pLentilox-EV-Luc luciferase expression vector 150519281 CVCL_B0DQ 697B3 hybridoma house mouse CVCL_B0DQ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10806; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10077 150519282 CVCL_B0E2 9C6 hybridoma house mouse CVCL_B0E2 CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human breast/ovarian cancer 70 kDa antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10785; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10056 150519283 CVCL_B0DD 35E10 hybridoma house mouse CVCL_B0DD CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human breast cancer 80 kDa antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10796; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10067 150519284 CVCL_B0DC 32A1 hybridoma house mouse CVCL_B0DC CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human breast cancer antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10795; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10066 150519285 CVCL_B0DF 388D4 hybridoma house mouse CVCL_B0DF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human breast/ovarian cancer antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10794; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10065 150519286 CVCL_B0DE 387H9 hybridoma house mouse CVCL_B0DE CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human breast cancer 40 kDa antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10802; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10073 150519287 CVCL_B0DH 421E8 hybridoma house mouse CVCL_B0DH CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human breast/ovarian cancer antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10793; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10064 150519288 CVCL_B0DG 41B4 hybridoma house mouse CVCL_B0DG CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human breast cancer 240 kDa antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10786; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10057 150519289 CVCL_B0DJ 44F4 hybridoma house mouse CVCL_B0DJ CL:0000010 Monoclonal antibody isotype: IgG3; Monoclonal antibody target: Human breast/ovarian cancer antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10787; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10058 150519290 CVCL_B0DI 44B2 hybridoma house mouse CVCL_B0DI CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human breast/ovarian cancer antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10797; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10068 150519291 CVCL_B0CZ KY-mBNP-I hybridoma house mouse CVCL_B0CZ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P40753; Mouse Nppb. 150519292 CVCL_B0DB 254H9 hybridoma house mouse CVCL_B0DB CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human breast cancer antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10792; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10063 150519293 CVCL_B0DA 219F3 hybridoma house mouse CVCL_B0DA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human breast/ovarian cancer antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10801; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10072 150519294 CVCL_B0CS 106.3 hybridoma house mouse CVCL_B0CS CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P16860; Human NPPB. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12044 150519295 CVCL_B0D4 106A10 hybridoma house mouse CVCL_B0D4 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human breast/ovarian cancer 55 kDa antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10789; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10060 150519296 CVCL_B0CR 3-631-436 hybridoma house mouse CVCL_B0CR CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P16860; Human NPPB. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6476 150519297 CVCL_B0D3 SGB3B4 hybridoma house mouse CVCL_B0D3 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human 150 kDa protein 'CDX'. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10879; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10205 150519298 CVCL_B0D6 140A7 hybridoma house mouse CVCL_B0D6 CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human breast cancer antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10798; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10069 150519299 CVCL_B0CU 8.1 hybridoma house mouse CVCL_B0CU CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P16860; Human NPPB. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12050 150519300 CVCL_B0D5 120H7 hybridoma house mouse CVCL_B0D5 CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human high molecular weight mucin. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10790; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10061 150519301 CVCL_B0CT 201.3 hybridoma house mouse CVCL_B0CT CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P16860; Human NPPB. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12045 150519302 CVCL_B0D8 203E2 hybridoma house mouse CVCL_B0D8 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human high molecular weight mucin. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10799; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10070 150519303 CVCL_B0CW CHO 3-631-436 AM8 transformed cell line CVCL_B0CW CL:0000010 Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line) Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Transformant: NCIt; C44386; Gamma radiation; Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Produces the heavy and light chains of monoclonal antibody 3-631-436 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8368 150519304 CVCL_B0D7 200F9 hybridoma house mouse CVCL_B0D7 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human high molecular weight mucin. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10791; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10062 150519305 CVCL_B0CV CHO 3-631-436 AM5 transformed cell line CVCL_B0CV CL:0000010 Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line) Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Transformant: NCIt; C44386; Gamma radiation; Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Produces the heavy and light chains of monoclonal antibody 3-631-436 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8369 150519306 CVCL_B0CY BC203 hybridoma house mouse CVCL_B0CY CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P16860; Human NPPB. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-3515 150519307 CVCL_B0D9 204F4 hybridoma house mouse CVCL_B0D9 CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human high molecular weight mucin. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10800; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10071 150519308 CVCL_B0CX CHO 106.3 AM1 transformed cell line CVCL_B0CX CL:0000010 Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line) Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Transformant: NCIt; C44386; Gamma radiation; Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Produces the heavy and light chains of monoclonal antibody 106.3 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6987 150519309 CVCL_B0AI CX16-RV7 Endo transformed cell line human CVCL_B0AI CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Uterus, cervix, endocervical epithelium; UBERON=UBERON_0012252; Cell type: Epithelial cell; CL=CL_0000066. Female 150519310 CVCL_B0AH CX16-RV7 Ecto transformed cell line human CVCL_B0AH CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Uterus, cervix, ectocervical epithelium; UBERON=UBERON_0012251; Cell type: Epithelial cell; CL=CL_0000066. Female 150519311 CVCL_B0AK CX16-RV8 Ecto transformed cell line human CVCL_B0AK CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Uterus, cervix, ectocervical epithelium; UBERON=UBERON_0012251; Cell type: Epithelial cell; CL=CL_0000066. Female 150519312 CVCL_B0AJ CX16-RV7 TZ transformed cell line human CVCL_B0AJ CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Uterus, cervix, cervical transformation zone epithelium; UBERON=UBERON_8480035; Cell type: Epithelial cell; CL=CL_0000066. Female 150519313 CVCL_B0AM CX16-RV8 TZ transformed cell line human CVCL_B0AM CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Uterus, cervix, cervical transformation zone epithelium; UBERON=UBERON_8480035; Cell type: Epithelial cell; CL=CL_0000066. Female 150519314 CVCL_B0AL CX16-RV8 Endo transformed cell line human CVCL_B0AL CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Uterus, cervix, endocervical epithelium; UBERON=UBERON_0012252; Cell type: Epithelial cell; CL=CL_0000066. Female 150519315 CVCL_B0B0 HaCaT-16E6E7 transformed cell line human CVCL_B0B0 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Male 150519316 CVCL_B0AN CX16-RV9 Ecto transformed cell line human CVCL_B0AN CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Uterus, cervix, ectocervical epithelium; UBERON=UBERON_0012251; Cell type: Epithelial cell; CL=CL_0000066. Female 150519317 CVCL_B0AA CX16-RV2 TZ transformed cell line human CVCL_B0AA CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Uterus, cervix, cervical transformation zone epithelium; UBERON=UBERON_8480035; Cell type: Epithelial cell; CL=CL_0000066. Female Doubling time: ~30-40 hours (ATCC=CRL-3460) 150519318 CVCL_B0AC CX16-RV3 Endo transformed cell line human CVCL_B0AC CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Uterus, cervix, endocervical epithelium; UBERON=UBERON_0012252; Cell type: Epithelial cell; CL=CL_0000066. Female 150519319 CVCL_B0AB CX16-RV3 Ecto transformed cell line human CVCL_B0AB CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Uterus, cervix, ectocervical epithelium; UBERON=UBERON_0012251; Cell type: Epithelial cell; CL=CL_0000066. Female 150519320 CVCL_B0AE CX16-RV5 Ecto transformed cell line human CVCL_B0AE CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Uterus, cervix, ectocervical epithelium; UBERON=UBERON_0012251; Cell type: Epithelial cell; CL=CL_0000066. Female 150519321 CVCL_B0AD CX16-RV3 TZ transformed cell line human CVCL_B0AD CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Uterus, cervix, cervical transformation zone epithelium; UBERON=UBERON_8480035; Cell type: Epithelial cell; CL=CL_0000066. Female 150519322 CVCL_B0AG CX16-RV5 TZ transformed cell line human CVCL_B0AG CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Uterus, cervix, cervical transformation zone epithelium; UBERON=UBERON_8480035; Cell type: Epithelial cell; CL=CL_0000066. Female 150519323 CVCL_B0AF CX16-RV5 Endo transformed cell line human CVCL_B0AF CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Uterus, cervix, endocervical epithelium; UBERON=UBERON_0012252; Cell type: Epithelial cell; CL=CL_0000066. Female 150519324 CVCL_B0A9 CX16-RV2 Endo transformed cell line human CVCL_B0A9 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Uterus, cervix, endocervical epithelium; UBERON=UBERON_0012252; Cell type: Epithelial cell; CL=CL_0000066. Female Doubling time: ~30-40 hours (ATCC=CRL-3459) 150519325 CVCL_B0A8 CX16-RV2 Ecto transformed cell line human CVCL_B0A8 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Uterus, cervix, ectocervical epithelium; UBERON=UBERON_0012251; Cell type: Epithelial cell; CL=CL_0000066. Female Doubling time: ~30-40 hours (ATCC=CRL-3458) 150519326 CVCL_B0A1 SGC7901/OXA cancer cell line human CVCL_B0A1 CL:0000010 Population: African American; Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP); Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Problematic cell line: Contaminated Parent cell line (SGC-7901) has been shown to be a HeLa derivative. 150519327 CVCL_B0A0 MDA-MB-231br/eGFP cancer cell line human CVCL_B0A0 CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female Characteristics: Metastatic to brain Established after injection of the parent cell line in the left ventricle of the heart of female nude mice and retrieving the brain metastatic cells and repeating this procedure 6 times. Group: Triple negative breast cancer (TNBC) cell line 150519329 CVCL_B0A2 EO771.lmb cancer cell line house mouse CVCL_B0A2 CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: C57BL/6. Female Characteristics: Metastatic to lung 150519330 CVCL_B0A5 HeLa IFITM2/3-KO cancer cell line human CVCL_B0A5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5413; IFITM2; Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5414; IFITM3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 150519331 CVCL_B0A4 HeLa IFITM1/2/3-KO cancer cell line human CVCL_B0A4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5412; IFITM1; Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5413; IFITM2; Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5414; IFITM3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Characteristics: Facilitates the functional analysis of IFITMs and as well as their mechanisms of regulation Can also be used to identify other innate immunity factors and/or screen for new anti-infective drug candidates (ATCC=CRL-3452). 150519332 CVCL_B0A7 U2OS DR-GFP cancer cell line human CVCL_B0A7 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female Characteristics: Transfected with a DR-GFP reporter construct The DR-GFP construct which contains a tandem repeat of two inactive genes coding for EGFP. After transfection with an expression vector coding for the I-SceI enzyme, recombination induced by the cleavage of the I-SceI site recreates a functional EGFP.; Characteristics: Can be used to monitor homologous recombination efficiency using the DR-GFP reporter (ATCC=CRL-3455) Doubling time: ~18 hours (ATCC=CRL-3455) 150519333 CVCL_B0A6 A549 IFITM2/3-KO cancer cell line human CVCL_B0A6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5413; IFITM2; Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5414; IFITM3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male Characteristics: Has also reduced expression of IFITM1 150519334 CVCL_B0BJ HNPSV-5 transformed cell line human CVCL_B0BJ CL:0000010 Population: Japanese; Transformant: Ad12-SV40 hybrid virus; Derived from site: In situ; Intervertebral disc, nucleus pulposus; UBERON=UBERON_0002242. Female 150519335 CVCL_B0BI HNPSV-1 transformed cell line human CVCL_B0BI CL:0000010 Population: Japanese; Transformant: Ad12-SV40 hybrid virus; Derived from site: In situ; Intervertebral disc, nucleus pulposus; UBERON=UBERON_0002242. Male Senescence: Transformed but with a finite life span Senesces at 60-100 PDL (PubMed=15247572). 150519336 CVCL_B0BL D4-NP135 transformed cell line human CVCL_B0BL CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Intervertebral disc, nucleus pulposus; UBERON=UBERON_0002242. Female 150519337 CVCL_B0BK D4-NP124 transformed cell line human CVCL_B0BK CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Intervertebral disc, nucleus pulposus; UBERON=UBERON_0002242. Female 150519338 CVCL_B0BN D5-NP108 transformed cell line human CVCL_B0BN CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Intervertebral disc, nucleus pulposus; UBERON=UBERON_0002242. Male 150519339 CVCL_B0BM D4-NP143 transformed cell line human CVCL_B0BM CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Intervertebral disc, nucleus pulposus; UBERON=UBERON_0002242. Female 150519340 CVCL_B0C1 BBG-12 hybridoma house mouse CVCL_B0C1 CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: Porphyromonas gingivalis. Group: Patented cell line; Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10102 150519341 CVCL_B0BP D5-NP113 transformed cell line human CVCL_B0BP CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Intervertebral disc, nucleus pulposus; UBERON=UBERON_0002242. Male 150519342 CVCL_B0C0 BgII,VF9/2d hybridoma house mouse CVCL_B0C0 CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: Porphyromonas gingivalis (strain ATCC 33277 / DSM 20709 / CIP 103683 / JCM 12257 / NCTC 11834 / 2561). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9968 150519343 CVCL_B0BB HaCaT-pLVX spontaneously immortalized cell line human CVCL_B0BB CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Male Characteristics: Control cell line for a series of HaCaT HPV E5, E6 and E7 transfected cell lines 150519344 CVCL_B0BA HaCaT-84E7 spontaneously immortalized cell line human CVCL_B0BA CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; Q99FX2; Human papillomavirus type 84 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Male 150519345 CVCL_B0BD RK13-UL37 spontaneously immortalized cell line CVCL_B0BD CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; Q911W0; Suid herpesvirus 1 (strain Kaplan) tegument protein UL37 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518. Unspecified Characteristics: Expression of UL37 is under the control of the CMV promoter (PubMed=15731276) 150519346 CVCL_B0BC RK13-UL51 spontaneously immortalized cell line CVCL_B0BC CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; Q85227; Suid herpesvirus 1 (strain Kaplan) tegument protein UL51 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518. Unspecified Characteristics: Expression of UL51 is under the control of the CMV promoter (PubMed=15731276) 150519347 CVCL_B0BF 339.15.3.6 hybridoma house mouse CVCL_B0BF CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q16552; Human IL17A; Monoclonal antibody target: UniProtKB; Q96PD4; Human IL17F. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7987 150519348 CVCL_B0BE RK13-UL11 spontaneously immortalized cell line CVCL_B0BE CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; Q85040; Suid herpesvirus 1 (strain Kaplan) cytoplasmic envelopment protein 3 (UL11) Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518. Unspecified Characteristics: Expression of UL11 is under the control of the CMV promoter (PubMed=15731276) 150519349 CVCL_B0BH Hu5 finite cell line human CVCL_B0BH CL:0000010 Derived from site: In situ; Abdomen, skeletal muscle; UBERON=UBERON_0002378. Female Caution: Indicated as originating from a 44 year old female donor PubMed=12050145 and from a 42 year old in PubMed=16919240 150519350 CVCL_B0BG 339.15.5.3 hybridoma house mouse CVCL_B0BG CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q16552; Human IL17A; Monoclonal antibody target: UniProtKB; Q96PD4; Human IL17F. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7987 150519351 CVCL_B0AY HaCaT-16E5 spontaneously immortalized cell line human CVCL_B0AY CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P06927; Human papillomavirus type 16 protein E5; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Male 150519352 CVCL_B0AX 184E6E7 transformed cell line human CVCL_B0AX CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367. Female 150519353 CVCL_B0B9 HaCaT-84E6 spontaneously immortalized cell line human CVCL_B0B9 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; Q99FX3; Human papillomavirus type 84 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Male 150519354 CVCL_B0AZ HaCaT-16E6 spontaneously immortalized cell line human CVCL_B0AZ CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Male 150519355 CVCL_B0AQ CX16-RV9 TZ transformed cell line human CVCL_B0AQ CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Uterus, cervix, cervical transformation zone epithelium; UBERON=UBERON_8480035; Cell type: Epithelial cell; CL=CL_0000066. Female 150519356 CVCL_B0B2 HaCaT-18E5 spontaneously immortalized cell line human CVCL_B0B2 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P06792; Human papillomavirus type 18 protein E5; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Male 150519357 CVCL_B0AP CX16-RV9 Endo transformed cell line human CVCL_B0AP CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Uterus, cervix, endocervical epithelium; UBERON=UBERON_0012252; Cell type: Epithelial cell; CL=CL_0000066. Female 150519358 CVCL_B0B1 HaCaT-16E7 spontaneously immortalized cell line human CVCL_B0B1 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Male 150519359 CVCL_B0AS CX16-8 Endo transformed cell line human CVCL_B0AS CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Uterus, cervix, endocervical epithelium; UBERON=UBERON_0012252; Cell type: Epithelial cell; CL=CL_0000066. Female Characteristics: Transfected with the plasmid pMHPV16d, which contains two copies of the complete HPV16 genome in a head-to-tail configuration (PubMed=29944714) 150519360 CVCL_B0B4 HaCaT-18E7 spontaneously immortalized cell line human CVCL_B0B4 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P06788; Human papillomavirus type 18 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Male 150519361 CVCL_B0AR CX16-8 Ecto transformed cell line human CVCL_B0AR CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Uterus, cervix, ectocervical epithelium; UBERON=UBERON_0012251; Cell type: Epithelial cell; CL=CL_0000066. Female Characteristics: Transfected with the plasmid pMHPV16d, which contains two copies of the complete HPV16 genome in a head-to-tail configuration (PubMed=29944714) 150519362 CVCL_B0B3 HaCaT-18E6 spontaneously immortalized cell line human CVCL_B0B3 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P06463; Human papillomavirus type 18 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Male 150519363 CVCL_B0AU CX16-9 Ecto transformed cell line human CVCL_B0AU CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Uterus, cervix, ectocervical epithelium; UBERON=UBERON_0012251; Cell type: Epithelial cell; CL=CL_0000066. Female Characteristics: Transfected with the plasmid pMHPV16d, which contains two copies of the complete HPV16 genome in a head-to-tail configuration (PubMed=29944714) 150519364 CVCL_B0B6 HaCaT-62E6 spontaneously immortalized cell line human CVCL_B0B6 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; Q676V2; Human papillomavirus type 62 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Male 150519365 CVCL_B0AT CX16-8 TZ transformed cell line human CVCL_B0AT CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Uterus, cervix, cervical transformation zone epithelium; UBERON=UBERON_8480035; Cell type: Epithelial cell; CL=CL_0000066. Female Characteristics: Transfected with the plasmid pMHPV16d, which contains two copies of the complete HPV16 genome in a head-to-tail configuration (PubMed=29944714) 150519366 CVCL_B0B5 HaCaT-62E5 spontaneously immortalized cell line human CVCL_B0B5 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transduction; Gene=Human papillomavirus type 62 protein E5 Population: Caucasian; Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Male 150519367 CVCL_B0AW CX16-9 TZ transformed cell line human CVCL_B0AW CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Uterus, cervix, cervical transformation zone epithelium; UBERON=UBERON_8480035; Cell type: Epithelial cell; CL=CL_0000066. Female Characteristics: Transfected with the plasmid pMHPV16d, which contains two copies of the complete HPV16 genome in a head-to-tail configuration (PubMed=29944714) 150519368 CVCL_B0B8 HaCaT-84E5 spontaneously immortalized cell line human CVCL_B0B8 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transduction; Gene=Human papillomavirus type 84 protein E5 Population: Caucasian; Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Male 150519369 CVCL_B0AV CX16-9 Endo transformed cell line human CVCL_B0AV CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Uterus, cervix, endocervical epithelium; UBERON=UBERON_0012252; Cell type: Epithelial cell; CL=CL_0000066. Female Characteristics: Transfected with the plasmid pMHPV16d, which contains two copies of the complete HPV16 genome in a head-to-tail configuration (PubMed=29944714) 150519370 CVCL_B0B7 HaCaT-62E7 spontaneously immortalized cell line human CVCL_B0B7 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; Q676V1; Human papillomavirus type 62 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Male 150519371 CVCL_B0P8 BCHSCTi001-A induced pluripotent stem cell human CVCL_B0P8 From: Department of Hematopoietic Stem Cell Transplatation, Beijing Children's Hospital; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3546; F8; Simple; p.Arg391Cys (c.1171C>T); ClinVar=VCV000010125; Zygosity=Hemizygous (PubMed=34496342) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519372 CVCL_B0P7 174-24-11 hybridoma house mouse CVCL_B0P7 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q99062; Human CSF3R. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12700 150519373 CVCL_B0P9 UKWMPi007-A induced pluripotent stem cell human CVCL_B0P9 From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:11007; SLC2A3; Zygosity=Heterozygous (PubMed=34492570) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519374 CVCL_B0P0 A8G3.5 hybridoma house mouse CVCL_B0P0 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P13385; Human TDGF1. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3317 150519375 CVCL_B0P2 B3F6.17 hybridoma house mouse CVCL_B0P2 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P13385; Human TDGF1. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3319 150519376 CVCL_B0P1 A8H3.1 hybridoma house mouse CVCL_B0P1 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P13385; Human TDGF1. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3315 150519377 CVCL_B0P4 AHM-1 cancer cell line human CVCL_B0P4 CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Plasma cell; CL=CL_0000786. Male Characteristics: Produces IgA lambda Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8220 150519378 CVCL_B0P3 B6G7.10 hybridoma house mouse CVCL_B0P3 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P13385; Human TDGF1. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3313 150519379 CVCL_B0P6 163-93 hybridoma house mouse CVCL_B0P6 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q99062; Human CSF3R. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12699 150519380 CVCL_B0P5 AHM-3D3 cancer cell line human CVCL_B0P5 CL:0000010 Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG); Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Plasma cell; CL=CL_0000786. Male Group: Hybridoma fusion partner cell line; Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8221 150519381 CVCL_B0PX 1-10 [Mouse hybridoma against ouabain] hybridoma house mouse CVCL_B0PX CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_472805; Ouabain. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-812 150519382 CVCL_B0Q9 LCL-PI 17 transformed cell line human CVCL_B0Q9 CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519383 CVCL_B0PW A23-A/D3 hybridoma house mouse CVCL_B0PW CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P02769; Bovine ALB. Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0004 150519384 CVCL_B0Q8 LCL-PI 16 transformed cell line human CVCL_B0Q8 CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519385 CVCL_B0PZ 7-1 [Mouse hybridoma against ouabain] hybridoma house mouse CVCL_B0PZ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_472805; Ouabain. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-814 150519386 CVCL_B0PY 5A12 [Mouse hybridoma against ouabain] hybridoma house mouse CVCL_B0PY CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_472805; Ouabain. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-813 150519387 CVCL_B0Q1 Dig 26-10 hybridoma house mouse CVCL_B0Q1 CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin. 150519388 CVCL_B0PP SCMCi004-A induced pluripotent stem cell human CVCL_B0PP From: Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine; Shanghai; China CL:0000010 Population: Chinese; Karyotypic information: 45,XY,19,add(21)(p13) (PubMed=34298433); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 150519389 CVCL_B0Q0 8E4 [Mouse hybridoma against ouabain] hybridoma house mouse CVCL_B0Q0 CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI_472805; Ouabain. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-815 150519390 CVCL_B0Q3 Dig 24-2F8 hybridoma house mouse CVCL_B0Q3 CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin. 150519391 CVCL_B0PR HMSCATi001-A induced pluripotent stem cell human CVCL_B0PR From: Stem Cell Application and Translation Laboratory, Hebei Medical University; Shijiazhuang; China CL:0000010 Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519392 CVCL_B0Q2 Dig 26-20 hybridoma house mouse CVCL_B0Q2 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin. 150519393 CVCL_B0PQ GLNNFi001-A induced pluripotent stem cell human CVCL_B0PQ From: GROW Laboratory; Bangalore; India CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6938; CHST6; Simple; p.Val172Leu; Zygosity=Homozygous (PubMed=35472829) Population: Indian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519394 CVCL_B0Q5 Dig 35-20 hybridoma house mouse CVCL_B0Q5 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8113 150519395 CVCL_B0PT HMSCATi003-A induced pluripotent stem cell human CVCL_B0PT From: Stem Cell Application and Translation Laboratory, Hebei Medical University; Shijiazhuang; China CL:0000010 Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519396 CVCL_B0Q4 Dig 25-54 hybridoma house mouse CVCL_B0Q4 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin. 150519397 CVCL_B0PS HMSCATi002-A induced pluripotent stem cell human CVCL_B0PS From: Stem Cell Application and Translation Laboratory, Hebei Medical University; Shijiazhuang; China CL:0000010 Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519398 CVCL_B0PV KM-10 hybridoma house mouse CVCL_B0PV CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P02769; Bovine ALB. Group: Patented cell line 150519399 CVCL_B0Q7 LCL-PI 15 transformed cell line human CVCL_B0Q7 CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519400 CVCL_B0Q6 Dig 40-50 hybridoma house mouse CVCL_B0Q6 CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI_4551; Digoxin. 150519401 CVCL_B0PU KSCBi015-A induced pluripotent stem cell human CVCL_B0PU From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg190Gln (c.569G>A) (p.Arg63Gln, c.188G>A); ClinVar=VCV000003117; Zygosity=Heterozygous (PubMed=34509919) Population: Korean; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519402 CVCL_B0PH KITi001-C-41 induced pluripotent stem cell human CVCL_B0PH From: Korea Institute of Toxicology; Daejeon; South Korea CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Asian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Using CRISPR/Cas9 a EGFP-polyA-PGKp-neo construct was introduced at the C-terminus of one allele of ACTA2 (PubMed=34481189) 150519403 CVCL_B0PG UKWMPi012-B induced pluripotent stem cell human CVCL_B0PG From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany CL:0000010 Sequence variation: Gene amplification; HGNC; HGNC:11007; SLC2A3; Duplication; Zygosity=Heterozygous (PubMed=34492570) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519404 CVCL_B0PJ SCVIi017-A induced pluripotent stem cell human CVCL_B0PJ From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11947; TNNI3; Simple; p.Arg145Trp (c.433C>T); ClinVar=VCV000012426; Zygosity=Heterozygous (PubMed=34798544) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519405 CVCL_B0PI TMOi001-A-3 induced pluripotent stem cell human CVCL_B0PI From: National Institutes of Health; Bethesda; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple_edited; p.Ala111Leufs*7 (c.331delG); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34419745) Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female 150519406 CVCL_B0PL SCVIi019-A induced pluripotent stem cell human CVCL_B0PL From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11947; TNNI3; Simple; p.Arg79Cys (c.235C>T); ClinVar=VCV000043367; Zygosity=Heterozygous (PubMed=34798544) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519407 CVCL_B0PK SCVIi018-A induced pluripotent stem cell human CVCL_B0PK From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11947; TNNI3; Simple; p.Arg204Cys (c.610C>T); ClinVar=VCV000177631; Zygosity=Heterozygous (PubMed=34798544) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519408 CVCL_B0PN SCMCi003-A induced pluripotent stem cell human CVCL_B0PN From: Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine; Shanghai; China CL:0000010 Population: Chinese; Karyotypic information: 52,XY,t(9,22)(q34:q11.2),+11,14,17,21,22,Y (PubMed=34298433); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 150519409 CVCL_B0PM SCMCi002-A induced pluripotent stem cell human CVCL_B0PM From: Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine; Shanghai; China CL:0000010 Population: Chinese; Karyotypic information: 47,XX,del(5)(q22q25),del(7)(q22),del(12)(p11.2),+13 (PubMed=34298433); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Female 150519410 CVCL_B0PB UKWMPi008-A induced pluripotent stem cell human CVCL_B0PB From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:11007; SLC2A3; Zygosity=Heterozygous (PubMed=34492570) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519411 CVCL_B0PA UKWMPi007-B induced pluripotent stem cell human CVCL_B0PA From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:11007; SLC2A3; Zygosity=Heterozygous (PubMed=34492570) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519412 CVCL_B0PD UKWMPi011-A induced pluripotent stem cell human CVCL_B0PD From: Department of Neurology, University of Wurzburg; Wurzburg; Germany CL:0000010 Sequence variation: Gene amplification; HGNC; HGNC:11007; SLC2A3; Duplication; Zygosity=Heterozygous (PubMed=34492570) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519413 CVCL_B0PC UKWMPi008-B induced pluripotent stem cell human CVCL_B0PC From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:11007; SLC2A3; Zygosity=Heterozygous (PubMed=34492570) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519414 CVCL_B0PF UKWMPi012-A induced pluripotent stem cell human CVCL_B0PF From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany CL:0000010 Sequence variation: Gene amplification; HGNC; HGNC:11007; SLC2A3; Duplication; Zygosity=Heterozygous (PubMed=34492570) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519415 CVCL_B0PE UKWMPi011-B induced pluripotent stem cell human CVCL_B0PE From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany CL:0000010 Sequence variation: Gene amplification; HGNC; HGNC:11007; SLC2A3; Duplication; Zygosity=Heterozygous (PubMed=34492570) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519416 CVCL_B0MU H-CB-P1 hybridoma CVCL_B0MU CL:0000010 Monoclonal antibody isotype: IgM, lambda. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2104; Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0517 150519417 CVCL_B0N6 W8B2 hybridoma house mouse CVCL_B0N6 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P05186; Human ALPL. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2567 150519418 CVCL_B0N5 39D5 hybridoma house mouse CVCL_B0N5 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P13591; Human NCAM1/CD56. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2930 150519419 CVCL_B0MT B40-DE8 hybridoma house mouse CVCL_B0MT CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P01222; Human TSHB. Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0436 150519420 CVCL_B0MW H-CB-P3 hybridoma CVCL_B0MW CL:0000010 Monoclonal antibody isotype: IgM, kappa. Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0519 150519421 CVCL_B0N8 HEK293T PRKN KO transformed cell line human CVCL_B0N8 From: Durcan, Thomas M.; Montreal Neurological Institute, McGill University; Montreal; Canada CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8607; PRKN; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Miscellaneous: Cell line information from personal communication of Laflamme, Carl Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 150519422 CVCL_B0MV H-CB-P2 hybridoma CVCL_B0MV CL:0000010 Monoclonal antibody isotype: IgM, lambda. Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0518 150519423 CVCL_B0N7 MDCK-15D3 spontaneously immortalized cell line dog CVCL_B0N7 CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017155 150519424 CVCL_B0MY CB 63 hybridoma CVCL_B0MY CL:0000010 Monoclonal antibody isotype: IgM. Doubling time: 14 hours (PubMed=3343518) 150519425 CVCL_B0MX CB 15 hybridoma CVCL_B0MX CL:0000010 Monoclonal antibody isotype: IgM. Doubling time: 16 hours (PubMed=3343518) 150519426 CVCL_B0N9 Abcam SH-SY5Y PRKN KO cancer cell line human CVCL_B0N9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8607; PRKN; Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Female 150519427 CVCL_B0MZ CB 84 hybridoma CVCL_B0MZ CL:0000010 Monoclonal antibody isotype: IgG. Doubling time: 26 hours (PubMed=3343518) 150519428 CVCL_B0MM B25-AD5 hybridoma house mouse CVCL_B0MM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P01222; Human TSHB. Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0430 150519429 CVCL_B0ML B25-AB1 hybridoma house mouse CVCL_B0ML CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P01222; Human TSHB. Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0429 150519430 CVCL_B0N0 CB 86 hybridoma CVCL_B0N0 CL:0000010 Monoclonal antibody isotype: IgM. Doubling time: 24 hours (PubMed=3343518) 150519431 CVCL_B0MN B25-BB1 hybridoma house mouse CVCL_B0MN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P01222; Human TSHB. Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0431 150519432 CVCL_B0MQ B25-CF11 hybridoma house mouse CVCL_B0MQ CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P01222; Human TSHB. Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0433 150519433 CVCL_B0N2 CB 79 hybridoma CVCL_B0N2 CL:0000010 Monoclonal antibody isotype: IgG. Doubling time: 28 hours (PubMed=3343518) 150519434 CVCL_B0MP B25-BI8 hybridoma house mouse CVCL_B0MP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P01222; Human TSHB. Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0432 150519435 CVCL_B0N1 CB 87 hybridoma CVCL_B0N1 CL:0000010 Monoclonal antibody isotype: IgM. Doubling time: 36 hours (PubMed=3343518) 150519436 CVCL_B0MS B40-AE6 hybridoma house mouse CVCL_B0MS CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P01222; Human TSHB. Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0435 150519437 CVCL_B0N4 W7C5 hybridoma house mouse CVCL_B0N4 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q6YHK3; Human CD109. 150519438 CVCL_B0MR B40-AA3 hybridoma house mouse CVCL_B0MR CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P01222; Human TSHB. Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0434 150519439 CVCL_B0N3 PBG04 hybridoma CVCL_B0N3 CL:0000010 Monoclonal antibody isotype: IgM, lambda. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2577 150519440 CVCL_B0ME B9-AB9 hybridoma house mouse CVCL_B0ME CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P01215; Human CGA; Monoclonal antibody target: UniProtKB; P0DN86; Human CGB (Note=Also binds FSHB, LHB and TSHB). 150519441 CVCL_B0MD B27-AC9 hybridoma house mouse CVCL_B0MD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P01215; Human CGA; Monoclonal antibody target: UniProtKB; P0DN86; Human CGB (Note=Also recognizes LHB). 150519442 CVCL_B0MG B9-AA4 hybridoma house mouse CVCL_B0MG CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P01215; Human CGA; Monoclonal antibody target: UniProtKB; P0DN86; Human CGB (Note=Also recognizes LHB). 150519443 CVCL_B0MF B9-BG4 hybridoma house mouse CVCL_B0MF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P01215; Human CGA; Monoclonal antibody target: UniProtKB; P0DN86; Human CGB (Note=Also recognizes LHB). 150519444 CVCL_B0MI B32-BD11 hybridoma house mouse CVCL_B0MI CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P0DN86; Human CGB. 150519445 CVCL_B0MH B9-AA1 hybridoma house mouse CVCL_B0MH CL:0000010 Monoclonal antibody isotype: Not determined; Monoclonal antibody target: UniProtKB; P01215; Human CGA; Monoclonal antibody target: UniProtKB; P0DN86; Human CGB (Note=Also binds FSHB, LHB and TSHB). 150519446 CVCL_B0MK B32-BG4 hybridoma house mouse CVCL_B0MK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P0DN86; Human CGB. 150519447 CVCL_B0MJ B32-BF2 hybridoma house mouse CVCL_B0MJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P0DN86; Human CGB. 150519448 CVCL_B0MA B27-FG11 hybridoma house mouse CVCL_B0MA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P01215; Human CGA; Monoclonal antibody target: UniProtKB; P0DN86; Human CGB (Note=Also recognizes LHB). 150519449 CVCL_B0MC B20-CA2 hybridoma house mouse CVCL_B0MC CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P01215; Human CGA; Monoclonal antibody target: UniProtKB; P01229; Human LHB (Note=Also recognizes CGB). 150519450 CVCL_B0MB B32-BC11 hybridoma house mouse CVCL_B0MB CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P01215; Human CGA; Monoclonal antibody target: UniProtKB; P0DN86; Human CGB (Note=Also recognizes LHB). 150519451 CVCL_B0NV A17G12.1 hybridoma house mouse CVCL_B0NV CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P13385; Human TDGF1. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3314 150519452 CVCL_B0NU A10B2.18 hybridoma house mouse CVCL_B0NU CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P13385; Human TDGF1. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3311 150519453 CVCL_B0NX A27F6.1 hybridoma house mouse CVCL_B0NX CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P13385; Human TDGF1. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3310 150519454 CVCL_B0NW A18B3.11 hybridoma house mouse CVCL_B0NW CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P13385; Human TDGF1. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3312 150519455 CVCL_B0NZ A6F8.6 hybridoma house mouse CVCL_B0NZ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P13385; Human TDGF1. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3318 150519456 CVCL_B0NY A40G12.8 hybridoma house mouse CVCL_B0NY CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P13385; Human TDGF1. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3316 150519457 CVCL_B0NN G45-89 hybridoma house mouse CVCL_B0NN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120). 150519458 CVCL_B0NM G45-70 hybridoma house mouse CVCL_B0NM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120). 150519459 CVCL_B0NP 99-12-1 hybridoma house mouse CVCL_B0NP CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q07021; Human C1QBP. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11863 150519460 CVCL_B0NR 9C2C1A9 hybridoma house mouse CVCL_B0NR CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11862 150519461 CVCL_B0NQ 11G5G1B11 hybridoma house mouse CVCL_B0NQ CL:0000010 Monoclonal antibody isotype: IgG1+IgG2b; Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11861 150519462 CVCL_B0NT 169B hybridoma house mouse CVCL_B0NT CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q13349; Human ITGAD. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11906 150519463 CVCL_B0NS 169A [Mouse hybridoma against human ITGAD] hybridoma house mouse CVCL_B0NS CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q13349; Human ITGAD. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11907 150519464 CVCL_B0NF G3-42 hybridoma house mouse CVCL_B0NF CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04578; HIV-1 (isolate HXB2) env (Note=AA 33-511 = gp120 Also reacts with diverse HIV-1 isolates).. 150519465 CVCL_B0NE G3-299 hybridoma house mouse CVCL_B0NE CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04578; HIV-1 (isolate HXB2) env (Note=AA 33-511 = gp120 Also reacts with diverse HIV-1 isolates).. 150519466 CVCL_B0NH G3-519 hybridoma house mouse CVCL_B0NH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04578; HIV-1 (isolate HXB2) env (Note=AA 33-511 = gp120 Also reacts with diverse HIV-1 isolates).. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10747 150519467 CVCL_B0NG G3-508 hybridoma house mouse CVCL_B0NG CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04578; HIV-1 (isolate HXB2) env (Note=AA 33-511 = gp120 Also reacts with diverse HIV-1 isolates).. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10748 150519468 CVCL_B0NJ G3-537 hybridoma house mouse CVCL_B0NJ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04578; HIV-1 (isolate HXB2) env (Note=AA 33-511 = gp120 Also reacts with diverse HIV-1 isolates).. 150519469 CVCL_B0NI G3-536 hybridoma house mouse CVCL_B0NI CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04578; HIV-1 (isolate HXB2) env (Note=AA 33-511 = gp120 Also reacts with diverse HIV-1 isolates).. 150519470 CVCL_B0NL G45-60 hybridoma house mouse CVCL_B0NL CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10749 150519471 CVCL_B0NK G45-16 hybridoma house mouse CVCL_B0NK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120). 150519472 CVCL_B0NB 293.STAT1 BAX KO transformed cell line human CVCL_B0NB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:959; BAX; Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11362; STAT1 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Exhibits significantly increased adeno-associated virus (AAV) production capacity for gene therapy applications (ATCC=CRL-1573-VHG) 150519473 CVCL_B0NA PK-15/A11 spontaneously immortalized cell line pig CVCL_B0NA CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: Hampshire; VBO=VBO_0001146. Male Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 54 150519474 CVCL_B0ND G3-211 hybridoma house mouse CVCL_B0ND CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04578; HIV-1 (isolate HXB2) env (Note=AA 33-511 = gp120 Also reacts with diverse HIV-1 isolates).. 150519475 CVCL_B0NC 166-32 hybridoma house mouse CVCL_B0NC CL:0000010 Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized Fab antigen binding domain of the therapeutic antibody lampalizumab (FCFD4514S; RG7417) which was developed as a potential treatment of geographic atrophy (atrophy of the retinal cells, retinal pigment epithelium, and choriocapillaris) secondary to age-related macular degeneration Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P00746; Human CFD. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12476 150519476 CVCL_B0L4 7.159.2 hybridoma house mouse CVCL_B0L4 CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Biotechnology: The monoclonal antibody produced by this hybridoma is tested as a potential therapeutic antibody with antineoplastic activity under the name dusigitumab Monoclonal antibody isotype: IgG2, lambda; Monoclonal antibody target: UniProtKB; P05019; Human IGF1; Monoclonal antibody target: UniProtKB; P01344; Human IGF2 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7424 150519477 CVCL_B0KS WT.5 hybridoma CVCL_B0KS CL:0000010 Monoclonal antibody isotype: IgA; Monoclonal antibody target: UniProtKB; G3V8L7; Rat Itgam/Cd11b. 150519478 CVCL_B0L3 9E6 hybridoma house mouse CVCL_B0L3 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Cryptococcus neoformans var neoformans non-capsular antigen.. 150519479 CVCL_B0KR HESC-1 transformed cell line human CVCL_B0KR CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Ear, inner ear, endolymphatic sac; UBERON=UBERON_0002223; Cell type: Epithelial cell; CL=CL_0000066. Group: Patented cell line 150519480 CVCL_B0KU 3G12.7 hybridoma house mouse CVCL_B0KU CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_6887; Methylphenidate (Ritalin). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202069 150519481 CVCL_B0L6 7.234.2 hybridoma house mouse CVCL_B0L6 CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P01344; Human IGF2 (Note=Also recognizes IGF1) 150519482 CVCL_B0KT 2D11 hybridoma house mouse CVCL_B0KT CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P40424; Human PBX1. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201912 150519483 CVCL_B0L5 7.160.2 hybridoma house mouse CVCL_B0L5 CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P01344; Human IGF2 (Note=Also recognizes IGF1) 150519484 CVCL_B0KW 3G12 [Mouse hybridoma against PCV2 Cap] hybridoma house mouse CVCL_B0KW CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; V5N005; Porcine circovirus 2 (PCV2) isolate Nanjing caspid protein (Cap). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014198 150519485 CVCL_B0L8 7.34.1 hybridoma house mouse CVCL_B0L8 CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P01344; Human IGF2 (Note=Also recognizes IGF1) Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7423 150519486 CVCL_B0KV 2F8 [Mouse hybridoma against PCV2 Cap] hybridoma house mouse CVCL_B0KV CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; V5N005; Porcine circovirus 2 (PCV2) isolate Nanjing caspid protein (Cap). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014199 150519487 CVCL_B0L7 7.251.3 hybridoma house mouse CVCL_B0L7 CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P01344; Human IGF2 (Note=Also recognizes IGF1) Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7422 150519488 CVCL_B0KY 34893 2L transformed cell line human CVCL_B0KY CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1402; CACNB2; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13806; Rabbit CACNA2D1 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12108 150519489 CVCL_B0KX 3H11 [Mouse hybridoma against PCV2 Cap] hybridoma house mouse CVCL_B0KX CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; V5N005; Porcine circovirus 2 (PCV2) isolate Nanjing caspid protein (Cap). 150519490 CVCL_B0L9 8H9 [Mouse hybridoma against human CD276] hybridoma house mouse CVCL_B0L9 CL:0000010 Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized omburtamab potential therapeutic antibody against neuroblastoma Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10926 150519491 CVCL_B0KK CA4AF5 hybridoma house mouse CVCL_B0KK CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q5ZXP3; Legionella pneumophila subsp pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513) groEL (Note=Also reacts with many other Legionella species).. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10439 150519492 CVCL_B0KJ CE/F16 hybridoma house mouse CVCL_B0KJ CL:0000010 Monoclonal antibody isotype: IgG3, kappa; Monoclonal antibody target: UniProtKB; P01574; Human IFNB1 Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8048 Caution: This hybridoma along with 5 other described in PubMed=6205971 seem to have been described in two US patent applications that seem to have been rejected by the USPTO (see the two web links). 150519493 CVCL_B0KM GB5BE8 hybridoma house mouse CVCL_B0KM CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q5ZXP3; Legionella pneumophila subsp pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513) groEL (Note=Also reacts with many other Legionella species).. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10459 150519494 CVCL_B0KL GB5AF6 hybridoma house mouse CVCL_B0KL CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q5ZXP3; Legionella pneumophila subsp pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513) groEL (Note=Also reacts with many other Legionella species).. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10453 150519495 CVCL_B0L0 4E2 [Mouse hybridoma against C.neoformans non-capsular antigen] hybridoma house mouse CVCL_B0L0 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Cryptococcus neoformans var neoformans non-capsular antigen.. 150519496 CVCL_B0KN F4/CB5/K18 hybridoma house mouse CVCL_B0KN CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Legionella pneumophila subsp pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513).. 150519497 CVCL_B0L2 7C7 hybridoma house mouse CVCL_B0L2 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Cryptococcus neoformans var neoformans non-capsular antigen.. 150519498 CVCL_B0KQ F4/JD3.8/K101 hybridoma house mouse CVCL_B0KQ CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Legionella pneumophila subsp pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513).. 150519499 CVCL_B0L1 5D9 [Mouse hybridoma against C.neoformans non-capsular antigen] hybridoma house mouse CVCL_B0L1 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Cryptococcus neoformans var neoformans non-capsular antigen.. 150519500 CVCL_B0KP F4/CB5/K104 hybridoma house mouse CVCL_B0KP CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Legionella pneumophila subsp pneumophila (strain Philadelphia 1 / ATCC 33152 / DSM 7513).. 150519501 CVCL_B0KC 4D8 [Mouse hybridoma against human FOLH1] hybridoma house mouse CVCL_B0KC CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12487 150519502 CVCL_B0KB 4D4 [Mouse hybridoma against human FOLH1] hybridoma house mouse CVCL_B0KB CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12493 150519503 CVCL_B0KE CE/F11 hybridoma house mouse CVCL_B0KE CL:0000010 Monoclonal antibody isotype: IgG3, kappa; Monoclonal antibody target: UniProtKB; P01574; Human IFNB1 Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8043 Caution: This hybridoma along with 5 other described in PubMed=6205971 seem to have been described in two US patent applications that seem to have been rejected by the USPTO (see the two web links). 150519504 CVCL_B0KD 4E10-1.14 hybridoma house mouse CVCL_B0KD CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12310 150519505 CVCL_B0KG CE/F13 hybridoma house mouse CVCL_B0KG CL:0000010 Monoclonal antibody isotype: IgG3, kappa; Monoclonal antibody target: UniProtKB; P01574; Human IFNB1 Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8045 Caution: This hybridoma along with 5 other described in PubMed=6205971 seem to have been described in two US patent applications that seem to have been rejected by the USPTO (see the two web links). 150519506 CVCL_B0KF CE/F12 hybridoma house mouse CVCL_B0KF CL:0000010 Monoclonal antibody isotype: IgG3, kappa; Monoclonal antibody target: UniProtKB; P01574; Human IFNB1 Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8044 Caution: This hybridoma along with 5 other described in PubMed=6205971 seem to have been described in two US patent applications that seem to have been rejected by the USPTO (see the two web links). 150519507 CVCL_B0KI CE/F15 hybridoma house mouse CVCL_B0KI CL:0000010 Monoclonal antibody isotype: IgG3, kappa; Monoclonal antibody target: UniProtKB; P01574; Human IFNB1 Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8047 Caution: This hybridoma along with 5 other described in PubMed=6205971 seem to have been described in two US patent applications that seem to have been rejected by the USPTO (see the two web links). 150519508 CVCL_B0KH CE/F14 hybridoma house mouse CVCL_B0KH CL:0000010 Monoclonal antibody isotype: IgG3, kappa; Monoclonal antibody target: UniProtKB; P01574; Human IFNB1 Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8046 Caution: This hybridoma along with 5 other described in PubMed=6205971 seem to have been described in two US patent applications that seem to have been rejected by the USPTO (see the two web links). 150519509 CVCL_B0JZ 1G3 [Mouse hybridoma against human FOLH1] hybridoma house mouse CVCL_B0JZ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12489 150519510 CVCL_B0JY hMBL1.2 hybridoma house mouse CVCL_B0JY CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P11226; Human MBL2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12619 150519511 CVCL_B0KA 4C8B9 hybridoma house mouse CVCL_B0KA CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12492 150519512 CVCL_B0LT 24B11 hybridoma house mouse CVCL_B0LT CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P02879; Ricinus communis ricin (Note=AA 315-576 = B chain). 150519513 CVCL_B0M5 B24-BF10 hybridoma house mouse CVCL_B0M5 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P01215; Human CGA; Monoclonal antibody target: UniProtKB; P0DN86; Human CGB. 150519514 CVCL_B0LS 23D7 hybridoma house mouse CVCL_B0LS CL:0000010 Monoclonal antibody isotype: IgA; Monoclonal antibody target: UniProtKB; P02879; Ricinus communis ricin (Note=AA 36-302 = A chain). 150519515 CVCL_B0M4 H-BL-IgG/1 hybridoma house mouse CVCL_B0M4 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human IgG. Group: Patented cell line 150519516 CVCL_B0LV 33G2 hybridoma house mouse CVCL_B0LV CL:0000010 Monoclonal antibody isotype: IgA; Monoclonal antibody target: UniProtKB; P02879; Ricinus communis ricin (Note=AA 315-576 = B chain). 150519517 CVCL_B0M7 B27-BH2 hybridoma house mouse CVCL_B0M7 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P01215; Human CGA; Monoclonal antibody target: UniProtKB; P0DN86; Human CGB. 150519518 CVCL_B0LU 25A4 hybridoma house mouse CVCL_B0LU CL:0000010 Monoclonal antibody isotype: IgA; Monoclonal antibody target: UniProtKB; P02879; Ricinus communis ricin (Note=AA 36-302 = A chain). 150519519 CVCL_B0M6 B9-BA8 hybridoma house mouse CVCL_B0M6 CL:0000010 Monoclonal antibody isotype: IgA; Monoclonal antibody target: UniProtKB; P01215; Human CGA; Monoclonal antibody target: UniProtKB; P0DN86; Human CGB. 150519520 CVCL_B0LX 29/24 B11 hybridoma house mouse CVCL_B0LX CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P14174; Human MIF. Group: Patented cell line 150519521 CVCL_B0M9 B27-AD10 hybridoma house mouse CVCL_B0M9 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P01215; Human CGA; Monoclonal antibody target: UniProtKB; P0DN86; Human CGB (Note=Also recognizes LHB). 150519522 CVCL_B0LW 35H6 hybridoma house mouse CVCL_B0LW CL:0000010 Monoclonal antibody isotype: IgA; Monoclonal antibody target: UniProtKB; P02879; Ricinus communis ricin (Note=AA 315-576 = B chain). 150519523 CVCL_B0M8 B27-CE8 hybridoma house mouse CVCL_B0M8 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P01215; Human CGA; Monoclonal antibody target: UniProtKB; P0DN86; Human CGB (Note=Also recognizes LHB). 150519524 CVCL_B0LZ H-BL-IgE/1 hybridoma house mouse CVCL_B0LZ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human IgE. Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Karl-Marx-Universitat Leipzig, Zentralen Institut fur Molekularbiologie; DDR-0052 150519525 CVCL_B0LY H-BL-Ig kappa hybridoma house mouse CVCL_B0LY CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human Ig kappa light chains. Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Zentralinstitut fur Molekularbiologie; ZIM-0049 150519526 CVCL_B0LL 103B2 hybridoma house mouse CVCL_B0LL CL:0000010 Monoclonal antibody isotype: IgG3; Monoclonal antibody target: UniProtKB; Q04900; Human CD164. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2221 150519527 CVCL_B0LK RPDS-2M4 hybridoma house mouse CVCL_B0LK CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9Y4K0; Human LOXL2. Group: Patented cell line; Registration: International Depositary Authority, IDA of Canada (IDAC); 260310-03 150519528 CVCL_B0LN 40B8 hybridoma house mouse CVCL_B0LN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q6YHK3; Human CD109. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2279 150519529 CVCL_B0LM 105A5 hybridoma house mouse CVCL_B0LM CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; Q04900; Human CD164. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2222 150519530 CVCL_B0LP 12A07-A10 transformed cell line CVCL_B0LP CL:0000010 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B); Derived from site: In situ; Extraembryonic membrane; UBERON=UBERON_0005631. Unspecified Group: Bird cell line; Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2695 150519531 CVCL_B0M1 H-BL-IgE/3 hybridoma house mouse CVCL_B0M1 CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: Human IgE. Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Karl-Marx-Universitat Leipzig, Zentralen Institut fur Molekularbiologie; DDR-0094 150519532 CVCL_B0M0 H-BL-IgE/2 hybridoma house mouse CVCL_B0M0 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: Human IgE. Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Karl-Marx-Universitat Leipzig, Zentralen Institut fur Molekularbiologie; DDR-0053 150519533 CVCL_B0M3 H-BL-IgM/1 hybridoma house mouse CVCL_B0M3 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: Human IgM. Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Karl-Marx-Universitat Leipzig, Zentralen Institut fur Molekularbiologie; DDR-0056 150519534 CVCL_B0LR UNIVAX 70 hybridoma house mouse CVCL_B0LR CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P02879; Ricinus communis ricin (Note=AA 36-302 = A chain). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12054 150519535 CVCL_B0LQ AGE1.CS.pIX transformed cell line CVCL_B0LQ From: ProBioGen AG; Berlin; Germany CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P03281; Human adenovirus C serotype 5 pIX Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B); Derived from site: In situ; Somite; UBERON=UBERON_0002329; Breed/subspecies: ST4 compact; VBO=VBO_0017525. Unspecified Group: Bird cell line 150519536 CVCL_B0M2 H-BL-IgE/4 hybridoma house mouse CVCL_B0M2 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human IgE. Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Karl-Marx-Universitat Leipzig, Zentralen Institut fur Molekularbiologie; DDR-0095 150519537 CVCL_B0LD R604 hybrid cell line Norway rat CVCL_B0LD CL:0000010 Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine. Characteristics: Produces the chimeric monoclonal antibody EMAB604 against human LDLR Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-3692 150519538 CVCL_B0LC 4H2 [Mouse hybridoma against marinobufagenin] hybridoma house mouse CVCL_B0LC CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_146151; Marinobufagenin (MBG). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6788 150519539 CVCL_B0LF RPDS-1M19 hybridoma house mouse CVCL_B0LF CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9Y4K0; Human LOXL2. Group: Patented cell line; Registration: International Depositary Authority, IDA of Canada (IDAC); 050210-02 150519540 CVCL_B0LE RPDS-1M20 hybridoma house mouse CVCL_B0LE CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9Y4K0; Human LOXL2. Group: Patented cell line; Registration: International Depositary Authority, IDA of Canada (IDAC); 050210-04 150519541 CVCL_B0LH RPDS-1M27 hybridoma house mouse CVCL_B0LH CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9Y4K0; Human LOXL2. Group: Patented cell line; Registration: International Depositary Authority, IDA of Canada (IDAC); 050210-01 150519542 CVCL_B0LG RPDS-1M21 hybridoma house mouse CVCL_B0LG CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9Y4K0; Human LOXL2. Group: Patented cell line; Registration: International Depositary Authority, IDA of Canada (IDAC); 050210-03 150519543 CVCL_B0LJ RPDS-2M2 hybridoma house mouse CVCL_B0LJ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9Y4K0; Human LOXL2. Group: Patented cell line; Registration: International Depositary Authority, IDA of Canada (IDAC); 260310-02 150519544 CVCL_B0LI RPDS-1M31 hybridoma house mouse CVCL_B0LI CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9Y4K0; Human LOXL2. Group: Patented cell line; Registration: International Depositary Authority, IDA of Canada (IDAC); 260310-01 150519545 CVCL_B0KZ 192C transformed cell line human CVCL_B0KZ CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1392; CACNA1E; Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1402; CACNB2; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13806; Rabbit CACNA2D1 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 150519546 CVCL_B0LB 4G4 [Mouse hybridoma against marinobufagenin] hybridoma house mouse CVCL_B0LB CL:0000010 Discontinued: ATCC; PTA-6725; true. Monoclonal antibody isotype: IgG1; Monoclonal antibody target: ChEBI; CHEBI_146151; Marinobufagenin (MBG) Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6725 150519547 CVCL_B0LA 3E9 [Mouse hybridoma against marinobufagenin] hybridoma house mouse CVCL_B0LA CL:0000010 Discontinued: ATCC; PTA-6724; true. Monoclonal antibody isotype: IgG1; Monoclonal antibody target: ChEBI; CHEBI_146151; Marinobufagenin (MBG) Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6724 150519548 CVCL_B0J2 F97/8-11H2C hybridoma house mouse CVCL_B0J2 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P00734; Human F2 (Note=Recognizes AA 307-314 in activation peptide). 150519549 CVCL_B0IQ GM28092 finite cell line human CVCL_B0IQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Ser282Cysfs*9 (c.841_842CT[2]) (c.845_846delCT); ClinVar=VCV000012770; Zygosity=Heterozygous (Coriell=GM28092) Population: Caucasian; Polish; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150519550 CVCL_B0J1 F98/5-10H.7G hybridoma house mouse CVCL_B0J1 CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P00734; Human F2 (Note=Recognizes AA 307-314 in activation peptide). 150519551 CVCL_B0IP GM28091 finite cell line human CVCL_B0IP CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Ser282Cysfs*9 (c.841_842CT[2]) (c.845_846delCT); ClinVar=VCV000012770; Zygosity=Heterozygous (Coriell=GM28091) Population: Caucasian; Polish; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150519552 CVCL_B0IS AG24459 transformed cell line human CVCL_B0IS CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Part of: 90+ study cell line collection 150519553 CVCL_B0J4 F97/6-9A2C hybridoma house mouse CVCL_B0J4 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P00734; Human F2 (Note=Recognizes AA 307-314 in activation peptide). 150519554 CVCL_B0J3 F97/9-1A.6B hybridoma house mouse CVCL_B0J3 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P00734; Human F2 (Note=Recognizes AA 307-314 in activation peptide). 150519555 CVCL_B0IR GM28095 finite cell line human CVCL_B0IR CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Tyr133Asp (c.397T>G); Zygosity=Heterozygous (Coriell=GM28095); Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Arg192Profs*8 (c.574_575insCTGC); ClinVar=VCV000419973; Zygosity=Heterozygous (Coriell=GM28095) Population: Caucasian; Austrian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150519556 CVCL_B0J6 AC6C3-2B12 hybridoma CVCL_B0J6 CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human 32 kDa protein on the surface of many cancer cells. 150519557 CVCL_B0IU AG24457 transformed cell line human CVCL_B0IU CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Part of: 90+ study cell line collection 150519558 CVCL_B0J5 AC6C3 hybridoma CVCL_B0J5 CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human 32 kDa protein on the surface of many cancer cells. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10305 150519559 CVCL_B0IT AG24460 transformed cell line human CVCL_B0IT CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Part of: 90+ study cell line collection 150519560 CVCL_B0IW AG24444 transformed cell line human CVCL_B0IW CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Part of: 90+ study cell line collection 150519561 CVCL_B0J8 Expi293F Inducible transformed cell line human CVCL_B0J8 CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably expresses high levels of tetR When used with compatible inducible vectors the gene of interest is repressed with very low levels of basal expression until induction with tetracycline. Expression can be modulated by addition of different amounts of tetracycline (Thermo Fisher). Group: Serum/protein free medium cell line 150519562 CVCL_B0IV AG24447 transformed cell line human CVCL_B0IV CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Part of: 90+ study cell line collection 150519563 CVCL_B0J7 Expi293F GnTI- transformed cell line human CVCL_B0J7 CL:0000010 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Lacks N-acetylglucosaminyltransferase I activity and accordingly predominantly modifies glycoproteins with the Man5GlcNAc2 N-glycan Group: Serum/protein free medium cell line 150519564 CVCL_B0II GM28053 finite cell line human CVCL_B0II CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Ser282Cysfs*9 (c.841_842CT[2]) (c.845_846delCT); ClinVar=VCV000012770; Zygosity=Heterozygous (Coriell=GM28053) Population: Caucasian; Russian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150519565 CVCL_B0IH GM28257 finite cell line human CVCL_B0IH CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Glu13Ter (c.37G>T); ClinVar=VCV000001716; Zygosity=Heterozygous (Coriell=GM28257); Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; c.173+1G>A; ClinVar=VCV000554440; Zygosity=Heterozygous; Note=Splice donor mutation (Coriell=GM28257) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150519566 CVCL_B0IK GM28077 finite cell line human CVCL_B0IK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Tyr133Asp (c.397T>G); Zygosity=Heterozygous (Coriell=GM28077) Population: Caucasian; Austrian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150519567 CVCL_B0IJ GM28054 finite cell line human CVCL_B0IJ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Gly195Asp (c.584G>A); ClinVar=VCV002413125; Zygosity=Heterozygous (Coriell=GM28054); Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Ser282Cysfs*9 (c.841_842CT[2]) (c.845_846delCT); ClinVar=VCV000012770; Zygosity=Heterozygous (Coriell=GM28054) Population: Caucasian; Russian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150519568 CVCL_B0IM GM28079 finite cell line human CVCL_B0IM CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Arg192Profs*8 (c.574_575insCTGC); ClinVar=VCV000419973; Zygosity=Heterozygous (Coriell=GM28079) Population: Caucasian; Austrian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150519569 CVCL_B0IL GM28102 finite cell line human CVCL_B0IL CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11042; SLC6A1; Simple; p.Asp52Asn (c.154G>A); ClinVar=VCV001804228; Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28102) Population: Caucasian; Norwegian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150519570 CVCL_B0J0 F98/2-7C.6B hybridoma house mouse CVCL_B0J0 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P00734; Human F2 (Note=Recognizes AA 307-314 in activation peptide). 150519571 CVCL_B0IN GM28090 finite cell line human CVCL_B0IN CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Ser282Cysfs*9 (c.841_842CT[2]) (c.845_846delCT); ClinVar=VCV000012770; Zygosity=Homozygous (Coriell=GM28090) Population: Caucasian; Polish; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150519572 CVCL_B0IA GM28206 transformed cell line human CVCL_B0IA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:30032; PACS1; Simple; p.Arg203Trp (c.607C>T); ClinVar=VCV000039581; Zygosity=Heterozygous (Coriell=GM28206) Population: Bangladeshi; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519573 CVCL_B0IC GM28213 finite cell line human CVCL_B0IC CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Unexplicit; Ex10-11del; Zygosity=Mosaic (Coriell=GM28213) Population: Caucasian; Romanian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150519574 CVCL_B0IB GM28210 finite cell line human CVCL_B0IB CL:0000010 Sequence variation: Mutation; HGNC; HGNC:30032; PACS1; Simple; p.Arg203Trp (c.607C>T); ClinVar=VCV000039581; Zygosity=Heterozygous (Coriell=GM28210) Population: Bangladeshi; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150519575 CVCL_B0IE GM28234 finite cell line human CVCL_B0IE CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2212; COL6A2; Simple; p.Arg468Ter (c.1402C>T); ClinVar=VCV000565700; Zygosity=Homozygous (Coriell=GM28234); Sequence variation: Mutation; HGNC; HGNC:2213; COL6A3; Simple; p.Arg625Thr (c.1874G>C); ClinVar=VCV000964423; Zygosity=Heterozygous (Coriell=GM28234) Population: Jewish; Syrian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150519576 CVCL_B0ID GM28214 finite cell line human CVCL_B0ID CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg75Ter (c.223C>T); ClinVar=VCV000048672; Zygosity=Heterozygous (Coriell=GM28214) Population: Indian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150519577 CVCL_B0IG GM28252 induced pluripotent stem cell human CVCL_B0IG CL:0000010 Sequence variation: Gene amplification; HGNC; HGNC:9118; PMP22; Duplication; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7225; MPZ; Simple; c.448+64T>C (IVS3+64T>C); ClinVar=VCV000683189; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 150519578 CVCL_B0IF GM28249 induced pluripotent stem cell human CVCL_B0IF CL:0000010 Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Gly176Asp (c.527C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:756; ASPA; Simple; p.Ala305Glu (c.914C>A); ClinVar=VCV000002607; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Arg249Trp (c.745C>T); ClinVar=VCV000126510; Zygosity=Homozygous (from parent cell line) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150519579 CVCL_B0HX F89/160.1.5 hybridoma house mouse CVCL_B0HX CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P10279; Bovine PRNP (Note=Also reacts with sheep, mule deer, elk and many other species; recognizes the epitope 'Ile-His-Phe-Gly'). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12403 150519580 CVCL_B0I9 GM28211 finite cell line human CVCL_B0I9 CL:0000010 Population: Bangladeshi; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 150519581 CVCL_B0HW F99/97.6.1 hybridoma house mouse CVCL_B0HW CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P10279; Bovine PRNP (Note=Also reacts with sheep, mule deer, elk and many other species; recognizes the epitope 'Gln-Tyr-Gln-Arg-Glu-Ser'). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12696 150519582 CVCL_B0I8 GM28208 transformed cell line human CVCL_B0I8 CL:0000010 Population: Bangladeshi; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519583 CVCL_B0HZ 28F11 hybridoma house mouse CVCL_B0HZ CL:0000010 Characteristics: Produces a catalytic monoclonal antibody capable of cleaving a Gly-Phe bond when in presence of a metal ion cofactor (PubMed=2922606); Monoclonal antibody isotype: Not specified. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9971 150519584 CVCL_B0HY F89/193.1.5 hybridoma house mouse CVCL_B0HY CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P10279; Bovine PRNP (Note=Also reacts with sheep, mule deer and elk). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-114 150519585 CVCL_B0K3 3C4 [Mouse hybridoma against human FOLH1] hybridoma house mouse CVCL_B0K3 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12494 150519586 CVCL_B0JR WAe009-A-71 embryonic stem cell human CVCL_B0JR From: Sun Yat-sen University; Guangzhou; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11190; SOX10 (Note=1 of 2 alleles) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 150519587 CVCL_B0K2 3C2 [Mouse hybridoma against human FOLH1] hybridoma house mouse CVCL_B0K2 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA. 150519588 CVCL_B0JQ SHIPMi002-A induced pluripotent stem cell human CVCL_B0JQ From: Shanghai Institute of Precision Medicine, Shanghai Jiao Tong University School of Medicine; Shanghai; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519589 CVCL_B0K5 3C9 [Mouse hybridoma against human FOLH1] hybridoma house mouse CVCL_B0K5 CL:0000010 Monoclonal antibody isotype: IgG1 (Patent=US6150508); IgG2b (PubMed=9817391); Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12484 150519590 CVCL_B0JT H1975/OR [China Dongguan] cancer cell line human CVCL_B0JT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_90943; Osimertinib (AZD9291); Derived from site: In situ; Lung; UBERON=UBERON_0002048. Female 150519591 CVCL_B0K4 3C6 [Mouse hybridoma against human FOLH1] hybridoma house mouse CVCL_B0K4 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12491 150519592 CVCL_B0JS H1975/OR [China Guangzhou] cancer cell line human CVCL_B0JS CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_90943; Osimertinib (AZD9291); Derived from site: In situ; Lung; UBERON=UBERON_0002048. Female Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2019300 150519593 CVCL_B0K7 3E11 [Mouse hybridoma against human FOLH1] hybridoma house mouse CVCL_B0K7 CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12488 150519594 CVCL_B0JV 3F8 [Mouse hybridoma against human MBL2] hybridoma house mouse CVCL_B0JV CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P11226; Human MBL2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12621 150519595 CVCL_B0K6 3D7-1.1 hybridoma house mouse CVCL_B0K6 CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12309 150519596 CVCL_B0JU GS17F1C4 hybridoma house mouse CVCL_B0JU CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01032; Pig C5. 150519597 CVCL_B0JX 2A9 [Mouse hybridoma against human MBL2] hybridoma house mouse CVCL_B0JX CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P11226; Human MBL2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12620 150519598 CVCL_B0K9 3G6 [Mouse hybridoma against human FOLH1] hybridoma house mouse CVCL_B0K9 CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12485 150519599 CVCL_B0JW 1C10 [Mouse hybridoma against human MBL2] hybridoma house mouse CVCL_B0JW CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P11226; Human MBL2. 150519600 CVCL_B0K8 3E6 [Mouse hybridoma against human FOLH1] hybridoma house mouse CVCL_B0K8 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12486 150519601 CVCL_B0JJ CR4E8E10E10 transformed cell line human CVCL_B0JJ CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Monoclonal antibody isotype: IgM Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10304 150519602 CVCL_B0JI Ba-6 hybridoma house mouse CVCL_B0JI CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Brucella abortus (strain S99) major outer membrane 36-38 kDa protein. 150519603 CVCL_B0JL QAU-Bd-E-2 spontaneously immortalized cell line CVCL_B0JL CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Unspecified Virology: Susceptible to infection by Bactrocera dorsalis cripavirus (BdCV) Doubling time: 31.9 hours (PubMed=34435282) Group: Insect cell line 150519604 CVCL_B0JK NCI-H1975/AR cancer cell line human CVCL_B0JK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_90943; Osimertinib (AZD9291); Derived from site: In situ; Lung; UBERON=UBERON_0002048. Female Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201982 150519605 CVCL_B0JN EHTJUi005-A-3 induced pluripotent stem cell human CVCL_B0JN From: East Hospital Affiliated to Tongji University; Shanghai; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6636; LMNA Population: Chinese; Han; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female 150519606 CVCL_B0JM EHTJUi005-A-1 induced pluripotent stem cell human CVCL_B0JM From: East Hospital Affiliated to Tongji University; Shanghai; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11479; SUV39H1 Population: Chinese; Han; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female 150519607 CVCL_B0K1 2C7 [Mouse hybridoma against human FOLH1] hybridoma house mouse CVCL_B0K1 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12490 150519608 CVCL_B0JP SHIPMi001-A induced pluripotent stem cell human CVCL_B0JP From: Shanghai Institute of Precision Medicine, Shanghai Jiao Tong University School of Medicine; Shanghai; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Leu460Trpfs*6 (c.1377delC); ClinVar=VCV000188548; Zygosity=Heterozygous (PubMed=34785479) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519609 CVCL_B0K0 1G9 hybridoma house mouse CVCL_B0K0 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12495 150519610 CVCL_B0JB ID1-V-LUC hES embryonic stem cell human CVCL_B0JB CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Stem cell model for screening drugs for pulmonary hypertension and to find a novel lead compound for the treatment of pulmonary hypertension using BMP signaling; Characteristics: Transduced with a Id1-Venus-Luc-MC1-DTA construct in which expression of the genes for Venus and luciferase are under the control of a full-length human ID1 promoter Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.11091 150519611 CVCL_B0JA C2C12-BRE spontaneously immortalized cell line house mouse CVCL_B0JA CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134; Cell type: Myoblast; CL=CL_0000056; Breed/subspecies: C3H. Female Characteristics: Allows a sensitive, rapid and specific cell based assay for the simultaneous quantification of total and isoform specific BMP activity from biological samples (PubMed=19298647); Characteristics: Transfected with a construct in which the luciferase reporter gene is under the control of the BMP responsive element (BRE) of the Id1 promoter region 150519612 CVCL_B0JD Ba-1 hybridoma house mouse CVCL_B0JD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Brucella abortus (strain S99) 38-45 kDa component of smooth lipopolysaccharide (Note=Also reacts with Brucella melitensis 16M and Brucella suis). 150519613 CVCL_B0JC 4H12 [Mouse hybridoma against human MYH9] hybridoma house mouse CVCL_B0JC CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P35579; Human MYH9. 150519614 CVCL_B0JF Ba-3 hybridoma house mouse CVCL_B0JF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Brucella abortus (strain S99) 38-45 kDa component of smooth lipopolysaccharide. 150519615 CVCL_B0JE Ba-2 hybridoma house mouse CVCL_B0JE CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: Brucella abortus (strain S99) 38-45 kDa component of smooth lipopolysaccharide (Note=Also reacts with Brucella melitensis 16M and Brucella suis). 150519616 CVCL_B0JH Ba-5 hybridoma house mouse CVCL_B0JH CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Brucella abortus (strain S99) major outer membrane 25-27 kDa protein. 150519617 CVCL_B0JG Ba-4 hybridoma house mouse CVCL_B0JG CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: Brucella abortus (strain S99) major outer membrane 25-27 kDa protein. 150519618 CVCL_B0IY UMi033-A induced pluripotent stem cell human CVCL_B0IY From: Miller School of Medicine, University of Miami; Miami; USA. CL:0000010 150519619 CVCL_B0J9 Expi293F Inducible GnTI- transformed cell line human CVCL_B0J9 CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Lacks N-acetylglucosaminyltransferase I activity and accordingly predominantly modifies glycoproteins with the Man5GlcNAc2 N-glycan; Characteristics: Stably expresses high levels of tetR When used with compatible inducible vectors the gene of interest is repressed with very low levels of basal expression until induction with tetracycline. Expression can be modulated by addition of different amounts of tetracycline (Thermo Fisher). Group: Serum/protein free medium cell line 150519620 CVCL_B0IX UMi032-A induced pluripotent stem cell human CVCL_B0IX From: Miller School of Medicine, University of Miami; Miami; USA. CL:0000010 150519621 CVCL_B0IZ F98/5-3B.2C.4G hybridoma house mouse CVCL_B0IZ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P00734; Human F2 (Note=Recognizes AA 307-314 in activation peptide). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10291 150519622 CVCL_B0XB MAK16.1.39 hybridoma house mouse CVCL_B0XB CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P16860; Human NPPB. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2590 150519623 CVCL_B0XA 5F7 [Mouse/sheep hybridoma against C.botulinum botA] hybridoma CVCL_B0XA CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA). 150519624 CVCL_B0XD MAK18.4.34 hybridoma house mouse CVCL_B0XD CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P16860; Human NPPB. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2592 150519625 CVCL_B0XC MAK17.3.1 hybridoma house mouse CVCL_B0XC CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P16860; Human NPPB. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2591 150519626 CVCL_B0XF MAK1.21.3 hybridoma CVCL_B0XF CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P16860; Human NPPB. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2650 150519627 CVCL_B0XE MAK18.29.23 hybridoma house mouse CVCL_B0XE CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P16860; Human NPPB. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2593 150519628 CVCL_B0X8 4F7 [Mouse/sheep hybridoma against C.botulinum botA] hybridoma CVCL_B0X8 CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA). 150519629 CVCL_B0WW 6B2-2 hybridoma house mouse CVCL_B0WW CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-969 150519630 CVCL_B0X7 2G11 [Mouse hybridoma against C.botulinum botA] hybridoma CVCL_B0X7 CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA). 150519631 CVCL_B0WV 4A2-4 hybridoma house mouse CVCL_B0WV CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA). 150519632 CVCL_B0WY 6E10-10 hybridoma house mouse CVCL_B0WY CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA). 150519633 CVCL_B0X9 5E2 hybridoma CVCL_B0X9 CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA). 150519634 CVCL_B0WX 6C2-4 hybridoma house mouse CVCL_B0WX CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-970 150519635 CVCL_B0WZ 6E10-4 hybridoma house mouse CVCL_B0WZ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA). 150519636 CVCL_B0X0 6E10-5 hybridoma house mouse CVCL_B0X0 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA). 150519637 CVCL_B0WN HC11.208.1 hybridoma house mouse CVCL_B0WN CL:0000010 Monoclonal antibody isotype: IgG1. 150519638 CVCL_B0X2 6E9-1 hybridoma house mouse CVCL_B0X2 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA). 150519639 CVCL_B0WQ B1.1 hybridoma house mouse CVCL_B0WQ CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: UniProtKB; P01210; Human PENK (Note=AA 100-104 = Met-enkephalin). 150519640 CVCL_B0X1 6E10-8 hybridoma house mouse CVCL_B0X1 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA). 150519641 CVCL_B0WP A1.1 hybridoma house mouse CVCL_B0WP CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P01210; Human PENK (Note=AA 100-104 = Met-enkephalin). 150519642 CVCL_B0X4 6E9-4 hybridoma house mouse CVCL_B0X4 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA). 150519643 CVCL_B0WS B3.1 hybridoma house mouse CVCL_B0WS CL:0000010 Monoclonal antibody isotype: IgG3, lambda; Monoclonal antibody target: UniProtKB; P01210; Human PENK (Note=AA 100-104 = Met-enkephalin). 150519644 CVCL_B0X3 6E9-3 hybridoma house mouse CVCL_B0X3 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA). 150519645 CVCL_B0WR B2.1 hybridoma house mouse CVCL_B0WR CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01210; Human PENK (Note=AA 100-104 = Met-enkephalin). 150519646 CVCL_B0X6 16F9 hybridoma CVCL_B0X6 CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA). 150519647 CVCL_B0WU 4A2-2 hybridoma house mouse CVCL_B0WU CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-971 150519648 CVCL_B0WT 1C10 [Mouse/sheep heteromyeloma] hybrid cell line CVCL_B0WT From: Bioventix, Ltd; Farnham; United Kingdom CL:0000010 Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine. Group: Hybridoma fusion partner cell line 150519649 CVCL_B0X5 1G4 [Mouse hybridoma against C.botulinum botA] hybridoma CVCL_B0X5 CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: UniProtKB; P0DPI0; Clostridium botulinum botulinum neurotoxin type A (botA). 150519650 CVCL_B0WG BCIRL-Sf4FB-0614-SGS spontaneously immortalized cell line CVCL_B0WG CL:0000010 Derived from site: In situ; Fat body; UBERON=UBERON_0003917. Unspecified Group: Insect cell line 150519651 CVCL_B0WF BCIRL-SfNS-0518B-YL spontaneously immortalized cell line CVCL_B0WF CL:0000010 Derived from site: In situ; Nervous system; UBERON=UBERON_0001016. Unspecified Group: Insect cell line 150519652 CVCL_B0WI BCIRL-AtuNE-1129-SGS spontaneously immortalized cell line CVCL_B0WI CL:0000010 Unspecified Group: Insect cell line. 150519653 CVCL_B0WH BCIRL-AtuE-1127-SGS spontaneously immortalized cell line CVCL_B0WH CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Unspecified Group: Insect cell line 150519654 CVCL_B0WK 3B7 [Mouse hybridoma against FIV p24] hybridoma house mouse CVCL_B0WK CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P16087; Feline immunodeficiency virus (isolate Petaluma) (FIV) gag (Note=AA 136-357 = p24). 150519655 CVCL_B0WJ 1C11 [Mouse hybridoma against FIV p24] hybridoma house mouse CVCL_B0WJ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P16087; Feline immunodeficiency virus (isolate Petaluma) (FIV) gag (Note=AA 136-357 = p24). 150519656 CVCL_B0WM HC11.151.1 hybridoma house mouse CVCL_B0WM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P61769; Human B2M. 150519657 CVCL_B0WL HC11.13.1 hybridoma house mouse CVCL_B0WL CL:0000010 Monoclonal antibody isotype: IgG1. 150519658 CVCL_B0XP 5C1 hybridoma house mouse CVCL_B0XP CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P13686; Human ACP5. 150519659 CVCL_B0XR 293T/ACE2 [Japan 2021] transformed cell line human CVCL_B0XR CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13557; ACE2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Virology: Highly susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33686154) Group: SARS-CoV-2 research cell line 150519660 CVCL_B0XQ LXVI-5A5-C7 hybridoma house mouse CVCL_B0XQ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Leishmania mexicana venezuelensis. 150519661 CVCL_B0XS MRC5/ACE2 finite cell line human CVCL_B0XS CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597; Cell type: Fibroblast of lung; CL=CL_0002553. Male Virology: Highly susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33686154) Group: SARS-CoV-2 research cell line 150519662 CVCL_B0XH Trk27 hybridoma house mouse CVCL_B0XH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P13686; Human ACP5. 150519663 CVCL_B0XG MAK10.4.63 hybridoma house mouse CVCL_B0XG CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P16860; Human NPPB. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2654 150519664 CVCL_B0XJ Trk62 hybridoma house mouse CVCL_B0XJ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P13686; Human ACP5. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-7890 150519665 CVCL_B0XI Trk49 hybridoma house mouse CVCL_B0XI CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P13686; Human ACP5. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-8249 150519666 CVCL_B0XL 1F1 [Mouse hybridoma against human ACP5] hybridoma house mouse CVCL_B0XL CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P13686; Human ACP5. 150519667 CVCL_B0XK Trk73 hybridoma house mouse CVCL_B0XK CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; P13686; Human ACP5. 150519668 CVCL_B0XN 4E6 hybridoma house mouse CVCL_B0XN CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: UniProtKB; P13686; Human ACP5. 150519669 CVCL_B0XM 2H1 [Mouse hybridoma against human ACP5] hybridoma house mouse CVCL_B0XM CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P13686; Human ACP5. 150519670 CVCL_B0VB CEM231.6.7 hybridoma house mouse CVCL_B0VB CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P06731; Human CEACAM5/CEA/CD66e. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9620 150519671 CVCL_B0VA CHB235 hybridoma house mouse CVCL_B0VA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_42433; 4-[N'-(2-hydroxyethyl)thioureido]-L-benzyl EDTA. Group: Patented cell line 150519672 CVCL_B0VD 263A17 hybridoma house mouse CVCL_B0VD CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q99795; Human GPA33 150519673 CVCL_B0VC ECH037.2 hybridoma house mouse CVCL_B0VC CL:0000010 Characteristics: Tetradoma obtained by the biological fusion of two hybridomas; Monoclonal antibody target: ChEBI; CHEBI_42433; 4-[N'-(2-hydroxyethyl)thioureido]-L-benzyl EDTA (Note=The antibody binds to the chelated In+++ metal ion); Monoclonal antibody target: UniProtKB; P06731; Human CEACAM5/CEA/CD66e. 150519674 CVCL_B0UU AX-EA1-G1 hybridoma house mouse CVCL_B0UU CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P94217; Bacillus anthracis S-layer protein EA1 (eag). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2632 150519675 CVCL_B0V6 ICR-2A2 spontaneously immortalized cell line CVCL_B0V6 CL:0000010 Karyotypic information: Diploid. Unspecified Group: Amphibian cell line 150519676 CVCL_B0UT 12.5 hybridoma house mouse CVCL_B0UT CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: UniProtKB; Q16206; Human ENOX2. 150519677 CVCL_B0V5 ICR-2A1 spontaneously immortalized cell line CVCL_B0V5 CL:0000010 Unspecified Group: Amphibian cell line; Group: Haploid karyotype cell line. 150519678 CVCL_B0UW 1hFT.1.6D4.1C8 hybridoma house mouse CVCL_B0UW CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Human Mullerian duct-derived epithelial cell antigen PIPA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4220 150519679 CVCL_B0V8 2A81G5 hybridoma house mouse CVCL_B0V8 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_42433; 4-[N'-(2-hydroxyethyl)thioureido]-L-benzyl EDTA (Note=The antibody binds to the chelated Cd++ metal ion). 150519680 CVCL_B0UV 23a-14G9 hybridoma house mouse CVCL_B0UV CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Bacillus anthracis spore specific antigen. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6004 150519681 CVCL_B0V7 ICR B9 spontaneously immortalized cell line CVCL_B0V7 CL:0000010 Karyotypic information: Diploid; Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR); Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Unspecified Group: Amphibian cell line 150519682 CVCL_B0UY 306D326.26 hybridoma house mouse CVCL_B0UY CL:0000010 Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized sonepcizumab (LT1009; Asonex) therapeutic antibody candidate for treatment of patients with cancer or ocular diseases Discontinued: ATCC; SD-5362; true. Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_37550; Sphingosine 1-phosphate (S1P) 150519683 CVCL_B0V9 CHA255 hybridoma house mouse CVCL_B0V9 CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: ChEBI; CHEBI_42433; 4-[N'-(2-hydroxyethyl)thioureido]-L-benzyl EDTA (Note=The antibody binds to the chelated In+++ metal ion). Group: Patented cell line 150519684 CVCL_B0UX mPA7 hybridoma house mouse CVCL_B0UX CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P15529; Human CD46. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3706 150519685 CVCL_B0UZ CHO LH1 275 transformed cell line CVCL_B0UZ CL:0000010 Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Transfected with plasmid pATH1009 encoding the Ig heavy and light chains of humanized version (LT1009) of mAB (LT1002) produced by hybridoma 306D326.26 (Cellosaurus=CVCL_B0UY) Group: Patented cell line; Group: Serum/protein free medium cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8422 150519686 CVCL_B0UM NIKS-16 transformed cell line human CVCL_B0UM CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Male 150519687 CVCL_B0UL 2D4 [Mouse hybridoma against HPV18 E7] hybridoma house mouse CVCL_B0UL CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P06788; Human papillomavirus type 18 protein E7. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201402 150519688 CVCL_B0V0 1E12b hybridoma house mouse CVCL_B0V0 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_140691; Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) (Stage-specific embryonic antigen-3; SSEA-3). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-126149 150519689 CVCL_B0UN NIKS-16deltaE7 transformed cell line human CVCL_B0UN CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) (Note=With defective E7); Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Omics: Transcriptomics; Microarray Male 150519690 CVCL_B0V2 487 finite cell line human CVCL_B0V2 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn235Ile (c.704A>T); Zygosity=Unspecified (PubMed=10446856); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile251Val (c.751A>G); ClinVar=VCV001759315; Zygosity=Unspecified (PubMed=10446856); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu258Gly (c.773A>G); ClinVar=VCV000406590; Zygosity=Unspecified (PubMed=10446856) Derived from site: In situ; Synovium; UBERON=UBERON_0007616; Cell type: Fibroblast; CL=CL_0000057. Unspecified 150519691 CVCL_B0UQ JTUi007-A induced pluripotent stem cell human CVCL_B0UQ From: Sixth People's Hospital, Shanghai Jiao Tong University; Shanghai; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2433; CSF1R; Simple; p.Ile794Thr (c.2381T>C); ClinVar=VCV000029813; Zygosity=Heterozygous (PubMed=34837774) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519692 CVCL_B0V1 339.15.6.16 hybridoma house mouse CVCL_B0V1 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q16552; Human IL17A; Monoclonal antibody target: UniProtKB; Q96PD4; Human IL17F. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7989 150519693 CVCL_B0UP NIKS-18 transformed cell line human CVCL_B0UP CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Omics: Transcriptomics; Microarray Male 150519694 CVCL_B0US 12.1 [Mouse hybridoma against human ENOX2] hybridoma house mouse CVCL_B0US CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: UniProtKB; Q16206; Human ENOX2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4206 150519695 CVCL_B0V4 491 finite cell line human CVCL_B0V4 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp207Asp (c.621T>C); Zygosity=Unspecified (PubMed=10446856); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe212Tyr (c.635T>A); Zygosity=Unspecified (PubMed=10446856); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg290Cys (c.868C>T); ClinVar=VCV000216472; Zygosity=Unspecified (PubMed=10446856) Derived from site: In situ; Synovium; UBERON=UBERON_0007616; Cell type: Fibroblast; CL=CL_0000057. Unspecified 150519696 CVCL_B0V3 488 finite cell line human CVCL_B0V3 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (PubMed=10446856); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Arg (c.833C>G); ClinVar=VCV000376644; Zygosity=Unspecified (PubMed=10446856); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu289Leu (c.867C>T); ClinVar=VCV000233110; Zygosity=Unspecified (PubMed=10446856) Derived from site: In situ; Synovium; UBERON=UBERON_0007616; Cell type: Fibroblast; CL=CL_0000057. Unspecified 150519697 CVCL_B0UR OMB-037 hybrid cell line CVCL_B0UR CL:0000010 Group: Hybridoma fusion partner cell line; Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11086. 150519698 CVCL_B0UE 3B7 [Mouse hybridoma against M.honghuensis shell valve protein] hybridoma house mouse CVCL_B0UE CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Myxobolus honghuensis shell valve protein. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2013189 150519699 CVCL_B0UD 1C7 [Mouse hybridoma against M.honghuensis polar filament] hybridoma house mouse CVCL_B0UD CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Myxobolus honghuensis 130/180 kDa polar filament protein. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2013188 150519700 CVCL_B0UG 2D12 [Mouse hybridoma against M.rotundus protein] hybridoma house mouse CVCL_B0UG CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Myxobolus rotundus 91 kDa spore/trophozoite protein. 150519701 CVCL_B0UF 1A9 [Mouse hybridoma against M.rotundus 104 kDa spore protein] hybridoma house mouse CVCL_B0UF CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Myxobolus rotundus 104 kDa spore protein. 150519702 CVCL_B0UI HepG2/TC155 cancer cell line human CVCL_B0UI CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Genetic integration: Method=Transfection; Gene=UniProtKB; P03146; Hepatitis B virus genotype D subtype ayw capsid protein; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Characteristics: Transfected with a hepatitis B virus capsid protein that contains a tetracysteine (TC) C-C-P-G-C-C insertion in position 115 The TC tag specifically reacts with a membrane-permeable biarsenical fluorescent dye (ReAsH) (PubMed=24373334). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2013191 150519703 CVCL_B0UH HepG2.A64 cancer cell line human CVCL_B0UH CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Virology: Transfected with a plasmid pTriexHBV1.1 containing 1.1 copies of hepatitis B virus (HBV) DNA (GenBank: HQ638218.1) (PubMed=28382278) Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201163 150519704 CVCL_B0UK 2F10 [Mouse hybridoma against HPV16 E6] hybridoma house mouse CVCL_B0UK CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P03126; Human papillomavirus type 16 protein E6. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201401 150519705 CVCL_B0UJ S467 hybridoma house mouse CVCL_B0UJ CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; E7BY76; Grass carp reovirus (strain GCRV-HZ08) protein NS38 (S10). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2013193 150519706 CVCL_B0WA HEK293-FT APEX1 KO clone 1C4 transformed cell line human CVCL_B0WA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:587; APEX1 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Doubling time: 20.4 hours (PubMed=34529719) 150519707 CVCL_B0WC WAe001-A-66 embryonic stem cell human CVCL_B0WC From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=Photinus pyralis Akaluciferase (Akaluc) (Note=A luciferase-derived fluorescent protein) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Using CRISPR/Cas9 a construct containing the Akaluc gene under the control of a EF1a promoter was introduced in the AAVS1 safe harbor locus 150519708 CVCL_B0WB HEK293-FT APEX1 KO clone 2A9 transformed cell line human CVCL_B0WB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:587; APEX1 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Doubling time: 19.4 hours (PubMed=34529719) 150519709 CVCL_B0WE SKOV3-TAX/CBP cancer cell line human CVCL_B0WE CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin); Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol); Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Female 150519710 CVCL_B0WD HO8910-TAX/CBP cancer cell line human CVCL_B0WD CL:0000010 Population: African American; Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin); Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol); Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Problematic cell line: Contaminated Parent cell line (HO-8910) has been shown to be a HeLa derivative. 150519711 CVCL_B0VV 24-2-3 hybridoma house mouse CVCL_B0VV CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 with pyro-Glu3; N3pE-42). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2926 150519712 CVCL_B0W7 SYSUi006-A induced pluripotent stem cell human CVCL_B0W7 From: Center for Stem Cell Biology and Tissue Engineering, Sun Yat-sen University; Guangzhou; China. CL:0000010 Male 150519713 CVCL_B0VU 17-4-3 hybridoma house mouse CVCL_B0VU CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 with pyro-Glu3; N3pE-42). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2925 150519714 CVCL_B0W6 SYSUi005-A induced pluripotent stem cell human CVCL_B0W6 From: Center for Stem Cell Biology and Tissue Engineering, Sun Yat-sen University; Guangzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11949; TNNT2; Simple; p.Pro77Ser (c.229C>T); Zygosity=Heterozygous (PubMed=34942479) Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519715 CVCL_B0VX 6-1-6 hybridoma house mouse CVCL_B0VX CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 with pyro-Glu3; N3pE-42). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2924 150519716 CVCL_B0W9 NCC-LGFMS1-C1 cancer cell line human CVCL_B0W9 CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:23720; CREB3L2 + HGNC; HGNC:4010; FUS; Name(s)=FUS-CREB3L2 (PubMed=34535876) Population: Japanese; Derived from site: In situ; Rectus abdominis muscle; UBERON=UBERON_0002382. Omics: Phenotyping; Drug screening; Omics: Variations; SNP array analysis Female Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi); Doubling time: ~149.9 hours (PubMed=34535876) Part of: NCC sarcoma cell line panel 150519717 CVCL_B0VW 5-5-6 hybridoma house mouse CVCL_B0VW CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 with pyro-Glu3; N3pE-42). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2923 150519718 CVCL_B0W8 KMUGMCi001-A induced pluripotent stem cell human CVCL_B0W8 From: Kanazawa Medical University; Uchinada; Japan CL:0000010 Sequence variation: Mutation; HGNC; HGNC:175; ACVRL1; Simple; p.Phe259Lysfs*28 (c.772+3_772+4dup); Zygosity=Heterozygous (PubMed=35279593) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519719 CVCL_B0VZ CHO/CERT 2.41 transformed cell line CVCL_B0VZ CL:0000010 Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2205; CERT1 (Note=With p.Ser132Ala); Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX); Transformant: NCIt; C129640; Cobalt-60 gamma radiation; Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Has improved secretion characteristics in comparison to non-transgenic cell lines Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2990 150519720 CVCL_B0VY CHO/CERT 2.20 transformed cell line CVCL_B0VY CL:0000010 Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2205; CERT1 (Note=With p.Ser132Ala); Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX); Transformant: NCIt; C129640; Cobalt-60 gamma radiation; Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Has improved secretion characteristics in comparison to non-transgenic cell lines Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2989 150519721 CVCL_B0VN 4B1 [Mouse hybridoma against FLV gp70] hybridoma house mouse CVCL_B0VN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; A0A6G7H0D3; Feline leukemia virus (strain Kawakami-Theilen) env (Note=AA 32-445 = gp70/SU). 150519722 CVCL_B0VM 1C12 [Mouse hybridoma against FeLV p15E] hybridoma house mouse CVCL_B0VM CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; A0A6G7H0D3; Feline leukemia virus (strain Kawakami-Theilen) env (Note=AA 446-625 = p15E/TM). 150519723 CVCL_B0VP 6B2 [Mouse hybridoma against FeLV p15E] hybridoma house mouse CVCL_B0VP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; A0A6G7H0D3; Feline leukemia virus (strain Kawakami-Theilen) env (Note=AA 446-625 = p15E/TM). 150519724 CVCL_B0W1 9D11.2E8 hybridoma house mouse CVCL_B0W1 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07333; Human CSF1R/CD115. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2920 150519725 CVCL_B0W0 10H2.2F12 hybridoma house mouse CVCL_B0W0 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07333; Human CSF1R/CD115. 150519726 CVCL_B0W3 2DE9-BC1 hybridoma house mouse CVCL_B0W3 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; K0BVN3; Human betacoronavirus 2c (isolate EMC/2012) nucleoprotein (N). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); KCTC 13003BP 150519727 CVCL_B0VR 6G3 hybridoma house mouse CVCL_B0VR CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; A0A6G7H0D3; Feline leukemia virus (strain Kawakami-Theilen) env (Note=AA 32-445 = gp70/SU). 150519728 CVCL_B0W2 2DE12-AE6 hybridoma house mouse CVCL_B0W2 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; K0BVN3; Human betacoronavirus 2c (isolate EMC/2012) nucleoprotein (N). Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); KCTC 13002BP 150519729 CVCL_B0VQ 6D4 hybridoma house mouse CVCL_B0VQ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; A0A6G7H0D3; Feline leukemia virus (strain Kawakami-Theilen) env (Note=AA 32-445 = gp70/SU). 150519730 CVCL_B0W5 506-2G10G5 hybridoma house mouse CVCL_B0W5 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; A0A0G3U597; Middle East respiratory syndrome-related coronavirus (isolate KOR/KNIH/002_05_2015) spike protein (S). 150519731 CVCL_B0VT 8F3 hybridoma house mouse CVCL_B0VT CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; A0A6G7H0D3; Feline leukemia virus (strain Kawakami-Theilen) env (Note=AA 32-445 = gp70/SU). 150519732 CVCL_B0W4 492-1G10E4E2 hybridoma house mouse CVCL_B0W4 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; A0A0G3U597; Middle East respiratory syndrome-related coronavirus (isolate KOR/KNIH/002_05_2015) spike protein (S). 150519733 CVCL_B0VS 7B3 hybridoma house mouse CVCL_B0VS CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; A0A6G7H0D3; Feline leukemia virus (strain Kawakami-Theilen) env (Note=AA 32-445 = gp70/SU). 150519734 CVCL_B0VF 125M165DAAA hybridoma house mouse CVCL_B0VF CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q99795; Human GPA33 Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10106 150519735 CVCL_B0VE 125M10AA hybridoma house mouse CVCL_B0VE CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q99795; Human GPA33 Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10107 150519736 CVCL_B0VH 125N26F6AA hybridoma house mouse CVCL_B0VH CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q99795; Human GPA33 Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10109 150519737 CVCL_B0VG 125M96ABA hybridoma house mouse CVCL_B0VG CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q99795; Human GPA33 Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10108 150519738 CVCL_B0VJ 125Q54AAAA hybridoma house mouse CVCL_B0VJ CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q99795; Human GPA33 Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10105 150519739 CVCL_B0VI 125Q47BA hybridoma house mouse CVCL_B0VI CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q99795; Human GPA33 Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10104 150519740 CVCL_B0VL 1C1 [Mouse hybridoma against FeLV gp70] hybridoma house mouse CVCL_B0VL CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; A0A6G7H0D3; Feline leukemia virus (strain Kawakami-Theilen) env (Note=AA 32-445 = gp70/SU). 150519741 CVCL_B0VK 125R5AAAA hybridoma house mouse CVCL_B0VK CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q99795; Human GPA33 Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10103 150519742 CVCL_B0SZ 3D4 [Mouse hybridoma against HBV HBsAg] hybridoma house mouse CVCL_B0SZ CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Hepatitis B virus HBsAg. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8170 150519743 CVCL_B0TB MAb 1-5-1-3 hybridoma house mouse CVCL_B0TB CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P33261; Human CYP2C19. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3969 150519744 CVCL_B0TA MAb 1-1-11-1 hybridoma house mouse CVCL_B0TA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P33261; Human CYP2C19. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3971 150519745 CVCL_B0T4 1083-17-1A hybridoma house mouse CVCL_B0T4 CL:0000010 Biotechnology: Was used to produce the monoclonal antibody Edrecolomab (Panorex) which was evaluated as a therapeutic agent against stage III colorectal carcinoma Was never approved by FDA but was used in Germany in 1995. Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326. 150519746 CVCL_B0SS DASm244-5B3C3C6 hybridoma house mouse CVCL_B0SS CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: ChEBI; CHEBI_27958; Cocaine; Monoclonal antibody target: ChEBI; CHEBI_174315; Cocaethylene. 150519747 CVCL_B0SR DASm244-5A11H10A4 hybridoma house mouse CVCL_B0SR CL:0000010 Monoclonal antibody isotype: Not determined; Monoclonal antibody target: ChEBI; CHEBI_27958; Cocaine; Monoclonal antibody target: ChEBI; CHEBI_174315; Cocaethylene. 150519748 CVCL_B0T3 SW1694 cancer cell line human CVCL_B0T3 From: Scott and White Clinic; Temple; USA. CL:0000010 Unspecified 150519749 CVCL_B0T6 48-1 transformed cell line CVCL_B0T6 CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Monoclonal antibody isotype: IgM Group: Non-human primate cell line 150519750 CVCL_B0SU DS2D3 hybridoma house mouse CVCL_B0SU CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Bacillus thuringiensis crystal proteins Cry1A to Cry1F. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015145 150519751 CVCL_B0T5 1116-56-2 hybridoma house mouse CVCL_B0T5 CL:0000010 Monoclonal antibody isotype: IgG1. 150519752 CVCL_B0ST M12353 cancer cell line CVCL_B0ST CL:0000010 Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN); Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Group: Non-human primate cell line; Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015142 150519753 CVCL_B0T8 #132 PL12 SC-D1 hybridoma house mouse CVCL_B0T8 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P47712; Human PLA2G4A. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10563 150519754 CVCL_B0SW 5B8 hybridoma house mouse CVCL_B0SW CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P13945; Human ADRB3. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2016202 150519755 CVCL_B0SV 4G7 [Mouse hybridoma against human ADRB3] hybridoma house mouse CVCL_B0SV CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P13945; Human ADRB3. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015147 150519756 CVCL_B0T7 KC-88 hybridoma house mouse CVCL_B0T7 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: HTLV-1, HTLV-2 (Note=Also bind to STLV-1). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10562 150519757 CVCL_B0SY 5D9 [Mouse hybridoma against human ADRB3] hybridoma house mouse CVCL_B0SY CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P13945; Human ADRB3. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2016203 150519758 CVCL_B0T9 #132 PC3-1-SC-E8 hybridoma house mouse CVCL_B0T9 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P47712; Human PLA2G4A. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10564 150519759 CVCL_B0SX 5D1 [Mouse hybridoma against human ADRB3] hybridoma house mouse CVCL_B0SX CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P13945; Human ADRB3. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015146 150519760 CVCL_B0SK 6H6 [Mouse hybridoma against human F2] hybridoma house mouse CVCL_B0SK CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P00734; Human F2 (Note=Recognizes an abnormal form called PIVKA-II). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10541 150519761 CVCL_B0SJ 2H4 [Mouse hybridoma against human F2] hybridoma house mouse CVCL_B0SJ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P00734; Human F2 (Note=Recognizes an abnormal form called PIVKA-II). 150519762 CVCL_B0SM COC1501 hybridoma house mouse CVCL_B0SM CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_27958; Cocaine. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015136 150519763 CVCL_B0SL 3C10 [Mouse hybridoma against human F2] hybridoma house mouse CVCL_B0SL CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P00734; Human F2 (Note=Recognizes an abnormal form called PIVKA-II). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9638 150519764 CVCL_B0T0 5D3 [Mouse hybridoma against HBV HBsAg] hybridoma house mouse CVCL_B0T0 CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Hepatitis B virus HBsAg. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9801 150519765 CVCL_B0SN GNC92H2 hybridoma house mouse CVCL_B0SN CL:0000010 Biotechnology: The monoclonal antibody produced by this hybridoma as well as a humanized version are used in immunotherapeutical neutralization studies in rodents and human Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_27958; Cocaine. 150519766 CVCL_B0SQ DASm244-4D8A4A4 hybridoma house mouse CVCL_B0SQ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: ChEBI; CHEBI_27958; Cocaine; Monoclonal antibody target: ChEBI; CHEBI_174315; Cocaethylene. 150519767 CVCL_B0T2 SW1687 cancer cell line human CVCL_B0T2 From: Scott and White Clinic; Temple; USA. CL:0000010 Unspecified 150519768 CVCL_B0T1 5C11 [Mouse hybridoma against HBsAg] hybridoma house mouse CVCL_B0T1 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Hepatitis B virus HBsAg. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8171 150519769 CVCL_B0SP DASm244-3B10D9E3 hybridoma house mouse CVCL_B0SP CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: ChEBI; CHEBI_27958; Cocaine; Monoclonal antibody target: ChEBI; CHEBI_174315; Cocaethylene. 150519770 CVCL_B0SC LCL-IDDM-PI440 transformed cell line human CVCL_B0SC CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519771 CVCL_B0SB LCL-IDDM-PI437 transformed cell line human CVCL_B0SB CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519772 CVCL_B0SE LCL-IDDM-PI444 transformed cell line human CVCL_B0SE CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519773 CVCL_B0SD LCL-IDDM-PI443 transformed cell line human CVCL_B0SD CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519774 CVCL_B0SG LCL-IDDM-PI446 transformed cell line human CVCL_B0SG CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519775 CVCL_B0SF LCL-IDDM-PI445 transformed cell line human CVCL_B0SF CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519776 CVCL_B0SI LCL-IDDM-PI450 transformed cell line human CVCL_B0SI CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519777 CVCL_B0SH LCL-IDDM-PI447 transformed cell line human CVCL_B0SH CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519778 CVCL_B0UA S18-1C3 hybrid cell line human CVCL_B0UA CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018189 Problematic cell line: Probably contaminated Grand-parent cell line (CNE-2) has been shown to be a hybrid of HeLa and of cell line of unknown origin. 150519779 CVCL_B0UC SP2/0-02-AREG-SUN hybridoma house mouse CVCL_B0UC CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P15514; Human AREG. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018214 150519780 CVCL_B0UB S26 hybrid cell line human CVCL_B0UB CL:0000010 Group: Patented cell line Problematic cell line: Probably contaminated Parent cell line (CNE-2) has been shown to be a hybrid of HeLa and of cell line of unknown origin.. 150519781 CVCL_B0TT 3G3 [Mouse hybridoma against human PSCA] hybridoma house mouse CVCL_B0TT CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O43653; Human PSCA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12615 150519782 CVCL_B0U5 HuS-1 hybridoma house mouse CVCL_B0U5 CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P68871; Human HBB (Note=Recognizes Hb S, p.Glu7Val). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8660 150519783 CVCL_B0U4 1G7-2 hybridoma Norway rat CVCL_B0U4 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10540 150519784 CVCL_B0TS 3E6 [Mouse hybridoma against human PSCA] hybridoma house mouse CVCL_B0TS CL:0000010 Monoclonal antibody isotype: IgG3; Monoclonal antibody target: UniProtKB; O43653; Human PSCA. 150519785 CVCL_B0U7 11G7 hybridoma house mouse CVCL_B0U7 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O60603; Human TLR2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5014 150519786 CVCL_B0TV Ha1-1.16 hybridoma house mouse CVCL_B0TV CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; O43653; Human PSCA Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6698 150519787 CVCL_B0TU 4A10 [Mouse hybridoma against human PSCA] hybridoma house mouse CVCL_B0TU CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O43653; Human PSCA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12617 150519788 CVCL_B0U6 HuS-2 hybridoma house mouse CVCL_B0U6 CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: UniProtKB; P68871; Human HBB (Note=Recognizes Hb S, p.Glu7Val). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8661 150519789 CVCL_B0TX Ha1-4.120 hybridoma house mouse CVCL_B0TX CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; O43653; Human PSCA Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6700 150519790 CVCL_B0U9 S18 hybrid cell line human CVCL_B0U9 CL:0000010 Group: Patented cell line Problematic cell line: Probably contaminated Parent cell line (CNE-2) has been shown to be a hybrid of HeLa and of cell line of unknown origin.. 150519791 CVCL_B0U8 8H7 [Mouse hybridoma against A.lucorum EcR-A] hybridoma house mouse CVCL_B0U8 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; A0A0K0N8J0; Apolygus lucorum 20-hydroxy-ecdysone receptor (EcR-A). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2016206 150519792 CVCL_B0TW Ha1-4.117 hybridoma house mouse CVCL_B0TW CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; O43653; Human PSCA Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6699 150519793 CVCL_B0TZ Ha1-4.37 hybridoma house mouse CVCL_B0TZ CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; O43653; Human PSCA Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6702 150519794 CVCL_B0TY Ha1-4.121 hybridoma house mouse CVCL_B0TY CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O43653; Human PSCA Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6701 150519795 CVCL_B0TL MAb 763-15-20 hybridoma house mouse CVCL_B0TL CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11712; Human CYP2C9 (Note=Recognizes alleles CYP2C9*1, CYP2C9*2 and CYP2C9*3 Also binds CYP2C8).. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1078 150519796 CVCL_B0TK MAb 592-2-5 hybridoma house mouse CVCL_B0TK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11712; Human CYP2C9 (Note=Recognizes alleles CYP2C9*1, CYP2C9*2, CYP2C9*3 Also recognizes CYP2C18).. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12646 150519797 CVCL_B0TN 1G8 [Mouse hybridoma against human PSCA] hybridoma house mouse CVCL_B0TN CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; O43653; Human PSCA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12612 150519798 CVCL_B0TM MAb 763-15-5 hybridoma house mouse CVCL_B0TM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11712; Human CYP2C9 (Note=Recognizes alleles CYP2C9*1, CYP2C9*2 and CYP2C9*3). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1079 150519799 CVCL_B0U1 20G3-2 hybridoma Norway rat CVCL_B0U1 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10541 150519800 CVCL_B0TP 2A2 [Mouse hybridoma against human PSCA] hybridoma house mouse CVCL_B0TP CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O43653; Human PSCA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12613 150519801 CVCL_B0U0 Ha1-5.99 hybridoma house mouse CVCL_B0U0 CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O43653; Human PSCA Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6703 150519802 CVCL_B0U3 28G12-2 hybridoma Norway rat CVCL_B0U3 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10543 150519803 CVCL_B0TR 3C5 [Mouse hybridoma against human PSCA] hybridoma house mouse CVCL_B0TR CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; O43653; Human PSCA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12616 150519804 CVCL_B0U2 24D3-2 hybridoma Norway rat CVCL_B0U2 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P03375; HIV-1 isolate BH10 env (Note=AA 33-511 = gp120). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10542 150519805 CVCL_B0TQ 2H9 [Mouse hybridoma against human PSCA] hybridoma house mouse CVCL_B0TQ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O43653; Human PSCA. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12614 150519806 CVCL_B0TD MAb 1-7-4-8 hybridoma house mouse CVCL_B0TD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P33261; Human CYP2C19. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3970 150519807 CVCL_B0TC MAb 1-68-11 hybridoma house mouse CVCL_B0TC CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P11712; Human CYP2C9 (Note=Recognizes alleles CYP2C9*1, CYP2C9*2 and CYP2C9*3 Also recognizes CYP2C8, CYP2C18 and CYP2C19).. 150519808 CVCL_B0TF MAb 281-1-1 hybridoma house mouse CVCL_B0TF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P10632; Human CYP2C8. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12648 150519809 CVCL_B0TE MAb 13-1-3 hybridoma house mouse CVCL_B0TE CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P10632; Human CYP2C8. 150519810 CVCL_B0TH MAb 327-8-3 hybridoma house mouse CVCL_B0TH CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11712; Human CYP2C9 (Note=Recognizes alleles CYP2C9*1 and CYP2C9*2 Also recognizes CYP2C18).. 150519811 CVCL_B0TG MAb 292-2-3 hybridoma house mouse CVCL_B0TG CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11712; Human CYP2C9 (Note=Binds and inhibits allele CYP2C9*2). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12645 150519812 CVCL_B0TJ MAb 5-7-5 hybridoma house mouse CVCL_B0TJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P11712; Human CYP2C9 (Note=Binds also to CYP2C18 and CYP2C19). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12647 150519813 CVCL_B0TI MAb 5-1-5 hybridoma house mouse CVCL_B0TI CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P10632; Human CYP2C8. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12649 150519814 CVCL_B0QY LCL-IDDM-PI287 transformed cell line human CVCL_B0QY CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519815 CVCL_B0QX LCL-IDDM-PI286 transformed cell line human CVCL_B0QX CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519816 CVCL_B0R9 LCL-IDDM-PI298 transformed cell line human CVCL_B0R9 CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519817 CVCL_B0QZ LCL-IDDM-PI288 transformed cell line human CVCL_B0QZ CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519818 CVCL_B0QQ LCL-IDDM-PI260 transformed cell line human CVCL_B0QQ CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519819 CVCL_B0R2 LCL-IDDM-PI291 transformed cell line human CVCL_B0R2 CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519820 CVCL_B0QP LCL-IDDM-PI259 transformed cell line human CVCL_B0QP CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519821 CVCL_B0R1 LCL-IDDM-PI290 transformed cell line human CVCL_B0R1 CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519822 CVCL_B0QS LCL-IDDM-PI269 transformed cell line human CVCL_B0QS CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519823 CVCL_B0R4 LCL-IDDM-PI293 transformed cell line human CVCL_B0R4 CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519824 CVCL_B0QR LCL-IDDM-PI268 transformed cell line human CVCL_B0QR CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519825 CVCL_B0R3 LCL-IDDM-PI292 transformed cell line human CVCL_B0R3 CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519826 CVCL_B0QU LCL-IDDM-PI271 transformed cell line human CVCL_B0QU CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519827 CVCL_B0R6 LCL-IDDM-PI295 transformed cell line human CVCL_B0R6 CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519828 CVCL_B0QT LCL-IDDM-PI270 transformed cell line human CVCL_B0QT CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519829 CVCL_B0R5 LCL-IDDM-PI294 transformed cell line human CVCL_B0R5 CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519830 CVCL_B0QW LCL-IDDM-PI285 transformed cell line human CVCL_B0QW CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519831 CVCL_B0R8 LCL-IDDM-PI297 transformed cell line human CVCL_B0R8 CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519832 CVCL_B0QV LCL-IDDM-PI284 transformed cell line human CVCL_B0QV CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519833 CVCL_B0R7 LCL-IDDM-PI296 transformed cell line human CVCL_B0R7 CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519834 CVCL_B0QI LCL-PI 186 transformed cell line human CVCL_B0QI CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519835 CVCL_B0QH LCL-PI 90 transformed cell line human CVCL_B0QH CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519836 CVCL_B0QK LCL-PI 201 transformed cell line human CVCL_B0QK CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519837 CVCL_B0QJ LCL-PI 196 transformed cell line human CVCL_B0QJ CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519838 CVCL_B0QM LCL-PI 205 transformed cell line human CVCL_B0QM CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519839 CVCL_B0QL LCL-PI 202 transformed cell line human CVCL_B0QL CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519840 CVCL_B0R0 LCL-IDDM-PI289 transformed cell line human CVCL_B0R0 CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519841 CVCL_B0QN LCL-IDDM-PI258 transformed cell line human CVCL_B0QN CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519842 CVCL_B0QA LCL-PI 24 transformed cell line human CVCL_B0QA CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519843 CVCL_B0QC LCL-PI 44 transformed cell line human CVCL_B0QC CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519844 CVCL_B0QB LCL-PI 43 transformed cell line human CVCL_B0QB CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519845 CVCL_B0QE LCL-PI 54 [From CVI female patient] transformed cell line human CVCL_B0QE CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Caution: There seem to be two distinct cell lines which were assigned by NCBI_Iran the name LCL-PI 54 150519846 CVCL_B0QD LCL-PI 50 transformed cell line human CVCL_B0QD CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519847 CVCL_B0QG LCL-PI 69 transformed cell line human CVCL_B0QG CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519848 CVCL_B0QF LCL-PI 64 transformed cell line human CVCL_B0QF CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519849 CVCL_B0RZ LCL-IDDM-PI323 transformed cell line human CVCL_B0RZ CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519850 CVCL_B0RY LCL-IDDM-PI322 transformed cell line human CVCL_B0RY CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519851 CVCL_B0SA LCL-IDDM-PI427 transformed cell line human CVCL_B0SA CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519852 CVCL_B0RR LCL-IDDM-PI315 transformed cell line human CVCL_B0RR CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519853 CVCL_B0S3 LCL-IDDM-PI327 transformed cell line human CVCL_B0S3 CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519854 CVCL_B0RQ LCL-IDDM-PI314 transformed cell line human CVCL_B0RQ CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519855 CVCL_B0S2 LCL-IDDM-PI326 transformed cell line human CVCL_B0S2 CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519856 CVCL_B0RT LCL-IDDM-PI317 transformed cell line human CVCL_B0RT CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519857 CVCL_B0S5 LCL-IDDM-PI329 transformed cell line human CVCL_B0S5 CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519858 CVCL_B0RS LCL-IDDM-PI316 transformed cell line human CVCL_B0RS CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519859 CVCL_B0S4 LCL-IDDM-PI328 transformed cell line human CVCL_B0S4 CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519860 CVCL_B0RV LCL-IDDM-PI319 transformed cell line human CVCL_B0RV CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519861 CVCL_B0S7 LCL-IDDM-PI401 transformed cell line human CVCL_B0S7 CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519862 CVCL_B0RU LCL-IDDM-PI318 transformed cell line human CVCL_B0RU CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519863 CVCL_B0S6 LCL-IDDM-PI330 transformed cell line human CVCL_B0S6 CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519864 CVCL_B0RX LCL-IDDM-PI321 transformed cell line human CVCL_B0RX CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519865 CVCL_B0S9 LCL-IDDM-PI421 transformed cell line human CVCL_B0S9 CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519866 CVCL_B0RW LCL-IDDM-PI320 transformed cell line human CVCL_B0RW CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519867 CVCL_B0S8 LCL-IDDM-PI331 transformed cell line human CVCL_B0S8 CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519868 CVCL_B0RJ LCL-IDDM-PI308 transformed cell line human CVCL_B0RJ CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519869 CVCL_B0RI LCL-IDDM-PI307 transformed cell line human CVCL_B0RI CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519870 CVCL_B0RL LCL-IDDM-PI310 transformed cell line human CVCL_B0RL CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519871 CVCL_B0RK LCL-IDDM-PI309 transformed cell line human CVCL_B0RK CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519872 CVCL_B0RN LCL-IDDM-PI312 transformed cell line human CVCL_B0RN CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519873 CVCL_B0RM LCL-IDDM-PI311 transformed cell line human CVCL_B0RM CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519874 CVCL_B0RP LCL-IDDM-PI313 transformed cell line human CVCL_B0RP CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519875 CVCL_B0S1 LCL-IDDM-PI325 transformed cell line human CVCL_B0S1 CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519876 CVCL_B0S0 LCL-IDDM-PI324 transformed cell line human CVCL_B0S0 CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519877 CVCL_B0RB LCL-IDDM-PI300 transformed cell line human CVCL_B0RB CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519878 CVCL_B0RA LCL-IDDM-PI299 transformed cell line human CVCL_B0RA CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519879 CVCL_B0RD LCL-IDDM-PI302 transformed cell line human CVCL_B0RD CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519880 CVCL_B0RC LCL-IDDM-PI301 transformed cell line human CVCL_B0RC CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519881 CVCL_B0RF LCL-IDDM-PI304 transformed cell line human CVCL_B0RF CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519882 CVCL_B0RE LCL-IDDM-PI303 transformed cell line human CVCL_B0RE CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 150519883 CVCL_B0RH LCL-IDDM-PI306 transformed cell line human CVCL_B0RH CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519884 CVCL_B0RG LCL-IDDM-PI305 transformed cell line human CVCL_B0RG CL:0000010 Population: Iranian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 150519885 CVCL_W450 MMJ-2 cancer cell line human CVCL_W450 CL:0000010 Population: Japanese; Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Male Doubling time: 12-15 hours (Note=At 6th passage) (PubMed=8652447) 151357216 CVCL_B3EJ Abcam HEK293T PPP2R1B KO transformed cell line human CVCL_B3EJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9303; PPP2R1B; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357217 CVCL_B3EI Abcam HEK293T PPP1R16A KO transformed cell line human CVCL_B3EI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14941; PPP1R16A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357218 CVCL_B3EL Abcam HEK293T PPP4R2 KO transformed cell line human CVCL_B3EL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18296; PPP4R2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357219 CVCL_B3EK Abcam HEK293T PPP2R5C KO transformed cell line human CVCL_B3EK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9311; PPP2R5C; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357220 CVCL_B3EN Abcam HEK293T PPP6R1 KO transformed cell line human CVCL_B3EN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29195; PPP6R1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357221 CVCL_B3EM Abcam HEK293T PPP5C KO transformed cell line human CVCL_B3EM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9322; PPP5C; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357222 CVCL_B3EP Abcam HEK293T PQBP1 KO transformed cell line human CVCL_B3EP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9330; PQBP1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357223 CVCL_B3F1 Abcam HEK293T PRPS1 KO transformed cell line human CVCL_B3F1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9462; PRPS1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357224 CVCL_B3F0 Abcam HEK293T PRPF4B KO transformed cell line human CVCL_B3F0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17346; PRPF4B; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357225 CVCL_B3EB Abcam HEK293T POU4F2 KO transformed cell line human CVCL_B3EB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9219; POU4F2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357226 CVCL_B3EA Abcam HEK293T POP5 KO transformed cell line human CVCL_B3EA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17689; POP5; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357227 CVCL_B3ED Abcam HEK293T PPIF KO transformed cell line human CVCL_B3ED CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9259; PPIF; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357228 CVCL_B3EC Abcam HEK293T PPHLN1 KO transformed cell line human CVCL_B3EC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19369; PPHLN1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357229 CVCL_B3EF Abcam HEK293T PPM1B KO transformed cell line human CVCL_B3EF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9276; PPM1B; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357230 CVCL_B3EE Abcam HEK293T PPIH KO transformed cell line human CVCL_B3EE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14651; PPIH; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357231 CVCL_B3EH Abcam HEK293T PPM1G KO transformed cell line human CVCL_B3EH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9278; PPM1G; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357232 CVCL_B3EG Abcam HEK293T PPM1F KO transformed cell line human CVCL_B3EG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19388; PPM1F; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357233 CVCL_B3DY Abcam HEK293T PKN1 KO transformed cell line human CVCL_B3DY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9405; PKN1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357234 CVCL_B3DX Abcam HEK293T PIP5K1A KO transformed cell line human CVCL_B3DX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8994; PIP5K1A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357235 CVCL_B3E9 Abcam HEK293T POMK KO transformed cell line human CVCL_B3E9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26267; POMK; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357236 CVCL_B3DZ Abcam HEK293T PLCG1 KO transformed cell line human CVCL_B3DZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9065; PLCG1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357237 CVCL_B3DQ Abcam HEK293T PEA15 KO transformed cell line human CVCL_B3DQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8822; PEA15; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357238 CVCL_B3E2 Abcam HEK293T PLEKHJ1 KO transformed cell line human CVCL_B3E2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18211; PLEKHJ1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357239 CVCL_B3DP Abcam HEK293T PDXK KO transformed cell line human CVCL_B3DP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8819; PDXK; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357240 CVCL_B3E1 Abcam HEK293T PLD6 KO transformed cell line human CVCL_B3E1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30447; PLD6; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357241 CVCL_B3DS Abcam HEK293T PHF23 KO transformed cell line human CVCL_B3DS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28428; PHF23; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357242 CVCL_B3E4 Abcam HEK293T PLOD3 KO transformed cell line human CVCL_B3E4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9083; PLOD3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357243 CVCL_B3DR Abcam HEK293T PEX5 KO transformed cell line human CVCL_B3DR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9719; PEX5; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357244 CVCL_B3E3 Abcam HEK293T PLOD2 KO transformed cell line human CVCL_B3E3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9082; PLOD2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357245 CVCL_B3DU Abcam HEK293T PIGT KO transformed cell line human CVCL_B3DU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14938; PIGT; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357246 CVCL_B3E6 Abcam HEK293T PNP KO transformed cell line human CVCL_B3E6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7892; PNP; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357247 CVCL_B3DT Abcam HEK293T PHKA1 KO transformed cell line human CVCL_B3DT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8925; PHKA1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357248 CVCL_B3E5 Abcam HEK293T PLS3 KO transformed cell line human CVCL_B3E5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9091; PLS3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357249 CVCL_B3DW Abcam HEK293T PINK1 KO transformed cell line human CVCL_B3DW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14581; PINK1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357250 CVCL_B3E8 Abcam HEK293T POMGNT1 KO transformed cell line human CVCL_B3E8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19139; POMGNT1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357251 CVCL_B3DV Abcam HEK293T PIK3R2 KO transformed cell line human CVCL_B3DV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8980; PIK3R2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357252 CVCL_B3E7 Abcam HEK293T POLE3 KO transformed cell line human CVCL_B3E7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13546; POLE3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357253 CVCL_B3FK Abcam HEK293T RAB1A KO transformed cell line human CVCL_B3FK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9758; RAB1A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357254 CVCL_B3FJ Abcam HEK293T RAB14 KO transformed cell line human CVCL_B3FJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16524; RAB14; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357255 CVCL_B3FM Abcam HEK293T RAB2A KO transformed cell line human CVCL_B3FM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9763; RAB2A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357256 CVCL_B3FL Abcam HEK293T RAB1B KO transformed cell line human CVCL_B3FL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18370; RAB1B; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357257 CVCL_B3G0 Abcam HEK293T RHOA KO transformed cell line human CVCL_B3G0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:667; RHOA; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357258 CVCL_B3FN Abcam HEK293T RAB5IF KO transformed cell line human CVCL_B3FN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15870; RAB5IF; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357259 CVCL_B3FQ Abcam HEK293T RAD23A KO transformed cell line human CVCL_B3FQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9812; RAD23A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357260 CVCL_B3G2 Abcam HEK293T RNASEH2A KO transformed cell line human CVCL_B3G2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18518; RNASEH2A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357261 CVCL_B3FP Abcam HEK293T RAB6A KO transformed cell line human CVCL_B3FP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9786; RAB6A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357262 CVCL_B3G1 Abcam HEK293T RHOG KO transformed cell line human CVCL_B3G1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:672; RHOG; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357263 CVCL_B3FC Abcam HEK293T PTPRF KO transformed cell line human CVCL_B3FC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9670; PTPRF; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357264 CVCL_B3FB Abcam HEK293T PTPN11 KO transformed cell line human CVCL_B3FB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9644; PTPN11; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357265 CVCL_B3FE Abcam HEK293T PUS1 KO transformed cell line human CVCL_B3FE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15508; PUS1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357266 CVCL_B3FD Abcam HEK293T PTRH2 KO transformed cell line human CVCL_B3FD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24265; PTRH2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Discontinued: Abcam; ab266715; true Female 151357267 CVCL_B3FG Abcam HEK293T PXK KO transformed cell line human CVCL_B3FG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23326; PXK; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357268 CVCL_B3FF Abcam HEK293T PVR KO transformed cell line human CVCL_B3FF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9705; PVR; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357269 CVCL_B3FI Abcam HEK293T RAB13 KO transformed cell line human CVCL_B3FI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9762; RAB13; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357270 CVCL_B3FH Abcam HEK293T PYM1 KO transformed cell line human CVCL_B3FH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30258; PYM1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357271 CVCL_B3EZ Abcam HEK293T PRKRA KO transformed cell line human CVCL_B3EZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9438; PRKRA; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357272 CVCL_B3EY Abcam HEK293T PRKCZ KO 2 transformed cell line human CVCL_B3EY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9412; PRKCZ; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Discontinued: Abcam; ab266681; true Female 151357273 CVCL_B3FA Abcam HEK293T PTK2 KO transformed cell line human CVCL_B3FA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9611; PTK2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357274 CVCL_B3ER Abcam HEK293T PRDX1 KO transformed cell line human CVCL_B3ER CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9352; PRDX1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357275 CVCL_B3F3 Abcam HEK293T PSAT1 KO transformed cell line human CVCL_B3F3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19129; PSAT1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357276 CVCL_B3EQ Abcam HEK293T PRCC KO transformed cell line human CVCL_B3EQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9343; PRCC; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357277 CVCL_B3F2 Abcam HEK293T PRRC2B KO transformed cell line human CVCL_B3F2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28121; PRRC2B; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357278 CVCL_B3ET Abcam HEK293T PRDX4 KO transformed cell line human CVCL_B3ET CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17169; PRDX4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357279 CVCL_B3F5 Abcam HEK293T PSMD8 KO transformed cell line human CVCL_B3F5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9566; PSMD8; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357280 CVCL_B3ES Abcam HEK293T PRDX2 KO transformed cell line human CVCL_B3ES CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9353; PRDX2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357281 CVCL_B3F4 Abcam HEK293T PSIP1 KO transformed cell line human CVCL_B3F4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9527; PSIP1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357282 CVCL_B3EV Abcam HEK293T PRKCD KO transformed cell line human CVCL_B3EV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9399; PRKCD; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357283 CVCL_B3F7 Abcam HEK293T PSME3 KO transformed cell line human CVCL_B3F7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9570; PSME3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357284 CVCL_B3EU Abcam HEK293T PREP KO transformed cell line human CVCL_B3EU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9358; PREP; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357285 CVCL_B3F6 Abcam HEK293T PSME1 KO transformed cell line human CVCL_B3F6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9568; PSME1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357286 CVCL_B3EX Abcam HEK293T PRKCZ KO 1 transformed cell line human CVCL_B3EX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9412; PRKCZ; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Discontinued: Abcam; ab265073; true Female 151357287 CVCL_B3F9 Abcam HEK293T PTGES3 KO transformed cell line human CVCL_B3F9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16049; PTGES3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357288 CVCL_B3EW Abcam HEK293T PRKCSH KO transformed cell line human CVCL_B3EW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9411; PRKCSH; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357289 CVCL_B3F8 Abcam HEK293T PTDSS1 KO transformed cell line human CVCL_B3F8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9587; PTDSS1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357290 CVCL_B3CH Abcam HEK293T NME4 KO 2 transformed cell line human CVCL_B3CH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7852; NME4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357291 CVCL_B3CG Abcam HEK293T NME4 KO 1 transformed cell line human CVCL_B3CG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7852; NME4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357292 CVCL_B3CJ Abcam HEK293T NOL7 KO transformed cell line human CVCL_B3CJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21040; NOL7; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357293 CVCL_B3CI Abcam HEK293T NME6 KO transformed cell line human CVCL_B3CI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20567; NME6; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357294 CVCL_B3CL Abcam HEK293T NOSIP KO transformed cell line human CVCL_B3CL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17946; NOSIP; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357295 CVCL_B3CK Abcam HEK293T NONO KO transformed cell line human CVCL_B3CK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7871; NONO; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357296 CVCL_B3CN Abcam HEK293T NPM3 KO transformed cell line human CVCL_B3CN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7931; NPM3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357297 CVCL_B3CM Abcam HEK293T NPC2 KO transformed cell line human CVCL_B3CM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14537; NPC2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357298 CVCL_B3CB Abcam HEK293T NFATC3 KO transformed cell line human CVCL_B3CB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7777; NFATC3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357299 CVCL_B3CA Abcam HEK293T NEIL1 KO 2 transformed cell line human CVCL_B3CA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18448; NEIL1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357300 CVCL_B3CD Abcam HEK293T NIBAN2 KO transformed cell line human CVCL_B3CD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25282; NIBAN2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357301 CVCL_B3CC Abcam HEK293T NFE2L1 KO transformed cell line human CVCL_B3CC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7781; NFE2L1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357302 CVCL_B3CF Abcam HEK293T NME1 KO transformed cell line human CVCL_B3CF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7849; NME1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357303 CVCL_B3CE Abcam HEK293T NIT2 KO transformed cell line human CVCL_B3CE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29878; NIT2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357304 CVCL_B3BW Abcam HEK293T NCAPG2 KO transformed cell line human CVCL_B3BW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21904; NCAPG2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357305 CVCL_B3C8 Abcam HEK293T NEFM KO transformed cell line human CVCL_B3C8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7734; NEFM; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357306 CVCL_B3BV Abcam HEK293T NASP KO transformed cell line human CVCL_B3BV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7644; NASP; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357307 CVCL_B3C7 Abcam HEK293T NDUFV1 KO transformed cell line human CVCL_B3C7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7716; NDUFV1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357308 CVCL_B3BY Abcam HEK293T NCSTN KO transformed cell line human CVCL_B3BY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17091; NCSTN; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357309 CVCL_B3BX Abcam HEK293T NCOA2 KO transformed cell line human CVCL_B3BX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7669; NCOA2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357310 CVCL_B3C9 Abcam HEK293T NEIL1 KO 1 transformed cell line human CVCL_B3C9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18448; NEIL1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357311 CVCL_B3BZ Abcam HEK293T NDRG1 KO transformed cell line human CVCL_B3BZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7679; NDRG1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357312 CVCL_B3C0 Abcam HEK293T NDUFA11 KO transformed cell line human CVCL_B3C0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20371; NDUFA11; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357313 CVCL_B3BN Abcam HEK293T MYL6B KO transformed cell line human CVCL_B3BN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29823; MYL6B; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357314 CVCL_B3BQ Abcam HEK293T MZT2B KO transformed cell line human CVCL_B3BQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25886; MZT2B; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357315 CVCL_B3C2 Abcam HEK293T NDUFA7 KO transformed cell line human CVCL_B3C2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7691; NDUFA7; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357316 CVCL_B3BP Abcam HEK293T MYSM1 KO transformed cell line human CVCL_B3BP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29401; MYSM1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357317 CVCL_B3C1 Abcam HEK293T NDUFA4 KO transformed cell line human CVCL_B3C1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7687; NDUFA4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357318 CVCL_B3BS Abcam HEK293T NACA KO transformed cell line human CVCL_B3BS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7629; NACA; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357319 CVCL_B3C4 Abcam HEK293T NDUFB1 KO transformed cell line human CVCL_B3C4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7695; NDUFB1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357320 CVCL_B3BR Abcam HEK293T NABP2 KO transformed cell line human CVCL_B3BR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28412; NABP2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357321 CVCL_B3C3 Abcam HEK293T NDUFAF8 KO transformed cell line human CVCL_B3C3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33551; NDUFAF8; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357322 CVCL_B3BU Abcam HEK293T NANS KO transformed cell line human CVCL_B3BU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19237; NANS; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357323 CVCL_B3C6 Abcam HEK293T NDUFS3 KO transformed cell line human CVCL_B3C6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7710; NDUFS3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357324 CVCL_B3BT Abcam HEK293T NADK KO transformed cell line human CVCL_B3BT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29831; NADK; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357325 CVCL_B3C5 Abcam HEK293T NDUFC1 KO transformed cell line human CVCL_B3C5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7705; NDUFC1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357326 CVCL_B3DI Abcam HEK293T PCBD1 KO transformed cell line human CVCL_B3DI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8646; PCBD1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357327 CVCL_B3DH Abcam HEK293T PBK KO transformed cell line human CVCL_B3DH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18282; PBK; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357328 CVCL_B3DK Abcam HEK293T PCNP KO transformed cell line human CVCL_B3DK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30023; PCNP; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357329 CVCL_B3DJ Abcam HEK293T PCCB KO transformed cell line human CVCL_B3DJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8654; PCCB; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357330 CVCL_B3DM Abcam HEK293T PDAP1 KO transformed cell line human CVCL_B3DM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14634; PDAP1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357331 CVCL_B3DL Abcam HEK293T PCNT KO transformed cell line human CVCL_B3DL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16068; PCNT; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357332 CVCL_B3E0 Abcam HEK293T PLD3 KO transformed cell line human CVCL_B3E0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17158; PLD3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357333 CVCL_B3DN Abcam HEK293T PDCD6 KO transformed cell line human CVCL_B3DN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8765; PDCD6; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357334 CVCL_B3DA Abcam HEK293T PAK4 KO transformed cell line human CVCL_B3DA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16059; PAK4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357335 CVCL_B3DC Abcam HEK293T PAPOLA KO transformed cell line human CVCL_B3DC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14981; PAPOLA; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357336 CVCL_B3DB Abcam HEK293T PANK4 KO transformed cell line human CVCL_B3DB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19366; PANK4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357337 CVCL_B3DE Abcam HEK293T PARL KO transformed cell line human CVCL_B3DE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18253; PARL; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357338 CVCL_B3DD Abcam HEK293T PARK7 KO transformed cell line human CVCL_B3DD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16369; PARK7; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357339 CVCL_B3DG Abcam HEK293T PARP2 KO transformed cell line human CVCL_B3DG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:272; PARP2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357340 CVCL_B3DF Abcam HEK293T PARP1 KO transformed cell line human CVCL_B3DF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:270; PARP1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357341 CVCL_B3CX Abcam HEK293T NTPCR KO transformed cell line human CVCL_B3CX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28204; NTPCR; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357342 CVCL_B3D9 Abcam HEK293T PAIP2 KO transformed cell line human CVCL_B3D9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17970; PAIP2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357343 CVCL_B3CW Abcam HEK293T NT5C KO transformed cell line human CVCL_B3CW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17144; NT5C; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357344 CVCL_B3D8 Abcam HEK293T PAFAH1B3 KO transformed cell line human CVCL_B3D8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8576; PAFAH1B3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357345 CVCL_B3CZ Abcam HEK293T NUDT1 KO transformed cell line human CVCL_B3CZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8048; NUDT1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357346 CVCL_B3CY Abcam HEK293T NUCKS1 KO transformed cell line human CVCL_B3CY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29923; NUCKS1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357347 CVCL_B3CP Abcam HEK293T NPTN KO transformed cell line human CVCL_B3CP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17867; NPTN; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357348 CVCL_B3D1 Abcam HEK293T NUP210 KO transformed cell line human CVCL_B3D1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30052; NUP210; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357349 CVCL_B3D0 Abcam HEK293T NUDT5 KO transformed cell line human CVCL_B3D0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8052; NUDT5; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357350 CVCL_B3CR Abcam HEK293T NRAS KO transformed cell line human CVCL_B3CR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7989; NRAS; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357351 CVCL_B3D3 Abcam HEK293T OCIAD1 KO transformed cell line human CVCL_B3D3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16074; OCIAD1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357352 CVCL_B3CQ Abcam HEK293T NR2C2 KO transformed cell line human CVCL_B3CQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7972; NR2C2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357353 CVCL_B3D2 Abcam HEK293T OAZ1 KO transformed cell line human CVCL_B3D2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8095; OAZ1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357354 CVCL_B3CT Abcam HEK293T NSD1 KO transformed cell line human CVCL_B3CT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14234; NSD1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357355 CVCL_B3D5 Abcam HEK293T OTUB1 KO transformed cell line human CVCL_B3D5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23077; OTUB1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357356 CVCL_B3CS Abcam HEK293T NRDC KO transformed cell line human CVCL_B3CS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7995; NRDC; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357357 CVCL_B3D4 Abcam HEK293T OSTC KO transformed cell line human CVCL_B3D4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24448; OSTC; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357358 CVCL_B3CV Abcam HEK293T NSUN2 KO transformed cell line human CVCL_B3CV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25994; NSUN2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357359 CVCL_B3D7 Abcam HEK293T PACSIN3 KO transformed cell line human CVCL_B3D7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8572; PACSIN3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357360 CVCL_B3CU Abcam HEK293T NSDHL KO transformed cell line human CVCL_B3CU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13398; NSDHL; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357361 CVCL_B3D6 Abcam HEK293T OXA1L KO transformed cell line human CVCL_B3D6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8526; OXA1L; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357362 CVCL_B3AF Abcam HEK293T LYPLA2 KO transformed cell line human CVCL_B3AF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6738; LYPLA2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357363 CVCL_B3AE Abcam HEK293T LYPLA1 KO transformed cell line human CVCL_B3AE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6737; LYPLA1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357364 CVCL_B3AH Abcam HEK293T MACROH2A1 KO transformed cell line human CVCL_B3AH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4740; MACROH2A1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357365 CVCL_B3AG Abcam HEK293T M6PR KO transformed cell line human CVCL_B3AG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6752; M6PR; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Discontinued: Abcam; ab266668; true Female 151357366 CVCL_B3AJ Abcam HEK293T MAP2K2 KO transformed cell line human CVCL_B3AJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6842; MAP2K2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357367 CVCL_B3AI Abcam HEK293T MAF1 KO transformed cell line human CVCL_B3AI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24966; MAF1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357368 CVCL_B3AL Abcam HEK293T MAP3K7 KO transformed cell line human CVCL_B3AL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6859; MAP3K7; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357369 CVCL_B3AK Abcam HEK293T MAP3K10 KO transformed cell line human CVCL_B3AK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6849; MAP3K10; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357370 CVCL_B3AB Abcam HEK293T LRRC59 KO transformed cell line human CVCL_B3AB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28817; LRRC59; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357371 CVCL_B3AA Abcam HEK293T LRP5 KO transformed cell line human CVCL_B3AA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6697; LRP5; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357372 CVCL_B3AD Abcam HEK293T LUC7L2 KO transformed cell line human CVCL_B3AD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21608; LUC7L2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357373 CVCL_B3AC Abcam HEK293T LTA4H KO transformed cell line human CVCL_B3AC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6710; LTA4H; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357374 CVCL_B3A6 Abcam HEK293T LIN28B KO transformed cell line human CVCL_B3A6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32207; LIN28B; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357375 CVCL_B3A5 Abcam HEK293T LGALS1 KO transformed cell line human CVCL_B3A5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6561; LGALS1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357376 CVCL_B3A8 Abcam HEK293T LMAN2 KO transformed cell line human CVCL_B3A8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16986; LMAN2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357377 CVCL_B3A7 Abcam HEK293T LMAN1 KO transformed cell line human CVCL_B3A7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6631; LMAN1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357378 CVCL_B3A9 Abcam HEK293T LPAR3 KO transformed cell line human CVCL_B3A9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14298; LPAR3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357379 CVCL_B3A0 Abcam HEK293T LAMTOR4 KO transformed cell line human CVCL_B3A0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33772; LAMTOR4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357380 CVCL_B3A2 Abcam HEK293T LARP1 KO transformed cell line human CVCL_B3A2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29531; LARP1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Discontinued: Abcam; ab266295; true Female 151357381 CVCL_B3A1 Abcam HEK293T LAPTM4A KO transformed cell line human CVCL_B3A1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6924; LAPTM4A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357382 CVCL_B3A4 Abcam HEK293T LDHB KO transformed cell line human CVCL_B3A4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6541; LDHB; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357383 CVCL_B3A3 Abcam HEK293T LBR KO transformed cell line human CVCL_B3A3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6518; LBR; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357384 CVCL_B3BG Abcam HEK293T MTMR4 KO transformed cell line human CVCL_B3BG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7452; MTMR4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357385 CVCL_B3BF Abcam HEK293T MTHFD2 KO transformed cell line human CVCL_B3BF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7434; MTHFD2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357386 CVCL_B3BI Abcam HEK293T MTR KO transformed cell line human CVCL_B3BI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7468; MTR; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357387 CVCL_B3BH Abcam HEK293T MTOR KO transformed cell line human CVCL_B3BH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3942; MTOR; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357388 CVCL_B3BK Abcam HEK293T MTRNR2L8 KO transformed cell line human CVCL_B3BK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37165; MTRNR2L8; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357389 CVCL_B3BJ Abcam HEK293T MTRNR2L1 KO transformed cell line human CVCL_B3BJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37155; MTRNR2L1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357390 CVCL_B3BM Abcam HEK293T MYC KO transformed cell line human CVCL_B3BM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7553; MYC; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357391 CVCL_B3BL Abcam HEK293T MTX1 KO transformed cell line human CVCL_B3BL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7504; MTX1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357392 CVCL_B3BA Abcam HEK293T MRPL50 KO transformed cell line human CVCL_B3BA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16654; MRPL50; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357393 CVCL_B3BC Abcam HEK293T MT2A KO transformed cell line human CVCL_B3BC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7406; MT2A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Discontinued: Abcam; ab266538; true Female 151357394 CVCL_B3BB Abcam HEK293T MRPS28 KO transformed cell line human CVCL_B3BB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14513; MRPS28; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357395 CVCL_B3BE Abcam HEK293T MTHFD1L KO transformed cell line human CVCL_B3BE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21055; MTHFD1L; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357396 CVCL_B3BD Abcam HEK293T MTCH2 KO transformed cell line human CVCL_B3BD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17587; MTCH2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357397 CVCL_B3AV Abcam HEK293T MATK KO transformed cell line human CVCL_B3AV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6906; MATK; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Discontinued: Abcam; ab266171; true Female 151357398 CVCL_B3B7 Abcam HEK293T MPST KO transformed cell line human CVCL_B3B7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7223; MPST; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357399 CVCL_B3AU Abcam HEK293T MAT2B KO transformed cell line human CVCL_B3AU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6905; MAT2B; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357400 CVCL_B3B6 Abcam HEK293T MPP2 KO transformed cell line human CVCL_B3B6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7220; MPP2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357401 CVCL_B3AX Abcam HEK293T MDH2 KO transformed cell line human CVCL_B3AX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6971; MDH2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357402 CVCL_B3B9 Abcam HEK293T MRPL2 KO transformed cell line human CVCL_B3B9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14056; MRPL2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357403 CVCL_B3AW Abcam HEK293T MCL1 KO transformed cell line human CVCL_B3AW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6943; MCL1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357404 CVCL_B3B8 Abcam HEK293T MRFAP1 KO transformed cell line human CVCL_B3B8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24549; MRFAP1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357405 CVCL_B3AZ Abcam HEK293T MEX3B KO transformed cell line human CVCL_B3AZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25297; MEX3B; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357406 CVCL_B3AY Abcam HEK293T MEA1 KO transformed cell line human CVCL_B3AY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6986; MEA1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357407 CVCL_B3AN Abcam HEK293T MAPK12 KO transformed cell line human CVCL_B3AN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6874; MAPK12; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357408 CVCL_B3AM Abcam HEK293T MAP7D1 KO transformed cell line human CVCL_B3AM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25514; MAP7D1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357409 CVCL_B3AP Abcam HEK293T MAPK14 KO transformed cell line human CVCL_B3AP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6876; MAPK14; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357410 CVCL_B3B1 Abcam HEK293T MKNK2 KO transformed cell line human CVCL_B3B1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7111; MKNK2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357411 CVCL_B3B0 Abcam HEK293T MIX23 KO transformed cell line human CVCL_B3B0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31136; MIX23; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357412 CVCL_B3AR Abcam HEK293T MAPK8IP1 KO transformed cell line human CVCL_B3AR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6882; MAPK8IP1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357413 CVCL_B3B3 Abcam HEK293T MMADHC KO transformed cell line human CVCL_B3B3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25221; MMADHC; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357414 CVCL_B3AQ Abcam HEK293T MAPK3 KO transformed cell line human CVCL_B3AQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6877; MAPK3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357415 CVCL_B3B2 Abcam HEK293T MKRN1 KO transformed cell line human CVCL_B3B2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7112; MKRN1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357416 CVCL_B3AT Abcam HEK293T MAPKAPK5 KO transformed cell line human CVCL_B3AT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6889; MAPKAPK5; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357417 CVCL_B3B5 Abcam HEK293T MPP1 KO transformed cell line human CVCL_B3B5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7219; MPP1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357418 CVCL_B3AS Abcam HEK293T MAPK9 KO transformed cell line human CVCL_B3AS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6886; MAPK9; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357419 CVCL_B3B4 Abcam HEK293T MPDU1 KO transformed cell line human CVCL_B3B4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7207; MPDU1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357420 CVCL_B3MR CHIpMSC3 somatic stem cell human CVCL_B3MR CL:0000010 Sequence variation: Mutation; HGNC; HGNC:59; ABCC8; Simple; p.Arg1493Gln (c.4478G>A) (R1494Q); ClinVar=VCV000370910; Zygosity=Homozygous (PubMed=31525223) Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Cell type: Mesenchymal stem cell; CL=CL_0000134. Male 151357421 CVCL_B3N3 Sua-5B-IE8-Act::Cas9-2A-Neo spontaneously immortalized cell line CVCL_B3N3 CL:0000010 Genetic integration: Method=Transfection; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 Breed/subspecies: Suakoko 2La. Unspecified Characteristics: Modified using a Minos mediated integration cassette (MiMIC) to deliver a recombination-mediated cassette (RMCE) acceptor, to add a docking site for recombination via the bacteriophage FC31 integrase; Characteristics: A N-3xFLAG-spCas9-T2A-Neo construct was integrated in the Act5C locus (PubMed=34819517) Doubling time: ~20 hours (DGRC=334) Group: Insect cell line; Group: Malaria research cell line 151357422 CVCL_B3MQ CHIpMSC1 somatic stem cell human CVCL_B3MQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:59; ABCC8; Simple; p.Gly316Arg (c.946G>A); ClinVar=VCV001687413; Zygosity=Heterozygous (PubMed=31525223) Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Cell type: Mesenchymal stem cell; CL=CL_0000134. Male 151357423 CVCL_B3N2 Sua-5B-IE8 spontaneously immortalized cell line CVCL_B3N2 CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)) Breed/subspecies: Suakoko 2La. Unspecified Characteristics: Modified using a Minos mediated integration cassette (MiMIC) to deliver a recombination-mediated cassette (RMCE) acceptor, to add a docking site for recombination via the bacteriophage FC31 integrase Doubling time: ~20 hours (DGRC=333) Group: Insect cell line; Group: Malaria research cell line 151357424 CVCL_B3N5 C6/36-HE8 spontaneously immortalized cell line CVCL_B3N5 CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)). Unspecified Characteristics: Modified using a Minos mediated integration cassette (MiMIC) to deliver a recombination-mediated cassette (RMCE) acceptor, to add a docking site for recombination via the bacteriophage FC31 integrase Doubling time: ~24 hours (DGRC=336) Group: Insect cell line 151357425 CVCL_B3MT NCKDi003-A induced pluripotent stem cell human CVCL_B3MT From: National Center of Kidney Diseases; Nanjing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2023; CLCN5; Simple; p.Thr347Pro (c.1042A>C) (p.Thr277Pro, c.829A>C); Zygosity=Unspecified (PubMed=34547705) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Caution: Mutation indicated as hemizygous in title of PubMed=34547705 but this cell line is from a normal X,X female patient so it can't be hemizygous 151357426 CVCL_B3MS JEI-001 telomerase immortalized cell line human CVCL_B3MS CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; c.515delG; Zygosity=Heterozygous (PubMed=34539995); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Chinese; Derived from site: In situ; Peripheral nervous system, vestibular nerve; UBERON=UBERON_0003723; Cell type: Schwann cell; CL=CL_0002573. Omics: Transcriptomics; RNAseq Male Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2019182 151357427 CVCL_B3N4 NAMRU2-CQ-01-1.7 spontaneously immortalized cell line CVCL_B3N4 CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)) Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female Characteristics: Modified using a Minos mediated integration cassette (MiMIC) to deliver a recombination-mediated cassette (RMCE) acceptor, to add a docking site for recombination via the bacteriophage FC31 integrase Doubling time: ~24 hours (DGRC=335) Group: Insect cell line 151357428 CVCL_B3MV 1C8 [Mouse hybridoma against N.fowleri NfCPB-L] hybridoma house mouse CVCL_B3MV CL:0000010 Monoclonal antibody isotype: IgG3, kappa; Monoclonal antibody target: UniProtKB; X5D911; Naegleria fowleri cathepsin B-like (NfCPB-L). 151357429 CVCL_B3N7 btl>Ras attP-L3 spontaneously immortalized cell line fruit fly CVCL_B3N7 CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Epithelial cell; CL=CL_0000066. Unspecified Characteristics: btl-Gal4 driving UAS-RasV12 and UAS-p35 (baculovirus anti-apoptotic factor p35) with an attP flanked cassette for RMCE Group: Insect cell line 151357430 CVCL_B3N6 BPT-1 spontaneously immortalized cell line CVCL_B3N6 CL:0000010 Derived from site: In situ; Trophectoderm; UBERON=UBERON_0004345. Female Doubling time: ~96 hours (PubMed=15293218) 151357431 CVCL_B3MU SDPHi001-A induced pluripotent stem cell human CVCL_B3MU From: Shandong Provincial Hospital Affiliated to Shandong First Medical University; Jinan; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151357432 CVCL_B3MX 2C9 [Mouse hybridoma against N.fowleri NfCPB] hybridoma house mouse CVCL_B3MX CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; X5D761; Naegleria fowleri cathepsin B (NfCPB). 151357433 CVCL_B3N9 ENTZ HLC 2 cancer cell line human CVCL_B3N9 CL:0000010 Derived from site: In situ; Larynx; UBERON=UBERON_0001737. Unspecified 151357434 CVCL_B3MW 1D9 [Mouse hybridoma against N.fowleri NfCPB-L] hybridoma house mouse CVCL_B3MW CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; X5D911; Naegleria fowleri cathepsin B-like (NfCPB-L). 151357435 CVCL_B3N8 ENTZ HLC 1 cancer cell line human CVCL_B3N8 CL:0000010 Derived from site: In situ; Larynx; UBERON=UBERON_0001737. Unspecified 151357436 CVCL_B3MJ MK-31M finite cell line human CVCL_B3MJ CL:0000010 Population: Japanese. Female 151357437 CVCL_B3MI MK-31F finite cell line human CVCL_B3MI CL:0000010 Population: Japanese. Male 151357438 CVCL_B3ML HCC1419/TDR cancer cell line human CVCL_B3ML CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala74fs*47 (c.220_226delGCCCCTG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Heterozygous (from parent cell line) Selected for resistance to: DrugBank; DB05773; Trastuzumab emtansine (T-DM1); Derived from site: In situ; Breast; UBERON=UBERON_0000310. Female 151357439 CVCL_B3MK Akata delta2 EBER1(+) cancer cell line human CVCL_B3MK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Cell type: B-cell; CL=CL_0000236. Female Virology: EBV-negative cell line re-infected with recombinant EBV whose genome is KO for EBER1 and EBER2 and which was knocked-in for EBER1 only 151357440 CVCL_B3MN SKBR3/TDR cancer cell line human CVCL_B3MN CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: DrugBank; DB05773; Trastuzumab emtansine (T-DM1); Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 151357441 CVCL_B3MM HCC1954/TDR cancer cell line human CVCL_B3MM CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:2092; CLTC + HGNC; HGNC:29559; VMP1; Name(s)=CLTC-VMP1 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163Cys (c.488A>G); ClinVar=VCV000127814; Zygosity=Homozygous (from parent cell line) Population: East Indian; Selected for resistance to: DrugBank; DB05773; Trastuzumab emtansine (T-DM1); Derived from site: In situ; Breast; UBERON=UBERON_0000310. Female 151357442 CVCL_B3MP CHIpMSC2 somatic stem cell human CVCL_B3MP CL:0000010 Derived from site: In situ; Pancreas; UBERON=UBERON_0001264; Cell type: Mesenchymal stem cell; CL=CL_0000134. Female 151357443 CVCL_B3N0 HEK293-mir122 transformed cell line human CVCL_B3N0 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:31501; MIR122; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357444 CVCL_B3MB DR-EcoScreen-HS cancer cell line house mouse CVCL_B3MB CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase Derived from site: In situ; Liver; UBERON=UBERON_0002107; Breed/subspecies: C57L/J. Biotechnology: Used in a bioassay for the determination of polychlorinated dibenzo-p-dioxins (PCDDs), polychlorinated dibenzofurans (PCDFs) and dioxin-like polychlorinated biphenyls (DL-PCBs) in environmental and food samples Female Characteristics: Acts through the activation of a luciferase reporter gene under the control of dioxin-response elements (DREs); Characteristics: Has higher responsiveness to TCDD than DR-EcoScreen (JCRB=JCRB1853) 151357445 CVCL_B3MA Cx43KOM104-E7(+/+) spontaneously immortalized cell line house mouse CVCL_B3MA CL:0000010 Miscellaneous: The 3 cell lines Cx43KOM104-E7(-/-) (Cellosaurus=CVCL_B3MA), Cx43KOM104-E4(+/-) (Cellosaurus=CVCL_B3M8) and Cx43KOM104-E6(-/-) (Cellosaurus=CVCL_B3M9) originate from embryos of different Gja1 genotype which are the outcome of a cross betwee two Gja(+/-) mice Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C57BL/6. Unspecified 151357446 CVCL_B3MD MK-37b finite cell line human CVCL_B3MD CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Discontinued: JCRB; KURB2731; probable Ambiguous 151357447 CVCL_B3MC D21-iPSC#2 induced pluripotent stem cell human CVCL_B3MC CL:0000010 Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173. Female Characteristics: While originating from a Down syndrome patient, this cell line has lost the extra copy of chromosome 21 151357448 CVCL_B3MF MK-42 finite cell line human CVCL_B3MF CL:0000010 Population: Japanese. Female 151357449 CVCL_B3ME MK-37a finite cell line human CVCL_B3ME CL:0000010 Derived from site: In situ; Gonad; UBERON=UBERON_0000991. Ambiguous 151357450 CVCL_B3MH MK-31 finite cell line human CVCL_B3MH CL:0000010 Population: Japanese; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151357451 CVCL_B3MG MK-36 finite cell line human CVCL_B3MG CL:0000010 Population: Japanese; Karyotypic information: 46,XY,inv(20)mat (JCRB=KURB2798); Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173. Male 151357452 CVCL_B3LY T21-iPSC#1 induced pluripotent stem cell human CVCL_B3LY CL:0000010 Karyotypic information: 47,XX,+21 (PubMed=30760866); Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173. Female 151357453 CVCL_B3M9 Cx43KOM104-E6(-/-) spontaneously immortalized cell line house mouse CVCL_B3M9 CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:95713; Gja1 Miscellaneous: The 3 cell lines Cx43KOM104-E7(-/-) (Cellosaurus=CVCL_B3MA), Cx43KOM104-E4(+/-) (Cellosaurus=CVCL_B3M8) and Cx43KOM104-E6(-/-) (Cellosaurus=CVCL_B3M9) originate from embryos of different Gja1 genotype which are the outcome of a cross betwee two Gja(+/-) mice Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C57BL/6. Unspecified 151357454 CVCL_B3LX D21-iPSC#1 induced pluripotent stem cell human CVCL_B3LX CL:0000010 Karyotypic information: 46,XX [17/20]; 45,X [1/20]; 45,XX,-12 [1/20]; 90,XXXX,-14,-17 [1/20] (JCRB=JCRB1836); Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173. Female Characteristics: While originating from a Down syndrome patient, this cell line has lost the extra copy of chromosome 21 151357455 CVCL_B3LZ T21-iPSC#5 induced pluripotent stem cell human CVCL_B3LZ CL:0000010 Karyotypic information: 47,XX,+21 (PubMed=30760866); Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173. Female 151357456 CVCL_B3NS CHOPi007-A induced pluripotent stem cell human CVCL_B3NS From: Children's Hospital of Philadelphia; Philadelphia; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:20774; TUBB4A; Simple; p.Asp249Asn (c.745G>A); ClinVar=VCV000050985; Zygosity=Heterozygous (PubMed=37003180) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151357457 CVCL_B3NR CHOPi006-A induced pluripotent stem cell human CVCL_B3NR From: Children's Hospital of Philadelphia; Philadelphia; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:20774; TUBB4A; Simple; p.Asp249Asn (c.745G>A); ClinVar=VCV000050985; Zygosity=Heterozygous (PubMed=37003180) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151357458 CVCL_B3NU CSUASOi008-A induced pluripotent stem cell human CVCL_B3NU From: Central South University, Aier School of Ophthalmology; Changsha; China CL:0000010 Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151357459 CVCL_B3NT CIBi010-A induced pluripotent stem cell human CVCL_B3NT From: Cell Inspire Biotechnology; Shenzhen; China CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)) Population: Asian; Derived from site: In situ; Urine; UBERON=UBERON_0001088; Cell type: Epithelial cell of kidney; CL=CL_0002518. Male Characteristics: Using CRISPR/Cas9 a T2A-mCherry construct was integrated in front of the stop codon of both alleles of ASGR1 (PubMed=35561459) 151357460 CVCL_B3NW DHMCi006-A induced pluripotent stem cell human CVCL_B3NW From: Dietmar Hopp Metabolic Center, Center for Child and Adolescent Medicine Heidelberg; Heidelberg; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9016; PKHD1; Simple; p.Arg2111Gly (c.6331A>G); Zygosity=Heterozygous (PubMed=34695767); Sequence variation: Mutation; HGNC; HGNC:9016; PKHD1; Simple; p.Arg2573Cys (c.7717C>T); ClinVar=VCV000499806; Zygosity=Heterozygous (PubMed=34695767) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151357461 CVCL_B3NV CSUXHi006-A induced pluripotent stem cell human CVCL_B3NV From: Department of Neurology, Xiangya Hospital of Central South University; Changsha; China. CL:0000010 Male 151357462 CVCL_B3NY DMBi002-A induced pluripotent stem cell human CVCL_B3NY From: Department of Medical Biotechnology, Jagiellonian University; Krakow; Poland CL:0000010 Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=34678665) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151357463 CVCL_B3NX DHMCi007-A induced pluripotent stem cell human CVCL_B3NX From: Dietmar Hopp Metabolic Center, Center for Child and Adolescent Medicine Heidelberg; Heidelberg; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9016; PKHD1; Simple; p.Asp2762Val (c.8285A>T); ClinVar=VCV000522472; Zygosity=Homozygous (PubMed=34688127) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151357464 CVCL_B3NK SIE-MSH-805-At spontaneously immortalized cell line CVCL_B3NK CL:0000010 Unspecified Group: Insect cell line. 151357465 CVCL_B3NJ SIE-MSH-805-F spontaneously immortalized cell line CVCL_B3NJ CL:0000010 Unspecified Group: Insect cell line. 151357466 CVCL_B3NM BBANTWi007-A induced pluripotent stem cell human CVCL_B3NM From: Biobank Antwerpen; Antwerp; Belgium CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; c.4714+95GGGT[3] (c.4813+3_4813+6dupGGGT); ClinVar=VCV000254157; Zygosity=Heterozygous (PubMed=35247843) Population: Caucasian; Belgian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151357467 CVCL_B3NL BBANTWi006-A induced pluripotent stem cell human CVCL_B3NL From: Biobank Antwerpen; Antwerp; Belgium CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; c.4714+95GGGT[3] (c.4813+3_4813+6dupGGGT); ClinVar=VCV000254157; Zygosity=Heterozygous (PubMed=35247843) Population: Caucasian; Belgian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151357468 CVCL_B3NN BCMi002-A induced pluripotent stem cell human CVCL_B3NN From: Baylor College of Medicine; Houston; USA CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151357469 CVCL_B3NQ CHOPi005-A induced pluripotent stem cell human CVCL_B3NQ From: Children's Hospital of Philadelphia; Philadelphia; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:20774; TUBB4A; Simple; p.Asp249Asn (c.745G>A); ClinVar=VCV000050985; Zygosity=Heterozygous (PubMed=37003180) Population: Asian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151357470 CVCL_B3NP CCMi005-A induced pluripotent stem cell human CVCL_B3NP From: Centro Cardiologico Monzino; Milan; Italy CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex45-50del; Zygosity=Hemizygous (PubMed=35961103) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151357471 CVCL_B3NC SMG-hu-1 transformed cell line human CVCL_B3NC CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736. Female 151357472 CVCL_B3NB ENTZ HTC 2 cancer cell line human CVCL_B3NB CL:0000010 Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Unspecified 151357473 CVCL_B3NE IOZCAS-Ha-8 spontaneously immortalized cell line CVCL_B3NE CL:0000010 Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female Doubling time: 34.1 hours (Patent=CN112695010B) Group: Insect cell line; Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.17690 151357474 CVCL_B3ND IOZCAS-Myse-1 spontaneously immortalized cell line CVCL_B3ND CL:0000010 Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female Doubling time: ~34 hours (PubMed=34599689) Group: Insect cell line; Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.17282 151357475 CVCL_B3NG SIE-MSH-805 spontaneously immortalized cell line CVCL_B3NG CL:0000010 Unspecified Group: Insect cell line. 151357476 CVCL_B3NF IOZCAS-Spex-IX telomerase immortalized cell line CVCL_B3NF CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female Doubling time: 70.09 hours (Patent=CN102807969B) Group: Insect cell line; Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.4506 151357477 CVCL_B3NI AH9 hybridoma house mouse CVCL_B3NI CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q9F6Z8; Acinetobacter baumannii beta-lactamase IMP-4. Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.20287 151357478 CVCL_B3NH 1AA4 hybridoma house mouse CVCL_B3NH CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q9F6Z8; Acinetobacter baumannii beta-lactamase IMP-4. Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.20288 151357479 CVCL_B3MZ AF6 hybridoma house mouse CVCL_B3MZ CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Acanthamoeba castellanii galactose-binding protein. 151357480 CVCL_B3MY 2D6 hybridoma house mouse CVCL_B3MY CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; X5D761; Naegleria fowleri cathepsin B (NfCPB). 151357481 CVCL_B3NA ENTZ HTC 1 cancer cell line human CVCL_B3NA CL:0000010 Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Unspecified 151357482 CVCL_B3KP Abcam HEK293T UBXN6 KO transformed cell line human CVCL_B3KP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14928; UBXN6; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357483 CVCL_B3L1 Abcam HEK293T USP33 KO transformed cell line human CVCL_B3L1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20059; USP33; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357484 CVCL_B3L0 Abcam HEK293T USP24 KO transformed cell line human CVCL_B3L0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12623; USP24; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Discontinued: Abcam; ab266643; true Female 151357485 CVCL_B3KR Abcam HEK293T UCK1 KO transformed cell line human CVCL_B3KR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14859; UCK1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357486 CVCL_B3L3 Abcam HEK293T UTP11 KO transformed cell line human CVCL_B3L3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24329; UTP11; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357487 CVCL_B3KQ Abcam HEK293T UCHL1 KO transformed cell line human CVCL_B3KQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12513; UCHL1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357488 CVCL_B3L2 Abcam HEK293T USP7 KO transformed cell line human CVCL_B3L2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12630; USP7; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357489 CVCL_B3KT Abcam HEK293T UFL1 KO transformed cell line human CVCL_B3KT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23039; UFL1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357490 CVCL_B3L5 Abcam HEK293T VAT1 KO transformed cell line human CVCL_B3L5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16919; VAT1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357491 CVCL_B3KS Abcam HEK293T UFC1 KO transformed cell line human CVCL_B3KS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26941; UFC1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357492 CVCL_B3L4 Abcam HEK293T VAMP8 KO transformed cell line human CVCL_B3L4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12647; VAMP8; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357493 CVCL_B3KV Abcam HEK293T UFSP2 KO transformed cell line human CVCL_B3KV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25640; UFSP2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357494 CVCL_B3L7 Abcam HEK293T VDAC3 KO transformed cell line human CVCL_B3L7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12674; VDAC3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357495 CVCL_B3KU Abcam HEK293T UFM1 KO transformed cell line human CVCL_B3KU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20597; UFM1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357496 CVCL_B3L6 Abcam HEK293T VDAC1 KO transformed cell line human CVCL_B3L6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12669; VDAC1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357497 CVCL_B3KH Abcam HEK293T TYK2 KO transformed cell line human CVCL_B3KH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12440; TYK2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357498 CVCL_B3KG Abcam HEK293T TXNRD3 KO transformed cell line human CVCL_B3KG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20667; TXNRD3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357499 CVCL_B3KJ Abcam HEK293T UBE2E1 KO transformed cell line human CVCL_B3KJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12477; UBE2E1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357500 CVCL_B3KI Abcam HEK293T UBE2A KO transformed cell line human CVCL_B3KI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12472; UBE2A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357501 CVCL_B3KL Abcam HEK293T UBE2J2 KO transformed cell line human CVCL_B3KL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19268; UBE2J2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357502 CVCL_B3KK Abcam HEK293T UBE2G1 KO transformed cell line human CVCL_B3KK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12482; UBE2G1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357503 CVCL_B3KN Abcam HEK293T UBXN1 KO transformed cell line human CVCL_B3KN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18402; UBXN1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357504 CVCL_B3KM Abcam HEK293T UBE2S KO transformed cell line human CVCL_B3KM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17895; UBE2S; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357505 CVCL_B3KB Abcam HEK293T TUBB4B KO transformed cell line human CVCL_B3KB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20771; TUBB4B; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357506 CVCL_B3KA Abcam HEK293T TUBB2A KO transformed cell line human CVCL_B3KA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12412; TUBB2A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357507 CVCL_B3KD Abcam HEK293T TXNDC5 KO transformed cell line human CVCL_B3KD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21073; TXNDC5; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357508 CVCL_B3KC Abcam HEK293T TWF2 KO transformed cell line human CVCL_B3KC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9621; TWF2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357509 CVCL_B3KF Abcam HEK293T TXNRD2 KO transformed cell line human CVCL_B3KF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18155; TXNRD2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357510 CVCL_B3KE Abcam HEK293T TXNL1 KO transformed cell line human CVCL_B3KE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12436; TXNL1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357511 CVCL_B3JW Abcam HEK293T TOP2B KO transformed cell line human CVCL_B3JW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11990; TOP2B; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357512 CVCL_B3K8 Abcam HEK293T TROAP KO transformed cell line human CVCL_B3K8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12327; TROAP; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357513 CVCL_B3JV Abcam HEK293T TOP1MT KO transformed cell line human CVCL_B3JV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29787; TOP1MT; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357514 CVCL_B3K7 Abcam HEK293T TRMT1 KO transformed cell line human CVCL_B3K7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25980; TRMT1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357515 CVCL_B3JY Abcam HEK293T TPM3 KO transformed cell line human CVCL_B3JY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12012; TPM3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357516 CVCL_B3JX Abcam HEK293T TP53INP2 KO transformed cell line human CVCL_B3JX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16104; TP53INP2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357517 CVCL_B3K9 Abcam HEK293T TTLL12 KO transformed cell line human CVCL_B3K9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28974; TTLL12; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357518 CVCL_B3JZ Abcam HEK293T TPM4 KO transformed cell line human CVCL_B3JZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12013; TPM4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357519 CVCL_B3LQ Abcam HEK293T ZYX KO 2 transformed cell line human CVCL_B3LQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13200; ZYX; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357520 CVCL_B3M2 T21-iPSC#12 induced pluripotent stem cell human CVCL_B3M2 CL:0000010 Karyotypic information: 47,XX,+21 (PubMed=30760866); Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173. Female 151357521 CVCL_B3LP Abcam HEK293T ZNRD2 KO transformed cell line human CVCL_B3LP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11328; ZNRD2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357522 CVCL_B3M1 T21-iPSC#9 induced pluripotent stem cell human CVCL_B3M1 CL:0000010 Karyotypic information: 47,XX,+21 (PubMed=30760866); Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173. Female 151357523 CVCL_B3M4 HeLa-TMPRSS2 cancer cell line human CVCL_B3M4 CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11876; TMPRSS2; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Virology: Can be used to isolate human coronavirus 229E (HCoV-229E) (JCRB=JCRB1838) 151357524 CVCL_B3LS Vero PVR1/2 DKO spontaneously immortalized cell line green monkey CVCL_B3LS CL:0000010 Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9S1N4; PVR1; Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9S1L1; PVR2 Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819; Cell type: Epithelial cell of kidney; CL=CL_0002518. Female Virology: Not susceptible to infection by poliovirus Group: Non-human primate cell line 151357525 CVCL_B3M3 T21-KC-K4DT telomerase immortalized cell line human CVCL_B3M3 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173; Cell type: Keratinocyte; CL=CL_0000312. Female 151357526 CVCL_B3LR Vero PVR1 KO spontaneously immortalized cell line green monkey CVCL_B3LR CL:0000010 Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9S1N4; PVR1 Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819; Cell type: Epithelial cell of kidney; CL=CL_0002518. Female Group: Non-human primate cell line 151357527 CVCL_B3LU Akata EBER(-) EBV cancer cell line human CVCL_B3LU CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Cell type: B-cell; CL=CL_0000236. Female Virology: EBV-negative cell line re-infected with recombinant EBV whose genome is KO for EBER1 and EBER2 151357528 CVCL_B3M6 Akata EBER(+) EBV cancer cell line human CVCL_B3M6 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Cell type: B-cell; CL=CL_0000236. Female Virology: EBV-negative cell line re-infected with recombinant EBV whose genome is KO for EBER1 and EBER2 and which was knocked-in for both EBERs 151357529 CVCL_B3M5 BALM-24 cancer cell line human CVCL_B3M5 CL:0000010 Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female Virology: EBV-negative 151357530 CVCL_B3LT Vero PVR2 KO spontaneously immortalized cell line green monkey CVCL_B3LT CL:0000010 Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9S1L1; PVR2 Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819; Cell type: Epithelial cell of kidney; CL=CL_0002518. Female Group: Non-human primate cell line 151357531 CVCL_B3M8 Cx43KOM104-E4(+/-) spontaneously immortalized cell line house mouse CVCL_B3M8 CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:95713; Gja1 (Note=1 of 2 alleles) Miscellaneous: The 3 cell lines Cx43KOM104-E7(-/-) (Cellosaurus=CVCL_B3MA), Cx43KOM104-E4(+/-) (Cellosaurus=CVCL_B3M8) and Cx43KOM104-E6(-/-) (Cellosaurus=CVCL_B3M9) originate from embryos of different Gja1 genotype which are the outcome of a cross betwee two Gja(+/-) mice Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: C57BL/6. Unspecified 151357532 CVCL_B3LW HeLa-ACE2 cancer cell line human CVCL_B3LW CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151357533 CVCL_B3LV HeLa-ACE2-TMPRSS2 cancer cell line human CVCL_B3LV CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2; Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11876; TMPRSS2; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Virology: Can be used to isolate human coronavirus NL63 (HCoV-NL63) (JCRB=JCRB1835) 151357534 CVCL_B3M7 TYEK-2 cancer cell line human CVCL_B3M7 CL:0000010 Population: Japanese; Derived from site: Metastatic; Esophagus; UBERON=UBERON_0001043. Male Doubling time: 21.9 hours (JCRB=JCRB1848) 151357535 CVCL_B3LI Abcam HEK293T YIPF3 KO transformed cell line human CVCL_B3LI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21023; YIPF3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357536 CVCL_B3LH Abcam HEK293T YIF1A KO transformed cell line human CVCL_B3LH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16688; YIF1A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357537 CVCL_B3LK Abcam HEK293T ZC3H15 KO transformed cell line human CVCL_B3LK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29528; ZC3H15; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357538 CVCL_B3LJ Abcam HEK293T YWHAG KO transformed cell line human CVCL_B3LJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12852; YWHAG; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357539 CVCL_B3LM Abcam HEK293T ZNF593 KO transformed cell line human CVCL_B3LM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30943; ZNF593; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357540 CVCL_B3LL Abcam HEK293T ZFR KO transformed cell line human CVCL_B3LL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17277; ZFR; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357541 CVCL_B3M0 T21-iPSC#6 induced pluripotent stem cell human CVCL_B3M0 CL:0000010 Karyotypic information: 47,XX,+21 (PubMed=30760866); Karyotypic information: At 66th passage: 46,X0,+21 (JCRB=JCRB1839); Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173. Female 151357542 CVCL_B3LN Abcam HEK293T ZNHIT1 KO transformed cell line human CVCL_B3LN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21688; ZNHIT1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357543 CVCL_B3LA Abcam HEK293T WASF3 KO 1 transformed cell line human CVCL_B3LA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12734; WASF3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357544 CVCL_B3LC Abcam HEK293T WDR83OS KO transformed cell line human CVCL_B3LC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30203; WDR83OS; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357545 CVCL_B3LB Abcam HEK293T WASF3 KO 2 transformed cell line human CVCL_B3LB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12734; WASF3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357546 CVCL_B3LE Abcam HEK293T WNK2 KO 2 transformed cell line human CVCL_B3LE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14542; WNK2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357547 CVCL_B3LD Abcam HEK293T WNK2 KO 1 transformed cell line human CVCL_B3LD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14542; WNK2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357548 CVCL_B3LG Abcam HEK293T YDJC KO transformed cell line human CVCL_B3LG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27158; YDJC; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357549 CVCL_B3LF Abcam HEK293T YBX3 KO transformed cell line human CVCL_B3LF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2428; YBX3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357550 CVCL_B3KX Abcam HEK293T UQCC2 KO transformed cell line human CVCL_B3KX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21237; UQCC2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357551 CVCL_B3L9 Abcam HEK293T VRK1 KO transformed cell line human CVCL_B3L9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12718; VRK1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357552 CVCL_B3KW Abcam HEK293T ULK3 KO transformed cell line human CVCL_B3KW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19703; ULK3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357553 CVCL_B3L8 Abcam HEK293T VKORC1 KO transformed cell line human CVCL_B3L8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23663; VKORC1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357554 CVCL_B3KZ Abcam HEK293T USP16 KO transformed cell line human CVCL_B3KZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12614; USP16; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357555 CVCL_B3KY Abcam HEK293T UQCRQ KO transformed cell line human CVCL_B3KY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29594; UQCRQ; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357556 CVCL_B3IN Abcam HEK293T SUCLG2 KO transformed cell line human CVCL_B3IN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11450; SUCLG2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357557 CVCL_B3IM Abcam HEK293T SUCLG1 KO transformed cell line human CVCL_B3IM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11449; SUCLG1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357558 CVCL_B3IP Abcam HEK293T SUFU KO transformed cell line human CVCL_B3IP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16466; SUFU; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357559 CVCL_B3J1 Abcam HEK293T TAOK2 KO transformed cell line human CVCL_B3J1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16835; TAOK2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357560 CVCL_B3J0 Abcam HEK293T TALDO1 KO transformed cell line human CVCL_B3J0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11559; TALDO1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357561 CVCL_B3IR Abcam HEK293T SURF4 KO transformed cell line human CVCL_B3IR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11476; SURF4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357562 CVCL_B3J3 Abcam HEK293T TBRG4 KO transformed cell line human CVCL_B3J3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17443; TBRG4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357563 CVCL_B3IQ Abcam HEK293T SUPT20H KO transformed cell line human CVCL_B3IQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20596; SUPT20H; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357564 CVCL_B3J2 Abcam HEK293T TAX1BP1 KO transformed cell line human CVCL_B3J2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11575; TAX1BP1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357565 CVCL_B3IT Abcam HEK293T SYNGR2 KO transformed cell line human CVCL_B3IT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11499; SYNGR2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357566 CVCL_B3J5 Abcam HEK293T TEAD4 KO transformed cell line human CVCL_B3J5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11717; TEAD4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357567 CVCL_B3IS Abcam HEK293T SYAP1 KO transformed cell line human CVCL_B3IS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16273; SYAP1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357568 CVCL_B3J4 Abcam HEK293T TCEAL9 KO transformed cell line human CVCL_B3J4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30084; TCEAL9; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357569 CVCL_B3IF Abcam HEK293T STK16 KO transformed cell line human CVCL_B3IF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11394; STK16; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357570 CVCL_B3IE Abcam HEK293T STK11 KO transformed cell line human CVCL_B3IE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11389; STK11; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357571 CVCL_B3IH Abcam HEK293T STRADB KO transformed cell line human CVCL_B3IH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13205; STRADB; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357572 CVCL_B3IG Abcam HEK293T STK35 KO transformed cell line human CVCL_B3IG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16254; STK35; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357573 CVCL_B3IJ Abcam HEK293T STT3A KO transformed cell line human CVCL_B3IJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6172; STT3A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357574 CVCL_B3II Abcam HEK293T STRAP KO transformed cell line human CVCL_B3II CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30796; STRAP; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357575 CVCL_B3IL Abcam HEK293T STX10 KO transformed cell line human CVCL_B3IL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11428; STX10; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357576 CVCL_B3IK Abcam HEK293T STT3B KO transformed cell line human CVCL_B3IK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30611; STT3B; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357577 CVCL_B3IB Abcam HEK293T SSNA1 KO transformed cell line human CVCL_B3IB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11321; SSNA1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357578 CVCL_B3IA Abcam HEK293T SSBP4 KO transformed cell line human CVCL_B3IA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15676; SSBP4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357579 CVCL_B3ID Abcam HEK293T STAM KO transformed cell line human CVCL_B3ID CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11357; STAM; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357580 CVCL_B3IC Abcam HEK293T SSR4 KO transformed cell line human CVCL_B3IC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11326; SSR4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357581 CVCL_B3HU Abcam HEK293T SNRNP40 KO transformed cell line human CVCL_B3HU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30857; SNRNP40; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357582 CVCL_B3I6 Abcam HEK293T SRP9 KO transformed cell line human CVCL_B3I6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11304; SRP9; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357583 CVCL_B3HT Abcam HEK293T SNCA KO transformed cell line human CVCL_B3HT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357584 CVCL_B3I5 Abcam HEK293T SRP68 KO transformed cell line human CVCL_B3I5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11302; SRP68; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357585 CVCL_B3HW Abcam HEK293T SOD2 KO transformed cell line human CVCL_B3HW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11180; SOD2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357586 CVCL_B3I8 Abcam HEK293T SRSF5 KO transformed cell line human CVCL_B3I8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10787; SRSF5; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357587 CVCL_B3HV Abcam HEK293T SNX3 KO transformed cell line human CVCL_B3HV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11174; SNX3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Discontinued: Abcam; ab266164; true Female 151357588 CVCL_B3I7 Abcam HEK293T SRSF10 KO transformed cell line human CVCL_B3I7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16713; SRSF10; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357589 CVCL_B3HY Abcam HEK293T SPAG5 KO transformed cell line human CVCL_B3HY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13452; SPAG5; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357590 CVCL_B3HX Abcam HEK293T SORBS3 KO transformed cell line human CVCL_B3HX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30907; SORBS3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357591 CVCL_B3I9 Abcam HEK293T SRSF6 KO transformed cell line human CVCL_B3I9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10788; SRSF6; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357592 CVCL_B3HZ Abcam HEK293T SPAG7 KO transformed cell line human CVCL_B3HZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11216; SPAG7; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357593 CVCL_B3K0 Abcam HEK293T TRABD KO transformed cell line human CVCL_B3K0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28805; TRABD; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357594 CVCL_B3JN Abcam HEK293T TMEM259 KO transformed cell line human CVCL_B3JN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17039; TMEM259; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357595 CVCL_B3JQ Abcam HEK293T TMEM97 KO transformed cell line human CVCL_B3JQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28106; TMEM97; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357596 CVCL_B3K2 Abcam HEK293T TRAPPC2L KO transformed cell line human CVCL_B3K2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30887; TRAPPC2L; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357597 CVCL_B3JP Abcam HEK293T TMEM59 KO transformed cell line human CVCL_B3JP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1239; TMEM59; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357598 CVCL_B3K1 Abcam HEK293T TRAF2 KO transformed cell line human CVCL_B3K1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11562; TANK; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357599 CVCL_B3JS Abcam HEK293T TMSB4X KO transformed cell line human CVCL_B3JS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11881; TMSB4X; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357600 CVCL_B3K4 Abcam HEK293T TRIP10 KO transformed cell line human CVCL_B3K4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12304; TRIP10; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357601 CVCL_B3JR Abcam HEK293T TMSB10 KO transformed cell line human CVCL_B3JR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11879; TMSB10; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357602 CVCL_B3K3 Abcam HEK293T TRIO KO transformed cell line human CVCL_B3K3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12303; TRIO; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357603 CVCL_B3JU Abcam HEK293T TOMM7 KO transformed cell line human CVCL_B3JU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21648; TOMM7; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357604 CVCL_B3K6 Abcam HEK293T TRIP13 KO 2 transformed cell line human CVCL_B3K6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12307; TRIP13; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357605 CVCL_B3JT Abcam HEK293T TOMM6 KO transformed cell line human CVCL_B3JT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:34528; TOMM6; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357606 CVCL_B3K5 Abcam HEK293T TRIP13 KO 1 transformed cell line human CVCL_B3K5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12307; TRIP13; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357607 CVCL_B3JG Abcam HEK293T TMEM106C KO transformed cell line human CVCL_B3JG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28775; TMEM106C; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357608 CVCL_B3JF Abcam HEK293T TMED9 KO transformed cell line human CVCL_B3JF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24878; TMED9; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357609 CVCL_B3JI Abcam HEK293T TMEM147 KO transformed cell line human CVCL_B3JI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30414; TMEM147; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357610 CVCL_B3JH Abcam HEK293T TMEM126B KO transformed cell line human CVCL_B3JH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30883; TMEM126B; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357611 CVCL_B3JK Abcam HEK293T TMEM160 KO transformed cell line human CVCL_B3JK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26042; TMEM160; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357612 CVCL_B3JJ Abcam HEK293T TMEM14B KO transformed cell line human CVCL_B3JJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21384; TMEM14B; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357613 CVCL_B3JM Abcam HEK293T TMEM208 KO transformed cell line human CVCL_B3JM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25015; TMEM208; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357614 CVCL_B3JL Abcam HEK293T TMEM165 KO transformed cell line human CVCL_B3JL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30760; TMEM165; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357615 CVCL_B3JA Abcam HEK293T TIPRL KO transformed cell line human CVCL_B3JA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30231; TIPRL; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357616 CVCL_B3JC Abcam HEK293T TLE1 KO transformed cell line human CVCL_B3JC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11837; TLE1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357617 CVCL_B3JB Abcam HEK293T TK1 KO transformed cell line human CVCL_B3JB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11830; TK1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357618 CVCL_B3JE Abcam HEK293T TMED4 KO transformed cell line human CVCL_B3JE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22301; TMED4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357619 CVCL_B3JD Abcam HEK293T TMED10 KO transformed cell line human CVCL_B3JD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16998; TMED10; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357620 CVCL_B3IV Abcam HEK293T SYP KO 2 transformed cell line human CVCL_B3IV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11506; SYP; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357621 CVCL_B3J7 Abcam HEK293T TFDP2 KO transformed cell line human CVCL_B3J7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11751; TFDP2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357622 CVCL_B3IU Abcam HEK293T SYP KO 1 transformed cell line human CVCL_B3IU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11506; SYP; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357623 CVCL_B3J6 Abcam HEK293T TECR KO transformed cell line human CVCL_B3J6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4551; TECR; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357624 CVCL_B3IX Abcam HEK293T TACC1 KO transformed cell line human CVCL_B3IX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11522; TACC1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357625 CVCL_B3J9 Abcam HEK293T TIMM17B KO transformed cell line human CVCL_B3J9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17310; TIMM17B; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357626 CVCL_B3IW Abcam HEK293T TAB1 KO transformed cell line human CVCL_B3IW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18157; TAB1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357627 CVCL_B3J8 Abcam HEK293T TIMM17A KO transformed cell line human CVCL_B3J8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17315; TIMM17A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357628 CVCL_B3IZ Abcam HEK293T TAGLN2 KO transformed cell line human CVCL_B3IZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11554; TAGLN2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357629 CVCL_B3IY Abcam HEK293T TACC3 KO transformed cell line human CVCL_B3IY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11524; TACC3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357630 CVCL_B3GL Abcam HEK293T SDHD KO transformed cell line human CVCL_B3GL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10683; SDHD; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357631 CVCL_B3GK Abcam HEK293T SDF4 KO transformed cell line human CVCL_B3GK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24188; SDF4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357632 CVCL_B3GN Abcam HEK293T SEC13 KO transformed cell line human CVCL_B3GN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10697; SEC13; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357633 CVCL_B3GM Abcam HEK293T SEC11A KO transformed cell line human CVCL_B3GM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17718; SEC11A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357634 CVCL_B3GP Abcam HEK293T SEC61B KO transformed cell line human CVCL_B3GP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16993; SEC61B; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357635 CVCL_B3H1 Abcam HEK293T SIVA1 KO transformed cell line human CVCL_B3H1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17712; SIVA1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357636 CVCL_B3H0 Abcam HEK293T SHPK KO transformed cell line human CVCL_B3H0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1492; SHPK; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357637 CVCL_B3GR Abcam HEK293T SELENOH KO transformed cell line human CVCL_B3GR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18251; SELENOH; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357638 CVCL_B3H3 Abcam HEK293T SLC25A10 KO transformed cell line human CVCL_B3H3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10980; SLC25A10; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357639 CVCL_B3GQ Abcam HEK293T SEC61G KO transformed cell line human CVCL_B3GQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18277; SEC61G; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357640 CVCL_B3H2 Abcam HEK293T SLC19A1 KO transformed cell line human CVCL_B3H2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10937; SLC19A1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357641 CVCL_B3GD Abcam HEK293T RTL8C KO transformed cell line human CVCL_B3GD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2569; RTL8C; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357642 CVCL_B3GC Abcam HEK293T RRAS2 KO transformed cell line human CVCL_B3GC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17271; RRAS2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357643 CVCL_B3GF Abcam HEK293T S100A13 KO transformed cell line human CVCL_B3GF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10490; S100A13; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357644 CVCL_B3GE Abcam HEK293T RTN3 KO transformed cell line human CVCL_B3GE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10469; RTN3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357645 CVCL_B3GH Abcam HEK293T SCO1 KO transformed cell line human CVCL_B3GH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10603; SCO1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357646 CVCL_B3GG Abcam HEK293T SARNP KO transformed cell line human CVCL_B3GG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24432; SARNP; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357647 CVCL_B3GJ Abcam HEK293T SDF2L1 KO transformed cell line human CVCL_B3GJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10676; SDF2L1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357648 CVCL_B3GI Abcam HEK293T SCYL1 KO transformed cell line human CVCL_B3GI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14372; SCYL1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357649 CVCL_B3FZ Abcam HEK293T RFX5 KO transformed cell line human CVCL_B3FZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9986; RFX5; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357650 CVCL_B3GB Abcam HEK293T RRAGD KO transformed cell line human CVCL_B3GB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19903; RRAGD; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357651 CVCL_B3GA Abcam HEK293T RRAGA KO transformed cell line human CVCL_B3GA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16963; RRAGA; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357652 CVCL_B3FS Abcam HEK293T RBM3 KO transformed cell line human CVCL_B3FS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9900; RBM3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357653 CVCL_B3G4 Abcam HEK293T RNF167 KO transformed cell line human CVCL_B3G4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24544; RNF167; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357654 CVCL_B3FR Abcam HEK293T RANBP1 KO transformed cell line human CVCL_B3FR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9847; RANBP1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357655 CVCL_B3G3 Abcam HEK293T RNF10 KO transformed cell line human CVCL_B3G3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10055; RNF10; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357656 CVCL_B3FU Abcam HEK293T RBM42 KO transformed cell line human CVCL_B3FU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28117; RBM42; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357657 CVCL_B3G6 Abcam HEK293T RPE KO transformed cell line human CVCL_B3G6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10293; RPE; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357658 CVCL_B3FT Abcam HEK293T RBM4 KO transformed cell line human CVCL_B3FT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9901; RBM4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357659 CVCL_B3G5 Abcam HEK293T RNF181 KO transformed cell line human CVCL_B3G5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28037; RNF181; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357660 CVCL_B3FW Abcam HEK293T RCN2 KO transformed cell line human CVCL_B3FW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9935; RCN2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357661 CVCL_B3G8 Abcam HEK293T RPL22 KO transformed cell line human CVCL_B3G8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10315; RPL22; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357662 CVCL_B3FV Abcam HEK293T RCN1 KO transformed cell line human CVCL_B3FV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9934; RCN1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357663 CVCL_B3G7 Abcam HEK293T RPF1 KO transformed cell line human CVCL_B3G7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30350; RPF1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357664 CVCL_B3FY Abcam HEK293T REXO2 KO transformed cell line human CVCL_B3FY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17851; REXO2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357665 CVCL_B3FX Abcam HEK293T REPIN1 KO transformed cell line human CVCL_B3FX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17922; REPIN1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357666 CVCL_B3G9 Abcam HEK293T RPL36AL KO transformed cell line human CVCL_B3G9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10346; RPL36AL; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357667 CVCL_B3HM Abcam HEK293T SLX9 KO transformed cell line human CVCL_B3HM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15811; SLX9; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357668 CVCL_B3HL Abcam HEK293T SLC9A3R2 KO transformed cell line human CVCL_B3HL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11076; NHERF2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357669 CVCL_B3I0 Abcam HEK293T SPAST KO transformed cell line human CVCL_B3I0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11233; SPAST; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357670 CVCL_B3HN Abcam HEK293T SMAD9 KO transformed cell line human CVCL_B3HN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6774; SMAD9; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357671 CVCL_B3HQ Abcam HEK293T SMARCB1 KO transformed cell line human CVCL_B3HQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11103; SMARCB1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357672 CVCL_B3I2 Abcam HEK293T SPHK2 KO transformed cell line human CVCL_B3I2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18859; SPHK2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357673 CVCL_B3HP Abcam HEK293T SMARCA4 KO transformed cell line human CVCL_B3HP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11100; SMARCA4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357674 CVCL_B3I1 Abcam HEK293T SPCS1 KO transformed cell line human CVCL_B3I1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23401; SPCS1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357675 CVCL_B3HS Abcam HEK293T SMO KO transformed cell line human CVCL_B3HS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11119; SMO; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357676 CVCL_B3I4 Abcam HEK293T SRP14 KO transformed cell line human CVCL_B3I4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11299; SRP14; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357677 CVCL_B3HR Abcam HEK293T SMARCD1 KO transformed cell line human CVCL_B3HR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11106; SMARCD1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357678 CVCL_B3I3 Abcam HEK293T SQSTM1 KO transformed cell line human CVCL_B3I3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357679 CVCL_B3HE Abcam HEK293T SLC35A4 KO transformed cell line human CVCL_B3HE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20753; SLC35A4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357680 CVCL_B3HD Abcam HEK293T SLC30A5 KO transformed cell line human CVCL_B3HD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19089; SLC30A5; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357681 CVCL_B3HG Abcam HEK293T SLC38A10 KO transformed cell line human CVCL_B3HG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28237; SLC38A10; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357682 CVCL_B3HF Abcam HEK293T SLC35F2 KO transformed cell line human CVCL_B3HF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23615; SLC35F2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357683 CVCL_B3HI Abcam HEK293T SLC41A3 KO transformed cell line human CVCL_B3HI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31046; SLC41A3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357684 CVCL_B3HH Abcam HEK293T SLC39A14 KO transformed cell line human CVCL_B3HH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20858; SLC39A14; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357685 CVCL_B3HK Abcam HEK293T SLC7A1 KO transformed cell line human CVCL_B3HK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11057; SLC7A1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357686 CVCL_B3HJ Abcam HEK293T SLC5A6 KO transformed cell line human CVCL_B3HJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11041; SLC5A6; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357687 CVCL_B3HA Abcam HEK293T SLC25A40 KO transformed cell line human CVCL_B3HA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29680; SLC25A40; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357688 CVCL_B3HC Abcam HEK293T SLC27A4 KO transformed cell line human CVCL_B3HC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10998; SLC27A4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357689 CVCL_B3HB Abcam HEK293T SLC25A46 KO transformed cell line human CVCL_B3HB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25198; SLC25A46; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357690 CVCL_B3GT Abcam HEK293T SERBP1 KO transformed cell line human CVCL_B3GT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17860; SERBP1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357691 CVCL_B3H5 Abcam HEK293T SLC25A22 KO transformed cell line human CVCL_B3H5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19954; SLC25A22; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357692 CVCL_B3GS Abcam HEK293T SEPHS1 KO transformed cell line human CVCL_B3GS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19685; SEPHS1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357693 CVCL_B3H4 Abcam HEK293T SLC25A15 KO transformed cell line human CVCL_B3H4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10985; SLC25A15; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357694 CVCL_B3GV Abcam HEK293T SETD2 KO transformed cell line human CVCL_B3GV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18420; SETD2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357695 CVCL_B3H7 Abcam HEK293T SLC25A32 KO transformed cell line human CVCL_B3H7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29683; SLC25A32; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357696 CVCL_B3GU Abcam HEK293T SERP1 KO transformed cell line human CVCL_B3GU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10759; SERP1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357697 CVCL_B3H6 Abcam HEK293T SLC25A23 KO transformed cell line human CVCL_B3H6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19375; SLC25A23; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357698 CVCL_B3GX Abcam HEK293T SH2B2 KO transformed cell line human CVCL_B3GX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17381; SH2B2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357699 CVCL_B3H9 Abcam HEK293T SLC25A39 KO transformed cell line human CVCL_B3H9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24279; SLC25A39; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357700 CVCL_B3GW Abcam HEK293T SGTA KO transformed cell line human CVCL_B3GW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10819; SGTA; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357701 CVCL_B3H8 Abcam HEK293T SLC25A38 KO transformed cell line human CVCL_B3H8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26054; SLC25A38; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357702 CVCL_B3GZ Abcam HEK293T SH3GL1 KO transformed cell line human CVCL_B3GZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10830; SH3GL1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357703 CVCL_B3GY Abcam HEK293T SH3BGRL3 KO transformed cell line human CVCL_B3GY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15568; SH3BGRL3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357704 CVCL_B2SY Abcam HEK293T BRCA2 KO 2 transformed cell line human CVCL_B2SY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1101; BRCA2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357705 CVCL_B2SX Abcam HEK293T BRCA2 KO 1 transformed cell line human CVCL_B2SX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1101; BRCA2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357706 CVCL_B2T9 Abcam HEK293T C1orf43 KO transformed cell line human CVCL_B2T9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29876; C1orf43; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357707 CVCL_B2SZ Abcam HEK293T BRD2 KO transformed cell line human CVCL_B2SZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1103; BRD2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357708 CVCL_B2SQ Abcam HEK293T BCL2L2-PABPN1 KO transformed cell line human CVCL_B2SQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:42959; BCL2L2-PABPN1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357709 CVCL_B2T2 Abcam HEK293T BRPF1 KO transformed cell line human CVCL_B2T2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14255; BRPF1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357710 CVCL_B2SP Abcam HEK293T BCKDHA KO transformed cell line human CVCL_B2SP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:986; BCKDHA; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357711 CVCL_B2T1 Abcam HEK293T BRD9 KO transformed cell line human CVCL_B2T1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25818; BRD9; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357712 CVCL_B2SS Abcam HEK293T BEX3 KO transformed cell line human CVCL_B2SS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13388; BEX3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357713 CVCL_B2T4 Abcam HEK293T BTBD1 KO transformed cell line human CVCL_B2T4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1120; BTBD1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357714 CVCL_B2SR Abcam HEK293T BCR KO transformed cell line human CVCL_B2SR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1014; BCR; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357715 CVCL_B2T3 Abcam HEK293T BSG KO transformed cell line human CVCL_B2T3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1116; BSG; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357716 CVCL_B2SU Abcam HEK293T BLVRB KO transformed cell line human CVCL_B2SU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1063; BLVRB; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357717 CVCL_B2T6 Abcam HEK293T BZW1 KO transformed cell line human CVCL_B2T6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18380; BZW1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357718 CVCL_B2ST Abcam HEK293T BLVRA KO transformed cell line human CVCL_B2ST CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1062; BLVRA; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357719 CVCL_B2T5 Abcam HEK293T BTRC KO transformed cell line human CVCL_B2T5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1144; BTRC; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357720 CVCL_B2SW Abcam HEK293T BRAP KO transformed cell line human CVCL_B2SW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1099; BRAP; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357721 CVCL_B2T8 Abcam HEK293T C19orf48 KO transformed cell line human CVCL_B2T8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29667; C19orf48P; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357722 CVCL_B2SV Abcam HEK293T BMI1 KO transformed cell line human CVCL_B2SV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1066; BMI1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357723 CVCL_B2T7 Abcam HEK293T C12orf57 KO transformed cell line human CVCL_B2T7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29521; C12orf57; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357724 CVCL_B2SI Abcam HEK293T ATRAID KO transformed cell line human CVCL_B2SI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24090; ATRAID; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357725 CVCL_B2SH Abcam HEK293T ATP5MF KO transformed cell line human CVCL_B2SH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:848; ATP5MF; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357726 CVCL_B2SK Abcam HEK293T B2M KO transformed cell line human CVCL_B2SK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357727 CVCL_B2SJ Abcam HEK293T ATXN2L KO transformed cell line human CVCL_B2SJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31326; ATXN2L; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357728 CVCL_B2SM Abcam HEK293T BAMBI KO transformed cell line human CVCL_B2SM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30251; BAMBI; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357729 CVCL_B2SL Abcam HEK293T B4GALT2 KO transformed cell line human CVCL_B2SL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:925; B4GALT2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357730 CVCL_B2T0 Abcam HEK293T BRD3 KO transformed cell line human CVCL_B2T0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1104; BRD3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357731 CVCL_B2SN Abcam HEK293T BCAP31 KO transformed cell line human CVCL_B2SN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16695; BCAP31; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357732 CVCL_B2SA Abcam HEK293T ATG3 KO transformed cell line human CVCL_B2SA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20962; ATG3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357733 CVCL_B2SC Abcam HEK293T ATOX1 KO transformed cell line human CVCL_B2SC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:798; ATOX1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357734 CVCL_B2SB Abcam HEK293T ATG4C KO transformed cell line human CVCL_B2SB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16040; ATG4C; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357735 CVCL_B2SE Abcam HEK293T ATP5IF1 KO transformed cell line human CVCL_B2SE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:871; ATP5IF1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357736 CVCL_B2SD Abcam HEK293T ATP2C1 KO transformed cell line human CVCL_B2SD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13211; ATP2C1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357737 CVCL_B2SG Abcam HEK293T ATP5MC3 KO transformed cell line human CVCL_B2SG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:843; ATP5MC3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357738 CVCL_B2SF Abcam HEK293T ATP5MC2 KO transformed cell line human CVCL_B2SF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:842; ATP5MC2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357739 CVCL_B2TZ Abcam HEK293T CDK10 KO transformed cell line human CVCL_B2TZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1770; CDK10; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357740 CVCL_B2TY Abcam HEK293T CDH2 KO transformed cell line human CVCL_B2TY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1759; CDH2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357741 CVCL_B2UA Abcam HEK293T CHCHD6 KO transformed cell line human CVCL_B2UA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28184; CHCHD6; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357742 CVCL_B2TR Abcam HEK293T CD164 KO transformed cell line human CVCL_B2TR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1632; CD164; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357743 CVCL_B2U3 Abcam HEK293T CELF1 KO transformed cell line human CVCL_B2U3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2549; CELF1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357744 CVCL_B2TQ Abcam HEK293T CCP110 KO transformed cell line human CVCL_B2TQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24342; CCP110; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357745 CVCL_B2U2 Abcam HEK293T CDV3 KO transformed cell line human CVCL_B2U2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26928; CDV3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357746 CVCL_B2TT Abcam HEK293T CD2BP2 KO transformed cell line human CVCL_B2TT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1656; CD2BP2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357747 CVCL_B2U5 Abcam HEK293T CERS2 KO transformed cell line human CVCL_B2U5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14076; CERS2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Discontinued: Abcam; ab266198; true Female 151357748 CVCL_B2TS Abcam HEK293T CD276 KO transformed cell line human CVCL_B2TS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19137; CD276; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357749 CVCL_B2U4 Abcam HEK293T CERK KO transformed cell line human CVCL_B2U4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19256; CERK; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357750 CVCL_B2TV Abcam HEK293T CDC14B KO transformed cell line human CVCL_B2TV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1719; CDC14B; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357751 CVCL_B2U7 Abcam HEK293T CERT1 KO transformed cell line human CVCL_B2U7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2205; CERT1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357752 CVCL_B2TU Abcam HEK293T CD47 KO transformed cell line human CVCL_B2TU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1682; CD47; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357753 CVCL_B2U6 Abcam HEK293T CERS6 KO transformed cell line human CVCL_B2U6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23826; CERS6; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357754 CVCL_B2TX Abcam HEK293T CDC42 KO transformed cell line human CVCL_B2TX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1736; CDC42; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357755 CVCL_B2U9 Abcam HEK293T CHCHD3 KO transformed cell line human CVCL_B2U9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21906; CHCHD3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357756 CVCL_B2TW Abcam HEK293T CDC16 KO transformed cell line human CVCL_B2TW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1720; CDC16; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Discontinued: Abcam; ab267254; true Female 151357757 CVCL_B2U8 Abcam HEK293T CHCHD2 KO transformed cell line human CVCL_B2U8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21645; CHCHD2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357758 CVCL_B2TJ Abcam HEK293T CBL KO transformed cell line human CVCL_B2TJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1541; CBL; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357759 CVCL_B2TI Abcam HEK293T CASP1 KO transformed cell line human CVCL_B2TI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1499; CASP1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Discontinued: Abcam; ab266226; true Female 151357760 CVCL_B2TL Abcam HEK293T CCND2 KO transformed cell line human CVCL_B2TL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1583; CCND2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357761 CVCL_B2TK Abcam HEK293T CBX1 KO transformed cell line human CVCL_B2TK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1551; CBX1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357762 CVCL_B2TN Abcam HEK293T CCNI KO transformed cell line human CVCL_B2TN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1595; CCNI; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357763 CVCL_B2TM Abcam HEK293T CCND3 KO transformed cell line human CVCL_B2TM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1585; CCND3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Discontinued: Abcam; ab266518; true Female 151357764 CVCL_B2TP Abcam HEK293T CCNL2 KO transformed cell line human CVCL_B2TP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20570; CCNL2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357765 CVCL_B2U1 Abcam HEK293T CDK5 KO transformed cell line human CVCL_B2U1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1774; CDK5; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357766 CVCL_B2U0 Abcam HEK293T CDK11A KO transformed cell line human CVCL_B2U0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1730; CDK11A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357767 CVCL_B2TB Abcam HEK293T CA2 KO transformed cell line human CVCL_B2TB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1373; CA2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357768 CVCL_B2TA Abcam HEK293T C20orf27 KO transformed cell line human CVCL_B2TA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15873; ADISSP; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357769 CVCL_B2TD Abcam HEK293T CAMK2D KO transformed cell line human CVCL_B2TD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1462; CAMK2D; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357770 CVCL_B2TC Abcam HEK293T CALM3 KO transformed cell line human CVCL_B2TC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1449; CALM3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357771 CVCL_B2TF Abcam HEK293T CANX KO transformed cell line human CVCL_B2TF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1473; CANX; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357772 CVCL_B2TE Abcam HEK293T CAMKK2 KO transformed cell line human CVCL_B2TE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1470; CAMKK2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357773 CVCL_B2TH Abcam HEK293T CARM1 KO transformed cell line human CVCL_B2TH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23393; CARM1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357774 CVCL_B2TG Abcam HEK293T CAPN2 KO transformed cell line human CVCL_B2TG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1479; CAPN2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357775 CVCL_B2QW Abcam A-549 TRIM34 KO 2 cancer cell line human CVCL_B2QW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10063; TRIM34; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357776 CVCL_B2R8 Abcam HEK293T ADRM1 KO transformed cell line human CVCL_B2R8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15759; ADRM1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357777 CVCL_B2QV Abcam A-549 TRIM22 KO cancer cell line human CVCL_B2QV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16379; TRIM22; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357778 CVCL_B2R7 Abcam HEK293T ADPGK KO transformed cell line human CVCL_B2R7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25250; ADPGK; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357779 CVCL_B2QY Abcam A-549 TRIM56 KO 2 cancer cell line human CVCL_B2QY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19028; TRIM56; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357780 CVCL_B2QX Abcam A-549 TRIM38 KO 2 cancer cell line human CVCL_B2QX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10059; TRIM38; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357781 CVCL_B2R9 Abcam HEK293T AGA KO transformed cell line human CVCL_B2R9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:318; AGA; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357782 CVCL_B2QZ Abcam A-549 USP18 KO 2 cancer cell line human CVCL_B2QZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12616; USP18; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357783 CVCL_B2R0 Abcam A-549 ZC3HAV1 KO 1 cancer cell line human CVCL_B2R0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23721; ZC3HAV1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357784 CVCL_B2QN Abcam A-549 TMEM140 KO 2 cancer cell line human CVCL_B2QN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21870; TMEM140; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357785 CVCL_B2QQ Abcam A-549 TNFAIP3 KO 2 cancer cell line human CVCL_B2QQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11896; TNFAIP3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357786 CVCL_B2R2 Abcam HEK293T AADAT KO transformed cell line human CVCL_B2R2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17929; AADAT; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357787 CVCL_B2QP Abcam A-549 TMEM64 KO 2 cancer cell line human CVCL_B2QP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25441; TMEM64; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357788 CVCL_B2R1 Abcam A-549 ZCCHC2 KO 1 cancer cell line human CVCL_B2R1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22916; ZCCHC2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357789 CVCL_B2QS Abcam A-549 TRANK1 KO 2 cancer cell line human CVCL_B2QS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29011; TRANK1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357790 CVCL_B2R4 Abcam HEK293T ACADVL KO transformed cell line human CVCL_B2R4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:92; ACADVL; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357791 CVCL_B2QR Abcam A-549 TP53 KO cancer cell line human CVCL_B2QR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357792 CVCL_B2R3 Abcam HEK293T ABCF2 KO transformed cell line human CVCL_B2R3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:71; ABCF2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357793 CVCL_B2QU Abcam A-549 TRIM21 KO 1 cancer cell line human CVCL_B2QU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11312; TRIM21; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357794 CVCL_B2R6 Abcam HEK293T ADARB1 KO transformed cell line human CVCL_B2R6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:226; ADARB1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357795 CVCL_B2QT Abcam A-549 TRIM14 KO 1 cancer cell line human CVCL_B2QT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16283; TRIM14; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357796 CVCL_B2R5 Abcam HEK293T ADAR KO transformed cell line human CVCL_B2R5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:225; ADAR; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357797 CVCL_B2QG Abcam A-549 TENT5A KO 1 cancer cell line human CVCL_B2QG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18345; TENT5A; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357798 CVCL_B2QF Abcam A-549 TEAD2 KO cancer cell line human CVCL_B2QF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11715; TEAD2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357799 CVCL_B2QI Abcam A-549 TGFBR2 KO 1 cancer cell line human CVCL_B2QI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11773; TGFBR2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357800 CVCL_B2QH Abcam A-549 TGFB1 KO cancer cell line human CVCL_B2QH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11766; TGFB1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357801 CVCL_B2QK Abcam A-549 THEMIS2 KO 1 cancer cell line human CVCL_B2QK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16839; THEMIS2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357802 CVCL_B2QJ Abcam A-549 TGM2 KO 2 cancer cell line human CVCL_B2QJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11778; TGM2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357803 CVCL_B2QM Abcam A-549 TMEM106B KO cancer cell line human CVCL_B2QM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22407; TMEM106B; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357804 CVCL_B2QL Abcam A-549 TLDC2 KO 1 cancer cell line human CVCL_B2QL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16112; TLDC2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357805 CVCL_B2QA Abcam A-549 SPINK1 KO 2 cancer cell line human CVCL_B2QA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11244; SPINK1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Discontinued: Abcam; ab267205; true Male 151357806 CVCL_B2QC Abcam A-549 STAT2 KO 3 cancer cell line human CVCL_B2QC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11363; STAT2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357807 CVCL_B2QB Abcam A-549 STAT2 KO 1 cancer cell line human CVCL_B2QB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11363; STAT2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357808 CVCL_B2QE Abcam A-549 TDRD7 KO 2 cancer cell line human CVCL_B2QE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30831; TDRD7; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357809 CVCL_B2QD Abcam A-549 TAP2 KO cancer cell line human CVCL_B2QD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18655; SEC14L3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357810 CVCL_B2RX Abcam HEK293T ARAF KO transformed cell line human CVCL_B2RX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:646; ARAF; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357811 CVCL_B2S9 Abcam HEK293T ARRB2 KO transformed cell line human CVCL_B2S9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:712; ARRB2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357812 CVCL_B2RW Abcam HEK293T APRT KO transformed cell line human CVCL_B2RW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:626; APRT; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357813 CVCL_B2S8 Abcam HEK293T ARPP19 KO transformed cell line human CVCL_B2S8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16967; ARPP19; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357814 CVCL_B2RZ Abcam HEK293T ARF5 KO transformed cell line human CVCL_B2RZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:658; ARF5; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357815 CVCL_B2RY Abcam HEK293T ARF3 KO transformed cell line human CVCL_B2RY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:654; ARF3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357816 CVCL_B2RP Abcam HEK293T ANP32B KO transformed cell line human CVCL_B2RP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16677; ANP32B; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357817 CVCL_B2S1 Abcam HEK293T ARHGDIA KO 1 transformed cell line human CVCL_B2S1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:678; ARHGDIA; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357818 CVCL_B2S0 Abcam HEK293T ARFIP1 KO transformed cell line human CVCL_B2S0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21496; ARFIP1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357819 CVCL_B2RR Abcam HEK293T AP1B1 KO transformed cell line human CVCL_B2RR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:554; AP1B1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357820 CVCL_B2S3 Abcam HEK293T ARHGEF1 KO transformed cell line human CVCL_B2S3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:681; ARHGEF1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357821 CVCL_B2RQ Abcam HEK293T ANXA11 KO transformed cell line human CVCL_B2RQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:535; ANXA11; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357822 CVCL_B2S2 Abcam HEK293T ARHGDIA KO 2 transformed cell line human CVCL_B2S2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:678; ARHGDIA; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357823 CVCL_B2RT Abcam HEK293T APEH KO transformed cell line human CVCL_B2RT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:586; APEH; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357824 CVCL_B2S5 Abcam HEK293T ARL6IP1 KO transformed cell line human CVCL_B2S5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:697; ARL6IP1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357825 CVCL_B2RS Abcam HEK293T APBB1 KO transformed cell line human CVCL_B2RS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:581; APBB1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357826 CVCL_B2S4 Abcam HEK293T ARID1A KO transformed cell line human CVCL_B2S4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11110; ARID1A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357827 CVCL_B2RV Abcam HEK293T APP KO transformed cell line human CVCL_B2RV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:620; APP; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357828 CVCL_B2S7 Abcam HEK293T ARPC5L KO transformed cell line human CVCL_B2S7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23366; ARPC5L; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357829 CVCL_B2RU Abcam HEK293T APEX2 KO transformed cell line human CVCL_B2RU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17889; APEX2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357830 CVCL_B2S6 Abcam HEK293T ARL6IP4 KO transformed cell line human CVCL_B2S6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18076; ARL6IP4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357831 CVCL_B2RH Abcam HEK293T ALDH9A1 KO transformed cell line human CVCL_B2RH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:412; ALDH9A1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357832 CVCL_B2RG Abcam HEK293T ALDH18A1 KO transformed cell line human CVCL_B2RG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9722; ALDH18A1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357833 CVCL_B2RJ Abcam HEK293T ALKBH5 KO transformed cell line human CVCL_B2RJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25996; ALKBH5; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357834 CVCL_B2RI Abcam HEK293T ALKBH2 KO transformed cell line human CVCL_B2RI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32487; ALKBH2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357835 CVCL_B2RL Abcam HEK293T ANAPC15 KO transformed cell line human CVCL_B2RL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24531; ANAPC15; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357836 CVCL_B2RK Abcam HEK293T AMPD2 KO transformed cell line human CVCL_B2RK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:469; AMPD2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357837 CVCL_B2RN Abcam HEK293T ANP32A KO transformed cell line human CVCL_B2RN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13233; ANP32A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357838 CVCL_B2RM Abcam HEK293T ANKRD52 KO transformed cell line human CVCL_B2RM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26614; ANKRD52; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357839 CVCL_B2RB Abcam HEK293T AK2 KO transformed cell line human CVCL_B2RB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:362; AK2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357840 CVCL_B2RA Abcam HEK293T AIFM1 KO transformed cell line human CVCL_B2RA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8768; AIFM1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357841 CVCL_B2RD Abcam HEK293T AKAP1 KO transformed cell line human CVCL_B2RD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:367; AKAP1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357842 CVCL_B2RC Abcam HEK293T AK3 KO transformed cell line human CVCL_B2RC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17376; AK3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357843 CVCL_B2RF Abcam HEK293T ALAS1 KO transformed cell line human CVCL_B2RF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:396; ALAS1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357844 CVCL_B2RE Abcam HEK293T AKR1A1 KO transformed cell line human CVCL_B2RE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:380; AKR1A1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357845 CVCL_B2P6 Abcam A-549 NR3C1 KO cancer cell line human CVCL_B2P6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7978; NR3C1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357846 CVCL_B2P5 Abcam A-549 NMI KO cancer cell line human CVCL_B2P5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7854; NMI; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357847 CVCL_B2P8 Abcam A-549 OAS1 KO 2 cancer cell line human CVCL_B2P8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8086; OAS1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357848 CVCL_B2P7 Abcam A-549 NT5C3A KO 1 cancer cell line human CVCL_B2P7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17820; NT5C3A; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357849 CVCL_B2P9 Abcam A-549 OAS2 KO 2 cancer cell line human CVCL_B2P9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8087; OAS2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357850 CVCL_B2P0 Abcam A-549 MSX1 KO 2 cancer cell line human CVCL_B2P0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7391; MSX1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357851 CVCL_B2P2 Abcam A-549 MYH2 KO 1 cancer cell line human CVCL_B2P2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7572; MYH2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Discontinued: Abcam; ab267027; true Male 151357852 CVCL_B2P1 Abcam A-549 MX2 KO 1 cancer cell line human CVCL_B2P1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7533; MX2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357853 CVCL_B2P4 Abcam A-549 NCOA7 KO 2 cancer cell line human CVCL_B2P4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21081; NCOA7; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357854 CVCL_B2P3 Abcam A-549 NBN KO cancer cell line human CVCL_B2P3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7652; NBN; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Discontinued: Abcam; ab276103; true Male 151357855 CVCL_B2PV Abcam A-549 RTP4 KO 2 cancer cell line human CVCL_B2PV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23992; RTP4; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357856 CVCL_B2Q7 Abcam A-549 SOCS1 KO cancer cell line human CVCL_B2Q7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19383; SOCS1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357857 CVCL_B2PU Abcam A-549 RSAD2 KO cancer cell line human CVCL_B2PU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30908; RSAD2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Discontinued: Abcam; ab267130; true Male 151357858 CVCL_B2Q6 Abcam A-549 SMAD3 KO 2 cancer cell line human CVCL_B2Q6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6769; SMAD3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357859 CVCL_B2PX Abcam A-549 SAMD9 KO 1 cancer cell line human CVCL_B2PX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1348; SAMD9; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357860 CVCL_B2Q9 Abcam A-549 SP140 KO 2 cancer cell line human CVCL_B2Q9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17133; SP140; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357861 CVCL_B2PW Abcam A-549 SAA1 KO 1 cancer cell line human CVCL_B2PW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10513; SAA1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Discontinued: Abcam; ab266994; true Male 151357862 CVCL_B2Q8 Abcam A-549 SP110 KO cancer cell line human CVCL_B2Q8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5401; SP110; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357863 CVCL_B2PZ Abcam A-549 SECTM1 KO 1 cancer cell line human CVCL_B2PZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10707; SECTM1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357864 CVCL_B2PY Abcam A-549 SAMD9L KO 1 cancer cell line human CVCL_B2PY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1349; SAMD9L; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357865 CVCL_B2PN Abcam A-549 PVR KO cancer cell line human CVCL_B2PN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9705; PVR; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357866 CVCL_B2PM Abcam A-549 PTPRK KO 1 cancer cell line human CVCL_B2PM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9674; PTPRK; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357867 CVCL_B2PP Abcam A-549 PYHIN1 KO 2 cancer cell line human CVCL_B2PP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28894; PYHIN1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357868 CVCL_B2Q1 Abcam A-549 SFRP1 KO cancer cell line human CVCL_B2Q1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10776; SFRP1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357869 CVCL_B2Q0 Abcam A-549 SERPING1 KO 1 cancer cell line human CVCL_B2Q0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1228; SERPING1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Discontinued: Abcam; ab266940; true Male 151357870 CVCL_B2PR Abcam A-549 RASGRP3 KO 1 cancer cell line human CVCL_B2PR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14545; RASGRP3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Discontinued: Abcam; ab267198; true Male 151357871 CVCL_B2Q3 Abcam A-549 SIDT1 KO 2 cancer cell line human CVCL_B2Q3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25967; SIDT1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357872 CVCL_B2PQ Abcam A-549 RAB27A KO cancer cell line human CVCL_B2PQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9766; RAB27A; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357873 CVCL_B2Q2 Abcam A-549 SHFL KO 2 cancer cell line human CVCL_B2Q2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25649; SHFL; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357874 CVCL_B2PT Abcam A-549 RNF19B KO 1 cancer cell line human CVCL_B2PT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26886; RNF19B; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357875 CVCL_B2Q5 Abcam A-549 SLC2A1 KO cancer cell line human CVCL_B2Q5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11005; SLC2A1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357876 CVCL_B2PS Abcam A-549 REC8 KO cancer cell line human CVCL_B2PS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16879; REC8; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357877 CVCL_B2Q4 Abcam A-549 SLC25A28 KO 1 cancer cell line human CVCL_B2Q4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23472; SLC25A28; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357878 CVCL_B2PF Abcam A-549 PARP9 KO 1 cancer cell line human CVCL_B2PF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24118; PARP9; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357879 CVCL_B2PE Abcam A-549 PARP14 KO 1 cancer cell line human CVCL_B2PE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29232; PARP14; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357880 CVCL_B2PH Abcam A-549 PLAAT4 KO 2 cancer cell line human CVCL_B2PH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9869; PLAAT4; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357881 CVCL_B2PG Abcam A-549 PDCD1LG2 KO cancer cell line human CVCL_B2PG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18731; PDCD1LG2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Discontinued: Abcam; ab267019; true Male 151357882 CVCL_B2PJ Abcam A-549 PLSCR1 KO 2 cancer cell line human CVCL_B2PJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9092; PLSCR1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357883 CVCL_B2PI Abcam A-549 PLEKHA4 KO 2 cancer cell line human CVCL_B2PI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14339; PLEKHA4; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357884 CVCL_B2PL Abcam A-549 PSMB8 KO 2 cancer cell line human CVCL_B2PL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9545; PSMB8; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357885 CVCL_B2PK Abcam A-549 PMAIP1 KO 2 cancer cell line human CVCL_B2PK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9108; PMAIP1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357886 CVCL_B2PB Abcam A-549 OASL KO 2 cancer cell line human CVCL_B2PB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8090; OASL; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357887 CVCL_B2PA Abcam A-549 OAS3 KO cancer cell line human CVCL_B2PA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8088; OAS3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357888 CVCL_B2PD Abcam A-549 PARP10 KO 2 cancer cell line human CVCL_B2PD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25895; PARP10; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357889 CVCL_B2PC Abcam A-549 OTOP3 KO 2 cancer cell line human CVCL_B2PC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19658; OTOP3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357890 CVCL_B2MS Abcam A-549 ERCC1 KO cancer cell line human CVCL_B2MS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3433; ERCC1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Discontinued: Abcam; ab276106; true Male 151357891 CVCL_B2N4 Abcam A-549 HLA-E KO 1 cancer cell line human CVCL_B2N4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4962; HLA-E; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357892 CVCL_B2MR Abcam A-549 EPSTI1 KO 1 cancer cell line human CVCL_B2MR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16465; EPSTI1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357893 CVCL_B2N3 Abcam A-549 HES4 KO cancer cell line human CVCL_B2N3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24149; HES4; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357894 CVCL_B2MU Abcam A-549 ETV7 KO 2 cancer cell line human CVCL_B2MU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18160; ETV7; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357895 CVCL_B2N6 Abcam A-549 HTR3D KO 2 cancer cell line human CVCL_B2N6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24004; HTR3D; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357896 CVCL_B2MT Abcam A-549 ETV6 KO 2 cancer cell line human CVCL_B2MT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3495; ETV6; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357897 CVCL_B2N5 Abcam A-549 HMOX1 KO cancer cell line human CVCL_B2N5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5013; HMOX1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357898 CVCL_B2MW Abcam A-549 GBP3 KO cancer cell line human CVCL_B2MW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4184; GBP3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357899 CVCL_B2N8 Abcam A-549 IFI16 KO 2 cancer cell line human CVCL_B2N8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5395; IFI16; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357900 CVCL_B2MV Abcam A-549 GBP2 KO 1 cancer cell line human CVCL_B2MV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4183; GBP2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357901 CVCL_B2N7 Abcam A-549 IDO1 KO 2 cancer cell line human CVCL_B2N7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6059; IDO1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Discontinued: Abcam; ab266950; true Male 151357902 CVCL_B2MY Abcam A-549 GCH1 KO 2 cancer cell line human CVCL_B2MY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4193; GCH1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357903 CVCL_B2MX Abcam A-549 GBP4 KO 2 cancer cell line human CVCL_B2MX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20480; GBP4; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357904 CVCL_B2N9 Abcam A-549 IFI35 KO cancer cell line human CVCL_B2N9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5399; IFI35; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357905 CVCL_B2MK Abcam A-549 DDX60L KO cancer cell line human CVCL_B2MK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26429; DDX60L; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357906 CVCL_B2MJ Abcam A-549 DDX58 KO 2 cancer cell line human CVCL_B2MJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19102; RIGI; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357907 CVCL_B2MM Abcam A-549 DSG2 KO 1 cancer cell line human CVCL_B2MM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3049; DSG2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357908 CVCL_B2ML Abcam A-549 DHX58 KO cancer cell line human CVCL_B2ML CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29517; DHX58; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357909 CVCL_B2N0 Abcam A-549 HAPLN3 KO 2 cancer cell line human CVCL_B2N0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21446; HAPLN3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357910 CVCL_B2MN Abcam A-549 DTX3L KO 1 cancer cell line human CVCL_B2MN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30323; DTX3L; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357911 CVCL_B2MQ Abcam A-549 EIF2AK2 KO 2 cancer cell line human CVCL_B2MQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9437; EIF2AK2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357912 CVCL_B2N2 Abcam A-549 HERC5 KO 2 cancer cell line human CVCL_B2N2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24368; HERC5; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357913 CVCL_B2MP Abcam A-549 DUSP4 KO cancer cell line human CVCL_B2MP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3070; DUSP4; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357914 CVCL_B2N1 Abcam A-549 HELZ2 KO 2 cancer cell line human CVCL_B2N1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30021; HELZ2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357915 CVCL_B2MC Abcam A-549 CFH KO cancer cell line human CVCL_B2MC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4883; CFH; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357916 CVCL_B2MB Abcam A-549 CEACAM1 KO 1 cancer cell line human CVCL_B2MB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1814; CEACAM1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357917 CVCL_B2ME Abcam A-549 CHEK2 KO cancer cell line human CVCL_B2ME CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16627; CHEK2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357918 CVCL_B2MD Abcam A-549 CFHR3 KO 2 cancer cell line human CVCL_B2MD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16980; CFHR3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357919 CVCL_B2MG Abcam A-549 CXCL10 KO 1 cancer cell line human CVCL_B2MG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10637; CXCL10; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357920 CVCL_B2MF Abcam A-549 CMPK2 KO 1 cancer cell line human CVCL_B2MF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27015; CMPK2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357921 CVCL_B2MI Abcam A-549 CYP24A1 KO cancer cell line human CVCL_B2MI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2602; CYP24A1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357922 CVCL_B2MH Abcam A-549 CXCL10 KO 3 cancer cell line human CVCL_B2MH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10637; CXCL10; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357923 CVCL_B2LZ Abcam HeLa ZRANB1 KO cancer cell line human CVCL_B2LZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18224; ZRANB1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151357924 CVCL_B2LY Abcam HeLa ZNHIT6 KO cancer cell line human CVCL_B2LY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26089; ZNHIT6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151357925 CVCL_B2MA Abcam A-549 CD274 KO 2 cancer cell line human CVCL_B2MA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17635; CD274; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357926 CVCL_B2NT Abcam A-549 LILRB4 KO cancer cell line human CVCL_B2NT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6608; LILRB4; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357927 CVCL_B2NS Abcam A-549 LGALS9 KO cancer cell line human CVCL_B2NS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6570; LGALS9; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357928 CVCL_B2NV Abcam A-549 MAP2K7 KO 2 cancer cell line human CVCL_B2NV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6847; MAP2K7; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357929 CVCL_B2NU Abcam A-549 LRRK2 KO cancer cell line human CVCL_B2NU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18618; LRRK2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Discontinued: Abcam; ab277993; true Male 151357930 CVCL_B2NX Abcam A-549 MAP3K15 KO 1 cancer cell line human CVCL_B2NX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31689; MAP3K15; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357931 CVCL_B2NW Abcam A-549 MAP3K11 KO 2 cancer cell line human CVCL_B2NW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6850; MAP3K11; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357932 CVCL_B2NZ Abcam A-549 MLH1 KO cancer cell line human CVCL_B2NZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7127; MLH1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357933 CVCL_B2NY Abcam A-549 MAP3K2 KO 1 cancer cell line human CVCL_B2NY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6854; MAP3K2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357934 CVCL_B2NL Abcam A-549 IRF7 KO 1 cancer cell line human CVCL_B2NL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6122; IRF7; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357935 CVCL_B2NK Abcam A-549 IRF3 KO 1 cancer cell line human CVCL_B2NK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6118; IRF3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357936 CVCL_B2NN Abcam A-549 ISM1 KO 2 cancer cell line human CVCL_B2NN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16213; ISM1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357937 CVCL_B2NM Abcam A-549 IRF9 KO cancer cell line human CVCL_B2NM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6131; IRF9; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357938 CVCL_B2NP Abcam A-549 KDM7A KO 1 cancer cell line human CVCL_B2NP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22224; KDM7A; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357939 CVCL_B2NR Abcam A-549 LAMP3 KO 2 cancer cell line human CVCL_B2NR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14582; LAMP3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357940 CVCL_B2NQ Abcam A-549 KRT7 KO cancer cell line human CVCL_B2NQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6445; KRT7; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357941 CVCL_B2ND Abcam A-549 IFIH1 KO 2 cancer cell line human CVCL_B2ND CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18873; IFIH1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357942 CVCL_B2NC Abcam A-549 IFI6 KO 2 cancer cell line human CVCL_B2NC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4054; IFI6; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357943 CVCL_B2NF Abcam A-549 IFIT5 KO 1 cancer cell line human CVCL_B2NF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13328; IFIT5; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357944 CVCL_B2NE Abcam A-549 IFIT2 KO 2 cancer cell line human CVCL_B2NE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5409; IFIT2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357945 CVCL_B2NH Abcam A-549 IL15RA KO 2 cancer cell line human CVCL_B2NH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5978; IL15RA; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357946 CVCL_B2NG Abcam A-549 IFNL3 KO cancer cell line human CVCL_B2NG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18365; IFNL3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357947 CVCL_B2NJ Abcam A-549 IRF2 KO 1 cancer cell line human CVCL_B2NJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6117; IRF2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357948 CVCL_B2NI Abcam A-549 IL6ST KO cancer cell line human CVCL_B2NI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6021; IL6ST; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357949 CVCL_B2MZ Abcam A-549 GMPR KO 2 cancer cell line human CVCL_B2MZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4376; GMPR; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357950 CVCL_B2NB Abcam A-549 IFI44L KO 2 cancer cell line human CVCL_B2NB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17817; IFI44L; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357951 CVCL_B2NA Abcam A-549 IFI44 KO 2 cancer cell line human CVCL_B2NA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16938; IFI44; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151357952 CVCL_B2ZB Abcam HEK293T ILKAP KO transformed cell line human CVCL_B2ZB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15566; ILKAP; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357953 CVCL_B2ZA Abcam HEK293T IL4R KO transformed cell line human CVCL_B2ZA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6015; IL4R; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357954 CVCL_B2ZD Abcam HEK293T IPO4 KO transformed cell line human CVCL_B2ZD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19426; IPO4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357955 CVCL_B2ZC Abcam HEK293T INVS KO transformed cell line human CVCL_B2ZC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17870; INVS; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357956 CVCL_B2ZF Abcam HEK293T IRS1 KO transformed cell line human CVCL_B2ZF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6125; IRS1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Discontinued: Abcam; ab267320; true Female 151357957 CVCL_B2ZE Abcam HEK293T IPPK KO transformed cell line human CVCL_B2ZE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14645; IPPK; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357958 CVCL_B2YW Abcam HEK293T HNRNPA0 KO transformed cell line human CVCL_B2YW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5030; HNRNPA0; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357959 CVCL_B2Z8 Abcam HEK293T IDH3G KO transformed cell line human CVCL_B2Z8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5386; IDH3G; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357960 CVCL_B2YV Abcam HEK293T HMGN3 KO transformed cell line human CVCL_B2YV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12312; HMGN3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357961 CVCL_B2Z7 Abcam HEK293T HSP90B1 KO transformed cell line human CVCL_B2Z7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12028; HSP90B1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357962 CVCL_B2YY Abcam HEK293T HNRNPA1L2 KO transformed cell line human CVCL_B2YY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27067; HNRNPA1L2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357963 CVCL_B2YX Abcam HEK293T HNRNPA1 KO transformed cell line human CVCL_B2YX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5031; HNRNPA1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357964 CVCL_B2Z9 Abcam HEK293T IKBKG KO transformed cell line human CVCL_B2Z9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5961; IKBKG; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357965 CVCL_B2YZ Abcam HEK293T HNRNPA2B1 KO transformed cell line human CVCL_B2YZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5033; HNRNPA2B1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357966 CVCL_B2Z0 Abcam HEK293T HNRNPA3 KO transformed cell line human CVCL_B2Z0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24941; HNRNPA3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357967 CVCL_B2YN Abcam HEK293T HEY1 KO transformed cell line human CVCL_B2YN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4880; HEY1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Discontinued: Abcam; ab267338; true Female 151357968 CVCL_B2YQ Abcam HEK293T HK1 KO transformed cell line human CVCL_B2YQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4922; HK1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357969 CVCL_B2Z2 Abcam HEK293T HNRNPR KO transformed cell line human CVCL_B2Z2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5047; HNRNPR; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357970 CVCL_B2YP Abcam HEK293T HINT2 KO transformed cell line human CVCL_B2YP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18344; HINT2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357971 CVCL_B2Z1 Abcam HEK293T HNRNPAB KO transformed cell line human CVCL_B2Z1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5034; HNRNPAB; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357972 CVCL_B2YS Abcam HEK293T HM13 KO transformed cell line human CVCL_B2YS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16435; HM13; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357973 CVCL_B2Z4 Abcam HEK293T HP1BP3 KO transformed cell line human CVCL_B2Z4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24973; HP1BP3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357974 CVCL_B2YR Abcam HEK293T HLA-E KO transformed cell line human CVCL_B2YR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4962; HLA-E; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357975 CVCL_B2Z3 Abcam HEK293T HNRNPUL1 KO transformed cell line human CVCL_B2Z3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17011; HNRNPUL1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357976 CVCL_B2YU Abcam HEK293T HMGN2 KO transformed cell line human CVCL_B2YU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4986; HMGN2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357977 CVCL_B2Z6 Abcam HEK293T HSP90AB1 KO transformed cell line human CVCL_B2Z6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5258; HSP90AB1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357978 CVCL_B2YT Abcam HEK293T HMGB2 KO transformed cell line human CVCL_B2YT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5000; HMGB2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357979 CVCL_B2Z5 Abcam HEK293T HSP90AA1 KO transformed cell line human CVCL_B2Z5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5253; HSP90AA1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357980 CVCL_B2YG Abcam HEK293T H3-3B KO transformed cell line human CVCL_B2YG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4765; H3-3B; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357981 CVCL_B2YF Abcam HEK293T GTF3C6 KO transformed cell line human CVCL_B2YF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20872; GTF3C6; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357982 CVCL_B2YI Abcam HEK293T HCFC1R1 KO transformed cell line human CVCL_B2YI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21198; HCFC1R1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357983 CVCL_B2YH Abcam HEK293T HADHA KO transformed cell line human CVCL_B2YH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4801; HADHA; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357984 CVCL_B2YK Abcam HEK293T HDAC2 KO 2 transformed cell line human CVCL_B2YK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4853; HDAC2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357985 CVCL_B2YJ Abcam HEK293T HDAC2 KO 1 transformed cell line human CVCL_B2YJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4853; HDAC2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357986 CVCL_B2YM Abcam HEK293T HDHD5 KO transformed cell line human CVCL_B2YM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1843; HDHD5; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357987 CVCL_B2YL Abcam HEK293T HDAC2 KO 3 transformed cell line human CVCL_B2YL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4853; HDAC2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357988 CVCL_B2ZX Abcam HEK293T KRTCAP2 KO transformed cell line human CVCL_B2ZX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28942; KRTCAP2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357989 CVCL_B2ZW Abcam HEK293T KNSTRN KO transformed cell line human CVCL_B2ZW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30767; KNSTRN; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357990 CVCL_B2ZZ Abcam HEK293T L3MBTL3 KO transformed cell line human CVCL_B2ZZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23035; L3MBTL3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357991 CVCL_B2ZY Abcam HEK293T KXD1 KO transformed cell line human CVCL_B2ZY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28420; KXD1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357992 CVCL_B2ZP Abcam HEK293T KDM6B KO transformed cell line human CVCL_B2ZP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29012; KDM6B; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357993 CVCL_B2ZR Abcam HEK293T KIAA0100 KO transformed cell line human CVCL_B2ZR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28960; BLTP2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357994 CVCL_B2ZQ Abcam HEK293T KHK KO transformed cell line human CVCL_B2ZQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6315; KHK; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357995 CVCL_B2ZT Abcam HEK293T KIF20A KO transformed cell line human CVCL_B2ZT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9787; KIF20A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357996 CVCL_B2ZS Abcam HEK293T KIF1C KO transformed cell line human CVCL_B2ZS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6317; KIF1C; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357997 CVCL_B2ZV Abcam HEK293T KLHDC3 KO transformed cell line human CVCL_B2ZV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20704; KLHDC3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357998 CVCL_B2ZU Abcam HEK293T KIF22 KO transformed cell line human CVCL_B2ZU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6391; KIF22; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151357999 CVCL_B2ZH Abcam HEK293T JMJD6 KO transformed cell line human CVCL_B2ZH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19355; JMJD6; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358000 CVCL_B2ZG Abcam HEK293T ITPA KO transformed cell line human CVCL_B2ZG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6176; ITPA; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358001 CVCL_B2ZJ Abcam HEK293T JUP KO transformed cell line human CVCL_B2ZJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6207; JUP; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358002 CVCL_B2ZI Abcam HEK293T JOSD1 KO transformed cell line human CVCL_B2ZI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28953; JOSD1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358003 CVCL_B2ZL Abcam HEK293T KDELR2 KO transformed cell line human CVCL_B2ZL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6305; KDELR2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358004 CVCL_B2ZK Abcam HEK293T KDELR1 KO transformed cell line human CVCL_B2ZK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6304; KDELR1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358005 CVCL_B2ZN Abcam HEK293T KDM5C KO 2 transformed cell line human CVCL_B2ZN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11114; KDM5C; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358006 CVCL_B2ZM Abcam HEK293T KDM5C KO 1 transformed cell line human CVCL_B2ZM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11114; KDM5C; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358007 CVCL_B2XB Abcam HEK293T FTSJ1 KO transformed cell line human CVCL_B2XB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13254; FTSJ1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358008 CVCL_B2XA Abcam HEK293T FTH1 KO transformed cell line human CVCL_B2XA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3976; FTH1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358009 CVCL_B2XD Abcam HEK293T FUS KO transformed cell line human CVCL_B2XD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4010; FUS; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358010 CVCL_B2XC Abcam HEK293T FUCA2 KO transformed cell line human CVCL_B2XC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4008; FUCA2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358011 CVCL_B2WU Abcam HEK293T FAM136A KO transformed cell line human CVCL_B2WU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25911; FAM136A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358012 CVCL_B2X6 Abcam HEK293T FLAD1 KO transformed cell line human CVCL_B2X6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24671; FLAD1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358013 CVCL_B2WT Abcam HEK293T FAM120A KO transformed cell line human CVCL_B2WT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13247; FAM120A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358014 CVCL_B2X5 Abcam HEK293T FKBP2 KO transformed cell line human CVCL_B2X5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3718; FKBP2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358015 CVCL_B2WW Abcam HEK293T FAM174C KO transformed cell line human CVCL_B2WW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26073; FAM174C; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358016 CVCL_B2X8 Abcam HEK293T FLOT2 KO transformed cell line human CVCL_B2X8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3758; FLOT2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358017 CVCL_B2WV Abcam HEK293T FAM162A KO transformed cell line human CVCL_B2WV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17865; FAM162A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358018 CVCL_B2X7 Abcam HEK293T FLOT1 KO transformed cell line human CVCL_B2X7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3757; FLOT1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358019 CVCL_B2WY Abcam HEK293T FANCG KO transformed cell line human CVCL_B2WY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3588; FANCG; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358020 CVCL_B2WX Abcam HEK293T FAM83D KO transformed cell line human CVCL_B2WX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16122; FAM83D; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358021 CVCL_B2X9 Abcam HEK293T FOXO3 KO transformed cell line human CVCL_B2X9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3821; FOXO3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358022 CVCL_B2WZ Abcam HEK293T FANCI KO transformed cell line human CVCL_B2WZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25568; FANCI; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358023 CVCL_B2WM Abcam HEK293T ERF KO transformed cell line human CVCL_B2WM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3444; ERF; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358024 CVCL_B2WL Abcam HEK293T EPHB4 KO 2 transformed cell line human CVCL_B2WL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3395; EPHB4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358025 CVCL_B2X0 Abcam HEK293T FCGRT KO transformed cell line human CVCL_B2X0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3621; FCGRT; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358026 CVCL_B2WN Abcam HEK293T ERGIC3 KO transformed cell line human CVCL_B2WN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15927; ERGIC3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358027 CVCL_B2WQ Abcam HEK293T ESD KO transformed cell line human CVCL_B2WQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3465; ESD; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358028 CVCL_B2X2 Abcam HEK293T FGF13 KO transformed cell line human CVCL_B2X2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3670; FGF13; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358029 CVCL_B2WP Abcam HEK293T ERP29 KO transformed cell line human CVCL_B2WP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13799; ERP29; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358030 CVCL_B2X1 Abcam HEK293T FCSK KO transformed cell line human CVCL_B2X1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29500; FCSK; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358031 CVCL_B2WS Abcam HEK293T F2R KO transformed cell line human CVCL_B2WS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3537; F2R; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Discontinued: Abcam; ab266398; true Female 151358032 CVCL_B2X4 Abcam HEK293T FKBP10 KO transformed cell line human CVCL_B2X4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18169; FKBP10; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358033 CVCL_B2WR Abcam HEK293T ETFA KO transformed cell line human CVCL_B2WR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3481; ETFA; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358034 CVCL_B2X3 Abcam HEK293T FGFR1 KO transformed cell line human CVCL_B2X3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3688; FGFR1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358035 CVCL_B2WE Abcam HEK293T EIF2D KO transformed cell line human CVCL_B2WE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6583; EIF2D; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358036 CVCL_B2WD Abcam HEK293T EIF2AK4 KO 2 transformed cell line human CVCL_B2WD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19687; EIF2AK4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358037 CVCL_B2WG Abcam HEK293T EIF4G2 KO transformed cell line human CVCL_B2WG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3297; EIF4G2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358038 CVCL_B2WF Abcam HEK293T EIF3K KO transformed cell line human CVCL_B2WF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24656; EIF3K; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358039 CVCL_B2WI Abcam HEK293T ELOF1 KO transformed cell line human CVCL_B2WI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28691; ELOF1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358040 CVCL_B2WH Abcam HEK293T EIF4H KO transformed cell line human CVCL_B2WH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12741; EIF4H; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358041 CVCL_B2WK Abcam HEK293T EPHB4 KO 1 transformed cell line human CVCL_B2WK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3395; EPHB4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358042 CVCL_B2WJ Abcam HEK293T EMD KO transformed cell line human CVCL_B2WJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3331; EMD; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358043 CVCL_B2YA Abcam HEK293T GSK3A KO transformed cell line human CVCL_B2YA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4616; GSK3A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358044 CVCL_B2YC Abcam HEK293T GSTK1 KO transformed cell line human CVCL_B2YC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16906; GSTK1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358045 CVCL_B2YB Abcam HEK293T GSS KO transformed cell line human CVCL_B2YB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4624; GSS; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358046 CVCL_B2YE Abcam HEK293T GTF2F1 KO transformed cell line human CVCL_B2YE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4652; GTF2F1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358047 CVCL_B2YD Abcam HEK293T GSTO1 KO transformed cell line human CVCL_B2YD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13312; GSTO1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358048 CVCL_B2XV Abcam HEK293T GNG4 KO transformed cell line human CVCL_B2XV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4407; GNG4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358049 CVCL_B2Y7 Abcam HEK293T GRHPR KO transformed cell line human CVCL_B2Y7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4570; GRHPR; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358050 CVCL_B2XU Abcam HEK293T GNB2 KO transformed cell line human CVCL_B2XU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4398; GNB2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358051 CVCL_B2Y6 Abcam HEK293T GPX1 KO transformed cell line human CVCL_B2Y6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4553; GPX1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358052 CVCL_B2XX Abcam HEK293T GNG8 KO transformed cell line human CVCL_B2XX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19664; GNG8; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358053 CVCL_B2Y9 Abcam HEK293T GRN KO transformed cell line human CVCL_B2Y9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4601; GRN; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358054 CVCL_B2XW Abcam HEK293T GNG5 KO transformed cell line human CVCL_B2XW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4408; GNG5; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358055 CVCL_B2Y8 Abcam HEK293T GRK2 KO transformed cell line human CVCL_B2Y8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:289; GRK2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358056 CVCL_B2XZ Abcam HEK293T GOLGA5 KO transformed cell line human CVCL_B2XZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4428; GOLGA5; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358057 CVCL_B2XY Abcam HEK293T GNPDA1 KO transformed cell line human CVCL_B2XY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4417; GNPDA1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358058 CVCL_B2XN Abcam HEK293T GHITM KO 2 transformed cell line human CVCL_B2XN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17281; GHITM; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358059 CVCL_B2XM Abcam HEK293T GHITM KO 1 transformed cell line human CVCL_B2XM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17281; GHITM; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358060 CVCL_B2XP Abcam HEK293T GIPC1 KO transformed cell line human CVCL_B2XP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1226; GIPC1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358061 CVCL_B2Y1 Abcam HEK293T GOLM1 KO transformed cell line human CVCL_B2Y1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15451; GOLM1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358062 CVCL_B2Y0 Abcam HEK293T GOLIM4 KO transformed cell line human CVCL_B2Y0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15448; GOLIM4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358063 CVCL_B2XR Abcam HEK293T GLI4 KO transformed cell line human CVCL_B2XR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4320; GLI4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358064 CVCL_B2Y3 Abcam HEK293T GPATCH4 KO transformed cell line human CVCL_B2Y3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25982; GPATCH4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358065 CVCL_B2XQ Abcam HEK293T GK KO transformed cell line human CVCL_B2XQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4289; GK; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358066 CVCL_B2Y2 Abcam HEK293T GPAA1 KO transformed cell line human CVCL_B2Y2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4446; GPAA1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358067 CVCL_B2XT Abcam HEK293T GNAI1 KO transformed cell line human CVCL_B2XT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4384; GNAI1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358068 CVCL_B2Y5 Abcam HEK293T GPI KO transformed cell line human CVCL_B2Y5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4458; GPI; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358069 CVCL_B2XS Abcam HEK293T GLYR1 KO transformed cell line human CVCL_B2XS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24434; GLYR1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358070 CVCL_B2Y4 Abcam HEK293T GPC4 KO transformed cell line human CVCL_B2Y4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4452; GPC4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358071 CVCL_B2XF Abcam HEK293T FYN KO transformed cell line human CVCL_B2XF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4037; FYN; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358072 CVCL_B2XE Abcam HEK293T FXYD5 KO transformed cell line human CVCL_B2XE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4029; FXYD5; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358073 CVCL_B2XH Abcam HEK293T G6PC3 KO transformed cell line human CVCL_B2XH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24861; G6PC3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358074 CVCL_B2XG Abcam HEK293T FZR1 KO transformed cell line human CVCL_B2XG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24824; FZR1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358075 CVCL_B2XJ Abcam HEK293T GAK KO transformed cell line human CVCL_B2XJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4113; GAK; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358076 CVCL_B2XI Abcam HEK293T GAA KO transformed cell line human CVCL_B2XI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4065; GAA; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358077 CVCL_B2XL Abcam HEK293T GDI2 KO transformed cell line human CVCL_B2XL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4227; GDI2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358078 CVCL_B2XK Abcam HEK293T GCN1 KO transformed cell line human CVCL_B2XK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4199; GCN1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358079 CVCL_B2UZ Abcam HEK293T COQ8A KO transformed cell line human CVCL_B2UZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16812; COQ8A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358080 CVCL_B2VB Abcam HEK293T CSTB KO transformed cell line human CVCL_B2VB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2482; CSTB; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358081 CVCL_B2VA Abcam HEK293T CSF2 KO transformed cell line human CVCL_B2VA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2434; CSF2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358082 CVCL_B2US Abcam HEK293T COA4 KO transformed cell line human CVCL_B2US CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24604; COA4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358083 CVCL_B2V4 Abcam HEK293T CPNE1 KO transformed cell line human CVCL_B2V4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2314; CPNE1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358084 CVCL_B2UR Abcam HEK293T COA3 KO transformed cell line human CVCL_B2UR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24990; COA3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358085 CVCL_B2V3 Abcam HEK293T COX8A KO transformed cell line human CVCL_B2V3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2294; COX8A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358086 CVCL_B2UU Abcam HEK293T COL6A2 KO transformed cell line human CVCL_B2UU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2212; COL6A2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Discontinued: Abcam; ab266482; true Female 151358087 CVCL_B2V6 Abcam HEK293T CPT1A KO transformed cell line human CVCL_B2V6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2328; CPT1A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358088 CVCL_B2UT Abcam HEK293T COL6A1 KO transformed cell line human CVCL_B2UT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2211; COL6A1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358089 CVCL_B2V5 Abcam HEK293T CPSF7 KO transformed cell line human CVCL_B2V5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30098; CPSF7; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358090 CVCL_B2UW Abcam HEK293T COMT KO transformed cell line human CVCL_B2UW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2228; COMT; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358091 CVCL_B2V8 Abcam HEK293T CREBBP KO transformed cell line human CVCL_B2V8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2348; CREBBP; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358092 CVCL_B2UV Abcam HEK293T COLGALT1 KO transformed cell line human CVCL_B2UV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26182; COLGALT1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358093 CVCL_B2V7 Abcam HEK293T CRAT KO transformed cell line human CVCL_B2V7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2342; CRAT; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358094 CVCL_B2UY Abcam HEK293T COPS7B KO transformed cell line human CVCL_B2UY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16760; COPS7B; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358095 CVCL_B2UX Abcam HEK293T COPS7A KO transformed cell line human CVCL_B2UX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16758; COPS7A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358096 CVCL_B2V9 Abcam HEK293T CRIM1 KO transformed cell line human CVCL_B2V9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2359; CRIM1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358097 CVCL_B2UK Abcam HEK293T CMC2 KO 2 transformed cell line human CVCL_B2UK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24447; CMC2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358098 CVCL_B2UJ Abcam HEK293T CMC2 KO 1 transformed cell line human CVCL_B2UJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24447; CMC2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358099 CVCL_B2UM Abcam HEK293T CNKSR3 KO transformed cell line human CVCL_B2UM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23034; CNKSR3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358100 CVCL_B2UL Abcam HEK293T CNIH4 KO transformed cell line human CVCL_B2UL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25013; CNIH4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358101 CVCL_B2V0 Abcam HEK293T COQ9 KO transformed cell line human CVCL_B2V0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25302; COQ9; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358102 CVCL_B2UN Abcam HEK293T CNOT1 KO transformed cell line human CVCL_B2UN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7877; CNOT1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358103 CVCL_B2UQ Abcam HEK293T COA1 KO transformed cell line human CVCL_B2UQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21868; COA1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358104 CVCL_B2V2 Abcam HEK293T COX7A2 KO transformed cell line human CVCL_B2V2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2288; COX7A2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358105 CVCL_B2UP Abcam HEK293T CNPY2 KO transformed cell line human CVCL_B2UP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13529; CNPY2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358106 CVCL_B2V1 Abcam HEK293T CORO1C KO transformed cell line human CVCL_B2V1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2254; CORO1C; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358107 CVCL_B2UC Abcam HEK293T CIB1 KO transformed cell line human CVCL_B2UC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16920; CIB1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358108 CVCL_B2UB Abcam HEK293T CHD1 KO transformed cell line human CVCL_B2UB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1915; CHD1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358109 CVCL_B2UE Abcam HEK293T CIRBP KO transformed cell line human CVCL_B2UE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1982; CIRBP; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358110 CVCL_B2UD Abcam HEK293T CIB2 KO transformed cell line human CVCL_B2UD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24579; CIB2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358111 CVCL_B2UG Abcam HEK293T CKMT1A KO transformed cell line human CVCL_B2UG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31736; CKMT1A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358112 CVCL_B2UF Abcam HEK293T CIT KO transformed cell line human CVCL_B2UF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1985; CIT; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358113 CVCL_B2UI Abcam HEK293T CLUH KO transformed cell line human CVCL_B2UI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29094; CLUH; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358114 CVCL_B2UH Abcam HEK293T CLTA KO transformed cell line human CVCL_B2UH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2090; CLTA; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358115 CVCL_B2WA Abcam HEK293T EEF1E1 KO transformed cell line human CVCL_B2WA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3212; EEF1E1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358116 CVCL_B2WC Abcam HEK293T EIF2AK4 KO 1 transformed cell line human CVCL_B2WC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19687; EIF2AK4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358117 CVCL_B2WB Abcam HEK293T EIF1 KO transformed cell line human CVCL_B2WB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3249; EIF1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358118 CVCL_B2VT Abcam HEK293T DEGS1 KO transformed cell line human CVCL_B2VT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13709; DEGS1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358119 CVCL_B2W5 Abcam HEK293T DYRK1A KO transformed cell line human CVCL_B2W5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3091; DYRK1A; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358120 CVCL_B2VS Abcam HEK293T DCXR KO transformed cell line human CVCL_B2VS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18985; DCXR; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358121 CVCL_B2W4 Abcam HEK293T DYNC2I2 KO transformed cell line human CVCL_B2W4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28296; DYNC2I2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358122 CVCL_B2VV Abcam HEK293T DGUOK KO transformed cell line human CVCL_B2VV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2858; DGUOK; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358123 CVCL_B2W7 Abcam HEK293T ECH1 KO transformed cell line human CVCL_B2W7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3149; ECH1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358124 CVCL_B2VU Abcam HEK293T DESI1 KO transformed cell line human CVCL_B2VU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24577; DESI1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358125 CVCL_B2W6 Abcam HEK293T E2F4 KO transformed cell line human CVCL_B2W6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3118; E2F4; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358126 CVCL_B2VX Abcam HEK293T DMPK KO transformed cell line human CVCL_B2VX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2933; DMPK; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358127 CVCL_B2W9 Abcam HEK293T EEF1B2 KO transformed cell line human CVCL_B2W9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3208; EEF1B2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358128 CVCL_B2VW Abcam HEK293T DIAPH1 KO transformed cell line human CVCL_B2VW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2876; DIAPH1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358129 CVCL_B2W8 Abcam HEK293T ECI2 KO transformed cell line human CVCL_B2W8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14601; ECI2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358130 CVCL_B2VZ Abcam HEK293T DNAJB1 KO transformed cell line human CVCL_B2VZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5270; DNAJB1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358131 CVCL_B2VY Abcam HEK293T DNAJA1 KO transformed cell line human CVCL_B2VY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5229; DNAJA1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358132 CVCL_B2VL Abcam HEK293T DAPK3 KO transformed cell line human CVCL_B2VL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2676; DAPK3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358133 CVCL_B2VK Abcam HEK293T DAPK1 KO transformed cell line human CVCL_B2VK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2674; DAPK1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358134 CVCL_B2VN Abcam HEK293T DAZAP1 KO 2 transformed cell line human CVCL_B2VN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2683; DAZAP1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358135 CVCL_B2VM Abcam HEK293T DAZAP1 KO 1 transformed cell line human CVCL_B2VM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2683; DAZAP1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358136 CVCL_B2VP Abcam HEK293T DAZAP2 KO transformed cell line human CVCL_B2VP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2684; DAZAP2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358137 CVCL_B2W1 Abcam HEK293T DR1 KO transformed cell line human CVCL_B2W1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3017; DR1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358138 CVCL_B2W0 Abcam HEK293T DNAJC2 KO transformed cell line human CVCL_B2W0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13192; DNAJC2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358139 CVCL_B2VR Abcam HEK293T DCTPP1 KO transformed cell line human CVCL_B2VR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28777; DCTPP1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358140 CVCL_B2W3 Abcam HEK293T DROSHA KO transformed cell line human CVCL_B2W3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17904; DROSHA; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358141 CVCL_B2VQ Abcam HEK293T DBI KO transformed cell line human CVCL_B2VQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2690; DBI; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358142 CVCL_B2W2 Abcam HEK293T DRG1 KO transformed cell line human CVCL_B2W2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3029; DRG1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358143 CVCL_B2VD Abcam HEK293T CTDSP1 KO transformed cell line human CVCL_B2VD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21614; CTDSP1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358144 CVCL_B2VC Abcam HEK293T CTDNEP1 KO transformed cell line human CVCL_B2VC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19085; CTDNEP1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358145 CVCL_B2VF Abcam HEK293T CTSL KO transformed cell line human CVCL_B2VF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2537; CTSL; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358146 CVCL_B2VE Abcam HEK293T CTSH KO transformed cell line human CVCL_B2VE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2535; CTSH; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358147 CVCL_B2VH Abcam HEK293T CYBA KO transformed cell line human CVCL_B2VH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2577; CYBA; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358148 CVCL_B2VG Abcam HEK293T CTTN KO transformed cell line human CVCL_B2VG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3338; CTTN; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358149 CVCL_B2VJ Abcam HEK293T DAG1 KO transformed cell line human CVCL_B2VJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2666; DAG1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358150 CVCL_B2VI Abcam HEK293T CYSTM1 KO transformed cell line human CVCL_B2VI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30239; CYSTM1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358151 CVCL_B4GK WG4140 finite cell line human CVCL_B4GK From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:68; ABCD4; Simple; c.542+1G>T; ClinVar=VCV000280107; Zygosity=Heterozygous; Note=Splice donor mutation (CelloPub=CLPUB00670; PubMed=22922874); Sequence variation: Mutation; HGNC; HGNC:68; ABCD4; Simple; p.Gly486Cys (c.1456G>T); ClinVar=VCV000037322; Zygosity=Heterozygous (CelloPub=CLPUB00670; PubMed=22922874) Miscellaneous: Cell line no longer available Population: Caucasian; German; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151358152 CVCL_B4GJ WG4066 finite cell line human CVCL_B4GJ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:68; ABCD4; Simple; p.Tyr319Cys (c.956A>G); ClinVar=VCV000037319; Zygosity=Heterozygous (CelloPub=CLPUB00670; PubMed=22922874); Sequence variation: Mutation; HGNC; HGNC:68; ABCD4; Simple; p.Glu583Leufs*9 (c.1746_1747insCT); ClinVar=VCV000037320; Zygosity=Heterozygous (CelloPub=CLPUB00670; PubMed=22922874); Sequence variation: Mutation; HGNC; HGNC:6694; LRP2; Simple; p.Arg1311His (c.3932G>A); ClinVar=VCV000893877; Zygosity=Heterozygous (CelloPub=CLPUB00670; PubMed=22922874); Sequence variation: Mutation; HGNC; HGNC:6694; LRP2; Simple; p.Arg3646His (c.10937G>A); ClinVar=VCV000074222; Zygosity=Heterozygous (CelloPub=CLPUB00670; PubMed=22922874); Sequence variation: Mutation; HGNC; HGNC:24759; TPRG1; Simple; p.Tyr61Ter (c.183_192del); Zygosity=Heterozygous (CelloPub=CLPUB00670; PubMed=22922874); Sequence variation: Mutation; HGNC; HGNC:24759; TPRG1; Simple; p.Ser141Ile (c.422G>T); Zygosity=Heterozygous (CelloPub=CLPUB00670; PubMed=22922874) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole exome sequencing Female 151358153 CVCL_B4GM WG4053 finite cell line human CVCL_B4GM From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358154 CVCL_B4GL WG3897 finite cell line human CVCL_B4GL From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358155 CVCL_B4H0 WG4042 finite cell line human CVCL_B4H0 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Ala24_Lys82del (c.70-4298_246+2311del6785); Zygosity=Heterozygous (CelloPub=CLPUB00671; PubMed=21303734); Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Heterozygous (CelloPub=CLPUB00671) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358156 CVCL_B4GN IMBB spontaneously immortalized cell line house mouse CVCL_B4GN CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:1097161; Bak1; Knockout cell: Method=KO mouse; MGI; MGI:99702; Bax Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Doubling time: ~24 hours (Patent=US8389276) Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-9386 151358157 CVCL_B4H2 NN10 cancer cell line house mouse CVCL_B4H2 CL:0000010 Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV); Breed/subspecies: ICFW. Characteristics: Constitutively synthesizes and secretes erythropoietin (PubMed=3861324) Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-235 151358158 CVCL_B4GQ PV014 transformed cell line human CVCL_B4GQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Thr238Ter (c.712_713delAC) (T237X); Zygosity=Heterozygous (CelloPub=CLPUB00671); Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Heterozygous (CelloPub=CLPUB00671); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7 Population: Caucasian; Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151358159 CVCL_B4GP B-LCL-HROC10 transformed cell line human CVCL_B4GP HLA typing: A*01:01:01,24:02:01; B*08:01:01,27:05:02; C*01:02:01,07:01:01; DPB1*02:02:01,04:01:01; DQA1*01:01:01,05:01:01; DQB1*02:01:01,05:01:01; DRB1*01:01:01,03:01:01 (CLS=302143) From: Linnebacher, Michael; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 151358160 CVCL_B4H1 IW32 cancer cell line house mouse CVCL_B4H1 CL:0000010 Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV); Breed/subspecies: ICFW. Characteristics: Constitutively synthesizes and secretes erythropoietin (PubMed=6578507; PubMed=6589018); Characteristics: One of the two copies of the EPO locus has undergone rearrangement and amplification (PubMed=2766927; PubMed=3561395) Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-234 151358161 CVCL_B4GC RAC-5E cancer cell line house mouse CVCL_B4GC CL:0000010 Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV); Breed/subspecies: BALB/c. Female Doubling time: 9 hours (PubMed=3756929) 151358162 CVCL_B4GB RAC-1P cancer cell line house mouse CVCL_B4GB CL:0000010 Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV); Breed/subspecies: BALB/c. Female 151358163 CVCL_B4GE RAC-2C cancer cell line house mouse CVCL_B4GE CL:0000010 Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV); Breed/subspecies: BALB/c. Female 151358164 CVCL_B4GD RAC-4E cancer cell line house mouse CVCL_B4GD CL:0000010 Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV); Breed/subspecies: BALB/c. Female 151358165 CVCL_B4GG RAC-11P cancer cell line house mouse CVCL_B4GG CL:0000010 Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV); Breed/subspecies: BALB/c. Female 151358166 CVCL_B4GF RAC-10P cancer cell line house mouse CVCL_B4GF CL:0000010 Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV); Breed/subspecies: BALB/c. Female Doubling time: 23 hours (PubMed=3756929) 151358167 CVCL_B4GI WG3630 finite cell line human CVCL_B4GI From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:68; ABCD4; Simple; p.Asn141Lys (c.423C>G); ClinVar=VCV001343599; Zygosity=Homozygous (PubMed=23141461); Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Ala222Val (c.665C>T) (C677T); ClinVar=VCV000003520; Zygosity=Homozygous (PubMed=23141461) Miscellaneous: Cell line no longer available Population: Chinese; Han; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole exome sequencing Male 151358168 CVCL_B4GH WG4095 finite cell line human CVCL_B4GH From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358169 CVCL_B4FZ GM2300 cancer cell line human CVCL_B4FZ CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified Characteristics: Early passage culture 151358170 CVCL_B4FY GM2217 cancer cell line human CVCL_B4FY CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163Ser (c.488A>C); Zygosity=Unspecified (PubMed=14961077) Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified Characteristics: Early passage culture 151358171 CVCL_B4GA RAC-311C cancer cell line house mouse CVCL_B4GA CL:0000010 Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV); Breed/subspecies: BALB/c. Female 151358172 CVCL_B4FR 368BR finite cell line human CVCL_B4FR CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 151358173 CVCL_B4G3 GM2401 cancer cell line human CVCL_B4G3 CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified Characteristics: Early passage culture 151358174 CVCL_B4FQ 47N30A32 hybridoma house mouse CVCL_B4FQ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01579; Human IFNG. Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-464 151358175 CVCL_B4G2 GM2345 cancer cell line human CVCL_B4G2 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=14961077) Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified Characteristics: Early passage culture 151358176 CVCL_B4FT GM139 cancer cell line human CVCL_B4FT CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified Characteristics: Early passage culture 151358177 CVCL_B4G5 GM2493 cancer cell line human CVCL_B4G5 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (PubMed=14961077) Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified Characteristics: Early passage culture 151358178 CVCL_B4FS GM133 cancer cell line human CVCL_B4FS CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=14961077) Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified Characteristics: Early passage culture 151358179 CVCL_B4G4 GM2455 cancer cell line human CVCL_B4G4 CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified Characteristics: Early passage culture 151358180 CVCL_B4FV GM1592 cancer cell line human CVCL_B4FV CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified Characteristics: Early passage culture 151358181 CVCL_B4G7 RAC-3C cancer cell line house mouse CVCL_B4G7 CL:0000010 Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV); Breed/subspecies: BALB/c. Female Doubling time: 23 hours (PubMed=3756929) 151358182 CVCL_B4FU GM1578 cancer cell line human CVCL_B4FU CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified Characteristics: Early passage culture 151358183 CVCL_B4G6 GM97 cancer cell line human CVCL_B4G6 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=14961077) Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified Characteristics: Early passage culture 151358184 CVCL_B4FX GM1600 cancer cell line human CVCL_B4FX CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified Characteristics: Early passage culture 151358185 CVCL_B4G9 RAC-31C cancer cell line house mouse CVCL_B4G9 CL:0000010 Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV); Breed/subspecies: BALB/c. Female Doubling time: 15 hours (PubMed=3756929) 151358186 CVCL_B4FW GM1596 cancer cell line human CVCL_B4FW CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220His (c.658T>C); ClinVar=VCV000376687; Zygosity=Unspecified (PubMed=14961077) Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified Characteristics: Early passage culture 151358187 CVCL_B4G8 RAC-34E cancer cell line house mouse CVCL_B4G8 CL:0000010 Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV); Breed/subspecies: BALB/c. Female Doubling time: 9.4 hours (PubMed=3756929) 151358188 CVCL_B4HL 4H11 [Mouse hybridoma against rat Hmgb1] hybridoma house mouse CVCL_B4HL CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1. 151358189 CVCL_B4HK 4C9 [Mouse hybridoma against rat Hmgb1] hybridoma house mouse CVCL_B4HK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1. 151358190 CVCL_B4HN 6E6 [Mouse hybridoma against rat Hmgb1] hybridoma house mouse CVCL_B4HN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5433 151358191 CVCL_B4HM 5C12 [Mouse hybridoma against human HMGB1] hybridoma house mouse CVCL_B4HM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P09429; Human HMGB1. 151358192 CVCL_B4HP 6H9 [Mouse hybridoma against rat Hmgb1] hybridoma house mouse CVCL_B4HP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1 (Note=Also recognizes human HMGB1 and human/rat Hmgb2). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5434 151358193 CVCL_B4I1 ML15-5F7.5B10 hybridoma house mouse CVCL_B4I1 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 last 23 residues; Abeta(20-42)). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7241 151358194 CVCL_B4I0 ML15-4B7.3A6 hybridoma house mouse CVCL_B4I0 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 last 23 residues; Abeta(20-42)). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7242 151358195 CVCL_B4HR 7H3 hybridoma house mouse CVCL_B4HR CL:0000010 Monoclonal antibody isotype: IgG1+IgG3; Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1. 151358196 CVCL_B4I3 ML15-7E5.5E12 hybridoma house mouse CVCL_B4I3 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 last 23 residues; Abeta(20-42)). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7809 151358197 CVCL_B4HQ 7G8 [Mouse hybridoma against human HMGB] hybridoma house mouse CVCL_B4HQ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P09429; Human HMGB1. 151358198 CVCL_B4I2 ML15-6A2-4B10 hybridoma house mouse CVCL_B4I2 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 last 23 residues; Abeta(20-42)). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7409 151358199 CVCL_B4HD 2E11 [Mouse hybridoma against rat Hmgb1] hybridoma house mouse CVCL_B4HD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1 (Note=Also recognizes human HMGB1 and human/rat Hmgb2). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5431 151358200 CVCL_B4HC 1C3 [Mouse hybridoma against human HMGB1] hybridoma house mouse CVCL_B4HC CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P09429; Human HMGB1. 151358201 CVCL_B4HF 2G7 [Mouse hybridoma against rat Hmgb1] hybridoma house mouse CVCL_B4HF CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1 (Note=Also reacts with human). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5432 151358202 CVCL_B4HE 2G5 [Mouse hybridoma against rat Hmgb1] hybridoma house mouse CVCL_B4HE CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1. 151358203 CVCL_B4HH 3E10 [Mouse hybridoma against human HMGB1] hybridoma house mouse CVCL_B4HH CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P09429; Human HMGB1. 151358204 CVCL_B4HG 3-5A6 hybridoma house mouse CVCL_B4HG CL:0000010 Monoclonal antibody isotype: IgG2a+IgG2b; Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1. 151358205 CVCL_B4HJ 4A10 [Mouse hybridoma against human HMGB1] hybridoma house mouse CVCL_B4HJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P09429; Human HMGB1. 151358206 CVCL_B4HI 3G8 [Mouse hybridoma against rat Hmgb1] hybridoma house mouse CVCL_B4HI CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1. 151358207 CVCL_B4GZ WG4008 finite cell line human CVCL_B4GZ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Heterozygous (CelloPub=CLPUB00671); Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; c.1339-1G>T; ClinVar=VCV001323238; Zygosity=Heterozygous; Note=Splice acceptor mutation (CelloPub=CLPUB00671; PubMed=21303734) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358208 CVCL_B4HB 1A9 [Mouse hybridoma against rat Hmgb1] hybridoma house mouse CVCL_B4HB CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1. 151358209 CVCL_B4HA 10D4 hybridoma house mouse CVCL_B4HA CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5435 151358210 CVCL_B4H4 NCC-MPNST6-C1 cancer cell line human CVCL_B4H4 CL:0000010 Population: Japanese; Derived from site: In situ; Right thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072. Omics: Phenotyping; Drug screening Male Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi); Doubling time: ~75 hours (PubMed=34775549) Part of: NCC sarcoma cell line panel 151358211 CVCL_B4GS WG1908 finite cell line human CVCL_B4GS From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Homozygous (CelloPub=CLPUB00671; PubMed=19136951) Population: Native North American; Dakelh; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358212 CVCL_B4H3 IW201 cancer cell line house mouse CVCL_B4H3 CL:0000010 Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV). 151358213 CVCL_B4GR WG3265 finite cell line human CVCL_B4GR From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Thr172Argfs*10 (c.515_516delAC); ClinVar=VCV000000517; Zygosity=Homozygous (CelloPub=CLPUB00671; PubMed=19136951) Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151358214 CVCL_B4GU WG1087 finite cell line human CVCL_B4GU From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Homozygous (CelloPub=CLPUB00671; PubMed=19136951) Population: Caucasian; French Canadian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358215 CVCL_B4H6 Y12 hybridoma house mouse CVCL_B4H6 CL:0000010 Monoclonal antibody isotype: IgG2b, kappa (PubMed=6180012); IgG3, kappa (PubMed=2295704); Monoclonal antibody target: UniProtKB; P27048; Mouse Snrpb. 151358216 CVCL_B4GT WG2432 finite cell line human CVCL_B4GT From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Homozygous (CelloPub=CLPUB00671; PubMed=19136951) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358217 CVCL_B4H5 Y2 hybridoma house mouse CVCL_B4H5 CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P27048; Mouse Snrpb. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8050 151358218 CVCL_B4H8 HeLa TUBA4A KO cancer cell line human CVCL_B4H8 From: Durcan, Thomas M.; Montreal Neurological Institute, McGill University; Montreal; Canada CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12407; TUBA4A Miscellaneous: Cell line information from personal communication of Laflamme, Carl Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151358219 CVCL_B4GW WG1903 finite cell line human CVCL_B4GW CL:0000010 Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Homozygous (CelloPub=CLPUB00671; PubMed=19136951) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151358220 CVCL_B4H7 E85 hybridoma house mouse CVCL_B4H7 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P69905; Human HBA1 (Note=Glycated; N-deoxyfructosyllysine). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10616 151358221 CVCL_B4GV WG1173 finite cell line human CVCL_B4GV From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Homozygous (CelloPub=CLPUB00671; PubMed=19136951) Population: Caucasian; French Canadian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358222 CVCL_B4GY WG1959 finite cell line human CVCL_B4GY From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Lys281fs*4 (c.842_845delAGAG); Zygosity=Heterozygous (CelloPub=CLPUB00671; PubMed=19136951); Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Heterozygous (CelloPub=CLPUB00671; PubMed=19136951) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151358223 CVCL_B4H9 DPH1.1 hybridoma house mouse CVCL_B4H9 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P09429; Human HMGB1 (Note=Also reacts with mouse and rat Immunized with AA 165-181 which is conserved in mammals).. Group: Patented cell line; Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 10002 151358224 CVCL_B4GX WG1350 finite cell line human CVCL_B4GX From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Homozygous (CelloPub=CLPUB00671; PubMed=19136951) Population: El Salvadoran; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358225 CVCL_B4EI WG3599 finite cell line human CVCL_B4EI From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala631Glnfs*17 (c.1891delG); ClinVar=VCV000242511; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358226 CVCL_B4EH WG3820 finite cell line human CVCL_B4EH From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gln624Arg (c.1871A>G); ClinVar=VCV001459267; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Arab; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358227 CVCL_B4EK WG3397 finite cell line human CVCL_B4EK From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Caribbean; Barbadian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358228 CVCL_B4EJ WG3564 finite cell line human CVCL_B4EJ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Pro654_Arg655insTer (c.1962_1963delTC) (p.Pro654Profs*2); ClinVar=VCV000552144; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358229 CVCL_B4EM WG1220 finite cell line human CVCL_B4EM From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:25221; MMADHC; Simple; p.Arg250Ter (c.748C>T); ClinVar=VCV000000767; Zygosity=Homozygous (PubMed=18385497) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151358230 CVCL_B4EL WG3447 finite cell line human CVCL_B4EL From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg727Ter (c.2179C>T); ClinVar=VCV000218998; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Indian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358231 CVCL_B4F0 WG3377 finite cell line human CVCL_B4F0 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Thr238Ter (c.712_713delAC) (T237X); Zygosity=Heterozygous (CelloPub=CLPUB00671; PubMed=19136951); Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Heterozygous (CelloPub=CLPUB00671; PubMed=19136951) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151358232 CVCL_B4EN WG1437 finite cell line human CVCL_B4EN From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:25221; MMADHC; Simple; p.Arg54Ter (c.160C>T); ClinVar=VCV000000765; Zygosity=Heterozygous (PubMed=18385497); Sequence variation: Mutation; HGNC; HGNC:25221; MMADHC; Simple; p.Leu103_Ser108dup (c.307_324dup); ClinVar=VCV000000766; Zygosity=Heterozygous (PubMed=18385497) Miscellaneous: Cell line no longer available Population: Caribbean; Haitian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151358233 CVCL_B4EA WG4027 finite cell line human CVCL_B4EA From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Gln (c.683G>A); ClinVar=VCV002136408; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Moroccan; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358234 CVCL_B4EC WG3439 finite cell line human CVCL_B4EC From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly427Asp (c.1280G>A); ClinVar=VCV000218990; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Asian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358235 CVCL_B4EB WG3426 finite cell line human CVCL_B4EB From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Caucasian; German/Polish; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358236 CVCL_B4EE WG3664 finite cell line human CVCL_B4EE From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Lys520Asn (c.1560G>C); Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Pakistani; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358237 CVCL_B4ED WG3482 finite cell line human CVCL_B4ED From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg474Ter (c.1420C>T); ClinVar=VCV000554873; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Middle Eastern; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358238 CVCL_B4EG WG3547 finite cell line human CVCL_B4EG From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg581Ter (c.1741C>T); ClinVar=VCV000554675; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Lebanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358239 CVCL_B4EF WG3705 finite cell line human CVCL_B4EF From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2548; CUBN; Simple; p.Gly1167Val (c.3500G>T); ClinVar=VCV001444711; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:2548; CUBN; Simple; p.Ile2071Val (c.6211A>G); ClinVar=VCV001478369; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala555Thr (c.1663G>A); ClinVar=VCV000203850; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Chinese/Asian ethnic group; Hmong; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358240 CVCL_B4DX WG3637 finite cell line human CVCL_B4DX From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Met266Tyrfs*7 (c.795_796insT); Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg403Ter (c.1207C>T); ClinVar=VCV000167310; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358241 CVCL_B4E9 WG3721 finite cell line human CVCL_B4E9 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Val136Phe (c.406G>T); ClinVar=VCV001071892; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358242 CVCL_B4E8 WG3742 finite cell line human CVCL_B4E8 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358243 CVCL_B4DW WG4169 finite cell line human CVCL_B4DW From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.753+3A>G; ClinVar=VCV003061795; Zygosity=Heterozygous; Note=Splice donor mutation (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.1332+1delG; ClinVar=VCV000554656; Zygosity=Heterozygous; Note=Splice donor mutation (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Caucasian; French Canadian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358244 CVCL_B4DZ WG3760 finite cell line human CVCL_B4DZ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala324Thr (c.970G>A); ClinVar=VCV000550893; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg616Cys (c.1846C>T); ClinVar=VCV000551499; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Caution: MMUT c.1846C>T mutation indicated incorrectly as being causative of p.Pro649Leu in CelloPub=CLPUB00669 and PubMed=27233228 (personal communication of Rosenblatt, David S.) 151358245 CVCL_B4DY WG3602 finite cell line human CVCL_B4DY From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly312Val (c.935G>T); ClinVar=VCV000218988; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly637Arg (c.1909G>A); ClinVar=VCV001486406; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358246 CVCL_B4E1 WG3310 finite cell line human CVCL_B4E1 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu394Phefs*30 (c.1181dupT); ClinVar=VCV000222930; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gln659Ter (c.1975C>T); ClinVar=VCV000222939; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358247 CVCL_B4DP WG3972 finite cell line human CVCL_B4DP From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Pro194Leu (c.581C>T); ClinVar=VCV001073632; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Caucasian; Portuguese and Mexican and Southeast Asian; Lao/Thai; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358248 CVCL_B4E0 WG3669 finite cell line human CVCL_B4E0 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ser354Trpfs*20 (c.1061delCinsGGA); Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ser357Metfs*5 (c.1065_1068dupATGG); ClinVar=VCV000280817; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Afghan; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358249 CVCL_B4DR WG3374 finite cell line human CVCL_B4DR From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn219Tyr (c.655A>T); ClinVar=VCV000001886; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Glu414Lysfs*17 (c.1240delG); Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Caucasian; French Canadian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358250 CVCL_B4E3 WG3794 finite cell line human CVCL_B4E3 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Val19Glyfs*39 (c.55dupG); ClinVar=VCV000222906; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Pakistani; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358251 CVCL_B4DQ WG3499 finite cell line human CVCL_B4DQ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:16732; MCEE; Simple; p.Arg143His (c.428G>A); ClinVar=VCV000336936; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Glu211del (c.631_633delGAG); Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: African or African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358252 CVCL_B4E2 WG3707 finite cell line human CVCL_B4E2 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly427Asp (c.1280G>A); ClinVar=VCV000218990; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Unexplicit; Ex13 del; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:11653; TCN2; Simple; p.Arg170Gln (c.509G>A); ClinVar=VCV000341197; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Chinese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358253 CVCL_B4E5 WG3325 finite cell line human CVCL_B4E5 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg93His (c.278G>A); ClinVar=VCV000001880; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Arab; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358254 CVCL_B4DT WG3520 finite cell line human CVCL_B4DT From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358255 CVCL_B4DS WG3556 finite cell line human CVCL_B4DS From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn219Tyr (c.655A>T); ClinVar=VCV000001886; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.1332+1delG; ClinVar=VCV000554656; Zygosity=Heterozygous; Note=Splice donor mutation (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358256 CVCL_B4E4 WG3784 finite cell line human CVCL_B4E4 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Pro86Leu (c.257C>T); ClinVar=VCV000553773; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Indian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358257 CVCL_B4DV WG3329 finite cell line human CVCL_B4DV From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu494Ter (c.1481T>A); ClinVar=VCV000551275; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Korean; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358258 CVCL_B4E7 WG3361 finite cell line human CVCL_B4E7 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Caucasian and Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358259 CVCL_B4E6 WG3336 finite cell line human CVCL_B4E6 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358260 CVCL_B4DU WG3965 finite cell line human CVCL_B4DU From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Tyr429Ter (c.1287C>G); ClinVar=VCV000554278; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358261 CVCL_B4FJ 30N47-1 hybridoma house mouse CVCL_B4FJ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01579; Human IFNG. Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-463 151358262 CVCL_B4FI MODE-K.CD46 transformed cell line house mouse CVCL_B4FI CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6953; CD46; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Small intestine, duodenum; UBERON=UBERON_0002114; Cell type: Epithelial cell of intestine; CL=CL_0002563; Breed/subspecies: C3H/HeJ. Female 151358263 CVCL_B4FL 47N30A35 hybridoma house mouse CVCL_B4FL CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01579; Human IFNG. Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-465 151358264 CVCL_B4FK 47N3-6 hybridoma house mouse CVCL_B4FK CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01579; Human IFNG. Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-466 151358265 CVCL_B4FN 47N48B22 hybridoma house mouse CVCL_B4FN CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01579; Human IFNG. Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-469 151358266 CVCL_B4FM 47N38B27 hybridoma house mouse CVCL_B4FM CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01579; Human IFNG. Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-468 151358267 CVCL_B4FP 47N9-11 hybridoma house mouse CVCL_B4FP CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01579; Human IFNG. Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-467 151358268 CVCL_B4G1 GM2328 cancer cell line human CVCL_B4G1 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Ser (c.481G>T); Zygosity=Unspecified (PubMed=14961077) Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified Characteristics: Early passage culture 151358269 CVCL_B4G0 GM2313 cancer cell line human CVCL_B4G0 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=14961077) Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified Characteristics: Early passage culture 151358270 CVCL_B4FB HC11/Twist spontaneously immortalized cell line house mouse CVCL_B4FB CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98872; Twist1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Cell type: Epithelial cell of mammary gland; CL=CL_0002327; Breed/subspecies: BALB/c. Female 151358271 CVCL_B4FA HC11/MV7 spontaneously immortalized cell line house mouse CVCL_B4FA CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Cell type: Epithelial cell of mammary gland; CL=CL_0002327; Breed/subspecies: BALB/c. Female Characteristics: Control cell line for HC11/Twist (Cellosaurus=CVCL_B4FB) and HC11/Wnt-1 (Cellosaurus=CVCL_B4FC) (PubMed=12702582) 151358272 CVCL_B4FD RAC/MV7 cancer cell line house mouse CVCL_B4FD CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV); Breed/subspecies: BALB/c. Female Characteristics: Control cell line for RAC/Wnt-1 (Cellosaurus=CVCL_B4FE) 151358273 CVCL_B4FC HC11/Wnt-1 spontaneously immortalized cell line house mouse CVCL_B4FC CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98953; Wnt1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Cell type: Epithelial cell of mammary gland; CL=CL_0002327; Breed/subspecies: BALB/c. Female 151358274 CVCL_B4FF RAC/Wnt-1 #9 cancer cell line house mouse CVCL_B4FF CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98953; Wnt1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV); Breed/subspecies: BALB/c. Female Characteristics: Expresses Wnt1 at a high level (PubMed=10197631) 151358275 CVCL_B4FE RAC/Wnt-1 cancer cell line house mouse CVCL_B4FE CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98953; Wnt1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 11757; Mouse mammary tumor virus (MMTV); Breed/subspecies: BALB/c. Female 151358276 CVCL_B4FH MODE-K.CD150 transformed cell line house mouse CVCL_B4FH CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10903; SLAMF1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Small intestine, duodenum; UBERON=UBERON_0002114; Cell type: Epithelial cell of intestine; CL=CL_0002563; Breed/subspecies: C3H/HeJ. Female 151358277 CVCL_B4FG MODE-K transformed cell line house mouse CVCL_B4FG CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Small intestine, duodenum; UBERON=UBERON_0002114; Cell type: Epithelial cell of intestine; CL=CL_0002563; Breed/subspecies: C3H/HeJ. Female Doubling time: 15 hours (PubMed=7693823) 151358278 CVCL_B4EY WG3298 finite cell line human CVCL_B4EY From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358279 CVCL_B4F9 C57/Wnt-1 spontaneously immortalized cell line house mouse CVCL_B4F9 CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98953; Wnt1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Cell type: Epithelial cell of mammary gland; CL=CL_0002327; Breed/subspecies: C57BL/6. Female 151358280 CVCL_B4EX WG3287 finite cell line human CVCL_B4EX From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358281 CVCL_B4EZ WG3322 finite cell line human CVCL_B4EZ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358282 CVCL_B4F2 WG3470 finite cell line human CVCL_B4F2 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358283 CVCL_B4EQ WG3583 finite cell line human CVCL_B4EQ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:25221; MMADHC; Simple; p.Ser228Ter (c.683C>G); ClinVar=VCV002507317; Zygosity=Homozygous (CelloPub=CLPUB00671; PubMed=19058814) Miscellaneous: Cell line no longer available Population: Mexican; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358284 CVCL_B4EP WG3280 finite cell line human CVCL_B4EP From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:25221; MMADHC; Simple; p.Leu21Ilefs*2 (c.60_61insAT); ClinVar=VCV000219001; Zygosity=Heterozygous (CelloPub=CLPUB00671; PubMed=19058814); Sequence variation: Mutation; HGNC; HGNC:25221; MMADHC; Simple; p.Cys153Metfs*10 (c.455dupC); ClinVar=VCV000219002; Zygosity=Heterozygous (CelloPub=CLPUB00671; PubMed=19058814) Miscellaneous: Cell line no longer available Population: Lebanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151358285 CVCL_B4F1 WG3412 finite cell line human CVCL_B4F1 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358286 CVCL_B4ES WG1191 finite cell line human CVCL_B4ES From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358287 CVCL_B4F4 WG3589 finite cell line human CVCL_B4F4 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358288 CVCL_B4F3 WG3560 finite cell line human CVCL_B4F3 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358289 CVCL_B4ER WG3745 finite cell line human CVCL_B4ER From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:25221; MMADHC; Simple; p.Asp246Gly (c.737A>G); ClinVar=VCV000839892; Zygosity=Homozygous (CelloPub=CLPUB00671; PubMed=19058814) Miscellaneous: Cell line no longer available Population: Mexican; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358290 CVCL_B4EU WG2951 finite cell line human CVCL_B4EU From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358291 CVCL_B4F6 WG3732 finite cell line human CVCL_B4F6 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358292 CVCL_B4ET WG2025 finite cell line human CVCL_B4ET From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358293 CVCL_B4F5 WG3728 finite cell line human CVCL_B4F5 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358294 CVCL_B4F8 C57/MV7 spontaneously immortalized cell line house mouse CVCL_B4F8 CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Cell type: Epithelial cell of mammary gland; CL=CL_0002327; Breed/subspecies: C57BL/6. Female Characteristics: Control cell line for C57/Wnt-1 (Cellosaurus=CVCL_B4F9) 151358295 CVCL_B4EW WG3224 finite cell line human CVCL_B4EW From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358296 CVCL_B4EV WG3185 finite cell line human CVCL_B4EV From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358297 CVCL_B4F7 WG3646 finite cell line human CVCL_B4F7 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:25221; MMADHC; Simple; p.Ser228Ter (c.683C>G); ClinVar=VCV002507317; Zygosity=Homozygous (from autologous cell line WG3583) Miscellaneous: Cell line no longer available Population: Mexican; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358298 CVCL_B4CG WG2341 finite cell line human CVCL_B4CG From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Cys560Tyr (c.1679G>A); ClinVar=VCV000554451; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.2125-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Italian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358299 CVCL_B4CF WG3233 finite cell line human CVCL_B4CF From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly427Asp (c.1280G>A); ClinVar=VCV000218990; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.1677-1G>A; ClinVar=VCV000550012; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Asian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358300 CVCL_B4CI WG2451 finite cell line human CVCL_B4CI From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala191Glu (c.572C>A); ClinVar=VCV000203854; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available; Miscellaneous: Second MMUT mutation was not detected Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358301 CVCL_B4CH WG2658 finite cell line human CVCL_B4CH From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gln18Ter (c.52C>T); ClinVar=VCV000001877; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available; Miscellaneous: Second MMUT mutation was not detected Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358302 CVCL_B4CK WG2646 finite cell line human CVCL_B4CK From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Pro86Leu (c.257C>T); ClinVar=VCV000553773; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly94Arg (c.280G>A); ClinVar=VCV000167312; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Hispanic and Native North American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358303 CVCL_B4CJ WG2269 finite cell line human CVCL_B4CJ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Glu451Ter (c.1351G>T); ClinVar=VCV000557114; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available; Miscellaneous: Second MMUT mutation was not detected Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358304 CVCL_B4CM WG2670 finite cell line human CVCL_B4CM From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Met186Val (c.556A>G); ClinVar=VCV000551460; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358305 CVCL_B4CL WG2910 finite cell line human CVCL_B4CL From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Pro86Leu (c.257C>T); ClinVar=VCV000553773; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Trp105Arg (c.313T>C); ClinVar=VCV000001878; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358306 CVCL_B4CA WG3065 finite cell line human CVCL_B4CA From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu443Phefs*5 (c.1328dupT); ClinVar=VCV000934454; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.1956+1G>A; ClinVar=VCV002734886; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=16281286) Miscellaneous: Cell line no longer available Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358307 CVCL_B4CC WG2083 finite cell line human CVCL_B4CC From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gln218His (c.654A>C); ClinVar=VCV000551243; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.1677-1G>A; ClinVar=VCV000550012; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Dutch; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358308 CVCL_B4CB WG2883 finite cell line human CVCL_B4CB From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.753+2T>A; ClinVar=VCV000203856; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg581Ter (c.1741C>T); ClinVar=VCV000554675; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358309 CVCL_B4CE WG3017 finite cell line human CVCL_B4CE From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ile412del (c.1230CAT[1]) (c.1233_1235delCAT); ClinVar=VCV000978689; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.1957-2A>G; ClinVar=VCV000555787; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358310 CVCL_B4CD WG2219 finite cell line human CVCL_B4CD From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.1957-2A>G; ClinVar=VCV000555787; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ile697Valfs*4 (c.2089_2101del); Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Danish; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358311 CVCL_B4BV WG2153 finite cell line human CVCL_B4BV From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg403Ter (c.1207C>T); ClinVar=VCV000167310; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358312 CVCL_B4C7 WG3218 finite cell line human CVCL_B4C7 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly291Glu (c.870G>A); Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg511Ter (c.1531C>T); ClinVar=VCV000556124; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Greek Cypriot; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358313 CVCL_B4C6 WG2634 finite cell line human CVCL_B4C6 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg474Ter (c.1420C>T); ClinVar=VCV000554873; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian and African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358314 CVCL_B4BU WG2786 finite cell line human CVCL_B4BU From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369Cys (c.1105C>T); ClinVar=VCV000218989; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg403Ter (c.1207C>T); ClinVar=VCV000167310; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358315 CVCL_B4C9 WG0497 finite cell line human CVCL_B4C9 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.753+2T>A; ClinVar=VCV000203856; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.1332+1delG; ClinVar=VCV000554656; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=16281286) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358316 CVCL_B4BX WG2202 finite cell line human CVCL_B4BX From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn219Metfs*3 (c.656delA); ClinVar=VCV001073471; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358317 CVCL_B4BW WG1512 finite cell line human CVCL_B4BW From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg474Ter (c.1420C>T); ClinVar=VCV000554873; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358318 CVCL_B4C8 WG3031 finite cell line human CVCL_B4C8 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu434Hisfs*3 (c.1301_1302delTC); Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Pro615Arg (c.1844C>G); ClinVar=VCV000550276; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358319 CVCL_B4BZ WG2719 finite cell line human CVCL_B4BZ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ser594Argfs*11 (c.1778_1782delAAAGT); Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Asian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358320 CVCL_B4BY WG2435 finite cell line human CVCL_B4BY From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.His386Arg (c.1157A>G); Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Asian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358321 CVCL_B4BN WG2474 finite cell line human CVCL_B4BN From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Gln (c.683G>A); ClinVar=VCV002136408; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg467Ter (c.1399C>T); ClinVar=VCV000495778; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358322 CVCL_B4BM WG3170 finite cell line human CVCL_B4BM From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Gln (c.683G>A); ClinVar=VCV002136408; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly630Glu (c.1889G>A); ClinVar=VCV000426995; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358323 CVCL_B4C1 WG1784 finite cell line human CVCL_B4C1 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg403Ter (c.1207C>T); ClinVar=VCV000167310; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Thr566Arg (c.1697C>G); Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian and African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358324 CVCL_B4BP WG3191 finite cell line human CVCL_B4BP From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asp244Leufs*39 (c.729_730insTT); ClinVar=VCV000552079; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu305Ser (c.914T>C); ClinVar=VCV000556865; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Asian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358325 CVCL_B4C0 WG1864 finite cell line human CVCL_B4C0 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.His386Asn (c.1156C>A); ClinVar=VCV000558672; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ser389del (c.1166_1168delCTT); Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358326 CVCL_B4BR WG2174 finite cell line human CVCL_B4BR From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369Cys (c.1105C>T); ClinVar=VCV000218989; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gln383Pro (c.1148A>C); Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358327 CVCL_B4C3 WG2683 finite cell line human CVCL_B4C3 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly355Ilefs*8 (c.1062delTinsCATCCAGA); Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg403Ter (c.1207C>T); ClinVar=VCV000167310; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358328 CVCL_B4C2 WG2271 finite cell line human CVCL_B4C2 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly145Ser (c.433G>A); Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg403Ter (c.1207C>T); ClinVar=VCV000167310; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Scottish; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358329 CVCL_B4BQ WG2871 finite cell line human CVCL_B4BQ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly158Glufs*22 (c.459delT); Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu347Arg (c.1040T>G); ClinVar=VCV000807633; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Greek; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358330 CVCL_B4BT WG2433 finite cell line human CVCL_B4BT From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala191Glu (c.572C>A); ClinVar=VCV000203854; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369Cys (c.1105C>T); ClinVar=VCV000218989; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358331 CVCL_B4C5 WG3027 finite cell line human CVCL_B4C5 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly427Asp (c.1280G>A); ClinVar=VCV000218990; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly544Ter (c.1630_1631delGGinsTA); ClinVar=VCV000203860; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Chinese; Taiwan; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358332 CVCL_B4BS WG2077 finite cell line human CVCL_B4BS From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369Cys (c.1105C>T); ClinVar=VCV000218989; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Tyr429Ter (c.1287C>G); ClinVar=VCV000554278; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358333 CVCL_B4C4 WG2454 finite cell line human CVCL_B4C4 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gln383His (c.1149G>T); Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg403Ter (c.1207C>T); ClinVar=VCV000167310; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358334 CVCL_B4DH WG3863 finite cell line human CVCL_B4DH From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gln218His (c.654A>C); ClinVar=VCV000551243; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358335 CVCL_B4DG WG3337 finite cell line human CVCL_B4DG From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gln218His (c.654A>C); ClinVar=VCV000551243; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Caucasian and Mexican; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358336 CVCL_B4DJ WG3679 finite cell line human CVCL_B4DJ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn189Ile (c.566A>T); ClinVar=VCV000222915; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn219Tyr (c.655A>T); ClinVar=VCV000001886; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Caucasian and Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358337 CVCL_B4DI WG3529 finite cell line human CVCL_B4DI From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Caucasian and Southeast Asian; Filipino; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358338 CVCL_B4DL WG3495 finite cell line human CVCL_B4DL From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala191Glu (c.572C>A); ClinVar=VCV000203854; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Caucasian; English/Irish; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358339 CVCL_B4DK WG2700 finite cell line human CVCL_B4DK From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Met186Val (c.556A>G); ClinVar=VCV000551460; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358340 CVCL_B4DN WG3869 finite cell line human CVCL_B4DN From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala191Glu (c.572C>A); ClinVar=VCV000203854; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.754-2A>G; ClinVar=VCV000552691; Zygosity=Heterozygous; Note=Splice acceptor mutation (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358341 CVCL_B4DM WG4055 finite cell line human CVCL_B4DM From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala191Glu (c.572C>A); ClinVar=VCV000203854; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Aboriginal Australian and Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358342 CVCL_B4DB WG3427 finite cell line human CVCL_B4DB From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu10Phefs*39 (c.29dupT); ClinVar=VCV000553287; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Val553Glyfs*17 (c.1658delT); ClinVar=VCV001069591; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358343 CVCL_B4DA WG3572 finite cell line human CVCL_B4DA From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:16692; CD320; Simple; p.Gly220Arg (c.658G>A); ClinVar=VCV000136684; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Met1Thr (c.2T>C); ClinVar=VCV000222903; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly544Ter (c.1630_1631delGGinsTA); ClinVar=VCV000203860; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Palestinian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358344 CVCL_B4DD WG3650 finite cell line human CVCL_B4DD From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg31Ter (c.91C>T); ClinVar=VCV000092688; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Glu117Ter (c.349G>T); ClinVar=VCV000001882; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Korean; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358345 CVCL_B4DC WG3512 finite cell line human CVCL_B4DC From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg31Ter (c.91C>T); ClinVar=VCV000092688; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108His (c.323G>A); ClinVar=VCV000100707; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:11653; TCN2; Simple; p.Leu30Arg (c.89T>G); ClinVar=VCV000529781; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: African or African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358346 CVCL_B4DF WG3654 finite cell line human CVCL_B4DF From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.146_147ins279; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asp125_Asn126insGlu (c.372_374dupGGA) (p.K124_D125insE); ClinVar=VCV000203861; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358347 CVCL_B4DE WG3473 finite cell line human CVCL_B4DE From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Trp43Ter (c.129G>A); ClinVar=VCV000222908; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Tyr100Cys (c.299A>G); ClinVar=VCV000218991; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358348 CVCL_B4CW WG2209 finite cell line human CVCL_B4CW From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Phe174Ser (c.521T>C); ClinVar=VCV000218986; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Phe573Ser (c.1718T>C); ClinVar=VCV000284235; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358349 CVCL_B4D8 WG2468 finite cell line human CVCL_B4D8 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Population: Caucasian; Dutch/German; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358350 CVCL_B4CV WG1186 finite cell line human CVCL_B4CV From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg511Ter (c.1531C>T); ClinVar=VCV000556124; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.His678Arg (c.2033A>G); Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358351 CVCL_B4D7 WG3126 finite cell line human CVCL_B4D7 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11450; SUCLG2; Simple; p.Arg91Ser (c.273A>T); Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available; Miscellaneous: No MMUT mutations were detected Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358352 CVCL_B4CY WG3246 finite cell line human CVCL_B4CY From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Phe573Ser (c.1718T>C); ClinVar=VCV000284235; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly623Arg (c.1867G>A); ClinVar=VCV000001884; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358353 CVCL_B4CX WG2600 finite cell line human CVCL_B4CX From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Thr370Pro (c.1108A>C); ClinVar=VCV000203847; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Phe573Ser (c.1718T>C); ClinVar=VCV000284235; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358354 CVCL_B4D9 WG3468 finite cell line human CVCL_B4D9 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Met1Val (c.1A>G); Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358355 CVCL_B4CZ WG3369 finite cell line human CVCL_B4CZ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.753+2T>A; ClinVar=VCV000203856; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Met700Lys (c.2099T>A); ClinVar=VCV000218997; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358356 CVCL_B4D0 WG3036 finite cell line human CVCL_B4D0 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.753+1G>A; ClinVar=VCV000633322; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358357 CVCL_B4CN WG2679 finite cell line human CVCL_B4CN From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gln218His (c.654A>C); ClinVar=VCV000551243; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358358 CVCL_B4D2 WG1827 finite cell line human CVCL_B4D2 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly215Cys (c.643G>T); ClinVar=VCV000418341; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Italian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358359 CVCL_B4CQ WG2456 finite cell line human CVCL_B4CQ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Tyr316Cys (c.947A>G); ClinVar=VCV000640484; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369Cys (c.1105C>T); ClinVar=VCV000218989; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358360 CVCL_B4CP WG2958 finite cell line human CVCL_B4CP From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn189Lys (c.567T>G); ClinVar=VCV000618734; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Thr230Ile (c.689C>T); ClinVar=VCV001512244; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Korean; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358361 CVCL_B4D1 WG3067 finite cell line human CVCL_B4D1 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358362 CVCL_B4D4 WG1600 finite cell line human CVCL_B4D4 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Tyr231Asn (c.691T>A); ClinVar=VCV000218992; Zygosity=Heterozygous (PubMed=9285782; PubMed=16281286) Miscellaneous: Cell line no longer available; Miscellaneous: Second MMUT mutation was not detected Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358363 CVCL_B4CS WG2983 finite cell line human CVCL_B4CS From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala324Thr (c.970G>A); ClinVar=VCV000550893; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn341Lysfs*20 (c.1022dupA); ClinVar=VCV000553958; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358364 CVCL_B4D3 WG2190 finite cell line human CVCL_B4D3 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369Cys (c.1105C>T); ClinVar=VCV000218989; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358365 CVCL_B4CR WG2429 finite cell line human CVCL_B4CR From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala324Thr (c.970G>A); ClinVar=VCV000550893; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala631Glnfs*17 (c.1891delG); ClinVar=VCV000242511; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358366 CVCL_B4D6 WG2545 finite cell line human CVCL_B4D6 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available; Miscellaneous: No MMUT mutations were detected Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358367 CVCL_B4CU WG2606 finite cell line human CVCL_B4CU From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Phe174Ser (c.521T>C); ClinVar=VCV000218986; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg467Ter (c.1399C>T); ClinVar=VCV000495778; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358368 CVCL_B4D5 WG2319 finite cell line human CVCL_B4D5 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11449; SUCLG1; Simple; p.Glu145Lys (c.433G>A); Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228); Sequence variation: Mutation; HGNC; HGNC:11449; SUCLG1; Simple; p.Asn171His (c.511A>C); Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228) Miscellaneous: Cell line no longer available Population: Caucasian; Irish/Italian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358369 CVCL_B4CT WG2547 finite cell line human CVCL_B4CT From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.1083+2T>A; ClinVar=VCV000495775; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu443Phefs*5 (c.1328dupT); ClinVar=VCV000934454; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358370 CVCL_B4AE WG3127 finite cell line human CVCL_B4AE From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly94Arg (c.280G>A); ClinVar=VCV000167312; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Mexican; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358371 CVCL_B4AD WG2469 finite cell line human CVCL_B4AD From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly94Arg (c.280G>A); ClinVar=VCV000167312; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Mexican; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358372 CVCL_B4AG WG2622 finite cell line human CVCL_B4AG From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg727Ter (c.2179C>T); ClinVar=VCV000218998; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Turkish; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358373 CVCL_B4AF WG2608 finite cell line human CVCL_B4AF From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg581Ter (c.1741C>T); ClinVar=VCV000554675; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358374 CVCL_B4AI WG2672 finite cell line human CVCL_B4AI From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg31Ter (c.91C>T); ClinVar=VCV000092688; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly284Ter (c.850G>T); ClinVar=VCV000553762; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358375 CVCL_B4AH WG2041 finite cell line human CVCL_B4AH From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu443Phefs*5 (c.1328dupT); ClinVar=VCV000934454; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358376 CVCL_B4AK WG2187 finite cell line human CVCL_B4AK From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg93His (c.278G>A); ClinVar=VCV000001880; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gln514Argfs*24 (c.1541delA); Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358377 CVCL_B4AJ WG2821 finite cell line human CVCL_B4AJ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly87Glu (c.260G>A); ClinVar=VCV000558311; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg467Ter (c.1399C>T); ClinVar=VCV000495778; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358378 CVCL_B4AA WG2310 finite cell line human CVCL_B4AA From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala732Trpfs*6 (c.2194_2197delGCCGinsTGGAA); ClinVar=VCV000222942; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358379 CVCL_B4AC WG2348 finite cell line human CVCL_B4AC From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly94Arg (c.280G>A); ClinVar=VCV000167312; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358380 CVCL_B4AB WG2325 finite cell line human CVCL_B4AB From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358381 CVCL_B4A5 WG2312 finite cell line human CVCL_B4A5 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358382 CVCL_B4A4 WG1800 finite cell line human CVCL_B4A4 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Homozygous (PubMed=9452100; PubMed=16281286) Miscellaneous: Cell line no longer available Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151358383 CVCL_B4A7 WG2896 finite cell line human CVCL_B4A7 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: African; Nigerian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358384 CVCL_B4A6 WG2628 finite cell line human CVCL_B4A6 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358385 CVCL_B4A9 WG3070 finite cell line human CVCL_B4A9 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg727Ter (c.2179C>T); ClinVar=VCV000218998; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Palestinian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358386 CVCL_B4A8 WG3068 finite cell line human CVCL_B4A8 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358387 CVCL_B4A1 WG2680 finite cell line human CVCL_B4A1 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly623Arg (c.1867G>A); ClinVar=VCV000001884; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian and African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358388 CVCL_B4A0 WG3207 finite cell line human CVCL_B4A0 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly623Arg (c.1867G>A); ClinVar=VCV000001884; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358389 CVCL_B4A3 WG1562 finite cell line human CVCL_B4A3 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Homozygous (PubMed=9452100; PubMed=16281286) Miscellaneous: Cell line no longer available Population: African; Ghanaian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151358390 CVCL_B4A2 WG2839 finite cell line human CVCL_B4A2 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly642Arg (c.1924G>C); ClinVar=VCV000551102; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Irish; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358391 CVCL_B4BF WG2798 finite cell line human CVCL_B4BF From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Val227Asnfs*16 (c.671_678dupAATTTATG); ClinVar=VCV000554641; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg616Cys (c.1846C>T); ClinVar=VCV000551499; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Spanish; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358392 CVCL_B4BE WG2638 finite cell line human CVCL_B4BE From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Val227Asnfs*16 (c.671_678dupAATTTATG); ClinVar=VCV000554641; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg727Ter (c.2179C>T); ClinVar=VCV000218998; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358393 CVCL_B4BH WG3040 finite cell line human CVCL_B4BH From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Glu688Ter (c.2062G>T); ClinVar=VCV002136402; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Southeast Asian; Vietnamese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358394 CVCL_B4BG WG2872 finite cell line human CVCL_B4BG From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg511Ter (c.1531C>T); ClinVar=VCV000556124; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358395 CVCL_B4BJ WG3112 finite cell line human CVCL_B4BJ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ser262Asn (c.785G>A); ClinVar=VCV001499715; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358396 CVCL_B4BI WG3044 finite cell line human CVCL_B4BI From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Glu224Ter (c.670G>T); ClinVar=VCV000552718; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358397 CVCL_B4BL WG2644 finite cell line human CVCL_B4BL From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.1332+1delG; ClinVar=VCV000554656; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358398 CVCL_B4BK WG3210 finite cell line human CVCL_B4BK From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly203Arg (c.607G>A); ClinVar=VCV000218987; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358399 CVCL_B4BB WG1608 finite cell line human CVCL_B4BB From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn219Tyr (c.655A>T); ClinVar=VCV000001886; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.His350Tyr (c.1048C>T); Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358400 CVCL_B4BA WG2973 finite cell line human CVCL_B4BA From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly215Ser (c.643G>A); ClinVar=VCV000001888; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu346del (c.1036_1038delCTT); Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Italian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358401 CVCL_B4BD WG3071 finite cell line human CVCL_B4BD From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Val227Asnfs*16 (c.671_678dupAATTTATG); ClinVar=VCV000554641; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn341Lysfs*20 (c.1022dupA); ClinVar=VCV000553958; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358402 CVCL_B4BC WG3020 finite cell line human CVCL_B4BC From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn219Tyr (c.655A>T); ClinVar=VCV000001886; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn720Serfs*17 (c.2159_2160delAT); ClinVar=VCV001459265; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; English/French; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358403 CVCL_B4B6 WG2247 finite cell line human CVCL_B4B6 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala191Glu (c.572C>A); ClinVar=VCV000203854; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly203Arg (c.607G>A); ClinVar=VCV000218987; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358404 CVCL_B4AU WG2924 finite cell line human CVCL_B4AU From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu281Ser (c.842T>C); ClinVar=VCV000203858; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358405 CVCL_B4B5 WG1605 finite cell line human CVCL_B4B5 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala191Glu (c.572C>A); ClinVar=VCV000203854; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Pro649Leufs*23 (c.1946delC); ClinVar=VCV000556782; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358406 CVCL_B4AT WG2659 finite cell line human CVCL_B4AT From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly94Val (c.281G>T); ClinVar=VCV000657887; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Trp105Arg (c.313T>C); ClinVar=VCV000001878; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358407 CVCL_B4B8 WG1693 finite cell line human CVCL_B4B8 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala191Glu (c.572C>A); ClinVar=VCV000203854; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn219Tyr (c.655A>T); ClinVar=VCV000001886; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358408 CVCL_B4AW WG3192 finite cell line human CVCL_B4AW From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358409 CVCL_B4B7 WG2676 finite cell line human CVCL_B4B7 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala191Glu (c.572C>A); ClinVar=VCV000203854; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Tyr429Ter (c.1287C>G); ClinVar=VCV000554278; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358410 CVCL_B4AV WG3158 finite cell line human CVCL_B4AV From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gln589Ter (c.1765C>T); ClinVar=VCV000845401; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Mexican; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358411 CVCL_B4AY WG2515 finite cell line human CVCL_B4AY From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108His (c.323G>A); ClinVar=VCV000100707; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly623Arg (c.1867G>A); ClinVar=VCV000001884; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358412 CVCL_B4B9 WG2597 finite cell line human CVCL_B4B9 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala197Glu (c.591C>A); ClinVar=VCV002734895; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly637Arg (c.1909G>A); ClinVar=VCV001486406; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358413 CVCL_B4AX WG3200 finite cell line human CVCL_B4AX From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Mexican; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358414 CVCL_B4AZ WG1601 finite cell line human CVCL_B4AZ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108His (c.323G>A); ClinVar=VCV000100707; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ser594Argfs*11 (c.1778_1782delAAAGT); Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358415 CVCL_B4AM WG2405 finite cell line human CVCL_B4AM From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Pro86Leu (c.257C>T); ClinVar=VCV000553773; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly94Arg (c.280G>A); ClinVar=VCV000167312; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358416 CVCL_B4AL WG2416 finite cell line human CVCL_B4AL From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg93His (c.278G>A); ClinVar=VCV000001880; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu518Pro (c.1553T>C); ClinVar=VCV000218994; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Portuguese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358417 CVCL_B4B0 WG2717 finite cell line human CVCL_B4B0 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108His (c.323G>A); ClinVar=VCV000100707; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg727Ter (c.2179C>T); ClinVar=VCV000218998; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Korean; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358418 CVCL_B4AN WG2873 finite cell line human CVCL_B4AN From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly94Arg (c.280G>A); ClinVar=VCV000167312; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn341Lysfs*20 (c.1022dupA); ClinVar=VCV000553958; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358419 CVCL_B4B2 WG3050 finite cell line human CVCL_B4B2 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg152Ter (c.454C>T); ClinVar=VCV000426467; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg629Lysfs*12 (c.1885dupA); ClinVar=VCV000568904; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Chinese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358420 CVCL_B4AQ WG3140 finite cell line human CVCL_B4AQ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly94Val (c.281G>T); ClinVar=VCV000657887; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Thr370Pro (c.1108A>C); ClinVar=VCV000203847; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358421 CVCL_B4B1 WG2691 finite cell line human CVCL_B4B1 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ser135Ter (c.404C>A); Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn341Lysfs*20 (c.1022dupA); ClinVar=VCV000553958; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358422 CVCL_B4AP WG3211 finite cell line human CVCL_B4AP From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly94Val (c.281G>T); ClinVar=VCV000657887; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg152Ter (c.454C>T); ClinVar=VCV000426467; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358423 CVCL_B4B4 WG2603 finite cell line human CVCL_B4B4 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly161Ter (c.481G>T); Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg694Trp (c.2080C>T); ClinVar=VCV000218996; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358424 CVCL_B4AS WG3205 finite cell line human CVCL_B4AS From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly94Val (c.281G>T); ClinVar=VCV000657887; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly623Arg (c.1867G>A); ClinVar=VCV000001884; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358425 CVCL_B4AR WG2838 finite cell line human CVCL_B4AR From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly94Val (c.281G>T); ClinVar=VCV000657887; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly284Ter (c.850G>T); ClinVar=VCV000553762; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358426 CVCL_B4B3 WG3051 finite cell line human CVCL_B4B3 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.385+3insTAAGGGT; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg152Ter (c.454C>T); ClinVar=VCV000426467; Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Chinese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358427 CVCL_B4P4 7BC9.1 hybridoma house mouse CVCL_B4P4 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human antigen on lung cancer cell line BEN. 151358428 CVCL_B4P3 7B5.4 hybridoma house mouse CVCL_B4P3 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human antigen on lung cancer cells (Note=Also recognizes many other type of cells). 151358429 CVCL_B4P6 G523 cancer cell line human CVCL_B4P6 CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Omics: Genomics; ChIP-seq; CTCF; Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; Chromosome conformation analysis; Hi-C; Omics: Transcriptomics; RNAseq Male Group: Cancer stem cell line 151358430 CVCL_B4P5 E14 cancer cell line human CVCL_B4P5 CL:0000010 Unspecified 151358431 CVCL_B4P8 G583 cancer cell line human CVCL_B4P8 CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Omics: Genomics; ChIP-seq; CTCF; Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; Chromosome conformation analysis; Hi-C; Omics: Transcriptomics; RNAseq Male Group: Cancer stem cell line 151358432 CVCL_B4P7 G567 cancer cell line human CVCL_B4P7 CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Omics: Genomics; ChIP-seq; CTCF; Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; Chromosome conformation analysis; Hi-C; Omics: Transcriptomics; RNAseq Female Group: Cancer stem cell line 151358433 CVCL_B4P9 UCF0010 finite cell line human CVCL_B4P9 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151358434 CVCL_B4P0 7B17.7 hybridoma house mouse CVCL_B4P0 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human antigen on lung cancer cells (Note=Also recognizes many other type of cells). 151358435 CVCL_B4P2 7B3.5 hybridoma house mouse CVCL_B4P2 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human antigen on lung cancer cells (Note=Also recognizes many other type of cells). 151358436 CVCL_B4P1 7B24.4 hybridoma house mouse CVCL_B4P1 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human antigen on lung cancer cell line BEN. 151358437 CVCL_B4NZ 4EAB8.2 hybridoma house mouse CVCL_B4NZ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human antigen on lung cancer cells. 151358438 CVCL_B4NY 4EAB3.7 hybridoma house mouse CVCL_B4NY CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human antigen on lung cancer cells. 151358439 CVCL_B4PT UCF0048 finite cell line human CVCL_B4PT CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151358440 CVCL_B4Q5 UCF0078 finite cell line human CVCL_B4Q5 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151358441 CVCL_B4PS UCF0047 finite cell line human CVCL_B4PS CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151358442 CVCL_B4Q4 UCF0075 finite cell line human CVCL_B4Q4 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151358443 CVCL_B4PV UCF0051 finite cell line human CVCL_B4PV CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151358444 CVCL_B4Q7 UCF0082 finite cell line human CVCL_B4Q7 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151358445 CVCL_B4PU UCF0049 finite cell line human CVCL_B4PU CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151358446 CVCL_B4Q6 UCF0079 finite cell line human CVCL_B4Q6 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151358447 CVCL_B4PX UCF0056 finite cell line human CVCL_B4PX CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151358448 CVCL_B4Q9 UCF0084 finite cell line human CVCL_B4Q9 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151358449 CVCL_B4PW UCF0052 finite cell line human CVCL_B4PW CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151358450 CVCL_B4Q8 UCF0083 finite cell line human CVCL_B4Q8 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151358451 CVCL_B4PZ UCF0058 finite cell line human CVCL_B4PZ CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151358452 CVCL_B4PY UCF0057 finite cell line human CVCL_B4PY CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151358453 CVCL_B4PL UCF0033 finite cell line human CVCL_B4PL CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151358454 CVCL_B4PK UCF0029 finite cell line human CVCL_B4PK CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151358455 CVCL_B4PN UCF0039 finite cell line human CVCL_B4PN CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151358456 CVCL_B4PM UCF0034 finite cell line human CVCL_B4PM CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151358457 CVCL_B4PP UCF0040 finite cell line human CVCL_B4PP CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151358458 CVCL_B4Q1 UCF0062 finite cell line human CVCL_B4Q1 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151358459 CVCL_B4Q0 UCF0060 finite cell line human CVCL_B4Q0 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151358460 CVCL_B4PR UCF0043 finite cell line human CVCL_B4PR CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151358461 CVCL_B4Q3 UCF0070 finite cell line human CVCL_B4Q3 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151358462 CVCL_B4PQ UCF0042 finite cell line human CVCL_B4PQ CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151358463 CVCL_B4Q2 UCF0068 finite cell line human CVCL_B4Q2 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151358464 CVCL_B4PD UCF0019 finite cell line human CVCL_B4PD CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151358465 CVCL_B4PC UCF0018 finite cell line human CVCL_B4PC CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151358466 CVCL_B4PF UCF0023 finite cell line human CVCL_B4PF CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151358467 CVCL_B4PE UCF0022 finite cell line human CVCL_B4PE CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151358468 CVCL_B4PH UCF0025 finite cell line human CVCL_B4PH CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151358469 CVCL_B4PG UCF0024 finite cell line human CVCL_B4PG CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151358470 CVCL_B4PJ UCF0028 finite cell line human CVCL_B4PJ CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151358471 CVCL_B4PI UCF0026 finite cell line human CVCL_B4PI CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151358472 CVCL_B4PB UCF0012 finite cell line human CVCL_B4PB CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151358473 CVCL_B4PA UCF0011 finite cell line human CVCL_B4PA CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151358474 CVCL_B4MQ UCB1139 transformed cell line human CVCL_B4MQ CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358475 CVCL_B4N2 UCB1218 transformed cell line human CVCL_B4N2 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358476 CVCL_B4MP UCB1136 transformed cell line human CVCL_B4MP CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358477 CVCL_B4N1 UCB1216 transformed cell line human CVCL_B4N1 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358478 CVCL_B4N4 AG03141.hTERT clone 8 telomerase immortalized cell line human CVCL_B4N4 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Gln748Ter (c.2242C>T) (2476C>T); ClinVar=VCV000835212; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Spanish; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358479 CVCL_B4MS UCB1196 transformed cell line human CVCL_B4MS CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358480 CVCL_B4N3 C8 [Human colon adenocarcinoma] cancer cell line human CVCL_B4N3 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ile1307Lysfs*7 (c.3920_3921delTA); ClinVar=VCV001736195; Zygosity=Unspecified (PubMed=9482574). Unspecified 151358481 CVCL_B4MR UCB1148 transformed cell line human CVCL_B4MR CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; CAGE-seq Female Part of: GenCord collection 151358482 CVCL_B4N6 SAL02 hybridoma house mouse CVCL_B4N6 CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11954 151358483 CVCL_B4MU UCB1200 transformed cell line human CVCL_B4MU CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358484 CVCL_B4N5 S3(LD5G11F4) hybridoma house mouse CVCL_B4N5 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin. 151358485 CVCL_B4MT UCB1199 transformed cell line human CVCL_B4MT CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; CAGE-seq Female Part of: GenCord collection 151358486 CVCL_B4N8 SAL04 hybridoma house mouse CVCL_B4N8 CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin. 151358487 CVCL_B4MW UCB1206 transformed cell line human CVCL_B4MW CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358488 CVCL_B4N7 SAL03 hybridoma house mouse CVCL_B4N7 CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin. 151358489 CVCL_B4MV UCB1203 transformed cell line human CVCL_B4MV CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358490 CVCL_B4MI UCB1117 transformed cell line human CVCL_B4MI CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; CAGE-seq Female Part of: GenCord collection 151358491 CVCL_B4MH UCB1113 transformed cell line human CVCL_B4MH CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358492 CVCL_B4MK UCB1120 transformed cell line human CVCL_B4MK CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358493 CVCL_B4MJ UCB1119 transformed cell line human CVCL_B4MJ CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358494 CVCL_B4MM UCB1130 transformed cell line human CVCL_B4MM CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358495 CVCL_B4ML UCB1129 transformed cell line human CVCL_B4ML CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358496 CVCL_B4N0 UCB1212 transformed cell line human CVCL_B4N0 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358497 CVCL_B4MN UCB1131 transformed cell line human CVCL_B4MN CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358498 CVCL_B4MA UCB1101 transformed cell line human CVCL_B4MA CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358499 CVCL_B4MC UCB1103 transformed cell line human CVCL_B4MC CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358500 CVCL_B4MB UCB1102 transformed cell line human CVCL_B4MB CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358501 CVCL_B4ME UCB1107 transformed cell line human CVCL_B4ME CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358502 CVCL_B4MD UCB1105 transformed cell line human CVCL_B4MD CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358503 CVCL_B4MG UCB1112 transformed cell line human CVCL_B4MG CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358504 CVCL_B4MF UCB1108 transformed cell line human CVCL_B4MF CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358505 CVCL_B4LX UCB1079 transformed cell line human CVCL_B4LX CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358506 CVCL_B4M9 UCB1100 transformed cell line human CVCL_B4M9 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358507 CVCL_B4LW UCB1077 transformed cell line human CVCL_B4LW CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358508 CVCL_B4M8 UCB1099 transformed cell line human CVCL_B4M8 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358509 CVCL_B4LZ UCB1083 transformed cell line human CVCL_B4LZ CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358510 CVCL_B4LY UCB1080 transformed cell line human CVCL_B4LY CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358511 CVCL_B4NR M79 hybridoma house mouse CVCL_B4NR CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326. 151358512 CVCL_B4NQ M77 hybridoma house mouse CVCL_B4NQ CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326. 151358513 CVCL_B4NT 3E11.5 hybridoma house mouse CVCL_B4NT CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human antigen on lung cancer cells (Note=Also recognizes many other type of cells). 151358514 CVCL_B4NS 3E10.2 hybridoma house mouse CVCL_B4NS CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human antigen on lung cancer cells (Note=Also recognizes many other type of cells). 151358515 CVCL_B4NV 3E19.8 hybridoma house mouse CVCL_B4NV CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human antigen on lung cancer cells. 151358516 CVCL_B4NU 3E14.5 hybridoma house mouse CVCL_B4NU CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human antigen on lung cancer cells (Note=Also recognizes many other type of cells). 151358517 CVCL_B4NX 4EAB10.4 hybridoma house mouse CVCL_B4NX CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human antigen on lung cancer cells. 151358518 CVCL_B4NW 3E22.1 hybridoma house mouse CVCL_B4NW CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human antigen on lung cancer cells (Note=Also recognizes many other type of cells). 151358519 CVCL_B4NJ SAL23 hybridoma house mouse CVCL_B4NJ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin. 151358520 CVCL_B4NI SAL22 hybridoma house mouse CVCL_B4NI CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin. 151358521 CVCL_B4NL SAL25 hybridoma house mouse CVCL_B4NL CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin. 151358522 CVCL_B4NK SAL24 hybridoma house mouse CVCL_B4NK CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin. 151358523 CVCL_B4NN M72 [Mouse hybridoma against human EPCAM] hybridoma house mouse CVCL_B4NN CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326. 151358524 CVCL_B4NP M74 hybridoma house mouse CVCL_B4NP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P16422; Human EPCAM/CD326. 151358525 CVCL_B4NB SAL07 hybridoma house mouse CVCL_B4NB CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin. 151358526 CVCL_B4NA SAL06 hybridoma house mouse CVCL_B4NA CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin. 151358527 CVCL_B4ND SAL09 hybridoma house mouse CVCL_B4ND CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin. 151358528 CVCL_B4NC SAL08 hybridoma house mouse CVCL_B4NC CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin. 151358529 CVCL_B4NF SAL11 hybridoma house mouse CVCL_B4NF CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin. 151358530 CVCL_B4NE SAL10 hybridoma house mouse CVCL_B4NE CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin. 151358531 CVCL_B4NH SAL13 hybridoma house mouse CVCL_B4NH CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin. 151358532 CVCL_B4NG SAL12 hybridoma house mouse CVCL_B4NG CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin. 151358533 CVCL_B4MY UCB1208 transformed cell line human CVCL_B4MY CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358534 CVCL_B4N9 SAL05 hybridoma house mouse CVCL_B4N9 CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_80025; Salinomycin. 151358535 CVCL_B4MX UCB1207 transformed cell line human CVCL_B4MX CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358536 CVCL_B4MZ UCB1210 transformed cell line human CVCL_B4MZ CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358537 CVCL_B4L0 WG0291 finite cell line human CVCL_B4L0 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358538 CVCL_B4KN D11-M3 cancer cell line human CVCL_B4KN CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=22383533). Unspecified 151358539 CVCL_B4KQ D14-M2 cancer cell line human CVCL_B4KQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533) Omics: Transcriptomics; RNAseq. Unspecified 151358540 CVCL_B4L2 Twin-N finite cell line human CVCL_B4L2 From: University of Geneva; Geneva; Switzerland CL:0000010 Population: Caucasian; Donor information: Twin-DS (Cellosaurus=CVCL_B4L1) and Twin-N originate from monozygotic twins discordant for trisomy 21; Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; ChIP-seq; H3K4me3; Omics: Proteomics; Omics: Proteomics; Quantitative; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq; Omics: Transcriptomics; RNAseq; Single cell Female Doubling time: 43.3 hours (PubMed=29089484) 151358541 CVCL_B4KP D14-M1 cancer cell line human CVCL_B4KP CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533). Unspecified 151358542 CVCL_B4L1 Twin-DS finite cell line human CVCL_B4L1 From: University of Geneva; Geneva; Switzerland CL:0000010 Population: Caucasian; Donor information: Twin-DS and Twin-N (Cellosaurus=CVCL_B4L2) originate from monozygotic twins discordant for trisomy 21; Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; ChIP-seq; H3K4me3; Omics: Proteomics; Omics: Proteomics; Quantitative; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq; Omics: Transcriptomics; RNAseq; Single cell Female Doubling time: 48.4 hours (PubMed=29089484) 151358543 CVCL_B4KS M408 cancer cell line human CVCL_B4KS CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=25645078). Unspecified 151358544 CVCL_B4L4 UCF1014 finite cell line human CVCL_B4L4 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq; Single cell Female Part of: GenCord collection 151358545 CVCL_B4KR M311 [Human melanoma] cancer cell line human CVCL_B4KR CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Homozygous (PubMed=25645078; PubMed=27533468). Unspecified 151358546 CVCL_B4L3 Twin-N-iPSCs line#7 induced pluripotent stem cell human CVCL_B4L3 From: University of Geneva; Geneva; Switzerland CL:0000010 Population: Caucasian; Karyotypic information: 46,XX (PubMed=32739879); Donor information: Twin-DS-iPSC (Cellosaurus=CVCL_W088) and Twin-N-iPSC originate from monozygotic twins discordant for trisomy 21; Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; RNAseq Female 151358547 CVCL_B4KU MM160113 cancer cell line human CVCL_B4KU From: URPP Biobank, University of Zurich; Zurich; Switzerland CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000040469; Zygosity=Homozygous (DepMap=ACH-002512) Derived from site: Metastatic; Not specified. Male Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE) 151358548 CVCL_B4L6 UCB1001 transformed cell line human CVCL_B4L6 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358549 CVCL_B4KT IGRMel1 cancer cell line human CVCL_B4KT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=27533468) Derived from site: Metastatic; Not specified. Unspecified 151358550 CVCL_B4L5 UCB1014 transformed cell line human CVCL_B4L5 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq; Omics: Transcriptomics; RNAseq; Single cell Female Part of: GenCord collection 151358551 CVCL_B4KG D18 cancer cell line human CVCL_B4KG CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533); Sequence variation: Mutation; HGNC; HGNC:9612; PTK2B; Simple; p.Gly414Val (c.1241G>T); Zygosity=Heterozygous (PubMed=22383533). Unspecified 151358552 CVCL_B4KF C003 cancer cell line human CVCL_B4KF CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533). Unspecified Characteristics: Early passage culture 151358553 CVCL_B4KI C004-2 cancer cell line human CVCL_B4KI CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533) Derived from site: Metastatic; Not specified. Female Characteristics: Early passage culture 151358554 CVCL_B4KH C028-2 cancer cell line human CVCL_B4KH CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=22383533) Derived from site: Metastatic; Not specified. Omics: Variations; SNP array analysis Unspecified Characteristics: Early passage culture 151358555 CVCL_B4KK C045 cancer cell line human CVCL_B4KK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533). Unspecified Characteristics: Early passage culture 151358556 CVCL_B4KJ C042-2 cancer cell line human CVCL_B4KJ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533) Derived from site: Metastatic; Not specified. Unspecified Characteristics: Early passage culture 151358557 CVCL_B4KM D11-M2 cancer cell line human CVCL_B4KM CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=22383533) Omics: Transcriptomics; RNAseq. Unspecified 151358558 CVCL_B4KL C088-2 cancer cell line human CVCL_B4KL CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (PubMed=22383533) Derived from site: Metastatic; Not specified. Omics: Transcriptomics; RNAseq Unspecified Characteristics: Early passage culture 151358559 CVCL_B4KA C016 cancer cell line human CVCL_B4KA CL:0000010 Derived from site: Metastatic; Not specified. Omics: Transcriptomics; RNAseq Unspecified Characteristics: Early passage culture 151358560 CVCL_B4KC C076 cancer cell line human CVCL_B4KC CL:0000010 Derived from site: Metastatic; Not specified. Omics: Transcriptomics; RNAseq Unspecified Characteristics: Early passage culture 151358561 CVCL_B4KB C074 cancer cell line human CVCL_B4KB CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533) Derived from site: Metastatic; Not specified. Omics: Transcriptomics; RNAseq Unspecified Characteristics: Early passage culture 151358562 CVCL_B4KE C094 cancer cell line human CVCL_B4KE CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533) Derived from site: Metastatic; Not specified. Omics: Transcriptomics; RNAseq Unspecified Characteristics: Early passage culture 151358563 CVCL_B4KD C088 cancer cell line human CVCL_B4KD CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (PubMed=22383533) Derived from site: Metastatic; Not specified. Omics: Transcriptomics; RNAseq Unspecified Characteristics: Early passage culture 151358564 CVCL_B4JV 13G5-57 hybridoma house mouse CVCL_B4JV CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; Q13332; Human PTPRS. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11359 151358565 CVCL_B4K7 NOVOe001-A embryonic stem cell human CVCL_B4K7 From: Novo Nordisk A/S; Bagsvaerd; Denmark CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 151358566 CVCL_B4JU 13G5-52 hybridoma house mouse CVCL_B4JU CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; Q13332; Human PTPRS. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11358 151358567 CVCL_B4K6 WG4152 finite cell line human CVCL_B4K6 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151358568 CVCL_B4JX 22H8-84 hybridoma house mouse CVCL_B4JX CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q13332; Human PTPRS. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11361 151358569 CVCL_B4K9 C006 cancer cell line human CVCL_B4K9 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Homozygous (PubMed=22383533) Derived from site: Metastatic; Not specified. Omics: Transcriptomics; RNAseq Unspecified Characteristics: Early passage culture 151358570 CVCL_B4JW 14A8-85 hybridoma house mouse CVCL_B4JW CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q13332; Human PTPRS. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11360 151358571 CVCL_B4K8 C001 cancer cell line human CVCL_B4K8 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=22383533) Derived from site: Metastatic; Not specified. Omics: Transcriptomics; RNAseq Unspecified Characteristics: Early passage culture 151358572 CVCL_B4JZ 55E7-79 hybridoma house mouse CVCL_B4JZ CL:0000010 Monoclonal antibody isotype: IgG1+IgG2b, kappa; Monoclonal antibody target: UniProtKB; Q13332; Human PTPRS. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11363 151358573 CVCL_B4JY 49F2-30 hybridoma house mouse CVCL_B4JY CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q13332; Human PTPRS. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11362 151358574 CVCL_B4LP UCB1070 transformed cell line human CVCL_B4LP CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358575 CVCL_B4M1 UCB1087 transformed cell line human CVCL_B4M1 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358576 CVCL_B4M0 UCB1086 transformed cell line human CVCL_B4M0 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358577 CVCL_B4LR UCB1072 transformed cell line human CVCL_B4LR CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358578 CVCL_B4M3 UCB1091 transformed cell line human CVCL_B4M3 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358579 CVCL_B4LQ UCB1071 transformed cell line human CVCL_B4LQ CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358580 CVCL_B4M2 UCB1089 transformed cell line human CVCL_B4M2 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358581 CVCL_B4LT UCB1074 transformed cell line human CVCL_B4LT CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358582 CVCL_B4M5 UCB1094 transformed cell line human CVCL_B4M5 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358583 CVCL_B4LS UCB1073 transformed cell line human CVCL_B4LS CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358584 CVCL_B4M4 UCB1092 transformed cell line human CVCL_B4M4 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358585 CVCL_B4LV UCB1076 transformed cell line human CVCL_B4LV CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358586 CVCL_B4M7 UCB1098 transformed cell line human CVCL_B4M7 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358587 CVCL_B4LU UCB1075 transformed cell line human CVCL_B4LU CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358588 CVCL_B4M6 UCB1096 transformed cell line human CVCL_B4M6 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358589 CVCL_B4LH UCB1053 transformed cell line human CVCL_B4LH CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358590 CVCL_B4LG UCB1052 transformed cell line human CVCL_B4LG CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358591 CVCL_B4LJ UCB1058 transformed cell line human CVCL_B4LJ CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358592 CVCL_B4LI UCB1056 transformed cell line human CVCL_B4LI CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358593 CVCL_B4LL UCB1064 transformed cell line human CVCL_B4LL CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358594 CVCL_B4LK UCB1061 transformed cell line human CVCL_B4LK CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358595 CVCL_B4LN UCB1069 transformed cell line human CVCL_B4LN CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358596 CVCL_B4LM UCB1067 transformed cell line human CVCL_B4LM CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358597 CVCL_B4LB UCB1025 transformed cell line human CVCL_B4LB CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358598 CVCL_B4LA UCB1023 transformed cell line human CVCL_B4LA CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358599 CVCL_B4LD UCB1029 transformed cell line human CVCL_B4LD CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358600 CVCL_B4LC UCB1027 transformed cell line human CVCL_B4LC CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358601 CVCL_B4LF UCB1048 transformed cell line human CVCL_B4LF CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358602 CVCL_B4LE UCB1046 transformed cell line human CVCL_B4LE CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358603 CVCL_B4KW CCLF-UPGI-0061-T cancer cell line human CVCL_B4KW CL:0000010 Derived from site: Metastatic; Not specified. Part of: Cancer Cell Line Factory (CCLF) cell models; Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE) 151358604 CVCL_B4L8 UCB1012 transformed cell line human CVCL_B4L8 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358605 CVCL_B4KV CCLF-UPGI-0005-T cancer cell line human CVCL_B4KV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser127Pro (c.379T>C); ClinVar=VCV000934410; Zygosity=Homozygous (DepMap=ACH-002446) Derived from site: Metastatic; Not specified. Part of: Cancer Cell Line Factory (CCLF) cell models; Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE) 151358606 CVCL_B4L7 UCB1011 transformed cell line human CVCL_B4L7 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151358607 CVCL_B4KY WG0290 finite cell line human CVCL_B4KY From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358608 CVCL_B4KX GM00301 finite cell line human CVCL_B4KX CL:0000010 Cell type: Fibroblast; CL=CL_0000057. Discontinued: Coriell; GM00301; probable 151358609 CVCL_B4L9 UCB1016 transformed cell line human CVCL_B4L9 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; CAGE-seq; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151358610 CVCL_B4KZ WG0548 finite cell line human CVCL_B4KZ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358611 CVCL_B4IM YTA1 finite cell line human CVCL_B4IM CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: IL2 dependent 151358612 CVCL_B4IL STH4 transformed cell line human CVCL_B4IL CL:0000010 Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male 151358613 CVCL_B4J0 BEP2D H2B transformed cell line human CVCL_B4J0 CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male 151358614 CVCL_B4IN YTH3 transformed cell line human CVCL_B4IN CL:0000010 Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: IL2 independent 151358615 CVCL_B4J2 BEP2D H2BT transformed cell line human CVCL_B4J2 CL:0000010 Karyotypic information: Has lost chromosome Y (PubMed=9214610); Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male Characteristics: Tumorigenic in nude mice 151358616 CVCL_B4IQ YTA1H transformed cell line human CVCL_B4IQ CL:0000010 Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: IL2 independent 151358617 CVCL_B4J1 BEP2D H2BFT transformed cell line human CVCL_B4J1 CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male 151358618 CVCL_B4IP YTH5 transformed cell line human CVCL_B4IP CL:0000010 Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: IL2 independent 151358619 CVCL_B4IS BEP2D Fe60T1 transformed cell line human CVCL_B4IS CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C129641; Iron-56 ion irradiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male Characteristics: Tumorigenic in nude mice 151358620 CVCL_B4J4 BEP2D H3A transformed cell line human CVCL_B4J4 CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male 151358621 CVCL_B4IR BEP1B transformed cell line human CVCL_B4IR CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male 151358622 CVCL_B4J3 BEP2D H2BT2L transformed cell line human CVCL_B4J3 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=10426802) Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male Characteristics: Tumorigenic in nude mice 151358623 CVCL_B4IE 147BR finite cell line human CVCL_B4IE CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 151358624 CVCL_B4ID LB188 transformed cell line human CVCL_B4ID CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151358625 CVCL_B4IG 78LO finite cell line human CVCL_B4IG CL:0000010 Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403; Cell type: Fibroblast of skin; CL=CL_0002620. Female Doubling time: 36.0 hours (PubMed=6459055) 151358626 CVCL_B4IF 148BR finite cell line human CVCL_B4IF CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 151358627 CVCL_B4II 791T/36 hybridoma house mouse CVCL_B4II CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P08174; Human CD55. 151358628 CVCL_B4IH A206 transformed cell line human CVCL_B4IH CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo); Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238; Cell type: Astrocyte; CL=CL_0000127. Unspecified 151358629 CVCL_B4IK iChEC-1 transformed cell line human CVCL_B4IK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4883; CFH; Simple; p.Val62Ile (c.184G>A); ClinVar=VCV000016550; Zygosity=Homozygous (PubMed=30571950); Sequence variation: Mutation; HGNC; HGNC:13941; SLC44A4; Simple; p.Asp123Val (c.368A>T); ClinVar=VCV001266965; Zygosity=Homozygous (PubMed=30571950); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Population: Caucasian; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Eye, choroid; UBERON=UBERON_0001776; Cell type: Endothelial cell; CL=CL_0000115. Female 151358630 CVCL_B4IJ 791T/48 hybridoma house mouse CVCL_B4IJ CL:0000010 Monoclonal antibody isotype: IgG2b. 151358631 CVCL_B4IA MDCK-2B2 transformed cell line dog CVCL_B4IA CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201323 151358632 CVCL_B4IC ciChEnC conditionally immortalized cell line human CVCL_B4IC CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Eye, choroid; UBERON=UBERON_0001776; Cell type: Endothelial cell; CL=CL_0000115. Female Characteristics: Can be maintained in culture at the permissive temperature of 33 Celsius for up to 27 passages without signs of senescence 151358633 CVCL_B4IB 2CFSMEo-/6REP-CFTR transformed cell line human CVCL_B4IB CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Gln2Ter (c.4C>T); ClinVar=VCV000053980; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1884; CFTR Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-); Derived from site: In situ; Lung, bronchus, submucosal gland; UBERON=UBERON_8410043; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Unspecified 151358634 CVCL_B4HT 9G2 [Mouse hybridoma against rat Hmgb1] hybridoma house mouse CVCL_B4HT CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1. 151358635 CVCL_B4I5 Myok9 transformed cell line dog CVCL_B4I5 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Miscellaneous: Sex of donor from personal communication of Nghiem, Peter P Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Muscle, vastus lateralis; UBERON=UBERON_0001379; Cell type: Myoblast; CL=CL_0000056; Breed/subspecies: Golden Retriever x Labrador Retriever; VBO=VBO_0200610+VBO_0200800. Female Doubling time: ~16 hours (PubMed=32246189) 151358636 CVCL_B4HS 9G1 hybridoma house mouse CVCL_B4HS CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P63159; Rat Hmgb1. 151358637 CVCL_B4I4 KM162C14Q telomerase immortalized cell line human CVCL_B4I4 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Muscle; UBERON=UBERON_0001630; Cell type: Myoblast; CL=CL_0000056. Unspecified 151358638 CVCL_B4I7 15303MN clone 3 telomerase immortalized cell line dog CVCL_B4I7 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134; Cell type: Myoblast; CL=CL_0000056; Breed/subspecies: Beagle; VBO=VBO_0200131. Male 151358639 CVCL_B4HV ML13-7C6.1D4.4A9.5G8 hybridoma house mouse CVCL_B4HV CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 last 23 residues; Abeta(20-42)). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7240 151358640 CVCL_B4I6 15303MN clone 2 telomerase immortalized cell line dog CVCL_B4I6 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134; Cell type: Myoblast; CL=CL_0000056; Breed/subspecies: Beagle; VBO=VBO_0200131. Male 151358641 CVCL_B4HU ML13-4D10.3F3 hybridoma house mouse CVCL_B4HU CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 last 23 residues; Abeta(20-42)). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7405 151358642 CVCL_B4I9 CXMDJ clone 9 telomerase immortalized cell line dog CVCL_B4I9 CL:0000010 Sequence variation: Mutation; VGNC; VGNC:54134; DMD; Unexplicit; Ex7del; Zygosity=Hemizygous (PubMed=33567244); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134; Cell type: Myoblast; CL=CL_0000056; Breed/subspecies: Beagle; VBO=VBO_0200131. Male 151358643 CVCL_B4HX ML15-10F11.3D9 hybridoma house mouse CVCL_B4HX CL:0000010 Discontinued: ATCC; PTA-7239; true. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 last 23 residues; Abeta(20-42)) Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7239 151358644 CVCL_B4I8 CXMDJ clone 8 telomerase immortalized cell line dog CVCL_B4I8 CL:0000010 Sequence variation: Mutation; VGNC; VGNC:54134; DMD; Unexplicit; Ex7del; Zygosity=Hemizygous (PubMed=33567244); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=MGI; MGI:88357; Cdk4; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134; Cell type: Myoblast; CL=CL_0000056; Breed/subspecies: Beagle; VBO=VBO_0200131. Male 151358645 CVCL_B4HW ML15-10C1.5C6.3H4 hybridoma house mouse CVCL_B4HW CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 last 23 residues; Abeta(20-42)). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7810 151358646 CVCL_B4HZ ML15-3B10.2D5.3F1 hybridoma house mouse CVCL_B4HZ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 last 23 residues; Abeta(20-42)). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7851 151358647 CVCL_B4HY ML15-2F2.3E12 hybridoma house mouse CVCL_B4HY CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP42 last 23 residues; Abeta(20-42)). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7408 151358648 CVCL_B4JN BEP2D R30-5B transformed cell line human CVCL_B4JN CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male 151358649 CVCL_B4JM BEP2D R30-4B transformed cell line human CVCL_B4JM CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male 151358650 CVCL_B4JP BEP2D R30-6A transformed cell line human CVCL_B4JP CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male 151358651 CVCL_B4K1 RBSV1A transformed cell line human CVCL_B4K1 CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 151358652 CVCL_B4K0 BRL-5 spontaneously immortalized cell line Norway rat CVCL_B4K0 CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=RGD; 2687; Ghr; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Liver; UBERON=UBERON_0002107; Breed/subspecies: Buffalo; RS=RS_0000163. 151358653 CVCL_B4JR AI206 hybridoma house mouse CVCL_B4JR CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Anti-idiotypic against monoclonal antibody YH206. 151358654 CVCL_B4K3 BRL-6005 cancer cell line human CVCL_B4K3 CL:0000010 Unspecified 151358655 CVCL_B4K2 RBSV3 transformed cell line human CVCL_B4K2 CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 151358656 CVCL_B4JQ YH206 hybridoma house mouse CVCL_B4JQ CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Human heavily glycosylated mucin-like antigen. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2001 151358657 CVCL_B4JT 10F7-38 hybridoma house mouse CVCL_B4JT CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q13332; Human PTPRS. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11357 151358658 CVCL_B4K5 WG3838 finite cell line human CVCL_B4K5 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Gln27Arg (c.80A>G); ClinVar=VCV000552467; Zygosity=Heterozygous (PubMed=29302025); Sequence variation: Mutation; HGNC; HGNC:9352; PRDX1; Simple; c.515-2A>T; ClinVar=VCV000495210; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=29302025) Miscellaneous: Cell line no longer available Population: Japanese and Korean; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Caution: The mutation indicated in PubMed=29302025 for MMACHC (c.81G>A) is incorrect The correct mutation is c.80G>A (personal communication of Rosenblatt, David S.). 151358659 CVCL_B4JS 9H5-4 hybridoma house mouse CVCL_B4JS CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q13332; Human PTPRS. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11356 151358660 CVCL_B4K4 BRL-6278 cancer cell line human CVCL_B4K4 CL:0000010 Unspecified 151358661 CVCL_B4JF BEP2D R30T3L transformed cell line human CVCL_B4JF CL:0000010 Karyotypic information: Has lost chromosome Y (PubMed=9214610); Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male Characteristics: Tumorigenic in nude mice 151358662 CVCL_B4JE BEP2D R30T1L2A transformed cell line human CVCL_B4JE CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Ile (c.644G>T); ClinVar=VCV000376660; Zygosity=Unspecified (PubMed=10426802) Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male Characteristics: Tumorigenic in nude mice 151358663 CVCL_B4JH BEP2D R30T5L2P transformed cell line human CVCL_B4JH CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Asn (c.417G>T); ClinVar=VCV000584923; Zygosity=Unspecified (PubMed=10426802) Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male Characteristics: Tumorigenic in nude mice 151358664 CVCL_B4JG BEP2D R30T5L2 transformed cell line human CVCL_B4JG CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Asn (c.417G>T); ClinVar=VCV000584923; Zygosity=Unspecified (PubMed=10426802) Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male Characteristics: Tumorigenic in nude mice 151358665 CVCL_B4JJ BEP2D R5D7A4C transformed cell line human CVCL_B4JJ CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male 151358666 CVCL_B4JI BEP2D R5D7A2C transformed cell line human CVCL_B4JI CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male 151358667 CVCL_B4JL BEP2D R30-3C transformed cell line human CVCL_B4JL CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male 151358668 CVCL_B4JK BEP2D R30-2C transformed cell line human CVCL_B4JK CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male 151358669 CVCL_B4JB BEP2D R3D7 transformed cell line human CVCL_B4JB CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male Characteristics: Tumorigenic in nude mice 151358670 CVCL_B4JA BEP2D R30T5 transformed cell line human CVCL_B4JA CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male Characteristics: Tumorigenic in nude mice 151358671 CVCL_B4JD BEP2D R30T1L transformed cell line human CVCL_B4JD CL:0000010 Karyotypic information: Has lost chromosome Y (PubMed=9214610); Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male Characteristics: Tumorigenic in nude mice 151358672 CVCL_B4JC BEP2D R5D7 transformed cell line human CVCL_B4JC CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male 151358673 CVCL_B4IU BEP2D Fe60T3 transformed cell line human CVCL_B4IU CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C129641; Iron-56 ion irradiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male Characteristics: Tumorigenic in nude mice 151358674 CVCL_B4J6 BEP2D R30 transformed cell line human CVCL_B4J6 CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male 151358675 CVCL_B4IT BEP2D Fe60T2 transformed cell line human CVCL_B4IT CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C129641; Iron-56 ion irradiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male Characteristics: Tumorigenic in nude mice 151358676 CVCL_B4J5 BEP2D R2D6 transformed cell line human CVCL_B4J5 CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male 151358677 CVCL_B4IW BEP2D H1A transformed cell line human CVCL_B4IW CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male 151358678 CVCL_B4J8 BEP2D R30T2 transformed cell line human CVCL_B4J8 CL:0000010 Karyotypic information: Has lost chromosome Y (PubMed=9214610); Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male Characteristics: Tumorigenic in nude mice 151358679 CVCL_B4IV BEP2D Fe60T4 transformed cell line human CVCL_B4IV CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C129641; Iron-56 ion irradiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male Characteristics: Tumorigenic in nude mice 151358680 CVCL_B4J7 BEP2D R30T1 transformed cell line human CVCL_B4J7 CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male Characteristics: Tumorigenic in nude mice 151358681 CVCL_B4IY BEP2D H1ATN transformed cell line human CVCL_B4IY CL:0000010 Karyotypic information: Has lost chromosome Y (PubMed=9214610); Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male Characteristics: Tumorigenic in nude mice 151358682 CVCL_B4IX BEP2D H1ATBA1 transformed cell line human CVCL_B4IX CL:0000010 Karyotypic information: Has lost chromosome Y (PubMed=9214610); Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male Characteristics: Tumorigenic in nude mice 151358683 CVCL_B4J9 BEP2D R30T3 transformed cell line human CVCL_B4J9 CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male Characteristics: Tumorigenic in nude mice 151358684 CVCL_B4IZ BEP2D H1B transformed cell line human CVCL_B4IZ CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C16279; Alpha radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Male 151358685 CVCL_B3UZ 597 induced pluripotent stem cell human CVCL_B3UZ From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151358686 CVCL_B3UY 595 induced pluripotent stem cell human CVCL_B3UY From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151358687 CVCL_B3VA SNUhES47 embryonic stem cell human CVCL_B3VA From: Seoul National University; Seoul; South Korea CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12017005 151358688 CVCL_B3UR 1013 induced pluripotent stem cell human CVCL_B3UR From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151358689 CVCL_B3V3 CHA-hES63 embryonic stem cell human CVCL_B3V3 From: CHA University; Seongnam; South Korea CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12021002 151358690 CVCL_B3V2 CHA-hES62 embryonic stem cell human CVCL_B3V2 From: CHA University; Seongnam; South Korea CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12021001 151358691 CVCL_B3UQ PEO1X cancer cell line human CVCL_B3UQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Tyr1655Ter (c.4965C>G) (5193C>G); ClinVar=VCV000037936; Zygosity=Hemizygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Asp (c.731G>A); ClinVar=VCV000372785; Zygosity=Unspecified (CelloPub=CLPUB00667) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP); Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Female Doubling time: 47.84 hours (CelloPub=CLPUB00667) 151358692 CVCL_B3UT 1579 induced pluripotent stem cell human CVCL_B3UT From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2153; CNGB3; Simple; p.Thr383Ilefs*13 (c.1148delC); ClinVar=VCV000005225; Zygosity=Heterozygous (PubMed=32011687); Sequence variation: Mutation; HGNC; HGNC:2153; CNGB3; Simple; c.1663-2137C>T (chr8:g.87618576G>A); ClinVar=VCV000635823; Zygosity=Heterozygous; Note=Incorporates cryptic exon 14b (PubMed=32011687) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151358693 CVCL_B3V5 CHA-hES59 embryonic stem cell human CVCL_B3V5 From: CHA University; Seongnam; South Korea CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12018001 151358694 CVCL_B3US 1096 induced pluripotent stem cell human CVCL_B3US From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151358695 CVCL_B3V4 CHA-hES64 embryonic stem cell human CVCL_B3V4 From: CHA University; Seongnam; South Korea CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12021003 151358696 CVCL_B3UV 1581 induced pluripotent stem cell human CVCL_B3UV From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2153; CNGB3; Simple; c.1663-2137C>T (chr8:g.87618576G>A); ClinVar=VCV000635823; Zygosity=Heterozygous; Note=Incorporates cryptic exon 14b (PubMed=32011687) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151358697 CVCL_B3V7 CHA-hES61 embryonic stem cell human CVCL_B3V7 From: CHA University; Seongnam; South Korea CL:0000010 Karyotypic information: 70,XXX,+12; Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12018003 151358698 CVCL_B3UU 1580 induced pluripotent stem cell human CVCL_B3UU From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2153; CNGB3; Simple; p.Thr383Ilefs*13 (c.1148delC); ClinVar=VCV000005225; Zygosity=Heterozygous (PubMed=32011687); Sequence variation: Mutation; HGNC; HGNC:2153; CNGB3; Simple; c.1663-2137C>T (chr8:g.87618576G>A); ClinVar=VCV000635823; Zygosity=Heterozygous; Note=Incorporates cryptic exon 14b (PubMed=32011687) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151358699 CVCL_B3V6 CHA-hES60 embryonic stem cell human CVCL_B3V6 From: CHA University; Seongnam; South Korea CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12018002 151358700 CVCL_B3UX 591 [Human iPSC] induced pluripotent stem cell human CVCL_B3UX From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151358701 CVCL_B3V9 SNUhES46 embryonic stem cell human CVCL_B3V9 From: Seoul National University; Seoul; South Korea CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12017006 151358702 CVCL_B3UW 1582 induced pluripotent stem cell human CVCL_B3UW From: Fujifilm Cellular Dynamics International, Inc.; Madison; USA CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151358703 CVCL_B3V8 SNUhES45 embryonic stem cell human CVCL_B3V8 From: Seoul National University; Seoul; South Korea CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12017004 151358704 CVCL_B3UJ WG3332 finite cell line human CVCL_B3UJ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:19331; MMAB; Simple; c.291-1G>A; ClinVar=VCV000219004; Zygosity=Heterozygous; Note=Splice acceptor mutation (CelloPub=CLPUB00662); Sequence variation: Mutation; HGNC; HGNC:19331; MMAB; Simple; p.Gln234Ter (c.700C>T); ClinVar=VCV000203820; Zygosity=Heterozygous (CelloPub=CLPUB00662) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358705 CVCL_B3UI WG3293 finite cell line human CVCL_B3UI From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:19331; MMAB; Simple; c.197-1G>T; ClinVar=VCV000219008; Zygosity=Homozygous; Note=Splice acceptor mutation (CelloPub=CLPUB00662) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358706 CVCL_B3UL WG2664 finite cell line human CVCL_B3UL From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:18871; MMAA; Simple; p.Arg145Ter (c.433C>T); ClinVar=VCV000003160; Zygosity=Heterozygous (CelloPub=CLPUB00662); Sequence variation: Mutation; HGNC; HGNC:18871; MMAA; Simple; p.Thr198Serfs*6 (c.593_596delCTGA) (c.592_595del); ClinVar=VCV000203815; Zygosity=Heterozygous (CelloPub=CLPUB00662) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358707 CVCL_B3UK WG1641 finite cell line human CVCL_B3UK From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:19331; MMAB; Simple; p.Gln234Ter (c.700C>T); ClinVar=VCV000203820; Zygosity=Homozygous (CelloPub=CLPUB00662) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358708 CVCL_B3UN IV-A1-j spontaneously immortalized cell line CVCL_B3UN CL:0000010 Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line) Selected for resistance to: Diphtheria A chain:insulin (DTaI); Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Male Characteristics: Resistant to an insulin-diphtheria-A chain toxic conjugate (DTaI) 151358709 CVCL_B3UM WG3365 finite cell line human CVCL_B3UM From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; c.916-1G>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (CelloPub=CLPUB00671; PubMed=21303734); Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Heterozygous (CelloPub=CLPUB00671; PubMed=19136951) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151358710 CVCL_B3V1 KRIBBi004-A induced pluripotent stem cell human CVCL_B3V1 From: Korea Research Institute of Bioscience and Biotechnology; Daejeon; South Korea CL:0000010 Karyotypic information: 46,XX,t(1;5)(p31.1;p35.1) (PubMed=34736040); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Female 151358711 CVCL_B3UP LMH17 finite cell line CVCL_B3UP CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Cell type: Mammary alveolar epithelial cell; CL=CL_0002325; Breed/subspecies: Holstein; VBO=VBO_0000237. Female 151358712 CVCL_B3V0 KRIBBi003-A induced pluripotent stem cell human CVCL_B3V0 From: Korea Research Institute of Bioscience and Biotechnology; Daejeon; South Korea CL:0000010 Sequence variation: Mutation; HGNC; HGNC:8926; PHKA2; Simple; p.Ala1076Glufs*40 (c.3227_3231del); Zygosity=Hemizygous (PubMed=34740118) Population: Korean; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male 151358713 CVCL_B3UB ICGi035-A induced pluripotent stem cell human CVCL_B3UB From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2183; VPS13B; Simple; c.3870+1G>T; ClinVar=VCV000559917; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=35026660) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358714 CVCL_B3UA WG0614 finite cell line human CVCL_B3UA From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483; Cell type: Fibroblast of skin; CL=CL_0002620. 151358715 CVCL_B3UD MCH014 finite cell line human CVCL_B3UD From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 151358716 CVCL_B3UC ICGi035-B induced pluripotent stem cell human CVCL_B3UC From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2183; VPS13B; Simple; c.3870+1G>T; ClinVar=VCV000559917; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=35026660) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358717 CVCL_B3UF WG2408 finite cell line human CVCL_B3UF From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Homozygous (CelloPub=CLPUB00662; PubMed=16281286) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358718 CVCL_B3UE WG2181 finite cell line human CVCL_B3UE From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg31Ter (c.91C>T); ClinVar=VCV000092688; Zygosity=Homozygous (CelloPub=CLPUB00662; PubMed=16281286) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358719 CVCL_B3UH WG2147 finite cell line human CVCL_B3UH From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:19331; MMAB; Simple; p.Val188_Ala192dup (c.563_577dupTGTGCCGCCGGGCCG); ClinVar=VCV000203822; Zygosity=Homozygous (CelloPub=CLPUB00662) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358720 CVCL_B3UG WG2662 finite cell line human CVCL_B3UG From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Lys48Phefs*2 (c.141_142insTTTT); Zygosity=Homozygous (CelloPub=CLPUB00662; PubMed=16281286) Miscellaneous: Cell line no longer available Population: Pacific; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358721 CVCL_B3VZ WG3163 finite cell line human CVCL_B3VZ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg31Ter (c.91C>T); ClinVar=VCV000092688; Zygosity=Homozygous (CelloPub=CLPUB00662; PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian and Native North American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358722 CVCL_B3WB WG0103 finite cell line human CVCL_B3WB From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358723 CVCL_B3WA WG0107 finite cell line human CVCL_B3WA From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Population: Caucasian; French Canadian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358724 CVCL_B3W4 C7788 transformed cell line human CVCL_B3W4 From: Institute for Basic Research in Developmental Disabilities; Staten Island; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; c.509-1G>C; ClinVar=VCV000002644; Zygosity=Heterozygous (PubMed=9295267); Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Arg208Ter (c.622C>T); ClinVar=VCV000002643; Zygosity=Heterozygous (PubMed=9295267) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. 151358725 CVCL_B3VS WG0735 finite cell line human CVCL_B3VS From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Thr227Met (c.680C>T); ClinVar=VCV000800827; Zygosity=Homozygous (PubMed=7726158; PubMed=8940272) Miscellaneous: Cell line no longer available Population: African and Indian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358726 CVCL_B3W3 C7787 transformed cell line human CVCL_B3W3 From: Institute for Basic Research in Developmental Disabilities; Staten Island; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; c.509-1G>C; ClinVar=VCV000002644; Zygosity=Heterozygous (PubMed=9295267); Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Arg208Ter (c.622C>T); ClinVar=VCV000002643; Zygosity=Heterozygous (PubMed=9295267) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. 151358727 CVCL_B3VR WG0670 finite cell line human CVCL_B3VR From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Gly149Val (c.446_447delinsTT) (458_459GC>TT); ClinVar=VCV000848483; Zygosity=Homozygous (PubMed=8940272) Miscellaneous: Cell line no longer available Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358728 CVCL_B3W6 C7790 transformed cell line human CVCL_B3W6 From: Institute for Basic Research in Developmental Disabilities; Staten Island; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; c.509-1G>C; ClinVar=VCV000002644; Zygosity=Heterozygous (PubMed=9295267) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151358729 CVCL_B3VU WG1654 finite cell line human CVCL_B3VU From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151358730 CVCL_B3W5 C7789 transformed cell line human CVCL_B3W5 From: Institute for Basic Research in Developmental Disabilities; Staten Island; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Arg208Ter (c.622C>T); ClinVar=VCV000002643; Zygosity=Heterozygous (PubMed=9295267) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151358731 CVCL_B3VT WG1396 finite cell line human CVCL_B3VT From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg52Gln (c.155G>A); ClinVar=VCV000570071; Zygosity=Heterozygous (PubMed=7726158; PubMed=8940272); Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg357Cys (c.1069C>T); ClinVar=VCV001452549; Zygosity=Heterozygous (PubMed=7726158; PubMed=8940272) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358732 CVCL_B3W8 WG0229 finite cell line human CVCL_B3W8 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358733 CVCL_B3VW WG1772 finite cell line human CVCL_B3VW From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg51Pro (c.152G>C); ClinVar=VCV003769560; Zygosity=Heterozygous (PubMed=8940272); Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; c.237-1G>T (c.249-1G>T); ClinVar=VCV002733826; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=8940272) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151358734 CVCL_B3W7 WG0109 finite cell line human CVCL_B3W7 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358735 CVCL_B3VV WG1767 finite cell line human CVCL_B3VV From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Leu323Pro (c.968T>C); ClinVar=VCV000003529; Zygosity=Heterozygous (PubMed=8940272); Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg377Cys (c.1129C>T); ClinVar=VCV000003528; Zygosity=Heterozygous (PubMed=8940272) Miscellaneous: Cell line no longer available Population: African American and Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358736 CVCL_B3VY WG0356 finite cell line human CVCL_B3VY From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg325Cys (c.973C>T); ClinVar=VCV000975600; Zygosity=Homozygous (PubMed=7726158; PubMed=8940272) Miscellaneous: Cell line no longer available Population: Caucasian; Italian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151358737 CVCL_B3W9 WG0140 finite cell line human CVCL_B3W9 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358738 CVCL_B3VX WG1886 finite cell line human CVCL_B3VX From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358739 CVCL_B3VK WG0138 finite cell line human CVCL_B3VK From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:93; ACAT1; Simple; p.Met1Lys (c.2T>A); ClinVar=VCV000002838; Zygosity=Homozygous (PubMed=8103405) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358740 CVCL_B3VJ NCC-GCTB4-C1 cancer cell line human CVCL_B3VJ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Gly35Trp (c.103G>T) (G34W); Zygosity=Heterozygous (PubMed=34731453) Population: Japanese; Derived from site: In situ; Bone, left proximal tibia; UBERON=UBERON_0008772. Omics: Phenotyping; Drug screening Male Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi); Doubling time: 65.78 hours (PubMed=34731453) Part of: NCC sarcoma cell line panel 151358741 CVCL_B3VM WG0421 finite cell line human CVCL_B3VM From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple; p.Tyr140Cys (c.419A>G); ClinVar=VCV000371634; Zygosity=Heterozygous (DOI=10.26502/acbr.50170022); Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple; p.Arg297Ter (c.889C>T); ClinVar=VCV000001562; Zygosity=Heterozygous (DOI=10.26502/acbr.50170022) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358742 CVCL_B3VL WG0026 finite cell line human CVCL_B3VL From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:93; ACAT1; Simple; c.1163+2T>C (IVS11,T-C,+2); ClinVar=VCV000002837; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=8103405) Miscellaneous: Cell line no longer available Population: Caucasian; Dutch; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151358743 CVCL_B3W0 WG0305 finite cell line human CVCL_B3W0 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Cys365Tyr (c.1094G>A); ClinVar=VCV000002642; Zygosity=Homozygous (PubMed=9295267) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358744 CVCL_B3VN WG0354 finite cell line human CVCL_B3VN From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; c.780+1G>A (c.792+1G>A); ClinVar=VCV002733824; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=7726158; PubMed=8940272) Miscellaneous: Cell line no longer available Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358745 CVCL_B3W2 C7786 transformed cell line human CVCL_B3W2 From: Institute for Basic Research in Developmental Disabilities; Staten Island; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Arg208Ter (c.622C>T); ClinVar=VCV000002643; Zygosity=Heterozygous (PubMed=9295267) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. 151358746 CVCL_B3VQ WG0458 finite cell line human CVCL_B3VQ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg52Gln (c.155G>A); ClinVar=VCV000570071; Zygosity=Heterozygous (PubMed=7726158; PubMed=8940272); Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg335Cys (c.1003C>T); ClinVar=VCV002054912; Zygosity=Heterozygous (PubMed=7726158; PubMed=8940272) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151358747 CVCL_B3W1 WG0308 finite cell line human CVCL_B3W1 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Cys365Arg (c.1093T>C); ClinVar=VCV000002641; Zygosity=Heterozygous (PubMed=9295267) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358748 CVCL_B3VP WG0355 finite cell line human CVCL_B3VP From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; c.780+1G>A (c.792+1G>A); ClinVar=VCV002733824; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=7726158; PubMed=8940272) Miscellaneous: Cell line no longer available Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358749 CVCL_B3VC SNUhES49 embryonic stem cell human CVCL_B3VC From: Seoul National University; Seoul; South Korea CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12017008 151358750 CVCL_B3VB SNUhES48 embryonic stem cell human CVCL_B3VB From: Seoul National University; Seoul; South Korea CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12017007 151358751 CVCL_B3VE CHA-hES57 embryonic stem cell human CVCL_B3VE From: CHA University; Seongnam; South Korea CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12017002 151358752 CVCL_B3VD CHA-hES56 embryonic stem cell human CVCL_B3VD From: CHA University; Seongnam; South Korea CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12017001 151358753 CVCL_B3VG CHA-FT-NT17 embryonic stem cell human CVCL_B3VG From: CHA University; Seongnam; South Korea CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Produced by somatic cell nuclear transfer from a dermal fibroblast (hDF) cells donated from a 42-year-old female patient with central areolar choroidal dystrophy 151358754 CVCL_B3VF CHA-hES58 embryonic stem cell human CVCL_B3VF From: CHA University; Seongnam; South Korea CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12017003 151358755 CVCL_B3VI CHA-FT-NT19 embryonic stem cell human CVCL_B3VI CL:0000010 Karyotypic information: 47,XYY (PubMed=32502464); Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Produced by somatic cell nuclear transfer from mononucleated cells from cord blood Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12019002 151358756 CVCL_B3VH CHA-FT-NT18 embryonic stem cell human CVCL_B3VH From: CHA University; Seongnam; South Korea CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Produced by somatic cell nuclear transfer from mononucleated cells from cord blood Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12019001 151358757 CVCL_B3SX HeLa-mCAT#8 TAL-CERS2#18 cancer cell line human CVCL_B3SX CL:0000010 Knockout cell: Method=TALEN; HGNC; HGNC:14076; CERS2 (Note=3 of 4 alleles); Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151358758 CVCL_B3T9 HHUUKDi009-A induced pluripotent stem cell human CVCL_B3T9 From: Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 151358759 CVCL_B3T8 C57M10 spontaneously immortalized cell line house mouse CVCL_B3T8 CL:0000010 Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966; Cell type: Muller glia; CL=CL_0000636. Unspecified 151358760 CVCL_B3SW HeLa-mCAT#8 TAL-CERS2#16 cancer cell line human CVCL_B3SW CL:0000010 Knockout cell: Method=TALEN; HGNC; HGNC:14076; CERS2; Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151358761 CVCL_B3SZ HeLa-mCAT#8 TAL-CE#14 cancer cell line human CVCL_B3SZ CL:0000010 Knockout cell: Method=TALEN; HGNC; HGNC:2205; CERT1; Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151358762 CVCL_B3SY HeLa-mCAT#8 TAL-CE#1 cancer cell line human CVCL_B3SY CL:0000010 Knockout cell: Method=TALEN; HGNC; HGNC:2205; CERT1; Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151358763 CVCL_B3T1 HeLa-mCAT#8 TAL-CERS2#18-CERT#10 cancer cell line human CVCL_B3T1 CL:0000010 Knockout cell: Method=TALEN; HGNC; HGNC:14076; CERS2 (Note=3 of 4 alleles); Knockout cell: Method=TALEN; HGNC; HGNC:2205; CERT1; Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151358764 CVCL_B3SP II-II6B3 hybridoma house mouse CVCL_B3SP CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P02460; Chicken COL2A1. 151358765 CVCL_B3T0 HeLa-mCAT#8 TAL-CE#3 cancer cell line human CVCL_B3T0 CL:0000010 Knockout cell: Method=TALEN; HGNC; HGNC:2205; CERT1; Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151358766 CVCL_B3T3 HeLa-mCAT#8 TAL-UG#7 cancer cell line human CVCL_B3T3 CL:0000010 Knockout cell: Method=TALEN; HGNC; HGNC:12524; UGCG; Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151358767 CVCL_B3SR V-DH2 hybridoma house mouse CVCL_B3SR CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: Chicken type V collagen. 151358768 CVCL_B3T2 HeLa-mCAT#8 TAL-UG#3 cancer cell line human CVCL_B3T2 CL:0000010 Knockout cell: Method=TALEN; HGNC; HGNC:12524; UGCG; Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151358769 CVCL_B3SQ V-ABI2 hybridoma house mouse CVCL_B3SQ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Chicken type V collagen. 151358770 CVCL_B3T5 HeLa-mCAT#8 TAL-B4G5#2 cancer cell line human CVCL_B3T5 CL:0000010 Knockout cell: Method=TALEN; HGNC; HGNC:928; B4GALT5; Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151358771 CVCL_B3ST MA-108 finite cell line CVCL_B3ST CL:0000010 Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293. Unspecified Group: Non-human primate cell line 151358772 CVCL_B3SS FMC46 hybridoma house mouse CVCL_B3SS CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P14151; Human SELL/CD62L. 151358773 CVCL_B3T4 HeLa-mCAT#8 TAL-CE#14-UG#2 cancer cell line human CVCL_B3T4 CL:0000010 Knockout cell: Method=TALEN; HGNC; HGNC:2205; CERT1; Knockout cell: Method=TALEN; HGNC; HGNC:12524; UGCG; Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151358774 CVCL_B3SV HeLa-mCAT#8 TAL-CERS2#13 cancer cell line human CVCL_B3SV CL:0000010 Knockout cell: Method=TALEN; HGNC; HGNC:14076; CERS2 (Note=3 of 4 alleles); Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151358775 CVCL_B3T7 KUMi003-A induced pluripotent stem cell human CVCL_B3T7 From: Korea University Medical School Hospital; Seoul; South Korea CL:0000010 Population: Korean; Donor information: Established from a patient suffering from acute promyelocytic leukemia but as a normal karyotype; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 151358776 CVCL_B3T6 GZHMCi008-A induced pluripotent stem cell human CVCL_B3T6 From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China CL:0000010 Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151358777 CVCL_B3SU HeLa-mCAT#8 cancer cell line human CVCL_B3SU CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151358778 CVCL_B3SH HeLa ANXA11 KO cancer cell line human CVCL_B3SH From: Durcan, Thomas M.; Montreal Neurological Institute, McGill University; Montreal; Canada CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:535; ANXA11 Miscellaneous: Cell line information from personal communication of Laflamme, Carl Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151358779 CVCL_B3SG TRA-8 hybridoma house mouse CVCL_B3SG CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; O14763; Human TNFRSF10B/CD262. 151358780 CVCL_B3SJ SMBCi013-A induced pluripotent stem cell human CVCL_B3SJ From: Shandong Medical Biotechnological Center; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.Ser975Tyr (c.2924C>A) (p.Ser768Tyr, c.2303C>A); ClinVar=VCV000862055; Zygosity=Heterozygous (PubMed=34995846); Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.Arg1319Ter (c.3955C>T) (p.Arg1112Ter, c.3334C>T); ClinVar=VCV000035728; Zygosity=Heterozygous (PubMed=34995846) Population: Chinese; Han; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male 151358781 CVCL_B3SI SMBCi011-A induced pluripotent stem cell human CVCL_B3SI From: Shandong Medical Biotechnological Center; Jinan; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male 151358782 CVCL_B3SL CMT-1026 cancer cell line dog CVCL_B3SL CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: Teddy Bear. Female Doubling time: 23.95 hours (PubMed=34712723) Group: Triple negative breast cancer (TNBC) cell line 151358783 CVCL_B3SK SMCPGi001-A induced pluripotent stem cell human CVCL_B3SK From: The Seven Medical Center of PLA General Hospital; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5042; HNRNPH2; Simple; p.Arg206Trp (c.616C>T); ClinVar=VCV000225760; Zygosity=Heterozygous; Note=De novo mutation (PubMed=34763229) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151358784 CVCL_B3SN II-5B2 hybridoma house mouse CVCL_B3SN CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P02460; Chicken COL2A1. 151358785 CVCL_B3SM II-2B1 hybridoma house mouse CVCL_B3SM CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P02460; Chicken COL2A1. 151358786 CVCL_B3SB WAe009-A-72 embryonic stem cell human CVCL_B3SB From: Anzhen Hospital, Capital Medical University; Beijing; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2198; COL1A2 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 151358787 CVCL_B3SA WAe009-A-75 embryonic stem cell human CVCL_B3SA From: Shenzhen People's Hospital; Shenzhen; China CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 151358788 CVCL_B3SD GM28007 finite cell line human CVCL_B3SD CL:0000010 Sequence variation: Mutation; HGNC; HGNC:20311; CHAMP1; Simple; p.Ile486Tyrfs*2 (c.1455dup); Zygosity=Heterozygous; Note=De novo mutation (Coriell=GM28007) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151358789 CVCL_B3SC HCC827-Luc-mCh-Puro cancer cell line human CVCL_B3SC CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Female 151358790 CVCL_B3SF MDCK-II Abcc1 spontaneously immortalized cell line dog CVCL_B3SF CL:0000010 Genetic integration: Method=Transfection; Gene=RGD; 3112; Abcc1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female 151358791 CVCL_B3SE GM28063 finite cell line human CVCL_B3SE CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11474; SURF1; Simple; p.Asn178Glufs*9 (c.532_535delAATA); ClinVar=VCV000372719; Zygosity=Heterozygous (Coriell=GM28063) Population: Indian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151358792 CVCL_B3TY CHO-hGluN1-hGluN2A spontaneously immortalized cell line CVCL_B3TY From: Evotec, Aptuit; Verona; Italy CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4584; GRIN1; Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4585; GRIN2A; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Upon induction by tetracycline expresses an heterodimeric human NMDA receptor GRIN1/GRIN2A (Evotec) 151358793 CVCL_B3TX MCH042 finite cell line human CVCL_B3TX From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358794 CVCL_B3U9 WG0516 finite cell line human CVCL_B3U9 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483; Cell type: Fibroblast of skin; CL=CL_0002620. 151358795 CVCL_B3TZ CHO-hGluN1-hGluN2B spontaneously immortalized cell line CVCL_B3TZ From: Evotec, Aptuit; Verona; Italy CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4584; GRIN1; Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4586; GRIN2B; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Upon induction by tetracycline expresses an heterodimeric human NMDA receptor GRIN1/GRIN2b (Evotec) 151358796 CVCL_B3TQ NCC-DDLPS4-C1 cancer cell line human CVCL_B3TQ CL:0000010 Population: Japanese; Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693. Omics: Phenotyping; Drug screening; Omics: Variations; SNP array analysis Male Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi); Doubling time: 72.5 hours (PubMed=34834427) Part of: NCC sarcoma cell line panel 151358797 CVCL_B3U2 WG0067 finite cell line human CVCL_B3U2 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483; Cell type: Fibroblast of skin; CL=CL_0002620. 151358798 CVCL_B3U1 CHO-hGluN1-hGluN2D spontaneously immortalized cell line CVCL_B3U1 From: Evotec, Aptuit; Verona; Italy CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4587; GRIN2C; Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4588; GRIN2D; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Upon induction by tetracycline expresses an heterodimeric human NMDA receptor GRIN1/GRIN2D (Evotec) 151358799 CVCL_B3TP NCC-UPS1-C1 cancer cell line human CVCL_B3TP CL:0000010 Population: Japanese; Derived from site: In situ; Back, hypodermis; UBERON=UBERON_0001137+UBERON_0002072. Omics: Phenotyping; Drug screening; Omics: Proteomics Male Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi); Doubling time: ~40.9 hours (DOI=10.11418/jtca.36.41) Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE); Part of: NCC sarcoma cell line panel 151358800 CVCL_B3TS NCC-CCS1B-C1 cancer cell line human CVCL_B3TS CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF (PubMed=29197033) Population: Japanese; Derived from site: Metastatic; Left thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072. Omics: Genomics; Whole exome sequencing; Omics: Phenotyping; Drug screening; Omics: Proteomics; Omics: Transcriptomics; RNAseq Female Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi); Doubling time: 20 hours (PubMed=29197033) Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE); Part of: NCC sarcoma cell line panel 151358801 CVCL_B3U4 WG0153 finite cell line human CVCL_B3U4 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483; Cell type: Fibroblast of skin; CL=CL_0002620. 151358802 CVCL_B3TR NCC-CCS1-X4-C1 cancer cell line human CVCL_B3TR CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF (PubMed=29197033) Population: Japanese; Derived from site: Metastatic; Left thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072. Omics: Genomics; Whole exome sequencing; Omics: Phenotyping; Drug screening; Omics: Proteomics; Omics: Transcriptomics; RNAseq Female Characteristics: Established from a fourth generation xenograft established by subcutaneous injection in female NOD/Shi-scid IL-2Rgammanull mice Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi); Doubling time: 17 hours (PubMed=29197033) Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE); Part of: NCC sarcoma cell line panel 151358803 CVCL_B3U3 WG0124 finite cell line human CVCL_B3U3 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483; Cell type: Fibroblast of skin; CL=CL_0002620. 151358804 CVCL_B3U6 WG0240 finite cell line human CVCL_B3U6 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483; Cell type: Fibroblast of skin; CL=CL_0002620. 151358805 CVCL_B3TU WG0674 finite cell line human CVCL_B3TU From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151358806 CVCL_B3TT NCC-CCS1B-X2-C1 cancer cell line human CVCL_B3TT CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF (PubMed=29197033) Population: Japanese; Derived from site: Metastatic; Left thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072. Omics: Genomics; Whole exome sequencing; Omics: Phenotyping; Drug screening; Omics: Proteomics; Omics: Transcriptomics; RNAseq Female Characteristics: Established from a second generation xenograft established by subcutaneous injection in female NOD/Shi-scid IL-2Rgammanull mice Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi); Doubling time: 20 hours (PubMed=29197033) Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE); Part of: NCC sarcoma cell line panel 151358807 CVCL_B3U5 WG0220 finite cell line human CVCL_B3U5 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483; Cell type: Fibroblast of skin; CL=CL_0002620. 151358808 CVCL_B3TW MCH033 finite cell line human CVCL_B3TW From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 151358809 CVCL_B3U8 WG0449 finite cell line human CVCL_B3U8 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358810 CVCL_B3TV MCH012 finite cell line human CVCL_B3TV From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 151358811 CVCL_B3U7 WG0241 finite cell line human CVCL_B3U7 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483; Cell type: Fibroblast of skin; CL=CL_0002620. 151358812 CVCL_B3TI COG-LL-329 cancer cell line human CVCL_B3TI CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: T-cell; CL=CL_0000084. Male 151358813 CVCL_B3TH COG-LL-319 cancer cell line human CVCL_B3TH CL:0000010 Karyotypic information: 46,XX,der(7)t(1;7)(q32;q36),del(9)(p11.2),der(19)t(1;19)(q23;p13.3) (COG); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151358814 CVCL_B3TK COG-LL-355 cancer cell line human CVCL_B3TK CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 151358815 CVCL_B3TJ COG-LL-332 cancer cell line human CVCL_B3TJ CL:0000010 Karyotypic information: 46,XY,t(1;9)(p34;q34) (COG); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: T-cell; CL=CL_0000084. Male 151358816 CVCL_B3TM NCC-pRMS1-C1 cancer cell line human CVCL_B3TM CL:0000010 Population: Japanese; Derived from site: In situ; Right thigh, skeletal muscle; UBERON=UBERON_0004252. Omics: Phenotyping; Drug screening Male Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi); Doubling time: 61 hours (DOI=10.11418/jtca.38.1) Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE); Part of: NCC sarcoma cell line panel 151358817 CVCL_B3TL COG-LL-356 cancer cell line human CVCL_B3TL CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 151358818 CVCL_B3U0 CHO-hGluN1-hGluN2C spontaneously immortalized cell line CVCL_B3U0 From: Evotec, Aptuit; Verona; Italy CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4584; GRIN1; Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4587; GRIN2C; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Upon induction by tetracycline expresses an heterodimeric human NMDA receptor GRIN1/GRIN2C (Evotec) 151358819 CVCL_B3TN NCC-pRMS1-X4-C1 cancer cell line human CVCL_B3TN CL:0000010 Population: Japanese; Derived from site: In situ; Right thigh, skeletal muscle; UBERON=UBERON_0004252. Omics: Phenotyping; Drug screening Male Characteristics: Established from a fourth generation xenograft established by subcutaneous injection in female NOD/Shi-scid IL-2Rgammanull mice Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi); Doubling time: 40 hours (DOI=10.11418/jtca.38.1) Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE); Part of: NCC sarcoma cell line panel 151358820 CVCL_B3TA HUSTTJi001-A induced pluripotent stem cell human CVCL_B3TA From: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Wuhan; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:14539; RNF213; Simple; p.Arg4810Lys (c.14429G>A); ClinVar=VCV000039700; Zygosity=Heterozygous (PubMed=34749017) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151358821 CVCL_B3TC COG-LY-459 cancer cell line human CVCL_B3TC CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female 151358822 CVCL_B3TB COG-LY-460 cancer cell line human CVCL_B3TB CL:0000010 Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: B-cell; CL=CL_0000236. Female 151358823 CVCL_B3TE COG-LY-457 cancer cell line human CVCL_B3TE CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: B-cell; CL=CL_0000236. Female 151358824 CVCL_B3TD COG-LY-458 cancer cell line human CVCL_B3TD CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female 151358825 CVCL_B3TG CHLA-233 cancer cell line human CVCL_B3TG CL:0000010 Unspecified 151358826 CVCL_B3TF CHLA-221 cancer cell line human CVCL_B3TF CL:0000010 Unspecified 151358827 CVCL_B3R7 EHD E2C5 hybridoma house mouse CVCL_B3R7 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Epizootic hemorrhagic disease virus 2 (EHDV-2). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2021180 151358828 CVCL_B3QV PICALM6A transformed cell line house mouse CVCL_B3QV CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:2385902; Picalm; Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7132; KMT2A (Note=KMT2A-MLLT1 fusion); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7134; MLLT1 (Note=KMT2A-MLLT1 fusion) Transformant: KMT2A-MLLT1; Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107; Breed/subspecies: fit1 Picalmfit1-5R. Unspecified 151358829 CVCL_B3R6 5E8 hybridoma house mouse CVCL_B3R6 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q14980; Human NUMA1. Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.10586 151358830 CVCL_B3QU LMM117 hybridoma house mouse CVCL_B3QU CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04141; Human CSF2. 151358831 CVCL_B3R9 A640-BB-3 transformed cell line house mouse CVCL_B3R9 CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA640); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/cAnN. Female 151358832 CVCL_B3QX PICALM6D transformed cell line house mouse CVCL_B3QX CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:2385902; Picalm; Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7132; KMT2A (Note=KMT2A-MLLT1 fusion); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7134; MLLT1 (Note=KMT2A-MLLT1 fusion) Transformant: KMT2A-MLLT1; Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107. Unspecified 151358833 CVCL_B3R8 A640-BB-1 transformed cell line house mouse CVCL_B3R8 CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA640); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/cAnN. Female 151358834 CVCL_B3QW PICALM6B transformed cell line house mouse CVCL_B3QW CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:2385902; Picalm; Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7132; KMT2A (Note=KMT2A-MLLT1 fusion); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7134; MLLT1 (Note=KMT2A-MLLT1 fusion) Transformant: KMT2A-MLLT1; Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107. Unspecified 151358835 CVCL_B3QZ 4T1.3 cancer cell line house mouse CVCL_B3QZ CL:0000010 Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG); Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: BALB/cfC3H. Female Characteristics: Metastasizes with high frequency to bone upon orthotopic injection into the mammary fat pad of immunocompetent female BALB/c mice (PubMed=27177471) 151358836 CVCL_B3QY 2G8D10 hybridoma house mouse CVCL_B3QY CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; M4I2H9; Orf virus major core protein 4a (ORFV086). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201471 151358837 CVCL_B3QN ShK cancer cell line human CVCL_B3QN CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5853; IGL; Name(s)=IGL-BCL2 (PubMed=12967475); Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=12967475). Population: Japanese 151358838 CVCL_B3QM MTX-TK cancer cell line human CVCL_B3QM CL:0000010 Population: Japanese; Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX); Derived from site: In situ; Brain; UBERON=UBERON_0000955. Male 151358839 CVCL_B3R1 NOD-iPS#5 induced pluripotent stem cell house mouse CVCL_B3R1 CL:0000010 Derived from site: In situ; Tail, tip; UBERON=UBERON_0010162; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: NOD/Lt. Male 151358840 CVCL_B3QP OYB cancer cell line human CVCL_B3QP CL:0000010 Population: Japanese. Unspecified 151358841 CVCL_B3R0 MY.1E12 hybridoma house mouse CVCL_B3R0 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P15941; Human MUC1/CD227 (Note=Recognizes the sialylalpha2-3Galactosylbeta1-3N-acetylgalactosaminide trisaccharide onto the Thr within the VTS repeats). 151358842 CVCL_B3R3 NOD-iPS#17 induced pluripotent stem cell house mouse CVCL_B3R3 CL:0000010 Derived from site: In situ; Tail, tip; UBERON=UBERON_0010162; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: NOD/Lt. Male 151358843 CVCL_B3QR RbM2 hybridoma house mouse CVCL_B3QR CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Rabbit 50 Kda lysosomal membrane antigen. 151358844 CVCL_B3R2 NOD-iPS#11 induced pluripotent stem cell house mouse CVCL_B3R2 CL:0000010 Derived from site: In situ; Tail, tip; UBERON=UBERON_0010162; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: NOD/Lt. Male 151358845 CVCL_B3QQ PCL2021 cancer cell line human CVCL_B3QQ CL:0000010 Unspecified 151358846 CVCL_B3R5 11A10 hybridoma house mouse CVCL_B3R5 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q14980; Human NUMA1. Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.10585 151358847 CVCL_B3QT LMM111 hybridoma house mouse CVCL_B3QT CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04141; Human CSF2. 151358848 CVCL_B3R4 1G11 spontaneously immortalized cell line house mouse CVCL_B3R4 CL:0000010 Derived from site: In situ; Lung, endothelium; UBERON=UBERON_0013479; Cell type: Lung microvascular endothelial cell; CL=CL_2000016; Breed/subspecies: C57BL/6NCrLBR. Female 151358849 CVCL_B3QS LMM102 hybridoma house mouse CVCL_B3QS CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P04141; Human CSF2. 151358850 CVCL_B3QF LM cancer cell line human CVCL_B3QF CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Homozygous (PubMed=9671307) Derived from site: In situ; Liver; UBERON=UBERON_0002107. Female 151358851 CVCL_B3QE AS [Human rhabdoid tumor] cancer cell line human CVCL_B3QE CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Heterozygous (PubMed=9671307) Derived from site: In situ; Abdomen; UBERON=UBERON_0000916. Female 151358852 CVCL_B3QH A-20 hybridoma house mouse CVCL_B3QH CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45 (Note=Isoform Ly5.1). Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK2003-077 151358853 CVCL_B3QG MT [Human rhabdoid tumor] cancer cell line human CVCL_B3QG CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Heterozygous (PubMed=9671307) Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072. Male 151358854 CVCL_B3QJ PCNSL-MSK cancer cell line human CVCL_B3QJ From: Memorial Sloan Kettering Cancer Center; New York; USA CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Omics: Variations; Array-based CGH Male 151358855 CVCL_B3QI 104-2 hybridoma house mouse CVCL_B3QI CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45 (Note=Isoform Ly5.2). Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK2003-077 151358856 CVCL_B3QL MTX-RAJI cancer cell line human CVCL_B3QL CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 151358857 CVCL_B3QK MTX-HKBML cancer cell line human CVCL_B3QK CL:0000010 Population: Japanese; Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Brain; UBERON=UBERON_0000955. Male 151358858 CVCL_B3QB NPC-BM29 cancer cell line human CVCL_B3QB CL:0000010 Population: Chinese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Female Characteristics: Invasive subline of NPC-BM1 Doubling time: 18.2 hours (In 10% FBS), 26.8 hours (Note=In 2% FBS) (PubMed=19930697) 151358859 CVCL_B3QA NP550-hTert telomerase immortalized cell line human CVCL_B3QA CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Chinese; Donor information: Established from the non-malignant tissue of a patient diagnosed with nasopharyngeal carcinoma (from parent cell line NP550); Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951; Cell type: Epithelial cell of nasopharynx; CL=CL_1001573. Male 151358860 CVCL_B3QD Rag2-/- pro-B cells finite cell line house mouse CVCL_B3QD CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:97849; Rag2 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Pro-B cell; CL=CL_0000826; Breed/subspecies: 129S6/SvEvTac-Rag2tm1Fwa. Unspecified Characteristics: Rag2-/- pro-B cells maintained on OP42 stromal cells 151358861 CVCL_B3QC NPC-BM00 cancer cell line human CVCL_B3QC CL:0000010 Population: Chinese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Female Characteristics: Non-invasive subline of NPC-BM1 Doubling time: 18.7 hours (In 10% FBS), 30.7 hours (Note=In 2% FBS) (PubMed=19930697) 151358862 CVCL_B3RW CPG8 transformed cell line human CVCL_B3RW CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151358863 CVCL_B3S8 MUPS-1 cancer cell line human CVCL_B3S8 CL:0000010 Population: African American; Derived from site: In situ; Right mandible, hypodermis; UBERON=UBERON_0001684+UBERON_0002072. Omics: Transcriptomics; RNAseq Male Doubling time: 93.14 hours (PubMed=32652895) 151358864 CVCL_B3RV CPG7 transformed cell line human CVCL_B3RV CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151358865 CVCL_B3S7 WAe009-A-74 embryonic stem cell human CVCL_B3S7 From: Shenzhen People's Hospital; Shenzhen; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple_edited; p.Tyr616Cys (c.1847A>G); ClinVar=VCV000067295; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=35247842) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 151358866 CVCL_B3RY ICGi034-A induced pluripotent stem cell human CVCL_B3RY From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=35007918) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151358867 CVCL_B3RX ICGi033-A induced pluripotent stem cell human CVCL_B3RX From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[77] (c.52CAG(46)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=35872525) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151358868 CVCL_B3S9 TT1 [Human thyroid carcinoma] cancer cell line human CVCL_B3S9 CL:0000010 Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046. 151358869 CVCL_B3RZ SXMUi001-A induced pluripotent stem cell human CVCL_B3RZ From: Shanxi Medical University; Taiyuan; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3551; F9; Simple; p.Arg75Ter (c.223C>T); ClinVar=VCV000010572; Zygosity=Hemizygous (Patent=CN113881637B; PubMed=35121195) Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.22359 151358870 CVCL_B3S0 SIAISi014-A induced pluripotent stem cell human CVCL_B3S0 From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China. CL:0000010 151358871 CVCL_B3RN NCC-UPS3-C1 cancer cell line human CVCL_B3RN CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Unspecified (PubMed=34665443); Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Unspecified (PubMed=34665443) Population: Japanese; Derived from site: Metastatic; Left buttock, hypodermis; UBERON=UBERON_0013691+UBERON_0002072. Omics: Phenotyping; Drug screening; Omics: Variations; SNP array analysis Female Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi); Doubling time: 61.6 hours (PubMed=34665443) Part of: NCC sarcoma cell line panel 151358872 CVCL_B3RQ ICGi031-A induced pluripotent stem cell human CVCL_B3RQ From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~1700] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151358873 CVCL_B3S2 SIAISi016-A induced pluripotent stem cell human CVCL_B3S2 From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Heterozygous; Note=ApoE4 allele (PubMed=37148820); Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg176Cys (c.526C>T); ClinVar=VCV000017848; Zygosity=Heterozygous; Note=ApoE2 allele (PubMed=37148820) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151358874 CVCL_B3S1 SIAISi015-A induced pluripotent stem cell human CVCL_B3S1 From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China. CL:0000010 151358875 CVCL_B3RP WAe009-A-67 embryonic stem cell human CVCL_B3RP From: Institute of Health Service and Transfusion Medicine; Beijing; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10852; SHMT2 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 151358876 CVCL_B3RS CPG10 transformed cell line human CVCL_B3RS CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151358877 CVCL_B3S4 SIAISi018-A induced pluripotent stem cell human CVCL_B3S4 From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151358878 CVCL_B3RR ICGi032-A induced pluripotent stem cell human CVCL_B3RR From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151358879 CVCL_B3S3 SIAISi017-A induced pluripotent stem cell human CVCL_B3S3 From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China CL:0000010 Population: Chinese/Asian ethnic group: Hui; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151358880 CVCL_B3RU CPG18 transformed cell line human CVCL_B3RU CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151358881 CVCL_B3S6 WAe009-A-73 embryonic stem cell human CVCL_B3S6 From: Anzhen Hospital, Capital Medical University; Beijing; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10486; S100A1 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 151358882 CVCL_B3S5 CIPi001-A induced pluripotent stem cell human CVCL_B3S5 From: Children's Hospital of Capital Institute of Pediatrics; Beijing; China CL:0000010 Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151358883 CVCL_B3RT CPG166 transformed cell line human CVCL_B3RT CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151358884 CVCL_B3RG SV-BB-5 transformed cell line house mouse CVCL_B3RG CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=SV68C); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/cAnN. Female 151358885 CVCL_B3RF SV-BB-4 transformed cell line house mouse CVCL_B3RF CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=SV68C); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/cAnN. Female 151358886 CVCL_B3RI 28-12 (Ara) transformed cell line house mouse CVCL_B3RI CL:0000010 Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C); Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=SV68C); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: ICR. Female 151358887 CVCL_B3RH 28-12 transformed cell line house mouse CVCL_B3RH CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=SV68C); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: ICR. Female 151358888 CVCL_B3RK CQ8-A2D9 hybridoma house mouse CVCL_B3RK CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P30556; Human AGTR1 (Note=Immunized with the peptide 181-AFHYESQ-187 and recognizes it). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017108 151358889 CVCL_B3RJ 2D9 [Mouse hybridoma against H.hepaticus cdtB] hybridoma house mouse CVCL_B3RJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q7VG76; Helicobacter hepaticus cdtB. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2021140 151358890 CVCL_B3RM NCC-MFS3-C1 cancer cell line human CVCL_B3RM CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Unspecified (PubMed=33990915); Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Unspecified (PubMed=33990915) Population: Japanese; Derived from site: In situ; Thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072. Omics: Phenotyping; Drug screening; Omics: Variations; SNP array analysis Female Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi); Doubling time: ~36 hours (PubMed=33990915) Part of: NCC sarcoma cell line panel 151358891 CVCL_B3RL NCC-MFS4-C1 cancer cell line human CVCL_B3RL CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Unspecified (PubMed=34383271); Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Unspecified (PubMed=34383271) Population: Japanese; Derived from site: In situ; Lower leg, hypodermis; UBERON=UBERON_0003823+UBERON_0002072. Omics: Phenotyping; Drug screening; Omics: Variations; SNP array analysis Female Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi); Doubling time: ~64 hours (PubMed=34383271) Part of: NCC sarcoma cell line panel 151358892 CVCL_B3RA A640-BB-4 transformed cell line house mouse CVCL_B3RA CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA640); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/cAnN. Female 151358893 CVCL_B3RC SV-BB-1 transformed cell line house mouse CVCL_B3RC CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=SV68C); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/cAnN. Female 151358894 CVCL_B3RB A640-BB-5 transformed cell line house mouse CVCL_B3RB CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA640); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/cAnN. Female 151358895 CVCL_B3RE SV-BB-3 transformed cell line house mouse CVCL_B3RE CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=SV68C); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/cAnN. Female 151358896 CVCL_B3RD SV-BB-2 transformed cell line house mouse CVCL_B3RD CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=SV68C); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/cAnN. Female 151358897 CVCL_B3P5 DRICUi007-A induced pluripotent stem cell human CVCL_B3P5 From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: ECACC; 66770032; true Male 151358898 CVCL_B3P4 DRICUi006-A induced pluripotent stem cell human CVCL_B3P4 From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: ECACC; 66770030; true Male 151358899 CVCL_B3P7 DRICUi009-A induced pluripotent stem cell human CVCL_B3P7 From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: ECACC; 66770033; true Female 151358900 CVCL_B3P6 DRICUi008-A induced pluripotent stem cell human CVCL_B3P6 From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom CL:0000010 Discontinued: ECACC; 66770031; true. Male 151358901 CVCL_B3P9 1BH3 hybridoma house mouse CVCL_B3P9 CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; A1Z0H6; Pseudomonas fluorescens (strain G2) 3-phosphoshikimate 1-carboxyvinyltransferase (aroA). Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.10494 151358902 CVCL_B3P8 HCT 116 SYT1 KO cancer cell line human CVCL_B3P8 From: Durcan, Thomas M.; Montreal Neurological Institute, McGill University; Montreal; Canada CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11509; SYT1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151358903 CVCL_B3P1 DRICUi003-A induced pluripotent stem cell human CVCL_B3P1 From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: ECACC; 66770024; true Female 151358904 CVCL_B3P0 DRICUi002-A induced pluripotent stem cell human CVCL_B3P0 From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom CL:0000010 Discontinued: ECACC; 66770023; true. Female 151358905 CVCL_B3P3 DRICUi005-A induced pluripotent stem cell human CVCL_B3P3 From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: ECACC; 66770026; true Female 151358906 CVCL_B3P2 DRICUi004-A induced pluripotent stem cell human CVCL_B3P2 From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: ECACC; 66770025; true Female 151358907 CVCL_B3NZ DRICUi001-A induced pluripotent stem cell human CVCL_B3NZ From: UK Dementia Research Institute, Cardiff University; Cardiff; United Kingdom CL:0000010 Discontinued: ECACC; 66770022; true. Male 151358908 CVCL_B3Q6 NP446-CDK4R24C-hTert telomerase immortalized cell line human CVCL_B3Q6 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Chinese; Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951; Cell type: Epithelial cell of nasopharynx; CL=CL_1001573. Female 151358909 CVCL_B3PU SK-JHRCC-62-LN cancer cell line human CVCL_B3PU From: Memorial Sloan Kettering Cancer Center; New York; USA CL:0000010 Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. Male 151358910 CVCL_B3Q5 NP361-cyclinD1-hTert telomerase immortalized cell line human CVCL_B3Q5 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Chinese; Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951. Female 151358911 CVCL_B3PT SK-JHRCC-228 cancer cell line human CVCL_B3PT From: Memorial Sloan Kettering Cancer Center; New York; USA CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male 151358912 CVCL_B3PW Dnmt1(Y495C)-1 embryonic stem cell house mouse CVCL_B3PW From: Birla Institute of Technology and Science Pilani, Hyderabad Campus; Hyderabad; India CL:0000010 Genetic integration: Method=Homologous recombination; Gene=MGI; MGI:94912; Dnmt1 (Note=With p.Tyr501Cys; equivalent to human p.Tyr495Cys); Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: 129X1/SvJ x 129S1/Sv-Oca2+Tyr+KitlSl-J. Male 151358913 CVCL_B3Q8 NP550-CDK4R24C-hTert telomerase immortalized cell line human CVCL_B3Q8 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Chinese; Donor information: Established from the non-malignant tissue of a patient diagnosed with nasopharyngeal carcinoma (from parent cell line NP550); Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951; Cell type: Epithelial cell of nasopharynx; CL=CL_1001573. Male 151358914 CVCL_B3Q7 NP446-cyclinD1-hTert telomerase immortalized cell line human CVCL_B3Q7 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Chinese; Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951; Cell type: Epithelial cell of nasopharynx; CL=CL_1001573. Female 151358915 CVCL_B3PV SK-JHRCC-219 cancer cell line human CVCL_B3PV From: Memorial Sloan Kettering Cancer Center; New York; USA CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Homozygous (PubMed=32359397) Derived from site: Metastatic; Bone; UBERON=UBERON_0002481. Male 151358916 CVCL_B3PY AIBNi014-A induced pluripotent stem cell human CVCL_B3PY From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; c.1236-3dupT; ClinVar=VCV000181847; Zygosity=Homozygous (PubMed=34507142); Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Leu2135_Arg2136insTer (c.6404_6405insTT) (p.Arg2136fs); ClinVar=VCV000220763; Zygosity=Heterozygous (PubMed=34507142) Population: Caucasian; Derived from site: In situ; Nose, nasal cavity, olfactory mucosa; UBERON=UBERON_0005386. Female 151358917 CVCL_B3Q9 NP550-cyclinD1-hTert telomerase immortalized cell line human CVCL_B3Q9 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Chinese; Donor information: Established from the non-malignant tissue of a patient diagnosed with nasopharyngeal carcinoma (from parent cell line NP550); Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951; Cell type: Epithelial cell of nasopharynx; CL=CL_1001573. Male 151358918 CVCL_B3PX WAe009-A-70 embryonic stem cell human CVCL_B3PX From: Zhengzhou University Second Affiliated Hospital; Zhengzhou; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3756; FLNC Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 151358919 CVCL_B3PZ AIBNi013-A induced pluripotent stem cell human CVCL_B3PZ From: Australian Institute for Bioengineering and Nanotechnology; Brisbane; Australia CL:0000010 Derived from site: In situ; Nose, nasal cavity, olfactory mucosa; UBERON=UBERON_0005386. Male 151358920 CVCL_B3PM CCLF-PEDS-0008-T cancer cell line human CVCL_B3PM CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala148Thr (c.442G>A); ClinVar=VCV000041580; Zygosity=Heterozygous (DSMZ=ACC-969) Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072. Female Doubling time: ~2-3 days (DSMZ=ACC-969) Part of: Cancer Cell Line Factory (CCLF) cell models; Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE) 151358921 CVCL_B3PL CCLF-PEDS-0003-T cancer cell line human CVCL_B3PL CL:0000010 Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072. Part of: Cancer Cell Line Factory (CCLF) cell models; Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE) 151358922 CVCL_B3Q0 SKOV3/MRP7 cancer cell line human CVCL_B3Q0 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:52; ABCC10; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Female Doubling time: 68.19 +- 1.53 hours (PubMed=34631561) 151358923 CVCL_B3PN CCLF-PEDS-0009-T cancer cell line human CVCL_B3PN CL:0000010 Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Male Part of: Cancer Cell Line Factory (CCLF) cell models; Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE) 151358924 CVCL_B3Q2 CPGHi004-A induced pluripotent stem cell human CVCL_B3Q2 From: Chinese PLA Institute of Otolaryngology, Chinese PLA General Hospital; Beijing; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151358925 CVCL_B3PQ UOK353 cancer cell line human CVCL_B3PQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg181His (c.542G>A); ClinVar=VCV000142320; Zygosity=Heterozygous (PubMed=32259323) Population: African American; Karyotypic information: 43,XX,-4,-9,-15,t(19;22)(p13.1;q11.2) (PubMed=32259323); Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Female Doubling time: ~72 hours (PubMed=32259323) 151358926 CVCL_B3PP CCLF-PEDS-0018-T undefined cell line type human CVCL_B3PP CL:0000010 Cell type: Fibroblast; CL=CL_0000057. Male Part of: Cancer Cell Line Factory (CCLF) cell models; Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE) 151358927 CVCL_B3Q1 HEK293-MRP7 transformed cell line human CVCL_B3Q1 CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:52; ABCC10; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151358928 CVCL_B3Q4 NP361-CDK4R24C-hTert telomerase immortalized cell line human CVCL_B3Q4 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Chinese; Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951. Female 151358929 CVCL_B3PS RMC2C cancer cell line human CVCL_B3PS CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Homozygous (PubMed=32359397) Population: African American; Karyotypic information: Near hypertriploid karyotype (PubMed=32359397); Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male Doubling time: 32 hours (PubMed=32359397) 151358930 CVCL_B3Q3 NP361hTert telomerase immortalized cell line human CVCL_B3Q3 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Chinese; Derived from site: In situ; Pharynx, nasopharynx, epithelium; UBERON=UBERON_0001951. Female 151358931 CVCL_B3PR UOK360 cancer cell line human CVCL_B3PR CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; p.Ser258Valfs*23 (c.771insA); Zygosity=Homozygous (PubMed=32259323) Population: African American; Karyotypic information: Hypertriploid karyotype (PubMed=32259323); Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Female Doubling time: ~24 hours (PubMed=32259323) 151358932 CVCL_B3PE HCEM-1 telomerase immortalized cell line human CVCL_B3PE CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Japanese; Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266; Cell type: Cementoblast; CL=CL_0000061. Unspecified 151358933 CVCL_B3PD TR-IL2-YT cancer cell line human CVCL_B3PD CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6001; IL2; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Pericardial effusion; UBERON=UBERON_0002409; Cell type: Natural killer cell; CL=CL_0000623. Male 151358934 CVCL_B3PG MS215 finite cell line human CVCL_B3PG CL:0000010 Derived from site: In situ; Eye, choroid; UBERON=UBERON_0001776; Cell type: Melanocyte of choroid; CL=CL_4030000. Unspecified Doubling time: 20.5 hours (CelloPub=CLPUB00655) 151358935 CVCL_B3PF HCEM-2 telomerase immortalized cell line human CVCL_B3PF CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Japanese; Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266; Cell type: Cementoblast; CL=CL_0000061. Unspecified 151358936 CVCL_B3PI BS153-ResE cancer cell line human CVCL_B3PI CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line) Selected for resistance to: ChEBI; CHEBI_114785; Erlotinib; Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified 151358937 CVCL_B3PH vCor.4U finite cell line human CVCL_B3PH From: Ncardia B.V (formerly Axiogenesis); Leiden; Netherlands. CL:0000010 Cell type: Cardiomyocyte; CL=CL_0002495. Female 151358938 CVCL_B3PK CCLF-PEDS-0001-T cancer cell line human CVCL_B3PK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr107_Phe113del (c.320_340delACGGTTTCCGTCTGGGCTTCT); Zygosity=Heterozygous (DepMap=ACH-001163) Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male Part of: Cancer Cell Line Factory (CCLF) cell models; Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE) 151358939 CVCL_B3PJ A375-RMR SCH 0.25 cancer cell line human CVCL_B3PJ From: Johannessen, Cory M.; Broad Institute of MIT and Harvard; Harvard; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (DepMap=ACH-002003); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436); Selected for resistance to: ChEBI; CHEBI_75998; Trametinib (Mekinist; GSK1120212); Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511. Female Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE) 151358940 CVCL_B3PA 2EA2 hybridoma house mouse CVCL_B3PA CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; A1Z0H6; Pseudomonas fluorescens (strain G2) 3-phosphoshikimate 1-carboxyvinyltransferase (aroA). Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.10495 151358941 CVCL_B3PC TR-IL2-NK-92 cancer cell line human CVCL_B3PC CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6001; IL2; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Natural killer cell; CL=CL_0000623. Male 151358942 CVCL_B3PB ERMCL spontaneously immortalized cell line human CVCL_B3PB CL:0000010 Miscellaneous: As no cell line name was provided in the papers, we assigned the name based on the abbreviation of the cell line description Derived from site: In situ; Eye, retina, neuroretina; UBERON=UBERON_0003902. Female 151358943 CVCL_B3ZA WG3357 finite cell line human CVCL_B3ZA From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4839; HCFC1; Simple; p.Thr1481Met (c.4442C>T); ClinVar=VCV000382802; Zygosity=Heterozygous (PubMed=31462756) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151358944 CVCL_B3ZC WG4142 finite cell line human CVCL_B3ZC From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151358945 CVCL_B3ZB WG4131 finite cell line human CVCL_B3ZB From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:16692; CD320; Simple; p.Glu88del (c.256GAG[2]) (c.262_264delGAG); ClinVar=VCV000203643; Zygosity=Heterozygous (PubMed=31462756); Sequence variation: Mutation; HGNC; HGNC:16692; CD320; Simple; p.Gly220Arg (c.658G>A); ClinVar=VCV000136684; Zygosity=Heterozygous (PubMed=31462756) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151358946 CVCL_B3ZE WG2046 finite cell line human CVCL_B3ZE From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly215Cys (c.643G>T); ClinVar=VCV000418341; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Indian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358947 CVCL_B3ZD WG4190 finite cell line human CVCL_B3ZD From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11529; EPCAM; Simple; p.Gln167Profs*21 (c.499dupC); ClinVar=VCV000012774; Zygosity=Homozygous (PubMed=31462756) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151358948 CVCL_B3YV WG2686 finite cell line human CVCL_B3YV From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151358949 CVCL_B3Z7 WG3023 finite cell line human CVCL_B3Z7 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4839; HCFC1; Simple; p.Pro1492Leu (c.4475C>T); ClinVar=VCV002432377; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228; PubMed=31462756) Miscellaneous: Cell line no longer available Population: Arab; Saudi Arabian and Turkish; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151358950 CVCL_B3YU WG2625 finite cell line human CVCL_B3YU From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2548; CUBN; Simple; p.Ser3329Leu (c.9986C>T); ClinVar=VCV000532212; Zygosity=Heterozygous (PubMed=31462756); Sequence variation: Mutation; HGNC; HGNC:8653; PCCA; Simple; p.Glu584Ter (c.1749_1750delGGinsTT); Zygosity=Heterozygous (PubMed=31462756); Sequence variation: Mutation; HGNC; HGNC:8653; PCCA; Unexplicit; Ex21 intragenic 9-kb duplication; Zygosity=Heterozygous (PubMed=31462756) Miscellaneous: Cell line no longer available Donor information: Established from a patient which had elevated level of methylmalonic acid thus was originally diagnosed as suffering from methylmalonic acidemia; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151358951 CVCL_B3Z6 WG3099 finite cell line human CVCL_B3Z6 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151358952 CVCL_B3YX WG2716 finite cell line human CVCL_B3YX From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151358953 CVCL_B3Z9 WG3221 finite cell line human CVCL_B3Z9 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151358954 CVCL_B3YW WG2701 finite cell line human CVCL_B3YW From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg445Trp (c.1333C>T); ClinVar=VCV000973456; Zygosity=Heterozygous (PubMed=31462756) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151358955 CVCL_B3Z8 WG3162 finite cell line human CVCL_B3Z8 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151358956 CVCL_B3YZ WG2727 finite cell line human CVCL_B3YZ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151358957 CVCL_B3YY WG2718 finite cell line human CVCL_B3YY From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151358958 CVCL_B3YN WG2316 finite cell line human CVCL_B3YN From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151358959 CVCL_B3YM WG1606 finite cell line human CVCL_B3YM From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly203Arg (c.607G>A); ClinVar=VCV000218987; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358960 CVCL_B3YP WG2324 finite cell line human CVCL_B3YP From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151358961 CVCL_B3Z1 WG2740 finite cell line human CVCL_B3Z1 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151358962 CVCL_B3Z0 WG2731 finite cell line human CVCL_B3Z0 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:27288; ACSF3; Simple; p.Pro285Leu (c.854C>T); ClinVar=VCV000381877; Zygosity=Heterozygous (PubMed=31462756) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151358963 CVCL_B3YR WG2389 finite cell line human CVCL_B3YR From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151358964 CVCL_B3Z3 WG2837 finite cell line human CVCL_B3Z3 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:27288; ACSF3; Simple; p.Arg558Trp (c.1672C>T); ClinVar=VCV000031134; Zygosity=Heterozygous (PubMed=31462756) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151358965 CVCL_B3YQ WG2368 finite cell line human CVCL_B3YQ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151358966 CVCL_B3Z2 WG2823 finite cell line human CVCL_B3Z2 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151358967 CVCL_B3YT WG2575 finite cell line human CVCL_B3YT From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151358968 CVCL_B3Z5 WG3092 finite cell line human CVCL_B3Z5 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151358969 CVCL_B3YS WG2436 finite cell line human CVCL_B3YS From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4268; CBLIF; Simple; p.Lys145del (c.432GAA[1]) (c.435_437delGAA); ClinVar=VCV000208192; Zygosity=Heterozygous (PubMed=31462756) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151358970 CVCL_B3Z4 WG3086 finite cell line human CVCL_B3Z4 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2548; CUBN; Simple; p.Ser865Asn (c.2594G>A); ClinVar=VCV000265086; Zygosity=Heterozygous (PubMed=31462756); Sequence variation: Mutation; HGNC; HGNC:2548; CUBN; Simple; p.Asn2157Asp (c.6469A>G); ClinVar=VCV000695565; Zygosity=Heterozygous (PubMed=31462756) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151358971 CVCL_B3YF 3-11 hybridoma house mouse CVCL_B3YF CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P20062; Human TCN2. 151358972 CVCL_B3YE 2-6 hybridoma house mouse CVCL_B3YE CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P20062; Human TCN2. 151358973 CVCL_B3YH 3-9 hybridoma house mouse CVCL_B3YH CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P20062; Human TCN2. 151358974 CVCL_B3YG 3-5 [Mouse hybridoma against human TCN2] hybridoma house mouse CVCL_B3YG CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P20062; Human TCN2. 151358975 CVCL_B3YJ 5-18 hybridoma house mouse CVCL_B3YJ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P20062; Human TCN2. 151358976 CVCL_B3YI 4-7 hybridoma house mouse CVCL_B3YI CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P20062; Human TCN2. 151358977 CVCL_B3YL WG2808 finite cell line human CVCL_B3YL From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala191Glu (c.572C>A); ClinVar=VCV000203854; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358978 CVCL_B3YK WG2842 finite cell line human CVCL_B3YK From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Trp105Arg (c.313T>C); ClinVar=VCV000001878; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Mexican; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358979 CVCL_B3ZW WG1612 finite cell line human CVCL_B3ZW From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg467Ter (c.1399C>T); ClinVar=VCV000495778; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358980 CVCL_B3ZV WG1919 finite cell line human CVCL_B3ZV From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu685dup (c.2053_2055dupCTC) (684insL); Zygosity=Homozygous (PubMed=9554742; PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358981 CVCL_B3ZY WG3059 finite cell line human CVCL_B3ZY From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly544Ter (c.1630_1631delGGinsTA); ClinVar=VCV000203860; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Chinese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358982 CVCL_B3ZX WG1727 finite cell line human CVCL_B3ZX From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg474Ter (c.1420C>T); ClinVar=VCV000554873; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Canadian Dariusleut Hutterite; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358983 CVCL_B3ZZ WG3118 finite cell line human CVCL_B3ZZ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg616Cys (c.1846C>T); ClinVar=VCV000551499; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358984 CVCL_B3ZN WG1797 finite cell line human CVCL_B3ZN From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn388His (c.1162A>C); ClinVar=VCV001804011; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Pakistani; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358985 CVCL_B3ZQ WG1999 finite cell line human CVCL_B3ZQ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg403Ter (c.1207C>T); ClinVar=VCV000167310; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Spanish; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358986 CVCL_B3ZP WG3122 finite cell line human CVCL_B3ZP From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Val399Glufs*24 (c.1196_1197delTG); ClinVar=VCV000578141; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Brazilian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358987 CVCL_B3ZS WG3026 finite cell line human CVCL_B3ZS From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly427Asp (c.1280G>A); ClinVar=VCV000218990; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Chinese; Taiwan; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358988 CVCL_B3ZR WG2562 finite cell line human CVCL_B3ZR From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg403Ter (c.1207C>T); ClinVar=VCV000167310; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358989 CVCL_B3ZU WG1738 finite cell line human CVCL_B3ZU From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala191Glu (c.572C>A); ClinVar=VCV000203854; Zygosity=Heterozygous (PubMed=9554742; PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Val633Gly (c.1898T>G); ClinVar=VCV000449393; Zygosity=Heterozygous (PubMed=9554742; PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Irish/Italian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358990 CVCL_B3ZT WG1517 finite cell line human CVCL_B3ZT From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg152Ter (c.454C>T); ClinVar=VCV000426467; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Gln (c.683G>A); ClinVar=VCV002136408; Zygosity=Heterozygous (PubMed=9554742; PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151358991 CVCL_B3ZG WG2503 finite cell line human CVCL_B3ZG From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly215Ser (c.643G>A); ClinVar=VCV000001888; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Egyptian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358992 CVCL_B3ZF WG2419 finite cell line human CVCL_B3ZF From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly215Ser (c.643G>A); ClinVar=VCV000001888; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Italian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358993 CVCL_B3ZI WG2516 finite cell line human CVCL_B3ZI From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ser306Phe (c.917C>T); ClinVar=VCV000553978; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Southeast Asian; Filipino; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358994 CVCL_B3ZH WG2541 finite cell line human CVCL_B3ZH From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358995 CVCL_B3ZK WG1510 finite cell line human CVCL_B3ZK From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu346del (c.1036_1038delCTT); Zygosity=Homozygous (PubMed=9554742; PubMed=16281286) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 151358996 CVCL_B3ZJ WG1431 finite cell line human CVCL_B3ZJ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly312Val (c.935G>T); ClinVar=VCV000218988; Zygosity=Homozygous (PubMed=9554742; PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151358997 CVCL_B3ZM WG3056 finite cell line human CVCL_B3ZM From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Greek; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358998 CVCL_B3ZL WG2377 finite cell line human CVCL_B3ZL From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Turkish; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151358999 CVCL_B3XA WG2076 finite cell line human CVCL_B3XA From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg111Ter (c.331C>T); ClinVar=VCV000001424; Zygosity=Homozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359000 CVCL_B3XC WG1719 finite cell line human CVCL_B3XC From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Homozygous (PubMed=19370762); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; c.792_818del27; Zygosity=Heterozygous (PubMed=19370762) Miscellaneous: Cell line no longer available Population: Jewish; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151359001 CVCL_B3XB WG3387 finite cell line human CVCL_B3XB From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Met1Val (c.1A>G); ClinVar=VCV000381577; Zygosity=Heterozygous (PubMed=19370762); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (PubMed=19370762) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151359002 CVCL_B3X5 WG1176 finite cell line human CVCL_B3X5 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg132Ter (c.394C>T); ClinVar=VCV000001423; Zygosity=Homozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359003 CVCL_B3WT WG2599 finite cell line human CVCL_B3WT From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg132Ter (c.394C>T); ClinVar=VCV000001423; Zygosity=Heterozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359004 CVCL_B3WS WG2460 finite cell line human CVCL_B3WS From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Tyr222Ter (c.666C>A); ClinVar=VCV000496436; Zygosity=Heterozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359005 CVCL_B3X4 WG3366 finite cell line human CVCL_B3X4 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Homozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359006 CVCL_B3WV WG3072 finite cell line human CVCL_B3WV From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg111Ter (c.331C>T); ClinVar=VCV000001424; Zygosity=Heterozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359007 CVCL_B3X7 WG3183 finite cell line human CVCL_B3X7 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg132Ter (c.394C>T); ClinVar=VCV000001423; Zygosity=Homozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359008 CVCL_B3X6 WG2722 finite cell line human CVCL_B3X6 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg132Ter (c.394C>T); ClinVar=VCV000001423; Zygosity=Homozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359009 CVCL_B3WU WG3014 finite cell line human CVCL_B3WU From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg111Ter (c.331C>T); ClinVar=VCV000001424; Zygosity=Heterozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359010 CVCL_B3X9 WG1422 finite cell line human CVCL_B3X9 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg111Ter (c.331C>T); ClinVar=VCV000001424; Zygosity=Homozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359011 CVCL_B3WX WG3480 finite cell line human CVCL_B3WX From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668; PubMed=19370762); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg161Gln (c.482G>A); ClinVar=VCV000001425; Zygosity=Heterozygous (CelloPub=CLPUB00668; PubMed=19370762) Miscellaneous: Cell line no longer available Population: Caucasian and Chinese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151359012 CVCL_B3X8 WG1539 finite cell line human CVCL_B3X8 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg111Ter (c.331C>T); ClinVar=VCV000001424; Zygosity=Homozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359013 CVCL_B3WW WG3130 finite cell line human CVCL_B3WW From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg161Gln (c.482G>A); ClinVar=VCV000001425; Zygosity=Heterozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359014 CVCL_B3WZ WG3514 finite cell line human CVCL_B3WZ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668; PubMed=19370762); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Tyr222Ter (c.666C>A); ClinVar=VCV000496436; Zygosity=Heterozygous (CelloPub=CLPUB00668; PubMed=19370762) Miscellaneous: Cell line no longer available Population: Caucasian; Italian and Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151359015 CVCL_B3WY WG3281 finite cell line human CVCL_B3WY From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg111Ter (c.331C>T); ClinVar=VCV000001424; Zygosity=Heterozygous (CelloPub=CLPUB00668); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Tyr222Ter (c.666C>A); ClinVar=VCV000496436; Zygosity=Heterozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359016 CVCL_B3WL WG1496 finite cell line human CVCL_B3WL From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg111Ter (c.331C>T); ClinVar=VCV000001424; Zygosity=Heterozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359017 CVCL_B3WK WG1481 finite cell line human CVCL_B3WK From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg132Ter (c.394C>T); ClinVar=VCV000001423; Zygosity=Heterozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359018 CVCL_B3WN WG2113 finite cell line human CVCL_B3WN From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala191Glu (c.572C>A); ClinVar=VCV000203854; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Native North American; Cherokee; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359019 CVCL_B3WM WG1958 finite cell line human CVCL_B3WM From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu685Arg (c.2054T>G); ClinVar=VCV000218995; Zygosity=Homozygous (PubMed=9554742; PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; Italian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151359020 CVCL_B3WP WG2328 finite cell line human CVCL_B3WP From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Tyr316Cys (c.947A>G); ClinVar=VCV000640484; Zygosity=Heterozygous (PubMed=16281286); Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly426Ter (c.1276G>T); Zygosity=Heterozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Caucasian; French Canadian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359021 CVCL_B3X1 WG3686 finite cell line human CVCL_B3X1 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg161Gln (c.482G>A); ClinVar=VCV000001425; Zygosity=Heterozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359022 CVCL_B3X0 WG3665 finite cell line human CVCL_B3X0 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg111Ter (c.331C>T); ClinVar=VCV000001424; Zygosity=Heterozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359023 CVCL_B3WR WG2339 finite cell line human CVCL_B3WR From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg161Gln (c.482G>A); ClinVar=VCV000001425; Zygosity=Heterozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359024 CVCL_B3X3 WG2452 finite cell line human CVCL_B3X3 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Homozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359025 CVCL_B3WQ WG1692 finite cell line human CVCL_B3WQ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg132Ter (c.394C>T); ClinVar=VCV000001423; Zygosity=Heterozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359026 CVCL_B3X2 WG2279 finite cell line human CVCL_B3X2 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Homozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359027 CVCL_B3WD WG0370 finite cell line human CVCL_B3WD From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359028 CVCL_B3WC WG0098 finite cell line human CVCL_B3WC From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359029 CVCL_B3WF WG1127 finite cell line human CVCL_B3WF From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg111Ter (c.331C>T); ClinVar=VCV000001424; Zygosity=Heterozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359030 CVCL_B3WE WG1070 finite cell line human CVCL_B3WE From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg132Ter (c.394C>T); ClinVar=VCV000001423; Zygosity=Heterozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359031 CVCL_B3WH WG1135 finite cell line human CVCL_B3WH From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg111Ter (c.331C>T); ClinVar=VCV000001424; Zygosity=Heterozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359032 CVCL_B3WG WG1129 finite cell line human CVCL_B3WG From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg132Ter (c.394C>T); ClinVar=VCV000001423; Zygosity=Heterozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359033 CVCL_B3WJ WG1404 finite cell line human CVCL_B3WJ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg132Ter (c.394C>T); ClinVar=VCV000001423; Zygosity=Heterozygous (CelloPub=CLPUB00668); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Tyr222Ter (c.666C>A); ClinVar=VCV000496436; Zygosity=Heterozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359034 CVCL_B3WI WG1391 finite cell line human CVCL_B3WI From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg161Gln (c.482G>A); ClinVar=VCV000001425; Zygosity=Heterozygous (CelloPub=CLPUB00668) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359035 CVCL_B3YB 1-9 hybridoma house mouse CVCL_B3YB CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P20062; Human TCN2. 151359036 CVCL_B3YA 1-6 hybridoma house mouse CVCL_B3YA CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P20062; Human TCN2. 151359037 CVCL_B3YD 2-2 [Mouse hybridoma against human TCN2] hybridoma house mouse CVCL_B3YD CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P20062; Human TCN2. 151359038 CVCL_B3YC 2-13 hybridoma house mouse CVCL_B3YC CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P20062; Human TCN2. 151359039 CVCL_B3XU MBU-7 cancer cell line human CVCL_B3XU CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (PubMed=34707142); Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (PubMed=34707142); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=34707142); Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (PubMed=34707142) Miscellaneous: Doubling time from personal communication of Diesch, Jeannine Population: Caucasian; Karyotypic information: Compared to the parent cell line, has a complete trisomy of chromosome 7 (PubMed=34707142); Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. Male Doubling time: 30-40 hours (Direct_author_submission); ~48 hours (DSMZ=ACC-909) 151359040 CVCL_B3Y6 WG2860 finite cell line human CVCL_B3Y6 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Pro95Arg (c.284C>G); ClinVar=VCV000218985; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Iraqi; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359041 CVCL_B3XT PNL2 hybridoma house mouse CVCL_B3XT CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human melanocyte-associated antigen. 151359042 CVCL_B3Y5 WG3199 finite cell line human CVCL_B3Y5 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Mexican; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359043 CVCL_B3Y8 1-12 hybridoma house mouse CVCL_B3Y8 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P20062; Human TCN2. 151359044 CVCL_B3XW WG3129 finite cell line human CVCL_B3XW From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg153Ter (c.457C>T); ClinVar=VCV000550539; Zygosity=Heterozygous (PubMed=19370762); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg161Ter (c.481C>T); ClinVar=VCV000095703; Zygosity=Heterozygous (PubMed=19370762); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Glu170Cysfs*36 (c.507_519del13); ClinVar=VCV000556017; Zygosity=Heterozygous (PubMed=19370762) Miscellaneous: Cell line no longer available Population: Asian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151359045 CVCL_B3XV MBU-8 cancer cell line human CVCL_B3XV CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (PubMed=34707142); Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (PubMed=34707142); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=34707142); Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (PubMed=34707142) Miscellaneous: Doubling time from personal communication of Diesch, Jeannine Population: Caucasian; Karyotypic information: Compared to the parent cell line, has a complete trisomy of chromosome 18 as well as a partial trisomy of 7 and tetrasomy of 8p (PubMed=34707142); Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. Male Doubling time: 30-40 hours (Direct_author_submission); ~30 hours (DSMZ=ACC-910) 151359046 CVCL_B3Y7 WG3733 finite cell line human CVCL_B3Y7 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:16692; CD320; Simple; p.Glu88del (c.256GAG[2]) (c.262_264delGAG); ClinVar=VCV000203643; Zygosity=Homozygous (PubMed=20524213) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359047 CVCL_B3XY WG3561 finite cell line human CVCL_B3XY From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Trp157Ter (c.471G>A); ClinVar=VCV000553844; Zygosity=Heterozygous (PubMed=19370762); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Tyr222Ter (c.666C>A); ClinVar=VCV000496436; Zygosity=Heterozygous (PubMed=19370762) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151359048 CVCL_B3Y9 1-2 hybridoma house mouse CVCL_B3Y9 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P20062; Human TCN2. 151359049 CVCL_B3XX WG3458 finite cell line human CVCL_B3XX From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg161Gln (c.482G>A); ClinVar=VCV000001425; Zygosity=Homozygous (PubMed=19370762) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151359050 CVCL_B3XZ WG3580 finite cell line human CVCL_B3XZ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Trp203Ter (c.609G>A); ClinVar=VCV000030800; Zygosity=Heterozygous (PubMed=19370762); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Lys220del (c.658_660delAAG); ClinVar=VCV000095707; Zygosity=Heterozygous (PubMed=19370762) Miscellaneous: Cell line no longer available Population: Chinese; Taiwan; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151359051 CVCL_B3XM UCSFi001-A-58 induced pluripotent stem cell human CVCL_B3XM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6188; JAG1 Population: Japanese; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151359052 CVCL_B3XL WG3539 finite cell line human CVCL_B3XL From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Gly147Asp (c.440G>A); ClinVar=VCV000203829; Zygosity=Heterozygous (PubMed=19370762); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Trp157Valfs*24 (c.468_469delCT); Zygosity=Heterozygous (PubMed=19370762) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151359053 CVCL_B3Y0 WG2471 finite cell line human CVCL_B3Y0 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (PubMed=19370762); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg153Ter (c.457C>T); ClinVar=VCV000550539; Zygosity=Heterozygous (PubMed=19370762) Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151359054 CVCL_B3XN UCSFi001-A-59 induced pluripotent stem cell human CVCL_B3XN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6188; JAG1 Population: Japanese; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151359055 CVCL_B3XQ MM04H hybridoma house mouse CVCL_B3XQ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P28676; Human GCA. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2021182 151359056 CVCL_B3Y2 WG2322 finite cell line human CVCL_B3Y2 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Mexican; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359057 CVCL_B3XP ATCi001-A induced pluripotent stem cell human CVCL_B3XP From: Aegicare (Shenzhen) Technology Co; Shenzhen; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:30224; SLC52A2; Simple; p.Ala26Profs*42 (c.75_76insCCTGG); Zygosity=Heterozygous (PubMed=34736036); Sequence variation: Mutation; HGNC; HGNC:30224; SLC52A2; Simple; p.Cys278delinsCysLeuLeuGly (c.832_833insGCCTGCTGG); Zygosity=Heterozygous (PubMed=34736036) Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151359058 CVCL_B3Y1 WG1713 finite cell line human CVCL_B3Y1 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359059 CVCL_B3XS HMB-50 hybridoma house mouse CVCL_B3XS CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P40967; Human PMEL. 151359060 CVCL_B3Y4 WG3174 finite cell line human CVCL_B3Y4 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Mexican; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359061 CVCL_B3XR HMB-45 hybridoma house mouse CVCL_B3XR CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P40967; Human PMEL. 151359062 CVCL_B3Y3 WG2564 finite cell line human CVCL_B3Y3 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Homozygous (PubMed=16281286) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359063 CVCL_B3XE WG2711 finite cell line human CVCL_B3XE From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (PubMed=19370762); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Tyr130Cys (c.389A>G); ClinVar=VCV000297484; Zygosity=Heterozygous (PubMed=19370762) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359064 CVCL_B3XD WG1705 finite cell line human CVCL_B3XD From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (PubMed=19370762); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Leu116Pro (c.347T>C); ClinVar=VCV000001422; Zygosity=Heterozygous (PubMed=19370762) Miscellaneous: Cell line no longer available Population: Caucasian; German; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151359065 CVCL_B3XG WG3423 finite cell line human CVCL_B3XG From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (PubMed=19370762); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Trp203Ter (c.608G>A); ClinVar=VCV000095706; Zygosity=Heterozygous (PubMed=19370762) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151359066 CVCL_B3XF WG3676 finite cell line human CVCL_B3XF From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (PubMed=19370762); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg189Valfs*21 (c.565delC); ClinVar=VCV000553238; Zygosity=Heterozygous (PubMed=19370762) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151359067 CVCL_B3XI WG2636 finite cell line human CVCL_B3XI From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Asn110Aspfs*13 (c.328_331delAACC); ClinVar=VCV000203835; Zygosity=Homozygous (PubMed=19370762) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151359068 CVCL_B3XH WG3496 finite cell line human CVCL_B3XH From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (PubMed=19370762); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Tyr205Ter (c.615C>G); ClinVar=VCV000281007; Zygosity=Heterozygous (PubMed=19370762) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151359069 CVCL_B3XK WG3308 finite cell line human CVCL_B3XK From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Asn110Aspfs*13 (c.328_331delAACC); ClinVar=VCV000203835; Zygosity=Homozygous (PubMed=19370762) Miscellaneous: Cell line no longer available Population: Mexican; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151359070 CVCL_B3XJ WG2863 finite cell line human CVCL_B3XJ From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Asn110Aspfs*13 (c.328_331delAACC); ClinVar=VCV000203835; Zygosity=Homozygous (PubMed=19370762); Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Ile190Tyrfs*13 (c.567dupT); ClinVar=VCV000556708; Zygosity=Heterozygous (PubMed=19370762) Miscellaneous: Cell line no longer available Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151359071 CVCL_B5IL ICSSUi001-A induced pluripotent stem cell human CVCL_B5IL From: Institute for Cardiovascular Science of Soochow University; Suzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys2633Gly (c.7897T>G); ClinVar=VCV000984411; Zygosity=Heterozygous (PubMed=35231796) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359072 CVCL_B5IK FDCHi007-A induced pluripotent stem cell human CVCL_B5IK From: Children's Hospital of Fudan University; Shanghai; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2972; DNM1; Simple; p.Ala182Asp (c.545C>A); ClinVar=VCV000421787; Zygosity=Heterozygous; Note=De novo mutation (PubMed=35184021) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151359073 CVCL_B5IN ICSSUi003-A induced pluripotent stem cell human CVCL_B5IN From: Institute for Cardiovascular Science of Soochow University; Suzhou; China. CL:0000010 151359074 CVCL_B5IM ICSSUi002-A induced pluripotent stem cell human CVCL_B5IM From: Institute for Cardiovascular Science of Soochow University; Suzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Ala222Val (c.665C>T) (C677T); ClinVar=VCV000003520; Zygosity=Homozygous (PubMed=35305471) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359075 CVCL_B5IP ITXi001-A induced pluripotent stem cell human CVCL_B5IP From: Institut du Thorax; Nantes; France CL:0000010 Population: Caucasian; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Omics: Transcriptomics; Microarray Female 151359076 CVCL_B5J1 MDCi233-B induced pluripotent stem cell human CVCL_B5J1 From: Max Delbruck Center Berlin Buch; Berlin; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Leu369Pro (c.1106T>C); Zygosity=Heterozygous (hPSCreg=MDCi233-B); Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Arg1768_Pro1776del (c.5302_5328delCGGCCCCTCTACAGCCCCCTGCAGCCA); Zygosity=Heterozygous (hPSCreg=MDCi233-B) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359077 CVCL_B5J0 MDCi233-A induced pluripotent stem cell human CVCL_B5J0 From: Max Delbruck Center Berlin Buch; Berlin; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Leu369Pro (c.1106T>C); Zygosity=Heterozygous (hPSCreg=MDCi233-A); Sequence variation: Mutation; HGNC; HGNC:3097; DYSF; Simple; p.Arg1768_Pro1776del (c.5302_5328delCGGCCCCTCTACAGCCCCCTGCAGCCA); Zygosity=Heterozygous (hPSCreg=MDCi233-A) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359078 CVCL_B5IR MILi001-C induced pluripotent stem cell human CVCL_B5IR From: Miltenyi Biotec B.V.; Gladbach; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 151359079 CVCL_B5IQ MILi001-B induced pluripotent stem cell human CVCL_B5IQ From: Miltenyi Biotec B.V.; Gladbach; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 151359080 CVCL_B5ID ISMMSi039-A induced pluripotent stem cell human CVCL_B5ID From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Asian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151359081 CVCL_B5IC ISMMSi038-A induced pluripotent stem cell human CVCL_B5IC From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151359082 CVCL_B5IF ISMMSi041-A induced pluripotent stem cell human CVCL_B5IF From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Asian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151359083 CVCL_B5IE ISMMSi040-A induced pluripotent stem cell human CVCL_B5IE From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Asian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151359084 CVCL_B5IH ISMMSi043-A induced pluripotent stem cell human CVCL_B5IH From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: African American; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151359085 CVCL_B5IG ISMMSi042-A induced pluripotent stem cell human CVCL_B5IG From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Jewish; Ashkenazi; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151359086 CVCL_B5IJ FDCHi006-A induced pluripotent stem cell human CVCL_B5IJ From: Children's Hospital of Fudan University; Shanghai; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151359087 CVCL_B5II UKWNLi005-A induced pluripotent stem cell human CVCL_B5II From: Department of Neurology, University of Wurzburg; Wurzburg; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Ser126Gly (c.376A>G); ClinVar=VCV000163547; Zygosity=Hemizygous (PubMed=35325818) Derived from site: In situ; Leg, skin, dermis; UBERON=UBERON_0001511+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151359088 CVCL_B5HZ ISMMSi027-A induced pluripotent stem cell human CVCL_B5HZ From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Hispanic; Karyotypic information: 46,XY,t(1;17)(p34;q23) (PubMed=34739849); Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151359089 CVCL_B5IB ISMMSi037-A induced pluripotent stem cell human CVCL_B5IB From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151359090 CVCL_B5IA ISMMSi036-A induced pluripotent stem cell human CVCL_B5IA From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Asian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151359091 CVCL_B5HS ISMMSi020-A induced pluripotent stem cell human CVCL_B5HS From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151359092 CVCL_B5I4 ISMMSi030-A induced pluripotent stem cell human CVCL_B5I4 From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151359093 CVCL_B5HR ISMMSi019-A induced pluripotent stem cell human CVCL_B5HR From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151359094 CVCL_B5I3 ISMMSi029-A induced pluripotent stem cell human CVCL_B5I3 From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Asian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151359095 CVCL_B5HU ISMMSi022-A induced pluripotent stem cell human CVCL_B5HU From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Hispanic; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151359096 CVCL_B5I6 ISMMSi032-A induced pluripotent stem cell human CVCL_B5I6 From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: African American; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151359097 CVCL_B5HT ISMMSi021-A induced pluripotent stem cell human CVCL_B5HT From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Hispanic; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151359098 CVCL_B5I5 ISMMSi031-A induced pluripotent stem cell human CVCL_B5I5 From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151359099 CVCL_B5HW ISMMSi024-A induced pluripotent stem cell human CVCL_B5HW From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Hispanic; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151359100 CVCL_B5I8 ISMMSi034-A induced pluripotent stem cell human CVCL_B5I8 From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151359101 CVCL_B5HV ISMMSi023-A induced pluripotent stem cell human CVCL_B5HV From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Asian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151359102 CVCL_B5I7 ISMMSi033-A induced pluripotent stem cell human CVCL_B5I7 From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Hispanic; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151359103 CVCL_B5HY ISMMSi026-A induced pluripotent stem cell human CVCL_B5HY From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151359104 CVCL_B5HX ISMMSi025-A induced pluripotent stem cell human CVCL_B5HX From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Jewish; Ashkenazi; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151359105 CVCL_B5I9 ISMMSi035-A induced pluripotent stem cell human CVCL_B5I9 From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Asian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151359106 CVCL_B5IT MPIi008-A induced pluripotent stem cell human CVCL_B5IT From: Max Planck Institute for Molecular Biomedicine; Munster; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg394Leu (c.181G>T); Zygosity=Heterozygous (PubMed=35667217) Population: Caucasian; Derived from site: In situ; Testis, tunica albuginea; UBERON=UBERON_0006610; Cell type: Fibroblast; CL=CL_0000057. Male 151359107 CVCL_B5IS MNZTASi001-A induced pluripotent stem cell human CVCL_B5IS From: Menzies Institute for Medical Research, University of Tasmania; Hobart; Australia CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Genomics; Whole genome sequencing Male 151359108 CVCL_B5IV NCKDi005-A induced pluripotent stem cell human CVCL_B5IV From: National Center of Kidney Diseases; Nanjing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2206; COL4A4; Simple; p.Gly408Cysfs*29 (c.1221_1222insTGCAGGCATGATAGGACCCCCT); Zygosity=Homozygous (PubMed=34942480) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359109 CVCL_B5IU NCKDi004-A induced pluripotent stem cell human CVCL_B5IU From: National Center of Kidney Diseases; Nanjing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2204; COL4A3; Simple; p.Met1Ile (c.3G>A); Zygosity=Homozygous (PubMed=34626894) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359110 CVCL_B5IX NDi004-B induced pluripotent stem cell human CVCL_B5IX From: University of Notre Dame; Notre Dame; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg4198Ter (c.12592C>T); ClinVar=VCV000158722; Zygosity=Heterozygous (PubMed=35550987) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151359111 CVCL_B5IW NDi004-A induced pluripotent stem cell human CVCL_B5IW From: University of Notre Dame; Notre Dame; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg4198Ter (c.12592C>T); ClinVar=VCV000158722; Zygosity=Heterozygous (PubMed=35550987) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151359112 CVCL_B5IZ NYSCFi003-A induced pluripotent stem cell human CVCL_B5IZ From: New York Stem Cell Foundation; New York; USA CL:0000010 Population: Caucasian; Cell type: Fibroblast; CL=CL_0000057. Male 151359113 CVCL_B5IY NDi004-C induced pluripotent stem cell human CVCL_B5IY From: University of Notre Dame; Notre Dame; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg4198Ter (c.12592C>T); ClinVar=VCV000158722; Zygosity=Heterozygous (PubMed=35550987) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151359114 CVCL_B5GJ TRNDi010-D-1 induced pluripotent stem cell human CVCL_B5GJ From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Heterozygous (PubMed=34619643); Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple_corrected; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34619643) Population: Caucasian; English; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151359115 CVCL_B5GI TRNDi010-D induced pluripotent stem cell human CVCL_B5GI From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Homozygous (PubMed=34619643) Population: Caucasian; English; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151359116 CVCL_B5GL ZJUi008-A induced pluripotent stem cell human CVCL_B5GL From: Zhejiang University School of Medicine; Hangzhou; China. CL:0000010 151359117 CVCL_B5GK TRNDi010-D-2 induced pluripotent stem cell human CVCL_B5GK From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple_corrected; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34619643) Population: Caucasian; English; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151359118 CVCL_B5GN ZOCi004-A induced pluripotent stem cell human CVCL_B5GN From: Zhongshan Ophthalmic Center, Sun Yat-sen University; Guangzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10457; RS1; Simple; p.Glu72Lys (c.214G>A); ClinVar=VCV000009888; Zygosity=Hemizygous (PubMed=36270067) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359119 CVCL_B5GM ZOCi002-A induced pluripotent stem cell human CVCL_B5GM From: Zhongshan Ophthalmic Center, Sun Yat-sen University; Guangzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10457; RS1; Simple; p.Arg102Gln (c.305G>A); ClinVar=VCV000009896; Zygosity=Hemizygous (PubMed=34798543) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359120 CVCL_B5H1 FDZSi003-A induced pluripotent stem cell human CVCL_B5H1 From: Zhongshan Hospital of Fudan University; Shanghai; China. CL:0000010 151359121 CVCL_B5GP ZSYYDNi001-A induced pluripotent stem cell human CVCL_B5GP From: Department of Neurology, Sun Yat-sen University First Affiliated Hospital; Guangzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex51del; Zygosity=Hemizygous (PubMed=34619646) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359122 CVCL_B5H0 ULBi004-A induced pluripotent stem cell human CVCL_B5H0 From: Universite Libre de Bruxelles; Brussels; Belgium CL:0000010 Population: Caucasian; Derived from site: In situ; Muscle; UBERON=UBERON_0001630; Cell type: Fibroblast of muscle; CL=CL_1001609. Female 151359123 CVCL_B5GB OCUT-4 cancer cell line human CVCL_B5GB CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24357248) Population: Japanese; Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046. Male 151359124 CVCL_B5GA OCUT-3 cancer cell line human CVCL_B5GA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24357248) Population: Japanese; Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. Male 151359125 CVCL_B5GD OCUT-6 cancer cell line human CVCL_B5GD CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=24357248) Population: Japanese; Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046. Female 151359126 CVCL_B5GC OCUT-5 cancer cell line human CVCL_B5GC CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24357248) Population: Japanese; Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. Female 151359127 CVCL_B5GF OCUT-1F cancer cell line human CVCL_B5GF CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=24357248); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Homozygous; Note=In promoter (from parent cell line) Population: Japanese; Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046. Female 151359128 CVCL_B5GE OCUT-1C cancer cell line human CVCL_B5GE CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=24357248); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Homozygous; Note=In promoter (from parent cell line) Population: Japanese; Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046. Female 151359129 CVCL_B5GH JTUi009-A induced pluripotent stem cell human CVCL_B5GH From: Sixth People's Hospital, Shanghai Jiao Tong University; Shanghai; China. CL:0000010 151359130 CVCL_B5GG JTUi008-A induced pluripotent stem cell human CVCL_B5GG From: Sixth People's Hospital, Shanghai Jiao Tong University; Shanghai; China. CL:0000010 Male 151359131 CVCL_B5FY SYSUSCi002-A induced pluripotent stem cell human CVCL_B5FY From: Center for Stem Cell Biology and Tissue Engineering, Sun Yat-sen University; Guangzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1663; CD36; Simple; p.Thr111Serfs*22 (c.332_333delCA) (c.329_330delAC); ClinVar=VCV000225309; Zygosity=Homozygous (PubMed=35305469) Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151359132 CVCL_B5G9 SYSUe011-A-1 embryonic stem cell human CVCL_B5G9 From: Sun Yat-sen University; Guangzhou; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2892; DKK2; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 151359133 CVCL_B5FX SYSUSCi001-A induced pluripotent stem cell human CVCL_B5FX From: Center for Stem Cell Biology and Tissue Engineering, Sun Yat-sen University; Guangzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1040; BFSP1; Simple; p.Glu269Lys (c.805G>A); Zygosity=Heterozygous (PubMed=34995847); Sequence variation: Mutation; HGNC; HGNC:10012; RHO; Simple; p.Leu125Pro (c.374T>C); Zygosity=Heterozygous (PubMed=34995847) Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359134 CVCL_B5FZ UCLi020-A induced pluripotent stem cell human CVCL_B5FZ From: University College London; London; United Kingdom. CL:0000010 151359135 CVCL_B5G2 REF-WT1A transformed cell line Norway rat CVCL_B5G2 CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: Fischer 344; RS=RS_0000215. Unspecified 151359136 CVCL_B5FQ SCVIi024-A induced pluripotent stem cell human CVCL_B5FQ From: Stanford Cardiovascular Institute; Palo Alto; USA. CL:0000010 151359137 CVCL_B5G1 REF-WT10A transformed cell line Norway rat CVCL_B5G1 CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: Fischer 344; RS=RS_0000215. Unspecified 151359138 CVCL_B5FP SCVIi025-A induced pluripotent stem cell human CVCL_B5FP From: Stanford Cardiovascular Institute; Palo Alto; USA. CL:0000010 151359139 CVCL_B5G4 REF-WT6A transformed cell line Norway rat CVCL_B5G4 CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: Fischer 344; RS=RS_0000215. Omics: Proteomics; 2DE Unspecified 151359140 CVCL_B5FS SCVIi021-A induced pluripotent stem cell human CVCL_B5FS From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg377Cys (c.1129C>T); ClinVar=VCV000048031; Zygosity=Heterozygous (PubMed=34954454) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359141 CVCL_B5G3 REF-WT2A transformed cell line Norway rat CVCL_B5G3 CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: Fischer 344; RS=RS_0000215. Omics: Proteomics; 2DE Unspecified 151359142 CVCL_B5FR SCVIi020-A induced pluripotent stem cell human CVCL_B5FR From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg377Cys (c.1129C>T); ClinVar=VCV000048031; Zygosity=Heterozygous (PubMed=34954454) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359143 CVCL_B5FU SCVIi023-A induced pluripotent stem cell human CVCL_B5FU From: Stanford Cardiovascular Institute; Palo Alto; USA. CL:0000010 151359144 CVCL_B5G6 ZZUi033-A induced pluripotent stem cell human CVCL_B5G6 From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6470; L1CAM; Simple; p.Ile219Val (c.655A>G); Zygosity=Hemizygous (PubMed=35042084) Population: Chinese; Han; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151359145 CVCL_B5G5 LCPHi002-A induced pluripotent stem cell human CVCL_B5G5 From: The Institute for Tissue Engineering and Regenerative Medicine, Liaocheng People's Hospital; Liaocheng; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1908; VPS13A; Simple; p.Ala1428fs (c.4282_4289delinsA); Zygosity=Heterozygous (PubMed=35093716) Population: Chinese; Han; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151359146 CVCL_B5FT SCVIi022-A induced pluripotent stem cell human CVCL_B5FT From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg377Cys (c.1129C>T); ClinVar=VCV000048031; Zygosity=Heterozygous (PubMed=34954454) Population: Native American; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151359147 CVCL_B5FW SUSMi003-A induced pluripotent stem cell human CVCL_B5FW From: Stanford University School of Medicine; Stanford; USA CL:0000010 Cell type: Fibroblast; CL=CL_0000057. Omics: Variations; SNP array analysis Male 151359148 CVCL_B5G8 ZZUi035-A induced pluripotent stem cell human CVCL_B5G8 From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China. CL:0000010 151359149 CVCL_B5FV SHCHNDi001-A induced pluripotent stem cell human CVCL_B5FV From: Shanghai Children's Hospital; Shanghai; China. CL:0000010 151359150 CVCL_B5G7 ZZUi034-A induced pluripotent stem cell human CVCL_B5G7 From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China CL:0000010 Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151359151 CVCL_B5HK ISMMSi015-A induced pluripotent stem cell human CVCL_B5HK From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Jewish; Ashkenazi; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151359152 CVCL_B5HJ ISMMSi014-A induced pluripotent stem cell human CVCL_B5HJ From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151359153 CVCL_B5HM ISMMSi017-A induced pluripotent stem cell human CVCL_B5HM From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: African American; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; RNAseq Male 151359154 CVCL_B5HL ISMMSi016-A induced pluripotent stem cell human CVCL_B5HL From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151359155 CVCL_B5I0 ISMMSi028-A induced pluripotent stem cell human CVCL_B5I0 From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Hispanic; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151359156 CVCL_B5HN ISMMSi017-B induced pluripotent stem cell human CVCL_B5HN From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: African American; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151359157 CVCL_B5HQ ISMMSi018-A induced pluripotent stem cell human CVCL_B5HQ From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151359158 CVCL_B5I2 ISMMSi028-C induced pluripotent stem cell human CVCL_B5I2 From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Hispanic; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151359159 CVCL_B5HP ISMMSi017-C induced pluripotent stem cell human CVCL_B5HP From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: African American; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing Male 151359160 CVCL_B5I1 ISMMSi028-B induced pluripotent stem cell human CVCL_B5I1 From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Hispanic; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151359161 CVCL_B5HC ISMMSi007-A induced pluripotent stem cell human CVCL_B5HC From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Asian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151359162 CVCL_B5HB ISMMSi006-A induced pluripotent stem cell human CVCL_B5HB From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Asian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151359165 CVCL_B5HG ISMMSi011-A induced pluripotent stem cell human CVCL_B5HG From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151359166 CVCL_B5HF ISMMSi010-A induced pluripotent stem cell human CVCL_B5HF From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151359167 CVCL_B5HI ISMMSi013-A induced pluripotent stem cell human CVCL_B5HI From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151359168 CVCL_B5HH ISMMSi012-A induced pluripotent stem cell human CVCL_B5HH From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151359169 CVCL_B5GZ UOWi010-A induced pluripotent stem cell human CVCL_B5GZ From: University of Wollongong; Wollongong; Australia. CL:0000010 151359170 CVCL_B5GY HGS4 cancer cell line house mouse CVCL_B5GY CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:109337; Brca2 (Note=1 of 2 alleles); Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten; Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53 Derived from site: In situ; Mesentery; UBERON=UBERON_0002095; Breed/subspecies: B6.129P2-Trp53tm1Brn/J.Ptenfl/f x C57BL/6J-Brca2fl/fl. Female Characteristics: When injected i.p produces omental tumors and metastases to splenoportal fat, lesser omentum, and mesentery, with extensive disease established by 12-20 weeks (PubMed=31940494). 151359171 CVCL_B5HA ISMMSi005-A induced pluripotent stem cell human CVCL_B5HA From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151359172 CVCL_B5H3 HAD9 embryonic stem cell human CVCL_B5H3 From: Hadassah Hebrew University Medical Center; Jerusalem; Israel CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Unspecified 151359173 CVCL_B5GR XWHNi001-A induced pluripotent stem cell human CVCL_B5GR From: Department of Neurology, Xuan Wu Hospital; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Val717Ile (c.2149G>A); ClinVar=VCV000018088; Zygosity=Homozygous (PubMed=35149456) Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151359174 CVCL_B5H2 GENYOi007-A induced pluripotent stem cell human CVCL_B5H2 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3057; DTNA; Simple; p.Val742Phe (c.2224G>T); ClinVar=VCV000140609; Zygosity=Heterozygous; Note=Produces a novel splice site which skips exon 21 and leads to a shorter alternative transcript (from autologous cell line FMD patient III.4 LCL); Sequence variation: Mutation; HGNC; HGNC:25911; FAM136A; Simple; p.Gln76Ter (c.226C>T) (p.Gln183Ter, c.547C>T); ClinVar=VCV000140608; Zygosity=Heterozygous (from autologous cell line FMD patient III.4 LCL) Population: Caucasian; Spanish; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151359175 CVCL_B5GQ ZJYYPHi001-A induced pluripotent stem cell human CVCL_B5GQ From: Yuyao People's Hospital of Zhejiang Province; Yuyao city; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Arg513Cys (c.1537C>T); ClinVar=VCV000201456; Zygosity=Heterozygous (PubMed=34678660) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151359176 CVCL_B5H5 FAMRCi011-B induced pluripotent stem cell human CVCL_B5H5 From: Federal Almazov North-West Medical Research Centre; St Petersburg; Russia. CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3756; FLNC; Simple; p.Arg1267Gln (c.3800G>A); ClinVar=VCV000539409; Zygosity=Heterozygous (hPSCreg=FAMRCi011-B) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Variations; Array-based CGH Male 151359177 CVCL_B5GT XACHi017-A induced pluripotent stem cell human CVCL_B5GT From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China. CL:0000010 151359178 CVCL_B5H4 FAMRCi011-A induced pluripotent stem cell human CVCL_B5H4 From: Federal Almazov North-West Medical Research Centre; St Petersburg; Russia. CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3756; FLNC; Simple; p.Arg1267Gln (c.3800G>A); ClinVar=VCV000539409; Zygosity=Heterozygous (PubMed=39315490) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Variations; Array-based CGH Male 151359179 CVCL_B5GS XACHi016-A induced pluripotent stem cell human CVCL_B5GS From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China. CL:0000010 151359180 CVCL_B5H7 FAMRCi009-A induced pluripotent stem cell human CVCL_B5H7 From: Federal Almazov North-West Medical Research Centre; St Petersburg; Russia. CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3756; FLNC; Simple; p.Val2297Met (c.6889G>A) (p.Val2264Met, c.6790G>A); ClinVar=VCV000641618; Zygosity=Heterozygous (PubMed=34971933) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359181 CVCL_B5GV HGS1 cancer cell line house mouse CVCL_B5GV CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:109337; Brca2; Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten; Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53 Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358; Breed/subspecies: B6.129P2-Trp53tm1Brn/J.Ptenfl/f x C57BL/6J-Brca2fl/fl. Female Characteristics: When injected i.p produces omental tumors and metastases to splenoportal fat, lesser omentum, and mesentery, with extensive disease established by 12-20 weeks (PubMed=31940494). 151359182 CVCL_B5H6 FAMRCi010-A induced pluripotent stem cell human CVCL_B5H6 From: Federal Almazov North-West Medical Research Centre; St Petersburg; Russia. CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3756; FLNC; Simple; p.Gly2011Arg (c.6031G>A); ClinVar=VCV000472122; Zygosity=Heterozygous (PubMed=34971931) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151359183 CVCL_B5GU UUIGPi015-A induced pluripotent stem cell human CVCL_B5GU From: Department of Immunology, Genetics and Pathology, Uppsala University; Uppsala; Sweden CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:10585; SCN1A; Zygosity=Heterozygous; Note=2,9 Mbp deletion that spans 10 genes (PubMed=35203050) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151359184 CVCL_B5GX HGS3 cancer cell line house mouse CVCL_B5GX CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:109337; Brca2 (Note=1 of 2 alleles); Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten; Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53 Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889; Breed/subspecies: B6.129P2-Trp53tm1Brn/J.Ptenfl/f x C57BL/6J-Brca2fl/fl. Female Characteristics: When injected i.p produces omental tumors and metastases to splenoportal fat, lesser omentum, and mesentery, with extensive disease established by 12-20 weeks (PubMed=31940494). 151359185 CVCL_B5H9 ISMMSi004-A induced pluripotent stem cell human CVCL_B5H9 From: Icahn School of Medicine at Mount Sinai; New York; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151359186 CVCL_B5H8 HCPRi001-A induced pluripotent stem cell human CVCL_B5H8 From: Hastings Center for Pulmonary Research, University of Southern California; Los Angeles; USA. CL:0000010 151359187 CVCL_B5GW HGS2 cancer cell line house mouse CVCL_B5GW CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:109337; Brca2; Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten; Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53 Derived from site: In situ; Fallopian tube; UBERON=UBERON_0003889; Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Breed/subspecies: B6.129P2-Trp53tm1Brn/J.Ptenfl/f x C57BL/6J-Brca2fl/fl. Female Characteristics: When injected i.p produces omental tumors and metastases to splenoportal fat, lesser omentum, and mesentery, with extensive disease established by 12-20 weeks (PubMed=31940494). 151359188 CVCL_B5EH BER-DSRCT cancer cell line human CVCL_B5EH CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:12796; WT1; Name(s)=EWSR1-WT1, EWS-WT1; Note=EWSR1 Ex7-WT1 Ex8 fusion (PubMed=34841430); Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Pro2139Leufs*9; Zygosity=Unspecified (PubMed=34841430). Karyotypic information: Near triploid karyotype (PubMed=34841430) Female Doubling time: 30.5 hours (PubMed=34841430) 151359189 CVCL_B5EG SK-DSRCT2 cancer cell line human CVCL_B5EG CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:12796; WT1; Name(s)=EWSR1-WT1, EWS-WT1; Note=EWSR1 Ex9-WT1 Ex8 fusion (PubMed=34841430); Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Asn564Asp (c.1690A>G); ClinVar=VCV000376261; Zygosity=Unspecified (PubMed=34841430); Sequence variation: Mutation; HGNC; HGNC:9949; RECQL4; Simple; p.Val767Glyfs*76; Zygosity=Unspecified (PubMed=34841430) Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916. Male Doubling time: 59.5 hours (PubMed=34841430) 151359190 CVCL_B5EJ ICGi036-A induced pluripotent stem cell human CVCL_B5EJ From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Ser177Leu (c.530C>T); ClinVar=VCV000003686; Zygosity=Heterozygous (PubMed=34999421); Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Cys352Arg (c.1054T>C); ClinVar=VCV000251618; Zygosity=Heterozygous (PubMed=34999421) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151359191 CVCL_B5EI BOD-DSRCT cancer cell line human CVCL_B5EI CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:12796; WT1; Name(s)=EWSR1-WT1, EWS-WT1; Note=EWSR1 Ex7-WT1 Ex8 fusion (PubMed=34841430); Sequence variation: Mutation; HGNC; HGNC:14010; MGA; Simple; p.Leu2167Glyfs*27; Zygosity=Unspecified (PubMed=34841430). Doubling time: 46.6 hours (PubMed=34841430) 151359192 CVCL_B5EL ICGi034-B induced pluripotent stem cell human CVCL_B5EL From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line ICGi034-A) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151359193 CVCL_B5EK ICGi037-A induced pluripotent stem cell human CVCL_B5EK From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Trp443Arg (c.1327T>C); ClinVar=VCV000998052; Zygosity=Heterozygous (PubMed=35152179); Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Glu714_Ile796del (c.2141-966_2390-330del); Zygosity=Heterozygous (hPSCreg=ICGi037-A) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151359194 CVCL_B5EN ICGi038-A induced pluripotent stem cell human CVCL_B5EN From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; c.940+3_940+6delGAGT; ClinVar=VCV000869390; Zygosity=Heterozygous (PubMed=35152178); Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Arg416Trp (c.1246C>T); ClinVar=VCV000183110; Zygosity=Heterozygous (PubMed=35152178) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151359195 CVCL_B5EM ICGi034-C induced pluripotent stem cell human CVCL_B5EM From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from autologous cell line ICGi034-A) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151359196 CVCL_B5EB CAM-45B spontaneously immortalized cell line CVCL_B5EB CL:0000010 Derived from site: In situ; Muscle; UBERON=UBERON_0001630. Unspecified Group: Fish cell line 151359197 CVCL_B5EA CAM-45A spontaneously immortalized cell line CVCL_B5EA CL:0000010 Derived from site: In situ; Muscle; UBERON=UBERON_0001630. Unspecified Group: Fish cell line 151359198 CVCL_B5ED ALL spontaneously immortalized cell line CVCL_B5ED CL:0000010 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Unspecified Virology: Susceptible to infection by viral hemorrhagic septicemia virus (VHSV), red-spotted grouper nervous necrosis virus (RGNNV) and largemouth bass virus (LMBV) (PubMed=34624134) Group: Fish cell line 151359199 CVCL_B5EC CAM-47A spontaneously immortalized cell line CVCL_B5EC CL:0000010 Derived from site: In situ; Muscle; UBERON=UBERON_0001630. Unspecified Group: Fish cell line 151359200 CVCL_B5EF SK-DSRCT1 cancer cell line human CVCL_B5EF CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:12796; WT1; Name(s)=EWSR1-WT1, EWS-WT1; Note=EWSR1 Ex10-WT1 Ex8 fusion (PubMed=34841430); Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Met1634Ter (c.4899delC); Zygosity=Unspecified (PubMed=34841430) Derived from site: In situ; Ascites; UBERON=UBERON_0007795. Female Doubling time: 23.4 hours (PubMed=34841430) 151359201 CVCL_B5EE Sf-RVNLec1 spontaneously immortalized cell line CVCL_B5EE CL:0000010 Knockout cell: Method=CRISPR/Cas9; UniProtKB; H2BEB9; Mgat1 Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female Characteristics: Produces immature, relatively minimally processed N-glycan precursors that can be removed from the polypeptide backbone using endo-beta-N-acetylglucosaminidase H (PubMed=34838817); Virology: Devoid of SfRV rhabdovirus (from parent cell line Sf-RVN) Group: Insect cell line; Group: Recombinant protein production insect cell line 151359202 CVCL_B5E8 CAM-44A spontaneously immortalized cell line CVCL_B5E8 CL:0000010 Derived from site: In situ; Muscle; UBERON=UBERON_0001630. Unspecified Group: Fish cell line 151359203 CVCL_B5DW HEK293 THAP7HBM #34 transformed cell line human CVCL_B5DW CL:0000010 Sequence variation: Mutation; HGNC; HGNC:23190; THAP7; Simple_edited; p.His230Ala (c.688_689CA>GC); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202); Sequence variation: Mutation; HGNC; HGNC:23190; THAP7; Simple_edited; p.Tyr232Ala (c.694_695TA>GC); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359204 CVCL_B5E7 CMAfin1 spontaneously immortalized cell line CVCL_B5E7 CL:0000010 Derived from site: In situ; Dorsal fin; UBERON=UBERON_0003097. Unspecified Doubling time: 11.8 +- 1.61 days (Note=In 5% FBS), 6.3 +- 0.27 days (Note=In 10% FBS), 4.6 +- 0.19 days (Note=In 15% FBS), 4.1 +- 0.15 days (Note=In 20% FBS) (PubMed=36349563) Group: Fish cell line 151359205 CVCL_B5DV HEK293 THAP7DCC #40 transformed cell line human CVCL_B5DV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:23190; THAP7; Simple_edited; p.Lys241Ter (c.721A>T); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202); Sequence variation: Mutation; HGNC; HGNC:23190; THAP7; Simple_edited; p.Arg242Ter (c.727_728CG>TA); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359206 CVCL_B5DY HEK293 THAP7null #29 transformed cell line human CVCL_B5DY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23190; THAP7 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359207 CVCL_B5E9 CAM-44B spontaneously immortalized cell line CVCL_B5E9 CL:0000010 Derived from site: In situ; Muscle; UBERON=UBERON_0001630. Unspecified Group: Fish cell line 151359208 CVCL_B5DX HEK293 THAP7HBM #76 transformed cell line human CVCL_B5DX CL:0000010 Sequence variation: Mutation; HGNC; HGNC:23190; THAP7; Simple_edited; p.His230Ala (c.688_689CA>GC); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202); Sequence variation: Mutation; HGNC; HGNC:23190; THAP7; Simple_edited; p.Tyr232Ala (c.694_695TA>GC); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359209 CVCL_B5DZ HEK293 THAP7null #32 transformed cell line human CVCL_B5DZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23190; THAP7 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359210 CVCL_B5E0 HEK293 THAP7null #44 transformed cell line human CVCL_B5E0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23190; THAP7 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359211 CVCL_B5DN CBW spontaneously immortalized cell line CVCL_B5DN CL:0000010 Derived from site: In situ; Snout; UBERON=UBERON_0006333. Unspecified Doubling time: 28.05 +- 3.73 hours (PubMed=11330178) Group: Fish cell line 151359212 CVCL_B5DQ ART [Acipenser] spontaneously immortalized cell line CVCL_B5DQ CL:0000010 Derived from site: In situ; Testis; UBERON=UBERON_0000473. Male Doubling time: 55.57 hours (PubMed=30484862) Group: Fish cell line 151359213 CVCL_B5E2 HEK293 THAP11HBM #1 transformed cell line human CVCL_B5E2 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:23194; THAP11; Simple_edited; p.His244Ala (c.730_731AT>GC); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=31905202); Sequence variation: Mutation; HGNC; HGNC:23194; THAP11; Simple_edited; p.Tyr246Ala (c.736_737TA>GC); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=31905202) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359214 CVCL_B5DP CrEK spontaneously immortalized cell line CVCL_B5DP CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Unspecified Characteristics: Optimal growth at 28 Celsius (PubMed=34843633); Virology: Highly susceptible to infection by Chinese rice-field eels rhabdovirus (CrERV) (PubMed=34843633) Group: Fish cell line 151359215 CVCL_B5E1 HEK293 THAP11F80L #8 transformed cell line human CVCL_B5E1 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:23194; THAP11; Simple_edited; p.Phe80Leu (c.240C>G); ClinVar=VCV000393304; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Omics: Transcriptomics; RNAseq Female 151359216 CVCL_B5DS HEK293 THAP7DCC #7 transformed cell line human CVCL_B5DS CL:0000010 Sequence variation: Mutation; HGNC; HGNC:23190; THAP7; Simple_edited; p.Lys241Ter (c.721A>T); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202); Sequence variation: Mutation; HGNC; HGNC:23190; THAP7; Simple_edited; p.Arg242Ter (c.727_728CG>TA); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359217 CVCL_B5E4 RTdi-MI spontaneously immortalized cell line CVCL_B5E4 CL:0000010 Derived from site: In situ; Intestine; Note=Distal part; UBERON=UBERON_0000160. Unspecified Doubling time: 4.4 days (PubMed=34205481) Group: Fish cell line 151359218 CVCL_B5E3 GCK-84 spontaneously immortalized cell line CVCL_B5E3 CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Unspecified Group: Fish cell line 151359219 CVCL_B5DR SCC-DF spontaneously immortalized cell line CVCL_B5DR CL:0000010 Derived from site: In situ; Dorsal fin; UBERON=UBERON_0003097. Unspecified Group: Fish cell line; Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201525 151359220 CVCL_B5DU HEK293 THAP7DCC #36 transformed cell line human CVCL_B5DU CL:0000010 Sequence variation: Mutation; HGNC; HGNC:23190; THAP7; Simple_edited; p.Lys241Ter (c.721A>T); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202); Sequence variation: Mutation; HGNC; HGNC:23190; THAP7; Simple_edited; p.Arg242Ter (c.727_728CG>TA); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359221 CVCL_B5E6 pORF121-mAb-3D9 hybridoma house mouse CVCL_B5E6 CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; K7PC12; Cyprinid herpesvirus 2 ORF121. 151359222 CVCL_B5DT HEK293 THAP7DCC #27 transformed cell line human CVCL_B5DT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:23190; THAP7; Simple_edited; p.Lys241Ter (c.721A>T); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202); Sequence variation: Mutation; HGNC; HGNC:23190; THAP7; Simple_edited; p.Arg242Ter (c.727_728CG>TA); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31905202) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359223 CVCL_B5E5 RTpi-MI spontaneously immortalized cell line CVCL_B5E5 CL:0000010 Derived from site: In situ; Intestine; Note=Proximal part; UBERON=UBERON_0000160. Unspecified Doubling time: 3.0 days (PubMed=34205481) Group: Fish cell line 151359224 CVCL_B5FI BabESC-4 embryonic stem cell CVCL_B5FI CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K27me3; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Genomics; ChIP-seq; H3K9me3; Omics: Genomics; DNA methylation analysis; Methylated DNA immunoprecipitation sequencing (MeDIP-Seq); Omics: Transcriptomics; RNAseq Female Group: Non-human primate cell line 151359225 CVCL_B5FH biPS-160-5 induced pluripotent stem cell CVCL_B5FH CL:0000010 Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416; Cell type: Fibroblast of skin; CL=CL_0002620. Male Group: Non-human primate cell line 151359226 CVCL_B5FK M14939#3 induced pluripotent stem cell CVCL_B5FK CL:0000010 Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K27me3; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Genomics; ChIP-seq; H3K9me3; Omics: Genomics; DNA methylation analysis; Methylated DNA immunoprecipitation sequencing (MeDIP-Seq); Omics: Transcriptomics; RNAseq. Group: Non-human primate cell line 151359227 CVCL_B5FJ BabESC-15 embryonic stem cell CVCL_B5FJ CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K27me3; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Genomics; ChIP-seq; H3K9me3; Omics: Genomics; DNA methylation analysis; Methylated DNA immunoprecipitation sequencing (MeDIP-Seq); Omics: Transcriptomics; RNAseq Female Group: Non-human primate cell line 151359228 CVCL_B5FM SCVIi026-A induced pluripotent stem cell human CVCL_B5FM From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Glu1784Lys (c.5350G>A) (p.Glu1783Lys, c.5347G>A); ClinVar=VCV000009377; Zygosity=Heterozygous (PubMed=34856468) Population: East Asian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151359229 CVCL_B5FL SNUARTe003 embryonic stem cell pig CVCL_B5FL CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322; Breed/subspecies: Landrace x Yorkshire x Duroc; VBO=VBO_0001161+VBO_0001212+VBO_0001127. Female Characteristics: Contains a porcine OCT4 upstream region-derived dual reporter system composed of two constructs, pOCT4-deltaPE-eGFP and pOCT4-deltaDE-DsRed2 (PubMed=34861590) 151359230 CVCL_B5G0 UCLi019-A induced pluripotent stem cell human CVCL_B5G0 From: University College London; London; United Kingdom. CL:0000010 151359231 CVCL_B5FN SCVIi027-A induced pluripotent stem cell human CVCL_B5FN From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Pro701Leu (c.2102C>T); ClinVar=VCV000067713; Zygosity=Heterozygous (PubMed=34856468) Population: Latino or Hispanic; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359232 CVCL_B5FA MRIi003-A-2 induced pluripotent stem cell human CVCL_B5FA From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7568; MYH10 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359233 CVCL_B5FC MRIi003-A-3 induced pluripotent stem cell human CVCL_B5FC From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17993; TRPM4 (Note=1 of 2 alleles) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359234 CVCL_B5FB MRIi002-A induced pluripotent stem cell human CVCL_B5FB From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany. CL:0000010 Female 151359235 CVCL_B5FE biPS-90-11 induced pluripotent stem cell CVCL_B5FE CL:0000010 Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416; Cell type: Fibroblast of skin; CL=CL_0002620. Male Group: Non-human primate cell line 151359236 CVCL_B5FD MRIi003-A-4 induced pluripotent stem cell human CVCL_B5FD From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17993; TRPM4 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359237 CVCL_B5FG biPS-160-2 induced pluripotent stem cell CVCL_B5FG CL:0000010 Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K27me3; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Genomics; ChIP-seq; H3K9me3; Omics: Genomics; DNA methylation analysis; Methylated DNA immunoprecipitation sequencing (MeDIP-Seq); Omics: Transcriptomics; RNAseq Male Group: Non-human primate cell line 151359238 CVCL_B5FF biPS-90-25 induced pluripotent stem cell CVCL_B5FF CL:0000010 Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416; Cell type: Fibroblast of skin; CL=CL_0002620. Male Group: Non-human primate cell line 151359239 CVCL_B5EX ICANi002-A induced pluripotent stem cell human CVCL_B5EX From: INSERM U1166-Institute of Cardiometabolism and Nutrition; Paris; France CL:0000010 Population: Caucasian; Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151359240 CVCL_B5F9 MRIi003-A-1 induced pluripotent stem cell human CVCL_B5F9 From: Klinikum rechts der Isar, Technical University of Munich; Munich; Germany CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7568; MYH10 (Note=1 of 2 alleles) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359241 CVCL_B5EW HEBHMUi011-A induced pluripotent stem cell human CVCL_B5EW From: Hebei Medical University; Shijiazhuang; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=35305470) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359242 CVCL_B5F8 UNCi009-A induced pluripotent stem cell human CVCL_B5F8 From: University of North Carolina at Chapel Hill; Chapel Hill; USA. CL:0000010 151359243 CVCL_B5EZ ICANi002-A-2 induced pluripotent stem cell human CVCL_B5EZ From: INSERM U1166-Institute of Cardiometabolism and Nutrition; Paris; France CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10593; SCN5A (Note=1 of 2 alleles) Population: Caucasian; Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151359244 CVCL_B5EY ICANi002-A-1 induced pluripotent stem cell human CVCL_B5EY From: INSERM U1166-Institute of Cardiometabolism and Nutrition; Paris; France CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3756; FLNC; Unexplicit_edited; Ex42del; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34883448) Population: Caucasian; Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151359245 CVCL_B5EP DHMi004-A induced pluripotent stem cell human CVCL_B5EP From: German Heart Center Munich; Munich; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11604; TBX5; Simple; p.Pro85Thr (c.253C>A) (c.920C>A); ClinVar=VCV000626359; Zygosity=Heterozygous; Note=De novo mutation (PubMed=34894535) Population: Caucasian; Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013; Cell type: Fibroblast; CL=CL_0000057. Male 151359246 CVCL_B5F1 UMi035-A induced pluripotent stem cell human CVCL_B5F1 From: Miller School of Medicine, University of Miami; Miami; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Homozygous (from parent cell line) Population: Jewish; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151359247 CVCL_B5F0 UMi034-A induced pluripotent stem cell human CVCL_B5F0 From: Miller School of Medicine, University of Miami; Miami; USA. CL:0000010 151359248 CVCL_B5F3 UNCi004-A induced pluripotent stem cell human CVCL_B5F3 From: University of North Carolina at Chapel Hill; Chapel Hill; USA. CL:0000010 151359249 CVCL_B5ER ZZUPMCi001-A induced pluripotent stem cell human CVCL_B5ER From: Precision Medicine Center, Zhengzhou University; Zhengzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:8617; PAX3; Simple; p.Gly42Alafs*68 (c.123delG); ClinVar=VCV001048553; Zygosity=Heterozygous (PubMed=34864221) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Genomics; Whole exome sequencing Female 151359250 CVCL_B5EQ DHMi005-A induced pluripotent stem cell human CVCL_B5EQ From: German Heart Center Munich; Munich; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013; Cell type: Fibroblast; CL=CL_0000057. Male 151359251 CVCL_B5F2 UNCi003-A induced pluripotent stem cell human CVCL_B5F2 From: University of North Carolina at Chapel Hill; Chapel Hill; USA. CL:0000010 151359252 CVCL_B5F5 UNCi006-A induced pluripotent stem cell human CVCL_B5F5 From: University of North Carolina at Chapel Hill; Chapel Hill; USA. CL:0000010 151359253 CVCL_B5ET ZZUNEUi024-A induced pluripotent stem cell human CVCL_B5ET From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China. CL:0000010 151359254 CVCL_B5F4 UNCi005-A induced pluripotent stem cell human CVCL_B5F4 From: University of North Carolina at Chapel Hill; Chapel Hill; USA. CL:0000010 151359255 CVCL_B5ES ZZUNEUi023-A induced pluripotent stem cell human CVCL_B5ES From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple; p.Arg26562Ter (c.79684C>T); ClinVar=VCV000222861; Zygosity=Heterozygous (PubMed=34883393) Population: Kazakh; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359256 CVCL_B5EV HEBHMUi010-A induced pluripotent stem cell human CVCL_B5EV From: Hebei Medical University; Shijiazhuang; China CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151359257 CVCL_B5F7 UNCi008-A induced pluripotent stem cell human CVCL_B5F7 From: University of North Carolina at Chapel Hill; Chapel Hill; USA. CL:0000010 151359258 CVCL_B5F6 UNCi007-A induced pluripotent stem cell human CVCL_B5F6 From: University of North Carolina at Chapel Hill; Chapel Hill; USA. CL:0000010 151359259 CVCL_B5EU ZZUNEUi025-A induced pluripotent stem cell human CVCL_B5EU From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; c.772+1G>A; ClinVar=VCV000042790; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=35257994) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359260 CVCL_B5CF UCB1146 transformed cell line human CVCL_B5CF CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359261 CVCL_B5CE UCB1143 transformed cell line human CVCL_B5CE CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359262 CVCL_B5CH UCB1198 transformed cell line human CVCL_B5CH CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359263 CVCL_B5CG UCB1197 transformed cell line human CVCL_B5CG CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359264 CVCL_B5CJ UCB1204 transformed cell line human CVCL_B5CJ CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359265 CVCL_B5CI UCB1201 transformed cell line human CVCL_B5CI CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359266 CVCL_B5CL UCB1211 transformed cell line human CVCL_B5CL CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359267 CVCL_B5CK UCB1205 transformed cell line human CVCL_B5CK CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359268 CVCL_B5CB UCB1138 transformed cell line human CVCL_B5CB CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359269 CVCL_B5CA UCB1135 transformed cell line human CVCL_B5CA CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359270 CVCL_B5CD UCB1140 transformed cell line human CVCL_B5CD CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359271 CVCL_B5CC UCB1137 transformed cell line human CVCL_B5CC CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359272 CVCL_B5BU UCB1085 transformed cell line human CVCL_B5BU CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359273 CVCL_B5C6 UCB1124 transformed cell line human CVCL_B5C6 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359274 CVCL_B5BT UCB1084 transformed cell line human CVCL_B5BT CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359275 CVCL_B5C5 UCB1123 transformed cell line human CVCL_B5C5 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359276 CVCL_B5BW UCB1090 transformed cell line human CVCL_B5BW CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359277 CVCL_B5C8 UCB1126 transformed cell line human CVCL_B5C8 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359278 CVCL_B5BV UCB1088 transformed cell line human CVCL_B5BV CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359279 CVCL_B5C7 UCB1125 transformed cell line human CVCL_B5C7 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359280 CVCL_B5BY UCB1104 transformed cell line human CVCL_B5BY CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359281 CVCL_B5BX UCB1093 transformed cell line human CVCL_B5BX CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359282 CVCL_B5C9 UCB1128 transformed cell line human CVCL_B5C9 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359283 CVCL_B5BZ BFSF_OMKS_1 induced pluripotent stem cell CVCL_B5BZ CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; RNAseq Unspecified 151359284 CVCL_B5BM UCB1057 transformed cell line human CVCL_B5BM CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359285 CVCL_B5BL UCB1055 transformed cell line human CVCL_B5BL CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359286 CVCL_B5C0 BFSF_OMKS_2 induced pluripotent stem cell CVCL_B5C0 CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; RNAseq Unspecified 151359287 CVCL_B5BN UCB1030 transformed cell line human CVCL_B5BN CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359288 CVCL_B5BQ UCB1063 transformed cell line human CVCL_B5BQ CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359289 CVCL_B5C2 UCB1109 transformed cell line human CVCL_B5C2 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359290 CVCL_B5BP UCB1059 transformed cell line human CVCL_B5BP CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359291 CVCL_B5C1 UCB1106 transformed cell line human CVCL_B5C1 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359292 CVCL_B5BS UCB1078 transformed cell line human CVCL_B5BS CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359293 CVCL_B5C4 UCB1116 transformed cell line human CVCL_B5C4 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359294 CVCL_B5BR UCB1068 transformed cell line human CVCL_B5BR CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359295 CVCL_B5C3 UCB1115 transformed cell line human CVCL_B5C3 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359296 CVCL_B5DG HeLa1.3 hTR-50-3xMS2 TCAB1-/- cancer cell line human CVCL_B5DG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25522; WRAP53 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Characteristics: Using CRISPR/Cas9 3 MS2 stem loops sequences flanked by homologous telomerase RNA (hTR) sequences were knocked in; Characteristics: Has exceptionally long telomeres of approximately 23 kb in length (from parent cell line HeLa1.3 hTR-50-3xMS2) 151359297 CVCL_B5DF HeLa1.3 hTR-50-3xMS2 cancer cell line human CVCL_B5DF CL:0000010 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Characteristics: Using CRISPR/Cas9 3 MS2 stem loops sequences flanked by homologous telomerase RNA (hTR) sequences were knocked in; Characteristics: Has exceptionally long telomeres of approximately 23 kb in length (from parent cell line HeLa1.3) 151359298 CVCL_B5DI CAB-80 spontaneously immortalized cell line CVCL_B5DI CL:0000010 Karyotypic information: Heteroploid karyotype (CelloPub=CLPUB00673); Derived from site: In situ; Blastula; UBERON=UBERON_0000307. Unspecified Characteristics: Optimal growth at 22 to 28 Celsius (CelloPub=CLPUB00673) Doubling time: 21-45 hours (CelloPub=CLPUB00673) Group: Fish cell line 151359299 CVCL_B5DH HeLa1.3 hTR-50-3xMS2 TERT-/- cancer cell line human CVCL_B5DH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11730; TERT Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Characteristics: Using CRISPR/Cas9 3 MS2 stem loops sequences flanked by homologous telomerase RNA (hTR) sequences were knocked in; Characteristics: Has exceptionally long telomeres of approximately 23 kb in length (from parent cell line HeLa1.3 hTR-50-3xMS2) 151359300 CVCL_B5DK AHZC 88 spontaneously immortalized cell line CVCL_B5DK CL:0000010 Transformant: NCIt; C17231; Ultraviolet radiation; Derived from site: In situ; Snout; UBERON=UBERON_0006333. Unspecified Characteristics: Capable of growing from 4 to 38 Celsius, the optimal temperature is 27 Celsius CelloPub=CLPUB00674) Group: Fish cell line 151359301 CVCL_B5DJ WM-9001 spontaneously immortalized cell line CVCL_B5DJ CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358. Unspecified Characteristics: Optimal growth at 30 to 37 Celsius (PubMed=11229590) Doubling time: 19.71 +- 3.74 hours (PubMed=11229590; PubMed=11330178) Group: Fish cell line 151359302 CVCL_B5DM CBT spontaneously immortalized cell line CVCL_B5DM CL:0000010 Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164. Unspecified Doubling time: 33.40 +- 20.08 hours (PubMed=11330178) Group: Fish cell line 151359303 CVCL_B5DL CBS [Piaractus] spontaneously immortalized cell line CVCL_B5DL CL:0000010 Derived from site: In situ; Anal fin; UBERON=UBERON_4000163. Unspecified Doubling time: 27.00 +- 12.60 hours (PubMed=11330178) Group: Fish cell line 151359304 CVCL_B5DA HeLa1.3 cancer cell line human CVCL_B5DA CL:0000010 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Characteristics: Has exceptionally long telomeres of approximately 23 kb in length (PubMed=19864690) Caution: The second allele values for D13S317 is incorrectly indicated as 13.5 in PubMed=19864690 (personal communication of de Lange, Titia through Korch, Christopher T.) 151359305 CVCL_B5DC U2OS RAD52 KO clone #1 cancer cell line human CVCL_B5DC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9824; RAD52; Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 151359306 CVCL_B5DB HeLa204 cancer cell line human CVCL_B5DB CL:0000010 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Characteristics: Has telomeres of approximately 3-7 kb in length (from parent cell line HeLaII) 151359307 CVCL_B5DE U2OS RAD52 KO clone #3 cancer cell line human CVCL_B5DE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9824; RAD52; Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 151359308 CVCL_B5DD U2OS RAD52 KO clone #2 cancer cell line human CVCL_B5DD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9824; RAD52; Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 151359309 CVCL_B5CV 2C6 [Mouse hybridoma against imazethapyr] hybridoma house mouse CVCL_B5CV CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI_82022; Imazethapyr (Pursuit) (Note=Also recognizes imazamox and imazapic). 151359310 CVCL_B5D7 SU-LL-1 cancer cell line human CVCL_B5D7 CL:0000010 Karyotypic information: 49,XY,+ 1,-2,-5,+der(5)t(2;5)(p23;q35),+7,-21,+der(21q),+3mar (PubMed=8432193). Male 151359311 CVCL_B5CU 1D2 [Mouse hybridoma against imazethapyr] hybridoma house mouse CVCL_B5CU CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_82022; Imazethapyr (Pursuit) (Note=Also recognizes imazamox, imazamethabenz-methyl and imazapic). 151359312 CVCL_B5D6 Melu cancer cell line human CVCL_B5D6 CL:0000010 Karyotypic information: 56,X,-X,+2,+5,+7,+ 8,12q+,+15,+19,+20,+22,+3mar (PubMed=8432193); Derived from site: Metastatic; Not specified. Female 151359313 CVCL_B5CX 3A5 [Mouse hybridoma against imazamethabenz-methyl] hybridoma house mouse CVCL_B5CX CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_2894; Imazamethabenz-methyl (Assert) (Note=Also recognizes imazethapyr, imazamethabenz-methyl and imazapic). 151359314 CVCL_B5D9 HeLa1.2.11 cancer cell line human CVCL_B5D9 CL:0000010 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Characteristics: Has exceptionally long telomeres of approximately 23 kb in length (PubMed=10338214) Caution: The second allele values for D13S317 is incorrectly indicated as 13.5 in PubMed=19864690 (personal communication of de Lange, Titia through Korch, Christopher T.) 151359315 CVCL_B5CW 3A2 [Mouse hybridoma against imazaquin] hybridoma house mouse CVCL_B5CW CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_5869; Imazaquin (Scepter) (Note=Also recognizes imazethapyr, imazamox and imazapic). 151359316 CVCL_B5D8 SU-LyB.1 undefined cell line type human CVCL_B5D8 CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Unspecified 151359317 CVCL_B5CZ SPL.IVB5 hybridoma house mouse CVCL_B5CZ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Human low density lipoprotein (LDL). 151359318 CVCL_B5CY SPL.IID2 hybridoma house mouse CVCL_B5CY CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Human low density lipoprotein (LDL). 151359319 CVCL_B5CN UCB1215 transformed cell line human CVCL_B5CN CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359320 CVCL_B5CM UCB1214 transformed cell line human CVCL_B5CM CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359321 CVCL_B5D1 SPL.IID2A2 hybridoma house mouse CVCL_B5D1 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Human low density lipoprotein (LDL). 151359322 CVCL_B5CP UCB1217 transformed cell line human CVCL_B5CP CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359323 CVCL_B5D0 SPL.IVA5 hybridoma house mouse CVCL_B5D0 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Human low density lipoprotein (LDL). 151359324 CVCL_B5CR 14D7 hybridoma house mouse CVCL_B5CR CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_6964; Molinate. 151359325 CVCL_B5D3 SPL.IVA5A1 hybridoma house mouse CVCL_B5D3 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Human low density lipoprotein (LDL). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8535 151359326 CVCL_B5D2 SPL.IVB5A1 hybridoma house mouse CVCL_B5D2 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Human low density lipoprotein (LDL). 151359327 CVCL_B5CQ U2OS VGF KO cancer cell line human CVCL_B5CQ From: Durcan, Thomas M.; Montreal Neurological Institute, McGill University; Montreal; Canada CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12684; VGF; Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Miscellaneous: Cell line information from personal communication of Laflamme, Carl Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 151359328 CVCL_B5CT 1A5 [Mouse hybridoma against imazethapyr] hybridoma house mouse CVCL_B5CT CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI_82022; Imazethapyr (Pursuit) (Note=Also recognizes imazaquin, imazamethabenz-methyl and imazapic). 151359329 CVCL_B5D5 HeLaII cancer cell line human CVCL_B5D5 CL:0000010 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Characteristics: Has telomeres of approximately 3-7 kb in length (PubMed=8432193) Caution: The second allele values for D13S317 is incorrectly indicated as 13.5 in PubMed=19864690 (personal communication of de Lange, Titia through Korch, Christopher T.) 151359330 CVCL_B5CS 16C11 hybridoma house mouse CVCL_B5CS CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_6964; Molinate. 151359331 CVCL_B5D4 HeLaI cancer cell line human CVCL_B5D4 CL:0000010 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Characteristics: Has telomeres of approximately 25-30 kb in length (PubMed=8432193) 151359332 CVCL_B4WZ UCT0119 finite cell line human CVCL_B4WZ CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359333 CVCL_B4XB UCT0130 finite cell line human CVCL_B4XB CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359334 CVCL_B4XA UCB0130 transformed cell line human CVCL_B4XA CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359335 CVCL_B4WS UCB0115 transformed cell line human CVCL_B4WS CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359336 CVCL_B4X4 UCB0124 transformed cell line human CVCL_B4X4 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359337 CVCL_B4WR UCT0114 finite cell line human CVCL_B4WR CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359338 CVCL_B4X3 UCT0122 finite cell line human CVCL_B4X3 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359339 CVCL_B4WU UCB0116 transformed cell line human CVCL_B4WU CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359340 CVCL_B4X6 UCB0125 transformed cell line human CVCL_B4X6 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359341 CVCL_B4WT UCT0115 finite cell line human CVCL_B4WT CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359342 CVCL_B4X5 UCT0124 finite cell line human CVCL_B4X5 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359343 CVCL_B4WW UCB0117 transformed cell line human CVCL_B4WW CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359344 CVCL_B4X8 UCB0128 transformed cell line human CVCL_B4X8 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359345 CVCL_B4WV UCT0116 finite cell line human CVCL_B4WV CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359346 CVCL_B4X7 UCT0125 finite cell line human CVCL_B4X7 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359347 CVCL_B4WY UCB0119 transformed cell line human CVCL_B4WY CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359348 CVCL_B4WX UCT0117 finite cell line human CVCL_B4WX CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359349 CVCL_B4X9 UCT0128 finite cell line human CVCL_B4X9 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359350 CVCL_B4WK UCT0110 finite cell line human CVCL_B4WK CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359351 CVCL_B4WJ UCB0110 transformed cell line human CVCL_B4WJ CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359352 CVCL_B4WM UCT0112 finite cell line human CVCL_B4WM CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359353 CVCL_B4WL UCB0112 transformed cell line human CVCL_B4WL CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359354 CVCL_B4X0 UCB0121 transformed cell line human CVCL_B4X0 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359355 CVCL_B4WN UCB0113 transformed cell line human CVCL_B4WN CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359356 CVCL_B4WQ UCB0114 transformed cell line human CVCL_B4WQ CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359357 CVCL_B4X2 UCB0122 transformed cell line human CVCL_B4X2 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359358 CVCL_B4WP UCT0113 finite cell line human CVCL_B4WP CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359359 CVCL_B4X1 UCT0121 finite cell line human CVCL_B4X1 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359360 CVCL_B4WC UCT0100 finite cell line human CVCL_B4WC CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359361 CVCL_B4WB UCB0100 transformed cell line human CVCL_B4WB CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359362 CVCL_B4WE UCT0103 finite cell line human CVCL_B4WE CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359363 CVCL_B4WD UCB0103 transformed cell line human CVCL_B4WD CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359364 CVCL_B4WG UCT0105 finite cell line human CVCL_B4WG CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359365 CVCL_B4WF UCB0105 transformed cell line human CVCL_B4WF CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359366 CVCL_B4WI UCT0108 finite cell line human CVCL_B4WI CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359367 CVCL_B4WH UCB0108 transformed cell line human CVCL_B4WH CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359368 CVCL_B4YA UCB0187 transformed cell line human CVCL_B4YA CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359369 CVCL_B4YC UCB0188 transformed cell line human CVCL_B4YC CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359370 CVCL_B4YB UCT0187 finite cell line human CVCL_B4YB CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359371 CVCL_B4XT UCB0167 transformed cell line human CVCL_B4XT CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359372 CVCL_B4Y5 UCT0180 finite cell line human CVCL_B4Y5 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359373 CVCL_B4Y4 UCB0180 transformed cell line human CVCL_B4Y4 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359374 CVCL_B4XS UCT0164 finite cell line human CVCL_B4XS CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359375 CVCL_B4XV UCB0169 transformed cell line human CVCL_B4XV CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359376 CVCL_B4Y7 UCT0181 finite cell line human CVCL_B4Y7 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359377 CVCL_B4Y6 UCB0181 transformed cell line human CVCL_B4Y6 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359378 CVCL_B4XU UCT0167 finite cell line human CVCL_B4XU CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359379 CVCL_B4XX UCB0172 transformed cell line human CVCL_B4XX CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359380 CVCL_B4Y9 UCT0183 finite cell line human CVCL_B4Y9 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359381 CVCL_B4Y8 UCB0183 transformed cell line human CVCL_B4Y8 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359382 CVCL_B4XW UCT0169 finite cell line human CVCL_B4XW CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359383 CVCL_B4XZ UCT0172 finite cell line human CVCL_B4XZ CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359384 CVCL_B4XY UCF0172 finite cell line human CVCL_B4XY CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359385 CVCL_B4XL UCT0144 finite cell line human CVCL_B4XL CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359386 CVCL_B4XK UCB0144 transformed cell line human CVCL_B4XK CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359387 CVCL_B4XN UCT0152 finite cell line human CVCL_B4XN CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359388 CVCL_B4XM UCB0152 transformed cell line human CVCL_B4XM CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359389 CVCL_B4XP UCB0155 transformed cell line human CVCL_B4XP CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359390 CVCL_B4Y1 UCT0176 finite cell line human CVCL_B4Y1 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359391 CVCL_B4Y0 UCB0176 transformed cell line human CVCL_B4Y0 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359392 CVCL_B4XR UCB0164 transformed cell line human CVCL_B4XR CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359393 CVCL_B4Y3 UCT0177 finite cell line human CVCL_B4Y3 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359394 CVCL_B4Y2 UCB0177 transformed cell line human CVCL_B4Y2 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359395 CVCL_B4XQ UCT0155 finite cell line human CVCL_B4XQ CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359396 CVCL_B4XD UCT0137 finite cell line human CVCL_B4XD CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359397 CVCL_B4XC UCB0137 transformed cell line human CVCL_B4XC CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359398 CVCL_B4XF UCT0139 finite cell line human CVCL_B4XF CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359399 CVCL_B4XE UCB0139 transformed cell line human CVCL_B4XE CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359400 CVCL_B4XH UCT0140 finite cell line human CVCL_B4XH CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359401 CVCL_B4XG UCB0140 transformed cell line human CVCL_B4XG CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359402 CVCL_B4XJ UCT0141 finite cell line human CVCL_B4XJ CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359403 CVCL_B4XI UCB0141 transformed cell line human CVCL_B4XI CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359404 CVCL_B4UY UCT0041 finite cell line human CVCL_B4UY CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359405 CVCL_B4UX UCF0041 finite cell line human CVCL_B4UX CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359406 CVCL_B4V9 UCF0050 finite cell line human CVCL_B4V9 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359407 CVCL_B4UZ UCB0042 transformed cell line human CVCL_B4UZ CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359408 CVCL_B4UQ UCB0024 transformed cell line human CVCL_B4UQ CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359409 CVCL_B4V2 UCF0045 finite cell line human CVCL_B4V2 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359410 CVCL_B4V1 UCB0045 transformed cell line human CVCL_B4V1 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359411 CVCL_B4UP UCT0019 finite cell line human CVCL_B4UP CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359412 CVCL_B4US UCB0025 transformed cell line human CVCL_B4US CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359413 CVCL_B4V4 UCB0048 transformed cell line human CVCL_B4V4 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359414 CVCL_B4UR UCT0024 finite cell line human CVCL_B4UR CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359415 CVCL_B4V3 UCT0045 finite cell line human CVCL_B4V3 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359416 CVCL_B4UU UCB0034 transformed cell line human CVCL_B4UU CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359417 CVCL_B4V6 UCB0049 transformed cell line human CVCL_B4V6 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359418 CVCL_B4UT UCT0025 finite cell line human CVCL_B4UT CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359419 CVCL_B4V5 UCT0048 finite cell line human CVCL_B4V5 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359420 CVCL_B4UW UCB0041 transformed cell line human CVCL_B4UW CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359421 CVCL_B4V8 UCB0050 transformed cell line human CVCL_B4V8 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359422 CVCL_B4UV UCT0034 finite cell line human CVCL_B4UV CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359423 CVCL_B4V7 UCT0049 finite cell line human CVCL_B4V7 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359424 CVCL_B4UI PD42 transformed cell line human CVCL_B4UI HLA typing: A*02:06,24:02; B*07:02,55:01; C*01:02,07:02 (PubMed=28832583); HLA typing: DPA1*01:03,02:02; DPB1*04:01,05:01; DQA1*01:01,01:02; DQB1*05:01,06:02; DRB1*01:02,15:01; DRB5*01:01 (PubMed=31611696) From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Proteomics; HLA class I peptidome; Omics: Proteomics; HLA class II peptidome Unspecified 151359425 CVCL_B4UH GD149 transformed cell line human CVCL_B4UH HLA typing: A*01:01,24:02; B*38:01,44:03; C*06:02,12:03 (PubMed=28832583); HLA typing: DPA1*01:03,02:01; DPB1*03:01(124:01),04:01(350:01); DQA1*01:10,02:01; DQB1*02:02,06:03; DRB1*07:01,13:01; DRB3*01:01; DRB4*01:01 (PubMed=31611696) From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Proteomics; HLA class I peptidome; Omics: Proteomics; HLA class II peptidome Unspecified 151359426 CVCL_B4UK MD155 transformed cell line human CVCL_B4UK HLA typing: A*02:01,24:02; B*15:01,18:01; C*03:03,07:01 (PubMed=28832583); HLA typing: DQB1*03,06; DRB1*11,13 (Direct_author_submission) From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland CL:0000010 Miscellaneous: HLA class II typing from personal communication of Bassani-Sternberg, Michal Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Proteomics; HLA class I peptidome Unspecified 151359427 CVCL_B4UJ RA957 transformed cell line human CVCL_B4UJ HLA typing: A*02:20,68:01; B*35:03,39:01; C*04:01,07:02 (PubMed=28832583); HLA typing: DPA1*01:03; DPB1*04:01(105:01),04:02(126:01); DQA1*03:03,04:01; DQB1*03:01,04:02; DRB1*04:01,08:01; DRB4*01:03 (PubMed=31611696) From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Proteomics; HLA class I peptidome; Omics: Proteomics; HLA class II peptidome Unspecified 151359428 CVCL_B4UM UCT0018 finite cell line human CVCL_B4UM CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359429 CVCL_B4UL UCB0018 transformed cell line human CVCL_B4UL CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359430 CVCL_B4V0 UCT0042 finite cell line human CVCL_B4V0 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359431 CVCL_B4UN UCB0019 transformed cell line human CVCL_B4UN CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359432 CVCL_B4UA UCF0305 finite cell line human CVCL_B4UA CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359433 CVCL_B4UC UCF0275 finite cell line human CVCL_B4UC CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359434 CVCL_B4UB UCF0285 finite cell line human CVCL_B4UB CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359435 CVCL_B4UE BP455 transformed cell line human CVCL_B4UE HLA typing: A*02:01,31:01; B*39:06,40:01; C*03:04,07:02 (Direct_author_submission); HLA typing: DPA1*01:03; DPB1*02:01; DQA1*01:05,01:10; DQB1*05:01,06:03; DRB1*10:01,13:01; DRB3*01:01 (PubMed=31611696) From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland CL:0000010 Miscellaneous: HLA class I typing from personal communication of Bassani-Sternberg, Michal Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Proteomics; HLA class II peptidome Unspecified 151359436 CVCL_B4UD UCF0184 finite cell line human CVCL_B4UD CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359437 CVCL_B4UG CM467 transformed cell line human CVCL_B4UG HLA typing: A*01:01,24:02; B*13:02,39:06; C*06:02,12:03 (PubMed=28832583); HLA typing: DPA1*01:03; DPB1*02:01,23:01; DQA1*01:02,02:01; DQB1*02:02,05:02; DRB1*07:01,16:01; DRB4*01:03; DRB5*02:02 (PubMed=31611696) From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Proteomics; HLA class I peptidome; Omics: Proteomics; HLA class II peptidome Unspecified 151359438 CVCL_B4UF CD165 transformed cell line human CVCL_B4UF HLA typing: A*02:05,24:02; B*15:01,50:01; C*03:03,06:02 (PubMed=28832583); HLA typing: DPA1*01:03; DPB1*04:01(105:01),04:02(126:01); DQA1*05:05; DQB1*03:01; DRB1*11:01; DRB3*02:02 (PubMed=31611696) From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Proteomics; HLA class I peptidome; Omics: Proteomics; HLA class II peptidome Unspecified 151359439 CVCL_B4VZ UCT0087 finite cell line human CVCL_B4VZ CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359440 CVCL_B4VY UCB0087 transformed cell line human CVCL_B4VY CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359441 CVCL_B4WA UCT0097 finite cell line human CVCL_B4WA CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359442 CVCL_B4VR UCB0081 transformed cell line human CVCL_B4VR CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359443 CVCL_B4W3 UCT0093 finite cell line human CVCL_B4W3 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359444 CVCL_B4W2 UCB0093 transformed cell line human CVCL_B4W2 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359445 CVCL_B4VQ UCT0079 finite cell line human CVCL_B4VQ CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359446 CVCL_B4W5 UCF0094 finite cell line human CVCL_B4W5 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359447 CVCL_B4VT UCT0081 finite cell line human CVCL_B4VT CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359448 CVCL_B4W4 UCB0094 transformed cell line human CVCL_B4W4 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359449 CVCL_B4VS UCF0081 finite cell line human CVCL_B4VS CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359450 CVCL_B4W7 UCB0095 transformed cell line human CVCL_B4W7 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359451 CVCL_B4VV UCT0083 finite cell line human CVCL_B4VV CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359452 CVCL_B4VU UCB0083 transformed cell line human CVCL_B4VU CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359453 CVCL_B4W6 UCT0094 finite cell line human CVCL_B4W6 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359454 CVCL_B4W9 UCB0097 transformed cell line human CVCL_B4W9 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359455 CVCL_B4VX UCT0086 finite cell line human CVCL_B4VX CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359456 CVCL_B4VW UCB0086 transformed cell line human CVCL_B4VW CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359457 CVCL_B4W8 UCT0095 finite cell line human CVCL_B4W8 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359458 CVCL_B4VJ UCT0062 finite cell line human CVCL_B4VJ CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359459 CVCL_B4VI UCB0062 transformed cell line human CVCL_B4VI CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359460 CVCL_B4VL UCT0070 finite cell line human CVCL_B4VL CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359461 CVCL_B4VK UCB0070 transformed cell line human CVCL_B4VK CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359462 CVCL_B4VN UCT0078 finite cell line human CVCL_B4VN CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359463 CVCL_B4VM UCB0078 transformed cell line human CVCL_B4VM CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359464 CVCL_B4VP UCB0079 transformed cell line human CVCL_B4VP CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359465 CVCL_B4W1 UCT0088 finite cell line human CVCL_B4W1 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359466 CVCL_B4W0 UCB0088 transformed cell line human CVCL_B4W0 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359467 CVCL_B4VB UCB0051 transformed cell line human CVCL_B4VB CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359468 CVCL_B4VA UCT0050 finite cell line human CVCL_B4VA CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359469 CVCL_B4VD UCB0055 transformed cell line human CVCL_B4VD CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359470 CVCL_B4VC UCT0051 finite cell line human CVCL_B4VC CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359471 CVCL_B4VF UCT0055 finite cell line human CVCL_B4VF CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359472 CVCL_B4VE UCF0055 finite cell line human CVCL_B4VE CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359473 CVCL_B4VH UCT0060 finite cell line human CVCL_B4VH CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359474 CVCL_B4VG UCB0060 transformed cell line human CVCL_B4VG CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359475 CVCL_B4SW UCF0228 finite cell line human CVCL_B4SW CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359476 CVCL_B4T8 UCF0247 finite cell line human CVCL_B4T8 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359477 CVCL_B4SV UCF0227 finite cell line human CVCL_B4SV CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359478 CVCL_B4T7 UCF0246 finite cell line human CVCL_B4T7 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359479 CVCL_B4SY UCF0231 finite cell line human CVCL_B4SY CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359480 CVCL_B4SX UCF0230 finite cell line human CVCL_B4SX CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359481 CVCL_B4T9 UCF0249 finite cell line human CVCL_B4T9 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359482 CVCL_B4SZ UCF0234 finite cell line human CVCL_B4SZ CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359483 CVCL_B4T0 UCF0235 finite cell line human CVCL_B4T0 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359484 CVCL_B4SN UCF0217 finite cell line human CVCL_B4SN CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359485 CVCL_B4SQ UCF0221 finite cell line human CVCL_B4SQ CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359486 CVCL_B4T2 UCF0239 finite cell line human CVCL_B4T2 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359487 CVCL_B4SP UCF0218 finite cell line human CVCL_B4SP CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359488 CVCL_B4T1 UCF0236 finite cell line human CVCL_B4T1 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359489 CVCL_B4SS UCF0223 finite cell line human CVCL_B4SS CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359490 CVCL_B4T4 UCF0243 finite cell line human CVCL_B4T4 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359491 CVCL_B4SR UCF0222 finite cell line human CVCL_B4SR CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359492 CVCL_B4T3 UCF0242 finite cell line human CVCL_B4T3 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359493 CVCL_B4SU UCF0226 finite cell line human CVCL_B4SU CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359494 CVCL_B4T6 UCF0245 finite cell line human CVCL_B4T6 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359495 CVCL_B4ST UCF0225 finite cell line human CVCL_B4ST CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359496 CVCL_B4T5 UCF0244 finite cell line human CVCL_B4T5 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359497 CVCL_B4SG UCF0202 finite cell line human CVCL_B4SG CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359498 CVCL_B4SF UCF0201 finite cell line human CVCL_B4SF CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359499 CVCL_B4SI UCF0205 finite cell line human CVCL_B4SI CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359500 CVCL_B4SH UCF0204 finite cell line human CVCL_B4SH CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359501 CVCL_B4SK UCF0211 finite cell line human CVCL_B4SK CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359502 CVCL_B4SJ UCF0210 finite cell line human CVCL_B4SJ CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359503 CVCL_B4SM UCF0216 finite cell line human CVCL_B4SM CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359504 CVCL_B4SL UCF0212 finite cell line human CVCL_B4SL CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359505 CVCL_B4SA UCF0190 finite cell line human CVCL_B4SA CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359506 CVCL_B4SC UCF0194 finite cell line human CVCL_B4SC CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359507 CVCL_B4SB UCF0193 finite cell line human CVCL_B4SB CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359508 CVCL_B4SE UCF0198 finite cell line human CVCL_B4SE CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359509 CVCL_B4SD UCF0195 finite cell line human CVCL_B4SD CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359510 CVCL_B4TX UCF0283 finite cell line human CVCL_B4TX CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359511 CVCL_B4U9 UCF0304 finite cell line human CVCL_B4U9 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359512 CVCL_B4TW UCF0282 finite cell line human CVCL_B4TW CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359513 CVCL_B4U8 UCF0303 finite cell line human CVCL_B4U8 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359514 CVCL_B4TZ UCF0288 finite cell line human CVCL_B4TZ CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359515 CVCL_B4TY UCF0284 finite cell line human CVCL_B4TY CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359516 CVCL_B4TP UCF0272 finite cell line human CVCL_B4TP CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359517 CVCL_B4U1 UCF0290 finite cell line human CVCL_B4U1 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359518 CVCL_B4U0 UCF0289 finite cell line human CVCL_B4U0 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359519 CVCL_B4TR UCF0274 finite cell line human CVCL_B4TR CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359520 CVCL_B4U3 UCF0293 finite cell line human CVCL_B4U3 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359521 CVCL_B4TQ UCF0273 finite cell line human CVCL_B4TQ CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359522 CVCL_B4U2 UCF0292 finite cell line human CVCL_B4U2 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359523 CVCL_B4TT UCF0277 finite cell line human CVCL_B4TT CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359524 CVCL_B4U5 UCF0295 finite cell line human CVCL_B4U5 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359525 CVCL_B4TS UCF0276 finite cell line human CVCL_B4TS CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359526 CVCL_B4U4 UCF0294 finite cell line human CVCL_B4U4 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359527 CVCL_B4TV UCF0279 finite cell line human CVCL_B4TV CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359528 CVCL_B4U7 UCF0300 finite cell line human CVCL_B4U7 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359529 CVCL_B4TU UCF0278 finite cell line human CVCL_B4TU CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359530 CVCL_B4U6 UCF0298 finite cell line human CVCL_B4U6 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359531 CVCL_B4TH UCF0258 finite cell line human CVCL_B4TH CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359532 CVCL_B4TG UCF0257 finite cell line human CVCL_B4TG CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359533 CVCL_B4TJ UCF0266 finite cell line human CVCL_B4TJ CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359534 CVCL_B4TI UCF0262 finite cell line human CVCL_B4TI CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359535 CVCL_B4TL UCF0268 finite cell line human CVCL_B4TL CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359536 CVCL_B4TK UCF0267 finite cell line human CVCL_B4TK CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359537 CVCL_B4TN UCF0271 finite cell line human CVCL_B4TN CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359538 CVCL_B4TM UCF0270 finite cell line human CVCL_B4TM CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359539 CVCL_B4TB UCF0251 finite cell line human CVCL_B4TB CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359540 CVCL_B4TA UCF0250 finite cell line human CVCL_B4TA CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359541 CVCL_B4TD UCF0253 finite cell line human CVCL_B4TD CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359542 CVCL_B4TC UCF0252 finite cell line human CVCL_B4TC CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359543 CVCL_B4TF UCF0255 finite cell line human CVCL_B4TF CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359544 CVCL_B4TE UCF0254 finite cell line human CVCL_B4TE CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359545 CVCL_B4QU UCF0112 finite cell line human CVCL_B4QU CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359546 CVCL_B4R6 UCF0125 finite cell line human CVCL_B4R6 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359547 CVCL_B4QT UCF0110 finite cell line human CVCL_B4QT CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359548 CVCL_B4R5 UCF0124 finite cell line human CVCL_B4R5 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359549 CVCL_B4QW UCF0114 finite cell line human CVCL_B4QW CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359550 CVCL_B4R8 UCF0129 finite cell line human CVCL_B4R8 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359551 CVCL_B4QV UCF0113 finite cell line human CVCL_B4QV CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359552 CVCL_B4R7 UCF0128 finite cell line human CVCL_B4R7 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359553 CVCL_B4QY UCF0116 finite cell line human CVCL_B4QY CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359554 CVCL_B4QX UCF0115 finite cell line human CVCL_B4QX CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359555 CVCL_B4R9 UCF0130 finite cell line human CVCL_B4R9 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359556 CVCL_B4QZ UCF0117 finite cell line human CVCL_B4QZ CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359557 CVCL_B4QM UCF0101 finite cell line human CVCL_B4QM CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359558 CVCL_B4QL UCF0100 finite cell line human CVCL_B4QL CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359559 CVCL_B4R0 UCF0119 finite cell line human CVCL_B4R0 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359560 CVCL_B4QN UCF0102 finite cell line human CVCL_B4QN CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359561 CVCL_B4QQ UCF0105 finite cell line human CVCL_B4QQ CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359562 CVCL_B4R2 UCF0121 finite cell line human CVCL_B4R2 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359563 CVCL_B4QP UCF0103 finite cell line human CVCL_B4QP CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359564 CVCL_B4R1 UCF0120 finite cell line human CVCL_B4R1 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359565 CVCL_B4QS UCF0108 finite cell line human CVCL_B4QS CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359566 CVCL_B4R4 UCF0123 finite cell line human CVCL_B4R4 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359567 CVCL_B4QR UCF0106 finite cell line human CVCL_B4QR CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359568 CVCL_B4R3 UCF0122 finite cell line human CVCL_B4R3 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359569 CVCL_B4QE UCF0090 finite cell line human CVCL_B4QE CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359570 CVCL_B4QD UCF0089 finite cell line human CVCL_B4QD CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359571 CVCL_B4QG UCF0093 finite cell line human CVCL_B4QG CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359572 CVCL_B4QF UCF0092 finite cell line human CVCL_B4QF CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359573 CVCL_B4QI UCF0097 finite cell line human CVCL_B4QI CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359574 CVCL_B4QH UCF0095 finite cell line human CVCL_B4QH CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359575 CVCL_B4QK UCF0099 finite cell line human CVCL_B4QK CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359576 CVCL_B4QJ UCF0098 finite cell line human CVCL_B4QJ CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359577 CVCL_B4QA UCF0086 finite cell line human CVCL_B4QA CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359578 CVCL_B4QC UCF0088 finite cell line human CVCL_B4QC CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359579 CVCL_B4QB UCF0087 finite cell line human CVCL_B4QB CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359580 CVCL_B4RV UCF0165 finite cell line human CVCL_B4RV CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359581 CVCL_B4S7 UCF0187 finite cell line human CVCL_B4S7 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359582 CVCL_B4RU UCF0164 finite cell line human CVCL_B4RU CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359583 CVCL_B4S6 UCF0185 finite cell line human CVCL_B4S6 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359584 CVCL_B4RX UCF0168 finite cell line human CVCL_B4RX CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359585 CVCL_B4S9 UCF0189 finite cell line human CVCL_B4S9 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359586 CVCL_B4RW UCF0167 finite cell line human CVCL_B4RW CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359587 CVCL_B4S8 UCF0188 finite cell line human CVCL_B4S8 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359588 CVCL_B4RZ UCF0171 finite cell line human CVCL_B4RZ CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359589 CVCL_B4RY UCF0169 finite cell line human CVCL_B4RY CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359590 CVCL_B4RN UCF0150 finite cell line human CVCL_B4RN CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359591 CVCL_B4RM UCF0149 finite cell line human CVCL_B4RM CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359592 CVCL_B4RP UCF0152 finite cell line human CVCL_B4RP CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359593 CVCL_B4S1 UCF0176 finite cell line human CVCL_B4S1 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359594 CVCL_B4S0 UCF0174 finite cell line human CVCL_B4S0 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359595 CVCL_B4RR UCF0155 finite cell line human CVCL_B4RR CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359596 CVCL_B4S3 UCF0180 finite cell line human CVCL_B4S3 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359597 CVCL_B4RQ UCF0154 finite cell line human CVCL_B4RQ CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359598 CVCL_B4S2 UCF0177 finite cell line human CVCL_B4S2 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359599 CVCL_B4RT UCF0161 finite cell line human CVCL_B4RT CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359600 CVCL_B4S5 UCF0183 finite cell line human CVCL_B4S5 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359601 CVCL_B4RS UCF0159 finite cell line human CVCL_B4RS CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359602 CVCL_B4S4 UCF0181 finite cell line human CVCL_B4S4 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359603 CVCL_B4RF UCF0138 finite cell line human CVCL_B4RF CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359604 CVCL_B4RE UCF0137 finite cell line human CVCL_B4RE CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359605 CVCL_B4RH UCF0140 finite cell line human CVCL_B4RH CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359606 CVCL_B4RG UCF0139 finite cell line human CVCL_B4RG CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359607 CVCL_B4RJ UCF0142 finite cell line human CVCL_B4RJ CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359608 CVCL_B4RI UCF0141 finite cell line human CVCL_B4RI CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359609 CVCL_B4RL UCF0146 finite cell line human CVCL_B4RL CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359610 CVCL_B4RK UCF0144 finite cell line human CVCL_B4RK CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359611 CVCL_B4RB UCF0132 finite cell line human CVCL_B4RB CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359612 CVCL_B4RA UCF0131 finite cell line human CVCL_B4RA CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359613 CVCL_B4RD UCF0134 finite cell line human CVCL_B4RD CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Female Part of: GenCord collection 151359614 CVCL_B4RC UCF0133 finite cell line human CVCL_B4RC CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; miRNA profiling; Microarray; Omics: Variations; SNP array analysis Male Part of: GenCord collection 151359615 CVCL_B5AD SP-2 [Mouse hybridoma against human LGALS3BP] hybridoma house mouse CVCL_B5AD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q08380; Human LGALS3BP. 151359616 CVCL_B5AC 465.12S hybridoma house mouse CVCL_B5AC CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q08380; Human LGALS3BP. 151359617 CVCL_B5AF A-1-18 hybridoma house mouse CVCL_B5AF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human antigen on melanoma cells. 151359618 CVCL_B5AE SK-MEL-25 subclone-5 cancer cell line human CVCL_B5AE CL:0000010 Derived from site: Metastatic; Not specified. Female 151359619 CVCL_B5AH A-1-27 hybridoma house mouse CVCL_B5AH CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human antigen on melanoma cells. 151359620 CVCL_B5AG A-1-19 hybridoma house mouse CVCL_B5AG CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human antigen on melanoma cells. 151359621 CVCL_B5AJ A-1-6 hybridoma house mouse CVCL_B5AJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human antigen on melanoma cells. 151359622 CVCL_B5AI A-1-43 hybridoma house mouse CVCL_B5AI CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human antigen on melanoma cells. 151359623 CVCL_B5AB 225.28S hybridoma house mouse CVCL_B5AB CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q6UVK1; Human CSPG4. 151359624 CVCL_B5AA RCV58 transformed cell line human CVCL_B5AA CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: IgG memory B cell; CL=CL_0000979. Unspecified Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: UniProtKB; P03524; Rabies virus glycoprotein (G) 151359625 CVCL_B5A4 19G7-C10 hybridoma house mouse CVCL_B5A4 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q0PJ46; Plasmodium falciparum lactate dehydrogenase (PfLDH). Group: Malaria research cell line; Group: Patented cell line 151359626 CVCL_B5A3 10D3G2 hybridoma house mouse CVCL_B5A3 CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; Q0PJ46; Plasmodium falciparum lactate dehydrogenase (PfLDH). Group: Malaria research cell line 151359627 CVCL_B5A6 17E4-D6 hybridoma house mouse CVCL_B5A6 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q0PJ46; Plasmodium falciparum lactate dehydrogenase (PfLDH). Group: Malaria research cell line; Group: Patented cell line 151359628 CVCL_B5A5 7G9-G1 hybridoma house mouse CVCL_B5A5 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q0PJ46; Plasmodium falciparum lactate dehydrogenase (PfLDH). Group: Malaria research cell line; Group: Patented cell line 151359629 CVCL_B5A8 6C9(B)-G7 hybridoma house mouse CVCL_B5A8 CL:0000010 Monoclonal antibody isotype: IgA, kappa; Monoclonal antibody target: UniProtKB; Q0PJ46; Plasmodium falciparum lactate dehydrogenase (PfLDH). Group: Malaria research cell line; Group: Patented cell line 151359630 CVCL_B5A7 6C9(A)-D6 hybridoma house mouse CVCL_B5A7 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q0PJ46; Plasmodium falciparum lactate dehydrogenase (PfLDH). Group: Malaria research cell line; Group: Patented cell line 151359631 CVCL_B5A9 RCV20 transformed cell line human CVCL_B5A9 CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: IgG memory B cell; CL=CL_0000979. Unspecified Monoclonal antibody isotype: IgG3, kappa; Monoclonal antibody target: UniProtKB; P03524; Rabies virus glycoprotein (G) 151359632 CVCL_B5A0 10A5H5 hybridoma house mouse CVCL_B5A0 CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; Q0PJ46; Plasmodium falciparum lactate dehydrogenase (PfLDH). Group: Malaria research cell line 151359633 CVCL_B5A2 10C4D5 hybridoma house mouse CVCL_B5A2 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q0PJ46; Plasmodium falciparum lactate dehydrogenase (PfLDH). Group: Malaria research cell line 151359634 CVCL_B5A1 10B6D1 hybridoma house mouse CVCL_B5A1 CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; Q0PJ46; Plasmodium falciparum lactate dehydrogenase (PfLDH). Group: Malaria research cell line 151359635 CVCL_B5BE UCB1022 transformed cell line human CVCL_B5BE CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359636 CVCL_B5BD UCB1021 transformed cell line human CVCL_B5BD CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359637 CVCL_B5BG UCB1028 transformed cell line human CVCL_B5BG CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359638 CVCL_B5BF UCB1026 transformed cell line human CVCL_B5BF CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359639 CVCL_B5BI UCB1040 transformed cell line human CVCL_B5BI CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359640 CVCL_B5BH UCB1037 transformed cell line human CVCL_B5BH CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359641 CVCL_B5BK UCB1047 transformed cell line human CVCL_B5BK CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359642 CVCL_B5BJ UCB1045 transformed cell line human CVCL_B5BJ CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359643 CVCL_B5BA UCB1008 transformed cell line human CVCL_B5BA CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359644 CVCL_B5BC UCB1015 transformed cell line human CVCL_B5BC CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359645 CVCL_B5BB UCB1013 transformed cell line human CVCL_B5BB CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359646 CVCL_B5AT S-17-52 hybridoma house mouse CVCL_B5AT CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human antigen found in many types of cancer cells. 151359647 CVCL_B5B5 UCB1000 transformed cell line human CVCL_B5B5 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359648 CVCL_B5AS S-13-24 hybridoma house mouse CVCL_B5AS CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human antigen found in many types of cancer cells. 151359649 CVCL_B5B4 UCB0161 transformed cell line human CVCL_B5B4 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359650 CVCL_B5AV S-18-325 hybridoma house mouse CVCL_B5AV CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human antigen found in many types of cancer cells. 151359651 CVCL_B5B7 UCB1004 transformed cell line human CVCL_B5B7 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359652 CVCL_B5AU S-18-24 hybridoma house mouse CVCL_B5AU CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human antigen found in many types of cancer cells. 151359653 CVCL_B5B6 UCB1002 transformed cell line human CVCL_B5B6 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359654 CVCL_B5AX S-19-57 hybridoma house mouse CVCL_B5AX CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human antigen found in melanoma, neuroblastoma and teratoma cancer cells. 151359655 CVCL_B5B9 UCB1007 transformed cell line human CVCL_B5B9 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359656 CVCL_B5AW S-19-352 hybridoma house mouse CVCL_B5AW CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human antigen found in all cell lines. 151359657 CVCL_B5B8 UCB1006 transformed cell line human CVCL_B5B8 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359658 CVCL_B5AY S-cl-57 hybridoma house mouse CVCL_B5AY CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human antigen found in melanoma, neuroblastoma and teratoma cancer cells. 151359659 CVCL_B5AL A-10-365 hybridoma house mouse CVCL_B5AL CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human antigen found in many types of cancer cells. 151359660 CVCL_B5AK A-10-33-1 hybridoma house mouse CVCL_B5AK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human antigen found in many types of cancer cells. 151359661 CVCL_B5AN A-11-352 hybridoma house mouse CVCL_B5AN CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human antigen found in many types of cancer cells. 151359662 CVCL_B5AM A-11-124 hybridoma house mouse CVCL_B5AM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human antigen found in melanoma, neuroblastoma and teratoma cancer cells. 151359663 CVCL_B5AP A-8-125 hybridoma house mouse CVCL_B5AP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human antigen found in melanoma, neuroblastoma and teratoma cancer cells. 151359664 CVCL_B5B1 BD1 hybridoma house mouse CVCL_B5B1 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_27827; Paraoxon. 151359665 CVCL_B5B0 S-cl-69 hybridoma house mouse CVCL_B5B0 CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human antigen found in many types of cancer cells. 151359666 CVCL_B5B3 0.5alpha transformed cell line human CVCL_B5B3 CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P03381; Human T-cell leukemia virus 1 (HTLV-1) env (Note=AA 21-312 = gp46/SU) 151359667 CVCL_B5AR S-13-16 hybridoma house mouse CVCL_B5AR CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human antigen found in melanoma, neuroblastoma and teratoma cancer cells. 151359668 CVCL_B5AQ A-8-17 hybridoma house mouse CVCL_B5AQ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human antigen found in many types of cancer cells. 151359669 CVCL_B5B2 CE3 hybridoma house mouse CVCL_B5B2 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_27827; Paraoxon. 151359670 CVCL_B4ZB UCB0282 transformed cell line human CVCL_B4ZB CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359671 CVCL_B4ZA UCT0277 finite cell line human CVCL_B4ZA CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359672 CVCL_B4ZD UCB0284 transformed cell line human CVCL_B4ZD CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359673 CVCL_B4ZC UCT0282 finite cell line human CVCL_B4ZC CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359674 CVCL_B4YU UCT0234 finite cell line human CVCL_B4YU CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359675 CVCL_B4Z6 UCT0271 finite cell line human CVCL_B4Z6 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359676 CVCL_B4YT UCB0234 transformed cell line human CVCL_B4YT CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359677 CVCL_B4Z5 UCB0271 transformed cell line human CVCL_B4Z5 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359678 CVCL_B4YW UCT0243 finite cell line human CVCL_B4YW CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359679 CVCL_B4Z8 UCT0276 finite cell line human CVCL_B4Z8 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359680 CVCL_B4YV UCB0243 transformed cell line human CVCL_B4YV CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359681 CVCL_B4Z7 UCB0276 transformed cell line human CVCL_B4Z7 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359682 CVCL_B4YY UCT0251 finite cell line human CVCL_B4YY CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359683 CVCL_B4YX UCB0251 transformed cell line human CVCL_B4YX CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359684 CVCL_B4Z9 UCB0277 transformed cell line human CVCL_B4Z9 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359685 CVCL_B4YZ UCB0253 transformed cell line human CVCL_B4YZ CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359686 CVCL_B4YM UCB0226 transformed cell line human CVCL_B4YM CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359687 CVCL_B4YL UCT0225 finite cell line human CVCL_B4YL CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359688 CVCL_B4Z0 UCT0253 finite cell line human CVCL_B4Z0 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359689 CVCL_B4YN UCT0226 finite cell line human CVCL_B4YN CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359690 CVCL_B4YQ UCT0227 finite cell line human CVCL_B4YQ CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359691 CVCL_B4Z2 UCT0255 finite cell line human CVCL_B4Z2 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359692 CVCL_B4YP UCB0227 transformed cell line human CVCL_B4YP CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359693 CVCL_B4Z1 UCB0255 transformed cell line human CVCL_B4Z1 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359694 CVCL_B4YS UCT0228 finite cell line human CVCL_B4YS CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359695 CVCL_B4Z4 UCT0270 finite cell line human CVCL_B4Z4 CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359696 CVCL_B4YR UCB0228 transformed cell line human CVCL_B4YR CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359697 CVCL_B4Z3 UCB0270 transformed cell line human CVCL_B4Z3 CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359698 CVCL_B4YE UCB0217 transformed cell line human CVCL_B4YE CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359699 CVCL_B4YD UCT0188 finite cell line human CVCL_B4YD CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359700 CVCL_B4YG UCB0218 transformed cell line human CVCL_B4YG CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359701 CVCL_B4YF UCT0217 finite cell line human CVCL_B4YF CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359702 CVCL_B4YI UCB0223 transformed cell line human CVCL_B4YI CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359703 CVCL_B4YH UCT0218 finite cell line human CVCL_B4YH CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359704 CVCL_B4YK UCB0225 transformed cell line human CVCL_B4YK CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359705 CVCL_B4YJ UCT0223 finite cell line human CVCL_B4YJ CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359706 CVCL_B4ZV NIZEDSM1iT21-C13 induced pluripotent stem cell human CVCL_B4ZV CL:0000010 Karyotypic information: Trisomic Chr21 cell line that originate from a mosaic Down syndrome individual; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359707 CVCL_B4ZU NIZEDSM1iT21-C6 induced pluripotent stem cell human CVCL_B4ZU CL:0000010 Karyotypic information: Trisomic Chr21 cell line that originate from a mosaic Down syndrome individual; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359708 CVCL_B4ZX D7E hybridoma house mouse CVCL_B4ZX CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; Q4PRK9; Plasmodium vivax lactate dehydrogenase (PvLDH). Group: Malaria research cell line 151359709 CVCL_B4ZW D2H hybridoma house mouse CVCL_B4ZW CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; Q4PRK9; Plasmodium vivax lactate dehydrogenase (PvLDH). Group: Malaria research cell line 151359710 CVCL_B4ZZ 10A5H3 hybridoma house mouse CVCL_B4ZZ CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; Q0PJ46; Plasmodium falciparum lactate dehydrogenase (PfLDH). Group: Malaria research cell line 151359711 CVCL_B4ZY 10A4E11 hybridoma house mouse CVCL_B4ZY CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; Q0PJ46; Plasmodium falciparum lactate dehydrogenase (PfLDH). Group: Malaria research cell line 151359712 CVCL_B4ZN UCT0313 finite cell line human CVCL_B4ZN CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359713 CVCL_B4ZM UCF0313 finite cell line human CVCL_B4ZM CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359714 CVCL_B4ZP CM05287 finite cell line human CVCL_B4ZP CL:0000010 Karyotypic information: 60% trisomy 21, 40% normal karyotype (PubMed=25694335); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; RNAseq; Single cell 151359715 CVCL_B4ZR NIZEDSM1iD21-C7 induced pluripotent stem cell human CVCL_B4ZR CL:0000010 Karyotypic information: Disomic Chr21 cell line that originate from a mosaic Down syndrome individual; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359716 CVCL_B4ZQ NIZEDSM1iD21-C3 induced pluripotent stem cell human CVCL_B4ZQ CL:0000010 Karyotypic information: Disomic Chr21 cell line that originate from a mosaic Down syndrome individual; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359717 CVCL_B4ZT NIZEDSM1iT21-C5 induced pluripotent stem cell human CVCL_B4ZT CL:0000010 Karyotypic information: Trisomic Chr21 cell line that originate from a mosaic Down syndrome individual; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359718 CVCL_B4ZS NIZEDSM1iD21-C9 induced pluripotent stem cell human CVCL_B4ZS CL:0000010 Karyotypic information: Disomic Chr21 cell line that originate from a mosaic Down syndrome individual; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151359719 CVCL_B4ZF UCB0285 transformed cell line human CVCL_B4ZF CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Male Part of: GenCord collection 151359720 CVCL_B4ZE UCT0284 finite cell line human CVCL_B4ZE CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359721 CVCL_B4ZH UCB0295 transformed cell line human CVCL_B4ZH CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359722 CVCL_B4ZG UCT0285 finite cell line human CVCL_B4ZG CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Male Part of: GenCord collection 151359723 CVCL_B4ZJ UCB0304 transformed cell line human CVCL_B4ZJ CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; ChIP-seq; H3K27ac; Omics: Genomics; ChIP-seq; H3K4me1; Omics: Genomics; ChIP-seq; H3K4me3; Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Part of: GenCord collection 151359724 CVCL_B4ZI UCT0295 finite cell line human CVCL_B4ZI CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359725 CVCL_B4ZL UCB0313 transformed cell line human CVCL_B4ZL CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359726 CVCL_B4ZK UCT0304 finite cell line human CVCL_B4ZK CL:0000010 Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Female Part of: GenCord collection 151359727 CVCL_B1AH Abcam THP-1 LYZ KO cancer cell line human CVCL_B1AH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6740; LYZ; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359728 CVCL_B1AG Abcam THP-1 LGALS9 KO cancer cell line human CVCL_B1AG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6570; LGALS9; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359729 CVCL_B1AJ Abcam THP-1 RIPK1 KO cancer cell line human CVCL_B1AJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10019; RIPK1; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359730 CVCL_B1AI Abcam THP-1 PTPN6 KO cancer cell line human CVCL_B1AI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9658; PTPN6; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359731 CVCL_B1AL Abcam THP-1 TNF KO cancer cell line human CVCL_B1AL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11892; TNF; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359732 CVCL_B1AK Abcam THP-1 STING1 KO cancer cell line human CVCL_B1AK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27962; STING1; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359733 CVCL_B1AN Abcam HEK293 ACP1 KO transformed cell line human CVCL_B1AN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:122; ACP1 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359734 CVCL_B1AM Abcam THP-1 TREM2 KO cancer cell line human CVCL_B1AM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17761; TREM2; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359735 CVCL_B1AB Abcam THP-1 CHI3L1 KO cancer cell line human CVCL_B1AB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1932; CHI3L1; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359736 CVCL_B1AA Abcam THP-1 CCL3 KO cancer cell line human CVCL_B1AA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10627; CCL3; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359737 CVCL_B1AD Abcam THP-1 CXCR2 KO cancer cell line human CVCL_B1AD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6027; CXCR2; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359738 CVCL_B1AC Abcam THP-1 CXCL10 KO cancer cell line human CVCL_B1AC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10637; CXCL10; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359739 CVCL_B1AF Abcam THP-1 LATS1 KO cancer cell line human CVCL_B1AF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6514; LATS1; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359740 CVCL_B1AE Abcam THP-1 IL1B KO cancer cell line human CVCL_B1AE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5992; IL1B; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359741 CVCL_B1A8 Abcam THP-1 CASP1 KO cancer cell line human CVCL_B1A8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1499; CASP1; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359742 CVCL_B1A7 Abcam THP-1 BCL2 KO cancer cell line human CVCL_B1A7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:990; BCL2; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Discontinued: Abcam; ab276113; true Male 151359743 CVCL_B1A9 Abcam THP-1 CASP9 KO cancer cell line human CVCL_B1A9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1511; CASP9; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359744 CVCL_B1A0 Abcam MCF-7 TPBG KO cancer cell line human CVCL_B1A0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12004; TPBG; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 151359745 CVCL_B1A2 Abcam THP-1 ATG12 KO cancer cell line human CVCL_B1A2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:588; ATG12; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359746 CVCL_B1A1 Abcam THP-1 ANPEP KO cancer cell line human CVCL_B1A1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:500; ANPEP; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359747 CVCL_B1A4 Abcam THP-1 ATG16L1 KO cancer cell line human CVCL_B1A4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21498; ATG16L1; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359748 CVCL_B1A3 Abcam THP-1 ATG14 KO cancer cell line human CVCL_B1A3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19962; ATG14; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359749 CVCL_B1A6 Abcam THP-1 ATG7 KO cancer cell line human CVCL_B1A6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16935; ATG7; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359750 CVCL_B1A5 Abcam THP-1 ATG5 KO cancer cell line human CVCL_B1A5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:589; ATG5; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151359751 CVCL_B1BI Abcam HEK293 SMAD5 KO transformed cell line human CVCL_B1BI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6771; SMAD5 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359752 CVCL_B1BH Abcam HEK293 SIRT1 KO transformed cell line human CVCL_B1BH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359753 CVCL_B1BK Abcam Raji CD27 KO cancer cell line human CVCL_B1BK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11922; CD27; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 151359754 CVCL_B1BJ Abcam HEK293 SMARCC1 KO transformed cell line human CVCL_B1BJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11104; SMARCC1 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359755 CVCL_B1BM Abcam Raji CD74 KO 2 cancer cell line human CVCL_B1BM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1697; CD74; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 151359756 CVCL_B1BL Abcam Raji CD74 KO 1 cancer cell line human CVCL_B1BL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1697; CD74; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 151359757 CVCL_B1C0 Abcam A-431 DDAH1 KO cancer cell line human CVCL_B1C0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2715; DDAH1; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151359758 CVCL_B1BN Abcam Raji CD80 KO cancer cell line human CVCL_B1BN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1700; CD80; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 151359759 CVCL_B1BA Abcam HEK293 PDCD6IP KO transformed cell line human CVCL_B1BA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8766; PDCD6IP Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359760 CVCL_B1BC Abcam HEK293 PHF6 KO transformed cell line human CVCL_B1BC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18145; PHF6 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359761 CVCL_B1BB Abcam HEK293 PHF10 KO transformed cell line human CVCL_B1BB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18250; PHF10 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359762 CVCL_B1BE Abcam HEK293 PRMT6 KO transformed cell line human CVCL_B1BE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18241; PRMT6 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359763 CVCL_B1BD Abcam HEK293 PLXNB2 KO transformed cell line human CVCL_B1BD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9104; PLXNB2 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359764 CVCL_B1BG Abcam HEK293 SESN2 KO transformed cell line human CVCL_B1BG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20746; SESN2 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359765 CVCL_B1BF Abcam HEK293 SDHA KO transformed cell line human CVCL_B1BF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10680; SDHA Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359766 CVCL_B1AX Abcam HEK293 GJA1 KO transformed cell line human CVCL_B1AX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4274; GJA1 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359767 CVCL_B1B9 Abcam HEK293 NKX2-5 KO transformed cell line human CVCL_B1B9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2488; NKX2-5 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359768 CVCL_B1AW Abcam HEK293 GATA2 KO transformed cell line human CVCL_B1AW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4171; GATA2 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359769 CVCL_B1B8 Abcam HEK293 NDRG1 KO transformed cell line human CVCL_B1B8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7679; NDRG1 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359770 CVCL_B1AZ Abcam HEK293 HK2 KO transformed cell line human CVCL_B1AZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4923; HK2 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359771 CVCL_B1AY Abcam HEK293 GYS1 KO transformed cell line human CVCL_B1AY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4706; GYS1 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359772 CVCL_B1AP Abcam HEK293 ATP13A2 KO transformed cell line human CVCL_B1AP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30213; ATP13A2 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359773 CVCL_B1B1 Abcam HEK293 HOXA9 KO 2 transformed cell line human CVCL_B1B1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5109; HOXA9 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359774 CVCL_B1B0 Abcam HEK293 HOXA9 KO 1 transformed cell line human CVCL_B1B0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5109; HOXA9 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359775 CVCL_B1AR Abcam HEK293 DDX17 KO transformed cell line human CVCL_B1AR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2740; DDX17 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359776 CVCL_B1B3 Abcam HEK293 IFNGR1 KO transformed cell line human CVCL_B1B3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5439; IFNGR1 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359777 CVCL_B1AQ Abcam HEK293 DCP1A KO transformed cell line human CVCL_B1AQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18714; DCP1A Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359778 CVCL_B1B2 Abcam HEK293 HRAS KO transformed cell line human CVCL_B1B2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5173; HRAS Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359779 CVCL_B1AT Abcam HEK293 FGFR3 KO transformed cell line human CVCL_B1AT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3690; FGFR3 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359780 CVCL_B1B5 Abcam HEK293 KMT5A KO transformed cell line human CVCL_B1B5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29489; KMT5A Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359781 CVCL_B1AS Abcam HEK293 E2F1 KO transformed cell line human CVCL_B1AS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3113; E2F1 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359782 CVCL_B1B4 Abcam HEK293 IRS2 KO transformed cell line human CVCL_B1B4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6126; IRS2 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359783 CVCL_B1AV Abcam HEK293 FOXO3 KO transformed cell line human CVCL_B1AV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3821; FOXO3 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359784 CVCL_B1B7 Abcam HEK293 MFN2 KO transformed cell line human CVCL_B1B7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16877; MFN2 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359785 CVCL_B1AU Abcam HEK293 FOXC1 KO transformed cell line human CVCL_B1AU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3800; FOXC1 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Discontinued: Abcam; ab269474; true Female 151359786 CVCL_B1B6 Abcam HEK293 LAMP2 KO transformed cell line human CVCL_B1B6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6501; LAMP2 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151359787 CVCL_B0ZB Abcam K-562 CSF3 KO cancer cell line human CVCL_B0ZB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2438; CSF3; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. Female 151359788 CVCL_B0ZA Abcam K-562 ADAM17 KO cancer cell line human CVCL_B0ZA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:195; ADAM17; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. Female 151359789 CVCL_B0ZD Abcam PC-3 CXCL8 KO cancer cell line human CVCL_B0ZD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6025; CXCL8; Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Bone; UBERON=UBERON_0002481. Male 151359790 CVCL_B0ZC Abcam Calu-3 TMPRSS2 KO cancer cell line human CVCL_B0ZC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11876; TMPRSS2; Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Omics: Transcriptomics; Microarray Male Group: SARS-CoV-2 research cell line 151359791 CVCL_B0ZF Abcam A-375 IL13RA2 KO cancer cell line human CVCL_B0ZF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5975; IL13RA2; Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511. Female 151359792 CVCL_B0ZE Abcam SK-N-BE(2) GRM5 KO cancer cell line human CVCL_B0ZE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4597; GRM5; Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Discontinued: Abcam; ab273376; true Male 151359793 CVCL_B0ZH Abcam Hep-G2 ACE2 KO cancer cell line human CVCL_B0ZH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13557; ACE2; Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 151359794 CVCL_B0ZG Abcam U-87MG MAPT KO cancer cell line human CVCL_B0ZG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6893; MAPT; Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian Discontinued: Abcam; ab269490; true. Male Problematic cell line: Misidentified Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala. 151359795 CVCL_B0YY Abcam U2OS CD40 KO cancer cell line human CVCL_B0YY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11919; CD40; Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 151359796 CVCL_B0Z9 Abcam Jurkat TAL1 KO cancer cell line human CVCL_B0Z9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11556; TAL1; Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male 151359797 CVCL_B0YX Abcam U2OS ACO1 KO cancer cell line human CVCL_B0YX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:117; ACO1; Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 151359798 CVCL_B0YZ Abcam U2OS FHL2 KO cancer cell line human CVCL_B0YZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3703; FHL2; Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 151359799 CVCL_B0YQ Abcam SW480 ACAT1 KO cancer cell line human CVCL_B0YQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:93; ACAT1; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151359800 CVCL_B0Z2 Abcam U2OS SUV39H2 KO cancer cell line human CVCL_B0Z2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17287; SUV39H2; Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 151359801 CVCL_B0YP Abcam RAW 264.7 Prkaa1 KO cancer cell line house mouse CVCL_B0YP CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2145955; Prkaa1 Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male 151359802 CVCL_B0Z1 Abcam U2OS PICALM KO cancer cell line human CVCL_B0Z1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15514; PICALM; Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 151359803 CVCL_B0YS Abcam SW480 DDIT3 KO cancer cell line human CVCL_B0YS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2726; DDIT3; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151359804 CVCL_B0Z4 Abcam U2OS TNC KO cancer cell line human CVCL_B0Z4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5318; TNC; Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 151359805 CVCL_B0YR Abcam SW480 ALDH2 KO cancer cell line human CVCL_B0YR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:404; ALDH2; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151359806 CVCL_B0Z3 Abcam U2OS THY1 KO cancer cell line human CVCL_B0Z3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11801; THY1; Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 151359807 CVCL_B0Z6 Abcam Jurkat IFNG KO cancer cell line human CVCL_B0Z6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5438; IFNG; Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male 151359808 CVCL_B0YU Abcam SW480 ITGA6 KO cancer cell line human CVCL_B0YU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6142; ITGA6; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151359809 CVCL_B0Z5 Abcam Jurkat CD1C KO cancer cell line human CVCL_B0Z5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1636; CD1C; Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male 151359810 CVCL_B0YT Abcam SW480 ELAVL1 KO cancer cell line human CVCL_B0YT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3312; ELAVL1; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151359811 CVCL_B0Z8 Abcam Jurkat PTPN2 KO cancer cell line human CVCL_B0Z8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9650; PTPN2; Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male 151359812 CVCL_B0YW Abcam SW480 SERPINA1 KO cancer cell line human CVCL_B0YW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8941; SERPINA1; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151359813 CVCL_B0Z7 Abcam Jurkat IKZF1 KO cancer cell line human CVCL_B0Z7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13176; IKZF1; Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male 151359814 CVCL_B0YV Abcam SW480 LCN2 KO cancer cell line human CVCL_B0YV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6526; LCN2; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151359815 CVCL_B0YI Abcam SH-SY5Y PDGFRB KO cancer cell line human CVCL_B0YI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8804; PDGFRB; Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Female 151359816 CVCL_B0YH Abcam SH-SY5Y PDGFRA KO cancer cell line human CVCL_B0YH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8803; PDGFRA; Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Female 151359817 CVCL_B0YK Abcam SH-SY5Y PINK1 KO cancer cell line human CVCL_B0YK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14581; PINK1; Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Female 151359818 CVCL_B0YJ Abcam SH-SY5Y DLG4 KO cancer cell line human CVCL_B0YJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2903; DLG4; Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Female 151359819 CVCL_B0YM Abcam RAW 264.7 Ccl7 KO cancer cell line house mouse CVCL_B0YM CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:99512; Ccl7 Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male 151359820 CVCL_B0YL Abcam Caco-2 ACE2 KO cancer cell line human CVCL_B0YL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13557; ACE2; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male Group: SARS-CoV-2 research cell line 151359821 CVCL_B0Z0 Abcam U2OS HNRNPD KO cancer cell line human CVCL_B0Z0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5036; HNRNPD; Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 151359822 CVCL_B0YN Abcam RAW 264.7 Cd68 KO cancer cell line house mouse CVCL_B0YN CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88342; Cd68 Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male 151359823 CVCL_B0ZZ Abcam MCF-7 TLE1 KO cancer cell line human CVCL_B0ZZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11837; TLE1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 151359824 CVCL_B0ZY Abcam MCF-7 PDE3B KO cancer cell line human CVCL_B0ZY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8779; PDE3B; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 151359825 CVCL_B0ZR Abcam Hep-G2 SLC2A1 KO cancer cell line human CVCL_B0ZR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11005; SLC2A1; Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 151359826 CVCL_B0ZQ Abcam Hep-G2 NFKB2 KO cancer cell line human CVCL_B0ZQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7795; NFKB2; Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 151359827 CVCL_B0ZT Abcam MCF-7 ATAD2 KO cancer cell line human CVCL_B0ZT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30123; ATAD2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 151359828 CVCL_B0ZS Abcam Hep-G2 TFEB KO cancer cell line human CVCL_B0ZS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11753; TFEB; Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 151359829 CVCL_B0ZV Abcam MCF-7 BMI1 KO cancer cell line human CVCL_B0ZV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1066; BMI1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 151359830 CVCL_B0ZU Abcam MCF-7 ATM KO cancer cell line human CVCL_B0ZU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:795; ATM; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 151359831 CVCL_B0ZX Abcam MCF-7 HES1 KO cancer cell line human CVCL_B0ZX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5192; HES1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 151359832 CVCL_B0ZW Abcam MCF-7 BRD4 KO cancer cell line human CVCL_B0ZW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13575; BRD4; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Discontinued: Abcam; ab282674; true Female 151359833 CVCL_B0ZJ Abcam Hep-G2 B2M KO cancer cell line human CVCL_B0ZJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M; Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 151359834 CVCL_B0ZI Abcam Hep-G2 ARRB2 KO cancer cell line human CVCL_B0ZI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:712; ARRB2; Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 151359835 CVCL_B0ZL Abcam Hep-G2 CTNNB1 KO cancer cell line human CVCL_B0ZL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2514; CTNNB1; Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 151359836 CVCL_B0ZK Abcam Hep-G2 CD63 KO cancer cell line human CVCL_B0ZK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1692; CD63; Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 151359837 CVCL_B0ZN Abcam Hep-G2 MTOR KO cancer cell line human CVCL_B0ZN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3942; MTOR; Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Discontinued: Abcam; ab277829; true Male 151359838 CVCL_B0ZM Abcam Hep-G2 LRP6 KO cancer cell line human CVCL_B0ZM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6698; LRP6; Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 151359839 CVCL_B0ZP Abcam Hep-G2 NF2 KO cancer cell line human CVCL_B0ZP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7773; NF2; Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 151359840 CVCL_B1IP Abcam HeLa ABHD6 KO cancer cell line human CVCL_B1IP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21398; ABHD6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359841 CVCL_B1J1 Abcam HeLa ADARB1 KO cancer cell line human CVCL_B1J1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:226; ADARB1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359842 CVCL_B1J0 Abcam HeLa ADAM9 KO cancer cell line human CVCL_B1J0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:216; ADAM9 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359843 CVCL_B1IR Abcam HeLa ACAD9 KO cancer cell line human CVCL_B1IR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21497; ACAD9 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359844 CVCL_B1J3 Abcam HeLa ADCY3 KO cancer cell line human CVCL_B1J3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:234; ADCY3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359845 CVCL_B1IQ Abcam HeLa ABL1 KO 1 cancer cell line human CVCL_B1IQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:76; ABL1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359846 CVCL_B1J2 Abcam HeLa ADCK2 KO cancer cell line human CVCL_B1J2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19039; ADCK2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359847 CVCL_B1IT Abcam HeLa ACOT9 KO cancer cell line human CVCL_B1IT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17152; ACOT9 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359848 CVCL_B1J5 Abcam HeLa ADK KO cancer cell line human CVCL_B1J5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:257; ADK Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359849 CVCL_B1IS Abcam HeLa ACHE KO cancer cell line human CVCL_B1IS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:108; ACHE Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359850 CVCL_B1J4 Abcam HeLa ADCY7 KO cancer cell line human CVCL_B1J4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:238; ADCY7 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359851 CVCL_B1IV Abcam HeLa ACSL1 KO cancer cell line human CVCL_B1IV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3569; ACSL1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359852 CVCL_B1J7 Abcam HeLa AGO1 KO cancer cell line human CVCL_B1J7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3262; AGO1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359853 CVCL_B1IU Abcam HeLa ACOX3 KO cancer cell line human CVCL_B1IU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:121; ACOX3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359854 CVCL_B1J6 Abcam HeLa ADRB1 KO cancer cell line human CVCL_B1J6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:285; ADRB1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab261831; true Female 151359855 CVCL_B1IH Abcam A-549 ZC3HAV1 KO 2 cancer cell line human CVCL_B1IH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23721; ZC3HAV1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359856 CVCL_B1IG Abcam A-549 VCAM1 KO cancer cell line human CVCL_B1IG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12663; VCAM1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359857 CVCL_B1IJ Abcam HeLa AAK1 KO cancer cell line human CVCL_B1IJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19679; AAK1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359858 CVCL_B1II Abcam A-549 ZCCHC2 KO 2 cancer cell line human CVCL_B1II CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22916; ZCCHC2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359859 CVCL_B1IL Abcam HeLa ABCC3 KO cancer cell line human CVCL_B1IL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:54; ABCC3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359860 CVCL_B1IK Abcam HeLa ABCC1 KO cancer cell line human CVCL_B1IK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:51; ABCC1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359861 CVCL_B1IN Abcam HeLa ABHD17A KO cancer cell line human CVCL_B1IN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28756; ABHD17A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359862 CVCL_B1IM Abcam HeLa ABCF3 KO cancer cell line human CVCL_B1IM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:72; ABCF3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359863 CVCL_B1IB Abcam A-549 TRIM21 KO 2 cancer cell line human CVCL_B1IB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11312; TRIM21; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359864 CVCL_B1IA Abcam A-549 TRIM14 KO 2 cancer cell line human CVCL_B1IA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16283; TRIM14; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359865 CVCL_B1ID Abcam A-549 TRIM38 KO 1 cancer cell line human CVCL_B1ID CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10059; TRIM38; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359866 CVCL_B1IC Abcam A-549 TRIM34 KO 1 cancer cell line human CVCL_B1IC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10063; TRIM34; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359867 CVCL_B1IF Abcam A-549 USP18 KO 1 cancer cell line human CVCL_B1IF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12616; USP18; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359868 CVCL_B1IE Abcam A-549 TRIM56 KO 1 cancer cell line human CVCL_B1IE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19028; TRIM56; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359869 CVCL_B1HW Abcam A-549 TEAD1 KO cancer cell line human CVCL_B1HW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11714; TEAD1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359870 CVCL_B1I8 Abcam A-549 TRANK1 KO 1 cancer cell line human CVCL_B1I8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29011; TRANK1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359871 CVCL_B1HV Abcam A-549 TDRD7 KO 1 cancer cell line human CVCL_B1HV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30831; TDRD7; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359872 CVCL_B1I7 Abcam A-549 TNFSF10 KO cancer cell line human CVCL_B1I7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11925; TNFSF10; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359873 CVCL_B1HY Abcam A-549 TENT5A KO 2 cancer cell line human CVCL_B1HY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18345; TENT5A; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359874 CVCL_B1HX Abcam A-549 TEAD4 KO cancer cell line human CVCL_B1HX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11717; TEAD4; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359875 CVCL_B1I9 Abcam A-549 TREX1 KO cancer cell line human CVCL_B1I9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12269; TREX1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359876 CVCL_B1HZ Abcam A-549 TGFBR1 KO cancer cell line human CVCL_B1HZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11772; TGFBR1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359877 CVCL_B1JQ Abcam HeLa APH1A KO cancer cell line human CVCL_B1JQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29509; APH1A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359878 CVCL_B1K2 Abcam HeLa ARNTL KO cancer cell line human CVCL_B1K2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:701; BMAL1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359879 CVCL_B1JP Abcam HeLa AP1M2 KO cancer cell line human CVCL_B1JP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:558; AP1M2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359880 CVCL_B1K1 Abcam HeLa ARL8B KO cancer cell line human CVCL_B1K1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25564; ARL8B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359881 CVCL_B1JS Abcam HeLa APPL1 KO cancer cell line human CVCL_B1JS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24035; APPL1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359882 CVCL_B1K4 Abcam HeLa ASCC2 KO cancer cell line human CVCL_B1K4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24103; ASCC2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265781; true Female 151359883 CVCL_B1JR Abcam HeLa APLNR KO cancer cell line human CVCL_B1JR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:339; APLNR Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359884 CVCL_B1K3 Abcam HeLa ASAP1 KO cancer cell line human CVCL_B1K3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2720; ASAP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359885 CVCL_B1JU Abcam HeLa ARAP3 KO cancer cell line human CVCL_B1JU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24097; ARAP3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359886 CVCL_B1K6 Abcam HeLa ASS1 KO cancer cell line human CVCL_B1K6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:758; ASS1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359887 CVCL_B1JT Abcam HeLa APTX KO cancer cell line human CVCL_B1JT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15984; APTX Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359888 CVCL_B1K5 Abcam HeLa ASH1L KO cancer cell line human CVCL_B1K5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19088; ASH1L Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359889 CVCL_B1JW Abcam HeLa ARFIP2 KO cancer cell line human CVCL_B1JW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17160; ARFIP2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265813; true Female 151359890 CVCL_B1K8 Abcam HeLa ATAD2 KO cancer cell line human CVCL_B1K8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30123; ATAD2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359891 CVCL_B1JV Abcam HeLa ARF1 KO cancer cell line human CVCL_B1JV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:652; ARF1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359892 CVCL_B1K7 Abcam HeLa ASXL1 KO cancer cell line human CVCL_B1K7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18318; ASXL1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359893 CVCL_B1JI Abcam HeLa ANKRD13A KO cancer cell line human CVCL_B1JI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21268; ANKRD13A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359894 CVCL_B1JH Abcam HeLa ALPP KO cancer cell line human CVCL_B1JH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:439; ALPP Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab261763; true Female 151359895 CVCL_B1JK Abcam HeLa ANTXR1 KO cancer cell line human CVCL_B1JK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21014; ANTXR1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359896 CVCL_B1JJ Abcam HeLa ANKRD17 KO cancer cell line human CVCL_B1JJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23575; ANKRD17 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359897 CVCL_B1JM Abcam HeLa ANXA6 KO cancer cell line human CVCL_B1JM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:544; ANXA6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359898 CVCL_B1JL Abcam HeLa ANXA3 KO cancer cell line human CVCL_B1JL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:541; ANXA3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359899 CVCL_B1K0 Abcam HeLa ARL2BP KO cancer cell line human CVCL_B1K0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17146; ARL2BP Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359900 CVCL_B1JN Abcam HeLa AP1M1 KO cancer cell line human CVCL_B1JN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13667; AP1M1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359901 CVCL_B1JA Abcam HeLa AK1 KO cancer cell line human CVCL_B1JA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:361; AK1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359902 CVCL_B1JC Abcam HeLa AKAP11 KO cancer cell line human CVCL_B1JC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:369; AKAP11 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359903 CVCL_B1JB Abcam HeLa AK4 KO cancer cell line human CVCL_B1JB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:363; AK4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359904 CVCL_B1JE Abcam HeLa AKT3 KO cancer cell line human CVCL_B1JE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:393; AKT3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265687; true Female 151359905 CVCL_B1JD Abcam HeLa AKT1 KO cancer cell line human CVCL_B1JD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:391; AKT1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359906 CVCL_B1JG Abcam HeLa ALK KO cancer cell line human CVCL_B1JG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:427; ALK Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab266003; true Female 151359907 CVCL_B1JF Abcam HeLa ALDH3A2 KO cancer cell line human CVCL_B1JF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:403; ALDH3A2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359908 CVCL_B1IX Abcam HeLa ACTA2 KO cancer cell line human CVCL_B1IX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:130; ACTA2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359909 CVCL_B1J9 Abcam HeLa AIP KO cancer cell line human CVCL_B1J9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:358; AIP Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359910 CVCL_B1IW Abcam HeLa ACSL3 KO cancer cell line human CVCL_B1IW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3570; ACSL3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359911 CVCL_B1J8 Abcam HeLa AGO3 KO cancer cell line human CVCL_B1J8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18421; AGO3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359912 CVCL_B1IZ Abcam HeLa ADAM17 KO cancer cell line human CVCL_B1IZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:195; ADAM17 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359913 CVCL_B1IY Abcam HeLa ACTN1 KO cancer cell line human CVCL_B1IY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:163; ACTN1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151359914 CVCL_B1GN Abcam A-549 NRP1 KO cancer cell line human CVCL_B1GN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8004; NRP1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359915 CVCL_B1GM Abcam A-549 NR1H2 KO cancer cell line human CVCL_B1GM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7965; NR1H2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359916 CVCL_B1GP Abcam A-549 NT5C3A KO 2 cancer cell line human CVCL_B1GP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17820; NT5C3A; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359917 CVCL_B1H1 Abcam A-549 PMAIP1 KO 1 cancer cell line human CVCL_B1H1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9108; PMAIP1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359918 CVCL_B1H0 Abcam A-549 PLSCR1 KO 1 cancer cell line human CVCL_B1H0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9092; PLSCR1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359919 CVCL_B1GR Abcam A-549 OAS2 KO 3 cancer cell line human CVCL_B1GR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8087; OAS2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359920 CVCL_B1H3 Abcam A-549 PTGS2 KO cancer cell line human CVCL_B1H3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9605; PTGS2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359921 CVCL_B1GQ Abcam A-549 OAS2 KO 1 cancer cell line human CVCL_B1GQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8087; OAS2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359922 CVCL_B1H2 Abcam A-549 PSMB8 KO 1 cancer cell line human CVCL_B1H2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9545; PSMB8; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359923 CVCL_B1GT Abcam A-549 OTOP3 KO 1 cancer cell line human CVCL_B1GT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19658; OTOP3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359924 CVCL_B1H5 Abcam A-549 PYHIN1 KO 1 cancer cell line human CVCL_B1H5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28894; PYHIN1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359925 CVCL_B1GS Abcam A-549 OASL KO 1 cancer cell line human CVCL_B1GS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8090; OASL; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359926 CVCL_B1H4 Abcam A-549 PTPRK KO 2 cancer cell line human CVCL_B1H4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9674; PTPRK; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359927 CVCL_B1GF Abcam A-549 MAP3K2 KO 2 cancer cell line human CVCL_B1GF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6854; MAP3K2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359928 CVCL_B1GE Abcam A-549 MAP3K15 KO 2 cancer cell line human CVCL_B1GE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31689; MAP3K15; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359929 CVCL_B1GH Abcam A-549 MX1 KO cancer cell line human CVCL_B1GH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7532; MX1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Discontinued: Abcam; ab267035; true Male 151359930 CVCL_B1GG Abcam A-549 MSX1 KO 1 cancer cell line human CVCL_B1GG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7391; MSX1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359931 CVCL_B1GJ Abcam A-549 MYH2 KO 2 cancer cell line human CVCL_B1GJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7572; MYH2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Discontinued: Abcam; ab267028; true Male 151359932 CVCL_B1GI Abcam A-549 MX2 KO 2 cancer cell line human CVCL_B1GI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7533; MX2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359933 CVCL_B1GL Abcam A-549 NLRC5 KO cancer cell line human CVCL_B1GL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29933; NLRC5; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359934 CVCL_B1GK Abcam A-549 NCOA7 KO 1 cancer cell line human CVCL_B1GK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21081; NCOA7; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359935 CVCL_B1GB Abcam A-549 MAP2K7 KO 1 cancer cell line human CVCL_B1GB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6847; MAP2K7; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359936 CVCL_B1GA Abcam A-549 LMO2 KO cancer cell line human CVCL_B1GA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6642; LMO2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Discontinued: Abcam; ab267167; true Male 151359937 CVCL_B1GD Abcam A-549 MAP3K14 KO cancer cell line human CVCL_B1GD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6853; MAP3K14; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359938 CVCL_B1GC Abcam A-549 MAP3K11 KO 1 cancer cell line human CVCL_B1GC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6850; MAP3K11; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359939 CVCL_B1FU Abcam A-549 IFIH1 KO 1 cancer cell line human CVCL_B1FU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18873; IFIH1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359940 CVCL_B1G6 Abcam A-549 KDM7A KO 2 cancer cell line human CVCL_B1G6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22224; KDM7A; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359941 CVCL_B1FT Abcam A-549 IFI6 KO 1 cancer cell line human CVCL_B1FT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4054; IFI6; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359942 CVCL_B1G5 Abcam A-549 JAK2 KO cancer cell line human CVCL_B1G5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6192; JAK2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359943 CVCL_B1FW Abcam A-549 IFIT3 KO cancer cell line human CVCL_B1FW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5411; IFIT3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359944 CVCL_B1G8 Abcam A-549 LAP3 KO cancer cell line human CVCL_B1G8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18449; LAP3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359945 CVCL_B1FV Abcam A-549 IFIT2 KO 1 cancer cell line human CVCL_B1FV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5409; IFIT2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359946 CVCL_B1G7 Abcam A-549 LAMP3 KO 1 cancer cell line human CVCL_B1G7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14582; LAMP3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359947 CVCL_B1FY Abcam A-549 IL15RA KO 1 cancer cell line human CVCL_B1FY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5978; IL15RA; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359948 CVCL_B1FX Abcam A-549 IFIT5 KO 2 cancer cell line human CVCL_B1FX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13328; IFIT5; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359949 CVCL_B1G9 Abcam A-549 LGALS9C KO cancer cell line human CVCL_B1G9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33874; LGALS9C; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359950 CVCL_B1FZ Abcam A-549 IL6 KO cancer cell line human CVCL_B1FZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6018; IL6; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359951 CVCL_B1I0 Abcam A-549 TGM2 KO 1 cancer cell line human CVCL_B1I0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11778; TGM2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359952 CVCL_B1HN Abcam A-549 SMAD6 KO cancer cell line human CVCL_B1HN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6772; SMAD6; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359953 CVCL_B1HQ Abcam A-549 SP140 KO 1 cancer cell line human CVCL_B1HQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17133; SP140; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359954 CVCL_B1I2 Abcam A-549 THEMIS2 KO 2 cancer cell line human CVCL_B1I2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16839; THEMIS2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359955 CVCL_B1HP Abcam A-549 SP100 KO cancer cell line human CVCL_B1HP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11206; SP100; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359956 CVCL_B1I1 Abcam A-549 TGOLN2 KO cancer cell line human CVCL_B1I1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15450; TGOLN2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359957 CVCL_B1HS Abcam A-549 SPINK1 KO 3 cancer cell line human CVCL_B1HS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11244; SPINK1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Discontinued: Abcam; ab267206; true Male 151359958 CVCL_B1I4 Abcam A-549 TMEM140 KO 1 cancer cell line human CVCL_B1I4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21870; TMEM140; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359959 CVCL_B1HR Abcam A-549 SPINK1 KO 1 cancer cell line human CVCL_B1HR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11244; SPINK1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Discontinued: Abcam; ab267204; true Male 151359960 CVCL_B1I3 Abcam A-549 TLDC2 KO 2 cancer cell line human CVCL_B1I3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16112; TLDC2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359961 CVCL_B1HU Abcam A-549 SYN1 KO cancer cell line human CVCL_B1HU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11494; SYN1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Discontinued: Abcam; ab266917; true Male 151359962 CVCL_B1I6 Abcam A-549 TNFAIP3 KO 1 cancer cell line human CVCL_B1I6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11896; TNFAIP3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359963 CVCL_B1HT Abcam A-549 STAT2 KO 2 cancer cell line human CVCL_B1HT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11363; STAT2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359964 CVCL_B1I5 Abcam A-549 TMEM64 KO 1 cancer cell line human CVCL_B1I5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25441; TMEM64; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359965 CVCL_B1HG Abcam A-549 SECTM1 KO 2 cancer cell line human CVCL_B1HG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10707; SECTM1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359966 CVCL_B1HF Abcam A-549 SAMD9L KO 2 cancer cell line human CVCL_B1HF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1349; SAMD9L; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359967 CVCL_B1HI Abcam A-549 SHFL KO 1 cancer cell line human CVCL_B1HI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25649; SHFL; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359968 CVCL_B1HH Abcam A-549 SERPING1 KO 2 cancer cell line human CVCL_B1HH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1228; SERPING1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Discontinued: Abcam; ab266941; true Male 151359969 CVCL_B1HK Abcam A-549 SLC15A3 KO cancer cell line human CVCL_B1HK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18068; SLC15A3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359970 CVCL_B1HJ Abcam A-549 SIDT1 KO 1 cancer cell line human CVCL_B1HJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25967; SIDT1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359971 CVCL_B1HM Abcam A-549 SMAD3 KO 1 cancer cell line human CVCL_B1HM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6769; SMAD3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359972 CVCL_B1HL Abcam A-549 SLC25A28 KO 2 cancer cell line human CVCL_B1HL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23472; SLC25A28; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359973 CVCL_B1HA Abcam A-549 RNF19B KO 2 cancer cell line human CVCL_B1HA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26886; RNF19B; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359974 CVCL_B1HC Abcam A-549 S100A4 KO cancer cell line human CVCL_B1HC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10494; S100A4; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359975 CVCL_B1HB Abcam A-549 RTP4 KO 1 cancer cell line human CVCL_B1HB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23992; RTP4; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359976 CVCL_B1HE Abcam A-549 SAMD9 KO 2 cancer cell line human CVCL_B1HE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1348; SAMD9; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359977 CVCL_B1HD Abcam A-549 SAA1 KO 2 cancer cell line human CVCL_B1HD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10513; SAA1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359978 CVCL_B1GV Abcam A-549 PARP12 KO cancer cell line human CVCL_B1GV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21919; PARP12; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359979 CVCL_B1H7 Abcam A-549 RAB29 KO cancer cell line human CVCL_B1H7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9789; RAB29; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359980 CVCL_B1GU Abcam A-549 PARP10 KO 1 cancer cell line human CVCL_B1GU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25895; PARP10; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359981 CVCL_B1H6 Abcam A-549 RAB10 KO cancer cell line human CVCL_B1H6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9759; RAB10; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359982 CVCL_B1GX Abcam A-549 PARP9 KO 2 cancer cell line human CVCL_B1GX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24118; PARP9; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359983 CVCL_B1H9 Abcam A-549 RICTOR KO cancer cell line human CVCL_B1H9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28611; RICTOR; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359984 CVCL_B1GW Abcam A-549 PARP14 KO 2 cancer cell line human CVCL_B1GW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29232; PARP14; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359985 CVCL_B1H8 Abcam A-549 RASGRP3 KO 2 cancer cell line human CVCL_B1H8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14545; RASGRP3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Discontinued: Abcam; ab267199; true Male 151359986 CVCL_B1GZ Abcam A-549 PLEKHA4 KO 1 cancer cell line human CVCL_B1GZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14339; PLEKHA4; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359987 CVCL_B1GY Abcam A-549 PLAAT4 KO 1 cancer cell line human CVCL_B1GY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9869; PLAAT4; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359988 CVCL_B1EL Abcam A-549 ATF3 KO cancer cell line human CVCL_B1EL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:785; ATF3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359989 CVCL_B1EK Abcam A-549 APOL6 KO 2 cancer cell line human CVCL_B1EK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14870; APOL6; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359990 CVCL_B1EN Abcam A-549 BATF2 KO 1 cancer cell line human CVCL_B1EN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25163; BATF2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359991 CVCL_B1EM Abcam A-549 ATP10A KO cancer cell line human CVCL_B1EM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13542; ATP10A; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359992 CVCL_B1EP Abcam A-549 BRCA1 KO cancer cell line human CVCL_B1EP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1100; BRCA1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Discontinued: Abcam; ab276099; true Male 151359993 CVCL_B1F1 Abcam A-549 DDX60 KO cancer cell line human CVCL_B1F1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25942; DDX60; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359994 CVCL_B1F0 Abcam A-549 DDX58 KO 1 cancer cell line human CVCL_B1F0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19102; RIGI; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359995 CVCL_B1ER Abcam A-549 CD274 KO 1 cancer cell line human CVCL_B1ER CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17635; CD274; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359996 CVCL_B1F3 Abcam A-549 DNAH5 KO cancer cell line human CVCL_B1F3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2950; DNAH5; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359997 CVCL_B1EQ Abcam A-549 CA12 KO cancer cell line human CVCL_B1EQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1371; CA12; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359998 CVCL_B1F2 Abcam A-549 DEPDC5 KO cancer cell line human CVCL_B1F2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18423; DEPDC5; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151359999 CVCL_B1ED Abcam HCT 116 UBE2H KO cancer cell line human CVCL_B1ED CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12484; UBE2H; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360000 CVCL_B1EC Abcam HCT 116 TUBB3 KO cancer cell line human CVCL_B1EC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20772; TUBB3; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360001 CVCL_B1EF Abcam HCT 116 ZFYVE16 KO cancer cell line human CVCL_B1EF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20756; ZFYVE16; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360002 CVCL_B1EE Abcam HCT 116 UBE2K KO cancer cell line human CVCL_B1EE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4914; UBE2K; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360003 CVCL_B1EH Abcam A-549 ABCG2 KO cancer cell line human CVCL_B1EH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:74; ABCG2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360004 CVCL_B1EG Abcam A-549 ABCC1 KO cancer cell line human CVCL_B1EG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:51; ABCC1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360005 CVCL_B1EJ Abcam A-549 APOL2 KO 2 cancer cell line human CVCL_B1EJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:619; APOL2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360006 CVCL_B1EI Abcam A-549 ANGPTL6 KO cancer cell line human CVCL_B1EI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23140; ANGPTL6; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360007 CVCL_B1DZ Abcam HCT 116 PLK2 KO cancer cell line human CVCL_B1DZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19699; PLK2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360008 CVCL_B1EB Abcam HCT 116 TSPO KO cancer cell line human CVCL_B1EB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1158; TSPO; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360009 CVCL_B1EA Abcam HCT 116 TRIB3 KO cancer cell line human CVCL_B1EA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16228; TRIB3; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360010 CVCL_B1DS Abcam HCT 116 KRAS KO cancer cell line human CVCL_B1DS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6407; KRAS; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360011 CVCL_B1E4 Abcam HCT 116 RXRA KO cancer cell line human CVCL_B1E4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10477; RXRA; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360012 CVCL_B1DR Abcam HCT 116 ITGB1 KO cancer cell line human CVCL_B1DR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6153; ITGB1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360013 CVCL_B1E3 Abcam HCT 116 RRM2B KO cancer cell line human CVCL_B1E3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17296; RRM2B; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360014 CVCL_B1DU Abcam HCT 116 MLST8 KO cancer cell line human CVCL_B1DU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24825; MLST8; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360015 CVCL_B1E6 Abcam HCT 116 SP3 KO cancer cell line human CVCL_B1E6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11208; SP3; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360016 CVCL_B1DT Abcam HCT 116 MELK KO cancer cell line human CVCL_B1DT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16870; MELK; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360017 CVCL_B1E5 Abcam HCT 116 SLC9A3R1 KO cancer cell line human CVCL_B1E5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11075; NHERF1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360018 CVCL_B1DW Abcam HCT 116 NFKB2 KO cancer cell line human CVCL_B1DW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7795; NFKB2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360019 CVCL_B1E8 Abcam HCT 116 TLE5 KO cancer cell line human CVCL_B1E8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:307; TLE5; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360020 CVCL_B1DV Abcam HCT 116 MORF4L2 KO cancer cell line human CVCL_B1DV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16849; MORF4L2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360021 CVCL_B1E7 Abcam HCT 116 SQSTM1 KO cancer cell line human CVCL_B1E7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360022 CVCL_B1DY Abcam HCT 116 PKN2 KO cancer cell line human CVCL_B1DY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9406; PKN2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360023 CVCL_B1DX Abcam HCT 116 NR2F2 KO cancer cell line human CVCL_B1DX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7976; NR2F2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360024 CVCL_B1E9 Abcam HCT 116 TMSB10 KO cancer cell line human CVCL_B1E9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11879; TMSB10; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360025 CVCL_B1FM Abcam A-549 HTR3D KO 1 cancer cell line human CVCL_B1FM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24004; HTR3D; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360026 CVCL_B1FL Abcam A-549 HLA-E KO 2 cancer cell line human CVCL_B1FL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4962; HLA-E; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360027 CVCL_B1G0 Abcam A-549 IRF1 KO cancer cell line human CVCL_B1G0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6116; IRF1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360028 CVCL_B1FN Abcam A-549 IDO1 KO 1 cancer cell line human CVCL_B1FN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6059; IDO1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360029 CVCL_B1FQ Abcam A-549 IFI27 KO cancer cell line human CVCL_B1FQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5397; IFI27; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360030 CVCL_B1G2 Abcam A-549 IRF3 KO 2 cancer cell line human CVCL_B1G2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6118; IRF3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360031 CVCL_B1FP Abcam A-549 IFI16 KO 1 cancer cell line human CVCL_B1FP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5395; IFI16; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360032 CVCL_B1G1 Abcam A-549 IRF2 KO 2 cancer cell line human CVCL_B1G1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6117; IRF2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360033 CVCL_B1FS Abcam A-549 IFI44L KO 1 cancer cell line human CVCL_B1FS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17817; IFI44L; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360034 CVCL_B1G4 Abcam A-549 ISM1 KO 1 cancer cell line human CVCL_B1G4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16213; ISM1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360035 CVCL_B1FR Abcam A-549 IFI44 KO 1 cancer cell line human CVCL_B1FR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16938; IFI44; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360036 CVCL_B1G3 Abcam A-549 IRF7 KO 2 cancer cell line human CVCL_B1G3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6122; IRF7; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360037 CVCL_B1FE Abcam A-549 GCH1 KO 1 cancer cell line human CVCL_B1FE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4193; GCH1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360038 CVCL_B1FD Abcam A-549 GBP4 KO 1 cancer cell line human CVCL_B1FD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20480; GBP4; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360039 CVCL_B1FG Abcam A-549 HAPLN3 KO 1 cancer cell line human CVCL_B1FG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21446; HAPLN3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360040 CVCL_B1FF Abcam A-549 GMPR KO 1 cancer cell line human CVCL_B1FF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4376; GMPR; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360041 CVCL_B1FI Abcam A-549 HERC5 KO 1 cancer cell line human CVCL_B1FI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24368; HERC5; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360042 CVCL_B1FH Abcam A-549 HELZ2 KO 1 cancer cell line human CVCL_B1FH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30021; HELZ2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360043 CVCL_B1FK Abcam A-549 H1-2 KO cancer cell line human CVCL_B1FK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4716; H1-2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360044 CVCL_B1FJ Abcam A-549 HERC6 KO cancer cell line human CVCL_B1FJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26072; HERC6; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360045 CVCL_B1FA Abcam A-549 ETV7 KO 1 cancer cell line human CVCL_B1FA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18160; ETV7; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360046 CVCL_B1FC Abcam A-549 GBP2 KO 2 cancer cell line human CVCL_B1FC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4183; GBP2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360047 CVCL_B1FB Abcam A-549 GBP1 KO cancer cell line human CVCL_B1FB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4182; GBP1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360048 CVCL_B1ET Abcam A-549 CEACAM1 KO 2 cancer cell line human CVCL_B1ET CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1814; CEACAM1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360049 CVCL_B1F5 Abcam A-549 DTX3L KO 2 cancer cell line human CVCL_B1F5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30323; DTX3L; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360050 CVCL_B1ES Abcam A-549 CD9 KO cancer cell line human CVCL_B1ES CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1709; CD9; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360051 CVCL_B1F4 Abcam A-549 DSG2 KO 2 cancer cell line human CVCL_B1F4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3049; DSG2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360052 CVCL_B1EV Abcam A-549 CHEK1 KO cancer cell line human CVCL_B1EV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1925; CHEK1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360053 CVCL_B1F7 Abcam A-549 EPAS1 KO cancer cell line human CVCL_B1F7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3374; EPAS1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360054 CVCL_B1EU Abcam A-549 CFHR3 KO 1 cancer cell line human CVCL_B1EU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16980; CFHR3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360055 CVCL_B1F6 Abcam A-549 EIF2AK2 KO 1 cancer cell line human CVCL_B1F6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9437; EIF2AK2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360056 CVCL_B1EX Abcam A-549 CMPK2 KO 2 cancer cell line human CVCL_B1EX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27015; CMPK2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360057 CVCL_B1F9 Abcam A-549 ETV6 KO 1 cancer cell line human CVCL_B1F9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3495; ETV6; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360058 CVCL_B1EW Abcam A-549 CHMP2B KO cancer cell line human CVCL_B1EW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24537; CHMP2B; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360059 CVCL_B1F8 Abcam A-549 EPSTI1 KO 2 cancer cell line human CVCL_B1F8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16465; EPSTI1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360060 CVCL_B1EZ Abcam A-549 CYP1B1 KO 1 cancer cell line human CVCL_B1EZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2597; CYP1B1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360061 CVCL_B1EY Abcam A-549 CXCL10 KO 2 cancer cell line human CVCL_B1EY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10637; CXCL10; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360062 CVCL_B1CJ Abcam A-431 P4HB KO cancer cell line human CVCL_B1CJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8548; P4HB; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360063 CVCL_B1CI Abcam A-431 NT5E KO cancer cell line human CVCL_B1CI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8021; NT5E; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360064 CVCL_B1CL Abcam A-431 PPP2R5D KO cancer cell line human CVCL_B1CL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9312; PPP2R5D; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360065 CVCL_B1CK Abcam A-431 PERP KO cancer cell line human CVCL_B1CK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17637; PERP; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360066 CVCL_B1CN Abcam A-431 SOS1 KO cancer cell line human CVCL_B1CN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11187; SOS1; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360067 CVCL_B1CM Abcam A-431 PXN KO cancer cell line human CVCL_B1CM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9718; PXN; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360068 CVCL_B1CP Abcam A-431 STK24 KO cancer cell line human CVCL_B1CP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11403; STK24; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360069 CVCL_B1D1 IRCC-Neuromed-NULU cancer cell line human CVCL_B1D1 CL:0000010 Derived from site: In situ; Brain, temporo-parietal junction; UBERON=UBERON_0023852. Female 151360070 CVCL_B1D0 IRCC-Neuromed-IP cancer cell line human CVCL_B1D0 CL:0000010 Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871. Male 151360071 CVCL_B1CB Abcam A-431 KRT13 KO cancer cell line human CVCL_B1CB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6415; KRT13; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360072 CVCL_B1CA Abcam A-431 IL1RN KO 1 cancer cell line human CVCL_B1CA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6000; IL1RN; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360073 CVCL_B1CD Abcam A-431 KRT15 KO cancer cell line human CVCL_B1CD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6421; KRT15; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360074 CVCL_B1CC Abcam A-431 KRT14 KO cancer cell line human CVCL_B1CC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6416; KRT14; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360075 CVCL_B1CF Abcam A-431 MYL9 KO cancer cell line human CVCL_B1CF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15754; MYL9; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360076 CVCL_B1CE Abcam A-431 MMP14 KO cancer cell line human CVCL_B1CE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7160; MMP14; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360077 CVCL_B1CH Abcam A-431 NEK9 KO cancer cell line human CVCL_B1CH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18591; NEK9; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360078 CVCL_B1CG Abcam A-431 NBN KO cancer cell line human CVCL_B1CG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7652; NBN; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360079 CVCL_B1BY Abcam A-431 CTNNB1 KO cancer cell line human CVCL_B1BY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2514; CTNNB1; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360080 CVCL_B1BX Abcam A-431 CLDN1 KO cancer cell line human CVCL_B1BX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2032; CLDN1; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360081 CVCL_B1C9 Abcam A-431 HSP90AB1 KO cancer cell line human CVCL_B1C9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5258; HSP90AB1; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360082 CVCL_B1BZ Abcam A-431 CTSD KO cancer cell line human CVCL_B1BZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2529; CTSD; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360083 CVCL_B1C2 Abcam A-431 DPF2 KO cancer cell line human CVCL_B1C2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9964; DPF2; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360084 CVCL_B1BQ Abcam Raji CXCR5 KO cancer cell line human CVCL_B1BQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1060; CXCR5; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 151360085 CVCL_B1C1 Abcam A-431 DHCR24 KO cancer cell line human CVCL_B1C1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2859; DHCR24; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360086 CVCL_B1BP Abcam Raji CD86 KO cancer cell line human CVCL_B1BP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1705; CD86; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 151360087 CVCL_B1BS Abcam A-431 B2M KO cancer cell line human CVCL_B1BS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360088 CVCL_B1C4 Abcam A-431 EPCAM KO cancer cell line human CVCL_B1C4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11529; EPCAM; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360089 CVCL_B1BR Abcam A-431 ADRB2 KO cancer cell line human CVCL_B1BR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:286; ADRB2; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360090 CVCL_B1C3 Abcam A-431 DUSP6 KO cancer cell line human CVCL_B1C3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3072; DUSP6; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360091 CVCL_B1BU Abcam A-431 CAV1 KO cancer cell line human CVCL_B1BU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1527; CAV1; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360092 CVCL_B1C6 Abcam A-431 GRB2 KO cancer cell line human CVCL_B1C6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4566; GRB2; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360093 CVCL_B1BT Abcam A-431 BST2 KO cancer cell line human CVCL_B1BT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1119; BST2; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360094 CVCL_B1C5 Abcam A-431 G3BP1 KO cancer cell line human CVCL_B1C5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30292; G3BP1; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360095 CVCL_B1BW Abcam A-431 CENPB KO cancer cell line human CVCL_B1BW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1852; CENPB; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360096 CVCL_B1C8 Abcam A-431 HLA-A KO cancer cell line human CVCL_B1C8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360097 CVCL_B1BV Abcam A-431 CBFB KO cancer cell line human CVCL_B1BV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1539; CBFB; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360098 CVCL_B1C7 Abcam A-431 H1-0 KO cancer cell line human CVCL_B1C7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4714; H1-0; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360099 CVCL_B1DK Abcam HCT 116 GNA13 KO cancer cell line human CVCL_B1DK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4381; GNA13; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360100 CVCL_B1DJ Abcam HCT 116 GLI4 KO cancer cell line human CVCL_B1DJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4320; GLI4; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360101 CVCL_B1DM Abcam HCT 116 GRB2 KO cancer cell line human CVCL_B1DM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4566; GRB2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360102 CVCL_B1DL Abcam HCT 116 GNB1 KO cancer cell line human CVCL_B1DL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4396; GNB1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360103 CVCL_B1E0 Abcam HCT 116 PODXL KO cancer cell line human CVCL_B1E0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9171; PODXL; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360104 CVCL_B1DN Abcam HCT 116 HELLS KO cancer cell line human CVCL_B1DN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4861; HELLS; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360105 CVCL_B1DQ Abcam HCT 116 HK2 KO cancer cell line human CVCL_B1DQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4923; HK2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360106 CVCL_B1E2 Abcam HCT 116 RBBP7 KO cancer cell line human CVCL_B1E2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9890; RBBP7; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360107 CVCL_B1DP Abcam HCT 116 HIF1A KO cancer cell line human CVCL_B1DP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4910; HIF1A; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360108 CVCL_B1E1 Abcam HCT 116 POR KO cancer cell line human CVCL_B1E1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9208; POR; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360109 CVCL_B1DC Abcam HCT 116 CTNNB1 KO cancer cell line human CVCL_B1DC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2514; CTNNB1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360110 CVCL_B1DB Abcam HCT 116 CSNK2A1 KO cancer cell line human CVCL_B1DB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2457; CSNK2A1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360111 CVCL_B1DE Abcam HCT 116 DMPK KO cancer cell line human CVCL_B1DE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2933; DMPK; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360112 CVCL_B1DD Abcam HCT 116 DIAPH1 KO cancer cell line human CVCL_B1DD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2876; DIAPH1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360113 CVCL_B1DG Abcam HCT 116 EPHA2 KO cancer cell line human CVCL_B1DG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3386; EPHA2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360114 CVCL_B1DF Abcam HCT 116 EIF1 KO cancer cell line human CVCL_B1DF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3249; EIF1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360115 CVCL_B1DI Abcam HCT 116 FSCN1 KO cancer cell line human CVCL_B1DI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11148; FSCN1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360116 CVCL_B1DH Abcam HCT 116 FGFR4 KO 1 cancer cell line human CVCL_B1DH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3691; FGFR4; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360117 CVCL_B1CZ IRCC-Neuromed-VEM cancer cell line human CVCL_B1CZ CL:0000010 Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871. Male 151360118 CVCL_B1CY IRCC-Neuromed-ZAR cancer cell line human CVCL_B1CY CL:0000010 Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871. Male 151360119 CVCL_B1DA Abcam HCT 116 CDKN1A KO 1 cancer cell line human CVCL_B1DA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1784; CDKN1A; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360120 CVCL_B1CR Abcam A-431 VCL KO cancer cell line human CVCL_B1CR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12665; VCL; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360121 CVCL_B1D3 IRCC-Neuromed-DA cancer cell line human CVCL_B1D3 CL:0000010 Derived from site: In situ; Brain, central sulcus; UBERON=UBERON_0002916. Female 151360122 CVCL_B1CQ Abcam A-431 VAMP8 KO cancer cell line human CVCL_B1CQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12647; VAMP8; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151360123 CVCL_B1D2 IRCC-Neuromed-CG cancer cell line human CVCL_B1D2 CL:0000010 Derived from site: In situ; Brain, temporo-insular lobe. Female 151360124 CVCL_B1CT Ham-2 cancer cell line CVCL_B1CT CL:0000010 Transformant: ChEBI; CHEBI_35807; N-nitrosodimethylamine (NDMA; Dimethylnitrosamine; DMN); Transformant: NCBI_TaxID; 6198; Opisthorchis viverrini. Male Characteristics: Obtained by both Opisthorchis viverrini infection and N-nitrosodimethylamine treatment (PubMed=34549357) Doubling time: 45.8 +- 2.1 hours (PubMed=34549357) 151360125 CVCL_B1D5 IRCC-Neuromed-MI cancer cell line human CVCL_B1D5 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Unspecified (PubMed=33398536) Derived from site: In situ; Brain, temporo-parietal junction; UBERON=UBERON_0023852. Female 151360126 CVCL_B1CS Abcam A-431 NDRG1 KO cancer cell line human CVCL_B1CS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7679; NDRG1; Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Discontinued: Abcam; ab277849; true Female 151360127 CVCL_B1D4 IRCC-Neuromed-FL cancer cell line human CVCL_B1D4 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Unspecified (PubMed=33398536) Derived from site: In situ; Brain, cerebral cortex, insular lobe; UBERON=UBERON_0002022. Female 151360128 CVCL_B1D7 Abcam HCT 116 ADAM17 KO cancer cell line human CVCL_B1D7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:195; ADAM17; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360129 CVCL_B1CV IRCC-Neuromed-CL cancer cell line human CVCL_B1CV CL:0000010 Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525. Male 151360130 CVCL_B1CU IRCC-Neuromed-COGI cancer cell line human CVCL_B1CU CL:0000010 Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525. Male 151360131 CVCL_B1D9 Abcam HCT 116 CD2BP2 KO cancer cell line human CVCL_B1D9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1656; CD2BP2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360132 CVCL_B1CX IRCC-Neuromed-DNA cancer cell line human CVCL_B1CX CL:0000010 Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871. Male 151360133 CVCL_B1D8 Abcam HCT 116 ATF3 KO cancer cell line human CVCL_B1D8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:785; ATF3; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151360134 CVCL_B1CW IRCC-Neuromed-PAP cancer cell line human CVCL_B1CW CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Unspecified (PubMed=33398536) Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871. Male 151360135 CVCL_B0YA XF27/28.43E2 hybridoma house mouse CVCL_B0YA CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4054 151360136 CVCL_B0YC XF3.10B8 hybridoma house mouse CVCL_B0YC CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3151 151360137 CVCL_B0YB XF27/28.55G4 hybridoma house mouse CVCL_B0YB CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195 151360138 CVCL_B0YE XF3.6A2 hybridoma house mouse CVCL_B0YE CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3148 151360139 CVCL_B0YD XF3.5F1 hybridoma house mouse CVCL_B0YD CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3147 151360140 CVCL_B0YG Abcam HEK293 JUN KO transformed cell line human CVCL_B0YG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6204; JUN Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151360141 CVCL_B0YF Abcam HEK293 SDHB KO transformed cell line human CVCL_B0YF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10681; SDHB Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151360142 CVCL_B0XX XF11.1D8 hybridoma house mouse CVCL_B0XX CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3030 151360143 CVCL_B0Y9 XF27/28.36F11 hybridoma house mouse CVCL_B0Y9 CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4053 151360144 CVCL_B0XW AAVpro 293T transformed cell line human CVCL_B0XW CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151360145 CVCL_B0Y8 XF27/28.36A12 hybridoma house mouse CVCL_B0Y8 CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4052 151360146 CVCL_B0XZ XF11.1G8 hybridoma house mouse CVCL_B0XZ CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3027 151360147 CVCL_B0XY XF11.1F8 hybridoma house mouse CVCL_B0XY CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3150 151360148 CVCL_B0Y1 XF11.4D10 hybridoma house mouse CVCL_B0Y1 CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3026 151360149 CVCL_B0Y0 XF11.4C4 hybridoma house mouse CVCL_B0Y0 CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3028 151360150 CVCL_B0Y3 XF22.3C9.6 hybridoma house mouse CVCL_B0Y3 CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3702 151360151 CVCL_B0Y2 XF11.5H1 hybridoma house mouse CVCL_B0Y2 CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3029 151360152 CVCL_B0XT Abcam HEK293T SIGMAR1 KO transformed cell line human CVCL_B0XT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8157; SIGMAR1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151360153 CVCL_B0Y5 XF27/28.7D5 hybridoma house mouse CVCL_B0Y5 CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4049 151360154 CVCL_B0Y4 XF22.9E6 hybridoma house mouse CVCL_B0Y4 CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3859 151360155 CVCL_B0XV Abcam HeLa SORT1 KO cancer cell line human CVCL_B0XV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11186; SORT1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360156 CVCL_B0Y7 XF27/28.25G10 hybridoma house mouse CVCL_B0Y7 CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4051 151360157 CVCL_B0XU HeLa SIGMAR1 KO cancer cell line human CVCL_B0XU From: Durcan, Thomas M.; Montreal Neurological Institute, McGill University; Montreal; Canada CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8157; SIGMAR1 Miscellaneous: Cell line information from personal communication of Laflamme, Carl Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360158 CVCL_B0Y6 XF27/28.18B5 hybridoma house mouse CVCL_B0Y6 CL:0000010 Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195 Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4050 151360159 CVCL_B2CI Abcam HeLa PSME4 KO cancer cell line human CVCL_B2CI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20635; PSME4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360160 CVCL_B2CH Abcam HeLa PSMD5 KO cancer cell line human CVCL_B2CH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9563; PSMD5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360161 CVCL_B2CK Abcam HeLa PTBP1 KO cancer cell line human CVCL_B2CK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9583; PTBP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360162 CVCL_B2CJ Abcam HeLa PSRC1 KO cancer cell line human CVCL_B2CJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24472; PSRC1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360163 CVCL_B2CM Abcam HeLa PTGER3 KO cancer cell line human CVCL_B2CM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9595; PTGER3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360164 CVCL_B2CL Abcam HeLa PTEN KO cancer cell line human CVCL_B2CL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9588; PTEN Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360165 CVCL_B2D0 Abcam HeLa RAB20 KO cancer cell line human CVCL_B2D0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18260; RAB20 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360166 CVCL_B2CN Abcam HeLa PTGFRN KO cancer cell line human CVCL_B2CN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9601; PTGFRN Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360167 CVCL_B2CA Abcam HeLa PRSS23 KO cancer cell line human CVCL_B2CA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14370; PRSS23 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360168 CVCL_B2CC Abcam HeLa PSCA KO cancer cell line human CVCL_B2CC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9500; PSCA Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360169 CVCL_B2CB Abcam HeLa PSAP KO cancer cell line human CVCL_B2CB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9498; PSAP Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360170 CVCL_B2CE Abcam HeLa PSKH1 KO cancer cell line human CVCL_B2CE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9529; PSKH1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360171 CVCL_B2CD Abcam HeLa PSENEN KO cancer cell line human CVCL_B2CD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30100; PSENEN Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265826; true Female 151360172 CVCL_B2CG Abcam HeLa PSMD10 KO cancer cell line human CVCL_B2CG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9555; PSMD10 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360173 CVCL_B2CF Abcam HeLa PSMB10 KO cancer cell line human CVCL_B2CF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9538; PSMB10 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360174 CVCL_B2BX Abcam HeLa PPP1R3C KO cancer cell line human CVCL_B2BX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9293; PPP1R3C Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360175 CVCL_B2C9 Abcam HeLa PRSS21 KO cancer cell line human CVCL_B2C9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9485; PRSS21 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360176 CVCL_B2BW Abcam HeLa PPP1R26 KO cancer cell line human CVCL_B2BW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29089; PPP1R26 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360177 CVCL_B2C8 Abcam HeLa PRRT2 KO cancer cell line human CVCL_B2C8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30500; PRRT2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360178 CVCL_B2BZ Abcam HeLa PPP3CA KO cancer cell line human CVCL_B2BZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9314; PPP3CA Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360179 CVCL_B2BY Abcam HeLa PPP2R5E KO cancer cell line human CVCL_B2BY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9313; PPP2R5E Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360180 CVCL_B2BP Abcam HeLa PPID KO cancer cell line human CVCL_B2BP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9257; PPID Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360181 CVCL_B2C1 Abcam HeLa PRAP1 KO cancer cell line human CVCL_B2C1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23304; PRAP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360182 CVCL_B2C0 Abcam HeLa PPP4R3B KO cancer cell line human CVCL_B2C0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29267; PPP4R3B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360183 CVCL_B2BR Abcam HeLa PPM1H KO cancer cell line human CVCL_B2BR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18583; PPM1H Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360184 CVCL_B2C3 Abcam HeLa PRKAR1B KO cancer cell line human CVCL_B2C3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9390; PRKAR1B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360185 CVCL_B2BQ Abcam HeLa PPM1A KO cancer cell line human CVCL_B2BQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9275; PPM1A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360186 CVCL_B2C2 Abcam HeLa PRKACB KO cancer cell line human CVCL_B2C2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9381; PRKACB Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360187 CVCL_B2BT Abcam HeLa PPP1R13L KO cancer cell line human CVCL_B2BT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18838; PPP1R13L Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360188 CVCL_B2C5 Abcam HeLa PRKCD KO cancer cell line human CVCL_B2C5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9399; PRKCD Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360189 CVCL_B2BS Abcam HeLa PPP1CC KO cancer cell line human CVCL_B2BS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9283; PPP1CC Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360190 CVCL_B2C4 Abcam HeLa PRKAR2A KO cancer cell line human CVCL_B2C4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9391; PRKAR2A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360191 CVCL_B2BV Abcam HeLa PPP1R2 KO cancer cell line human CVCL_B2BV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9288; PPP1R2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360192 CVCL_B2C7 Abcam HeLa PRKD3 KO cancer cell line human CVCL_B2C7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9408; PRKD3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360193 CVCL_B2BU Abcam HeLa PPP1R15B KO cancer cell line human CVCL_B2BU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14951; PPP1R15B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360194 CVCL_B2C6 Abcam HeLa PRKCI KO cancer cell line human CVCL_B2C6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9404; PRKCI Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360195 CVCL_B2DJ Abcam HeLa RBPMS KO cancer cell line human CVCL_B2DJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19097; RBPMS Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360196 CVCL_B2DI Abcam HeLa RBL1 KO cancer cell line human CVCL_B2DI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9893; RBL1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360197 CVCL_B2DL Abcam HeLa RELA KO cancer cell line human CVCL_B2DL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9955; RELA Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360198 CVCL_B2DK Abcam HeLa RCHY1 KO cancer cell line human CVCL_B2DK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17479; RCHY1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360199 CVCL_B2DN Abcam HeLa REXO4 KO cancer cell line human CVCL_B2DN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12820; REXO4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360200 CVCL_B2DM Abcam HeLa RELB KO cancer cell line human CVCL_B2DM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9956; RELB Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360201 CVCL_B2DP Abcam HeLa RFWD3 KO cancer cell line human CVCL_B2DP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25539; RFWD3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360202 CVCL_B2E1 Abcam HeLa ROCK2 KO cancer cell line human CVCL_B2E1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10252; ROCK2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360203 CVCL_B2E0 Abcam HeLa RNF41 KO cancer cell line human CVCL_B2E0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18401; RNF41 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360204 CVCL_B2DB Abcam HeLa RALBP1 KO cancer cell line human CVCL_B2DB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9841; RALBP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360205 CVCL_B2DA Abcam HeLa RALA KO cancer cell line human CVCL_B2DA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9839; RALA Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360206 CVCL_B2DD Abcam HeLa RANBP2 KO cancer cell line human CVCL_B2DD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9848; RANBP2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360207 CVCL_B2DC Abcam HeLa RANBP10 KO cancer cell line human CVCL_B2DC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29285; RANBP10 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360208 CVCL_B2DF Abcam HeLa RARA KO cancer cell line human CVCL_B2DF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9864; RARA Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360209 CVCL_B2DE Abcam HeLa RAP1GDS1 KO cancer cell line human CVCL_B2DE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9859; RAP1GDS1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360210 CVCL_B2DH Abcam HeLa RBBP7 KO cancer cell line human CVCL_B2DH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9890; RBBP7 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360211 CVCL_B2DG Abcam HeLa RAVER1 KO cancer cell line human CVCL_B2DG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30296; RAVER1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360212 CVCL_B2CY Abcam HeLa QRICH1 KO cancer cell line human CVCL_B2CY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24713; QRICH1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360213 CVCL_B2CX Abcam HeLa PXN KO cancer cell line human CVCL_B2CX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9718; PXN Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360214 CVCL_B2D9 Abcam HeLa RAF1 KO cancer cell line human CVCL_B2D9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9829; RAF1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360215 CVCL_B2CZ Abcam HeLa QTRT1 KO cancer cell line human CVCL_B2CZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23797; QTRT1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360216 CVCL_B2CQ Abcam HeLa PTGS2 KO cancer cell line human CVCL_B2CQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9605; PTGS2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360217 CVCL_B2D2 Abcam HeLa RAB31 KO cancer cell line human CVCL_B2D2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9771; RAB31 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360218 CVCL_B2CP Abcam HeLa PTGR1 KO cancer cell line human CVCL_B2CP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18429; PTGR1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360219 CVCL_B2D1 Abcam HeLa RAB27A KO cancer cell line human CVCL_B2D1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9766; RAB27A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360220 CVCL_B2CS Abcam HeLa PTPN13 KO cancer cell line human CVCL_B2CS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9646; PTPN13 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360221 CVCL_B2D4 Abcam HeLa RAB7A KO cancer cell line human CVCL_B2D4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9788; RAB7A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360222 CVCL_B2CR Abcam HeLa PTPN1 KO cancer cell line human CVCL_B2CR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9642; PTPN1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360223 CVCL_B2D3 Abcam HeLa RAB35 KO cancer cell line human CVCL_B2D3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9774; RAB35 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360224 CVCL_B2CU Abcam HeLa PTS KO cancer cell line human CVCL_B2CU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9689; PTS Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360225 CVCL_B2D6 Abcam HeLa RAB9A KO cancer cell line human CVCL_B2D6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9792; RAB9A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360226 CVCL_B2CT Abcam HeLa PTPRS KO cancer cell line human CVCL_B2CT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9681; PTPRS Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360227 CVCL_B2D5 Abcam HeLa RAB8A KO cancer cell line human CVCL_B2D5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7007; RAB8A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360228 CVCL_B2CW Abcam HeLa PUS7 KO cancer cell line human CVCL_B2CW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26033; PUS7 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360229 CVCL_B2D8 Abcam HeLa RAD1 KO cancer cell line human CVCL_B2D8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9806; RAD1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360230 CVCL_B2CV Abcam HeLa PUM1 KO cancer cell line human CVCL_B2CV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14957; PUM1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360231 CVCL_B2D7 Abcam HeLa RABAC1 KO cancer cell line human CVCL_B2D7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9794; RABAC1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360232 CVCL_B2AG Abcam HeLa PERP KO cancer cell line human CVCL_B2AG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17637; PERP Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360233 CVCL_B2AF Abcam HeLa PEG10 KO cancer cell line human CVCL_B2AF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14005; PEG10 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360234 CVCL_B2AI Abcam HeLa PGAM5 KO cancer cell line human CVCL_B2AI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28763; PGAM5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360235 CVCL_B2AH Abcam HeLa PFKP KO cancer cell line human CVCL_B2AH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8878; PFKP Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360236 CVCL_B2AK Abcam HeLa PHF6 KO cancer cell line human CVCL_B2AK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18145; PHF6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360237 CVCL_B2AJ Abcam HeLa PGR KO cancer cell line human CVCL_B2AJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8910; PGR Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360238 CVCL_B2AM Abcam HeLa PHLDA3 KO cancer cell line human CVCL_B2AM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8934; PHLDA3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360239 CVCL_B2AL Abcam HeLa PHIP KO cancer cell line human CVCL_B2AL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15673; PHIP Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360240 CVCL_B2AA Abcam HeLa PDGFD KO cancer cell line human CVCL_B2AA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30620; PDGFD Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265304; true Female 151360241 CVCL_B2AC Abcam HeLa PDHA1 KO cancer cell line human CVCL_B2AC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8806; PDHA1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360242 CVCL_B2AB Abcam HeLa PDGFRA KO cancer cell line human CVCL_B2AB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8803; PDGFRA Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab261827; true Female 151360243 CVCL_B2AE Abcam HeLa PDK4 KO cancer cell line human CVCL_B2AE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8812; PDK4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360244 CVCL_B2AD Abcam HeLa PDIA5 KO cancer cell line human CVCL_B2AD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24811; PDIA5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360245 CVCL_B2A7 Abcam HeLa PDE3B KO cancer cell line human CVCL_B2A7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8779; PDE3B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360246 CVCL_B2A6 Abcam HeLa PDCD4 KO cancer cell line human CVCL_B2A6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8763; PDCD4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360247 CVCL_B2A9 Abcam HeLa PDGFC KO cancer cell line human CVCL_B2A9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8801; PDGFC Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360248 CVCL_B2A8 Abcam HeLa PDE4B KO cancer cell line human CVCL_B2A8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8781; PDE4B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360249 CVCL_B2A1 Abcam HeLa PATL1 KO cancer cell line human CVCL_B2A1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26721; PATL1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360250 CVCL_B2A0 Abcam HeLa PARP3 KO cancer cell line human CVCL_B2A0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:273; PARP3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360251 CVCL_B2A3 Abcam HeLa PCOLCE2 KO cancer cell line human CVCL_B2A3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8739; PCOLCE2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360252 CVCL_B2A2 Abcam HeLa PCNT KO cancer cell line human CVCL_B2A2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16068; PCNT Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360253 CVCL_B2A5 Abcam HeLa PDCD10 KO cancer cell line human CVCL_B2A5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8761; PDCD10 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360254 CVCL_B2A4 Abcam HeLa PDCD1 KO cancer cell line human CVCL_B2A4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8760; PDCD1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360255 CVCL_B2BH Abcam HeLa POLM KO cancer cell line human CVCL_B2BH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9185; POLM Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360256 CVCL_B2BG Abcam HeLa POLL KO cancer cell line human CVCL_B2BG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9184; POLL Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360257 CVCL_B2BJ Abcam HeLa PON2 KO cancer cell line human CVCL_B2BJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9205; PON2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360258 CVCL_B2BI Abcam HeLa POLR1D KO cancer cell line human CVCL_B2BI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20422; POLR1D Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360259 CVCL_B2BL Abcam HeLa PORCN KO cancer cell line human CVCL_B2BL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17652; PORCN Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360260 CVCL_B2BK Abcam HeLa POR KO cancer cell line human CVCL_B2BK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9208; POR Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360261 CVCL_B2BN Abcam HeLa PPIB KO cancer cell line human CVCL_B2BN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9255; PPIB Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360262 CVCL_B2BM Abcam HeLa POSTN KO cancer cell line human CVCL_B2BM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16953; POSTN Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360263 CVCL_B2BB Abcam HeLa PODXL KO cancer cell line human CVCL_B2BB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9171; PODXL Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360264 CVCL_B2BA Abcam HeLa PNKD KO cancer cell line human CVCL_B2BA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9153; PNKD Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360265 CVCL_B2BD Abcam HeLa POLB KO cancer cell line human CVCL_B2BD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9174; POLB Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab261748; true Female 151360266 CVCL_B2BC Abcam HeLa POGK KO cancer cell line human CVCL_B2BC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18800; POGK Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360267 CVCL_B2BF Abcam HeLa POLE4 KO cancer cell line human CVCL_B2BF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18755; POLE4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360268 CVCL_B2BE Abcam HeLa POLDIP3 KO cancer cell line human CVCL_B2BE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23782; POLDIP3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360269 CVCL_B2AW Abcam HeLa PITPNB KO cancer cell line human CVCL_B2AW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9002; PITPNB Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360270 CVCL_B2B8 Abcam HeLa PML KO cancer cell line human CVCL_B2B8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9113; PML Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360271 CVCL_B2AV Abcam HeLa PIP5K1C KO cancer cell line human CVCL_B2AV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8996; PIP5K1C Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360272 CVCL_B2B7 Abcam HeLa PLK2 KO cancer cell line human CVCL_B2B7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19699; PLK2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360273 CVCL_B2AY Abcam HeLa PKN2 KO cancer cell line human CVCL_B2AY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9406; PKN2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360274 CVCL_B2AX Abcam HeLa PKDCC KO cancer cell line human CVCL_B2AX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25123; PKDCC Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360275 CVCL_B2B9 Abcam HeLa PMS2 KO cancer cell line human CVCL_B2B9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9122; PMS2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360276 CVCL_B2AZ Abcam HeLa PKP3 KO cancer cell line human CVCL_B2AZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9025; PKP3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360277 CVCL_B2B0 Abcam HeLa PLA2G12A KO cancer cell line human CVCL_B2B0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18554; PLA2G12A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360278 CVCL_B2AN Abcam HeLa PI4K2A KO cancer cell line human CVCL_B2AN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30031; PI4K2A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360279 CVCL_B2AQ Abcam HeLa PICALM KO cancer cell line human CVCL_B2AQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15514; PICALM Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360280 CVCL_B2B2 Abcam HeLa PLA2G4A KO cancer cell line human CVCL_B2B2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9035; PLA2G4A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360281 CVCL_B2AP Abcam HeLa PI4K2B KO cancer cell line human CVCL_B2AP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18215; PI4K2B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360282 CVCL_B2B1 Abcam HeLa PLA2G15 KO cancer cell line human CVCL_B2B1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17163; PLA2G15 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360283 CVCL_B2AS Abcam HeLa PIK3R1 KO cancer cell line human CVCL_B2AS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8979; PIK3R1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360284 CVCL_B2B4 Abcam HeLa PLCB1 KO cancer cell line human CVCL_B2B4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15917; PLCB1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360285 CVCL_B2AR Abcam HeLa PIK3C2A KO cancer cell line human CVCL_B2AR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8971; PIK3C2A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360286 CVCL_B2B3 Abcam HeLa PLAA KO cancer cell line human CVCL_B2B3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9043; PLAA Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360287 CVCL_B2AU Abcam HeLa PIP4K2C KO cancer cell line human CVCL_B2AU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23786; PIP4K2C Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360288 CVCL_B2B6 Abcam HeLa PLD2 KO cancer cell line human CVCL_B2B6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9068; PLD2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360289 CVCL_B2AT Abcam HeLa PIP4K2A KO cancer cell line human CVCL_B2AT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8997; PIP4K2A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360290 CVCL_B2B5 Abcam HeLa PLCB3 KO cancer cell line human CVCL_B2B5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9056; PLCB3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360291 CVCL_B2KQ Abcam HeLa USP54 KO cancer cell line human CVCL_B2KQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23513; USP54 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360292 CVCL_B2L2 Abcam HeLa VIM KO cancer cell line human CVCL_B2L2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12692; VIM Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360293 CVCL_B2KP Abcam HeLa USP42 KO cancer cell line human CVCL_B2KP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20068; USP42 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360294 CVCL_B2L1 Abcam HeLa VEGFA KO cancer cell line human CVCL_B2L1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12680; VEGFA Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab255445; true Female 151360295 CVCL_B2KS Abcam HeLa USP9X KO cancer cell line human CVCL_B2KS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12632; USP9X Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360296 CVCL_B2L4 Abcam HeLa VOPP1 KO cancer cell line human CVCL_B2L4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:34518; VOPP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360297 CVCL_B2KR Abcam HeLa USP8 KO cancer cell line human CVCL_B2KR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12631; USP8 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360298 CVCL_B2L3 Abcam HeLa VKORC1 KO cancer cell line human CVCL_B2L3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23663; VKORC1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360299 CVCL_B2KU Abcam HeLa VASP KO cancer cell line human CVCL_B2KU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12652; VASP Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360300 CVCL_B2L6 Abcam HeLa VRK3 KO cancer cell line human CVCL_B2L6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18996; VRK3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360301 CVCL_B2KT Abcam HeLa VAC14 KO cancer cell line human CVCL_B2KT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25507; VAC14 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360302 CVCL_B2L5 Abcam HeLa VRK2 KO cancer cell line human CVCL_B2L5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12719; VRK2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360303 CVCL_B2KW Abcam HeLa VAV2 KO cancer cell line human CVCL_B2KW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12658; VAV2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360304 CVCL_B2L8 Abcam HeLa WASF2 KO cancer cell line human CVCL_B2L8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12733; WASF2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360305 CVCL_B2KV Abcam HeLa VAV1 KO cancer cell line human CVCL_B2KV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12657; VAV1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265196; true Female 151360306 CVCL_B2L7 Abcam HeLa VTI1B KO cancer cell line human CVCL_B2L7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17793; VTI1B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360307 CVCL_B2KI Abcam HeLa USP14 KO cancer cell line human CVCL_B2KI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12612; USP14 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360308 CVCL_B2KH Abcam HeLa USP1 KO cancer cell line human CVCL_B2KH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12607; USP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360309 CVCL_B2KK Abcam HeLa USP22 KO cancer cell line human CVCL_B2KK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12621; USP22 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360310 CVCL_B2KJ Abcam HeLa USP18 KO cancer cell line human CVCL_B2KJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12616; USP18 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265458; true Female 151360311 CVCL_B2KM Abcam HeLa USP40 KO 1 cancer cell line human CVCL_B2KM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20069; USP40 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360312 CVCL_B2KL Abcam HeLa USP34 KO cancer cell line human CVCL_B2KL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20066; USP34 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360313 CVCL_B2L0 Abcam HeLa VDR KO cancer cell line human CVCL_B2L0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12679; VDR Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360314 CVCL_B2KN Abcam HeLa USP40 KO 2 cancer cell line human CVCL_B2KN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20069; USP40 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360315 CVCL_B2KA Abcam HeLa UBE3B KO 2 cancer cell line human CVCL_B2KA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13478; UBE3B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360316 CVCL_B2KC Abcam HeLa UBXN4 KO cancer cell line human CVCL_B2KC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14860; UBXN4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360317 CVCL_B2KB Abcam HeLa UBQLN1 KO cancer cell line human CVCL_B2KB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12508; UBQLN1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360318 CVCL_B2KE Abcam HeLa UHMK1 KO cancer cell line human CVCL_B2KE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19683; UHMK1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360319 CVCL_B2KD Abcam HeLa UGCG KO cancer cell line human CVCL_B2KD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12524; UGCG Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265916; true Female 151360320 CVCL_B2KG Abcam HeLa USB1 KO cancer cell line human CVCL_B2KG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25792; USB1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360321 CVCL_B2KF Abcam HeLa UNG KO cancer cell line human CVCL_B2KF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12572; UNG Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360322 CVCL_B2JX Abcam HeLa TTC3 KO cancer cell line human CVCL_B2JX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12393; TTC3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360323 CVCL_B2K9 Abcam HeLa UBE3B KO 1 cancer cell line human CVCL_B2K9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13478; UBE3B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360324 CVCL_B2JW Abcam HeLa TSSK4 KO cancer cell line human CVCL_B2JW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19825; TSSK4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360325 CVCL_B2K8 Abcam HeLa UBE2O KO cancer cell line human CVCL_B2K8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29554; UBE2O Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360326 CVCL_B2JZ Abcam HeLa TWF1 KO cancer cell line human CVCL_B2JZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9620; TWF1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360327 CVCL_B2JY Abcam HeLa TUBB3 KO cancer cell line human CVCL_B2JY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20772; TUBB3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360328 CVCL_B2M3 Abcam A-549 APOL6 KO 1 cancer cell line human CVCL_B2M3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14870; APOL6; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360329 CVCL_B2LR Abcam HeLa ZMAT3 KO cancer cell line human CVCL_B2LR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29983; ZMAT3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360330 CVCL_B2M2 Abcam A-549 APOL2 KO 1 cancer cell line human CVCL_B2M2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:619; APOL2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360331 CVCL_B2LQ Abcam HeLa ZDHHC7 KO cancer cell line human CVCL_B2LQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18459; ZDHHC7 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360332 CVCL_B2M5 Abcam A-549 ATM KO cancer cell line human CVCL_B2M5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:795; ATM; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360333 CVCL_B2LT Abcam HeLa ZMYM3 KO cancer cell line human CVCL_B2LT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13054; ZMYM3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360334 CVCL_B2M4 Abcam A-549 ARRDC3 KO cancer cell line human CVCL_B2M4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29263; ARRDC3; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360335 CVCL_B2LS Abcam HeLa ZMPSTE24 KO cancer cell line human CVCL_B2LS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12877; ZMPSTE24 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360336 CVCL_B2M7 Abcam A-549 BATF2 KO 2 cancer cell line human CVCL_B2M7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25163; BATF2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360337 CVCL_B2LV Abcam HeLa ZNF609 KO cancer cell line human CVCL_B2LV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29003; ZNF609 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360338 CVCL_B2M6 Abcam A-549 ATR KO cancer cell line human CVCL_B2M6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:882; ATR; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360339 CVCL_B2LU Abcam HeLa ZNF326 KO cancer cell line human CVCL_B2LU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14104; ZNF326 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360340 CVCL_B2M9 Abcam A-549 CBR1 KO cancer cell line human CVCL_B2M9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1548; CBR1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360341 CVCL_B2LX Abcam HeLa ZNF692 KO cancer cell line human CVCL_B2LX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26049; ZNF692 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360342 CVCL_B2M8 Abcam A-549 BSG KO cancer cell line human CVCL_B2M8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1116; BSG; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360343 CVCL_B2LW Abcam HeLa ZNF622 KO cancer cell line human CVCL_B2LW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30958; ZNF622 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360344 CVCL_B2LJ Abcam HeLa WWC2 KO cancer cell line human CVCL_B2LJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24148; WWC2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360345 CVCL_B2LI Abcam HeLa WSB2 KO cancer cell line human CVCL_B2LI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19222; WSB2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360346 CVCL_B2LL Abcam HeLa YY1AP1 KO cancer cell line human CVCL_B2LL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30935; YY1AP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360347 CVCL_B2LK Abcam HeLa YES1 KO cancer cell line human CVCL_B2LK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12841; YES1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360348 CVCL_B2LN Abcam HeLa ZCCHC17 KO cancer cell line human CVCL_B2LN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30246; ZCCHC17 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360349 CVCL_B2LM Abcam HeLa ZAP70 KO cancer cell line human CVCL_B2LM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12858; ZAP70 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265522; true Female 151360350 CVCL_B2M1 Abcam A-549 ALDH1A1 KO cancer cell line human CVCL_B2M1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:402; ALDH1A1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360351 CVCL_B2LP Abcam HeLa ZDHHC6 KO cancer cell line human CVCL_B2LP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19160; ZDHHC6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360352 CVCL_B2M0 Abcam A-549 ABCC2 KO cancer cell line human CVCL_B2M0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:53; ABCC2; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151360353 CVCL_B2LB Abcam HeLa WDR4 KO cancer cell line human CVCL_B2LB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12756; WDR4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360354 CVCL_B2LA Abcam HeLa WDR13 KO cancer cell line human CVCL_B2LA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14352; WDR13 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360355 CVCL_B2LD Abcam HeLa WDR45 KO cancer cell line human CVCL_B2LD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28912; WDR45 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360356 CVCL_B2LC Abcam HeLa WDR41 KO cancer cell line human CVCL_B2LC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25601; WDR41 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360357 CVCL_B2LF Abcam HeLa WDR6 KO cancer cell line human CVCL_B2LF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12758; WDR6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360358 CVCL_B2LE Abcam HeLa WDR59 KO cancer cell line human CVCL_B2LE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25706; WDR59 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360359 CVCL_B2LH Abcam HeLa WRNIP1 KO cancer cell line human CVCL_B2LH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20876; WRNIP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360360 CVCL_B2LG Abcam HeLa WNT5A KO cancer cell line human CVCL_B2LG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12784; WNT5A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360361 CVCL_B2KY Abcam HeLa VCL KO cancer cell line human CVCL_B2KY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12665; VCL Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360362 CVCL_B2KX Abcam HeLa VAV3 KO cancer cell line human CVCL_B2KX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12659; VAV3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360363 CVCL_B2L9 Abcam HeLa WBP2 KO cancer cell line human CVCL_B2L9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12738; WBP2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360364 CVCL_B2KZ Abcam HeLa VCPIP1 KO cancer cell line human CVCL_B2KZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30897; VCPIP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360365 CVCL_B2J0 Abcam HeLa TNFAIP3 KO cancer cell line human CVCL_B2J0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11896; TNFAIP3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360366 CVCL_B2IN Abcam HeLa TLK1 KO cancer cell line human CVCL_B2IN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11841; TLK1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360367 CVCL_B2IQ Abcam HeLa TM9SF4 KO cancer cell line human CVCL_B2IQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30797; TM9SF4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360368 CVCL_B2J2 Abcam HeLa TNFRSF10B KO cancer cell line human CVCL_B2J2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11905; TNFRSF10B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360369 CVCL_B2IP Abcam HeLa TM4SF1 KO cancer cell line human CVCL_B2IP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11853; TM4SF1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360370 CVCL_B2J1 Abcam HeLa TNFRSF10A KO cancer cell line human CVCL_B2J1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11904; TNFRSF10A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360371 CVCL_B2IS Abcam HeLa TMEM175 KO cancer cell line human CVCL_B2IS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28709; TMEM175 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360372 CVCL_B2J4 Abcam HeLa TNFRSF8 KO cancer cell line human CVCL_B2J4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11923; TNFRSF8 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265460; true Female 151360373 CVCL_B2IR Abcam HeLa TMEM126A KO cancer cell line human CVCL_B2IR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25382; TMEM126A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360374 CVCL_B2J3 Abcam HeLa TNFRSF1A KO cancer cell line human CVCL_B2J3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11916; TNFRSF1A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360375 CVCL_B2IU Abcam HeLa TMEM69 KO cancer cell line human CVCL_B2IU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28035; TMEM69 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360376 CVCL_B2J6 Abcam HeLa TNIP1 KO cancer cell line human CVCL_B2J6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16903; TNIP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360377 CVCL_B2IT Abcam HeLa TMEM30A KO cancer cell line human CVCL_B2IT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16667; TMEM30A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360378 CVCL_B2J5 Abcam HeLa TNFSF10 KO cancer cell line human CVCL_B2J5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11925; TNFSF10 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360379 CVCL_B2IG Abcam HeLa TGM2 KO cancer cell line human CVCL_B2IG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11778; TGM2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360380 CVCL_B2IF Abcam HeLa TGFB1 KO cancer cell line human CVCL_B2IF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11766; TGFB1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360381 CVCL_B2II Abcam HeLa THOC3 KO cancer cell line human CVCL_B2II CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19072; THOC3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360382 CVCL_B2IH Abcam HeLa THAP7 KO cancer cell line human CVCL_B2IH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23190; THAP7 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360383 CVCL_B2IK Abcam HeLa TIAL1 KO cancer cell line human CVCL_B2IK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11804; TIAL1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360384 CVCL_B2IJ Abcam HeLa THY1 KO cancer cell line human CVCL_B2IJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11801; THY1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360385 CVCL_B2IM Abcam HeLa TLE1 KO cancer cell line human CVCL_B2IM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11837; TLE1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360386 CVCL_B2IL Abcam HeLa TJP1 KO cancer cell line human CVCL_B2IL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11827; TJP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360387 CVCL_B2IA Abcam HeLa TCF7 KO cancer cell line human CVCL_B2IA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11639; TCF7 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360388 CVCL_B2IC Abcam HeLa TFAP2A KO cancer cell line human CVCL_B2IC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11742; TFAP2A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360389 CVCL_B2IB Abcam HeLa TDP2 KO cancer cell line human CVCL_B2IB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17768; TDP2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360390 CVCL_B2IE Abcam HeLa TFG KO cancer cell line human CVCL_B2IE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11758; TFG Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360391 CVCL_B2ID Abcam HeLa TFAP4 KO cancer cell line human CVCL_B2ID CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11745; TFAP4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360392 CVCL_B2HV Abcam HeLa SUGP2 KO cancer cell line human CVCL_B2HV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18641; SUGP2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360393 CVCL_B2I7 Abcam HeLa TBC1D7 KO cancer cell line human CVCL_B2I7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21066; TBC1D7 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360394 CVCL_B2HU Abcam HeLa STX17 KO cancer cell line human CVCL_B2HU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11432; STX17 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360395 CVCL_B2I6 Abcam HeLa TAP2 KO cancer cell line human CVCL_B2I6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:44; TAP2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360396 CVCL_B2HX Abcam HeLa SURF6 KO cancer cell line human CVCL_B2HX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11478; SURF6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360397 CVCL_B2I9 Abcam HeLa TBL1X KO cancer cell line human CVCL_B2I9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11585; TBL1X Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab264717; true Female 151360398 CVCL_B2HW Abcam HeLa SUGT1 KO cancer cell line human CVCL_B2HW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16987; SUGT1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360399 CVCL_B2I8 Abcam HeLa TBKBP1 KO cancer cell line human CVCL_B2I8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30140; TBKBP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360400 CVCL_B2HZ Abcam HeLa SYNJ1 KO cancer cell line human CVCL_B2HZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11503; SYNJ1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360401 CVCL_B2HY Abcam HeLa SUZ12 KO cancer cell line human CVCL_B2HY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17101; SUZ12 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360402 CVCL_B2JP Abcam HeLa TRIM29 KO cancer cell line human CVCL_B2JP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17274; TRIM29 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360403 CVCL_B2K1 Abcam HeLa TXNDC9 KO cancer cell line human CVCL_B2K1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24110; TXNDC9 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360404 CVCL_B2K0 Abcam HeLa TXLNA KO cancer cell line human CVCL_B2K0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30685; TXLNA Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360405 CVCL_B2JR Abcam HeLa TRMT2A KO cancer cell line human CVCL_B2JR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24974; TRMT2A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360406 CVCL_B2K3 Abcam HeLa UBE2D4 KO cancer cell line human CVCL_B2K3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21647; UBE2D4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360407 CVCL_B2JQ Abcam HeLa TRIM7 KO cancer cell line human CVCL_B2JQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16278; TRIM7 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360408 CVCL_B2K2 Abcam HeLa TYMP KO cancer cell line human CVCL_B2K2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3148; TYMP Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360409 CVCL_B2JT Abcam HeLa TSC22D4 KO cancer cell line human CVCL_B2JT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21696; TSC22D4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360410 CVCL_B2K5 Abcam HeLa UBE2H KO cancer cell line human CVCL_B2K5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12484; UBE2H Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360411 CVCL_B2JS Abcam HeLa TRPM7 KO cancer cell line human CVCL_B2JS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17994; TRPM7 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360412 CVCL_B2K4 Abcam HeLa UBE2F KO cancer cell line human CVCL_B2K4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12480; UBE2F Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360413 CVCL_B2JV Abcam HeLa TSSK3 KO cancer cell line human CVCL_B2JV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15473; TSSK3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360414 CVCL_B2K7 Abcam HeLa UBE2K KO cancer cell line human CVCL_B2K7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4914; UBE2K Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360415 CVCL_B2JU Abcam HeLa TSPO KO cancer cell line human CVCL_B2JU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1158; TSPO Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360416 CVCL_B2K6 Abcam HeLa UBE2J1 KO cancer cell line human CVCL_B2K6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17598; UBE2J1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360417 CVCL_B2JH Abcam HeLa TRAF5 KO cancer cell line human CVCL_B2JH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12035; TRAF5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360418 CVCL_B2JG Abcam HeLa TRAF3 KO cancer cell line human CVCL_B2JG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12033; TRAF3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265101; true Female 151360419 CVCL_B2JJ Abcam HeLa TRAF7 KO cancer cell line human CVCL_B2JJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20456; TRAF7 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab264998; true Female 151360420 CVCL_B2JI Abcam HeLa TRAF6 KO cancer cell line human CVCL_B2JI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12036; TRAF6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360421 CVCL_B2JL Abcam HeLa TRIB3 KO cancer cell line human CVCL_B2JL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16228; TRIB3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360422 CVCL_B2JK Abcam HeLa TREX1 KO cancer cell line human CVCL_B2JK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12269; TREX1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360423 CVCL_B2JN Abcam HeLa TRIM24 KO cancer cell line human CVCL_B2JN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11812; TRIM24 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360424 CVCL_B2JM Abcam HeLa TRIM16 KO cancer cell line human CVCL_B2JM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17241; TRIM16 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360425 CVCL_B2JB Abcam HeLa TOMM70A KO cancer cell line human CVCL_B2JB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11985; TOMM70 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360426 CVCL_B2JA Abcam HeLa TOMM34 KO cancer cell line human CVCL_B2JA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15746; TOMM34 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360427 CVCL_B2JD Abcam HeLa TP53I3 KO cancer cell line human CVCL_B2JD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19373; TP53I3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360428 CVCL_B2JC Abcam HeLa TOR3A KO cancer cell line human CVCL_B2JC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11997; TOR3A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360429 CVCL_B2JF Abcam HeLa TPGS2 KO cancer cell line human CVCL_B2JF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24561; TPGS2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360430 CVCL_B2JE Abcam HeLa TPD52L1 KO cancer cell line human CVCL_B2JE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12006; TPD52L1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360431 CVCL_B2IW Abcam HeLa TMPRSS6 KO cancer cell line human CVCL_B2IW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16517; TMPRSS6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360432 CVCL_B2J8 Abcam HeLa TNKS1BP1 KO cancer cell line human CVCL_B2J8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19081; TNKS1BP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360433 CVCL_B2IV Abcam HeLa TMOD3 KO cancer cell line human CVCL_B2IV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11873; TMOD3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360434 CVCL_B2J7 Abcam HeLa TNK1 KO cancer cell line human CVCL_B2J7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11940; TNK1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360435 CVCL_B2IY Abcam HeLa TMUB1 partial KO cancer cell line human CVCL_B2IY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21709; TMUB1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360436 CVCL_B2IX Abcam HeLa TMUB1 KO cancer cell line human CVCL_B2IX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21709; TMUB1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360437 CVCL_B2J9 Abcam HeLa TOB1 KO cancer cell line human CVCL_B2J9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11979; TOB1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360438 CVCL_B2IZ Abcam HeLa TNC KO cancer cell line human CVCL_B2IZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5318; TNC Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360439 CVCL_B2GM Abcam HeLa SMARCC1 KO cancer cell line human CVCL_B2GM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11104; SMARCC1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360440 CVCL_B2GL Abcam HeLa SMARCA2 KO cancer cell line human CVCL_B2GL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11098; SMARCA2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360441 CVCL_B2H0 Abcam HeLa SOAT1 KO cancer cell line human CVCL_B2H0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11177; SOAT1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360442 CVCL_B2GN Abcam HeLa SMC1B KO cancer cell line human CVCL_B2GN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11112; SMC1B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360443 CVCL_B2GQ Abcam HeLa SMURF2 KO cancer cell line human CVCL_B2GQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16809; SMURF2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360444 CVCL_B2H2 Abcam HeLa SOX17 KO cancer cell line human CVCL_B2H2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18122; SOX17 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360445 CVCL_B2GP Abcam HeLa SMIM4 KO cancer cell line human CVCL_B2GP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37257; UQCC5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360446 CVCL_B2H1 Abcam HeLa SOCS4 KO cancer cell line human CVCL_B2H1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19392; SOCS4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360447 CVCL_B2GS Abcam HeLa SNAP29 KO cancer cell line human CVCL_B2GS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11133; SNAP29 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360448 CVCL_B2H4 Abcam HeLa SP100 KO cancer cell line human CVCL_B2H4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11206; SP100 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360449 CVCL_B2GR Abcam HeLa SNAI1 KO cancer cell line human CVCL_B2GR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11128; SNAI1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360450 CVCL_B2H3 Abcam HeLa SP1 KO cancer cell line human CVCL_B2H3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11205; SP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360451 CVCL_B2GE Abcam HeLa SLC9A3R1 KO cancer cell line human CVCL_B2GE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11075; NHERF1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360452 CVCL_B2GD Abcam HeLa SLC7A6 KO cancer cell line human CVCL_B2GD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11064; SLC7A6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360453 CVCL_B2GG Abcam HeLa SLPI KO cancer cell line human CVCL_B2GG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11092; SLPI Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360454 CVCL_B2GF Abcam HeLa SLCO4A1 KO cancer cell line human CVCL_B2GF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10953; SLCO4A1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360455 CVCL_B2GI Abcam HeLa SMAD2 KO cancer cell line human CVCL_B2GI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6768; SMAD2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360456 CVCL_B2GH Abcam HeLa SMAD1 KO cancer cell line human CVCL_B2GH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6767; SMAD1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360457 CVCL_B2GK Abcam HeLa SMAD7 KO cancer cell line human CVCL_B2GK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6773; SMAD7 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360458 CVCL_B2GJ Abcam HeLa SMAD3 KO cancer cell line human CVCL_B2GJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6769; SMAD3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360459 CVCL_B2GA Abcam HeLa SLC44A1 KO cancer cell line human CVCL_B2GA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18798; SLC44A1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360460 CVCL_B2GC Abcam HeLa SLC52A2 KO cancer cell line human CVCL_B2GC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30224; SLC52A2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360461 CVCL_B2GB Abcam HeLa SLC50A1 KO cancer cell line human CVCL_B2GB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30657; SLC50A1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360462 CVCL_B2FT Abcam HeLa SLC2A4 KO cancer cell line human CVCL_B2FT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11009; SLC2A4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360463 CVCL_B2G5 Abcam HeLa SLC39A1 KO cancer cell line human CVCL_B2G5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12876; SLC39A1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360464 CVCL_B2FS Abcam HeLa SLC25A5 KO cancer cell line human CVCL_B2FS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10991; SLC25A5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360465 CVCL_B2G4 Abcam HeLa SLC38A9 KO cancer cell line human CVCL_B2G4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26907; SLC38A9 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360466 CVCL_B2FV Abcam HeLa SLC30A1 KO cancer cell line human CVCL_B2FV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11012; SLC30A1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360467 CVCL_B2G7 Abcam HeLa SLC39A9 KO cancer cell line human CVCL_B2G7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20182; SLC39A9 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360468 CVCL_B2FU Abcam HeLa SLC2A8 KO cancer cell line human CVCL_B2FU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13812; SLC2A8 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360469 CVCL_B2G6 Abcam HeLa SLC39A8 KO cancer cell line human CVCL_B2G6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20862; SLC39A8 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360470 CVCL_B2FX Abcam HeLa SLC35A1 KO cancer cell line human CVCL_B2FX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11021; SLC35A1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360471 CVCL_B2G9 Abcam HeLa SLC43A3 KO cancer cell line human CVCL_B2G9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17466; SLC43A3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360472 CVCL_B2FW Abcam HeLa SLC30A7 KO cancer cell line human CVCL_B2FW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19306; SLC30A7 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360473 CVCL_B2G8 Abcam HeLa SLC3A2 KO cancer cell line human CVCL_B2G8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11026; SLC3A2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360474 CVCL_B2FZ Abcam HeLa SLC35A5 KO cancer cell line human CVCL_B2FZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20792; SLC35A5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360475 CVCL_B2FY Abcam HeLa SLC35A2 KO cancer cell line human CVCL_B2FY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11022; SLC35A2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360476 CVCL_B2HN Abcam HeLa STK17A KO cancer cell line human CVCL_B2HN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11395; STK17A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360477 CVCL_B2HM Abcam HeLa STK10 KO cancer cell line human CVCL_B2HM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11388; STK10 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360478 CVCL_B2HP Abcam HeLa STK3 KO cancer cell line human CVCL_B2HP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11406; STK3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360479 CVCL_B2I1 Abcam HeLa TACC2 KO cancer cell line human CVCL_B2I1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11523; TACC2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360480 CVCL_B2I0 Abcam HeLa SYNJ2 KO cancer cell line human CVCL_B2I0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11504; SYNJ2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360481 CVCL_B2HR Abcam HeLa STK4 KO cancer cell line human CVCL_B2HR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11408; STK4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360482 CVCL_B2I3 Abcam HeLa TAF12 KO cancer cell line human CVCL_B2I3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11545; TAF12 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360483 CVCL_B2HQ Abcam HeLa STK38L KO cancer cell line human CVCL_B2HQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17848; STK38L Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360484 CVCL_B2I2 Abcam HeLa TAF11 KO cancer cell line human CVCL_B2I2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11544; TAF11 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360485 CVCL_B2HT Abcam HeLa STS KO cancer cell line human CVCL_B2HT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11425; STS Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360486 CVCL_B2I5 Abcam HeLa TAOK3 KO cancer cell line human CVCL_B2I5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18133; TAOK3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360487 CVCL_B2HS Abcam HeLa STK40 KO cancer cell line human CVCL_B2HS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21373; STK40 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360488 CVCL_B2I4 Abcam HeLa TANK KO cancer cell line human CVCL_B2I4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11562; TANK Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360489 CVCL_B2HF Abcam HeLa STAG2 KO cancer cell line human CVCL_B2HF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11355; STAG2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360490 CVCL_B2HE Abcam HeLa SSBP3 KO cancer cell line human CVCL_B2HE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15674; SSBP3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360491 CVCL_B2HH Abcam HeLa STAR KO cancer cell line human CVCL_B2HH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11359; STAR Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360492 CVCL_B2HG Abcam HeLa STAMBP KO cancer cell line human CVCL_B2HG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16950; STAMBP Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360493 CVCL_B2HJ Abcam HeLa STAT2 KO cancer cell line human CVCL_B2HJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11363; STAT2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360494 CVCL_B2HI Abcam HeLa STAT1 KO cancer cell line human CVCL_B2HI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11362; STAT1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360495 CVCL_B2HL Abcam HeLa STAT5B KO cancer cell line human CVCL_B2HL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11367; STAT5B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360496 CVCL_B2HK Abcam HeLa STAT3 KO cancer cell line human CVCL_B2HK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11364; STAT3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360497 CVCL_B2HB Abcam HeLa SRD5A1 KO cancer cell line human CVCL_B2HB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11284; SRD5A1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360498 CVCL_B2HA Abcam HeLa SQLE KO cancer cell line human CVCL_B2HA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11279; SQLE Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360499 CVCL_B2HD Abcam HeLa SS18 KO cancer cell line human CVCL_B2HD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11340; SS18 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360500 CVCL_B2HC Abcam HeLa SRGN KO cancer cell line human CVCL_B2HC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9361; SRGN Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360501 CVCL_B2GU Abcam HeLa SNCG KO cancer cell line human CVCL_B2GU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11141; SNCG Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360502 CVCL_B2H6 Abcam HeLa SPG11 KO cancer cell line human CVCL_B2H6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11226; SPG11 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360503 CVCL_B2GT Abcam HeLa SNAPIN KO cancer cell line human CVCL_B2GT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17145; SNAPIN Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360504 CVCL_B2H5 Abcam HeLa SPCS3 KO cancer cell line human CVCL_B2H5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26212; SPCS3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360505 CVCL_B2GW Abcam HeLa SNRPB2 KO cancer cell line human CVCL_B2GW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11155; SNRPB2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360506 CVCL_B2H8 Abcam HeLa SPP1 KO cancer cell line human CVCL_B2H8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11255; SPP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab255435; true Female 151360507 CVCL_B2GV Abcam HeLa SNRK KO cancer cell line human CVCL_B2GV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30598; SNRK Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360508 CVCL_B2H7 Abcam HeLa SPOP KO cancer cell line human CVCL_B2H7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11254; SPOP Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360509 CVCL_B2GY Abcam HeLa SNX17 KO cancer cell line human CVCL_B2GY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14979; SNX17 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360510 CVCL_B2GX Abcam HeLa SNX12 KO cancer cell line human CVCL_B2GX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14976; SNX12 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360511 CVCL_B2H9 Abcam HeLa SPR KO cancer cell line human CVCL_B2H9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11257; SPR Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360512 CVCL_B2GZ Abcam HeLa SNX2 KO cancer cell line human CVCL_B2GZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11173; SNX2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360513 CVCL_B2EK Abcam HeLa S1PR1 KO cancer cell line human CVCL_B2EK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3165; S1PR1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360514 CVCL_B2EJ Abcam HeLa S100P KO cancer cell line human CVCL_B2EJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10504; S100P Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360515 CVCL_B2EM Abcam HeLa SCAMP1 KO cancer cell line human CVCL_B2EM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10563; SCAMP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360516 CVCL_B2EL Abcam HeLa SCAF11 KO cancer cell line human CVCL_B2EL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10784; SCAF11 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360517 CVCL_B2F0 Abcam HeLa SENP5 KO cancer cell line human CVCL_B2F0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28407; SENP5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360518 CVCL_B2EN Abcam HeLa SCAND1 KO cancer cell line human CVCL_B2EN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10566; SCAND1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360519 CVCL_B2EQ Abcam HeLa SCD5 KO cancer cell line human CVCL_B2EQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21088; SCD5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360520 CVCL_B2F2 Abcam HeLa SERTAD3 KO cancer cell line human CVCL_B2F2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17931; SERTAD3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360521 CVCL_B2EP Abcam HeLa SCD KO cancer cell line human CVCL_B2EP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10571; SCD Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360522 CVCL_B2F1 Abcam HeLa SERPINB5 KO cancer cell line human CVCL_B2F1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8949; SERPINB5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360523 CVCL_B2EC Abcam HeLa RTN4RL2 KO cancer cell line human CVCL_B2EC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23053; RTN4RL2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360524 CVCL_B2EB Abcam HeLa RRP36 KO cancer cell line human CVCL_B2EB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21374; RRP36 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360525 CVCL_B2EE Abcam HeLa RYK KO cancer cell line human CVCL_B2EE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10481; RYK Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360526 CVCL_B2ED Abcam HeLa RUNX1 KO cancer cell line human CVCL_B2ED CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10471; RUNX1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360527 CVCL_B2EG Abcam HeLa S100A16 KO cancer cell line human CVCL_B2EG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20441; S100A16 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360528 CVCL_B2EF Abcam HeLa S100A11 KO cancer cell line human CVCL_B2EF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10488; S100A11 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360529 CVCL_B2EI Abcam HeLa S100A8 KO cancer cell line human CVCL_B2EI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10498; S100A8 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265632; true Female 151360530 CVCL_B2EH Abcam HeLa S100A4 KO cancer cell line human CVCL_B2EH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10494; S100A4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360531 CVCL_B2DZ Abcam HeLa RNF4 KO cancer cell line human CVCL_B2DZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10067; RNF4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360532 CVCL_B2DY Abcam HeLa RNF2 KO cancer cell line human CVCL_B2DY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10061; RNF2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360533 CVCL_B2EA Abcam HeLa RRM2B KO cancer cell line human CVCL_B2EA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17296; RRM2B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360534 CVCL_B2DR Abcam HeLa RHOT2 KO cancer cell line human CVCL_B2DR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21169; RHOT2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360535 CVCL_B2E3 Abcam HeLa RPL36A KO cancer cell line human CVCL_B2E3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10359; RPL36A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360536 CVCL_B2DQ Abcam HeLa RHOT1 KO cancer cell line human CVCL_B2DQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21168; RHOT1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360537 CVCL_B2E2 Abcam HeLa RORC KO cancer cell line human CVCL_B2E2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10260; RORC Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360538 CVCL_B2DT Abcam HeLa RIOK3 KO cancer cell line human CVCL_B2DT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11451; RIOK3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360539 CVCL_B2E5 Abcam HeLa RPS27L KO cancer cell line human CVCL_B2E5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18476; RPS27L Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360540 CVCL_B2DS Abcam HeLa RIN1 KO cancer cell line human CVCL_B2DS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18749; RIN1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360541 CVCL_B2E4 Abcam HeLa RPRM KO cancer cell line human CVCL_B2E4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24201; RPRM Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360542 CVCL_B2DV Abcam HeLa RIPOR1 KO cancer cell line human CVCL_B2DV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25836; RIPOR1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360543 CVCL_B2E7 Abcam HeLa RRAGC KO cancer cell line human CVCL_B2E7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19902; RRAGC Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360544 CVCL_B2DU Abcam HeLa RIPK2 KO cancer cell line human CVCL_B2DU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10020; RIPK2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360545 CVCL_B2E6 Abcam HeLa RRAGB KO cancer cell line human CVCL_B2E6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19901; RRAGB Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360546 CVCL_B2DX Abcam HeLa RNF149 KO cancer cell line human CVCL_B2DX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23137; RNF149 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360547 CVCL_B2E9 Abcam HeLa RRBP1 KO cancer cell line human CVCL_B2E9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10448; RRBP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360548 CVCL_B2DW Abcam HeLa RMDN3 KO cancer cell line human CVCL_B2DW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25550; RMDN3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360549 CVCL_B2E8 Abcam HeLa RRAS KO cancer cell line human CVCL_B2E8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10447; RRAS Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265306; true Female 151360550 CVCL_B2FL Abcam HeLa SLC20A2 KO cancer cell line human CVCL_B2FL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10947; SLC20A2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360551 CVCL_B2FK Abcam HeLa SLC1A4 KO cancer cell line human CVCL_B2FK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10942; SLC1A4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360552 CVCL_B2FN Abcam HeLa SLC25A13 KO cancer cell line human CVCL_B2FN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10983; SLC25A13 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360553 CVCL_B2FM Abcam HeLa SLC22A5 KO cancer cell line human CVCL_B2FM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10969; SLC22A5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360554 CVCL_B2FP Abcam HeLa SLC25A20 KO cancer cell line human CVCL_B2FP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1421; SLC25A20 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360555 CVCL_B2G1 Abcam HeLa SLC35C1 KO cancer cell line human CVCL_B2G1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20197; SLC35C1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360556 CVCL_B2G0 Abcam HeLa SLC35B2 KO cancer cell line human CVCL_B2G0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16872; SLC35B2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360557 CVCL_B2FR Abcam HeLa SLC25A40 KO cancer cell line human CVCL_B2FR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29680; SLC25A40 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360558 CVCL_B2G3 Abcam HeLa SLC38A5 KO cancer cell line human CVCL_B2G3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18070; SLC38A5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360559 CVCL_B2FQ Abcam HeLa SLC25A29 KO cancer cell line human CVCL_B2FQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20116; SLC25A29 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360560 CVCL_B2G2 Abcam HeLa SLC35E2B KO cancer cell line human CVCL_B2G2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33941; SLC35E2B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360561 CVCL_B2FD Abcam HeLa SIKE1 KO cancer cell line human CVCL_B2FD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26119; SIKE1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360562 CVCL_B2FC Abcam HeLa SIK1 KO cancer cell line human CVCL_B2FC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11142; SIK1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360563 CVCL_B2FF Abcam HeLa SIRT5 KO cancer cell line human CVCL_B2FF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14933; SIRT5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265617; true Female 151360564 CVCL_B2FE Abcam HeLa SIPA1 KO cancer cell line human CVCL_B2FE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10885; SIPA1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360565 CVCL_B2FH Abcam HeLa SLC11A2 KO cancer cell line human CVCL_B2FH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10908; SLC11A2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360566 CVCL_B2FG Abcam HeLa SIRT6 KO cancer cell line human CVCL_B2FG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14934; SIRT6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360567 CVCL_B2FJ Abcam HeLa SLC17A5 KO cancer cell line human CVCL_B2FJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10933; SLC17A5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360568 CVCL_B2FI Abcam HeLa SLC12A9 KO cancer cell line human CVCL_B2FI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17435; SLC12A9 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360569 CVCL_B2EZ Abcam HeLa SELENOS KO cancer cell line human CVCL_B2EZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30396; SELENOS Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360570 CVCL_B2FB Abcam HeLa SIAH1 KO cancer cell line human CVCL_B2FB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10857; SIAH1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360571 CVCL_B2FA Abcam HeLa SHKBP1 KO cancer cell line human CVCL_B2FA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19214; SHKBP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360572 CVCL_B2ES Abcam HeLa SCN1B KO cancer cell line human CVCL_B2ES CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10586; SCN1B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360573 CVCL_B2F4 Abcam HeLa SETD7 KO cancer cell line human CVCL_B2F4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30412; SETD7 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360574 CVCL_B2ER Abcam HeLa SCFD2 KO cancer cell line human CVCL_B2ER CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30676; SCFD2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360575 CVCL_B2F3 Abcam HeLa SESN2 KO cancer cell line human CVCL_B2F3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20746; SESN2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360576 CVCL_B2EU Abcam HeLa SCRIB KO cancer cell line human CVCL_B2EU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30377; SCRIB Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360577 CVCL_B2F6 Abcam HeLa SH2D4A KO cancer cell line human CVCL_B2F6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26102; SH2D4A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360578 CVCL_B2ET Abcam HeLa SCNN1D KO cancer cell line human CVCL_B2ET CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10601; SCNN1D Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360579 CVCL_B2F5 Abcam HeLa SFN KO cancer cell line human CVCL_B2F5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10773; SFN Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360580 CVCL_B2EW Abcam HeLa SDHAF2 KO cancer cell line human CVCL_B2EW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26034; SDHAF2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360581 CVCL_B2F8 Abcam HeLa SHC3 KO cancer cell line human CVCL_B2F8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18181; SHC3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360582 CVCL_B2EV Abcam HeLa SCYL2 KO cancer cell line human CVCL_B2EV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19286; SCYL2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360583 CVCL_B2F7 Abcam HeLa SHC2 KO cancer cell line human CVCL_B2F7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29869; SHC2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360584 CVCL_B2EY Abcam HeLa SELENBP1 KO cancer cell line human CVCL_B2EY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10719; SELENBP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360585 CVCL_B2EX Abcam HeLa SEC16A KO cancer cell line human CVCL_B2EX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29006; SEC16A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360586 CVCL_B2F9 Abcam HeLa SHC4 KO cancer cell line human CVCL_B2F9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16743; SHC4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360587 CVCL_B1QX Abcam HeLa EIF4EBP1 KO cancer cell line human CVCL_B1QX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3288; EIF4EBP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360588 CVCL_B1R9 Abcam HeLa ENG KO cancer cell line human CVCL_B1R9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3349; ENG Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360589 CVCL_B1R8 Abcam HeLa ADGRE1 KO cancer cell line human CVCL_B1R8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3336; ADGRE1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360590 CVCL_B1QW Abcam HeLa EIF3H KO cancer cell line human CVCL_B1QW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3273; EIF3H Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360591 CVCL_B1QZ Abcam HeLa ELK1 KO cancer cell line human CVCL_B1QZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3321; ELK1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360592 CVCL_B1QY Abcam HeLa EIPR1 KO cancer cell line human CVCL_B1QY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12383; EIPR1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360593 CVCL_B1QP Abcam HeLa ECHDC1 KO cancer cell line human CVCL_B1QP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21489; ECHDC1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360594 CVCL_B1R1 Abcam HeLa ELOVL5 KO cancer cell line human CVCL_B1R1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21308; ELOVL5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265942; true Female 151360595 CVCL_B1R0 Abcam HeLa ELL2 KO cancer cell line human CVCL_B1R0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17064; ELL2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360596 CVCL_B1QR Abcam HeLa EFNA1 KO cancer cell line human CVCL_B1QR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3221; EFNA1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265232; true Female 151360597 CVCL_B1R3 Abcam HeLa EMC2 KO cancer cell line human CVCL_B1R3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28963; EMC2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360598 CVCL_B1QQ Abcam HeLa EEA1 KO cancer cell line human CVCL_B1QQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3185; EEA1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360599 CVCL_B1R2 Abcam HeLa EMC10 KO cancer cell line human CVCL_B1R2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27609; EMC10 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360600 CVCL_B1QT Abcam HeLa EGFR KO cancer cell line human CVCL_B1QT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3236; EGFR Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360601 CVCL_B1R5 Abcam HeLa EMC8 KO cancer cell line human CVCL_B1R5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7864; EMC8 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360602 CVCL_B1QS Abcam HeLa EGF KO cancer cell line human CVCL_B1QS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3229; EGF Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360603 CVCL_B1R4 Abcam HeLa EMC6 KO cancer cell line human CVCL_B1R4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28430; EMC6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360604 CVCL_B1QV Abcam HeLa EIF2AK2 KO cancer cell line human CVCL_B1QV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9437; EIF2AK2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360605 CVCL_B1R7 Abcam HeLa EMP1 KO cancer cell line human CVCL_B1R7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3333; EMP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360606 CVCL_B1QU Abcam HeLa EI24 KO cancer cell line human CVCL_B1QU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13276; EI24 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360607 CVCL_B1R6 Abcam HeLa EML4 KO cancer cell line human CVCL_B1R6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1316; EML4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360608 CVCL_B1QH Abcam HeLa DYNLL1 KO cancer cell line human CVCL_B1QH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15476; DYNLL1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360609 CVCL_B1QG Abcam HeLa DTX3 KO cancer cell line human CVCL_B1QG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24457; DTX3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360610 CVCL_B1QJ Abcam HeLa DYRK3 KO cancer cell line human CVCL_B1QJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3094; DYRK3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360611 CVCL_B1QI Abcam HeLa DYNLT3 KO cancer cell line human CVCL_B1QI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11694; DYNLT3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360612 CVCL_B1QL Abcam HeLa DYSF KO cancer cell line human CVCL_B1QL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3097; DYSF Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab264764; true Female 151360613 CVCL_B1QK Abcam HeLa DYRK4 KO cancer cell line human CVCL_B1QK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3095; DYRK4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360614 CVCL_B1QN Abcam HeLa ECE2 KO cancer cell line human CVCL_B1QN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13275; ECE2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360615 CVCL_B1QM Abcam HeLa E2F3 KO cancer cell line human CVCL_B1QM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3115; E2F3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360616 CVCL_B1QB Abcam HeLa DNMT3A KO cancer cell line human CVCL_B1QB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2978; DNMT3A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360617 CVCL_B1QA Abcam HeLa DNAJC14 KO cancer cell line human CVCL_B1QA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24581; DNAJC14 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360618 CVCL_B1QD Abcam HeLa DPM2 KO cancer cell line human CVCL_B1QD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3006; DPM2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360619 CVCL_B1QC Abcam HeLa DPH2 KO cancer cell line human CVCL_B1QC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3004; DPH2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360620 CVCL_B1QF Abcam HeLa DSTYK KO cancer cell line human CVCL_B1QF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29043; DSTYK Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360621 CVCL_B1QE Abcam HeLa DSG2 KO cancer cell line human CVCL_B1QE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3049; DSG2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360622 CVCL_B1RY Abcam HeLa FAS KO cancer cell line human CVCL_B1RY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11920; FAS Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360623 CVCL_B1RX Abcam HeLa FANCD2 KO cancer cell line human CVCL_B1RX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3585; FANCD2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360624 CVCL_B1S9 Abcam HeLa FOCAD KO cancer cell line human CVCL_B1S9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23377; FOCAD Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360625 CVCL_B1RZ Abcam HeLa FASTK KO cancer cell line human CVCL_B1RZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24676; FASTK Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360626 CVCL_B1RQ Abcam HeLa EXOSC1 KO cancer cell line human CVCL_B1RQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17286; EXOSC1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265194; true Female 151360627 CVCL_B1S2 Abcam HeLa FER KO cancer cell line human CVCL_B1S2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3655; FER Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360628 CVCL_B1RP Abcam HeLa EXOC7 KO cancer cell line human CVCL_B1RP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23214; EXOC7 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360629 CVCL_B1S1 Abcam HeLa FCER2 KO cancer cell line human CVCL_B1S1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3612; FCER2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab266040; true Female 151360630 CVCL_B1RS Abcam HeLa FABP5 KO cancer cell line human CVCL_B1RS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3560; FABP5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360631 CVCL_B1S4 Abcam HeLa FHL1 KO cancer cell line human CVCL_B1S4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3702; FHL1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360632 CVCL_B1RR Abcam HeLa EZR KO cancer cell line human CVCL_B1RR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12691; EZR Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab264912; true Female 151360633 CVCL_B1S3 Abcam HeLa FERMT2 KO cancer cell line human CVCL_B1S3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15767; FERMT2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360634 CVCL_B1RU Abcam HeLa FAM20B KO cancer cell line human CVCL_B1RU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23017; FAM20B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360635 CVCL_B1S6 Abcam HeLa FIBP KO cancer cell line human CVCL_B1S6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3705; FIBP Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360636 CVCL_B1RT Abcam HeLa FADD KO cancer cell line human CVCL_B1RT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3573; FADD Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360637 CVCL_B1S5 Abcam HeLa FHL2 KO cancer cell line human CVCL_B1S5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3703; FHL2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360638 CVCL_B1RW Abcam HeLa FAM98A KO cancer cell line human CVCL_B1RW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24520; FAM98A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360639 CVCL_B1S8 Abcam HeLa FLYWCH1 KO cancer cell line human CVCL_B1S8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25404; FLYWCH1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360640 CVCL_B1RV Abcam HeLa FAM3C KO cancer cell line human CVCL_B1RV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18664; FAM3C Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360641 CVCL_B1S7 Abcam HeLa FLII KO cancer cell line human CVCL_B1S7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3750; FLII Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360642 CVCL_B1RI Abcam HeLa ERMP1 KO cancer cell line human CVCL_B1RI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23703; ERMP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360643 CVCL_B1RH Abcam HeLa ERI3 KO cancer cell line human CVCL_B1RH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17276; ERI3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360644 CVCL_B1RK Abcam HeLa ESRP2 KO cancer cell line human CVCL_B1RK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26152; ESRP2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360645 CVCL_B1RJ Abcam HeLa ERN1 KO cancer cell line human CVCL_B1RJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3449; ERN1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360646 CVCL_B1RM Abcam HeLa ETV5 KO cancer cell line human CVCL_B1RM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3494; ETV5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360647 CVCL_B1RL Abcam HeLa ETNK1 KO cancer cell line human CVCL_B1RL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24649; ETNK1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360648 CVCL_B1S0 Abcam HeLa FBXO11 KO cancer cell line human CVCL_B1S0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13590; FBXO11 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360649 CVCL_B1RN Abcam HeLa EXOC2 KO cancer cell line human CVCL_B1RN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24968; EXOC2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360650 CVCL_B1RA Abcam HeLa ENPP2 KO cancer cell line human CVCL_B1RA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3357; ENPP2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360651 CVCL_B1RC Abcam HeLa EPHA2 KO cancer cell line human CVCL_B1RC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3386; EPHA2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360652 CVCL_B1RB Abcam HeLa EPHA1 KO cancer cell line human CVCL_B1RB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3385; EPHA1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360653 CVCL_B1RE Abcam HeLa EPHB3 KO cancer cell line human CVCL_B1RE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3394; EPHB3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265529; true Female 151360654 CVCL_B1RD Abcam HeLa EPHA4 KO cancer cell line human CVCL_B1RD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3388; EPHA4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360655 CVCL_B1RG Abcam HeLa ERGIC2 KO cancer cell line human CVCL_B1RG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30208; ERGIC2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360656 CVCL_B1RF Abcam HeLa EPS8L2 KO cancer cell line human CVCL_B1RF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21296; EPS8L2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360657 CVCL_B1P7 Abcam HeLa CREB3L2 KO cancer cell line human CVCL_B1P7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23720; CREB3L2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360658 CVCL_B1P6 Abcam HeLa CPT2 KO cancer cell line human CVCL_B1P6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2330; CPT2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360659 CVCL_B1P9 Abcam HeLa CRK KO cancer cell line human CVCL_B1P9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2362; CRK Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360660 CVCL_B1P8 Abcam HeLa CREB5 KO cancer cell line human CVCL_B1P8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16844; CREB5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360661 CVCL_B1P1 Abcam HeLa COL9A3 KO cancer cell line human CVCL_B1P1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2219; COL9A3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360662 CVCL_B1P0 Abcam HeLa COL5A1 KO cancer cell line human CVCL_B1P0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2209; COL5A1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360663 CVCL_B1P3 Abcam HeLa COQ8B KO cancer cell line human CVCL_B1P3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19041; COQ8B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360664 CVCL_B1P2 Abcam HeLa COP1 KO cancer cell line human CVCL_B1P2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17440; COP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab266013; true Female 151360665 CVCL_B1P5 Abcam HeLa CPS1 KO cancer cell line human CVCL_B1P5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2323; CPS1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360666 CVCL_B1P4 Abcam HeLa CPA4 KO cancer cell line human CVCL_B1P4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15740; CPA4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360667 CVCL_B1PW Abcam HeLa DDIT3 KO cancer cell line human CVCL_B1PW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2726; DDIT3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360668 CVCL_B1Q8 Abcam HeLa DNAJC10 KO cancer cell line human CVCL_B1Q8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24637; DNAJC10 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360669 CVCL_B1PV Abcam HeLa DDB2 KO cancer cell line human CVCL_B1PV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2718; DDB2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360670 CVCL_B1Q7 Abcam HeLa DNAJB4 KO cancer cell line human CVCL_B1Q7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14886; DNAJB4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360671 CVCL_B1PY Abcam HeLa DDR2 KO cancer cell line human CVCL_B1PY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2731; DDR2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab264864; true Female 151360672 CVCL_B1PX Abcam HeLa DDR1 KO cancer cell line human CVCL_B1PX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2730; DDR1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360673 CVCL_B1Q9 Abcam HeLa DNAJC13 KO cancer cell line human CVCL_B1Q9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30343; DNAJC13 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360674 CVCL_B1PZ Abcam HeLa DENND4B KO cancer cell line human CVCL_B1PZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29044; DENND4B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360675 CVCL_B1Q0 Abcam HeLa DENND5A KO cancer cell line human CVCL_B1Q0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19344; DENND5A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360676 CVCL_B1PN Abcam HeLa CXCL1 KO cancer cell line human CVCL_B1PN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4602; CXCL1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360677 CVCL_B1PQ Abcam HeLa CYRIB KO cancer cell line human CVCL_B1PQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25216; CYRIB Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360678 CVCL_B1Q2 Abcam HeLa DGKD KO cancer cell line human CVCL_B1Q2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2851; DGKD Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360679 CVCL_B1PP Abcam HeLa CXCR4 KO cancer cell line human CVCL_B1PP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2561; CXCR4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360680 CVCL_B1Q1 Abcam HeLa DENR KO cancer cell line human CVCL_B1Q1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2769; DENR Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360681 CVCL_B1PS Abcam HeLa DAB2 KO cancer cell line human CVCL_B1PS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2662; DAB2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360682 CVCL_B1Q4 Abcam HeLa DHRS13 KO cancer cell line human CVCL_B1Q4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28326; DHRS13 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360683 CVCL_B1PR Abcam HeLa CCN1 KO cancer cell line human CVCL_B1PR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2654; CCN1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360684 CVCL_B1Q3 Abcam HeLa DHCR7 KO cancer cell line human CVCL_B1Q3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2860; DHCR7 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360685 CVCL_B1PU Abcam HeLa DCAF12 KO cancer cell line human CVCL_B1PU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19911; DCAF12 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360686 CVCL_B1Q6 Abcam HeLa DMAC2 KO cancer cell line human CVCL_B1Q6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25496; DMAC2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360687 CVCL_B1PT Abcam HeLa DAXX KO cancer cell line human CVCL_B1PT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2681; DAXX Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360688 CVCL_B1Q5 Abcam HeLa DLD KO cancer cell line human CVCL_B1Q5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2898; DLD Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360689 CVCL_B1PG Abcam HeLa CSNK1G1 KO cancer cell line human CVCL_B1PG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2454; CSNK1G1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360690 CVCL_B1PF Abcam HeLa CSNK1E KO cancer cell line human CVCL_B1PF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2453; CSNK1E Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360691 CVCL_B1PI Abcam HeLa CSTF2 KO cancer cell line human CVCL_B1PI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2484; CSTF2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360692 CVCL_B1PH Abcam HeLa CSRP1 KO cancer cell line human CVCL_B1PH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2469; CSRP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360693 CVCL_B1PK Abcam HeLa CTNNB1 KO cancer cell line human CVCL_B1PK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2514; CTNNB1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360694 CVCL_B1PJ Abcam HeLa CTDSPL KO cancer cell line human CVCL_B1PJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16890; CTDSPL Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360695 CVCL_B1PM Abcam HeLa CUTC KO cancer cell line human CVCL_B1PM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24271; CUTC Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360696 CVCL_B1PL Abcam HeLa CTSC KO cancer cell line human CVCL_B1PL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2528; CTSC Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360697 CVCL_B1PA Abcam HeLa CRKL KO cancer cell line human CVCL_B1PA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2363; CRKL Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360698 CVCL_B1PC Abcam HeLa CSAD KO cancer cell line human CVCL_B1PC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18966; CSAD Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360699 CVCL_B1PB Abcam HeLa CRY1 KO cancer cell line human CVCL_B1PB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2384; CRY1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360700 CVCL_B1PE Abcam HeLa CSNK1D KO cancer cell line human CVCL_B1PE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2452; CSNK1D Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360701 CVCL_B1PD Abcam HeLa CSF1R KO cancer cell line human CVCL_B1PD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2433; CSF1R Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360702 CVCL_B1MT Abcam HeLa CD70 KO cancer cell line human CVCL_B1MT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11937; CD70 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360703 CVCL_B1N5 Abcam HeLa CDK8 KO cancer cell line human CVCL_B1N5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1779; CDK8 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360704 CVCL_B1MS Abcam HeLa CD58 KO cancer cell line human CVCL_B1MS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1688; CD58 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360705 CVCL_B1N4 Abcam HeLa CDK6 KO cancer cell line human CVCL_B1N4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1777; CDK6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360706 CVCL_B1MV Abcam HeLa CDC25C KO cancer cell line human CVCL_B1MV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1727; CDC25C Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360707 CVCL_B1N7 Abcam HeLa CDKN1A KO cancer cell line human CVCL_B1N7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1784; CDKN1A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360708 CVCL_B1MU Abcam HeLa CD9 KO cancer cell line human CVCL_B1MU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1709; CD9 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360709 CVCL_B1N6 Abcam HeLa CDKL1 KO cancer cell line human CVCL_B1N6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1781; CDKL1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360710 CVCL_B1MX Abcam HeLa CDC42EP4 KO cancer cell line human CVCL_B1MX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17147; CDC42EP4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360711 CVCL_B1N9 Abcam HeLa CEBPB KO cancer cell line human CVCL_B1N9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1834; CEBPB Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360712 CVCL_B1MW Abcam HeLa CDC42BPA KO cancer cell line human CVCL_B1MW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1737; CDC42BPA Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360713 CVCL_B1N8 Abcam HeLa CDKN2B KO cancer cell line human CVCL_B1N8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1788; CDKN2B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360714 CVCL_B1MZ Abcam HeLa CDK12 KO cancer cell line human CVCL_B1MZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24224; CDK12 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265209; true Female 151360715 CVCL_B1MY Abcam HeLa CDC42SE1 KO cancer cell line human CVCL_B1MY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17719; CDC42SE1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360716 CVCL_B1ML Abcam HeLa CCND1 KO 2 cancer cell line human CVCL_B1ML CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1582; CCND1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360717 CVCL_B1MK Abcam HeLa CCND1 KO 1 cancer cell line human CVCL_B1MK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1582; CCND1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360718 CVCL_B1MN Abcam HeLa CD276 KO cancer cell line human CVCL_B1MN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19137; CD276 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360719 CVCL_B1MM Abcam HeLa CD160 KO cancer cell line human CVCL_B1MM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17013; CD160 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265834; true Female 151360720 CVCL_B1MP Abcam HeLa CD28 KO cancer cell line human CVCL_B1MP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1653; CD28 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab261739; true Female 151360721 CVCL_B1N1 Abcam HeLa CDK19 KO cancer cell line human CVCL_B1N1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19338; CDK19 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360722 CVCL_B1N0 Abcam HeLa CDK17 KO cancer cell line human CVCL_B1N0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8750; CDK17 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360723 CVCL_B1MR Abcam HeLa CD44 KO cancer cell line human CVCL_B1MR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1681; CD44 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360724 CVCL_B1N3 Abcam HeLa CDK4 KO cancer cell line human CVCL_B1N3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1773; CDK4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360725 CVCL_B1MQ Abcam HeLa CD38 KO cancer cell line human CVCL_B1MQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1667; CD38 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265951; true Female 151360726 CVCL_B1N2 Abcam HeLa CDK3 KO cancer cell line human CVCL_B1N2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1772; CDK3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360727 CVCL_B1MD Abcam HeLa CBS KO cancer cell line human CVCL_B1MD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1550; CBS Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360728 CVCL_B1MC Abcam HeLa CBLL1 KO cancer cell line human CVCL_B1MC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21225; CBLL1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360729 CVCL_B1MF Abcam HeLa CCDC137 KO cancer cell line human CVCL_B1MF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33451; CCDC137 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360730 CVCL_B1ME Abcam HeLa CBX3 KO cancer cell line human CVCL_B1ME CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1553; CBX3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360731 CVCL_B1MH Abcam HeLa CCL2 KO cancer cell line human CVCL_B1MH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10618; CCL2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360732 CVCL_B1MG Abcam HeLa CCDC6 KO cancer cell line human CVCL_B1MG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18782; CCDC6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360733 CVCL_B1MJ Abcam HeLa CCN2 KO cancer cell line human CVCL_B1MJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2500; CCN2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360734 CVCL_B1MI Abcam HeLa CCL20 KO cancer cell line human CVCL_B1MI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10619; CCL20 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360735 CVCL_B1LZ Abcam HeLa CALD1 KO cancer cell line human CVCL_B1LZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1441; CALD1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360736 CVCL_B1MB Abcam HeLa CBLB KO cancer cell line human CVCL_B1MB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1542; CBLB Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360737 CVCL_B1MA Abcam HeLa CAVIN1 KO cancer cell line human CVCL_B1MA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9688; CAVIN1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360738 CVCL_B1NU Abcam HeLa COL4A1 KO cancer cell line human CVCL_B1NU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2202; COL4A1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360739 CVCL_B1NT Abcam HeLa COIL KO cancer cell line human CVCL_B1NT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2184; COIL Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360740 CVCL_B1NW Abcam HeLa COL4A3 KO cancer cell line human CVCL_B1NW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2204; COL4A3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360741 CVCL_B1NV Abcam HeLa COL4A2 KO cancer cell line human CVCL_B1NV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2203; COL4A2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360742 CVCL_B1NY Abcam HeLa COL4A5 KO cancer cell line human CVCL_B1NY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2207; COL4A5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360743 CVCL_B1NX Abcam HeLa COL4A4 KO cancer cell line human CVCL_B1NX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2206; COL4A4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360744 CVCL_B1NZ Abcam HeLa COL4A6 KO cancer cell line human CVCL_B1NZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2208; COL4A6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360745 CVCL_B1NM Abcam HeLa CLPX KO cancer cell line human CVCL_B1NM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2088; CLPX Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360746 CVCL_B1NL Abcam HeLa CLOCK KO 2 cancer cell line human CVCL_B1NL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2082; CLOCK Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360747 CVCL_B1NN Abcam HeLa CLTCL1 KO cancer cell line human CVCL_B1NN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2093; CLTCL1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360748 CVCL_B1NQ Abcam HeLa CNOT7 KO cancer cell line human CVCL_B1NQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14101; CNOT7 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360749 CVCL_B1NP Abcam HeLa CNN1 KO cancer cell line human CVCL_B1NP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2155; CNN1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265620; true Female 151360750 CVCL_B1NS Abcam HeLa CNP KO cancer cell line human CVCL_B1NS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2158; CNP Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360751 CVCL_B1NR Abcam HeLa CNOT9 KO cancer cell line human CVCL_B1NR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10445; CNOT9 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360752 CVCL_B1NE Abcam HeLa CIC KO cancer cell line human CVCL_B1NE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14214; CIC Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360753 CVCL_B1ND Abcam HeLa CHMP4A KO cancer cell line human CVCL_B1ND CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20274; CHMP4A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360754 CVCL_B1NG Abcam HeLa CLCN7 KO cancer cell line human CVCL_B1NG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2025; CLCN7 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360755 CVCL_B1NF Abcam HeLa CISD1 KO cancer cell line human CVCL_B1NF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30880; CISD1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360756 CVCL_B1NI Abcam HeLa CLK3 KO cancer cell line human CVCL_B1NI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2071; CLK3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360757 CVCL_B1NH Abcam HeLa CLK1 KO cancer cell line human CVCL_B1NH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2068; CLK1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360758 CVCL_B1NK Abcam HeLa CLOCK KO 1 cancer cell line human CVCL_B1NK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2082; CLOCK Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360759 CVCL_B1NJ Abcam HeLa CLK4 KO cancer cell line human CVCL_B1NJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13659; CLK4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360760 CVCL_B1NA Abcam HeLa CEP57 KO cancer cell line human CVCL_B1NA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30794; CEP57 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360761 CVCL_B1NC Abcam HeLa CHEK2 KO cancer cell line human CVCL_B1NC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16627; CHEK2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360762 CVCL_B1NB Abcam HeLa CHAT KO cancer cell line human CVCL_B1NB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1912; CHAT Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab266018; true Female 151360763 CVCL_B1KR Abcam HeLa ATP5F1E KO cancer cell line human CVCL_B1KR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:838; ATP5F1E Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360764 CVCL_B1L3 Abcam HeLa BCAR3 KO cancer cell line human CVCL_B1L3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:973; BCAR3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360765 CVCL_B1KQ Abcam HeLa ATP2B4 KO cancer cell line human CVCL_B1KQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:817; ATP2B4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360766 CVCL_B1L2 Abcam HeLa BBC3 KO cancer cell line human CVCL_B1L2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17868; BBC3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360767 CVCL_B1KT Abcam HeLa AXL KO 2 cancer cell line human CVCL_B1KT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:905; AXL Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360768 CVCL_B1L5 Abcam HeLa BCL2L2 KO cancer cell line human CVCL_B1L5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:995; BCL2L2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360769 CVCL_B1KS Abcam HeLa AXL KO 1 cancer cell line human CVCL_B1KS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:905; AXL Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360770 CVCL_B1L4 Abcam HeLa BCL10 KO cancer cell line human CVCL_B1L4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:989; BCL10 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360771 CVCL_B1KV Abcam HeLa AZIN1 KO cancer cell line human CVCL_B1KV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16432; AZIN1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360772 CVCL_B1L7 Abcam HeLa BCOR KO cancer cell line human CVCL_B1L7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20893; BCOR Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360773 CVCL_B1KU Abcam HeLa AZI2 KO cancer cell line human CVCL_B1KU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24002; AZI2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360774 CVCL_B1L6 Abcam HeLa BCL6 KO cancer cell line human CVCL_B1L6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1001; BCL6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360775 CVCL_B1KX Abcam HeLa BAG2 KO cancer cell line human CVCL_B1KX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:938; BAG2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360776 CVCL_B1L9 Abcam HeLa BIRC2 KO cancer cell line human CVCL_B1L9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:590; BIRC2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360777 CVCL_B1KW Abcam HeLa B4GALT1 KO cancer cell line human CVCL_B1KW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:924; B4GALT1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360778 CVCL_B1L8 Abcam HeLa BECN1 KO cancer cell line human CVCL_B1L8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1034; BECN1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360779 CVCL_B1KJ Abcam HeLa ATG2B KO cancer cell line human CVCL_B1KJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20187; ATG2B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360780 CVCL_B1KI Abcam HeLa ATG2A KO cancer cell line human CVCL_B1KI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29028; ATG2A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360781 CVCL_B1KL Abcam HeLa ATG4B KO cancer cell line human CVCL_B1KL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20790; ATG4B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360782 CVCL_B1KK Abcam HeLa ATG4A KO cancer cell line human CVCL_B1KK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16489; ATG4A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360783 CVCL_B1KN Abcam HeLa ATP13A3 KO cancer cell line human CVCL_B1KN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24113; ATP13A3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360784 CVCL_B1KM Abcam HeLa ATG4D KO cancer cell line human CVCL_B1KM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20789; ATG4D Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360785 CVCL_B1KP Abcam HeLa ATP2B1 KO cancer cell line human CVCL_B1KP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:814; ATP2B1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360786 CVCL_B1L1 Abcam HeLa BAZ1B KO cancer cell line human CVCL_B1L1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:961; BAZ1B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360787 CVCL_B1L0 Abcam HeLa BAZ1A KO cancer cell line human CVCL_B1L0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:960; BAZ1A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360788 CVCL_B1KB Abcam HeLa ATG10 KO cancer cell line human CVCL_B1KB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20315; ATG10 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360789 CVCL_B1KA Abcam HeLa ATF6 KO cancer cell line human CVCL_B1KA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:791; ATF6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360790 CVCL_B1KD Abcam HeLa ATG14 KO cancer cell line human CVCL_B1KD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19962; ATG14 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360791 CVCL_B1KC Abcam HeLa ATG101 KO cancer cell line human CVCL_B1KC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25679; ATG101 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360792 CVCL_B1KF Abcam HeLa ATG16L1 KO 2 cancer cell line human CVCL_B1KF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21498; ATG16L1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360793 CVCL_B1KE Abcam HeLa ATG16L1 KO 1 cancer cell line human CVCL_B1KE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21498; ATG16L1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360794 CVCL_B1KH Abcam HeLa ATG16L2 KO cancer cell line human CVCL_B1KH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25464; ATG16L2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360795 CVCL_B1KG Abcam HeLa ATG16L1 KO 3 cancer cell line human CVCL_B1KG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21498; ATG16L1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360796 CVCL_B1JY Abcam HeLa ARID2 KO cancer cell line human CVCL_B1JY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18037; ARID2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360797 CVCL_B1JX Abcam HeLa ARHGEF2 KO cancer cell line human CVCL_B1JX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:682; ARHGEF2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360798 CVCL_B1K9 Abcam HeLa ATF3 KO cancer cell line human CVCL_B1K9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:785; ATF3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360799 CVCL_B1JZ Abcam HeLa ARL13B KO cancer cell line human CVCL_B1JZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25419; ARL13B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360800 CVCL_B1LS Abcam HeLa C1orf131 KO cancer cell line human CVCL_B1LS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25332; C1orf131 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360801 CVCL_B1M4 Abcam HeLa CASP3 KO cancer cell line human CVCL_B1M4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1504; CASP3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360802 CVCL_B1LR Abcam HeLa C1D KO cancer cell line human CVCL_B1LR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29911; C1D Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab266023; true Female 151360803 CVCL_B1M3 Abcam HeLa CAPG KO cancer cell line human CVCL_B1M3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1474; CAPG Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360804 CVCL_B1LU Abcam HeLa C6orf62 KO cancer cell line human CVCL_B1LU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20998; C6orf62 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360805 CVCL_B1M6 Abcam HeLa CASP8 KO cancer cell line human CVCL_B1M6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1509; CASP8 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360806 CVCL_B1LT Abcam HeLa C5orf51 KO cancer cell line human CVCL_B1LT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27750; RIMOC1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360807 CVCL_B1M5 Abcam HeLa CASP7 KO cancer cell line human CVCL_B1M5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1508; CASP7 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360808 CVCL_B1LW Abcam HeLa C9orf78 KO cancer cell line human CVCL_B1LW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24932; C9orf78 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360809 CVCL_B1M8 Abcam HeLa CAT KO 2 cancer cell line human CVCL_B1M8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1516; CAT Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360810 CVCL_B1LV Abcam HeLa C9orf69 KO cancer cell line human CVCL_B1LV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31009; TMEM250 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360811 CVCL_B1M7 Abcam HeLa CAT KO 1 cancer cell line human CVCL_B1M7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1516; CAT Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360812 CVCL_B1LY Abcam HeLa CACNB3 KO cancer cell line human CVCL_B1LY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1403; CACNB3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360813 CVCL_B1LX Abcam HeLa CACNA2D1 KO cancer cell line human CVCL_B1LX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1399; CACNA2D1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360814 CVCL_B1M9 Abcam HeLa CAV1 KO cancer cell line human CVCL_B1M9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1527; CAV1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360815 CVCL_B1LK Abcam HeLa BRSK2 KO cancer cell line human CVCL_B1LK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11405; BRSK2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360816 CVCL_B1LJ Abcam HeLa BRSK1 KO cancer cell line human CVCL_B1LJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18994; BRSK1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360817 CVCL_B1LM Abcam HeLa BTN3A2 KO cancer cell line human CVCL_B1LM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1139; BTN3A2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360818 CVCL_B1LL Abcam HeLa BRWD1 KO cancer cell line human CVCL_B1LL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12760; BRWD1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360819 CVCL_B1M0 Abcam HeLa CALM2 KO cancer cell line human CVCL_B1M0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1445; CALM2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360820 CVCL_B1LN Abcam HeLa BUB1 KO cancer cell line human CVCL_B1LN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1148; BUB1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360821 CVCL_B1LQ Abcam HeLa C19orf33 KO cancer cell line human CVCL_B1LQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16668; C19orf33 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360822 CVCL_B1M2 Abcam HeLa CAMKK1 KO cancer cell line human CVCL_B1M2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1469; CAMKK1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360823 CVCL_B1LP Abcam HeLa C11orf58 KO cancer cell line human CVCL_B1LP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16990; C11orf58 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360824 CVCL_B1M1 Abcam HeLa CAMK2G KO cancer cell line human CVCL_B1M1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1463; CAMK2G Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360825 CVCL_B1LC Abcam HeLa BMP2 KO cancer cell line human CVCL_B1LC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1069; BMP2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360826 CVCL_B1LB Abcam HeLa BLOC1S1 KO cancer cell line human CVCL_B1LB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4200; BLOC1S1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360827 CVCL_B1LE Abcam HeLa BMPR1A KO cancer cell line human CVCL_B1LE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1076; BMPR1A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360828 CVCL_B1LD Abcam HeLa BMP2K KO cancer cell line human CVCL_B1LD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18041; BMP2K Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360829 CVCL_B1LG Abcam HeLa BRAF KO cancer cell line human CVCL_B1LG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1097; BRAF Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360830 CVCL_B1LF Abcam HeLa BOD1 KO cancer cell line human CVCL_B1LF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25114; BOD1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360831 CVCL_B1LI Abcam HeLa BRK1 KO cancer cell line human CVCL_B1LI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23057; BRK1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360832 CVCL_B1LH Abcam HeLa BRE KO cancer cell line human CVCL_B1LH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1106; BABAM2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360833 CVCL_B1KZ Abcam HeLa BAX KO cancer cell line human CVCL_B1KZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:959; BAX Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360834 CVCL_B1KY Abcam HeLa BAK1 KO cancer cell line human CVCL_B1KY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:949; BAK1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360835 CVCL_B1LA Abcam HeLa BLMH KO cancer cell line human CVCL_B1LA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1059; BLMH Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360836 CVCL_B1ZA Abcam HeLa NTRK2 KO cancer cell line human CVCL_B1ZA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8032; NTRK2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab261808; true Female 151360837 CVCL_B1ZC Abcam HeLa NUDT3 KO cancer cell line human CVCL_B1ZC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8050; NUDT3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360838 CVCL_B1ZB Abcam HeLa NUDT2 KO cancer cell line human CVCL_B1ZB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8049; NUDT2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360839 CVCL_B1ZE Abcam HeLa NUPR1 KO cancer cell line human CVCL_B1ZE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29990; NUPR1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360840 CVCL_B1ZD Abcam HeLa NUP153 KO cancer cell line human CVCL_B1ZD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8062; NUP153 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360841 CVCL_B1ZG Abcam HeLa OBSCN KO cancer cell line human CVCL_B1ZG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15719; OBSCN Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360842 CVCL_B1ZF Abcam HeLa OAS1 KO cancer cell line human CVCL_B1ZF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8086; OAS1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360843 CVCL_B1YX Abcam HeLa NPTX1 KO cancer cell line human CVCL_B1YX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7952; NPTX1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360844 CVCL_B1Z9 Abcam HeLa NSD2 KO cancer cell line human CVCL_B1Z9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12766; NSD2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360845 CVCL_B1YW Abcam HeLa NPR1 KO cancer cell line human CVCL_B1YW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7943; NPR1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360846 CVCL_B1Z8 Abcam HeLa NRG4 KO cancer cell line human CVCL_B1Z8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29862; NRG4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360847 CVCL_B1YZ Abcam HeLa NR2F2 KO cancer cell line human CVCL_B1YZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7976; NR2F2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab261829; true Female 151360848 CVCL_B1YY Abcam HeLa NPY4R KO cancer cell line human CVCL_B1YY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9329; NPY4R Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360849 CVCL_B1YP Abcam HeLa NLRX1 KO cancer cell line human CVCL_B1YP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29890; NLRX1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360850 CVCL_B1Z1 Abcam HeLa NR3C2 KO cancer cell line human CVCL_B1Z1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7979; NR3C2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360851 CVCL_B1Z0 Abcam HeLa NR3C1 KO cancer cell line human CVCL_B1Z0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7978; NR3C1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360852 CVCL_B1YR Abcam HeLa NOMO2 KO cancer cell line human CVCL_B1YR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22652; NOMO2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360853 CVCL_B1Z3 Abcam HeLa NRAS KO 2 cancer cell line human CVCL_B1Z3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7989; NRAS Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360854 CVCL_B1YQ Abcam HeLa NNMT KO cancer cell line human CVCL_B1YQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7861; NNMT Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360855 CVCL_B1Z2 Abcam HeLa NRAS KO 1 cancer cell line human CVCL_B1Z2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7989; NRAS Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360856 CVCL_B1YT Abcam HeLa NOTCH1 KO cancer cell line human CVCL_B1YT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7881; NOTCH1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360857 CVCL_B1Z5 Abcam HeLa NRBF2 KO cancer cell line human CVCL_B1Z5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19692; NRBF2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360858 CVCL_B1YS Abcam HeLa NOS2 KO cancer cell line human CVCL_B1YS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7873; NOS2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360859 CVCL_B1Z4 Abcam HeLa NRAS KO 3 cancer cell line human CVCL_B1Z4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7989; NRAS Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab267225; true Female 151360860 CVCL_B1YV Abcam HeLa NPPB KO cancer cell line human CVCL_B1YV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7940; NPPB Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360861 CVCL_B1Z7 Abcam HeLa NRG2 KO cancer cell line human CVCL_B1Z7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7998; NRG2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360862 CVCL_B1YU Abcam HeLa NPHS1 KO cancer cell line human CVCL_B1YU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7908; NPHS1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265099; true Female 151360863 CVCL_B1Z6 Abcam HeLa NRBP2 KO cancer cell line human CVCL_B1Z6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19339; NRBP2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360864 CVCL_B1YH Abcam HeLa NEFH KO cancer cell line human CVCL_B1YH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7737; NEFH Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab255413; true Female 151360865 CVCL_B1YG Abcam HeLa NDUFB9 KO cancer cell line human CVCL_B1YG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7704; NDUFB9 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360866 CVCL_B1YJ Abcam HeLa NF1 KO cancer cell line human CVCL_B1YJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7765; NF1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360867 CVCL_B1YI Abcam HeLa NEK6 KO cancer cell line human CVCL_B1YI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7749; NEK6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360868 CVCL_B1YL Abcam HeLa NFATC1 KO cancer cell line human CVCL_B1YL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7775; NFATC1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265199; true Female 151360869 CVCL_B1YK Abcam HeLa NF2 KO cancer cell line human CVCL_B1YK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7773; NF2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360870 CVCL_B1YN Abcam HeLa NLK KO cancer cell line human CVCL_B1YN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29858; NLK Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360871 CVCL_B1YM Abcam HeLa NLGN4X KO cancer cell line human CVCL_B1YM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14287; NLGN4X Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360872 CVCL_B1ZY Abcam HeLa PAQR5 KO cancer cell line human CVCL_B1ZY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29645; PAQR5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360873 CVCL_B1ZX Abcam HeLa PAQR4 KO cancer cell line human CVCL_B1ZX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26386; PAQR4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360874 CVCL_B1ZZ Abcam HeLa PARD6A KO cancer cell line human CVCL_B1ZZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15943; PARD6A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360875 CVCL_B1ZQ Abcam HeLa P2RX5 KO cancer cell line human CVCL_B1ZQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8536; P2RX5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360876 CVCL_B1ZP Abcam HeLa OXCT1 KO cancer cell line human CVCL_B1ZP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8527; OXCT1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360877 CVCL_B1ZS Abcam HeLa PAK1 KO cancer cell line human CVCL_B1ZS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8590; PAK1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360878 CVCL_B1ZR Abcam HeLa PACSIN2 KO cancer cell line human CVCL_B1ZR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8571; PACSIN2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360879 CVCL_B1ZU Abcam HeLa PALM KO cancer cell line human CVCL_B1ZU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8594; PALM Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360880 CVCL_B1ZT Abcam HeLa PAK2 KO cancer cell line human CVCL_B1ZT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8591; PAK2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360881 CVCL_B1ZW Abcam HeLa PAPSS2 KO cancer cell line human CVCL_B1ZW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8604; PAPSS2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360882 CVCL_B1ZV Abcam HeLa PALS1 KO cancer cell line human CVCL_B1ZV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18669; PALS1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360883 CVCL_B1ZI Abcam HeLa OGFR KO cancer cell line human CVCL_B1ZI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15768; OGFR Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360884 CVCL_B1ZH Abcam HeLa OGA KO cancer cell line human CVCL_B1ZH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7056; OGA Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360885 CVCL_B1ZK Abcam HeLa OSMR KO cancer cell line human CVCL_B1ZK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8507; OSMR Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360886 CVCL_B1ZJ Abcam HeLa OSBPL5 KO cancer cell line human CVCL_B1ZJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16392; OSBPL5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360887 CVCL_B1ZM Abcam HeLa OTUD7B KO cancer cell line human CVCL_B1ZM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16683; OTUD7B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360888 CVCL_B1ZL Abcam HeLa OTUD4 KO cancer cell line human CVCL_B1ZL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24949; OTUD4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360889 CVCL_B1ZN Abcam HeLa OTX2 KO cancer cell line human CVCL_B1ZN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8522; OTX2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265267; true Female 151360890 CVCL_B1XA Abcam HeLa MME KO cancer cell line human CVCL_B1XA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7154; MME Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab264794; true Female 151360891 CVCL_B1XC Abcam HeLa MMRN1 KO cancer cell line human CVCL_B1XC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7178; MMRN1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360892 CVCL_B1XB Abcam HeLa MMP24 KO cancer cell line human CVCL_B1XB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7172; MMP24 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360893 CVCL_B1XE Abcam HeLa MPLKIP KO cancer cell line human CVCL_B1XE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16002; MPLKIP Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360894 CVCL_B1XD Abcam HeLa MOK KO cancer cell line human CVCL_B1XD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9833; MOK Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360895 CVCL_B1WV Abcam HeLa MC2R KO cancer cell line human CVCL_B1WV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6930; MC2R Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360896 CVCL_B1X7 Abcam HeLa MLEC KO cancer cell line human CVCL_B1X7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28973; MLEC Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360897 CVCL_B1WU Abcam HeLa MBD4 KO cancer cell line human CVCL_B1WU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6919; MBD4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360898 CVCL_B1X6 Abcam HeLa MKNK1 KO cancer cell line human CVCL_B1X6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7110; MKNK1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360899 CVCL_B1WX Abcam HeLa MCFD2 KO cancer cell line human CVCL_B1WX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18451; MCFD2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360900 CVCL_B1X9 Abcam HeLa MLKL KO cancer cell line human CVCL_B1X9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26617; MLKL Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360901 CVCL_B1WW Abcam HeLa MCAM KO cancer cell line human CVCL_B1WW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6934; MCAM Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360902 CVCL_B1X8 Abcam HeLa MLH1 KO cancer cell line human CVCL_B1X8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7127; MLH1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360903 CVCL_B1WZ Abcam HeLa MERTK KO cancer cell line human CVCL_B1WZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7027; MERTK Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab264765; true Female 151360904 CVCL_B1WY Abcam HeLa MEOX1 KO cancer cell line human CVCL_B1WY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7013; MEOX1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360905 CVCL_B1WN Abcam HeLa MAP4K3 KO cancer cell line human CVCL_B1WN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6865; MAP4K3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360906 CVCL_B1WM Abcam HeLa MAP4 KO cancer cell line human CVCL_B1WM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6862; MAP4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360907 CVCL_B1WP Abcam HeLa MAPK1 KO cancer cell line human CVCL_B1WP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6871; MAPK1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360908 CVCL_B1X1 Abcam HeLa METTL5 KO cancer cell line human CVCL_B1X1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25006; METTL5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360909 CVCL_B1X0 Abcam HeLa MET KO cancer cell line human CVCL_B1X0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7029; MET Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360910 CVCL_B1WR Abcam HeLa MAPK7 KO cancer cell line human CVCL_B1WR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6880; MAPK7 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360911 CVCL_B1X3 Abcam HeLa MIOS KO cancer cell line human CVCL_B1X3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21905; MIOS Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360912 CVCL_B1WQ Abcam HeLa MAPK6 KO cancer cell line human CVCL_B1WQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6879; MAPK6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360913 CVCL_B1X2 Abcam HeLa MFSD1 KO cancer cell line human CVCL_B1X2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25874; MFSD1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360914 CVCL_B1WT Abcam HeLa MBD1 KO cancer cell line human CVCL_B1WT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6916; MBD1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360915 CVCL_B1X5 Abcam HeLa MKI67 KO cancer cell line human CVCL_B1X5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7107; MKI67 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360916 CVCL_B1WS Abcam HeLa MAST2 KO cancer cell line human CVCL_B1WS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19035; MAST2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360917 CVCL_B1X4 Abcam HeLa MISP KO cancer cell line human CVCL_B1X4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27000; MISP Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360918 CVCL_B1WF Abcam HeLa MAN1C1 KO cancer cell line human CVCL_B1WF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19080; MAN1C1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360919 CVCL_B1WE Abcam HeLa MALT1 KO cancer cell line human CVCL_B1WE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6819; MALT1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360920 CVCL_B1WH Abcam HeLa MAP3K11 KO cancer cell line human CVCL_B1WH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6850; MAP3K11 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360921 CVCL_B1WG Abcam HeLa MAP3K1 KO cancer cell line human CVCL_B1WG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6848; MAP3K1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360922 CVCL_B1WJ Abcam HeLa MAP3K2 KO cancer cell line human CVCL_B1WJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6854; MAP3K2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360923 CVCL_B1WI Abcam HeLa MAP3K12 KO cancer cell line human CVCL_B1WI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6851; MAP3K12 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360924 CVCL_B1WL Abcam HeLa MAP3K8 KO cancer cell line human CVCL_B1WL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6860; MAP3K8 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360925 CVCL_B1WK Abcam HeLa MAP3K20 KO cancer cell line human CVCL_B1WK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17797; MAP3K20 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360926 CVCL_B1YB Abcam HeLa NDC1 KO cancer cell line human CVCL_B1YB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25525; NDC1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360927 CVCL_B1YA Abcam HeLa NCL KO cancer cell line human CVCL_B1YA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7667; NCL Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360928 CVCL_B1YD Abcam HeLa NDUFA2 KO cancer cell line human CVCL_B1YD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7685; NDUFA2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360929 CVCL_B1YC Abcam HeLa NDUFA13 KO cancer cell line human CVCL_B1YC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17194; NDUFA13 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360930 CVCL_B1YF Abcam HeLa NDUFB5 KO cancer cell line human CVCL_B1YF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7700; NDUFB5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360931 CVCL_B1YE Abcam HeLa NDUFA6 KO cancer cell line human CVCL_B1YE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7690; NDUFA6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360932 CVCL_B1XW Abcam HeLa MTMR3 KO cancer cell line human CVCL_B1XW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7451; MTMR3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360933 CVCL_B1Y8 Abcam HeLa NCAPD3 KO cancer cell line human CVCL_B1Y8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28952; NCAPD3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360934 CVCL_B1XV Abcam HeLa MTMR2 KO cancer cell line human CVCL_B1XV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7450; MTMR2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360935 CVCL_B1Y7 Abcam HeLa NCAM1 KO cancer cell line human CVCL_B1Y7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7656; NCAM1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265275; true Female 151360936 CVCL_B1XY Abcam HeLa MVB12A KO cancer cell line human CVCL_B1XY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25153; MVB12A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360937 CVCL_B1XX Abcam HeLa MUC1 KO cancer cell line human CVCL_B1XX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7508; MUC1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360938 CVCL_B1Y9 Abcam HeLa NCK1 KO cancer cell line human CVCL_B1Y9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7664; NCK1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360939 CVCL_B1XZ Abcam HeLa MVP KO cancer cell line human CVCL_B1XZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7531; MVP Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360940 CVCL_B1Y0 Abcam HeLa MYG1 KO cancer cell line human CVCL_B1Y0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17590; MYG1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360941 CVCL_B1XN Abcam HeLa MSH6 KO cancer cell line human CVCL_B1XN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7329; MSH6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360942 CVCL_B1XQ Abcam HeLa MT1X KO cancer cell line human CVCL_B1XQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7405; MT1X Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360943 CVCL_B1Y2 Abcam HeLa MYOF KO cancer cell line human CVCL_B1Y2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3656; MYOF Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360944 CVCL_B1XP Abcam HeLa MSL1 KO cancer cell line human CVCL_B1XP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27905; MSL1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360945 CVCL_B1Y1 Abcam HeLa MYL9 KO cancer cell line human CVCL_B1Y1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15754; MYL9 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360946 CVCL_B1XS Abcam HeLa MTCH1 KO cancer cell line human CVCL_B1XS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17586; MTCH1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360947 CVCL_B1Y4 Abcam HeLa MZT1 KO cancer cell line human CVCL_B1Y4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33830; MZT1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360948 CVCL_B1XR Abcam HeLa MTAP KO cancer cell line human CVCL_B1XR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7413; MTAP Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360949 CVCL_B1Y3 Abcam HeLa MYPN KO cancer cell line human CVCL_B1Y3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23246; MYPN Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360950 CVCL_B1XU Abcam HeLa MTMR14 KO cancer cell line human CVCL_B1XU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26190; MTMR14 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360951 CVCL_B1Y6 Abcam HeLa NARF KO cancer cell line human CVCL_B1Y6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29916; NARF Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360952 CVCL_B1XT Abcam HeLa MTFP1 KO cancer cell line human CVCL_B1XT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26945; MTFP1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360953 CVCL_B1Y5 Abcam HeLa NAA60 KO cancer cell line human CVCL_B1Y5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25875; NAA60 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360954 CVCL_B1XG Abcam HeLa MPRIP KO cancer cell line human CVCL_B1XG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30321; MPRIP Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360955 CVCL_B1XF Abcam HeLa MPND KO cancer cell line human CVCL_B1XF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25934; MPND Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360956 CVCL_B1XI Abcam HeLa MPZL1 KO cancer cell line human CVCL_B1XI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7226; MPZL1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360957 CVCL_B1XH Abcam HeLa MPV17 KO cancer cell line human CVCL_B1XH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7224; MPV17 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360958 CVCL_B1XK Abcam HeLa MRPL40 KO cancer cell line human CVCL_B1XK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14491; MRPL40 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360959 CVCL_B1XJ Abcam HeLa MRAS KO cancer cell line human CVCL_B1XJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7227; MRAS Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360960 CVCL_B1XM Abcam HeLa MSH5 KO cancer cell line human CVCL_B1XM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7328; MSH5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360961 CVCL_B1XL Abcam HeLa MRPS7 KO cancer cell line human CVCL_B1XL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14499; MRPS7 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360962 CVCL_B1VA Abcam HeLa KIT KO cancer cell line human CVCL_B1VA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6342; KIT Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab264768; true Female 151360963 CVCL_B1VC Abcam HeLa KMT2C KO cancer cell line human CVCL_B1VC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13726; KMT2C Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360964 CVCL_B1VB Abcam HeLa KLC1 KO cancer cell line human CVCL_B1VB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6387; KLC1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360965 CVCL_B1UT Abcam HeLa ITFG1 KO cancer cell line human CVCL_B1UT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30697; ITFG1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360966 CVCL_B1V5 Abcam HeLa KDM6A KO cancer cell line human CVCL_B1V5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12637; KDM6A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360967 CVCL_B1US Abcam HeLa ITCH KO cancer cell line human CVCL_B1US CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13890; ITCH Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360968 CVCL_B1V4 Abcam HeLa KDM1B KO cancer cell line human CVCL_B1V4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21577; KDM1B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360969 CVCL_B1UV Abcam HeLa ITGA2 KO cancer cell line human CVCL_B1UV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6137; ITGA2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360970 CVCL_B1V7 Abcam HeLa KIAA1191 KO cancer cell line human CVCL_B1V7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29209; KIAA1191 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360971 CVCL_B1UU Abcam HeLa ITGA11 KO cancer cell line human CVCL_B1UU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6136; ITGA11 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360972 CVCL_B1V6 Abcam HeLa KHDC4 KO cancer cell line human CVCL_B1V6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29145; KHDC4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360973 CVCL_B1UX Abcam HeLa IVNS1ABP KO cancer cell line human CVCL_B1UX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16951; IVNS1ABP Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360974 CVCL_B1V9 Abcam HeLa KIFC3 KO cancer cell line human CVCL_B1V9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6326; KIFC3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360975 CVCL_B1UW Abcam HeLa ITGA6 KO cancer cell line human CVCL_B1UW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6142; ITGA6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360976 CVCL_B1V8 Abcam HeLa KIF7 KO cancer cell line human CVCL_B1V8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30497; KIF7 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360977 CVCL_B1UZ Abcam HeLa JAG2 KO cancer cell line human CVCL_B1UZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6189; JAG2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360978 CVCL_B1UY Abcam HeLa IWS1 KO cancer cell line human CVCL_B1UY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25467; IWS1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360979 CVCL_B1UL Abcam HeLa IP6K2 KO cancer cell line human CVCL_B1UL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17313; IP6K2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360980 CVCL_B1UK Abcam HeLa INPP5K KO cancer cell line human CVCL_B1UK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33882; INPP5K Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360981 CVCL_B1UN Abcam HeLa IRF1 KO cancer cell line human CVCL_B1UN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6116; IRF1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360982 CVCL_B1UM Abcam HeLa IPO9 KO cancer cell line human CVCL_B1UM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19425; IPO9 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360983 CVCL_B1V1 Abcam HeLa KCNJ11 KO cancer cell line human CVCL_B1V1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6257; KCNJ11 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360984 CVCL_B1UP Abcam HeLa IRF3 KO cancer cell line human CVCL_B1UP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6118; IRF3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360985 CVCL_B1V0 Abcam HeLa JKAMP KO cancer cell line human CVCL_B1V0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20184; JKAMP Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360986 CVCL_B1UR Abcam HeLa IRF9 KO cancer cell line human CVCL_B1UR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6131; IRF9 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360987 CVCL_B1V3 Abcam HeLa KDM1A KO cancer cell line human CVCL_B1V3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29079; KDM1A Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360988 CVCL_B1UQ Abcam HeLa IRF7 KO cancer cell line human CVCL_B1UQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6122; IRF7 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360989 CVCL_B1V2 Abcam HeLa KCNN4 KO cancer cell line human CVCL_B1V2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6293; KCNN4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360990 CVCL_B1UD Abcam HeLa IL13RA1 KO cancer cell line human CVCL_B1UD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5974; IL13RA1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265998; true Female 151360991 CVCL_B1UC Abcam HeLa IKBKB KO cancer cell line human CVCL_B1UC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5960; IKBKB Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360992 CVCL_B1UF Abcam HeLa IL1RAP KO cancer cell line human CVCL_B1UF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5995; IL1RAP Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360993 CVCL_B1UE Abcam HeLa IL18 KO cancer cell line human CVCL_B1UE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5986; IL18 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360994 CVCL_B1UH Abcam HeLa IL6ST KO cancer cell line human CVCL_B1UH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6021; IL6ST Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360995 CVCL_B1UG Abcam HeLa IL20 KO cancer cell line human CVCL_B1UG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6002; IL20 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360996 CVCL_B1UJ Abcam HeLa INF2 KO cancer cell line human CVCL_B1UJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23791; INF2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360997 CVCL_B1UI Abcam HeLa INA KO cancer cell line human CVCL_B1UI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6057; INA Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360998 CVCL_B1WB Abcam HeLa LYPLA2 KO cancer cell line human CVCL_B1WB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6738; LYPLA2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151360999 CVCL_B1WA Abcam HeLa LY6K KO cancer cell line human CVCL_B1WA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24225; LY6K Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361000 CVCL_B1WD Abcam HeLa MAGT1 KO cancer cell line human CVCL_B1WD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28880; MAGT1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361001 CVCL_B1WC Abcam HeLa MAGEA6 KO cancer cell line human CVCL_B1WC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6804; MAGEA6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361002 CVCL_B1VU Abcam HeLa LIN7C KO cancer cell line human CVCL_B1VU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17789; LIN7C Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361003 CVCL_B1W6 Abcam HeLa LRRK1 KO cancer cell line human CVCL_B1W6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18608; LRRK1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361004 CVCL_B1VT Abcam HeLa LIMCH1 KO cancer cell line human CVCL_B1VT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29191; LIMCH1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361005 CVCL_B1W5 Abcam HeLa LRRC58 KO cancer cell line human CVCL_B1W5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26968; LRRC58 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361006 CVCL_B1VW Abcam HeLa LIX1L KO cancer cell line human CVCL_B1VW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28715; LIX1L Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361007 CVCL_B1W8 Abcam HeLa LTB4R2 KO cancer cell line human CVCL_B1W8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19260; LTB4R2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361008 CVCL_B1VV Abcam HeLa LITAF KO cancer cell line human CVCL_B1VV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16841; LITAF Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361009 CVCL_B1W7 Abcam HeLa LRWD1 KO cancer cell line human CVCL_B1W7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21769; LRWD1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361010 CVCL_B1VY Abcam HeLa LMNA KO cancer cell line human CVCL_B1VY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6636; LMNA Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361011 CVCL_B1VX Abcam HeLa LMF2 KO cancer cell line human CVCL_B1VX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25096; LMF2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361012 CVCL_B1W9 Abcam HeLa LXN KO cancer cell line human CVCL_B1W9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13347; LXN Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361013 CVCL_B1VZ Abcam HeLa LMNB1 KO cancer cell line human CVCL_B1VZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6637; LMNB1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361014 CVCL_B1VM Abcam HeLa LAMTOR2 KO cancer cell line human CVCL_B1VM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29796; LAMTOR2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361015 CVCL_B1VL Abcam HeLa LAMTOR1 KO cancer cell line human CVCL_B1VL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26068; LAMTOR1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361016 CVCL_B1W0 Abcam HeLa LOX KO cancer cell line human CVCL_B1W0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6664; LOX Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361017 CVCL_B1VN Abcam HeLa LAMTOR3 KO cancer cell line human CVCL_B1VN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15606; LAMTOR3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361018 CVCL_B1VQ Abcam HeLa LARP4B KO cancer cell line human CVCL_B1VQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28987; LARP4B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361019 CVCL_B1W2 Abcam HeLa LPGAT1 KO cancer cell line human CVCL_B1W2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28985; LPGAT1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361020 CVCL_B1VP Abcam HeLa LANCL1 KO cancer cell line human CVCL_B1VP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6508; LANCL1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361021 CVCL_B1W1 Abcam HeLa LOXL2 KO cancer cell line human CVCL_B1W1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6666; LOXL2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361022 CVCL_B1VS Abcam HeLa LIF KO cancer cell line human CVCL_B1VS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6596; LIF Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361023 CVCL_B1W4 Abcam HeLa LRRC41 KO cancer cell line human CVCL_B1W4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16917; LRRC41 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361024 CVCL_B1VR Abcam HeLa LDB1 KO cancer cell line human CVCL_B1VR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6532; LDB1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361025 CVCL_B1W3 Abcam HeLa LPL KO cancer cell line human CVCL_B1W3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6677; LPL Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361026 CVCL_B1VE Abcam HeLa L1CAM KO 1 cancer cell line human CVCL_B1VE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6470; L1CAM Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361027 CVCL_B1VD Abcam HeLa KRT8 KO cancer cell line human CVCL_B1VD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6446; KRT8 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361028 CVCL_B1VG Abcam HeLa L3MBTL2 KO cancer cell line human CVCL_B1VG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18594; L3MBTL2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361029 CVCL_B1VF Abcam HeLa L1CAM KO 2 cancer cell line human CVCL_B1VF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6470; L1CAM Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361030 CVCL_B1VI Abcam HeLa LAMB1 KO cancer cell line human CVCL_B1VI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6486; LAMB1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361031 CVCL_B1VH Abcam HeLa LAMA3 KO cancer cell line human CVCL_B1VH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6483; LAMA3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361032 CVCL_B1VK Abcam HeLa LAMP3 KO cancer cell line human CVCL_B1VK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14582; LAMP3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361033 CVCL_B1VJ Abcam HeLa LAMP2 KO cancer cell line human CVCL_B1VJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6501; LAMP2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361034 CVCL_B1SZ Abcam HeLa GMNN KO cancer cell line human CVCL_B1SZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17493; GMNN Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361035 CVCL_B1SY Abcam HeLa GLRX2 KO cancer cell line human CVCL_B1SY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16065; GLRX2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361036 CVCL_B1TA Abcam HeLa GSTM4 KO cancer cell line human CVCL_B1TA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4636; GSTM4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361037 CVCL_B1SR Abcam HeLa GDA KO cancer cell line human CVCL_B1SR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4212; GDA Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361038 CVCL_B1T3 Abcam HeLa GNG11 KO cancer cell line human CVCL_B1T3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4403; GNG11 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361039 CVCL_B1SQ Abcam HeLa GBA KO cancer cell line human CVCL_B1SQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4177; GBA1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361040 CVCL_B1T2 Abcam HeLa GNB4 KO cancer cell line human CVCL_B1T2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20731; GNB4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361041 CVCL_B1ST Abcam HeLa GEMIN6 KO cancer cell line human CVCL_B1ST CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20044; GEMIN6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361042 CVCL_B1T5 Abcam HeLa GNS KO cancer cell line human CVCL_B1T5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4422; GNS Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361043 CVCL_B1SS Abcam HeLa GDE1 KO cancer cell line human CVCL_B1SS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29644; GDE1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361044 CVCL_B1T4 Abcam HeLa GNPAT KO cancer cell line human CVCL_B1T4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4416; GNPAT Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361045 CVCL_B1SV Abcam HeLa GIT1 KO cancer cell line human CVCL_B1SV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4272; GIT1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361046 CVCL_B1T7 Abcam HeLa GPSM2 KO cancer cell line human CVCL_B1T7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29501; GPSM2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361047 CVCL_B1SU Abcam HeLa GGCX KO cancer cell line human CVCL_B1SU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4247; GGCX Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361048 CVCL_B1T6 Abcam HeLa GOLM2 KO cancer cell line human CVCL_B1T6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24892; GOLM2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361049 CVCL_B1SX Abcam HeLa GLOD4 KO cancer cell line human CVCL_B1SX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14111; GLOD4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361050 CVCL_B1T9 Abcam HeLa GRK4 KO cancer cell line human CVCL_B1T9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4543; GRK4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361051 CVCL_B1SW Abcam HeLa GLA KO cancer cell line human CVCL_B1SW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4296; GLA Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361052 CVCL_B1T8 Abcam HeLa GPX4 KO cancer cell line human CVCL_B1T8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4556; GPX4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361053 CVCL_B1SJ Abcam HeLa GABRE KO cancer cell line human CVCL_B1SJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4085; GABRE Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361054 CVCL_B1SI Abcam HeLa FZD6 KO cancer cell line human CVCL_B1SI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4044; FZD6 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361055 CVCL_B1SL Abcam HeLa GAGE12J KO cancer cell line human CVCL_B1SL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17778; GAGE12J Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361056 CVCL_B1SK Abcam HeLa GADD45B KO cancer cell line human CVCL_B1SK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4096; GADD45B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361057 CVCL_B1SN Abcam HeLa GALK1 KO cancer cell line human CVCL_B1SN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4118; GALK1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361058 CVCL_B1SM Abcam HeLa GAL KO cancer cell line human CVCL_B1SM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4114; GAL Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361059 CVCL_B1SP Abcam HeLa GANC KO cancer cell line human CVCL_B1SP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4139; GANC Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361060 CVCL_B1T1 Abcam HeLa GNB1 KO cancer cell line human CVCL_B1T1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4396; GNB1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361061 CVCL_B1T0 Abcam HeLa GNA13 KO cancer cell line human CVCL_B1T0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4381; GNA13 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361062 CVCL_B1SB Abcam HeLa FOXA1 KO cancer cell line human CVCL_B1SB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5021; FOXA1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361063 CVCL_B1SA Abcam HeLa FOLR1 KO cancer cell line human CVCL_B1SA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3791; FOLR1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361064 CVCL_B1SD Abcam HeLa FTL KO 1 cancer cell line human CVCL_B1SD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3999; FTL Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361065 CVCL_B1SC Abcam HeLa FOXA2 KO cancer cell line human CVCL_B1SC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5022; FOXA2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265862; true Female 151361066 CVCL_B1SF Abcam HeLa FXR1 KO cancer cell line human CVCL_B1SF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4023; FXR1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361067 CVCL_B1SE Abcam HeLa FTL KO 2 cancer cell line human CVCL_B1SE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3999; FTL Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361068 CVCL_B1SH Abcam HeLa FZD2 KO cancer cell line human CVCL_B1SH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4040; FZD2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361069 CVCL_B1SG Abcam HeLa FZD1 KO cancer cell line human CVCL_B1SG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4038; FZD1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361070 CVCL_B1TZ Abcam HeLa HSPA8 KO cancer cell line human CVCL_B1TZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5241; HSPA8 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361071 CVCL_B1UB Abcam HeLa IGF1R KO cancer cell line human CVCL_B1UB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5465; IGF1R Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361072 CVCL_B1UA Abcam HeLa IFNGR1 KO cancer cell line human CVCL_B1UA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5439; IFNGR1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361073 CVCL_B1TS Abcam HeLa HNRNPDL KO cancer cell line human CVCL_B1TS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5037; HNRNPDL Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361074 CVCL_B1U4 Abcam HeLa IDE KO cancer cell line human CVCL_B1U4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5381; IDE Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361075 CVCL_B1TR Abcam HeLa HMGN4 KO cancer cell line human CVCL_B1TR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4989; HMGN4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361076 CVCL_B1U3 Abcam HeLa ICAM1 KO cancer cell line human CVCL_B1U3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5344; ICAM1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361077 CVCL_B1TU Abcam HeLa HPDL KO cancer cell line human CVCL_B1TU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28242; HPDL Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361078 CVCL_B1U6 Abcam HeLa IDS KO cancer cell line human CVCL_B1U6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5389; IDS Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361079 CVCL_B1TT Abcam HeLa HPCAL1 KO cancer cell line human CVCL_B1TT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5145; HPCAL1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361080 CVCL_B1U5 Abcam HeLa IDH1 KO cancer cell line human CVCL_B1U5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5382; IDH1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361081 CVCL_B1TW Abcam HeLa HPSE KO cancer cell line human CVCL_B1TW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5164; HPSE Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361082 CVCL_B1U8 Abcam HeLa IFITM3 KO cancer cell line human CVCL_B1U8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5414; IFITM3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361083 CVCL_B1TV Abcam HeLa HPS5 KO cancer cell line human CVCL_B1TV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17022; HPS5 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361084 CVCL_B1U7 Abcam HeLa IER2 KO cancer cell line human CVCL_B1U7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28871; IER2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361085 CVCL_B1TY Abcam HeLa HSD3B7 KO cancer cell line human CVCL_B1TY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18324; HSD3B7 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361086 CVCL_B1TX Abcam HeLa HR KO cancer cell line human CVCL_B1TX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5172; HR Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361087 CVCL_B1U9 Abcam HeLa IFNE KO cancer cell line human CVCL_B1U9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18163; IFNE Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361088 CVCL_B1TK Abcam HeLa HES1 KO cancer cell line human CVCL_B1TK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5192; HES1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361089 CVCL_B1TJ Abcam HeLa HERC4 KO cancer cell line human CVCL_B1TJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24521; HERC4 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361090 CVCL_B1TM Abcam HeLa HIBADH KO cancer cell line human CVCL_B1TM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4907; HIBADH Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361091 CVCL_B1TL Abcam HeLa HGF KO cancer cell line human CVCL_B1TL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4893; HGF Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Discontinued: Abcam; ab265221; true Female 151361092 CVCL_B1U0 Abcam HeLa HSPB1 KO cancer cell line human CVCL_B1U0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5246; HSPB1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361093 CVCL_B1TN Abcam HeLa HINT1 KO cancer cell line human CVCL_B1TN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4912; HINT1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361094 CVCL_B1TQ Abcam HeLa HMGB1 KO cancer cell line human CVCL_B1TQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4983; HMGB1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361095 CVCL_B1U2 Abcam HeLa HTT KO cancer cell line human CVCL_B1U2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4851; HTT Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361096 CVCL_B1TP Abcam HeLa HIPK3 KO cancer cell line human CVCL_B1TP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4915; HIPK3 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361097 CVCL_B1U1 Abcam HeLa HSPB8 KO cancer cell line human CVCL_B1U1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30171; HSPB8 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361098 CVCL_B1TC Abcam HeLa GTPBP2 KO cancer cell line human CVCL_B1TC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4670; GTPBP2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361099 CVCL_B1TB Abcam HeLa GSTT2B KO cancer cell line human CVCL_B1TB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33437; GSTT2B Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361100 CVCL_B1TE Abcam HeLa H1-2 KO cancer cell line human CVCL_B1TE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4716; H1-2 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361101 CVCL_B1TD Abcam HeLa GYS1 KO cancer cell line human CVCL_B1TD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4706; GYS1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361102 CVCL_B1TG Abcam HeLa HAO1 KO cancer cell line human CVCL_B1TG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4809; HAO1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361103 CVCL_B1TF Abcam HeLa HAGH KO cancer cell line human CVCL_B1TF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4805; HAGH Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361104 CVCL_B1TI Abcam HeLa HENMT1 KO cancer cell line human CVCL_B1TI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26400; HENMT1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151361105 CVCL_B1TH Abcam HeLa HELLS KO cancer cell line human CVCL_B1TH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4861; HELLS Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151665932 CVCL_B5J3 HAP1 FASTKD2 (-) 2 cancer cell line human CVCL_B5J3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29160; FASTKD2; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151665933 CVCL_B5J2 1B5 [Mouse myogenic] cancer cell line house mouse CVCL_B5J2 CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:99659; Ryr1; Genetic integration: Method=Transduction; Gene=MGI; MGI:97275; Myod1; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134; Cell type: Fibroblast of skeletal muscle; CL=CL_0011027; Breed/subspecies: 129SV ry1(53). Unspecified Characteristics: Can be induced to differentiate into noncontractile multinucleated myotubes (PubMed=9472036) Doubling time: ~18-24 hours (PubMed=9472036) 151665934 CVCL_B5JM HAP1 C17orf80 (-) 2 cancer cell line human CVCL_B5JM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29601; C17orf80; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151665935 CVCL_B5JL HAP1 BCKDHA (-) 2 cancer cell line human CVCL_B5JL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:986; BCKDHA; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151665936 CVCL_B5K0 HAP1 DHTKD1 (-) 6 cancer cell line human CVCL_B5K0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23537; DHTKD1; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151665937 CVCL_B5JN HAP1 C17orf80 (-) 3 cancer cell line human CVCL_B5JN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29601; C17orf80; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Discontinued: Horizon_Discovery; HZGHC007058c017; true Male Group: Haploid karyotype cell line 151665938 CVCL_B5JQ HAP1 C17orf80 (-) 5 cancer cell line human CVCL_B5JQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29601; C17orf80; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Discontinued: Horizon_Discovery; HZGHC007058c022; true Male Group: Haploid karyotype cell line 151665939 CVCL_B5K2 HAP1 ECHS1 (-) 3 cancer cell line human CVCL_B5K2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3151; ECHS1; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151665940 CVCL_B5JP HAP1 C17orf80 (-) 4 cancer cell line human CVCL_B5JP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29601; C17orf80; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Discontinued: Horizon_Discovery; HZGHC007058c019; true Male Group: Haploid karyotype cell line 151665941 CVCL_B5K1 HAP1 ECHS1 (-) 2 cancer cell line human CVCL_B5K1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3151; ECHS1; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151665942 CVCL_B5JS HAP1 CCDC92 (-) 2 cancer cell line human CVCL_B5JS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29563; CCDC92; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151665943 CVCL_B5K4 HAP1 ECHS1 (-) 5 cancer cell line human CVCL_B5K4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3151; ECHS1; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151665944 CVCL_B5JR HAP1 C7orf55 (-) 2 cancer cell line human CVCL_B5JR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26946; FMC1; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151665945 CVCL_B5K3 HAP1 ECHS1 (-) 4 cancer cell line human CVCL_B5K3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3151; ECHS1; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151665946 CVCL_B5JE END-1 cancer cell line human CVCL_B5JE CL:0000010 Female Characteristics: Established from an undifferentiated endometrial carcinoma serially transplanted into nude mice (PubMed=1176207) Doubling time: 14 hours (PubMed=1176207). 151665947 CVCL_B5JD alpha-Mel/37 hybridoma house mouse CVCL_B5JD CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human antigen on melanoma cells. 151665948 CVCL_B5JG HAP1 ALOX5 (-) 2 cancer cell line human CVCL_B5JG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:435; ALOX5; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151665949 CVCL_B5JF HAP1 ACSL4 (-) 2 cancer cell line human CVCL_B5JF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3571; ACSL4; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151665950 CVCL_B5JI HAP1 ARRDC1 (-) 2 cancer cell line human CVCL_B5JI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28633; ARRDC1; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Discontinued: Horizon_Discovery; HZGHC006798c007; true Male Group: Haploid karyotype cell line 151665951 CVCL_B5JH HAP1 ALOX5 (-) 3 cancer cell line human CVCL_B5JH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:435; ALOX5; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Discontinued: Horizon_Discovery; HZGHC007043c012; true Male Group: Haploid karyotype cell line 151665952 CVCL_B5JK HAP1 ATE1 (-) 2 cancer cell line human CVCL_B5JK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:782; ATE1; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151665953 CVCL_B5JJ HAP1 ARRDC1 (-) 3 cancer cell line human CVCL_B5JJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28633; ARRDC1; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151665954 CVCL_B5JA alpha-Mel/12 hybridoma house mouse CVCL_B5JA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human antigen on melanoma cells. 151665955 CVCL_B5JC alpha-Mel/34 hybridoma house mouse CVCL_B5JC CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human antigen on melanoma cells. 151665956 CVCL_B5JB alpha-Mel/14 hybridoma house mouse CVCL_B5JB CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human antigen on melanoma cells. 151665957 CVCL_B5J5 HAP1 FASTKD2 (-) 4 cancer cell line human CVCL_B5J5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29160; FASTKD2; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151665958 CVCL_B5J4 HAP1 FASTKD2 (-) 3 cancer cell line human CVCL_B5J4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29160; FASTKD2; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151665959 CVCL_B5J7 alpha-Mel/5 hybridoma house mouse CVCL_B5J7 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human antigen on melanoma cells. 151665960 CVCL_B5J6 HAP1 DHX30 (-) cancer cell line human CVCL_B5J6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16716; DHX30; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151665961 CVCL_B5J9 alpha-Mel/11 hybridoma house mouse CVCL_B5J9 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human antigen on melanoma cells. 151665962 CVCL_B5J8 alpha-Mel/7 hybridoma house mouse CVCL_B5J8 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human antigen on melanoma cells. 151665963 CVCL_B5R5 CBiPS-E7C9 induced pluripotent stem cell human CVCL_B5R5 CL:0000010 Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; DNA methylation analysis; Omics: Transcriptomics; RNAseq; Omics: Variations; SNP array analysis Unspecified Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection 151665964 CVCL_B5QT GM02340 iPSC clone 1 induced pluripotent stem cell human CVCL_B5QT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (from parent cell line) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; Microarray Female 151665965 CVCL_B5R4 CBiPS-E7C12 induced pluripotent stem cell human CVCL_B5R4 CL:0000010 Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; DNA methylation analysis; Omics: Transcriptomics; RNAseq; Omics: Variations; SNP array analysis Unspecified Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection 151665966 CVCL_B5QS ICNDXHi001-A induced pluripotent stem cell human CVCL_B5QS From: Innovation Center for Neurological Disorders, Xuanwu Hospital, National Clinical Research Center for Geriatric Diseases, Capital Medical University; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Leu658Val (c.1972C>G) (p.Leu266Val, c.796C>G or p.Leu583Val, c.1747C>G); ClinVar=VCV000014266; Zygosity=Heterozygous (PubMed=34995843) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151665967 CVCL_B5QV iHUF3 induced pluripotent stem cell human CVCL_B5QV CL:0000010 Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; Microarray Female 151665968 CVCL_B5R7 LZ6+3 induced pluripotent stem cell human CVCL_B5R7 CL:0000010 Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; DNA methylation analysis; Omics: Transcriptomics; RNAseq; Omics: Variations; SNP array analysis Male 151665969 CVCL_B5QU GM02340 iPSC clone 6 induced pluripotent stem cell human CVCL_B5QU CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (from parent cell line) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Transcriptomics; Microarray Female 151665970 CVCL_B5R6 LZ6+2 induced pluripotent stem cell human CVCL_B5R6 CL:0000010 Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; DNA methylation analysis; Omics: Transcriptomics; RNAseq; Omics: Variations; SNP array analysis Male 151665971 CVCL_B5QX CBiPS-E17C1 induced pluripotent stem cell human CVCL_B5QX CL:0000010 Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; DNA methylation analysis; Omics: Transcriptomics; RNAseq; Omics: Variations; SNP array analysis Unspecified Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection 151665972 CVCL_B5R9 UMNi001-C induced pluripotent stem cell human CVCL_B5R9 CL:0000010 Derived from site: In situ; Foreskin, skin, dermis; UBERON=UBERON_0001471+UBERON_0002067; Cell type: Fibroblast of foreskin; CL=CL_1001608. Omics: Genomics; DNA methylation analysis; Omics: Transcriptomics; RNAseq; Omics: Variations; SNP array analysis Male Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection 151665973 CVCL_B5QW CBiPS-E12C1 induced pluripotent stem cell human CVCL_B5QW CL:0000010 Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; DNA methylation analysis; Omics: Transcriptomics; RNAseq; Omics: Variations; SNP array analysis Female Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection 151665974 CVCL_B5R8 LZ6+10 induced pluripotent stem cell human CVCL_B5R8 CL:0000010 Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; DNA methylation analysis; Omics: Transcriptomics; RNAseq; Omics: Variations; SNP array analysis Male 151665975 CVCL_B5QZ CBiPS-E20C2 induced pluripotent stem cell human CVCL_B5QZ CL:0000010 Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; DNA methylation analysis; Omics: Transcriptomics; RNAseq; Omics: Variations; SNP array analysis Unspecified Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection 151665976 CVCL_B5QY CBiPS-E17C6 induced pluripotent stem cell human CVCL_B5QY CL:0000010 Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; DNA methylation analysis; Omics: Transcriptomics; RNAseq; Omics: Variations; SNP array analysis Female Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection 151665977 CVCL_B5QL WAe009-A-80 embryonic stem cell human CVCL_B5QL From: Qiqihar Medical University; Qiqihar; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28956; GPD1L Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 151665978 CVCL_B5QK WAe009-A-79 embryonic stem cell human CVCL_B5QK From: Anzhen Hospital, Capital Medical University; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple_edited; p.Leu114Pro (c.341T>C); ClinVar=VCV000053036; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37244124) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 151665979 CVCL_B5QN WAe009-A-82 embryonic stem cell human CVCL_B5QN From: Southern Medical University; Guangzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:8507; OSMR; Simple_edited; p.Gly513Asp (c.1538G>A); ClinVar=VCV000802119; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=35714449) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 151665980 CVCL_B5QM WAe009-A-81 embryonic stem cell human CVCL_B5QM From: Center for Stem Cell Biology and Tissue Engineering, Sun Yat-sen University; Guangzhou; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7391; MSX1 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 151665981 CVCL_B5R1 CBiPS-E5C3 induced pluripotent stem cell human CVCL_B5R1 CL:0000010 Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; DNA methylation analysis; Omics: Transcriptomics; RNAseq; Omics: Variations; SNP array analysis Female Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection 151665982 CVCL_B5QP WAe001-A-76 embryonic stem cell human CVCL_B5QP From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10018; RING1 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 151665983 CVCL_B5R0 CBiPS-E24C2 induced pluripotent stem cell human CVCL_B5R0 CL:0000010 Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; DNA methylation analysis; Omics: Transcriptomics; RNAseq; Omics: Variations; SNP array analysis Unspecified Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection 151665984 CVCL_B5R3 CBiPS-E7C1 induced pluripotent stem cell human CVCL_B5R3 CL:0000010 Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; DNA methylation analysis; Omics: Transcriptomics; RNAseq; Omics: Variations; SNP array analysis Unspecified Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection 151665985 CVCL_B5QR CPGHi006-A induced pluripotent stem cell human CVCL_B5QR From: Chinese PLA Institute of Otolaryngology, Chinese PLA General Hospital; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9009; PKD2; Unexplicit; Ex3-15del; Zygosity=Heterozygous (PubMed=35091308) Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151665986 CVCL_B5R2 CBiPS-E32C9 induced pluripotent stem cell human CVCL_B5R2 CL:0000010 Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Omics: Genomics; DNA methylation analysis; Omics: Transcriptomics; RNAseq; Omics: Variations; SNP array analysis Unspecified Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection 151665987 CVCL_B5QQ CPGHi005-A induced pluripotent stem cell human CVCL_B5QQ From: Chinese PLA Institute of Otolaryngology, Chinese PLA General Hospital; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11190; SOX10; Unexplicit; SVA-F retrotransposon insertion in intron 2; Zygosity=Heterozygous (PubMed=35691110) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151665988 CVCL_B5QD ITXi002-A induced pluripotent stem cell human CVCL_B5QD From: Institut du Thorax; Nantes; France CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; SNP array analysis Male 151665989 CVCL_B5QC ITXi011-A induced pluripotent stem cell human CVCL_B5QC From: Institut du Thorax; Nantes; France CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Arg4959Glu (c.14876G>A); Zygosity=Heterozygous (PubMed=35101670) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151665990 CVCL_B5QF ITXi002-A-2 induced pluripotent stem cell human CVCL_B5QF From: Institut du Thorax; Nantes; France CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14361; IRX5 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; SNP array analysis Male 151665991 CVCL_B5QE ITXi002-A-1 induced pluripotent stem cell human CVCL_B5QE From: Institut du Thorax; Nantes; France CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14361; IRX5 (Note=1 of 2 alleles) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; SNP array analysis Male 151665992 CVCL_B5QH ITXi001-A-1 induced pluripotent stem cell human CVCL_B5QH From: Institut du Thorax; Nantes; France CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21718; GPR146 Population: Caucasian; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Female 151665993 CVCL_B5QG ITXi002-A-3 induced pluripotent stem cell human CVCL_B5QG From: Institut du Thorax; Nantes; France CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; SNP array analysis Male Characteristics: Using CRISPR/Cas9 a HA tag was introduced at the C-termini of IRX5 (PubMed=34929443) 151665994 CVCL_B5QJ WAe009-A-78 embryonic stem cell human CVCL_B5QJ From: National Center for Cardiovascular Diseases and Fuwai Hospital; Beijing; China CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11595; TBX18 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female 151665995 CVCL_B5QI WAe009-A-76 embryonic stem cell human CVCL_B5QI From: Research Institute of Molecular Pathology; Vienna; Austria CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP); Genetic integration: Method=TALEN; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)); Genetic integration: Method=TALEN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Using TALEN a construct containing CAGGS:loxP-STOP-loxp_mCherryNLS-T2A-PuroR was introduced in the AAVS1 safe harbor locus (hPSCreg=WAe009-A-76); Characteristics: Using CRISPR/Cas9 a construct containing T2A-H2B-Venus-p2A-CreERT was introduced at the C-terminus of BEST1 (hPSCreg=WAe009-A-76) 151665996 CVCL_B5PZ JWR-26c hybrid cell line CVCL_B5PZ CL:0000010 Group: Human/rodent somatic cell hybrid. 151665997 CVCL_B5QB ITXi010-A induced pluripotent stem cell human CVCL_B5QB From: Institut du Thorax; Nantes; France CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Tyr2476Asp (c.7426T>G); Zygosity=Heterozygous (PubMed=35101670) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151665998 CVCL_B5QA ITXi009-A induced pluripotent stem cell human CVCL_B5QA From: Institut du Thorax; Nantes; France CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Arg4959Glu (c.14876G>A); Zygosity=Heterozygous (PubMed=35101670) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151665999 CVCL_B5RU CSUASOi010-A induced pluripotent stem cell human CVCL_B5RU From: Central South University, Aier School of Ophthalmology; Changsha; China CL:0000010 Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666000 CVCL_B5S6 PUMCHi018-A induced pluripotent stem cell human CVCL_B5S6 From: Peking Union Medical College Hospital; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:19977; RDH12; Simple; p.Arg62Ter (c.184C>T); ClinVar=VCV000002050; Zygosity=Heterozygous (PubMed=35016144); Sequence variation: Mutation; HGNC; HGNC:19977; RDH12; Simple; p.Val146Asp (c.437T>A); ClinVar=VCV000841398; Zygosity=Heterozygous (PubMed=35016144) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666001 CVCL_B5S5 CRMi003-A-2 induced pluripotent stem cell human CVCL_B5S5 CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 7AV5G; mTurquoise2 (Note=Tq2, cyan fluorescent protein derived from GFP); Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Male Characteristics: Expresses a doxycycline inducible H2B-mTurquoise2 reporter Instrumental to track cells and to temporally assess cell divisions and apoptosis in iPSC-based differentiation and cell toxicity assays (PubMed=34775202).; Characteristics: Using CRISPR/Cas9 a T2A-PuroR-CAG-rTA3G-H2B-mTurquoise2-TRE3G construct was introduced in the AAVS1 safe harbor locus (PubMed=34775202) 151666002 CVCL_B5RT CSUASOi009-A induced pluripotent stem cell human CVCL_B5RT From: Central South University, Aier School of Ophthalmology; Changsha; China. CL:0000010 151666003 CVCL_B5RW BCHCNi001-A induced pluripotent stem cell human CVCL_B5RW From: Department of Neurology, Beijing Children's Hospital; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:25695; CARS2; Simple; p.Gly476Arg (c.1426G>A); Zygosity=Homozygous (PubMed=34953328) Population: Chinese; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666004 CVCL_B5S8 PUMCHi007-A induced pluripotent stem cell human CVCL_B5S8 From: Peking Union Medical College Hospital; Beijing; China. CL:0000010 151666005 CVCL_B5RV CSUASOi011-A induced pluripotent stem cell human CVCL_B5RV From: Central South University, Aier School of Ophthalmology; Changsha; China. CL:0000010 151666006 CVCL_B5S7 PUMCHi017-A induced pluripotent stem cell human CVCL_B5S7 From: Peking Union Medical College Hospital; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1940; CHM; Unexplicit; Ex1-2del; Zygosity=Hemizygous (PubMed=35032821) Population: Chinese; Han; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666007 CVCL_B5RY SKLRMe001-A embryonic stem cell human CVCL_B5RY From: State Key Laboratory of Reproductive Medicine, Nanjing Medical University; Nanjing; China CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 151666008 CVCL_B5S9 PUMCHi008-A induced pluripotent stem cell human CVCL_B5S9 From: Peking Union Medical College Hospital; Beijing; China. CL:0000010 151666009 CVCL_B5RX UIi001-A induced pluripotent stem cell human CVCL_B5RX From: University of Iowa; Iowa City; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666010 CVCL_B5RZ KSCBi014-A induced pluripotent stem cell human CVCL_B5RZ From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Thr152Profs*14 (c.453delC); ClinVar=VCV000200598; Zygosity=Heterozygous (PubMed=34678663) Population: Korean; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666011 CVCL_B5RM CHA-NTK6 embryonic stem cell human CVCL_B5RM From: CHA University; Seongnam; South Korea CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Omics: Transcriptomics; RNAseq Female Characteristics: Produced by somatic cell nuclear transfer from a dermal fibroblast (hDF) cells donated from a 52-year-old female patient with age-related macular degeneration 151666012 CVCL_B5RL UNIZARi001-A induced pluripotent stem cell human CVCL_B5RL From: University of Zaragoza; Zaragoza; Spain CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11831; TK2; Simple; p.Arg130Trp (c.388C>T); ClinVar=VCV000038988; Zygosity=Heterozygous (PubMed=34973561); Sequence variation: Mutation; HGNC; HGNC:11831; TK2; Simple; p.Lys202del (c.604_606delAAG); ClinVar=VCV000038995; Zygosity=Heterozygous (PubMed=34973561) Population: Hispanic; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666013 CVCL_B5S0 KSCBi016-A induced pluripotent stem cell human CVCL_B5S0 From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea. CL:0000010 151666014 CVCL_B5RN CHA-NTK7 embryonic stem cell human CVCL_B5RN From: CHA University; Seongnam; South Korea CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Omics: Transcriptomics; RNAseq Female Characteristics: Produced by somatic cell nuclear transfer from a dermal fibroblast (hDF) cells donated from a 52-year-old female patient with age-related macular degeneration 151666015 CVCL_B5RQ CHAHESe001-A-1 embryonic stem cell human CVCL_B5RQ From: Konkuk University; Seoul; South Korea CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: The parent cell line was produced by somatic cell nuclear transfer from a dermal fibroblast (hDF) cells donated from a 59-year-old male patient with age-related macular degeneration 151666016 CVCL_B5S2 KICRi002-A-5 induced pluripotent stem cell human CVCL_B5S2 From: Department of Immunology, Genetics and Pathology, Uppsala University; Uppsala; Sweden CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9187; POLR2A (Note=1 of 2 alleles) Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666017 CVCL_B5RP CHA-NTK8 embryonic stem cell human CVCL_B5RP From: CHA University; Seongnam; South Korea CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Omics: Transcriptomics; RNAseq Male Characteristics: Produced by somatic cell nuclear transfer from a dermal fibroblast (hDF) cells donated from a 59-year-old male patient with age-related macular degeneration 151666018 CVCL_B5S1 KICRi002-A-4 induced pluripotent stem cell human CVCL_B5S1 From: Department of Immunology, Genetics and Pathology, Uppsala University; Uppsala; Sweden CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14881; ZEB2 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666019 CVCL_B5S4 HVRDe008-A-2 embryonic stem cell human CVCL_B5S4 CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Using CRISPR/Cas9 a P2A-eSpCas9-IRES-PuroR-pA construct was introduced at the C-terminus of one allele of GAPDH (PubMed=34741877) 151666020 CVCL_B5RS SHCDNi006-A induced pluripotent stem cell human CVCL_B5RS From: Shanghai Children's Hospital, Shanghai Jiao Tong University; Shanghai; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:18865; KCNT1; Simple; p.Ala934Thr (c.2800G>A); ClinVar=VCV000039594; Zygosity=Heterozygous; Note=De novo mutation (PubMed=35537242) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666021 CVCL_B5RR CHA-NTK9 embryonic stem cell human CVCL_B5RR From: CHA University; Seongnam; South Korea CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Produced by somatic cell nuclear transfer from a dermal fibroblast (hDF) cells donated from a 59-year-old male patient with age-related macular degeneration 151666022 CVCL_B5S3 IRFMNi001-B-1 induced pluripotent stem cell human CVCL_B5S3 From: Istituto di Ricerche Farmacologiche Mario Negri (IRCCS); Bergamo; Italy CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA Population: Caucasian; Derived from site: In situ; Foreskin, skin, dermis; UBERON=UBERON_0001471+UBERON_0002067; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 151666023 CVCL_B5RE SW4#SE induced pluripotent stem cell human CVCL_B5RE CL:0000010 Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Female 151666024 CVCL_B5RD SW4#N1 induced pluripotent stem cell human CVCL_B5RD CL:0000010 Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Omics: Transcriptomics; Microarray Female 151666025 CVCL_B5RG SW8#5P induced pluripotent stem cell human CVCL_B5RG CL:0000010 Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Female 151666026 CVCL_B5RF SW8#20I induced pluripotent stem cell human CVCL_B5RF CL:0000010 Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Omics: Transcriptomics; Microarray Female 151666027 CVCL_B5RI T1D HKSV#D induced pluripotent stem cell human CVCL_B5RI CL:0000010 Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Omics: Transcriptomics; Microarray Male 151666028 CVCL_B5RH T1D HKLV#2 induced pluripotent stem cell human CVCL_B5RH CL:0000010 Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Omics: Transcriptomics; Microarray Male 151666029 CVCL_B5RK T2D2 HKSV#i induced pluripotent stem cell human CVCL_B5RK CL:0000010 Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Omics: Transcriptomics; Microarray Male 151666030 CVCL_B5RJ T2D1 HKSV#A induced pluripotent stem cell human CVCL_B5RJ CL:0000010 Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Omics: Transcriptomics; Microarray Female 151666031 CVCL_B5RA SW10#20A induced pluripotent stem cell human CVCL_B5RA CL:0000010 Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Male 151666032 CVCL_B5RC SW3#B induced pluripotent stem cell human CVCL_B5RC CL:0000010 Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Omics: Transcriptomics; Microarray Female 151666033 CVCL_B5RB SW10#5P induced pluripotent stem cell human CVCL_B5RB CL:0000010 Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Male 151666034 CVCL_B5P2 TF173B induced pluripotent stem cell human CVCL_B5P2 CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666035 CVCL_B5P5 SPF [Trachinotus] spontaneously immortalized cell line CVCL_B5P5 CL:0000010 Derived from site: In situ; Fin; UBERON=UBERON_0008897. Unspecified Doubling time: 27 hours (Note=At 55th passage) (PubMed=34609743) Group: Fish cell line 151666036 CVCL_B5P4 SPE spontaneously immortalized cell line CVCL_B5P4 CL:0000010 Derived from site: In situ; Eye; UBERON=UBERON_0000970. Unspecified Doubling time: 34 hours (Note=At 72th passage) (PubMed=34609743) Group: Fish cell line 151666037 CVCL_B5P7 SPH [Trachinotus] spontaneously immortalized cell line CVCL_B5P7 CL:0000010 Derived from site: In situ; Heart; UBERON=UBERON_0000948. Unspecified Doubling time: 36 hours (Note=At 61th passage) (PubMed=34609743) Group: Fish cell line 151666038 CVCL_B5P6 SPG spontaneously immortalized cell line CVCL_B5P6 CL:0000010 Derived from site: In situ; Gill; UBERON=UBERON_0002535. Unspecified Doubling time: 29 hours (Note=At 45th passage) (PubMed=34609743) Group: Fish cell line 151666039 CVCL_B5P9 WG1826 finite cell line human CVCL_B5P9 From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666040 CVCL_B5P8 SPK spontaneously immortalized cell line CVCL_B5P8 CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Unspecified Doubling time: 30 hours (Note=At 66th passage) (PubMed=34609743) Group: Fish cell line 151666041 CVCL_B5P1 88.6/D800-B spontaneously immortalized cell line house mouse CVCL_B5P1 CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:97570; Abcb1a; Knockout cell: Method=KO mouse; MGI; MGI:97568; Abcb1b; Sequence variation: Mutation; MGI; MGI:1347061; Abcg2; Simple; p.Arg482Ser (c.1446G>T); Zygosity=Homozygous (PubMed=11956086) Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified 151666042 CVCL_B5P0 88.6/D800-A spontaneously immortalized cell line house mouse CVCL_B5P0 CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:97570; Abcb1a; Knockout cell: Method=KO mouse; MGI; MGI:97568; Abcb1b; Sequence variation: Mutation; MGI; MGI:1347061; Abcg2; Simple; p.Arg482Met (c.1445G>T); Zygosity=Homozygous (PubMed=11956086) Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified 151666043 CVCL_B5NY 88.6/D200-A spontaneously immortalized cell line house mouse CVCL_B5NY CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:97570; Abcb1a; Knockout cell: Method=KO mouse; MGI; MGI:97568; Abcb1b Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified 151666044 CVCL_B5NX 88.6 spontaneously immortalized cell line house mouse CVCL_B5NX CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:97570; Abcb1a; Knockout cell: Method=KO mouse; MGI; MGI:97568; Abcb1b Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified 151666045 CVCL_B5NZ 88.6/D200-B spontaneously immortalized cell line house mouse CVCL_B5NZ CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:97570; Abcb1a; Knockout cell: Method=KO mouse; MGI; MGI:97568; Abcb1b Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified 151666046 CVCL_B5PS AG27611 induced pluripotent stem cell human CVCL_B5PS CL:0000010 Population: Caucasian; German; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666047 CVCL_B5Q4 ITXi005-A induced pluripotent stem cell human CVCL_B5Q4 From: Institut du Thorax; Nantes; France CL:0000010 Population: Caucasian; French; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666048 CVCL_B5PR AG27609 induced pluripotent stem cell human CVCL_B5PR CL:0000010 Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=30699343) Population: Caucasian; Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666049 CVCL_B5Q3 SCVIi041-A induced pluripotent stem cell human CVCL_B5Q3 From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg133Gln (c.398G>A); ClinVar=VCV000200934; Zygosity=Heterozygous (PubMed=34999423) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666050 CVCL_B5PU AG27875 induced pluripotent stem cell human CVCL_B5PU CL:0000010 Population: African American; Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 151666051 CVCL_B5Q6 ITXi007-A induced pluripotent stem cell human CVCL_B5Q6 From: Institut du Thorax; Nantes; France CL:0000010 Population: Caucasian; French; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Female 151666052 CVCL_B5PT AG27703 induced pluripotent stem cell human CVCL_B5PT CL:0000010 Population: Caucasian; Karyotypic information: 47,XY,+21 (Coriell=AG27703); Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666053 CVCL_B5Q5 ITXi006-A induced pluripotent stem cell human CVCL_B5Q5 From: Institut du Thorax; Nantes; France CL:0000010 Population: Caucasian; French; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666054 CVCL_B5Q8 ITXi003-A induced pluripotent stem cell human CVCL_B5Q8 From: Institut du Thorax; Nantes; France CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Variations; SNP array analysis Male 151666055 CVCL_B5PW TS-408 finite cell line human CVCL_B5PW CL:0000010 Population: Jewish; Ashkenazi; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151666056 CVCL_B5Q7 ITXi008-A induced pluripotent stem cell human CVCL_B5Q7 From: Institut du Thorax; Nantes; France CL:0000010 Population: Caucasian; French; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666057 CVCL_B5PV NCC-DMM1-C1 cancer cell line human CVCL_B5PV CL:0000010 Population: Japanese; Transformant: ChEBI; CHEBI_46661; Asbestos; Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977. Omics: Phenotyping; Drug screening; Omics: Variations; SNP array analysis Male Doubling time: 25.9 hours (PubMed=35069873) 151666058 CVCL_B5PY JoVa finite cell line human CVCL_B5PY CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151666059 CVCL_B5Q9 ITXi004-A induced pluripotent stem cell human CVCL_B5Q9 From: Institut du Thorax; Nantes; France CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Variations; SNP array analysis Female 151666060 CVCL_B5PX TS-495 finite cell line human CVCL_B5PX CL:0000010 Population: Jewish; Ashkenazi; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151666061 CVCL_B5PK AG28262 induced pluripotent stem cell human CVCL_B5PK CL:0000010 Population: Southeast Asian; Filipino; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666062 CVCL_B5PJ AG28205 induced pluripotent stem cell human CVCL_B5PJ CL:0000010 Population: Caucasian; Italian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666063 CVCL_B5PM AG28278 induced pluripotent stem cell human CVCL_B5PM CL:0000010 Population: Caucasian; Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666064 CVCL_B5PL AG28269 induced pluripotent stem cell human CVCL_B5PL CL:0000010 Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666065 CVCL_B5Q0 JWR-5 hybrid cell line CVCL_B5Q0 CL:0000010 Group: Human/rodent somatic cell hybrid. 151666066 CVCL_B5PN AG28340 induced pluripotent stem cell human CVCL_B5PN CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Gly608Gly (c.1824C>T); ClinVar=VCV000014500; Zygosity=Heterozygous; Note=Creates an exonic consensus splice donor sequence that leads to the activation of a cryptic splice site which in turn causes skipping of 150 bp of the LMNA mRNA leading to the deletion of 50 amino acids (Coriell=AG28340) Population: African American; Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666067 CVCL_B5PQ AG27608 induced pluripotent stem cell human CVCL_B5PQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=30699343) Population: Caucasian; German; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666068 CVCL_B5Q2 SCVIi040-A induced pluripotent stem cell human CVCL_B5Q2 From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg133Gln (c.398G>A); ClinVar=VCV000200934; Zygosity=Heterozygous (PubMed=34999423) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666069 CVCL_B5PP AG27606 induced pluripotent stem cell human CVCL_B5PP CL:0000010 Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=30699343) Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666070 CVCL_B5Q1 SCVIi039-A induced pluripotent stem cell human CVCL_B5Q1 From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg133Gln (c.398G>A); ClinVar=VCV000200934; Zygosity=Heterozygous (PubMed=34999423) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666071 CVCL_B5PC WG1871 finite cell line human CVCL_B5PC From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg157Gln (c.470G>A); ClinVar=VCV000003519; Zygosity=Heterozygous (PubMed=8940272) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666072 CVCL_B5PB WG2073 finite cell line human CVCL_B5PB From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666073 CVCL_B5PE iMSC#3 telomerase immortalized cell line human CVCL_B5PE CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540. Omics: Genomics; DNA methylation analysis; Omics: Transcriptomics; Microarray; Omics: Variations; Array-based CGH; Omics: Variations; SNP array analysis Male 151666074 CVCL_B5PD WG1872 finite cell line human CVCL_B5PD From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg567Ter (c.1699C>T); ClinVar=VCV000660609; Zygosity=Heterozygous (from familial inference of WG1779; WG1871) Miscellaneous: Cell line no longer available Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666075 CVCL_B5PG AG28041 induced pluripotent stem cell human CVCL_B5PG CL:0000010 Population: African American; Karyotypic information: 46,XX,inv(9)(pter->p11::q13->p11::q13->qter) (Coriell=AG28041); Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666076 CVCL_B5PF MCF7-FGFR1 cancer cell line human CVCL_B5PF CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3688; FGFR1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 151666077 CVCL_B5PI AG28057 induced pluripotent stem cell human CVCL_B5PI CL:0000010 Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666078 CVCL_B5PH AG28049 induced pluripotent stem cell human CVCL_B5PH CL:0000010 Population: Caucasian; Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666079 CVCL_B5PA WG1951 finite cell line human CVCL_B5PA From: Montreal Children's Hospital cell repository; Montreal; Canada CL:0000010 Miscellaneous: Cell line no longer available Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666080 CVCL_B5N1 RCM-25 hybridoma CVCL_B5N1 CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P04460; Rabbit MYH6. 151666081 CVCL_B5MP SCC15/R1 cancer cell line human CVCL_B5MP CL:0000010 Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX); Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Male Doubling time: 1.5-1.7 days (PubMed=6201865) 151666082 CVCL_B5N0 CCM-52 hybridoma house mouse CVCL_B5N0 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P29616; Chicken MYH6 (Note=Also reacts with mouse). 151666083 CVCL_B5N3 1003-pK4 clone 8129 cancer cell line house mouse CVCL_B5N3 CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134; Cell type: Myoblast; CL=CL_0000056; Breed/subspecies: C3H. Unspecified 151666084 CVCL_B5MR SCC15/R3 cancer cell line human CVCL_B5MR CL:0000010 Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX); Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Male Doubling time: 1.5-1.7 days (PubMed=6201865) 151666085 CVCL_B5N2 RCM-37 hybridoma CVCL_B5N2 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P04460; Rabbit MYH6. 151666086 CVCL_B5MQ SCC15/R2 cancer cell line human CVCL_B5MQ CL:0000010 Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX); Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Male Doubling time: 1.5-1.7 days (PubMed=6201865) 151666087 CVCL_B5N5 120G8 hybridoma CVCL_B5N5 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q8R2Q8; Mouse Bst2/Cd317. 151666088 CVCL_B5MT F9K4b2 cancer cell line house mouse CVCL_B5MT CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Breed/subspecies: 129/Sv. Male 151666089 CVCL_B5N4 C1 [Mouse teratocarcinoma] cancer cell line house mouse CVCL_B5N4 CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134; Cell type: Myoblast; CL=CL_0000056; Breed/subspecies: C3H. Unspecified Characteristics: Established from a tumor obtained by injection of parent cell line into irradiated syngeneic mice (PubMed=2153146); Characteristics: After injection into syngeneic mice, produce typical osteosarcomas 151666090 CVCL_B5MS SCC15/R4 cancer cell line human CVCL_B5MS CL:0000010 Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX); Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Male Doubling time: 1.5-1.7 days (PubMed=6201865) 151666091 CVCL_B5MV C17 [Mouse teratocarcinoma] cancer cell line house mouse CVCL_B5MV CL:0000010 Breed/subspecies: C3H. Unspecified 151666092 CVCL_B5N7 MFUM-BrTNBC-1 cancer cell line human CVCL_B5N7 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:393; AKT3; Simple; p.Lys294Ter (c.880A>T); Zygosity=Heterozygous (PubMed=35011679); Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Tyr2037Ter (c.6111C>G); Zygosity=Heterozygous (PubMed=35011679); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly32Arg (c.94G>C); ClinVar=VCV001690925; Zygosity=Heterozygous (PubMed=35011679); Sequence variation: Mutation; HGNC; HGNC:7993; NRBP1; Simple; p.Lys217Ter (c.649A>T); Zygosity=Heterozygous (PubMed=35011679); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=35011679); Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Gln829Ter (c.2485C>T); Zygosity=Heterozygous (PubMed=35011679) Population: Caucasian; Slovenian; Derived from site: In situ; Breast; UBERON=UBERON_0000310. Female Characteristics: Shown by ICC and PCR to be ER-negative, PR-negative and ERBB2-negative (PubMed=35011679) Doubling time: 80 hours (PubMed=35011679) Group: Triple negative breast cancer (TNBC) cell line 151666093 CVCL_B5MU 1C11 [Mouse teratocarcinoma] cancer cell line house mouse CVCL_B5MU CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Breed/subspecies: 129/Sv. Male Characteristics: Tumorigenic in syngeneic mice (PubMed=2155426); Characteristics: Presents two states: an immature phenotype (1C11 precursor) and a more differentiated state (1C11*) After induction by Bt2cAMP and cyclohexanecarboxylate, 1C11* cells extend neurites and express neural markers such as NCAM1, synaptophysin and [Met5]enkephalin in >95% of the clonal population (PubMed=2155426). Doubling time: 20 hours (PubMed=2155426) 151666094 CVCL_B5N6 927 hybridoma CVCL_B5N6 CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; Q8R2Q8; Mouse Bst2/Cd317. 151666095 CVCL_B5MH 77RD40 finite cell line human CVCL_B5MH CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666096 CVCL_B5MG 77RD224 finite cell line human CVCL_B5MG CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 151666097 CVCL_B5MJ 79RD200 finite cell line human CVCL_B5MJ CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 151666098 CVCL_B5MI 77RD6 finite cell line human CVCL_B5MI CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 151666099 CVCL_B5ML 79RD257 finite cell line human CVCL_B5ML CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666100 CVCL_B5MK 79RD220 finite cell line human CVCL_B5MK CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666101 CVCL_B5MN 81RD5 finite cell line human CVCL_B5MN CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 151666102 CVCL_B5MM 80RD143 finite cell line human CVCL_B5MM CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 151666103 CVCL_B5MB AT8BI finite cell line human CVCL_B5MB CL:0000010 Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Met1Thr (c.2T>C); ClinVar=VCV000187275; Zygosity=Unspecified (from autologous cell line AT8BI LCL) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666104 CVCL_B5MA M-3405 finite cell line human CVCL_B5MA CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 151666105 CVCL_B5MD AT4LA finite cell line human CVCL_B5MD CL:0000010 Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666106 CVCL_B5MC AT5LA finite cell line human CVCL_B5MC CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 151666107 CVCL_B5MF 77RD218 finite cell line human CVCL_B5MF CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 151666108 CVCL_B5ME AT3LA finite cell line human CVCL_B5ME CL:0000010 Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666109 CVCL_B5M8 alphaTN4-1-26 transformed cell line house mouse CVCL_B5M8 CL:0000010 Genetic integration: Method=Transfection; Gene=RGD; 2279; Cat; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803; Cell type: Epithelial cell of ocular lens; CL=CL_0002224; Breed/subspecies: Cryaa-TAg transgenic. Unspecified 151666110 CVCL_B5LW CS4MI finite cell line human CVCL_B5LW CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666111 CVCL_B5LV CS5MI finite cell line human CVCL_B5LV CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666112 CVCL_B5M7 N/N1003A-KL spontaneously immortalized cell line CVCL_B5M7 CL:0000010 Genetic integration: Method=Transfection; Gene=RGD; 2279; Cat; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803; Cell type: Epithelial cell of ocular lens; CL=CL_0002224; Breed/subspecies: New Zealand white; VBO=VBO_0001267. Female 151666113 CVCL_B5LY AP57P finite cell line human CVCL_B5LY CL:0000010 Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; c.564+1G>A (p.Leu188Profs*4); ClinVar=VCV000995826; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=33355142); Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; p.Trp322Ter (c.966delG) (p.Gly321_Trp322insTer); ClinVar=VCV000995825; Zygosity=Homozygous (PubMed=33355142); Sequence variation: Mutation; HGNC; HGNC:404; ALDH2; Simple; p.Glu504Lys (c.1510G>A) (p.Glu487Lys); ClinVar=VCV000018390; Zygosity=Heterozygous; Note=Allele ALDH2*2 (PubMed=33355142) Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666114 CVCL_B5LX CS1ATM finite cell line human CVCL_B5LX CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666115 CVCL_B5M9 SC [Human Marfan syndrome] finite cell line human CVCL_B5M9 From: Departement Scienze Biomediche e Biotecnologie, Universita degli Studi di Brescia; Brescia; Italy CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666116 CVCL_B5LZ AP57P(SVT) transformed cell line human CVCL_B5LZ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; c.564+1G>A (p.Leu188Profs*4); ClinVar=VCV000995826; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; p.Trp322Ter (c.966delG) (p.Gly321_Trp322insTer); ClinVar=VCV000995825; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:404; ALDH2; Simple; p.Glu504Lys (c.1510G>A) (p.Glu487Lys); ClinVar=VCV000018390; Zygosity=Heterozygous; Note=Allele ALDH2*2 (from parent cell line) Population: Japanese; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666117 CVCL_B5NQ PGPC3_87 induced pluripotent stem cell human CVCL_B5NQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:17993; TRPM4; Simple; p.Gly844Asp (c.2531G>A); ClinVar=VCV000035489; Zygosity=Heterozygous (from inference of genome of donor) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666118 CVCL_B5NP PGPC3_75 induced pluripotent stem cell human CVCL_B5NP CL:0000010 Sequence variation: Mutation; HGNC; HGNC:17993; TRPM4; Simple; p.Gly844Asp (c.2531G>A); ClinVar=VCV000035489; Zygosity=Heterozygous (PubMed=31813827); Sequence variation: Mutation; HGNC; HGNC:13077; ZNF283; Simple; p.Cys21Ter (c.63C>A); Zygosity=Heterozygous (PubMed=31813827) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151666119 CVCL_B5NR PGPC3_93 induced pluripotent stem cell human CVCL_B5NR CL:0000010 Sequence variation: Mutation; HGNC; HGNC:17993; TRPM4; Simple; p.Gly844Asp (c.2531G>A); ClinVar=VCV000035489; Zygosity=Heterozygous (from inference of genome of donor) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666120 CVCL_B5NU KOT52/D320 spontaneously immortalized cell line house mouse CVCL_B5NU CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:97570; Abcb1a; Knockout cell: Method=KO mouse; MGI; MGI:97568; Abcb1b; Knockout cell: Method=KO mouse; MGI; MGI:102676; Abcc1; Sequence variation: Mutation; MGI; MGI:1347061; Abcg2; Simple; p.Arg482Met (c.1445G>T); Zygosity=Heterozygous (PubMed=11956086) Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin); Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 151666121 CVCL_B5NT KOT52 spontaneously immortalized cell line house mouse CVCL_B5NT CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:97570; Abcb1a; Knockout cell: Method=KO mouse; MGI; MGI:97568; Abcb1b; Knockout cell: Method=KO mouse; MGI; MGI:102676; Abcc1 Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 151666122 CVCL_B5NW KOT52/D800 spontaneously immortalized cell line house mouse CVCL_B5NW CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:97570; Abcb1a; Knockout cell: Method=KO mouse; MGI; MGI:97568; Abcb1b; Knockout cell: Method=KO mouse; MGI; MGI:102676; Abcc1; Sequence variation: Mutation; MGI; MGI:1347061; Abcg2; Simple; p.Arg482Met (c.1445G>T); Zygosity=Heterozygous (PubMed=11956086) Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin); Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 151666123 CVCL_B5NV KOT52/D80 spontaneously immortalized cell line house mouse CVCL_B5NV CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:97570; Abcb1a; Knockout cell: Method=KO mouse; MGI; MGI:97568; Abcb1b; Knockout cell: Method=KO mouse; MGI; MGI:102676; Abcc1 Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin); Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 151666124 CVCL_B5NI PGPC17_142 induced pluripotent stem cell human CVCL_B5NI CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666125 CVCL_B5NH PGPC17_11_MYBPC3_KO induced pluripotent stem cell human CVCL_B5NH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7551; MYBPC3 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Genomics; Whole genome sequencing Male 151666126 CVCL_B5NK PGPC17_45 induced pluripotent stem cell human CVCL_B5NK CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666127 CVCL_B5NJ PGPC17_4 induced pluripotent stem cell human CVCL_B5NJ CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666128 CVCL_B5NM PGPC3_23 induced pluripotent stem cell human CVCL_B5NM CL:0000010 Sequence variation: Mutation; HGNC; HGNC:17993; TRPM4; Simple; p.Gly844Asp (c.2531G>A); ClinVar=VCV000035489; Zygosity=Heterozygous (from inference of genome of donor) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666129 CVCL_B5NL PGPC17_80 induced pluripotent stem cell human CVCL_B5NL CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666130 CVCL_B5NN PGPC3_66 induced pluripotent stem cell human CVCL_B5NN CL:0000010 Sequence variation: Mutation; HGNC; HGNC:17993; TRPM4; Simple; p.Gly844Asp (c.2531G>A); ClinVar=VCV000035489; Zygosity=Heterozygous (from inference of genome of donor) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666131 CVCL_B5NA PGPC1_73 induced pluripotent stem cell human CVCL_B5NA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3581; BPTF; Simple; p.Lys1039Ter (c.3115A>T); Zygosity=Heterozygous (PubMed=31813827); Sequence variation: Mutation; HGNC; HGNC:3039; DSCAM; Simple; c.509-1G>A; dbSNP=rs1569089053; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=31813827); Sequence variation: Mutation; HGNC; HGNC:4199; GCN1; Simple; p.Ser2475Profs*19 (c.7423delT); Zygosity=Heterozygous (PubMed=31813827) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151666132 CVCL_B5NC PGPC14_16 induced pluripotent stem cell human CVCL_B5NC CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6242; KCNE2; Simple; p.Thr10Met (c.29C>T); Zygosity=Heterozygous (from inference of genome of donor) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666133 CVCL_B5NB PGPC1_96 induced pluripotent stem cell human CVCL_B5NB CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666134 CVCL_B5NE PGPC14_70 induced pluripotent stem cell human CVCL_B5NE CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6242; KCNE2; Simple; p.Thr10Met (c.29C>T); Zygosity=Heterozygous (from inference of genome of donor) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666135 CVCL_B5ND PGPC14_26 induced pluripotent stem cell human CVCL_B5ND CL:0000010 Sequence variation: Mutation; HGNC; HGNC:25491; FRMD4A; Simple; c.563+1G>T; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=31813827); Sequence variation: Mutation; HGNC; HGNC:6242; KCNE2; Simple; p.Thr10Met (c.29C>T); Zygosity=Heterozygous (from inference of genome of donor); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158His (c.473G>A); ClinVar=VCV000141963; Zygosity=Heterozygous (PubMed=31813827); Sequence variation: Mutation; HGNC; HGNC:32669; TRIM71; Simple; p.Arg655Ter (c.1963C>T); Zygosity=Heterozygous (PubMed=31813827) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Female 151666136 CVCL_B5NG PGPC17_11 induced pluripotent stem cell human CVCL_B5NG CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10250; ROBO2; Simple; p.Trp874Ter (c.2621G>A); Zygosity=Heterozygous (PubMed=31813827) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Genomics; Whole genome sequencing; Omics: Transcriptomics; RNAseq Male 151666137 CVCL_B5NF PGPC14_94 induced pluripotent stem cell human CVCL_B5NF CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6242; KCNE2; Simple; p.Thr10Met (c.29C>T); Zygosity=Heterozygous (from inference of genome of donor) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666138 CVCL_B5MX C17-S1 clone 1003 cancer cell line house mouse CVCL_B5MX CL:0000010 Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134; Cell type: Myoblast; CL=CL_0000056; Breed/subspecies: C3H. Unspecified 151666139 CVCL_B5N9 PGPC1_67 induced pluripotent stem cell human CVCL_B5N9 CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666140 CVCL_B5MW C17-S1 cancer cell line house mouse CVCL_B5MW CL:0000010 Breed/subspecies: C3H. Unspecified 151666141 CVCL_B5N8 PGPC1_30 induced pluripotent stem cell human CVCL_B5N8 CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666142 CVCL_B5MZ C17-S1-D-T984-15 cancer cell line house mouse CVCL_B5MZ CL:0000010 Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134; Cell type: Myoblast; CL=CL_0000056; Breed/subspecies: C3H. Unspecified Characteristics: No longer differentiates in vitro into myogenic tissue (PubMed=7029000) 151666143 CVCL_B5MY C17-S1-D-T984 cancer cell line house mouse CVCL_B5MY CL:0000010 Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134; Cell type: Myoblast; CL=CL_0000056; Breed/subspecies: C3H. Unspecified 151666144 CVCL_B5KN HAP1 PEX3 (-) 3 cancer cell line human CVCL_B5KN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8858; PEX3; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666145 CVCL_B5KM HAP1 PEX3 (-) 2 cancer cell line human CVCL_B5KM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8858; PEX3; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Discontinued: Horizon_Discovery; HZGHC006955c009; true Male Group: Haploid karyotype cell line 151666146 CVCL_B5KP HAP1 PMS1 (-) 2 cancer cell line human CVCL_B5KP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9121; PMS1; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Discontinued: Horizon_Discovery; HZGHC007262c008; true Male Group: Haploid karyotype cell line 151666147 CVCL_B5L1 HAP1 TMEM189 (-) 2 cancer cell line human CVCL_B5L1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16735; PEDS1; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666148 CVCL_B5L0 HAP1 TLR4 (-) 3 cancer cell line human CVCL_B5L0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11850; TLR4; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666149 CVCL_B5KR HAP1 PPARGC1A (-) 3 cancer cell line human CVCL_B5KR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9237; PPARGC1A; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666150 CVCL_B5L3 HAP1 TMEM39B (-) 2 cancer cell line human CVCL_B5L3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25510; TMEM39B; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666151 CVCL_B5KQ HAP1 PPARGC1A (-) 2 cancer cell line human CVCL_B5KQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9237; PPARGC1A; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666152 CVCL_B5L2 HAP1 TMEM189 (-) 3 cancer cell line human CVCL_B5L2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16735; PEDS1; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666153 CVCL_B5KT HAP1 RAB1A (-) 2 cancer cell line human CVCL_B5KT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9758; RAB1A; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666154 CVCL_B5L5 HAP1 TMEM8A (-) 2 cancer cell line human CVCL_B5L5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17205; PGAP6; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666155 CVCL_B5KS HAP1 PPARGC1A (-) 4 cancer cell line human CVCL_B5KS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9237; PPARGC1A; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666156 CVCL_B5L4 HAP1 TMEM69 (-) 2 cancer cell line human CVCL_B5L4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28035; TMEM69; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666157 CVCL_B5KF HAP1 NDUFS3 (-) 2 cancer cell line human CVCL_B5KF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7710; NDUFS3; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Discontinued: Horizon_Discovery; HZGHC006832c010; true Male Group: Haploid karyotype cell line 151666158 CVCL_B5KE END-2 cancer cell line human CVCL_B5KE CL:0000010 Female Characteristics: Established from an undifferentiated endometrial carcinoma serially transplanted into nude mice (PubMed=1176207) Doubling time: 16 hours (PubMed=1176207). 151666159 CVCL_B5KH HAP1 NDUFS3 (-) 4 cancer cell line human CVCL_B5KH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7710; NDUFS3; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666160 CVCL_B5KG HAP1 NDUFS3 (-) 3 cancer cell line human CVCL_B5KG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7710; NDUFS3; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666161 CVCL_B5KJ HAP1 NR5A2 (-) 2 cancer cell line human CVCL_B5KJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7984; NR5A2; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666162 CVCL_B5KI HAP1 NMRK1 (-) 2 cancer cell line human CVCL_B5KI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26057; NMRK1; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Discontinued: Horizon_Discovery; HZGHC007276c002; true Male Group: Haploid karyotype cell line 151666163 CVCL_B5KL HAP1 PAN3 (-) 2 cancer cell line human CVCL_B5KL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29991; PAN3; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666164 CVCL_B5KK HAP1 NUDT9 (-) 2 cancer cell line human CVCL_B5KK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8056; NUDT9; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666165 CVCL_B5KB HAP1 MDH2 (-) 2 cancer cell line human CVCL_B5KB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6971; MDH2; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Discontinued: Horizon_Discovery; HZGHC006847c007; true Male Group: Haploid karyotype cell line 151666166 CVCL_B5KA HAP1 LPIN1 (-) 2 cancer cell line human CVCL_B5KA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13345; LPIN1; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666167 CVCL_B5KD HAP1 MYO18A (-) 3 cancer cell line human CVCL_B5KD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31104; MYO18A; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666168 CVCL_B5KC HAP1 MYO18A (-) 2 cancer cell line human CVCL_B5KC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31104; MYO18A; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666169 CVCL_B5JU HAP1 DGUOK (-) 2 cancer cell line human CVCL_B5JU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2858; DGUOK; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666170 CVCL_B5K6 HAP1 GLB1 (-) 2 cancer cell line human CVCL_B5K6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4298; GLB1; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Discontinued: Horizon_Discovery; HZGHC007272c006; true Male Group: Haploid karyotype cell line 151666171 CVCL_B5JT HAP1 CCDC92 (-) 3 cancer cell line human CVCL_B5JT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29563; CCDC92; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Discontinued: Horizon_Discovery; HZGHC006949c010; true Male Group: Haploid karyotype cell line 151666172 CVCL_B5K5 HAP1 ESR1 (-) 2 cancer cell line human CVCL_B5K5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3467; ESR1; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666173 CVCL_B5JW HAP1 DHTKD1 (-) 2 cancer cell line human CVCL_B5JW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23537; DHTKD1; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Discontinued: Horizon_Discovery; HZGHC006849c005; true Male Group: Haploid karyotype cell line 151666174 CVCL_B5K8 HAP1 HECTD1 (-) 2 cancer cell line human CVCL_B5K8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20157; HECTD1; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666175 CVCL_B5JV HAP1 DGUOK (-) 3 cancer cell line human CVCL_B5JV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2858; DGUOK; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Discontinued: Horizon_Discovery; HZGHC006865c011; true Male Group: Haploid karyotype cell line 151666176 CVCL_B5K7 HAP1 GSDMD (-) 2 cancer cell line human CVCL_B5K7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25697; GSDMD; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Discontinued: Horizon_Discovery; HZGHC007097c005; true Male Group: Haploid karyotype cell line 151666177 CVCL_B5JY HAP1 DHTKD1 (-) 4 cancer cell line human CVCL_B5JY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23537; DHTKD1; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Discontinued: Horizon_Discovery; HZGHC006849c011; true Male Group: Haploid karyotype cell line 151666178 CVCL_B5JX HAP1 DHTKD1 (-) 3 cancer cell line human CVCL_B5JX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23537; DHTKD1; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Discontinued: Horizon_Discovery; HZGHC006849c008; true Male Group: Haploid karyotype cell line 151666179 CVCL_B5K9 HAP1 HIF1AN (-) 2 cancer cell line human CVCL_B5K9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17113; HIF1AN; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666180 CVCL_B5JZ HAP1 DHTKD1 (-) 5 cancer cell line human CVCL_B5JZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23537; DHTKD1; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666181 CVCL_B5M0 FA50P finite cell line human CVCL_B5M0 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; p.Trp322Ter (c.966delG) (p.Gly321_Trp322insTer); ClinVar=VCV000995825; Zygosity=Homozygous (PubMed=33355142); Sequence variation: Mutation; HGNC; HGNC:404; ALDH2; Simple; p.Glu504Lys (c.1510G>A) (p.Glu487Lys); ClinVar=VCV000018390; Zygosity=Heterozygous; Note=Allele ALDH2*2 (PubMed=33355142) Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666182 CVCL_B5LN GM02351 finite cell line human CVCL_B5LN CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Discontinued: Coriell; GM02351; probable Female 151666183 CVCL_B5M2 AP39P-iPSC#1 induced pluripotent stem cell human CVCL_B5M2 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; c.564+1G>A (p.Leu188Profs*4); ClinVar=VCV000995826; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=33512438); Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; p.Ala278Pro (c.832G>C); ClinVar=VCV000995827; Zygosity=Heterozygous (PubMed=33512438); Sequence variation: Mutation; HGNC; HGNC:404; ALDH2; Simple; p.Glu504Lys (c.1510G>A) (p.Glu487Lys); ClinVar=VCV000018390; Zygosity=Heterozygous; Note=Allele ALDH2*2 (PubMed=33512438) Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666184 CVCL_B5LQ N19OS finite cell line human CVCL_B5LQ CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 151666185 CVCL_B5LP AG22791 finite cell line house mouse CVCL_B5LP CL:0000010 Sequence variation: Mutation; MGI; MGI:109330; Prop1; Simple; p.Ser83Pro (c.247T>C) (Prop1 df); Zygosity=Homozygous (Coriell=AG22791) Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620; Breed/subspecies: Ames dwarf. Male Part of: NIA Aging Cell Repository's Ames Dwarf Mouse Collection 151666186 CVCL_B5M1 FA50P-iPSC#1 induced pluripotent stem cell human CVCL_B5M1 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; p.Trp322Ter (c.966delG) (p.Gly321_Trp322insTer); ClinVar=VCV000995825; Zygosity=Homozygous (PubMed=33512438); Sequence variation: Mutation; HGNC; HGNC:404; ALDH2; Simple; p.Glu504Lys (c.1510G>A) (p.Glu487Lys); ClinVar=VCV000018390; Zygosity=Heterozygous; Note=Allele ALDH2*2 (PubMed=33512438) Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666187 CVCL_B5M4 AP39P-iPSC#2 induced pluripotent stem cell human CVCL_B5M4 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; c.564+1G>A (p.Leu188Profs*4); ClinVar=VCV000995826; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=33512438); Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; p.Ala278Pro (c.832G>C); ClinVar=VCV000995827; Zygosity=Heterozygous (PubMed=33512438); Sequence variation: Mutation; HGNC; HGNC:404; ALDH2; Simple; p.Glu504Lys (c.1510G>A) (p.Glu487Lys); ClinVar=VCV000018390; Zygosity=Heterozygous; Note=Allele ALDH2*2 (PubMed=33512438) Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666188 CVCL_B5LS CS1YO finite cell line human CVCL_B5LS CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666189 CVCL_B5M3 FA50P-iPSC#2 induced pluripotent stem cell human CVCL_B5M3 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:253; ADH5; Simple; p.Trp322Ter (c.966delG) (p.Gly321_Trp322insTer); ClinVar=VCV000995825; Zygosity=Homozygous (PubMed=33512438); Sequence variation: Mutation; HGNC; HGNC:404; ALDH2; Simple; p.Glu504Lys (c.1510G>A) (p.Glu487Lys); ClinVar=VCV000018390; Zygosity=Heterozygous; Note=Allele ALDH2*2 (PubMed=33512438) Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666190 CVCL_B5LR N20OS finite cell line human CVCL_B5LR CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified 151666191 CVCL_B5LU CS1YOM finite cell line human CVCL_B5LU CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666192 CVCL_B5M6 MK-40 finite cell line human CVCL_B5M6 CL:0000010 Population: Japanese; Karyotypic information: 46,XX,inv(9)(p13;q21)pat (JCRB=KURB2800); Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173. Unspecified 151666193 CVCL_B5LT CS1YOF finite cell line human CVCL_B5LT CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666194 CVCL_B5M5 MK-41 finite cell line human CVCL_B5M5 CL:0000010 Population: Japanese; Karyotypic information: 48,XY,+16,+22 (JCRB=KURB2801); Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106. Female 151666195 CVCL_B5LG GM28283 finite cell line human CVCL_B5LG CL:0000010 Sequence variation: Mutation; HGNC; HGNC:30171; HSPB8; Simple; p.Pro173Serfs*43 (c.515dupC); ClinVar=VCV000986227; Zygosity=Heterozygous (Coriell=GM28283) Population: Caucasian; Donor information: At sampling donor was not affected with inclusion myopathy but possess the mutation affecting his brother, mother and uncle; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666196 CVCL_B5LF GM28302 transformed cell line human CVCL_B5LF CL:0000010 Population: Jewish; Ashkenazi and Jewish; Moroccan; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666197 CVCL_B5LI IGR-10 cancer cell line human CVCL_B5LI CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9801; RAC1; Simple; p.Pro29Ser (c.85C>T); ClinVar=VCV000376362; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542. Male 151666198 CVCL_B5LH IPC-167 cancer cell line human CVCL_B5LH CL:0000010 Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542. Female 151666199 CVCL_B5LK IPC-164 cancer cell line human CVCL_B5LK CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097. Female 151666200 CVCL_B5LJ IGR-5 finite cell line human CVCL_B5LJ CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666201 CVCL_B5LM RCMGi007-A induced pluripotent stem cell human CVCL_B5LM From: Research Centre for Medical Genetics; Moscow; Russia. CL:0000010 Female 151666202 CVCL_B5LL IMEDEAi001-F-1 induced pluripotent stem cell human CVCL_B5LL From: Instituto Mediterraneo de Estudios Avanzados; Esporles; Spain CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple_corrected; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous; Note=By TALEN (PubMed=32373648) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Variations; Array-based CGH Female 151666203 CVCL_B5LA BREC1 transformed cell line CVCL_B5LA CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Rumen; UBERON=UBERON_0007365; Cell type: Epithelial cell; CL=CL_0000066; Breed/subspecies: Angus; VBO=VBO_0000104. Omics: Transcriptomics; RNAseq Male 151666204 CVCL_B5LC GM28299 finite cell line human CVCL_B5LC CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gly237Valfs*11 (c.710delG) (p.Gly249Valfs*11, c.746delG); ClinVar=VCV000011846; Zygosity=Heterozygous (Coriell=GM28299) Population: Jewish; Ashkenazi and Jewish; Moroccan; Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666205 CVCL_B5LB GM28047 transformed cell line human CVCL_B5LB CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11055; SLC6A8; Simple; p.Phe107del (c.318CTT[1]) (c.321_323delCTT); ClinVar=VCV000021448; Zygosity=Hemizygous (Coriell=GM28047) Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666206 CVCL_B5LE GM28301 transformed cell line human CVCL_B5LE CL:0000010 Population: Jewish; Ashkenazi; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666207 CVCL_B5LD GM28300 transformed cell line human CVCL_B5LD CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Gly237Valfs*11 (c.710delG) (p.Gly249Valfs*11, c.746delG); ClinVar=VCV000011846; Zygosity=Heterozygous (Coriell=GM28300) Population: Jewish; Ashkenazi and Jewish; Moroccan; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666208 CVCL_B5KV HAP1 SGSH (-) 2 cancer cell line human CVCL_B5KV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10818; SGSH; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666209 CVCL_B5L7 HAP1 YTHDF1 (-) 2 cancer cell line human CVCL_B5L7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15867; YTHDF1; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666210 CVCL_B5KU HAP1 SEC31B (-) 2 cancer cell line human CVCL_B5KU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23197; SEC31B; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666211 CVCL_B5L6 HAP1 WDR45 (-) 2 cancer cell line human CVCL_B5L6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28912; WDR45; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666212 CVCL_B5L9 8H5 [Mouse/rat hybridoma against human GABARAP] hybridoma CVCL_B5L9 CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; O95166; Human GABARAP. 151666213 CVCL_B5KX HAP1 SHPRH (-) 2 cancer cell line human CVCL_B5KX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19336; SHPRH; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666214 CVCL_B5L8 HAP1 YTHDF1 (-) 3 cancer cell line human CVCL_B5L8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15867; YTHDF1; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666215 CVCL_B5KZ HAP1 TLR4 (-) 2 cancer cell line human CVCL_B5KZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11850; TLR4; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666216 CVCL_B5KY HAP1 SHPRH (-) 3 cancer cell line human CVCL_B5KY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19336; SHPRH; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Group: Haploid karyotype cell line 151666217 CVCL_B6KM Mel Ch cancer cell line human CVCL_B6KM CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00680) Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097. Unspecified Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 706D 151666218 CVCL_B6KL Mel Bgf cancer cell line human CVCL_B6KL CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (CelloPub=CLPUB00680) Derived from site: Metastatic; Right thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072. Unspecified Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 714D 151666219 CVCL_B6L0 Mel 263 cancer cell line human CVCL_B6L0 CL:0000010 Unspecified 151666220 CVCL_B6KN Mel Gi cancer cell line human CVCL_B6KN CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00680). Unspecified 151666221 CVCL_B6KQ Mel H cancer cell line human CVCL_B6KQ HLA typing: A*03,30; B*07,13 (Patent=RU2402604) CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00680) Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542. Unspecified Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 715D 151666222 CVCL_B6L2 Mel IG cancer cell line human CVCL_B6L2 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2434; CSF2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072. Female Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 700D 151666223 CVCL_B6L1 Mel 26G cancer cell line human CVCL_B6L1 CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2434; CSF2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo. Unspecified Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 701D 151666224 CVCL_B6KP Mel Gus cancer cell line human CVCL_B6KP CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (CelloPub=CLPUB00680) Derived from site: Metastatic; Right thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072. Unspecified Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 707D 151666225 CVCL_B6L4 Mel 31G cancer cell line human CVCL_B6L4 CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2434; CSF2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo. Unspecified Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 698D 151666226 CVCL_B6KS Mel Is cancer cell line human CVCL_B6KS CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00680). Unspecified 151666227 CVCL_B6L3 Mel 311 cancer cell line human CVCL_B6L3 CL:0000010 Unspecified 151666228 CVCL_B6KR Mel Hn cancer cell line human CVCL_B6KR CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00680). Unspecified 151666229 CVCL_B6KE Mel Z cancer cell line human CVCL_B6KE CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00680; PubMed=28881731; PubMed=30551515) Derived from site: Metastatic; Interscapular region, hypodermis; UBERON=UBERON_8480066+UBERON_0002072. Female Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 711D 151666230 CVCL_B6KD Mel Il cancer cell line human CVCL_B6KD CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (CelloPub=CLPUB00680; PubMed=28881731; PubMed=30551515) Derived from site: Metastatic; Chest, hypodermis; UBERON=UBERON_0001443+UBERON_0002072. Unspecified Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 686D 151666231 CVCL_B6KG Mel Mtp cancer cell line human CVCL_B6KG CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (CelloPub=CLPUB00680; PubMed=30551515) Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097. Unspecified Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 705D 151666232 CVCL_B6KF Mel IL/R cancer cell line human CVCL_B6KF CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=30551515) Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032); Derived from site: Metastatic; Chest, hypodermis; UBERON=UBERON_0001443+UBERON_0002072. Unspecified 151666233 CVCL_B6KI NCC-UPS4-C1 cancer cell line human CVCL_B6KI CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Heterozygous (PubMed=35118583); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu286Lys (c.856G>A); ClinVar=VCV000183752; Zygosity=Heterozygous (PubMed=35118583) Population: Japanese; Derived from site: Metastatic; Right knee, hypodermis; UBERON=UBERON_0001465+UBERON_0002072. Omics: Phenotyping; Drug screening; Omics: Variations; SNP array analysis Female Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi); Doubling time: 76 hours (PubMed=35118583) Part of: NCC sarcoma cell line panel 151666234 CVCL_B6KH Mel Me cancer cell line human CVCL_B6KH HLA typing: A*02,31; B*56,58 (Patent=RU2402603) CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (CelloPub=CLPUB00680; PubMed=30551515) Derived from site: Metastatic; Back, skin; UBERON=UBERON_0001068. Male Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 712D 151666235 CVCL_B6KK Mel Kor-TurboRFP cancer cell line human CVCL_B6KK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection; Gene=FPbase; AHNXC; TurboRFP (Note=Orange fluorescent protein derived from eqFP578); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072. Unspecified Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 730D 151666236 CVCL_B6KJ TSK-CHO1 cancer cell line human CVCL_B6KJ CL:0000010 Population: Japanese; Derived from site: In situ; Bone, cranium, clivus; UBERON=UBERON_0004108. Female Doubling time: 47.8 hours (PubMed=35098443) 151666237 CVCL_B6KA Mel Rac cancer cell line human CVCL_B6KA HLA typing: A*23,26; B*08,39 (Patent=RU2402602) CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (CelloPub=CLPUB00680); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (DOI=10.17650/1726-9784-2018-17-4-27-35; PubMed=28881731) Derived from site: Metastatic; Right thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072. Male Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 710D 151666238 CVCL_B6KC Mel Ibr subclone cancer cell line human CVCL_B6KC CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line) Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072. Female 151666239 CVCL_B6KB Mel Kor cancer cell line human CVCL_B6KB CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (CelloPub=CLPUB00680) Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072. Unspecified Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 687D 151666240 CVCL_B6K5 Mel min-16 cancer cell line human CVCL_B6K5 CL:0000010 Derived from site: Metastatic; Not specified. Unspecified 151666241 CVCL_B6JT Mel min-5 cancer cell line human CVCL_B6JT CL:0000010 Derived from site: Metastatic; Not specified. Unspecified 151666242 CVCL_B6K4 Mel min-15 cancer cell line human CVCL_B6K4 CL:0000010 Derived from site: Metastatic; Not specified. Unspecified 151666243 CVCL_B6JS Mel min-4 cancer cell line human CVCL_B6JS CL:0000010 Derived from site: Metastatic; Not specified. Unspecified 151666244 CVCL_B6K7 Mel min-18 cancer cell line human CVCL_B6K7 CL:0000010 Derived from site: Metastatic; Not specified. Unspecified 151666245 CVCL_B6JV Mel min-7 cancer cell line human CVCL_B6JV CL:0000010 Derived from site: Metastatic; Not specified. Unspecified 151666246 CVCL_B6K6 Mel min-17 cancer cell line human CVCL_B6K6 CL:0000010 Derived from site: Metastatic; Not specified. Unspecified 151666247 CVCL_B6JU Mel min-6 cancer cell line human CVCL_B6JU CL:0000010 Derived from site: Metastatic; Not specified. Unspecified 151666248 CVCL_B6K9 Mel Cher 5C cancer cell line human CVCL_B6K9 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (from parent cell line) Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. Male 151666249 CVCL_B6JX U2OS CHMP2B KO cancer cell line human CVCL_B6JX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24537; CHMP2B; Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female 151666250 CVCL_B6K8 Mel Cher cancer cell line human CVCL_B6K8 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00680; DOI=10.17650/1726-9784-2018-17-4-27-35); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=28881731) Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. Male Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 704D 151666251 CVCL_B6JW Mel min-8 cancer cell line human CVCL_B6JW CL:0000010 Derived from site: Metastatic; Not specified. Unspecified 151666252 CVCL_B6JZ Mel min-10 cancer cell line human CVCL_B6JZ CL:0000010 Derived from site: Metastatic; Not specified. Unspecified 151666253 CVCL_B6JY Mel min-9 cancer cell line human CVCL_B6JY CL:0000010 Derived from site: Metastatic; Not specified. Unspecified 151666254 CVCL_B6LN 7D8 hybridoma house mouse CVCL_B6LN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q03040; Lake Victoria marburgvirus (strain Popp-67) matrix protein VP40. Group: Patented cell line 151666255 CVCL_B6LM 7C4 hybridoma house mouse CVCL_B6LM CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q03040; Lake Victoria marburgvirus (strain Popp-67) matrix protein VP40. 151666256 CVCL_B6LP 7H10 [Mouse hybridoma against Marburg virus VP40] hybridoma house mouse CVCL_B6LP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q03040; Lake Victoria marburgvirus (strain Popp-67) matrix protein VP40. Group: Patented cell line 151666257 CVCL_B6M1 Ea3.2 factor-dependent cell line house mouse CVCL_B6M1 CL:0000010 Derived from site: In situ; Spleen; UBERON=UBERON_0002106; Cell type: Pre-B cell; CL=CL_0000817; Breed/subspecies: BALB/c. Unspecified Characteristics: IL3 dependent Doubling time: 15-17 hours (PubMed=6201749) 151666258 CVCL_B6M0 Ea3.15 factor-dependent cell line house mouse CVCL_B6M0 CL:0000010 Derived from site: In situ; Spleen; UBERON=UBERON_0002106; Cell type: Pre-B cell; CL=CL_0000817; Breed/subspecies: BALB/c. Unspecified Characteristics: IL3 dependent Doubling time: 19 hours (PubMed=6201749) 151666259 CVCL_B6M3 8G3 hybridoma house mouse CVCL_B6M3 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q03039; Lake Victoria marburgvirus (strain Popp-67) polymerase cofactor VP35. 151666260 CVCL_B6LR MPS VII iPSC induced pluripotent stem cell human CVCL_B6LR CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666261 CVCL_B6M2 9C7 hybridoma house mouse CVCL_B6M2 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P35263; Lake Victoria marburgvirus (strain Popp-67) nucleoprotein (NP). 151666262 CVCL_B6LQ Mel KG cancer cell line human CVCL_B6LQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2434; CSF2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072. Unspecified Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 699D 151666263 CVCL_B6M5 9G6 [Mouse hybridoma against Lake Victoria marburgvirus VP40] hybridoma house mouse CVCL_B6M5 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q03040; Lake Victoria marburgvirus (strain Popp-67) matrix protein VP40. 151666264 CVCL_B6LT Anti-NG-R1 hybridoma house mouse CVCL_B6LT CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_77149; Notoginsenoside R1. 151666265 CVCL_B6M4 9D8 [Mouse hybridoma against Marburg virus VP35] hybridoma house mouse CVCL_B6M4 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q03039; Lake Victoria marburgvirus (strain Popp-67) polymerase cofactor VP35. 151666266 CVCL_B6LS 9F [Mouse hybridoma against ginkgolic acids] hybridoma house mouse CVCL_B6LS CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_5354; Ginkgolic acids (Ginkgoic acid). 151666267 CVCL_B6LF 3F9 [Mouse hybridoma against Lake Victoria marburgvirus VP35] hybridoma house mouse CVCL_B6LF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q03039; Lake Victoria marburgvirus (strain Popp-67) polymerase cofactor VP35. 151666268 CVCL_B6LE 1C1 [Mouse hybridoma against ZEBOV VP40] hybridoma house mouse CVCL_B6LE CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q05128; Zaire ebolavirus (strain Mayinga-76) matrix protein VP40. Group: Patented cell line 151666269 CVCL_B6LH 5F1 hybridoma house mouse CVCL_B6LH CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P35263; Lake Victoria marburgvirus (strain Popp-67) nucleoprotein (NP). 151666270 CVCL_B6LG 4A2 [Mouse hybridoma against ZEBOV VP40] hybridoma house mouse CVCL_B6LG CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q05128; Zaire ebolavirus (strain Mayinga-76) matrix protein VP40. Group: Patented cell line 151666271 CVCL_B6LJ 1C6 [Mouse hybridoma against ZEBOV VP35] hybridoma house mouse CVCL_B6LJ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q05127; Zaire ebolavirus (strain Mayinga-76) polymerase cofactor VP35. 151666272 CVCL_B6LI 5F10 hybridoma house mouse CVCL_B6LI CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P06725; Human cytomegalovirus (strain AD169) 65 kDa phosphoprotein (pp65). Group: Patented cell line 151666273 CVCL_B6LL 7B11 [Rat hybridoma against ZEBOV NP] hybridoma Norway rat CVCL_B6LL CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: UniProtKB; P18272; Zaire ebolavirus (strain Mayinga-76) nucleoprotein (NP). Group: Patented cell line 151666274 CVCL_B6LK 6F7 [Mouse hybridoma against ZEBOV VP35] hybridoma house mouse CVCL_B6LK CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q05127; Zaire ebolavirus (strain Mayinga-76) polymerase cofactor VP35. 151666275 CVCL_B6LB Mel S cancer cell line human CVCL_B6LB CL:0000010 Unspecified 151666276 CVCL_B6LA Mel Kis cancer cell line human CVCL_B6LA CL:0000010 Unspecified 151666277 CVCL_B6LD 1B2 [Mouse hybridoma against ZEBOV NP] hybridoma house mouse CVCL_B6LD CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P18272; Zaire ebolavirus (strain Mayinga-76) nucleoprotein (NP). Group: Patented cell line 151666278 CVCL_B6LC Mel ILG cancer cell line human CVCL_B6LC CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2434; CSF2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: Metastatic; Chest, hypodermis; UBERON=UBERON_0001443+UBERON_0002072. Unspecified Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 697D 151666279 CVCL_B6L6 Mel 226 cancer cell line human CVCL_B6L6 CL:0000010 Unspecified 151666280 CVCL_B6KU Mel R cancer cell line human CVCL_B6KU CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00680). Unspecified 151666281 CVCL_B6KT Mel Ksen cancer cell line human CVCL_B6KT CL:0000010 Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542. Female Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 713D 151666282 CVCL_B6L5 MEL-REO cancer cell line human CVCL_B6L5 CL:0000010 Unspecified 151666283 CVCL_B6L8 Mel 82 cancer cell line human CVCL_B6L8 CL:0000010 Unspecified 151666284 CVCL_B6KW RIM9 hybridoma house mouse CVCL_B6KW CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P07498; Human CASK (Note=AA 57-134 = Lactapin). Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 722D 151666285 CVCL_B6L7 Mel 259 cancer cell line human CVCL_B6L7 CL:0000010 Unspecified 151666286 CVCL_B6KV Mel Si cancer cell line human CVCL_B6KV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Gln (c.1790T>A); ClinVar=VCV000076687; Zygosity=Unspecified (CelloPub=CLPUB00680); Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00680) Derived from site: Metastatic; Back, skin; UBERON=UBERON_0001068. Female Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 708D 151666287 CVCL_B6KY 1H8 [Mouse hybridoma against sheep IgG] hybridoma house mouse CVCL_B6KY CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Sheep IgG. Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 73 151666288 CVCL_B6KX A-4A7 hybridoma house mouse CVCL_B6KX CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P09466; Human PAEP. Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 722D 151666289 CVCL_B6L9 Mel E cancer cell line human CVCL_B6L9 CL:0000010 Unspecified 151666290 CVCL_B6KZ Mel PG cancer cell line human CVCL_B6KZ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2434; CSF2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072. Unspecified Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 702D 151666291 CVCL_B6IK NH50362 induced pluripotent stem cell human CVCL_B6IK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (NHCDR=NH50362). Population: Caucasian Male 151666292 CVCL_B6IJ NH50361 induced pluripotent stem cell human CVCL_B6IJ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (NHCDR=NH50361). Population: Caucasian Male 151666293 CVCL_B6IM mPAC-4.4 transformed cell line house mouse CVCL_B6IM CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT) Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV); Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Breed/subspecies: C3H. Unspecified 151666294 CVCL_B6IL mPAC-4.3 transformed cell line house mouse CVCL_B6IL CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT) Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV); Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Breed/subspecies: C3H. Unspecified 151666295 CVCL_B6J0 NIH/3T3-174 transformed cell line house mouse CVCL_B6J0 CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98447; Surf6; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: NIH Swiss. Male Characteristics: Overexpresses SURF6 in the presence of doxycycline; Characteristics: Transfected with two constructs: 1) pcDNA3.1(-)rtTA which contains a rtTA and a neo gene The reverse tetracycline-controlled transactivator (rtTA) is a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16. 2) pBI-mSURF6 that contains a bidirectorial tetracycline-responsible element (Tre) flanked by two minimal bi-directorial CMV promoters which govern co-expression of SURF6 and EGFP. Group: Patented cell line 151666296 CVCL_B6IN DZ-MAb hybridoma house mouse CVCL_B6IN CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_42202; Daidzin (Daidzein 7-O-beta-D-glucoside); Monoclonal antibody target: ChEBI; CHEBI_27514; Genistin (Genistein 7-O-beta-D-glucoside). 151666297 CVCL_B6IQ 2H9 [Mouse hybridoma against trans-resveratrol] hybridoma house mouse CVCL_B6IQ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: ChEBI; CHEBI_45713; Trans-resveratrol. Group: Patented cell line; Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-121 151666298 CVCL_B6J2 mEER transformed cell line house mouse CVCL_B6J2 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val); Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Miscellaneous: Age/sex of donor from personal communication of Vermeer, Paola D Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729; Cell type: Epithelial cell; CL=CL_0000066; Breed/subspecies: C57BL/6. Male Caution: Was originally said to be derived from tonsils, an anatomical structure that does not exist in mouse 151666299 CVCL_B6IP 1B1 [Mouse hybridoma against trans-resveratrol] hybridoma house mouse CVCL_B6IP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: ChEBI; CHEBI_45713; Trans-resveratrol. Group: Patented cell line; Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-122 151666300 CVCL_B6J1 P56 hybridoma Norway rat CVCL_B6J1 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P12004; Human PCNA. Group: Patented cell line; Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-107 151666301 CVCL_B6IC NH50353 induced pluripotent stem cell human CVCL_B6IC CL:0000010 Population: Caucasian. Female 151666302 CVCL_B6IB NH50352 induced pluripotent stem cell human CVCL_B6IB CL:0000010 Population: Caucasian. Female 151666303 CVCL_B6IE NH50355 induced pluripotent stem cell human CVCL_B6IE CL:0000010 Population: Asian. Male 151666304 CVCL_B6ID NH50354 induced pluripotent stem cell human CVCL_B6ID CL:0000010 Population: Asian. Male 151666305 CVCL_B6IG NH50357 induced pluripotent stem cell human CVCL_B6IG CL:0000010 Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (NHCDR=NH50357). Population: Caucasian Male 151666306 CVCL_B6IF NH50356 induced pluripotent stem cell human CVCL_B6IF CL:0000010 Population: Asian. Male 151666307 CVCL_B6II NH50360 induced pluripotent stem cell human CVCL_B6II CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (NHCDR=NH50360). Population: Caucasian Male 151666308 CVCL_B6IH NH50358 induced pluripotent stem cell human CVCL_B6IH CL:0000010 Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (NHCDR=NH50358). Population: Caucasian Male 151666309 CVCL_B6HZ NH50340 finite cell line human CVCL_B6HZ CL:0000010 Population: Southeast Asian; Filipino; Donor information: At sampling donor was not affected with X-linked dystonia parkinsonism but at risk for disease; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666310 CVCL_B6HY NH50339 induced pluripotent stem cell human CVCL_B6HY CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666311 CVCL_B6IA NH50351 induced pluripotent stem cell human CVCL_B6IA CL:0000010 Population: Caucasian. Female 151666312 CVCL_B6HR NH50332 induced pluripotent stem cell human CVCL_B6HR CL:0000010 Population: African American; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Female 151666313 CVCL_B6I3 NH50344 induced pluripotent stem cell human CVCL_B6I3 CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666314 CVCL_B6HQ NH50331 induced pluripotent stem cell human CVCL_B6HQ CL:0000010 Population: African American; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Female 151666315 CVCL_B6I2 NH50343 induced pluripotent stem cell human CVCL_B6I2 CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666316 CVCL_B6HT NH50334 induced pluripotent stem cell human CVCL_B6HT CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Female 151666317 CVCL_B6I5 NH50346 induced pluripotent stem cell human CVCL_B6I5 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Glu365Lys (c.1093G>A) (E326K); ClinVar=VCV000199044; Zygosity=Heterozygous (NHCDR=NH50346). Population: Caucasian Male 151666318 CVCL_B6HS NH50333 induced pluripotent stem cell human CVCL_B6HS CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Female 151666319 CVCL_B6I4 NH50345 induced pluripotent stem cell human CVCL_B6I4 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Glu365Lys (c.1093G>A) (E326K); ClinVar=VCV000199044; Zygosity=Heterozygous (NHCDR=NH50345). Population: Caucasian Male 151666320 CVCL_B6HV NH50336 induced pluripotent stem cell human CVCL_B6HV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Heterozygous (NHCDR=NH50336) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Male Characteristics: Non-edited control for NH50337 (Cellosaurus=CVCL_B6HW) 151666321 CVCL_B6I7 NH50348 induced pluripotent stem cell human CVCL_B6I7 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (NHCDR=NH50348). Population: Caucasian Female 151666322 CVCL_B6HU NH50335 induced pluripotent stem cell human CVCL_B6HU CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Female 151666323 CVCL_B6I6 NH50347 induced pluripotent stem cell human CVCL_B6I6 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Glu365Lys (c.1093G>A) (E326K); ClinVar=VCV000199044; Zygosity=Heterozygous (NHCDR=NH50347). Population: Caucasian Male 151666324 CVCL_B6HX NH50338 induced pluripotent stem cell human CVCL_B6HX CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666325 CVCL_B6I9 NH50350 induced pluripotent stem cell human CVCL_B6I9 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (NHCDR=NH50350). Population: Caucasian Female 151666326 CVCL_B6HW NH50337 induced pluripotent stem cell human CVCL_B6HW CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_corrected; p.Asn279Lys (c.837T>G) (N596K, c.1788T>G or N614K, c.1842T>G); ClinVar=VCV000014253; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (NHCDR=NH50337) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Male 151666327 CVCL_B6I8 NH50349 induced pluripotent stem cell human CVCL_B6I8 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Heterozygous (NHCDR=NH50349). Population: Caucasian Female 151666328 CVCL_B6JK Mel Ibr cancer cell line human CVCL_B6JK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00680; PubMed=28881731) Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072. Female Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 689D 151666329 CVCL_B6JN PiGAS cancer cell line human CVCL_B6JN CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072. Unspecified Characteristics: Transfected with a construct pGL3-6xGAS-FFL-Neo that contains six gamma-interferon-activated sites (GAS) followed by a minimum SV40 promoter and the Luc gene Group: Patented cell line; Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-161 151666330 CVCL_B6JM Mel P cancer cell line human CVCL_B6JM CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00680) Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072. Unspecified Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 688D 151666331 CVCL_B6JP Mel min-1 cancer cell line human CVCL_B6JP CL:0000010 Derived from site: Metastatic; Not specified. Unspecified 151666332 CVCL_B6K1 Mel min-12 cancer cell line human CVCL_B6K1 CL:0000010 Derived from site: Metastatic; Not specified. Unspecified 151666333 CVCL_B6K0 Mel min-11 cancer cell line human CVCL_B6K0 CL:0000010 Derived from site: Metastatic; Not specified. Unspecified 151666334 CVCL_B6K3 Mel min-14 cancer cell line human CVCL_B6K3 CL:0000010 Derived from site: Metastatic; Not specified. Unspecified 151666335 CVCL_B6JR Mel min-3 cancer cell line human CVCL_B6JR CL:0000010 Derived from site: Metastatic; Not specified. Unspecified 151666336 CVCL_B6K2 Mel min-13 cancer cell line human CVCL_B6K2 CL:0000010 Derived from site: Metastatic; Not specified. Unspecified 151666337 CVCL_B6JQ Mel min-2 cancer cell line human CVCL_B6JQ CL:0000010 Derived from site: Metastatic; Not specified. Unspecified 151666338 CVCL_B6JD N52 hybridoma house mouse CVCL_B6JD CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P08833; Human IGFBP1 (Note=Indicated to recognizes PAMG-1 but it is not 100% clear if PAMG-1=IGFBP1). Group: Patented cell line; Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-92 151666339 CVCL_B6JC C-HAlb spontaneously immortalized cell line CVCL_B6JC CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:399; ALB; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Group: Patented cell line; Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-179 151666340 CVCL_B6JF N42 hybridoma house mouse CVCL_B6JF CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P08833; Human IGFBP1 (Note=Indicated to recognizes PAMG-1 but it is not 100% clear if PAMG-1=IGFBP1). Group: Patented cell line; Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-94 151666341 CVCL_B6JE N271 hybridoma house mouse CVCL_B6JE CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P08833; Human IGFBP1 (Note=Indicated to recognizes PAMG-1 but it is not 100% clear if PAMG-1=IGFBP1). Group: Patented cell line; Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-93 151666342 CVCL_B6JH 4G1-D2 hybridoma house mouse CVCL_B6JH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P0DTW1; Human GAGE1. Group: Patented cell line; Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-174 151666343 CVCL_B6JG MEL-P cancer cell line human CVCL_B6JG CL:0000010 Derived from site: In situ; Neck, skin; UBERON=UBERON_0001417. Male Doubling time: 22-24 hours (Note=At 50th passage) (PubMed=8819123) 151666344 CVCL_B6JJ AMACR, clone G8 hybridoma house mouse CVCL_B6JJ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q9UHK6; Human AMACR. Group: Patented cell line; Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-166 151666345 CVCL_B6JI 6H9 [Mouse hybridoma against human AMACR] hybridoma house mouse CVCL_B6JI CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9UHK6; Human AMACR. 151666346 CVCL_B6IZ 3A3 [Mouse hybridoma against plumbagin] hybridoma house mouse CVCL_B6IZ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_8273; Plumbagin. 151666347 CVCL_B6JB mEERL95 transformed cell line house mouse CVCL_B6JB CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val); Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729; Cell type: Epithelial cell; CL=CL_0000066; Breed/subspecies: C57BL/6. Omics: Transcriptomics; Microarray Male Characteristics: Established from a tumor in a C57BL/6JRj mouse which was implanted with the parent cell line (PubMed=29313973) 151666348 CVCL_B6JA MOSEC Trp53-/-;Pten-/- DKO clone 4 transformed cell line house mouse CVCL_B6JA CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:109583; Pten; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:98834; Trp53 Derived from site: In situ; Oviduct epithelium; UBERON=UBERON_0004804; Breed/subspecies: C57BL/6. Female 151666349 CVCL_B6IS 4A3 hybridoma house mouse CVCL_B6IS CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: ChEBI; CHEBI_15948; Lycopene. Group: Patented cell line; Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-171 151666350 CVCL_B6J4 MLM #1 transformed cell line house mouse CVCL_B6J4 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val); Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729; Cell type: Epithelial cell; CL=CL_0000066; Breed/subspecies: C57BL/6. Omics: Transcriptomics; Microarray Male Characteristics: Established from lung tumors obtained after injection of the parent cell line into a mouse that was then treated with cisplatin/radiation therapy (CRT) (PubMed=27013584) 151666351 CVCL_B6IR 3B12 [Mouse hybridoma against lycopene] hybridoma house mouse CVCL_B6IR CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: ChEBI; CHEBI_15948; Lycopene. 151666352 CVCL_B6J3 mEERL transformed cell line house mouse CVCL_B6J3 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val); Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Miscellaneous: Age/sex of donor from personal communication of Vermeer, Paola D Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729; Cell type: Epithelial cell; CL=CL_0000066; Breed/subspecies: C57BL/6. Omics: Transcriptomics; Microarray Male Caution: Was originally said to be derived from tonsils, an anatomical structure that does not exist in mouse 151666353 CVCL_B6IU 6B9 [Mouse hybridoma against lycopene] hybridoma house mouse CVCL_B6IU CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: ChEBI; CHEBI_15948; Lycopene. Group: Patented cell line; Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-172 151666354 CVCL_B6J6 MLM #5 transformed cell line house mouse CVCL_B6J6 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val); Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729; Cell type: Epithelial cell; CL=CL_0000066; Breed/subspecies: C57BL/6. Omics: Transcriptomics; Microarray Male Characteristics: Established from lung tumors obtained after injection of the parent cell line into a mouse that was then treated with cisplatin/radiation therapy (CRT) (PubMed=27013584) 151666355 CVCL_B6IT 4F10 [Mouse hybridoma against lycopene] hybridoma house mouse CVCL_B6IT CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: ChEBI; CHEBI_15948; Lycopene. 151666356 CVCL_B6J5 MLM #3 transformed cell line house mouse CVCL_B6J5 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val); Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729; Cell type: Epithelial cell; CL=CL_0000066; Breed/subspecies: C57BL/6. Omics: Transcriptomics; Microarray Male Characteristics: Established from lung tumors obtained after injection of the parent cell line into a mouse that was then treated with cisplatin/radiation therapy (CRT) (PubMed=27013584) 151666357 CVCL_B6IW 6C3 [Mouse hybridoma against lutein] hybridoma house mouse CVCL_B6IW CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_28838; Lutein. 151666359 CVCL_B6IV 2F3 [Mouse hybridoma against lutein and other carotenoids] hybridoma house mouse CVCL_B6IV CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_40968; Astaxanthin; Monoclonal antibody target: ChEBI; CHEBI_17579; Beta-carotene; Monoclonal antibody target: ChEBI; CHEBI_28838; Lutein. 151666360 CVCL_B6J7 MLM #10 transformed cell line house mouse CVCL_B6J7 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val); Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729; Cell type: Epithelial cell; CL=CL_0000066; Breed/subspecies: C57BL/6. Omics: Transcriptomics; Microarray Male Characteristics: Established from lung tumors obtained after injection of the parent cell line into a mouse that was then treated with cisplatin/radiation therapy (CRT) (PubMed=27013584) 151666361 CVCL_B6IY 1B3 [Mouse hybridoma against aconitine-type alkaloids] hybridoma house mouse CVCL_B6IY CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_2430; Aconitine; Monoclonal antibody target: ChEBI; CHEBI_5831; Hypaconitine; Monoclonal antibody target: ChEBI; CHEBI_6089; Jesaconitine; Monoclonal antibody target: ChEBI; CHEBI_6773; Mesaconitine. 151666362 CVCL_B6IX 6H8 hybridoma house mouse CVCL_B6IX CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_28838; Lutein. Group: Patented cell line; Registration: International Depositary Authority, Russian National Collection of Industrial Microorganisms; VKPM H-176 151666363 CVCL_B6J9 MOSEC Trp53-/-;Pten-/- DKO clone 2 transformed cell line house mouse CVCL_B6J9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:109583; Pten; Knockout cell: Method=CRISPR/Cas9; MGI; MGI:98834; Trp53 Derived from site: In situ; Oviduct epithelium; UBERON=UBERON_0004804; Breed/subspecies: C57BL/6. Female 151666364 CVCL_B6GI 1C1 [Mouse hybridoma against artemisinin/artesunate] hybridoma house mouse CVCL_B6GI CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_223316; (+)-artemisinin; Monoclonal antibody target: ChEBI; CHEBI_63918; Artesunate. 151666365 CVCL_B6GH 5F7 [Mouse hybridoma against thebaine] hybridoma house mouse CVCL_B6GH CL:0000010 Monoclonal antibody isotype: IgG2b, lambda; Monoclonal antibody target: ChEBI; CHEBI_9519; Thebaine. 151666366 CVCL_B6GK 5C6 hybridoma house mouse CVCL_B6GK CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_34975; Sennoside B. 151666367 CVCL_B6GJ 9D6 hybridoma house mouse CVCL_B6GJ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_2981; Baicalin. 151666368 CVCL_B6GM 7H12 hybridoma house mouse CVCL_B6GM CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_34975; Sennoside B. 151666369 CVCL_B6GL 5C7 [Mouse hybridoma against sennoside B] hybridoma house mouse CVCL_B6GL CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI_34975; Sennoside B. 151666370 CVCL_B6H0 MC3T3-NM4 spontaneously immortalized cell line house mouse CVCL_B6H0 CL:0000010 Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339; Cell type: Osteoblast; CL=CL_0000062; Breed/subspecies: C57BL/6. Unspecified Characteristics: Compared to the parent cell line, lost the ability for mineral deposition (PubMed=11136541) 151666371 CVCL_B6GN 4G6 hybridoma house mouse CVCL_B6GN CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: ChEBI; CHEBI_15939; Glycyrrhizin (Uralsaponin A); Monoclonal antibody target: ChEBI; CHEBI_189708; Glycyrrhetic acid 3-O-glucuronide. 151666372 CVCL_B6GA 1H5 [Mouse hybridoma against thebaine] hybridoma house mouse CVCL_B6GA CL:0000010 Monoclonal antibody isotype: IgG2b, lambda; Monoclonal antibody target: ChEBI; CHEBI_9519; Thebaine. 151666373 CVCL_B6GC 2G1 [Mouse hybridoma against thebaine] hybridoma house mouse CVCL_B6GC CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: ChEBI; CHEBI_9519; Thebaine. 151666374 CVCL_B6GB 2F3 [Mouse hybridoma against thebaine] hybridoma house mouse CVCL_B6GB CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: ChEBI; CHEBI_9519; Thebaine. 151666375 CVCL_B6GE 3A11 [Mouse hybridoma against thebaine] hybridoma house mouse CVCL_B6GE CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: ChEBI; CHEBI_9519; Thebaine. 151666376 CVCL_B6GD 2G4 [Mouse hybridoma against thebaine] hybridoma house mouse CVCL_B6GD CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: ChEBI; CHEBI_9519; Thebaine. 151666377 CVCL_B6GG 5B6 hybridoma house mouse CVCL_B6GG CL:0000010 Monoclonal antibody isotype: IgG2a, lambda; Monoclonal antibody target: ChEBI; CHEBI_9519; Thebaine. 151666378 CVCL_B6GF 4C7 [Mouse hybridoma against thebaine] hybridoma house mouse CVCL_B6GF CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: ChEBI; CHEBI_9519; Thebaine. 151666379 CVCL_B6G9 6B9 [Mouse hybridoma against codeine] hybridoma house mouse CVCL_B6G9 CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: ChEBI; CHEBI_16714; Codeine. 151666380 CVCL_B6FX 9D12 [Mouse hybridoma against forskolin] hybridoma house mouse CVCL_B6FX CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI_42471; Forskolin. 151666381 CVCL_B6FW 4G12 [Mouse hybridoma against forskolin] hybridoma house mouse CVCL_B6FW CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI_42471; Forskolin. 151666382 CVCL_B6G8 4H4 [Mouse hybridoma against codeine] hybridoma house mouse CVCL_B6G8 CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: ChEBI; CHEBI_16714; Codeine. 151666383 CVCL_B6FZ 1D5-3B-7 hybridoma house mouse CVCL_B6FZ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_16118; Berberine. 151666384 CVCL_B6FY 9E12 hybridoma house mouse CVCL_B6FY CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI_42471; Forskolin. 151666385 CVCL_B6G1 9G7 [Mouse hybridoma against ginsenoside Rb1] hybridoma house mouse CVCL_B6G1 CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI_67989; Ginsenoside Rb1. Group: Patented cell line 151666386 CVCL_B6FP SMG-BD9 hybridoma house mouse CVCL_B6FP CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_9185; Solamargine. 151666387 CVCL_B6G0 1F4 hybridoma house mouse CVCL_B6G0 CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI_67987; Ginsenoside Rg1. Group: Patented cell line 151666388 CVCL_B6G3 anti-Rf hybridoma house mouse CVCL_B6G3 CL:0000010 Monoclonal antibody isotype: IgG3, kappa; Monoclonal antibody target: ChEBI; CHEBI_67986; Ginsenoside Rf. 151666389 CVCL_B6FR SMG-G9 hybridoma house mouse CVCL_B6FR CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: ChEBI; CHEBI_9185; Solamargine. 151666390 CVCL_B6G2 4G10 [Mouse hybridoma against ginsenoside Re] hybridoma house mouse CVCL_B6G2 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_77148; Ginsenoside Re. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM AP-20188 151666391 CVCL_B6FQ SMG-G4 hybridoma house mouse CVCL_B6FQ CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: ChEBI; CHEBI_9185; Solamargine. 151666392 CVCL_B6FT 11A9 hybridoma house mouse CVCL_B6FT CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI_42471; Forskolin. 151666393 CVCL_B6G5 2A8 [Mouse hybridoma against saikosaponin A] hybridoma house mouse CVCL_B6G5 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_8996; Saikosaponin A. 151666394 CVCL_B6G4 1G6 [Mouse hybridoma against saikosaponin A] hybridoma house mouse CVCL_B6G4 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_8996; Saikosaponin A. 151666395 CVCL_B6FS SMG-G10 hybridoma house mouse CVCL_B6FS CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: ChEBI; CHEBI_9185; Solamargine. 151666396 CVCL_B6FV 1A9 [Mouse hybridoma against forskolin] hybridoma house mouse CVCL_B6FV CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_42471; Forskolin. 151666397 CVCL_B6G7 4B9 [Mouse hybridoma against saikosaponins A/C] hybridoma house mouse CVCL_B6G7 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_8996; Saikosaponin A; Monoclonal antibody target: ChEBI; CHEBI_189704; Saikosaponin C. 151666398 CVCL_B6FU 122F9 hybridoma house mouse CVCL_B6FU CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI_42471; Forskolin. 151666399 CVCL_B6G6 3G10 hybridoma house mouse CVCL_B6G6 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_8996; Saikosaponin A; Monoclonal antibody target: ChEBI; CHEBI_183954; Saikosaponin B2. 151666400 CVCL_B6HJ NH50326 induced pluripotent stem cell human CVCL_B6HJ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_corrected; p.Val337Met (c.1009G>A) (V654M, c.1960G>A or V672M, c.2014G>A); ClinVar=VCV000014252; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (NHCDR=NH50326) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Male 151666401 CVCL_B6HI NH50325 induced pluripotent stem cell human CVCL_B6HI CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Val337Met (c.1009G>A) (V654M, c.1960G>A or V672M, c.2014G>A); ClinVar=VCV000014252; Zygosity=Heterozygous (NHCDR=NH50325) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Male Characteristics: Non-edited control for NH50326 (Cellosaurus=CVCL_B6HJ) 151666402 CVCL_B6HL NH50328 induced pluripotent stem cell human CVCL_B6HL CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Ala9Asp (c.26C>A); ClinVar=VCV000016013; Zygosity=Heterozygous (NHCDR=NH50328) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Female Characteristics: Non-edited control for NH50327 (Cellosaurus=CVCL_B6HK) 151666403 CVCL_B6HK NH50327 induced pluripotent stem cell human CVCL_B6HK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple_corrected; p.Ala9Asp (c.26C>A); ClinVar=VCV000016013; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (NHCDR=NH50327) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Female 151666404 CVCL_B6HN NH50359 induced pluripotent stem cell human CVCL_B6HN CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[179] (c.52CAG(179)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (NHCDR=NH50359) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Non-edited control for NH50329 (Cellosaurus=CVCL_B6HM) 151666405 CVCL_B6HM NH50329 induced pluripotent stem cell human CVCL_B6HM CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion_corrected; p.Gln18[179] (c.52CAG(179)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (NHCDR=NH50329) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666406 CVCL_B6HP NH50330 induced pluripotent stem cell human CVCL_B6HP CL:0000010 Population: African American; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Erythroblast; CL=CL_0000765. Female 151666407 CVCL_B6I1 NH50342 finite cell line human CVCL_B6I1 CL:0000010 Population: Southeast Asian; Filipino; Donor information: At sampling donor was not affected with X-linked dystonia parkinsonism but at risk for disease; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666408 CVCL_B6I0 NH50341 finite cell line human CVCL_B6I0 CL:0000010 Population: Southeast Asian; Filipino; Donor information: At sampling donor was not affected with X-linked dystonia parkinsonism but at risk for disease; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666409 CVCL_B6HB MRL28.8A stromal cell line house mouse CVCL_B6HB CL:0000010 Derived from site: In situ; Thymus; UBERON=UBERON_0002370; Cell type: Stromal cell of thymus; CL=CL_4030001; Breed/subspecies: MRL/Mp-lpr/lpr. Unspecified 151666410 CVCL_B6HA MRL28 stromal cell line house mouse CVCL_B6HA CL:0000010 Derived from site: In situ; Thymus; UBERON=UBERON_0002370; Cell type: Stromal cell of thymus; CL=CL_4030001; Breed/subspecies: MRL/Mp-lpr/lpr. Unspecified 151666411 CVCL_B6HD KKE transformed cell line house mouse CVCL_B6HD CL:0000010 Transformant: NCBI_TaxID; 11841; Gross passage A murine leukemia virus (Gross-MuLV); Cell type: T-cell; CL=CL_0000084; Breed/subspecies: BALB/c H-2k. Unspecified 151666412 CVCL_B6HC N3 transformed cell line house mouse CVCL_B6HC CL:0000010 Transformant: Recombinant retrovirus 3RV/VN-11; Derived from site: In situ; Embryonic brain; UBERON=UBERON_0006238; Cell type: Microglial cell; CL=CL_0000129; Breed/subspecies: CD-1. Unspecified 151666413 CVCL_B6HF NH50322 induced pluripotent stem cell human CVCL_B6HF CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666414 CVCL_B6HE NRBB transformed cell line house mouse CVCL_B6HE CL:0000010 Transformant: NCBI_TaxID; 11841; Gross passage A murine leukemia virus (Gross-MuLV); Cell type: T-cell; CL=CL_0000084; Breed/subspecies: BALB/c H-2b. Unspecified 151666415 CVCL_B6HH NH50324 induced pluripotent stem cell human CVCL_B6HH CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666416 CVCL_B6HG NH50323 induced pluripotent stem cell human CVCL_B6HG CL:0000010 Population: African American; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666417 CVCL_B6GY ROSE 199 spontaneously immortalized cell line Norway rat CVCL_B6GY CL:0000010 Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304; Cell type: Epithelial cell of ovary; CL=CL_2000064; Breed/subspecies: Fischer 344; RS=RS_0000215. Female 151666418 CVCL_B6GX A13/BACii transformed cell line CVCL_B6GX CL:0000010 Transformant: ChEBI; CHEBI_29865; Benzo[a]pyrene; Derived from site: In situ; Joint articular cartilage; UBERON=UBERON_0010996; Cell type: Chondrocyte; CL=CL_0000138. Female 151666419 CVCL_B6H9 MRL104 stromal cell line house mouse CVCL_B6H9 CL:0000010 Derived from site: In situ; Thymus; UBERON=UBERON_0002370; Cell type: Stromal cell of thymus; CL=CL_4030001; Breed/subspecies: MRL/Mp-lpr/lpr. Unspecified 151666420 CVCL_B6GZ ROSE 239 spontaneously immortalized cell line Norway rat CVCL_B6GZ CL:0000010 Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304; Cell type: Epithelial cell of ovary; CL=CL_2000064; Breed/subspecies: Fischer 344; RS=RS_0000215. Female 151666421 CVCL_B6GQ 5A8 [Mouse hybridoma against glycyrrhizin] hybridoma house mouse CVCL_B6GQ CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: ChEBI; CHEBI_15939; Glycyrrhizin (Uralsaponin A). 151666422 CVCL_B6H2 mPAC-4.1 transformed cell line house mouse CVCL_B6H2 CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT) Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV); Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Breed/subspecies: C3H. Unspecified 151666423 CVCL_B6GP 5A5 [Mouse hybridoma against glycyrrhizin] hybridoma house mouse CVCL_B6GP CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: ChEBI; CHEBI_15939; Glycyrrhizin (Uralsaponin A); Monoclonal antibody target: ChEBI; CHEBI_189708; Glycyrrhetic acid 3-O-glucuronide. 151666424 CVCL_B6H1 mPAC-4 transformed cell line house mouse CVCL_B6H1 CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT) Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV); Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Breed/subspecies: C3H. Unspecified 151666425 CVCL_B6GS 2C4 [Mouse hybridoma against 2,4-D/2,4-DP] hybridoma house mouse CVCL_B6GS CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_16738; 2,4-dichlorophenol (2,4-DP); Monoclonal antibody target: ChEBI; CHEBI_28854; 2,4-dichlorophenoxyacetic acid (2,4-D). Group: Patented cell line 151666426 CVCL_B6H4 mPAC-4.1.1.1 transformed cell line house mouse CVCL_B6H4 CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT) Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV); Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Breed/subspecies: C3H. Unspecified 151666427 CVCL_B6GR 5B4 [Mouse hybridoma against glycyrrhizin] hybridoma house mouse CVCL_B6GR CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: ChEBI; CHEBI_15939; Glycyrrhizin (Uralsaponin A); Monoclonal antibody target: ChEBI; CHEBI_189708; Glycyrrhetic acid 3-O-glucuronide. 151666428 CVCL_B6H3 mPAC-4.1.1 transformed cell line house mouse CVCL_B6H3 CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT) Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV); Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Breed/subspecies: C3H. Unspecified 151666429 CVCL_B6GU HCS-TG cancer cell line human CVCL_B6GU CL:0000010 Population: Japanese; Derived from site: In situ; Bone, ilium; UBERON=UBERON_0001273. Male Characteristics: Established from a tumor obtained by subcutaneous injection of cancer cell in athymic ICR nu/nu mice (PubMed=15118855) 151666430 CVCL_B6H6 mPAC-4.1.2.1 transformed cell line house mouse CVCL_B6H6 CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT) Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV); Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Breed/subspecies: C3H. Unspecified 151666431 CVCL_B6GT DDCS2 cancer cell line human CVCL_B6GT CL:0000010 Derived from site: In situ; Right distal femur, cartilage; UBERON=UBERON_0010129. Male Doubling time: 60-72 hours (PubMed=34767468) 151666432 CVCL_B6H5 mPAC-4.1.2 transformed cell line house mouse CVCL_B6H5 CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT) Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV); Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Breed/subspecies: C3H. Unspecified 151666433 CVCL_B6GW HCS-TG E2 cancer cell line human CVCL_B6GW CL:0000010 Population: Japanese; Derived from site: In situ; Bone, ilium; UBERON=UBERON_0001273. Male Doubling time: 48 hours (Note=In 20% FBS) (PubMed=15118855) 151666434 CVCL_B6H8 mDCT15 transformed cell line house mouse CVCL_B6H8 CL:0000010 Transformant: Ad12-SV40 hybrid virus; Derived from site: In situ; Kidney, distal convoluted tubule; UBERON=UBERON_0001292; Cell type: Epithelial cell; CL=CL_0000066. Unspecified 151666435 CVCL_B6GV HCS-TG C3 cancer cell line human CVCL_B6GV CL:0000010 Population: Japanese; Derived from site: In situ; Bone, ilium; UBERON=UBERON_0001273. Male Doubling time: 68 hours (Note=In 20% FBS) (PubMed=15118855) 151666436 CVCL_B6H7 mPAC-4.1.2.2 transformed cell line house mouse CVCL_B6H7 CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT) Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV); Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Breed/subspecies: C3H. Unspecified 151666437 CVCL_B6EG SV40RH1 transformed cell line Norway rat CVCL_B6EG CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Unspecified 151666438 CVCL_B6EF P9 transformed cell line Norway rat CVCL_B6EF CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=p6-1); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Unspecified 151666439 CVCL_B6EI NPC2-hTERT telomerase immortalized cell line human CVCL_B6EI CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatic stellate cell; CL=CL_0000632. Female 151666440 CVCL_B6EH Hc3716-hTERT telomerase immortalized cell line human CVCL_B6EH CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Unspecified Doubling time: ~2.5 days (PubMed=20456367) 151666441 CVCL_B6EK OUMS-29/TK transformed cell line human CVCL_B6EK CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Population: Japanese; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo); Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Male Characteristics: The introduction of HSV-1 TK gene makes the cell line 100x as sensitive to ganciclovir (GCV) compared with unmodified cells This suicide gene can be used as a safeguard in the use of this cell line in hybrid artificial liver (PubMed=11575821). 151666442 CVCL_B6EJ HepLL transformed cell line human CVCL_B6EJ CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Population: Chinese; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Male 151666443 CVCL_B6EM OUMS-29/H-14 transformed cell line human CVCL_B6EM CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5024; HNF4A (Note=Isoform Alpha-2); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo); Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Male 151666444 CVCL_B6EL OUMS-29/H-11 transformed cell line human CVCL_B6EL CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5024; HNF4A (Note=Isoform Alpha-2); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Population: Japanese; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo); Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Male 151666445 CVCL_B6EA AFP-27-NP hybridoma house mouse CVCL_B6EA CL:0000010 Characteristics: Non-producing clone; Monoclonal antibody isotype: IgG; Monoclonal antibody target: UniProtKB; P02771; Human AFP. 151666446 CVCL_B6EC C3-II-B-2-3 transformed cell line Norway rat CVCL_B6EC CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Unspecified 151666447 CVCL_B6EB TCL-598 cancer cell line human CVCL_B6EB CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518. Unspecified Characteristics: Produces and secretes pro-urokinase (DOI=10.1038/nbt0784-628) 151666448 CVCL_B6EE C8-IV transformed cell line Norway rat CVCL_B6EE CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVE); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Unspecified 151666449 CVCL_B6ED C4-1-B-2 transformed cell line Norway rat CVCL_B6ED CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=p6-1); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Unspecified 151666450 CVCL_B6E7 BRAD-5 transformed cell line human CVCL_B6E7 CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q02161; Human RHD 151666451 CVCL_B6DV HL3 transformed cell line CVCL_B6DV CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3796; FOS; Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gln61Leu) Transformant: FOS+HRAS; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Lymphocyte; CL=CL_0000542. Unspecified Group: Fish cell line 151666452 CVCL_B6E6 BRAD-3 transformed cell line human CVCL_B6E6 CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Monoclonal antibody isotype: IgG3, kappa; Monoclonal antibody target: UniProtKB; Q02161; Human RHD 151666453 CVCL_B6DU KB-26.5 hybridoma house mouse CVCL_B6DU CL:0000010 Monoclonal antibody isotype: IgG3, kappa; Monoclonal antibody target: ChEBI; CHEBI_62485; Blood group A antigen type 1 (Alpha-D-GalpNAc-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->3)-beta-D-GlcpNAc). 151666454 CVCL_B6E9 AFP-27 hybridoma house mouse CVCL_B6E9 From: Vessella, Robert Louis; Department of Urologic Surgery at the University of Minnesota; Minneapolis; USA CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: UniProtKB; P02771; Human AFP. 151666455 CVCL_B6DX HL8 transformed cell line CVCL_B6DX CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3796; FOS; Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gln61Leu) Transformant: FOS+HRAS; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Lymphocyte; CL=CL_0000542. Unspecified Group: Fish cell line 151666456 CVCL_B6E8 BTSN6 transformed cell line human CVCL_B6E8 CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Monoclonal antibody isotype: IgG1 151666457 CVCL_B6DW HL7 transformed cell line CVCL_B6DW CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3796; FOS; Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gln61Leu) Transformant: FOS+HRAS; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Lymphocyte; CL=CL_0000542. Unspecified Group: Fish cell line 151666458 CVCL_B6DZ PL51 transformed cell line CVCL_B6DZ CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3796; FOS; Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gln61Leu) Transformant: FOS+HRAS; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Lymphocyte; CL=CL_0000542. Unspecified Group: Fish cell line 151666459 CVCL_B6DY HL9 transformed cell line CVCL_B6DY CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3796; FOS; Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gln61Leu) Transformant: FOS+HRAS; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Lymphocyte; CL=CL_0000542. Unspecified Group: Fish cell line 151666460 CVCL_B6DN TMHepTG4912 10 cancer cell line house mouse CVCL_B6DN CL:0000010 Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Breed/subspecies: C57BL/6 x SJL transgenic TG4912. Characteristics: Established from a transgenic mice that contains a human SERPINA1 promoter driving the expression of SV40 T-antigen (PubMed=1369183) 151666461 CVCL_B6DM TMHepTG2984 2 cancer cell line house mouse CVCL_B6DM CL:0000010 Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:8941; SERPINA1; Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc Transformant: Myc; Derived from site: In situ; Liver; UBERON=UBERON_0002107; Breed/subspecies: C57BL/6 x SJL transgenic TG2984. Characteristics: Established from a transgenic mice that contains a human SERPINA1 promoter driving the expression of a mouse Myc as well as a second SERPINA1 promoter in front of a full copy of SERPINA1 (PubMed=1369183) 151666462 CVCL_B6E1 Caco-2-SF cancer cell line human CVCL_B6E1 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male Group: Serum/protein free medium cell line 151666463 CVCL_B6DP TMhep39 cancer cell line house mouse CVCL_B6DP CL:0000010 Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:3551; F9; Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:8941; SERPINA1; Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc Transformant: Myc; Derived from site: In situ; Liver; UBERON=UBERON_0002107; Breed/subspecies: C57BL/6 x SJL transgenic TG3960 x TG2984 x TG4912. Characteristics: Established from a triple transgenic mice that contains 1) a human SERPINA1 promoter driving the expression of a mouse Myc as well as a second SERPINA1 promoter in front of a full copy of SERPINA1, 2) a human SERPINA1 promoter driving the expression of SV40 T-antigen and 3) a human F9 promoter driving the expression of F9 (PubMed=1369183) 151666464 CVCL_B6E0 PAT-206 spontaneously immortalized cell line human CVCL_B6E0 CL:0000010 Karyotypic information: Has a modal chromosome number of 61 (PubMed=21559682); Donor information: Established from a patient with breast cancer metastasized to the peritoneal cavity; Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235. Female Doubling time: ~36 hours (PubMed=21559682; PubMed=22358691) 151666465 CVCL_B6DR HL-60 clone F8 cancer cell line human CVCL_B6DR CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_16134; Ammonia; Selected for resistance to: ChEBI; CHEBI_24996; Lactate; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666466 CVCL_B6E3 WTC-mEGFP-G3BP1-cl1 induced pluripotent stem cell human CVCL_B6E3 CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP) Population: Japanese; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Using CRISPR/Cas9 G3BP1 has been endogenously tagged in one allele at the N-terminus with mEGFP Part of: Allen Cell Collection 151666467 CVCL_B6E2 HD7/1A1.15.24 hybridoma human CVCL_B6E2 CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; Q02161; Human RHD. Doubling time: ~24 hours (PubMed=3101287) 151666468 CVCL_B6DQ TMhep48 cancer cell line house mouse CVCL_B6DQ CL:0000010 Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:3551; F9; Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:8941; SERPINA1; Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc Transformant: Myc; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Breed/subspecies: C57BL/6 x SJL transgenic TG3960 x TG2984 x TG4912. Characteristics: Established from a triple transgenic mice that contains 1) a human SERPINA1 promoter driving the expression of a mouse Myc as well as a second SERPINA1 promoter in front of a full copy of SERPINA1, 2) a human SERPINA1 promoter driving the expression of SV40 T-antigen and 3) a human F9 promoter driving the expression of F9 (PubMed=1369183) Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-989 151666469 CVCL_B6E5 BTSN5 transformed cell line human CVCL_B6E5 CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q02161; Human RHD 151666470 CVCL_B6DT H1R8 hybridoma house mouse CVCL_B6DT CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: ChEBI; CHEBI_62485; Blood group A antigen type 1 (Alpha-D-GalpNAc-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->3)-beta-D-GlcpNAc); Monoclonal antibody target: ChEBI; CHEBI_62486; Blood group A antigen type 2 (Alpha-D-GalpNAc-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->4)-beta-D-GlcpNAc). 151666471 CVCL_B6E4 BTSN4 transformed cell line human CVCL_B6E4 CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q02161; Human RHD 151666472 CVCL_B6DS HL-60 clone H6 cancer cell line human CVCL_B6DS CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_16134; Ammonia; Selected for resistance to: ChEBI; CHEBI_24996; Lactate; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666473 CVCL_B6FH Veggie-CHO transformed cell line CVCL_B6FH CL:0000010 Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line) Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Transformant: NCIt; C44386; Gamma radiation; Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Doubling time: 22.5 hours (PubMed=19003404) Group: Serum/protein free medium cell line 151666474 CVCL_B6FG F6D2 cancer cell line human CVCL_B6FG CL:0000010 Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Arg146Ter (c.436C>T); Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser576Ter (c.1727C>G); Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: African American; Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV); Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male Characteristics: The expression of the beta-galactosidase gene (lacZ) is under the control of a hypoxia-inducible EPO promoter (PubMed=22358881) Doubling time: 45 hours (PubMed=22358881) 151666475 CVCL_B6FJ MAb 12a hybridoma house mouse CVCL_B6FJ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: ChEBI; CHEBI_79068; Crocin. 151666476 CVCL_B6FI Veggie-CHO:FLT-3L spontaneously immortalized cell line CVCL_B6FI CL:0000010 Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3766; FLT3LG; Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Transformant: NCIt; C44386; Gamma radiation; Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Doubling time: 21.2 +- 2.9 hours (PubMed=19003404) Group: Serum/protein free medium cell line 151666477 CVCL_B6FL MAb 11h hybridoma house mouse CVCL_B6FL CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: ChEBI; CHEBI_79068; Crocin. 151666478 CVCL_B6FK MAb 1d hybridoma house mouse CVCL_B6FK CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: ChEBI; CHEBI_79068; Crocin. 151666479 CVCL_B6FN SMG-F3 hybridoma house mouse CVCL_B6FN CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: ChEBI; CHEBI_9185; Solamargine. 151666480 CVCL_B6FM SMG-B3 hybridoma house mouse CVCL_B6FM CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: ChEBI; CHEBI_9185; Solamargine. 151666481 CVCL_B6FB WB6 conditionally immortalized cell line Norway rat CVCL_B6FB CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182; Breed/subspecies: Wistar; RS=RS_0000955. Unspecified Characteristics: Proliferates at the permissive temperature (33 Celsius) Rapid decrease in cell proliferation at the restrictive temperature (39 Celsius) (PubMed=10762059). Doubling time: 28.7 hours (Note=At 15th passage), 23.5 hours (Note=At 50th passage) (PubMed=10762059) 151666482 CVCL_B6FA WA1 conditionally immortalized cell line Norway rat CVCL_B6FA CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182; Breed/subspecies: Wistar; RS=RS_0000955. Unspecified Characteristics: Proliferates at the permissive temperature (33 Celsius) Rapid decrease in cell proliferation at the restrictive temperature (39 Celsius) (PubMed=10762059). Doubling time: 42.2 hours (Note=At 15th passage), 30.8 hours (Note=At 50th passage) (PubMed=10762059) 151666483 CVCL_B6FD RFM spontaneously immortalized cell line CVCL_B6FD CL:0000010 Derived from site: In situ; Head kidney; UBERON=UBERON_0007132; Cell type: Macrophage; CL=CL_0000235. Unspecified Group: Fish cell line 151666484 CVCL_B6FC HepZ transformed cell line human CVCL_B6FC CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1582; CCND1; Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3113; E2F1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Unspecified Characteristics: Transfected with albumin-promoter regulated antisense constructs against RB1 and TP53 Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2302 151666485 CVCL_B6FF ADG undefined cell line type CVCL_B6FF CL:0000010 Unspecified Problematic cell line: Misidentified/contaminated Originally thought to originate from an abalone but rather seem to either be from a protist or a fungi living in the digestive gland of the abalone (PubMed=22358657).. 151666486 CVCL_B6FE RFF spontaneously immortalized cell line CVCL_B6FE CL:0000010 Derived from site: In situ; Dorsal fin; UBERON=UBERON_0003097. Unspecified Group: Fish cell line 151666487 CVCL_B6F8 BQ1 conditionally immortalized cell line Norway rat CVCL_B6F8 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182; Breed/subspecies: Brown Norway; RS=RS_0000113. Unspecified Characteristics: Proliferates at the permissive temperature (33 Celsius) Rapid decrease in cell proliferation at the restrictive temperature (39 Celsius) (PubMed=10762059). Doubling time: 59.3 hours (Note=At 15th passage), 23.7 hours (Note=At 50th passage) (PubMed=10762059) 151666488 CVCL_B6EW RH 3 transformed cell line Norway rat CVCL_B6EW CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182; Breed/subspecies: Wistar; RS=RS_0000955. Male 151666489 CVCL_B6EV RH 2 transformed cell line Norway rat CVCL_B6EV CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182; Breed/subspecies: Wistar; RS=RS_0000955. Male 151666490 CVCL_B6F7 RH/Thy66A transformed cell line CVCL_B6F7 CL:0000010 Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Thymus; UBERON=UBERON_0002370; Cell type: Thymocyte; CL=CL_0000893; Breed/subspecies: New Zealand white; VBO=VBO_0001267. Unspecified 151666491 CVCL_B6EY RH 6 transformed cell line Norway rat CVCL_B6EY CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182; Breed/subspecies: Wistar; RS=RS_0000955. Male 151666492 CVCL_B6F9 BV1 conditionally immortalized cell line Norway rat CVCL_B6F9 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182; Breed/subspecies: Brown Norway; RS=RS_0000113. Male Characteristics: Proliferates at the permissive temperature (33 Celsius) Rapid decrease in cell proliferation at the restrictive temperature (39 Celsius) (PubMed=10762059). Doubling time: 33.4 hours (Note=At 15th passage), 17.8 hours (Note=At 50th passage) (PubMed=10762059) 151666493 CVCL_B6EX RH 4 transformed cell line Norway rat CVCL_B6EX CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182; Breed/subspecies: Wistar; RS=RS_0000955. Male 151666494 CVCL_B6EZ RH 7 transformed cell line Norway rat CVCL_B6EZ CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182; Breed/subspecies: Wistar; RS=RS_0000955. Male 151666495 CVCL_B6F0 RH 8 transformed cell line Norway rat CVCL_B6F0 CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182; Breed/subspecies: Wistar; RS=RS_0000955. Male 151666496 CVCL_B6EN TTNT-16 telomerase immortalized cell line human CVCL_B6EN CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Unspecified Characteristics: Because it has been transduced by a construct containing LoxP sites, transfection with the Cre recombinase eliminates the SV40 T gene thus reverting the cells to a non-immortal phenotype; Characteristics: Transduced with a retroviral vector SSR#197 (MoMLV/LTR-LoxP-hTERT-IRES-EGFP-LoxP-MoMLV/LTR) expressing hTERT and eGFP flanked by a pair of loxP sites 151666497 CVCL_B6F2 AdPX3 transformed cell line Norway rat CVCL_B6F2 CL:0000010 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182; Breed/subspecies: Fischer 344; RS=RS_0000215. Male 151666498 CVCL_B6EQ TTNT-16-3 telomerase immortalized cell line human CVCL_B6EQ CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P06956; Escherichia phage P1 cre; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Unspecified Characteristics: Reversibly immortalized; exposure to tamoxifen induces the expression of the Cre gene that effects Cre/LoxP recombination and excise the TERT gene; Characteristics: Transduced with a retroviral vector SSR#197 (MoMLV/LTR-LoxP-hTERT-IRES-EGFP-LoxP-MoMLV/LTR) expressing hTERT and eGFP flanked by a pair of loxP sites and a plasmid pCAGMerCreMer/Puro that expresses Cre fused to 2 mutant estrogen-receptor ligand-binding domains (MerCreMer) under the control of the CAG promoter Doubling time: ~48 hours (PubMed=17434229) 151666499 CVCL_B6F1 RH 9 transformed cell line Norway rat CVCL_B6F1 CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182; Breed/subspecies: Wistar; RS=RS_0000955. Male 151666500 CVCL_B6EP TPH1 transformed cell line human CVCL_B6EP CL:0000010 Transformant: NCBI_TaxID; 3052230; Hepatitis C virus; Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Unspecified 151666501 CVCL_B6F4 C8-B transformed cell line Norway rat CVCL_B6F4 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182; Breed/subspecies: Lewis; RS=RS_0000121. Male Characteristics: Transduced with the retroviral vector SSR#69 (MoMLV/LTR-LoxP-HygroR-HSV/TK-IRES-SV40T-LoxP-Neo-MoMLV/LTR) expressing HygroR, HSV-1 TK and SV40 T-antigen flanked by two loxP sites (PubMed=11097476); Characteristics: Because it has been transduced by a construct containing LoxP sites, transfection with the Cre recombinase eliminates the SV40 T gene thus reverting the cells to a non-immortal phenotype (PubMed=11097476) 151666502 CVCL_B6ES SVHep B4 transformed cell line Norway rat CVCL_B6ES CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=Strain LP); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182; Breed/subspecies: Wistar; RS=RS_0000955. Male 151666503 CVCL_B6F3 AdPX4 transformed cell line Norway rat CVCL_B6F3 CL:0000010 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182; Breed/subspecies: Fischer 344; RS=RS_0000215. Male 151666504 CVCL_B6ER YOCK-13 telomerase immortalized cell line human CVCL_B6ER CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6081; INS (Note=Engineered variant); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P06956; Escherichia phage P1 cre; Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR); Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Unspecified Characteristics: Expresses an insulin variant which is a single-chain modified insulin which is made of the signal sequence of albumin, the A chain followed by short turn-forming heptapeptide (GGGPGKR) and the B chain This construct does not require pancreas-specific enzymatic processing (PubMed=14693704).; Characteristics: Reversibly immortalized; exposure to tamoxifen induces the expression of the Cre gene that effects Cre/LoxP recombination and excise the TERT gene; Characteristics: Transduced with three constructs: 1) a retroviral vector SSR#197 (MoMLV/LTR-LoxP-hTERT-IRES-EGFP-LoxP-MoMLV/LTR) expressing hTERT and eGFP flanked by a pair of loxP sites, 2) a plasmid pCAGMerCreMer/Puro that expresses Cre fused to 2 mutant estrogen-receptor ligand-binding domains (MerCreMer) under the control of the CAG promoter and 3) a plasmid vector expressing modified insulin and zeocin resistance genes under the control of the rat L-PK promoter 151666505 CVCL_B6EU RH 10 transformed cell line Norway rat CVCL_B6EU CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182; Breed/subspecies: Wistar; RS=RS_0000955. Male 151666506 CVCL_B6F6 RH/Thy2 transformed cell line CVCL_B6F6 CL:0000010 Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Thymus; UBERON=UBERON_0002370; Cell type: Thymocyte; CL=CL_0000893; Breed/subspecies: New Zealand white; VBO=VBO_0001267. Unspecified 151666507 CVCL_B6F5 C8-B/Ras transformed cell line Norway rat CVCL_B6F5 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182; Breed/subspecies: Lewis; RS=RS_0000121. Male Characteristics: Tumorigenic; Characteristics: Transduced with the retroviral vector SSR#69 (MoMLV/LTR-LoxP-HygroR-HSV/TK-IRES-SV40T-LoxP-Neo-MoMLV/LTR) expressing HygroR, HSV-1 TK and SV40 T-antigen flanked by two loxP sites (from parent cell line C8-B); Characteristics: Because it has been transduced by a construct containing LoxP sites, transfection with the Cre recombinase eliminates the SV40 T gene thus reverting the cells to a non-immortal phenotype (from parent cell line C8-B) 151666508 CVCL_B6ET RH 1 transformed cell line Norway rat CVCL_B6ET CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182; Breed/subspecies: Wistar; RS=RS_0000955. Male 151666509 CVCL_B6T6 Ab7 [Mouse hybridoma against F.tularensis O-antigen] hybridoma house mouse CVCL_B6T6 CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Francisella tularensis subsp tularensis (strain SCHU S4 / Schu 4) lipopolysaccharide O-antigen.. 151666510 CVCL_B6SU TrJ5 hybridoma CVCL_B6SU CL:0000010 Monoclonal antibody isotype: IgM, lambda; Monoclonal antibody target: UniProtKB; P01889; Human HLA-B (Note=Recognizes alleles B*12=B*38/B*39). 151666511 CVCL_B6T5 Ab6 [Mouse hybridoma against F.tularensis O-antigen] hybridoma house mouse CVCL_B6T5 CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Francisella tularensis subsp tularensis (strain SCHU S4 / Schu 4) lipopolysaccharide O-antigen.. 151666512 CVCL_B6ST UL/F11 hybridoma CVCL_B6ST CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; P26663; Hepatitis C virus genotype 1b (isolate BK) genome polyprotein (Note=AA 1-150 = Core protein p21). 151666513 CVCL_B6T8 Ab9 [Mouse hybridoma against F.tularensis O-antigen] hybridoma house mouse CVCL_B6T8 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Francisella tularensis subsp tularensis (strain SCHU S4 / Schu 4) lipopolysaccharide O-antigen.. 151666514 CVCL_B6SW TrJ3 hybridoma CVCL_B6SW CL:0000010 Monoclonal antibody isotype: IgM, lambda; Monoclonal antibody target: UniProtKB; P01889; Human HLA-B (Note=Recognizes alleles B*12=B*44/B*45). 151666515 CVCL_B6T7 Ab8 [Mouse hybridoma against F.tularensis O-antigen] hybridoma house mouse CVCL_B6T7 CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Francisella tularensis subsp tularensis (strain SCHU S4 / Schu 4) lipopolysaccharide O-antigen.. 151666516 CVCL_B6SV UL/F14 hybridoma CVCL_B6SV CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P01889; Human HLA-B (Note=Recognizes alleles B*12=B*44/B*45). 151666517 CVCL_B6SY TrB12 hybridoma human CVCL_B6SY CL:0000010 Monoclonal antibody isotype: IgG, kappa; Monoclonal antibody target: UniProtKB; P01909; Human HLA-DQA1; Monoclonal antibody target: UniProtKB; P01920; Human HLA-DQB1. 151666518 CVCL_B6T9 Ab10 [Mouse hybridoma against F.tularensis O-antigen] hybridoma house mouse CVCL_B6T9 CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q5NID3; Francisella tularensis subsp tularensis (strain SCHU S4 / Schu 4) rplL.. 151666519 CVCL_B6SX TrD3 hybridoma human CVCL_B6SX CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P01889; Human HLA-B (Note=Recognizes HLA-Bw6 epitope). 151666520 CVCL_B6SZ TrJ1 hybridoma CVCL_B6SZ CL:0000010 Monoclonal antibody isotype: IgM, lambda; Monoclonal antibody target: UniProtKB; P01909; Human HLA-DQA1 (Note=Recognizes allele DQA1*05); Monoclonal antibody target: UniProtKB; P01920; Human HLA-DQB1 (Note=Recognizes allele DQB1*02). 151666521 CVCL_B6SM BS 45 hybridoma house mouse CVCL_B6SM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P23276; Human KEL/CD238. Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-268 151666522 CVCL_B6SL BS 50 hybridoma house mouse CVCL_B6SL CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P60568; Human IL2 (Note=Also regognizes IgG lambda). Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-313 151666523 CVCL_B6T0 TU165 hybridoma house mouse CVCL_B6T0 CL:0000010 Characteristics: Produces a mAb that acts in a T-cell receptor-like manner (PubMed=8449221); Characteristics: The produced mAb recognizes the nonapeptide LPPHDITPY from EBV EBNA6/EBNA3C when bound to HLAB*35:01 (PubMed=9878435); Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; P01889; Human HLA-B (Note=Recognizes allele B*35:01); Monoclonal antibody target: UniProtKB; P03204; Epstein-Barr virus (strain B95-8) nuclear antigen 6 (Note=Recognizes AA 98-106) Caution: TU165 has a U umlaut and should thus be transcribed as TUE165, but the umlaut is most often ommitted in online resources. 151666524 CVCL_B6SN BRIC 107 hybridoma house mouse CVCL_B6SN CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P23276; Human KEL/CD238. 151666525 CVCL_B6T2 Ab3 [Mouse hybridoma against F.tularensis O-antigen] hybridoma house mouse CVCL_B6T2 CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Francisella tularensis subsp tularensis (strain SCHU S4 / Schu 4) lipopolysaccharide O-antigen.. 151666526 CVCL_B6SQ BRIC 203 hybridoma house mouse CVCL_B6SQ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P23276; Human KEL/CD238. 151666527 CVCL_B6T1 Ab2 [Mouse hybridoma against F.tularensis O-antigen] hybridoma house mouse CVCL_B6T1 CL:0000010 Monoclonal antibody isotype: IgG3, kappa; Monoclonal antibody target: Francisella tularensis subsp tularensis (strain SCHU S4 / Schu 4) lipopolysaccharide O-antigen.. 151666528 CVCL_B6SP BRIC 18 hybridoma house mouse CVCL_B6SP CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P23276; Human KEL/CD238. 151666529 CVCL_B6T4 Ab5 [Mouse hybridoma against F.tularensis O-antigen] hybridoma house mouse CVCL_B6T4 CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Francisella tularensis subsp tularensis (strain SCHU S4 / Schu 4) lipopolysaccharide O-antigen.. 151666530 CVCL_B6SS UL/F10 hybridoma CVCL_B6SS CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P26663; Hepatitis C virus genotype 1b (isolate BK) genome polyprotein (Note=AA 1-150 = Core protein p21) 151666531 CVCL_B6T3 Ab4 [Mouse hybridoma against F.tularensis O-antigen] hybridoma house mouse CVCL_B6T3 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Francisella tularensis subsp tularensis (strain SCHU S4 / Schu 4) lipopolysaccharide O-antigen.. 151666532 CVCL_B6SR BRIC 68 hybridoma house mouse CVCL_B6SR CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P23276; Human KEL/CD238. 151666533 CVCL_B6SE HEK293 GFP-DUSP12 transformed cell line human CVCL_B6SE CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3067; DUSP12; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Stably overexpress a eGFP-DUSP12 fusion protein (PubMed=21556130) 151666534 CVCL_B6SD FC-2.15 hybridoma house mouse CVCL_B6SD CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: ChEBI; CHEBI_61711; Alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc (Sialyl Lewis X; CD15; SSEA-1). 151666535 CVCL_B6SG IST-1 [Mouse hybridoma against human FN] hybridoma house mouse CVCL_B6SG CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P02751; Human FN1. 151666536 CVCL_B6SF HEK293 CHI3L1 transformed cell line human CVCL_B6SF CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1932; CHI3L1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151666537 CVCL_B6SI IST-3 hybridoma house mouse CVCL_B6SI CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P02751; Human FN1. 151666538 CVCL_B6SH IST-2 hybridoma house mouse CVCL_B6SH CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P02751; Human FN1. 151666539 CVCL_B6SK IST-9 hybridoma house mouse CVCL_B6SK CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P02751; Human FN1 (Note=Recognizes the ED-A domain Also reacts with dog, mouse, pig and rat).. 151666540 CVCL_B6SJ IST-4 hybridoma house mouse CVCL_B6SJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P02751; Human FN1 (Note=Recognizes the 5th FNIII domain). 151666541 CVCL_B6SA ME510 hybridoma house mouse CVCL_B6SA CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human unknown antigen. 151666542 CVCL_B6SC FKH1 hybridoma house mouse CVCL_B6SC CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: Human melanoma 50/70 kDa antigen. 151666543 CVCL_B6SB ME515 hybridoma house mouse CVCL_B6SB CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Not specified ganglioside. 151666544 CVCL_B6TV NWR 5764 iPSC-c503 induced pluripotent stem cell CVCL_B6TV CL:0000010 Donor information: Established from a rhinoceros named Nadi that lived in San Diego Zoo Safari Park and died in 2007; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Group: Endangered species/breed cell line 151666545 CVCL_B6U7 UL-101/68 hybridoma house mouse CVCL_B6U7 CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P04439; Human HLA-A (Note=Recognizes allele A*03). 151666546 CVCL_B6TU NWR 5765 iPSC-c509 induced pluripotent stem cell CVCL_B6TU CL:0000010 Donor information: Established from a rhinoceros named Suni that lived in Dvur Kralove zoo and died in 2014; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Group: Endangered species/breed cell line 151666547 CVCL_B6U6 TU110 hybridoma house mouse CVCL_B6U6 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P01889; Human HLA-B (Note=Recognizes allele B*13) Caution: TU110 has a U umlaut and should thus be transcribed as TUE110, but the umlaut is most often ommitted in online resources. 151666548 CVCL_B6TX NWR 6571 iPSC-c505 induced pluripotent stem cell CVCL_B6TX CL:0000010 Donor information: Established from a rhinoceros named Dinka that lived in San Diego Zoo Safari Park and died in 1991; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Group: Endangered species/breed cell line 151666549 CVCL_B6U9 UL-39/24 hybridoma house mouse CVCL_B6U9 CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P04439; Human HLA-A (Note=Recognizes alleles A*02/A*69). 151666550 CVCL_B6TW NWR 6571 iPSC-c502 induced pluripotent stem cell CVCL_B6TW CL:0000010 Donor information: Established from a rhinoceros named Dinka that lived in San Diego Zoo Safari Park and died in 1991; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Group: Endangered species/breed cell line 151666551 CVCL_B6U8 UL-39/10 hybridoma house mouse CVCL_B6U8 CL:0000010 Monoclonal antibody isotype: IgG3; Monoclonal antibody target: UniProtKB; P01889; Human HLA-B (Note=Recognizes allele B*13). 151666552 CVCL_B6TZ NWR 8174 iPSC-c501 induced pluripotent stem cell CVCL_B6TZ CL:0000010 Donor information: Established from a rhinoceros named Nasima that lived in Dvur Kralove zoo and died in 1992; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Group: Endangered species/breed cell line 151666553 CVCL_B6TY NWR 8173 iPSC-c505 induced pluripotent stem cell CVCL_B6TY CL:0000010 Donor information: Established from Najin, one the last two Northern white rhinoceros still alive; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Group: Endangered species/breed cell line 151666554 CVCL_B6TN 5D6 [Mouse hybridoma against influenza D HE] hybridoma house mouse CVCL_B6TN CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; A0A140AT86; Influenza D virus (D/swine/Italy/199724-3/2015) hemagglutinin-esterase-fusion protein (HE). 151666555 CVCL_B6TM 5D4 hybridoma house mouse CVCL_B6TM CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; A0A140AT86; Influenza D virus (D/swine/Italy/199724-3/2015) hemagglutinin-esterase-fusion protein (HE). 151666556 CVCL_B6TP 1E1 [Mouse hybridoma against influenza D HE] hybridoma house mouse CVCL_B6TP CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; A0A140AT86; Influenza D virus (D/swine/Italy/199724-3/2015) hemagglutinin-esterase-fusion protein (HE). 151666557 CVCL_B6U1 SWR 21328 iPSC-c560 induced pluripotent stem cell CVCL_B6U1 CL:0000010 Donor information: Established from a rhinoceros named Amani that lives in San Diego Zoo Safari Park; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Group: Endangered species/breed cell line 151666558 CVCL_B6U0 NWR 9939 iPSC-c5101 induced pluripotent stem cell CVCL_B6U0 CL:0000010 Donor information: Established from a rhinoceros named Saut that lived in San Diego Zoo Safari Park and died in 1997; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Group: Endangered species/breed cell line 151666559 CVCL_B6TR 1E2 [Mouse hybridoma against influenza D HE CRISPR/Cas9 edited] hybridoma house mouse CVCL_B6TR CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q08101; Bovine herpesvirus 1 envelope glycoprotein E (gE). Characteristics: Using CRISPR/Cas9 a bovine herpesvirus type 1 glycoprotein E (BoHV1gE)-GFP fusion was inserted in the C region of the Ig light chain V12.41/J4/C (PubMed=34171554); Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; A0A140AT86; Influenza D virus (D/swine/Italy/199724-3/2015) hemagglutinin-esterase-fusion protein (HE) 151666560 CVCL_B6U3 SWR 21409 iPSC-c550 induced pluripotent stem cell CVCL_B6U3 CL:0000010 Donor information: Established from a rhinoceros named Wallis that lives in San Diego Zoo Safari Park; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Group: Endangered species/breed cell line 151666561 CVCL_B6TQ 1D11 hybridoma house mouse CVCL_B6TQ CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP). Characteristics: Using CRISPR/Cas9 GFP was inserted in the C region of the Ig light chain V12.41/J4/C (PubMed=34171554); Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; A0A140AT86; Influenza D virus (D/swine/Italy/199724-3/2015) hemagglutinin-esterase-fusion protein (HE) 151666562 CVCL_B6U2 SWR 21409 iPSC-c5156 induced pluripotent stem cell CVCL_B6U2 CL:0000010 Donor information: Established from a rhinoceros named Wallis that lives in San Diego Zoo Safari Park; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Group: Endangered species/breed cell line 151666563 CVCL_B6TT NWR 5765 iPSC-c508 induced pluripotent stem cell CVCL_B6TT CL:0000010 Donor information: Established from a rhinoceros named Suni that lived in Dvur Kralove zoo and died in 2014; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Group: Endangered species/breed cell line 151666564 CVCL_B6U5 TU101 hybridoma house mouse CVCL_B6U5 CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P04439; Human HLA-A (Note=Recognizes alleles A*02/A*28) Caution: TU101 has a U umlaut and should thus be transcribed as TUE101, but the umlaut is most often ommitted in online resources. 151666565 CVCL_B6TS NWR 5765 iPSC-c507 induced pluripotent stem cell CVCL_B6TS CL:0000010 Donor information: Established from a rhinoceros named Suni that lived in Dvur Kralove zoo and died in 2014; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Group: Endangered species/breed cell line 151666566 CVCL_B6U4 NWR 9947 iPSC-c5101 induced pluripotent stem cell CVCL_B6U4 CL:0000010 Donor information: Established from a rhinoceros named Angalifu that lived in San Diego Zoo Safari Park and died in 2014; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Group: Endangered species/breed cell line 151666567 CVCL_B6TF 1D4 [Mouse hybridoma against influenza D HE] hybridoma house mouse CVCL_B6TF CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; A0A140AT86; Influenza D virus (D/swine/Italy/199724-3/2015) hemagglutinin-esterase-fusion protein (HE). 151666568 CVCL_B6TE Ab31 hybridoma house mouse CVCL_B6TE CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q5NFG7; Francisella tularensis subsp tularensis (strain SCHU S4 / Schu 4) dnaK.. 151666569 CVCL_B6TH 2E12 [Mouse hybridoma against influenza D HE] hybridoma house mouse CVCL_B6TH CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; A0A140AT86; Influenza D virus (D/swine/Italy/199724-3/2015) hemagglutinin-esterase-fusion protein (HE). 151666570 CVCL_B6TG 2E11 [Mouse hybridoma against influenza D HE] hybridoma house mouse CVCL_B6TG CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; A0A140AT86; Influenza D virus (D/swine/Italy/199724-3/2015) hemagglutinin-esterase-fusion protein (HE). 151666571 CVCL_B6TJ 2E9 [Mouse hybridoma against influenza D HE] hybridoma house mouse CVCL_B6TJ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; A0A140AT86; Influenza D virus (D/swine/Italy/199724-3/2015) hemagglutinin-esterase-fusion protein (HE). 151666572 CVCL_B6TI 2E3 [Mouse hybridoma against influenza D HE] hybridoma house mouse CVCL_B6TI CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; A0A140AT86; Influenza D virus (D/swine/Italy/199724-3/2015) hemagglutinin-esterase-fusion protein (HE). 151666573 CVCL_B6TL 4G4 [Mouse hybridoma against influenza D HE] hybridoma house mouse CVCL_B6TL CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; A0A140AT86; Influenza D virus (D/swine/Italy/199724-3/2015) hemagglutinin-esterase-fusion protein (HE). 151666574 CVCL_B6TK 3G3 [Mouse hybridoma against influenza D HE] hybridoma house mouse CVCL_B6TK CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; A0A140AT86; Influenza D virus (D/swine/Italy/199724-3/2015) hemagglutinin-esterase-fusion protein (HE). 151666575 CVCL_B6TB Ab12 [Mouse hybridoma against F.tularensis O-antigen] hybridoma house mouse CVCL_B6TB CL:0000010 Monoclonal antibody isotype: IgG3, kappa; Monoclonal antibody target: UniProtKB; Q5NEE1; Francisella tularensis subsp tularensis (strain SCHU S4 / Schu 4) groEL.. 151666576 CVCL_B6TA Ab11 [Mouse hybridoma against F.tularensis O-antigen] hybridoma house mouse CVCL_B6TA CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; Q5NE75; Francisella tularensis subsp tularensis (strain SCHU S4 / Schu 4) membrane protein FTT_1778c.. 151666577 CVCL_B6TD Ab17 hybridoma house mouse CVCL_B6TD CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; Q5NI56; Francisella tularensis subsp tularensis (strain SCHU S4 / Schu 4) yidC.. 151666578 CVCL_B6TC Ab13 [Mouse hybridoma against F.tularensis O-antigen] hybridoma house mouse CVCL_B6TC CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q5NFG7; Francisella tularensis subsp tularensis (strain SCHU S4 / Schu 4) dnaK.. 151666579 CVCL_B6R4 Akata deltaLMP2A cancer cell line human CVCL_B6R4 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Cell type: B-cell; CL=CL_0000236. Female Virology: EBV-negative cell line re-infected with recombinant EBV whose genome is KO for LMP2A 151666580 CVCL_B6QS Lico D-23 spontaneously immortalized cell line human CVCL_B6QS CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Mixed Characteristics: Mixture of 23 cell lines Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8492 151666581 CVCL_B6QR 691-I-5Nu4B hybridoma house mouse CVCL_B6QR CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: Human melanoma cell surface antigen. 151666582 CVCL_B6R3 Akata delta1 EBER2(+) cancer cell line human CVCL_B6R3 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Cell type: B-cell; CL=CL_0000236. Female Virology: EBV-negative cell line re-infected with recombinant EBV whose genome is KO for EBER1 and EBER2 and which was knocked-in for EBER2 only 151666583 CVCL_B6R6 Akata ZKO cancer cell line human CVCL_B6R6 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Cell type: B-cell; CL=CL_0000236. Female Virology: EBV-negative cell line re-infected with recombinant EBV whose genome is KO for BZLF1 151666584 CVCL_B6QU HNSC.100 transformed cell line human CVCL_B6QU CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: v-Myc; Derived from site: In situ; Fetal brain, diencephalon; UBERON=UBERON_0006222; Derived from site: In situ; Fetal brain, telencephalon; UBERON=UBERON_0014371; Cell type: Neural stem cell; CL=CL_0000047. Unspecified Doubling time: 1.7 +- 0.08 days (PubMed=10683274) 151666585 CVCL_B6QT IhNSCs transformed cell line human CVCL_B6QT CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Transformant: v-Myc; Derived from site: In situ; Fetal brain, diencephalon; UBERON=UBERON_0006222; Derived from site: In situ; Fetal brain, telencephalon; UBERON=UBERON_0014371; Cell type: Neural stem cell; CL=CL_0000047. Male Doubling time: 2-3 days (PubMed=17556596) 151666586 CVCL_B6R5 Yub2564c somatic stem cell human CVCL_B6R5 CL:0000010 Derived from site: In situ; Foot, toe, cartilage; UBERON=UBERON_0010685. Female 151666587 CVCL_B6QW 1R [Rat embryo fibroblast] transformed cell line Norway rat CVCL_B6QW CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified 151666588 CVCL_B6R8 U-CH17PII cancer cell line human CVCL_B6R8 CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous or homozygous (from autologous cell lines U-CH17M; U-CH17P; U-CH17S) Derived from site: In situ; Bone, sacrum; UBERON=UBERON_0003690. Male Doubling time: 3-4 days (Chordoma Foundation) 151666589 CVCL_B6QV 5R transformed cell line Norway rat CVCL_B6QV CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified 151666590 CVCL_B6R7 Akata deltagp85 cancer cell line human CVCL_B6R7 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leufs*57 (c.569delC); ClinVar=VCV000825904; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Japanese; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Cell type: B-cell; CL=CL_0000236. Female Virology: EBV-negative cell line re-infected with recombinant EBV whose genome is KO for BXLF2/gp85 151666591 CVCL_B6QY RE 2 transformed cell line Norway rat CVCL_B6QY CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03254; Human adenovirus C serotype 2 E1A protein; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 10515; Human adenovirus C serotype 2; Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified 151666592 CVCL_B6QX 2R transformed cell line Norway rat CVCL_B6QX CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified 151666593 CVCL_B6R9 U3-DT transformed cell line human CVCL_B6R9 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Japanese and Korean; Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540. Omics: Transcriptomics; Microarray Female Senescence: Long term culture of parent cell line (maximum PDL is 252) (PubMed=25978455); Doubling time: 22 hours (PubMed=25978455) 151666594 CVCL_B6QK 691-6-5 hybridoma house mouse CVCL_B6QK CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human melanoma cell surface antigen. 151666595 CVCL_B6QJ 691-6 hybridoma house mouse CVCL_B6QJ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human melanoma cell surface antigen. 151666596 CVCL_B6QM T21M transformed cell line Norway rat CVCL_B6QM CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03355; Moloney murine leukemia virus (MoMLV) gag-pol Derived from site: In situ; Thymus; UBERON=UBERON_0002370; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: Osborne-Mendel; RS=RS_0000629. Unspecified 151666597 CVCL_B6QL SK 37-7 hybridoma house mouse CVCL_B6QL CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: Human HLA-DR + HLA-DQ. 151666598 CVCL_B6R0 dl-884-3Y1-KO2 transformed cell line Norway rat CVCL_B6R0 CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=dl-884); Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: Fischer 344; RS=RS_0000215. Female 151666599 CVCL_B6QN T24M [Rat thymus] transformed cell line Norway rat CVCL_B6QN CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03355; Moloney murine leukemia virus (MoMLV) gag-pol Derived from site: In situ; Thymus; UBERON=UBERON_0002370; Breed/subspecies: Osborne-Mendel; RS=RS_0000629. Unspecified 151666600 CVCL_B6QQ 691-6-37 hybridoma house mouse CVCL_B6QQ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human melanoma cell surface antigen. 151666601 CVCL_B6R2 Yub2564a somatic stem cell human CVCL_B6R2 CL:0000010 Derived from site: In situ; Foot, adipose tissue; UBERON=UBERON_0002387+UBERON_0001013. Female 151666602 CVCL_B6QP 691-6-11 hybridoma house mouse CVCL_B6QP CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human melanoma cell surface antigen. 151666603 CVCL_B6R1 GM1 [Human GM1 gangliosidosis] finite cell line human CVCL_B6R1 CL:0000010 Population: Japanese; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Discontinued: JCRB; KURB1986; probable Male 151666604 CVCL_B6QC 691-19-19 hybridoma house mouse CVCL_B6QC CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human melanoma cell surface antigen. 151666605 CVCL_B6QB 691-19 hybridoma house mouse CVCL_B6QB CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human melanoma cell surface antigen. 151666606 CVCL_B6QE 691-2-4 hybridoma house mouse CVCL_B6QE CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human melanoma cell surface antigen. 151666607 CVCL_B6QD 691-2 hybridoma house mouse CVCL_B6QD CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human melanoma cell surface antigen. 151666608 CVCL_B6QG 691-4-144 hybridoma house mouse CVCL_B6QG CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human melanoma cell surface antigen. 151666609 CVCL_B6QF 691-4 hybridoma house mouse CVCL_B6QF CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human melanoma cell surface antigen. 151666610 CVCL_B6QI 691-4-27 hybridoma house mouse CVCL_B6QI CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human melanoma cell surface antigen. 151666611 CVCL_B6QH 691-4-155 hybridoma house mouse CVCL_B6QH CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human melanoma cell surface antigen. 151666612 CVCL_B6PZ TJU-UM001-tdTomato cancer cell line human CVCL_B6PZ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Gln209Pro (c.626A>C); ClinVar=VCV000375957; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)) Derived from site: Metastatic; Liver; UBERON=UBERON_0002107. Unspecified Doubling time: ~72 hours (PubMed=26613897) 151666613 CVCL_B6PY TJU-UM004 cancer cell line human CVCL_B6PY CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Gln209Pro (c.626A>C); ClinVar=VCV000375957; Zygosity=Homozygous (PubMed=25952648) Derived from site: Metastatic; Eye socket; UBERON=UBERON_0001697. Unspecified 151666614 CVCL_B6QA 691-13-17 hybridoma house mouse CVCL_B6QA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P01911; Human HLA-DRB1. 151666615 CVCL_B6RT DMBi004-A induced pluripotent stem cell human CVCL_B6RT From: Department of Medical Biotechnology, Jagiellonian University; Krakow; Poland CL:0000010 Population: Caucasian; Derived from site: In situ; Synovium; UBERON=UBERON_0007616; Cell type: Fibroblast; CL=CL_0000057. Female 151666616 CVCL_B6S5 ME416 hybridoma house mouse CVCL_B6S5 CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Not specified ganglioside. 151666617 CVCL_B6RS DMBi003-A induced pluripotent stem cell human CVCL_B6RS From: Department of Medical Biotechnology, Jagiellonian University; Krakow; Poland CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666618 CVCL_B6S4 ME325 hybridoma house mouse CVCL_B6S4 CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human unknown antigen. 151666619 CVCL_B6RV FC-5.01 hybridoma house mouse CVCL_B6RV CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P08962; Human CD63. 151666620 CVCL_B6S7 ME491 hybridoma house mouse CVCL_B6S7 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P08962; Human CD63. 151666621 CVCL_B6RU HeLa VAPB KO cancer cell line human CVCL_B6RU From: Durcan, Thomas M.; Montreal Neurological Institute, McGill University; Montreal; Canada CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12649; VAPB Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 151666622 CVCL_B6S6 ME425 hybridoma house mouse CVCL_B6S6 CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human unknown antigen. 151666623 CVCL_B6RX 8E8 hybridoma house mouse CVCL_B6RX CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; O00254; Human F2RL2 (Note=Immunized with AA 31-47). 151666624 CVCL_B6S9 ME493 hybridoma house mouse CVCL_B6S9 CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P08962; Human CD63. 151666625 CVCL_B6RW JS-1 hybridoma house mouse CVCL_B6RW CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P02751; Human FN1. 151666626 CVCL_B6S8 ME492 hybridoma house mouse CVCL_B6S8 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P08962; Human CD63. 151666627 CVCL_B6RZ 5C7 [Rat hybridoma against rat Chrna4] hybridoma house mouse CVCL_B6RZ CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P09483; Rat Chrna4 (Note=Recognizes AA 216-227). 151666628 CVCL_B6RY 1D6-3-8 hybridoma house mouse CVCL_B6RY CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P04757; Rat Chrna3 (Note=Recognizes AA 206-217). 151666629 CVCL_B6RL MHHi001-A-9 induced pluripotent stem cell human CVCL_B6RL From: Hannover Medical School, LEBAO (MHH); Hannover; Germany CL:0000010 Genetic integration: Method=TALEN; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=TALEN; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=TALEN; Gene=Entacmaea quadricolor RCaMP1h (Note=Red fluorescent calcium sensor) Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female Characteristics: Using TALEN a CAG-promoter driven RCaMP1h and a pMYH6-Neo-pPGKp-HygroR construct were introduced in both alleles of the AAVS1 safe harbor locus (PubMed=35152180) 151666630 CVCL_B6RK MHHi001-A-8 induced pluripotent stem cell human CVCL_B6RK From: Hannover Medical School, LEBAO (MHH); Hannover; Germany CL:0000010 Genetic integration: Method=TALEN; Gene=FPbase; F5GKU; GCaMP6f (Note=Green fluorescent calcium sensor); Genetic integration: Method=TALEN; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=TALEN; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. Female Characteristics: Using TALEN a CAG-promoter driven GCamP6f and a pMYH6-Neo-pPGKp-HygroR construct were introduced in both alleles of the AAVS1 safe harbor locus (PubMed=35152180) 151666631 CVCL_B6RN ICGi039-B induced pluripotent stem cell human CVCL_B6RN From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Genomics; Whole exome sequencing Male 151666632 CVCL_B6RM ICGi039-A induced pluripotent stem cell human CVCL_B6RM From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Genomics; Whole exome sequencing Male 151666633 CVCL_B6RP ICGi039-C induced pluripotent stem cell human CVCL_B6RP From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Genomics; Whole exome sequencing Male 151666634 CVCL_B6S1 ME109 hybridoma house mouse CVCL_B6S1 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: Human melanoma 92 kDa antigen. 151666635 CVCL_B6S0 4BL spontaneously immortalized cell line human CVCL_B6S0 CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Variations; Array-based CGH Female 151666636 CVCL_B6RR KLRMMEi002-A induced pluripotent stem cell human CVCL_B6RR From: Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University; Guangzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; c.8559-2A>G (p.Tyr2854_Arg2894del); ClinVar=VCV000048604; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=35152177) Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666637 CVCL_B6S3 ME165 hybridoma house mouse CVCL_B6S3 CL:0000010 Monoclonal antibody isotype: IgG3; Monoclonal antibody target: Human melanoma 200 kDa antigen. 151666638 CVCL_B6RQ ICGi040-A induced pluripotent stem cell human CVCL_B6RQ From: The Federal Research Center Institute of Cytology and Genetics; Novosibirsk; Russia CL:0000010 Population: Caucasian; Karyotypic information: 47,XY,+mar [26]; 46,XY [4] (PubMed=35303600); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666639 CVCL_B6S2 ME121 hybridoma house mouse CVCL_B6S2 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: Human melanoma 80 kDa membrane antigen. 151666640 CVCL_B6RD iKLF1.7 induced pluripotent stem cell human CVCL_B6RD CL:0000010 Genetic integration: Method=ZFN; Gene=HGNC; HGNC:3467; ESR1 (Note=Ligand-binding domain; with p.Gly400Val, p.Met543Ala and p.Leu544Ala = ET[T2]); Genetic integration: Method=ZFN; Gene=HGNC; HGNC:6345; KLF1; Genetic integration: Method=ZFN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR). Female Characteristics: Using ZFN a CAG-HA-KLF1-ERT2 construct has been inserted at the AAVS1 safe harbor locus so as to allow temporally controlled activation during macrophage differentiation 151666641 CVCL_B6RC iKLF1.6 induced pluripotent stem cell human CVCL_B6RC CL:0000010 Genetic integration: Method=ZFN; Gene=HGNC; HGNC:3467; ESR1 (Note=Ligand-binding domain; with p.Gly400Val, p.Met543Ala and p.Leu544Ala = ET[T2]); Genetic integration: Method=ZFN; Gene=HGNC; HGNC:6345; KLF1; Genetic integration: Method=ZFN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR). Female Characteristics: Using ZFN a CAG-HA-KLF1-ERT2 construct has been inserted at the AAVS1 safe harbor locus so as to allow temporally controlled activation during macrophage differentiation 151666642 CVCL_B6RF KUIMSi012-A-1 induced pluripotent stem cell human CVCL_B6RF From: Kyoto University; Kyoto; Japan CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)) Population: African American; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Characteristics: Using CRISPR/Cas9 a 2A-tdTomato construct was integrated at the C-terminus of one allele of GAPDH (PubMed=35176664) 151666643 CVCL_B6RE iKLF1.12 induced pluripotent stem cell human CVCL_B6RE CL:0000010 Genetic integration: Method=ZFN; Gene=HGNC; HGNC:3467; ESR1 (Note=Ligand-binding domain; with p.Gly400Val, p.Met543Ala and p.Leu544Ala = ET[T2]); Genetic integration: Method=ZFN; Gene=HGNC; HGNC:6345; KLF1; Genetic integration: Method=ZFN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR). Female Characteristics: Using ZFN a CAG-HA-KLF1-ERT2 construct has been inserted at the AAVS1 safe harbor locus so as to allow temporally controlled activation during macrophage differentiation 151666644 CVCL_B6RH KUIMSi012-A-3 induced pluripotent stem cell human CVCL_B6RH From: Kyoto University; Kyoto; Japan CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: African American; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Characteristics: Using CRISPR/Cas9 a 2A-tdTomato construct in combination with a PGKp-hygroR-pA construct was integrated at the C-terminus of both alleles of SOX10 (PubMed=35144211) 151666645 CVCL_B6RG KUIMSi012-A-2 induced pluripotent stem cell human CVCL_B6RG From: Kyoto University; Kyoto; Japan CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)) Population: African American; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Characteristics: Using CRISPR/Cas9 a 2A-tdTomato construct was integrated at the C-terminus of both alleles of GAPDH (PubMed=35176664) 151666646 CVCL_B6RJ ATCi002-A induced pluripotent stem cell human CVCL_B6RJ From: Aegicare (Shenzhen) Technology Co; Shenzhen; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4452; GPC4; Simple; c.877+1G>A; Zygosity=Hemizygous; Note=Splice donor mutation (PubMed=35168097) Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666647 CVCL_B6RI YCMi006-A induced pluripotent stem cell human CVCL_B6RI From: Yonsei University College of Medicine; Seoul; South Korea CL:0000010 Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Ile343Met (c.1029C>G); ClinVar=VCV001306956; Zygosity=Heterozygous (PubMed=35917599) Population: Korean; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666648 CVCL_B6QZ RE 6 transformed cell line Norway rat CVCL_B6QZ CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03254; Human adenovirus C serotype 2 E1A protein; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 10515; Human adenovirus C serotype 2; Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified 151666649 CVCL_B6RB iKLF1.2 induced pluripotent stem cell human CVCL_B6RB CL:0000010 Genetic integration: Method=ZFN; Gene=HGNC; HGNC:3467; ESR1 (Note=Ligand-binding domain; with p.Gly400Val, p.Met543Ala and p.Leu544Ala = ET[T2]); Genetic integration: Method=ZFN; Gene=HGNC; HGNC:6345; KLF1; Genetic integration: Method=ZFN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR). Female Characteristics: Using ZFN a CAG-HA-KLF1-ERT2 construct has been inserted at the AAVS1 safe harbor locus so as to allow temporally controlled activation during macrophage differentiation 151666650 CVCL_B6RA iKLF1.1 induced pluripotent stem cell human CVCL_B6RA CL:0000010 Genetic integration: Method=ZFN; Gene=HGNC; HGNC:3467; ESR1 (Note=Ligand-binding domain; with p.Gly400Val, p.Met543Ala and p.Leu544Ala = ET[T2]); Genetic integration: Method=ZFN; Gene=HGNC; HGNC:6345; KLF1; Genetic integration: Method=ZFN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR). Female Characteristics: Using ZFN a CAG-HA-KLF1-ERT2 construct has been inserted at the AAVS1 safe harbor locus so as to allow temporally controlled activation during macrophage differentiation 151666651 CVCL_B6P2 TaA2 clone E3 transformed cell line CVCL_B6P2 CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Characteristics: Infected by Theileria annulata isolate Ankara 151666652 CVCL_B6P1 TaA2 clone C9 transformed cell line CVCL_B6P1 CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Characteristics: Infected by Theileria annulata isolate Ankara 151666653 CVCL_B6P4 TaA2 clone D7 transformed cell line CVCL_B6P4 CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Characteristics: Infected by Theileria annulata isolate Ankara 151666654 CVCL_B6P3 TaA2 clone D3 transformed cell line CVCL_B6P3 CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Characteristics: Infected by Theileria annulata isolate Ankara 151666655 CVCL_B6P6 1C7 [Mouse hybridoma against T.annulata macroschizonts] hybridoma house mouse CVCL_B6P6 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Theileria annulata antigen on macroschizonts. 151666656 CVCL_B6P5 TaA2 clone D7B12 transformed cell line CVCL_B6P5 CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Characteristics: Infected by Theileria annulata isolate Ankara 151666657 CVCL_B6P8 4A4 [Mouse hybridoma against T.annulata macroschizonts] hybridoma house mouse CVCL_B6P8 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Theileria annulata antigen on macroschizonts. 151666658 CVCL_B6P7 2G2 hybridoma house mouse CVCL_B6P7 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Theileria annulata antigen on macroschizonts. 151666659 CVCL_B6P0 TaA2 transformed cell line CVCL_B6P0 CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Characteristics: Infected by Theileria annulata isolate Ankara 151666660 CVCL_B6NX EA2.31 hybridoma house mouse CVCL_B6NX CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P29317; Human EPHA2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4380 151666661 CVCL_B6NW LK17 clone K9 hybrid cell line house mouse CVCL_B6NW CL:0000010 Derived from site: In situ; Testis; UBERON=UBERON_0000473; Cell type: Leydig cell; CL=CL_0000178. Characteristics: Produces high level of testosterone; Characteristics: The parent cell line is an hybrid of 6-week-old BALB/c mice Leydig cells with a tioguanine resistant clone of MA-10 151666662 CVCL_B6NZ Eph101.530.241 hybridoma house mouse CVCL_B6NZ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P29317; Human EPHA2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4724 151666663 CVCL_B6NY EA5.12 hybridoma house mouse CVCL_B6NY CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P29317; Human EPHA2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4381 151666664 CVCL_B6PR Carousel cancer cell line human CVCL_B6PR CL:0000010 Population: Caucasian; Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female 151666665 CVCL_B6Q3 DUR 4R hybrid cell line CVCL_B6Q3 CL:0000010 151666666 CVCL_B6Q2 DUV finite cell line human CVCL_B6Q2 CL:0000010 Karyotypic information: 46,X,t(X;15) (PubMed=69325); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666667 CVCL_B6PQ MUi030-A induced pluripotent stem cell human CVCL_B6PQ From: Mahidol University; Bangkok; Thailand CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Homozygous (PubMed=37890332) Population: Southeast Asian; Thai; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666668 CVCL_B6Q5 DUR 10R hybrid cell line CVCL_B6Q5 CL:0000010 151666669 CVCL_B6PT Jacket cancer cell line human CVCL_B6PT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Phe814Val (c.2440T>G); Zygosity=Hemizygous (Cellaria); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Homozygous (Cellaria); Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Gly477Ser (c.1429G>A); ClinVar=VCV000455136; Zygosity=Heterozygous (Cellaria); Sequence variation: Mutation; HGNC; HGNC:7527; MUTYH; Simple; p.Val493Met (c.1477G>A) (p.Val468Met, c.1402G>A); ClinVar=VCV000140942; Zygosity=Heterozygous (Cellaria); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Homozygous (Cellaria) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 151666670 CVCL_B6Q4 DUR 5R hybrid cell line CVCL_B6Q4 CL:0000010 151666671 CVCL_B6PS Ferry cancer cell line human CVCL_B6PS CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Cys282Arg (c.844T>C) (p.Cys350Arg, c.1048T>C); Zygosity=Heterozygous (Cellaria) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Female 151666672 CVCL_B6Q7 691-I-5Nu 4 hybridoma house mouse CVCL_B6Q7 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human melanoma cell surface antigen. 151666673 CVCL_B6PV Wood cancer cell line human CVCL_B6PV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu424Gln (c.1270G>C); ClinVar=VCV001352477; Zygosity=Heterozygous (Cellaria) Population: Caucasian; Derived from site: In situ; Breast; UBERON=UBERON_0000310. Female 151666674 CVCL_B6Q6 BREN finite cell line human CVCL_B6Q6 CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666675 CVCL_B6PU Powder cancer cell line human CVCL_B6PU CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11119; SMO; Simple; p.Leu23dup (c.49CTG[8]); ClinVar=VCV000769335; Zygosity=Heterozygous (Cellaria) Population: Caucasian; Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female 151666676 CVCL_B6Q9 691-13 hybridoma house mouse CVCL_B6Q9 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human melanoma cell surface antigen. 151666677 CVCL_B6PX TJU-UM003 cancer cell line human CVCL_B6PX CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000375955; Zygosity=Heterozygous (PubMed=24354797; PubMed=25952648) Derived from site: Metastatic; Retroperitoneal space; UBERON=UBERON_0003693. Unspecified 151666678 CVCL_B6Q8 691-I-5Nu-4-42 hybridoma house mouse CVCL_B6Q8 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: Human melanoma cell surface antigen. 151666679 CVCL_B6PW TJU-UM001 cancer cell line human CVCL_B6PW CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Gln209Pro (c.626A>C); ClinVar=VCV000375957; Zygosity=Heterozygous (PubMed=24354797; PubMed=25952648) Derived from site: Metastatic; Liver; UBERON=UBERON_0002107. Unspecified 151666680 CVCL_B6PJ TC-1/E2 transformed cell line house mouse CVCL_B6PJ CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val); Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2; Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Epithelial cell; CL=CL_0000066; Breed/subspecies: C57BL/6. Unspecified 151666681 CVCL_B6PI EL4-B7-1+B7-2 cancer cell line house mouse CVCL_B6PI CL:0000010 Genetic integration: Method=Transfection; Gene=MGI; MGI:101775; Cd80; Genetic integration: Method=Transfection; Gene=MGI; MGI:101773; Cd86; Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: T-cell; CL=CL_0000084; Breed/subspecies: C57BL/6N. Unspecified 151666682 CVCL_B6PL EL4B7-2 cancer cell line house mouse CVCL_B6PL CL:0000010 Genetic integration: Method=Transfection; Gene=MGI; MGI:101773; Cd86; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: T-cell; CL=CL_0000084; Breed/subspecies: C57BL/6N. Unspecified Caution: There are two EL4 Cd86 (B7-2) transfected cell lines: EL4B7-2 (Cellosaurus=CVCL_B6PL) and EL4-B7-2 (Cellosaurus=CVCL_B6PH) 151666683 CVCL_B6PK EL4/E2 cancer cell line house mouse CVCL_B6PK CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: T-cell; CL=CL_0000084; Breed/subspecies: C57BL/6N. Unspecified 151666684 CVCL_B6PN MUi031-A induced pluripotent stem cell human CVCL_B6PN From: Mahidol University; Bangkok; Thailand CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Homozygous (PubMed=35151019) Population: Southeast Asian; Thai; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666685 CVCL_B6PM K1735-B7 cancer cell line house mouse CVCL_B6PM CL:0000010 Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:101775; Cd80; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Breed/subspecies: C3H/HeN. Unspecified 151666686 CVCL_B6PP MUi029-A induced pluripotent stem cell human CVCL_B6PP From: Mahidol University; Bangkok; Thailand. CL:0000010 151666687 CVCL_B6Q1 WM164 VDR KO cancer cell line human CVCL_B6Q1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12679; VDR; Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Arm, skin; UBERON=UBERON_0002427. Male 151666688 CVCL_B6Q0 WM164-Bch4 cancer cell line human CVCL_B6Q0 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Arm, skin; UBERON=UBERON_0002427. Male Characteristics: Highly invasive variant obtained from WM164 cells by four serial passages of these cells in the Boyden chamber assay (PubMed=2156614) 151666689 CVCL_B6PB 4F2 [Mouse hybridoma against T.annulata macroschizonts] hybridoma house mouse CVCL_B6PB CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Theileria annulata antigen on macroschizonts (Note=Also reacts with Theileria parva). 151666690 CVCL_B6PA 1C12 [Mouse hybridoma against T.annulata macroschizonts] hybridoma house mouse CVCL_B6PA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Theileria annulata antigen on macroschizonts (Note=Also reacts with sporozoites). 151666691 CVCL_B6PD 2E4 [Mouse hybridoma against T.annulata macroschizonts] hybridoma house mouse CVCL_B6PD CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Theileria annulata antigen on macroschizonts (Note=Also reacts with sporozoites). 151666692 CVCL_B6PC 1E11 [Mouse hybridoma against T.annulata macroschizonts] hybridoma house mouse CVCL_B6PC CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Theileria annulata antigen on macroschizonts (Note=Also reacts with sporozoites). 151666693 CVCL_B6PF BoMac transformed cell line CVCL_B6PF CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=776); Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358; Cell type: Peritoneal macrophage; CL=CL_0000581; Breed/subspecies: Jersey; VBO=VBO_0000250. Female Virology: Persistently infected by bovine viral diarrhea virus (BVDV) (PubMed=29316971) Doubling time: 24 hours (PubMed=7676607) 151666694 CVCL_B6PE TM3-SF spontaneously immortalized cell line house mouse CVCL_B6PE CL:0000010 Derived from site: In situ; Testis; UBERON=UBERON_0000473; Cell type: Leydig cell; CL=CL_0000178; Breed/subspecies: BALB/c. Male Doubling time: ~4-5 days (PubMed=16786125) Group: Serum/protein free medium cell line 151666695 CVCL_B6PH EL4-B7-2 cancer cell line house mouse CVCL_B6PH CL:0000010 Genetic integration: Method=Transfection; Gene=MGI; MGI:101773; Cd86; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: T-cell; CL=CL_0000084; Breed/subspecies: C57BL/6N. Unspecified Caution: There are two EL4 Cd86 (B7-2) transfected cell lines: EL4B7-2 (Cellosaurus=CVCL_B6PL) and EL4-B7-2 (Cellosaurus=CVCL_B6PH) 151666696 CVCL_B6PG EL4B7-1 cancer cell line house mouse CVCL_B6PG CL:0000010 Genetic integration: Method=Transfection; Gene=MGI; MGI:101775; Cd80; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: T-cell; CL=CL_0000084; Breed/subspecies: C57BL/6N. Unspecified 151666697 CVCL_B6P9 1F2 [Mouse hybridoma against T.annulata macroschizonts] hybridoma house mouse CVCL_B6P9 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Theileria annulata antigen on macroschizonts (Note=Also reacts with Theileria parva). 151666698 CVCL_B6N0 3C6.4.2 hybridoma house mouse CVCL_B6N0 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O75888; Human TNFSF13/CD256. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1347 151666699 CVCL_B6MN HCEFi spontaneously immortalized cell line CVCL_B6MN CL:0000010 Derived from site: In situ; Embryonic heart; UBERON=UBERON_0003084; Cell type: Fibroblast of heart; CL=CL_0002548; Breed/subspecies: White Leghorn SPAFAS. Unspecified Group: Bird cell line 151666700 CVCL_B6N2 5E8.7.4 hybridoma house mouse CVCL_B6N2 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O75888; Human TNFSF13/CD256. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1344 151666701 CVCL_B6MQ VCEFi spontaneously immortalized cell line CVCL_B6MQ CL:0000010 Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: East Lansing Line 0 (ELL-0). Unspecified Group: Bird cell line 151666702 CVCL_B6N1 5E11.1.2 hybridoma house mouse CVCL_B6N1 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; O75888; Human TNFSF13/CD256. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1346 151666703 CVCL_B6MP SkCEFi spontaneously immortalized cell line CVCL_B6MP CL:0000010 Derived from site: In situ; Embryonic skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620; Breed/subspecies: White Leghorn SPAFAS. Unspecified Group: Bird cell line 151666704 CVCL_B6MS BoCEFi spontaneously immortalized cell line CVCL_B6MS CL:0000010 Derived from site: In situ; Embryonic bone; UBERON=UBERON_0002481; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: East Lansing Line 0 (ELL-0). Unspecified Group: Bird cell line 151666705 CVCL_B6N4 TF8-11D12 hybridoma house mouse CVCL_B6N4 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P13726; Human F3/CD142. 151666706 CVCL_B6N3 5G8.2.2 hybridoma house mouse CVCL_B6N3 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; O75888; Human TNFSF13/CD256. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1345 151666707 CVCL_B6MR LF-1 spontaneously immortalized cell line CVCL_B6MR CL:0000010 Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: East Lansing Line 0 (ELL-0). Unspecified Virology: Compared to the parent cell line, has a 1.5 fold improvement in supporting the replication of Marek's disease virus (Patent=US20200179507) Group: Bird cell line; Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-123527 151666708 CVCL_B6N6 TF8-5G9 hybridoma house mouse CVCL_B6N6 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P13726; Human F3/CD142. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9382 151666709 CVCL_B6MU Tp(Kilifi) transformed cell line CVCL_B6MU CL:0000010 Derived from site: In situ; Lymph node; UBERON=UBERON_0000029; Cell type: T-cell; CL=CL_0000084. Female Characteristics: Infected by Theileria parva isolate Kilifi 151666710 CVCL_B6N5 TF8-5C4 hybridoma house mouse CVCL_B6N5 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P13726; Human F3/CD142. 151666711 CVCL_B6MT TpM(588) transformed cell line CVCL_B6MT CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Characteristics: Infected by Theileria parva isolate Muguga 151666712 CVCL_B6MG TCL-Fuj3 transformed cell line human CVCL_B6MG CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified 151666713 CVCL_B6MF 1E9 hybridoma house mouse CVCL_B6MF CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_2622; Amarogentin. 151666714 CVCL_B6MI TCL-Sug2 transformed cell line human CVCL_B6MI CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified 151666715 CVCL_B6MH TCL-Fuj4 transformed cell line human CVCL_B6MH CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified 151666716 CVCL_B6MK AL/N-E spontaneously immortalized cell line house mouse CVCL_B6MK CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Epithelial cell; CL=CL_0000066; Breed/subspecies: AL/N. Unspecified 151666717 CVCL_B6MJ TCL-Tan transformed cell line human CVCL_B6MJ CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified 151666718 CVCL_B6MM BCEFi spontaneously immortalized cell line CVCL_B6MM CL:0000010 Derived from site: In situ; Embryonic breast; UBERON=UBERON_0000310; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: White Leghorn SPAFAS. Unspecified Group: Bird cell line 151666719 CVCL_B6ML AL/N-F spontaneously immortalized cell line house mouse CVCL_B6ML CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: AL/N. Unspecified 151666720 CVCL_B6MA 3H10-2F4 hybridoma house mouse CVCL_B6MA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_77148; Ginsenoside Re; Monoclonal antibody target: ChEBI; CHEBI_67987; Ginsenoside Rg1. 151666721 CVCL_B6MC 2D3B5 hybridoma house mouse CVCL_B6MC CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_8822; Retrorsine (Note=Also recognizes many other pyrrolizidine alkaloids). 151666722 CVCL_B6MB 2C3C5 hybridoma house mouse CVCL_B6MB CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_8822; Retrorsine (Note=Also recognizes many other pyrrolizidine alkaloids). 151666723 CVCL_B6ME 2B4 [Mouse hybridoma against asiaticoside] hybridoma house mouse CVCL_B6ME CL:0000010 Monoclonal antibody isotype: IgG1, lambda; Monoclonal antibody target: ChEBI; CHEBI_79928; Asiaticoside. 151666724 CVCL_B6MD 5F2B1 hybridoma house mouse CVCL_B6MD CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_8822; Retrorsine (Note=Also recognizes many other pyrrolizidine alkaloids). 151666725 CVCL_B6LV 1A6 [Mouse hybridoma against mitragynine] hybridoma house mouse CVCL_B6LV CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_6956; Mitragynine. 151666726 CVCL_B6M7 6A1 hybridoma house mouse CVCL_B6M7 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_71019; Omacetaxine mepesuccinate (Homoharringtonine; HHT). 151666727 CVCL_B6LU AA9 [Mouse hybridoma against puerarin] hybridoma house mouse CVCL_B6LU CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_8633; Puerarin; Monoclonal antibody target: ChEBI; CHEBI_2979; Baicalein (Note=58% reactivity compared to puerarin). 151666728 CVCL_B6M6 E8 hybridoma house mouse CVCL_B6M6 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: ChEBI; CHEBI_18418; (RS)-norcoclaurine (Higenamine). 151666729 CVCL_B6M9 Anti-PF hybridoma house mouse CVCL_B6M9 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_7889; Paeoniflorin. 151666730 CVCL_B6LX Ea3.10 factor-dependent cell line house mouse CVCL_B6LX CL:0000010 Derived from site: In situ; Spleen; UBERON=UBERON_0002106; Cell type: Pre-B cell; CL=CL_0000817; Breed/subspecies: BALB/c. Unspecified Characteristics: IL3 dependent Doubling time: 20 hours (PubMed=6201749) 151666731 CVCL_B6M8 1H1 hybridoma house mouse CVCL_B6M8 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_6949; Miroestrol. 151666732 CVCL_B6LW RTS7c transformed cell line human CVCL_B6LW CL:0000010 Derived from site: In situ; Hand, skin, epidermis; UBERON=UBERON_0001519+UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Unspecified 151666733 CVCL_B6LZ Ea3.13 factor-dependent cell line house mouse CVCL_B6LZ CL:0000010 Derived from site: In situ; Spleen; UBERON=UBERON_0002106; Cell type: Pre-B cell; CL=CL_0000817; Breed/subspecies: BALB/c. Unspecified Characteristics: IL3 dependent Doubling time: 15-17 hours (PubMed=6201749) 151666734 CVCL_B6LY Ea3.11 factor-dependent cell line house mouse CVCL_B6LY CL:0000010 Derived from site: In situ; Spleen; UBERON=UBERON_0002106; Cell type: Pre-B cell; CL=CL_0000817; Breed/subspecies: BALB/c. Unspecified Characteristics: IL3 dependent Doubling time: 15-17 hours (PubMed=6201749) 151666735 CVCL_B6NP Eph099B-210.248 hybridoma house mouse CVCL_B6NP CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P29317; Human EPHA2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4574 151666736 CVCL_B6NR Flow12000 finite cell line human CVCL_B6NR From: Flow Laboratories (which ceased operation); Rockville; USA CL:0000010 Derived from site: In situ; Nose, nasal cavity, olfactory mucosa; UBERON=UBERON_0005386. 151666737 CVCL_B6NQ Eph099B-233.152 hybridoma house mouse CVCL_B6NQ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P29317; Human EPHA2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5194 151666738 CVCL_B6NT LIM6-TR cancer cell line human CVCL_B6NT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Selected for resistance to: UniProtKB; P50591; Human TNFSF10/CD253; Derived from site: In situ; Colon; UBERON=UBERON_0001155; Cell type: Epithelial cell of colon; CL=CL_0011108. Female Characteristics: Has high liver-metastasizing ability during cecal growth (from parent cell line LiM6) 151666739 CVCL_B6NS LS174T-LM12 cancer cell line human CVCL_B6NS CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155; Cell type: Epithelial cell of colon; CL=CL_0011108. Female Characteristics: Produces low amount of mucin in culture (PubMed=3664476) 151666740 CVCL_B6NV LK17 hybrid cell line house mouse CVCL_B6NV CL:0000010 Derived from site: In situ; Testis; UBERON=UBERON_0000473; Cell type: Leydig cell; CL=CL_0000178. Characteristics: Hybrid of 6-week-old BALB/c mice Leydig cells with a tioguanine resistant clone of MA-10 151666741 CVCL_B6NU MA-10 mutant clone LK cancer cell line house mouse CVCL_B6NU CL:0000010 Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG); Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Derived from site: In situ; Testis; UBERON=UBERON_0000473; Cell type: Leydig cell; CL=CL_0000178; Breed/subspecies: C57BL/6J. Male 151666742 CVCL_B6NH CHO-Flt-3 spontaneously immortalized cell line CVCL_B6NH CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3765; FLT3 Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female 151666743 CVCL_B6NG 8213 hybridoma house mouse CVCL_B6NG CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; Q8TDQ0; Human HAVCR2/CD366. 151666744 CVCL_B6NJ Flt-3A20.9 hybridoma house mouse CVCL_B6NJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P36888; Human FLT3. 151666745 CVCL_B6NI P3XBcl-2-13 cancer cell line house mouse CVCL_B6NI CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:990; BCL2; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine; Cell type: Plasma cell; CL=CL_0000786; Breed/subspecies: BALB/c. Female Characteristics: Enhances the outgrowth of hybridomas following somatic fusion with immune lymphocytes isolated from pooled peripheral lymph nodes (PLN) 8-14 days after the initial immunization (PubMed=9309429) Group: Hybridoma fusion partner cell line 151666746 CVCL_B6NL Flt-3B7.5 hybridoma house mouse CVCL_B6NL CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P36888; Human FLT3. 151666747 CVCL_B6NK Flt-3B3.33 hybridoma house mouse CVCL_B6NK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P36888; Human FLT3. 151666748 CVCL_B6NN Eph099B-208.261 hybridoma house mouse CVCL_B6NN CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P29317; Human EPHA2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4573 151666749 CVCL_B6NM Eph099B-102.147 hybridoma house mouse CVCL_B6NM CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P29317; Human EPHA2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4572 151666750 CVCL_B6NB TF9-6B4 hybridoma house mouse CVCL_B6NB CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P13726; Human F3/CD142. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9381 151666751 CVCL_B6NA TF9-5B7 hybridoma house mouse CVCL_B6NA CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P13726; Human F3/CD142. 151666752 CVCL_B6ND 644 hybridoma house mouse CVCL_B6ND CL:0000010 Miscellaneous: As the immunized splenic B-cells are from humanized 'KM' mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG4; Monoclonal antibody target: UniProtKB; Q8TDQ0; Human HAVCR2/CD366 151666753 CVCL_B6NC 512 hybridoma house mouse CVCL_B6NC CL:0000010 Miscellaneous: As the immunized splenic B-cells are from humanized 'KM' mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8TDQ0; Human HAVCR2/CD366 151666754 CVCL_B6NF 4545 hybridoma house mouse CVCL_B6NF CL:0000010 Miscellaneous: As the immunized splenic B-cells are from humanized 'KM' mice the produced mAB is of human origin. Monoclonal antibody isotype: IgG2; Monoclonal antibody target: UniProtKB; Q8TDQ0; Human HAVCR2/CD366 151666755 CVCL_B6NE 4177 hybridoma house mouse CVCL_B6NE CL:0000010 Miscellaneous: As the immunized splenic B-cells are from humanized 'KM' mice the produced mAB is of human origin. Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q8TDQ0; Human HAVCR2/CD366 151666756 CVCL_B6MW hT-SerC telomerase immortalized cell line human CVCL_B6MW CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Testis; UBERON=UBERON_0000473; Cell type: Sertoli cell; CL=CL_0000216. Omics: Transcriptomics; Microarray Male 151666757 CVCL_B6N8 TF9-1B8 hybridoma house mouse CVCL_B6N8 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P13726; Human F3/CD142. 151666758 CVCL_B6MV hS1 telomerase immortalized cell line human CVCL_B6MV CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT Population: Chinese; Derived from site: In situ; Testis; UBERON=UBERON_0000473; Cell type: Sertoli cell; CL=CL_0000216. Omics: Transcriptomics; Microarray Male Doubling time: 1.3 days (Note=In 10% FBS), 1.03 days (Note=In 15% FBS) (PubMed=28152522) 151666759 CVCL_B6N7 TF9-10H10 hybridoma house mouse CVCL_B6N7 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P13726; Human F3/CD142. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9383 151666760 CVCL_B6MY 64M2 spontaneously immortalized cell line CVCL_B6MY CL:0000010 Miscellaneous: It is probable that what is termed '64M2' in PubMed=8799617 is termed 'cell culture 2' in PubMed=1499835 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Group: Fish cell line 151666761 CVCL_B6MX F13L-3 spontaneously immortalized cell line CVCL_B6MX CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Unspecified Group: Fish cell line 151666762 CVCL_B6N9 TF9-2C4 hybridoma house mouse CVCL_B6N9 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P13726; Human F3/CD142. 151666763 CVCL_B6MZ 2H8 [Mouse hybridoma against phenylethanolamine A] hybridoma house mouse CVCL_B6MZ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: ChEBI; CHEBI_144925; 1-(4-methoxyphenyl)-2-\{[4-(4-nitrophenyl)butan-2-yl]amino\}ethanol (Phenylethylamine A). 151666764 CVCL_B5ZA HE3-2 finite cell line CVCL_B5ZA CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Female 151666765 CVCL_B5ZC MBEC2 transformed cell line house mouse CVCL_B5ZC CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=777); Derived from site: In situ; Brain, capillary; UBERON=UBERON_8480001; Cell type: Endothelial cell; CL=CL_0000115; Breed/subspecies: BALB/c. Unspecified 151666766 CVCL_B5ZB HE4-2 finite cell line CVCL_B5ZB CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Female 151666767 CVCL_B5YT 2E1 [Mouse hybridoma against SVA VP1] hybridoma house mouse CVCL_B5YT CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q155Z9; Senecavirus A genome polyprotein (Note=AA 674-937 = Capsid protein VP1). 151666768 CVCL_B5Z5 4I16 hybridoma house mouse CVCL_B5Z5 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q8QL52; Alphavirus salmon subtype 2 (SAV2) structural polyprotein (Note=AA 355-792 = Spike glycoprotein E2). 151666769 CVCL_B5YS 2A5 [Mouse hybridoma against SVA VP3] hybridoma house mouse CVCL_B5YS CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q155Z9; Senecavirus A genome polyprotein (Note=AA 435-673 = Capsid protein VP3). 151666770 CVCL_B5Z4 49K16 hybridoma house mouse CVCL_B5Z4 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q8QL52; Alphavirus salmon subtype 2 (SAV2) structural polyprotein (Note=AA 355-792 = Spike glycoprotein E2). 151666771 CVCL_B5YV 3F2 [Mouse hybridoma against SVA VP2] hybridoma house mouse CVCL_B5YV CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; Q155Z9; Senecavirus A genome polyprotein (Note=AA 151-434 = Capsid protein VP2). 151666772 CVCL_B5Z7 71L2 hybridoma house mouse CVCL_B5Z7 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q8QL53; Alphavirus salmon subtype 2 (SAV2) polyprotein P1234 (Note=AA 1-561 = mRNA-capping enzyme nsP1). 151666773 CVCL_B5YU 3E2 hybridoma house mouse CVCL_B5YU CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; Q155Z9; Senecavirus A genome polyprotein (Note=AA 151-434 = Capsid protein VP2). 151666774 CVCL_B5Z6 51B8 hybridoma house mouse CVCL_B5Z6 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q8QL52; Alphavirus salmon subtype 2 (SAV2) structural polyprotein (Note=AA 355-792 = Spike glycoprotein E2). 151666775 CVCL_B5Z9 8A16 hybridoma house mouse CVCL_B5Z9 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q8QL53; Alphavirus salmon subtype 2 (SAV2) polyprotein P1234 (Note=AA 1-561 = mRNA-capping enzyme nsP1). 151666776 CVCL_B5YX NCC-MFS5-C1 cancer cell line human CVCL_B5YX CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=35053323); Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=35053323); Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=35053323) Population: Japanese; Derived from site: In situ; Right elbow, hypodermis; UBERON=UBERON_0001461+UBERON_0002072. Omics: Phenotyping; Drug screening; Omics: Variations; SNP array analysis Male Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi); Doubling time: 91.7 hours (PubMed=35053323) Part of: NCC sarcoma cell line panel 151666777 CVCL_B5YW 4B8 [Mouse hybridoma against SVA VP2] hybridoma house mouse CVCL_B5YW CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q155Z9; Senecavirus A genome polyprotein (Note=AA 151-434 = Capsid protein VP2). 151666778 CVCL_B5Z8 78K5 hybridoma house mouse CVCL_B5Z8 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q8QL52; Alphavirus salmon subtype 2 (SAV2) structural polyprotein (Note=AA 861-1322 = Spike glycoprotein E1). 151666779 CVCL_B5YZ ASG-10 spontaneously immortalized cell line CVCL_B5YZ CL:0000010 Derived from site: In situ; Gill; UBERON=UBERON_0002535; Cell type: Epithelial cell; CL=CL_0000066. Omics: Proteomics; Quantitative; Omics: Transcriptomics; RNAseq Unspecified Virology: Susceptible to infection by infectious haematopoetic necrosis virus (IHNV), infectious pancreatic necrosis virus (IPNV), Pacific salmon paramyxovirus (PSPV), Atlantic salmon reovirus TS (TSRV) and viral hemorrhagic septicemia virus (VHSV) (PubMed=29444101) Group: Fish cell line 151666780 CVCL_B5YY LG-1 spontaneously immortalized cell line CVCL_B5YY CL:0000010 Derived from site: In situ; Gill; UBERON=UBERON_0002535; Cell type: Epithelial cell; CL=CL_0000066. Unspecified Virology: Susceptible to infection by salmonid alphavirus 1 (SAV1) (PubMed=34572091) Doubling time: 14 days (Note=At 20 Celsius) (PubMed=34572091) Group: Fish cell line 151666781 CVCL_B5YL 1A3 [Mouse hybridoma against SVA VP2] hybridoma house mouse CVCL_B5YL CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q155Z9; Senecavirus A genome polyprotein (Note=AA 151-434 = Capsid protein VP2). 151666782 CVCL_B5YK 2G6 [Mouse hybridoma against SVA VP1] hybridoma house mouse CVCL_B5YK CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q155Z9; Senecavirus A genome polyprotein (Note=AA 674-937 = Capsid protein VP1). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017226 151666783 CVCL_B5YN 1C12 [Mouse hybridoma against SVA VP2] hybridoma house mouse CVCL_B5YN CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q155Z9; Senecavirus A genome polyprotein (Note=AA 151-434 = Capsid protein VP2). 151666784 CVCL_B5YM 1A5 [Mouse hybridoma against SVA VP3] hybridoma house mouse CVCL_B5YM CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; Q155Z9; Senecavirus A genome polyprotein (Note=AA 435-673 = Capsid protein VP3). 151666785 CVCL_B5Z1 17H23 hybridoma house mouse CVCL_B5Z1 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q8QL52; Alphavirus salmon subtype 2 (SAV2) structural polyprotein (Note=AA 355-792 = Spike glycoprotein E2 Recognizes other salmonid alphavirus (SAV) E2).. 151666786 CVCL_B5YP 1C2 [Mouse hybridoma against SVA VP1] hybridoma house mouse CVCL_B5YP CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q155Z9; Senecavirus A genome polyprotein (Note=AA 674-937 = Capsid protein VP1). 151666787 CVCL_B5Z0 ASG-13 spontaneously immortalized cell line CVCL_B5Z0 CL:0000010 Derived from site: In situ; Gill; UBERON=UBERON_0002535; Cell type: Fibroblast; CL=CL_0000057. Unspecified Virology: Susceptible to infection by infectious haematopoetic necrosis virus (IHNV), infectious pancreatic necrosis virus (IPNV), Pacific salmon paramyxovirus (PSPV), Atlantic salmon reovirus TS (TSRV) and viral hemorrhagic septicemia virus (VHSV) (PubMed=29444101) Group: Fish cell line 151666788 CVCL_B5YR 1F5 [Mouse hybridoma against SVA VP1] hybridoma house mouse CVCL_B5YR CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: UniProtKB; Q155Z9; Senecavirus A genome polyprotein (Note=AA 674-937 = Capsid protein VP1). 151666789 CVCL_B5Z3 3E17 hybridoma house mouse CVCL_B5Z3 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q8QL53; Alphavirus salmon subtype 2 (SAV2) polyprotein P1234 (Note=AA 1421-1984 = Non-structural protein 3). 151666790 CVCL_B5Z2 19F3 hybridoma house mouse CVCL_B5Z2 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q8QL53; Alphavirus salmon subtype 2 (SAV2) polyprotein P1234 (Note=AA 1-561`= mRNA-capping enzyme nsP1). 151666791 CVCL_B5YQ 1E7 [Mouse hybridoma against SVA VP1] hybridoma house mouse CVCL_B5YQ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q155Z9; Senecavirus A genome polyprotein (Note=AA 674-937 = Capsid protein VP1). 151666792 CVCL_B5YD A431-AC3 cancer cell line human CVCL_B5YD CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4056; G6PC1; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003. Female 151666793 CVCL_B5YC Ho-15-D3 transformed cell line house mouse CVCL_B5YC CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:95607; G6pc; Genetic integration: Method=Transfection; Gene=MGI; MGI:95607; G6pc; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA255); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Unspecified 151666794 CVCL_B5YF SNE 2 transformed cell line human CVCL_B5YF CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. 151666795 CVCL_B5YE SNE 1 transformed cell line human CVCL_B5YE CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. 151666796 CVCL_B5YH SNE 3 transformed cell line human CVCL_B5YH CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. 151666797 CVCL_B5YG Josh 5 transformed cell line human CVCL_B5YG CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male 151666798 CVCL_B5YJ PO-88 undefined cell line type CVCL_B5YJ CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Unspecified Group: Non-human primate cell line 151666799 CVCL_B5YI LCL22 transformed cell line human CVCL_B5YI CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Characteristics: Expresses membrane IgM and IgD, together with lower levels of IgG and IgA, with expression of kappa and lambda light chains; both IgM kappa and lambda were present in the cytoplasm (PubMed=1326002) 151666800 CVCL_B5ZU C2BBe1 MDR1/BCRP KO cancer cell line human CVCL_B5ZU CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:40; ABCB1; Knockout cell: Method=ZFN; HGNC; HGNC:74; ABCG2; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151666801 CVCL_B5ZT C2BBe1 MDR1 KO cancer cell line human CVCL_B5ZT CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:40; ABCB1; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151666802 CVCL_B5ZW C2BBe1 MDR1/MRP2 KO cancer cell line human CVCL_B5ZW CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:40; ABCB1; Knockout cell: Method=ZFN; HGNC; HGNC:53; ABCC2; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151666803 CVCL_B5ZV C2BBe1 MRP2 KO cancer cell line human CVCL_B5ZV CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:53; ABCC2; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151666804 CVCL_B5ZY C2BBe1 MRP1 KO cancer cell line human CVCL_B5ZY CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:51; ABCC1; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151666805 CVCL_B5ZX C2BBe1 MRP2/BCRP KO cancer cell line human CVCL_B5ZX CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:53; ABCC2; Knockout cell: Method=ZFN; HGNC; HGNC:74; ABCG2; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151666806 CVCL_B5ZZ C2BBe1 MRP5 KO cancer cell line human CVCL_B5ZZ CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:56; ABCC5; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151666807 CVCL_B5ZM Spli-S spontaneously immortalized cell line CVCL_B5ZM CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Unspecified Virology: Susceptible to infection by Spodoptera littoralis multicapsid nucleopolyhedrovirus (SpliMNPV) (CelloPub=CLPUB00678; CelloPub=CLPUB00679) Doubling time: 31 hours (Note=At 19th passage), 27 hours (Note=At 120th passage) (CelloPub=CLPUB00678; CelloPub=CLPUB00679) Group: Insect cell line 151666808 CVCL_B5ZL Spli-C spontaneously immortalized cell line CVCL_B5ZL CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Unspecified Virology: Highly susceptible to infection by Spodoptera littoralis multicapsid nucleopolyhedrovirus (SpliMNPV) (CelloPub=CLPUB00678; CelloPub=CLPUB00679; PubMed=31069609) Doubling time: 30.5 hours (Note=At 19th passage), 26 hours (Note=At 120th passage) (CelloPub=CLPUB00678; CelloPub=CLPUB00679) Group: Insect cell line 151666809 CVCL_B5ZN PoCo83-3 transformed cell line pig CVCL_B5ZN CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Colon, proximal; UBERON=UBERON_0008972; Cell type: Epithelial cell of colon; CL=CL_0011108. Male Doubling time: 20.3 hours (Note=At 18th passage), 20.47 hours (Note=At 34th passage) (PubMed=28052271) 151666810 CVCL_B5ZQ SA7K MDR1 KO transformed cell line human CVCL_B5ZQ CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:40; ABCB1 Population: African American; Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134; Cell type: Epithelial cell of proximal tubule; CL=CL_0002306. Female Characteristics: The parent cell line was established by zinc finger nuclease-mediated knockout of a cell cycle protein (from parent cell line SA7K) 151666811 CVCL_B5ZP SA7K transformed cell line human CVCL_B5ZP CL:0000010 Population: African American; Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134; Cell type: Epithelial cell of proximal tubule; CL=CL_0002306. Female Characteristics: The cell line was established by zinc finger nuclease-mediated knockout of a cell cycle protein (Sigma-Aldrich=MTOX1030) 151666812 CVCL_B5ZS C2BBe1 BCRP KO cancer cell line human CVCL_B5ZS CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:74; ABCG2; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151666813 CVCL_B5ZR SA7K OCT2 KO transformed cell line human CVCL_B5ZR CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:10966; SLC22A2 Population: African American; Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134; Cell type: Epithelial cell of proximal tubule; CL=CL_0002306. Female Characteristics: The parent cell line was established by zinc finger nuclease-mediated knockout of a cell cycle protein (from parent cell line SA7K) 151666814 CVCL_B5ZE NK92-CD16 cancer cell line human CVCL_B5ZE CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3619; FCGR3A Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Natural killer cell; CL=CL_0000623. Male 151666815 CVCL_B5ZD MBEC0 transformed cell line house mouse CVCL_B5ZD CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=777); Derived from site: In situ; Brain, capillary; UBERON=UBERON_8480001; Cell type: Endothelial cell; CL=CL_0000115; Breed/subspecies: BALB/c. Unspecified 151666816 CVCL_B5ZG Hepa/HS cancer cell line house mouse CVCL_B5ZG CL:0000010 Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transduction; Gene=MGI; MGI:99480; Cebpa; Genetic integration: Method=Transduction; Gene=MGI; MGI:88373; Cebpb; Genetic integration: Method=Transduction; Gene=MGI; MGI:104982; Cebpg; Genetic integration: Method=Transduction; Gene=MGI; MGI:1347476; Foxa2; Genetic integration: Method=Transduction; Gene=MGI; MGI:98504; Hnf1a; Genetic integration: Method=Transduction; Gene=MGI; MGI:98505; Hnf1b; Genetic integration: Method=Transduction; Gene=MGI; MGI:109128; Hnf4a; Genetic integration: Method=Transduction; Gene=MGI; MGI:1196423; Onecut1 Derived from site: In situ; Liver; UBERON=UBERON_0002107; Breed/subspecies: C57L/J. Omics: Transcriptomics; Microarray Female Characteristics: When doxycycline-induced, overexpresses 8 liver-enriched transcription factors (LETFs) (from parent cell line Hepa/8F5); Characteristics: The parent cell line was modified to enable switching between proliferation and expression of proteins for liver function in response to heat by introducing a new heat-inducible gene expression/amplification system (pHSP-tTA-TRE-tTA-pEF1a-Puro) which was transferred using a PiggyBac transposon vector (PubMed=34149171) 151666817 CVCL_B5ZF NK92-41BB cancer cell line human CVCL_B5ZF CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3619; FCGR3A (Note=Extracellular domain) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Natural killer cell; CL=CL_0000623. Male Characteristics: Transfected with the CD16-CAR construct that consist of the signal peptide, the FCGR3/CD16A extracellular domain, the CD8A extracellular domain, the CD28 TM and co-activation domains, the 4-1BB co-activation domain and finally the CD247/CD3Z signaling domain 151666818 CVCL_B5ZI WAe009-A-R embryonic stem cell human CVCL_B5ZI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8002; NRL (Note=1 of 2 alleles); Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Valuable tool for studying human rod development and disease and testing therapeutic strategies for retinitis pigmentosa (PubMed=29402929); Characteristics: Using CRISPR/Cas9 a single allele of NRL was replaced with an eGFP reporter gene (PubMed=29402929) 151666819 CVCL_B5ZH HUC-5 finite cell line human CVCL_B5ZH CL:0000010 Population: Japanese; Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331; Cell type: Fibroblast; CL=CL_0000057. Male 151666820 CVCL_B5ZK Spli-B spontaneously immortalized cell line CVCL_B5ZK CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Unspecified Virology: Susceptible to infection by Spodoptera littoralis multicapsid nucleopolyhedrovirus (SpliMNPV) (CelloPub=CLPUB00678; CelloPub=CLPUB00679; PubMed=31069609) Doubling time: 44.5 hours (Note=At 19th passage), 32 hours (Note=At 120th passage) (CelloPub=CLPUB00678; CelloPub=CLPUB00679) Group: Insect cell line 151666821 CVCL_B5ZJ WA09 CRX+/tdTomato embryonic stem cell human CVCL_B5ZJ CL:0000010 Knockout cell: Method=BAC homologous recombination; HGNC; HGNC:2383; CRX (Note=1 of 2 alleles); Genetic integration: Method=Transfection/transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)) Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Female Characteristics: Using BAC homologous recombination a single allele of CRX was replaced with a tdTomato reporter gene (PubMed=29230913) 151666822 CVCL_B5WZ LS803 transformed cell line human CVCL_B5WZ CL:0000010 Transformant: Ad-SV40 hybrid virus; Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195; Cell type: Fibroblast of bone marrow; CL=CL_0002240. Unspecified 151666823 CVCL_B5WY LS802 transformed cell line human CVCL_B5WY CL:0000010 Transformant: Ad-SV40 hybrid virus; Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195; Cell type: Fibroblast of bone marrow; CL=CL_0002240. Unspecified 151666824 CVCL_B5XA HGF25 finite cell line human CVCL_B5XA CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 151666825 CVCL_B5X3 LS501 transformed cell line human CVCL_B5X3 CL:0000010 Transformant: Ad-SV40 hybrid virus; Donor information: Established from a patient suffering from acute nonlymphocytic leukemia; Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195; Cell type: Fibroblast of bone marrow; CL=CL_0002240. Unspecified 151666826 CVCL_B5WR MMH-D2 spontaneously immortalized cell line house mouse CVCL_B5WR CL:0000010 Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:7029; MET (Note=With p.Met1_Leu955del = cyto-Met) Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Unspecified 151666827 CVCL_B5WQ EqS01a cancer cell line CVCL_B5WQ CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified Virology: Infected by bovine papillomavirus-1 (BPV-1) Doubling time: 32.7 hours (PubMed=18191170) 151666828 CVCL_B5X2 LP101 transformed cell line human CVCL_B5X2 CL:0000010 Transformant: Ad-SV40 hybrid virus; Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195; Cell type: Macrophage; CL=CL_0000235. Unspecified 151666829 CVCL_B5X5 HGF3 finite cell line human CVCL_B5X5 CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 151666830 CVCL_B5WT MMH-E14 spontaneously immortalized cell line house mouse CVCL_B5WT CL:0000010 Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:7029; MET (Note=With p.Met1_Leu955del = cyto-Met) Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Unspecified 151666831 CVCL_B5X4 HGF1 finite cell line human CVCL_B5X4 CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 151666832 CVCL_B5WS MMH-D6 spontaneously immortalized cell line house mouse CVCL_B5WS CL:0000010 Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:7029; MET (Note=With p.Met1_Leu955del = cyto-Met) Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. 151666833 CVCL_B5X7 HGF11 finite cell line human CVCL_B5X7 CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 151666834 CVCL_B5WV MMH-E14 pal. spontaneously immortalized cell line house mouse CVCL_B5WV CL:0000010 Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:7029; MET (Note=With p.Met1_Leu955del = cyto-Met) Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Unspecified Characteristics: Clone that can spread with multiple projections (PubMed=9817765) 151666835 CVCL_B5X6 HGF10 finite cell line human CVCL_B5X6 CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 151666836 CVCL_B5WU MMH-E14 ep. spontaneously immortalized cell line house mouse CVCL_B5WU CL:0000010 Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:7029; MET (Note=With p.Met1_Leu955del = cyto-Met) Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Unspecified 151666837 CVCL_B5X9 HGF22 finite cell line human CVCL_B5X9 CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 151666838 CVCL_B5WX LS801 transformed cell line human CVCL_B5WX CL:0000010 Transformant: Ad-SV40 hybrid virus; Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195; Cell type: Fibroblast of bone marrow; CL=CL_0002240. Unspecified 151666839 CVCL_B5X8 HGF13 finite cell line human CVCL_B5X8 CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 151666840 CVCL_B5WW IDIBGIi005-A induced pluripotent stem cell human CVCL_B5WW From: Institut d'Investigacio Biomedica de Girona Dr Josep Trueta; Salt; Spain. CL:0000010 Population: Caucasian; Derived from site: In situ; Back, skin; UBERON=UBERON_0001068; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666841 CVCL_B5WJ IM-HREC transformed cell line human CVCL_B5WJ CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966; Cell type: Retinal endothelial cell; CL=CL_0002585. 151666842 CVCL_B5WI IM-HBlSMC transformed cell line human CVCL_B5WI CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Urinary bladder, smooth muscle; UBERON=UBERON_0004228. Caution: Indicated as P10951-IM in the online catalog but as P10561-IM in the technical sheet 151666843 CVCL_B5WL IM-HAEC transformed cell line human CVCL_B5WL CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Thoracic aorta; UBERON=UBERON_0001515; Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545. 151666844 CVCL_B5WK IM-HCEpiC transformed cell line human CVCL_B5WK CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772; Cell type: Epithelial cell of cornea; CL=CL_0000575. 151666845 CVCL_B5WN MDCK tGFP-APP spontaneously immortalized cell line dog CVCL_B5WN CL:0000010 Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:620; APP Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female Characteristics: Allows to perform assays to evaluate the endogenous secretase proteolytic process in living cells (Innoprot=P30701) 151666846 CVCL_B5WM U2OS tGFP-ADCYAP1R1 cancer cell line human CVCL_B5WM CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:242; ADCYAP1R1 Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female Characteristics: Has been designed to assay potential agonists/antagonists against ADCYAP1R1, modulating its activation and the following redistribution process inside the cells (Innoprot=P30214); Characteristics: Transfected with ADCYAP1R1 N-terminally tagged with turboGFP 151666847 CVCL_B5X1 HAS701 transformed cell line human CVCL_B5X1 CL:0000010 Transformant: Ad-SV40 hybrid virus; Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195; Cell type: Fibroblast of bone marrow; CL=CL_0002240. Unspecified 151666848 CVCL_B5WP V79MZh1B1 spontaneously immortalized cell line CVCL_B5WP CL:0000010 Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2597; CYP1B1; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9208; POR; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Male 151666849 CVCL_B5X0 AA101 transformed cell line human CVCL_B5X0 CL:0000010 Transformant: Ad-SV40 hybrid virus; Derived from site: In situ; Bone marrow, stroma; UBERON=UBERON_0007195; Cell type: Fibroblast of bone marrow; CL=CL_0002240. Unspecified 151666850 CVCL_B5WB TIEC1 telomerase immortalized cell line CVCL_B5WB CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; W8LAG; ZsGreen (Note=FP506, green fluorescent protein derived from Zoanthus sp); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Small intestine; UBERON=UBERON_0002108; Cell type: Epithelial cell of intestine; CL=CL_0002563. Unspecified 151666851 CVCL_B5WA HTLC-7 transformed cell line human CVCL_B5WA CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Unspecified Doubling time: 14-20 days (PubMed=11370807) 151666852 CVCL_B5WD TIEC3 telomerase immortalized cell line CVCL_B5WD CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; W8LAG; ZsGreen (Note=FP506, green fluorescent protein derived from Zoanthus sp); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Small intestine; UBERON=UBERON_0002108; Cell type: Epithelial cell of intestine; CL=CL_0002563. Unspecified 151666853 CVCL_B5WC TIEC2 telomerase immortalized cell line CVCL_B5WC CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; W8LAG; ZsGreen (Note=FP506, green fluorescent protein derived from Zoanthus sp); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Small intestine; UBERON=UBERON_0002108; Cell type: Epithelial cell of intestine; CL=CL_0002563. Unspecified 151666854 CVCL_B5WF IM-HCEC transformed cell line human CVCL_B5WF CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Eye, cornea, endothelium; UBERON=UBERON_0001985; Cell type: Endothelial cell of cornea; CL=CL_0000132. 151666855 CVCL_B5WE iSEC transformed cell line human CVCL_B5WE CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV); Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107; Cell type: Endothelial cell of hepatic sinusoid; CL=CL_1000398. Unspecified 151666856 CVCL_B5WH IM-HK transformed cell line human CVCL_B5WH CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7 Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Eye, cornea; UBERON=UBERON_0000964; Cell type: Keratocyte; CL=CL_0002363. 151666857 CVCL_B5WG IM-HA transformed cell line human CVCL_B5WG CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956; Cell type: Astrocyte of cerebral cortex; CL=CL_0002605. 151666858 CVCL_B5XZ PDL 9 finite cell line human CVCL_B5XZ CL:0000010 Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266; Cell type: Fibroblast of periodontal ligament; CL=CL_2000017. Male 151666859 CVCL_B5YB HGF16 finite cell line human CVCL_B5YB CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 151666860 CVCL_B5YA HGF15 finite cell line human CVCL_B5YA CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 151666861 CVCL_B5Y4 HGF4 finite cell line human CVCL_B5Y4 CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 151666862 CVCL_B5XS PDL 2 finite cell line human CVCL_B5XS CL:0000010 Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266; Cell type: Fibroblast of periodontal ligament; CL=CL_2000017. Male 151666863 CVCL_B5Y3 HGF2 finite cell line human CVCL_B5Y3 CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 151666864 CVCL_B5XR PDL 1 finite cell line human CVCL_B5XR CL:0000010 Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266; Cell type: Fibroblast of periodontal ligament; CL=CL_2000017. Female 151666865 CVCL_B5Y6 HGF6 finite cell line human CVCL_B5Y6 CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 151666866 CVCL_B5XU PDL 4 finite cell line human CVCL_B5XU CL:0000010 Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266; Cell type: Fibroblast of periodontal ligament; CL=CL_2000017. Male 151666867 CVCL_B5Y5 HGF5 finite cell line human CVCL_B5Y5 CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 151666868 CVCL_B5XT PDL 3 finite cell line human CVCL_B5XT CL:0000010 Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266; Cell type: Fibroblast of periodontal ligament; CL=CL_2000017. Male 151666869 CVCL_B5Y8 HGF9 finite cell line human CVCL_B5Y8 CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 151666870 CVCL_B5XW PDL 6 finite cell line human CVCL_B5XW CL:0000010 Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266; Cell type: Fibroblast of periodontal ligament; CL=CL_2000017. Female 151666871 CVCL_B5Y7 HGF7 finite cell line human CVCL_B5Y7 CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 151666872 CVCL_B5XV PDL 5 finite cell line human CVCL_B5XV CL:0000010 Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266; Cell type: Fibroblast of periodontal ligament; CL=CL_2000017. Female 151666873 CVCL_B5XY PDL 8 finite cell line human CVCL_B5XY CL:0000010 Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266; Cell type: Fibroblast of periodontal ligament; CL=CL_2000017. Female 151666874 CVCL_B5Y9 HGF12 finite cell line human CVCL_B5Y9 CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 151666875 CVCL_B5XX PDL 7 finite cell line human CVCL_B5XX CL:0000010 Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266; Cell type: Fibroblast of periodontal ligament; CL=CL_2000017. Male 151666876 CVCL_B5XK HGF 8 finite cell line human CVCL_B5XK CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Female 151666877 CVCL_B5XJ HGF 7 finite cell line human CVCL_B5XJ CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Female 151666878 CVCL_B5XM HGF 10 finite cell line human CVCL_B5XM CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Female 151666879 CVCL_B5XL HGF 9 finite cell line human CVCL_B5XL CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Male 151666880 CVCL_B5Y0 PDL 10 finite cell line human CVCL_B5Y0 CL:0000010 Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266; Cell type: Fibroblast of periodontal ligament; CL=CL_2000017. Female 151666881 CVCL_B5XN HGF 11 finite cell line human CVCL_B5XN CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Male 151666882 CVCL_B5XQ HGF 13 finite cell line human CVCL_B5XQ CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Male 151666883 CVCL_B5Y2 SKH1 [Mouse hybridoma against human 40 kDa cytokeratin] hybridoma house mouse CVCL_B5Y2 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human 40 kDa cytokeratin. 151666884 CVCL_B5XP HGF 12 finite cell line human CVCL_B5XP CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Female 151666885 CVCL_B5Y1 PDL 11 finite cell line human CVCL_B5Y1 CL:0000010 Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266; Cell type: Fibroblast of periodontal ligament; CL=CL_2000017. Male 151666886 CVCL_B5XC HGF42 finite cell line human CVCL_B5XC CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 151666887 CVCL_B5XB HGF27 finite cell line human CVCL_B5XB CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Unspecified 151666888 CVCL_B5XE HGF 2 finite cell line human CVCL_B5XE CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Female 151666889 CVCL_B5XD HGF 1 finite cell line human CVCL_B5XD CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Female 151666890 CVCL_B5XG HGF 4 finite cell line human CVCL_B5XG CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Female 151666891 CVCL_B5XF HGF 3 finite cell line human CVCL_B5XF CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Male 151666892 CVCL_B5XI HGF 6 finite cell line human CVCL_B5XI CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Female 151666893 CVCL_B5XH HGF 5 finite cell line human CVCL_B5XH CL:0000010 Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Male 151666894 CVCL_B5V9 CET-IPF-FFCYSTFIB2-500 induced pluripotent stem cell human CVCL_B5V9 From: Cellular Engineering Technologies (CET), Inc.; Coralville; USA; From: John Paul II Medical Research Institute; Coralville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (JP2MRI) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666895 CVCL_B5UX TRNDi022-D induced pluripotent stem cell human CVCL_B5UX From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666896 CVCL_B5V8 CET.IPS.FFALP1-500 induced pluripotent stem cell human CVCL_B5V8 From: Cellular Engineering Technologies (CET), Inc.; Coralville; USA; From: John Paul II Medical Research Institute; Coralville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:8941; SERPINA1; Simple; p.Glu366Lys (c.1096G>A); ClinVar=VCV000017967; Zygosity=Homozygous; Note=Z allele (JP2MRI) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666897 CVCL_B5UW TRNDi022-C induced pluripotent stem cell human CVCL_B5UW From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666898 CVCL_B5UZ TRNDi026-B induced pluripotent stem cell human CVCL_B5UZ From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666899 CVCL_B5UY TRNDi026-A induced pluripotent stem cell human CVCL_B5UY From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666900 CVCL_B5UP TRNDi020-A induced pluripotent stem cell human CVCL_B5UP From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666901 CVCL_B5V1 TRNDi027-A induced pluripotent stem cell human CVCL_B5V1 From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Pro237Ser (c.709C>T); ClinVar=VCV000021142; Zygosity=Heterozygous (PubMed=29631617); Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Heterozygous (PubMed=29631617) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666902 CVCL_B5V0 TRNDi026-C induced pluripotent stem cell human CVCL_B5V0 From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666903 CVCL_B5V3 TRNDi008-B induced pluripotent stem cell human CVCL_B5V3 From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5389; IDS; Simple; p.His70Profs*29 (c.208dupC) (c.208insC); ClinVar=VCV000195037; Zygosity=Hemizygous (from parent cell line) Population: Caribbean; Haitian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666904 CVCL_B5UR TRNDi020-C induced pluripotent stem cell human CVCL_B5UR From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666905 CVCL_B5UQ TRNDi020-B induced pluripotent stem cell human CVCL_B5UQ From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666906 CVCL_B5V2 TRNDi027-B induced pluripotent stem cell human CVCL_B5V2 From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Pro237Ser (c.709C>T); ClinVar=VCV000021142; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666907 CVCL_B5V5 NCATS-CL6482 induced pluripotent stem cell human CVCL_B5V5 From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Population: Caucasian; Italian; Cell type: Fibroblast; CL=CL_0000057. Male 151666908 CVCL_B5UT TRNDi020-E induced pluripotent stem cell human CVCL_B5UT From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666909 CVCL_B5V4 NCATS-CL6481 induced pluripotent stem cell human CVCL_B5V4 From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Population: Caucasian; Italian; Cell type: Fibroblast; CL=CL_0000057. Male 151666910 CVCL_B5US TRNDi020-D induced pluripotent stem cell human CVCL_B5US From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666911 CVCL_B5V7 NCATS-CL6484 induced pluripotent stem cell human CVCL_B5V7 From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Population: Caucasian; Cell type: Fibroblast; CL=CL_0000057. Male 151666912 CVCL_B5UV TRNDi022-B induced pluripotent stem cell human CVCL_B5UV From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666913 CVCL_B5V6 NCATS-CL6483 induced pluripotent stem cell human CVCL_B5V6 From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Population: Caucasian; Cell type: Fibroblast; CL=CL_0000057. Male 151666914 CVCL_B5UU TRNDi022-A induced pluripotent stem cell human CVCL_B5UU From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666915 CVCL_B5UH TRNDi017-A induced pluripotent stem cell human CVCL_B5UH From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666916 CVCL_B5UG TRNDi016-B induced pluripotent stem cell human CVCL_B5UG From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666917 CVCL_B5UJ TRNDi019-A induced pluripotent stem cell human CVCL_B5UJ From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666918 CVCL_B5UI TRNDi017-B induced pluripotent stem cell human CVCL_B5UI From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666919 CVCL_B5UL TRNDi019-C induced pluripotent stem cell human CVCL_B5UL From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666920 CVCL_B5UK TRNDi019-B induced pluripotent stem cell human CVCL_B5UK From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666921 CVCL_B5UN TRNDi019-E induced pluripotent stem cell human CVCL_B5UN From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666922 CVCL_B5UM TRNDi019-D induced pluripotent stem cell human CVCL_B5UM From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666923 CVCL_B5UB TRNDi014-C induced pluripotent stem cell human CVCL_B5UB From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666924 CVCL_B5UA TRNDi014-B induced pluripotent stem cell human CVCL_B5UA From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666925 CVCL_B5UD TRNDi015-B induced pluripotent stem cell human CVCL_B5UD From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666926 CVCL_B5UC TRNDi015-A induced pluripotent stem cell human CVCL_B5UC From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666927 CVCL_B5UF TRNDi016-A induced pluripotent stem cell human CVCL_B5UF From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666928 CVCL_B5UE TRNDi015-C induced pluripotent stem cell human CVCL_B5UE From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666929 CVCL_B5VY Hepc/2B6.68 cancer cell line human CVCL_B5VY CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2615; CYP2B6; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 151666930 CVCL_B5VX Hepc/2A6L.14 cancer cell line human CVCL_B5VX CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2610; CYP2A6; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 151666931 CVCL_B5W9 HTLC-19 transformed cell line human CVCL_B5W9 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Unspecified Doubling time: 14-20 days (PubMed=11370807) 151666932 CVCL_B5VZ Hepc/2C19.12 cancer cell line human CVCL_B5VZ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2621; CYP2C19; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 151666933 CVCL_B5W2 Hepc/2D6.39 cancer cell line human CVCL_B5W2 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2625; CYP2D6; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 151666934 CVCL_B5VQ mKSA207-H transformed cell line house mouse CVCL_B5VQ CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA207); Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: BALB/c. Unspecified Characteristics: Heat-adapted, grows at 39.8 Celsius 151666935 CVCL_B5W1 Hepc/2C9.1 cancer cell line human CVCL_B5W1 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2623; CYP2C9; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 151666936 CVCL_B5VP mKSA207-CH transformed cell line house mouse CVCL_B5VP CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA207); Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: BALB/c. Unspecified Characteristics: Heat-adapted, grows at 39.8 Celsius 151666937 CVCL_B5W4 Hepc/3A4.2-30 cancer cell line human CVCL_B5W4 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2637; CYP3A4; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 151666938 CVCL_B5VS mKS(tsC) transformed cell line house mouse CVCL_B5VS CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsC307); Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: BALB/c. Unspecified 151666939 CVCL_B5W3 Hepc/2E1.3-8 cancer cell line human CVCL_B5W3 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2631; CYP2E1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 151666940 CVCL_B5VR mKS(tsB) transformed cell line house mouse CVCL_B5VR CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsB206); Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: BALB/c. Unspecified 151666941 CVCL_B5W6 HTLC-17 transformed cell line human CVCL_B5W6 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Unspecified Doubling time: 7-10 days (PubMed=11370807) 151666942 CVCL_B5VU mKS(wt)-H transformed cell line house mouse CVCL_B5VU CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: BALB/c. Unspecified Characteristics: Heat-adapted, grows at 39.8 Celsius 151666943 CVCL_B5W5 HEK293-UGT2B9 transformed cell line human CVCL_B5W5 CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; O02663; Macaca fascicularis UGT2B9 Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 151666944 CVCL_B5VT mKS(wt) transformed cell line house mouse CVCL_B5VT CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: BALB/c. Unspecified 151666945 CVCL_B5VW Hepc/1A2.9 cancer cell line human CVCL_B5VW CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2596; CYP1A2; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 151666946 CVCL_B5W8 HTLC-15 transformed cell line human CVCL_B5W8 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Unspecified Doubling time: 14-20 days (PubMed=11370807) 151666947 CVCL_B5VV Hepc/1A1.4 cancer cell line human CVCL_B5VV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2595; CYP1A1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 151666948 CVCL_B5W7 HTLC-11 transformed cell line human CVCL_B5W7 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Unspecified Doubling time: 14-20 days (PubMed=11370807) 151666949 CVCL_B5VI BALB/3T3 clone A31 THO2 transformed cell line house mouse CVCL_B5VI CL:0000010 Selected for resistance to: ChEBI; CHEBI_472805; Ouabain; Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG); Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: BALB/c. Unspecified Characteristics: Deficient in hypoxanthine-guanine phosphoribosyltransferase (HGPRT) Doubling time: 30 hours (PubMed=1028169); 16 hours (Note=In 10% FBS), 20.4 hours (Note=In 1% FBS) (PubMed=701383) 151666950 CVCL_B5VH BALB/3T3 clone A31 NTG2 transformed cell line house mouse CVCL_B5VH CL:0000010 Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG); Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: BALB/c. Unspecified 151666951 CVCL_B5VK BALB/3T3 clone A31 ts2-TGO transformed cell line house mouse CVCL_B5VK CL:0000010 Selected for resistance to: ChEBI; CHEBI_472805; Ouabain; Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG); Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: BALB/c. Unspecified 151666952 CVCL_B5VJ BALB/3T3 clone A31 ts2-TG-31 transformed cell line house mouse CVCL_B5VJ CL:0000010 Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG); Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: BALB/c. Unspecified 151666953 CVCL_B5VM mKSA207 conditionally immortalized cell line house mouse CVCL_B5VM CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA207); Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: BALB/c. Unspecified Characteristics: At temperatures above 39.5 Celsius fails to form colonies either in soft agar or on plastic and fails to sustain growth in monolayer culture (PubMed=204069) 151666954 CVCL_B5VL BALB/3T3 clone A31 H transformed cell line house mouse CVCL_B5VL CL:0000010 Transformant: ChEBI; CHEBI_189529; Nitrosocarbaryl; Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: BALB/c. Unspecified 151666955 CVCL_B5W0 Hepc/2C8.46 cancer cell line human CVCL_B5W0 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2622; CYP2C8; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 151666956 CVCL_B5VN mKSA207-C conditionally immortalized cell line house mouse CVCL_B5VN CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA207); Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Breed/subspecies: BALB/c. Unspecified 151666957 CVCL_B5VA AD-2 spontaneously immortalized cell line house mouse CVCL_B5VA CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Osteoblast; CL=CL_0000062; Breed/subspecies: SAMR1. Unspecified 151666958 CVCL_B5VC U-33/gamma-2 spontaneously immortalized cell line house mouse CVCL_B5VC CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:97747; Pparg (Note=Isoform 2); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Osteoblast; CL=CL_0000062; Breed/subspecies: SAMR1. Omics: Transcriptomics; Microarray Unspecified 151666959 CVCL_B5VB U-33/c spontaneously immortalized cell line house mouse CVCL_B5VB CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Osteoblast; CL=CL_0000062; Breed/subspecies: SAMR1. Omics: Transcriptomics; Microarray Unspecified Characteristics: Control cell line for U-33/gamma-2 (Cellosaurus=CVCL_B5VC) 151666960 CVCL_B5VE BALB/3T3 clone A31 ts2 transformed cell line house mouse CVCL_B5VE CL:0000010 Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: BALB/c. Unspecified Characteristics: Temperature sensitive At the non-permissive temperature of 38 Celsius cease to proliferate due to a defect in DNA synthesis (PubMed=182373). Doubling time: 35-40 hours (Note=At 33 Celsius) (PubMed=182373) 151666961 CVCL_B5VD BALB/3T3 clone A31 Ts-1 transformed cell line house mouse CVCL_B5VD CL:0000010 Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: BALB/c. Unspecified Characteristics: Temperature sensitive At the non-permissive temperature (38-38.5 Celsius) cell division cease (PubMed=4798834). Doubling time: 30-32 hours (Note=At 33 Celsius), 22-24 hours (Note=At 38.5 Celsius) (PubMed=4798834) 151666962 CVCL_B5VG BALB/3T3 clone A31 ts22 transformed cell line house mouse CVCL_B5VG CL:0000010 Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: BALB/c. Unspecified Characteristics: Temperature sensitive (PubMed=6933701) 151666963 CVCL_B5VF BALB/3T3 clone A31 ts2R transformed cell line house mouse CVCL_B5VF CL:0000010 Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG); Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: BALB/c. Unspecified Characteristics: Revertant of parent cell line, no longer temperature sensitive (PubMed=6933701) 151666964 CVCL_B5SV HUVEC/TERT66 telomerase immortalized cell line human CVCL_B5SV CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Miscellaneous: STR profile and sex of donor from personal communication of Evercyte Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066; Cell type: Endothelial cell of umbilical vein; CL=CL_0002618. Female Doubling time: ~72 hours (Evercyte=CHT-006-0066) 151666965 CVCL_B5T7 SCTCi016-A induced pluripotent stem cell human CVCL_B5T7 From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10294; RPE65; Simple; c.11+5G>A; ClinVar=VCV000098825; Zygosity=Homozygous (PubMed=35121194) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666966 CVCL_B5T6 SCTCi017-A induced pluripotent stem cell human CVCL_B5T6 From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Cys1488Arg (c.4462T>C); ClinVar=VCV000099284; Zygosity=Heterozygous (PubMed=37441824); Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; c.5196+1137G>A; ClinVar=VCV000438100; Zygosity=Heterozygous (PubMed=37441824) Derived from site: In situ; Finger, skin; UBERON=UBERON_0003533; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666967 CVCL_B5SX RA-MSC/TERT308 telomerase immortalized cell line human CVCL_B5SX CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Miscellaneous: STR profile and sex of donor from personal communication of Evercyte Derived from site: In situ; Amnion; UBERON=UBERON_0000305; Cell type: Mesenchymal stem cell of amnion; CL=CL_0002537. Female Doubling time: 28-34 hours (Evercyte=CHT-050-0308) 151666968 CVCL_B5T9 SCTCi015-A induced pluripotent stem cell human CVCL_B5T9 From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5394; CFI; Simple; p.Gly119Arg (c.355G>A); ClinVar=VCV000066014; Zygosity=Heterozygous (PubMed=35526389) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666969 CVCL_B5SW HDMVEC/TERT164-B telomerase immortalized cell line human CVCL_B5SW CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Miscellaneous: STR profile from personal communication of Evercyte Derived from site: In situ; Skin, microvascular endothelium; UBERON=UBERON_0002097+UBERON_0008339; Cell type: Dermis microvascular lymphatic vessel endothelial cell; CL=CL_2000041. Female Doubling time: 72-96 hours (Evercyte=CHT-013-0164-B) 151666970 CVCL_B5T8 SCTCi018-A induced pluripotent stem cell human CVCL_B5T8 From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; c.4539+2001G>A; ClinVar=VCV00056042; Zygosity=Heterozygous (PubMed=37441824); Sequence variation: Mutation; HGNC; HGNC:34; ABCA4; Simple; p.Leu1631Pro (c.4892T>C); ClinVar=VCV000099328; Zygosity=Heterozygous (PubMed=37441824) Derived from site: In situ; Finger, skin; UBERON=UBERON_0003533; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666971 CVCL_B5SZ WJ-MSC/TERT273 telomerase immortalized cell line human CVCL_B5SZ CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Miscellaneous: STR profile and sex of donor from personal communication of Evercyte Derived from site: In situ; Umbilical cord, Wharton's jelly; UBERON=UBERON_0003422; Cell type: Mesenchymal stem cell of Wharton's jelly; CL=CL_0002568. Female Doubling time: 40-44 hours (Evercyte=CHT-059-0273) 151666972 CVCL_B5SY P-MSC/TERT308 telomerase immortalized cell line human CVCL_B5SY CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Miscellaneous: STR profile from personal communication of Evercyte Derived from site: In situ; Placenta; UBERON=UBERON_0001987; Cell type: Mesenchymal stem cell; CL=CL_0000134. Female Doubling time: 30-36 hours (Evercyte=CHT-051-0308) 151666973 CVCL_B5SN cen2 finite cell line human CVCL_B5SN CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666974 CVCL_B5SM cen3 finite cell line human CVCL_B5SM CL:0000010 Karyotypic information: Gains an extra copy of chromosome 7, X and 18 during progression towards senescence (PubMed=10530795); Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666975 CVCL_B5T1 ASC/TERT300 telomerase immortalized cell line human CVCL_B5T1 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Miscellaneous: STR profile, sex and age of donor from personal communication of Evercyte Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013; Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570. Female Doubling time: 30-36 hours (Evercyte=CHT-001-0300) 151666976 CVCL_B5SP cen4 finite cell line human CVCL_B5SP CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666977 CVCL_B5T0 BM-MSC/TERT292 telomerase immortalized cell line human CVCL_B5T0 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Miscellaneous: STR profile, sex and age of donor from personal communication of Evercyte Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540. Female Doubling time: 34-38 hours (Evercyte=CHT-063-0292) 151666978 CVCL_B5SR CYHI finite cell line human CVCL_B5SR CL:0000010 Derived from site: In situ; Axilla, skin; UBERON=UBERON_0015474; Cell type: Myoepithelial cell; CL=CL_0000185. Female Senescence: Senesces at 45-60 PDL (PubMed=10341211) 151666979 CVCL_B5T3 RS-1C9 transformed cell line human CVCL_B5T3 CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3415; EPO; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134; Cell type: Epithelial cell of proximal tubule; CL=CL_0002306. Male 151666980 CVCL_B5SQ cen1 finite cell line human CVCL_B5SQ CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151666981 CVCL_B5T2 CP-MSC/TERT308 telomerase immortalized cell line human CVCL_B5T2 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Miscellaneous: STR profile from personal communication of Evercyte Derived from site: In situ; Placenta, chorionic plate; UBERON=UBERON_0004027; Cell type: Mesenchymal stem cell; CL=CL_0000134. Female Doubling time: 28-34 hours (Evercyte=CHT-064-0308) 151666982 CVCL_B5ST PODO/SVTERT152 transformed cell line human CVCL_B5ST CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Miscellaneous: STR profile from personal communication of Evercyte Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Urine; UBERON=UBERON_0001088; Cell type: Podocyte; CL=CL_0000653. Male Doubling time: 24-32 hours (Evercyte=CLHT-033-0152) 151666983 CVCL_B5SS HDF/TERT164 telomerase immortalized cell line human CVCL_B5SS CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Miscellaneous: STR profile and age of donor from personal communication of Evercyte Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female Doubling time: 60-72 hours (Evercyte=CHT-008-0164) 151666984 CVCL_B5SF PUMCHi019-A induced pluripotent stem cell human CVCL_B5SF From: Peking Union Medical College Hospital; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:8140; OPA1; Simple; p.Ser269Pro (c.805T>C); ClinVar=VCV001185094; Zygosity=Heterozygous; Note=De novo mutation (PubMed=35152176) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666985 CVCL_B5SE PUMCHi013-A induced pluripotent stem cell human CVCL_B5SE From: Peking Union Medical College Hospital; Beijing; China. CL:0000010 151666986 CVCL_B5SH MUSIe002-A-1 embryonic stem cell human CVCL_B5SH From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16262; YAP1 Population: Southeast Asian; Thai; Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 151666987 CVCL_B5SG MUSIe002-A embryonic stem cell human CVCL_B5SG From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand CL:0000010 Population: Southeast Asian; Thai; Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male 151666988 CVCL_B5SJ MUSIi017-A induced pluripotent stem cell human CVCL_B5SJ From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand CL:0000010 Donor information: Established from healthy donor with Rh negative type O blood (PubMed=38852425); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666989 CVCL_B5SI MUSIi016-A induced pluripotent stem cell human CVCL_B5SI From: Faculty of Medicine Siriraj Hospital, Mahidol University; Bangkok; Thailand CL:0000010 Sequence variation: Mutation; HGNC; HGNC:79; ABO; Simple; p.Thr88Profs*31 (c.261delG); ClinVar=VCV000017735; Zygosity=Homozygous; Note=Allele ABO*O.01 (PubMed=36603353) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 151666990 CVCL_B5SL CUIMCi004-A induced pluripotent stem cell human CVCL_B5SL From: Columbia University Irving Medical Center; New York; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:8108; OCRL; Simple; p.Leu713Argfs*28 (c.2136_2139del+1insCT); Zygosity=Hemizygous (PubMed=35074682) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151666991 CVCL_B5SK DHMi005-A-1 induced pluripotent stem cell human CVCL_B5SK From: German Heart Center Munich; Munich; Germany CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11604; TBX5; Simple_edited; p.Pro85Thr (c.253C>A) (c.920C>A); ClinVar=VCV000626359; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=35121196) Population: Caucasian; Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013; Cell type: Fibroblast; CL=CL_0000057. Male 151666992 CVCL_B5SB PUMCHi010-A induced pluripotent stem cell human CVCL_B5SB From: Peking Union Medical College Hospital; Beijing; China. CL:0000010 151666993 CVCL_B5SA PUMCHi009-A induced pluripotent stem cell human CVCL_B5SA From: Peking Union Medical College Hospital; Beijing; China. CL:0000010 151666994 CVCL_B5SD PUMCHi012-A induced pluripotent stem cell human CVCL_B5SD From: Peking Union Medical College Hospital; Beijing; China. CL:0000010 151666995 CVCL_B5SC PUMCHi011-A induced pluripotent stem cell human CVCL_B5SC From: Peking Union Medical College Hospital; Beijing; China. CL:0000010 151666996 CVCL_B5U8 TRNDi013-F induced pluripotent stem cell human CVCL_B5U8 From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666997 CVCL_B5TW TRNDi028-C induced pluripotent stem cell human CVCL_B5TW From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Thr408Met (c.1223C>T) (T369M); ClinVar=VCV000093447; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151666998 CVCL_B5U7 TRNDi013-E induced pluripotent stem cell human CVCL_B5U7 From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151666999 CVCL_B5TV TRNDi028-B induced pluripotent stem cell human CVCL_B5TV From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Thr408Met (c.1223C>T) (T369M); ClinVar=VCV000093447; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151667000 CVCL_B5TY HT151A induced pluripotent stem cell human CVCL_B5TY From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Trp392Ter (c.1176G>A); ClinVar=VCV000003936; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Heterozygous (from parent cell line) Population: Jewish; Ashkenazi; Derived from site: In situ; Heart, pericardium; UBERON=UBERON_0002407; Cell type: Fibroblast of heart; CL=CL_0002548. Female 151667001 CVCL_B5TX HT134A induced pluripotent stem cell human CVCL_B5TX From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Homozygous (Coriell=GM27466) Population: Caucasian; Cell type: Fibroblast; CL=CL_0000057. Male 151667002 CVCL_B5U9 TRNDi014-A induced pluripotent stem cell human CVCL_B5U9 From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151667003 CVCL_B5TZ HT151C induced pluripotent stem cell human CVCL_B5TZ From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Trp392Ter (c.1176G>A); ClinVar=VCV000003936; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Heterozygous (from parent cell line) Population: Jewish; Ashkenazi; Derived from site: In situ; Heart, pericardium; UBERON=UBERON_0002407; Cell type: Fibroblast of heart; CL=CL_0002548. Female 151667004 CVCL_B5U0 HT134E induced pluripotent stem cell human CVCL_B5U0 From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Cell type: Fibroblast; CL=CL_0000057. Male 151667006 CVCL_B5TQ NCATS-CL7569 induced pluripotent stem cell human CVCL_B5TQ From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple; p.Arg626Ter (c.1876C>T); ClinVar=VCV000001561; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Cell type: Fibroblast; CL=CL_0000057. Male 151667007 CVCL_B5U2 TRNDi011-B induced pluripotent stem cell human CVCL_B5U2 From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151667008 CVCL_B5TP NCATS-CL7568 induced pluripotent stem cell human CVCL_B5TP From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple; p.Glu153Lys (c.457G>A); ClinVar=VCV001067431; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151667009 CVCL_B5U1 TRNDi011-A induced pluripotent stem cell human CVCL_B5U1 From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151667010 CVCL_B5TS NCATS-CL9316 induced pluripotent stem cell human CVCL_B5TS From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Arg854Ter (c.2560C>T); ClinVar=VCV000004034; Zygosity=Homozygous (from parent cell line) Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151667011 CVCL_B5U4 TRNDi013-B induced pluripotent stem cell human CVCL_B5U4 From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151667012 CVCL_B5TR TRNDi042-A induced pluripotent stem cell human CVCL_B5TR From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple; p.Arg626Ter (c.1876C>T); ClinVar=VCV000001561; Zygosity=Homozygous (PubMed=39579553) Population: Caucasian; Cell type: Fibroblast; CL=CL_0000057. Male 151667013 CVCL_B5U3 TRNDi013-A induced pluripotent stem cell human CVCL_B5U3 From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151667014 CVCL_B5U6 TRNDi013-D induced pluripotent stem cell human CVCL_B5U6 From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151667015 CVCL_B5TU TRNDi028-A induced pluripotent stem cell human CVCL_B5TU From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Thr408Met (c.1223C>T) (T369M); ClinVar=VCV000093447; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151667016 CVCL_B5TT NCATS-CL9318 induced pluripotent stem cell human CVCL_B5TT From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Arg854Ter (c.2560C>T); ClinVar=VCV000004034; Zygosity=Homozygous (from parent cell line) Population: African American; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151667017 CVCL_B5U5 TRNDi013-C induced pluripotent stem cell human CVCL_B5U5 From: NIH-NCATS-TRND Branch; Rockville; USA. CL:0000010 151667018 CVCL_B5TG PODO/TERT252 telomerase immortalized cell line human CVCL_B5TG CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Miscellaneous: Cell line available upon request to Evercyte; Miscellaneous: Cell line information from personal communication of Evercyte Derived from site: In situ; Urine; UBERON=UBERON_0001088; Cell type: Podocyte; CL=CL_0000653. Female 151667019 CVCL_B5TF DSM ACC2258 transformed cell line human CVCL_B5TF CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Colon; UBERON=UBERON_0001155; Cell type: Epithelial cell of colon; CL=CL_0011108. Female Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2258 151667020 CVCL_B5TI LF/TERT309 telomerase immortalized cell line human CVCL_B5TI CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Miscellaneous: Sex and age of donor from personal communication of Evercyte Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Fibroblast of lung; CL=CL_0002553. Female Doubling time: ~36 hours (Evercyte=CHT-067-0309) 151667021 CVCL_B5TH PODO/TERT255 telomerase immortalized cell line human CVCL_B5TH CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Miscellaneous: Cell line available upon request to Evercyte; Miscellaneous: Cell line information from personal communication of Evercyte Derived from site: In situ; Kidney, glomerulus; UBERON=UBERON_0000074; Cell type: Podocyte; CL=CL_0000653. Male 151667022 CVCL_B5TK HT147D induced pluripotent stem cell human CVCL_B5TK From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151667023 CVCL_B5TJ HT142C induced pluripotent stem cell human CVCL_B5TJ From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; c.590-7G>A (IVS5AS-7G>A); ClinVar=VCV000222996; Zygosity=Heterozygous (Coriell=GM28383); Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; p.Trp402Ter (c.1205G>A); ClinVar=VCV000011908; Zygosity=Heterozygous (Coriell=GM28383) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151667024 CVCL_B5TM HT148D induced pluripotent stem cell human CVCL_B5TM From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151667025 CVCL_B5TL HT148A induced pluripotent stem cell human CVCL_B5TL From: NIH-NCATS-TRND Branch; Rockville; USA CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151667026 CVCL_B5TA SCTCi014-A induced pluripotent stem cell human CVCL_B5TA From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5394; CFI; Simple; p.Gly119Arg (c.355G>A); ClinVar=VCV000066014; Zygosity=Heterozygous (PubMed=35526386) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151667027 CVCL_B5TC IDIBGIi002-A induced pluripotent stem cell human CVCL_B5TC From: Institut d'Investigacio Biomedica de Girona Dr Josep Trueta; Salt; Spain. CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Val1525Met (c.4573G>A) (p.Val1524Met, c.4570G>A); ClinVar=VCV000067910; Zygosity=Heterozygous (PubMed=35772296) Population: Caucasian; Derived from site: In situ; Back, skin, dermis; UBERON=UBERON_0001068+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 151667028 CVCL_B5TB IDIBGIi001-A induced pluripotent stem cell human CVCL_B5TB From: Institut d'Investigacio Biomedica de Girona Dr Josep Trueta; Salt; Spain. CL:0000010 Population: Caucasian; Derived from site: In situ; Neck, skin; UBERON=UBERON_0001417; Cell type: Fibroblast of skin; CL=CL_0002620. Male Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 151667029 CVCL_B5TE IDIBGIi004-A induced pluripotent stem cell human CVCL_B5TE From: Institut d'Investigacio Biomedica de Girona Dr Josep Trueta; Salt; Spain. CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Val1525Met (c.4573G>A) (p.Val1524Met, c.4570G>A); ClinVar=VCV000067910; Zygosity=Heterozygous (PubMed=35772296) Population: Caucasian; Derived from site: In situ; Back, skin, dermis; UBERON=UBERON_0001068+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 151667030 CVCL_B5TD IDIBGIi003-A induced pluripotent stem cell human CVCL_B5TD From: Institut d'Investigacio Biomedica de Girona Dr Josep Trueta; Salt; Spain. CL:0000010 Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Val1525Met (c.4573G>A) (p.Val1524Met, c.4570G>A); ClinVar=VCV000067910; Zygosity=Heterozygous (PubMed=35772296) Population: Caucasian; Derived from site: In situ; Back, skin, dermis; UBERON=UBERON_0001068+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection 151667031 CVCL_B6CE HF-4 hybridoma human CVCL_B6CE CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Nucleic acids: ssDNA, poly(A), poly(G) and poly(dC). 151667032 CVCL_B6CD HL-349 hybridoma human CVCL_B6CD CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_16991; DNA; Monoclonal antibody target: ChEBI; CHEBI_33697; RNA. 151667033 CVCL_B6CG HB-7 hybridoma human CVCL_B6CG CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Nucleic acids: ssDNA, poly(A), poly(G) and poly(dC). 151667034 CVCL_B6CF HF-7 hybridoma human CVCL_B6CF CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Nucleic acids: ssDNA, poly(A), poly(G) and poly(dC). 151667035 CVCL_B6CI HB-5 hybridoma human CVCL_B6CI CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_73300; Poly(deoxythymidylic acid) (poly(dT)). 151667036 CVCL_B6CH HL-259 hybridoma human CVCL_B6CH CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Nucleic acids: ssDNA, poly(A), poly(G) and poly(dC). 151667037 CVCL_B6CK EMK-F7 hybridoma human CVCL_B6CK CL:0000010 Anecdotal: The peripheral blood cells that were hybridized with the HO-323 cell line were obtained from Kotaro Koyama who injected himself with stomach cancer cell lines MKN-28 and MKN-45 (PubMed=2121682). Monoclonal antibody isotype: IgG; Monoclonal antibody target: Human antigen on stomach cancer cell lines 151667038 CVCL_B6CJ SH-9 [Human hybridoma against poly(dT)] hybridoma human CVCL_B6CJ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_73300; Poly(deoxythymidylic acid) (poly(dT)). 151667039 CVCL_B6CA SH-9 [Mouse hybridoma against human MUC16] hybridoma house mouse CVCL_B6CA CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16. 151667040 CVCL_B6CC HL-321 hybridoma human CVCL_B6CC CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Nucleic acids: poly(dT), poly(I) and poly(dU). 151667041 CVCL_B6CB SU-1 hybridoma human CVCL_B6CB CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Nucleic acids: dsDNA, ssDNA and RNA. 151667042 CVCL_B6BT MSC IGF-1#3 finite cell line house mouse CVCL_B6BT CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5464; IGF1; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540; Breed/subspecies: C57BL/6-EGFP transgenic. Male 151667043 CVCL_B6C5 Vero-EGFP-SBV-N spontaneously immortalized cell line green monkey CVCL_B6C5 CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; H2AM13; Schmallenberg virus (SBV) nucleoprotein (N); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819; Cell type: Epithelial cell of kidney; CL=CL_0002518. Female Characteristics: Transfected with a fusion eGFP-SBV-N protein Group: Non-human primate cell line 151667044 CVCL_B6C4 2H12 [Mouse hybridoma against human IL37] hybridoma house mouse CVCL_B6C4 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q9NZH6; Human IL37. 151667045 CVCL_B6BS MSC IGF-1#2 finite cell line house mouse CVCL_B6BS CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5464; IGF1; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540; Breed/subspecies: C57BL/6-EGFP transgenic. Male 151667046 CVCL_B6C7 E6 hybridoma house mouse CVCL_B6C7 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Labeo rohita thymocyte 166.2 kDa protein. 151667047 CVCL_B6BV Sf9-GFP spontaneously immortalized cell line CVCL_B6BV CL:0000010 Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein); Genetic integration: Method=Transfection; Gene=UniProtKB; P17501; Autographa californica nuclear polyhedrosis virus (AcMNPV) GP64; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female Characteristics: Expresses GFP at the cell surface Transfected with a vector containing a fused AcMNPV gp64-GFP construct (PubMed=28365799). Group: Insect cell line 151667048 CVCL_B6C6 2C8 [Mouse hybridoma against SBV N] hybridoma house mouse CVCL_B6C6 CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; H2AM13; Schmallenberg virus (SBV) nucleoprotein (N). 151667049 CVCL_B6BU hTBME telomerase immortalized cell line CVCL_B6BU CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Cell type: Epithelial cell of mammary gland; CL=CL_0002327. Female Doubling time: ~54 hours (PubMed=28918563) 151667050 CVCL_B6BX 1C6 [Mouse hybridoma against human IL37] hybridoma house mouse CVCL_B6BX CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q9NZH6; Human IL37 (Note=Isoform B). 151667051 CVCL_B6C9 HO-323-3 transformed cell line human CVCL_B6C9 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>A); ClinVar=VCV000142714; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Spleen; UBERON=UBERON_0002106; Cell type: B-cell; CL=CL_0000236. Male Group: Hybridoma fusion partner cell line 151667052 CVCL_B6BW H5-GFP spontaneously immortalized cell line CVCL_B6BW CL:0000010 Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein); Genetic integration: Method=Transfection; Gene=UniProtKB; P17501; Autographa californica nuclear polyhedrosis virus (AcMNPV) GP64; Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Unspecified Characteristics: Expresses GFP at the cell surface Transfected with a vector containing a fused AcMNPV gp64-GFP construct (PubMed=28365799). Group: Insect cell line 151667053 CVCL_B6C8 MARC-145 PBD-1+EGFP clone 9/D6 spontaneously immortalized cell line CVCL_B6C8 CL:0000010 Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=VGNC; VGNC:87240; Pig DEFB1 Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518. Unspecified Characteristics: Transfected with a Neo-CMV-DEFB1-IRES-EGFP construct (PubMed=25297006) Group: Non-human primate cell line Problematic cell line: Misidentified Grand-parent cell line (MA-104) has been shown to be from Chlorocebus pygerythrus instead of Rhesus macaque. 151667054 CVCL_B6BZ 1D4 [Mouse hybridoma against human IL37] hybridoma house mouse CVCL_B6BZ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q9NZH6; Human IL37. 151667055 CVCL_B6BY 1D10 hybridoma house mouse CVCL_B6BY CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q9NZH6; Human IL37. 151667056 CVCL_B6BL ELLU clone #136 transformed cell line human CVCL_B6BL CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7 Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Erythroid progenitor cell; CL=CL_0000038. Unspecified Characteristics: Expresses HBA1, HBA2 and HBG1 (PubMed=34817797) 151667057 CVCL_B6BK ELLU clone #131 transformed cell line human CVCL_B6BK CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7 Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Erythroid progenitor cell; CL=CL_0000038. Unspecified Characteristics: Expresses HBA1, HBA2 and HBG1 (PubMed=34817797) 151667058 CVCL_B6BN STPDLDS transformed cell line human CVCL_B6BN CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Japanese; Karyotypic information: Has a large number of abnormal chromosomes (PubMed=34590290); Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266; Cell type: Fibroblast of periodontal ligament; CL=CL_2000017. Male 151667059 CVCL_B6BM STPDL transformed cell line human CVCL_B6BM CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Japanese; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266; Cell type: Fibroblast of periodontal ligament; CL=CL_2000017. Male 151667060 CVCL_B6C1 2D1 [Mouse hybridoma against human IL37] hybridoma house mouse CVCL_B6C1 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q9NZH6; Human IL37 (Note=Isoform B). 151667061 CVCL_B6BP MSC G-CSF#1 finite cell line house mouse CVCL_B6BP CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2438; CSF3; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540; Breed/subspecies: C57BL/6-EGFP transgenic. Male 151667062 CVCL_B6C0 2A3 [Mouse hybridoma against human IL37] hybridoma house mouse CVCL_B6C0 CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q9NZH6; Human IL37. 151667063 CVCL_B6C3 2F5 [Mouse hybridoma against human IL37] hybridoma house mouse CVCL_B6C3 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q9NZH6; Human IL37 (Note=Isoform B). 151667064 CVCL_B6BR MSC IGF-1#1 finite cell line house mouse CVCL_B6BR CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5464; IGF1; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540; Breed/subspecies: C57BL/6-EGFP transgenic. Male 151667065 CVCL_B6C2 2E9 [Mouse hybridoma against human IL37] hybridoma house mouse CVCL_B6C2 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q9NZH6; Human IL37 (Note=Isoform B). 151667066 CVCL_B6BQ MSC G-CSF#2 finite cell line house mouse CVCL_B6BQ CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2438; CSF3; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540; Breed/subspecies: C57BL/6-EGFP transgenic. Male 151667067 CVCL_B6DF CG3/12/26 hybridoma house mouse CVCL_B6DF CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: Chuzan virus (isolate K-47). 151667068 CVCL_B6DE CG53/2/4 hybridoma house mouse CVCL_B6DE CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Chuzan virus (isolate K-47) 100 kDa antigen. 151667069 CVCL_B6DH CM1/33 hybridoma house mouse CVCL_B6DH CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Chuzan virus (isolate K-47) 41 kDa antigen. 151667070 CVCL_B6DG CG14/3/1 hybridoma house mouse CVCL_B6DG CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: Chuzan virus (isolate K-47). 151667071 CVCL_B6DJ CM5/57 hybridoma house mouse CVCL_B6DJ CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Chuzan virus (isolate K-47). 151667072 CVCL_B6DI CM3/5/3 hybridoma house mouse CVCL_B6DI CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Chuzan virus (isolate K-47). 151667073 CVCL_B6DL CM23/24 hybridoma house mouse CVCL_B6DL CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Chuzan virus (isolate K-47). 151667074 CVCL_B6DK CM11/33 hybridoma house mouse CVCL_B6DK CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Chuzan virus (isolate K-47). 151667075 CVCL_B6DB CG31 hybridoma house mouse CVCL_B6DB CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Chuzan virus (isolate K-47). 151667076 CVCL_B6DA CG13/14/2 hybridoma house mouse CVCL_B6DA CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Chuzan virus (isolate K-47). 151667077 CVCL_B6DD CG49 hybridoma house mouse CVCL_B6DD CL:0000010 Monoclonal antibody isotype: IgG2a, kappa+lambda; Monoclonal antibody target: Chuzan virus (isolate K-47). 151667078 CVCL_B6DC CG41/44/11 hybridoma house mouse CVCL_B6DC CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Chuzan virus (isolate K-47). 151667079 CVCL_B6CU 9P-13-4 hybridoma human CVCL_B6CU CL:0000010 Characteristics: Seems to secrete two different mAbs; Monoclonal antibody isotype: IgA+IgM. 151667080 CVCL_B6D6 CG1/1 hybridoma house mouse CVCL_B6D6 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Chuzan virus (isolate K-47) 41 kDa antigen. 151667081 CVCL_B6CT 9L-27-9 hybridoma human CVCL_B6CT CL:0000010 Characteristics: Seems to secrete two different mAbs; Monoclonal antibody isotype: IgA+IgM. 151667082 CVCL_B6D5 F3(B6) hybridoma house mouse CVCL_B6D5 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P47712; Human PLA2G4A. 151667083 CVCL_B6D8 CG12 hybridoma house mouse CVCL_B6D8 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Chuzan virus (isolate K-47). 151667084 CVCL_B6CW IM-9-P3 transformed cell line human CVCL_B6CW CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Female Characteristics: Produces prolactin Problematic cell line: Misclassified Grand-parent cell line originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line. 151667085 CVCL_B6D7 CG2/2D hybridoma house mouse CVCL_B6D7 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Chuzan virus (isolate K-47). 151667086 CVCL_B6CV IM-9-P transformed cell line human CVCL_B6CV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Female Characteristics: Produces prolactin But after approximately 7 months in culture the capacity to synthesize prolactin is greatly reduced (PubMed=1366653; PubMed=2836165). Problematic cell line: Misclassified Parent cell line originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line. 151667087 CVCL_B6CY IM-9-P33 transformed cell line human CVCL_B6CY CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Female Characteristics: Produces high quantity of prolactin Problematic cell line: Misclassified Ancestral cell line originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line. 151667088 CVCL_B6D9 CG7 hybridoma house mouse CVCL_B6D9 CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: Chuzan virus (isolate K-47). 151667089 CVCL_B6CX IM-9-P6 transformed cell line human CVCL_B6CX CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Female Characteristics: Compared to the parent cell line, has lost the ability to produces prolactin Problematic cell line: Misclassified Grand-parent cell line originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line. 151667090 CVCL_B6CZ IM-9-P31 transformed cell line human CVCL_B6CZ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Female Characteristics: Produces low quantity of prolactin Problematic cell line: Misclassified Ancestral cell line originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line. 151667091 CVCL_B6CM KMK-41 hybridoma human CVCL_B6CM CL:0000010 Monoclonal antibody isotype: Not specified. 151667092 CVCL_B6CL FMK-H3 hybridoma human CVCL_B6CL CL:0000010 Anecdotal: The peripheral blood cells that were hybridized with the HO-323 cell line were obtained from Kotaro Koyama who injected himself with stomach cancer cell lines MKN-28 and MKN-45 (PubMed=2121682). Monoclonal antibody isotype: IgM; Monoclonal antibody target: Human antigen on stomach cancer cell lines 151667093 CVCL_B6D0 IM-9-P32 transformed cell line human CVCL_B6D0 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Female Characteristics: Produces medium quantity of prolactin Problematic cell line: Misclassified Ancestral cell line originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line. 151667094 CVCL_B6CN SH-75 hybridoma human CVCL_B6CN CL:0000010 Monoclonal antibody isotype: Not specified. 151667095 CVCL_B6D2 P7E9C7 hybridoma human CVCL_B6D2 CL:0000010 Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: UniProtKB; P11439; Pseudomonas aeruginosa exotoxin A (eta). Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-1810; Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50139 151667096 CVCL_B6CQ SH-77 hybridoma human CVCL_B6CQ CL:0000010 Monoclonal antibody isotype: Not specified. 151667097 CVCL_B6D1 PEA7-1-6D transformed cell line human CVCL_B6D1 CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Donor information: Established from a healthy donor infected with Pseudomonas aeruginosa; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-1809; Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50138 151667098 CVCL_B6CP SH-76 hybridoma human CVCL_B6CP CL:0000010 Monoclonal antibody isotype: Not specified. 151667099 CVCL_B6D4 HH-1 hybridoma human CVCL_B6D4 CL:0000010 Characteristics: Tridoma obtained by the biological fusion of an hybridoma (AGC-78) with an EBV-transformed LCL cell line; Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: Human antigen on cancer cell line A431; Monoclonal antibody target: UniProtKB; P11439; Pseudomonas aeruginosa exotoxin A (eta). Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-1811; Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50162 151667100 CVCL_B6CS SH-83 hybridoma human CVCL_B6CS CL:0000010 Monoclonal antibody isotype: Not specified. 151667101 CVCL_B6D3 AGC-78 hybridoma human CVCL_B6D3 CL:0000010 Monoclonal antibody isotype: IgG2, kappa; Monoclonal antibody target: Human antigen on cancer cell line A431. Group: Patented cell line; Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-1812; Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50165 151667102 CVCL_B6CR SH-78 hybridoma human CVCL_B6CR CL:0000010 Monoclonal antibody isotype: Not specified. 151667103 CVCL_B6AC HepaRG FXR KO cancer cell line human CVCL_B6AC CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:7967; NR1H4 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Discontinued: Sigma-Aldrich; MTOX1031; true Female 151667104 CVCL_B6AB HepaRG CYP3A4 KO cancer cell line human CVCL_B6AB CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:2637; CYP3A4 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Discontinued: Sigma-Aldrich; MTOX1026; true Female 151667105 CVCL_B6AE HepaRG MDR1 KO cancer cell line human CVCL_B6AE CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:40; ABCB1 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Female 151667106 CVCL_B6AD HepaRG MATE1 KO cancer cell line human CVCL_B6AD CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:25588; SLC47A1 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Discontinued: Sigma-Aldrich; MTOX1022; true Female 151667107 CVCL_B6AG HepaRG MRP2 KO cancer cell line human CVCL_B6AG CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:53; ABCC2 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Female 151667108 CVCL_B6AF HepaRG MDR3 KO cancer cell line human CVCL_B6AF CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:45; ABCB4 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Female 151667109 CVCL_B6AI HepaRG MRP3 KO cancer cell line human CVCL_B6AI CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:54; ABCC3 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Female 151667110 CVCL_B6AH HepaRG MRP2/MRP4 KO cancer cell line human CVCL_B6AH CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:53; ABCC2; Knockout cell: Method=ZFN; HGNC; HGNC:55; ABCC4 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Discontinued: Sigma-Aldrich; MTOX1103; true Female 151667111 CVCL_B6AA HepaRG CAR KO cancer cell line human CVCL_B6AA CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:7969; NR1I3 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Female 151667112 CVCL_B6A3 C2BBe1 MRP6 KO cancer cell line human CVCL_B6A3 CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:57; ABCC6; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Discontinued: Sigma-Aldrich; MTOX1096; true Male 151667113 CVCL_B6A2 C2BBe1 MRP3 KO cancer cell line human CVCL_B6A2 CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:54; ABCC3; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151667114 CVCL_B6A5 HUPEC 004 FSGS G1/G2 conditionally immortalized cell line human CVCL_B6A5 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Population: African American; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Urine; UBERON=UBERON_0001088; Cell type: Podocyte-like epithelial cell; CL=CL_0000653. Male 151667115 CVCL_B6A4 C2BBe1 MRP3/MRP4 KO cancer cell line human CVCL_B6A4 CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:54; ABCC3; Knockout cell: Method=ZFN; HGNC; HGNC:55; ABCC4; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Discontinued: Sigma-Aldrich; MTOX1098; true Male 151667116 CVCL_B6A7 HepaRG AHR KO cancer cell line human CVCL_B6A7 CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:348; AHR Derived from site: In situ; Liver; UBERON=UBERON_0002107. Female 151667117 CVCL_B6A6 HepaRG 5F cancer cell line human CVCL_B6A6 CL:0000010 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Female Characteristics: These cells were modified with the use of transfected mRNA encoding ZFNs targeting a specific site (Sigma-Aldrich=MTOX1010) 151667118 CVCL_B6A9 HepaRG BSEP KO cancer cell line human CVCL_B6A9 CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:42; ABCB11 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Female 151667119 CVCL_B6A8 HepaRG BCRP KO cancer cell line human CVCL_B6A8 CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:74; ABCG2 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Female 151667120 CVCL_B6A1 C2BBe1 MRP4 KO cancer cell line human CVCL_B6A1 CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:55; ABCC4; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151667121 CVCL_B6A0 C2BBe1 MRP7 KO cancer cell line human CVCL_B6A0 CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:52; ABCC10; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 151667122 CVCL_B6BD ELLU clone #110 transformed cell line human CVCL_B6BD CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7 Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Erythroid progenitor cell; CL=CL_0000038. Unspecified Characteristics: Expresses HBA1, HBA2 and HBG1 This clone does not express BCL11A and thus expresses HBE1 and HBZ instead of adult beta globin (PubMed=34817797). 151667123 CVCL_B6BC ELLU clone #104 transformed cell line human CVCL_B6BC CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7 Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Erythroid progenitor cell; CL=CL_0000038. Unspecified Characteristics: Expresses HBA1, HBA2 and HBG1 Also expresses HBB (PubMed=34817797). 151667124 CVCL_B6BF ELLU clone #121 transformed cell line human CVCL_B6BF CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7 Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Erythroid progenitor cell; CL=CL_0000038. Unspecified Characteristics: Expresses HBA1, HBA2 and HBG1 (PubMed=34817797) 151667125 CVCL_B6BE ELLU clone #116 transformed cell line human CVCL_B6BE CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7 Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Erythroid progenitor cell; CL=CL_0000038. Unspecified Characteristics: Expresses HBA1, HBA2 and HBG1 Also expresses HBB (PubMed=34817797). 151667126 CVCL_B6BH ELLU clone #125 transformed cell line human CVCL_B6BH CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7 Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Erythroid progenitor cell; CL=CL_0000038. Unspecified Characteristics: Expresses HBA1, HBA2 and HBG1 (PubMed=34817797) 151667127 CVCL_B6BG ELLU clone #123 transformed cell line human CVCL_B6BG CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7 Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Erythroid progenitor cell; CL=CL_0000038. Unspecified Characteristics: Expresses HBA1, HBA2 and HBG1 (PubMed=34817797) 151667128 CVCL_B6BJ ELLU clone #127 transformed cell line human CVCL_B6BJ CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7 Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Erythroid progenitor cell; CL=CL_0000038. Unspecified Characteristics: Expresses HBA1, HBA2 and HBG1 (PubMed=34817797) 151667129 CVCL_B6BI ELLU clone #126 transformed cell line human CVCL_B6BI CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7 Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Erythroid progenitor cell; CL=CL_0000038. Unspecified Characteristics: Expresses HBA1, HBA2 and HBG1 (PubMed=34817797) 151667130 CVCL_B6AZ MuRTE21 spontaneously immortalized cell line house mouse CVCL_B6AZ CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53 Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134; Cell type: Epithelial cell of proximal tubule; CL=CL_0002306. Male 151667131 CVCL_B6BB PTEN-KO BMSC finite cell line CVCL_B6BB CL:0000010 Knockout cell: Method=CRISPR/Cas9; UniProtKB; G1SVU9; PTEN Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540. Unspecified 151667132 CVCL_B6BA MuRTE82 spontaneously immortalized cell line house mouse CVCL_B6BA CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53 Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134; Cell type: Epithelial cell of proximal tubule; CL=CL_0002306. Male 151667133 CVCL_B6AS HepaRG PXR KO cancer cell line human CVCL_B6AS CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:7968; NR1I2 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Female 151667134 CVCL_B6B4 MuRTE42 spontaneously immortalized cell line house mouse CVCL_B6B4 CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53 Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134; Cell type: Epithelial cell of proximal tubule; CL=CL_0002306. Male 151667135 CVCL_B6AR HepaRG POR KO cancer cell line human CVCL_B6AR CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:9208; POR Derived from site: In situ; Liver; UBERON=UBERON_0002107. Discontinued: Sigma-Aldrich; MTOX1025; true Female 151667136 CVCL_B6B3 MuRTE31 spontaneously immortalized cell line house mouse CVCL_B6B3 CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53 Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134; Cell type: Epithelial cell of proximal tubule; CL=CL_0002306. Male 151667137 CVCL_B6AU HepaRG SOD2 KO cancer cell line human CVCL_B6AU CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:11180; SOD2 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Discontinued: Sigma-Aldrich; MTOX1027; true Female 151667138 CVCL_B6B6 MuRTE61 spontaneously immortalized cell line house mouse CVCL_B6B6 CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53 Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134; Cell type: Epithelial cell of proximal tubule; CL=CL_0002306. Male 151667139 CVCL_B6AT HepaRG PXR/CAR KO cancer cell line human CVCL_B6AT CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:7968; NR1I2; Knockout cell: Method=ZFN; HGNC; HGNC:7969; NR1I3 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Discontinued: Sigma-Aldrich; MTOX1014; true Female 151667140 CVCL_B6B5 MuRTE52 spontaneously immortalized cell line house mouse CVCL_B6B5 CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53 Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134; Cell type: Epithelial cell of proximal tubule; CL=CL_0002306. Male 151667141 CVCL_B6B8 MuRTE72 spontaneously immortalized cell line house mouse CVCL_B6B8 CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53 Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134; Cell type: Epithelial cell of proximal tubule; CL=CL_0002306. Male 151667142 CVCL_B6AW SA7K MATE1/MATE2K KO transformed cell line human CVCL_B6AW CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:25588; SLC47A1; Knockout cell: Method=ZFN; HGNC; HGNC:26439; SLC47A2 Population: African American; Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134; Cell type: Epithelial cell of proximal tubule; CL=CL_0002306. Female Characteristics: The parent cell line was established by zinc finger nuclease-mediated knockout of a cell cycle protein (from parent cell line SA7K) 151667143 CVCL_B6B7 MuRTE71 spontaneously immortalized cell line house mouse CVCL_B6B7 CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53 Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134; Cell type: Epithelial cell of proximal tubule; CL=CL_0002306. Male 151667144 CVCL_B6AV SA7K MATE1 KO transformed cell line human CVCL_B6AV CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:25588; SLC47A1 Population: African American; Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134; Cell type: Epithelial cell of proximal tubule; CL=CL_0002306. Female Characteristics: The parent cell line was established by zinc finger nuclease-mediated knockout of a cell cycle protein (from parent cell line SA7K) 151667145 CVCL_B6AY MuRTE15 spontaneously immortalized cell line house mouse CVCL_B6AY CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53 Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134; Cell type: Epithelial cell of proximal tubule; CL=CL_0002306. Male 151667146 CVCL_B6B9 MuRTE73 spontaneously immortalized cell line house mouse CVCL_B6B9 CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53 Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134; Cell type: Epithelial cell of proximal tubule; CL=CL_0002306. Male 151667147 CVCL_B6AX SA7K MATE2K KO transformed cell line human CVCL_B6AX CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:26439; SLC47A2 Population: African American; Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134; Cell type: Epithelial cell of proximal tubule; CL=CL_0002306. Female Characteristics: The parent cell line was established by zinc finger nuclease-mediated knockout of a cell cycle protein (from parent cell line SA7K) 151667148 CVCL_B6AK HepaRG MRP6 KO cancer cell line human CVCL_B6AK CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:57; ABCC6 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Discontinued: Sigma-Aldrich; MTOX1104; true Female 151667149 CVCL_B6AJ HepaRG MRP4 KO cancer cell line human CVCL_B6AJ CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:55; ABCC4 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Discontinued: Sigma-Aldrich; MTOX1106; true Female 151667150 CVCL_B6AM HepaRG OATP1B1/OATP1B3 KO cancer cell line human CVCL_B6AM CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:10959; SLCO1B1; Knockout cell: Method=ZFN; HGNC; HGNC:10961; SLCO1B3 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Discontinued: Sigma-Aldrich; MTOX1017; true Female 151667151 CVCL_B6AL HepaRG OATP1B1 KO cancer cell line human CVCL_B6AL CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:10959; SLCO1B1 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Discontinued: Sigma-Aldrich; MTOX1015; true Female 151667152 CVCL_B6B0 MuRTE22 spontaneously immortalized cell line house mouse CVCL_B6B0 CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53 Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134; Cell type: Epithelial cell of proximal tubule; CL=CL_0002306. Male 151667153 CVCL_B6AN HepaRG OATP1B3 KO cancer cell line human CVCL_B6AN CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:10961; SLCO1B3 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Female 151667154 CVCL_B6AQ HepaRG PERK KO cancer cell line human CVCL_B6AQ CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:3255; EIF2AK3 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Female 151667155 CVCL_B6B2 MuRTE24 spontaneously immortalized cell line house mouse CVCL_B6B2 CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53 Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134; Cell type: Epithelial cell of proximal tubule; CL=CL_0002306. Male 151667156 CVCL_B6AP HepaRG P66SHC KO cancer cell line human CVCL_B6AP CL:0000010 Knockout cell: Method=ZFN; HGNC; HGNC:10840; SHC1 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Discontinued: Sigma-Aldrich; MTOX1023; true Female 151667157 CVCL_B6B1 MuRTE23 spontaneously immortalized cell line house mouse CVCL_B6B1 CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53 Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134; Cell type: Epithelial cell of proximal tubule; CL=CL_0002306. Male 151667158 CVCL_B6YZ UFERSA-PC1 finite cell line CVCL_B6YZ CL:0000010 Miscellaneous: Age/sex of donor and cell line name from personal communication of Pereira, Alexsandra Fernandes Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151667159 CVCL_B6ZB IMC-118 cancer cell line dog CVCL_B6ZB CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: Beagle; VBO=VBO_0200131. Female Characteristics: Luminal type B inflammatory and ERBB2+ (Patent=CN113980904B; PubMed=35429113) Doubling time: 50.31 hours (Patent=CN113980904B; PubMed=35429113) Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2021285 151667160 CVCL_B6ZA RNCEC/HL-032 finite cell line CVCL_B6ZA CL:0000010 Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772; Cell type: Epithelial cell of cornea; CL=CL_0000575; Breed/subspecies: New Zealand white; VBO=VBO_0001267. Unspecified Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201677 151667161 CVCL_B6YS iTIME.219 telomerase immortalized cell line human CVCL_B6YS CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.); Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR; Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Foreskin, skin, dermis, microvascular endothelium; UBERON=UBERON_0001471+UBERON_0008339. Male Characteristics: rKSHV.219 includes a RFP-GFP-PuroR construct that contains RFP under the control of the lytic PAN RNA promoter, GFP under the control of human EF1a promoter and PuroR expressed by the RSV promoter; Characteristics: Transduced with pRetroX-Tet-On that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 and with RetroX-Tight-Hyg-RTA; Virology: Maintains latent rKSHV.219 as indicated by expression of constitutively expressed (eGFP) but not a lytic phase (RFP) reporter gene When exposed to either sodium butyrate or doxycycline, the cells are activated to lytic replication and express RFP and KSHV lytic genes and release large quantities of infectious virus (PubMed=33937098).; Virology: Infected with a recombinant human herpesvirus 8 (HHV-8/KSHV) rKSHV.219 151667162 CVCL_B6Z4 MNUEC/HL-027 finite cell line house mouse CVCL_B6Z4 CL:0000010 Derived from site: In situ; Endometrium, epithelium; UBERON=UBERON_0004811; Cell type: Epithelial cell; CL=CL_0000066; Breed/subspecies: C57BL/6. Female Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015108 151667163 CVCL_B6Z3 AD [Mouse hybridoma against phenacetin] hybridoma house mouse CVCL_B6Z3 CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI_8050; Phenacetin. Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.19681 151667164 CVCL_B6YR TIME.219 telomerase immortalized cell line human CVCL_B6YR CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.); Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Foreskin, skin, dermis, microvascular endothelium; UBERON=UBERON_0001471+UBERON_0008339. Male Characteristics: rKSHV.219 includes a RFP-GFP-PuroR construct that contains RFP under the control of the lytic PAN RNA promoter, GFP under the control of human EF1a promoter and PuroR expressed by the RSV promoter; Virology: Infected with a recombinant human herpesvirus 8 (HHV-8/KSHV) rKSHV.219 151667165 CVCL_B6Z6 HNCEC/HL-043 finite cell line human CVCL_B6Z6 CL:0000010 Population: Chinese; Derived from site: In situ; Eye, conjunctival epithelium; UBERON=UBERON_0006763; Cell type: Epithelial cell of conjunctiva; CL=CL_1000432. Male Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201676 151667166 CVCL_B6YU iSLK cancer cell line human CVCL_B6YU CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Leu98Pro (c.293T>C); ClinVar=VCV001502192; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: Metastatic; Skin; UBERON=UBERON_0002097. Male Problematic cell line: Contaminated Shown to be a Caki-1 derivative (PubMed=22987579). The parent cell line was originally thought to originate from a 28 year old male patient with HIV-1 negative Kaposi sarcoma. 151667167 CVCL_B6Z5 MFC/HL-041 finite cell line house mouse CVCL_B6Z5 CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620; Breed/subspecies: NIH Swiss. Unspecified Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201714 151667168 CVCL_B6YT ZYXY-T1 cancer cell line human CVCL_B6YT CL:0000010 Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC 202143 151667169 CVCL_B6Z8 HNCEC/HL-008 finite cell line human CVCL_B6Z8 CL:0000010 Population: Chinese; Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772; Cell type: Epithelial cell of cornea; CL=CL_0000575. Female Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201550 151667170 CVCL_B6YW NWR 17626 iPSC-c501 induced pluripotent stem cell CVCL_B6YW CL:0000010 Donor information: Established from Fatu, one the last two Northern white rhinoceros still alive; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Group: Endangered species/breed cell line 151667171 CVCL_B6Z7 HBCC/HL-004 cancer cell line human CVCL_B6Z7 CL:0000010 Population: Chinese; Derived from site: In situ; Breast; UBERON=UBERON_0000310. Female Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201535 151667172 CVCL_B6YV iSLK.219 cancer cell line human CVCL_B6YV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Leu98Pro (c.293T>C); ClinVar=VCV001502192; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.); Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR; Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: Metastatic; Skin; UBERON=UBERON_0002097. Male Characteristics: rKSHV.219 includes a RFP-GFP-PuroR construct that contains RFP under the control of the lytic PAN RNA promoter, GFP under the control of human EF1a promoter and PuroR expressed by the RSV promoter; Characteristics: Transduced with pRetroX-Tet-On that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 and with RetroX-Tight-Hyg-RTA; Virology: Maintains latent rKSHV.219 as indicated by expression of constitutively expressed (eGFP) but not a lytic phase (RFP) reporter gene When exposed to either sodium butyrate or doxycycline, the cells are activated to lytic replication and express RFP and KSHV lytic genes and release large quantities of infectious virus (PubMed=21419799).; Virology: Infected with a recombinant human herpesvirus 8 (HHV-8/KSHV) rKSHV.219 Problematic cell line: Contaminated Shown to be a Caki-1 derivative (PubMed=22987579). The grand-parent cell line was originally thought to originate from a 28 year old male patient with HIV-1 negative Kaposi sarcoma. 151667173 CVCL_B6YY NWR 17626 iPSC-c5103 induced pluripotent stem cell CVCL_B6YY CL:0000010 Donor information: Established from Fatu, one the last two Northern white rhinoceros still alive; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Group: Endangered species/breed cell line 151667174 CVCL_B6YX NWR 17626 iPSC-c5101 induced pluripotent stem cell CVCL_B6YX CL:0000010 Donor information: Established from Fatu, one the last two Northern white rhinoceros still alive; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Group: Endangered species/breed cell line 151667175 CVCL_B6Z9 VvmAb1m1n7 hybridoma house mouse CVCL_B6Z9 CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: Vibrio vulnificus membrane protein. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2016146 151667176 CVCL_B6YK HUVECs-hTERT telomerase immortalized cell line human CVCL_B6YK CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066; Cell type: Endothelial cell of umbilical vein; CL=CL_0002618. 151667177 CVCL_B6YJ FPKLPV-WBPH spontaneously immortalized cell line CVCL_B6YJ CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the institution and the species Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Unspecified Group: Insect cell line 151667178 CVCL_B6YM ZYXY-M2 cancer cell line human CVCL_B6YM CL:0000010 Population: Chinese; Karyotypic information: 47,XY,+12 [1]; 48,XY,+12,+9 [9] (DOI=10.1182/blood-2021-152639); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Omics: Genomics; Whole exome sequencing Male Doubling time: 48-72 hours (DOI=10.1182/blood-2021-152639) Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC 202145 151667179 CVCL_B6YL FPKLPV-BPH spontaneously immortalized cell line CVCL_B6YL CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the institution and the species Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Unspecified Group: Insect cell line 151667180 CVCL_B6Z0 UFERSA-PC2 finite cell line CVCL_B6Z0 CL:0000010 Miscellaneous: Age/sex of donor and cell line name from personal communication of Pereira, Alexsandra Fernandes Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151667181 CVCL_B6YN HaCaT-hGSTP1 ARE-SV40p-Luc2 spontaneously immortalized cell line human CVCL_B6YN CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.843_844CC>TT); Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2) Population: Caucasian; Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Male Characteristics: Expression of the luciferase reporter gene is under the control of the antioxidant response element (ARE) of GSTP1 (Patent=CN113265423B) Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2021113 151667182 CVCL_B6Z2 UFERSA-PC4 finite cell line CVCL_B6Z2 CL:0000010 Miscellaneous: Age/sex of donor and cell line name from personal communication of Pereira, Alexsandra Fernandes Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151667183 CVCL_B6YQ ZYXY-M1 luc cancer cell line human CVCL_B6YQ CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151667184 CVCL_B6Z1 UFERSA-PC3 finite cell line CVCL_B6Z1 CL:0000010 Miscellaneous: Age/sex of donor and cell line name from personal communication of Pereira, Alexsandra Fernandes Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151667185 CVCL_B6YP ZYXY-M1 cancer cell line human CVCL_B6YP CL:0000010 Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC 202144 151667186 CVCL_B6YC OFEC18-FGBC spontaneously immortalized cell line CVCL_B6YC CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358. Unspecified Doubling time: 73.8 hours (PubMed=33110952) Group: Fish cell line 151667187 CVCL_B6YB alphaTC1-6 ins2:eGFP cancer cell line house mouse CVCL_B6YB CL:0000010 Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006; Cell type: Pancreatic alpha cell; CL=CL_0002351; Breed/subspecies: C57BL/6 x DBA/2. Unspecified Characteristics: Transfected with a PuroR-ins2-eGFP construct where the expression of the eGFP gene is under the control of the mouse ins2 promoter (PubMed=34871457) 151667188 CVCL_B6YE HCD-57 SHP2-E76K cancer cell line house mouse CVCL_B6YE CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9644; PTPN11 (Note=With p.Glu76Lys) Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV); Derived from site: In situ; Spleen; UBERON=UBERON_0002106; Breed/subspecies: NIH Swiss. Unspecified Characteristics: EPO independent (DOI=10.1182/blood-2021-150007) 151667189 CVCL_B6YD HCD-57 SHP2-D61Y cancer cell line house mouse CVCL_B6YD CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9644; PTPN11 (Note=With p.Asp61Tyr) Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV); Derived from site: In situ; Spleen; UBERON=UBERON_0002106; Breed/subspecies: NIH Swiss. Unspecified Characteristics: EPO independent (DOI=10.1182/blood-2021-150007) 151667190 CVCL_B6YG 0840-FusionRed cancer cell line dog CVCL_B6YG CL:0000010 Genetic integration: Method=Transfection; Gene=FPbase; S6A7A; FusionRed (Note=Bright red fluorescent protein derived from eqFP578); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Prostate; UBERON=UBERON_0002367; Breed/subspecies: Pitbull Terrier; VBO=VBO_0200054. Male 151667191 CVCL_B6YF EO-1 cancer cell line dog CVCL_B6YF CL:0000010 Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029; Cell type: T-cell; CL=CL_0000084; Breed/subspecies: English Bulldog; VBO=VBO_0200485. Female Doubling time: 28.4 hours (PubMed=28668559) 151667192 CVCL_B6YI FPKLPV-SBPH spontaneously immortalized cell line CVCL_B6YI CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the institution and the species Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Unspecified Group: Insect cell line 151667193 CVCL_B6YH 0846-FusionRed cancer cell line dog CVCL_B6YH CL:0000010 Genetic integration: Method=Transfection; Gene=FPbase; S6A7A; FusionRed (Note=Bright red fluorescent protein derived from eqFP578); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Prostate; UBERON=UBERON_0002367; Breed/subspecies: German Roughhaired Pointer; VBO=VBO_0200575. Male 151667194 CVCL_B6ZT V/1Ki-Delta spontaneously immortalized cell line CVCL_B6ZT CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Virology: Persistently infected by Swiss snake colony virus 1 (SwSCV-1) Group: Reptilian cell line 151667195 CVCL_B6ZS I/1Ki-Delta spontaneously immortalized cell line CVCL_B6ZS CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518. Virology: Persistently infected by Swiss snake colony virus 1 (SwSCV-1) Group: Reptilian cell line 151667196 CVCL_B6ZV V/5Lu-Delta spontaneously immortalized cell line CVCL_B6ZV CL:0000010 Derived from site: In situ; Lung, smooth muscle; UBERON=UBERON_0004225; Cell type: Vascular associated smooth muscle cell; CL=CL_0000359. Virology: Persistently infected by Swiss snake colony virus 1 (SwSCV-1) Group: Reptilian cell line 151667197 CVCL_B6ZU V/2Hz-Delta spontaneously immortalized cell line CVCL_B6ZU CL:0000010 Derived from site: In situ; Heart; UBERON=UBERON_0000948; Cell type: Cardiomyocyte; CL=CL_0002495. Virology: Persistently infected by Swiss snake colony virus 1 (SwSCV-1) Group: Reptilian cell line 151667198 CVCL_B6ZX I/1Ki-1.2xDelta spontaneously immortalized cell line CVCL_B6ZX CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518. Virology: Persistently infected by a '1.2 genome' Swiss snake colony virus 1 (SwSCV-1) This is a construct bearing two copies of the genomic and antigenomic ribozymes (PubMed=35062311). Group: Reptilian cell line 151667199 CVCL_B6ZW V/1Liv-Delta spontaneously immortalized cell line CVCL_B6ZW CL:0000010 Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatic stellate cell; CL=CL_0000632. Virology: Persistently infected by Swiss snake colony virus 1 (SwSCV-1) Group: Reptilian cell line 151667200 CVCL_B6ZZ SCVIi035-A induced pluripotent stem cell human CVCL_B6ZZ From: Stanford Cardiovascular Institute; Palo Alto; USA. CL:0000010 Male 151667201 CVCL_B6ZY SCVIi036-A induced pluripotent stem cell human CVCL_B6ZY From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Ile154Leufs*5 (c.459delC); ClinVar=VCV000042755; Zygosity=Heterozygous (PubMed=35413566); Sequence variation: Mutation; HGNC; HGNC:9386; PRKAG2; Simple; p.Thr568Met (c.1703C>T); ClinVar=VCV000181464; Zygosity=Heterozygous (PubMed=35413566) Population: Southeast Asian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151667202 CVCL_B6ZL V/1Ki spontaneously immortalized cell line CVCL_B6ZL CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Group: Reptilian cell line 151667203 CVCL_B6ZK I/1Ki spontaneously immortalized cell line CVCL_B6ZK CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518. Group: Reptilian cell line 151667204 CVCL_B6ZN V/2Hz spontaneously immortalized cell line CVCL_B6ZN CL:0000010 Derived from site: In situ; Heart; UBERON=UBERON_0000948; Cell type: Cardiomyocyte; CL=CL_0002495. Group: Reptilian cell line 151667205 CVCL_B6ZM V/1Liv spontaneously immortalized cell line CVCL_B6ZM CL:0000010 Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatic stellate cell; CL=CL_0000632. Group: Reptilian cell line 151667206 CVCL_B6ZP V/4Br spontaneously immortalized cell line CVCL_B6ZP CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Group: Reptilian cell line 151667207 CVCL_B6ZR V/5Lu spontaneously immortalized cell line CVCL_B6ZR CL:0000010 Derived from site: In situ; Lung, smooth muscle; UBERON=UBERON_0004225; Cell type: Vascular associated smooth muscle cell; CL=CL_0000359. Group: Reptilian cell line 151667208 CVCL_B6ZQ V/4Lu spontaneously immortalized cell line CVCL_B6ZQ CL:0000010 Derived from site: In situ; Lung; UBERON=UBERON_0002048. Group: Reptilian cell line 151667209 CVCL_B6ZD ZX2021H cancer cell line human CVCL_B6ZD CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Asp22Asn (c.64G>A); ClinVar=VCV000040335; Zygosity=Unspecified (PubMed=35297208); Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Cys2134Tyrfs*8 (c.6401_6402delGT) (p.L2133fs, c.6398_6399del); ClinVar=VCV000818199; Zygosity=Unspecified (PubMed=35297208); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Unspecified (PubMed=35297208) Population: Chinese; Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429. Male Doubling time: ~29.8 hours (PubMed=35297208) Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2021215 151667210 CVCL_B6ZC Res1-6 cancer cell line house mouse CVCL_B6ZC CL:0000010 Derived from site: In situ; Liver; UBERON=UBERON_0002107; Breed/subspecies: C57L/J. Female Characteristics: Resistant to antibodies against CD274/PD-L1 (Patent=CN114009399B) Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2021234 151667211 CVCL_B6ZF 6E4 hybridoma house mouse CVCL_B6ZF CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Enzootic nasal tumour virus of goats (ENTV-2). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202181 151667212 CVCL_B6ZE 6F3H hybridoma house mouse CVCL_B6ZE CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; O11424; Duck adenovirus 1 fiber protein. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2021286 151667213 CVCL_B6ZH IgM-1 hybridoma house mouse CVCL_B6ZH CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human IgM. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201843 151667214 CVCL_B6ZG A5 hybridoma house mouse CVCL_B6ZG CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_169037; Armillaric acid. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2021127 151667215 CVCL_B6ZJ JHJ hybridoma house mouse CVCL_B6ZJ CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: ChEBI; CHEBI_34692; Dicofol (Kelthane). Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.22329 151667216 CVCL_B6ZI 3B8.10D9 hybridoma house mouse CVCL_B6ZI CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: ChEBI; CHEBI_34692; Dicofol (Kelthane); Monoclonal antibody target: ChEBI; CHEBI_190399; 4,4'-dichlorobenzhydrol (DCBH). 151667217 CVCL_B6WY 9-1 hybridoma house mouse CVCL_B6WY CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P09104; Human ENO2. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015103 151667218 CVCL_B6WX 2-2 [Mouse hybridoma against human ENO2] hybridoma house mouse CVCL_B6WX CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P09104; Human ENO2. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015104 151667219 CVCL_B6X9 3-26-1 hybridoma house mouse CVCL_B6X9 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201208 151667220 CVCL_B6WZ 1-10-1 hybridoma house mouse CVCL_B6WZ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human high density lipoprotein (HDL). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201599 151667221 CVCL_B6X2 13-2 hybridoma house mouse CVCL_B6X2 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P08727; Human KRT19 (Note=AA 301-400 = CYFRA21-1). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201597 151667222 CVCL_B6WQ BS 59 hybridoma house mouse CVCL_B6WQ CL:0000010 Monoclonal antibody isotype: IgG3; Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Leu20 and p.Glu24 Recognizes N blood group antigen).. 151667223 CVCL_B6X1 10-2 hybridoma house mouse CVCL_B6X1 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P08727; Human KRT19 (Note=AA 301-400 = CYFRA21-1). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201596 151667224 CVCL_B6WP BS 57 hybridoma house mouse CVCL_B6WP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Ser20 and p.Gly24 Recognizes M blood group antigen).. 151667225 CVCL_B6X4 27-1 hybridoma house mouse CVCL_B6X4 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P19429; Human TNNI3. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201592 151667226 CVCL_B6WS BS 75 hybridoma house mouse CVCL_B6WS CL:0000010 Monoclonal antibody isotype: Not determined; Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Leu20 and p.Glu24 Recognizes N blood group antigen).. 151667227 CVCL_B6X3 18-1 hybridoma house mouse CVCL_B6X3 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P19429; Human TNNI3. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201593 151667228 CVCL_B6WR BS 61 hybridoma house mouse CVCL_B6WR CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Leu20 and p.Glu24 Recognizes N blood group antigen).. 151667229 CVCL_B6X6 7-1 [Mouse hybridoma against human CKB/CKM] hybridoma house mouse CVCL_B6X6 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P12277; Human CKB; Monoclonal antibody target: UniProtKB; P06732; Human CKM. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201591 151667230 CVCL_B6WU LM 17/20 hybridoma house mouse CVCL_B6WU CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=Recognizes both M and N blood group antigens). 151667231 CVCL_B6X5 4-2 hybridoma house mouse CVCL_B6X5 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P12277; Human CKB; Monoclonal antibody target: UniProtKB; P06732; Human CKM. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201590 151667232 CVCL_B6WT LM 17/19 hybridoma house mouse CVCL_B6WT CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=Recognizes both M and N blood group antigens). 151667233 CVCL_B6X8 3-20-1 hybridoma house mouse CVCL_B6X8 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201202 151667234 CVCL_B6WW 9-2 hybridoma house mouse CVCL_B6WW CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P02144; Human MB. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015102 151667235 CVCL_B6WV 49-2 hybridoma house mouse CVCL_B6WV CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P02144; Human MB. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015101 151667236 CVCL_B6X7 4D1 [Mouse hybridoma against SYNV P] hybridoma house mouse CVCL_B6X7 CL:0000010 Monoclonal antibody isotype: IgG2b, lambda; Monoclonal antibody target: UniProtKB; P21299; Sonchus yellow net virus (SYNV) phosphoprotein (P). Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.9326 151667237 CVCL_B6WI BS 38 hybridoma house mouse CVCL_B6WI CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Ser20 and p.Gly24 Recognizes M blood group antigen).. 151667238 CVCL_B6WH 8-1 hybridoma house mouse CVCL_B6WH CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P02649; Human APOE. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201595 151667239 CVCL_B6WK BS 40 hybridoma house mouse CVCL_B6WK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Leu20 and p.Glu24 Recognizes N blood group antigen).. 151667240 CVCL_B6WJ BS 39 hybridoma house mouse CVCL_B6WJ CL:0000010 Monoclonal antibody isotype: IgG3; Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=Recognizes both M and N blood group antigens). 151667241 CVCL_B6WM BS 42 hybridoma house mouse CVCL_B6WM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Leu20 and p.Glu24 Recognizes N blood group antigen).. 151667242 CVCL_B6WL BS 41 hybridoma house mouse CVCL_B6WL CL:0000010 Monoclonal antibody isotype: IgG3; Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Leu20 and p.Glu24 Recognizes N blood group antigen).. 151667243 CVCL_B6X0 1-35-1 hybridoma house mouse CVCL_B6X0 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Human high density lipoprotein (HDL). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201598 151667244 CVCL_B6WN BS 44 hybridoma house mouse CVCL_B6WN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Ser20 and p.Gly24 Recognizes M blood group antigen).. 151667245 CVCL_B6WA 1E5 [Mouse hybridoma against amantadine] hybridoma house mouse CVCL_B6WA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_2618; Amantadine. Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.10865 151667246 CVCL_B6WC G1-OA embryonic stem cell house mouse CVCL_B6WC CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Germ line stem cell; CL=CL_0000014; Breed/subspecies: BALB/c. Female 151667247 CVCL_B6WB anti-S6K2/B2 hybridoma house mouse CVCL_B6WB CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q9UBS0; Human RPS6KB2. 151667248 CVCL_B6WE D4 [Mouse hybridoma against human RICTOR] hybridoma house mouse CVCL_B6WE CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q6R327; Human RICTOR. 151667249 CVCL_B6WD G1-T embryonic stem cell house mouse CVCL_B6WD CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Germ line stem cell; CL=CL_0000014; Breed/subspecies: BALB/c. Female 151667250 CVCL_B6WG 23-1 hybridoma house mouse CVCL_B6WG CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P02649; Human APOE. Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201594 151667251 CVCL_B6WF ZJED0-02 hybridoma house mouse CVCL_B6WF CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; X5H5A9; Zaire ebolavirus (strain Makona) envelope glycoprotein (GP). Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201584 151667252 CVCL_B6XZ MDCK-79 spontaneously immortalized cell line dog CVCL_B6XZ CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372. Female Characteristics: Obtained from the parent cell line by limited dilution method so as to obtain a cell line with low ABCB1 expression (PubMed=36651516) 151667253 CVCL_B6XY NSC-19 hybrid cell line house mouse CVCL_B6XY CL:0000010 Characteristics: Produced by the fusion of motor neuron enriched, embryonic 12-14 days mouse spinal cord cells with N18TG2 (PubMed=1467557). 151667254 CVCL_B6YA R-7 transformed cell line CVCL_B6YA CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Vibrissa, skin, dermal papilla; UBERON=UBERON_0011933+UBERON_0000412; Cell type: Hair follicle dermal papilla cell; CL=CL_0000346; Breed/subspecies: White Rex; VBO=VBO_0017529. Female 151667255 CVCL_B6XR BUTE1D transformed cell line CVCL_B6XR CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pW2); Derived from site: In situ; Endometrium, epithelium; UBERON=UBERON_0004811; Cell type: Epithelial cell; CL=CL_0000066; Breed/subspecies: Holstein; VBO=VBO_0000237. Female 151667256 CVCL_B6Y3 MSH spontaneously immortalized cell line CVCL_B6Y3 CL:0000010 Derived from site: In situ; Heart; UBERON=UBERON_0000948. Unspecified Group: Fish cell line 151667257 CVCL_B6XQ BUTE1C transformed cell line CVCL_B6XQ CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pW2); Derived from site: In situ; Endometrium, epithelium; UBERON=UBERON_0004811; Cell type: Epithelial cell; CL=CL_0000066; Breed/subspecies: Holstein; VBO=VBO_0000237. Female 151667258 CVCL_B6Y2 TrJ6 hybridoma CVCL_B6Y2 CL:0000010 Monoclonal antibody isotype: IgM, lambda; Monoclonal antibody target: UniProtKB; P01920; Human HLA-DQB1. 151667259 CVCL_B6Y5 KTS spontaneously immortalized cell line CVCL_B6Y5 CL:0000010 Derived from site: In situ; Fin; UBERON=UBERON_0008897. Unspecified Characteristics: Capable of growing from 23 to 30 Celsius, the optimal temperature is 27 Celsius (DOI=10.1016/j.aquaculture.2020.735534) Group: Fish cell line 151667260 CVCL_B6XT SYSUIMi001-A induced pluripotent stem cell human CVCL_B6XT From: Sun Yat-sen University Fifth Affiliated Hospital; Zhuhai; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:13266; DDX24; Simple; p.Glu271Lys (c.811G>A); Zygosity=Heterozygous (PubMed=35091306) Population: Chinese; Han; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151667261 CVCL_B6Y4 ALF [Acanthopagrus latus] spontaneously immortalized cell line CVCL_B6Y4 CL:0000010 Derived from site: In situ; Fin; UBERON=UBERON_0008897. Unspecified Group: Fish cell line 151667262 CVCL_B6XS BUTE1E transformed cell line CVCL_B6XS CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pW2); Derived from site: In situ; Endometrium, epithelium; UBERON=UBERON_0004811; Cell type: Epithelial cell; CL=CL_0000066; Breed/subspecies: Holstein; VBO=VBO_0000237. Female 151667263 CVCL_B6Y7 Aag2INF spontaneously immortalized cell line CVCL_B6Y7 CL:0000010 Anecdotal: Was accidentally created by a student that was working with Aag-2 and also manipulating samples containing arboviruses. Unspecified Virology: Persistently infected by Chikungunya virus and Mayaro virus (PubMed=34878970); Virology: The Chikungunya virus in this cell line has accumulated non-synonymous mutations and encodes a shorter nsP3 gene and has lost the capacity to infect mammalian cells (PubMed=34878970) Group: Insect cell line 151667264 CVCL_B6XV SYSUIMi003-A induced pluripotent stem cell human CVCL_B6XV From: Sun Yat-sen University Fifth Affiliated Hospital; Zhuhai; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:13266; DDX24; Simple; p.Glu271Lys (c.811G>A); Zygosity=Heterozygous (PubMed=35091306) Population: Chinese; Han; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151667265 CVCL_B6Y6 SK-BR-3/nab-P cancer cell line human CVCL_B6Y6 CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol); Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 151667266 CVCL_B6XU SYSUIMi002-A induced pluripotent stem cell human CVCL_B6XU From: Sun Yat-sen University Fifth Affiliated Hospital; Zhuhai; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:13266; DDX24; Simple; p.Glu271Lys (c.811G>A); Zygosity=Heterozygous (PubMed=35091306) Population: Chinese; Han; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 151667267 CVCL_B6Y9 mDPCET transformed cell line house mouse CVCL_B6Y9 CL:0000010 Genetic integration: Method=Transduction; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg Fused to Cre = CreERT2).; Genetic integration: Method=Transduction; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2); Genetic integration: Method=Transduction; Gene=UniProtKB; P06956; Escherichia phage P1 cre; Genetic integration: Method=Transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Embryonic tooth bud, dental papilla, molar; UBERON=UBERON_0015844; Cell type: Mesenchymal cell; CL=CL_0008019; Breed/subspecies: CD-1. Unspecified Characteristics: Reversibly immortalized; exposure to tamoxifen induces the expression of the Cre gene that effects Cre/LoxP recombination and excise the SV40 TAG gene (PubMed=23299318); Characteristics: Transduced with a pHLox-CMV-TAg-IRES-TK lentiviral construct as well as a pCAG-ERT2iCreERT2-neo construct (PubMed=23299318) 151667268 CVCL_B6XX N6HB426-20 hybridoma house mouse CVCL_B6XX CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; Q14973; Human SLC10A1. 151667269 CVCL_B6XW iEM transformed cell line human CVCL_B6XW CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Skin, sweat gland; UBERON=UBERON_0001820; Cell type: Myoepithelial cell of sweat gland; CL=CL_1000417. Unspecified 151667270 CVCL_B6Y8 mDPC6T transformed cell line house mouse CVCL_B6Y8 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Embryonic tooth bud, dental papilla, molar; UBERON=UBERON_0015844; Cell type: Mesenchymal cell; CL=CL_0008019; Breed/subspecies: CD-1. Unspecified Characteristics: Transduced with a pHLox-CMV-TAg-IRES-TK lentiviral construct The TK gene allows selection using ganciclovir (GCV). 151667271 CVCL_B6XJ SFL [Kareius] spontaneously immortalized cell line CVCL_B6XJ CL:0000010 Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Fibroblast; CL=CL_0000057. Unspecified Characteristics: The optimal growth temperature is 22 Celsius (DOI=10.1111/j.1749-7345.2010.00445.x) Doubling time: 38.8 hours (DOI=10.1111/j.1749-7345.2010.00445.x) Group: Fish cell line 151667272 CVCL_B6XI PSD-LWHT transformed cell line CVCL_B6XI CL:0000010 Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Back, skin, dermis; UBERON=UBERON_0001068+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female Doubling time: 68.9 hours (PubMed=30064049) Group: Cetacean cell line 151667273 CVCL_B6XL BFIB2 transformed cell line CVCL_B6XL CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pW2); Derived from site: In situ; Endometrium; UBERON=UBERON_0001295; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: Holstein; VBO=VBO_0000237. Female Doubling time: 28.35 hours (PubMed=35064470) 151667274 CVCL_B6XK BFIB1 transformed cell line CVCL_B6XK CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pW2); Derived from site: In situ; Endometrium; UBERON=UBERON_0001295; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: Holstein; VBO=VBO_0000237. Female 151667275 CVCL_B6XN BUTE1A transformed cell line CVCL_B6XN CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pW2); Derived from site: In situ; Endometrium, epithelium; UBERON=UBERON_0004811; Cell type: Epithelial cell; CL=CL_0000066; Breed/subspecies: Holstein; VBO=VBO_0000237. Female Doubling time: 74.99 hours (PubMed=35064470) 151667276 CVCL_B6XM BFIB3 transformed cell line CVCL_B6XM CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pW2); Derived from site: In situ; Endometrium; UBERON=UBERON_0001295; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: Holstein; VBO=VBO_0000237. Female 151667277 CVCL_B6XP BUTE1B transformed cell line CVCL_B6XP CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pW2); Derived from site: In situ; Endometrium, epithelium; UBERON=UBERON_0004811; Cell type: Epithelial cell; CL=CL_0000066; Breed/subspecies: Holstein; VBO=VBO_0000237. Female 151667278 CVCL_B6Y1 GrB spontaneously immortalized cell line CVCL_B6Y1 CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified Characteristics: Can grow between 22 to 27 Celsius, with an optimal growth temperature of 27 Celsius (DOI=10.1111/are.15702); Virology: Susceptible to infection by tilapia lake virus 2017A (TiLV-2017A) (DOI=10.1111/are.15702) Group: Fish cell line 151667279 CVCL_B6Y0 SW620/Ad300-ABCB1ko cancer cell line human CVCL_B6Y0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:40; ABCB1; Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin); Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. Male 151667280 CVCL_B6XB G6 [Mouse ESC] embryonic stem cell house mouse CVCL_B6XB CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Germ line stem cell; CL=CL_0000014; Breed/subspecies: BALB/c. 151667281 CVCL_B6XA G4 [Mouse germ stem cell] embryonic stem cell house mouse CVCL_B6XA CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Germ line stem cell; CL=CL_0000014; Breed/subspecies: BALB/c. 151667283 CVCL_B6XC G7 embryonic stem cell house mouse CVCL_B6XC CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Germ line stem cell; CL=CL_0000014; Breed/subspecies: BALB/c. 151667284 CVCL_B6XF ACRJ-PC28 cancer cell line human CVCL_B6XF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1787; CDKN2A; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: Caribbean; Jamaican; Derived from site: In situ; Prostate; UBERON=UBERON_0002367. Omics: Transcriptomics; RNAseq Male Characteristics: Lack of expression of AR (DOI=10.1158/1538-7755.DISP21-PO-138; PubMed=36643868) Doubling time: 45 hours (DOI=10.1158/1538-7755.DISP21-PO-138; PubMed=36643868) 151667285 CVCL_B6XE C5 [Mouse hybridoma against V.anguillarum] hybridoma house mouse CVCL_B6XE CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: Vibrio anguillarum. 151667286 CVCL_B6XH HCF spontaneously immortalized cell line CVCL_B6XH CL:0000010 Derived from site: In situ; Fin; UBERON=UBERON_0008897; Cell type: Fibroblast; CL=CL_0000057. Unspecified Group: Fish cell line 151667288 CVCL_B6UW BM9.1 cancer cell line human CVCL_B6UW CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line) Population: African; Kenyan; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Transformant: NCIt; C44386; Gamma radiation; Derived from site: In situ; Groin; UBERON=UBERON_0008337; Cell type: B-cell; CL=CL_0000236. Female Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842) 151667289 CVCL_B6V8 TrC5 hybridoma human CVCL_B6V8 CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: UniProtKB; P01909; Human HLA-DQA1. 151667290 CVCL_B6UV BM8.5 cancer cell line human CVCL_B6UV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line) Population: African; Kenyan; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Transformant: NCIt; C44386; Gamma radiation; Derived from site: In situ; Groin; UBERON=UBERON_0008337; Cell type: B-cell; CL=CL_0000236. Female Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842) 151667291 CVCL_B6V7 TrB50 hybridoma human CVCL_B6V7 CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: UniProtKB; P04440; Human HLA-DPB1. 151667292 CVCL_B6UY BM11.1 cancer cell line human CVCL_B6UY CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line) Population: African; Kenyan; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Transformant: NCIt; C44386; Gamma radiation; Derived from site: In situ; Groin; UBERON=UBERON_0008337; Cell type: B-cell; CL=CL_0000236. Female Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842) 151667293 CVCL_B6UX BM10.1 cancer cell line human CVCL_B6UX CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line) Population: African; Kenyan; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Transformant: NCIt; C44386; Gamma radiation; Derived from site: In situ; Groin; UBERON=UBERON_0008337; Cell type: B-cell; CL=CL_0000236. Female Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842) 151667294 CVCL_B6V9 TrE11 hybridoma human CVCL_B6V9 CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P04440; Human HLA-DPB1. 151667295 CVCL_B6UZ BM12.1 cancer cell line human CVCL_B6UZ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line) Population: African; Kenyan; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Transformant: NCIt; C44386; Gamma radiation; Derived from site: In situ; Groin; UBERON=UBERON_0008337; Cell type: B-cell; CL=CL_0000236. Female Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842) 151667296 CVCL_B6V0 BM13.1 cancer cell line human CVCL_B6V0 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line) Population: African; Kenyan; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Transformant: NCIt; C44386; Gamma radiation; Derived from site: In situ; Groin; UBERON=UBERON_0008337; Cell type: B-cell; CL=CL_0000236. Female Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842) 151667297 CVCL_B6UN BM1.5 cancer cell line human CVCL_B6UN CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line) Population: African; Kenyan; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Transformant: NCIt; C44386; Gamma radiation; Derived from site: In situ; Groin; UBERON=UBERON_0008337; Cell type: B-cell; CL=CL_0000236. Female Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842) 151667298 CVCL_B6V2 BM15.3 cancer cell line human CVCL_B6V2 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line) Population: African; Kenyan; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Transformant: NCIt; C44386; Gamma radiation; Derived from site: In situ; Groin; UBERON=UBERON_0008337; Cell type: B-cell; CL=CL_0000236. Female Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842) 151667299 CVCL_B6UQ BM3.1 cancer cell line human CVCL_B6UQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line) Population: African; Kenyan; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Transformant: NCIt; C44386; Gamma radiation; Derived from site: In situ; Groin; UBERON=UBERON_0008337; Cell type: B-cell; CL=CL_0000236. Female Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842) 151667300 CVCL_B6V1 BM14.1 cancer cell line human CVCL_B6V1 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line) Population: African; Kenyan; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Transformant: NCIt; C44386; Gamma radiation; Derived from site: In situ; Groin; UBERON=UBERON_0008337; Cell type: B-cell; CL=CL_0000236. Female Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842) 151667301 CVCL_B6UP BM2.2 cancer cell line human CVCL_B6UP CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line) Population: African; Kenyan; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Transformant: NCIt; C44386; Gamma radiation; Derived from site: In situ; Groin; UBERON=UBERON_0008337; Cell type: B-cell; CL=CL_0000236. Female Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842) 151667302 CVCL_B6V4 BM2.2.3 cancer cell line human CVCL_B6V4 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line) Population: African; Kenyan; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Transformant: NCIt; C44386; Gamma radiation; Derived from site: In situ; Groin; UBERON=UBERON_0008337; Cell type: B-cell; CL=CL_0000236. Female Characteristics: Obtained from the grand-parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins 151667303 CVCL_B6US BM5.2 cancer cell line human CVCL_B6US CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line) Population: African; Kenyan; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Transformant: NCIt; C44386; Gamma radiation; Derived from site: In situ; Groin; UBERON=UBERON_0008337; Cell type: B-cell; CL=CL_0000236. Female Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842) 151667304 CVCL_B6V3 BM19 cancer cell line human CVCL_B6V3 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line) Population: African; Kenyan; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Transformant: NCIt; C44386; Gamma radiation; Derived from site: In situ; Groin; UBERON=UBERON_0008337; Cell type: B-cell; CL=CL_0000236. Female Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=2995242) 151667305 CVCL_B6UR BM4.1 cancer cell line human CVCL_B6UR CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line) Population: African; Kenyan; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Transformant: NCIt; C44386; Gamma radiation; Derived from site: In situ; Groin; UBERON=UBERON_0008337; Cell type: B-cell; CL=CL_0000236. Female Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842) 151667306 CVCL_B6UU BM7.4 cancer cell line human CVCL_B6UU CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line) Population: African; Kenyan; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Transformant: NCIt; C44386; Gamma radiation; Derived from site: In situ; Groin; UBERON=UBERON_0008337; Cell type: B-cell; CL=CL_0000236. Female Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842) 151667307 CVCL_B6V6 UL-F6 hybridoma CVCL_B6V6 CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P01889; Human HLA-B (Note=Recognizes allele B*27). 151667308 CVCL_B6UT BM6.3 cancer cell line human CVCL_B6UT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line) Population: African; Kenyan; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Transformant: NCIt; C44386; Gamma radiation; Derived from site: In situ; Groin; UBERON=UBERON_0008337; Cell type: B-cell; CL=CL_0000236. Female Characteristics: Obtained from the parent cell line that was subjected to 3 Gy of gamma-irradiation and selected for cells having mutations of MHC class 1 and class 2 genes with mAb against MHC proteins (PubMed=3872842) 151667309 CVCL_B6V5 UL-4F11 hybridoma CVCL_B6V5 CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P01889; Human HLA-B (Note=Recognizes allele B*27). 151667310 CVCL_B6UG M305 hybridoma house mouse CVCL_B6UG CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q7L513; Human FCRLA. 151667311 CVCL_B6UF M204 hybridoma house mouse CVCL_B6UF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q7L513; Human FCRLA. 151667312 CVCL_B6UI M515 hybridoma house mouse CVCL_B6UI CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q7L513; Human FCRLA. 151667313 CVCL_B6UH M409 [Mouse hybridoma against human FCRLA] hybridoma house mouse CVCL_B6UH CL:0000010 Monoclonal antibody isotype: IgG3; Monoclonal antibody target: UniProtKB; Q7L513; Human FCRLA. 151667314 CVCL_B6UK BJAB-HR1K cancer cell line human CVCL_B6UK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line) Population: African; Kenyan; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Groin; UBERON=UBERON_0008337; Cell type: B-cell; CL=CL_0000236. Female Virology: EBV-negative cell line infected with EBV from P3HR-1 cell line (Cellosaurus=CVCL_2676) (PubMed=175026) 151667315 CVCL_B6UJ M616 hybridoma house mouse CVCL_B6UJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q7L513; Human FCRLA. 151667316 CVCL_B6UM BJAB-B95.8.6 cancer cell line human CVCL_B6UM CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line) Population: African; Kenyan; Karyotypic information: 45,XX,-8,3q+,7p+,8q+,10p+,11p+,inv(13) (PubMed=2995242); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Groin; UBERON=UBERON_0008337; Cell type: B-cell; CL=CL_0000236. Female Virology: EBV-negative cell line infected with EBV strain B95-8 151667317 CVCL_B6UL II-WA-Ramos cancer cell line human CVCL_B6UL CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Asp (c.760_761AT>GA); Zygosity=Homozygous (from parent cell line) Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: B-cell; CL=CL_0000236. Male Virology: EBV-negative cell line infected with EBV from P3HR-1 cell line (Cellosaurus=CVCL_2676) 151667318 CVCL_B6UA UL-52 hybridoma house mouse CVCL_B6UA CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P01903; Human HLA-DRA; Monoclonal antibody target: UniProtKB; P79483; Human HLA-DRB3. 151667319 CVCL_B6UC N/92 hybridoma house mouse CVCL_B6UC CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Leu20 and p.Glu24 Recognizes N blood group antigen).. 151667320 CVCL_B6UB N/61 hybridoma house mouse CVCL_B6UB CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Leu20 and p.Glu24 Recognizes N blood group antigen).. 151667321 CVCL_B6UE M101 [Mouse hybridoma against human FCRLA] hybridoma house mouse CVCL_B6UE CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q7L513; Human FCRLA. 151667322 CVCL_B6UD 425/2B hybridoma house mouse CVCL_B6UD CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (Note=With p.Ser20 and p.Gly24 Recognizes M blood group antigen).. 151667323 CVCL_B6VX 13C2 hybridoma house mouse CVCL_B6VX CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 151667324 CVCL_B6W9 1F10 [Mouse hybridoma against CoA] hybridoma house mouse CVCL_B6W9 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: ChEBI; CHEBI_15346; Coenzyme A (CoA). 151667325 CVCL_B6VW 12F11 hybridoma house mouse CVCL_B6VW CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 151667326 CVCL_B6W8 G1 [Mouse germ stem cell] embryonic stem cell house mouse CVCL_B6W8 CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Germ line stem cell; CL=CL_0000014; Breed/subspecies: BALB/c. Female 151667327 CVCL_B6VZ 14C8 hybridoma house mouse CVCL_B6VZ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 151667328 CVCL_B6VY 13G4 hybridoma house mouse CVCL_B6VY CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 151667329 CVCL_B6W1 21B7 hybridoma house mouse CVCL_B6W1 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 151667330 CVCL_B6VP 296B11 hybridoma house mouse CVCL_B6VP CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA). 151667331 CVCL_B6W0 17F9 hybridoma house mouse CVCL_B6W0 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 151667332 CVCL_B6W3 21F4 hybridoma house mouse CVCL_B6W3 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 151667333 CVCL_B6VR 296H8 hybridoma house mouse CVCL_B6VR CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA). 151667334 CVCL_B6W2 21D7 hybridoma house mouse CVCL_B6W2 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 151667335 CVCL_B6VQ 296G2 hybridoma house mouse CVCL_B6VQ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA). 151667336 CVCL_B6VT 11B5 hybridoma house mouse CVCL_B6VT CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 151667337 CVCL_B6W5 24H7 hybridoma house mouse CVCL_B6W5 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 151667338 CVCL_B6W4 23B4 hybridoma house mouse CVCL_B6W4 CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 151667339 CVCL_B6VS 296H9 hybridoma house mouse CVCL_B6VS CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA). 151667340 CVCL_B6VV 12C7 hybridoma house mouse CVCL_B6VV CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 151667341 CVCL_B6W7 27C10 hybridoma house mouse CVCL_B6W7 CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 151667342 CVCL_B6VU 11G5 hybridoma house mouse CVCL_B6VU CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 151667343 CVCL_B6W6 26B9 hybridoma house mouse CVCL_B6W6 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P07288; Human KLK3/PSA. 151667344 CVCL_B6VH 293F4 hybridoma house mouse CVCL_B6VH CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA). 151667345 CVCL_B6VG 293D2 hybridoma house mouse CVCL_B6VG CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA). 151667346 CVCL_B6VJ 294F7 hybridoma house mouse CVCL_B6VJ CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA). 151667347 CVCL_B6VI 294F5 hybridoma house mouse CVCL_B6VI CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA). 151667348 CVCL_B6VL 295A5 hybridoma house mouse CVCL_B6VL CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA). 151667349 CVCL_B6VK 294G2 hybridoma house mouse CVCL_B6VK CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA). 151667350 CVCL_B6VN 296A10 hybridoma house mouse CVCL_B6VN CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA). 151667351 CVCL_B6VM 295D2 hybridoma house mouse CVCL_B6VM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA). 151667352 CVCL_B6VB TrH6 hybridoma human CVCL_B6VB CL:0000010 Monoclonal antibody isotype: IgM, lambda; Monoclonal antibody target: UniProtKB; P79483; Human HLA-DRB3. 151667353 CVCL_B6VA TrG6 hybridoma human CVCL_B6VA CL:0000010 Monoclonal antibody isotype: IgG; Monoclonal antibody target: UniProtKB; P01920; Human HLA-DQB1. 151667354 CVCL_B6VD 291C10 hybridoma house mouse CVCL_B6VD CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA). 151667355 CVCL_B6VC 291B2 hybridoma house mouse CVCL_B6VC CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA). 151667356 CVCL_B6VF 293C8 hybridoma house mouse CVCL_B6VF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA). 151667357 CVCL_B6VE 291F8 hybridoma house mouse CVCL_B6VE CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: UniProtKB; P16155; Chlamydia trachomatis major outer membrane porin (MOMP) serovar F (ompA). 151667358 CVCL_B7BK GM3498B-HV1 transformed cell line human CVCL_B7BK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Cys1055Gly (c.3163T>G); ClinVar=VCV001728339; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; English and Jewish; Ashkenazi; Transformant: NCBI_TaxID; 11807; Harvey murine sarcoma virus (Ha-MSV); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151667359 CVCL_B7BJ H5G11 hybridoma house mouse CVCL_B7BJ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P11279; Human LAMP1/CD107a. 151667360 CVCL_B7BL GM3498B-HV2 transformed cell line human CVCL_B7BL CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Tyr736Leufs*5 (c.2207_2212delATCTGAinsTAGATTC) (2281del6ins7) (BLMAsh); ClinVar=VCV000005454; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Cys1055Gly (c.3163T>G); ClinVar=VCV001728339; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; English and Jewish; Ashkenazi; Transformant: NCBI_TaxID; 11807; Harvey murine sarcoma virus (Ha-MSV); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 151667361 CVCL_B7AB CCRF-CEM C7/H cancer cell line human CVCL_B7AB CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female Characteristics: Sensitive to glucocorticoid-mediated lysis; Characteristics: Cultured under hypoxia for 5 weeks (PubMed=31221196) 151667362 CVCL_B7AA CCRF-CEM C7-14 cancer cell line human CVCL_B7AA CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female Characteristics: Sensitive to glucocorticoid-mediated lysis 151667363 CVCL_B7AD CCRF-CEM C7/HDR-C2 cancer cell line human CVCL_B7AD CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female Characteristics: Made glucocorticoid resistant by culturing the grand-parent cell line under hypoxia for 5 weeks after a single dexamethasone (Dex) treatment (PubMed=31221196) 151667364 CVCL_B7AC CCRF-CEM C7/HDR cancer cell line human CVCL_B7AC CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female Characteristics: Made glucocorticoid resistant by culturing the parent cell line under hypoxia for 5 weeks after a single dexamethasone (Dex) treatment (PubMed=31221196) 151667365 CVCL_B7AF VII/2Liv spontaneously immortalized cell line CVCL_B7AF CL:0000010 Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107. Group: Reptilian cell line 151667366 CVCL_B7AH CCRF-CEM C7-SC14/H cancer cell line human CVCL_B7AH CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female Characteristics: Sensitive to glucocorticoid-mediated lysis; Characteristics: Cultured under hypoxia for 5 weeks (PubMed=31221196) 151667367 CVCL_B7AG CCRF-CEM C7-SC14 cancer cell line human CVCL_B7AG CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female Characteristics: Sensitive to glucocorticoid-mediated lysis 151667368 CVCL_B7A9 CCRF-CEM C1-15 cancer cell line human CVCL_B7A9 CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female Characteristics: Resistant to glucocorticoid-mediated lysis 151667369 CVCL_B7A2 SCVIi033-A induced pluripotent stem cell human CVCL_B7A2 From: Stanford Cardiovascular Institute; Palo Alto; USA. CL:0000010 Female 151667370 CVCL_B7A1 SCVIi037-A induced pluripotent stem cell human CVCL_B7A1 From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Ile154Leufs*5 (c.459delC); ClinVar=VCV000042755; Zygosity=Heterozygous (PubMed=35413566); Sequence variation: Mutation; HGNC; HGNC:9386; PRKAG2; Simple; p.Thr568Met (c.1703C>T); ClinVar=VCV000181464; Zygosity=Heterozygous (PubMed=35413566) Population: Southeast Asian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 151667371 CVCL_B7A4 CHO-K1 DeltaGMD spontaneously immortalized cell line CVCL_B7A4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; UniProtKB; Q8K3X3; Gmds Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Group: Serum/protein free medium cell line 151667372 CVCL_B7A3 SCVIi032-A induced pluripotent stem cell human CVCL_B7A3 From: Stanford Cardiovascular Institute; Palo Alto; USA. CL:0000010 Male 151667373 CVCL_B7A6 PANDA cancer cell line human CVCL_B7A6 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=34818028); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Unspecified (PubMed=34818028) Karyotypic information: Complex hypertriploid karyotype (PubMed=34818028); Derived from site: In situ; Pancreas; UBERON=UBERON_0001264. Omics: Metabolomics Male Doubling time: 36 hours (PubMed=34818028) 151667374 CVCL_B7A5 CHO-K1 DeltaGMDDeltaGFT spontaneously immortalized cell line CVCL_B7A5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; UniProtKB; G3HCE4; Fut8; Knockout cell: Method=CRISPR/Cas9; UniProtKB; Q8K3X3; Gmds Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Group: Serum/protein free medium cell line 151667375 CVCL_B7A8 CCRF-CEM C1 cancer cell line human CVCL_B7A8 CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female Characteristics: Resistant to glucocorticoid-mediated lysis Doubling time: 25 +- 3 hours (PubMed=6134583) 151667376 CVCL_B7A7 HXEX-ALL1/HDR cancer cell line human CVCL_B7A7 CL:0000010 Population: Chinese; Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. Male Characteristics: Made glucocorticoid resistant by culturing the parent cell line under hypoxia for 5 weeks after a single dexamethasone (Dex) treatment (PubMed=31221196) 151667377 CVCL_B7A0 SCVIi034-A induced pluripotent stem cell human CVCL_B7A0 From: Stanford Cardiovascular Institute; Palo Alto; USA. CL:0000010 Female 151667378 CVCL_B7BC H4F8 hybridoma house mouse CVCL_B7BC CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08962; Human CD63. 151667379 CVCL_B7BB H4C4 hybridoma house mouse CVCL_B7BB CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P16070; Human CD44. 151667380 CVCL_B7BE H52 hybridoma house mouse CVCL_B7BE CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P05107; Human ITGB2/CD18. 151667382 CVCL_B7BG H5C6 hybridoma house mouse CVCL_B7BG CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P08962; Human CD63. 151667383 CVCL_B7BF H5A4 hybridoma house mouse CVCL_B7BF CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P11215; Human ITGAM/CD11b. 151667384 CVCL_B7BI H5B9 hybridoma house mouse CVCL_B7BI CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P05107; Human ITGB2/CD18. 151667385 CVCL_B7BH H5D2 hybridoma house mouse CVCL_B7BH CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P08962; Human CD63. 151667386 CVCL_B7AZ HOMC-D4 transformed cell line human CVCL_B7AZ CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Japanese; Karyotypic information: 45,XY,-13,-22,+mar [55%] (PubMed=34663305); Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Greater omentum mesothelium; UBERON=UBERON_0005670; Cell type: Mesothelial cell; CL=CL_0000077. Omics: Transcriptomics; Microarray Male 151667387 CVCL_B7AY HOMC-B1 transformed cell line human CVCL_B7AY CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Japanese; Karyotypic information: 45,XY,-13 [80%] (PubMed=34663305); Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Greater omentum mesothelium; UBERON=UBERON_0005670; Cell type: Mesothelial cell; CL=CL_0000077. Omics: Transcriptomics; Microarray Male 151667388 CVCL_B7BA H4B4 hybridoma house mouse CVCL_B7BA CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P13473; Human LAMP2/CD107b. 151667389 CVCL_B7AR Pell-1 cancer cell line human CVCL_B7AR CL:0000010 Population: Japanese; Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. Male Doubling time: 28 hours (PubMed=34821060) 151667390 CVCL_B7B3 PMAC4 cancer cell line human CVCL_B7B3 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:13726; KMT2C; Simple; p.Glu1750Ter (c.5248G>T); Zygosity=Unspecified (PubMed=34663790) Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Anal canal; UBERON=UBERON_0000159. Omics: Genomics; Whole exome sequencing Male Doubling time: 25 hours (PubMed=34663790) 151667391 CVCL_B7AQ LIXC127 cancer cell line human CVCL_B7AQ CL:0000010 Population: Chinese; Han; Derived from site: In situ; Bile duct; UBERON=UBERON_0002394. Female Doubling time: 43.6 hours (Patent=CN107541494B) Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201662 151667392 CVCL_B7B2 PMAC3 cancer cell line human CVCL_B7B2 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Pro (c.1637A>C); ClinVar=VCV000375898; Zygosity=Unspecified (PubMed=34663790) Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Anal canal; UBERON=UBERON_0000159. Omics: Genomics; Whole exome sequencing Female Doubling time: 33 hours (PubMed=34663790) 151667393 CVCL_B7B5 CONACYT-CenVir-Brain spontaneously immortalized cell line CVCL_B7B5 CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the institution, the species Latin name and the tissue Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified Group: Fish cell line 151667394 CVCL_B7AT KU-Lu-MPPt3 CS cancer cell line human CVCL_B7AT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del; Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Omics: Transcriptomics; Microarray Female 151667395 CVCL_B7AS KU-Lu-MPPt3 AD cancer cell line human CVCL_B7AS CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del; Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Omics: Transcriptomics; Microarray Female 151667396 CVCL_B7B4 PMAC5 cancer cell line human CVCL_B7B4 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (PubMed=34663790); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly279Trp (c.835G>T); Zygosity=Unspecified (PubMed=34663790) Derived from site: In situ; Anal canal; UBERON=UBERON_0000159. Omics: Genomics; Whole exome sequencing Female Doubling time: 24 hours (PubMed=34663790) 151667397 CVCL_B7B7 MHM23 hybridoma house mouse CVCL_B7B7 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P05107; Human ITGB2/CD18. 151667398 CVCL_B7AV wAflu1.tet spontaneously immortalized cell line CVCL_B7AV CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Unspecified Characteristics: Cured of Wolbachia strain wFlu infection by tetracycline (PubMed=34584163) Group: Insect cell line 151667399 CVCL_B7B6 CONACYT-CenVir-Heart spontaneously immortalized cell line CVCL_B7B6 CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the institution, the species Latin name and the tissue Derived from site: In situ; Heart; UBERON=UBERON_0000948. Unspecified Group: Fish cell line 151667400 CVCL_B7AU wAflu1 spontaneously immortalized cell line CVCL_B7AU CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Unspecified Characteristics: Infected by Wolbachia strain wFlu (PubMed=34584163) Group: Insect cell line 151667401 CVCL_B7B9 H4A3 hybridoma house mouse CVCL_B7B9 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P11279; Human LAMP1/CD107a (Note=Also reacts with rat and hamster) 151667402 CVCL_B7AX HOMC-A4 transformed cell line human CVCL_B7AX CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Japanese; Karyotypic information: 46,XY,-14,-20,+2mar [45%] (PubMed=34663305); Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Greater omentum mesothelium; UBERON=UBERON_0005670; Cell type: Mesothelial cell; CL=CL_0000077. Omics: Transcriptomics; Microarray Male 151667403 CVCL_B7AW Aflu2 spontaneously immortalized cell line CVCL_B7AW CL:0000010 Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922. Unspecified Characteristics: Not infected by Wolbachia strain wFlu (PubMed=34584163) Group: Insect cell line 151667404 CVCL_B7B8 MHM24 hybridoma house mouse CVCL_B7B8 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P20701; Human ITGAL/CD11a. 151667405 CVCL_B7AJ CCRF-CEM C7-SC2 cancer cell line human CVCL_B7AJ CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female Characteristics: Sensitive to glucocorticoid-mediated lysis 151667406 CVCL_B7AI CCRF-CEM C7-SC14/HDR cancer cell line human CVCL_B7AI CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female Characteristics: Made glucocorticoid resistant by culturing the parent cell line under hypoxia for 5 weeks after a single dexamethasone (Dex) treatment (PubMed=31221196) 151667407 CVCL_B7AL CCRF-CEM C7-SC2/HDR cancer cell line human CVCL_B7AL CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female Characteristics: Made glucocorticoid resistant by culturing the parent cell line under hypoxia for 5 weeks after a single dexamethasone (Dex) treatment (PubMed=31221196) 151667408 CVCL_B7AK CCRF-CEM C7-SC2/H cancer cell line human CVCL_B7AK CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female Characteristics: Sensitive to glucocorticoid-mediated lysis; Characteristics: Cultured under hypoxia for 5 weeks (PubMed=31221196) 151667409 CVCL_B7AN NALM-6/HDR cancer cell line human CVCL_B7AN CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Made glucocorticoid resistant by culturing the parent cell line under hypoxia for 5 weeks after a single dexamethasone (Dex) treatment (PubMed=31221196; PubMed=34823530) Doubling time: 19-22 hours (PubMed=34823530) 151667410 CVCL_B7AM NALM-6/H cancer cell line human CVCL_B7AM CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Cultured under hypoxia for 5 weeks (PubMed=34823530) 151667411 CVCL_B7AP NALM-6/HDR-C5 cancer cell line human CVCL_B7AP CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:50800; DUX4 + HGNC; HGNC:5477; IGH; Name(s)=IGH-DUX4; Note=The translocation occurs in the silenced IGH allele (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Arg1068Ter (c.3202C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Gln45Ter (c.133C>T); ClinVar=VCV000393019; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male Characteristics: Made glucocorticoid resistant by culturing the grand-parent cell line under hypoxia for 5 weeks after a single dexamethasone (Dex) treatment (PubMed=34823530) 151667412 CVCL_B7B1 PMAC2 cancer cell line human CVCL_B7B1 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Glu458Ter (c.1372G>T); Zygosity=Unspecified (PubMed=34663790) Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Anal canal; UBERON=UBERON_0000159. Omics: Genomics; Whole exome sequencing Female Doubling time: 41 hours (PubMed=34663790) 151667413 CVCL_B7B0 PMAC1 cancer cell line human CVCL_B7B0 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:13726; KMT2C; Simple; p.Gln88Ter (c.262C>T); Zygosity=Unspecified (PubMed=34663790); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu726Lys (c.2176G>A); ClinVar=VCV000376476; Zygosity=Unspecified (PubMed=34663790) Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Anal canal; UBERON=UBERON_0000159. Omics: Genomics; Whole exome sequencing Male Doubling time: 47 hours (PubMed=34663790) 152995580 CVCL_B7MN FDOVL cancer cell line human CVCL_B7MN CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Ile1432Thr (c.4295C>T); Zygosity=Homozygous (PubMed=36982170); Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Cys702fs (c.2104_2111del); Zygosity=Heterozygous (PubMed=36982170); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu252del (c.754_756delCTC); ClinVar=VCV000998484; Zygosity=Heterozygous (PubMed=36982170) Population: Chinese; Derived from site: Metastatic; Pelvic lymph node; UBERON=UBERON_0015876. Omics: Genomics; Whole exome sequencing Female Doubling time: 87 hours (Patent=CN110835623B; PubMed=36982170) Group: Patented cell line; Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.15484 152995581 CVCL_B7MM TS 065 cancer cell line human CVCL_B7MM From: Johns Hopkins University School of Medicine; Baltimore; USA. CL:0000010 152995582 CVCL_B7MP LLC-PK1/NRa1 spontaneously immortalized cell line pig CVCL_B7MP CL:0000010 Selected for resistance to: ChEBI; CHEBI_7507; Neomycin; Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Hampshire; VBO=VBO_0001146. Male 152995583 CVCL_B7N1 STB6 Gill spontaneously immortalized cell line CVCL_B7N1 CL:0000010 Derived from site: In situ; Gill; UBERON=UBERON_0002535; Cell type: Epithelial cell; CL=CL_0000066. Unspecified Group: Fish cell line 152995584 CVCL_B7N0 STB5 Gill spontaneously immortalized cell line CVCL_B7N0 CL:0000010 Derived from site: In situ; Gill; UBERON=UBERON_0002535; Cell type: Epithelial cell; CL=CL_0000066. Unspecified Group: Fish cell line 152995585 CVCL_B7N3 HCC827-HGF2 cancer cell line human CVCL_B7N3 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4893; HGF; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Female 152995586 CVCL_B7MR VA10 transformed cell line human CVCL_B7MR CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Female 152995587 CVCL_B7N2 HCC827-HGF1 cancer cell line human CVCL_B7N2 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2236_2250del15); ClinVar=VCV000177620; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4893; HGF; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Female 152995588 CVCL_B7MQ LLC-PK1/NRa3 spontaneously immortalized cell line pig CVCL_B7MQ CL:0000010 Selected for resistance to: ChEBI; CHEBI_7507; Neomycin; Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518; Breed/subspecies: Hampshire; VBO=VBO_0001146. Male 152995589 CVCL_B7N5 A549/TS1 cancer cell line human CVCL_B7N5 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12441; TYMS; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 152995590 CVCL_B7MT SDM161 cancer cell line human CVCL_B7MT From: University Hospital of Zurich; Zurich; Switzerland CL:0000010 Miscellaneous: Cell line information from personal communication of Wipplinger, Martin Population: Caucasian; Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977. Female 152995591 CVCL_B7N4 MTA-13 cancer cell line house mouse CVCL_B7N4 CL:0000010 Selected for resistance to: ChEBI; CHEBI_63616; Pemetrexed (Alimta; LY231514); Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA); Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: T-cell; CL=CL_0000084; Breed/subspecies: DBA/2. Female 152995592 CVCL_B7MS SDM117 cancer cell line human CVCL_B7MS From: University Hospital of Zurich; Zurich; Switzerland CL:0000010 Miscellaneous: Cell line information from personal communication of Wipplinger, Martin Population: Caucasian; Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977. Male 152995593 CVCL_B7MF UWO23 cancer cell line human CVCL_B7MF CL:0000010 Transformant: NCBI_TaxID; 10586; Human papillomavirus type 33 (HPV33); Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Omics: Genomics; Whole exome sequencing Male Doubling time: 50 +- 6 hours (PubMed=35317874) 152995594 CVCL_B7ME UWO17 cancer cell line human CVCL_B7ME CL:0000010 Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Omics: Genomics; Whole exome sequencing Female Doubling time: 40 +- 4 hours (PubMed=35317874) 152995595 CVCL_B7MH UWO37 cancer cell line human CVCL_B7MH CL:0000010 Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372. Omics: Genomics; Whole exome sequencing Male Doubling time: 41 +- 4 hours (PubMed=35317874) 152995596 CVCL_B7MG UWO31 cancer cell line human CVCL_B7MG CL:0000010 Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723. Omics: Genomics; Whole exome sequencing Female Doubling time: 62 +- 6 hours (PubMed=35317874) 152995597 CVCL_B7MJ CAL-85-2 cancer cell line human CVCL_B7MJ CL:0000010 Population: Asian; Derived from site: Metastatic; Thorax; UBERON=UBERON_0000915. Female 152995598 CVCL_B7MI Col-GFP HSC transformed cell line house mouse CVCL_B7MI CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Miscellaneous: Age/sex of donor from personal communication of Weiskirchen, Ralf Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatic stellate cell; CL=CL_0000632; Breed/subspecies: pCol9GFP-HS4,5 transgenic. Male Doubling time: ~16 hours (DSMZ=ACC-941) 152995599 CVCL_B7ML TS 031 cancer cell line human CVCL_B7ML From: Johns Hopkins University School of Medicine; Baltimore; USA. CL:0000010 152995600 CVCL_B7MK TS 0120 cancer cell line human CVCL_B7MK From: Johns Hopkins University School of Medicine; Baltimore; USA. CL:0000010 152995601 CVCL_B7MB KEN transformed cell line human CVCL_B7MB CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9986; RFX5; Simple; p.Arg149Gln (c.446G>A); ClinVar=VCV000007648; Zygosity=Homozygous (from familial inference of KER) Population: Turkish; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152995602 CVCL_B7MA PAS [Human LCL] transformed cell line human CVCL_B7MA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9986; RFX5; Simple; p.Gln51Metfs*32 (c.151_154delCAAG); Zygosity=Heterozygous (PubMed=10079298) Population: Turkish; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152995603 CVCL_B7MD UJSi002-A induced pluripotent stem cell human CVCL_B7MD From: Jiangsu University; Jiangsu; China CL:0000010 Population: Chinese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152995604 CVCL_B7MC INMi005-A induced pluripotent stem cell human CVCL_B7MC From: Institute for Neurosciences of Montpellier; Montpellier; France CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Cys759Phe (c.2276G>T); ClinVar=VCV000002356; Zygosity=Heterozygous (PubMed=35248879); Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Leu2451Pro (c.7352T>C); Zygosity=Heterozygous (PubMed=35248879) Population: Caucasian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 152995605 CVCL_B7LU SaA LCL transformed cell line human CVCL_B7LU CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Leu469Pro (c.1406T>C) (T1524C); Zygosity=Homozygous (PubMed=11466404) Population: Caucasian; Greek; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152995606 CVCL_B7M6 SSI transformed cell line human CVCL_B7M6 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9986; RFX5; Simple; p.Gln321Ter (c.961C>T); Zygosity=Homozygous (PubMed=10395672) Population: Caucasian; Dutch and Indonesian; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 152995607 CVCL_B7LT SaA fibroblast transformed cell line human CVCL_B7LT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Leu469Pro (c.1406T>C) (T1524C); Zygosity=Homozygous (from autologous cell line SaA LCL) Population: Caucasian; Greek; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 152995608 CVCL_B7M5 WSI transformed cell line human CVCL_B7M5 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9986; RFX5; Simple; p.Gln321Ter (c.961C>T); Zygosity=Heterozygous (PubMed=10395672) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 152995609 CVCL_B7M8 OSE transformed cell line human CVCL_B7M8 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9986; RFX5; Simple; p.Gln51Metfs*32 (c.151_154delCAAG); Zygosity=Homozygous (PubMed=10079298); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Population: Turkish; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 152995610 CVCL_B7LW SaE LCL transformed cell line human CVCL_B7LW CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Leu469Pro (c.1406T>C) (T1524C); Zygosity=Homozygous (PubMed=11466404) Population: Caucasian; Greek; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152995611 CVCL_B7M7 6.1.6 transformed cell line human CVCL_B7M7 HLA typing: A*01,02; B*08,27; C*01 (PubMed=6967232) CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9988; RFXAP; Simple; p.Gly102Argfs*5 (c.302dupG) (1-BP INS, 413G); ClinVar=VCV000007649; Zygosity=Heterozygous (PubMed=9118943); Sequence variation: Mutation; HGNC; HGNC:9988; RFXAP; Simple; p.Ser132Glnfs*43 (c.392dupG) (1-BP INS, 505G); ClinVar=VCV000007650; Zygosity=Heterozygous (PubMed=9118943) Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG); Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191); Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE); Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female Characteristics: Good model for bare lymphocyte syndorme 2 as it does not express MHC class II determinants due to mutations in the RFXAP gene 152995612 CVCL_B7LV SaE fibroblast transformed cell line human CVCL_B7LV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Leu469Pro (c.1406T>C) (T1524C); Zygosity=Homozygous (from autologous cell line SaE LCL) Population: Caucasian; Greek; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 152995613 CVCL_B7LY SaM LCL transformed cell line human CVCL_B7LY CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Leu469Pro (c.1406T>C) (T1524C); Zygosity=Homozygous (PubMed=11466404) Population: Caucasian; Greek; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152995614 CVCL_B7M9 MAS transformed cell line human CVCL_B7M9 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9986; RFX5; Simple; p.Gln51Metfs*32 (c.151_154delCAAG); Zygosity=Heterozygous (PubMed=10079298) Population: Turkish; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152995615 CVCL_B7LX SaM fibroblast transformed cell line human CVCL_B7LX CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Leu469Pro (c.1406T>C) (T1524C); Zygosity=Homozygous (from autologous cell line SaM LCL) Population: Caucasian; Greek; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female 152995616 CVCL_B7LZ Fern transformed cell line human CVCL_B7LZ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Phe962Ser (c.2885T>C) (F961S); Zygosity=Homozygous (PubMed=10501838) Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. 152995617 CVCL_B7NN CT26-PD-L1 KO cancer cell line house mouse CVCL_B7NN CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1926446; Cd274; Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line) Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU); Derived from site: In situ; Colon; UBERON=UBERON_0001155; Breed/subspecies: BALB/c. Female 152995618 CVCL_B7NQ MC38-Luc-RFP cancer cell line house mouse CVCL_B7NQ CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH); Derived from site: In situ; Colon; UBERON=UBERON_0001155; Breed/subspecies: C57BL/6. Female Characteristics: Transduced with a SFFV-Luc-PGKp-tdTomato-T2A-PuroR lentiviral reporter construct 152995619 CVCL_B7NP CT26-hPD-L1 cancer cell line house mouse CVCL_B7NP CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1926446; Cd274; Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17635; CD274; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU); Derived from site: In situ; Colon; UBERON=UBERON_0001155; Breed/subspecies: BALB/c. Female 152995620 CVCL_B7NS B16/F10-Luc-RFP cancer cell line house mouse CVCL_B7NS CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Breed/subspecies: C57BL/6. Male Characteristics: Transduced with a SFFV-Luc-PGKp-tdTomato-T2A-PuroR lentiviral reporter construct 152995621 CVCL_B7NR A375-Luc-RFP cancer cell line human CVCL_B7NR CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511. Female Characteristics: Transduced with a SFFV-Luc-PGKp-tdTomato-T2A-PuroR lentiviral reporter construct 152995622 CVCL_B7NU HCT116-Luc-GFP cancer cell line human CVCL_B7NU CL:0000010 Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male Characteristics: Transduced with a CAG-Luc-PGKp-GFP-T2A-PuroR lentiviral reporter construct 152995623 CVCL_B7NT HeLa-Luc-RFP cancer cell line human CVCL_B7NT CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Characteristics: Transduced with a SFFV-Luc-PGKp-tdTomato-T2A-PuroR lentiviral reporter construct 152995624 CVCL_B7NG KOL02C2TT induced pluripotent stem cell human CVCL_B7NG CL:0000010 Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152995625 CVCL_B7NF KOL01SB1CC induced pluripotent stem cell human CVCL_B7NF CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5293; HTR2A; Simple; p.Ser34Ser (c.102T>C) (T102C) (rs6313); ClinVar=VCV000515935; Zygosity=Homozygous (PubMed=27916472; PubMed=34999422) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152995626 CVCL_B7NI SB3 [Acipenser] spontaneously immortalized cell line CVCL_B7NI CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Epithelial cell; CL=CL_0000066. Unspecified Group: Fish cell line 152995627 CVCL_B7NH KOL02SB2CC induced pluripotent stem cell human CVCL_B7NH CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5293; HTR2A; Simple; p.Ser34Ser (c.102T>C) (T102C) (rs6313); ClinVar=VCV000515935; Zygosity=Homozygous (PubMed=27916472; PubMed=34999422) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152995628 CVCL_B7NK TI-3 hybridoma house mouse CVCL_B7NK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P08057; Bovine TNNI3. 152995629 CVCL_B7NJ ZPR-1 hybridoma house mouse CVCL_B7NJ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q6DH07; Danio rerio arr3a. 152995630 CVCL_B7NM MC38-PD-L1 KO cancer cell line house mouse CVCL_B7NM CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1926446; Cd274 Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH); Derived from site: In situ; Colon; UBERON=UBERON_0001155; Breed/subspecies: C57BL/6. Female 152995631 CVCL_B7NL MC38-hPD-L1 cancer cell line house mouse CVCL_B7NL CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1926446; Cd274; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17635; CD274; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH); Derived from site: In situ; Colon; UBERON=UBERON_0001155; Breed/subspecies: C57BL/6. Female 152995632 CVCL_B7NA PC9/TS2 cancer cell line human CVCL_B7NA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12441; TYMS; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: Chinese; Han and Japanese; Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. Male 152995633 CVCL_B7NC CGRM03C3TT induced pluripotent stem cell human CVCL_B7NC CL:0000010 Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152995634 CVCL_B7NB GarL spontaneously immortalized cell line CVCL_B7NB CL:0000010 Miscellaneous: Age at sampling from personal communication of Bols, Niels C Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Epithelial cell; CL=CL_0000066. Unspecified Group: Fish cell line 152995635 CVCL_B7NE KOL01C1TT induced pluripotent stem cell human CVCL_B7NE CL:0000010 Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152995636 CVCL_B7ND CGRM03SB3CC induced pluripotent stem cell human CVCL_B7ND CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5293; HTR2A; Simple; p.Ser34Ser (c.102T>C) (T102C) (rs6313); ClinVar=VCV000515935; Zygosity=Homozygous (PubMed=34999422) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152995637 CVCL_B7N7 H1299/TS1 cancer cell line human CVCL_B7N7 CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12441; TYMS; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: Caucasian; Karyotypic information: Has lost chromosome Y (from parent cell line NCI-H1299); Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. Male 152995638 CVCL_B7MV HeLa ITCH KO cancer cell line human CVCL_B7MV From: Ayoubi, Riham; Montreal Neurological Institute, McGill University; Montreal; Canada CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13890; ITCH Miscellaneous: Cell line information from personal communication of Laflamme, Carl Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 152995639 CVCL_B7N6 A549/TS2 cancer cell line human CVCL_B7N6 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12441; TYMS; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 152995640 CVCL_B7MU JAR-Smad3/c cancer cell line human CVCL_B7MU CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6769; SMAD3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo. Male 152995641 CVCL_B7MX ASCF spontaneously immortalized cell line CVCL_B7MX CL:0000010 Miscellaneous: Age at sampling from personal communication of Pham, Phuc H Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164; Cell type: Fibroblast; CL=CL_0000057. Unspecified Group: Fish cell line 152995642 CVCL_B7N9 PC9/TS1 cancer cell line human CVCL_B7N9 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu746_Ala750del (c.2235_2249del15); ClinVar=VCV000163343; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12441; TYMS; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: Chinese; Han and Japanese; Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. Male 152995643 CVCL_B7N8 H1299/TS2 cancer cell line human CVCL_B7N8 CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12441; TYMS; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR) Population: Caucasian; Karyotypic information: Has lost chromosome Y (from parent cell line NCI-H1299); Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. Male 152995644 CVCL_B7MW Mel Ku cancer cell line human CVCL_B7MW CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097. Unspecified 152995645 CVCL_B7MZ STBH spontaneously immortalized cell line CVCL_B7MZ CL:0000010 Derived from site: In situ; Heart; UBERON=UBERON_0000948; Cell type: Epithelial cell; CL=CL_0000066. Unspecified Group: Fish cell line 152995646 CVCL_B7MY HK13 spontaneously immortalized cell line CVCL_B7MY CL:0000010 Miscellaneous: Age at sampling from personal communication of Pham, Phuc H Derived from site: In situ; Head kidney; UBERON=UBERON_0007132; Cell type: Epithelial cell of kidney; CL=CL_0002518. Unspecified Virology: Derived from a piscine orthoreovirus-1 (PRV-1) infected fish Group: Fish cell line 152995647 CVCL_B7KL BCH-RB31 cancer cell line human CVCL_B7KL CL:0000010 Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Asp1581Glyfs*15 (c.4742_4976del) (p.Asp1547Glyfs*15, c.4640_4874del); Zygosity=Unspecified (CHECT); Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser347fs (c.1039dupT); ClinVar=VCV002920668; Zygosity=Unspecified (CHECT). Female 152995648 CVCL_B7KK BCH-N-SL cancer cell line human CVCL_B7KK CL:0000010 Male 152995649 CVCL_B7KN BCH-RB33 cancer cell line human CVCL_B7KN CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Homozygous (CHECT) Omics: Transcriptomics; RNAseq. Male 152995650 CVCL_B7KM BCH-RB32 cancer cell line human CVCL_B7KM CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Homozygous (CHECT); Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Gln308Ter (c.922C>T); ClinVar=VCV002094186; Zygosity=Unspecified (CHECT). Female 152995651 CVCL_B7KP BCH-RB34 cancer cell line human CVCL_B7KP CL:0000010 Male 152995652 CVCL_B7L1 BCH-RB46 cancer cell line human CVCL_B7L1 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Ser1127Argfs*25 (c.3381_3402del); Zygosity=Unspecified (CHECT); Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; Ex24-27del; Zygosity=Unspecified (CHECT) Omics: Transcriptomics; RNAseq. Female 152995653 CVCL_B7L0 BCH-RB45 cancer cell line human CVCL_B7L0 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg320Ter (c.958C>T); ClinVar=VCV000126824; Zygosity=Unspecified (CHECT) Omics: Transcriptomics; RNAseq. Female 152995654 CVCL_B7KR BCH-RB36 cancer cell line human CVCL_B7KR CL:0000010 Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Leu1284Serfs*1 (c.4211_4791del) (p.Leu1250Serfs*1, c.4109_4689del); Zygosity=Unspecified (CHECT); Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg251Ter (c.751C>T); ClinVar=VCV000428681; Zygosity=Heterozygous (CHECT); Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg455Ter (c.1363C>T); ClinVar=VCV000126837; Zygosity=Heterozygous (CHECT). Male 152995655 CVCL_B7L3 BCH-RB48 cancer cell line human CVCL_B7L3 CL:0000010 Male 152995656 CVCL_B7KQ BCH-RB35 cancer cell line human CVCL_B7KQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Cys1080Ter (c.3238_3239ins); Zygosity=Unspecified (CHECT) Omics: Transcriptomics; RNAseq. Female 152995657 CVCL_B7L2 BCH-RB47 cancer cell line human CVCL_B7L2 CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Homozygous (CHECT). Female 152995658 CVCL_B7KD BCH-N-DW cancer cell line human CVCL_B7KD CL:0000010 Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Male 152995659 CVCL_B7KC BCH-N-DR cancer cell line human CVCL_B7KC CL:0000010 Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Male 152995660 CVCL_B7KF BCH-N-KB cancer cell line human CVCL_B7KF CL:0000010 Male 152995661 CVCL_B7KE BCH-N-JW cancer cell line human CVCL_B7KE CL:0000010 Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Male 152995662 CVCL_B7KH BCH-N-LR cancer cell line human CVCL_B7KH CL:0000010 Male 152995663 CVCL_B7KG BCH-N-KE cancer cell line human CVCL_B7KG CL:0000010 Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Male 152995664 CVCL_B7KJ BCH-N-NS cancer cell line human CVCL_B7KJ CL:0000010 Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Male 152995665 CVCL_B7KI BCH-N-MS cancer cell line human CVCL_B7KI CL:0000010 Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Male 152995666 CVCL_B7JZ MC-BR-BTY-0006 cancer cell line human CVCL_B7JZ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Gln2829Leu (c.8486A>C); Zygosity=Homozygous (PubMed=34145270); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174His (c.521G>A); Zygosity=Homozygous (PubMed=34145270) Derived from site: In situ; Breast; UBERON=UBERON_0000310. Omics: Genomics; Whole exome sequencing Female Characteristics: Established from a nude mouse xenograft (PubMed=34145270) Doubling time: 48-72 hours (PubMed=34145270) Group: Triple negative breast cancer (TNBC) cell line 152995667 CVCL_B7KB BCH-N-AD cancer cell line human CVCL_B7KB CL:0000010 Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Male 152995668 CVCL_B7KA VIP2 transformed cell line human CVCL_B7KA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9988; RFXAP; Simple; p.Ser123Thrfs*15 (c.368delG) (484delG); ClinVar=VCV000007651; Zygosity=Homozygous (PubMed=20197681) Population: Caucasian; Austrian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152995669 CVCL_B7JS CHO/PA16-TROP2-RAP-MAP spontaneously immortalized cell line CVCL_B7JS CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11530; TACSTD2 (Note=With a N-terminal GLEGGVAMPGAEDDVV = PA16-tag, C-terminal DMVNPGLEDRIE = RAP-tag and GDGMVPPGIEDK = MAP-tag); Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR) Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female 152995670 CVCL_B7K4 FZA transformed cell line human CVCL_B7K4 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9987; RFXANK; Simple; p.Leu195Pro (c.584T>C); ClinVar=VCV000827735; Zygosity=Homozygous (PubMed=10725724); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 152995671 CVCL_B7K3 EBA transformed cell line human CVCL_B7K3 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9987; RFXANK; Simple; p.Glu102Ter (c.304G>T); Zygosity=Homozygous (PubMed=10725724); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 152995672 CVCL_B7JR TrMab-6 hybridoma house mouse CVCL_B7JR CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2. Part of: Tohoku University Antibody Bank hybridoma collection 152995673 CVCL_B7JU Lec1/TROP2 spontaneously immortalized cell line CVCL_B7JU CL:0000010 Sequence variation: Mutation; UniProtKB; Q924C0; Mgat1; Simple; p.Gln339Arg; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; UniProtKB; Q924C0; Mgat1; Simple; p.Lys401Arg; Zygosity=Unspecified (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11530; TACSTD2 (Note=With a C-terminal GVAMPGAEDDVV = PA-tag) Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female 152995674 CVCL_B7K6 Nacera transformed cell line human CVCL_B7K6 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9987; RFXANK; Simple; c.338-25_338del (752delG26bp) (752delG-25) (26-BP DEL, NT752) (I5E6-25_I5E6+1); ClinVar=VCV001435455; Zygosity=Homozygous (PubMed=9806546; PubMed=10072068) Population: Algerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152995675 CVCL_B7K5 Bequit transformed cell line human CVCL_B7K5 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9987; RFXANK; Simple; c.338-25_338del (752delG26bp) (752delG-25) (26-BP DEL, NT752) (I5E6-25_I5E6+1); ClinVar=VCV001435455; Zygosity=Homozygous (PubMed=9806546; PubMed=10072068) Population: Algerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152995676 CVCL_B7JT CHO/TROP2-PA spontaneously immortalized cell line CVCL_B7JT CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11530; TACSTD2 (Note=With a C-terminal GVAMPGAEDDVV = PA-tag) Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female 152995677 CVCL_B7K8 BCH transformed cell line human CVCL_B7K8 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Glu381Ter (c.1141G>T) (G1256T); ClinVar=VCV000009541; Zygosity=Heterozygous (PubMed=9099848); Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; c.3317+1G>A (IVS18DS,G-A,+1) (del3349-3432); ClinVar=VCV000009542; Zygosity=Heterozygous (PubMed=9099848) Population: Caucasian; Austrian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152995678 CVCL_B7JW Lec8/TROP2 spontaneously immortalized cell line CVCL_B7JW CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11530; TACSTD2 (Note=With a C-terminal GVAMPGAEDDVV = PA-tag) Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female 152995679 CVCL_B7JV Lec2/TROP2 spontaneously immortalized cell line CVCL_B7JV CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11530; TACSTD2 (Note=With a C-terminal GVAMPGAEDDVV = PA-tag) Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female 152995680 CVCL_B7K7 Ramia transformed cell line human CVCL_B7K7 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9987; RFXANK; Simple; c.338-25_338del (752delG26bp) (752delG-25) (26-BP DEL, NT752) (I5E6-25_I5E6+1); ClinVar=VCV001435455; Zygosity=Homozygous (PubMed=10725724) Population: Algerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152995681 CVCL_B7JY CAB spontaneously immortalized cell line CVCL_B7JY CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified Characteristics: Optimal growth at 26 Celsius (PubMed=34448109) Group: Fish cell line 152995682 CVCL_B7JX ciPEC conditionally immortalized cell line human CVCL_B7JX CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR); Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Kidney, glomerulus; UBERON=UBERON_0000074; Cell type: Parietal epithelial cell; CL=CL_1000452. Doubling time: 35 hours (PubMed=34181939) 152995683 CVCL_B7K9 VIP1 transformed cell line human CVCL_B7K9 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Glu381Ter (c.1141G>T) (G1256T); ClinVar=VCV000009541; Zygosity=Homozygous (PubMed=20197681) Population: Caucasian; Austrian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152995684 CVCL_B7LM ShA transformed cell line human CVCL_B7LM CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9988; RFXAP; Simple; p.Pro12Argfs (c.35insGCGGGCG) (151ins7(GCGGGCG)fs329X); Zygosity=Homozygous (PubMed=9536093) Population: Druze; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 152995685 CVCL_B7LL AkO transformed cell line human CVCL_B7LL CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9988; RFXAP; Simple; p.Gln55Ter (c.163C>T); ClinVar=VCV000007652; Zygosity=Homozygous (PubMed=9536093) Population: Turkish; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 152995686 CVCL_B7M0 Ind transformed cell line human CVCL_B7M0 CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 152995687 CVCL_B7LN ShG transformed cell line human CVCL_B7LN CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9988; RFXAP; Simple; p.Pro12Argfs (c.35insGCGGGCG) (151ins7(GCGGGCG)fs329X); Zygosity=Homozygous (PubMed=9536093) Population: Druze; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 152995688 CVCL_B7M2 ETU transformed cell line human CVCL_B7M2 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Leu1051_Asp1078del (c.3153_3236del84); Zygosity=Heterozygous (PubMed=10663561) Population: Turkish; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152995689 CVCL_B7LQ Ss transformed cell line human CVCL_B7LQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9988; RFXAP; Simple; p.Ser123Thrfs*15 (c.368delG) (484delG); ClinVar=VCV000007651; Zygosity=Homozygous (PubMed=9536093) Population: Algerian; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 152995690 CVCL_B7M1 AST [Human LCL] transformed cell line human CVCL_B7M1 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Leu1051_Asp1078del (c.3153_3236del84); Zygosity=Heterozygous (PubMed=10663561) Population: Turkish; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152995691 CVCL_B7LP KER transformed cell line human CVCL_B7LP CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9986; RFX5; Simple; p.Arg149Gln (c.446G>A); ClinVar=VCV000007648; Zygosity=Homozygous (PubMed=12368908) Population: Turkish; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152995692 CVCL_B7M4 FSI transformed cell line human CVCL_B7M4 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9986; RFX5; Simple; p.Gln321Ter (c.961C>T); Zygosity=Heterozygous (PubMed=10395672) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 152995693 CVCL_B7LS UW-DS transformed cell line human CVCL_B7LS HLA typing: A*01,29; B*12,37 (PubMed=6967232) CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 152995694 CVCL_B7M3 ATU transformed cell line human CVCL_B7M3 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Leu1051_Asp1078del (c.3153_3236del84); Zygosity=Homozygous (PubMed=10663561) Population: Turkish; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 152995695 CVCL_B7LR G4B1 hybridoma house mouse CVCL_B7LR CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P08138; Human NGFR/CD271 (Note=Recognizes the glycosylated protein). Part of: Tohoku University Antibody Bank hybridoma collection 152995696 CVCL_B7LE BCH-RB59 cancer cell line human CVCL_B7LE CL:0000010 Male 152995697 CVCL_B7LD BCH-RB58 cancer cell line human CVCL_B7LD CL:0000010 Female 152995698 CVCL_B7LG ZM fibroblast transformed cell line human CVCL_B7LG CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9988; RFXAP; Simple; p.Ser123Thrfs*14 (c.368delG) (484delG); ClinVar=VCV000007651; Zygosity=Homozygous (PubMed=9287230) Population: Moroccan; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. 152995699 CVCL_B7LF BCH-P-SS cancer cell line human CVCL_B7LF CL:0000010 Derived from site: In situ; Chest wall; UBERON=UBERON_0016435. Female 152995700 CVCL_B7LI DERM transformed cell line human CVCL_B7LI CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-); Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male 152995701 CVCL_B7LH ZM LCL transformed cell line human CVCL_B7LH CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9988; RFXAP; Simple; p.Ser123Thrfs*15 (c.368delG) (484delG); ClinVar=VCV000007651; Zygosity=Homozygous (PubMed=9287230) Population: Moroccan; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. 152995702 CVCL_B7LK DA transformed cell line human CVCL_B7LK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9988; RFXAP; Simple; p.Ser123Thrfs*15 (c.368delG) (484delG); ClinVar=VCV000007651; Zygosity=Homozygous (PubMed=9118943; PubMed=9287230) Population: Algerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152995703 CVCL_B7LJ ABI transformed cell line human CVCL_B7LJ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9988; RFXAP; Simple; p.Gln55Ter (c.163C>T); ClinVar=VCV000007652; Zygosity=Homozygous (PubMed=9287230); Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Population: Turkish; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-); Derived from site: In situ; Amnion; UBERON=UBERON_0000305; Cell type: Fibroblast; CL=CL_0000057. 152995704 CVCL_B7LA BCH-RB55 cancer cell line human CVCL_B7LA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg455Ter (c.1363C>T); ClinVar=VCV000126837; Zygosity=Homozygous (CHECT). Female 152995705 CVCL_B7LC BCH-RB57 cancer cell line human CVCL_B7LC CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg455Ter (c.1363C>T); ClinVar=VCV000126837; Zygosity=Mosaic (CHECT). Male 152995706 CVCL_B7LB BCH-RB56 cancer cell line human CVCL_B7LB CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser485Tyrfs*9 (c.1454_1457delCTTT); ClinVar=VCV000847352; Zygosity=Homozygous (CHECT). Male 152995707 CVCL_B7KT BCH-RB38 cancer cell line human CVCL_B7KT CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Heterozygous (CHECT); Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Leu775Ter (c.2324T>A); Zygosity=Unspecified (CHECT); Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.1961-1G>T; ClinVar=VCV000930927; Zygosity=Heterozygous; Note=Splice acceptor mutation (CHECT) Omics: Transcriptomics; RNAseq. Male 152995708 CVCL_B7L5 BCH-RB50 cancer cell line human CVCL_B7L5 CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Homozygous (CHECT); Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Glu1114Serfs*45 (c.3340delG); Zygosity=Unspecified (CHECT). Male 152995709 CVCL_B7KS BCH-RB37 cancer cell line human CVCL_B7KS CL:0000010 Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Val1237Glyfs*8 (c.3709dupG) (p.Val1203Glyfs*8, c.3607dupG); Zygosity=Unspecified (CHECT); Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gln62Ter (c.184C>T); ClinVar=VCV001417347; Zygosity=Homozygous (CHECT) Omics: Transcriptomics; RNAseq. Male 152995710 CVCL_B7L4 BCH-RB49 cancer cell line human CVCL_B7L4 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg467Ter (c.1399C>T); ClinVar=VCV000092839; Zygosity=Homozygous (CHECT). Female 152995711 CVCL_B7KV BCH-RB40 cancer cell line human CVCL_B7KV CL:0000010 Omics: Transcriptomics; RNAseq. Male 152995712 CVCL_B7L7 BCH-RB52 cancer cell line human CVCL_B7L7 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.380+1G>A; ClinVar=VCV000428727; Note=Splice donor mutation; Zygosity=Heterozygous (CHECT); Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg787Ter (c.2359C>T); ClinVar=VCV000013073; Zygosity=Heterozygous (CHECT). Female 152995713 CVCL_B7KU BCH-RB39 cancer cell line human CVCL_B7KU CL:0000010 Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Glu1114Ter (c.3340G>T); Zygosity=Unspecified (CHECT); Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gln354Glufs*7 (c.1060_1061delCA); ClinVar=VCV000126828; Zygosity=Homozygous (CHECT). Male 152995714 CVCL_B7L6 BCH-RB51 cancer cell line human CVCL_B7L6 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gln685Ter (c.2053C>T); ClinVar=VCV000237668; Zygosity=Heterozygous (CHECT); Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.2520+1G>C; ClinVar=VCV003237106; Note=Splice donor mutation; Zygosity=Mosaic (CHECT). Female 152995715 CVCL_B7KX BCH-RB42 cancer cell line human CVCL_B7KX CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Heterozygous (CHECT); Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg455Ter (c.1363C>T); ClinVar=VCV000126837; Zygosity=Heterozygous (CHECT). Male 152995716 CVCL_B7L9 BCH-RB54 cancer cell line human CVCL_B7L9 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg418Serfs*9 (c.1251_1252delAA); ClinVar=VCV000428712; Zygosity=Homozygous (CHECT). Female 152995717 CVCL_B7KW BCH-RB41 cancer cell line human CVCL_B7KW CL:0000010 Female 152995718 CVCL_B7L8 BCH-RB53 cancer cell line human CVCL_B7L8 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg255Ter (c.763C>T); ClinVar=VCV000126820; Zygosity=Unspecified (CHECT). Female 152995719 CVCL_B7KZ BCH-RB44 cancer cell line human CVCL_B7KZ CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Homozygous (CHECT). Male 152995720 CVCL_B7KY BCH-RB43 cancer cell line human CVCL_B7KY CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Homozygous (CHECT). Male 152995721 CVCL_B7IJ 94P0496 finite cell line human CVCL_B7IJ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Homozygous (PubMed=29445421) Population: Caucasian; Polish; Karyotypic information: Mosaic; 46,XY; 45,XY,der(6)(6pter->6q11.1::13q11->13q21.33::20q11.22->20qter),-13 (PubMed=29445421); Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Omics: Genomics; Whole genome sequencing Male 152995722 CVCL_B7II RB355 Eto-R cancer cell line human CVCL_B7II CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; Ex2-6del; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; IVS20+1G>A; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP); Derived from site: In situ; Eye, globe; UBERON=UBERON_0010230. Female Problematic cell line: Contaminated Parent cell line (RB355) has been shown to be a Y-79 derivative. 152995723 CVCL_B7IL MDBK527 spontaneously immortalized cell line CVCL_B7IL CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male Characteristics: Adapted to growth without serum in suspension; Virology: Can be used for the production of a bovine alphaherpesvirus-1 (BoHV-1) vaccine Group: Patented cell line; Group: Serum/protein free medium cell line; Group: Vaccine production cell line 152995724 CVCL_B7IK SCI13D finite cell line human CVCL_B7IK CL:0000010 Karyotypic information: 46,XY,+10 (PubMed=34572381); Derived from site: In situ; Lung, bronchoalveolar fluid; UBERON=UBERON_0006538; Cell type: Fibroblast of lung; CL=CL_0002553. Male 152995725 CVCL_B7IN IP4 finite cell line human CVCL_B7IN CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Pro772_His773insProTyrAsnPro (P772_H773insPYNP); Zygosity=Heterozygous (PubMed=34429452) Derived from site: In situ; Nose, nasal cavity; UBERON=UBERON_0001707. Male Doubling time: 55 hours (PubMed=34429452) 152995726 CVCL_B7IM BC-PAK1 cancer cell line human CVCL_B7IM CL:0000010 Sequence variation: Mutation; HGNC; HGNC:14214; CIC; Simple; p.Ala1591Alafs*28 (c.4773T>TGC); Zygosity=Heterozygous (PubMed=34495459); Sequence variation: Mutation; HGNC; HGNC:13726; KMT2C; Simple; p.Tyr987Ter (c.2961C>G); ClinVar=VCV000694634; Zygosity=Heterozygous (PubMed=34495459); Sequence variation: Mutation; HGNC; HGNC:8554; PABPC1; Simple; p.Lys333Lysfs*21 (c.999delT); Zygosity=Heterozygous (PubMed=34495459) Population: Pakistani; Derived from site: In situ; Breast; UBERON=UBERON_0000310. Omics: Genomics; Whole exome sequencing Female Characteristics: ER-positive, PR-positive and ERBB2-negative 152995727 CVCL_B7J1 HindIIIG-1 transformed cell line Norway rat CVCL_B7J1 CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein; Genetic integration: Method=Transfection; Gene=UniProtKB; P03246; Human adenovirus C serotype 5 E1B 19 kDa protein; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B); Transformant: NCIt; C17262; X-Ray; Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified 152995728 CVCL_B7IP IP4/K4DT telomerase immortalized cell line human CVCL_B7IP CL:0000010 Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Pro772_His773insProTyrAsnPro (P772_H773insPYNP); Zygosity=Heterozygous (PubMed=34429452); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT Karyotypic information: 46,XY [24/50]; 46,XY,add(8)(q24) [26/50] (PubMed=34429452); Derived from site: In situ; Nose, nasal cavity; UBERON=UBERON_0001707. Male Doubling time: 51 hours (PubMed=34429452) 152995729 CVCL_B7J0 LYCT spontaneously immortalized cell line CVCL_B7J0 CL:0000010 Derived from site: In situ; Testis; UBERON=UBERON_0000473. Male Group: Fish cell line 152995730 CVCL_B7IB AIK2 telomerase immortalized cell line human CVCL_B7IB CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT Population: Japanese; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Male 152995731 CVCL_B7IA AIK1 telomerase immortalized cell line human CVCL_B7IA CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT Population: Japanese; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Male 152995732 CVCL_B7ID WERI-Rb-1 Eto-R cancer cell line human CVCL_B7ID CL:0000010 Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16); Derived from site: In situ; Eye, globe; UBERON=UBERON_0010230. Omics: Proteomics; Quantitative Female 152995733 CVCL_B7IC AIK3 telomerase immortalized cell line human CVCL_B7IC CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT Population: Japanese; Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003; Cell type: Keratinocyte; CL=CL_0000312. Male 152995734 CVCL_B7IF Y-79 CDDP-R cancer cell line human CVCL_B7IF CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; Ex2-6del; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; IVS20+1G>A; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP); Derived from site: In situ; Eye, globe; UBERON=UBERON_0010230. Female 152995735 CVCL_B7IE WERI-Rb-1 CDDP-R cancer cell line human CVCL_B7IE CL:0000010 Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP); Derived from site: In situ; Eye, globe; UBERON=UBERON_0010230. Female 152995736 CVCL_B7IH RB355 CDDP-R cancer cell line human CVCL_B7IH CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; Ex2-6del; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; IVS20+1G>A; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP); Derived from site: In situ; Eye, globe; UBERON=UBERON_0010230. Female Problematic cell line: Contaminated Parent cell line (RB355) has been shown to be a Y-79 derivative. 152995737 CVCL_B7IG Y-79 Eto-R cancer cell line human CVCL_B7IG CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; Ex2-6del; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; IVS20+1G>A; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16); Derived from site: In situ; Eye, globe; UBERON=UBERON_0010230. Female 152995738 CVCL_B7HY KU-CAS3 cancer cell line human CVCL_B7HY CL:0000010 Population: Korean; Derived from site: In situ; Scalp, skin; UBERON=UBERON_8300000. Male Doubling time: 34 hours (PubMed=34693591) 152995739 CVCL_B7I9 AIF3 telomerase immortalized cell line human CVCL_B7I9 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT Population: Japanese; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 152995740 CVCL_B7HX NSG-70-WNT5A-GFP cancer cell line human CVCL_B7HX CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12784; WNT5A Population: Indian; Derived from site: In situ; Brain; UBERON=UBERON_0000955. Male Group: Cancer stem cell line 152995741 CVCL_B7HZ KU-CAS5 cancer cell line human CVCL_B7HZ CL:0000010 Population: Korean; Derived from site: In situ; Scalp, skin; UBERON=UBERON_8300000. Female Doubling time: 29 hours (PubMed=34693591) Caution: Originally the supplementary figure 1 of PubMed=34693591 displayed a STR profile for KU-CAS5 which was identical to that of KU-CAS3 But the file was updated on January 13, 2023 with the currently displayed STR profile. 152995742 CVCL_B7HQ MA11 cancer cell line human CVCL_B7HQ CL:0000010 Population: Caucasian; Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Female Group: Triple negative breast cancer (TNBC) cell line 152995743 CVCL_B7I2 PC-B-148CA cancer cell line human CVCL_B7I2 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Thr3033Asnfs*11 (c.9097dupA); ClinVar=VCV000038208; Zygosity=Heterozygous (PubMed=34651665); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous (PubMed=34651665); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Homozygous (PubMed=34651665) Population: Southeast Asian; Thai; Karyotypic information: 47-58 chromosomes with loss of both copies of chr X (PubMed=34651665); Derived from site: In situ; Breast; UBERON=UBERON_0000310. Female Doubling time: 155.7 +- 5.2 hours (PubMed=34651665) Group: Triple negative breast cancer (TNBC) cell line 152995744 CVCL_B7HP 2BG2 hybridoma house mouse CVCL_B7HP CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q9RAJ4; Mycobacterium paratuberculosis 35 kDa major membrane protein (mmpI). 152995745 CVCL_B7I1 PC-B-142CA cancer cell line human CVCL_B7I1 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Pro871Leu (c.2612C>T); ClinVar=VCV000041812; Zygosity=Homozygous (PubMed=34651665); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser425Cys (c.1274C>G); Zygosity=Homozygous (PubMed=34651665); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; c.7806-14T>C; ClinVar=VCV000126158; Zygosity=Homozygous (PubMed=34651665); Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Glu839Lys (c.2515G>A); ClinVar=VCV000013862; Zygosity=Heterozygous (PubMed=34651665); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Cys420Arg (c.1258T>C); ClinVar=VCV000031945; Zygosity=Heterozygous (PubMed=34651665); Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln224Ter (c.670C>T); Zygosity=Homozygous (PubMed=34651665); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile232Thr (c.695T>C); ClinVar=VCV000141224; Zygosity=Homozygous (PubMed=34651665) Population: Southeast Asian; Thai; Karyotypic information: 38 chromosomes with a chr X monosomy (PubMed=34651665); Derived from site: In situ; Breast; UBERON=UBERON_0000310. Female Characteristics: ER-negative, PR-negative, ERBB2-positive Doubling time: 45 +- 3 hours (PubMed=34651665) 152995746 CVCL_B7I4 AIA1 telomerase immortalized cell line human CVCL_B7I4 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT Population: Japanese; Derived from site: In situ; Skin, adipose tissue; UBERON=UBERON_0002097+UBERON_0001013; Cell type: Stromal cell; CL=CL_0000499. Male 152995747 CVCL_B7HS mCCDcl1 Ed1 spontaneously immortalized cell line house mouse CVCL_B7HS CL:0000010 Derived from site: In situ; Kidney, cortical collecting duct; UBERON=UBERON_0004203; Cell type: Kidney collecting duct principal cell; CL=CL_1001431. Omics: Transcriptomics; RNAseq Male 152995748 CVCL_B7I3 ELHK spontaneously immortalized cell line CVCL_B7I3 CL:0000010 Derived from site: In situ; Head kidney; UBERON=UBERON_0007132; Cell type: Fibroblast; CL=CL_0000057. Unspecified Characteristics: Can grow at temperatures ranging from 24 to 32 Celsius with an optimal growth temperature at 28 Celsius (DOI=10.1016/j.aqrep.2021.100899); Virology: Susceptible to infection by Singapore grouper iridovirus (SGIV) and red-spotted grouper nervous necrosis virus (RGNNV) (DOI=10.1016/j.aqrep.2021.100899) Group: Fish cell line 152995749 CVCL_B7HR mCCDcl1 spontaneously immortalized cell line house mouse CVCL_B7HR CL:0000010 Miscellaneous: Doubling time from personal communication of Rossier, Bernard Claude; Miscellaneous: Sex of mouse and STR profile from personal communication of Hummler, Edith Derived from site: In situ; Kidney, cortical collecting duct; UBERON=UBERON_0004203; Cell type: Kidney collecting duct principal cell; CL=CL_1001431. Omics: Transcriptomics; RNAseq Male Characteristics: Expresses epithelial sodium channels (ENaC) as well as the necessary cellular machinery to enable their stimulation by physiological concentrations of aldosterone, including 11-betahydroxysteroid dehydrogenase (HSD11b2), mineralocorticoid and glucocorticoid receptors and have therefore been used as a model for the study of principal cells physiology (PubMed=15743993; PubMed=29357433) Doubling time: ~24 hours (Direct_author_submission) 152995750 CVCL_B7I6 AIA3 telomerase immortalized cell line human CVCL_B7I6 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT Population: Japanese; Derived from site: In situ; Skin, adipose tissue; UBERON=UBERON_0002097+UBERON_0001013; Cell type: Stromal cell; CL=CL_0000499. Male 152995751 CVCL_B7HU mCCDcl1 Ed3 spontaneously immortalized cell line house mouse CVCL_B7HU CL:0000010 Derived from site: In situ; Kidney, cortical collecting duct; UBERON=UBERON_0004203; Cell type: Kidney collecting duct principal cell; CL=CL_1001431. Omics: Transcriptomics; RNAseq Male 152995752 CVCL_B7I5 AIA2 telomerase immortalized cell line human CVCL_B7I5 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT Population: Japanese; Derived from site: In situ; Skin, adipose tissue; UBERON=UBERON_0002097+UBERON_0001013; Cell type: Stromal cell; CL=CL_0000499. Male 152995753 CVCL_B7HT mCCDcl1 Ed2 spontaneously immortalized cell line house mouse CVCL_B7HT CL:0000010 Derived from site: In situ; Kidney, cortical collecting duct; UBERON=UBERON_0004203; Cell type: Kidney collecting duct principal cell; CL=CL_1001431. Omics: Transcriptomics; RNAseq Male 152995754 CVCL_B7I8 AIF2 telomerase immortalized cell line human CVCL_B7I8 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT Population: Japanese; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 152995755 CVCL_B7HW NSG-70-GFP cancer cell line human CVCL_B7HW CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP) Population: Indian; Derived from site: In situ; Brain; UBERON=UBERON_0000955. Male Group: Cancer stem cell line 152995756 CVCL_B7I7 AIF1 telomerase immortalized cell line human CVCL_B7I7 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT Population: Japanese; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 152995757 CVCL_B7HV NSG-70 cancer cell line human CVCL_B7HV CL:0000010 Population: Indian; Derived from site: In situ; Brain; UBERON=UBERON_0000955. Male Doubling time: ~150 hours (PubMed=35430703) Group: Cancer stem cell line 152995758 CVCL_B7JK SCLC-J1 cancer cell line human CVCL_B7JK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Simple; p.Gly1111Val (c.3332_3333delGGinsTT); Zygosity=Homozygous (PubMed=34381882); Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple; p.Gly936Cys (c.2806G>T); Zygosity=Homozygous (PubMed=34381882); Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Leu218Val (c.652T>G); ClinVar=VCV000572140; Zygosity=Homozygous (PubMed=34381882) Population: Japanese; Donor information: Established from a one pack per day smoker (PubMed=34381882); Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Male Doubling time: 64.5 hours (PubMed=34381882) 152995759 CVCL_B7JJ PEO4-iPSC-OSKM-05 induced pluripotent stem cell human CVCL_B7JJ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Tyr1655Tyr (c.4965C>T) (5193C>T); ClinVar=VCV001657967; Zygosity=Hemizygous; Note=De novo mutation that cancels the c.4965C>G (5193C>G) mutation in the patient (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Arg160Trp (c.478A>T); ClinVar=VCV000412204; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Asp (c.731G>A); ClinVar=VCV000372785; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Female 152995760 CVCL_B7JM DF-1-AvBD9 spontaneously immortalized cell line CVCL_B7JM CL:0000010 Genetic integration: Method=Transduction; Gene=CGNC; 49917; AvBD9/Gallinacin-9; Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: East Lansing Line 0 (ELL-0). Unspecified Group: Bird cell line 152995761 CVCL_B7JL KDF finite cell line CVCL_B7JL CL:0000010 Donor information: Established from a rhinoceros named Puntung, the second last Sumatran rhinoceros to survive in captivity in Malaysia and died in 2017 of terminal cancer; Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Fibroblast; CL=CL_0000057. Female Doubling time: 20.45 hours (Note=At 5th passage), 22.35 hours (Note=At 10th and 15th passages) (DOI=10.46754/jssm.2021.06.008) Group: Endangered species/breed cell line 152995762 CVCL_B7K0 MC-BR-BTY-0019 cancer cell line human CVCL_B7K0 CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=34145270); Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=34145270); Sequence variation: Gene deletion; HGNC; HGNC:6844; MAP2K4; Zygosity=Homozygous (PubMed=34145270); Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Leu2088Profs*11 (c.6261_6262insC); Zygosity=Heterozygous (PubMed=34145270); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp146Ter (c.438G>A); ClinVar=VCV000428890; Zygosity=Homozygous (PubMed=34145270) Derived from site: In situ; Breast; UBERON=UBERON_0000310. Omics: Genomics; Whole exome sequencing Female Characteristics: Established from a nude mouse xenograft (PubMed=34145270); Characteristics: ER-negative, PR-negative, ERBB2-positive (PubMed=34145270) Doubling time: 24-48 hours (PubMed=34145270) 152995763 CVCL_B7JN MCF10A BLV spontaneously immortalized cell line human CVCL_B7JN CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line) Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367. Female Virology: Infected with bovine leukemia virus from the peripheral blood of BLV-infected adult cows Does not release viral particles into the cell culture supernatant. 152995764 CVCL_B7K2 KAIMRC2 cancer cell line human CVCL_B7K2 CL:0000010 Population: Arab; Saudi Arabian; Derived from site: In situ; Breast; UBERON=UBERON_0000310. Female Doubling time: ~16 hours (PubMed=34073849) Group: Triple negative breast cancer (TNBC) cell line 152995765 CVCL_B7JQ TrMab-29 hybridoma house mouse CVCL_B7JQ CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2. Part of: Tohoku University Antibody Bank hybridoma collection 152995766 CVCL_B7K1 MCF-7 PRODH KO cancer cell line human CVCL_B7K1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9453; PRODH; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152995767 CVCL_B7JP MCF7/TROP2-KO cancer cell line human CVCL_B7JP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11530; TACSTD2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152995768 CVCL_B7JC PC-R1 transformed cell line human CVCL_B7JC HLA typing: DRB1*02,04 (PubMed=9892213) CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371; Cell type: Epithelial cell; CL=CL_0000066. Male 152995769 CVCL_B7JB PC-H1 finite cell line human CVCL_B7JB HLA typing: DRB1*03,06 (PubMed=9892213) CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371; Cell type: Epithelial cell; CL=CL_0000066. Male Senescence: SV40-transformed but with a finite life span 152995770 CVCL_B7JE EPN spontaneously immortalized cell line human CVCL_B7JE CL:0000010 Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428; Cell type: Epithelial cell of prostate; CL=CL_0002231. Male 152995771 CVCL_B7JD PC-S1 transformed cell line human CVCL_B7JD HLA typing: DRB1*04,12 (PubMed=9892213) CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371; Cell type: Epithelial cell; CL=CL_0000066. Male 152995772 CVCL_B7JG OUC-SebSc-Skm-1 spontaneously immortalized cell line CVCL_B7JG CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the institution, the species Latin name and the tissue Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134; Cell type: Myoblast; CL=CL_0000056. Omics: Transcriptomics; RNAseq Female Group: Fish cell line 152995773 CVCL_B7JF EPN-PKM3 spontaneously immortalized cell line human CVCL_B7JF CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9612; PTK2B (Note=With p.Lys457Ala); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428; Cell type: Epithelial cell of prostate; CL=CL_0002231. Male 152995774 CVCL_B7JI PEO4-iPSC-OSKM-03 induced pluripotent stem cell human CVCL_B7JI CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Tyr1655Tyr (c.4965C>T) (5193C>T); ClinVar=VCV001657967; Zygosity=Hemizygous; Note=De novo mutation that cancels the c.4965C>G (5193C>G) mutation in the patient (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Arg160Trp (c.478A>T); ClinVar=VCV000412204; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Asp (c.731G>A); ClinVar=VCV000372785; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795. Female 152995775 CVCL_B7JH YG-PLL cancer cell line human CVCL_B7JH CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: Metastatic; Left inguinal lymph node; UBERON=UBERON_0001542; Cell type: T-cell; CL=CL_0000084. Male Characteristics: IL2 and IL4 dependent Doubling time: ~35 hours (PubMed=34334531) 152995776 CVCL_B7IZ LYCO spontaneously immortalized cell line CVCL_B7IZ CL:0000010 Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female Group: Fish cell line 152995777 CVCL_B7IY hEM3 ARID1A-KO transformed cell line human CVCL_B7IY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11110; ARID1A Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Endometrium, epithelium; UBERON=UBERON_0004811; Cell type: Epithelial cell; CL=CL_0000066. Female 152995778 CVCL_B7JA PC-E1 transformed cell line human CVCL_B7JA HLA typing: DRB1*04,07 (PubMed=9892213) CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371; Cell type: Epithelial cell; CL=CL_0000066. Male 152995779 CVCL_B7J3 HPr-1 transformed cell line human CVCL_B7J3 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Hispanic; Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428; Cell type: Epithelial cell of prostate; CL=CL_0002231. Male 152995780 CVCL_B7IR NP2/K4DT telomerase immortalized cell line human CVCL_B7IR CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT Karyotypic information: 46,XY [21/50]; 46,XY,del(6)(q21;qter) [29/50] (PubMed=34429452); Derived from site: In situ; Nose, nasal cavity, maxillary sinus; Note=From a polyp; UBERON=UBERON_0001764. Male Doubling time: 59 hours (PubMed=34429452) 152995781 CVCL_B7IQ NP2 [Human nose] finite cell line human CVCL_B7IQ CL:0000010 Derived from site: In situ; Nose, nasal cavity, maxillary sinus; Note=From a polyp; UBERON=UBERON_0001764. Male Doubling time: 62 hours (PubMed=34429452) 152995782 CVCL_B7J2 PC-346CF cancer cell line human CVCL_B7J2 CL:0000010 Derived from site: In situ; Prostate; UBERON=UBERON_0002367. Male Characteristics: Established from tumors in male nude mice injected with the parent cell line; Characteristics: Androgen insensitive 152995783 CVCL_B7J5 BC-H1 transformed cell line human CVCL_B7J5 HLA typing: DRB1*07,11 (PubMed=9892213) CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371; Cell type: Epithelial cell; CL=CL_0000066. Female 152995784 CVCL_B7IT NP3/T telomerase immortalized cell line human CVCL_B7IT CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT Karyotypic information: 46,XY [5/50]; 47,XY,+4 [45/50] (PubMed=34429452); Transformant: NCBI_TaxID; 10598; Human papillomavirus type 58 (HPV58); Derived from site: In situ; Nose, nasal cavity, maxillary sinus; Note=From a polyp; UBERON=UBERON_0001764. Male Doubling time: 62 hours (PubMed=34429452) 152995785 CVCL_B7J4 HPr-1-AR transformed cell line human CVCL_B7J4 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:644; AR; Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Hispanic; Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428; Cell type: Epithelial cell of prostate; CL=CL_0002231. Male 152995786 CVCL_B7IS NP3 [Human nose] finite cell line human CVCL_B7IS CL:0000010 Transformant: NCBI_TaxID; 10598; Human papillomavirus type 58 (HPV58); Derived from site: In situ; Nose, nasal cavity, maxillary sinus; Note=From a polyp; UBERON=UBERON_0001764. Male Doubling time: 63 hours (PubMed=34429452) 152995787 CVCL_B7IV CAK [Cromileptes] spontaneously immortalized cell line CVCL_B7IV CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Unspecified Characteristics: Optimal growth at 26 Celsius Group: Fish cell line 152995788 CVCL_B7J7 CC-B1 transformed cell line human CVCL_B7J7 HLA typing: DRB1*03,06 (PubMed=9892213) CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371; Cell type: Epithelial cell; CL=CL_0000066. Unspecified 152995789 CVCL_B7J6 BC-K1 finite cell line human CVCL_B7J6 HLA typing: DRB1*03,14 (PubMed=9892213) CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371; Cell type: Epithelial cell; CL=CL_0000066. Female Senescence: SV40-transformed but with a finite life span 152995790 CVCL_B7IU GBRS spontaneously immortalized cell line CVCL_B7IU CL:0000010 Derived from site: In situ; Fin; UBERON=UBERON_0008897. Unspecified Group: Fish cell line 152995791 CVCL_B7IX hEM3 transformed cell line human CVCL_B7IX CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Endometrium, epithelium; UBERON=UBERON_0004811; Cell type: Epithelial cell; CL=CL_0000066. Female 152995792 CVCL_B7J9 LC-M1 transformed cell line human CVCL_B7J9 HLA typing: DRB1*09,11 (PubMed=9892213) CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371; Cell type: Epithelial cell; CL=CL_0000066. Unspecified 152995793 CVCL_B7J8 LC-D1 transformed cell line human CVCL_B7J8 HLA typing: DRB1*03,13 (PubMed=9892213) CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371; Cell type: Epithelial cell; CL=CL_0000066. Unspecified 152995794 CVCL_B7IW SPNE1 cancer cell line human CVCL_B7IW CL:0000010 Population: Chinese; Derived from site: In situ; Pancreas; UBERON=UBERON_0001264. Omics: Genomics; Whole exome sequencing Female Doubling time: ~140 hours (PubMed=35394261) 152995795 CVCL_B7GH CTCL-3 cancer cell line human CVCL_B7GH CL:0000010 Population: African American; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: IL2 dependent 152995796 CVCL_B7GG 603B-iNOS antisense transformed cell line house mouse CVCL_B7GG CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7873; NOS2 (Note=In antisense orientation); Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=U19tsA58); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Cholangiocyte; CL=CL_1000488; Breed/subspecies: BALB/c. Female Characteristics: Transduced with an antisense human INOS gene fragment (PubMed=14977638) 152995797 CVCL_B7GJ CHK-Q_SF spontaneously immortalized cell line CVCL_B7GJ CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518. Omics: Transcriptomics; Microarray Female Group: Serum/protein free medium cell line 152995798 CVCL_B7GI CTCL-2 cancer cell line human CVCL_B7GI CL:0000010 Population: African American; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Female Characteristics: IL2 independent Caution: Indicated as originating from a 60 year old in PubMed=6256763 and 64 year old in PubMed=6272125 152995799 CVCL_B7GL BERP35T1 transformed cell line human CVCL_B7GL CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C129642; Plutonium-238 alpha particle radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Omics: Transcriptomics; RNAseq Male Characteristics: Established from tumors obtained from xenografts of the parent cell line implanted in BALB/c nude mice 152995800 CVCL_B7GK CHK-Q_SS spontaneously immortalized cell line CVCL_B7GK CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518. Omics: Transcriptomics; Microarray Female Characteristics: Adapted to both serum-free and suspension condition Group: Serum/protein free medium cell line 152995801 CVCL_B7GN ODM-2 transformed cell line human CVCL_B7GN CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=8-4); Derived from site: In situ; Eye, ciliary body, ciliary epithelium; UBERON=UBERON_0001778; Cell type: Non-pigmented ciliary epithelial cell; CL=CL_0002304. Male Doubling time: ~24 hours (PubMed=2553750) 152995802 CVCL_B7GM BERP35T4 transformed cell line human CVCL_B7GM CL:0000010 Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Transformant: NCIt; C129642; Plutonium-238 alpha particle radiation; Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031; Cell type: Epithelial cell of bronchus; CL=CL_0002328. Omics: Transcriptomics; RNAseq Male Characteristics: Established from tumors obtained from xenografts of the parent cell line implanted in BALB/c nude mice 152995803 CVCL_B7GB IBEC line A transformed cell line house mouse CVCL_B7GB CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Cholangiocyte; CL=CL_1000488; Breed/subspecies: BALB/c/aNn. Female Doubling time: ~24-48 hours (PubMed=10421641) 152995804 CVCL_B7GA 3F12 [Mouse hybridoma against I.punctatus Ig light chains] hybridoma house mouse CVCL_B7GA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Ictalurus punctatus Ig light chains G-type. 152995805 CVCL_B7GD IBEC line C transformed cell line house mouse CVCL_B7GD CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Cholangiocyte; CL=CL_1000488; Breed/subspecies: BALB/c/aNn. Female Doubling time: ~72-96 hours (PubMed=10421641) 152995806 CVCL_B7GC IBEC line B transformed cell line house mouse CVCL_B7GC CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Cholangiocyte; CL=CL_1000488; Breed/subspecies: BALB/c/aNn. Female Doubling time: ~168-192 hours (PubMed=10421641) 152995807 CVCL_B7GF 603B transformed cell line house mouse CVCL_B7GF CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=U19tsA58); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Cholangiocyte; CL=CL_1000488; Breed/subspecies: BALB/c. Female 152995808 CVCL_B7GE IBEC line D transformed cell line house mouse CVCL_B7GE CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Cholangiocyte; CL=CL_1000488; Breed/subspecies: BALB/c/aNn. Female Doubling time: ~24-48 hours (PubMed=10421641) 152995809 CVCL_B7FW alpha48T transformed cell line CVCL_B7FW CL:0000010 Transformant: NCBI_TaxID; 11886; Rous sarcoma virus (Note=Bryan high titer; RSV-BH); Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified Group: Bird cell line 152995810 CVCL_B7G8 MCEC-1 conditionally immortalized cell line house mouse CVCL_B7G8 CL:0000010 Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58); Derived from site: In situ; Heart; UBERON=UBERON_0000948; Cell type: Cardiac endothelial cell; CL=CL_0010008; Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse. Unspecified 152995811 CVCL_B7FV alpha40T transformed cell line CVCL_B7FV CL:0000010 Transformant: NCBI_TaxID; 11886; Rous sarcoma virus (Note=Bryan high titer; RSV-BH); Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified Group: Bird cell line 152995812 CVCL_B7G7 MJ7/18 hybridoma CVCL_B7G7 CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; Q63961; Mouse Eng/Cd105. 152995813 CVCL_B7FY QOR1 CJ07-18/1/F6 transformed cell line CVCL_B7FY CL:0000010 Transformant: NCIt; C17231; Ultraviolet radiation; Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified Group: Bird cell line; Group: Patented cell line; Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 08020603 152995814 CVCL_B7G9 1G7 [Mouse hybridoma against I.punctatus Ig light chains] hybridoma house mouse CVCL_B7G9 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: Ictalurus punctatus Ig light chains F-type. 152995815 CVCL_B7FX QOR2-sf transformed cell line CVCL_B7FX CL:0000010 Transformant: NCIt; C17231; Ultraviolet radiation; Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified Group: Bird cell line; Group: Patented cell line; Group: Serum/protein free medium cell line; Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 08020602 152995816 CVCL_B7FZ COR CJ0780 transformed cell line CVCL_B7FZ CL:0000010 Transformant: NCIt; C17231; Ultraviolet radiation; Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified Group: Bird cell line; Group: Patented cell line; Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 08020604 152995817 CVCL_B7G0 BLN-5 cancer cell line human CVCL_B7G0 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=28148826) Derived from site: In situ; Brain; UBERON=UBERON_0000955. Omics: Transcriptomics; RNAseq Unspecified 152995818 CVCL_B7FN DFSC somatic stem cell human CVCL_B7FN CL:0000010 Derived from site: In situ; Dental follicle; UBERON=UBERON_0008969. Unspecified 152995819 CVCL_B7G2 BLN-2 cancer cell line human CVCL_B7G2 CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Omics: Transcriptomics; RNAseq Unspecified 152995820 CVCL_B7FQ HROG17 T1 M1 cancer cell line human CVCL_B7FQ From: Linnebacher, Michael; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Brain, left parieto-occipital lobe. Male Characteristics: Established from a patient-derived xenograft 152995821 CVCL_B7G1 BLN-1 cancer cell line human CVCL_B7G1 CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Omics: Transcriptomics; RNAseq Unspecified 152995822 CVCL_B7FP HROG06 T0 M2 cancer cell line human CVCL_B7FP From: Linnebacher, Michael; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811. Male Characteristics: Established from a patient-derived xenograft 152995823 CVCL_B7G4 BLN-6 cancer cell line human CVCL_B7G4 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=28148826) Derived from site: In situ; Brain; UBERON=UBERON_0000955. Omics: Transcriptomics; RNAseq Unspecified 152995824 CVCL_B7FS HK-CRISPR-mEGFP-NUP358 no.97 cancer cell line human CVCL_B7FS CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP) Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Characteristics: Using CRISPR/Cas9D10A NUP358 has been endogenously tagged in both alleles at the N-terminus with mEGFP (CLS=301575) 152995825 CVCL_B7G3 BLN-4 cancer cell line human CVCL_B7G3 CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Omics: Transcriptomics; RNAseq Unspecified 152995826 CVCL_B7FR HROG12 T0 M1 cancer cell line human CVCL_B7FR From: Linnebacher, Michael; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Brain, right fronto-parietal lobe. Male Characteristics: Established from a patient-derived xenograft 152995827 CVCL_B7FU 3T transformed cell line CVCL_B7FU CL:0000010 Transformant: NCBI_TaxID; 11886; Rous sarcoma virus (Note=Bryan high titer; RSV-BH); Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922; Cell type: Fibroblast; CL=CL_0000057. Unspecified Group: Bird cell line 152995828 CVCL_B7G6 BLN-9 cancer cell line human CVCL_B7G6 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=28148826) Derived from site: In situ; Brain; UBERON=UBERON_0000955. Omics: Transcriptomics; RNAseq Unspecified 152995829 CVCL_B7G5 BLN-8 cancer cell line human CVCL_B7G5 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=28148826) Derived from site: In situ; Brain; UBERON=UBERON_0000955. Omics: Transcriptomics; RNAseq Unspecified 152995830 CVCL_B7FT HK-2xZFN-Smc4-mEGFP no.82-68 cancer cell line human CVCL_B7FT CL:0000010 Genetic integration: Method=ZFN; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP) Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Characteristics: Using ZFN SMC4 has been endogenously tagged in both alleles at the C-terminus with mEGFP 152995831 CVCL_B7HI 9CE5 hybridoma house mouse CVCL_B7HI CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Bovine herpesvirus 1 (IVRI isolate No 216).. 152995832 CVCL_B7HH 9BC6 hybridoma house mouse CVCL_B7HH CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: Bovine herpesvirus 1 (IVRI isolate No 216).. 152995833 CVCL_B7HK 1AG2 hybridoma house mouse CVCL_B7HK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q9RAJ4; Mycobacterium paratuberculosis 35 kDa major membrane protein (mmpI). 152995834 CVCL_B7HJ WCRC-25 cancer cell line human CVCL_B7HJ CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Heterozygous (CelloPub=CLPUB00696); Sequence variation: Mutation; HGNC; HGNC:1748; CDH1; Simple; p.Gln706Ter (c.2116C>T); Zygosity=Heterozygous (CelloPub=CLPUB00696) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Omics: Transcriptomics; RNAseq Female Characteristics: ER-positive, PR-negative and ERBB2-negative Doubling time: ~5 days (CelloPub=CLPUB00696) 152995835 CVCL_B7HM 1DE8 hybridoma house mouse CVCL_B7HM CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q9RAJ4; Mycobacterium paratuberculosis 35 kDa major membrane protein (mmpI). 152995836 CVCL_B7HL 1AG8 hybridoma house mouse CVCL_B7HL CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; Q9RAJ4; Mycobacterium paratuberculosis 35 kDa major membrane protein (mmpI). 152995837 CVCL_B7I0 3A3 [Mouse hybridoma against human NEK2] hybridoma house mouse CVCL_B7I0 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; P51955; Human NEK2. 152995838 CVCL_B7HN 2BD2 hybridoma house mouse CVCL_B7HN CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q9RAJ4; Mycobacterium paratuberculosis 35 kDa major membrane protein (mmpI). 152995839 CVCL_B7HA UG-GlyPy-Hem-1 spontaneously immortalized cell line CVCL_B7HA CL:0000010 Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the institution, the species Latin name and the tissue Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011; Cell type: Hemocyte; CL=CL_0000387. Unspecified Group: Insect cell line 152995840 CVCL_B7HC COS7 moRIII-gamma transformed cell line CVCL_B7HC CL:0000010 Genetic integration: Method=Transfection; Gene=MGI; MGI:95496; Fcer1g; Genetic integration: Method=Transfection; Gene=MGI; MGI:95500; Fcgr3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1); Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male Group: Non-human primate cell line 152995841 CVCL_B7HB COS7-moRIII transformed cell line CVCL_B7HB CL:0000010 Genetic integration: Method=Transfection; Gene=MGI; MGI:95500; Fcgr3; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1); Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male Group: Non-human primate cell line 152995842 CVCL_B7HE 3AC3 hybridoma house mouse CVCL_B7HE CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Bovine herpesvirus 1 (IVRI isolate No 216).. 152995843 CVCL_B7HD COS7-pc transformed cell line CVCL_B7HD CL:0000010 Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1); Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Male Characteristics: Control cell line for COS7-moRIII (Cellosaurus=CVCL_B7HB) and COS7 moRIII-gamma (Cellosaurus=CVCL_B7HC) (DOI=10.1080/09712119.2011.558685) Group: Non-human primate cell line 152995844 CVCL_B7HG 9AG3 hybridoma house mouse CVCL_B7HG CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Bovine herpesvirus 1 (IVRI isolate No 216).. 152995845 CVCL_B7HF 9AE3 hybridoma house mouse CVCL_B7HF CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Bovine herpesvirus 1 (IVRI isolate No 216).. 152995846 CVCL_B7H9 CMT-Star cancer cell line dog CVCL_B7H9 CL:0000010 Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin); Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray Female Doubling time: 24.4 +- 0.028 hours (DOI=10.1080/09712119.2022.2032719) 152995847 CVCL_B7GX MhCT08-E cancer cell line human CVCL_B7GX CL:0000010 Population: Indian; Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723; Cell type: Epithelial cell; CL=CL_0000066. Female Doubling time: 23.61 +- 1.32 hours (PubMed=35796014) 152995848 CVCL_B7GW CAE606 cancer cell line human CVCL_B7GW CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Trp110Ter (c.329G>A); ClinVar=VCV000376304; Zygosity=Homozygous (PubMed=35349366); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu28Lysfs*16 (c.81delT); Zygosity=Homozygous (PubMed=35349366) Derived from site: In situ; Ear, auditory canal; UBERON=UBERON_0001352. Male Doubling time: 25.8 hours (PubMed=35349366) 152995849 CVCL_B7H8 CMT-Stylo cancer cell line dog CVCL_B7H8 CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; miRNA profiling; Microarray Female Doubling time: 23.55 +- 1.8 hours (DOI=10.1080/09712119.2022.2032719) 152995850 CVCL_B7GZ MhCT12-E cancer cell line human CVCL_B7GZ CL:0000010 Population: Indian; Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723; Cell type: Epithelial cell; CL=CL_0000066. Female Doubling time: 25.54 +- 0.64 hours (PubMed=35796014) 152995851 CVCL_B7GY MhCT08-F cancer cell line human CVCL_B7GY CL:0000010 Population: Indian; Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723; Cell type: Fibroblast; CL=CL_0000057. Female Doubling time: 32.23 +- 0.91 hours (PubMed=35796014) 152995852 CVCL_B7GP 8-SVHCE transformed cell line human CVCL_B7GP CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Eye, ciliary body, ciliary epithelium; UBERON=UBERON_0001778; Cell type: Non-pigmented ciliary epithelial cell; CL=CL_0002304. Unspecified 152995853 CVCL_B7H1 PHG spontaneously immortalized cell line CVCL_B7H1 CL:0000010 Derived from site: In situ; Gill; UBERON=UBERON_0002535; Cell type: Fibroblast; CL=CL_0000057. Unspecified Doubling time: ~42 hours (Note=At 11th passage) (PubMed=35169909) Group: Fish cell line 152995854 CVCL_B7H0 MhCT12-F cancer cell line human CVCL_B7H0 CL:0000010 Population: Indian; Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723; Cell type: Fibroblast; CL=CL_0000057. Female Doubling time: 39.73 +- 1.35 hours (PubMed=35796014) 152995855 CVCL_B7H3 AGS-PTX-R cancer cell line human CVCL_B7H3 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol); Derived from site: In situ; Stomach; UBERON=UBERON_0000945. Female Doubling time: 25.6-25.8 hours (PubMed=35122114) 152995856 CVCL_B7GR SV40-PE transformed cell line CVCL_B7GR CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=8-4); Derived from site: In situ; Eye, ciliary body, ciliary epithelium; UBERON=UBERON_0001778; Cell type: Pigmented ciliary epithelial cell; CL=CL_0002303. Unspecified 152995857 CVCL_B7H2 AGS-5FU-R cancer cell line human CVCL_B7H2 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU); Derived from site: In situ; Stomach; UBERON=UBERON_0000945. Female 152995858 CVCL_B7GQ SV40-NPE transformed cell line CVCL_B7GQ CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=8-4); Derived from site: In situ; Eye, ciliary body, ciliary epithelium; UBERON=UBERON_0001778; Cell type: Non-pigmented ciliary epithelial cell; CL=CL_0002304. Unspecified 152995859 CVCL_B7GT IBBISTi004-B induced pluripotent stem cell human CVCL_B7GT From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 152995860 CVCL_B7H5 OATL9 cancer cell line human CVCL_B7H5 CL:0000010 Population: Japanese; Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. 152995861 CVCL_B7H4 HCM-MEC010 cancer cell line human CVCL_B7H4 CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:16062; CRTC1 + HGNC; HGNC:16259; MAML2; Name(s)=CRTC1-MAML2, MECT1-MAML2; Note=In frame CRTC1 exon 1 fused to MAML2 exon 2 (PubMed=35251626). Population: Japanese; Derived from site: In situ; Oral cavity, hard palate; UBERON=UBERON_0003216. Omics: Transcriptomics; RNAseq Female 152995862 CVCL_B7GS IBBISTi004-A induced pluripotent stem cell human CVCL_B7GS From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 152995863 CVCL_B7H7 HEp-2/VCR cancer cell line human CVCL_B7H7 CL:0000010 Population: African American; Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR); Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female Problematic cell line: Contaminated Parent cell line (HEp-2) has been shown to be a HeLa derivative. 152995864 CVCL_B7GV MPT-S1 cancer cell line human CVCL_B7GV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; c.6079_6082delAATT; Zygosity=Heterozygous (PubMed=35365682); Sequence variation: Mutation; HGNC; HGNC:11957; MED12; Simple; p.Gly44Asp (c.131G>A); ClinVar=VCV000092220; Zygosity=Heterozygous (PubMed=35365682); Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.1530_1531delAG; Zygosity=Heterozygous (PubMed=35365682); Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.1588_1589delAA; Zygosity=Heterozygous (PubMed=35365682); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.750_754delinsA; Zygosity=Heterozygous (PubMed=35365682); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu252del (c.754_756delCTC); ClinVar=VCV000998484; Zygosity=Heterozygous (PubMed=35365682) Population: Chinese; Derived from site: In situ; Breast; UBERON=UBERON_0000310. Omics: Genomics; Whole exome sequencing Female Characteristics: Established from a nude mouse xenograft Doubling time: 2-3 days (PubMed=35365682) 152995865 CVCL_B7GU IBBISTi004-C induced pluripotent stem cell human CVCL_B7GU From: Instituto de Medicina Molecular Joao Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa; Lisboa; Portugal CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 152995866 CVCL_B7H6 MELS cancer cell line human CVCL_B7H6 CL:0000010 Population: Japanese; Derived from site: In situ; Rectum; UBERON=UBERON_0001052. Male 152995867 CVCL_B7V7 Abcam Hep-G2 SLC7A11 KO cancer cell line human CVCL_B7V7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11059; SLC7A11; Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 152995868 CVCL_B7UV e-mHepC transformed cell line house mouse CVCL_B7UV CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6348; KLF4 Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995869 CVCL_B7V6 Abcam Hep-G2 ARG1 KO cancer cell line human CVCL_B7V6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:663; ARG1; Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 152995870 CVCL_B7UU CI-muHepa transformed cell line house mouse CVCL_B7UU CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052); Characteristics: Tumorigenic (PubMed=29520052) 152995871 CVCL_B7UX 10-4A(BFP) transformed cell line Norway rat CVCL_B7UX CL:0000010 Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; BFJKS; TagBFP (Note=Blue fluorescent protein derived from eqFP578); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3; Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog; Genetic integration: Method=Transduction; Gene=MGI; MGI:99187; Zfp42; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Alveolar type 2 fibroblast; CL=CL_4028006; Breed/subspecies: Sprague Dawley; RS=RS_0000681. Male Characteristics: Using CRISPR/Cas9 a T2A-TagBFP-NLS construct was introduced at the C-terminus of Acta2 (PubMed=33162897); Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (from parent cell line 10-4A) 152995872 CVCL_B7V9 Abcam Jurkat CD247 KO cancer cell line human CVCL_B7V9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1677; CD247; Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male 152995873 CVCL_B7UW 10-4A transformed cell line Norway rat CVCL_B7UW CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3; Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog; Genetic integration: Method=Transduction; Gene=MGI; MGI:99187; Zfp42; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Lung; UBERON=UBERON_0002048; Cell type: Alveolar type 2 fibroblast; CL=CL_4028006; Breed/subspecies: Sprague Dawley; RS=RS_0000681. Omics: Transcriptomics; RNAseq Male Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=33162897) 152995874 CVCL_B7V8 Abcam Jurkat CD1A KO cancer cell line human CVCL_B7V8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1634; CD1A; Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male 152995875 CVCL_B7UZ 533 OOS cancer cell line human CVCL_B7UZ CL:0000010 Derived from site: In situ; Ascites; UBERON=UBERON_0007795. Female Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 742D 152995876 CVCL_B7UY 485 colo can cancer cell line human CVCL_B7UY CL:0000010 Derived from site: Metastatic; Abdominal wall; UBERON=UBERON_0003697. Male Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 740D 152995877 CVCL_B7UN e-hUVEC-6 transformed cell line human CVCL_B7UN CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066; Cell type: Endothelial cell of umbilical vein; CL=CL_0002618. Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995878 CVCL_B7UM e-hUVEC-5 transformed cell line human CVCL_B7UM CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5109; HOXA9; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6348; KLF4; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC; Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066; Cell type: Endothelial cell of umbilical vein; CL=CL_0002618. Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995879 CVCL_B7UP e-hUVEC-7 transformed cell line human CVCL_B7UP CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066; Cell type: Endothelial cell of umbilical vein; CL=CL_0002618. Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995880 CVCL_B7V1 TAM-1 cancer cell line human CVCL_B7V1 HLA typing: A*02; B*06,27 (PubMed=2939141) CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Unspecified 152995881 CVCL_B7V0 716 SS MNV cancer cell line human CVCL_B7V0 CL:0000010 Derived from site: Metastatic; Colon; UBERON=UBERON_0001155. Female Group: Patented cell line; Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 790D 152995882 CVCL_B7UR e-hUVEC-9 transformed cell line human CVCL_B7UR CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066; Cell type: Endothelial cell of umbilical vein; CL=CL_0002618. Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995883 CVCL_B7V3 IBMS-iPSC-069-05 induced pluripotent stem cell human CVCL_B7V3 From: Institute of Biomedical Sciences, Academia Sinica; Taipei; Taiwan CL:0000010 Population: Asian. Male 152995884 CVCL_B7UQ e-hUVEC-8 transformed cell line human CVCL_B7UQ CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066; Cell type: Endothelial cell of umbilical vein; CL=CL_0002618. Male Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995885 CVCL_B7V2 TAM-6 transformed cell line human CVCL_B7V2 HLA typing: A*02; B*06,27 (PubMed=2939141) CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Unspecified 152995886 CVCL_B7V5 Abcam Hep-G2 APOE KO cancer cell line human CVCL_B7V5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:613; APOE; Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 152995887 CVCL_B7UT e-mHepA transformed cell line house mouse CVCL_B7UT CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6348; KLF4; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995888 CVCL_B7V4 Abcam A-375 NT5E KO cancer cell line human CVCL_B7V4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8021; NT5E; Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511. Female 152995889 CVCL_B7US e-hUVEC-10 transformed cell line human CVCL_B7US CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC Karyotypic information: 84-88<4n>XXXX,-3,-4,+9,i(21)(q10) (PubMed=29520052); Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066; Cell type: Endothelial cell of umbilical vein; CL=CL_0002618. Female Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995890 CVCL_B7UF e-hStr-3 transformed cell line human CVCL_B7UF CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11195; SOX2; Genetic integration: Method=Transduction; Gene=MGI; MGI:102811; Lmo2; Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog; Genetic integration: Method=Transduction; Gene=MGI; MGI:103262; Yap1; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7 Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Stromal cell of bone marrow; CL=CL_0010001. Female Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995891 CVCL_B7UE e-hStr-2 transformed cell line human CVCL_B7UE CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3527; EZH2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7545; MYB; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC; Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog; Genetic integration: Method=Transduction; Gene=MGI; MGI:103262; Yap1; Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7 Karyotypic information: 44<2n>XY,der(5)t(5;14)(p12;q11),-13,-21 (PubMed=29520052); Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Stromal cell of bone marrow; CL=CL_0010001. Female Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995892 CVCL_B7UH e-hStr-5 transformed cell line human CVCL_B7UH CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11195; SOX2; Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1; Genetic integration: Method=Transduction; Gene=MGI; MGI:102811; Lmo2; Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog; Genetic integration: Method=Transduction; Gene=MGI; MGI:103262; Yap1; Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7 Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Stromal cell of bone marrow; CL=CL_0010001. Female Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995893 CVCL_B7UG e-hStr-4 transformed cell line human CVCL_B7UG CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3527; EZH2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11195; SOX2; Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7 Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Stromal cell of bone marrow; CL=CL_0010001. Female Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995894 CVCL_B7UJ CI-huVEC transformed cell line human CVCL_B7UJ CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC Karyotypic information: 46XY,+5,-13 (PubMed=29520052); Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066; Cell type: Endothelial cell of umbilical vein; CL=CL_0002618. Male Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995895 CVCL_B7UI e-hUVEC-1 transformed cell line human CVCL_B7UI CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3527; EZH2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7545; MYB; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC; Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog; Genetic integration: Method=Transduction; Gene=MGI; MGI:99187; Zfp42; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7 Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066; Cell type: Endothelial cell of umbilical vein; CL=CL_0002618. Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995896 CVCL_B7UL e-hUVEC-4 transformed cell line human CVCL_B7UL CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5363; ID4; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17101; SUZ12; Genetic integration: Method=Transduction; Gene=MGI; MGI:99187; Zfp42 Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066; Cell type: Endothelial cell of umbilical vein; CL=CL_0002618. Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995897 CVCL_B7UK e-hUVEC-3 transformed cell line human CVCL_B7UK CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3; Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1; Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog; Genetic integration: Method=Transduction; Gene=MGI; MGI:103262; Yap1 Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066; Cell type: Endothelial cell of umbilical vein; CL=CL_0002618. Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995898 CVCL_B7UB e-hOB-3 transformed cell line human CVCL_B7UB CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Karyotypic information: 46<2n>XX,add(22)(q13) (at 21th passage); 46<2n>XX,ins(15)(q11),add(22)(q13) (at 66th passage) (PubMed=29520052); Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Bone; UBERON=UBERON_0002481; Cell type: Osteoblast; CL=CL_0000062. Female Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995899 CVCL_B7UA e-hOB-2 transformed cell line human CVCL_B7UA CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3527; EZH2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC; Genetic integration: Method=Transduction; Gene=MGI; MGI:88138; Bcl2; Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog; Genetic integration: Method=Transduction; Gene=MGI; MGI:99187; Zfp42; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Karyotypic information: 40-47<2n>add(X)(q27),add(10)(p11),-13,add(14)(q32),+20,+21,+22 (PubMed=29520052); Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Bone; UBERON=UBERON_0002481; Cell type: Osteoblast; CL=CL_0000062. Female Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995900 CVCL_B7UD e-hStr-1 transformed cell line human CVCL_B7UD CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3527; EZH2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11195; SOX2; Genetic integration: Method=Transduction; Gene=MGI; MGI:102811; Lmo2; Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog; Genetic integration: Method=Transduction; Gene=MGI; MGI:103262; Yap1; Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein Karyotypic information: 111<5n>XXXX,-X,del(X)(q25),del(1)(p22),i(21)(q10) (PubMed=29520052); Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Stromal cell of bone marrow; CL=CL_0010001. Female Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995901 CVCL_B7UC e-hOB-4 transformed cell line human CVCL_B7UC CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2514; CTNNB1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Bone; UBERON=UBERON_0002481; Cell type: Osteoblast; CL=CL_0000062. Female Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995902 CVCL_B7VW Abcam Raji AIM2 KO cancer cell line human CVCL_B7VW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:357; AIM2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152995903 CVCL_B7W8 Abcam Raji BRD2 KO cancer cell line human CVCL_B7W8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1103; BRD2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152995904 CVCL_B7VV Abcam Raji AHR KO cancer cell line human CVCL_B7VV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:348; AHR; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152995905 CVCL_B7W7 Abcam Raji BRD1 KO cancer cell line human CVCL_B7W7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1102; BRD1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152995906 CVCL_B7VY Abcam Raji ALKBH1 KO cancer cell line human CVCL_B7VY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17911; ALKBH1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152995907 CVCL_B7VX Abcam Raji ALCAM KO cancer cell line human CVCL_B7VX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:400; ALCAM; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152995908 CVCL_B7W9 Abcam Raji BRD9 KO cancer cell line human CVCL_B7W9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25818; BRD9; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152995909 CVCL_B7VZ Abcam Raji ALYREF KO cancer cell line human CVCL_B7VZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19071; ALYREF; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152995910 CVCL_B7W0 Abcam Raji APOBEC3B KO cancer cell line human CVCL_B7W0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17352; APOBEC3B; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152995911 CVCL_B7VN Abcam SH-SY5Y EFNB2 KO cancer cell line human CVCL_B7VN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3227; EFNB2; Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Female 152995912 CVCL_B7W2 Abcam Raji ATF5 KO cancer cell line human CVCL_B7W2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:790; ATF5; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152995913 CVCL_B7VQ Abcam SH-SY5Y LMOD1 KO cancer cell line human CVCL_B7VQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6647; LMOD1; Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Female 152995914 CVCL_B7W1 Abcam Raji ASAH1 KO cancer cell line human CVCL_B7W1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:735; ASAH1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152995915 CVCL_B7VP Abcam SH-SY5Y SNAP25 KO cancer cell line human CVCL_B7VP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11132; SNAP25; Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Female 152995916 CVCL_B7VS Abcam Raji AATF KO cancer cell line human CVCL_B7VS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19235; AATF; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152995917 CVCL_B7W4 Abcam Raji ATG9A KO cancer cell line human CVCL_B7W4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22408; ATG9A; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152995918 CVCL_B7VR Abcam K-562 EP300 KO cancer cell line human CVCL_B7VR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3373; EP300; Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. Female 152995919 CVCL_B7W3 Abcam Raji ATG3 KO cancer cell line human CVCL_B7W3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20962; ATG3; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152995920 CVCL_B7VU Abcam Raji AGTR1 KO cancer cell line human CVCL_B7VU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:336; AGTR1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152995921 CVCL_B7W6 Abcam Raji BMPR2 KO cancer cell line human CVCL_B7W6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1078; BMPR2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152995922 CVCL_B7VT Abcam Raji ABCB1 KO cancer cell line human CVCL_B7VT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:40; ABCB1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152995923 CVCL_B7W5 Abcam Raji BAK1 KO cancer cell line human CVCL_B7W5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:949; BAK1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152995924 CVCL_B7VG Abcam RAW 264.7 Ccr2 KO cancer cell line house mouse CVCL_B7VG CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:106185; Ccr2 Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male 152995925 CVCL_B7VF Abcam Jurkat PVRIG KO cancer cell line human CVCL_B7VF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32190; PVRIG; Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male 152995926 CVCL_B7VI Abcam RAW 264.7 Sirpa KO cancer cell line house mouse CVCL_B7VI CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:108563; Sirpa Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male 152995927 CVCL_B7VH Abcam RAW 264.7 Cx3cr1 KO cancer cell line house mouse CVCL_B7VH CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1333815; Cx3cr1 Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male 152995928 CVCL_B7VK Abcam RAW 264.7 Cdkn1b KO cancer cell line house mouse CVCL_B7VK CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:104565; Cdkn1b Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV); Derived from site: In situ; Ascites; UBERON=UBERON_0007795; Cell type: Macrophage; CL=CL_0000235; Breed/subspecies: BALB/c. Male 152995929 CVCL_B7VJ Abcam Neuro-2a Arc KO cancer cell line house mouse CVCL_B7VJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88067; Arc Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010; Cell type: Neural crest derived neuroblast; CL=CL_0002676; Breed/subspecies: A/J. Male 152995930 CVCL_B7VM Abcam HCT 116 XPO1 KO cancer cell line human CVCL_B7VM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12825; XPO1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152995931 CVCL_B7VL Abcam A-549 XPO1 KO cancer cell line human CVCL_B7VL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12825; XPO1; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 152995932 CVCL_B7VA Abcam Jurkat LCK KO cancer cell line human CVCL_B7VA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6524; LCK; Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male 152995933 CVCL_B7VC Abcam Jurkat ZAP70 KO cancer cell line human CVCL_B7VC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12858; ZAP70; Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male 152995934 CVCL_B7VB Abcam Jurkat LEF1 KO cancer cell line human CVCL_B7VB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6551; LEF1; Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male 152995935 CVCL_B7VE Abcam Jurkat TP53 KO cancer cell line human CVCL_B7VE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53; Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male 152995936 CVCL_B7VD Abcam Jurkat IDH2 KO cancer cell line human CVCL_B7VD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5383; IDH2; Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male 152995937 CVCL_B7ST NIHTVBi017-A induced pluripotent stem cell human CVCL_B7ST From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9545; PSMB8; Simple; p.Thr75Met (c.224C>T); ClinVar=VCV000659832; Zygosity=Homozygous (PubMed=35660921) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152995938 CVCL_B7T5 UCL-CTRL002 finite cell line human CVCL_B7T5 From: University College London; London; United Kingdom CL:0000010 Miscellaneous: Doubling time information from personal communication of Koletsi, Sofia Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Doubling time: 48 hours (Direct_author_submission) 152995939 CVCL_B7SS NIHTVBi016-A induced pluripotent stem cell human CVCL_B7SS From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9545; PSMB8; Simple; p.Thr75Met (c.224C>T); ClinVar=VCV000659832; Zygosity=Homozygous (PubMed=35660921) Population: Latino or Hispanic; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152995940 CVCL_B7T4 UCL-CTRL001 finite cell line human CVCL_B7T4 From: University College London; London; United Kingdom CL:0000010 Miscellaneous: Doubling time information from personal communication of Koletsi, Sofia Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Doubling time: 48 hours (Direct_author_submission) 152995941 CVCL_B7SV NIHTVBi019-A induced pluripotent stem cell human CVCL_B7SV From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4200; BLOC1S1; Simple; p.His69Pro (c.206A>C); Zygosity=Heterozygous (PubMed=36070637); Sequence variation: Mutation; HGNC; HGNC:4200; BLOC1S1; Simple; p.Gly120Glu (c.359G>A); Zygosity=Heterozygous (PubMed=36070637) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152995942 CVCL_B7SU NIHTVBi018-A induced pluripotent stem cell human CVCL_B7SU From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9545; PSMB8; Simple; p.Thr75Met (c.224C>T); ClinVar=VCV000659832; Zygosity=Homozygous (PubMed=35660921) Population: Latino or Hispanic; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152995943 CVCL_B7T6 UCL-CTRL003 finite cell line human CVCL_B7T6 From: University College London; London; United Kingdom CL:0000010 Miscellaneous: Doubling time information from personal communication of Koletsi, Sofia Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Doubling time: 48 hours (Direct_author_submission) 152995944 CVCL_B7SX NIHTVBi020-A induced pluripotent stem cell human CVCL_B7SX From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4200; BLOC1S1; Simple; p.His69Pro (c.206A>C); Zygosity=Heterozygous (PubMed=36070637) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152995945 CVCL_B7T9 UCL-E001K finite cell line human CVCL_B7T9 From: University College London; London; United Kingdom CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Glu365Lys (c.1093G>A) (E326K); ClinVar=VCV000199044; Zygosity=Heterozygous (PubMed=36130205) Miscellaneous: Doubling time information from personal communication of Koletsi, Sofia Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Doubling time: 72 hours (Direct_author_submission) 152995946 CVCL_B7SW NIHTVBi019-A-1 induced pluripotent stem cell human CVCL_B7SW From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4200; BLOC1S1; Simple_corrected; p.His69Pro (c.206A>C); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=36070637); Sequence variation: Mutation; HGNC; HGNC:4200; BLOC1S1; Simple_corrected; p.Gly120Glu (c.359G>A); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=36070637) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152995947 CVCL_B7T8 UCL-YCTRL001 finite cell line human CVCL_B7T8 From: University College London; London; United Kingdom CL:0000010 Miscellaneous: Doubling time information from personal communication of Koletsi, Sofia Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Doubling time: ~2 days (Direct_author_submission) 152995948 CVCL_B7SZ NIHTVBi022-A induced pluripotent stem cell human CVCL_B7SZ From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4200; BLOC1S1; Simple; p.Leu62Pro (c.185T>C); Zygosity=Homozygous (PubMed=36070637) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152995949 CVCL_B7SY NIHTVBi021-A induced pluripotent stem cell human CVCL_B7SY From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4200; BLOC1S1; Simple; p.Gly120Glu (c.359G>A); Zygosity=Heterozygous (PubMed=36070637) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152995950 CVCL_B7SL SCVIi043-A induced pluripotent stem cell human CVCL_B7SL From: Stanford Cardiovascular Institute; Palo Alto; USA. CL:0000010 152995951 CVCL_B7SK SCVIi042-A induced pluripotent stem cell human CVCL_B7SK From: Stanford Cardiovascular Institute; Palo Alto; USA. CL:0000010 152995952 CVCL_B7SN SCVIi045-A induced pluripotent stem cell human CVCL_B7SN From: Stanford Cardiovascular Institute; Palo Alto; USA. CL:0000010 152995953 CVCL_B7SM SCVIi044-A induced pluripotent stem cell human CVCL_B7SM From: Stanford Cardiovascular Institute; Palo Alto; USA. CL:0000010 152995954 CVCL_B7SP SCVIi046-A induced pluripotent stem cell human CVCL_B7SP From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Population: Pacific; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152995955 CVCL_B7T1 ZZUNEUi026-A induced pluripotent stem cell human CVCL_B7T1 From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:12665; VCL; Simple; p.Met209Leu (c.625A>T); ClinVar=VCV000488174; Zygosity=Heterozygous (PubMed=35567849) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152995956 CVCL_B7T0 NIHTVBi023-A induced pluripotent stem cell human CVCL_B7T0 From: National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA. CL:0000010 152995957 CVCL_B7SR SCVIi048-A induced pluripotent stem cell human CVCL_B7SR From: Stanford Cardiovascular Institute; Palo Alto; USA. CL:0000010 152995958 CVCL_B7T3 ZZUNEUi028-A induced pluripotent stem cell human CVCL_B7T3 From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Arg502Trp (c.1504C>T); ClinVar=VCV000042540; Zygosity=Heterozygous (PubMed=35772297) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152995959 CVCL_B7SQ SCVIi047-A induced pluripotent stem cell human CVCL_B7SQ From: Stanford Cardiovascular Institute; Palo Alto; USA. CL:0000010 152995960 CVCL_B7T2 ZZUNEUi027-A induced pluripotent stem cell human CVCL_B7T2 From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Tyr43Cys (c.128A>G); ClinVar=VCV000067182; Zygosity=Heterozygous (PubMed=35700634) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152995961 CVCL_B7SD Scid.adh.2C2 cancer cell line house mouse CVCL_B7SD CL:0000010 Sequence variation: Mutation; MGI; MGI:104779; Prkdc; Simple; p.Tyr4046Ter (c.12138T>A) (Prkdc(scid)); Zygosity=Homozygous (from inference of genetic background of Scid mice) Derived from site: In situ; Thymus; UBERON=UBERON_0002370; Cell type: T-cell; CL=CL_0000084; Breed/subspecies: C.B.-17-scid (CB17/Icr-Prkdcscid/IcrIcoCrl). Characteristics: Overexpresses PU.1 (Spi1) 152995962 CVCL_B7SC Scid.adh cancer cell line house mouse CVCL_B7SC CL:0000010 Sequence variation: Mutation; MGI; MGI:104779; Prkdc; Simple; p.Tyr4046Ter (c.12138T>A) (Prkdc(scid)); Zygosity=Homozygous (from inference of genetic background of Scid mice) Derived from site: In situ; Thymus; UBERON=UBERON_0002370; Cell type: T-cell; CL=CL_0000084; Breed/subspecies: C.B.-17-scid (CB17/Icr-Prkdcscid/IcrIcoCrl). 152995963 CVCL_B7SF Scid.adh.14B2 cancer cell line house mouse CVCL_B7SF CL:0000010 Derived from site: In situ; Thymus; UBERON=UBERON_0002370; Cell type: T-cell; CL=CL_0000084; Breed/subspecies: C.B.-17-scid (CB17/Icr-Prkdcscid/IcrIcoCrl). 152995964 CVCL_B7SE Scid.adh.6D4 cancer cell line house mouse CVCL_B7SE CL:0000010 Sequence variation: Mutation; MGI; MGI:104779; Prkdc; Simple; p.Tyr4046Ter (c.12138T>A) (Prkdc(scid)); Zygosity=Homozygous (from inference of genetic background of Scid mice) Derived from site: In situ; Thymus; UBERON=UBERON_0002370; Cell type: T-cell; CL=CL_0000084; Breed/subspecies: C.B.-17-scid (CB17/Icr-Prkdcscid/IcrIcoCrl). Characteristics: Overexpresses PU.1 (Spi1) 152995965 CVCL_B7SH CSSi014-A induced pluripotent stem cell human CVCL_B7SH From: Fondazione Casa Sollievo della Sofferenza IRCCS; San Giovanni Rotondo; Italy CL:0000010 Sequence variation: Mutation; HGNC; HGNC:5389; IDS; Simple; p.Pro160Leu (c.479C>T); Zygosity=Hemizygous (PubMed=35759972) Population: Caucasian; Italian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 152995966 CVCL_B7SG CSSi013-A induced pluripotent stem cell human CVCL_B7SG From: Fondazione Casa Sollievo della Sofferenza IRCCS; San Giovanni Rotondo; Italy CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Gly376Asp (c.1127G>A); Zygosity=Heterozygous (PubMed=35714448) Population: Caucasian; Italian; Donor information: At sampling donor was not affected with amyotrophic lateral sclerosis; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 152995967 CVCL_B7SJ SCVIi050-A induced pluripotent stem cell human CVCL_B7SJ From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9080; PLN; Simple; p.Arg14del (c.37_39AGA[1]) (c.40_42delAGA) (R14del); ClinVar=VCV000044580; Zygosity=Heterozygous (PubMed=35853412) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152995968 CVCL_B7SI SCVIi049-A induced pluripotent stem cell human CVCL_B7SI From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9080; PLN; Simple; p.Arg9Cys (c.25C>T); ClinVar=VCV000013636; Zygosity=Heterozygous (PubMed=35853412) Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 152995969 CVCL_B7RZ SJSC cancer cell line human CVCL_B7RZ CL:0000010 Derived from site: In situ; Liver; UBERON=UBERON_0002107. Omics: Transcriptomics; Microarray Female 152995970 CVCL_B7SB HEK293-MRP7-C18 transformed cell line human CVCL_B7SB CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:52; ABCC10; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 152995971 CVCL_B7SA HEK293-MRP7-C17 transformed cell line human CVCL_B7SA CL:0000010 Genetic integration: Method=Transfection; Gene=HGNC; HGNC:52; ABCC10; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female 152995972 CVCL_B7TU e-hChon-1 transformed cell line human CVCL_B7TU CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3527; EZH2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6348; KLF4; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC; Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1; Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog; Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT); Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein Karyotypic information: 46<2n>XX,del(2)(q3?),-4,add(7)(p14),+21,add(22)(q13) (PubMed=29520052); Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV); Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Femoral head, cartilage; UBERON=UBERON_8480062; Cell type: Chondrocyte; CL=CL_0000138. Female Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995973 CVCL_B7U6 e-hMEC-1 transformed cell line human CVCL_B7U6 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3527; EZH2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4317; GLI1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5109; HOXA9; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11195; SOX2; Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Skin, microvascular endothelium; UBERON=UBERON_0002097+UBERON_0008339; Cell type: Microvascular endothelial cell; CL=CL_2000008. Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995974 CVCL_B7U5 e-hLEC-2 transformed cell line human CVCL_B7U5 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Endothelial cell of lymphatic vessel; CL=CL_0002138. Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995975 CVCL_B7TT J.CaM1.7 cancer cell line human CVCL_B7TT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: Deficient for LCK activity due to a deletion of exon 7 Also lacks LAT expression. Can re-express LAT after protein kinase C (PKC) activation (PubMed=33562083). 152995976 CVCL_B7TW e-hChon-3 transformed cell line human CVCL_B7TW CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11195; SOX2; Genetic integration: Method=Transduction; Gene=MGI; MGI:88138; Bcl2; Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog; Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Femoral head, cartilage; UBERON=UBERON_8480062; Cell type: Chondrocyte; CL=CL_0000138. Female Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995977 CVCL_B7U8 e-hMEC-3 transformed cell line human CVCL_B7U8 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3527; EZH2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5109; HOXA9; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3; Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog Derived from site: In situ; Skin, microvascular endothelium; UBERON=UBERON_0002097+UBERON_0008339; Cell type: Microvascular endothelial cell; CL=CL_2000008. Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995978 CVCL_B7TV e-hChon-2 transformed cell line human CVCL_B7TV CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3527; EZH2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6348; KLF4; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11195; SOX2; Genetic integration: Method=Transduction; Gene=MGI; MGI:102811; Lmo2; Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Femoral head, cartilage; UBERON=UBERON_8480062; Cell type: Chondrocyte; CL=CL_0000138. Female Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995979 CVCL_B7U7 e-hMEC-2 transformed cell line human CVCL_B7U7 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3; Genetic integration: Method=Transduction; Gene=MGI; MGI:88138; Bcl2 Derived from site: In situ; Skin, microvascular endothelium; UBERON=UBERON_0002097+UBERON_0008339; Cell type: Microvascular endothelial cell; CL=CL_2000008. Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995980 CVCL_B7TY CI-huFIB transformed cell line human CVCL_B7TY CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5109; HOXA9; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7545; MYB; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995981 CVCL_B7TX e-hChon-4 transformed cell line human CVCL_B7TX CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3527; EZH2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS; Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog Derived from site: In situ; Femoral head, cartilage; UBERON=UBERON_8480062; Cell type: Chondrocyte; CL=CL_0000138. Female Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995982 CVCL_B7U9 e-hOB-1 transformed cell line human CVCL_B7U9 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Karyotypic information: 46<2n>XX (PubMed=29520052); Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Bone; UBERON=UBERON_0002481; Cell type: Osteoblast; CL=CL_0000062. Female Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995983 CVCL_B7TZ e-hDFib2 transformed cell line human CVCL_B7TZ CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7 Karyotypic information: 44<2n>XY,der(2)t(2;4)(p24;p11),-4,-13,add(14)(p11) (PubMed=29520052); Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995984 CVCL_B7TM RIL-175-KC cancer cell line house mouse CVCL_B7TM CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val); Genetic integration: Method=Transduction; Gene=MGI; MGI:108068; Cxcl1 Breed/subspecies: C57BL/6. Unspecified Caution: We are not certain that the Cxcl1 gene is from mouse or from human as the paper does not mention the source of the construct 152995985 CVCL_B7TL RIL-175-GM-CSF cancer cell line house mouse CVCL_B7TL CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val); Genetic integration: Method=Transduction; Gene=MGI; MGI:1339752; Csf2 Breed/subspecies: C57BL/6. Unspecified Caution: We are not certain that the Csf2 gene is from mouse or from human as the paper does not mention the source of the construct 152995986 CVCL_B7U0 e-hDFib3 transformed cell line human CVCL_B7U0 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995987 CVCL_B7TN RIL175-R cancer cell line house mouse CVCL_B7TN CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val) Selected for resistance to: ChEBI; CHEBI_50924; Sorafenib (Nexavar); Breed/subspecies: C57BL/6. Unspecified 152995988 CVCL_B7U2 e-hFib-2 transformed cell line human CVCL_B7U2 CL:0000010 Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog Karyotypic information: 69<3n>XXYY,+X/Y,t(2;5)(p16;q13),+3,+5,-9,+11,-13,+16,+20,-21,-22 (PubMed=29520052); Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995989 CVCL_B7TQ F3II-NM cancer cell line house mouse CVCL_B7TQ CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: BALB/c. Female Characteristics: Established through the following protocol: the parental cell line was inoculated in the subcutis of BALB/c mice, a pulmonary metastatic tumor was transplanted by surgery in another mouse The transplantation process was repeated twice and the cell line was established from primary culture of the resulting tumor (CelloPub=CLPUB00707). Doubling time: 31.71 hours (CelloPub=CLPUB00707) 152995990 CVCL_B7U1 e-hFib-1 transformed cell line human CVCL_B7U1 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3527; EZH2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:667; RHOA Karyotypic information: 78<3n>XXYY,+1,add(2)(p24),-3,+6,+7,+del(8)(q21),+9,add(9)(p2?),+10,der(10)t(5;10)(q15:p15),+11,+18,der(19)t(11;19)(q13;p13),+20,+21,+22,+2mar (PubMed=29520052); Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995991 CVCL_B7TP J558L-CD40L cancer cell line house mouse CVCL_B7TP CL:0000010 Genetic integration: Method=Transfection; Gene=MGI; MGI:88337; Cd40lg; Genetic integration: Method=Transfection; Gene=UniProtKB; P06988; Escherichia coli hisD Cell type: Plasma cell; CL=CL_0000786; Breed/subspecies: BALB/c. Unspecified 152995992 CVCL_B7TS C6rho0 cancer cell line Norway rat CVCL_B7TS CL:0000010 Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU); Derived from site: In situ; Brain; UBERON=UBERON_0000955; Breed/subspecies: Wistar Furth; RS=RS_0000982. Male Characteristics: Cell line devoid of mitochondrial DNA (rho0) Obtained by growth of parental cell line with ethidium bromide and 2',3'dideoxycytidine. 152995993 CVCL_B7U4 e-hLEC-1 transformed cell line human CVCL_B7U4 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3796; FOS; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5361; ID2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6348; KLF4; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC; Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Endothelial cell of lymphatic vessel; CL=CL_0002138. Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995994 CVCL_B7U3 e-hFib-3 transformed cell line human CVCL_B7U3 CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3527; EZH2; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5360; ID1; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5362; ID3; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7553; MYC; Genetic integration: Method=Transduction; Gene=MGI; MGI:1919200; Nanog; Genetic integration: Method=Transduction; Gene=MGI; MGI:103262; Yap1; Genetic integration: Method=Transduction; Gene=MGI; MGI:99187; Zfp42; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=Hepatitis C virus core protein Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male Characteristics: Transduced with a lentiviral library consisting of 33 genes, some of which are retained in the immortalized cell line (CI-SCREEN) (PubMed=29520052) 152995995 CVCL_B7TR F3II-TP cancer cell line house mouse CVCL_B7TR CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: BALB/c. Female Characteristics: Established through the following protocol: the parental cell line was inoculated in the subcutis of BALB/c mice, the produced tumor was transplanted by surgery in another mouse The transplantation process was repeated twice and the cell line was established from primary culture of the resulting tumor (CelloPub=CLPUB00707). Doubling time: 25.52 hours (CelloPub=CLPUB00707) 152995996 CVCL_B7TE SK/IFN-gamma cancer cell line human CVCL_B7TE CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5438; IFNG; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Male Characteristics: Intermediate type (I-type) (from parent cell line SK-N-BE(2)-C); Characteristics: MYCN-amplified NBL cell line (from parent cell line SK-N-BE(2)-C) 152995997 CVCL_B7TD ACN/neo cancer cell line human CVCL_B7TD CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn184fs*6 (c.545_546insA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe113Ser (c.338T>C); ClinVar=VCV000823709; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo. Population: Caucasian Unspecified Problematic cell line: Probably contaminated Parent cell line (ACN) has been shown to probably be a melanoma cell line. 152995998 CVCL_B7TG Abcam THP-1 TYROBP KO cancer cell line human CVCL_B7TG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12449; TYROBP; Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line); Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152995999 CVCL_B7TF SK/neo cancer cell line human CVCL_B7TF CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. Male Characteristics: Intermediate type (I-type) (from parent cell line SK-N-BE(2)-C); Characteristics: MYCN-amplified NBL cell line (from parent cell line SK-N-BE(2)-C) 152996000 CVCL_B7TI HUH7-R cancer cell line human CVCL_B7TI CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line) Population: Japanese; Selected for resistance to: ChEBI; CHEBI_50924; Sorafenib (Nexavar); Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 152996001 CVCL_B7TH BNL/R transformed cell line house mouse CVCL_B7TH CL:0000010 Selected for resistance to: ChEBI; CHEBI_50924; Sorafenib (Nexavar); Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA); Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107; Breed/subspecies: BALB/c. Unspecified 152996002 CVCL_B7TK RIL-175 cancer cell line house mouse CVCL_B7TK CL:0000010 Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53; Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val) Breed/subspecies: C57BL/6. Unspecified 152996003 CVCL_B7TJ HUH7-R-LUC cancer cell line human CVCL_B7TJ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase Population: Japanese; Selected for resistance to: ChEBI; CHEBI_50924; Sorafenib (Nexavar); Derived from site: In situ; Liver; UBERON=UBERON_0002107. Male 152996004 CVCL_B7TA UCL-N001S finite cell line human CVCL_B7TA From: University College London; London; United Kingdom CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous (PubMed=36130205) Miscellaneous: Doubling time information from personal communication of Koletsi, Sofia Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Female Doubling time: 48 hours (Direct_author_submission) 152996005 CVCL_B7TC ACN/IFN-gamma cancer cell line human CVCL_B7TC CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn184fs*6 (c.545_546insA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe113Ser (c.338T>C); ClinVar=VCV000823709; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5438; IFNG; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo. Population: Caucasian Unspecified Problematic cell line: Probably contaminated Parent cell line (ACN) has been shown to probably be a melanoma cell line. 152996006 CVCL_B7TB UCL-N002S finite cell line human CVCL_B7TB From: University College London; London; United Kingdom CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous (PubMed=36130205) Miscellaneous: Doubling time information from personal communication of Koletsi, Sofia Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male Doubling time: 96 hours (Direct_author_submission) 152996007 CVCL_B7R3 M-T61 hybridoma house mouse CVCL_B7R3 CL:0000010 Monoclonal antibody isotype: IgG2b, kappa; Monoclonal antibody target: Human antigen on T-cells. 152996008 CVCL_B7QR MUC 2-63 hybridoma house mouse CVCL_B7QR CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human antigen on gliomas, neuroblastomas and melanomas as well as embryonic and fetal cells. 152996009 CVCL_B7R2 M-T321 hybridoma house mouse CVCL_B7R2 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01730; Human CD4. 152996010 CVCL_B7QQ MUC 15-22 hybridoma house mouse CVCL_B7QQ CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: Human antigen on gliomas, neuroblastomas and melanomas as well as embryonic and fetal cells. 152996011 CVCL_B7R5 85HG-59 cancer cell line human CVCL_B7R5 CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified 152996012 CVCL_B7QT MUC 8-22 hybridoma house mouse CVCL_B7QT CL:0000010 Monoclonal antibody isotype: IgG2a. 152996013 CVCL_B7R4 85HG-3 cancer cell line human CVCL_B7R4 CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified 152996014 CVCL_B7QS MUC 7-22 hybridoma house mouse CVCL_B7QS CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: Human antigen on gliomas, neuroblastomas and melanomas as well as embryonic and fetal cells. 152996015 CVCL_B7R7 85HG-64 cancer cell line human CVCL_B7R7 CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified 152996016 CVCL_B7QV M-T811 hybridoma house mouse CVCL_B7QV CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P01732; Human CD8A; Monoclonal antibody target: UniProtKB; P10966; Human CD8B. 152996017 CVCL_B7R6 85HG-63 cancer cell line human CVCL_B7R6 CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified 152996018 CVCL_B7QU M-T411 hybridoma house mouse CVCL_B7QU CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P30203; Human CD6. 152996019 CVCL_B7R9 85HG-66 cancer cell line human CVCL_B7R9 CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified 152996020 CVCL_B7QX M-M522 hybridoma house mouse CVCL_B7QX CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; P11215; Human ITGAM/CD11b. 152996021 CVCL_B7R8 85HG-65 cancer cell line human CVCL_B7R8 CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified 152996022 CVCL_B7QW M-G1120 hybridoma house mouse CVCL_B7QW CL:0000010 Monoclonal antibody isotype: IgM, kappa; Monoclonal antibody target: ChEBI; CHEBI_61711; Alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc (Sialyl Lewis X; CD15; SSEA-1). 152996023 CVCL_B7QJ TVI spontaneously immortalized cell line CVCL_B7QJ CL:0000010 Derived from site: In situ; Eye, iris, dorsal part; UBERON=UBERON_8480063; Cell type: Epithelial cell; CL=CL_0000066. Unspecified Doubling time: 84 hours (PubMed=1010157) Group: Amphibian cell line 152996024 CVCL_B7QI SCHL spontaneously immortalized cell line CVCL_B7QI CL:0000010 Derived from site: In situ; Liver; UBERON=UBERON_0002107; Cell type: Hepatocyte; CL=CL_0000182. Unspecified Doubling time: 32.2 hours (PubMed=28691159) Group: Fish cell line 152996025 CVCL_B7QL 22/18 hybridoma house mouse CVCL_B7QL CL:0000010 Monoclonal antibody isotype: IgM; Monoclonal antibody target: Notophthalmus viridescens blastemal cells specific antigen. 152996026 CVCL_B7QK 12/101 hybridoma house mouse CVCL_B7QK CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Notophthalmus viridescens 102 kda protein in adult muscles. 152996027 CVCL_B7QN MUC 11-22 hybridoma house mouse CVCL_B7QN CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: Human antigen on gliomas, neuroblastomas and melanomas as well as embryonic and fetal cells. 152996028 CVCL_B7QM MUC 10-22 hybridoma house mouse CVCL_B7QM CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: Human antigen on gliomas, neuroblastomas and melanomas as well as embryonic and fetal cells. 152996029 CVCL_B7R1 M-T151 hybridoma house mouse CVCL_B7R1 CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P01730; Human CD4. 152996030 CVCL_B7QP MUC 14-22 hybridoma house mouse CVCL_B7QP CL:0000010 Monoclonal antibody isotype: IgG2a; Monoclonal antibody target: Human antigen on gliomas, neuroblastomas and melanomas as well as embryonic and fetal cells. 152996031 CVCL_B7R0 M-T1020 hybridoma house mouse CVCL_B7R0 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Human antigen on T-cells. 152996032 CVCL_B7QB SJU-1 spontaneously immortalized cell line CVCL_B7QB CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Unspecified Virology: Susceptible to infection by infectious pancreatic necrosis virus (IPNV) (DOI=10.1111/j.1095-8649.1973.tb04461.x) Group: Fish cell line 152996033 CVCL_B7QA FtGL spontaneously immortalized cell line CVCL_B7QA CL:0000010 Derived from site: In situ; Liver; UBERON=UBERON_0002107; Breed/subspecies: Fantail; VBO=VBO_0017499. Unspecified Virology: Susceptible to infection by cyprinid herpesvirus 2 (CyHV-2) (PubMed=33556411) Doubling time: 63.43 hours (PubMed=33556411) Group: Fish cell line 152996034 CVCL_B7QD SSB spontaneously immortalized cell line CVCL_B7QD CL:0000010 Derived from site: In situ; Embryonic brain; UBERON=UBERON_0006238. Unspecified Characteristics: Can grow at temperatures ranging from 20 to 37 Celsius with an optimum temperature of 29-30 Celsius (DOI=10.1007/BF02631047) Doubling time: 67 hours (Note=At 30th passage) (CelloPub=CLPUB00705; DOI=10.1007/BF02631047) Group: Fish cell line 152996035 CVCL_B7QC CrF spontaneously immortalized cell line CVCL_B7QC CL:0000010 Derived from site: In situ; Muscle; UBERON=UBERON_0001630; Cell type: Fibroblast of muscle; CL=CL_1001609. Male Characteristics: Optimal growth temperature is from 26 to 32 Celsius (PubMed=7422670) Group: Fish cell line 152996036 CVCL_B7QF RBT-H spontaneously immortalized cell line CVCL_B7QF CL:0000010 Derived from site: In situ; Heart; UBERON=UBERON_0000948. Unspecified Group: Fish cell line; Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC075 152996037 CVCL_B7QE NSB spontaneously immortalized cell line CVCL_B7QE CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified Doubling time: 84 hours (Note=At 6th passage) (CelloPub=CLPUB00705) Group: Fish cell line 152996038 CVCL_B7QH TSB spontaneously immortalized cell line CVCL_B7QH CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955; Cell type: Fibroblast; CL=CL_0000057. Male Characteristics: Optimal growth at 28 Celsius (DOI=10.1111/j.1095-8649.1987.tb05322.x) Group: Fish cell line 152996039 CVCL_B7QG OCrF-1 spontaneously immortalized cell line CVCL_B7QG CL:0000010 Derived from site: In situ; Fin; UBERON=UBERON_0008897. Unspecified Group: Fish cell line; Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC077 152996040 CVCL_B7PY LM38-LP cancer cell line house mouse CVCL_B7PY CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: BALB/c. Female Characteristics: Established from the mouse M38 transplantable tumor M38 is a spontaneously arising well differentiated ductal papillary adenocarcinoma (PubMed=14979922). Doubling time: 18 +- 1.1 hours (PubMed=14979922) 152996041 CVCL_B7Q9 FtGG spontaneously immortalized cell line CVCL_B7Q9 CL:0000010 Derived from site: In situ; Gill; UBERON=UBERON_0002535; Breed/subspecies: Fantail; VBO=VBO_0017499. Unspecified Virology: Highly susceptible to infection by cyprinid herpesvirus 2 (CyHV-2) (PubMed=33556411) Doubling time: 41.47 hours (PubMed=33556411) Group: Fish cell line; Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC083 152996042 CVCL_B7PX LM38-HP cancer cell line house mouse CVCL_B7PX CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: BALB/c. Female Characteristics: Established from the mouse M38 transplantable tumor M38 is a spontaneously arising well differentiated ductal papillary adenocarcinoma (PubMed=14979922). Doubling time: 10 +- 0.6 hours (PubMed=14979922) 152996043 CVCL_B7PZ LM38-D2 cancer cell line house mouse CVCL_B7PZ CL:0000010 Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911; Breed/subspecies: BALB/c. Female Doubling time: 33 +- 2.4 hours (PubMed=14979922) 152996044 CVCL_B7S4 1A9/CP10 cancer cell line human CVCL_B7S4 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line) Population: African American; Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP); Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female 152996045 CVCL_B7RS K-3506 cancer cell line human CVCL_B7RS CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*35:06); Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. Omics: Proteomics; HLA class I peptidome Female 152996046 CVCL_B7S3 A1847/CP6 cancer cell line human CVCL_B7S3 CL:0000010 Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP); Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female 152996047 CVCL_B7RR K-3504 cancer cell line human CVCL_B7RR CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*35:04); Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. Omics: Proteomics; HLA class I peptidome Female 152996048 CVCL_B7S6 A2780/C300 cancer cell line human CVCL_B7S6 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line) Population: African American; Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP); Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female 152996049 CVCL_B7RU SZGT-31 spontaneously immortalized cell line CVCL_B7RU CL:0000010 Derived from site: In situ; Testis; UBERON=UBERON_0000473; Cell type: Fibroblast; CL=CL_0000057. Male Characteristics: Optimal growth at 31 Celsius Doubling time: ~18 hours (DOI=10.1016/B978-0-12-427150-0.50040-1) Group: Fish cell line 152996050 CVCL_B7S5 A2780/C80 cancer cell line human CVCL_B7S5 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line) Population: African American; Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP); Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female 152996051 CVCL_B7RT K-3508 cancer cell line human CVCL_B7RT CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*35:08); Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. Omics: Proteomics; HLA class I peptidome Female 152996052 CVCL_B7S8 A2780/C50 cancer cell line human CVCL_B7S8 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line) Population: African American; Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP); Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female 152996053 CVCL_B7RW NF-HFO-2 finite cell line human CVCL_B7RW CL:0000010 Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471; Cell type: Fibroblast of foreskin; CL=CL_1001608. Male Senescence: Senesces at 65 +- 10 PDL (PubMed=6785281) 152996054 CVCL_B7S7 A2780/C100 cancer cell line human CVCL_B7S7 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line) Population: African American; Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP); Derived from site: In situ; Ovary; UBERON=UBERON_0000992. Female 152996055 CVCL_B7RV SZGT-37 spontaneously immortalized cell line CVCL_B7RV CL:0000010 Derived from site: In situ; Testis; UBERON=UBERON_0000473; Cell type: Fibroblast; CL=CL_0000057. Male Characteristics: Adapted to growth at 37 Celsius Doubling time: ~18 hours (DOI=10.1016/B978-0-12-427150-0.50040-1) Group: Fish cell line 152996056 CVCL_B7RY FW-4 hybridoma house mouse CVCL_B7RY CL:0000010 Monoclonal antibody isotype: IgA; Monoclonal antibody target: UniProtKB; P60568; Human IL2. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8456 152996057 CVCL_B7S9 3AKRP spontaneously immortalized cell line CVCL_B7S9 CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113. Unspecified Group: Amphibian cell line 152996058 CVCL_B7RX T-199 hybridoma house mouse CVCL_B7RX CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: Human antigen on the cell surface of neuroectodermally derived tumors. 152996059 CVCL_B7RK KE37/1 cancer cell line human CVCL_B7RK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Gln2459Ter (c.7375C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg571Gln (c.1712G>A); ClinVar=VCV000819886; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gly310Glu (c.929G>A); ClinVar=VCV000237678; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (from parent cell line). Population: Caucasian Male 152996060 CVCL_B7RJ B-187 transformed cell line human CVCL_B7RJ CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Donor information: Established from a patient suffering from acute myelogenous leukemia; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female 152996061 CVCL_B7RM K562/A*0201 cancer cell line human CVCL_B7RM CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*02:01); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. Female 152996062 CVCL_B7RL A1 [Newt ankle] spontaneously immortalized cell line CVCL_B7RL CL:0000010 Derived from site: In situ; Hindlimb, ankle, hypodermis; UBERON=UBERON_0001488+UBERON_0002072. Unspecified Group: Amphibian cell line 152996063 CVCL_B7S0 FC-IBC-02 cancer cell line human CVCL_B7S0 CL:0000010 Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Omics: Transcriptomics; Microarray; Omics: Transcriptomics; RNAseq Female Group: Triple negative breast cancer (TNBC) cell line 152996064 CVCL_B7RN K-3501 cancer cell line human CVCL_B7RN CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*35:01); Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. Omics: Proteomics; HLA class I peptidome Female 152996065 CVCL_B7S2 FC-muMCL1 cancer cell line house mouse CVCL_B7S2 CL:0000010 Transformant: ChEBI; CHEBI_53181; Pristane; Derived from site: In situ; Spleen; UBERON=UBERON_0002106; Breed/subspecies: C57BL/6 Em-cyclin D1 transgenic. Omics: Variations; Array-based CGH Male Doubling time: ~24 hours (PubMed=23271511) 152996066 CVCL_B7RQ K-3503 cancer cell line human CVCL_B7RQ CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*35:03); Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. Omics: Proteomics; HLA class I peptidome Female 152996067 CVCL_B7S1 EMF-011 cancer cell line human CVCL_B7S1 CL:0000010 Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female Group: Triple negative breast cancer (TNBC) cell line 152996068 CVCL_B7RP K-3502 cancer cell line human CVCL_B7RP CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*35:02); Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175. Omics: Proteomics; HLA class I peptidome Female 152996069 CVCL_B7RC TH4B spontaneously immortalized cell line CVCL_B7RC CL:0000010 Derived from site: In situ; Hindlimb, thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072. Unspecified Group: Amphibian cell line 152996070 CVCL_B7RB BlH1 spontaneously immortalized cell line CVCL_B7RB CL:0000010 Derived from site: In situ; Hindlimb, blastema; UBERON=UBERON_0012438. Unspecified Group: Amphibian cell line 152996071 CVCL_B7RE RPMI-8392 transformed cell line human CVCL_B7RE CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female 152996072 CVCL_B7RD RPMI-8382 transformed cell line human CVCL_B7RD CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female 152996073 CVCL_B7RG HUSP-3L transformed cell line human CVCL_B7RG CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152996074 CVCL_B7RF ASPC-3L transformed cell line human CVCL_B7RF CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152996075 CVCL_B7RI BES-1 transformed cell line human CVCL_B7RI CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Donor information: Established from a patient suffering from acute myelogenous leukemia; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female 152996076 CVCL_B7RH MANACA-2 cancer cell line human CVCL_B7RH CL:0000010 Male 152996077 CVCL_B7QZ M-N72 hybridoma house mouse CVCL_B7QZ CL:0000010 Monoclonal antibody isotype: IgM, kappa. 152996078 CVCL_B7QY M-M67 hybridoma house mouse CVCL_B7QY CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: Human antigen on monocytes (CDw12). 152996079 CVCL_B7RA TH4-7-5 cancer cell line human CVCL_B7RA CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955. Unspecified Virology: In vitro persistently infected by HIV-1 Produces substantial amounts of Nef (PubMed=1373627). Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-861 152996080 CVCL_B7P1 F6T cancer cell line human CVCL_B7P1 CL:0000010 Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Characteristics: IL2 dependent 152996081 CVCL_B7P0 C8ID cancer cell line human CVCL_B7P0 CL:0000010 Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Characteristics: IL2 dependent 152996082 CVCL_B7P3 Oh13T cancer cell line human CVCL_B7P3 CL:0000010 Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Characteristics: IL2 dependent 152996083 CVCL_B7P2 K3T cancer cell line human CVCL_B7P2 CL:0000010 Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Characteristics: IL2 dependent 152996084 CVCL_B7P5 Su9T01 cancer cell line human CVCL_B7P5 CL:0000010 Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray Characteristics: IL2 dependent 152996085 CVCL_B7P4 S1T cancer cell line human CVCL_B7P4 CL:0000010 Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Characteristics: IL2 dependent 152996086 CVCL_B7P7 MCF-7/PacR cancer cell line human CVCL_B7P7 CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Miscellaneous: Doubling time, ABCB1 status and STR profile from personal communication of Daniel, Petr Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol); Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Omics: Proteomics; Subcellular; Mitochondrion; 2DE-MS Female Characteristics: Generated by step-increasing drug concentration to 300 nm of paclitaxel Overexpresses ABCB1 which is amplified and inserted in chromosome 3 (PubMed=27664577; Direct_author_submission). Doubling time: ~25-30 hours (Direct_author_submission) 152996087 CVCL_B7P6 OATL4 cancer cell line human CVCL_B7P6 CL:0000010 Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Omics: Transcriptomics; Microarray 152996088 CVCL_B7NW HEK293-Luc-GFP transformed cell line human CVCL_B7NW CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP); Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Transduced with a CAG-Luc-PGKp-GFP-T2A-PuroR lentiviral reporter construct 152996089 CVCL_B7NV HCT116-NanoLuc-RFP cancer cell line human CVCL_B7NV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transduction; Gene=Oplophorus gracilirostris NanoLuc (Note=19 kDa ATP-independent bright luminescent protein derived from O.gracilirostris luciferase) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male Characteristics: Transduced with a CAG-NanoLuc-PGKp-TdTomato-T2A-PuroR lentiviral reporter construct 152996090 CVCL_B7NY HEK293-NanoLuc-RFP transformed cell line human CVCL_B7NY CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transduction; Gene=Oplophorus gracilirostris NanoLuc (Note=19 kDa ATP-independent bright luminescent protein derived from O.gracilirostris luciferase) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Transduced with a CAG-NanoLuc-PGKp-TdTomato-T2A-PuroR lentiviral reporter construct 152996091 CVCL_B7NX HEK293-Luc-RFP transformed cell line human CVCL_B7NX CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Transduced with a SFFV-Luc-PGKp-tdTomato-T2A-PuroR lentiviral reporter construct 152996092 CVCL_B7NZ Jurkat-Luc-RFP cancer cell line human CVCL_B7NZ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)); Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male Characteristics: Transduced with a SFFV-Luc-PGKp-tdTomato-T2A-PuroR lentiviral reporter construct 152996093 CVCL_B7PQ Ei 151 transformed cell line human CVCL_B7PQ CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Donor information: Established from a patient suffering from chronic lymphocytic leukemia; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152996094 CVCL_B7Q2 HEK293-TA-Lv-T7 R1D3 transformed cell line human CVCL_B7Q2 CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)); Genetic integration: Method=Transduction; Gene=UniProtKB; P00573; Bacteriophage T7 DNA-directed RNA polymerase; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Transduced with a lentiviral vector pLv-T7 containing T7-RNAP gene, puroR and mCherry 152996095 CVCL_B7Q1 Abcam A-549 ARID1A KO cancer cell line human CVCL_B7Q1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11110; ARID1A; Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Lung; UBERON=UBERON_0002048. Male 152996096 CVCL_B7PP Ei 81 transformed cell line human CVCL_B7PP CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Donor information: Established from a patient suffering from chronic lymphocytic leukemia; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152996097 CVCL_B7PS Abcam HCT 116 ARID1A KO cancer cell line human CVCL_B7PS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11110; ARID1A; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996098 CVCL_B7Q4 HEK293-TA-Lv-T7 R5B9 transformed cell line human CVCL_B7Q4 CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)); Genetic integration: Method=Transduction; Gene=UniProtKB; P00573; Bacteriophage T7 DNA-directed RNA polymerase; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Transduced with a lentiviral vector pLv-T7 containing T7-RNAP gene, puroR and mCherry 152996099 CVCL_B7Q3 HEK293-TA-Lv-T7 R1D8 transformed cell line human CVCL_B7Q3 CL:0000010 Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)); Genetic integration: Method=Transduction; Gene=UniProtKB; P00573; Bacteriophage T7 DNA-directed RNA polymerase; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR); Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5; Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA); Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113. Female Characteristics: Transduced with a lentiviral vector pLv-T7 containing T7-RNAP gene, puroR and mCherry 152996100 CVCL_B7PR JcTaxWT-Neo7 cancer cell line human CVCL_B7PR CL:0000010 Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transfection; Gene=UniProtKB; P03409; Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A) tax; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: T-cell; CL=CL_0000084. Male 152996101 CVCL_B7PU HCT116-A2 cancer cell line human CVCL_B7PU CL:0000010 Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Leu617Ile (c.1849C>A); Zygosity=Homozygous (PubMed=21619602) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin); Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male Doubling time: 25.0 hours (PubMed=21619602) 152996102 CVCL_B7Q6 SW620-Lv-T7 R3C5 cancer cell line human CVCL_B7Q6 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)); Genetic integration: Method=Transduction; Gene=UniProtKB; P00573; Bacteriophage T7 DNA-directed RNA polymerase; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. Male Characteristics: Transduced with a lentiviral vector pLv-T7 containing T7-RNAP gene, puroR and mCherry 152996103 CVCL_B7PT HCT116-s cancer cell line human CVCL_B7PT CL:0000010 Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Arg621His (c.1862G>A); Zygosity=Heterozygous (PubMed=21619602); Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Glu710Gly (c.2129A>G); Zygosity=Heterozygous (PubMed=21619602) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male Doubling time: 19.8 hours (PubMed=21619602) 152996104 CVCL_B7Q5 SW620-Lv-T7 R1C11 cancer cell line human CVCL_B7Q5 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)); Genetic integration: Method=Transduction; Gene=UniProtKB; P00573; Bacteriophage T7 DNA-directed RNA polymerase; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. Male Characteristics: Transduced with a lentiviral vector pLv-T7 containing T7-RNAP gene, puroR and mCherry 152996105 CVCL_B7Q8 FtGB spontaneously immortalized cell line CVCL_B7Q8 CL:0000010 Derived from site: In situ; Brain; UBERON=UBERON_0000955; Breed/subspecies: Fantail; VBO=VBO_0017499. Unspecified Virology: Susceptible to infection by cyprinid herpesvirus 2 (CyHV-2) (PubMed=33556411) Doubling time: 79.79 hours (PubMed=33556411) Group: Fish cell line 152996106 CVCL_B7PW HCT116-G7 cancer cell line human CVCL_B7PW CL:0000010 Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Arg621His (c.1862G>A); Zygosity=Heterozygous (PubMed=21619602); Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Glu710Gly (c.2129A>G); Zygosity=Heterozygous (PubMed=21619602) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin); Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male Doubling time: 42.1 hours (PubMed=21619602) 152996107 CVCL_B7PV HCT116-C8 cancer cell line human CVCL_B7PV CL:0000010 Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Arg621His (c.1862G>A); Zygosity=Heterozygous (PubMed=21619602); Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Glu710Gly (c.2129A>G); Zygosity=Heterozygous (PubMed=21619602) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin); Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male Doubling time: 38.7 hours (PubMed=21619602) 152996108 CVCL_B7Q7 SW620-Lv-T7 R3E6 cancer cell line human CVCL_B7Q7 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)); Genetic integration: Method=Transduction; Gene=UniProtKB; P00573; Bacteriophage T7 DNA-directed RNA polymerase; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Caucasian; Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029. Male Characteristics: Transduced with a lentiviral vector pLv-T7 containing T7-RNAP gene, puroR and mCherry 152996109 CVCL_B7PI Se21 transformed cell line human CVCL_B7PI CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Donor information: Established from a patient suffering from chronic lymphocytic leukemia; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152996110 CVCL_B7PH NCC-ES2-C1 cancer cell line human CVCL_B7PH CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=EWSR1 exon 7 fused to FLI1 exon 8 (PubMed=35441357) Population: Japanese; Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981. Omics: Phenotyping; Drug screening Male Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi); Doubling time: ~159 hours (PubMed=35441357) Part of: NCC sarcoma cell line panel 152996111 CVCL_B7PK SeA2 transformed cell line human CVCL_B7PK CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Donor information: Established from a patient suffering from chronic lymphocytic leukemia; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152996112 CVCL_B7PJ SeA1 transformed cell line human CVCL_B7PJ CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Donor information: Established from a patient suffering from chronic lymphocytic leukemia; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152996113 CVCL_B7PM Ei 26 transformed cell line human CVCL_B7PM CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Donor information: Established from a patient suffering from chronic lymphocytic leukemia; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152996114 CVCL_B7PL SeD transformed cell line human CVCL_B7PL CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Donor information: Established from a patient suffering from chronic lymphocytic leukemia; Derived from site: In situ; Spleen; UBERON=UBERON_0002106. Female 152996115 CVCL_B7Q0 MC38-hPD-L1-LZ cancer cell line house mouse CVCL_B7Q0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1926446; Cd274; Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; W8LAG; ZsGreen (Note=FP506, green fluorescent protein derived from Zoanthus sp); Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase; Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17635; CD274; Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH); Derived from site: In situ; Colon; UBERON=UBERON_0001155; Breed/subspecies: C57BL/6. Female Characteristics: Using CRISPR/Cas9 a construct containing a dual fusion reporter luciferase-ZsGreen (LZ) was introduced in one allele of the Rosa2 safe harbor locus (genOway) 152996116 CVCL_B7PN Ei 39 transformed cell line human CVCL_B7PN CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Donor information: Established from a patient suffering from chronic lymphocytic leukemia; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152996117 CVCL_B7PA SRD-14 transformed cell line CVCL_B7PA CL:0000010 Sequence variation: Gene deletion; UniProtKB; Q8CFA6; Insig1; Zygosity=Heterozygous; Note=The 2nd allele has a loss of function (PubMed=15247248) Selected for resistance to: ChEBI; CHEBI_77317; 4-[2,2-bis(diethoxyphosphoryl)ethenyl]-2,6-ditert-butylphenol] (SR12813); Transformant: NCIt; C129643; Cesium-137 gamma radiation; Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female 152996118 CVCL_B7PC SRD-14/pInsig-2 transformed cell line CVCL_B7PC CL:0000010 Sequence variation: Gene deletion; UniProtKB; Q8CFA6; Insig1; Zygosity=Heterozygous; Note=The 2nd allele has a loss of function (PubMed=15247248); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:20452; INSIG2; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Selected for resistance to: ChEBI; CHEBI_77317; 4-[2,2-bis(diethoxyphosphoryl)ethenyl]-2,6-ditert-butylphenol] (SR12813); Transformant: NCIt; C129643; Cesium-137 gamma radiation; Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Transfected with INSIG2 followed by 6 tandem copies of the Myc epitope 152996119 CVCL_B7PB SRD-14/pInsig-1 transformed cell line CVCL_B7PB CL:0000010 Sequence variation: Gene deletion; UniProtKB; Q8CFA6; Insig1; Zygosity=Heterozygous; Note=The 2nd allele has a loss of function (PubMed=15247248); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6083; INSIG1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Selected for resistance to: ChEBI; CHEBI_77317; 4-[2,2-bis(diethoxyphosphoryl)ethenyl]-2,6-ditert-butylphenol] (SR12813); Transformant: NCIt; C129643; Cesium-137 gamma radiation; Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Transfected with INSIG1 followed by 6 tandem copies of the Myc epitope 152996120 CVCL_B7PE SRD-15/pInsig-1 transformed cell line CVCL_B7PE CL:0000010 Sequence variation: Gene deletion; UniProtKB; Q8CFA6; Insig1; Zygosity=Heterozygous; Note=The 2nd allele has a loss of function (from parent cell line); Sequence variation: Gene deletion; UniProtKB; Q8CFA5; Insig2; Zygosity=Heterozygous (PubMed=15866869); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6083; INSIG1; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Selected for resistance to: ChEBI; CHEBI_77317; 4-[2,2-bis(diethoxyphosphoryl)ethenyl]-2,6-ditert-butylphenol] (SR12813); Selected for resistance to: ChEBI; CHEBI_42977; 25-hydroxycholesterol; Transformant: NCIt; C129643; Cesium-137 gamma radiation; Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Transfected with INSIG1 followed by 6 tandem copies of the Myc epitope (PubMed=15866869) 152996121 CVCL_B7PD SRD-15 transformed cell line CVCL_B7PD CL:0000010 Sequence variation: Gene deletion; UniProtKB; Q8CFA6; Insig1; Zygosity=Heterozygous; Note=The 2nd allele has a loss of function (from parent cell line); Sequence variation: Gene deletion; UniProtKB; Q8CFA5; Insig2; Zygosity=Heterozygous (PubMed=15866869) Selected for resistance to: ChEBI; CHEBI_77317; 4-[2,2-bis(diethoxyphosphoryl)ethenyl]-2,6-ditert-butylphenol] (SR12813); Selected for resistance to: ChEBI; CHEBI_42977; 25-hydroxycholesterol; Transformant: NCIt; C129643; Cesium-137 gamma radiation; Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female 152996122 CVCL_B7PG SRD-5 transformed cell line CVCL_B7PG CL:0000010 Sequence variation: Mutation; UniProtKB; P97260; Scap; Simple; p.Leu315Phe (c.943C>T); Zygosity=Heterozygous (PubMed=12482938) Selected for resistance to: ChEBI; CHEBI_42977; 25-hydroxycholesterol; Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU); Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female 152996123 CVCL_B7PF SRD-15/pInsig-2 transformed cell line CVCL_B7PF CL:0000010 Sequence variation: Gene deletion; UniProtKB; Q8CFA6; Insig1; Zygosity=Heterozygous; Note=The 2nd allele has a loss of function (from parent cell line); Sequence variation: Gene deletion; UniProtKB; Q8CFA5; Insig2; Zygosity=Heterozygous (PubMed=15866869); Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:20452; INSIG2; Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Selected for resistance to: ChEBI; CHEBI_77317; 4-[2,2-bis(diethoxyphosphoryl)ethenyl]-2,6-ditert-butylphenol] (SR12813); Selected for resistance to: ChEBI; CHEBI_42977; 25-hydroxycholesterol; Transformant: NCIt; C129643; Cesium-137 gamma radiation; Derived from site: In situ; Ovary; UBERON=UBERON_0000992; Cell type: Epithelial cell of ovary; CL=CL_2000064. Female Characteristics: Transfected with INSIG2 followed by 6 tandem copies of the Myc epitope (PubMed=15866869) 152996124 CVCL_B7P9 PC3PR cancer cell line human CVCL_B7P9 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol); Derived from site: Metastatic; Bone; UBERON=UBERON_0002481. Male 152996125 CVCL_B7P8 SK-BR-3/PacR cancer cell line human CVCL_B7P8 CL:0000010 Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line) Miscellaneous: Cell line no longer available (personal communication of Daniel, Petr) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol); Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996126 CVCL_B7EF Mel JuSo ABCB5 KO clone HO1 cancer cell line human CVCL_B7EF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:46; ABCB5; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012604; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097. Female 152996127 CVCL_B7EE NHKT finite cell line human CVCL_B7EE CL:0000010 Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 152996128 CVCL_B7EH Mel JuSo ABCB5 KO clone HO3 cancer cell line human CVCL_B7EH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:46; ABCB5; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012604; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097. Female 152996129 CVCL_B7EG Mel JuSo ABCB5 KO clone HO2 cancer cell line human CVCL_B7EG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:46; ABCB5; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012604; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097. Female 152996130 CVCL_B7EJ hTERT-DMECN telomerase immortalized cell line human CVCL_B7EJ CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Skin, dermis, microvascular endothelium; UBERON=UBERON_0002067; Cell type: Microvascular endothelial cell; CL=CL_2000008. Male Doubling time: ~56 hours (ATCC=CRL-4060) 152996131 CVCL_B7EI Mel JuSo ABCB5 KO clone HO4 cancer cell line human CVCL_B7EI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:46; ABCB5; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012604; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097. Female 152996132 CVCL_B7EL hTERT-NDM telomerase immortalized cell line human CVCL_B7EL CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Population: Asian; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Melanocyte of skin; CL=CL_1000458. Male Doubling time: ~123 hours (ATCC=CRL-4064) 152996133 CVCL_B7EK hTERT-GF telomerase immortalized cell line human CVCL_B7EK CL:0000010 Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT Karyotypic information: 46,XX,del(16)(q10) [17]; 46,XX [1] (ATCC=CRL-4061); Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828; Cell type: Fibroblast of gingiva; CL=CL_0002552. Female Doubling time: ~22-25 hours (ATCC=CRL-4061) 152996134 CVCL_B7EB SIAISi020-A induced pluripotent stem cell human CVCL_B7EB From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=35853414) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152996135 CVCL_B7EA SIAISi019-A induced pluripotent stem cell human CVCL_B7EA From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=35853414) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152996136 CVCL_B7ED A6/C1 spontaneously immortalized cell line African clawed frog CVCL_B7ED CL:0000010 Derived from site: In situ; Kidney; UBERON=UBERON_0002113; Cell type: Epithelial cell of kidney; CL=CL_0002518. Male Characteristics: Selected for its high transepithelial resistance and for its responsiveness to aldosterone and antidiuretic hormone (PubMed=8392584) Group: Amphibian cell line 152996137 CVCL_B7EC SJTUi003-A induced pluripotent stem cell human CVCL_B7EC From: Shanghai Jiao Tong University School of Medicine; Shanghai; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Heterozygous; Note=ApoE4 allele (PubMed=37343430) Population: Chinese; Han; Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 152996138 CVCL_B7DU HCEnC-21 finite cell line human CVCL_B7DU CL:0000010 Derived from site: In situ; Eye, cornea, endothelium; UBERON=UBERON_0001985; Cell type: Endothelial cell of cornea; CL=CL_0000132. Male Doubling time: ~30 hours (Note=At earlier passages), 39 hours (Note=At later passages) (PubMed=23284695) 152996139 CVCL_B7E6 MUi021-A induced pluripotent stem cell human CVCL_B7E6 From: Mahidol University; Bangkok; Thailand. CL:0000010 152996140 CVCL_B7DT HeLa SMOC1 KO cancer cell line human CVCL_B7DT From: Durcan, Thomas M.; Montreal Neurological Institute, McGill University; Montreal; Canada CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20318; SMOC1 Population: African American; Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18); Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. Female 152996141 CVCL_B7E5 MUi020-A induced pluripotent stem cell human CVCL_B7E5 From: Mahidol University; Bangkok; Thailand. CL:0000010 152996142 CVCL_B7DW iPSC-hDPSC induced pluripotent stem cell human CVCL_B7DW CL:0000010 Population: Caucasian; Derived from site: In situ; Tooth, molar, dental pulp; UBERON=UBERON_0015838; Cell type: Dental pulp stem cell; CL=CL_4030035. Unspecified 152996143 CVCL_B7E8 MUi034-A induced pluripotent stem cell human CVCL_B7E8 From: Mahidol University; Bangkok; Thailand CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4824; HBA2; Simple; p.Ter143Glnext*32 (c.427T>C); ClinVar=VCV000015624; Zygosity=Homozygous; Note=Hb Constant Spring (PubMed=36427475) Population: Southeast Asian; Thai; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152996144 CVCL_B7DV hTERT EP153T telomerase immortalized cell line human CVCL_B7DV CL:0000010 Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428; Cell type: Epithelial cell of prostate; CL=CL_0002231. Male 152996145 CVCL_B7E7 MUi033-A induced pluripotent stem cell human CVCL_B7E7 From: Mahidol University; Bangkok; Thailand CL:0000010 Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu27Lys (c.79G>A) (E26K); ClinVar=VCV000015161; Zygosity=Homozygous; Note=Hb E (PubMed=37890329) Population: Southeast Asian; Thai; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152996146 CVCL_B7DY SCVIi031-A induced pluripotent stem cell human CVCL_B7DY From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9080; PLN; Simple; p.Arg14del (c.37_39AGA[1]) (c.40_42delAGA) (R14del); ClinVar=VCV000044580; Zygosity=Heterozygous (PubMed=35700631) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152996147 CVCL_B7E9 NYSCF-AG0002-01-MR induced pluripotent stem cell human CVCL_B7E9 From: New York Stem Cell Foundation; New York; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:16877; MFN2; Simple; p.His361Tyr (c.1081C>T); ClinVar=VCV000637315; Zygosity=Unspecified (NYSCF). Population: Caucasian Male 152996148 CVCL_B7DX Vero-CDM spontaneously immortalized cell line green monkey CVCL_B7DX CL:0000010 Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819; Cell type: Epithelial cell of kidney; CL=CL_0002518. Female Characteristics: Adapted to the serum free, chemically-defined culture medium SciN4Vero (CLS=605372-CDM) Group: Non-human primate cell line; Group: Serum/protein free medium cell line; Group: Vaccine production cell line 152996149 CVCL_B7DZ SCVIi030-A induced pluripotent stem cell human CVCL_B7DZ From: Stanford Cardiovascular Institute; Palo Alto; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9080; PLN; Simple; p.Arg14del (c.37_39AGA[1]) (c.40_42delAGA) (R14del); ClinVar=VCV000044580; Zygosity=Heterozygous (PubMed=35700631) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152996150 CVCL_B7DM CPGHi001-A-1 induced pluripotent stem cell human CVCL_B7DM From: Chinese PLA Institute of Otolaryngology, Chinese PLA General Hospital; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:16513; TMC1; Simple_corrected; p.Met418Lys (c.1253T>A); ClinVar=VCV000183668; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=35247837) Population: Chinese; Han; Derived from site: In situ; Urine; UBERON=UBERON_0001088. Male 152996151 CVCL_B7DL CIBi011-A induced pluripotent stem cell human CVCL_B7DL From: Cell Inspire Biotechnology; Shenzhen; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173; Cell type: Amniocyte; CL=CL_0002323. Female 152996152 CVCL_B7E0 BBANTWi008-A induced pluripotent stem cell human CVCL_B7E0 From: Biobank Antwerpen; Antwerp; Belgium CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6769; SMAD3; Simple; p.Arg287Gln (c.860G>A); ClinVar=VCV000180524; Zygosity=Heterozygous (PubMed=36219981) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Omics: Variations; SNP array analysis Male 152996153 CVCL_B7DN CPGHi007-A induced pluripotent stem cell human CVCL_B7DN From: Chinese PLA General Hospital; Beijing; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152996154 CVCL_B7DQ CAPF 1 finite cell line dog CVCL_B7DQ CL:0000010 Derived from site: In situ; Prostate; UBERON=UBERON_0002367; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: Mixed breed; VBO=VBO_0200902. Male 152996155 CVCL_B7E2 SMBCi014-A induced pluripotent stem cell human CVCL_B7E2 From: Shandong Medical Biotechnological Center; Jinan; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:2197; COL1A1; Simple; p.Pro817Leufs*291 (c.2450delC); ClinVar=VCV000035912; Zygosity=Heterozygous (PubMed=35660813) Derived from site: In situ; Urine; UBERON=UBERON_0001088. Female 152996156 CVCL_B7DP CPGHi008-A induced pluripotent stem cell human CVCL_B7DP From: Chinese PLA Institute of Otolaryngology, Chinese PLA General Hospital; Beijing; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9016; PKHD1; Simple; p.Leu2665Pro (c.7994T>C); ClinVar=VCV002152014; Zygosity=Homozygous (PubMed=35405383) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152996157 CVCL_B7E1 FMUPDCi001-A induced pluripotent stem cell human CVCL_B7E1 From: Fetal Medicine unit and Prenatal Diagnosis Center, Shanghai 1st Maternity and Infant Hospital of Tongji University; Shanghai; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:25151; ADAT3; Simple; p.Arg58Thrfs (c.171dupA) (p.Arg74Thrfs, c.219dupA); dbSNP=rs1267546394; Zygosity=Heterozygous (PubMed=35405382); Sequence variation: Mutation; HGNC; HGNC:25151; ADAT3; Simple; p.Ala180Val (c.539C>T) (p.Ala196Val, c.587C>T); ClinVar=VCV004086440; Zygosity=Heterozygous (PubMed=35405382) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152996158 CVCL_B7DS Kodiak2016 cancer cell line dog CVCL_B7DS CL:0000010 Derived from site: In situ; Prostate; UBERON=UBERON_0002367; Breed/subspecies: Siberian Husky; VBO=VBO_0201233. Omics: Genomics; Whole genome sequencing Male 152996159 CVCL_B7E4 MUi032-A induced pluripotent stem cell human CVCL_B7E4 From: Mahidol University; Bangkok; Thailand CL:0000010 Sequence variation: Mutation; HGNC; HGNC:1940; CHM; Simple; p.Arg293Ter (c.877C>T); ClinVar=VCV000011154; Zygosity=Hemizygous (PubMed=36395688) Population: Southeast Asian; Thai; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152996160 CVCL_B7DR CAPF 3 finite cell line dog CVCL_B7DR CL:0000010 Derived from site: In situ; Prostate; UBERON=UBERON_0002367; Cell type: Fibroblast; CL=CL_0000057; Breed/subspecies: Mixed breed; VBO=VBO_0200902. Male 152996161 CVCL_B7E3 HEBHMUi012-A induced pluripotent stem cell human CVCL_B7E3 From: Hebei Medical University; Shijiazhuang; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=35717858) Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152996162 CVCL_B7FG B-LCL-HROC130 transformed cell line human CVCL_B7FG HLA typing: A*01:01:01,02:01:01; B*07:02:01; C*07:02:01; DPB1*04:01:01G,04:02:01G; DQB1*03:01:01,06:02:01; DRB1*12:01:01,15:01:01 (CLS=302032) From: Linnebacher, Michael; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female 152996163 CVCL_B7FF B-LCL-HROC118 transformed cell line human CVCL_B7FF HLA typing: A*01:01:01,23:01:01; B*49:01:01,57:01:01; C*06:02:01,07:01:01; DPB1*02:01:02,03:01:01; DQB1*05:01:01,06:02:01; DRB1*01:01:01,15:01:01 (CLS=302025) From: Linnebacher, Michael; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Discontinued: CLS; 302025; true Female 152996164 CVCL_B7FI U-2 OS-CRISPR-NUP96-Halo clone no.252 cancer cell line human CVCL_B7FI CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag) Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female Characteristics: Using CRISPR/Cas9D10A NUP96 has been endogenously tagged in both alleles at the C-terminus with a HaloTag (PubMed=31562488) 152996165 CVCL_B7FH B-LCL-PB16 transformed cell line human CVCL_B7FH HLA typing: A*01:01:01,24:02:01; B*08:01:01,27:05:02; C*02:02:02,07:01:01; DPB1*01:01:01,04:01:01; DQA1*05:01:01; DQB1*02:01:01; DRB1*03:01:01 (CLS=302145) CL:0000010 Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. 152996166 CVCL_B7FK U-2 OS-CRISPR-NUP96-mMaple clone no.16 cancer cell line human CVCL_B7FK CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; SXSQ9; mMaple (Note=Photoconvertible green fluorescent protein derived from cFP484) Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female Characteristics: Using CRISPR/Cas9D10A NUP96 has been endogenously tagged in both alleles at the C-terminus with mMaple (PubMed=31562488) 152996167 CVCL_B7FJ U-2 OS-CRISPR-NUP96-mEGFP clone no.195 cancer cell line human CVCL_B7FJ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP) Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female Characteristics: Using CRISPR/Cas9D10A NUP96 has been endogenously tagged in both alleles at the C-terminus with mEGFP (PubMed=31562488) 152996168 CVCL_B7FM U-2 OS-ZFN-SNAP-Nup107 no.294 cancer cell line human CVCL_B7FM CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=ZFN; Gene=HGNC; HGNC:7059; MGMT (Note=With p.Gly180_Asn207del and 19 mutations = SNAP-tag) Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female Characteristics: Using ZFN NUP107 has been endogenously tagged in both alleles at the N-terminus with a SNAP-tag (PubMed=29630062) 152996169 CVCL_B7FL U-2 OS-CRISPR-NUP96-SNAP clone #33 cancer cell line human CVCL_B7FL CL:0000010 Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line); Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:7059; MGMT (Note=With p.Gly180_Asn207del and 19 mutations = SNAP-tag) Population: Caucasian; Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979. Female Characteristics: Using CRISPR/Cas9D10A NUP96 has been endogenously tagged in both alleles at the C-terminus with a SNAP-tag (PubMed=31562488) 152996170 CVCL_B7FA HVEM 18.10 hybridoma house mouse CVCL_B7FA CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q92956; Human TNFRSF14/CD270. Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4752 152996171 CVCL_B7FC B-LCL-HROC195 transformed cell line human CVCL_B7FC HLA typing: A*01:01:01,68:01:02; B*08:01:01,51:01:01; C*07:01:01,15:02:01; DPB1*02:01:02,13:01:01; DQA1*01:03:01,05:05:01; DQB1*03:01:01,06:03:01; DRB1*08:04:01,13:01:01 (CLS=302043) From: Linnebacher, Michael; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female 152996172 CVCL_B7FB HVEM 11.8 hybridoma house mouse CVCL_B7FB CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q92956; Human TNFRSF14/CD270. 152996173 CVCL_B7FE B-LCL-HROC103 transformed cell line human CVCL_B7FE HLA typing: A*01:01:01,02:01:01; B*07:02:01,13:02:01; C*06:02:01,07:02:01; DPB1*04:01:01,13:01:01G; DQB1*02:02:01,06:02:01; DRB1*07:01:01,15:01:01 (CLS=302020) From: Linnebacher, Michael; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Male 152996174 CVCL_B7FD B-LCL-HROC06 transformed cell line human CVCL_B7FD From: Linnebacher, Michael; University of Rostock; Rostock; Germany CL:0000010 Population: Caucasian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: B-cell; CL=CL_0000236. Female 152996175 CVCL_B7F7 MM.1S-luc cancer cell line human CVCL_B7F7 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Val536_Asn545delValPheValAlaGlnThrValLeuGluAsninsAsp (c.1604-1630delTCTTTGTGGCCCAAACTGTTCTAGAAA); Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = effLuc) Population: African American; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Plasma cell; CL=CL_0000786. Female Characteristics: Produces IgA lambda (from parent cell line MM1.S) 152996176 CVCL_B7EV RP.0.03 finite cell line house mouse CVCL_B7EV CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Stromal cell of bone marrow; CL=CL_0010001; Breed/subspecies: C57BL/6. Unspecified 152996177 CVCL_B7EU AMUFAHi003-A induced pluripotent stem cell human CVCL_B7EU From: The First Affiliated Hospital of Anhui Medical University; Anhui; China CL:0000010 Sequence variation: Mutation; HGNC; HGNC:33630; PATL2; Simple; c.223-14_223-2delCCCTCCTGTTCCA; ClinVar=VCV000444049; Zygosity=Heterozygous (PubMed=35397397) Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152996178 CVCL_B7F6 F3-effLuc transformed cell line human CVCL_B7F6 CL:0000010 Genetic integration: Method=Transduction; Gene=MGI; MGI:98747; Thy1 (Note=With p.Gln108Arg = Thy1.1); Genetic integration: Method=Transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo; Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = effLuc) Transformant: v-Myc; Derived from site: In situ; Fetal brain, telencephalon; UBERON=UBERON_0014371; Cell type: Neural stem cell; CL=CL_0000047. Female Characteristics: Transduced with a CMV promoter controlled effLuc-IRES-Thy1.1 construct (PubMed=25198726) 152996179 CVCL_B7F9 PD-L1.3 hybridoma house mouse CVCL_B7F9 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q9NZQ7; Human CD274. 152996180 CVCL_B7EX RP.0.10 finite cell line house mouse CVCL_B7EX CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Stromal cell of bone marrow; CL=CL_0010001; Breed/subspecies: C57BL/6. Unspecified 152996181 CVCL_B7F8 PD-L2.1 hybridoma house mouse CVCL_B7F8 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q9BQ51; Human PDCD1LG2/CD273. 152996182 CVCL_B7EW RP.0.07 finite cell line house mouse CVCL_B7EW CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Stromal cell of bone marrow; CL=CL_0010001; Breed/subspecies: C57BL/6. Unspecified 152996183 CVCL_B7EZ UNIBSi017-A induced pluripotent stem cell human CVCL_B7EZ From: University of Brescia; Brescia; Italy CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6859; MAP3K7; Simple; p.Asn245_Gly246insValVal (c.737-7A>G) (IVS7AS,A-G,-7); ClinVar=VCV000974910; Zygosity=Heterozygous (PubMed=35700636) Population: Caucasian; Karyotypic information: 45,XX,rob(13;14)(q10;q10) (PubMed=35700636); Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Female 152996184 CVCL_B7EY RP.0.16 finite cell line house mouse CVCL_B7EY CL:0000010 Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371; Cell type: Stromal cell of bone marrow; CL=CL_0010001; Breed/subspecies: C57BL/6. Unspecified 152996185 CVCL_B7EN TFA1.4 induced pluripotent stem cell human CVCL_B7EN CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu220Pro (m.9185T>C); ClinVar=VCV000009647; Zygosity=Homoplasmic (PubMed=28132834) Cell type: Fibroblast; CL=CL_0000057. Female 152996186 CVCL_B7EM NCC-DDLPS5-C1 cancer cell line human CVCL_B7EM CL:0000010 Population: Japanese; Derived from site: In situ; Inguinal fat pad; UBERON=UBERON_0010410. Omics: Phenotyping; Drug screening; Omics: Variations; SNP array analysis Male Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi); Doubling time: 47 hours (PubMed=35292923) Part of: NCC sarcoma cell line panel 152996187 CVCL_B7F1 BTLA6.4 hybridoma house mouse CVCL_B7F1 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q7Z6A9; Human BTLA/CD272. 152996188 CVCL_B7EP TDA2.3 induced pluripotent stem cell human CVCL_B7EP CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu220Pro (m.9185T>C); ClinVar=VCV000009647; Zygosity=Homoplasmic (PubMed=28132834) Cell type: Fibroblast; CL=CL_0000057. Female 152996189 CVCL_B7F0 PD-1.6 hybridoma house mouse CVCL_B7F0 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q15116; Human PDCD1/PD1/CD279. 152996190 CVCL_B7F3 BTLA8.2 hybridoma house mouse CVCL_B7F3 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q7Z6A9; Human BTLA/CD272. Group: Patented cell line; Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4123 152996191 CVCL_B7ER TDA3.1 induced pluripotent stem cell human CVCL_B7ER CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu220Pro (m.9185T>C); ClinVar=VCV000009647; Zygosity=Homoplasmic (PubMed=28132834) Cell type: Fibroblast; CL=CL_0000057. Female 152996192 CVCL_B7F2 BTLA7.1 hybridoma house mouse CVCL_B7F2 CL:0000010 Monoclonal antibody isotype: IgG2b; Monoclonal antibody target: UniProtKB; Q7Z6A9; Human BTLA/CD272. 152996193 CVCL_B7EQ TFA2 induced pluripotent stem cell human CVCL_B7EQ CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu220Pro (m.9185T>C); ClinVar=VCV000009647; Zygosity=Homoplasmic (PubMed=28132834) Cell type: Fibroblast; CL=CL_0000057. Female 152996194 CVCL_B7ET AMUFAHi002-A induced pluripotent stem cell human CVCL_B7ET From: The First Affiliated Hospital of Anhui Medical University; Anhui; China CL:0000010 Population: Chinese; Han; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152996195 CVCL_B7F5 ANBL-6-luc cancer cell line human CVCL_B7F5 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Ter (c.991C>T); ClinVar=VCV000922893; Zygosity=Unspecified (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Tyr425Thrfs*36 (c.1272delC); Zygosity=Homozygous (from parent cell line); Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = effLuc) Population: Caucasian; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178; Cell type: Plasma cell; CL=CL_0000786. Female Characteristics: Produces Ig lambda; Characteristics: IL6 dependent 152996196 CVCL_B7ES BRCi021-A induced pluripotent stem cell human CVCL_B7ES From: RIKEN BioResource Research Center; Kyoto; Japan CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Tyr267Ter (c.801T>A); Zygosity=Heterozygous (PubMed=35500377) Population: Japanese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152996197 CVCL_B7F4 HVEM8.5 hybridoma house mouse CVCL_B7F4 CL:0000010 Monoclonal antibody isotype: IgG1; Monoclonal antibody target: UniProtKB; Q92956; Human TNFRSF14/CD270. 152996198 CVCL_B7CD SG237S finite cell line human CVCL_B7CD CL:0000010 Transformant: Ad5-SV40 hybrid virus (Note=1613 ori-); Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064. Female Senescence: Ad-5-SV40 transformed but with a finite life span Senesces after 78 PDL (PubMed=1693627). 152996199 CVCL_B7CC SG237R finite cell line human CVCL_B7CC CL:0000010 Transformant: Ad5-SV40 hybrid virus (Note=1613 ori-); Derived from site: In situ; Skin, eccrine sweat gland, duct; UBERON=UBERON_0035073. Female Senescence: Ad-5-SV40 transformed but with a finite life span Senesces after 38 PDL (PubMed=1693627). 152996200 CVCL_B7CF NP24(CF) finite cell line human CVCL_B7CF CL:0000010 Transformant: Ad5-SV40 hybrid virus (Note=1613 ori-); Derived from site: In situ; Nose, nasal cavity; Note=From a polyp; UBERON=UBERON_0001707; Cell type: Epithelial cell; CL=CL_0000066. Male Senescence: Ad-5-SV40 transformed but with a finite life span Senesces after 16 PDL (PubMed=1693627). 152996201 CVCL_B7CE NP23(CF) finite cell line human CVCL_B7CE CL:0000010 Transformant: Ad5-SV40 hybrid virus (Note=1613 ori-); Derived from site: In situ; Nose, nasal cavity; Note=From a polyp; UBERON=UBERON_0001707; Cell type: Epithelial cell; CL=CL_0000066. Male Senescence: Ad-5-SV40 transformed but with a finite life span Senesces after 20 PDL (PubMed=1693627). 152996202 CVCL_B7CH VRISGi002-A induced pluripotent stem cell human CVCL_B7CH From: Vinmec Research Insitute of Stem Cell and Gene Technology; Hanoi; Vietnam CL:0000010 Population: Southeast Asian; Vietnamese; Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Female 152996203 CVCL_B7CG NP34 transformed cell line human CVCL_B7CG CL:0000010 Transformant: Ad5-SV40 hybrid virus (Note=1613 ori-); Derived from site: In situ; Nose, nasal cavity; Note=From a polyp; UBERON=UBERON_0001707; Cell type: Epithelial cell; CL=CL_0000066. Male Senescence: May have a finite life span; not cultured over 48 PDL (PubMed=1693627) 152996204 CVCL_B7CJ 10B5.B4 hybridoma house mouse CVCL_B7CJ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; O24566; Maize 3-phosphoshikimate 1-carboxyvinyltransferase (Note=With p.Thr102Ile and p.Pro106Ser). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8900 152996205 CVCL_B7CI UMi040-A induced pluripotent stem cell human CVCL_B7CI From: Miller School of Medicine, University of Miami; Miami; USA CL:0000010 Sequence variation: Mutation; HGNC; HGNC:28472; TMEM43; Simple; p.Arg372Ter (c.1114C>T); ClinVar=VCV000403555; Zygosity=Heterozygous (PubMed=35364395) Population: Korean; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152996206 CVCL_B7BZ EC23 clone 3 transformed cell line human CVCL_B7BZ CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064. Unspecified 152996207 CVCL_B7CB SG224(CF)S transformed cell line human CVCL_B7CB CL:0000010 Transformant: Ad5-SV40 hybrid virus (Note=1613 ori-); Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064. Male Characteristics: Seems to be immortalized (PubMed=1693627) 152996208 CVCL_B7CA SG223(CF)S finite cell line human CVCL_B7CA CL:0000010 Transformant: Ad5-SV40 hybrid virus (Note=1613 ori-); Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064. Male Senescence: Ad-5-SV40 transformed but with a finite life span Senesces after 67 PDL (PubMed=1693627). 152996209 CVCL_B7C4 EC23 clone 9 transformed cell line human CVCL_B7C4 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064. Unspecified 152996210 CVCL_B7BS HIHCNi006-A-2 induced pluripotent stem cell human CVCL_B7BS From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11233; SPAST Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 152996211 CVCL_B7C3 EC23 clone 8 transformed cell line human CVCL_B7C3 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064. Unspecified 152996212 CVCL_B7BR HIHCNi006-A-1 induced pluripotent stem cell human CVCL_B7BR From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11233; SPAST (Note=1 of 2 alleles) Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 152996213 CVCL_B7C6 SG141R finite cell line human CVCL_B7C6 CL:0000010 Transformant: Ad5-SV40 hybrid virus (Note=1613 ori-); Derived from site: In situ; Skin, eccrine sweat gland, duct; UBERON=UBERON_0035073. Female Senescence: Ad-5-SV40 transformed but with a finite life span Senesces after 62 PDL (PubMed=1693627). 152996214 CVCL_B7BU SGDC-1D10 transformed cell line human CVCL_B7BU CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen; Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR) Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Skin, eccrine sweat gland, duct; UBERON=UBERON_0035073. Unspecified Doubling time: 30-35 hours (PubMed=35262932) 152996215 CVCL_B7BT JLUe003-A embryonic stem cell human CVCL_B7BT From: Jilin University; Changchun; China CL:0000010 Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358; Cell type: Embryonic stem cell; CL=CL_0002322. Male Characteristics: Using CRISPR/Cas9 two FLAG tags were introduced at the C-terminus of one allele of GFI1 (PubMed=35248880) 152996216 CVCL_B7C5 SG87 finite cell line human CVCL_B7C5 CL:0000010 Transformant: Ad5-SV40 hybrid virus (Note=1613 ori-); Derived from site: In situ; Skin, eccrine sweat gland; UBERON=UBERON_0000423. Female Senescence: Ad-5-SV40 transformed but with a finite life span Senesces after 63 PDL (PubMed=1693627). 152996217 CVCL_B7BW EC23 transformed cell line human CVCL_B7BW CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064. Unspecified 152996218 CVCL_B7C8 SG146S finite cell line human CVCL_B7C8 CL:0000010 Transformant: Ad5-SV40 hybrid virus (Note=1613 ori-); Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064. Female Senescence: Ad-5-SV40 transformed but with a finite life span Senesces after 74 PDL (PubMed=1693627). 152996219 CVCL_B7BV NCL-SG3 transformed cell line human CVCL_B7BV CL:0000010 Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40); Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064. Male Doubling time: ~70 hours (Note=In serum-free medium) (PubMed=2777923) 152996220 CVCL_B7C7 SG143(CF)R finite cell line human CVCL_B7C7 CL:0000010 Transformant: Ad5-SV40 hybrid virus (Note=1613 ori-); Derived from site: In situ; Skin, eccrine sweat gland, duct; UBERON=UBERON_0035073. Male Senescence: Ad-5-SV40 transformed but with a finite life span Senesces after 59 PDL (PubMed=1693627). 152996221 CVCL_B7BY EC23 clone 2 transformed cell line human CVCL_B7BY CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064. Unspecified 152996222 CVCL_B7BX EC23 clone 1 transformed cell line human CVCL_B7BX CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064. Unspecified 152996223 CVCL_B7C9 SG209(CF)S transformed cell line human CVCL_B7C9 CL:0000010 Transformant: Ad5-SV40 hybrid virus (Note=1613 ori-); Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064. Female Characteristics: Seems to be immortalized (PubMed=1693627) 152996224 CVCL_B7BM NCC-PMP1-C1 cancer cell line human CVCL_B7BM CL:0000010 Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=35207746) Population: Japanese; Derived from site: Metastatic; Right thigh; UBERON=UBERON_0000376. Omics: Phenotyping; Drug screening; Omics: Variations; SNP array analysis Male Doubling time: ~147 hours (PubMed=35207746) 152996225 CVCL_B7C0 EC23 clone 4 transformed cell line human CVCL_B7C0 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064. Unspecified 152996226 CVCL_B7BN SuSa-CP cancer cell line human CVCL_B7BN CL:0000010 Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP); Derived from site: In situ; Testis; UBERON=UBERON_0000473. Male Doubling time: 29.8 +- 0.8 hours (PubMed=2144165) 152996227 CVCL_B7C2 EC23 clone 7 transformed cell line human CVCL_B7C2 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064. Unspecified 152996228 CVCL_B7BQ HIHCNi006-A induced pluripotent stem cell human CVCL_B7BQ From: Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University of Tubingen; Tubingen; Germany CL:0000010 Population: Caucasian; Derived from site: In situ; Skin; UBERON=UBERON_0002097; Cell type: Fibroblast of skin; CL=CL_0002620. Male 152996229 CVCL_B7C1 EC23 clone 5 transformed cell line human CVCL_B7C1 CL:0000010 Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6; Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7; Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16); Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064. Unspecified 152996230 CVCL_B7BP RT112-CP cancer cell line human CVCL_B7BP CL:0000010 Sequence variation: Gene fusion; HGNC; HGNC:3690; FGFR3 + HGNC; HGNC:11524; TACC3; Name(s)=FGFR3-TACC3 (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser183Ter (c.548C>G); ClinVar=VCV000634701; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP); Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255. Female Doubling time: 21.5 +- 1.5 hours (PubMed=2144165) 152996231 CVCL_B7DE 1274A15 induced pluripotent stem cell human CVCL_B7DE From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152996232 CVCL_B7DD PD17-7 induced pluripotent stem cell human CVCL_B7DD From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. 152996233 CVCL_B7DG 1275A2 induced pluripotent stem cell human CVCL_B7DG From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152996234 CVCL_B7DF 1274A8 induced pluripotent stem cell human CVCL_B7DF From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152996235 CVCL_B7DI 783E2 induced pluripotent stem cell human CVCL_B7DI From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152996236 CVCL_B7DH 1275A3 induced pluripotent stem cell human CVCL_B7DH From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152996237 CVCL_B7DK PD12-1 induced pluripotent stem cell human CVCL_B7DK From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 152996238 CVCL_B7DJ N112-4 induced pluripotent stem cell human CVCL_B7DJ From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. 152996239 CVCL_B7DA N117-11 induced pluripotent stem cell human CVCL_B7DA From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 152996240 CVCL_B7DC 1263A18 induced pluripotent stem cell human CVCL_B7DC From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152996241 CVCL_B7DB N117-8 induced pluripotent stem cell human CVCL_B7DB From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan CL:0000010 Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067; Cell type: Fibroblast of skin; CL=CL_0002620. Male 152996242 CVCL_B7CT Panc.1.5C10.5D11 hybridoma house mouse CVCL_B7CT CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4244 152996243 CVCL_B7CS BLA.3.3B6.3D4 hybridoma house mouse CVCL_B7CS CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4218 152996244 CVCL_B7D4 DCR-2 hybridoma house mouse CVCL_B7D4 CL:0000010 Monoclonal antibody isotype: IgG1, kappa; Monoclonal antibody target: UniProtKB; Q8TDQ1; Human CD300LF/CD300f. Group: Patented cell line; Registration: International Depositary Authority, Cell Bank Australia; CBA20160029 152996245 CVCL_B7CV GT512muMAB 55A hybridoma house mouse CVCL_B7CV CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56747; Human CLDN6. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3089 152996246 CVCL_B7D7 HC-04.J7 cancer cell line human CVCL_B7D7 CL:0000010 Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line) Population: Caucasian; Derived from site: In situ; Liver; UBERON=UBERON_0002107. Omics: Proteomics; Omics: Transcriptomics; RNAseq Male Characteristics: Compared to the parent cell line, has an inscreased susceptibility to Plasmodium falciparum sporozoite invasion (PubMed=30891005) Group: Malaria research cell line Problematic cell line: Possibly contaminated Parent cell line (HC-04) has been shown to have an STR profile identical to that of Hep-G2. 152996247 CVCL_B7D6 4Z-B-1 cancer cell line human CVCL_B7D6 CL:0000010 Population: Chinese; Karyotypic information: Nearly triploid (PubMed=34141711); Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female Characteristics: ER-negative, PR-negative and ERBB2-positive (PubMed=34141711) Doubling time: 40 hours (PubMed=34141711) Group: Patented cell line; Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202123 152996248 CVCL_B7CU Skin.2.6A2.1A8 hybridoma house mouse CVCL_B7CU CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4245 152996249 CVCL_B7D9 1147F1 induced pluripotent stem cell human CVCL_B7D9 CL:0000010 Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Male 152996250 CVCL_B7CX GT512muMAB 60A hybridoma house mouse CVCL_B7CX CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56747; Human CLDN6. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3068 152996251 CVCL_B7CW GT512muMAB 59A hybridoma house mouse CVCL_B7CW CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56747; Human CLDN6. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3067 152996252 CVCL_B7D8 NDC hybrid cell line CVCL_B7D8 CL:0000010 Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG). Characteristics: Derived from the fusion of primary neonatal rat dorsal root ganglion neurons with mouse neuroblastoma cell line N18TG2 (PubMed=1979443) 152996253 CVCL_B7CZ GT512muMAB 64A hybridoma house mouse CVCL_B7CZ CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P56747; Human CLDN6. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3070 152996254 CVCL_B7CY GT512muMAB 61D hybridoma house mouse CVCL_B7CY CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P56747; Human CLDN6. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3069 152996255 CVCL_B7CL 12H1.B1 hybridoma house mouse CVCL_B7CL CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; O24566; Maize 3-phosphoshikimate 1-carboxyvinyltransferase (Note=With p.Thr102Ile and p.Pro106Ser). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8902 152996256 CVCL_B7CK 10B9.E8 hybridoma house mouse CVCL_B7CK CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; O24566; Maize 3-phosphoshikimate 1-carboxyvinyltransferase (Note=With p.Thr102Ile and p.Pro106Ser). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8901 152996257 CVCL_B7CN 1C5 [Mouse hybridoma against Pseudomonas P.J. 874 hpd] hybridoma house mouse CVCL_B7CN CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P80064; Pseudomonas sp (strain P.J. 874) 4-hydroxyphenylpyruvate dioxygenase (hpd) (Note=With p.Gly335Trp).. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10312 152996258 CVCL_B7CM 5E11.E11 hybridoma house mouse CVCL_B7CM CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; O24566; Maize 3-phosphoshikimate 1-carboxyvinyltransferase (Note=With p.Thr102Ile and p.Pro106Ser). Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8903 152996259 CVCL_B7CP 2E6 [Mouse hybridoma against Pseudomonas P.J. 874 hpd] hybridoma house mouse CVCL_B7CP CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P80064; Pseudomonas sp (strain P.J. 874) 4-hydroxyphenylpyruvate dioxygenase (hpd) (Note=With p.Gly335Trp).. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10313 152996260 CVCL_B7D1 GT512muMAB 66B hybridoma house mouse CVCL_B7D1 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56747; Human CLDN6. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3072 152996261 CVCL_B7D0 GT512muMAB 65A hybridoma house mouse CVCL_B7D0 CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P56747; Human CLDN6. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3071 152996262 CVCL_B7CR CA130.1.4C3.1H4 hybridoma house mouse CVCL_B7CR CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4217 152996263 CVCL_B7D3 GT512muMAB 89A hybridoma house mouse CVCL_B7D3 CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P56747; Human CLDN6. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3090 152996264 CVCL_B7CQ 6H11 hybridoma house mouse CVCL_B7CQ CL:0000010 Monoclonal antibody isotype: Not specified; Monoclonal antibody target: UniProtKB; P80064; Pseudomonas sp (strain P.J. 874) 4-hydroxyphenylpyruvate dioxygenase (hpd) (Note=With p.Gly335Trp).. Group: Patented cell line; Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10314 152996265 CVCL_B7D2 GT512muMAB 67A hybridoma house mouse CVCL_B7D2 CL:0000010 Monoclonal antibody isotype: IgG2a, kappa; Monoclonal antibody target: UniProtKB; P56747; Human CLDN6. Group: Patented cell line; Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3073 152996266 CVCL_B8P0 Abcam HCT 116 RSF1 KO cancer cell line human CVCL_B8P0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18118; RSF1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996267 CVCL_B8P2 Abcam HCT 116 RUNX1 KO cancer cell line human CVCL_B8P2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10471; RUNX1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996268 CVCL_B8P1 Abcam HCT 116 RSPO2 KO cancer cell line human CVCL_B8P1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28583; RSPO2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996269 CVCL_B8P4 Abcam HCT 116 S100A8 KO cancer cell line human CVCL_B8P4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10498; S100A8; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996270 CVCL_B8P3 Abcam HCT 116 RUNX3 KO cancer cell line human CVCL_B8P3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10473; RUNX3; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996271 CVCL_B8P6 Abcam HCT 116 SEMA4D KO cancer cell line human CVCL_B8P6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10732; SEMA4D; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996272 CVCL_B8P5 Abcam HCT 116 SALL4 KO cancer cell line human CVCL_B8P5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15924; SALL4; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996273 CVCL_B8NV Abcam HCT 116 RNF2 KO cancer cell line human CVCL_B8NV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10061; RNF2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996274 CVCL_B8NU Abcam HCT 116 RICTOR KO cancer cell line human CVCL_B8NU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28611; RICTOR; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996275 CVCL_B8NX Abcam HCT 116 ROS1 KO cancer cell line human CVCL_B8NX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10261; ROS1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996276 CVCL_B8NW Abcam HCT 116 RORC KO cancer cell line human CVCL_B8NW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10260; RORC; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996277 CVCL_B8NZ Abcam HCT 116 RPS6KA3 KO cancer cell line human CVCL_B8NZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10432; RPS6KA3; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996278 CVCL_B8NY Abcam HCT 116 RPS6KA1 KO cancer cell line human CVCL_B8NY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10430; RPS6KA1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996279 CVCL_B8PP Abcam HCT 116 SMARCA4 KO cancer cell line human CVCL_B8PP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11100; SMARCA4; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996280 CVCL_B8Q1 Abcam HCT 116 SP1 KO cancer cell line human CVCL_B8Q1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11205; SP1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996281 CVCL_B8Q0 Abcam HCT 116 SOX6 KO cancer cell line human CVCL_B8Q0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16421; SOX6; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996282 CVCL_B8PR Abcam HCT 116 SMARCD3 KO cancer cell line human CVCL_B8PR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11108; SMARCD3; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996283 CVCL_B8Q3 Abcam HCT 116 SPN KO cancer cell line human CVCL_B8Q3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11249; SPN; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996284 CVCL_B8PQ Abcam HCT 116 SMARCC1 KO cancer cell line human CVCL_B8PQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11104; SMARCC1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996285 CVCL_B8Q2 Abcam HCT 116 SPI1 KO cancer cell line human CVCL_B8Q2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11241; SPI1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996286 CVCL_B8PT Abcam HCT 116 SNAI1 KO cancer cell line human CVCL_B8PT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11128; SNAI1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996287 CVCL_B8Q5 Abcam HCT 116 SRC KO cancer cell line human CVCL_B8Q5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11283; SRC; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996288 CVCL_B8PS Abcam HCT 116 SMO KO cancer cell line human CVCL_B8PS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11119; SMO; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996289 CVCL_B8Q4 Abcam HCT 116 SPP1 KO cancer cell line human CVCL_B8Q4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11255; SPP1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996290 CVCL_B8PV Abcam HCT 116 SOS1 KO cancer cell line human CVCL_B8PV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11187; SOS1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996291 CVCL_B8Q7 Abcam HCT 116 SREBF2 KO cancer cell line human CVCL_B8Q7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11290; SREBF2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996292 CVCL_B8PU Abcam HCT 116 SNAI2 KO cancer cell line human CVCL_B8PU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11094; SNAI2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996293 CVCL_B8Q6 Abcam HCT 116 SREBF1 KO cancer cell line human CVCL_B8Q6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11289; SREBF1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996294 CVCL_B8PH Abcam HCT 116 SIRT7 KO cancer cell line human CVCL_B8PH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14935; SIRT7; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996295 CVCL_B8PG Abcam HCT 116 SIRT6 KO cancer cell line human CVCL_B8PG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14934; SIRT6; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996296 CVCL_B8PJ Abcam HCT 116 SMAD2 KO cancer cell line human CVCL_B8PJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6768; SMAD2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996297 CVCL_B8PI Abcam HCT 116 SLAMF1 KO cancer cell line human CVCL_B8PI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10903; SLAMF1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996298 CVCL_B8PL Abcam HCT 116 SMAD4 KO cancer cell line human CVCL_B8PL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6770; SMAD4; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996299 CVCL_B8PK Abcam HCT 116 SMAD3 KO cancer cell line human CVCL_B8PK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6769; SMAD3; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996300 CVCL_B8PN Abcam HCT 116 SMARCA1 KO cancer cell line human CVCL_B8PN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11097; SMARCA1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996301 CVCL_B8PM Abcam HCT 116 SMAD7 KO cancer cell line human CVCL_B8PM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6773; SMAD7; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996302 CVCL_B8PB Abcam HCT 116 SIRPA KO cancer cell line human CVCL_B8PB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9662; SIRPA; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996303 CVCL_B8PA Abcam HCT 116 SETD7 KO cancer cell line human CVCL_B8PA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30412; SETD7; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996304 CVCL_B8PD Abcam HCT 116 SIRT2 KO cancer cell line human CVCL_B8PD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10886; SIRT2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996305 CVCL_B8PC Abcam HCT 116 SIRT1 KO cancer cell line human CVCL_B8PC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996306 CVCL_B8PF Abcam HCT 116 SIRT4 KO cancer cell line human CVCL_B8PF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14932; SIRT4; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996307 CVCL_B8PE Abcam HCT 116 SIRT3 KO cancer cell line human CVCL_B8PE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14931; SIRT3; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996308 CVCL_B8P8 Abcam HCT 116 SENP1 KO cancer cell line human CVCL_B8P8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17927; SENP1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996309 CVCL_B8P7 Abcam HCT 116 SEMA7A KO cancer cell line human CVCL_B8P7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10741; SEMA7A; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996310 CVCL_B8P9 Abcam HCT 116 SERPINE1 KO cancer cell line human CVCL_B8P9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8583; SERPINE1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996311 CVCL_B8MM Abcam HCT 116 PIWIL4 KO cancer cell line human CVCL_B8MM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18444; PIWIL4; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996312 CVCL_B8ML Abcam HCT 116 PIK3R2 KO cancer cell line human CVCL_B8ML CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8980; PIK3R2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996313 CVCL_B8N0 Abcam HCT 116 PRF1 KO cancer cell line human CVCL_B8N0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9360; PRF1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996314 CVCL_B8MN Abcam HCT 116 PMEL KO cancer cell line human CVCL_B8MN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10880; PMEL; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996315 CVCL_B8MQ Abcam HCT 116 PMS2 KO cancer cell line human CVCL_B8MQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9122; PMS2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996316 CVCL_B8N2 Abcam HCT 116 PRKAA2 KO cancer cell line human CVCL_B8N2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9377; PRKAA2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996317 CVCL_B8MP Abcam HCT 116 PML KO cancer cell line human CVCL_B8MP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9113; PML; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996318 CVCL_B8N1 Abcam HCT 116 PRKAA1 KO cancer cell line human CVCL_B8N1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9376; PRKAA1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996319 CVCL_B8MS Abcam HCT 116 POLR2A KO cancer cell line human CVCL_B8MS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9187; POLR2A; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996320 CVCL_B8N4 Abcam HCT 116 PRKCA KO cancer cell line human CVCL_B8N4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9393; PRKCA; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996321 CVCL_B8MR Abcam HCT 116 POLQ KO cancer cell line human CVCL_B8MR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9186; POLQ; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996322 CVCL_B8N3 Abcam HCT 116 PRKAR1A KO cancer cell line human CVCL_B8N3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9388; PRKAR1A; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996323 CVCL_B8ME Abcam HCT 116 PECAM1 KO cancer cell line human CVCL_B8ME CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8823; PECAM1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996324 CVCL_B8MD Abcam HCT 116 PEBP1 KO cancer cell line human CVCL_B8MD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8630; PEBP1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996325 CVCL_B8MG Abcam HCT 116 PGF KO cancer cell line human CVCL_B8MG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8893; PGF; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996326 CVCL_B8MF Abcam HCT 116 PER1 KO cancer cell line human CVCL_B8MF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8845; PER1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996327 CVCL_B8MI Abcam HCT 116 PHF1 KO cancer cell line human CVCL_B8MI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8919; PHF1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996328 CVCL_B8MH Abcam HCT 116 PGR KO cancer cell line human CVCL_B8MH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8910; PGR; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996329 CVCL_B8MK Abcam HCT 116 PIK3R1 KO cancer cell line human CVCL_B8MK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8979; PIK3R1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996330 CVCL_B8MJ Abcam HCT 116 PHLPP1 KO cancer cell line human CVCL_B8MJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20610; PHLPP1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996331 CVCL_B8MA Abcam HCT 116 PDGFRB KO cancer cell line human CVCL_B8MA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8804; PDGFRB; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996332 CVCL_B8MC Abcam HCT 116 PDPN KO cancer cell line human CVCL_B8MC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29602; PDPN; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996333 CVCL_B8MB Abcam HCT 116 PDPK1 KO cancer cell line human CVCL_B8MB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8816; PDPK1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996334 CVCL_B8LT Abcam HCT 116 OLIG2 KO cancer cell line human CVCL_B8LT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9398; OLIG2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996335 CVCL_B8M5 Abcam HCT 116 PBK KO cancer cell line human CVCL_B8M5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18282; PBK; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996336 CVCL_B8LS Abcam HCT 116 NTRK3 KO cancer cell line human CVCL_B8LS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8033; NTRK3; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996337 CVCL_B8M4 Abcam HCT 116 PAX8 KO cancer cell line human CVCL_B8M4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8622; PAX8; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996338 CVCL_B8LV Abcam HCT 116 PADI4 KO cancer cell line human CVCL_B8LV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18368; PADI4; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996339 CVCL_B8M7 Abcam HCT 116 PDCD1 KO cancer cell line human CVCL_B8M7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8760; PDCD1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996340 CVCL_B8LU Abcam HCT 116 OPRM1 KO cancer cell line human CVCL_B8LU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8156; OPRM1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996341 CVCL_B8M6 Abcam HCT 116 PBRM1 KO cancer cell line human CVCL_B8M6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996342 CVCL_B8LX Abcam HCT 116 PAK2 KO cancer cell line human CVCL_B8LX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8591; PAK2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996343 CVCL_B8M9 Abcam HCT 116 PDGFRA KO cancer cell line human CVCL_B8M9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8803; PDGFRA; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996344 CVCL_B8LW Abcam HCT 116 PAK1 KO cancer cell line human CVCL_B8LW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8590; PAK1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996345 CVCL_B8M8 Abcam HCT 116 PDGFB KO cancer cell line human CVCL_B8M8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8800; PDGFB; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996346 CVCL_B8LZ Abcam HCT 116 PALB2 KO cancer cell line human CVCL_B8LZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26144; PALB2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996347 CVCL_B8LY Abcam HCT 116 PAK4 KO cancer cell line human CVCL_B8LY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16059; PAK4; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996348 CVCL_B8NN Abcam HCT 116 RARB KO cancer cell line human CVCL_B8NN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9865; RARB; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996349 CVCL_B8NM Abcam HCT 116 RAF1 KO cancer cell line human CVCL_B8NM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9829; RAF1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996350 CVCL_B8NP Abcam HCT 116 RB1 KO cancer cell line human CVCL_B8NP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996351 CVCL_B8NR Abcam HCT 116 RELA KO cancer cell line human CVCL_B8NR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9955; RELA; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996352 CVCL_B8NQ Abcam HCT 116 REL KO cancer cell line human CVCL_B8NQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9954; REL; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996353 CVCL_B8NT Abcam HCT 116 RET KO cancer cell line human CVCL_B8NT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9967; RET; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996354 CVCL_B8NS Abcam HCT 116 REST KO cancer cell line human CVCL_B8NS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9966; REST; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996355 CVCL_B8NF Abcam HCT 116 PTPN1 KO cancer cell line human CVCL_B8NF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9642; PTPN1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996356 CVCL_B8NE Abcam HCT 116 PTN KO cancer cell line human CVCL_B8NE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9630; PTN; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996357 CVCL_B8NH Abcam HCT 116 PTPN2 KO cancer cell line human CVCL_B8NH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9650; PTPN2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996358 CVCL_B8NG Abcam HCT 116 PTPN11 KO cancer cell line human CVCL_B8NG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9644; PTPN11; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996359 CVCL_B8NJ Abcam HCT 116 RAD50 KO cancer cell line human CVCL_B8NJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9816; RAD50; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996360 CVCL_B8NI Abcam HCT 116 PTPN6 KO cancer cell line human CVCL_B8NI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9658; PTPN6; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996361 CVCL_B8NL Abcam HCT 116 RAET1E KO cancer cell line human CVCL_B8NL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16793; RAET1E; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996362 CVCL_B8NK Abcam HCT 116 RAD51D KO cancer cell line human CVCL_B8NK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9823; RAD51D; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996363 CVCL_B8NB Abcam HCT 116 PTEN KO cancer cell line human CVCL_B8NB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9588; PTEN; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996364 CVCL_B8NA Abcam HCT 116 PTCH2 KO cancer cell line human CVCL_B8NA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9586; PTCH2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996365 CVCL_B8ND Abcam HCT 116 PTK6 KO cancer cell line human CVCL_B8ND CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9617; PTK6; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996366 CVCL_B8NC Abcam HCT 116 PTGS1 KO cancer cell line human CVCL_B8NC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9604; PTGS1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996367 CVCL_B8MU Abcam HCT 116 POU5F1 KO cancer cell line human CVCL_B8MU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9221; POU5F1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996368 CVCL_B8N6 Abcam HCT 116 PROCR KO cancer cell line human CVCL_B8N6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9452; PROCR; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996369 CVCL_B8MT Abcam HCT 116 POU2F2 KO cancer cell line human CVCL_B8MT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9213; POU2F2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996370 CVCL_B8N5 Abcam HCT 116 PRKCB KO cancer cell line human CVCL_B8N5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9395; PRKCB; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996371 CVCL_B8MW Abcam HCT 116 PPARD KO cancer cell line human CVCL_B8MW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9235; PPARD; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996372 CVCL_B8N8 Abcam HCT 116 PROX1 KO cancer cell line human CVCL_B8N8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9459; PROX1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996373 CVCL_B8MV Abcam HCT 116 PPARA KO cancer cell line human CVCL_B8MV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9232; PPARA; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996374 CVCL_B8N7 Abcam HCT 116 PROM1 KO cancer cell line human CVCL_B8N7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9454; PROM1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996375 CVCL_B8MY Abcam HCT 116 PRDM1 KO cancer cell line human CVCL_B8MY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9346; PRDM1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996376 CVCL_B8MX Abcam HCT 116 PPARG KO cancer cell line human CVCL_B8MX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9236; PPARG; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996377 CVCL_B8N9 Abcam HCT 116 PTCH1 KO cancer cell line human CVCL_B8N9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9585; PTCH1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996378 CVCL_B8MZ Abcam HCT 116 PRDM16 KO cancer cell line human CVCL_B8MZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14000; PRDM16; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996379 CVCL_B8KK Abcam HCT 116 MLH1 KO cancer cell line human CVCL_B8KK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7127; MLH1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996380 CVCL_B8KJ Abcam HCT 116 MKI67 KO cancer cell line human CVCL_B8KJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7107; MKI67; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996381 CVCL_B8KM Abcam HCT 116 MMP12 KO cancer cell line human CVCL_B8KM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7158; MMP12; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996382 CVCL_B8KL Abcam HCT 116 MMP1 KO cancer cell line human CVCL_B8KL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7155; MMP1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996383 CVCL_B8L0 Abcam HCT 116 MUC16 KO cancer cell line human CVCL_B8L0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15582; MUC16; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996384 CVCL_B8KN Abcam HCT 116 MMP2 KO cancer cell line human CVCL_B8KN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7166; MMP2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996385 CVCL_B8KQ Abcam HCT 116 MPO KO cancer cell line human CVCL_B8KQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7218; MPO; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996386 CVCL_B8L2 Abcam HCT 116 MYD88 KO cancer cell line human CVCL_B8L2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7562; MYD88; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996387 CVCL_B8KP Abcam HCT 116 MMP9 KO cancer cell line human CVCL_B8KP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7176; MMP9; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996388 CVCL_B8L1 Abcam HCT 116 MYB KO cancer cell line human CVCL_B8L1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7545; MYB; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996389 CVCL_B8KC Abcam HCT 116 MEF2C KO cancer cell line human CVCL_B8KC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6996; MEF2C; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996390 CVCL_B8KB Abcam HCT 116 MEF2A KO cancer cell line human CVCL_B8KB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6993; MEF2A; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996391 CVCL_B8KE Abcam HCT 116 MET KO cancer cell line human CVCL_B8KE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7029; MET; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996392 CVCL_B8KD Abcam HCT 116 MEN1 KO cancer cell line human CVCL_B8KD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7010; MEN1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996393 CVCL_B8KG Abcam HCT 116 MICA KO cancer cell line human CVCL_B8KG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7090; MICA; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996394 CVCL_B8KF Abcam HCT 116 MGMT KO cancer cell line human CVCL_B8KF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7059; MGMT; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996395 CVCL_B8KI Abcam HCT 116 MITF KO cancer cell line human CVCL_B8KI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7105; MITF; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996396 CVCL_B8KH Abcam HCT 116 MICB KO cancer cell line human CVCL_B8KH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7091; MICB; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996397 CVCL_B8JZ Abcam HCT 116 MAP2K1 KO cancer cell line human CVCL_B8JZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6840; MAP2K1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996398 CVCL_B8JY Abcam HCT 116 MALT1 KO cancer cell line human CVCL_B8JY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6819; MALT1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996399 CVCL_B8KA Abcam HCT 116 MED12 KO cancer cell line human CVCL_B8KA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11957; MED12; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996400 CVCL_B8JR Abcam HCT 116 LILRB1 KO cancer cell line human CVCL_B8JR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6605; LILRB1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996401 CVCL_B8K3 Abcam HCT 116 MAP3K7 KO cancer cell line human CVCL_B8K3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6859; MAP3K7; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996402 CVCL_B8JQ Abcam HCT 116 LGR5 KO cancer cell line human CVCL_B8JQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4504; LGR5; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996403 CVCL_B8K2 Abcam HCT 116 MAP3K11 KO cancer cell line human CVCL_B8K2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6850; MAP3K11; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996404 CVCL_B8JT Abcam HCT 116 LIN28B KO cancer cell line human CVCL_B8JT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32207; LIN28B; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996405 CVCL_B8K5 Abcam HCT 116 MAPK14 KO cancer cell line human CVCL_B8K5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6876; MAPK14; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996406 CVCL_B8JS Abcam HCT 116 LIN28A KO cancer cell line human CVCL_B8JS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15986; LIN28A; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996407 CVCL_B8K4 Abcam HCT 116 MAPK1 KO cancer cell line human CVCL_B8K4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6871; MAPK1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996408 CVCL_B8JV Abcam HCT 116 LRP5 KO cancer cell line human CVCL_B8JV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6697; LRP5; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996409 CVCL_B8K7 Abcam HCT 116 MDC1 KO cancer cell line human CVCL_B8K7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21163; MDC1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996410 CVCL_B8JU Abcam HCT 116 LMNA KO cancer cell line human CVCL_B8JU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6636; LMNA; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996411 CVCL_B8K6 Abcam HCT 116 MAPK3 KO cancer cell line human CVCL_B8K6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6877; MAPK3; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996412 CVCL_B8JX Abcam HCT 116 MAF KO cancer cell line human CVCL_B8JX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6776; MAF; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996413 CVCL_B8K9 Abcam HCT 116 MECP2 KO cancer cell line human CVCL_B8K9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6990; MECP2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996414 CVCL_B8JW Abcam HCT 116 LYN KO cancer cell line human CVCL_B8JW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6735; LYN; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996415 CVCL_B8K8 Abcam HCT 116 MECOM KO cancer cell line human CVCL_B8K8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3498; MECOM; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996416 CVCL_B8LL Abcam HCT 116 NR1H3 KO cancer cell line human CVCL_B8LL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7966; NR1H3; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996417 CVCL_B8LK Abcam HCT 116 NOTCH2 KO cancer cell line human CVCL_B8LK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7882; NOTCH2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996418 CVCL_B8LN Abcam HCT 116 NR4A3 KO cancer cell line human CVCL_B8LN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7982; NR4A3; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996419 CVCL_B8LM Abcam HCT 116 NR4A1 KO cancer cell line human CVCL_B8LM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7980; NR4A1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996420 CVCL_B8LP Abcam HCT 116 NRAS KO cancer cell line human CVCL_B8LP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7989; NRAS; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996421 CVCL_B8M1 Abcam HCT 116 PAX5 KO cancer cell line human CVCL_B8M1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8619; PAX5; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996422 CVCL_B8M0 Abcam HCT 116 PARP3 KO cancer cell line human CVCL_B8M0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:273; PARP3; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996423 CVCL_B8LR Abcam HCT 116 NTRK2 KO cancer cell line human CVCL_B8LR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8032; NTRK2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996424 CVCL_B8M3 Abcam HCT 116 PAX7 KO cancer cell line human CVCL_B8M3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8621; PAX7; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996425 CVCL_B8LQ Abcam HCT 116 NSD2 KO cancer cell line human CVCL_B8LQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12766; NSD2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996426 CVCL_B8M2 Abcam HCT 116 PAX6 KO cancer cell line human CVCL_B8M2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8620; PAX6; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996427 CVCL_B8LD Abcam HCT 116 NF1 KO cancer cell line human CVCL_B8LD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7765; NF1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996428 CVCL_B8LC Abcam HCT 116 NECTIN3 KO cancer cell line human CVCL_B8LC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17664; NECTIN3; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996429 CVCL_B8LF Abcam HCT 116 NFATC1 KO cancer cell line human CVCL_B8LF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7775; NFATC1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996430 CVCL_B8LE Abcam HCT 116 NF2 KO cancer cell line human CVCL_B8LE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7773; NF2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996431 CVCL_B8LH Abcam HCT 116 NFE2L2 KO cancer cell line human CVCL_B8LH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7782; NFE2L2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996432 CVCL_B8LG Abcam HCT 116 NFATC2 KO cancer cell line human CVCL_B8LG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7776; NFATC2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996433 CVCL_B8LJ Abcam HCT 116 NOTCH1 KO cancer cell line human CVCL_B8LJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7881; NOTCH1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996434 CVCL_B8LI Abcam HCT 116 NOS2 KO cancer cell line human CVCL_B8LI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7873; NOS2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996435 CVCL_B8KZ Abcam HCT 116 MUC1 KO cancer cell line human CVCL_B8KZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7508; MUC1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996436 CVCL_B8LB Abcam HCT 116 NECTIN2 KO cancer cell line human CVCL_B8LB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9707; NECTIN2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996437 CVCL_B8LA Abcam HCT 116 NCR1 KO cancer cell line human CVCL_B8LA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6731; NCR1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996438 CVCL_B8KS Abcam HCT 116 MRE11 KO cancer cell line human CVCL_B8KS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7230; MRE11; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996439 CVCL_B8L4 Abcam HCT 116 NANOG KO cancer cell line human CVCL_B8L4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20857; NANOG; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996440 CVCL_B8KR Abcam HCT 116 MRC1 KO cancer cell line human CVCL_B8KR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7228; MRC1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996441 CVCL_B8L3 Abcam HCT 116 MYOD1 KO cancer cell line human CVCL_B8L3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7611; MYOD1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996442 CVCL_B8KU Abcam HCT 116 MSH3 KO cancer cell line human CVCL_B8KU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7326; MSH3; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996443 CVCL_B8L6 Abcam HCT 116 NCAM1 KO cancer cell line human CVCL_B8L6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7656; NCAM1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996444 CVCL_B8KT Abcam HCT 116 MSH2 KO cancer cell line human CVCL_B8KT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7325; MSH2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996445 CVCL_B8L5 Abcam HCT 116 NBN KO cancer cell line human CVCL_B8L5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7652; NBN; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996446 CVCL_B8KW Abcam HCT 116 MSLN KO cancer cell line human CVCL_B8KW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7371; MSLN; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996447 CVCL_B8L8 Abcam HCT 116 NCF4 KO cancer cell line human CVCL_B8L8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7662; NCF4; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996448 CVCL_B8KV Abcam HCT 116 MSH6 KO cancer cell line human CVCL_B8KV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7329; MSH6; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996449 CVCL_B8L7 Abcam HCT 116 NCAM2 KO cancer cell line human CVCL_B8L7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7657; NCAM2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996450 CVCL_B8KY Abcam HCT 116 MTA2 KO cancer cell line human CVCL_B8KY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7411; MTA2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996451 CVCL_B8KX Abcam HCT 116 MSR1 KO cancer cell line human CVCL_B8KX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7376; MSR1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996452 CVCL_B8L9 Abcam HCT 116 NCOA1 KO cancer cell line human CVCL_B8L9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7668; NCOA1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996453 CVCL_B8II Abcam HCT 116 IL7R KO cancer cell line human CVCL_B8II CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6024; IL7R; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996454 CVCL_B8IH Abcam HCT 116 IL6R KO cancer cell line human CVCL_B8IH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6019; IL6R; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996455 CVCL_B8IK Abcam HCT 116 INPP5D KO cancer cell line human CVCL_B8IK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6079; INPP5D; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996456 CVCL_B8IJ Abcam HCT 116 IL9 KO cancer cell line human CVCL_B8IJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6029; IL9; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996457 CVCL_B8IM Abcam HCT 116 IRAK1 KO cancer cell line human CVCL_B8IM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6112; IRAK1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996458 CVCL_B8IL Abcam HCT 116 IQGAP1 KO cancer cell line human CVCL_B8IL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6110; IQGAP1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996459 CVCL_B8J0 Abcam HCT 116 JARID2 KO cancer cell line human CVCL_B8J0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6196; JARID2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996460 CVCL_B8IN Abcam HCT 116 IRAK4 KO cancer cell line human CVCL_B8IN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17967; IRAK4; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996461 CVCL_B8IA Abcam HCT 116 IL1A KO cancer cell line human CVCL_B8IA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5991; IL1A; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996462 CVCL_B8IC Abcam HCT 116 IL23A KO cancer cell line human CVCL_B8IC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15488; IL23A; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996463 CVCL_B8IB Abcam HCT 116 IL1B KO cancer cell line human CVCL_B8IB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5992; IL1B; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996464 CVCL_B8IE Abcam HCT 116 IL27 KO cancer cell line human CVCL_B8IE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19157; IL27; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996465 CVCL_B8ID Abcam HCT 116 IL23R KO cancer cell line human CVCL_B8ID CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19100; IL23R; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996466 CVCL_B8IG Abcam HCT 116 IL3RA KO cancer cell line human CVCL_B8IG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6012; IL3RA; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996467 CVCL_B8IF Abcam HCT 116 IL2RB KO cancer cell line human CVCL_B8IF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6009; IL2RB; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996468 CVCL_B8HX Abcam HCT 116 IFNGR1 KO cancer cell line human CVCL_B8HX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5439; IFNGR1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996469 CVCL_B8I9 Abcam HCT 116 IL18 KO cancer cell line human CVCL_B8I9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5986; IL18; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996470 CVCL_B8HW Abcam HCT 116 IFNB1 KO cancer cell line human CVCL_B8HW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5434; IFNB1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996471 CVCL_B8I8 Abcam HCT 116 IL17A KO cancer cell line human CVCL_B8I8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5981; IL17A; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996472 CVCL_B8HZ Abcam HCT 116 IGF1 KO cancer cell line human CVCL_B8HZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5464; IGF1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996473 CVCL_B8HY Abcam HCT 116 IFNGR2 KO cancer cell line human CVCL_B8HY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5440; IFNGR2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996474 CVCL_B8HP Abcam HCT 116 ICAM1 KO cancer cell line human CVCL_B8HP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5344; ICAM1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996475 CVCL_B8I1 Abcam HCT 116 IGF2BP1 KO cancer cell line human CVCL_B8I1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28866; IGF2BP1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996476 CVCL_B8I0 Abcam HCT 116 IGF1R KO cancer cell line human CVCL_B8I0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5465; IGF1R; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996477 CVCL_B8HR Abcam HCT 116 ICOSLG KO cancer cell line human CVCL_B8HR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17087; ICOSLG; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996478 CVCL_B8I3 Abcam HCT 116 IGF2BP3 KO cancer cell line human CVCL_B8I3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28868; IGF2BP3; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996479 CVCL_B8HQ Abcam HCT 116 ICOS KO cancer cell line human CVCL_B8HQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5351; ICOS; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996480 CVCL_B8I2 Abcam HCT 116 IGF2BP2 KO cancer cell line human CVCL_B8I2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28867; IGF2BP2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996481 CVCL_B8HT Abcam HCT 116 IDH2 KO cancer cell line human CVCL_B8HT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5383; IDH2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996482 CVCL_B8I5 Abcam HCT 116 IKBKE KO cancer cell line human CVCL_B8I5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14552; IKBKE; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996483 CVCL_B8HS Abcam HCT 116 IDH1 KO cancer cell line human CVCL_B8HS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5382; IDH1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996484 CVCL_B8I4 Abcam HCT 116 IHH KO cancer cell line human CVCL_B8I4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5956; IHH; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996485 CVCL_B8HV Abcam HCT 116 IFNAR1 KO cancer cell line human CVCL_B8HV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5432; IFNAR1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996486 CVCL_B8I7 Abcam HCT 116 IL15 KO cancer cell line human CVCL_B8I7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5977; IL15; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996487 CVCL_B8HU Abcam HCT 116 IFITM1 KO cancer cell line human CVCL_B8HU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5412; IFITM1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996488 CVCL_B8I6 Abcam HCT 116 IL12A KO cancer cell line human CVCL_B8I6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5969; IL12A; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996489 CVCL_B8JJ Abcam HCT 116 LAMP1 KO cancer cell line human CVCL_B8JJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6499; LAMP1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996490 CVCL_B8JI Abcam HCT 116 KRT1 KO cancer cell line human CVCL_B8JI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6412; KRT1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996491 CVCL_B8JL Abcam HCT 116 LATS2 KO cancer cell line human CVCL_B8JL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6515; LATS2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996492 CVCL_B8JK Abcam HCT 116 LATS1 KO cancer cell line human CVCL_B8JK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6514; LATS1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996493 CVCL_B8JN Abcam HCT 116 LGALS1 KO cancer cell line human CVCL_B8JN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6561; LGALS1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996494 CVCL_B8JM Abcam HCT 116 LCK KO cancer cell line human CVCL_B8JM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6524; LCK; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996495 CVCL_B8JP Abcam HCT 116 LGALS3 KO cancer cell line human CVCL_B8JP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6563; LGALS3; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996496 CVCL_B8K1 Abcam HCT 116 MAP2K4 KO cancer cell line human CVCL_B8K1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6844; MAP2K4; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996497 CVCL_B8K0 Abcam HCT 116 MAP2K2 KO cancer cell line human CVCL_B8K0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6842; MAP2K2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996498 CVCL_B8JB Abcam HCT 116 KITLG KO cancer cell line human CVCL_B8JB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6343; KITLG; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996499 CVCL_B8JA Abcam HCT 116 KIT KO cancer cell line human CVCL_B8JA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6342; KIT; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996500 CVCL_B8JD Abcam HCT 116 KLRB1 KO cancer cell line human CVCL_B8JD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6373; KLRB1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996501 CVCL_B8JC Abcam HCT 116 KLF4 KO cancer cell line human CVCL_B8JC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6348; KLF4; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996502 CVCL_B8JF Abcam HCT 116 KMT2A KO cancer cell line human CVCL_B8JF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7132; KMT2A; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996503 CVCL_B8JE Abcam HCT 116 KLRC1 KO cancer cell line human CVCL_B8JE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6374; KLRC1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996504 CVCL_B8JH Abcam HCT 116 KMT5A KO cancer cell line human CVCL_B8JH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29489; KMT5A; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996505 CVCL_B8JG Abcam HCT 116 KMT2D KO cancer cell line human CVCL_B8JG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7133; KMT2D; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996506 CVCL_B8IY Abcam HCT 116 JAK1 KO cancer cell line human CVCL_B8IY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6190; JAK1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996507 CVCL_B8IX Abcam HCT 116 ITPR1 KO cancer cell line human CVCL_B8IX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6180; ITPR1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996508 CVCL_B8J9 Abcam HCT 116 KEAP1 KO cancer cell line human CVCL_B8J9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23177; KEAP1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996509 CVCL_B8IZ Abcam HCT 116 JAK3 KO cancer cell line human CVCL_B8IZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6193; JAK3; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996510 CVCL_B8IQ Abcam HCT 116 ITGA2 KO cancer cell line human CVCL_B8IQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6137; ITGA2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996511 CVCL_B8J2 Abcam HCT 116 KAT2B KO cancer cell line human CVCL_B8J2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8638; KAT2B; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996512 CVCL_B8IP Abcam HCT 116 IRF4 KO cancer cell line human CVCL_B8IP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6119; IRF4; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996513 CVCL_B8J1 Abcam HCT 116 KAT2A KO cancer cell line human CVCL_B8J1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4201; KAT2A; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996514 CVCL_B8IS Abcam HCT 116 ITGAL KO cancer cell line human CVCL_B8IS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6148; ITGAL; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996515 CVCL_B8J4 Abcam HCT 116 KDM3A KO cancer cell line human CVCL_B8J4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20815; KDM3A; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996516 CVCL_B8IR Abcam HCT 116 ITGAE KO cancer cell line human CVCL_B8IR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6147; ITGAE; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996517 CVCL_B8J3 Abcam HCT 116 KDM1A KO cancer cell line human CVCL_B8J3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29079; KDM1A; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996518 CVCL_B8IU Abcam HCT 116 ITGAV KO cancer cell line human CVCL_B8IU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6150; ITGAV; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996519 CVCL_B8J6 Abcam HCT 116 KDM5B KO cancer cell line human CVCL_B8J6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18039; KDM5B; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996520 CVCL_B8IT Abcam HCT 116 ITGAM KO cancer cell line human CVCL_B8IT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6149; ITGAM; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996521 CVCL_B8J5 Abcam HCT 116 KDM5A KO cancer cell line human CVCL_B8J5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9886; KDM5A; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996522 CVCL_B8IW Abcam HCT 116 ITK KO cancer cell line human CVCL_B8IW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6171; ITK; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996523 CVCL_B8J8 Abcam HCT 116 KDR KO cancer cell line human CVCL_B8J8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6307; KDR; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996524 CVCL_B8IV Abcam HCT 116 ITGAX KO cancer cell line human CVCL_B8IV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6152; ITGAX; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996525 CVCL_B8J7 Abcam HCT 116 KDM6A KO cancer cell line human CVCL_B8J7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12637; KDM6A; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996526 CVCL_B8WW Abcam MCF-7 HNF1A KO cancer cell line human CVCL_B8WW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11621; HNF1A; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996527 CVCL_B8X8 Abcam MCF-7 IL12A KO cancer cell line human CVCL_B8X8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5969; IL12A; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996528 CVCL_B8WV Abcam MCF-7 HMGA2 KO cancer cell line human CVCL_B8WV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5009; HMGA2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996529 CVCL_B8X7 Abcam MCF-7 IGF2BP2 KO cancer cell line human CVCL_B8X7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28867; IGF2BP2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996530 CVCL_B8WY Abcam MCF-7 HRAS KO cancer cell line human CVCL_B8WY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5173; HRAS; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996531 CVCL_B8WX Abcam MCF-7 HOXA9 KO cancer cell line human CVCL_B8WX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5109; HOXA9; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996532 CVCL_B8X9 Abcam MCF-7 IL18 KO cancer cell line human CVCL_B8X9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5986; IL18; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996533 CVCL_B8WZ Abcam MCF-7 ICOS KO cancer cell line human CVCL_B8WZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5351; ICOS; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996534 CVCL_B8X0 Abcam MCF-7 IDH1 KO cancer cell line human CVCL_B8X0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5382; IDH1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996535 CVCL_B8WN Abcam MCF-7 HDAC6 KO cancer cell line human CVCL_B8WN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14064; HDAC6; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996536 CVCL_B8WQ Abcam MCF-7 HELQ KO cancer cell line human CVCL_B8WQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18536; HELQ; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996537 CVCL_B8X2 Abcam MCF-7 IFNB1 KO cancer cell line human CVCL_B8X2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5434; IFNB1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996538 CVCL_B8WP Abcam MCF-7 HDAC7 KO cancer cell line human CVCL_B8WP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14067; HDAC7; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996539 CVCL_B8X1 Abcam MCF-7 IDH2 KO cancer cell line human CVCL_B8X1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5383; IDH2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996540 CVCL_B8WS Abcam MCF-7 HGF KO cancer cell line human CVCL_B8WS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4893; HGF; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996541 CVCL_B8X4 Abcam MCF-7 IFNGR2 KO cancer cell line human CVCL_B8X4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5440; IFNGR2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996542 CVCL_B8WR Abcam MCF-7 HEY1 KO cancer cell line human CVCL_B8WR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4880; HEY1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996543 CVCL_B8X3 Abcam MCF-7 IFNGR1 KO cancer cell line human CVCL_B8X3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5439; IFNGR1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996544 CVCL_B8WU Abcam MCF-7 HLA-DRA KO cancer cell line human CVCL_B8WU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4947; HLA-DRA; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996545 CVCL_B8X6 Abcam MCF-7 IGF1R KO cancer cell line human CVCL_B8X6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5465; IGF1R; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996546 CVCL_B8WT Abcam MCF-7 HLA-A KO cancer cell line human CVCL_B8WT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996547 CVCL_B8X5 Abcam MCF-7 IGF1 KO cancer cell line human CVCL_B8X5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5464; IGF1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996548 CVCL_B8WG Abcam MCF-7 GSR KO cancer cell line human CVCL_B8WG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4623; GSR; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996549 CVCL_B8WF Abcam MCF-7 GSK3B KO cancer cell line human CVCL_B8WF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4617; GSK3B; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996550 CVCL_B8WI Abcam MCF-7 HCN1 KO cancer cell line human CVCL_B8WI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4845; HCN1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996551 CVCL_B8WH Abcam MCF-7 HAT1 KO cancer cell line human CVCL_B8WH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4821; HAT1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996552 CVCL_B8WK Abcam MCF-7 HDAC2 KO cancer cell line human CVCL_B8WK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4853; HDAC2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996553 CVCL_B8WJ Abcam MCF-7 HDAC1 KO cancer cell line human CVCL_B8WJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4852; HDAC1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996554 CVCL_B8WM Abcam MCF-7 HDAC5 KO cancer cell line human CVCL_B8WM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14068; HDAC5; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996555 CVCL_B8WL Abcam MCF-7 HDAC4 KO cancer cell line human CVCL_B8WL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14063; HDAC4; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996556 CVCL_B8WA Abcam MCF-7 GLI1 KO cancer cell line human CVCL_B8WA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4317; GLI1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996557 CVCL_B8WC Abcam MCF-7 GLS KO cancer cell line human CVCL_B8WC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4331; GLS; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996558 CVCL_B8WB Abcam MCF-7 GLI2 KO cancer cell line human CVCL_B8WB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4318; GLI2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996559 CVCL_B8WE Abcam MCF-7 GPNMB KO cancer cell line human CVCL_B8WE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4462; GPNMB; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996560 CVCL_B8WD Abcam MCF-7 GP1BA KO cancer cell line human CVCL_B8WD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4439; GP1BA; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996561 CVCL_B8XX Abcam MCF-7 KDM1A KO cancer cell line human CVCL_B8XX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29079; KDM1A; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996562 CVCL_B8Y9 Abcam MCF-7 LATS2 KO cancer cell line human CVCL_B8Y9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6515; LATS2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996563 CVCL_B8XW Abcam MCF-7 KAT2B KO cancer cell line human CVCL_B8XW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8638; KAT2B; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996564 CVCL_B8Y8 Abcam MCF-7 LATS1 KO cancer cell line human CVCL_B8Y8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6514; LATS1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996565 CVCL_B8XZ Abcam MCF-7 KDM5A KO cancer cell line human CVCL_B8XZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9886; KDM5A; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996566 CVCL_B8XY Abcam MCF-7 KDM3A KO cancer cell line human CVCL_B8XY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20815; KDM3A; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996567 CVCL_B8XP Abcam MCF-7 ITGAV KO cancer cell line human CVCL_B8XP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6150; ITGAV; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996568 CVCL_B8Y1 Abcam MCF-7 KDM6A KO cancer cell line human CVCL_B8Y1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12637; KDM6A; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996569 CVCL_B8Y0 Abcam MCF-7 KDM5B KO cancer cell line human CVCL_B8Y0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18039; KDM5B; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996570 CVCL_B8XR Abcam MCF-7 ITGB1 KO cancer cell line human CVCL_B8XR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6153; ITGB1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996571 CVCL_B8Y3 Abcam MCF-7 KEAP1 KO cancer cell line human CVCL_B8Y3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23177; KEAP1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996572 CVCL_B8XQ Abcam MCF-7 ITGAX KO cancer cell line human CVCL_B8XQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6152; ITGAX; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996573 CVCL_B8Y2 Abcam MCF-7 KDR KO cancer cell line human CVCL_B8Y2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6307; KDR; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996574 CVCL_B8XT Abcam MCF-7 ITPR1 KO cancer cell line human CVCL_B8XT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6180; ITPR1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996575 CVCL_B8Y5 Abcam MCF-7 KLF4 KO cancer cell line human CVCL_B8Y5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6348; KLF4; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996576 CVCL_B8XS Abcam MCF-7 ITK KO cancer cell line human CVCL_B8XS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6171; ITK; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996577 CVCL_B8Y4 Abcam MCF-7 KIT KO cancer cell line human CVCL_B8Y4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6342; KIT; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996578 CVCL_B8XV Abcam MCF-7 JAK3 KO cancer cell line human CVCL_B8XV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6193; JAK3; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996579 CVCL_B8Y7 Abcam MCF-7 KMT2D KO cancer cell line human CVCL_B8Y7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7133; KMT2D; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996580 CVCL_B8XU Abcam MCF-7 JAK1 KO cancer cell line human CVCL_B8XU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6190; JAK1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996581 CVCL_B8Y6 Abcam MCF-7 KMT2A KO cancer cell line human CVCL_B8Y6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7132; KMT2A; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996582 CVCL_B8XH Abcam MCF-7 INPP5D KO cancer cell line human CVCL_B8XH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6079; INPP5D; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996583 CVCL_B8XG Abcam MCF-7 IL7R KO cancer cell line human CVCL_B8XG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6024; IL7R; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996584 CVCL_B8XJ Abcam MCF-7 IRF4 KO cancer cell line human CVCL_B8XJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6119; IRF4; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996585 CVCL_B8XI Abcam MCF-7 IRAK4 KO cancer cell line human CVCL_B8XI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17967; IRAK4; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996586 CVCL_B8XL Abcam MCF-7 ITGAE KO cancer cell line human CVCL_B8XL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6147; ITGAE; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996587 CVCL_B8XK Abcam MCF-7 ITGA2 KO cancer cell line human CVCL_B8XK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6137; ITGA2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996588 CVCL_B8XN Abcam MCF-7 ITGAM KO cancer cell line human CVCL_B8XN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6149; ITGAM; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996589 CVCL_B8XM Abcam MCF-7 ITGAL KO cancer cell line human CVCL_B8XM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6148; ITGAL; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996590 CVCL_B8XB Abcam MCF-7 IL1B KO cancer cell line human CVCL_B8XB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5992; IL1B; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996591 CVCL_B8XA Abcam MCF-7 IL1A KO cancer cell line human CVCL_B8XA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5991; IL1A; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996592 CVCL_B8XD Abcam MCF-7 IL2RB KO cancer cell line human CVCL_B8XD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6009; IL2RB; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996593 CVCL_B8XC Abcam MCF-7 IL27 KO cancer cell line human CVCL_B8XC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19157; IL27; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996594 CVCL_B8XF Abcam MCF-7 IL6R KO cancer cell line human CVCL_B8XF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6019; IL6R; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996595 CVCL_B8XE Abcam MCF-7 IL3RA KO cancer cell line human CVCL_B8XE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6012; IL3RA; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996596 CVCL_B8UU Abcam MCF-7 DMC1 KO cancer cell line human CVCL_B8UU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2927; DMC1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996597 CVCL_B8V6 Abcam MCF-7 EHMT1 KO cancer cell line human CVCL_B8V6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24650; EHMT1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996598 CVCL_B8UT Abcam MCF-7 DGCR8 KO cancer cell line human CVCL_B8UT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2847; DGCR8; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996599 CVCL_B8V5 Abcam MCF-7 EGFR KO cancer cell line human CVCL_B8V5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3236; EGFR; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996600 CVCL_B8UW Abcam MCF-7 DNMT1 KO cancer cell line human CVCL_B8UW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2976; DNMT1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996601 CVCL_B8V8 Abcam MCF-7 EPC1 KO cancer cell line human CVCL_B8V8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19876; EPC1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996602 CVCL_B8UV Abcam MCF-7 DNAJB1 KO cancer cell line human CVCL_B8UV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5270; DNAJB1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996603 CVCL_B8V7 Abcam MCF-7 EP300 KO cancer cell line human CVCL_B8V7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3373; EP300; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996604 CVCL_B8UY Abcam MCF-7 DOT1L KO cancer cell line human CVCL_B8UY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24948; DOT1L; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996605 CVCL_B8UX Abcam MCF-7 DNMT3B KO cancer cell line human CVCL_B8UX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2979; DNMT3B; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996606 CVCL_B8V9 Abcam MCF-7 EPHA3 KO cancer cell line human CVCL_B8V9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3387; EPHA3; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996607 CVCL_B8UZ Abcam MCF-7 DROSHA KO cancer cell line human CVCL_B8UZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17904; DROSHA; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996608 CVCL_B8UM Abcam MCF-7 DCC KO cancer cell line human CVCL_B8UM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2701; DCC; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996609 CVCL_B8UL Abcam MCF-7 DAXX KO cancer cell line human CVCL_B8UL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2681; DAXX; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996610 CVCL_B8V0 Abcam MCF-7 DUSP4 KO cancer cell line human CVCL_B8V0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3070; DUSP4; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996611 CVCL_B8UN Abcam MCF-7 DDB2 KO cancer cell line human CVCL_B8UN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2718; DDB2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996612 CVCL_B8UQ Abcam MCF-7 DDR2 KO cancer cell line human CVCL_B8UQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2731; DDR2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996613 CVCL_B8V2 Abcam MCF-7 EBF1 KO cancer cell line human CVCL_B8V2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3126; EBF1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996614 CVCL_B8UP Abcam MCF-7 DDR1 KO cancer cell line human CVCL_B8UP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2730; DDR1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996615 CVCL_B8V1 Abcam MCF-7 E2F1 KO cancer cell line human CVCL_B8V1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3113; E2F1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996616 CVCL_B8US Abcam MCF-7 DEPTOR KO cancer cell line human CVCL_B8US CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22953; DEPTOR; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996617 CVCL_B8V4 Abcam MCF-7 EGF KO cancer cell line human CVCL_B8V4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3229; EGF; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996618 CVCL_B8UR Abcam MCF-7 DDX5 KO cancer cell line human CVCL_B8UR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2746; DDX5; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996619 CVCL_B8V3 Abcam MCF-7 EBI3 KO cancer cell line human CVCL_B8V3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3129; EBI3; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996620 CVCL_B8UE Abcam MCF-7 CSF3R KO cancer cell line human CVCL_B8UE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2439; CSF3R; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996621 CVCL_B8UD Abcam MCF-7 CSF1R KO cancer cell line human CVCL_B8UD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2433; CSF1R; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996622 CVCL_B8UG Abcam MCF-7 CTNNB1 KO cancer cell line human CVCL_B8UG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2514; CTNNB1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996623 CVCL_B8UF Abcam MCF-7 CTLA4 KO cancer cell line human CVCL_B8UF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2505; CTLA4; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996624 CVCL_B8UI Abcam MCF-7 CXCR4 KO cancer cell line human CVCL_B8UI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2561; CXCR4; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996625 CVCL_B8UH Abcam MCF-7 CXCR1 KO cancer cell line human CVCL_B8UH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6026; CXCR1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996626 CVCL_B8UK Abcam MCF-7 CYLD KO cancer cell line human CVCL_B8UK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2584; CYLD; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996627 CVCL_B8UJ Abcam MCF-7 CYBB KO cancer cell line human CVCL_B8UJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2578; CYBB; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996628 CVCL_B8UA Abcam MCF-7 CREB1 KO cancer cell line human CVCL_B8UA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2345; CREB1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996629 CVCL_B8UC Abcam MCF-7 CRLF2 KO cancer cell line human CVCL_B8UC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14281; CRLF2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996630 CVCL_B8UB Abcam MCF-7 CREBBP KO cancer cell line human CVCL_B8UB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2348; CREBBP; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996631 CVCL_B8VV Abcam MCF-7 FGFR4 KO cancer cell line human CVCL_B8VV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3691; FGFR4; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996632 CVCL_B8W7 Abcam MCF-7 GABRG2 KO cancer cell line human CVCL_B8W7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4087; GABRG2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996633 CVCL_B8VU Abcam MCF-7 FGFR2 KO cancer cell line human CVCL_B8VU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3689; FGFR2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996634 CVCL_B8W6 Abcam MCF-7 GABRA1 KO cancer cell line human CVCL_B8W6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4075; GABRA1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996635 CVCL_B8VX Abcam MCF-7 FLT1 KO cancer cell line human CVCL_B8VX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3763; FLT1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996636 CVCL_B8W9 Abcam MCF-7 GATA2 KO cancer cell line human CVCL_B8W9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4171; GATA2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996637 CVCL_B8VW Abcam MCF-7 FLI1 KO cancer cell line human CVCL_B8VW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3749; FLI1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996638 CVCL_B8W8 Abcam MCF-7 GATA1 KO cancer cell line human CVCL_B8W8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4170; GATA1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996639 CVCL_B8VZ Abcam MCF-7 FN1 KO cancer cell line human CVCL_B8VZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3778; FN1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996640 CVCL_B8VY Abcam MCF-7 FLT4 KO cancer cell line human CVCL_B8VY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3767; FLT4; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996641 CVCL_B8VN Abcam MCF-7 FBXO38 KO cancer cell line human CVCL_B8VN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28844; FBXO38; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996642 CVCL_B8VM Abcam MCF-7 FAS KO cancer cell line human CVCL_B8VM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11920; FAS; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996643 CVCL_B8VP Abcam MCF-7 FCER2 KO cancer cell line human CVCL_B8VP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3612; FCER2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996644 CVCL_B8W1 Abcam MCF-7 FOSL1 KO cancer cell line human CVCL_B8W1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13718; FOSL1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996645 CVCL_B8W0 Abcam MCF-7 FOS KO cancer cell line human CVCL_B8W0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3796; FOS; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996646 CVCL_B8VR Abcam MCF-7 FCGR2B KO cancer cell line human CVCL_B8VR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3618; FCGR2B; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996647 CVCL_B8W3 Abcam MCF-7 FOXO4 KO cancer cell line human CVCL_B8W3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7139; FOXO4; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996648 CVCL_B8VQ Abcam MCF-7 FCGR2A KO cancer cell line human CVCL_B8VQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3616; FCGR2A; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996649 CVCL_B8W2 Abcam MCF-7 FOXM1 KO cancer cell line human CVCL_B8W2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3818; FOXM1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996650 CVCL_B8VT Abcam MCF-7 FEN1 KO cancer cell line human CVCL_B8VT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3650; FEN1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996651 CVCL_B8W5 Abcam MCF-7 FTO KO cancer cell line human CVCL_B8W5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24678; FTO; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996652 CVCL_B8VS Abcam MCF-7 FCGR3A KO cancer cell line human CVCL_B8VS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3619; FCGR3A; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996653 CVCL_B8W4 Abcam MCF-7 FOXP1 KO cancer cell line human CVCL_B8W4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3823; FOXP1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996654 CVCL_B8VF Abcam MCF-7 ERCC5 KO cancer cell line human CVCL_B8VF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3437; ERCC5; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996655 CVCL_B8VE Abcam MCF-7 ERCC4 KO cancer cell line human CVCL_B8VE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3436; ERCC4; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996656 CVCL_B8VH Abcam MCF-7 ETS1 KO cancer cell line human CVCL_B8VH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3488; ETS1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996657 CVCL_B8VG Abcam MCF-7 ESR1 KO cancer cell line human CVCL_B8VG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3467; ESR1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996658 CVCL_B8VJ Abcam MCF-7 EZH1 KO cancer cell line human CVCL_B8VJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3526; EZH1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996659 CVCL_B8VI Abcam MCF-7 ETV6 KO cancer cell line human CVCL_B8VI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3495; ETV6; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996660 CVCL_B8VL Abcam MCF-7 FANCD2 KO cancer cell line human CVCL_B8VL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3585; FANCD2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996661 CVCL_B8VK Abcam MCF-7 FANCA KO cancer cell line human CVCL_B8VK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3582; FANCA; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996662 CVCL_B8VB Abcam MCF-7 ERBB2 KO cancer cell line human CVCL_B8VB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3430; ERBB2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996663 CVCL_B8VA Abcam MCF-7 EPHB2 KO cancer cell line human CVCL_B8VA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3393; EPHB2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996664 CVCL_B8VD Abcam MCF-7 ERBB4 KO cancer cell line human CVCL_B8VD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3432; ERBB4; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996665 CVCL_B8VC Abcam MCF-7 ERBB3 KO cancer cell line human CVCL_B8VC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3431; ERBB3; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996666 CVCL_B8SS Abcam MCF-7 BAX KO cancer cell line human CVCL_B8SS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:959; BAX; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996667 CVCL_B8T4 Abcam MCF-7 BRD3 KO cancer cell line human CVCL_B8T4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1104; BRD3; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996668 CVCL_B8SR Abcam MCF-7 BARD1 KO cancer cell line human CVCL_B8SR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:952; BARD1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996669 CVCL_B8T3 Abcam MCF-7 BRCA2 KO cancer cell line human CVCL_B8T3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1101; BRCA2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996670 CVCL_B8SU Abcam MCF-7 BCL11A KO cancer cell line human CVCL_B8SU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13221; BCL11A; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996671 CVCL_B8T6 Abcam MCF-7 BRIP1 KO cancer cell line human CVCL_B8T6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20473; BRIP1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996672 CVCL_B8ST Abcam MCF-7 BCL10 KO cancer cell line human CVCL_B8ST CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:989; BCL10; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996673 CVCL_B8T5 Abcam MCF-7 BRD7 KO cancer cell line human CVCL_B8T5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14310; BRD7; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996674 CVCL_B8SW Abcam MCF-7 BCL2 KO cancer cell line human CVCL_B8SW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:990; BCL2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996675 CVCL_B8T8 Abcam MCF-7 CALR KO cancer cell line human CVCL_B8T8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1455; CALR; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996676 CVCL_B8SV Abcam MCF-7 BCL11B KO cancer cell line human CVCL_B8SV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13222; BCL11B; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996677 CVCL_B8T7 Abcam MCF-7 CA9 KO cancer cell line human CVCL_B8T7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1383; CA9; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996678 CVCL_B8SY Abcam MCF-7 BCL6 KO cancer cell line human CVCL_B8SY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1001; BCL6; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996679 CVCL_B8SX Abcam MCF-7 BCL3 KO cancer cell line human CVCL_B8SX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:998; BCL3; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996680 CVCL_B8T9 Abcam MCF-7 CARD11 KO cancer cell line human CVCL_B8T9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16393; CARD11; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996681 CVCL_B8SK Abcam MCF-7 ARID1B KO cancer cell line human CVCL_B8SK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18040; ARID1B; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996682 CVCL_B8SJ Abcam MCF-7 ARID1A KO cancer cell line human CVCL_B8SJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11110; ARID1A; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996683 CVCL_B8SM Abcam MCF-7 ATF2 KO cancer cell line human CVCL_B8SM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:784; ATF2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996684 CVCL_B8SL Abcam MCF-7 ARNT KO cancer cell line human CVCL_B8SL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:700; ARNT; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996685 CVCL_B8T0 Abcam MCF-7 BMPR1A KO cancer cell line human CVCL_B8T0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1076; BMPR1A; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996686 CVCL_B8SN Abcam MCF-7 ATRX KO cancer cell line human CVCL_B8SN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:886; ATRX; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996687 CVCL_B8SQ Abcam MCF-7 B2M KO cancer cell line human CVCL_B8SQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996688 CVCL_B8T2 Abcam MCF-7 BRCA1 KO cancer cell line human CVCL_B8T2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1100; BRCA1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996689 CVCL_B8SP Abcam MCF-7 AXIN1 KO cancer cell line human CVCL_B8SP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:903; AXIN1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996690 CVCL_B8T1 Abcam MCF-7 BRAF KO cancer cell line human CVCL_B8T1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1097; BRAF; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996691 CVCL_B8SC Abcam MCF-7 ALKBH5 KO cancer cell line human CVCL_B8SC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25996; ALKBH5; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996692 CVCL_B8SB Abcam MCF-7 AKT3 KO cancer cell line human CVCL_B8SB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:393; AKT3; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996693 CVCL_B8SE Abcam MCF-7 ANGPT2 KO cancer cell line human CVCL_B8SE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:485; ANGPT2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996694 CVCL_B8SD Abcam MCF-7 ANGPT1 KO cancer cell line human CVCL_B8SD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:484; ANGPT1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996695 CVCL_B8SG Abcam MCF-7 AQP4 KO cancer cell line human CVCL_B8SG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:637; AQP4; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996696 CVCL_B8SF Abcam MCF-7 ANXA1 KO cancer cell line human CVCL_B8SF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:533; ANXA1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996697 CVCL_B8SI Abcam MCF-7 ARAF KO cancer cell line human CVCL_B8SI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:646; ARAF; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996698 CVCL_B8SH Abcam MCF-7 AR KO cancer cell line human CVCL_B8SH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:381; AKR1B1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996699 CVCL_B8RZ Abcam HCT 116 ZBTB16 KO cancer cell line human CVCL_B8RZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12930; ZBTB16; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996700 CVCL_B8RY Abcam HCT 116 YWHAB KO cancer cell line human CVCL_B8RY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12849; YWHAB; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996701 CVCL_B8SA Abcam MCF-7 AKT2 KO cancer cell line human CVCL_B8SA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:392; AKT2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996702 CVCL_B8TT Abcam MCF-7 CD86 KO cancer cell line human CVCL_B8TT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1705; CD86; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996703 CVCL_B8U5 Abcam MCF-7 CHD9 KO cancer cell line human CVCL_B8U5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25701; CHD9; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996704 CVCL_B8TS Abcam MCF-7 CD80 KO cancer cell line human CVCL_B8TS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1700; CD80; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996705 CVCL_B8U4 Abcam MCF-7 CHD5 KO cancer cell line human CVCL_B8U4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16816; CHD5; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996706 CVCL_B8TV Abcam MCF-7 CDK2 KO cancer cell line human CVCL_B8TV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1771; CDK2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996707 CVCL_B8U7 Abcam MCF-7 CLOCK KO cancer cell line human CVCL_B8U7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2082; CLOCK; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996708 CVCL_B8TU Abcam MCF-7 CDH11 KO cancer cell line human CVCL_B8TU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1750; CDH11; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996709 CVCL_B8U6 Abcam MCF-7 CHUK KO cancer cell line human CVCL_B8U6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1974; CHUK; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996710 CVCL_B8TX Abcam MCF-7 CDK6 KO cancer cell line human CVCL_B8TX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1777; CDK6; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996711 CVCL_B8U9 Abcam MCF-7 COL1A1 KO cancer cell line human CVCL_B8U9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2197; COL1A1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996712 CVCL_B8TW Abcam MCF-7 CDK5 KO cancer cell line human CVCL_B8TW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1774; CDK5; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996713 CVCL_B8U8 Abcam MCF-7 CNTNAP2 KO cancer cell line human CVCL_B8U8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13830; CNTNAP2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996714 CVCL_B8TZ Abcam MCF-7 CDKN1A KO cancer cell line human CVCL_B8TZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1784; CDKN1A; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996715 CVCL_B8TY Abcam MCF-7 CDK8 KO cancer cell line human CVCL_B8TY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1779; CDK8; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996716 CVCL_B8TL Abcam MCF-7 CD209 KO cancer cell line human CVCL_B8TL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1641; CD209; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996717 CVCL_B8TK Abcam MCF-7 CD19 KO cancer cell line human CVCL_B8TK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1633; CD19; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996718 CVCL_B8TN Abcam MCF-7 CD3E KO cancer cell line human CVCL_B8TN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1674; CD3E; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996719 CVCL_B8TM Abcam MCF-7 CD28 KO cancer cell line human CVCL_B8TM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1653; CD28; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996720 CVCL_B8TP Abcam MCF-7 CD4 KO cancer cell line human CVCL_B8TP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1678; CD4; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996721 CVCL_B8U1 Abcam MCF-7 CDX2 KO cancer cell line human CVCL_B8U1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1806; CDX2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996722 CVCL_B8U0 Abcam MCF-7 CDKN1B KO cancer cell line human CVCL_B8U0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1785; CDKN1B; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996723 CVCL_B8TR Abcam MCF-7 CD79A KO cancer cell line human CVCL_B8TR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1698; CD79A; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996724 CVCL_B8U3 Abcam MCF-7 CEBPA KO cancer cell line human CVCL_B8U3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1833; CEBPA; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996725 CVCL_B8TQ Abcam MCF-7 CD74 KO cancer cell line human CVCL_B8TQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1697; CD74; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996726 CVCL_B8U2 Abcam MCF-7 CEACAM5 KO cancer cell line human CVCL_B8U2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1817; CEACAM5; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996727 CVCL_B8TD Abcam MCF-7 CBLB KO cancer cell line human CVCL_B8TD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1542; CBLB; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996728 CVCL_B8TC Abcam MCF-7 CBL KO cancer cell line human CVCL_B8TC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1541; CBL; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996729 CVCL_B8TF Abcam MCF-7 CCNE1 KO cancer cell line human CVCL_B8TF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1589; CCNE1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996730 CVCL_B8TE Abcam MCF-7 CCND2 KO cancer cell line human CVCL_B8TE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1583; CCND2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996731 CVCL_B8TH Abcam MCF-7 CCR6 KO cancer cell line human CVCL_B8TH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1607; CCR6; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996732 CVCL_B8TG Abcam MCF-7 CCR4 KO cancer cell line human CVCL_B8TG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1605; CCR4; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996733 CVCL_B8TJ Abcam MCF-7 CD14 KO cancer cell line human CVCL_B8TJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1628; CD14; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996734 CVCL_B8TI Abcam MCF-7 CCR7 KO cancer cell line human CVCL_B8TI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1608; CCR7; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996735 CVCL_B8SZ Abcam MCF-7 BLM KO cancer cell line human CVCL_B8SZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1058; BLM; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996736 CVCL_B8TB Abcam MCF-7 CASP8 KO cancer cell line human CVCL_B8TB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1509; CASP8; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996737 CVCL_B8TA Abcam MCF-7 CARM1 KO cancer cell line human CVCL_B8TA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23393; CARM1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996738 CVCL_B8QQ Abcam HCT 116 TFAP2A KO cancer cell line human CVCL_B8QQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11742; TFAP2A; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996739 CVCL_B8R2 Abcam HCT 116 TMEM173 KO cancer cell line human CVCL_B8R2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27962; STING1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996740 CVCL_B8QP Abcam HCT 116 TET3 KO cancer cell line human CVCL_B8QP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28313; TET3; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996741 CVCL_B8R1 Abcam HCT 116 TLR7 KO cancer cell line human CVCL_B8R1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15631; TLR7; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996742 CVCL_B8QS Abcam HCT 116 TGFBR1 KO cancer cell line human CVCL_B8QS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11772; TGFBR1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996743 CVCL_B8R4 Abcam HCT 116 TNFRSF18 KO cancer cell line human CVCL_B8R4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11914; TNFRSF18; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996744 CVCL_B8QR Abcam HCT 116 TGFB1 KO cancer cell line human CVCL_B8QR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11766; TGFB1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996745 CVCL_B8R3 Abcam HCT 116 TNFRSF17 KO cancer cell line human CVCL_B8R3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11913; TNFRSF17; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996746 CVCL_B8QU Abcam HCT 116 THBD KO cancer cell line human CVCL_B8QU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11784; THBD; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996747 CVCL_B8R6 Abcam HCT 116 TNFRSF8 KO cancer cell line human CVCL_B8R6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11923; TNFRSF8; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996748 CVCL_B8QT Abcam HCT 116 TGFBR2 KO cancer cell line human CVCL_B8QT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11773; TGFBR2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996749 CVCL_B8R5 Abcam HCT 116 TNFRSF4 KO cancer cell line human CVCL_B8R5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11918; TNFRSF4; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996750 CVCL_B8QW Abcam HCT 116 TLR1 KO cancer cell line human CVCL_B8QW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11847; TLR1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996751 CVCL_B8R8 Abcam HCT 116 TNFSF11 KO cancer cell line human CVCL_B8R8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11926; TNFSF11; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996752 CVCL_B8QV Abcam HCT 116 TIA1 KO cancer cell line human CVCL_B8QV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11802; TIA1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996753 CVCL_B8R7 Abcam HCT 116 TNFRSF9 KO cancer cell line human CVCL_B8R7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11924; TNFRSF9; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996754 CVCL_B8QI Abcam HCT 116 TBX21 KO cancer cell line human CVCL_B8QI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11599; TBX21; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996755 CVCL_B8QH Abcam HCT 116 TAFFAZIN KO cancer cell line human CVCL_B8QH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11577; TAFAZZIN; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996756 CVCL_B8QK Abcam HCT 116 TEK KO cancer cell line human CVCL_B8QK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11724; TEK; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996757 CVCL_B8QJ Abcam HCT 116 TDO2 KO cancer cell line human CVCL_B8QJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11708; TDO2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996758 CVCL_B8QM Abcam HCT 116 TET1 KO cancer cell line human CVCL_B8QM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29484; TET1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996759 CVCL_B8QL Abcam HCT 116 TERT KO cancer cell line human CVCL_B8QL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11730; TERT; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996760 CVCL_B8R0 Abcam HCT 116 TLR6 KO cancer cell line human CVCL_B8R0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16711; TLR6; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996761 CVCL_B8QN Abcam HCT 116 TET2 KO cancer cell line human CVCL_B8QN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25941; TET2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996762 CVCL_B8QA Abcam HCT 116 STAT3 KO cancer cell line human CVCL_B8QA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11364; STAT3; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996763 CVCL_B8QC Abcam HCT 116 STAT6 KO cancer cell line human CVCL_B8QC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11368; STAT6; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996764 CVCL_B8QB Abcam HCT 116 STAT5B KO cancer cell line human CVCL_B8QB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11367; STAT5B; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996765 CVCL_B8QE Abcam HCT 116 SUFU KO cancer cell line human CVCL_B8QE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16466; SUFU; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996766 CVCL_B8QD Abcam HCT 116 STK11 KO cancer cell line human CVCL_B8QD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11389; STK11; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996767 CVCL_B8QG Abcam HCT 116 TACSTD2 KO cancer cell line human CVCL_B8QG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11530; TACSTD2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996768 CVCL_B8QF Abcam HCT 116 SYK KO cancer cell line human CVCL_B8QF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11491; SYK; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996769 CVCL_B8PX Abcam HCT 116 SOX11 KO cancer cell line human CVCL_B8PX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11191; SOX11; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996770 CVCL_B8Q9 Abcam HCT 116 STAG2 KO cancer cell line human CVCL_B8Q9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11355; STAG2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996771 CVCL_B8PW Abcam HCT 116 SOX10 KO cancer cell line human CVCL_B8PW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11190; SOX10; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996772 CVCL_B8Q8 Abcam HCT 116 SS18 KO cancer cell line human CVCL_B8Q8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11340; SS18; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996773 CVCL_B8PZ Abcam HCT 116 SOX2 KO cancer cell line human CVCL_B8PZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11195; SOX2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996774 CVCL_B8PY Abcam HCT 116 SOX17 KO cancer cell line human CVCL_B8PY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18122; SOX17; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996775 CVCL_B8RR Abcam HCT 116 VTCN1 KO cancer cell line human CVCL_B8RR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28873; VTCN1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996776 CVCL_B8S3 Abcam MCF-7 ACKR3 KO cancer cell line human CVCL_B8S3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23692; ACKR3; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996777 CVCL_B8RQ Abcam HCT 116 VSIR KO cancer cell line human CVCL_B8RQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30085; VSIR; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996778 CVCL_B8S2 Abcam MCF-7 ABL2 KO cancer cell line human CVCL_B8S2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:77; ABL2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996779 CVCL_B8RT Abcam HCT 116 WWTR1 KO cancer cell line human CVCL_B8RT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24042; WWTR1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996780 CVCL_B8S5 Abcam MCF-7 ACVR1B KO cancer cell line human CVCL_B8S5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:172; ACVR1B; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996781 CVCL_B8RS Abcam HCT 116 WT1 KO cancer cell line human CVCL_B8RS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12796; WT1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996782 CVCL_B8S4 Abcam MCF-7 ACTA2 KO cancer cell line human CVCL_B8S4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:130; ACTA2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996783 CVCL_B8RV Abcam HCT 116 XIAP KO cancer cell line human CVCL_B8RV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:592; XIAP; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996784 CVCL_B8S7 Abcam MCF-7 ADRB2 KO cancer cell line human CVCL_B8S7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:286; ADRB2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996785 CVCL_B8RU Abcam HCT 116 WNT3A KO cancer cell line human CVCL_B8RU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15983; WNT3A; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996786 CVCL_B8S6 Abcam MCF-7 ADAM10 KO cancer cell line human CVCL_B8S6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:188; ADAM10; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996787 CVCL_B8RX Abcam HCT 116 YTHDF2 KO cancer cell line human CVCL_B8RX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31675; YTHDF2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996788 CVCL_B8S9 Abcam MCF-7 AKT1 KO cancer cell line human CVCL_B8S9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:391; AKT1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996789 CVCL_B8RW Abcam HCT 116 XPC KO cancer cell line human CVCL_B8RW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12816; XPC; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996790 CVCL_B8S8 Abcam MCF-7 AGO2 KO cancer cell line human CVCL_B8S8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3263; AGO2; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996791 CVCL_B8RJ Abcam HCT 116 USP22 KO cancer cell line human CVCL_B8RJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12621; USP22; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996792 CVCL_B8RI Abcam HCT 116 UHRF1 KO cancer cell line human CVCL_B8RI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12556; UHRF1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996793 CVCL_B8RL Abcam HCT 116 VDR KO cancer cell line human CVCL_B8RL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12679; VDR; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996794 CVCL_B8RK Abcam HCT 116 USP8 KO cancer cell line human CVCL_B8RK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12631; USP8; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996795 CVCL_B8RN Abcam HCT 116 VEGFC KO cancer cell line human CVCL_B8RN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12682; VEGFC; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996796 CVCL_B8RM Abcam HCT 116 VEGFA KO cancer cell line human CVCL_B8RM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12680; VEGFA; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996797 CVCL_B8RP Abcam HCT 116 VIM KO cancer cell line human CVCL_B8RP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12692; VIM; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996798 CVCL_B8S1 Abcam MCF-7 ABCC1 KO cancer cell line human CVCL_B8S1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:51; ABCC1; Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line) Population: Caucasian; Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. Female 152996799 CVCL_B8S0 Abcam HCT 116 ZEB1 KO cancer cell line human CVCL_B8S0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11642; ZEB1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996800 CVCL_B8RB Abcam HCT 116 TRAF1 KO cancer cell line human CVCL_B8RB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12031; TRAF1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996801 CVCL_B8RA Abcam HCT 116 TP63 KO cancer cell line human CVCL_B8RA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15979; TP63; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996802 CVCL_B8RD Abcam HCT 116 TRIM28 KO cancer cell line human CVCL_B8RD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16384; TRIM28; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996803 CVCL_B8RC Abcam HCT 116 TRIM24 KO cancer cell line human CVCL_B8RC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11812; TRIM24; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996804 CVCL_B8RF Abcam HCT 116 TSC1 KO cancer cell line human CVCL_B8RF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12362; TSC1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996805 CVCL_B8RE Abcam HCT 116 TRIM33 KO cancer cell line human CVCL_B8RE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16290; TRIM33; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996806 CVCL_B8RH Abcam HCT 116 UBB KO cancer cell line human CVCL_B8RH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12463; UBB; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996807 CVCL_B8RG Abcam HCT 116 TSC2 KO cancer cell line human CVCL_B8RG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12363; TSC2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996808 CVCL_B8QY Abcam HCT 116 TLR3 KO cancer cell line human CVCL_B8QY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11849; TLR3; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996809 CVCL_B8QX Abcam HCT 116 TLR2 KO cancer cell line human CVCL_B8QX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11848; TLR2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996810 CVCL_B8R9 Abcam HCT 116 TP53BP1 KO cancer cell line human CVCL_B8R9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11999; TP53BP1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996811 CVCL_B8QZ Abcam HCT 116 TLR4 KO cancer cell line human CVCL_B8QZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11850; TLR4; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996812 CVCL_B7YZ Abcam Raji PTGES2 KO cancer cell line human CVCL_B7YZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17822; PTGES2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996813 CVCL_B7YY Abcam Raji PTGER4 KO cancer cell line human CVCL_B7YY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9596; PTGER4; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996814 CVCL_B7ZA Abcam Raji SDC4 KO cancer cell line human CVCL_B7ZA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10661; SDC4; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996815 CVCL_B7YR Abcam Raji PIK3CD KO cancer cell line human CVCL_B7YR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8977; PIK3CD; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996816 CVCL_B7Z3 Abcam Raji PUS1 KO cancer cell line human CVCL_B7Z3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15508; PUS1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996817 CVCL_B7YQ Abcam Raji PIK3CA KO cancer cell line human CVCL_B7YQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8975; PIK3CA; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996818 CVCL_B7Z2 Abcam Raji PTPN12 KO cancer cell line human CVCL_B7Z2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9645; PTPN12; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996819 CVCL_B7YT Abcam Raji PLA2G4A KO cancer cell line human CVCL_B7YT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9035; PLA2G4A; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996820 CVCL_B7Z5 Abcam Raji RING1 KO cancer cell line human CVCL_B7Z5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10018; RING1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996821 CVCL_B7YS Abcam Raji PIK3R4 KO cancer cell line human CVCL_B7YS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8982; PIK3R4; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996822 CVCL_B7Z4 Abcam Raji RAC2 KO cancer cell line human CVCL_B7Z4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9802; RAC2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996823 CVCL_B7YV Abcam Raji PLCG1 KO cancer cell line human CVCL_B7YV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9065; PLCG1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996824 CVCL_B7Z7 Abcam Raji ROR2 KO cancer cell line human CVCL_B7Z7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10257; ROR2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996825 CVCL_B7YU Abcam Raji PLCB3 KO cancer cell line human CVCL_B7YU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9056; PLCB3; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996826 CVCL_B7Z6 Abcam Raji ROCK2 KO cancer cell line human CVCL_B7Z6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10252; ROCK2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996827 CVCL_B7YX Abcam Raji PSEN1 KO cancer cell line human CVCL_B7YX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9508; PSEN1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996828 CVCL_B7Z9 Abcam Raji SCARB1 KO cancer cell line human CVCL_B7Z9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1664; SCARB1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996829 CVCL_B7YW Abcam Raji PRMT7 KO cancer cell line human CVCL_B7YW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25557; PRMT7; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996830 CVCL_B7Z8 Abcam Raji RYBP KO cancer cell line human CVCL_B7Z8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10480; RYBP; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996831 CVCL_B7YJ Abcam Raji NOTCH3 KO cancer cell line human CVCL_B7YJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7883; NOTCH3; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996832 CVCL_B7YI Abcam Raji NLRC4 KO cancer cell line human CVCL_B7YI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16412; NLRC4; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996833 CVCL_B7YL Abcam Raji NR1H4 KO cancer cell line human CVCL_B7YL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7967; NR1H4; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996834 CVCL_B7YK Abcam Raji NOTCH4 KO cancer cell line human CVCL_B7YK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7884; NOTCH4; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996835 CVCL_B7YN Abcam Raji PDCD1LG2 KO cancer cell line human CVCL_B7YN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18731; PDCD1LG2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996836 CVCL_B7YM Abcam Raji NR3C2 KO cancer cell line human CVCL_B7YM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7979; NR3C2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996837 CVCL_B7YP Abcam Raji PHF8 KO cancer cell line human CVCL_B7YP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20672; PHF8; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996838 CVCL_B7Z1 Abcam Raji PTP4A3 KO cancer cell line human CVCL_B7Z1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9636; PTP4A3; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996839 CVCL_B7Z0 Abcam Raji PTK2 KO cancer cell line human CVCL_B7Z0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9611; PTK2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996840 CVCL_B7YB Abcam Raji MMP8 KO cancer cell line human CVCL_B7YB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7175; MMP8; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996841 CVCL_B7YA Abcam Raji MMP13 KO cancer cell line human CVCL_B7YA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7159; MMP13; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996842 CVCL_B7YD Abcam Raji MTA3 KO cancer cell line human CVCL_B7YD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23784; MTA3; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996843 CVCL_B7YC Abcam Raji MS4A1 KO cancer cell line human CVCL_B7YC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7315; MS4A1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996844 CVCL_B7YF Abcam Raji NCR3LG1 KO cancer cell line human CVCL_B7YF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:42400; NCR3LG1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996845 CVCL_B7YE Abcam Raji NBR1 KO cancer cell line human CVCL_B7YE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6746; NBR1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996846 CVCL_B7YH Abcam Raji NFKB1 KO cancer cell line human CVCL_B7YH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7794; NFKB1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996847 CVCL_B7YG Abcam Raji NFATC2 KO cancer cell line human CVCL_B7YG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7776; NFATC2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996848 CVCL_B7ZZ Abcam Raji TNFRSF10B KO cancer cell line human CVCL_B7ZZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11905; TNFRSF10B; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996849 CVCL_B7ZS Abcam Raji TAPBP KO cancer cell line human CVCL_B7ZS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11566; TAPBP; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996850 CVCL_B7ZR Abcam Raji SUZ12 KO cancer cell line human CVCL_B7ZR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17101; SUZ12; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996851 CVCL_B7ZU Abcam Raji TBP KO cancer cell line human CVCL_B7ZU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11588; TBP; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996852 CVCL_B7ZT Abcam Raji TBK1 KO cancer cell line human CVCL_B7ZT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11584; TBK1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996853 CVCL_B7ZW Abcam Raji TFDP1 KO cancer cell line human CVCL_B7ZW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11749; TFDP1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996854 CVCL_B7ZV Abcam Raji TCF7L2 KO cancer cell line human CVCL_B7ZV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11641; TCF7L2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996855 CVCL_B7ZY Abcam Raji TLN1 KO cancer cell line human CVCL_B7ZY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11845; TLN1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996856 CVCL_B7ZX Abcam Raji TIMP3 KO cancer cell line human CVCL_B7ZX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11822; TIMP3; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996857 CVCL_B7ZK Abcam Raji SRF KO cancer cell line human CVCL_B7ZK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11291; SRF; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996858 CVCL_B7ZJ Abcam Raji SOCS3 KO cancer cell line human CVCL_B7ZJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19391; SOCS3; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996859 CVCL_B7ZM Abcam Raji STAT4 KO cancer cell line human CVCL_B7ZM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11365; STAT4; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996860 CVCL_B7ZL Abcam Raji SRPK1 KO cancer cell line human CVCL_B7ZL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11305; SRPK1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996861 CVCL_B7ZN Abcam Raji STAT5A KO cancer cell line human CVCL_B7ZN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11366; STAT5A; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996862 CVCL_B7ZQ Abcam Raji SUV39H1 KO cancer cell line human CVCL_B7ZQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11479; SUV39H1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996863 CVCL_B7ZP Abcam Raji STK4 KO cancer cell line human CVCL_B7ZP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11408; STK4; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996864 CVCL_B7ZC Abcam Raji SLFN11 KO cancer cell line human CVCL_B7ZC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26633; SLFN11; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996865 CVCL_B7ZB Abcam Raji SETD2 KO cancer cell line human CVCL_B7ZB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18420; SETD2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996866 CVCL_B7ZE Abcam Raji SMARCC2 KO cancer cell line human CVCL_B7ZE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11105; SMARCC2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996867 CVCL_B7ZD Abcam Raji SMARCAL1 KO cancer cell line human CVCL_B7ZD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11102; SMARCAL1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996868 CVCL_B7ZG Abcam Raji SMURF1 KO cancer cell line human CVCL_B7ZG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16807; SMURF1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996869 CVCL_B7ZF Abcam Raji SMARCE1 KO cancer cell line human CVCL_B7ZF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11109; SMARCE1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996870 CVCL_B7ZI Abcam Raji SMYD3 KO cancer cell line human CVCL_B7ZI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15513; SMYD3; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996871 CVCL_B7ZH Abcam Raji SMYD2 KO cancer cell line human CVCL_B7ZH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20982; SMYD2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996872 CVCL_B7WX Abcam Raji CUL4B KO cancer cell line human CVCL_B7WX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2555; CUL4B; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996873 CVCL_B7X9 Abcam Raji FABP4 KO cancer cell line human CVCL_B7X9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3559; FABP4; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996874 CVCL_B7WW Abcam Raji CUL3 KO cancer cell line human CVCL_B7WW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2553; CUL3; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996875 CVCL_B7X8 Abcam Raji EXO1 KO cancer cell line human CVCL_B7X8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3511; EXO1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996876 CVCL_B7WZ Abcam Raji DCP2 KO cancer cell line human CVCL_B7WZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24452; DCP2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996877 CVCL_B7WY Abcam Raji CXXC1 KO cancer cell line human CVCL_B7WY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24343; CXXC1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996878 CVCL_B7WP Abcam Raji CLU KO cancer cell line human CVCL_B7WP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2095; CLU; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996879 CVCL_B7X1 Abcam Raji DVL3 KO cancer cell line human CVCL_B7X1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3087; DVL3; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996880 CVCL_B7X0 Abcam Raji DLL1 KO cancer cell line human CVCL_B7X0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2908; DLL1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996881 CVCL_B7WR Abcam Raji CMTM6 KO cancer cell line human CVCL_B7WR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19177; CMTM6; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996882 CVCL_B7X3 Abcam Raji EHMT2 KO cancer cell line human CVCL_B7X3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14129; EHMT2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996883 CVCL_B7WQ Abcam Raji CMKLR1 KO cancer cell line human CVCL_B7WQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2121; CMKLR1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996884 CVCL_B7X2 Abcam Raji EGLN1 KO cancer cell line human CVCL_B7X2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1232; EGLN1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996885 CVCL_B7WT Abcam Raji CST3 KO cancer cell line human CVCL_B7WT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2475; CST3; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996886 CVCL_B7X5 Abcam Raji EPHB4 KO cancer cell line human CVCL_B7X5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3395; EPHB4; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996887 CVCL_B7WS Abcam Raji CNR2 KO cancer cell line human CVCL_B7WS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2160; CNR2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996888 CVCL_B7X4 Abcam Raji EIF2AK4 KO cancer cell line human CVCL_B7X4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19687; EIF2AK4; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996889 CVCL_B7WV Abcam Raji CUL2 KO cancer cell line human CVCL_B7WV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2552; CUL2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996890 CVCL_B7X7 Abcam Raji ETS2 KO cancer cell line human CVCL_B7X7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3489; ETS2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996891 CVCL_B7WU Abcam Raji CTSB KO cancer cell line human CVCL_B7WU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2527; CTSB; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996892 CVCL_B7X6 Abcam Raji ERAP1 KO cancer cell line human CVCL_B7X6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18173; ERAP1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996893 CVCL_B7WH Abcam Raji CD36 KO cancer cell line human CVCL_B7WH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1663; CD36; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996894 CVCL_B7WG Abcam Raji CCL22 KO cancer cell line human CVCL_B7WG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10621; CCL22; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996895 CVCL_B7WJ Abcam Raji CD58 KO cancer cell line human CVCL_B7WJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1688; CD58; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996896 CVCL_B7WI Abcam Raji CD48 KO cancer cell line human CVCL_B7WI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1683; CD48; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996897 CVCL_B7WL Abcam Raji CD81 KO cancer cell line human CVCL_B7WL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1701; CD81; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996898 CVCL_B7WK Abcam Raji CD59 KO cancer cell line human CVCL_B7WK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1689; CD59; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996899 CVCL_B7WN Abcam Raji CITED2 KO cancer cell line human CVCL_B7WN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1987; CITED2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996900 CVCL_B7WM Abcam Raji CD83 KO cancer cell line human CVCL_B7WM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1703; CD83; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996901 CVCL_B7WB Abcam Raji BTK KO cancer cell line human CVCL_B7WB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1133; BTK; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996902 CVCL_B7WA Abcam Raji BTG1 KO cancer cell line human CVCL_B7WA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1130; BTG1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996903 CVCL_B7WD Abcam Raji C3 KO cancer cell line human CVCL_B7WD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1318; C3; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996904 CVCL_B7WC Abcam Raji BTRC KO cancer cell line human CVCL_B7WC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1144; BTRC; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996905 CVCL_B7WF Abcam Raji CCRL2 KO cancer cell line human CVCL_B7WF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1612; CCRL2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996906 CVCL_B7WE Abcam Raji CASP3 KO cancer cell line human CVCL_B7WE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1504; CASP3; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996907 CVCL_B7XY Abcam Raji LAMP2 KO cancer cell line human CVCL_B7XY CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6501; LAMP2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996908 CVCL_B7XX Abcam Raji LAIR1 KO cancer cell line human CVCL_B7XX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6477; LAIR1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996909 CVCL_B7Y9 Abcam Raji MME KO cancer cell line human CVCL_B7Y9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7154; MME; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996910 CVCL_B7XZ Abcam Raji LDHA KO cancer cell line human CVCL_B7XZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6535; LDHA; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996911 CVCL_B7XQ Abcam Raji ITPR3 KO cancer cell line human CVCL_B7XQ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6182; ITPR3; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996912 CVCL_B7Y2 Abcam Raji MACROH2A1 KO cancer cell line human CVCL_B7Y2 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4740; MACROH2A1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996913 CVCL_B7XP Abcam Raji IL17RB KO cancer cell line human CVCL_B7XP CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18015; IL17RB; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996914 CVCL_B7Y1 Abcam Raji LMNB1 KO cancer cell line human CVCL_B7Y1 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6637; LMNB1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996915 CVCL_B7XS Abcam Raji JMJD6 KO cancer cell line human CVCL_B7XS CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19355; JMJD6; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996916 CVCL_B7Y4 Abcam Raji MAP2K3 KO cancer cell line human CVCL_B7Y4 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6843; MAP2K3; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996917 CVCL_B7XR Abcam Raji JAG1 KO cancer cell line human CVCL_B7XR CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6188; JAG1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996918 CVCL_B7Y3 Abcam Raji MAGEA3 KO cancer cell line human CVCL_B7Y3 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6801; MAGEA3; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996919 CVCL_B7XU Abcam Raji KDM1B KO cancer cell line human CVCL_B7XU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21577; KDM1B; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996920 CVCL_B7Y6 Abcam Raji MAPK7 KO cancer cell line human CVCL_B7Y6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6880; MAPK7; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996921 CVCL_B7XT Abcam Raji KAT7 KO cancer cell line human CVCL_B7XT CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17016; KAT7; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996922 CVCL_B7Y5 Abcam Raji MAP3K3 KO cancer cell line human CVCL_B7Y5 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6855; MAP3K3; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996923 CVCL_B7XW Abcam Raji KPNA2 KO cancer cell line human CVCL_B7XW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6395; KPNA2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996924 CVCL_B7Y8 Abcam Raji MBD3 KO cancer cell line human CVCL_B7Y8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6918; MBD3; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996925 CVCL_B7XV Abcam Raji KDM6B KO cancer cell line human CVCL_B7XV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29012; KDM6B; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996926 CVCL_B7Y7 Abcam Raji MBD1 KO cancer cell line human CVCL_B7Y7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6916; MBD1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996927 CVCL_B7XI Abcam Raji GPR132 KO cancer cell line human CVCL_B7XI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17482; GPR132; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996928 CVCL_B7XH Abcam Raji GLB1 KO cancer cell line human CVCL_B7XH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4298; GLB1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996929 CVCL_B7XK Abcam Raji HLA-B KO cancer cell line human CVCL_B7XK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4932; HLA-B; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996930 CVCL_B7XJ Abcam Raji GZMA KO cancer cell line human CVCL_B7XJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4708; GZMA; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996931 CVCL_B7XM Abcam Raji HSPG2 KO cancer cell line human CVCL_B7XM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5273; HSPG2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996932 CVCL_B7XL Abcam Raji HNF1B KO cancer cell line human CVCL_B7XL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11630; HNF1B; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996933 CVCL_B7Y0 Abcam Raji LGR6 KO cancer cell line human CVCL_B7Y0 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19719; LGR6; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996934 CVCL_B7XN Abcam Raji ID2 KO cancer cell line human CVCL_B7XN CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5361; ID2; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996935 CVCL_B7XA Abcam Raji FKBP5 KO cancer cell line human CVCL_B7XA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3721; FKBP5; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996936 CVCL_B7XC Abcam Raji FOXO3 KO cancer cell line human CVCL_B7XC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3821; FOXO3; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996937 CVCL_B7XB Abcam Raji FOXO1 KO cancer cell line human CVCL_B7XB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3819; FOXO1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996938 CVCL_B7XE Abcam Raji FTL KO cancer cell line human CVCL_B7XE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3999; FTL; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996939 CVCL_B7XD Abcam Raji FST KO cancer cell line human CVCL_B7XD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3971; FST; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996940 CVCL_B7XG Abcam Raji GAB1 KO cancer cell line human CVCL_B7XG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4066; GAB1; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996941 CVCL_B7XF Abcam Raji FZD7 KO cancer cell line human CVCL_B7XF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4045; FZD7; Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line) Population: African; Nigerian; Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV); Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397; Cell type: B-cell; CL=CL_0000236. Male 152996942 CVCL_B8GG Abcam HCT 116 FOXM1 KO cancer cell line human CVCL_B8GG CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3818; FOXM1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996943 CVCL_B8GF Abcam HCT 116 FOXG1 KO cancer cell line human CVCL_B8GF CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3811; FOXG1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996944 CVCL_B8GI Abcam HCT 116 FOXP1 KO cancer cell line human CVCL_B8GI CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3823; FOXP1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996945 CVCL_B8GH Abcam HCT 116 FOXO4 KO cancer cell line human CVCL_B8GH CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7139; FOXO4; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996946 CVCL_B8GK Abcam HCT 116 FLT3LG KO cancer cell line human CVCL_B8GK CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3766; FLT3LG; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996947 CVCL_B8GJ Abcam HCT 116 FOXP3 KO cancer cell line human CVCL_B8GJ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6106; FOXP3; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996948 CVCL_B8GM Abcam HCT 116 GABRG2 KO cancer cell line human CVCL_B8GM CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4087; GABRG2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996949 CVCL_B8GL Abcam HCT 116 GABRA1 KO cancer cell line human CVCL_B8GL CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4075; GABRA1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996950 CVCL_B8GA Abcam HCT 116 FOSL1 KO cancer cell line human CVCL_B8GA CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13718; FOSL1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996951 CVCL_B8GC Abcam HCT 116 FOXA2 KO cancer cell line human CVCL_B8GC CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5022; FOXA2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996952 CVCL_B8GB Abcam HCT 116 FOXA1 KO cancer cell line human CVCL_B8GB CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5021; FOXA1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996953 CVCL_B8GE Abcam HCT 116 FOXC2 KO cancer cell line human CVCL_B8GE CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3801; FOXC2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996954 CVCL_B8GD Abcam HCT 116 FOXC1 KO cancer cell line human CVCL_B8GD CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3800; FOXC1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996955 CVCL_B8FV Abcam HCT 116 FCER2 KO cancer cell line human CVCL_B8FV CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3612; FCER2; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996956 CVCL_B8G7 Abcam HCT 116 FOLH1 KO cancer cell line human CVCL_B8G7 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3788; FOLH1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996957 CVCL_B8FU Abcam HCT 116 FBXO38 KO cancer cell line human CVCL_B8FU CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28844; FBXO38; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996958 CVCL_B8G6 Abcam HCT 116 FN1 KO cancer cell line human CVCL_B8G6 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3778; FN1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996959 CVCL_B8FX Abcam HCT 116 FCGR2B KO cancer cell line human CVCL_B8FX CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3618; FCGR2B; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996960 CVCL_B8G9 Abcam HCT 116 FOS KO cancer cell line human CVCL_B8G9 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3796; FOS; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996961 CVCL_B8FW Abcam HCT 116 FCGR2A KO cancer cell line human CVCL_B8FW CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3616; FCGR2A; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996962 CVCL_B8G8 Abcam HCT 116 FOLR1 KO cancer cell line human CVCL_B8G8 CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3791; FOLR1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996963 CVCL_B8FZ Abcam HCT 116 FEN1 KO cancer cell line human CVCL_B8FZ CL:0000010 Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3650; FEN1; Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line); Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line) Population: Caucasian; Derived from site: In situ; Colon; UBERON=UBERON_0001155. Male 152996964 CVCL_B8FY Abcam HCT 116 FCGR3A KO cancer cell line human CVCL_B8FY CL:0000010 Knockout cell: Met